PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Heinzelman, P; Snow, CD; Smith, MA; Yu, XL; Kannan, A; Boulware, K; Villalobos, A; Govindarajan, S; Minshull, J; Arnold, FH				Heinzelman, Pete; Snow, Christopher D.; Smith, Matthew A.; Yu, Xinlin; Kannan, Arvind; Boulware, Kevin; Villalobos, Alan; Govindarajan, Sridhar; Minshull, Jeremy; Arnold, Frances H.			SCHEMA Recombination of a Fungal Cellulase Uncovers a Single Mutation That Contributes Markedly to Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE-GUIDED RECOMBINATION; FAMILY; PROTEINS; SITE	A quantitative linear model accurately (R-2 = 0.88) describes the thermostabilities of 54 characterized members of a family of fungal cellobiohydrolase class II (CBH II) cellulase chimeras made by SCHEMA recombination of three fungal enzymes, demonstrating that the contributions of SCHEMA sequence blocks to stability are predominantly additive. Thirty-one of 31 predicted thermostable CBH II chimeras have thermal inactivation temperatures higher than the most thermostable parent CBH II, from Humicola insolens, and the model predicts that hundreds more CBH II chimeras share this superior thermostability. Eight of eight thermostable chimeras assayed hydrolyze the solid cellulosic substrate Avicel at temperatures at least 5 degrees C above the most stable parent, and seven of these showed superior activity in 16-h Avicel hydrolysis assays. The sequence-stability model identified a single block of sequence that adds 8.5 degrees C to chimera thermostability. Mutating individual residues in this block identified the C313S substitution as responsible for the entire thermostabilizing effect. Introducing this mutation into the two recombination parent CBH IIs not featuring it (Hypocrea jecorina and H. insolens) decreased inactivation, increased maximum Avicel hydrolysis temperature, and improved long time hydrolysis performance. This mutation also stabilized and improved Avicel hydrolysis by Phanerochaete chrysosporium CBH II, which is only 55-56% identical to recombination parent CBH IIs. Furthermore, the C313S mutation increased total H. jecorina CBH II activity secreted by the Saccharomyces cerevisiae expression host more than 10-fold. Our results show that SCHEMA structure-guided recombination enables quantitative prediction of cellulase chimera thermostability and efficient identification of stabilizing mutations.	[Heinzelman, Pete; Snow, Christopher D.; Smith, Matthew A.; Yu, Xinlin; Kannan, Arvind; Boulware, Kevin; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Villalobos, Alan; Govindarajan, Sridhar; Minshull, Jeremy] DNA2 0 Inc, Menlo Pk, CA 94025 USA	California Institute of Technology	Arnold, FH (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 210-41, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu	Snow, Christopher/L-5624-2013	Snow, Christopher/0000-0002-7690-3519; Arnold, Frances H./0000-0002-4027-364X	Army-Industry Institute for Collaborative Biotechnologies; Caltech Innovation Institute	Army-Industry Institute for Collaborative Biotechnologies; Caltech Innovation Institute	This work was supported by grants from the Army-Industry Institute for Collaborative Biotechnologies and the Caltech Innovation Institute.	Endelman JB, 2004, PROTEIN ENG DES SEL, V17, P589, DOI 10.1093/protein/gzh067; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Koivula A, 1996, PROTEIN ENG, V9, P691, DOI 10.1093/protein/9.8.691; Li YG, 2007, NAT BIOTECHNOL, V25, P1051, DOI 10.1038/nbt1333; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Loksha IV, 2009, J COMPUT CHEM, V30, P999, DOI 10.1002/jcc.21204; Otey CR, 2006, PLOS BIOL, V4, P789, DOI 10.1371/journal.pbio.0040112; PERRY LJ, 1987, PROTEIN ENG, V1, P101, DOI 10.1093/protein/1.2.101; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Varrot A, 2003, CHEM COMMUN, P946, DOI 10.1039/b301592k; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401	14	94	105	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26229	26233		10.1074/jbc.C109.034058	http://dx.doi.org/10.1074/jbc.C109.034058			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19625252	hybrid, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000269969600002
J	Matthews, RG				Matthews, Rowena G.			A Love Affair with Vitamins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DEPENDENT METHIONINE SYNTHASE; HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE; COBALAMIN-BINDING DOMAIN; OLD YELLOW ENZYME; ESCHERICHIA-COLI; X-RAY; LIPOAMIDE DEHYDROGENASE; S-ADENOSYLMETHIONINE; RISK-FACTOR; PIG HEART		[Matthews, Rowena G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Matthews, Rowena G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Matthews, RG (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	rmatthew@umich.edu						Bandarian V, 2002, NAT STRUCT BIOL, V9, P53; Bandarian V, 2003, P NATL ACAD SCI USA, V100, P8156, DOI 10.1073/pnas.1133218100; BANERJEE RV, 1989, J BIOL CHEM, V264, P13888; BROWN KL, 1988, INORG CHEM, V27, P3548, DOI 10.1021/ic00293a023; Datta S, 2008, P NATL ACAD SCI USA, V105, P4115, DOI 10.1073/pnas.0800329105; DAUBNER SC, 1982, J BIOL CHEM, V257, P140; Dixon MM, 1996, STRUCTURE, V4, P1263, DOI 10.1016/S0969-2126(96)00135-9; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; Fleischhacker AS, 2007, BIOCHEMISTRY-US, V46, P12382, DOI 10.1021/bi701367c; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; FUJII K, 1974, J BIOL CHEM, V249, P6745; Goulding CW, 1997, BIOCHEMISTRY-US, V36, P8082, DOI 10.1021/bi9705164; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Hagemeier CH, 2006, P NATL ACAD SCI USA, V103, P18917, DOI 10.1073/pnas.0603650103; Hoover DM, 1997, BIOCHEMISTRY-US, V36, P127, DOI 10.1021/bi961693s; Jarrett JT, 1996, BIOCHEMISTRY-US, V35, P2464, DOI 10.1021/bi952389m; JOHNSON LN, 1993, ANNU REV BIOPH BIOM, V22, P199, DOI 10.1146/annurev.bb.22.060193.001215; KANG SS, 1991, AM J HUM GENET, V48, P536; Kornberg A, 2000, J BACTERIOL, V182, P3613, DOI 10.1128/JB.182.13.3613-3618.2000; KOUTMOS M, 2009, P NATL ACAD IN PRESS; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; LUSCHINSKY CL, 1992, J MOL BIOL, V225, P557, DOI 10.1016/0022-2836(92)90940-L; MANGUM JH, 1962, FED PROC, V21, P242; MARSH ENG, 1992, FEBS LETT, V310, P167, DOI 10.1016/0014-5793(92)81321-C; MATTHEWS RG, 1976, J BIOL CHEM, V251, P3956; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; MATTHEWS RG, 1969, J BIOL CHEM, V244, P1779; MATTHEWS RG, 1977, J BIOL CHEM, V252, P3199; MATTHEWS RG, 1975, J BIOL CHEM, V250, P9294; MATTHEWS RG, 2009, METAL IONS LIFE SCI; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; ROSSI M, 1985, J AM CHEM SOC, V107, P1729, DOI 10.1021/ja00292a046; Sheppard CA, 1999, J BACTERIOL, V181, P718, DOI 10.1128/JB.181.3.718-725.1999; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Weissbach H, 2008, J BIOL CHEM, V283, P23497, DOI 10.1074/jbc.X800006200; Wolthers KR, 2009, FEBS J, V276, P1942, DOI 10.1111/j.1742-4658.2009.06919.x; Yamada K, 2005, P NATL ACAD SCI USA, V102, P10454, DOI 10.1073/pnas.0504786102; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998	40	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26217	26228		10.1074/jbc.X109.041178	http://dx.doi.org/10.1074/jbc.X109.041178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19596855	Green Published, hybrid			2022-12-27	WOS:000269969600001
J	Herlax, V; Mate, S; Rimoldi, O; Bakas, L				Herlax, Vanesa; Mate, Sabina; Rimoldi, Omar; Bakas, Laura			Relevance of Fatty Acid Covalently Bound to Escherichia coli alpha-Hemolysin and Membrane Microdomains in the Oligomerization Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; LIPID RAFTS; PORE FORMATION; TOXIN; MECHANISM; BINDING; HLYA; PALMITOYLATION; ERYTHROCYTES; PURIFICATION	alpha-Hemolysin (HlyA) is an exotoxin secreted by some pathogenic strains of Escherichia coli that causes lysis of several mammalian cells, including erythrocytes of different species. HlyA is synthesized as a protoxin, pro-HlyA, which is activated by acylation at two internal lysines Lys-563 and Lys-689. It has been proposed that pore formation is the mechanism of cytolytic activity for this toxin, as shown in experiments with whole cells, planar lipid membranes, and liposomes, but these experiments have yielded conflicting results about the structure of the pore. In this study, HlyA cysteine replacement mutant proteins of amino acids have been labeled with Alexa-488 and Alexa-546. Fluorescence resonance energy transfer measurements, employing labeled toxin bound to sheep ghost erythrocytes, have demonstrated that HlyA oligomerizes on erythrocyte membranes. As the cytotoxic activity is absolutely dependent on acylation, we have studied the role of acylation in the oligomerization, demonstrating that fatty acids are essential in this process. On the other hand, fluorescence resonance energy transfer and the hemolytic activity decrease when the erythrocyte ghosts are cholesterol-depleted, hence indicating the role of membrane microdomains in the clustering of HlyA. Simultaneously, HlyA was found in detergent-resistant membranes. Pro-HlyA has also been found in detergent-resistant membranes, thus demonstrating that the importance of acyl chains in toxin oligomerization is the promotion of protein-protein interaction. These results change the concept of the main role assigned to acyl chain in the targeting of proteins to membrane microdomains.	[Herlax, Vanesa; Mate, Sabina; Rimoldi, Omar; Bakas, Laura] Univ Nacl La Plata, Inst Invest Bioquim La Plata, CCT La Plata, Consejo Nacl Invest Cient & Tecn, RA-1900 La Plata, Argentina; [Bakas, Laura] Univ Nacl La Plata, Dept Ciencias Biol, Fac Ciencias Exactas, RA-1900 La Plata, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata	Herlax, V (corresponding author), Univ Nacl La Plata, Inst Invest Bioquim La Plata, CCT La Plata, Consejo Nacl Invest Cient & Tecn, 60 & 120, RA-1900 La Plata, Argentina.	vherlax@atlas.med.unlp.edu.ar	Mate, Sabina/AAO-7301-2021	Herlax, Vanesa/0000-0003-4218-8702	Comision de Investigaciones Cientificas de la Provincia de Buenos Aires; Agencia Nacional de Promocion Cientifica, Argentina [BID 1728/OC-AR 26228, PIP CONICET 5742]	Comision de Investigaciones Cientificas de la Provincia de Buenos Aires; Agencia Nacional de Promocion Cientifica, Argentina(ANPCyT)	This work was supported by grants from the Comision de Investigaciones Cientificas de la Provincia de Buenos Aires, Agencia Nacional de Promocion Cientifica Grant BID 1728/OC-AR 26228, and PIP CONICET 5742, Argentina.	Bakas L, 2006, BIOPHYS J, V91, P3748, DOI 10.1529/biophysj.106.090019; BENZ R, 1992, FEMS MICROBIOL IMMUN, V105, P55; BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BOEHM DF, 1990, INFECT IMMUN, V58, P1959, DOI 10.1128/IAI.58.6.1959-1964.1990; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Cherukuri A, 2004, J IMMUNOL, V172, P370, DOI 10.4049/jimmunol.172.1.370; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; GADEBERG OV, 1984, INFECT IMMUN, V45, P255, DOI 10.1128/IAI.45.1.255-260.1984; GIRAUD F, 1984, BIOCHIM BIOPHYS ACTA, V778, P191, DOI 10.1016/0005-2736(84)90462-0; GOHLKE C, 1994, P NATL ACAD SCI USA, V91, P11660, DOI 10.1073/pnas.91.24.11660; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; Herlax V, 2003, CHEM PHYS LIPIDS, V122, P185, DOI 10.1016/S0009-3084(02)00191-3; Herlax V, 2007, BIOCHEMISTRY-US, V46, P5177, DOI 10.1021/bi0618013; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Hyland C, 2001, J BACTERIOL, V183, P5364, DOI 10.1128/JB.183.18.5364-5370.2001; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Koumanov KS, 2005, ARCH BIOCHEM BIOPHYS, V434, P150, DOI 10.1016/j.abb.2004.10.025; LACKOWICZ J, 1984, PRINCIPLE FLUORESCEN, P305; LAKOWICZ JR, 1990, BIOPHYS CHEM, V36, P99, DOI 10.1016/0301-4622(90)85014-W; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lim KB, 2000, J BIOL CHEM, V275, P36698, DOI 10.1074/jbc.C000544200; LUDWIG A, 1993, MOL GEN GENET, V241, P89, DOI 10.1007/BF00280205; MENESTRINA G, 1987, BIOCHIM BIOPHYS ACTA, V905, P109, DOI 10.1016/0005-2736(87)90014-9; Moayeri M, 1997, INFECT IMMUN, V65, P2233, DOI 10.1128/IAI.65.6.2233-2239.1997; MOAYERI M, 1994, INFECT IMMUN, V62, P4124, DOI 10.1128/IAI.62.10.4124-4134.1994; PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8720, DOI 10.1021/bi00489a031; Parsons M, 2004, BIOCHEM SOC T, V32, P431, DOI 10.1042/BST0320431; Pellett S, 1996, INFECT IMMUN, V64, P3081, DOI 10.1128/IAI.64.8.3081-3087.1996; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Sanchez-Magraner L, 2006, J BIOL CHEM, V281, P5461, DOI 10.1074/jbc.M512897200; Sharpe JC, 1999, J MEMBRANE BIOL, V171, P209, DOI 10.1007/s002329900572; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Soloaga A, 1998, BIOCHEMISTRY-US, V37, P6387, DOI 10.1021/bi9730994; Soloaga A, 1996, EUR J BIOCHEM, V238, P418, DOI 10.1111/j.1432-1033.1996.0418z.x; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85	45	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25199	25210		10.1074/jbc.M109.009365	http://dx.doi.org/10.1074/jbc.M109.009365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19596862	Green Published, hybrid			2022-12-27	WOS:000269734000054
J	Filhoulaud, G; Guillemain, G; Scharfmann, R				Filhoulaud, Gaelle; Guillemain, Ghislaine; Scharfmann, Raphael			The Hexosamine Biosynthesis Pathway Is Essential for Pancreatic Beta Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAUTERINE GROWTH-RETARDATION; N-ACETYLGLUCOSAMINE; INSULIN-RESISTANCE; EXOCRINE PANCREAS; PROGENITOR CELLS; O-GLYCOSYLATION; KEY ROLE; IN-VIVO; GLUCOSE; DIFFERENTIATION	Pancreatic exocrine and endocrine cells develop during embryonic life from endodermal progenitors. This process depends on activation of a hierarchy of transcription factors. Although information is available regarding the mesodermal signals controlling pancreas development, little is known about the role of environmental factors such as nutrients, including glucose, that also may impact development. Previously, we showed that glucose plays an important and specific role in beta cell development by activating the transition of Neurogenin3-positive endocrine progenitors into beta cells. Here, we examined the implication of glucose metabolism and more precisely the role of the hexosamine biosynthesis pathway (HBP) to understand the mechanisms by which glucose regulates beta cell development. We have established an in vitro model of endocrine and exocrine cells development from embryonic day 13.5 rat pancreases in a manner that replicates in vivo pancreas development perfectly. Using this model, we tested the effect of selective inhibitors and activators of the HBP and found that the HBP has a modest effect on cell proliferation and exocrine cell differentiation. On the other hand, beta cell development is tightly controlled by the HBP. Specifically, HBP activators increase beta cell development, whereas inhibitors repress such development. Importantly, both the HBP and glucose control the same steps in beta cell development.	[Filhoulaud, Gaelle; Guillemain, Ghislaine; Scharfmann, Raphael] Univ Paris 05, Fac Med, Hop Necker, Ctr Rech Croissance & Signalisat,INSERM,U845, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Guillemain, G (corresponding author), Univ Paris 05, Fac Med, Hop Necker, Ctr Rech Croissance & Signalisat,INSERM,U845, 156 Rue Vaugirard, F-75015 Paris, France.	ghislaine.guillemain@inserm.fr	Guillemain, Ghislaine/P-7740-2017; scharfmann, raphael/L-3296-2017	Guillemain, Ghislaine/0000-0002-8256-9545; Scharfmann, Raphael/0000-0001-7619-337X	European Union Framework Program; Association pour la Recherche sur le Diabete; Association Franc; Ministere de l'Education Nationale de la Recherche et de la Technologie	European Union Framework Program(European Commission); Association pour la Recherche sur le Diabete(Fondation ARC pour la Recherche sur le Cancer); Association Franc; Ministere de l'Education Nationale de la Recherche et de la Technologie	This work was supported by the 6th European Union Framework Program (Beta- Cell Therapy Integrated Project), the Association pour la Recherche sur le Diabete, and the Association Franc, aise des Diabetiques. 1 Supported by a Convention Industrielle de Formation par la Recherche grant from Servier and the Ministere de l'Education Nationale de la Recherche et de la Technologie.	Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Attali M, 2007, DIABETES, V56, P1248, DOI 10.2337/db06-1307; Baron AD, 1995, J CLIN INVEST, V96, P2792, DOI 10.1172/JCI118349; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Breant B, 2006, HORM RES, V65, P98, DOI 10.1159/000091513; CARDENAS ML, 1984, EUR J BIOCHEM, V145, P163, DOI 10.1111/j.1432-1033.1984.tb08536.x; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Duvillie B, 2006, DIABETES, V55, P582, DOI 10.2337/diabetes.55.03.06.db05-0839; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Garofano A, 1998, DIABETOLOGIA, V41, P1114, DOI 10.1007/s001250051038; Garofano A, 1997, DIABETOLOGIA, V40, P1231, DOI 10.1007/s001250050812; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guillemain G, 2007, J BIOL CHEM, V282, P15228, DOI 10.1074/jbc.M610986200; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Haumaitre C, 2008, MOL CELL BIOL, V28, P6373, DOI 10.1128/MCB.00413-08; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Holemans K, 2003, J PHYSIOL-LONDON, V547, P11, DOI 10.1113/jphysiol.2002.036582; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Hurtado-Guerrero R, 2008, CURR OPIN STRUC BIOL, V18, P551, DOI 10.1016/j.sbi.2008.09.005; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lemercier C, 1997, DEV BIOL, V182, P101, DOI 10.1006/dbio.1996.8454; Limesand SW, 2005, AM J PHYSIOL-REG I, V288, pR1297, DOI 10.1152/ajpregu.00494.2004; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Miralles F, 1998, DEVELOPMENT, V125, P1017; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Moreno TA, 2005, DEV BIOL, V288, P434, DOI 10.1016/j.ydbio.2005.09.050; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; PICTET RL, 1972, DEV BIOL, V29, P436, DOI 10.1016/0012-1606(72)90083-8; Remacle C, 2007, DIABETES OBES METAB, V9, P196, DOI 10.1111/j.1463-1326.2007.00790.x; Scharfmann R, 2000, DIABETOLOGIA, V43, P1083, DOI 10.1007/s001250051498; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; WESSELLS NK, 1966, EXP CELL RES, V43, P680, DOI 10.1016/0014-4827(66)90044-9	62	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24583	24594		10.1074/jbc.M109.025288	http://dx.doi.org/10.1074/jbc.M109.025288			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586915	Green Published, hybrid			2022-12-27	WOS:000269380200068
J	Sapparapu, G; Planque, SA; Nishiyama, Y; Foung, SK; Paul, S				Sapparapu, Gopal; Planque, Stephanie A.; Nishiyama, Yasuhiro; Foung, Steven K.; Paul, Sudhir			Antigen-specific Proteolysis by Hybrid Antibodies Containing Promiscuous Proteolytic Light Chains Paired with an Antigen-binding Heavy Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C-VIRUS; VASOACTIVE-INTESTINAL-PEPTIDE; NATURAL CATALYTIC ANTIBODIES; E2 ENVELOPE GLYCOPROTEIN; MYELIN BASIC-PROTEIN; BENCE-JONES PROTEINS; MAMMALIAN-CELLS; CONFORMATIONAL EPITOPES; HELICOBACTER-PYLORI; PHAGE DISPLAY	The antigen recognition site of antibodies consists of the heavy and light chain variable domains (V-L and V-H domains). V-L domains catalyze peptide bond hydrolysis independent of VH domains (Mei, S., Mody, B., Eklund, S. H., and Paul, S. (1991) J. Biol. Chem. 266, 15571-15574). VH domains bind antigens noncovalently independent of V-L domains (Ward, E. S., Gussow, D., Griffiths, A. D., Jones, P. T., and Winter, G. (1989) Nature 341, 544-546). We describe specific hydrolysis of fusion proteins of the hepatitis C virus E2 protein with glutathione S-transferase (GST-E2) or FLAG peptide (FLAG-E2) by antibodies containing the VH domain of an anti-E2 IgG paired with promiscuously catalytic VL domains. The hybrid IgG hydrolyzed the E2 fusion proteins more rapidly than the unpaired light chain. An active site-directed inhibitor of serine proteases inhibited the proteolytic activity of the hybrid IgG, indicating a serine protease mechanism. The hybrid IgG displayed noncovalent E2 binding in enzyme-linked immunosorbent assay tests. Immunoblotting studies suggested hydrolysis of FLAG-E2 at a bond within E2 located similar to 11 kDa from the N terminus. GST-E2 was hydrolyzed by the hybrid IgG at bonds in the GST tag. The differing cleavage pattern of FLAG-E2 and GST-E2 can be explained by the split-site model of catalysis, in which conformational differences in the E2 fusion protein substrates position alternate peptide bonds in register with the antibody catalytic subsite despite a common noncovalent binding mechanism. These studies provide proof-of-principle that the catalytic activity of a light chain can be rendered antigen-specific by pairing with a noncovalently binding heavy chain subunit.	[Sapparapu, Gopal; Planque, Stephanie A.; Nishiyama, Yasuhiro; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Foung, Steven K.] Stanford Univ, Dept Pathol, Stanford, CA 94304 USA	University of Texas System; University of Texas Health Science Center Houston; Stanford University	Paul, S (corresponding author), 6431 Fannin,MSB 2-230A, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu		Foung, Steven/0000-0001-7149-6160; Sapparapu, Gopal/0000-0001-9670-1757	National Institutes of Health [R01 HL079381]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL079381.	Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Cocquerel L, 2003, J VIROL, V77, P10677, DOI 10.1128/JVI.77.19.10677-10683.2003; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; DAVIES J, 1995, BIO-TECHNOL, V13, P475, DOI 10.1038/nbt0595-475; Dubuisson J, 1996, J VIROL, V70, P778, DOI 10.1128/JVI.70.2.778-786.1996; EDELMAN GM, 1963, P NATL ACAD SCI USA, V50, P753, DOI 10.1073/pnas.50.4.753; Flint M, 2004, J VIROL, V78, P6875, DOI 10.1128/JVI.78.13.6875-6882.2004; FournillierJacob A, 1996, J GEN VIROL, V77, P1055, DOI 10.1099/0022-1317-77-5-1055; Fracasso PM, 2007, CLIN CANCER RES, V13, P986, DOI 10.1158/1078-0432.CCR-06-1542; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Hayashi N, 2006, J GASTROENTEROL, V41, P17, DOI 10.1007/s00535-005-1740-7; Helle F, 2008, CELL MOL LIFE SCI, V65, P100, DOI 10.1007/s00018-007-7291-8; Hifumi E, 2005, FEBS J, V272, P4497, DOI 10.1111/j.1742-4658.2005.04869.x; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Iacob RE, 2008, J AM SOC MASS SPECTR, V19, P428, DOI 10.1016/j.jasms.2007.11.022; Jia ZS, 2008, J INT MED RES, V36, P1319, DOI 10.1177/147323000803600620; KALAGA R, 1995, J IMMUNOL, V155, P2695; Karle S, 2004, AIDS, V18, P329, DOI 10.1097/00002030-200401230-00026; Karle S, 2003, VACCINE, V21, P1213, DOI 10.1016/S0264-410X(02)00504-2; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Kurien BT, 2003, J IMMUNOL METHODS, V274, P1, DOI 10.1016/S0022-1759(02)00523-9; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Lee KJ, 1997, J BIOL CHEM, V272, P30040, DOI 10.1074/jbc.272.48.30040; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; MATSUURA K, 1994, BIOCHEM BIOPH RES CO, V204, P57, DOI 10.1006/bbrc.1994.2425; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; Mitsuda Y, 2007, MOL BIOTECHNOL, V36, P113, DOI 10.1007/s12033-007-0003-7; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Paul S, 2006, IMMUNOL LETT, V103, P8, DOI 10.1016/j.imlet.2005.10.003; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Paul S, 1996, MOL BIOTECHNOL, V5, P197, DOI 10.1007/BF02900358; PAUL S, 1990, J BIOL CHEM, V265, P11910; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2007, AIDS RES HUM RETROV, V23, P1541, DOI 10.1089/aid.2007.0081; Polosukhina DI, 2004, J CELL MOL MED, V8, P359, DOI 10.1111/j.1582-4934.2004.tb00325.x; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Poumbourios Pantelis, 2007, Antiviral Chemistry & Chemotherapy, V18, P169; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Rangan SK, 2003, BIOCHEMISTRY-US, V42, P14328, DOI 10.1021/bi035038d; RINDISBACHER L, 1995, J BIOL CHEM, V270, P14220, DOI 10.1074/jbc.270.23.14220; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; ROHOLT O, 1964, P NATL ACAD SCI USA, V51, P173, DOI 10.1073/pnas.51.2.173; Russell RS, 2009, J VIRAL HEPATITIS, V16, P621, DOI 10.1111/j.1365-2893.2009.01111.x; Schultz PG, 2002, ANGEW CHEM INT EDIT, V41, P4427, DOI 10.1002/1521-3773(20021202)41:23<4427::AID-ANIE4427>3.0.CO;2-K; SUN M, 1994, J BIOL CHEM, V269, P734; Taguchi H, 2008, J BIOL CHEM, V283, P36724, DOI 10.1074/jbc.M806766200; Takahashi N, 2001, NAT BIOTECHNOL, V19, P563, DOI 10.1038/89320; Tomiya N, 2004, GLYCOCONJUGATE J, V21, P343, DOI 10.1023/B:GLYC.0000046275.28315.87; Tyutyulkova S, 1996, BBA-MOL BASIS DIS, V1316, P217, DOI 10.1016/0925-4439(96)00028-2; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; WILSON IA, 1991, CIBA F SYMP, V159, P13; WILSON IA, 1991, CIBA F SYMP, V159, P28; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Yu XK, 2007, VIROLOGY, V367, P126, DOI 10.1016/j.virol.2007.05.038	64	11	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24622	24633		10.1074/jbc.M109.011858	http://dx.doi.org/10.1074/jbc.M109.011858			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19542217	hybrid, Green Published			2022-12-27	WOS:000269380200071
J	Tardito, S; Isella, C; Medico, E; Marchio, L; Bevilacqua, E; Hatzoglou, M; Bussolati, O; Franchi-Gazzola, R				Tardito, Saverio; Isella, Claudio; Medico, Enzo; Marchio, Luciano; Bevilacqua, Elena; Hatzoglou, Maria; Bussolati, Ovidio; Franchi-Gazzola, Renata			The Thioxotriazole Copper(II) Complex A0 Induces Endoplasmic Reticulum Stress and Paraptotic Death in Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; PROTEASOME INHIBITION; ER STRESS; IN-VITRO; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; PATHWAY; GENE; EXPRESSION; MUTATIONS	The copper(II) complex A0 induces a type of non-apoptotic cell death also known as paraptosis. Paraptosis involves extensive endoplasmic reticulum vacuolization in the absence of caspase activation. A wide panel of human cancer cell lines was used to demonstrate differences in cytotoxicity by the paraptosis-inducing drug A0 and the metal-based pro-apoptotic drug cisplatin. Gene expression profiling of the human fibrosarcoma HT1080 cells showed that, while cisplatin induced p53 targets, A0 up-regulated genes involved in the unfolded protein response (UPR) and response to heavy metals. The cytotoxic effects of A0 were associated with inhibition of the ubiquitin-proteasome system and accumulation of ubiquitinylated proteins, in a manner dependent on protein synthesis. Cycloheximide inhibited the accumulation of ubiquitinylated proteins and hampered A0-induced cell death process. The occurrence of the UPR during A0-induced death process was shown by the increased abundance of spliced XBP1 mRNA, transient eIF2 alpha phosphorylation, and a series of downstream events, including attenuation of global protein synthesis and increased expression of ATF4, CHOP, BIP, and GADD34. Mouse embryonic fibroblasts expressing a mutant eIF2 alpha, which could not be phosphorylated, were more resistant to A0 than wild type cells, pointing to a pro-death role of eIF2 alpha phosphorylation. A0 may thus represent the prototypical member of a new class of compounds that cause paraptotic cell death via mechanisms involving eIF2 alpha phosphorylation and the UPR.	[Tardito, Saverio; Bussolati, Ovidio; Franchi-Gazzola, Renata] Univ Parma, Dept Expt Med, Unit Gen & Clin Pathol, I-43100 Parma, Italy; [Marchio, Luciano] Univ Parma, Dept Gen & Inorgan Analyt & Phys Chem, I-43100 Parma, Italy; [Isella, Claudio; Medico, Enzo] Univ Torino, Inst Canc Res & Treatment, Oncogenom Ctr, Lab Funct Genom, I-10060 Candiolo, Italy; [Bevilacqua, Elena; Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	University of Parma; University of Parma; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; Case Western Reserve University	Franchi-Gazzola, R (corresponding author), Univ Parma, Dept Expt Med, Unit Gen & Clin Pathol, Via Volturno 39, I-43100 Parma, Italy.	renata.franchi@unipr.it	Medico, Enzo/AAC-3185-2021; Bussolati, Ovidio/B-7589-2013; Marchio', Luciano/E-4277-2014; Tardito, Saverio/AAJ-7727-2020; Isella, Claudio/F-7327-2012	Medico, Enzo/0000-0002-3917-2438; Bussolati, Ovidio/0000-0002-4301-2939; Marchio', Luciano/0000-0002-0025-1104; Tardito, Saverio/0000-0002-5294-8683; Isella, Claudio/0000-0003-0679-4756	National Institutes of Health [R01s DK60596, DK53307]; Ministero della Istruzione, della Universita e della Ricerca [PRIN 2007]; Universita degli Studi di Parma; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK060596, R01DK053307, R01DK060596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero della Istruzione, della Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Universita degli Studi di Parma; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01s DK60596 and DK53307 (to M. H.). This work was also supported by Ministero della Istruzione, della Universita e della Ricerca (PRIN 2007 to L. M.) and by Universita degli Studi di Parma (FIL, to R. F. G.).	Abraham MC, 2007, DEV CELL, V12, P73, DOI 10.1016/j.devcel.2006.11.012; Adsule S, 2006, J MED CHEM, V49, P7242, DOI 10.1021/jm060712l; Ahtoniemi T, 2007, MOL PHARMACOL, V71, P30, DOI 10.1124/mol.106.028415; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; ANDREWS PA, 1992, CANCER RES, V52, P1895; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chen YJ, 2002, BLOOD, V100, P1373, DOI 10.1182/blood-2002-01-0174; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Dallavalle F, 2002, J INORG BIOCHEM, V92, P95, DOI 10.1016/S0162-0134(02)00545-7; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Ding WX, 2007, APOPTOSIS, V12, P2233, DOI 10.1007/s10495-007-0142-0; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; DONAHUE TF, 1988, CELL, V54, P621, DOI 10.1016/S0092-8674(88)80006-0; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Fombonne J, 2006, APOPTOSIS, V11, P367, DOI 10.1007/s10495-006-4568-6; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; Gaccioli F, 2005, J INORG BIOCHEM, V99, P1573, DOI 10.1016/j.jinorgbio.2005.04.017; Galvan V, 2003, J BIOL CHEM, V278, P13325, DOI 10.1074/jbc.M211398200; Hirai S, 2004, HEARING RES, V198, P41, DOI 10.1016/j.heares.2004.07.012; Hong SH, 2007, BIOCHEM PHARMACOL, V74, P557, DOI 10.1016/j.bcp.2007.05.016; Jadus MR, 2003, CANCER GENE THER, V10, P411, DOI 10.1038/sj.cgt.7700583; Jambrina E, 2003, J BIOL CHEM, V278, P14134, DOI 10.1074/jbc.M211388200; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kar R, 2009, ONCOGENE, V28, P2556, DOI 10.1038/onc.2009.118; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Marzano C, 2006, J MED CHEM, V49, P7317, DOI 10.1021/jm0601248; Mimnaugh EG, 2006, MOL CANCER RES, V4, P667, DOI 10.1158/1541-7786.MCR-06-0019; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Muller P, 2007, J BIOL INORG CHEM, V12, P495, DOI 10.1007/s00775-006-0201-y; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; PILAR G, 1976, J CELL BIOL, V68, P339, DOI 10.1083/jcb.68.2.339; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Sasaki K, 2003, CELLS TISSUES ORGANS, V175, P34, DOI 10.1159/000073435; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schneider D, 2004, CELL DEATH DIFFER, V11, P760, DOI 10.1038/sj.cdd.4401377; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tardito S, 2006, HISTOCHEM CELL BIOL, V126, P473, DOI 10.1007/s00418-006-0183-4; Tardito S, 2007, J MED CHEM, V50, P1916, DOI 10.1021/jm061174f; Tardito S, 2009, CURR MED CHEM, V16, P1325, DOI 10.2174/092986709787846532; Ustundag Y, 2007, WORLD J GASTROENTERO, V13, P851, DOI 10.3748/wjg.v13.i6.851; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529	51	104	106	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24306	24319		10.1074/jbc.M109.026583	http://dx.doi.org/10.1074/jbc.M109.026583			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561079	Green Published, hybrid			2022-12-27	WOS:000269380200044
J	Zachos, NC; Li, XH; Kovbasnjuk, O; Hogema, B; Sarker, R; Lee, LJ; Li, M; de Jonge, H; Donowitz, M				Zachos, Nicholas C.; Li, Xuhang; Kovbasnjuk, Olga; Hogema, Boris; Sarker, Rafiquel; Lee, Luke J.; Li, Min; de Jonge, Hugo; Donowitz, Mark			NHERF3 (PDZK1) Contributes to Basal and Calcium Inhibition of NHE3 Activity in Caco-2BBe Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER NA+/H+ EXCHANGER; PROTEIN-KINASE-C; BRUSH-BORDER; APICAL MEMBRANE; MEDIATED INHIBITION; NAPI-IIA; DOMAIN; TRANSPORT; PHOSPHORYLATION; REQUIRES	Elevated intracellular Ca2+ ([Ca2+](i)) inhibition of NHE3 is reconstituted by NHERF2, but not NHERF1, by a mechanism involving the formation of multiprotein signaling complexes. To further evaluate the specificity of the NHERF family in calcium regulation of NHE3 activity, the current study determined whether NHERF3 reconstitutes elevated [Ca2+](i) regulation of NHE3. In vitro, NHERF3 bound the NHE3 C terminus between amino acids 588 and 667. In vivo, NHE3 and NHERF3 associate under basal conditions as indicated by coimmunoprecipitation, confocal microscopy, and fluorescence resonance energy transfer. Treatment of PS120/NHE3/NHERF3 cells, but not PS120/NHE3 cells, with the Ca2+ ionophore, 4-bromo-A23187 (0.5 mu M): 1) inhibited NHE3 V-max activity; 2) decreased NHE3 surface amount; 3) dissociated NHE3 and NHERF3 at the plasma membrane by confocal immunofluorescence and fluorescence resonance energy transfer. Similarly, in Caco-2BBe cells, NHERF3 and NHE3 colocalized in the BB under basal conditions but after elevation of [Ca2+](i) by carbachol, this overlap was abolished. NHERF3 short hairpin RNA knockdown (>50%) in Caco-2BBe cells significantly reduced basal NHE3 activity by decreasing BB NHE3 amount. Also, carbachol-mediated inhibition of NHE3 activity was abolished in Caco-2BBe cells in which NHERF3 protein expression was significantly reduced. In summary: 1) NHERF3 colocalizes and directly binds NHE3 at the plasma membrane under basal conditions; 2) NHERF3 reconstitutes [Ca2+](i) inhibition of NHE3 activity and dissociates from NHE3 in fibroblasts and polarized intestinal epithelial cells with elevated [Ca2+](i); 3) NHERF3 short hairpin RNA significantly reduced NHE3 basal activity and brush border expression in Caco-2BBe cells. These results demonstrate that NHERF3 reconstitutes calcium inhibition of NHE3 activity by anchoring NHE3 basally and releasing it with elevated Ca2+.	[Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, GI Div, Baltimore, MD 21205 USA; [Zachos, Nicholas C.; Li, Xuhang; Kovbasnjuk, Olga; Sarker, Rafiquel; Lee, Luke J.; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Li, Min] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Li, Min] Johns Hopkins Univ, Sch Med, Hopkins Ctr Epithelial Disorders, Baltimore, MD 21205 USA; [Hogema, Boris; de Jonge, Hugo] Erasmus Med Coll, Dept Biochem, NL-3015 GE Rotterdam, Netherlands	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Erasmus University Rotterdam; Erasmus MC	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, GI Div, 720 Rutland Ave,925 Ross Res Bldg, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Zachos, Nicholas/GWC-7914-2022		NIDDK [R01-DK26523, R01-DK61765, PO1-DK72084, K01-DK080930, R24-DK64388]; Hopkins Center for Epithelial Disorders [T32-DK07632]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084, K01DK080930, R01DK061765, R24DK064388, T32DK007632, R01DK026523] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK26523, R01-DK61765, PO1-DK72084, K01-DK080930, and R24-DK64388 (The Hopkins Basic Research Digestive Diseases Development Core Center) from the NIDDK. This work was also supported by Grant T32-DK07632 from The Hopkins Center for Epithelial Disorders.	Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; Capuano P, 2005, PFLUG ARCH EUR J PHY, V449, P392, DOI 10.1007/s00424-004-1351-9; Cavet ME, 1999, AM J PHYSIOL-CELL PH, V277, pC1111, DOI 10.1152/ajpcell.1999.277.6.C1111; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; DEBER CM, 1986, BIOCHEM BIOPH RES CO, V134, P731, DOI 10.1016/S0006-291X(86)80481-8; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Donowitz M, 2007, J PROTEOME RES, V6, P4068, DOI 10.1021/pr0701761; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Gasmi M, 1999, J VIROL, V73, P1828, DOI 10.1128/JVI.73.3.1828-1834.1999; Gisler SM, 2008, MOL CELL PROTEOMICS, V7, P1362, DOI 10.1074/mcp.M800079-MCP200; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hernando N, 2005, J PHYSIOL-LONDON, V567, P21, DOI 10.1113/jphysiol.2005.087049; Hillesheim J, 2007, PFLUG ARCH EUR J PHY, V454, P575, DOI 10.1007/s00424-007-0239-x; Janecki AJ, 1998, J BIOL CHEM, V273, P8790, DOI 10.1074/jbc.273.15.8790; Kato Y, 2006, MOL PHARMACOL, V70, P829, DOI 10.1124/mol.106.024158; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Kocher O, 1998, LAB INVEST, V78, P117; Kovbasnjuk O, 2001, J CELL SCI, V114, P4025; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Malmberg EK, 2008, BIOCHEM J, V410, P283, DOI 10.1042/BJ20071068; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Murtazina R, 2008, GASTROENTEROLOGY, V134, pA108; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Noshiro R, 2006, KIDNEY INT, V70, P275, DOI 10.1038/sj.ki.5001522; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Sakoda T, 1999, J MOL CELL CARDIOL, V31, P2037, DOI 10.1006/jmcc.1999.1035; Scott RO, 2002, J BIOL CHEM, V277, P22934, DOI 10.1074/jbc.M202434200; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Thelin WR, 2005, J PHYSIOL-LONDON, V567, P13, DOI 10.1113/jphysiol.2005.091041; Thomson RB, 2005, P NATL ACAD SCI USA, V102, P13331, DOI 10.1073/pnas.0506578102; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; WATSON AJM, 1991, AM J PHYSIOL, V261, pG229, DOI 10.1152/ajpgi.1991.261.2.G229; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zachos NC, 2008, CELL PHYSIOL BIOCHEM, V22, P693, DOI 10.1159/000185553	52	31	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23708	23718		10.1074/jbc.M109.012641	http://dx.doi.org/10.1074/jbc.M109.012641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19535329	hybrid, Green Published			2022-12-27	WOS:000269180000056
J	Taylor, DR; Parkin, ET; Cocklin, SL; Ault, JR; Ashcroft, AE; Turner, AJ; Hooper, NM				Taylor, David R.; Parkin, Edward T.; Cocklin, Sarah L.; Ault, James R.; Ashcroft, Alison E.; Turner, Anthony J.; Hooper, Nigel M.			Role of ADAMs in the Ectodomain Shedding and Conformational Conversion of the Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ANGIOTENSIN-CONVERTING ENZYME; HUMAN CEREBROSPINAL-FLUID; CELLULAR PRION; LIPID RAFTS; TRUNCATED FORMS; CULTURED-CELLS; SOLUBLE FORM; METALLOPROTEASE; DISINTEGRIN	The cellular prion protein (PrPC) is essential for the pathogenesis and transmission of prion diseases. PrPC is bound to the plasma membrane via a glycosylphosphatidylinositol anchor, although a secreted, soluble form has also been identified. Previously we reported that PrPC is subject to ectodomain shedding from the membrane by zinc metalloproteinases with a similar inhibition profile to those involved in shedding the amyloid precursor protein. Here we have used gain-of-function (overexpression) and loss-of-function (small interfering RNA knockdown) experiments in cells to identify the ADAMs (a disintegrin and metalloproteinases) involved in the ectodomain shedding of PrPC. These experiments revealed that ADAM9 and ADAM10, but not ADAM17, are involved in the shedding of PrPC and that ADAM9 exerts its effect on PrPC shedding via ADAM10. Using dominant negative, catalytically inactive mutants, we show that the catalytic activity of ADAM9 is required for its effect on ADAM10. Mass spectrometric analysis revealed that ADAM10, but not ADAM9, cleaved PrP between Gly(228) and Arg(229), three residues away from the site of glycosylphosphatidylinositol anchor attachment. The shedding of another membrane protein, the amyloid precursor protein beta-secretase BACE1, by ADAM9 is also mediated via ADAM10. Furthermore, we show that pharmacological inhibition of PrPC shedding or activation of both PrPC and PrPSc shedding by ADAM10 overexpression in scrapie-infected neuroblastoma N2a cells does not alter the formation of proteinase K-resistant PrPSc. Collectively, these data indicate that although PrPC can be shed through the action of ADAM family members, modulation of PrPC or PrPSc ectodomain shedding does not regulate prion conversion.	[Taylor, David R.; Parkin, Edward T.; Cocklin, Sarah L.; Turner, Anthony J.; Hooper, Nigel M.] Univ Leeds, Proteolysis Res Grp, Leeds LS2 9JT, W Yorkshire, England; [Ault, James R.; Ashcroft, Alison E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Taylor, David R.; Parkin, Edward T.; Cocklin, Sarah L.; Turner, Anthony J.; Hooper, Nigel M.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Hooper, NM (corresponding author), Univ Leeds, Proteolysis Res Grp, Leeds LS2 9JT, W Yorkshire, England.	n.m.hooper@leeds.ac.uk	Ault, James R/O-8904-2019; Ault, James/F-2864-2012	Ault, James R/0000-0002-5131-438X; Ault, James/0000-0002-5131-438X; Hooper, Nigel/0000-0002-5811-3484; Parkin, Edward/0000-0003-3270-3184; Taylor, David/0000-0003-1385-3961	Medical Research Council of Great Britain [G9824728]; Wellcome Trust [080229/Z/06/Z]; University of Leeds; MRC [G9824728] Funding Source: UKRI; Medical Research Council [G9824728] Funding Source: researchfish	Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Leeds; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council of Great Britain Grant G9824728, Wellcome Trust Grant 080229/Z/06/Z, and the University of Leeds.	Aguzzi A, 2006, J NEUROCHEM, V97, P1726, DOI 10.1111/j.1471-4159.2006.03909.x; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Heiseke A, 2008, TRAFFIC, V9, P1116, DOI 10.1111/j.1600-0854.2008.00750.x; Hooper NM, 2005, BIOCHEM SOC T, V33, P335, DOI 10.1042/BST0330335; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Hussain I, 2003, J BIOL CHEM, V278, P36264, DOI 10.1074/jbc.M304186200; Kahl S, 2000, J IMMUNOL, V165, P4463, DOI 10.4049/jimmunol.165.8.4463; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Kim CL, 2004, J GEN VIROL, V85, P3473, DOI 10.1099/vir.0.80113-0; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Leclerc E, 2001, EMBO J, V20, P1547, DOI 10.1093/emboj/20.7.1547; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Parkin E, 2009, J NEUROCHEM, V108, P1464, DOI 10.1111/j.1471-4159.2009.05907.x; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Parkin ET, 2003, J CELL SCI, V116, P3079, DOI 10.1242/jcs.00626; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; TAGLIAVINI F, 1992, BIOCHEM BIOPH RES CO, V184, P1398, DOI 10.1016/S0006-291X(05)80038-5; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; Takenobu H, 2003, J BIOL CHEM, V278, P17255, DOI 10.1074/jbc.M211835200; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Verheijen JH, 2006, CLIN CHEM, V52, P1168, DOI 10.1373/clinchem.2006.066720; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; Yang XY, 1996, J BIOL CHEM, V271, P11493, DOI 10.1074/jbc.271.19.11493	50	107	109	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22590	22600		10.1074/jbc.M109.032599	http://dx.doi.org/10.1074/jbc.M109.032599			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19564338	hybrid, Green Published			2022-12-27	WOS:000268963100012
J	Hung, YH; Robb, EL; Volitakis, I; Ho, M; Evin, G; Li, QX; Culvenor, JG; Masters, CL; Cherny, RA; Bush, AI				Hung, Ya Hui; Robb, Elysia L.; Volitakis, Irene; Ho, Michael; Evin, Genevieve; Li, Qiao-Xin; Culvenor, Janetta G.; Masters, Colin L.; Cherny, Robert A.; Bush, Ashley I.			Paradoxical Condensation of Copper with Elevated beta-Amyloid in Lipid Rafts under Cellular Copper Deficiency Conditions IMPLICATIONS FOR ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR-PROTEIN; GAMMA-SECRETASE; A-BETA; TRANSGENIC MICE; MOUSE MODEL; IN-VITRO; SUPEROXIDE-DISMUTASE; HIPPOCAMPAL-NEURONS; UP-REGULATION; BRAIN	Redox-active copper is implicated in the pathogenesis of Alzheimer disease (AD), beta-amyloid peptide (A beta) aggregation, and amyloid formation. A beta center dot copper complexes have been identified in AD and catalytically oxidize cholesterol and lipid to generate H2O2 and lipid peroxides. The site and mechanism of this abnormality is not known. Growing evidence suggests that amyloidogenic processing of the beta-amyloid precursor protein (APP) occurs in lipid rafts, membrane microdomains enriched in cholesterol. beta- and gamma-secretases, and A beta have been identified in lipid rafts in cultured cells, human and rodent brains, but the role of copper in lipid raft amyloidogenic processing is presently unknown. In this study, we found that copper modulates flotillin-2 association with cholesterol-rich lipid raft domains, and consequently A beta synthesis is attenuated via copper-mediated inhibition of APP endocytosis. We also found that total cellular copper is associated inversely with lipid raft copper levels, so that under intracellular copper deficiency conditions, A beta center dot copper complexes are more likely to form. This explains the paradoxical hypermetallation of A beta with copper under tissue copper deficiency conditions in AD.	[Hung, Ya Hui; Robb, Elysia L.; Volitakis, Irene; Cherny, Robert A.; Bush, Ashley I.] Oxidat Biol Lab, Parkville, Vic 3052, Australia; [Evin, Genevieve; Masters, Colin L.] Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia; [Hung, Ya Hui; Culvenor, Janetta G.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Volitakis, Irene; Ho, Michael; Evin, Genevieve; Li, Qiao-Xin; Culvenor, Janetta G.; Masters, Colin L.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne	Bush, AI (corresponding author), 155 Oak St, Parkville, Vic 3052, Australia.	a.bush@mhri.edu.au	Hung, Ya Hui/F-1951-2010; Bush, Ashley/Y-2457-2019; Evin, Genevieve M/E-5891-2013; Bush, Ashley I/A-1186-2007	Hung, Ya Hui/0000-0002-5440-2764; Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Volitakis, Irene/0000-0003-0766-817X	Alzheimer's Association Zenith Award; American Health Assistance Foundation; Australian Research Council, Bethlehem Griffiths Research Foundation; National Health and Medical Research Council (Australia)	Alzheimer's Association Zenith Award(Alzheimer's Association); American Health Assistance Foundation; Australian Research Council, Bethlehem Griffiths Research Foundation(Australian Research Council); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Alzheimer's Association Zenith Award (to A. I. B.) and grants (to A. I. B.) from the American Health Assistance Foundation, Australian Research Council, Bethlehem Griffiths Research Foundation, and National Health and Medical Research Council (Australia).	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Buxbaum JD, 2002, FRONT BIOSCI, V7, pA50, DOI 10.2741/buxbaum; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Chauhan NB, 2004, NEUROCHEM RES, V29, P1897, DOI 10.1023/B:NERE.0000042217.90204.8d; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Culvenor JG, 2000, EXP CELL RES, V255, P192, DOI 10.1006/excr.1999.4791; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Hoke DE, 2005, FEBS J, V272, P5544, DOI 10.1111/j.1742-4658.2005.04950.x; Hopt A, 2003, J NEUROSCI METH, V128, P159, DOI 10.1016/S0165-0270(03)00173-0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jiang DL, 2007, BIOCHEMISTRY-US, V46, P9270, DOI 10.1021/bi700508n; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Magaki S, 2007, NEUROSCI LETT, V418, P72, DOI 10.1016/j.neulet.2007.02.077; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Morris MC, 2006, ARCH NEUROL-CHICAGO, V63, P1085, DOI 10.1001/archneur.63.8.1085; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Nelson TJ, 2005, J BIOL CHEM, V280, P7377, DOI 10.1074/jbc.M409071200; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Puglielli L, 2005, J CLIN INVEST, V115, P2556, DOI 10.1172/JCI23610; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Squitti R, 2007, J NEURAL TRANSM, V114, P1589, DOI 10.1007/s00702-007-0777-6; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Svensson PA, 2003, ATHEROSCLEROSIS, V169, P71, DOI 10.1016/S0021-9150(03)00145-X; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Won JS, 2008, J NEUROCHEM, V105, P1536, DOI 10.1111/j.1471-4159.2008.05283.x; Yoshimoto N, 2005, J BIOSCI BIOENG, V100, P455, DOI 10.1263/jbb.100.455	70	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21899	21907		10.1074/jbc.M109.019521	http://dx.doi.org/10.1074/jbc.M109.019521			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542222	hybrid, Green Published			2022-12-27	WOS:000268783700014
J	Kobayashi, N; Kobayashi, N; Yamaguchi, A; Nishi, T				Kobayashi, Naoki; Kobayashi, Nobuyoshi; Yamaguchi, Akihito; Nishi, Tsuyoshi			Characterization of the ATP-dependent Sphingosine 1-Phosphate Transporter in Rat Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX; APOA-I; LYMPHOCYTE EGRESS; HUMAN PLASMA; HUMAN ABCA7; SPHINGOSINE-1-PHOSPHATE; CELLS; PLATELETS; RELEASE	Sphingosine 1-phosphate (S1P) is a bioactive lipid signal transmitter present in blood. Blood plasma S1P is supplied from erythrocytes and plays an important role in lymphocyte egress from lymphoid organs. However, the S1P export mechanism from erythrocytes to blood plasma is not well defined. To elucidate the mechanism of S1P export from erythrocytes, we performed the enzymatic characterization of S1P transporter in rat erythrocytes. Rat erythrocytes constitutively released S1P without any stimulus. The S1P release was reduced by an ABCA1 transporter inhibitor, glyburide, but not by a multidrug resistance-associated protein inhibitor, MK571, or a multidrug resistance protein inhibitor, cyclosporine A. Furthermore, we measured S1P transport activity using rat erythrocyte inside-out membrane vesicles (IOVs). Although the effective S1P transport into IOVs was observed in the presence of ATP, this activity was also supported by dATP and adenosine 5'-(beta, gamma,-imido) triphosphate. The rate of S1P transport increased depending on S1P concentration, with an apparent K-m value of 21 mu M. Two phosphorylated sphingolipids, dihydrosphingosine 1-phosphate and ceramide 1-phosphate, did not inhibit S1P transport. Similar to the intact erythrocytes, the uptake of S1P into IOVs was inhibited by glyburide and vanadate but not by the other ABC transporter inhibitors. These results suggest that S1P is exported from the erythrocytes by a novel ATP-dependent transporter.	[Kobayashi, Naoki; Kobayashi, Nobuyoshi; Yamaguchi, Akihito; Nishi, Tsuyoshi] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka 5670047, Japan; [Kobayashi, Naoki; Kobayashi, Nobuyoshi; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Nishi, T (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	tnishi@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Takeda Science Foundation (to T.N. and A.Y.).	Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Aoki S, 2005, J BIOCHEM, V138, P47, DOI 10.1093/jb/mvi100; Butter JJ, 2005, J CHROMATOGR B, V824, P65, DOI 10.1016/j.jchromb.2005.06.040; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092-JLR200; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Ikeda Y, 2003, BIOCHEM BIOPH RES CO, V311, P313, DOI 10.1016/j.bbrc.2003.10.002; Ito K, 2005, LIFE SCI, V77, P539, DOI 10.1016/j.lfs.2004.10.071; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Kobayashi A, 2006, J LIPID RES, V47, P1791, DOI 10.1194/jlr.M500546-JLR200; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Linsel-Nitschke P, 2005, J LIPID RES, V46, P86, DOI 10.1194/jlr.M400247-JLR200; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Prieschl EE, 1999, J EXP MED, V190, P1, DOI 10.1084/jem.190.1.1; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sasaki M, 2003, BIOCHEM BIOPH RES CO, V304, P777, DOI 10.1016/S0006-291X(03)00659-4; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Steck T L, 1974, Methods Enzymol, V31, P172; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Yang LB, 1999, BRIT J HAEMATOL, V107, P282, DOI 10.1046/j.1365-2141.1999.01697.x; Yatomi Y, 2000, BLOOD, V96, P3431; Yatomi Y, 1997, J BIOCHEM, V121, P969; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193	43	100	101	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21192	21200		10.1074/jbc.M109.006163	http://dx.doi.org/10.1074/jbc.M109.006163			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531471	Green Published, hybrid			2022-12-27	WOS:000268564400012
J	Pesiridis, GS; Diamond, E; Van Duyne, GD				Pesiridis, G. Scott; Diamond, Evan; Van Duyne, Gregory D.			Role of pICLn in Methylation of Sm Proteins by PRMT5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ARGININE METHYLTRANSFERASE; COMPLEX; BINDING; CORE; IDENTIFICATION; METHYLOSOME; BIOGENESIS; EXPRESSION; INTERACTS; RESIDUES	pICln is an essential, highly conserved 26-kDa protein whose functions include binding to Sm proteins in the cytoplasm of human cells and mediating the ordered and regulated assembly of the cell's RNA-splicing machinery by the survival motor neurons complex. pICln also interacts with PRMT5, the enzyme responsible for generating symmetric dimethylarginine modifications on the carboxyl-terminal regions of three of the canonical Sm proteins. To better understand the role of pICln in these cellular processes, we have investigated the properties of pICln and pICln.Sm complexes and the effects that pICln has on the methyltransferase activity of PRMT5. We find that pICln is a monomer in solution, binds with high affinity (K-d similar to 160 nM) to SmD3-SmB, and forms 1: 1 complexes with Sm proteins and Sm protein subcomplexes. The data support an end-capping model of pICln binding that supports current views of how pICln prevents Sm oligomerization on illicit RNA substrates. We have found that by co-expression with pICln, recombinant PRMT5 can be produced in a soluble, active form. PRMT5 alone has promiscuous activity toward a variety of known substrates. In the presence of pICln, however, PRMT5 methylation of Sm proteins is stimulated, but methylation of histones is inhibited. We have also found that mutations in pICln that do not affect Sm protein binding can still have a profound effect on the methyltransferase activity of the PRMT5 complex. Together, the data provide insights into pICln function and represent an important starting point for biochemical analyses of PRMT5.	[Van Duyne, Gregory D.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Van Duyne, GD (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, 242 Anat Chem Bldg, Philadelphia, PA 19104 USA.	vanduyne@mail.med.upenn.edu			NIGMS NIH HHS [T32 GM008275] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Buyse G, 1996, BIOCHEM BIOPH RES CO, V218, P822, DOI 10.1006/bbrc.1996.0146; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; EINARSON MB, 2007, COLD SPRING HARBOR P; Emma F, 1998, BBA-MOL CELL RES, V1404, P321, DOI 10.1016/S0167-4889(98)00073-1; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; GHOSH SK, 1988, J BIOL CHEM, V263, P19024; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Grimmler M, 2005, EMBO REP, V6, P70, DOI 10.1038/sj.embor.7400301; Jiang W, 2005, BIOCHEM BIOPH RES CO, V329, P522, DOI 10.1016/j.bbrc.2005.01.153; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Krapivinsky G, 1998, J BIOL CHEM, V273, P10811, DOI 10.1074/jbc.273.18.10811; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; PAULMICHL M, 1992, NATURE, V356, P238, DOI 10.1038/356238a0; Pellizzoni L, 2001, CURR BIOL, V11, P1079, DOI 10.1016/S0960-9822(01)00316-5; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Pu WT, 2000, J BIOL CHEM, V275, P12363, DOI 10.1074/jbc.275.17.12363; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Sanchez-Olea R, 1998, BBA-GEN SUBJECTS, V1381, P49, DOI 10.1016/S0304-4165(98)00009-9; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Strange K, 1998, J GEN PHYSIOL, V111, P617, DOI 10.1085/jgp.111.5.617; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Zaric B, 2005, J BIOL CHEM, V280, P16066, DOI 10.1074/jbc.M414481200; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	53	57	60	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21347	21359		10.1074/jbc.M109.015578	http://dx.doi.org/10.1074/jbc.M109.015578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520849	hybrid, Green Published			2022-12-27	WOS:000268564400029
J	Sewell, EWC; Pereira, MP; Brown, ED				Sewell, Edward W. C.; Pereira, Mark P.; Brown, Eric D.			The Wall Teichoic Acid Polymerase TagF Is Non-processive in Vitro and Amenableto Study Using Steady State Kinetic Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; CELL-WALL; SUCCESSIVE GLYCOSYLTRANSFER; POLY(GLYCEROL PHOSPHATE); NEISSERIA-MENINGITIDIS; GLYCEROL PHOSPHATE; BIOSYNTHESIS; ACCEPTOR; POLYSIALYLTRANSFERASE; BACILLUS-SUBTILIS-168	Wall teichoic acids are a chemically diverse group of anionic polymers that constitute up to 50% of the Gram-positive cell wall. These polymers play a pivotal role in virulence and have been implicated in a diverse range of physiological functions. The TagF-like family of enzymes has been shown to be responsible for wall teichoic acid priming and polymerization events. Although many such enzymes are well validated therapeutic targets, a mechanistic understanding of this enzyme family has remained elusive. TagF is the prototypical teichoic acid polymerase and uses CDP-glycerol to catalyze synthesis of the linear (1,3)-linked poly(glycerol phosphate) teichoic acid in Bacillus subtilis 168. Here we used a synthetic soluble analog of the natural substrate of the enzyme, Lipid phi, to conduct the first detailed mechanistic investigation of teichoic acid polymerization. Through the use of a new high pressure liquid chromatography- based assay to monitor single glycerol phosphate incorporations into the Lipid phi analog, we conducted a detailed analysis of reaction product formation patterns and unequivocally showed TagF to be non-processive in vitro. Furthermore by monitoring the kinetics of polymerization, we showed that Lipid phi analog species varying in size have the same K-m value of 2.6 mu M and validated use of Bi Bi velocity expressions to model the TagF enzyme system. Initial rate analysis showed that TagF catalyzes a sequential Bi Bi mechanism where both substrates are added to the enzyme prior to product release consistent with a single displacement chemical mechanism.	[Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	ebrown@mcmaster.ca			Canadian Institutes of Health Research [MOP-15496]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-15496 and a Canada Research Chair (held by E. D. B.).	Akita K, 2002, PLANT PHYSIOL, V130, P374, DOI 10.1104/pp.005587; Alderwick LJ, 2007, BIOCHEM SOC T, V35, P1325, DOI 10.1042/BST0351325; Alderwick LJ, 2008, PROTEIN EXPRES PURIF, V58, P332, DOI 10.1016/j.pep.2007.11.012; Badurina DS, 2003, BBA-PROTEINS PROTEOM, V1646, P196, DOI 10.1016/S1570-9639(03)00019-0; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Bhavsar AP, 2007, J BACTERIOL, V189, P6816, DOI 10.1128/JB.00910-07; Bhavsar AP, 2006, MOL MICROBIOL, V60, P1077, DOI 10.1111/j.1365-2958.2006.05169.x; Bhavsar AP, 2005, J BIOL CHEM, V280, P36691, DOI 10.1074/jbc.M507154200; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Cook P. F., 2007, ENZYME KINETICS MECH, P121; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; Guillaumie F, 2003, CARBOHYD RES, V338, P1951, DOI 10.1016/S0008-6215(03)00321-5; Ha S, 1999, J AM CHEM SOC, V121, P8415, DOI 10.1021/ja991556t; Hancock IC, 1997, BIOCHEM SOC T, V25, P183, DOI 10.1042/bst0250183; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; MAUEL C, 1991, J GEN MICROBIOL, V137, P929, DOI 10.1099/00221287-137-4-929; MAUEL C, 1989, MOL GEN GENET, V215, P388, DOI 10.1007/BF00427034; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Pereira MP, 2008, CHEMBIOCHEM, V9, P1385, DOI 10.1002/cbic.200800026; Pereira MP, 2004, BIOCHEMISTRY-US, V43, P11802, DOI 10.1021/bi048866v; PEREIRA MP, 2008, MICROBIAL G IN PRESS; Saffron CM, 2006, ENVIRON SCI TECHNOL, V40, P7662, DOI 10.1021/es0603610; Schertzer JW, 2008, J BACTERIOL, V190, P6940, DOI 10.1128/JB.00851-08; Schertzer JW, 2005, J BIOL CHEM, V280, P36683, DOI 10.1074/jbc.M507153200; Schertzer JW, 2003, J BIOL CHEM, V278, P18002, DOI 10.1074/jbc.M300706200; SEGAL IH, 1993, ENZYME KINETICS BEHA, P1; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; Vionnet J, 2007, GLYCOBIOLOGY, V17, P735, DOI 10.1093/glycob/cwm032; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2008, GLYCOBIOLOGY, V18, P177, DOI 10.1093/glycob/cwm126; Zhang YH, 2006, BIOCHEMISTRY-US, V45, P10895, DOI 10.1021/bi060872z	39	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21132	21138		10.1074/jbc.M109.010215	http://dx.doi.org/10.1074/jbc.M109.010215			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520862	hybrid, Green Published			2022-12-27	WOS:000268564400006
J	Tanaka, T; Ueno, M; Yamashita, T				Tanaka, Tatsuhide; Ueno, Masaki; Yamashita, Toshihide			Engulfment of Axon Debris by Microglia Requires p38 MAPK Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PERIPHERAL-NERVE INJURY; WALLERIAN DEGENERATION; NEURITE OUTGROWTH; APOPTOTIC CELLS; SPINAL-CORD; PHAGOCYTOSIS; RECEPTOR; CLEARANCE; CNS	The clearance of debris after injuries to the nervous system is a critical step for restoration of the injured neural network. Microglia are thought to be involved in elimination of degenerating neurons and axons in the central nervous system (CNS), presumably restoring a favorable environment after CNS injuries. However, the mechanism underlying debris clearance remains elusive. Here, we establish an in vitro assay system to estimate phagocytosis of axon debris. We employed a Wallerian degeneration model by cutting axons of the cortical explants. The cortical explants were co-cultured with primary microglia or the MG5 microglial cell line. The cortical neurites were then transected. MG5 cells efficiently phagocytosed the debris, whereas primary microglia showed phagocytic activity only when they were activated by lipopolysaccharide or interferon-beta. When MG5 cells or primary microglia were co-cultured with degenerated axons, p38 mitogen-activated protein kinase (MAPK) was activated in these cells. Engulfment of axon debris was blocked by the p38 MAPK inhibitor SB203580, indicating that p38 MAPK is required for phagocytic activity. Receptors that recognize dying cells appeared not to be involved in the process of phagocytosis of the axon debris. In addition, the axons undergoing Wallerian degeneration did not release lactate dehydrogenase, suggesting that degeneration of the severed axons and apoptosis may represent two distinct self-destruction programs. We observed regrowth of the severed neurites after axon debris was removed. This finding suggests that axon debris, in addition to myelin debris, is an inhibitory factor for axon regeneration.	[Tanaka, Tatsuhide; Ueno, Masaki; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka 5650871, Japan	Osaka University	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ttanaka@asahikawa-med.ac.jp; yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Tanaka, Tatsuhide/0000-0002-3373-9093; Ueno, Masaki/0000-0003-1484-9921; Yamashita, Toshihide/0000-0003-4559-7018	National Institute of Biomedical Innovation [05-12]; Japan Society for the Promotion of Science	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a research grant from the National Institute of Biomedical Innovation (05-12) and a Grant-in-Aid for Young Scientists (S) from the Japan Society for the Promotion of Science.	Bhat NR, 1998, J NEUROSCI, V18, P1633; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; Chan A, 2003, GLIA, V43, P231, DOI 10.1002/glia.10258; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Finn JT, 2000, J NEUROSCI, V20, P1333; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Ohsawa K, 1997, GLIA, V21, P285; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Sun HN, 2008, BIOL PHARM BULL, V31, P1711, DOI 10.1248/bpb.31.1711; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Vallieres N, 2006, GLIA, V53, P103, DOI 10.1002/glia.20266; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Yamagishi S, 2005, J BIOL CHEM, V280, P20384, DOI 10.1074/jbc.M501945200	30	68	73	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21626	21636		10.1074/jbc.M109.005603	http://dx.doi.org/10.1074/jbc.M109.005603			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531468	hybrid, Green Published			2022-12-27	WOS:000268564400056
J	Ghisolfi, L; Calastretti, A; Franzi, S; Canti, G; Donnini, M; Capaccioli, S; Nicolin, A; Bevilacqua, A				Ghisolfi, Laura; Calastretti, Angela; Franzi, Sara; Canti, Gianfranco; Donnini, Martino; Capaccioli, Sergio; Nicolin, Angelo; Bevilacqua, Annamaria			B Cell Lymphoma (Bcl)-2 Protein Is the Major Determinant in bcl-2 Adenine-Uridine-rich Element Turnover Overcoming HuR Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; BINDING PROTEIN; GENE-EXPRESSION; FAMILY-MEMBERS; POSTTRANSCRIPTIONAL REGULATION; DEGRADATION; AUF1; OLIGORIBONUCLEOTIDES; DIFFERENTIATION; TRISTETRAPROLIN	In the 3'-untranslated region, the destabilizing adenine-uridine (AU)-rich elements (AREs) control the expression of several transcripts through interactions with ARE-binding proteins (AUBPs) and RNA degradation machinery. Although the fundamental role for AUBPs and associated factors in eliciting ARE-dependent degradation of cognate mRNAs has been recently highlighted, the molecular mechanisms underlying the specific regulation of individual mRNA turnover have not yet been fully elucidated. Here we focused on the post-transcriptional regulation of bcl-2 mRNA in human cell lines under different conditions and genetic backgrounds. In the context of an AUBPs silencing approach, HuR knockdown reduced the expression of endogenous bcl-2, whereas unexpectedly, a bcl-2 ARE-reporter transcript increased significantly, suggesting that HuR expression has opposite effects on endogenous and ectopic bcl-2 ARE. Moreover, evidence was provided for the essential, specific and dose-dependent role of the Bcl-2 protein in regulating the decay kinetics of its own mRNA, as ascertained by a luciferase reporter system. Altogether, the data support a model whereby the Bcl-2 protein is the major determinant of its own ARE-dependent transcript half-life in living cells and its effect overcomes the activity of ARE-binding proteins.	[Ghisolfi, Laura; Calastretti, Angela; Franzi, Sara; Canti, Gianfranco; Nicolin, Angelo; Bevilacqua, Annamaria] Univ Milan, Dept Pharmacol, I-20129 Milan, Italy; [Donnini, Martino; Capaccioli, Sergio] Univ Florence, Dept Expt Pathol & Oncol, I-50134 Florence, Italy	University of Milan; University of Florence	Bevilacqua, A (corresponding author), Via Vanvitelli 32, I-20129 Milan, Italy.	annamaria.bevilacqua@unimi.it	Franzi, Sara/AAB-7683-2020; Ghisolfi, Laura/I-8609-2012; Bevilacqua, Annamaria/C-6357-2008	Bevilacqua, Annamaria/0000-0002-3136-3424; Franzi, Sara/0000-0003-1767-3431	Ministero dell'Istruzione, dell'Universita e della Ricerca, Istituto Superiore Sanita (Rome, Italy); Italian Association for Cancer Research	Ministero dell'Istruzione, dell'Universita e della Ricerca, Istituto Superiore Sanita (Rome, Italy); Italian Association for Cancer Research	The work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, Istituto Superiore Sanita (Rome, Italy), and the Italian Association for Cancer Research.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Akhtar RS, 2004, BBA-MOL CELL RES, V1644, P189, DOI 10.1016/j.bbamcr.2003.10.013; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bevilacqua A, 2003, J BIOL CHEM, V278, P23451, DOI 10.1074/jbc.M210620200; Bevilacqua A, 2007, MOL PHARMACOL, V71, P531, DOI 10.1124/mol.106.029041; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Cherradi N, 2006, MOL ENDOCRINOL, V20, P916, DOI 10.1210/me.2005-0121; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Ghisolfi L, 2005, MOL PHARMACOL, V68, P816, DOI 10.1124/mol.105.014357; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Hughes P, 2006, CURR DIRECT AUTOIMMU, V9, P74; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lin NY, 2007, FEBS J, V274, P867, DOI 10.1111/j.1742-4658.2007.05632.x; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Moncini S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-111; Nagaoka K, 2007, EXP CELL RES, V313, P2937, DOI 10.1016/j.yexcr.2007.04.017; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Papucci L, 2008, MOL PHARMACOL, V73, P498, DOI 10.1124/mol.107.038323; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; REED JC, 1988, NATURE, V336, P259, DOI 10.1038/336259a0; Shim J, 2002, MOL CELLS, V14, P323; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wesarg E, 2007, INT J CANCER, V121, P2387, DOI 10.1002/ijc.22977; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zeitlin BD, 2008, J CLIN ONCOL, V26, P4180, DOI 10.1200/JCO.2007.15.7693	48	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20946	20955		10.1074/jbc.M109.023721	http://dx.doi.org/10.1074/jbc.M109.023721			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19520857	Green Published, hybrid			2022-12-27	WOS:000268316100058
J	Tian, L; Hou, CX; Tian, KL; Holcomb, NC; Gu, LY; Li, GM				Tian, Lei; Hou, Caixia; Tian, Keli; Holcomb, Nathaniel C.; Gu, Liya; Li, Guo-Min			Mismatch Recognition Protein MutS beta Does Not Hijack (CAG)(n) Hairpin Repair in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; CAG REPEAT; DNA; HYDROLYSIS; INSTABILITY; MECHANISMS	CAG repeats form stable hairpin structures, which are believed to be responsible for CAG repeat expansions associated with certain human neurological diseases. Human cells possess an accurate DNA hairpin repair system that prevents expansion of disease-associated CAG repeats. Based on transgenic animal studies, it is suggested that (CAG)(n) expansion is caused by abnormal binding of the MutS beta mismatch recognition protein to (CAG)(n) hairpins, leading to hijacking mismatch repair function during (CAG)(n) hairpin repair. We demonstrate here that MutS beta displays identical biochemical and biophysical activities (including ATP-provoked conformational change, ATPase, ATP binding, and ADP binding) when interacting with a (CAG)(n) hairpin and a mismatch. More importantly, our in vitro functional hairpin repair assays reveal that excess MutS beta does not inhibit (CAG)(n) hairpin repair in HeLa nuclear extracts. Evidence presented here provides a novel view as to whether or not MutS beta is involved in CAG repeat instability in humans.	[Tian, Lei; Hou, Caixia; Tian, Keli; Holcomb, Nathaniel C.; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA	University of Kentucky	Li, GM (corresponding author), Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA.	gmli@uky.edu	Li, Guo-Min/I-5016-2014	Li, Guo-Min/0000-0002-9842-4578; Holcomb, Nathaniel/0000-0002-8214-2613	National Institutes of Health [GM072756, CA115942, CA104333]; NATIONAL CANCER INSTITUTE [R01CA115942, R01CA104333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072756 and CA115942 ( to G.-M. L.) and CA104333 ( to L. G.).	Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; GACY AM, 1995, CELL, V81, P533; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Hou CX, 2009, NAT STRUCT MOL BIOL, V16, P869, DOI 10.1038/nsmb.1638; JOHNSON MD, 1992, PHYSICIAN SPORTSMED, V20, P60, DOI 10.1080/00913847.1992.11947449; Lahue RS, 2003, FRONT BIOSCI-LANDMRK, V8, pS653, DOI 10.2741/1107; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; McMurray CT, 2008, DNA REPAIR, V7, P1121, DOI 10.1016/j.dnarep.2008.03.013; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Owen BAL, 2009, NAT STRUCT MOL BIOL, V16, P550, DOI 10.1038/nsmb.1596; Panigrahi GB, 2005, NAT STRUCT MOL BIOL, V12, P654, DOI 10.1038/nsmb959; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Takamatsu S, 1996, NUCLEIC ACIDS RES, V24, P640, DOI 10.1093/nar/24.4.640; Tian L, 2009, J BIOL CHEM, V284, P11557, DOI 10.1074/jbc.M900908200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	27	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20452	20456		10.1074/jbc.C109.014977	http://dx.doi.org/10.1074/jbc.C109.014977			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19525234	Green Published, hybrid			2022-12-27	WOS:000268316100005
J	Doroudgar, S; Thuerauf, DJ; Marcinko, MC; Belmont, PJ; Glembotski, CC				Doroudgar, Shirin; Thuerauf, Donna J.; Marcinko, Marie C.; Belmont, Peter J.; Glembotski, Christopher C.			Ischemia Activates the ATF6 Branch of the Endoplasmic Reticulum Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; GLUCOSE-REGULATED PROTEINS; TRANSCRIPTION FACTOR ATF6; DISULFIDE BOND FORMATION; INDUCIBLE FACTOR-I; NF-Y CBF; ER STRESS; REPERFUSION INJURY; MESSENGER-RNA; CARDIOMYOCYTE APOPTOSIS	Stresses that perturb the folding of nascent endoplasmic reticulum (ER) proteins activate the ER stress response. Upon ER stress, ER-associated ATF6 is cleaved; the resulting active cytosolic fragment of ATF6 translocates to the nucleus, binds to ER stress response elements (ERSEs), and induces genes, including the ER-targeted chaperone, GRP78. Recent studies showed that nutrient and oxygen starvation during tissue ischemia induce certain ER stress response genes, including GRP78; however, the role of ATF6 in mediating this induction has not been examined. In the current study, simulating ischemia (sI) in a primary cardiac myocyte model system caused a reduction in the level of ER-associated ATF6 with a coordinate increase of ATF6 in nuclear fractions. An ERSE in the GRP78 gene not previously shown to be required for induction by other ER stresses was found to bind ATF6 and to be critical for maximal ischemia-mediated GRP78 promoter induction. Activation of ATF6 and the GRP78 promoter, as well as grp78 mRNA accumulation during sI, were reversed upon simulated reperfusion (sI/R). Moreover, dominant-negative ATF6, or ATF6-targeted miRNA blocked sI-mediated grp78 induction, and the latter increased cardiac myocyte death upon simulated reperfusion, demonstrating critical roles for endogenous ATF6 in ischemia-mediated ER stress activation and cell survival. This is the first study to show that ATF6 is activated by ischemia but inactivated upon reperfusion, suggesting that it may play a role in the induction of ER stress response genes during ischemia that could have a preconditioning effect on cell survival during reperfusion.	San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Glembotski, CC (corresponding author), 5500 Campanile Dr, San Diego, CA 92182 USA.	cglembotski@sciences.sdsu.edu			National Institutes of Health [HL-075573, HL-085577]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085577, R01HL075573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-075573 and HL-085577.	Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bailey D, 2007, ANTIOXID REDOX SIGN, V9, P2305, DOI 10.1089/ars.2007.1796; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bose AK, 2007, CARDIOVASC DRUG THER, V21, P253, DOI 10.1007/s10557-007-6030-6; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chun YS, 2001, J CELL SCI, V114, P4051; Craig R, 2001, J BIOL CHEM, V276, P37621, DOI 10.1074/jbc.M103276200; Dudgeon DD, 2008, EUKARYOT CELL, V7, P2037, DOI 10.1128/EC.00291-08; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Gothie E, 2000, J BIOL CHEM, V275, P6922, DOI 10.1074/jbc.275.10.6922; Gustafsson AB, 2008, J MOL CELL CARDIOL, V44, P654, DOI 10.1016/j.yjmcc.2008.01.010; Hamada H, 2004, MOL CELL BIOL, V24, P8007, DOI 10.1128/MCB.24.18.8007-8017.2004; Harpster MH, 2006, MAMM GENOME, V17, P701, DOI 10.1007/s00335-005-0120-1; Hausenloy DJ, 2007, HEART, V93, P649, DOI 10.1136/hrt.2007.118828; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Law AYS, 2008, EXP CELL RES, V314, P1823, DOI 10.1016/j.yexcr.2008.03.001; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; May D, 2005, ONCOGENE, V24, P1011, DOI 10.1038/sj.onc.1208325; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oida Y, 2008, BRAIN RES, V1208, P217, DOI 10.1016/j.brainres.2008.02.068; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pan Y. C., 2004, PROGR ELECTROMAGNETI, V44, P1; Paris S, 2005, FEBS LETT, V579, P105, DOI 10.1016/j.febslet.2004.11.055; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Prachasilchai W, 2008, EUR J PHARMACOL, V592, P138, DOI 10.1016/j.ejphar.2008.06.108; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Roy B, 1996, J BIOL CHEM, V271, P28995, DOI 10.1074/jbc.271.46.28995; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Thuerauf DJ, 2004, J BIOL CHEM, V279, P21078, DOI 10.1074/jbc.M400713200; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Thuerauf DJ, 2007, J BIOL CHEM, V282, P22865, DOI 10.1074/jbc.M701213200; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Truettner JS, 2009, BRAIN RES, V1249, P9, DOI 10.1016/j.brainres.2008.10.032; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Vitadello M, 2003, FASEB J, V17, P923, DOI 10.1096/fj.02-0644fje; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang Q, 1997, NUCLEIC ACIDS RES, V25, P2800, DOI 10.1093/nar/25.14.2800; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yoshida H, 2007, ANTIOXID REDOX SIGN, V9, P2323, DOI 10.1089/ars.2007.1800; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	78	124	140	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29735	29745		10.1074/jbc.M109.018036	http://dx.doi.org/10.1074/jbc.M109.018036			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19622751	hybrid, Green Published			2022-12-27	WOS:000270896800055
J	Kuronuma, K; Mitsuzawa, H; Takeda, K; Nishitani, C; Chan, ED; Kuroki, Y; Nakamura, M; Voelker, DR				Kuronuma, Koji; Mitsuzawa, Hiroaki; Takeda, Katsuyuki; Nishitani, Chiaki; Chan, Edward D.; Kuroki, Yoshio; Nakamura, Mari; Voelker, Dennis R.			Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS SYNDROME; ACUTE LUNG INJURY; PROINFLAMMATORY CYTOKINE BIOSYNTHESIS; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; KINASE PHOSPHATASE-1; LPS; ACTIVATION; LIPIDS; GENE	Lipopolysaccharide (LPS), derived from Gram-negative bacteria, is a major cause of acute lung injury and respiratory distress syndrome. Pulmonary surfactant is secreted as a complex mixture of lipids and proteins onto the alveolar surface of the lung. Surfactant phospholipids are essential in reducing surface tension at the air-liquid interface and preventing alveolar collapse at the end of the respiratory cycle. In the present study, we determined that palmitoyl-oleoyl-phosphatidylglycerol and phosphatidylinositol, which are minor components of pulmonary surfactant, and synthetic dimyristoylphosphatidylglycerol regulated the inflammatory response of alveolar macrophages. The anionic lipids significantly inhibited LPS-induced nitric oxide and tumor necrosis factor-alpha production from rat and human alveolar macrophages and a U937 cell line by reducing the LPS-elicited phosphorylation of multiple intracellular protein kinases. The anionic lipids were also effective at attenuating inflammation when administered intratracheally to mice challenged with LPS. Binding studies revealed high affinity interactions between the palmitoyl-oleoyl-phosphatidylglycerol and the Toll-like receptor 4-interacting proteins CD14 and MD-2. Our data clearly identify important anti-inflammatory properties of the minor surfactant phospholipids at the environmental interface of the lung.	[Kuronuma, Koji; Mitsuzawa, Hiroaki; Chan, Edward D.; Nakamura, Mari; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Takeda, Katsuyuki] Natl Jewish Hlth, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA; [Nishitani, Chiaki; Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	National Jewish Health; National Jewish Health; Sapporo Medical University	Voelker, DR (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njc.org			National Institutes of Health [PHL 073907]; GCRC [M01-RR00051]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants PHL 073907 and GCRC M01-RR00051.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Atabai K, 2002, THORAX, V57, P452, DOI 10.1136/thorax.57.5.452; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; CLEMENTS JA, 1957, P SOC EXP BIOL MED, V95, P170; Cunningham MD, 2000, J IMMUNOL, V164, P3255, DOI 10.4049/jimmunol.164.6.3255; DING AH, 1988, J IMMUNOL, V141, P2407; DOBBS LG, 1978, AM REV RESPIR DIS, V118, P705, DOI 10.1164/arrd.1978.118.4.705; Flotte TR, 2001, CHEST, V120, p124S, DOI 10.1378/chest.120.3_suppl.124S; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Hashimoto M, 2003, J BIOL CHEM, V278, P44205, DOI 10.1074/jbc.M306735200; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hite RD, 2005, AM J PHYSIOL-LUNG C, V288, pL610, DOI 10.1152/ajplung.00273.2004; HONDA Y, 1988, LUNG, V166, P293, DOI 10.1007/BF02714060; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KING RJ, 1973, AM J PHYSIOL, V224, P788, DOI 10.1152/ajplegacy.1973.224.4.788; KUROKI Y, 1994, J BIOL CHEM, V269, P29793; KUROKI Y, 1988, J BIOL CHEM, V263, P3388; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; LEWIS JF, 1993, AM REV RESPIR DIS, V147, P218, DOI 10.1164/ajrccm/147.1.218; Markart P, 2007, THORAX, V62, P588, DOI 10.1136/thx.2006.062398; MCCORMACK FX, 1991, AM REV RESPIR DIS, V144, P160, DOI 10.1164/ajrccm/144.1.160; MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mueller M, 2005, J IMMUNOL, V174, P1091, DOI 10.4049/jimmunol.174.2.1091; Nag K, 1998, BIOPHYS J, V74, P2983, DOI 10.1016/S0006-3495(98)78005-1; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; O'Reilly D., 1992, BACULOVIRUS EXPRESSI, P109; OBRIEN AD, 1980, J IMMUNOL, V124, P20; PATTLE RE, 1955, NATURE, V175, P1125, DOI 10.1038/1751125b0; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Saydain G, 2002, AM J RESP CRIT CARE, V166, P839, DOI 10.1164/rccm.2104038; Schmidt R, 2002, AM J PHYSIOL-LUNG C, V283, pL1079, DOI 10.1152/ajplung.00484.2001; Schmidt R, 2001, AM J RESP CRIT CARE, V163, P95, DOI 10.1164/ajrccm.163.1.9903029; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; Wang PY, 1998, J BIOL CHEM, V273, P24309, DOI 10.1074/jbc.273.38.24309; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wright SM, 2000, J APPL PHYSIOL, V89, P1283, DOI 10.1152/jappl.2000.89.4.1283; Wu WI, 2000, J BIOL CHEM, V275, P14446, DOI 10.1074/jbc.275.19.14446; Wu YZ, 2003, AM J RESP CRIT CARE, V168, P692, DOI 10.1164/rccm.200304-467OC; Wuyts A, 1996, J IMMUNOL, V157, P1736; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	57	107	107	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25488	25500		10.1074/jbc.M109.040832	http://dx.doi.org/10.1074/jbc.M109.040832			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19584052	Green Published, hybrid			2022-12-27	WOS:000269738000006
J	Derler, I; Fahrner, M; Muik, M; Lackner, B; Schindl, R; Groschner, K; Romanin, C				Derler, Isabella; Fahrner, Marc; Muik, Martin; Lackner, Barbara; Schindl, Rainer; Groschner, Klaus; Romanin, Christoph			A Ca2+ Release-activated Ca2+ (CRAC) Modulatory Domain (CMD) within STIM1 Mediates Fast Ca2+-dependent Inactivation of ORAI1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; CALCIUM SENSOR; T-LYMPHOCYTES; EF-HAND; ENTRY; PERMEATION; DEPLETION; CELLS; SELECTIVITY	STIM1 and ORAI1, the two limiting components in the Ca2+ release-activated Ca2+ (CRAC) signaling cascade, have been reported to interact upon store depletion, culminating in CRAC current activation. We have recently identified a modulatory domain between amino acids 474 and 485 in the cytosolic part of STIM1 that comprises 7 negatively charged residues. A STIM1 C-terminal fragment lacking this domain exhibits enhanced interaction with ORAI1 and 2-3-fold higher ORAI1/CRAC current densities. Here we focused on the role of this CRAC modulatory domain (CMD) in the fast inactivation of ORAI1/CRAC channels, utilizing the whole-cell patch clamp technique. STIM1 mutants either with C-terminal deletions including CMD or with 7 alanines replacing the negative amino acids within CMD gave rise to ORAI1 currents that displayed significantly reduced or even abolished inactivation when compared with STIM1 mutants with preserved CMD. Consistent results were obtained with cytosolic C-terminal fragments of STIM1, both in ORAI1-expressing HEK 293 cells and in RBL-2H3 mast cells containing endogenous CRAC channels. Inactivation of the latter, however, was much more pronounced than that of ORAI1. The extent of inactivation of ORAI3 channels, which is also considerably more prominent than that of ORAI1, was also substantially reduced by co-expression of STIM1 constructs missing CMD. Regarding the dependence of inactivation on Ca2+, a decrease in intracellular Ca2+ chelator concentrations promoted ORAI1 current fast inactivation, whereas Ba2+ substitution for extracellular Ca2+ completely abrogated it. In summary, CMD within the STIM1 cytosolic part provides a negative feedback signal to Ca2+ entry by triggering fast Ca2+-dependent inactivation of ORAI/CRAC channels.	[Derler, Isabella; Fahrner, Marc; Muik, Martin; Lackner, Barbara; Schindl, Rainer; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharm, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Romanin, C (corresponding author), Univ Linz, Inst Biophys, A-4040 Linz, Austria.	christoph.romanin@jku.at	Groschner, Klaus/A-2550-2010; Fahrner, Marc/AAI-7927-2021; Derler, Isabella/B-7871-2019; Romanin, Christoph/D-5399-2009; Schindl, Rainer/E-3959-2013; Schindl, Rainer/V-4205-2019	Groschner, Klaus/0000-0002-8659-377X; Derler, Isabella/0000-0002-4768-146X; Romanin, Christoph/0000-0003-3756-4136; Schindl, Rainer/0000-0003-0896-8887; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Foundation (FWF) [P19820];  [P21118];  [W1201]	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); ; 	This work was supported by the Austrian Science Foundation (FWF) Project P19820 (to K. G.) and Project P21118 as well as Subproject 11 within W1201 (to C. R.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bakowski D, 2007, CELL CALCIUM, V42, P333, DOI 10.1016/j.ceca.2007.01.005; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Parekh AB, 2003, J PHYSIOL-LONDON, V547, P333, DOI 10.1113/jphysiol.2002.034140; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Scrimgeour N, 2009, J PHYSIOL-LONDON, V587, P2903, DOI 10.1113/jphysiol.2009.170662; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	39	94	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24933	24938		10.1074/jbc.C109.024083	http://dx.doi.org/10.1074/jbc.C109.024083			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19622747	Green Published, hybrid			2022-12-27	WOS:000269734000027
J	Gandhi, PS; Page, MJ; Chen, ZW; Bush-Pelc, L; Di Cera, E				Gandhi, Prafull S.; Page, Michael J.; Chen, Zhiwei; Bush-Pelc, Leslie; Di Cera, Enrico			Mechanism of the Anticoagulant Activity of Thrombin Mutant W215A/E217A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C ACTIVATOR; CRYSTAL-STRUCTURE; POTENT ANTICOAGULANT; MURINE THROMBIN; NA+ BINDING; SPECIFICITY; FIBRINOGEN; SITE; ENERGETICS; PROSTASIN	The thrombin mutant W215A/E217A (WE) is a potent anticoagulant both in vitro and in vivo. Previous x-ray structural studies have shown that WE assumes a partially collapsed conformation that is similar to the inactive E* form, which explains its drastically reduced activity toward substrate. Whether this collapsed conformation is genuine, rather than the result of crystal packing or the mutation introduced in the critical 215-217 beta-strand, and whether binding of thrombomodulin to exosite I can allosterically shift the E* form to the active E form to restore activity toward protein C are issues of considerable mechanistic importance to improve the design of an anticoagulant thrombin mutant for therapeutic applications. Here we present four crystal structures of WE in the human and murine forms that confirm the collapsed conformation reported previously under different experimental conditions and crystal packing. We also present structures of human and murine WE bound to exosite I with a fragment of the platelet receptor PAR1, which is unable to shift WE to the E form. These structural findings, along with kinetic and calorimetry data, indicate that WE is strongly stabilized in the E* form and explain why binding of ligands to exosite I has only a modest effect on the E*-E equilibrium for this mutant. The E* -> E transition requires the combined binding of thrombomodulin and protein C and restores activity of the mutant WE in the anticoagulant pathway.	[Gandhi, Prafull S.; Page, Michael J.; Chen, Zhiwei; Bush-Pelc, Leslie; Di Cera, Enrico] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, POB 8231, St Louis, MO 63110 USA.	enrico@wustl.edu			National Institutes of Health Research Grants [HL49413, HL58141, HL73813]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073813, R01HL049413, R01HL058141, R29HL049413] Funding Source: NIH RePORTER	National Institutes of Health Research Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grants HL49413, HL58141, and HL73813 ( to E. D. C.).	Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; AYALA YH, 1994, J MOL BIOL, V235, P733, DOI 10.1006/jmbi.1994.1024; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Bah A, 2009, J BIOL CHEM, V284, P20034, DOI 10.1074/jbc.M109.012344; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrette-Ng IH, 2002, J BIOL CHEM, V277, P39960, DOI 10.1074/jbc.M206978200; Bates SM, 2006, BRIT J HAEMATOL, V134, P3, DOI 10.1111/j.1365-2141.2006.06134.x; Berny MA, 2008, ARTERIOSCL THROM VAS, V28, P329, DOI 10.1161/ATVBAHA.107.156273; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bush LA, 2006, J BIOL CHEM, V281, P7183, DOI 10.1074/jbc.M512082200; Cantwell AM, 2000, J BIOL CHEM, V275, P39827, DOI 10.1074/jbc.C000751200; Carrell CJ, 2006, BIOPHYS CHEM, V121, P177, DOI 10.1016/j.bpc.2005.12.008; Carter WJ, 2004, J BIOL CHEM, V279, P26387, DOI 10.1074/jbc.M402364200; Carvalho AL, 2002, J MOL BIOL, V322, P325, DOI 10.1016/S0022-2836(02)00705-2; Dang QD, 1997, J BIOL CHEM, V272, P19649, DOI 10.1074/jbc.272.32.19649; Dang QD, 1997, NAT BIOTECHNOL, V15, P146, DOI 10.1038/nbt0297-146; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; Di Cera E, 2007, J THROMB HAEMOST, V5, P196; Di Cera E., 1995, THERMODYNAMIC THEORY; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; GRIFFIN JH, 1995, NATURE, V378, P337, DOI 10.1038/378337a0; Gruber A, 2006, J THROMB HAEMOST, V4, P392, DOI 10.1111/j.1538-7836.2006.01760.x; Gruber A, 2002, J BIOL CHEM, V277, P27581, DOI 10.1074/jbc.C200237200; Gruber A, 2007, BLOOD, V109, P3733, DOI 10.1182/blood-2006-07-035147; Hink-Schauer C, 2002, J BIOL CHEM, V277, P50923, DOI 10.1074/jbc.M207962200; Jing H, 1998, J MOL BIOL, V282, P1061, DOI 10.1006/jmbi.1998.2089; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; Marino F, 2007, J BIOL CHEM, V282, P16355, DOI 10.1074/jbc.M701323200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papaconstantinou ME, 2005, J BIOL CHEM, V280, P29393, DOI 10.1074/jbc.C500248200; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; Rickert KW, 2008, J BIOL CHEM, V283, P34864, DOI 10.1074/jbc.M805262200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Rohr KB, 2006, J MOL BIOL, V357, P195, DOI 10.1016/j.jmb.2005.12.037; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Spraggon G, 2009, PROTEIN SCI, V18, P1081, DOI 10.1002/pro.118; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; WU QY, 1991, P NATL ACAD SCI USA, V88, P6775, DOI 10.1073/pnas.88.15.6775; Wyman J., 1990, BINDING LINKAGE; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200	56	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24098	24105		10.1074/jbc.M109.025403	http://dx.doi.org/10.1074/jbc.M109.025403			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586901	hybrid, Green Published			2022-12-27	WOS:000269380200023
J	Lu, W; Laszlo, CF; Miao, ZX; Chen, H; Wu, SY				Lu, Wei; Laszlo, Csaba F.; Miao, Zhixin; Chen, Hao; Wu, Shiyong			The Role of Nitric-oxide Synthase in the Regulation of UVB Light-induced Phosphorylation of the alpha Subunit of Eukaryotic Initiation Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSFER-RNA-SYNTHETASE; HUMAN ENDOTHELIAL-CELLS; NF-KAPPA-B; TRANSLATIONAL CONTROL; MAMMALIAN HOMOLOG; PROTEIN; ACTIVATION; PEROXYNITRITE; APOPTOSIS	UV light induces phosphorylation of the alpha subunit of the eukaryotic initiation factor 2 (eIF2 alpha) and inhibits global protein synthesis. Both eIF2 kinases, protein kinase-like endoplasmic reticulum kinase (PERK) and general control of nonderepressible protein kinase 2 (GCN2), have been shown to phosphorylate eIF2 alpha in response to UV irradiation. However, the roles of PERK and GCN2 in UV-induced eIF2 alpha phosphorylation are controversial. The one or more upstream signaling pathways that lead to the activation of PERK or GCN2 remain unknown. In this report we provide data showing that both PERK and GCN2 contribute to UV-induced eIF2 alpha phosphorylation in human keratinocyte (HaCaT) and mouse embryonic fibroblast cells. Reduction of expression of PERK or GCN2 by small interfering RNA decreases phosphorylation of eIF2 alpha after UV irradiation. These data also show that nitric-oxide synthase (NOS)-mediated oxidative stress plays a role in regulation of eIF2 alpha phosphorylation upon UV irradiation. Treating the cells with the broad NOS inhibitor N-G-methyl-L-arginine, the free radical scavenger N-acetyl-L-cysteine, or the NOS substrate L-arginine partially inhibits UV-induced eIF2 alpha phosphorylation. The results presented above led us to propose that NOS mediates UV-induced eIF2 alpha phosphorylation by activation of both PERK and GCN2 via oxidative stress and L-arginine starvation signaling pathways.	[Lu, Wei; Laszlo, Csaba F.; Wu, Shiyong] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA; [Lu, Wei; Laszlo, Csaba F.; Miao, Zhixin; Chen, Hao; Wu, Shiyong] Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA; [Wu, Shiyong] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Wu, SY (corresponding author), Ohio Univ, Edison Biotechnol Inst, 101 Konneker Labs,Ridges Bldg 25, Athens, OH 45701 USA.	wus1@ohio.edu	Wu, Shiyong/I-3359-2013; Miao, Zhixin/G-2616-2013	Wu, Shiyong/0000-0002-4104-4160; 	National Institutes of Health [RO1 CA86928, R56 CA086928]; NATIONAL CANCER INSTITUTE [R01CA086928, R56CA086928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA86928 (to S. W.) and R56 CA086928 (to S. W.).	Allen DA, 2003, FASEB J, V17, P908, DOI 10.1096/fj.02-0130fje; Beattie PE, 2005, BRIT J DERMATOL, V152, P1001, DOI 10.1111/j.1365-2133.2005.06557.x; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Brostrom CO, 1996, J BIOL CHEM, V271, P24995, DOI 10.1074/jbc.271.40.24995; CLEMENS MJ, 1987, J BIOL CHEM, V262, P767; CRABEEL M, 1985, MOL CELL BIOL, V5, P3139, DOI 10.1128/MCB.5.11.3139; Crow J P, 1995, Adv Pharmacol, V34, P17; CURRAN RD, 1991, FASEB J, V5, P2085, DOI 10.1096/fasebj.5.7.1707021; DELICONSTANTINOS G, 1992, J CARDIOVASC PHARM, V20, pS63, DOI 10.1097/00005344-199204002-00019; DELICONSTANTINOS G, 1995, BRIT J PHARMACOL, V114, P1257, DOI 10.1111/j.1476-5381.1995.tb13341.x; Deliconstantinos G, 1996, EXP PHYSIOL, V81, P1021, DOI 10.1113/expphysiol.1996.sp003986; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Groves JT, 1999, CURR OPIN CHEM BIOL, V3, P226, DOI 10.1016/S1367-5931(99)80036-2; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HENDERSON LM, 1993, EUR J BIOCHEM, V217, P973, DOI 10.1111/j.1432-1033.1993.tb18328.x; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Huk I, 1997, CIRCULATION, V96, P667; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara K, 2001, FEBS LETT, V506, P135, DOI 10.1016/S0014-5793(01)02898-8; Kim YM, 1998, MOL MED, V4, P179, DOI 10.1007/BF03401915; KUBASZEWSKI E, 1994, BIOCHEM BIOPH RES CO, V200, P213, DOI 10.1006/bbrc.1994.1436; Kuchel JM, 2003, J INVEST DERMATOL, V121, P587, DOI 10.1046/j.1523-1747.2003.12415.x; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Malinski T, 2005, AM J CARDIOL, V96, p13I, DOI 10.1016/j.amjcard.2005.07.029; Mascarenhas C, 2008, MOL BIOL CELL, V19, P2995, DOI 10.1091/mbc.E07-11-1173; Ogawa Y, 2008, FREE RADICAL RES, V42, P674, DOI 10.1080/10715760802277396; Oh-Hashi K, 2001, FREE RADICAL BIO MED, V30, P213, DOI 10.1016/S0891-5849(00)00461-5; Oliver BL, 2005, J CELL PHYSIOL, V204, P45, DOI 10.1002/jcp.20261; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Parker SH, 2006, MOL CELL BIOCHEM, V293, P173, DOI 10.1007/s11010-006-9239-y; Pou S, 1999, J BIOL CHEM, V274, P9573, DOI 10.1074/jbc.274.14.9573; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Skoog D. A., 2007, PRINCIPLES INSTRUMEN, P13; SONENBERG N, 2000, TRANSLATION CONTROL, P547; Sood R, 2000, GENETICS, V154, P787; TYRRELL RM, 1986, PHOTOCHEM PHOTOBIOL, V44, P561, DOI 10.1111/j.1751-1097.1986.tb04709.x; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Weller R, 2002, SKIN PHARMACOL APPL, V15, P348, DOI 10.1159/000064540; Wiswedel I, 2007, FREE RADICAL RES, V41, P1017, DOI 10.1080/10715760701531430; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	48	37	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24281	24288		10.1074/jbc.M109.008821	http://dx.doi.org/10.1074/jbc.M109.008821			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586904	hybrid, Green Published			2022-12-27	WOS:000269380200041
J	Shell, SM; Li, ZK; Shkriabai, N; Kvaratskhelia, M; Brosey, C; Serrano, MA; Chazin, WJ; Musich, PR; Zou, Y				Shell, Steven M.; Li, Zhengke; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka; Brosey, Chris; Serrano, Moises A.; Chazin, Walter J.; Musich, Phillip R.; Zou, Yue			Checkpoint Kinase ATR Promotes Nucleotide Excision Repair of UV-induced DNA Damage via Physical Interaction with Xeroderma Pigmentosum Group A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-PROTEIN-A; STRUCTURAL BASIS; XPA; BINDING; RECOGNITION; HELIX; DOMAIN; CELLS; ELECTROSTATICS; IRRADIATION	In response to DNA damage, eukaryotic cells activate a series of DNA damage-dependent pathways that serve to arrest cell cycle progression and remove DNA damage. Coordination of cell cycle arrest and damage repair is critical for maintenance of genomic stability. However, this process is still poorly understood. Nucleotide excision repair (NER) and the ATR-dependent cell cycle checkpoint are the major pathways responsible for repair of UV-induced DNA damage. Here we show that ATR physically interacts with the NER factor Xeroderma pigmentosum group A (XPA). Using a mass spectrometry-based protein footprinting method, we found that ATR interacts with a helix-turn-helix motif in the minimal DNA-binding domain of XPA where an ATR phosphorylation site (serine 196) is located. XPA-deficient cells complemented with XPA containing a point mutation of S196A displayed a reduced repair efficiency of cyclobutane pyrimidine dimers as compared with cells complemented with wild-type XPA, although no effect was observed for repair of (6-4) photoproducts. This suggests that the ATR-dependent phosphorylation of XPA may promote NER repair of persistent DNA damage. In addition, a K188A point mutation of XPA that disrupts the ATR-XPA interaction inhibits the nuclear import of XPA after UV irradiation and, thus, significantly reduced DNA repair efficiency. By contrast, the S196A mutation has no effect on XPA nuclear translocation. Taken together, our results suggest that the ATR-XPA interaction mediated by the helix-turn-helix motif of XPA plays an important role in DNA-damage responses to promote cell survival and genomic stability after UV irradiation.	[Shell, Steven M.; Li, Zhengke; Serrano, Moises A.; Musich, Phillip R.; Zou, Yue] E Tennessee State Univ, James H Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA; [Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Brosey, Chris; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Brosey, Chris; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Brosey, Chris; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	East Tennessee State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zou, Y (corresponding author), E Tennessee State Univ, James H Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA.	zouy@etsu.edu	Classen, Scott/AAY-8176-2020; Zou, Yue/ABA-8429-2020; Li, Zhengke/J-8527-2016	Li, Zhengke/0000-0001-5560-343X; Musich, Phillip/0000-0001-8816-4242; Serrano, Moises/0000-0002-1037-9304	National Institutes of Health [CA86927, AG031503, AI077341, GM065484, CA092584]; NATIONAL CANCER INSTITUTE [R01CA086927, R56CA086927, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI077341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065484, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG031503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA86927 and AG031503 (to Y. Z.), AI077341 (to M. K.), and GM065484 and CA092584 (to W. J. C.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Aurora R, 1997, J BIOL CHEM, V272, P1413, DOI 10.1074/jbc.272.3.1413; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; BLAGDON DE, 1975, BIOPOLYMERS, V14, P241, DOI 10.1002/bip.1975.360140118; Buchko GW, 1999, BIOCHEMISTRY-US, V38, P15116, DOI 10.1021/bi991755p; Buchko GW, 2001, NUCLEIC ACIDS RES, V29, P2635, DOI 10.1093/nar/29.12.2635; Case D, 2006, AMBER 9; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Cleaver JE, 1997, BIOCHEM J, V328, P1, DOI 10.1042/bj3280001; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Croteau DL, 2008, DNA REPAIR, V7, P819, DOI 10.1016/j.dnarep.2008.01.018; DeLano W.L, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Guzder SN, 2006, MOL CELL BIOL, V26, P1135, DOI 10.1128/MCB.26.3.1135-1141.2006; Kobayashi N, 2001, PIGM CELL RES, V14, P94, DOI 10.1034/j.1600-0749.2001.140204.x; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; LEE SH, 1995, J BIOL CHEM, V270, P12801, DOI 10.1074/jbc.270.21.12801; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Lerner MG, 2006, APBS PLUGIN PYMOL; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Park CJ, 2006, FEBS J, V273, P1600, DOI 10.1111/j.1742-4658.2006.05189.x; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shell SM, 2005, BIOCHEMISTRY-US, V44, P971, DOI 10.1021/bi048208a; Shell SM, 2008, ADV EXP MED BIOL, V637, P103; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; SHOEMAKER KR, 1987, NATURE, V326, P563, DOI 10.1038/326563a0; SHOEMAKER KR, 1985, P NATL ACAD SCI USA, V82, P2349, DOI 10.1073/pnas.82.8.2349; Tripsianes K, 2007, NUCLEIC ACIDS RES, V35, P5789, DOI 10.1093/nar/gkm503; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	45	60	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24213	24222		10.1074/jbc.M109.000745	http://dx.doi.org/10.1074/jbc.M109.000745			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586908	hybrid, Green Published			2022-12-27	WOS:000269380200035
J	Li, YJ; Bolderson, E; Kumar, R; Muniandy, PA; Xue, YT; Richard, DJ; Seidman, M; Pandita, TK; Khanna, KK; Wang, WD				Li, Yongjiang; Bolderson, Emma; Kumar, Rakesh; Muniandy, Parameswary A.; Xue, Yutong; Richard, Derek J.; Seidman, Michael; Pandita, Tej K.; Khanna, Kum Kum; Wang, Weidong			hSSB1 and hSSB2 Form Similar Multiprotein Complexes That Participate in DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; BLOOMS-SYNDROME PROTEIN; RNA-POLYMERASE-II; TOPOISOMERASE-I; FANCONI-ANEMIA; RAD52 PROTEIN; BINDING; REPAIR; STABILITY	hSSB1 (human single strand DNA-binding protein 1) has been shown to participate in homologous recombination (HR)dependent repair of DNA double strand breaks (DSBs) and ataxia telangiectasia-mutated (ATM)-mediated checkpoint pathways. Here we present evidence that hSSB2, a homolog of hSSB1, plays a role similar to hSSB1 in DNA damage-response pathways. This was evidenced by findings that hSSB2-depleted cells resemble hSSB1-depleted cells in hypersensitivity to DNA-damaging reagents, reduced efficiency in HR-dependent repair of DSBs, and defective ATM-dependent phosphorylation. Notably, hSSB1 and hSSB2 form separate complexes with two identical proteins, INTS3 and hSSBIP1 (C9ORF80). Cells depleted of INTS3 and hSSBIP1 also exhibited hypersensitivity to DNA damage reagents, chromosomal instability, and reduced ATM-dependent phosphorylation. hSSBIP1 was rapidly recruited to laser-induced DSBs, a feature also similar to that reported for hSSB1. Depletion of INTS3 decreased the stability of hSSB1 and hSSBIP1, suggesting that INTS3 may provide a scaffold to allow proper assembly of the hSSB complexes. Thus, our data demonstrate that hSSB1 and hSSB2 form two separate complexes with similar structures, and both are required for efficient HR-dependent repair of DSBs and ATM-dependent signaling pathways.	[Li, Yongjiang; Xue, Yutong; Wang, Weidong] NIA, Genet Lab, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Muniandy, Parameswary A.; Seidman, Michael] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Bolderson, Emma; Richard, Derek J.; Khanna, Kum Kum] Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4029, Australia; [Kumar, Rakesh; Pandita, Tej K.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); QIMR Berghofer Medical Research Institute; Washington University (WUSTL)	Wang, WD (corresponding author), 251 Bayview Blvd,Rm 10B113, Baltimore, MD 21224 USA.	wangw@grc.nia.nih.gov	Richard, Derek/J-1338-2012; Bolderson, Emma/B-8743-2013; Wang, Weidong/AAV-2446-2021; Khanna, Kum Kum/I-1747-2013; Pandita, Tej K/AAM-9188-2020	Richard, Derek/0000-0002-4839-8471; kumar, rakesh/0000-0002-0741-3663; Bolderson, Emma/0000-0002-2849-1177; Wang, Weidong/0000-0002-0658-7928; Khanna, Kum Kum/0000-0001-8650-5381	National Institutes of Health [Z01: AG000657-09]; National Institute on Aging and National Institutes of Health [CA123232, CA129537]; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE ON AGING [ZIAAG000746, ZIAAG000747, ZIAAG000661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging and National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01: AG000657-09 from the Intramural Research Program of the National Institute on Aging and National Institutes of Health Grants CA123232 and CA129537 (to T. K. P.). This work was also supported by a grant from the National Health and Medical Research Council of Australia (to K. K. K.).	Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Inagaki Y, 2008, CANCER GENET CYTOGEN, V180, P30, DOI 10.1016/j.cancergencyto.2007.09.013; Jacobs EY, 2004, MOL CELL BIOL, V24, P846, DOI 10.1128/MCB.24.2.846-855.2004; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Liu Y, 2008, GENE DEV, V22, P2737, DOI 10.1101/gad.1732808; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; New JH, 2002, J BIOL CHEM, V277, P26171, DOI 10.1074/jbc.M203670200; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Uguen P, 2003, EMBO J, V22, P4544, DOI 10.1093/emboj/cdg430; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	29	76	85	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23525	23531		10.1074/jbc.C109.039586	http://dx.doi.org/10.1074/jbc.C109.039586			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19605351	Green Published, hybrid			2022-12-27	WOS:000269180000037
J	Argueso, P; Guzman-Aranguez, A; Mantelli, F; Cao, ZY; Ricciuto, J; Panjwani, N				Argueso, Pablo; Guzman-Aranguez, Ana; Mantelli, Flavio; Cao, Zhiyi; Ricciuto, Jessica; Panjwani, Noorjahan			Association of Cell Surface Mucins with Galectin-3 Contributes to the Ocular Surface Epithelial Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CORNEAL-LIMBAL; HUMAN BREAST; DRY EYE; ADHESION; EXPRESSION; CANCER; BINDING; BETA-1,3-GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN; GLYCANS	Maintenance of an intact mucosal barrier is critical to preventing damage to and infection of wet-surfaced epithelia. The mechanism of defense has been the subject of much investigation, and there is evidence now implicating O-glycosylated mucins on the epithelial cell surface. Here we investigate a new role for the carbohydrate-binding protein galectin-3 in stabilizing mucosal barriers through its interaction with mucins on the apical glycocalyx. Using the surface of the eye as a model system, we found that galectin-3 colocalized with two distinct membrane-associated mucins, MUC1 and MUC16, on the apical surface of epithelial cells and that both mucins bound to galectin-3 affinity columns in a galactose-dependent manner. Abrogation of the mucin-galectin interaction in four different mucosal epithelial cell types using competitive carbohydrate inhibitors of galectin binding, beta-lactose and modified citrus pectin, resulted in decreased levels of galectin-3 on the cell surface with concomitant loss of barrier function, as indicated by increased permeability to rose bengal diagnostic dye. Similarly, down-regulation of mucin O-glycosylation using a stable tetracycline-inducible RNA interfering system to knockdown c1galt1 (T-synthase), a critical galactosyltransferase required for the synthesis of core 1 O-glycans, resulted in decreased cell surface O-glycosylation, reduced cell surface galectin-3, and increased epithelial permeability. Taken together, these results suggest that galectin-3 plays a key role in maintaining mucosal barrier function through carbohydrate-dependent interactions with cell surface mucins.	[Argueso, Pablo; Guzman-Aranguez, Ana; Mantelli, Flavio; Ricciuto, Jessica] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; [Argueso, Pablo; Guzman-Aranguez, Ana; Mantelli, Flavio; Ricciuto, Jessica] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; [Cao, Zhiyi; Panjwani, Noorjahan] Ctr Vis Res, Dept Ophthalmol, Boston, MA 02114 USA; [Cao, Zhiyi; Panjwani, Noorjahan] New England Eye Ctr, Boston, MA 02114 USA; [Panjwani, Noorjahan] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Tufts University	Argueso, P (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	pablo.argueso@schepens.harvard.edu	guzman, ana/Y-8286-2019	Argueso, Pablo/0000-0001-7321-9503; Guzman-Aranguez, Ana/0000-0001-6722-2044	National Institutes of Health [R01EY014847, R01EY07088]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY007088, R01EY014847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY014847 (to P. A.) and R01EY07088 (to N. P.) (NEI), and a challenge grant from Research to Prevent Blindness (to Tufts medical center).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; ALBERSHEIM P, 1960, ARCH BIOCHEM BIOPHYS, V90, P46, DOI 10.1016/0003-9861(60)90609-3; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Argueso P, 2006, INVEST OPHTH VIS SCI, V47, P113, DOI 10.1167/iovs.05-0735; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bauer H, 1999, EXP CELL RES, V250, P434, DOI 10.1006/excr.1999.4558; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Bresalier RS, 1996, CANCER RES, V56, P4354; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; CHILDERS NK, 1989, ANNU REV MICROBIOL, V43, P503, DOI 10.1146/annurev.mi.43.100189.002443; Davies D E, 2001, Curr Allergy Asthma Rep, V1, P127, DOI 10.1007/s11882-001-0080-9; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; FEENSTRA RPG, 1992, OPHTHALMOLOGY, V99, P605; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gipson IK, 2007, OCUL SURF, V5, P179; Glinsky VV, 2001, CANCER RES, V61, P4851; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; HO MK, 1982, J IMMUNOL, V128, P1221; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; INOHARA H, 1995, CANCER RES, V55, P3267; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kardon R, 1999, INVEST OPHTH VIS SCI, V40, P1328; Khaldoyanidi SK, 2003, J BIOL CHEM, V278, P4127, DOI 10.1074/jbc.M209590200; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Mantelli F, 2009, INVEST OPHTH VIS SCI, V50, P2666, DOI 10.1167/iovs.08-2734; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Qin W, 2005, J INTERN MED, V258, P467, DOI 10.1111/j.1365-2796.2005.01558.x; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Ryeom SW, 2000, MOL BIOL CELL, V11, P1687, DOI 10.1091/mbc.11.5.1687; STEPP MA, 1993, INVEST OPHTH VIS SCI, V34, P1829; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200	37	188	189	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23037	23045		10.1074/jbc.M109.033332	http://dx.doi.org/10.1074/jbc.M109.033332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19556244	hybrid, Green Published			2022-12-27	WOS:000268963100056
J	Das, S; Harris, LG; Metge, BJ; Liu, SH; Riker, AI; Samant, RS; Shevde, LA				Das, Shamik; Harris, Lillianne G.; Metge, Brandon J.; Liu, Suhu; Riker, Adam I.; Samant, Rajeev S.; Shevde, Lalita A.			The Hedgehog Pathway Transcription Factor GLI1 Promotes Malignant Behavior of Cancer Cells by Up-regulating Osteopontin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; HUMAN BREAST-CANCER; MDA-MB-435 CELLS; SIGNALING PATHWAY; MELANOMA-CELLS; GROWTH-FACTOR; TUMOR-GROWTH; METASTASIS; EXPRESSION; ACTIVATION	The role of Hedgehog (Hh) signaling as a developmental pathway is well established. Several recent studies have implicated a role for this pathway in multiple cancers. In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens. We have further determined that OPN is a direct transcriptional target of GLI1. We have observed that OPN expression is stimulated in the presence of Hh ligands and inhibited in the presence of the Smoothened (SMO) inhibitor, cyclopamine. Transcriptional silencing of GLI1 negatively impacts OPN expression and compromises the ability of cancer cells to proliferate, migrate, and invade in vitro and interferes with their ability to grow as xenografts and spontaneously metastasize in nude mice. These altered attributes could be rescued by re-expressing OPN in the GLI1-silenced cells, suggesting that OPN is a critical downstream effector of active GLI1 signaling. Our observations lead us to conclude that the GLI1-mediated up-regulation of OPN promotes malignant behavior of cancer cells.	[Das, Shamik; Harris, Lillianne G.; Metge, Brandon J.; Liu, Suhu; Samant, Rajeev S.; Shevde, Lalita A.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Riker, Adam I.] Ochsner Canc Inst, Dept Surg, New Orleans, LA 70121 USA	University of South Alabama; Ochsner Health System	Shevde, LA (corresponding author), MCI 3018,1660 Springhill Ave, Mobile, AL 36604 USA.	lsamant@usouthal.edu		Samant, Rajeev/0000-0001-5681-4976	United States Department of Defense IDEA Award [07-1-0400]	United States Department of Defense IDEA Award(United States Department of Defense)	This work was supported by United States Department of Defense IDEA Award 07-1-0400 (to L.A.S.).	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bar-Eli M, 2007, PIGM CELL RES, V20, P341, DOI 10.1111/j.1600-0749.2007.00404.x; Bayless KJ, 1998, J CELL SCI, V111, P1165; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; BROWN LF, 1994, AM J PATHOL, V145, P610; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hayashi C, 2007, J CELL BIOCHEM, V101, P979, DOI 10.1002/jcb.21298; Hedley BD, 2008, INT J CANCER, V123, P526, DOI 10.1002/ijc.23542; HU DD, 1995, ANN NY ACAD SCI, V760, P312, DOI 10.1111/j.1749-6632.1995.tb44644.x; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, OSTEOARTHR CARTILAGE, V16, P70, DOI 10.1016/j.joca.2007.05.014; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Katagiri YU, 1999, CANCER RES, V59, P219; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Lacroix M, 2009, CANCER CHEMOTH PHARM, V63, P567, DOI 10.1007/s00280-008-0776-9; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; LIAW L, 1995, CIRC RES, V77, P665, DOI 10.1161/01.RES.77.4.665; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Nagase H, 1992, Matrix Suppl, V1, P237; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Pazolli E, 2009, CANCER RES, V69, P1230, DOI 10.1158/0008-5472.CAN-08-2970; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rae JM, 2004, CLIN EXP METASTAS, V21, P543, DOI 10.1007/s10585-004-3759-1; Rangaswami H, 2007, ONCOL REP, V18, P909; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; SADOWSKI HB, 1993, NATURE, V362, P79, DOI 10.1038/362079a0; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Seftor REB, 1999, CANCER METAST REV, V18, P359, DOI 10.1023/A:1006317125454; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Sharp JA, 1999, LAB INVEST, V79, P869; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Thayer Sarah, 2004, Clin Adv Hematol Oncol, V2, P63; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tuck AB, 2003, ONCOGENE, V22, P1198, DOI 10.1038/sj.onc.1206209; Tuck AB, 2000, J CELL BIOCHEM, V78, P465, DOI 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C; Tuck AB, 1999, ONCOGENE, V18, P4237, DOI 10.1038/sj.onc.1202799; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Urquidi V, 2002, CLIN CANCER RES, V8, P61; Varner J A, 1999, Angiogenesis, V3, P53, DOI 10.1023/A:1009019223744; Wai PY, 2006, SURGERY, V140, P132, DOI 10.1016/j.surg.2006.02.005; Watkins DN, 2003, CELL CYCLE, V2, P196, DOI 10.4161/cc.2.3.378; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wu YD, 2009, J BIOL CHEM, V284, P640, DOI 10.1074/jbc.M806916200; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Xuan YH, 2009, J CANCER RES CLIN, V135, P235, DOI 10.1007/s00432-008-0451-x; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3	69	93	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22888	22897		10.1074/jbc.M109.021949	http://dx.doi.org/10.1074/jbc.M109.021949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19556240	Green Published, hybrid			2022-12-27	WOS:000268963100042
J	Mccoll, G; Roberts, BR; Gunn, AP; Perez, KA; Tew, DJ; Masters, CL; Barnham, KJ; Cherny, RA; Bush, AI				Mccoll, Gawain; Roberts, Blaine R.; Gunn, Adam P.; Perez, Keyla A.; Tew, Deborah J.; Masters, Colin L.; Barnham, Kevin J.; Cherny, Robert A.; Bush, Ashley I.			The Caenorhabditis elegans A beta(1-42) Model of Alzheimer Disease Predominantly Expresses A beta(3-42)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYLOID PEPTIDE; A-BETA; GLUTAMINYL CYCLASE; INVERTEBRATE MODELS; IN-VITRO; AGGREGATION; PYROGLUTAMATE; PROTEIN; HYPOTHESIS; BRAIN	Transgenic expression of human amyloid beta (A beta) peptide in body wall muscle cells of Caenorhabditis elegans has been used to better understand aspects of Alzheimer disease (AD). In human aging and AD, A beta undergoes post-translational changes including covalent modifications, truncations, and oligomerization. Amino truncated A beta is increasingly recognized as potentially contributing to AD pathogenesis. Here we describe surface-enhanced laser desorption ionization-time of flight mass spectrometry mass spectrometry of A beta peptide in established transgenic C. elegans lines. Surprisingly, the A beta being expressed is not full-length 1-42 (amino acids) as expected but rather a 3-42 truncation product. In vitro analysis demonstrates that A beta(3-42) self-aggregates like A beta(1-42), but more rapidly, and forms fibrillar structures. Similarly, A beta(3-42) is also the more potent initiator of A beta(1-40) aggregation. Seeded aggregation via A beta(3-42) is further enhanced via co-incubation with the transition metal Cu(II). Although unexpected, the C. elegans model of A beta expression can now be co-opted to study the proteotoxic effects and processing of A beta(3-42).	[Mccoll, Gawain; Roberts, Blaine R.; Gunn, Adam P.; Perez, Keyla A.; Tew, Deborah J.; Masters, Colin L.; Barnham, Kevin J.; Cherny, Robert A.; Bush, Ashley I.] Mental Hlth Res Inst, AIB, Parkville, Vic 3052, Australia; [Mccoll, Gawain; Roberts, Blaine R.; Gunn, Adam P.; Masters, Colin L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Perez, Keyla A.; Tew, Deborah J.; Barnham, Kevin J.; Cherny, Robert A.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Perez, Keyla A.; Tew, Deborah J.; Barnham, Kevin J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne	Bush, AI (corresponding author), Mental Hlth Res Inst, AIB, 155 Oak St, Parkville, Vic 3052, Australia.	a.bush@mhri.edu.au	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Gunn, Adam P/D-5437-2012; McColl, Gawain/Y-8959-2018	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Gunn, Adam P/0000-0002-8181-4975; Roberts, Blaine/0000-0001-5466-0053; McColl, Gawain/0000-0002-6347-6722	Australian Research Council; National Health and Medical Research Council; AGL Shaw Trust; Harold and Cora Brennan Benevolent Trust; Marian and E. H. Flack Trust; Victorian State Government	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); AGL Shaw Trust; Harold and Cora Brennan Benevolent Trust; Marian and E. H. Flack Trust; Victorian State Government	This work was supported by funds from the Australian Research Council, National Health and Medical Research Council, AGL Shaw Trust, Harold and Cora Brennan Benevolent Trust, the Marian and E. H. Flack Trust, and the Operational Infrastructure Support program of the Victorian State Government.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bianchi Laura, 2006, WormBook, P1; Boyd-Kimball D, 2006, NEUROBIOL AGING, V27, P1239, DOI 10.1016/j.neurobiolaging.2005.07.001; Bush AI, 2008, J ALZHEIMERS DIS, V15, P223; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fay DS, 1998, J NEUROCHEM, V71, P1616; Florez-McClure ML, 2007, AUTOPHAGY, V3, P569, DOI 10.4161/auto.4776; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Klafki HW, 1996, ANAL BIOCHEM, V237, P24, DOI 10.1006/abio.1996.0195; Kraemer B, 2007, INT REV NEUROBIOL, V77, P219, DOI 10.1016/S0074-7742(06)77007-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, MECH AGEING DEV, V122, P1639, DOI 10.1016/S0047-6374(01)00291-3; Link CD, 2005, GENES BRAIN BEHAV, V4, P147, DOI 10.1111/j.1601-183X.2004.00105.x; Maler JM, 2007, PROTEOMICS, V7, P3815, DOI 10.1002/pmic.200700311; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Minniti AN, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-2; Miura T, 2004, J INORG BIOCHEM, V98, P10, DOI 10.1016/j.jinorgbio.2003.10.008; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; POHL T, 1991, P NATL ACAD SCI USA, V88, P10059, DOI 10.1073/pnas.88.22.10059; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schilling S, 2008, J NEUROCHEM, V106, P1225, DOI 10.1111/j.1471-4159.2008.05471.x; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; Shirotani K, 2002, NEUROSCI LETT, V327, P25, DOI 10.1016/S0304-3940(02)00351-8; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Sykes PA, 1999, FEBS LETT, V455, P159, DOI 10.1016/S0014-5793(99)00872-8; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008	50	96	96	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22697	22702		10.1074/jbc.C109.028514	http://dx.doi.org/10.1074/jbc.C109.028514			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19574211	Green Published, hybrid			2022-12-27	WOS:000268963100024
J	Nobbio, L; Sturla, L; Fiorese, F; Usai, C; Basile, G; Moreschi, I; Benvenuto, F; Zocchi, E; De Flora, A; Schenone, A; Bruzzone, S				Nobbio, Lucilla; Sturla, Laura; Fiorese, Fulvia; Usai, Cesare; Basile, Giovanna; Moreschi, Iliana; Benvenuto, Federica; Zocchi, Elena; De Flora, Antonio; Schenone, Angelo; Bruzzone, Santina			P2X7-mediated Increased Intracellular Calcium Causes Functional Derangement in Schwann Cells from Rats with CMT1A Neuropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; PERIPHERAL MYELIN PROTEIN-22; CYCLIC ADP-RIBOSE; ASCORBIC-ACID TREATMENT; P2X(7) RECEPTORS; MOUSE MODEL; PMP22 GENE; EXPRESSION; NERVE; ATP	Charcot-Marie-Tooth (CMT) is the most frequent inherited neuromuscular disorder, affecting 1 person in 2500. CMT1A, the most common form of CMT, is usually caused by a duplication of chromosome 17p11.2, containing the PMP22 (peripheral myelin protein-22) gene; overexpression of PMP22 in Schwann cells (SC) is believed to cause demyelination, although the underlying pathogenetic mechanisms remain unclear. Here we report an abnormally high basal concentration of intracellular calcium ([Ca2+](i)) in SC from CMT1A rats. By the use of specific pharmacological inhibitors and through down-regulation of expression by small interfering RNA, we demonstrate that the high [Ca2+](i) is caused by a PMP22-related overexpression of the P2X7 purinoceptor/channel leading to influx of extracellular Ca2+ into CMT1A SC. Correction of the altered [Ca2+](i) in CMT1A SC by small interfering RNA or with pharmacological inhibitors of P2X7 restores functional parameters of SC (migration and release of ciliary neurotrophic factor), which are typically defective in CMT1A SC. More significantly, stable down-regulation of the expression of P2X7 restores myelination in co-cultures of CMT1A SC with dorsal root ganglion sensory neurons. These results establish a pathogenetic link between high [Ca2+](i) and impaired SC function in CMT1A and identify overexpression of P2X7 as the molecular mechanism underlying both abnormalities. The development of P2X7 inhibitors is expected to provide a new therapeutic strategy for treatment of CMT1A neuropathy.	[Sturla, Laura; Basile, Giovanna; Moreschi, Iliana; Zocchi, Elena; De Flora, Antonio; Bruzzone, Santina] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Sturla, Laura; Basile, Giovanna; Moreschi, Iliana; Zocchi, Elena; De Flora, Antonio; Bruzzone, Santina] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Nobbio, Lucilla; Fiorese, Fulvia; Benvenuto, Federica; Schenone, Angelo] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy; [Nobbio, Lucilla; Fiorese, Fulvia; Benvenuto, Federica; Schenone, Angelo] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Usai, Cesare] CNR, Inst Biophys, I-16149 Genoa, Italy; [Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 15-1, I-16132 Genoa, Italy.	santina.bruzzone@unige.it	Nobbio, Lucilla/J-1213-2018; Bruzzone, Santina/A-4264-2015; schenone, angelo/I-3194-2012	Nobbio, Lucilla/0000-0003-2150-3953; Bruzzone, Santina/0000-0003-2034-3716; schenone, angelo/0000-0002-2604-7830; Usai, Cesare/0000-0001-8863-7759	Telethon [GGP06178] Funding Source: Medline	Telethon(Fondazione Telethon)		Abrams CK, 2002, P NATL ACAD SCI USA, V99, P3980, DOI 10.1073/pnas.261713499; Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brancolini C, 1999, MOL BIOL CELL, V10, P2441, DOI 10.1091/mbc.10.7.2441; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2007, J BIOL CHEM, V282, P5045, DOI 10.1074/jbc.M609802200; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Dell'Antonio G, 2002, NEUROSCI LETT, V327, P87, DOI 10.1016/S0304-3940(02)00385-3; Desarnaud F, 1998, J NEUROCHEM, V71, P1765; Di Virgilio F, 2006, NOVART FDN SYMP, V276, P275; Di Virgilio Francesco, 2006, Novartis Found Symp, V276, P253; DIVIRGILIO F, 2006, NOVART FDN SYMP, V276, P259; DYCK PJ, 1989, NEUROLOGY, V39, P1302, DOI 10.1212/WNL.39.10.1302; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Grafe P, 1999, J PHYSIOL-LONDON, V515, P377, DOI 10.1111/j.1469-7793.1999.377ac.x; GUIDA L, 1995, FEBS LETT, V368, P481, DOI 10.1016/0014-5793(95)00715-L; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 2002, CYCLIC ADP RIBOSE NA; Liu CL, 2004, AM J PHYSIOL-HEART C, V286, pH1688, DOI 10.1152/ajpheart.00576.2003; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McCarthy TV, 2003, FEBS LETT, V554, P133, DOI 10.1016/S0014-5793(03)01122-0; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Miras-Portugal MT, 2003, NEUROCHEM RES, V28, P1597, DOI 10.1023/A:1025690913206; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Niemann S, 2000, J NEUROSCI, V20, P4120; Nobbio L, 2004, NEUROBIOL DIS, V16, P263, DOI 10.1016/j.nbd.2004.02.007; Nobbio L, 2001, ANN NEUROL, V50, P47, DOI 10.1002/ana.1034; Nobbio L, 2009, J NEUROPATH EXP NEUR, V68, P441, DOI 10.1097/NEN.0b013e31819fa6ba; Pareyson D, 2006, PHARMACOL RES, V54, P436, DOI 10.1016/j.phrs.2006.09.001; Passage E, 2004, NAT MED, V10, P396, DOI 10.1038/nm1023; Saberan-Djoneidi D, 2000, GENE, V248, P223, DOI 10.1016/S0378-1119(00)00116-5; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; SMITH KJ, 1985, J NEUROL SCI, V71, P19, DOI 10.1016/0022-510X(85)90034-6; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; SUTER U, 1995, J NEUROSCI RES, V40, P145, DOI 10.1002/jnr.490400202; SUTER U, 1994, J BIOL CHEM, V269, P25795; Sutko JL, 1997, PHARMACOL REV, V49, P53; ten Asbroek ALMA, 2005, J NEUROSCI RES, V79, P825, DOI 10.1002/jnr.20406; Vigo T, 2005, MOL CELL NEUROSCI, V28, P703, DOI 10.1016/j.mcn.2004.11.016; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Yeung D, 2006, FASEB J, V20, P610, DOI 10.1096/fj.05-4022com; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	59	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23146	23158		10.1074/jbc.M109.027128	http://dx.doi.org/10.1074/jbc.M109.027128			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546221	Green Published, hybrid			2022-12-27	WOS:000268963100066
J	Yezid, H; Konate, K; Debaisieux, S; Bonhoure, A; Beaumelle, B				Yezid, Hocine; Konate, Karidia; Debaisieux, Solene; Bonhoure, Anne; Beaumelle, Bruno			Mechanism for HIV-1 Tat Insertion into the Endosome Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PENETRATING PEPTIDES; MOLECULAR-DYNAMICS SIMULATIONS; HEPARAN-SULFATE PROTEOGLYCANS; HUMAN-IMMUNODEFICIENCY-VIRUS; PSEUDOMONAS EXOTOXIN; DIPHTHERIA-TOXIN; T-DOMAIN; PROTEIN; TRANSLOCATION; ACTIVATION	The human immunodeficiency virus, type 1, transactivating protein Tat is a small protein that is strictly required for viral transcription and multiplication within infected cells. The infected cells actively secrete Tat using an unconventional secretion pathway. Extracellular Tat can affect different cell types and induce severe cell dysfunctions ranging from cell activation to cell death. To elicit most cell responses, Tat needs to reach the cell cytosol. To this end, Tat is endocytosed, and low endosomal pH will then trigger Tat translocation to the cytosol. Although this translocation step is critical for Tat cytosolic delivery, how Tat could interact with the endosome membrane is unknown, and the key residues involved in this interaction require identification. We found that, upon acidification below pH 6.0 (i.e. within the endosomal pH range), Tat inserts into model membranes such as monolayers or lipid vesicles. This insertion process relies on Tat single Trp, Trp-11, which is not needed for transactivation and could be replaced by another aromatic residue for membrane insertion. Nevertheless, Trp-11 is strictly required for translocation. Tat conformational changes induced by low pH involve a sensor made of its first acidic residue (Glu/Asp-2) and the end of its basic domain (residues 55-57). Mutation of one of these elements results in membrane insertion above pH 6.5. Tat basic domain is also required for efficient Tat endocytosis and membrane insertion. Together with the strict conservation of Tat Trp among different virus isolates, our results point to an important role for Tat-membrane interaction in the multiplication of human immunodeficiency virus type 1.	[Yezid, Hocine; Debaisieux, Solene; Bonhoure, Anne; Beaumelle, Bruno] Univ Montpellier 2, CNRS, UMR 5236, Ctr Etud Agents Pathogenes & Biotechnol Sante, F-34095 Montpellier 05, France; [Konate, Karidia] CNRS, UMR 5237, Ctr Rech Biochim Macromol, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Beaumelle, B (corresponding author), Univ Montpellier 2, CNRS, UMR 5236, Ctr Etud Agents Pathogenes & Biotechnol Sante, Case 100, F-34095 Montpellier 05, France.	bruno.beaumelle@univ-montp2.fr		Beaumelle, Bruno/0000-0002-4912-9134; Bonhoure, Anne/0000-0002-4664-2848	CNRS; Agence Nationale de Recherches sur le SIDA and Sidaction	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de Recherches sur le SIDA and Sidaction(ANRS)	This work was supported by the CNRS and by grants from the Agence Nationale de Recherches sur le SIDA and Sidaction.	Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Campos B, 1998, BIOCHEMISTRY-US, V37, P8004, DOI 10.1021/bi973142n; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Ensoli B, 2006, AIDS, V20, P2245, DOI 10.1097/QAD.0b013e3280112cd1; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gallo RC, 1999, P NATL ACAD SCI USA, V96, P8324, DOI 10.1073/pnas.96.15.8324; GUTHEIL WG, 1994, P NATL ACAD SCI USA, V91, P6594, DOI 10.1073/pnas.91.14.6594; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Huigen MCDG, 2004, EUR J CLIN INVEST, V34, P57, DOI 10.1111/j.1365-2362.2004.01282.x; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; JIANG JX, 1990, J BIOL CHEM, V265, P8636; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Mere J, 2005, J BIOL CHEM, V280, P21194, DOI 10.1074/jbc.M412656200; Musse AA, 2003, J BIOL CHEM, V278, P24491, DOI 10.1074/jbc.M302371200; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Pantano S, 2005, PROTEINS, V58, P638, DOI 10.1002/prot.20323; Pantano S, 2004, EUR BIOPHYS J BIOPHY, V33, P344, DOI 10.1007/s00249-003-0358-z; Pantano S, 2002, J MOL BIOL, V318, P1331, DOI 10.1016/S0022-2836(02)00217-6; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Rayne F, 2004, J VIROL, V78, P12054, DOI 10.1128/JVI.78.21.12054-12057.2004; Ren JH, 1999, BIOCHEMISTRY-US, V38, P976, DOI 10.1021/bi981576s; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rodriguez M, 2007, J CELL SCI, V120, P1405, DOI 10.1242/jcs.03427; Rosconi MP, 2002, J BIOL CHEM, V277, P16517, DOI 10.1074/jbc.M200442200; Rubartelli A, 1998, IMMUNOL TODAY, V19, P543, DOI 10.1016/S0167-5699(98)01351-6; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Soane L, 2005, J NEUROCHEM, V95, P230, DOI 10.1111/j.1471-4159.2005.03359.x; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Strebel Klaus, 2003, AIDS, V17 Suppl 4, pS25, DOI 10.1097/00002030-200317004-00003; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Thoren PEG, 2004, BIOCHEMISTRY-US, V43, P3471, DOI 10.1021/bi0360049; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wu RF, 2007, J BIOL CHEM, V282, P37412, DOI 10.1074/jbc.M704481200; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6	51	40	41	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22736	22746		10.1074/jbc.M109.023705	http://dx.doi.org/10.1074/jbc.M109.023705			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19549783	Green Published, hybrid			2022-12-27	WOS:000268963100028
J	Thoendel, M; Horswill, AR				Thoendel, Matthew; Horswill, Alexander R.			Identification of Staphylococcus aureus AgrD Residues Required for Autoinducing Peptide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I SIGNAL PEPTIDASE; ENTEROCOCCUS-FAECALIS; ACTIVATING PHEROMONE; VIRULENCE; GENE; EXPRESSION; SYSTEM; REGION; MODEL; PCR	Staphylococcus aureus regulates the production of extracellular virulence factors using the agr quorum-sensing system. This regulatory system responds to a secreted peptide thiolactone signal called an autoinducing peptide (AIP). The biosynthesis of AIP requires AgrD, the peptide precursor of AIP, and the integral membrane endopeptidase AgrB. In this study, we performed a molecular analysis of AgrD to identify peptide regions important for processing and AIP secretion. As a lead-in to this study, we discovered that AIP type I could be generated in Escherichia coli through the heterologous expression of the agrBD genes, allowing the use of E. coli as an expression host for investigating the biosynthetic pathway. One of the most conserved regions of AgrD is the charged C-terminal tail, and through truncation analysis, the first nine residues were found to be essential for AIP production and AgrB endopeptidase activity. Within this essential region, mutation of residues glutamate 34 or leucine 41 inhibited AIP production and AgrB activity. Following cleavage, AgrB is hypothesized to form an enzyme-bound intermediate with the AgrDN-terminal region, but clear evidence of this intermediate has never been presented. By inactivating the AgrD cysteine 28 residue, an AgrD-AgrB structure was stabilized and detected in immunoblots using N-terminal His(6)-tagged AgrD. Formation of the structure could not be detected using the AgrB C84S mutation, indicating the cysteine residue is essential for its formation. These studies provide new insights on the requirements and mechanism of S. aureus AIP biosynthesis.	[Thoendel, Matthew; Horswill, Alexander R.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa	Horswill, AR (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, 540F EMRB, Iowa City, IA 52242 USA.	alex-horswill@uiowa.edu			National Institutes of Health [AI078921]; NIAID; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI078921 from the NIAID. This work was also supported by an American Heart Association beginning grant-in-aid.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Cregg KM, 1996, J BACTERIOL, V178, P5712, DOI 10.1128/jb.178.19.5712-5718.1996; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jensen RO, 2008, J MOL BIOL, V381, P300, DOI 10.1016/j.jmb.2008.06.018; Kavanaugh JS, 2007, MOL MICROBIOL, V65, P780, DOI 10.1111/j.1365-2958.2007.05830.x; Koenig RL, 2004, J BACTERIOL, V186, P7549, DOI 10.1128/JB.186.22.7549-7555.2004; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malone CL, 2007, APPL ENVIRON MICROB, V73, P6036, DOI 10.1128/AEM.00912-07; Nakayama J, 2001, MOL MICROBIOL, V41, P145, DOI 10.1046/j.1365-2958.2001.02486.x; Nakayama J, 2006, J BACTERIOL, V188, P8321, DOI 10.1128/JB.00865-06; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Qiu RD, 2005, J BIOL CHEM, V280, P16695, DOI 10.1074/jbc.M411372200; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Sturme MHJ, 2005, J BACTERIOL, V187, P5224, DOI 10.1128/JB.187.15.5224-5235.2005; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Zhang LS, 2004, J BACTERIOL, V186, P6706, DOI 10.1128/JB.186.20.6706-6713.2004; Zhang LS, 2004, J BIOL CHEM, V279, P19448, DOI 10.1074/jbc.M311349200; Zhang LS, 2002, J BIOL CHEM, V277, P34736, DOI 10.1074/jbc.M205367200	33	51	51	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21828	21838		10.1074/jbc.M109.031757	http://dx.doi.org/10.1074/jbc.M109.031757			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520867	hybrid, Green Published			2022-12-27	WOS:000268783700006
J	Wang, PX; Wang, QH; Sun, J; Wu, J; Li, H; Zhang, NN; Huang, YC; Su, B; Li, RK; Liu, L; Zhang, Y; Elsholtz, HP; Hu, J; Gaisano, HY; Jin, TR				Wang, Peixiang; Wang, Qinghua; Sun, Jane; Wu, Jing; Li, Hang; Zhang, Nina; Huang, Yachi; Su, Brenda; Li, Ren-ke; Liu, Ling; Zhang, Yi; Elsholtz, Harry P.; Hu, Jim; Gaisano, Herbert Y.; Jin, Tianru			POU Homeodomain Protein Oct-1 Functions as a Sensor for Cyclic AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGLUCAGON GENE-EXPRESSION; ENDOCRINE-L-CELLS; PANCREATIC BETA-CELLS; HOMEOBOX GENE; TRANSCRIPTIONAL ACTIVATION; GLUCAGON GENE; INSULIN GENE; RESPONSE ELEMENT; BINDING PROTEIN; HORMONE GENE	Cyclic AMP is a fundamentally important second messenger for numerous peptide hormones and neurotransmitters that control gene expression, cell proliferation, and metabolic homeostasis. Here we show that cAMP works with the POU homeodomain protein Oct-1 to regulate gene expression in pancreatic and intestinal endocrine cells. This ubiquitously expressed transcription factor is known as a stress sensor. We found that it also functions as a repressor of Cdx-2, a proglucagon gene activator. Through a mechanism that involves the activation of exchange protein activated by cyclic AMP, elevation of cAMP leads to enhanced phosphorylation and nuclear exclusion of Oct-1 and reduced interactions between Oct-1 or nuclear co-repressors and the Cdx-2 gene promoter, detected by chromatin immunoprecipitation. In rat primary pancreatic islet cells, cAMP elevation also reduces nuclear Oct-1 content, which causes increased proglucagon and proinsulin mRNA expression. Our study therefore identifies a novel mechanism by which cAMP regulates hormone-gene expression and suggests that ubiquitously expressed Oct-1 may play a role in metabolic homeostasis by functioning as a sensor for cAMP.	[Liu, Ling; Jin, Tianru] Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; [Li, Ren-ke] Univ Hlth Network, Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON M5G 1L7, Canada; [Wang, Qinghua; Zhang, Nina; Huang, Yachi; Zhang, Yi; Jin, Tianru] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Sun, Jane; Elsholtz, Harry P.; Hu, Jim; Jin, Tianru] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L7, Canada; [Jin, Tianru] Univ Toronto, Dept Med, Toronto, ON M5G 1L7, Canada; [Wu, Jing; Hu, Jim] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wang, Qinghua; Zhang, Nina] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada; [Jin, Tianru] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510080, Guangdong, Peoples R China	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Sun Yat Sen University	Jin, TR (corresponding author), 10-354,Toronto Med Discovery Tower,101 Coll St, Toronto, ON M5G 1L7, Canada.	tianru.jin@utoronto.ca	zhang, nina/GXH-0962-2022; Wang, Qinghua/GVT-3252-2022	Huang, Ya-Chi/0000-0001-5168-1174; Li, Ren-Ke/0000-0002-2584-060X; Hu, Jim/0000-0001-9134-7103	Canadian Diabetes Association [2341]; Canadian Institutes of Health [62745, 79534, 86544, 77750]	Canadian Diabetes Association; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Diabetes Association Grant 2341 (to T. J.) and Canadian Institutes of Health Research Grants 62745 (to T. J.), 79534 (to Q. W.), 86544 (to H. Y. G.), and 77750 (to J. H.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Almeida R, 2005, J PATHOL, V207, P396, DOI 10.1002/path.1861; Belsham DD, 2000, MOL ENDOCRINOL, V14, P212, DOI 10.1210/me.14.2.212; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Chandran UR, 1999, J BIOL CHEM, V274, P2372, DOI 10.1074/jbc.274.4.2372; Chandran UR, 1996, J BIOL CHEM, V271, P20412, DOI 10.1074/jbc.271.34.20412; Chen L, 2005, FEBS J, V272, P2746, DOI 10.1111/j.1742-4658.2005.04694.x; Cheng CK, 2002, MOL ENDOCRINOL, V16, P1552, DOI 10.1210/me.16.7.1552; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; GERMAN MS, 1994, GENOMICS, V24, P403, DOI 10.1006/geno.1994.1639; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Gevrey JC, 2004, DIABETOLOGIA, V47, P926, DOI 10.1007/s00125-004-1380-0; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grenfell SJ, 1996, BIOCHEM J, V315, P889, DOI 10.1042/bj3150889; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Hitomi T, 2007, FEBS LETT, V581, P1087, DOI 10.1016/j.febslet.2007.01.092; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; JAMES R, 1994, J BIOL CHEM, V269, P15229; Jin T, 2008, J ENDOCRINOL, V198, P17, DOI 10.1677/JOE-08-0085; Jin TR, 1996, MOL CELL BIOL, V16, P19; Jin TR, 2001, J BIOL CHEM, V276, P14752, DOI 10.1074/jbc.M008277200; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kiyota T, 2008, DEV BIOL, V315, P579, DOI 10.1016/j.ydbio.2007.12.013; KNEPEL W, 1990, MOL CELL BIOL, V10, P6799, DOI 10.1128/MCB.10.12.6799; Laser B, 1996, J BIOL CHEM, V271, P28984, DOI 10.1074/jbc.271.46.28984; Lotfi S, 2006, ENDOCRINOLOGY, V147, P3727, DOI 10.1210/en.2006-0056; Lu F, 1996, ENDOCRINOLOGY, V137, P3710, DOI 10.1210/en.137.9.3710; Lyle KS, 2008, CELL SIGNAL, V20, P1104, DOI 10.1016/j.cellsig.2008.01.018; Marom K, 1997, MECH DEVELOP, V64, P41, DOI 10.1016/S0925-4773(97)00043-9; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Ni ZY, 2003, J BIOL CHEM, V278, P1380, DOI 10.1074/jbc.M206006200; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Ritz-Laser B, 1999, J BIOL CHEM, V274, P4124, DOI 10.1074/jbc.274.7.4124; ROBERTS SB, 1991, SCIENCE, V253, P1022, DOI 10.1126/science.1887216; Schild-Poulter C, 2007, ONCOGENE, V26, P3980, DOI 10.1038/sj.onc.1210165; Schild-Poulter C, 2003, CANCER RES, V63, P7197; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEGIL N, 1991, COLD SPRING HARB SYM, V56, P285; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; SUN J, 2009, ONCOGENE IN PRESS; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Tang QB, 2005, MOL ENDOCRINOL, V19, P2769, DOI 10.1210/me.2004-0463; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Thum T, 2008, J BIOL CHEM, V283, P19456, DOI 10.1074/jbc.M708309200; Trinh KY, 1999, J BIOL CHEM, V274, P6011, DOI 10.1074/jbc.274.9.6011; Vazquez-Martinez R, 2002, MOL ENDOCRINOL, V16, P2093, DOI 10.1210/me.2002-0139; Wang PX, 2006, ENDOCRINOLOGY, V147, P1950, DOI 10.1210/en.2005-0910; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Xu FH, 1999, J BIOL CHEM, V274, P34310, DOI 10.1074/jbc.274.48.34310; Yi FH, 2008, ENDOCRINOLOGY, V149, P2341, DOI 10.1210/en.2007-1142; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhao Y, 2005, J ENDOCRINOL, V186, P179, DOI 10.1677/joe.1.06152	72	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26456	26465		10.1074/jbc.M109.030668	http://dx.doi.org/10.1074/jbc.M109.030668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19617623	hybrid, Green Published			2022-12-27	WOS:000269969600027
J	Ardi, VC; Van den Steen, PE; Opdenakker, G; Schweighofer, B; Deryugina, EI; Quigley, JP				Ardi, Veronica C.; Van den Steen, Philippe E.; Opdenakker, Ghislain; Schweighofer, Bernhard; Deryugina, Elena I.; Quigley, James P.			Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activation in Vivo and Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYO CHORIOALLANTOIC MEMBRANE; MARROW-DERIVED CELLS; GELATINASE-B; MATRIX METALLOPROTEINASES; MATRIX-METALLOPROTEINASE-9 MMP-9; ENDOTHELIAL-CELLS; HEMOPEXIN DOMAIN; IV COLLAGENASE; BINDING; VEGF	The structural and catalytic requirements for neutrophil MMP-9 proenzyme (proMMP-9) to induce angiogenesis were investigated using a quantitative angiogenesis model based on grafting of collagen onplants onto the chorioallantoic membrane of chick embryos. Both physiological activation of neutrophil proMMP-9 and proteolytic activity of the generated MMP-9 enzyme were critically dependent on the tissue inhibitor of metalloproteinase (TIMP)-free status of the zymogen. The presence of an intact active site and hemopexin domain were required for full angiogenesis-inducing activity of the MMP-9 enzyme. Timed additions of TIMP-1 to the onplants containing TIMP-free neutrophil proMMP-9 indicated that in vivo activation of the zymogen occurred during the first 24 h after grafting. Within the onplant tissue, MMP-9 activation was accompanied by proteolytic modifications of fibrillar collagen and an influx of host proteins, the rate of which depended on the TIMP-free status of the zymogen. By quantifying the levels of host angiogenic factors, we demonstrated that basic fibroblast growth factor(FGF-2) was a major cytokine becoming bioavailable in the onplant tissue undergoing a neutrophil proMMP-9-mediated angiogenic switch. Inhibition of angiogenesis with specific function-blocking antibodies further indicated an involvement of a FGF-2/FGFR-2 pathway in neutrophil proMMP-9-induced angiogenesis. The enhanced angiogenesis catalyzed by neutrophil MMP-9 appears to evoke also a localized, low threshold level vascular endothelial growth factor (VEGF)/VEGFR-2 pathway, likely functioning in the formation and/or stabilization of blood vessels. That neutrophil proMMP-9, unencumbered by TIMP-1, directly mediates FGF-2-dependent angiogenesis was also demonstrated in our quantitative mouse angiogenesis model employing subcutaneous collagen implants, thus implicating the novel TIMP-free MMP-9/FGF-2/FGFR-2 pathway in proMMP-9-induced angiogenesis in a mammalian setting.	[Ardi, Veronica C.; Schweighofer, Bernhard; Deryugina, Elena I.; Quigley, James P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Van den Steen, Philippe E.; Opdenakker, Ghislain] Univ Louvain, Rega Inst, Immunobiol Lab, B-3000 Louvain, Belgium	Scripps Research Institute; KU Leuven	Quigley, JP (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd,SP30-3120, La Jolla, CA 92037 USA.	jquigley@scripps.edu	Schweighofer, Bernhard/B-2763-2011; Van den Steen, Philippe E/K-5132-2012; Schweighofer, Bernhard/C-2796-2009; Opdenakker, Ghislain/V-8562-2019; Opdenakker, Ghislain/Q-3130-2017	Schweighofer, Bernhard/0000-0003-0793-7376; Van den Steen, Philippe E/0000-0002-7334-9145; Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294	National Institutes of Health [CA55852, CA105412]; Postdoctoral Training [5T32 HL07195-31]; Geconcerteerde OnderzoeksActies [GOA/2007/15]; Excellentiefinanciering [EF/05/015]; Fund for Scientific Research of Flanders FWO-Vlaanderen; NATIONAL CANCER INSTITUTE [R01CA129484, R01CA055852, R01CA105412] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postdoctoral Training; Geconcerteerde OnderzoeksActies; Excellentiefinanciering(KU Leuven); Fund for Scientific Research of Flanders FWO-Vlaanderen(FWO); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA55852 and CA105412 (to J. P. Q.) and Postdoctoral Training Grant 5T32 HL07195-31 (to V. C. A.). This work was also supported by Geconcerteerde OnderzoeksActies GOA/2007/15, Excellentiefinanciering EF/05/015, and the Fund for Scientific Research of Flanders FWO-Vlaanderen (to G. O.).	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; BADWEY JA, 1982, BIOCHEM BIOPH RES CO, V106, P170, DOI 10.1016/0006-291X(82)92073-3; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bjorklund M, 2004, J BIOL CHEM, V279, P29589, DOI 10.1074/jbc.M401601200; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; Claffey KP, 2001, LAB INVEST, V81, P61, DOI 10.1038/labinvest.3780212; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4; Dolo V, 1999, ANN NY ACAD SCI, V878, P497, DOI 10.1111/j.1749-6632.1999.tb07707.x; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Geurts N, 2008, BIOCHEMISTRY-US, V47, P2689, DOI 10.1021/bi702260q; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hangai M, 2002, AM J PATHOL, V161, P1429, DOI 10.1016/S0002-9440(10)64418-5; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1084/jem.20050959; Huang SY, 2002, J NATL CANCER I, V94, P1134; Jodele S, 2005, CANCER RES, V65, P3200, DOI 10.1158/0008-5472.CAN-04-3770; Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62; Jubb AM, 2006, NAT REV CANCER, V6, P626, DOI 10.1038/nrc1946; Kanda S, 2004, J BIOL CHEM, V279, P4007, DOI 10.1074/jbc.M307569200; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; McDonnell K, 2005, LAB INVEST, V85, P747, DOI 10.1038/labinvest.3700269; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; MOLL UM, 1990, CANCER RES, V50, P6162; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Olson MW, 1998, J BIOL CHEM, V273, P10672, DOI 10.1074/jbc.273.17.10672; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Ribatti D, 1998, J SUBMICR CYTOL PATH, V30, P127; Ribatti D, 2002, J CELL MOL MED, V6, P439, DOI 10.1111/j.1582-4934.2002.tb00524.x; RIBATTI D, 1995, DEV BIOL, V170, P39, DOI 10.1006/dbio.1995.1193; Ribatti D, 1999, J CELL SCI, V112, P4213; Roeb E, 2002, J BIOL CHEM, V277, P50326, DOI 10.1074/jbc.M207446200; Seandel M, 2001, BLOOD, V97, P2323, DOI 10.1182/blood.V97.8.2323; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Tsunoda S, 2007, CANCER SCI, V98, P541, DOI 10.1111/j.1349-7006.2007.00432.x; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004; Vu TH, 1998, BIOL EXTRAC, P115; WATANABE H, 1993, J CELL SCI, V104, P991; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031	64	91	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25854	25866		10.1074/jbc.M109.033472	http://dx.doi.org/10.1074/jbc.M109.033472			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19608737	hybrid, Green Published			2022-12-27	WOS:000269738000043
J	Brenner, S; Heyes, DJ; Hay, S; Hough, MA; Eady, RR; Hasnain, SS; Scrutton, NS				Brenner, Sibylle; Heyes, Derren J.; Hay, Sam; Hough, Michael A.; Eady, Robert R.; Hasnain, S. Samar; Scrutton, Nigel S.			Demonstration of Proton-coupled Electron Transfer in the Copper-containing Nitrite Reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCALIGENES-XYLOSOXIDANS NCIMB-11015; HYDROGEN-ATOM TRANSFER; X-RAY-STRUCTURE; TYPE-2 COPPER; DISSIMILATORY NITRITE; SUBSTRATE-BINDING; ELECTROCHEMICAL APPROACH; RHODOBACTER-SPHAEROIDES; ANGSTROM RESOLUTION; ORDERED MECHANISM	The reduction of nitrite (NO2-) into nitric oxide (NO), catalyzed by nitrite reductase, is an important reaction in the denitrification pathway. In this study, the catalytic mechanism of the copper-containing nitrite reductase from Alcaligenes xylosoxidans (AxNiR) has been studied using single and multiple turnover experiments at pH 7.0 and is shown to involve two protons. A novel steady-state assay was developed, in which deoxyhemoglobin was employed as an NO scavenger. A moderate solvent kinetic isotope effect (SKIE) of 1.3 +/- 0.1 indicated the involvement of one protonation to the rate-limiting catalytic step. Laser photoexcitation experiments have been used to obtain single turnover data in H2O and D2O, which report on steps kinetically linked to inter-copper electron transfer (ET). In the absence of nitrite, a normal SKIE of similar to 1.33 +/- 0.05 was obtained, suggesting a protonation event that is kinetically linked to ET in substrate-free AxNiR. A nitrite titration gave a normal hyperbolic behavior for the deuterated sample. However, in H2O an unusual decrease in rate was observed at low nitrite concentrations followed by a subsequent acceleration in rate at nitrite concentrations of > 10 mM. As a consequence, the observed ET process was faster in D2O than in H2O above 0.1 mM nitrite, resulting in an inverted SKIE, which featured a significant dependence on the substrate concentration with a minimum value of similar to 0.61 +/- 0.02 between 3 and 10 mM. Our work provides the first experimental demonstration of proton-coupled electron transfer in both the resting and substrate-bound AxNiR, and two protons were found to be involved in turnover.	[Hough, Michael A.; Eady, Robert R.; Hasnain, S. Samar] Univ Liverpool, Mol Biophys Grp, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Brenner, Sibylle; Heyes, Derren J.; Hay, Sam; Scrutton, Nigel S.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Brenner, Sibylle; Heyes, Derren J.; Hay, Sam; Scrutton, Nigel S.] Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England	University of Liverpool; University of Manchester; University of Manchester	Hasnain, SS (corresponding author), Univ Liverpool, Mol Biophys Grp, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.	s.s.hasnain@liverpool.ac.uk; nigel.scrutton@manchester.ac.uk	Hay, Sam/D-5974-2012; Hough, Michael/H-4409-2013	Hay, Sam/0000-0003-3274-0938; Heyes, Derren/0000-0002-7453-1571; Hough, Michael/0000-0001-7377-6713	TgK Scientific Ltd.; Biotechnology and Biological Sciences Research Council [BB/D016290/1, BB/G005850/1]; BBSRC [BB/D01963X/1, BB/D016290/1, BB/G005850/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: researchfish	TgK Scientific Ltd.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by TgK Scientific Ltd. (Ph.D. studentship to S. B.) and by Biotechnology and Biological Sciences Research Council Project Grants BB/D016290/1 (to S. S. H.) and BB/G005850/1 (to N. S. S.).	ABRAHAM ZHL, 1993, BIOCHEM J, V295, P587, DOI 10.1042/bj2950587; Abraham ZHL, 1997, BIOCHEM J, V324, P511, DOI 10.1042/bj3240511; ADMAN ET, 1995, J BIOL CHEM, V270, P27458, DOI 10.1074/jbc.270.46.27458; Antonyuk SV, 2003, ACTA CRYSTALLOGR D, V59, P835, DOI 10.1107/S0907444903041441; Antonyuk SV, 2005, P NATL ACAD SCI USA, V102, P12041, DOI 10.1073/pnas.0504207102; Averill BA, 1996, CHEM REV, V96, P2951, DOI 10.1021/cr950056p; Baker SC, 1997, J MOL BIOL, V269, P440, DOI 10.1006/jmbi.1997.1070; Bernasconi C. F., 1976, RELAXATION KINETICS; Bisswanger H., 2008, ENZYME KINETICS PRIN; BURKHARD O, 1982, J APPL PHYSIOL, V52, P124, DOI 10.1152/jappl.1982.52.1.124; Chen KS, 2000, NATURE, V405, P814, DOI 10.1038/35015610; Costentin C, 2005, J AM CHEM SOC, V127, P12490, DOI 10.1021/ja053911n; Costentin C, 2008, CHEM REV, V108, P2145, DOI 10.1021/cr068065t; Cukier RI, 1999, J PHYS CHEM A, V103, P5989, DOI 10.1021/jp990329a; Cukier RI, 2004, BBA-BIOENERGETICS, V1655, P37, DOI 10.1016/j.bbabio.2003.06.011; Cukier RI, 1996, J PHYS CHEM-US, V100, P15428, DOI 10.1021/jp961025g; CUKIER RI, 1994, J PHYS CHEM-US, V98, P2377, DOI 10.1021/j100060a027; Cukier RI, 2002, J PHYS CHEM B, V106, P1746, DOI 10.1021/jp012396m; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; CUKIER RI, 1995, J PHYS CHEM-US, V99, P16101, DOI 10.1021/j100043a060; Davidson VL, 2000, ACCOUNTS CHEM RES, V33, P87, DOI 10.1021/ar9900616; Davidson VL, 2004, ARCH BIOCHEM BIOPHYS, V428, P32, DOI 10.1016/j.abb.2004.03.022; Davidson VL, 2002, BIOCHEMISTRY-US, V41, P14633, DOI 10.1021/bi026812k; De Marothy SA, 2007, J COMPUT CHEM, V28, P528, DOI 10.1002/jcc.20567; Dejam A, 2004, BLOOD CELL MOL DIS, V32, P423, DOI 10.1016/j.bcmd.2004.02.002; DODD FE, 1995, ACTA CRYSTALLOGR D, V51, P1052, DOI 10.1107/S0907444995007554; Dodd FE, 1997, ACTA CRYSTALLOGR D, V53, P406, DOI 10.1107/S0907444997002667; Dodd FE, 1998, J MOL BIOL, V282, P369, DOI 10.1006/jmbi.1998.2007; Ellis MJ, 2002, J MOL BIOL, V316, P51, DOI 10.1006/jmbi.2001.5304; Ellis MJ, 2001, ACTA CRYSTALLOGR D, V57, P1110, DOI 10.1107/S0907444901008654; Farver O, 1998, FEBS LETT, V436, P239, DOI 10.1016/S0014-5793(98)01120-X; Farver O, 2004, FEBS LETT, V561, P173, DOI 10.1016/S0014-5793(04)00171-1; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; Ghosh S, 2007, J AM CHEM SOC, V129, P10310, DOI 10.1021/ja072841c; Ghosh S, 2009, J AM CHEM SOC, V131, P277, DOI 10.1021/ja806873e; Graige MS, 1999, BIOCHEMISTRY-US, V38, P11465, DOI 10.1021/bi990708u; Hammes-Schiffer S, 2004, BBA-BIOENERGETICS, V1655, P29, DOI 10.1016/j.bbabio.2003.07.009; Hammes-Schiffer S, 2002, CHEMPHYSCHEM, V3, P33, DOI 10.1002/1439-7641(20020118)3:1<33::AID-CPHC33>3.0.CO;2-6; Hammes-Schiffer S, 2001, ACCOUNTS CHEM RES, V34, P273, DOI 10.1021/ar9901117; Hammes-Schiffer S, 2008, J PHYS CHEM B, V112, P14108, DOI 10.1021/jp805876e; Harris RL, 2005, J SYNCHROTRON RADIAT, V12, P13, DOI 10.1107/S0909049504027852; Hough MA, 2005, J MOL BIOL, V350, P300, DOI 10.1016/j.jmb.2005.04.006; Hough MA, 2008, J MOL BIOL, V378, P353, DOI 10.1016/j.jmb.2008.01.097; HOWES BD, 1994, BIOCHEMISTRY-US, V33, P3171, DOI 10.1021/bi00177a005; Ichiki H, 2001, J BACTERIOL, V183, P4149, DOI 10.1128/JB.183.14.4149-4156.2001; Karpefors M, 2000, BIOCHEMISTRY-US, V39, P5045, DOI 10.1021/bi9925221; Kataoka K, 2004, J BIOL CHEM, V279, P53374, DOI 10.1074/jbc.M410198200; Kataoka K, 2000, J BIOCHEM-TOKYO, V127, P345, DOI 10.1093/oxfordjournals.jbchem.a022613; KEEFFE JR, 1981, J AM CHEM SOC, V103, P2457, DOI 10.1021/ja00399a074; Kobayashi K, 1999, J BIOCHEM, V126, P408, DOI 10.1093/oxfordjournals.jbchem.a022465; Kohzuma T, 2006, INORG CHEM, V45, P8474, DOI 10.1021/ic0609195; Kuznetsova S, 2008, P NATL ACAD SCI USA, V105, P3250, DOI 10.1073/pnas.0707736105; Leskovac, 2003, COMPREHENSIVE ENZYME; MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Mayer JM, 2004, ANNU REV PHYS CHEM, V55, P363, DOI 10.1146/annurev.physchem.55.091602.094446; MOORE EG, 1976, J BIOL CHEM, V251, P2788; NORTHROP DB, 1981, ANNU REV BIOCHEM, V50, P103, DOI 10.1146/annurev.bi.50.070181.000535; Nurizzo D, 1997, STRUCTURE, V5, P1157, DOI 10.1016/S0969-2126(97)00267-0; ORII Y, 1995, PHOTOCHEM PHOTOBIOL, V61, P261, DOI 10.1111/j.1751-1097.1995.tb03969.x; ORII Y, 1993, BIOCHEMISTRY-US, V32, P11910, DOI 10.1021/bi00095a021; Prudencio M, 1999, J BACTERIOL, V181, P2323; Prudencio M, 2002, BIOCHEMISTRY-US, V41, P3430, DOI 10.1021/bi011955c; Rappaport F, 2001, BBA-BIOENERGETICS, V1503, P246, DOI 10.1016/S0005-2728(00)00228-0; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Segel IH, 1975, ENZYME KINETICS BEHA; Strange RW, 1999, J MOL BIOL, V287, P1001, DOI 10.1006/jmbi.1999.2648; STRANGE RW, 1995, NAT STRUCT BIOL, V2, P287, DOI 10.1038/nsb0495-287; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Sundararajan M, 2007, J PHYS CHEM B, V111, P5511, DOI 10.1021/jp066852o; Suzuki S, 1999, COORDIN CHEM REV, V190, P245, DOI 10.1016/S0010-8545(99)00069-7; Suzuki S, 1997, J BIOL INORG CHEM, V2, P265, DOI 10.1007/s007750050132; Suzuki S, 2000, ACCOUNTS CHEM RES, V33, P728, DOI 10.1021/ar9900257; THIBBLIN A, 1989, CHEM SOC REV, V18, P209, DOI 10.1039/cs9891800209; Weatherly SC, 2003, J PHYS CHEM B, V107, P372, DOI 10.1021/jp022085r; Wherland S, 2005, CHEMPHYSCHEM, V6, P805, DOI 10.1002/cphc.200400353; Wijma HJ, 2007, J AM CHEM SOC, V129, P8557, DOI 10.1021/ja071274q; Wijma HJ, 2006, J BIOL CHEM, V281, P16340, DOI 10.1074/jbc.M601610200; Wijma HJ, 2004, BIOCHEMISTRY-US, V43, P10467, DOI 10.1021/bi0496687; Yousafzai FK, 2002, J BIOL CHEM, V277, P34067, DOI 10.1074/jbc.M204305200; Zhao YW, 2002, BIOCHEMISTRY-US, V41, P7464, DOI 10.1021/bi0256274; ZUMFT WG, 1987, EUR J BIOCHEM, V168, P301, DOI 10.1111/j.1432-1033.1987.tb13421.x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	86	43	43	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25973	25983		10.1074/jbc.M109.012245	http://dx.doi.org/10.1074/jbc.M109.012245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19586913	hybrid, Green Published			2022-12-27	WOS:000269738000054
J	Jordan, JB; Poppe, L; Haniu, M; Arvedson, T; Syed, R; Li, V; Kohno, H; Kim, H; Schnier, PD; Harvey, TS; Miranda, LP; Cheetham, J; Sasu, BJ				Jordan, John B.; Poppe, Leszek; Haniu, Mitsuru; Arvedson, Tara; Syed, Rashid; Li, Vivian; Kohno, Hiko; Kim, Helen; Schnier, Paul D.; Harvey, Timothy S.; Miranda, Les P.; Cheetham, Janet; Sasu, Barbra J.			Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; ANTIMICROBIAL PEPTIDE HEPCIDIN; CORRELATION NMR-SPECTROSCOPY; BETA-TURN FORMATION; HEREDITARY HEMOCHROMATOSIS; IRON OVERLOAD; COUPLING-CONSTANTS; FERROPORTIN; PROTEINS; EXPRESSION	Hepcidin is a tightly folded 25-residue peptide hormone containing four disulfide bonds, which has been shown to act as the principal regulator of iron homeostasis in vertebrates. We used multiple techniques to demonstrate a disulfide bonding pattern for hepcidin different from that previously published. All techniques confirmed the following disulfide bond connectivity: Cys(1)-Cys(8), Cys(3)-Cys(6), Cys(2)-Cys(4), and Cys(5)-Cys(7). NMR studies reveal a new model for hepcidin that, at ambient temperatures, interconverts between two different conformations, which could be individually resolved by temperature variation. Using these methods, the solution structure of hepcidin was determined at 325 and 253 K in supercooled water. X-ray analysis of a co-crystal with Fab appeared to stabilize a hepcidin conformation similar to the high temperature NMR structure.	[Jordan, John B.; Poppe, Leszek; Syed, Rashid; Li, Vivian; Schnier, Paul D.; Harvey, Timothy S.; Miranda, Les P.; Cheetham, Janet] Amgen Inc, Dept Mol Struct, Thousand Oaks, CA 91320 USA; [Haniu, Mitsuru; Kohno, Hiko; Kim, Helen] Amgen Inc, Dept Prot Sci, Thousand Oaks, CA 91320 USA; [Arvedson, Tara; Sasu, Barbra J.] Amgen Inc, Dept Hematol, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen	Jordan, JB (corresponding author), 1 Amgen Ctr Dr,MS 14-2-A, Thousand Oaks, CA 91320 USA.	jbjordan@amgen.com; lpoppe@amgen.com	Harvey, Timothy S/F-9863-2013	Harvey, Timothy S/0000-0001-6270-1943	United States Department of Energy [DE-AC02-05CH11231]	United States Department of Energy(United States Department of Energy (DOE))	We thank Ching Chen for affinity determination of the anti-hepcidin antibody used for Fab generation; Jingwen Zhang for shHepc preparation; Noi Nuanamanee for ehHepc and chHepc production; Ann Hsu for chHepc characterization; and Gregory Dyas and Jacob Corcoran for hepcidin activity determination. We also acknowledge the helpful comments from the reviewers, which allowed us to improve upon the statistical analysis. ALS-Beamline 5.0.2 is supported by the United States Department of Energy under Contract DE-AC02-05CH11231.	Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; ATHERTON E, 1989, SOLID PHASE PEPTIDE, P216; Benitez BAS, 2000, PROTEINS, V40, P168, DOI 10.1002/(SICI)1097-0134(20000701)40:1<168::AID-PROT180>3.0.CO;2-N; Boisbouvier J, 2000, J BIOMOL NMR, V16, P197, DOI 10.1023/A:1008354007926; BRUSCHWEILER R, 1988, J MAGN RESON, V78, P178, DOI 10.1016/0022-2364(88)90171-0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHALAL RS, 1965, BR J APPL PHYS, V16, P231; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farnaud S, 2006, BIOMETALS, V19, P527, DOI 10.1007/s10534-005-5883-z; Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134; Fuchs PFJ, 2006, BIOPHYS J, V90, P2745, DOI 10.1529/biophysj.105.074401; Furrer J, 2004, J MAGN RESON, V166, P39, DOI 10.1016/j.jmr.2003.09.013; Gagliardo B, 2008, FEBS J, V275, P3793, DOI 10.1111/j.1742-4658.2008.06525.x; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HAASNOOT CAG, 1980, TETRAHEDRON, V36, P2783, DOI 10.1016/0040-4020(80)80155-4; HALLETT J, 1963, P PHYS SOC LOND, V82, P1046, DOI 10.1088/0370-1328/82/6/326; HANSEN PE, 1991, BIOCHEMISTRY-US, V30, P10457, DOI 10.1021/bi00107a014; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HU SFS, 2001, Patent No. 6210924; Hunter HN, 2002, J BIOL CHEM, V277, P37597, DOI 10.1074/jbc.M205305200; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Jaynes E.T., 2003, PROBABILITY THEORY L; KARPLUS M, 1959, J CHEM PHYS, V30, P15, DOI 10.1063/1.1729866; KESSLER H, 1988, MAGN RESON CHEM, V26, P919, DOI 10.1002/mrc.1260261018; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; KLAUS W, 1993, J MOL BIOL, V232, P897, DOI 10.1006/jmbi.1993.1438; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lauth X, 2005, J BIOL CHEM, V280, P9272, DOI 10.1074/jbc.M411154200; Lee PL, 2001, BLOOD CELL MOL DIS, V27, P783, DOI 10.1006/bcmd.2001.0445; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Nemeth E, 2006, BLOOD, V107, P328, DOI 10.1182/blood-2005-05-2049; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2003, NAT GENET, V34, P97, DOI 10.1038/ng1150; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; PRESS RD, 2001, MOL DIAGN, V6, P347; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Roy CN, 2005, CURR OPIN HEMATOL, V12, P107, DOI 10.1097/00062752-200503000-00001; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Walewska A, 2008, J AM CHEM SOC, V130, P14280, DOI 10.1021/ja804303p; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuan XM, 2003, ANN MED, V35, P578, DOI 10.1080/07853890310016342; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	56	165	190	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24155	24167		10.1074/jbc.M109.017764	http://dx.doi.org/10.1074/jbc.M109.017764			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19553669	Green Published, hybrid			2022-12-27	WOS:000269380200029
J	Kockx, M; Guo, DL; Traini, M; Gaus, K; Kay, J; Wimmer-Kleikamp, S; Rentero, C; Burnett, JR; Le Goff, W; Van Eck, M; Stow, JL; Jessup, W; Kritharides, L				Kockx, Maaike; Guo, Dongni Lily; Traini, Mathew; Gaus, Katharina; Kay, Jason; Wimmer-Kleikamp, Sabine; Rentero, Carles; Burnett, John R.; Le Goff, Wilfried; Van Eck, Miranda; Stow, Jennifer L.; Jessup, Wendy; Kritharides, Leonard			Cyclosporin A Decreases Apolipoprotein E Secretion from Human Macrophages via a Protein Phosphatase 2B-dependent and ATP-binding Cassette Transporter A1 (ABCA1)-independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REMNANT LIPOPROTEIN METABOLISM; HEPARAN-SULFATE PROTEOGLYCANS; CHOLESTEROL EFFLUX; CELL-SURFACE; EXTRACELLULAR-MATRIX; DENSITY-LIPOPROTEINS; FOAM CELLS; APOE; ATHEROSCLEROSIS; CALCINEURIN	Cyclosporin A (CsA) is an immunosuppressant that inhibits protein phosphatase 2B (PP2B/calcineurin) and is associated with hyperlipidemia, decreased cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1), and increased risk of atherosclerosis. Apolipoprotein E (apoE) is an important regulator of lipid metabolism and atherosclerosis, the secretion of which from human macrophages is regulated by the serine/threonine protein kinase A (PKA) and intracellular calcium (Ca2+) (Kockx, M., Guo, D. L., Huby, T., Lesnik, P., Kay, J., Sabaretnam, T., Jary, E., Hill, M., Gaus, K., Chapman, J., Stow, J. L., Jessup, W., and Kritharides, L. (2007) Circ. Res. 101, 607-616). As PP2B is Ca2+-dependent and has been linked to PKA-dependent processes, we investigated whether CsA modulated apoE secretion. CsA dose-and time-dependently inhibited secretion of apoE from primary human macrophages and from Chinese hamster ovary cells stably transfected with human apoE and increased cellular apoE levels without affecting apoE mRNA. [S-35] Met kinetic modeling studies showed that CsA inhibited both secretion and degradation of apoE, increasing the half-life of cellular apoE 2-fold. CsA also inhibited secretion from primary human Tangier disease macrophages and from mouse macrophages deficient in ABCA1, indicating that the effect is independent of the known inhibition of ABCA1 by CsA. The role of PP2B in mediating apoE secretion was confirmed using additional peptide and chemical inhibitors of PP2B. Importantly, kinetic modeling, live-cell imaging, and confocal microscopy all indicated that CsA inhibited apoE secretion by mechanisms quite distinct from those of PKA inhibition, most likely inducing accumulation of apoE in the endoplasmic reticulum compartment. Taken together, these results establish a novel mechanism for the pro-atherosclerotic effects of CsA, and establish for the first time a role for PP2B in regulating the intracellular transport and secretion of apoE.	[Kockx, Maaike; Guo, Dongni Lily; Traini, Mathew; Gaus, Katharina; Wimmer-Kleikamp, Sabine; Rentero, Carles; Jessup, Wendy; Kritharides, Leonard] Univ New S Wales, Sch Med Sci, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Kay, Jason; Stow, Jennifer L.] Univ Queensland, Brisbane, Qld 4072, Australia; [Burnett, John R.] Royal Perth Hosp, Dept Core Clin Pathol & Biochem, Perth, WA 6008, Australia; [Burnett, John R.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6000, Australia; [Le Goff, Wilfried] Univ Paris 06, UMR S551, F-75013 Paris, France; [Van Eck, Miranda] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2311 EZ Leiden, Netherlands; [Kritharides, Leonard] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW 2139, Australia	University of New South Wales Sydney; University of Queensland; Royal Perth Hospital; University of Western Australia; University of Western Australia; UDICE-French Research Universities; Sorbonne Universite; Leiden University; Leiden University - Excl LUMC; Concord Repatriation General Hospital; University of Sydney	Kritharides, L (corresponding author), Concord Hosp, Dept Cardiol, Sydney, NSW 2139, Australia.	l.kritharides@unsw.edu.au	Le Goff, Wilfried/N-7593-2019; Rentero Alfonso, Carles/L-4430-2017; Le Goff, Wilfried/N-6326-2017; Stow, Jennifer L/I-4723-2013; Kritharides, Leonard/AAQ-2720-2020	Le Goff, Wilfried/0000-0002-7611-9644; Rentero Alfonso, Carles/0000-0003-4684-0278; Le Goff, Wilfried/0000-0002-7611-9644; Stow, Jennifer L/0000-0002-5409-9101; Traini, Mathew/0000-0002-9423-5294; Gaus, Katharina/0000-0002-8009-9658; Kay, Jason/0000-0001-8944-6612	National Health and Medical Research Council of Australia [455251]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia Project Grant 455251.	AlRayyes O, 1996, HEPATOLOGY, V24, P613; APANAY DC, 1994, TRANSPLANTATION, V58, P663; Burgess JW, 2002, J BIOL CHEM, V277, P31318, DOI 10.1074/jbc.M204200200; BURNETT JR, 2007, 89 ANN M END SOC TOR; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; DENG JT, 1995, J LIPID RES, V36, P2129; Duan HW, 1997, J BIOL CHEM, V272, P31156, DOI 10.1074/jbc.272.49.31156; Gaus K, 2001, BIOCHEMISTRY-US, V40, P9363, DOI 10.1021/bi010323n; Greenow K, 2005, J MOL MED, V83, P329, DOI 10.1007/s00109-004-0631-3; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Ho YY, 2000, BIOCHEMISTRY-US, V39, P4746, DOI 10.1021/bi992294a; Huang ZH, 2004, J BIOL CHEM, V279, P29195, DOI 10.1074/jbc.M402631200; JI ZS, 1994, J BIOL CHEM, V269, P2764; Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200; Kockx M, 2008, ARTERIOSCL THROM VAS, V28, P1060, DOI 10.1161/ATVBAHA.108.164350; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; KRITHARIDES L, 1995, ARTERIOSCL THROM VAS, V15, P276, DOI 10.1161/01.ATV.15.2.276; Le Goff W, 2004, ARTERIOSCL THROM VAS, V24, P2155, DOI 10.1161/01.ATV.0000144811.94581.52; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Loor F, 2002, J MED CHEM, V45, P4598, DOI 10.1021/jm0109863; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mahley RW, 1999, J LIPID RES, V40, P1; Miller LW, 2002, AM J TRANSPLANT, V2, P807, DOI 10.1034/j.1600-6143.2002.20902.x; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Out R, 2008, CIRC RES, V102, P113, DOI 10.1161/CIRCRESAHA.107.161711; PRINCEN HMG, 1991, BIOCHEM J, V275, P501, DOI 10.1042/bj2750501; Sharom FJ, 1999, BIOCHEM PHARMACOL, V58, P571, DOI 10.1016/S0006-2952(99)00139-2; Terada H, 2003, J NEUROCHEM, V87, P1145, DOI 10.1046/j.1471-4159.2003.02098.x; Tory R, 2008, INT J PHARMACEUT, V358, P219, DOI 10.1016/j.ijpharm.2008.03.026; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Vaziri ND, 2000, J PHARMACOL EXP THER, V294, P778; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; WERNETTEHAMMOND ME, 1989, J BIOL CHEM, V264, P9094; Yancey PG, 2007, ARTERIOSCL THROM VAS, V27, P1123, DOI 10.1161/ATVBAHA.107.139592; ZANNIS VI, 1986, J BIOL CHEM, V261, P3415; ZANNIS VI, 1984, J BIOL CHEM, V259, P5495; Zhao YW, 2000, J BIOL CHEM, V275, P4759, DOI 10.1074/jbc.275.7.4759; Zhao YW, 2002, J BIOL CHEM, V277, P29477, DOI 10.1074/jbc.M200219200; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	43	21	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24144	24154		10.1074/jbc.M109.032615	http://dx.doi.org/10.1074/jbc.M109.032615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19589783	Green Published, hybrid			2022-12-27	WOS:000269380200028
J	Leverentz, MK; Campbell, RN; Connolly, Y; Whetton, AD; Reece, RJ				Leverentz, Michael K.; Campbell, Robert N.; Connolly, Yvonne; Whetton, Anthony D.; Reece, Richard J.			Mutation of a Phosphorylatable Residue in Put3p Affects the Magnitude of Rapamycin-induced PUT1 Activation in a Gat1p-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE UTILIZATION PATHWAY; CELL-GROWTH CONTROL; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATOR; BINUCLEAR CLUSTER; PROTEIN-KINASES; AMINO-ACID; NITROGEN; GENE; YEAST	Saccharomyces cerevisiae can utilize high quality (e.g. glutamine and ammonia) as well as low quality (e.g. gamma-amino butyric acid and proline) nitrogen sources. The transcriptional activator Put3p allows yeast cells to utilize proline as a nitrogen source through expression of the PUT1 and PUT2 genes. Put3p activates high level transcription of these genes by binding proline directly. However, Put3p also responds to other lower quality nitrogen sources. As nitrogen quality decreases, Put3p exhibits an increase in phosphorylation concurrent with an increase in PUT gene expression. The proline-independent activation of the PUT genes requires both Put3p and the positively acting GATA factors, Gln3p and Gat1p. Conversely, the phosphorylation of Put3p is not dependent on GATA factor activity. Here, we find that the mutation of Put3p at amino acid Tyr-788 modulates the proline-independent activation of PUT1 through Gat1p. The phosphorylation of Put3p appears to influence the association of Gat1p, but not Gln3p, to the PUT1 promoter. Combined, our findings suggest that this may represent a mechanism through which yeast cells rapidly adapt to use proline as a nitrogen source under nitrogen limiting conditions.	[Leverentz, Michael K.; Campbell, Robert N.; Reece, Richard J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Connolly, Yvonne; Whetton, Anthony D.] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England	University of Manchester; Paterson Institute for Cancer Research; University of Manchester	Reece, RJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Richard.Reece@manchester.ac.uk		Leverentz, Michael/0000-0003-4931-4732; WHETTON, ANTHONY D/0000-0002-1098-3878	Wellcome Trust; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Wellcome Trust and the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom ( to R.J.R.). 1 To whom correspondence	AXELROD JD, 1991, MOL CELL BIOL, V11, P564, DOI 10.1128/MCB.11.1.564; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COURCHESNE WE, 1983, MOL CELL BIOL, V3, P672, DOI 10.1128/MCB.3.4.672; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; desEtages SAG, 1996, GENETICS, V142, P1069; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Huang HL, 2000, MOL CELL BIOL, V20, P892, DOI 10.1128/MCB.20.3.892-899.2000; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Leverentz MK, 2006, BIOCHEM SOC T, V34, P794, DOI 10.1042/BST0340794; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; MARCZAK JE, 1991, MOL CELL BIOL, V11, P2609, DOI 10.1128/MCB.11.5.2609; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Oliveira EMM, 2005, FEMS YEAST RES, V5, P605, DOI 10.1016/j.femsyr.2004.11.011; RAI R, 1995, YEAST, V11, P247, DOI 10.1002/yea.320110307; SADOWSKI I, 1991, P NATL ACAD SCI USA, V88, P10510, DOI 10.1073/pnas.88.23.10510; Saxena D, 2003, EUKARYOT CELL, V2, P552, DOI 10.1128/EC.2.3.552-559.2003; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; Sellick CA, 2003, EMBO J, V22, P5147, DOI 10.1093/emboj/cdg480; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Swaminathan K, 1997, NAT STRUCT BIOL, V4, P751, DOI 10.1038/nsb0997-751; ter Schure EG, 1998, MICROBIOL-SGM, V144, P1451, DOI 10.1099/00221287-144-5-1451; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; van Werven FJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl003; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; XU SW, 1995, MOL CELL BIOL, V15, P2321; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; ZHENG P, 1993, MOL CELL BIOL, V13, P5829, DOI 10.1128/MCB.13.9.5829	39	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24115	24122		10.1074/jbc.M109.030361	http://dx.doi.org/10.1074/jbc.M109.030361			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574222	Green Published, hybrid			2022-12-27	WOS:000269380200025
J	Ors, A; Grimaldi, M; Kimata, Y; Wilkinson, CRM; Jones, N; Yamano, H				Ors, Aslihan; Grimaldi, Margaret; Kimata, Yuu; Wilkinson, Caroline R. M.; Jones, Nic; Yamano, Hiroyuki			The Transcription Factor Atf1 Binds and Activates the APC/C Ubiquitin Ligase in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; SCHIZOSACCHAROMYCES-POMBE; SEXUAL DEVELOPMENT; DNA-BINDING; DESTRUCTION BOX; GENE-EXPRESSION; PROTEIN; ENCODES; STRESS; COMPLEX/CYCLOSOME	Fission yeast Atf1 is a member of the ATF/CREB basic leucine zipper (bZIP) family of transcription factors with strong homology to mammalian ATF2. Atf1 regulates transcription in response to stress stimuli and also plays a role in controlling heterochromatin formation and recombination. However, its DNA binding independent role is poorly studied. Here, we report that Atf1 has a distinct role in regulating the anaphase-promoting complex/cyclosome (APC/C) ubiquitin ligase. We have identified atf1(+) as a dose-dependent suppressor of apc5-1, a mutation causing mitotic arrest. Remarkably, the suppression is not dependent upon the bZIP domain and is therefore independent of the ability of Atf1 to bind DNA. Interestingly, Atf1 physically binds the APC/C in vivo. Furthermore, we show that addition of purified Atf1 proteins into a cell-free system stimulates ubiquitylation of cyclin B and securin by the APC/C. These results reveal a novel role for Atf1 in cell cycle control through protein-protein interaction.	[Ors, Aslihan; Grimaldi, Margaret; Kimata, Yuu; Yamano, Hiroyuki] Marie Curie Res Inst, Cell Cycle Control Lab, Oxted RH8 0TL, Surrey, England; [Wilkinson, Caroline R. M.; Jones, Nic] Paterson Inst Canc Res, Canc Res UK Cell Regulat Lab, Manchester M20 4BX, Lancs, England	Paterson Institute for Cancer Research	Yamano, H (corresponding author), Marie Curie Res Inst, Cell Cycle Control Lab, Oxted RH8 0TL, Surrey, England.	h.yamano@mcri.ac.uk	Kimata, Yuu/U-2311-2017; Ors, Aslihan/A-3247-2012	Kimata, Yuu/0000-0001-6223-1320; 	Marie Curie Cancer Care; Association for International Cancer Research (AICR); Cancer Research UK [12485] Funding Source: researchfish	Marie Curie Cancer Care; Association for International Cancer Research (AICR); Cancer Research UK(Cancer Research UK)	This work was supported by Marie Curie Cancer Care and the Association for International Cancer Research (AICR).	AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BENBROOK DM, 1990, ONCOGENE, V5, P295; Bhoumik A, 2008, J BIOL CHEM, V283, P17605, DOI 10.1074/jbc.M802030200; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; RUSSELL PR, 1982, MOL CELL BIOL, V2, P106, DOI 10.1128/MCB.2.2.106; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Xue-Franzen YT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-303; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yoon HJ, 2006, J BIOL CHEM, V281, P32284, DOI 10.1074/jbc.M603867200	41	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23989	23994		10.1074/jbc.M109.018309	http://dx.doi.org/10.1074/jbc.M109.018309			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19584054	hybrid, Green Published			2022-12-27	WOS:000269380200013
J	Saegusa, J; Yamaji, S; Ieguchi, K; Wu, CY; Lam, KS; Liu, FT; Takada, YK; Takada, Y				Saegusa, Jun; Yamaji, Satoshi; Ieguchi, Katsuaki; Wu, Chun-Yi; Lam, Kit S.; Liu, Fu-Tong; Takada, Yoko K.; Takada, Yoshikazu			The Direct Binding of Insulin-like Growth Factor-1 (IGF-1) to Integrin alpha v beta 3 Is Involved in IGF-1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; SMOOTH-MUSCLE-CELLS; 1ST 3 DOMAINS; V BETA 3; CRYSTAL-STRUCTURE; ALPHA(V)BETA(3) EXPRESSION; EXTRACELLULAR SEGMENT; FACTOR RECEPTOR; LIGAND-BINDING; ADHESION	It has been proposed that ligand occupancy of integrin alpha v beta 3 with extracellular matrix ligands (e.g. vitronectin) plays a critical role in insulin-like growth factor-1 (IGF-1) signaling. We found that expression of alpha v beta 3 enhanced IGF-1-induced proliferation of Chinese hamster ovary cells in serum-free conditions (in the absence of vitronectin). We hypothesized that the direct integrin binding to IGF-1 may play a role in IGF-1 signaling. We demonstrated that alpha v beta 3 specifically and directly bound to IGF-1 in cell adhesion, enzyme-linked immunosorbent assay-type binding, and surface plasmon resonance studies. We localized the amino acid residues of IGF-1 that are critical for integrin binding by docking simulation and mutagenesis. We found that mutating two Arg residues at positions 36 and 37 in the C-domain of IGF-1 to Glu (the R36E/R37E mutation) effectively reduced integrin binding. Interestingly, although the mutant still bound to IGF1R, it was defective in inducing IGF1R phosphorylation, AKT and ERK1/2 activation, and cell proliferation. Furthermore wild type IGF-1 mediated co-precipitation of alpha v beta 3 and IGF1R, whereas the R36E/R37E mutant did not, suggesting that IGF-1 mediates the interaction between alpha v beta 3 and IGF1R. These results suggest that the direct binding to IGF-1 to integrin alpha v beta 3 plays a role in IGF-1 signaling through ternary complex formation (alpha v beta 3-IGF-IGF1R), and integrin-IGF-1 interaction is a novel target for drug discovery.	[Saegusa, Jun; Yamaji, Satoshi; Ieguchi, Katsuaki; Liu, Fu-Tong; Takada, Yoko K.] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Wu, Chun-Yi; Lam, Kit S.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Hematol Oncol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Res 3,Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu	Liu, FU-TONG/A-5749-2019	Liu, FU-TONG/0000-0002-3354-1001; takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health Grants [CA113298, CA131015, CA093373]; NATIONAL CANCER INSTITUTE [P30CA093373, U19CA113298, R01CA131015] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA113298, CA131015, and CA093373 ( to Y. T.).	Albelda S M, 1992, EXS, V61, P188; Artoni A, 2004, P NATL ACAD SCI USA, V101, P13114, DOI 10.1073/pnas.0404201101; AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; BAYNE ML, 1990, J BIOL CHEM, V265, P15648; Bojesen SE, 2005, ENDOCR-RELAT CANCER, V12, P945, DOI 10.1677/erc.1.01083; Chattopadhyay N, 2001, J EXP CLIN CANC RES, V20, P269; Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; Funes M, 2006, J BIOL CHEM, V281, P19310, DOI 10.1074/jbc.M603225200; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; Gladson CL, 1996, AM J PATHOL, V148, P1423; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones John I., 1995, Progress in Growth Factor Research, V6, P319, DOI 10.1016/0955-2235(95)00015-1; Liapis H, 1996, DIAGN MOL PATHOL, V5, P127, DOI 10.1097/00019606-199606000-00008; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Maile LA, 2006, MOL ENDOCRINOL, V20, P405, DOI 10.1210/me.2005-0241; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; PIGNATELLI M, 1992, HUM PATHOL, V23, P1159, DOI 10.1016/0046-8177(92)90034-Z; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Sengupta S, 2001, J EXP CLIN CANC RES, V20, P585; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Triantafilou M, 2000, HUM IMMUNOL, V61, P453, DOI 10.1016/S0198-8859(00)00103-8; Vonlaufen A, 2001, MODERN PATHOL, V14, P1126, DOI 10.1038/modpathol.3880447; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11217, DOI 10.1073/pnas.95.19.11217	34	61	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24106	24114		10.1074/jbc.M109.013201	http://dx.doi.org/10.1074/jbc.M109.013201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19578119	Green Published, hybrid			2022-12-27	WOS:000269380200024
J	Aygun, O; Xu, XH; Liu, YL; Takahashi, H; Kong, SE; Conaway, RC; Conaway, JW; Svejstrup, JQ				Ayguen, Ozan; Xu, Xiaohua; Liu, Yilun; Takahashi, Hidehisa; Kong, Stephanie E.; Conaway, Ronald C.; Conaway, Joan W.; Svejstrup, Jesper Q.			Direct Inhibition of RNA Polymerase II Transcription by RECQL5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR; REPLICATION FORK; MEDIATOR COMPLEX; HUMAN RECQ5-BETA; SYNDROME GENE; HELICASES; RECOMBINATION; INITIATION; CHROMATIN; IMPAIRMENT	DNA helicases of the RECQ family are important for maintaining genome integrity, from bacteria to humans. Although progress has been made in understanding the biochemical role of some human RECQ helicases, that of RECQL5 remains elusive. We recently reported that RECQL5 interacts with RNA polymerase II (RNAPII), pointing to a role for the protein in transcription. Here, we show that RECQL5 inhibits both initiation and elongation in transcription assays reconstituted with highly purified general transcription factors and RNAPII. Such inhibition is not observed with the related, much more active RECQL1 helicase or with a version of RECQL5 that has normal helicase activity but is impaired in its ability to interact with RNAPII. Indeed, RECQL5 helicase activity is not required for inhibition. We discuss our findings in light of the fact that RECQ5(-/-) mice have elevated levels of DNA recombination and a higher incidence of cancer.	[Ayguen, Ozan; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Xu, Xiaohua; Liu, Yilun] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Takahashi, Hidehisa; Kong, Stephanie E.; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Cancer Research UK; Yale University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, Blanche Lane, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk	xu, xiaohua/D-1152-2011; Hidehisa, Takahashi/E-2175-2012; liu, yi/GXE-9662-2022	Svejstrup, Jesper/0000-0003-4964-6147; Conaway, Joan/0000-0002-2786-0663; xu, xioahua/0000-0003-3790-6386	NIGMS; National Institutes of Health [R37 41628]; European Community [LSHG-CT-2005-512113]; Cancer Research UK; Bloom's Syndrome Foundation; American Cancer Society	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Cancer Research UK(Cancer Research UK); Bloom's Syndrome Foundation; American Cancer Society(American Cancer Society)	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grant R37 41628 (to R. C. C). This work was also supported by Integrated Project DNA Repair Grant LSHG-CT-2005-512113 from the European Community, an in-house grant from Cancer Research UK (to J.Q.S.), the Bloom's Syndrome Foundation, and by the American Cancer Society (to Y.L.).	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; CONAWAY JW, 1991, J BIOL CHEM, V266, P7804; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hu YD, 2005, MOL CELL BIOL, V25, P3431, DOI 10.1128/MCB.25.9.3431-3442.2005; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Hu YD, 2009, MOL BIOL CELL, V20, P114, DOI 10.1091/mbc.E08-06-0565; Jiang Y, 2004, MOL CELL, V14, P375, DOI 10.1016/S1097-2765(04)00234-5; Jimeno S, 2008, MOL GENET GENOMICS, V280, P327, DOI 10.1007/s00438-008-0368-8; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kitao S, 1999, GENOMICS, V61, P268, DOI 10.1006/geno.1999.5959; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shimamoto A, 2000, NUCLEIC ACIDS RES, V28, P1647, DOI 10.1093/nar/28.7.1647; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; TAN SY, 1994, J BIOL CHEM, V269, P25684; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Xie Z, 1996, J BIOL CHEM, V271, P11043, DOI 10.1074/jbc.271.19.11043; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	35	46	48	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23197	23203		10.1074/jbc.M109.015750	http://dx.doi.org/10.1074/jbc.M109.015750			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570979	hybrid, Green Published			2022-12-27	WOS:000269180000004
J	Hol, J; Kuchler, AM; Johansen, FE; Dalhus, B; Haraldsen, G; Oynebraten, I				Hol, Johanna; Kuchler, Axel M.; Johansen, Finn-Eirik; Dalhus, Bjorn; Haraldsen, Guttorm; Oynebraten, Inger			Molecular Requirements for Sorting of the Chemokine Interleukin-8/CXCL8 to Endothelial Weibel-Palade Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; P-SELECTIN EXPRESSION; REGULATED SECRETION; RECEPTOR-BINDING; CELLS; STORAGE; PROTEIN; MECHANISMS; EXOCYTOSIS; GLYCOSAMINOGLYCANS	Sorting of proteins to Weibel-Palade bodies (WPB) of endothelial cells allows rapid regulated secretion of leukocyte-recruiting P-selectin and chemokines as well as procoagulant von Willebrand factor (VWF). Here we show by domain swap studies that the exposed aspartic acid in loop 2 (Ser(44)-Asp(45)-Gly(46)) of the CXC chemokine interleukin (IL)-8 is crucial for targeting to WPB. Loop 2 also governs sorting of chemokines to alpha-granules of platelets, but the fingerprint of the loop 2 of these chemokines differs from that of IL-8. On the other hand, loop 2 of IL-8 closely resembles a surface-exposed sequence of the VWF propeptide, the region of VWF that directs sorting of the protein to WPB. We conclude that loop 2 of IL-8 constitutes a critical signal for sorting to WPB and propose a general role for this loop in the sorting of chemokines to compartments of regulated secretion.	[Kuchler, Axel M.; Johansen, Finn-Eirik; Haraldsen, Guttorm] Univ Oslo, Rikshosp, Univ Hosp, Div Pathol, N-0027 Oslo, Norway; [Hol, Johanna; Kuchler, Axel M.; Johansen, Finn-Eirik; Oynebraten, Inger] Univ Oslo, Rikshosp, Univ Hosp, Inst Pathol, N-0027 Oslo, Norway; [Dalhus, Bjorn] Univ Oslo, Rikshosp, Univ Hosp, Inst Clin Biochem & Med Microbiol, N-0027 Oslo, Norway; [Oynebraten, Inger] Univ Oslo, Rikshosp, Univ Hosp, Inst Immunol, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Haraldsen, G (corresponding author), Univ Oslo, Rikshosp, Univ Hosp, Div Pathol, Sognsvannsveien 20, N-0027 Oslo, Norway.	guttorm.haraldsen@rr-research.no	Haraldsen, Guttorm/I-2680-2013; Øynebråten, Inger/W-3369-2019; Haraldsen, Guttorm/W-4359-2019; Hol, Johanna/AAJ-8586-2020; Dalhus, Bjørn/AAK-2895-2020	Øynebråten, Inger/0000-0001-8914-5676; Hol, Johanna/0000-0001-5837-5006; Haraldsen, Guttorm/0000-0002-0064-9665	Research Council of Norway; Norwegian Cancer Society	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the Research Council of Norway and the Norwegian Cancer Society.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; Bierings R, 2007, J THROMB HAEMOST, V5, P2512, DOI 10.1111/j.1538-7836.2007.02768.x; Blandl T, 2003, PROTEIN SCI, V12, P237, DOI 10.1110/ps.0228603; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Campanella GSV, 2003, J BIOL CHEM, V278, P17066, DOI 10.1074/jbc.M212077200; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; Denis CV, 2001, P NATL ACAD SCI USA, V98, P4072, DOI 10.1073/pnas.061307098; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; El-Golli N, 2005, J BIOL CHEM, V280, P30329, DOI 10.1074/jbc.M503847200; Eppihimer MJ, 1997, AM J PHYSIOL-GASTR L, V273, pG1326, DOI 10.1152/ajpgi.1997.273.6.G1326; Gorr SU, 2001, MOL CELL ENDOCRINOL, V172, P1, DOI 10.1016/S0303-7207(00)00342-7; Haberichter SL, 2000, BLOOD, V96, P1808, DOI 10.1182/blood.V96.5.1808.h8001808_1808_1815; Haberichter SL, 2006, PEDIATR BLOOD CANCER, V46, P547, DOI 10.1002/pbc.20658; Haberichter SL, 2005, BLOOD, V105, P145, DOI 10.1182/blood-2004-02-0464; Haberichter SL, 2002, ARTERIOSCL THROM VAS, V22, P921, DOI 10.1161/01.ATV.0000017063.36768.87; Hammond MEW, 1996, J BIOL CHEM, V271, P8228, DOI 10.1074/jbc.271.14.8228; Harrison-Lavoie KJ, 2006, TRAFFIC, V7, P647, DOI 10.1111/j.1600-0854.2006.00415.x; Hartwell DM, 1998, J CELL BIOL, V143, P1129, DOI 10.1083/jcb.143.4.1129; HEBERT CA, 1990, J IMMUNOL, V145, P3033; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Karchin R, 2004, PROTEINS, V55, P508, DOI 10.1002/prot.20008; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Krieger E, 2004, PROTEINS, V54, P768, DOI 10.1002/prot.10590; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Lowman HB, 1997, PROTEIN SCI, V6, P598; Lui-Roberts WWY, 2005, J CELL BIOL, V170, P627, DOI 10.1083/jcb.200503054; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Metcalf DJ, 2008, J CELL SCI, V121, P19, DOI 10.1242/jcs.03494; Michaux G, 2003, BLOOD, V102, P2452, DOI 10.1182/blood-2003-02-0599; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; POWER CA, 1995, CYTOKINE, V7, P479, DOI 10.1006/cyto.1995.0065; Rajagopalan L, 2007, BIOPHYS J, V93, P2129, DOI 10.1529/biophysj.107.108761; ROMANI DW, 2003, EXP CELL RES, V286, P67; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Shahbazi S, 2007, J THROMB HAEMOST, V5, P1956, DOI 10.1111/j.1538-7836.2007.02681.x; Singh I, 1999, CLIN TRANSPLANT, V13, P76, DOI 10.1034/j.1399-0012.1999.130103.x; TARTAKOFF A, 1978, J CELL BIOL, V79, P694, DOI 10.1083/jcb.79.3.694; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wolff B, 1998, J EXP MED, V188, P1757, DOI 10.1084/jem.188.9.1757; Ye JQ, 2001, BIOCHEMISTRY-US, V40, P7820, DOI 10.1021/bi010252s	51	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23532	23539		10.1074/jbc.M900874200	http://dx.doi.org/10.1074/jbc.M900874200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19578117	Green Published, hybrid			2022-12-27	WOS:000269180000038
J	Koo, BH; Park, MY; Jeon, OH; Kim, DS				Koo, Bon-Hun; Park, Michael Y.; Jeon, Ok-Hee; Kim, Doo-Sik			Regulatory Mechanism of Matrix Metalloprotease-2 Enzymatic Activity by Factor Xa and Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; VEIN ENDOTHELIAL-CELLS; PRO-MMP-2 ACTIVATION; TISSUE INHIBITOR; PROGELATINASE-A; IV COLLAGENASE; GELATINASE-A; IN-VIVO; EFFICIENT ACTIVATION; TUMOR INVASION	Matrix metalloprotease (MMP)-2 plays a key role in many biological and pathological processes related to cell migration, invasion, and mitogenesis. MMP-2 is synthesized as a zymogen that is activated through either a conformational change or proteolysis of the propeptide. Several activating enzymes for pro-MMP-2 have been proposed, including metalloproteases and serine proteases. The mechanism of pro-MMP-2 activation by metalloproteases is well established, and the most studied activation mechanism involves cleavage of the propeptide by membrane type 1-MMP (MT1-MMP). In contrast, serine protease activation has not been thoroughly studied, although studies suggest that MT1-MMP may be involved in activation by thrombin and plasmin. Here, we demonstrate that factor Xa mediates MT1-MMP-independent processing of pro-MMP-2 in vascular smooth muscle cells and endothelial cells. Factor Xa and thrombin directly cleaved the propeptide on the carboxyl terminal sides of the Arg(98) and Arg(101) residues, whereas plasmin only cleaved the propeptide downstream of Arg(101). Moreover, processed MMP-2 showed enzymatic activity that was enhanced by intermolecular autoproteolytic processing at the Asn(109)-Tyr peptide bond. In addition to its role in activation, factor Xa rapidly degraded MMP-2, thereby restricting excessive MMP-2 activity. Thrombin also degraded MMP-2, but the degradation was reduced greatly under cell-associated conditions, resulting in an increase in processed MMP-2. Overall, factor Xa and thrombin regulate MMP-2 enzymatic activity through its activation and degradation. Thus, the net enzymatic activity results from a balance between MMP-2 activation and degradation.	[Koo, Bon-Hun; Park, Michael Y.; Jeon, Ok-Hee; Kim, Doo-Sik] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Natl Res Lab, Seoul 120749, South Korea	Yonsei University	Kim, DS (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Natl Res Lab, 134 Sinchon Dong, Seoul 120749, South Korea.	dskim@yonsei.ac.kr			Korean government (MOST) [ROA-2004-000-10297-0, 2009-0081759]	Korean government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government)	This work was supported by a Korea Science and Engineering Foundation grant funded by the Korean government (MOST Grants ROA-2004-000-10297-0 and 2009-0081759).	Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Bescond A, 1999, BIOCHEM BIOPH RES CO, V263, P498, DOI 10.1006/bbrc.1999.1391; Blanc-Brude OP, 2001, AM J PHYSIOL-CELL PH, V281, pC681, DOI 10.1152/ajpcell.2001.281.2.C681; Bono F, 1997, J CELL PHYSIOL, V172, P36, DOI 10.1002/(SICI)1097-4652(199707)172:1<36::AID-JCP4>3.0.CO;2-E; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Callahan MK, 2004, J NEUROIMMUNOL, V153, P150, DOI 10.1016/j.jneuroim.2004.05.004; Cao J, 2005, J BIOL CHEM, V280, P10974, DOI 10.1074/jbc.M412370200; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; Caterina JJ, 2000, J BIOL CHEM, V275, P26416, DOI 10.1074/jbc.M001271200; Chen DX, 2008, J EXP MED, V205, P1739, DOI 10.1084/jem.20071427; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; CRABBE T, 1994, FEBS LETT, V345, P14, DOI 10.1016/0014-5793(94)00412-9; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Ellerbroek SM, 1999, CANCER RES, V59, P1635; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Galis ZS, 1997, ARTERIOSCL THROM VAS, V17, P483, DOI 10.1161/01.ATV.17.3.483; Gilles C, 1996, INT J CANCER, V65, P209; Henderson N, 2007, AM J PHYSIOL-LUNG C, V292, pL1030, DOI 10.1152/ajplung.00317.2006; Herbert JM, 1998, J CLIN INVEST, V101, P993, DOI 10.1172/JCI1833; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Jackson MT, 2009, ARTHRITIS RHEUM-US, V60, P780, DOI 10.1002/art.24303; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; KAHAN C, 1992, J BIOL CHEM, V267, P13369; Koo BH, 2003, J BIOL CHEM, V278, P52578, DOI 10.1074/jbc.M310007200; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; LONSDALEECCLES JD, 1980, BIOCHIM BIOPHYS ACTA, V612, P401, DOI 10.1016/0005-2744(80)90123-0; MARMUR JD, 1993, J CLIN INVEST, V91, P2253, DOI 10.1172/JCI116452; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Monea S, 2002, J CELL PHYSIOL, V192, P160, DOI 10.1002/jcp.10126; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Nakada M, 2001, CANCER RES, V61, P8896; Nguyen M, 1999, LAB INVEST, V79, P467; Nie J, 2003, CANCER RES, V63, P6758; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; RAGOSTA M, 1994, CIRCULATION, V89, P1262, DOI 10.1161/01.CIR.89.3.1262; Rauch BH, 2002, CIRC RES, V90, P1122, DOI 10.1161/01.RES.0000019240.72809.76; Shamamian P, 2001, J CELL PHYSIOL, V189, P197, DOI 10.1002/jcp.10014; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; Sorsa T, 1997, J BIOL CHEM, V272, P21067, DOI 10.1074/jbc.272.34.21067; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Wallon UM, 1997, J BIOL CHEM, V272, P7473, DOI 10.1074/jbc.272.11.7473; Wang ZB, 2009, NEUROSCI LETT, V451, P199, DOI 10.1016/j.neulet.2009.01.003; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183	53	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23375	23385		10.1074/jbc.M109.036848	http://dx.doi.org/10.1074/jbc.M109.036848			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581306	hybrid, Green Published			2022-12-27	WOS:000269180000022
J	Zhong, DS; Xiong, L; Liu, TR; Liu, XJ; Liu, XG; Chen, J; Sun, SY; Khuri, FR; Zong, YP; Zhou, QH; Zhou, W				Zhong, Diansheng; Xiong, Li; Liu, Tongrui; Liu, Xiuju; Liu, Xiangguo; Chen, Jing; Sun, Shi-Yong; Khuri, Fadlo R.; Zong, Yaping; Zhou, Qinghua; Zhou, Wei			The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER RADIOTHERAPY; INSULIN; GROWTH; 2-DEOXY-D-GLUCOSE; GLUCOSE; KINASE; CELLS; PHOSPHORYLATION; ANTICANCER; METABOLISM	Recent molecular studies indicate that aerobic glycolysis plays an important role in tumorigenesis and is a valid target for cancer therapy. Although 2-deoxyglucose (2-DG) is well characterized as a glycolytic inhibitor, we recently discovered that it activates a prosurvival oncoprotein, AKT, through PI3K. In this study, we discovered that 2-DG treatments disrupted the binding between insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 (IGFBP3) so that the free form of IGF-1 could be released from the IGF-1.IGFBP3 complex to activate IGF-1 receptor (IGF1R) signaling. Because IGF1R signaling is involved, PI3K/AKT constitutes only one of the prosurvival pathways that are activated by 2-DG treatment; we validated that MEK-ERK signaling was also induced in an IGF1R-dependent manner in some cancer cell lines. Furthermore, our phospho-specific antibody microarray analysis indicated that 2-DG up-regulated the phosphorylation of 64 sites within various signaling pathways in H460 cells. Chemical inhibition of IGF1R reduced 57 of these up-regulations. These data suggest that 2-DG-induced activation of many survival pathways can be jointly attenuated through IGF1R inhibition. Our in vitro analysis demonstrated that treatment with a combination of subtoxic doses of 2-DG and the IGF1R inhibitor II reduced cancer cell proliferation 90% and promoted significant apoptosis.	[Zhong, Diansheng; Liu, Tongrui; Liu, Xiuju; Liu, Xiangguo; Chen, Jing; Sun, Shi-Yong; Khuri, Fadlo R.; Zhou, Wei] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Xiong, Li] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Zhou, Wei] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Zhou, Wei] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Zhong, Diansheng; Zhou, Qinghua] Tianjin Med Univ Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Envi, Tianjin 300052, Peoples R China; [Zong, Yaping] Full Moon Biosyst Inc, Sunnyvale, CA 94085 USA	Emory University; Emory University; Emory University; Emory University; Tianjin Medical University	Zhou, W (corresponding author), 1365 Clifton Rd NE,Ste C4084, Atlanta, GA 30322 USA.	wzhou2@emory.edu	Liu, Xiangguo/G-1091-2010; Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Xiong, Li/0000-0001-7354-0428; Liu, Xiangguo/0000-0002-1879-3817	National Institutes of Health [PO1 CA116676-030002, RO1 CA118470-01]; NATIONAL CANCER INSTITUTE [P01CA116676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or part, by National Institutes of Health Grants PO1 CA116676-030002 (to W.Z.) and RO1 CA118470-01 (to S.-Y. S.) from NCI.	Casa AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3273, DOI 10.2741/2925; Chang YS, 2004, ONCOGENE, V23, P6569, DOI 10.1038/sj.onc.1207882; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Grimberg A, 2003, CANCER BIOL THER, V2, P630; Kang HT, 2006, LIFE SCI, V78, P1392, DOI 10.1016/j.lfs.2005.07.001; KARCZMAR GS, 1992, CANCER RES, V52, P71; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; MCCOMB RB, 1964, CANCER RES, V24, P198; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; PARNIAK M, 1985, CAN J BIOCHEM CELL B, V63, P333, DOI 10.1139/o85-049; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; SRIDHAR R, 1979, IN VITRO CELL DEV B, V15, P685; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, CANCER RES, V65, P613; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhong DS, 2008, CANCER RES, V68, P7270, DOI 10.1158/0008-5472.CAN-08-1484; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559	24	86	89	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23225	23233		10.1074/jbc.M109.005280	http://dx.doi.org/10.1074/jbc.M109.005280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574224	Green Published, hybrid			2022-12-27	WOS:000269180000007
J	Guza, R; Ma, LA; Fang, QM; Pegg, AE; Tretyakova, N				Guza, Rebecca; Ma, Linan; Fang, Qingming; Pegg, Anthony E.; Tretyakova, Natalia			Cytosine Methylation Effects on the Repair of O-6-Methylguanines within CG Dinucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; HUMAN O6-METHYLGUANINE-DNA METHYLTRANSFERASE; DNA-BINDING MECHANISM; CELL LUNG-CANCER; EXOGENOUS CARCINOGENS; COMPLEX STABILITY; SEQUENCE CONTEXT; GUANINE ADDUCTS; P53 MUTATIONS; PROTEIN	O-6-Alkyldeoxyguanine adducts induced by tobacco-specific nitrosamines are repaired by O-6-alkylguanine DNA alkyltransferase (AGT), which transfers the O-6-alkyl group from the damaged base to a cysteine residue within the protein. In the present study, a mass spectrometry-based approach was used to analyze the effects of cytosine methylation on the kinetics of AGT repair of O-6-methyldeoxyguanosine (O-6-Me-dG) adducts placed within frequently mutated 5'-CG-3' dinucleotides of the p53 tumor suppressor gene. O-6-Me-dG-containing DNA duplexes were incubated with human recombinant AGT protein, followed by rapid quenching, acid hydrolysis, and isotope dilution high pressure liquid chromatography-electrospray ionization tandem mass spectrometry analysis of unrepaired O-6-methylguanine. Second-order rate constants were calculated in the absence or presence of the C-5 methyl group at neighboring cytosine residues. We found that the kinetics of AGT-mediated repair of O-6-Me-dG were affected by neighboring 5-methylcytosine (C-Me) in a sequence-dependent manner. AGT repair of O-6-Me-dG adducts placed within 5'-CG-3' dinucleotides of p53 codons 245 and 248 was hindered when MeC was present in both DNA strands. In contrast, cytosine methylation within p53 codon 158 slightly increased the rate of O-6-Me-dG repair by AGT. The effects of MeC located immediately 5' and in the base paired position to O-6-Me-dG were not additive as revealed by experiments with hypomethylated sequences. Furthermore, differences in dealkylation rates did not correlate with AGT protein affinity for cytosine-methylated and unmethylated DNA duplexes or with the rates of AGT-mediated nucleotide flipping, suggesting that C-Me influences other kinetic steps involved in repair, e. g. the rate of alkyl transfer from DNA to AGT.	[Guza, Rebecca; Tretyakova, Natalia] Univ Minnesota, Masonic Canc Ctr, Dept Med Chem, Minneapolis, MN 55455 USA; [Fang, Qingming; Pegg, Anthony E.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Tretyakova, N (corresponding author), Univ Minnesota, Masonic Canc Ctr 760E, Mayo Mail Code 806,420 Delaware St SE, Minneapolis, MN 55455 USA.	trety001@umn.edu	Fang, Qingming/B-6839-2008	Fang, Qingming/0000-0002-4006-0636	National Institutes of Health [CA-095039]; NCI [CA-018137]; NATIONAL CANCER INSTITUTE [R01CA095039, R37CA018137, R56CA095039, R01CA018137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-095039 (to N.T.) and CA-018137 (to A.P.) from the NCI.	Ahrendt SA, 2000, CANCER RES, V60, P3155; BASU AK, 1990, MUTAT RES, V233, P189, DOI 10.1016/0027-5107(90)90162-W; BENTIVEGNA SS, 1994, CANCER RES, V54, P327; BHATTACHARYYA D, 1990, EUR J BIOCHEM, V193, P337, DOI 10.1111/j.1432-1033.1990.tb19343.x; Coulter R, 2007, CHEM RES TOXICOL, V20, P1966, DOI 10.1021/tx700271j; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Delaney JC, 1999, CHEM BIOL, V6, P743, DOI 10.1016/S1074-5521(00)80021-6; DOLAN ME, 1988, CARCINOGENESIS, V9, P2139, DOI 10.1093/carcin/9.11.2139; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; Edara S, 1996, CANCER RES, V56, P5571; Essigmann J M, 1986, Prog Clin Biol Res, V209A, P433; FREDERICK CA, 1987, BIOPOLYMERS, V26, pS145, DOI 10.1002/bip.360260014; Fried MG, 1996, BIOCHEMISTRY-US, V35, P15295, DOI 10.1021/bi960971k; GEORGIADIS P, 1991, CANCER RES, V51, P5843; Guza R, 2006, CHEM RES TOXICOL, V19, P531, DOI 10.1021/tx050348d; Hazra TK, 1997, BIOCHEMISTRY-US, V36, P5769, DOI 10.1021/bi963085i; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; HEINEMANN U, 1992, J BIOL CHEM, V267, P7332; Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1; HOFFMANN D, 1994, J TOXICOL ENV HEALTH, V41, P1, DOI 10.1080/15287399409531825; Huang XW, 2002, CHEM RES TOXICOL, V15, P438, DOI 10.1021/tx015588h; Hussain SP, 1999, MUTAT RES-FUND MOL M, V428, P23, DOI 10.1016/S1383-5742(99)00028-9; Hussain SP, 2000, MUTAT RES-REV MUTAT, V462, P311, DOI 10.1016/S1383-5742(00)00015-6; LEFEBVRE A, 1995, EUR J BIOCHEM, V229, P445, DOI 10.1111/j.1432-1033.1995.0445k.x; LIEM LK, 1993, J MOL BIOL, V231, P950, DOI 10.1006/jmbi.1993.1344; Liu LP, 2002, CANCER RES, V62, P3037; Luu KX, 2002, BIOCHEMISTRY-US, V41, P8689, DOI 10.1021/bi025857i; Major GN, 1997, BIOCHEM SOC T, V25, pS359, DOI 10.1042/bst025359s; Marcourt L, 1999, EUR J BIOCHEM, V265, P1032, DOI 10.1046/j.1432-1327.1999.00819.x; Matter B, 2004, CHEM RES TOXICOL, V17, P731, DOI 10.1021/tx049974l; Mijal RS, 2006, CANCER RES, V66, P4968, DOI 10.1158/0008-5472.CAN-05-3803; Mijal RS, 2004, CHEM RES TOXICOL, V17, P424, DOI 10.1021/tx0342417; Muheim R, 2003, BIOCHEMISTRY-US, V42, P3247, DOI 10.1021/bi0268504; Norberg J, 2001, J MOL STRUC-THEOCHEM, V546, P51, DOI 10.1016/S0166-1280(01)00435-3; PETERSON LA, 1991, CANCER RES, V51, P5557; Rajesh M, 2005, BIOCHEMISTRY-US, V44, P2197, DOI 10.1021/bi0480032; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; Rasimas JJ, 2007, J BIOL CHEM, V282, P3357, DOI 10.1074/jbc.M608876200; SOWERS LC, 1987, BIOCHEM BIOPH RES CO, V148, P790, DOI 10.1016/0006-291X(87)90945-4; Spratt TE, 1999, BIOCHEMISTRY-US, V38, P6801, DOI 10.1021/bi982908w; TORNALETTI S, 1995, ONCOGENE, V10, P1493; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Wolf P, 2001, CANCER RES, V61, P8113; Xu-Welliver M, 2002, CARCINOGENESIS, V23, P823, DOI 10.1093/carcin/23.5.823; ZACHARIAS W, 1988, BIOCHEMISTRY-US, V27, P2970, DOI 10.1021/bi00408a046; Zang Z, 2005, J BIOL CHEM, V280, P30873, DOI 10.1074/jbc.M505283200; Ziegel R, 2004, BIOCHEMISTRY-US, V43, P540, DOI 10.1021/bi035259j	48	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22601	22610		10.1074/jbc.M109.000919	http://dx.doi.org/10.1074/jbc.M109.000919			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531487	hybrid, Green Published			2022-12-27	WOS:000268963100013
J	Hainzl, O; Lapina, MC; Buchner, J; Richter, K				Hainzl, Otmar; Lapina, Maria Claribel; Buchner, Johannes; Richter, Klaus			The Charged Linker Region Is an Important Regulator of Hsp90 Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP90; N-TERMINAL DOMAIN; ATPASE CYCLE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; STEROID-RECEPTOR; CLIENT PROTEIN; YEAST; HYDROLYSIS	Hsp90 is an ATP-dependent molecular chaperone which assists the maturation of a large set of target proteins. Members of the highly conserved Hsp90 family are found from bacteria to higher eukaryotes, with homologues in different organelles. The core architecture of Hsp90 is defined by the N-terminal ATP binding domain followed by the middle domain and the C-terminal dimerization domain. A long, highly charged linker between the N-terminal domain and the middle domain is a feature characteristic for Hsp90s of eukaryotic organisms. We set out to clarify the function of this linker by studying the effects of deletions in this region in vivo and in vitro. Here we show that increasing deletions in the charged linker region lead to defects ranging from mild temperature sensitivity to a lethal phenotype. The lethal deletion variants investigated in this study still exhibit ATPase activity. Deletion of the charged linker ultimately causes a loss of Hsp90 regulation by co-chaperones, as the sensitivity for Aha1-mediated ATPase acceleration declines, and binding of p23/Sba1 is lost in non-viable deletion constructs. In vivo client assays additionally demonstrated that the deletion of the linker had a pronounced effect on the ability of Hsp90 to facilitate client activation. A partial reconstruction of the linker sequence showed that the supplementation by artificial sequences can rescue the functionality of Hsp90 and restore the conformational flexibility of the protein, required for the processing of client proteins.	[Buchner, Johannes] Tech Univ Munich, Ctr Integrated Prot Sci, D-85747 Garching, Germany; Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	Technical University of Munich; Technical University of Munich	Buchner, J (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85747 Garching, Germany.	johannes.buchner@ch.tum.de	Richter, Klaus/A-2673-2010; Buchner, Johannes/A-2651-2010	Richter, Klaus/0000-0002-8952-9642; Buchner, Johannes/0000-0003-1282-7737	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and Fonds der Chemischen Industrie (to J. B. and K. R.).	Ahner A, 2005, ARCH BIOCHEM BIOPHYS, V435, P32, DOI 10.1016/j.abb.2004.11.005; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brodsky JL, 1998, BIOCHEMISTRY-US, V37, P18045, DOI 10.1021/bi980900g; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Fang YF, 1998, MOL CELL BIOL, V18, P3727, DOI 10.1128/MCB.18.7.3727; FARRELLY FW, 1984, J BIOL CHEM, V259, P5745; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; JAKOB U, 1995, J BIOL CHEM, V270, P14412, DOI 10.1074/jbc.270.24.14412; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Leskovar A, 2008, J BIOL CHEM, V283, P11677, DOI 10.1074/jbc.M709516200; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; TAMURA JK, 1990, J BIOL CHEM, V265, P21342; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109	55	106	107	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22559	22567		10.1074/jbc.M109.031658	http://dx.doi.org/10.1074/jbc.M109.031658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553666	Green Published, hybrid			2022-12-27	WOS:000268963100009
J	Wang, YF; Rathinam, R; Walch, A; Alahari, SK				Wang, Yanfang; Rathinam, Rajamani; Walch, Amelia; Alahari, Suresh K.			ST14 (Suppression of Tumorigenicity 14) Gene Is a Target for miR-27b, and the Inhibitory Effect of ST14 on Cell Growth Is Independent of miR-27b Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MICRORNA EXPRESSION PROFILES; MESSENGER-RNA; HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; OVARIAN-CANCER; METASTASIS; INVASION; PROTEIN; PROGNOSIS	MicroRNAs are noncoding, endogenous small RNAs that regulate target genes by cleavage of the targeted mRNA or translational repression. We investigated the microRNA-ome using 2-color microarrays in a highly invasive human breast cancer cell line, MDA-MB-231 (subline 4175) and a noninvasive breast epithelial cell line, MCF10A. We found 13 microRNAs that were up-regulated, and nine were down-regulated significantly in 4175 cells (p < 0.05, -fold change > 2) compared with MCF10A cells. Interestingly, miR-27b and its putative target gene, ST14 (suppressor of tumorigenicity 14), had inverse expression pattern in breast cancer cells. The 3'-untranslated region of ST14 contains a regulatory element for miR-27b, and our luciferase experiments indicate that antisense miR-27b enhances ST14 expression in cancer cells. Furthermore, antagomir of miR-27b suppressed cell invasion in 4175 cells, whereas pre-miR-27b stimulated invasion in moderately invasive ZR75 breast cancer cells. In addition, ST14 reduces cell proliferation as well as cell migration and invasion. Analysis of human breast tumors revealed that miR-27b expression increases during cancer progression, paralleling a decrease in ST14 expression. Furthermore, our data indicate that ST14 inhibits cells from entering into S phase by up-regulating p27, which results in down-regulation of cyclin E-CDK2 complexes, suggesting ST14 reduces cell growth through its effects on cell cycle-related proteins. Introduction of miR-27b into ST14-expressing cells did not suppress the effect on cell growth. These findings suggest that ST14 plays an important role in several biological processes, and some effects are not completely dependent on miR-27b regulation.	[Wang, Yanfang; Rathinam, Rajamani; Walch, Amelia; Alahari, Suresh K.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Alahari, Suresh K.] Louisiana State Univ, Hlth Sci Ctr, Stanley Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Alahari, SK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	salaha@lsuhsc.edu			National Institutes of Health [CA 115706]; National Institutes of Health COBRE [RR078766]; Louisiana Board of Regents [LEQSF-RD-A-14]; Louisiana Cancer Research Consortium;  [BCTR0600278]; NATIONAL CANCER INSTITUTE [R01CA115706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; Louisiana Cancer Research Consortium; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 115706 and National Institutes of Health COBRE Grant RR078766. This work was also supported by Susan Komen Grant BCTR0600278, Louisiana Board of Regents Grant LEQSF-RD-A-14, and funds from Louisiana Cancer Research Consortium (to S. K. A.).	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; DeGregori J, 2006, MOL CELL BIOL, V26, P1165, DOI 10.1128/MCB.26.4.1165-1169.2006; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hwang ES, 2009, EXP BIOL MED, V234, P105, DOI 10.3181/0806-RM-190; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang ZX, 2007, BIOCHEM BIOPH RES CO, V363, P542, DOI 10.1016/j.bbrc.2007.09.007; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Parr C, 2007, CLIN CANCER RES, V13, P3568, DOI 10.1158/1078-0432.CCR-06-2357; Parr C, 2006, INT J CANCER, V119, P1176, DOI 10.1002/ijc.21881; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Santin AD, 2003, CANCER, V98, P1898, DOI 10.1002/cncr.11753; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sun Li-feng, 2004, Zhonghua Yi Xue Za Zhi, V84, P843; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tanimoto H, 2005, BRIT J CANCER, V92, P278, DOI 10.1038/sj.bjc.6602320; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Tsui KH, 2008, ANTICANCER RES, V28, P1993; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang Y, 1998, CYTOGENET CELL GENET, V83, P56, DOI 10.1159/000015125; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	50	78	82	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23094	23106		10.1074/jbc.M109.012617	http://dx.doi.org/10.1074/jbc.M109.012617			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546220	hybrid, Green Published			2022-12-27	WOS:000268963100061
J	Adams, P; Kandiah, E; Effantin, G; Steven, AC; Ehrenfeld, E				Adams, Peter; Kandiah, Eaazhisai; Effantin, Gregory; Steven, Alasdair C.; Ehrenfeld, Ellie			Poliovirus 2C Protein Forms Homo-oligomeric Structures Required for ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA REPLICATION; LINKAGE MAP; NONSTRUCTURAL PROTEINS; GUANIDINE-RESISTANT; ELECTRON-MICROSCOPY; AMPHIPATHIC HELIX; ESCHERICHIA-COLI; PORTAL PROTEIN; VIRAL-PROTEINS; POLYPEPTIDE 2C	The poliovirus protein 2C plays an essential role in viral RNA replication, although its precise biochemical activities or structural requirements have not been elucidated. The protein has several distinctive properties, including ATPase activity and membrane and RNA binding, that are conserved among orthologs of many positive-strand RNA viruses. Sequence alignments have placed these proteins in the SF3 helicase family, a subset of the AAA+ ATPase superfamily. A feature common to AAA+ proteins is the formation of oligomeric rings that are essential for their catalytic functions. Here we show that a recombinant protein, MBP-2C, in which maltose-binding protein was fused to 2C, formed soluble oligomers and that ATPase activity was restricted to oligomer-containing fractions from gel-filtration chromatography. The active fraction was visualized by negative-staining electron microscopy as ring-like particles composed of 5-8 protomers. This conclusion was confirmed by mass measurements obtained by scanning transmission electron microscopy. Mutation of amino acid residues in the 2C nucleotide-binding domain demonstrated that loss of the ability to bind or hydrolyze ATP did not affect oligomerization. Co-expression of active MBP-2C and inactive mutant proteins generated mixed oligomers that exhibited little ATPase activity, suggesting that incorporation of inactive subunits eliminates the function of the entire particle. Finally, deletion of the N-terminal 38 amino acids blocked oligomerization of the fusion protein and eliminated ATPase activity, despite retention of an unaltered nucleotide-binding domain.	[Adams, Peter; Ehrenfeld, Ellie] NIAID, NIH, Bethesda, MD 20892 USA; [Kandiah, Eaazhisai; Effantin, Gregory; Steven, Alasdair C.] NIAMS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Ehrenfeld, E (corresponding author), NIAID, NIH, 50 South Dr,Room 6120, Bethesda, MD 20892 USA.	eehrenfeld@niaid.nih.gov	Kandiah, Eaazhisai/D-2354-2010	Kandiah, Eaazhisai/0000-0002-9877-7621	Intramural Research Programs of the NIAID; NIAMS; National Institutes of Health; NIH [5 P41 EB2181]; Department of Energy and Office of Biological and Environmental Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002181] Funding Source: NIH RePORTER	Intramural Research Programs of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy and Office of Biological and Environmental Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Intramural Research Programs of the NIAID and NIAMS, National Institutes of Health. The Brookhaven National Laboratory STEM is a National Institutes of Health supported resource center, NIH 5 P41 EB2181, with additional support provided by the Department of Energy and Office of Biological and Environmental Research.	Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V206, P64, DOI 10.1006/bbrc.1995.1010; ARGOS P, 1984, NUCLEIC ACIDS RES, V12, P7251, DOI 10.1093/nar/12.18.7251; Banerjee R, 2004, J VIROL, V78, P9243, DOI 10.1128/JVI.78.17.9243-9256.2004; Banerjee R, 2001, J GEN VIROL, V82, P2621, DOI 10.1099/0022-1317-82-11-2621; BIENZ K, 1990, J VIROL, V64, P1156, DOI 10.1128/JVI.64.3.1156-1163.1990; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Castella S, 2006, NUCLEIC ACIDS RES, V34, P3731, DOI 10.1093/nar/gkl554; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Collaco RF, 2003, J BIOL CHEM, V278, P34011, DOI 10.1074/jbc.M301537200; Cuconati A, 1998, J VIROL, V72, P1297, DOI 10.1128/JVI.72.2.1297-1307.1998; de Jong AS, 2002, J GEN VIROL, V83, P783, DOI 10.1099/0022-1317-83-4-783; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; ECHEVERRI AC, 1995, VIROLOGY, V208, P540, DOI 10.1006/viro.1995.1185; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1982, J MOL BIOL, V161, P134, DOI 10.1016/0022-2836(82)90282-0; Gai DH, 2004, J BIOL CHEM, V279, P38952, DOI 10.1074/jbc.M406160200; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P8413, DOI 10.1093/nar/17.21.8413; GORBALENYA AE, 1988, FEBS LETT, V235, P16, DOI 10.1016/0014-5793(88)81226-2; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; Kocsis E, 1995, ULTRAMICROSCOPY, V60, P219, DOI 10.1016/0304-3991(95)00070-2; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; LI JP, 1990, J VIROL, V64, P1102, DOI 10.1128/JVI.64.3.1102-1107.1990; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marin MS, 2000, J VIROL, V74, P10846, DOI 10.1128/JVI.74.22.10846-10851.2000; Maurizi MR, 1998, BIOCHEMISTRY-US, V37, P7778, DOI 10.1021/bi973093e; MIRZAYAN C, 1994, VIROLOGY, V199, P176, DOI 10.1006/viro.1994.1110; MOSESSON MW, 1981, J MOL BIOL, V153, P695, DOI 10.1016/0022-2836(81)90414-9; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; PASAMONTES L, 1986, J GEN VIROL, V67, P2415, DOI 10.1099/0022-1317-67-11-2415; PAUL AV, 1994, VIROLOGY, V199, P188, DOI 10.1006/viro.1994.1111; Pfister T, 2000, J VIROL, V74, P334, DOI 10.1128/JVI.74.1.334-343.2000; Pfister T, 1999, J BIOL CHEM, V274, P6992, DOI 10.1074/jbc.274.11.6992; PINCUS SE, 1986, J VIROL, V60, P793, DOI 10.1128/JVI.60.2.793-796.1986; Poliakov A, 2007, J STRUCT BIOL, V157, P371, DOI 10.1016/j.jsb.2006.09.003; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Tang WF, 2007, J BIOL CHEM, V282, P5888, DOI 10.1074/jbc.M611145200; TERSHAK DR, 1985, CAN J MICROBIOL, V31, P1166, DOI 10.1139/m85-220; Teterina NL, 2006, J VIROL, V80, P5327, DOI 10.1128/JVI.02684-05; Teterina NL, 2006, VIROLOGY, V344, P453, DOI 10.1016/j.virol.2005.08.044; TETERINA NL, 1992, J GEN VIROL, V73, P1977, DOI 10.1099/0022-1317-73-8-1977; Teterina NL, 1997, J VIROL, V71, P8962, DOI 10.1128/JVI.71.12.8962-8972.1997; THOMAS D, 1994, BIOL CELL, V80, P181, DOI 10.1016/0248-4900(94)90041-8; TOLSKAYA EA, 1994, J MOL BIOL, V236, P1310, DOI 10.1016/0022-2836(94)90060-4; Trus BL, 2004, J VIROL, V78, P12668, DOI 10.1128/JVI.78.22.12668-12671.2004; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Wall JS, 2000, METH MOL B, V148, P589; WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355; Yin J, 2007, J GEN VIROL, V88, P2259, DOI 10.1099/vir.0.82795-0; Zell R, 2005, J GEN VIROL, V86, P2763, DOI 10.1099/vir.0.81144-0	68	36	38	0	118	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22012	22021		10.1074/jbc.M109.031807	http://dx.doi.org/10.1074/jbc.M109.031807			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520852	Green Published, hybrid			2022-12-27	WOS:000268783700025
J	Ey, B; Eyking, A; Gerken, G; Podolsky, DK; Cario, E				Ey, Birgit; Eyking, Annette; Gerken, Guido; Podolsky, Daniel K.; Cario, Elke			TLR2 Mediates Gap Junctional Intercellular Communication through Connexin-43 in Intestinal Epithelial Barrier Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; CARDIAC MYOCYTES; MICE DEFICIENT; WOUND REPAIR; CELL-LINES; PHOSPHORYLATION; GENE; ACTIVATION	Gap junctional intercellular communication (GJIC) coordinates cellular functions essential for sustaining tissue homeostasis; yet its regulation in the intestine is not well understood. Here, we identify a novel physiological link between Toll-like receptor (TLR) 2 and GJIC through modulation of Connexin-43 (Cx43) during acute and chronic inflammatory injury of the intestinal epithelial cell (IEC) barrier. Data from in vitro studies reveal that TLR2 activation modulates Cx43 synthesis and increases GJIC via Cx43 during IEC injury. The ulcerative colitis-associated TLR2-R753Q mutant targets Cx43 for increased proteasomal degradation, impairing TLR2-mediated GJIC during intestinal epithelial wounding. In vivo studies using mucosal RNA interference show that TLR2-mediated mucosal healing depends functionally on intestinal epithelial Cx43 during acute inflammatory stress-induced damage. Mice deficient in TLR2 exhibit IEC-specific alterations in Cx43, whereas administration of a TLR2 agonist protects GJIC by blocking accumulation of Cx43 and its hyperphosphorylation at Ser(368) to prevent spontaneous chronic colitis in MDR1 alpha-deficient mice. Finally, adding the TLR2 agonist to three-dimensional intestinal mucosa-like cultures of human biopsies preserves intestinal epithelial Cx43 integrity and polarization ex vivo. In conclusion, Cx43 plays an important role in innate immune control of commensal-mediated intestinal epithelial wound repair.	[Cario, Elke] Univ Hosp Essen, Div Gastroenterol & Hepatol, D-45147 Essen, Germany; [Ey, Birgit; Eyking, Annette; Gerken, Guido; Cario, Elke] Univ Duisburg Essen, Sch Med, D-45147 Essen, Germany; [Podolsky, Daniel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Duisburg Essen; University of Duisburg Essen; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cario, E (corresponding author), Univ Hosp Essen, Div Gastroenterol & Hepatol, Virchowstr 171, D-45147 Essen, Germany.	elke.cario@uni-due.de		Gerken, Guido/0000-0001-6734-5001	Crohn's and Colitis Foundation of America (CCFA) [1790]; Deutsche Forschungsgemeinschaft [Ca226/4-2]; IFORES; National Institutes of Health [DK60049]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060049] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America (CCFA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IFORES; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Crohn's and Colitis Foundation of America (CCFA) Senior Research Award 1790 (to E. C.), Deutsche Forschungsgemeinschaft Grant Ca226/4-2 (to E. C.), and a grant from IFORES (to E. C.). This work was also supported in part by National Institutes of Health Grant DK60049 (to D. K. P.).	Almonacid LAV, 2009, VET J, V182, P452, DOI 10.1016/j.tvjl.2008.08.011; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Cario E, 2006, J IMMUNOL, V176, P4258, DOI 10.4049/jimmunol.176.7.4258; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; Chun J, 2006, J IMMUNOL, V177, P1330, DOI 10.4049/jimmunol.177.2.1330; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Collett A, 2008, INFLAMM BOWEL DIS, V14, P620, DOI 10.1002/ibd.20375; Cruciani V, 1999, EXP CELL RES, V251, P285, DOI 10.1006/excr.1999.4574; Derangeon M, 2008, J BIOL CHEM, V283, P30754, DOI 10.1074/jbc.M801556200; Dubina MV, 2002, ONCOGENE, V21, P4992, DOI 10.1038/sj.onc.1205630; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Kwak BR, 2001, MOL BIOL CELL, V12, P831, DOI 10.1091/mbc.12.4.831; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; Leaphart CL, 2007, GASTROENTEROLOGY, V132, P2395, DOI 10.1053/j.gastro.2007.03.029; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Lidington D, 2002, J CELL PHYSIOL, V193, P373, DOI 10.1002/jcp.10179; Martin FJ, 2008, J IMMUNOL, V180, P4986, DOI 10.4049/jimmunol.180.7.4986; Medeiros GA, 2009, MICROBES INFECT, V11, P264, DOI 10.1016/j.micinf.2008.11.012; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Merx S, 2007, HUM MOL GENET, V16, P1225, DOI 10.1093/hmg/ddm070; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Nguyen DD, 2007, GASTROENTEROLOGY, V133, P1188, DOI 10.1053/j.gastro.2007.07.010; Nusrat A, 2000, J CELL SCI, V113, P1771; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Panwala CM, 1998, J IMMUNOL, V161, P5733; PEPPER MS, 1989, J CELL BIOL, V109, P3027, DOI 10.1083/jcb.109.6.3027; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; Punturieri A, 2006, J IMMUNOL, V177, P673, DOI 10.4049/jimmunol.177.1.673; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Resta-Lenert S, 2005, AM J PHYSIOL-GASTR L, V289, pG153, DOI 10.1152/ajpgi.00395.2004; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Santos MF, 1997, J CLIN INVEST, V100, P216, DOI 10.1172/JCI119515; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schroder NWJ, 2003, J MOL MED-JMM, V81, P368, DOI 10.1007/s00109-003-0443-x; Schwab M, 2003, GASTROENTEROLOGY, V124, P26, DOI 10.1053/gast.2003.50010; Singh D, 2005, J BIOL CHEM, V280, P30416, DOI 10.1074/jbc.M506799200; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Teusch N, 2004, J IMMUNOL, V173, P507, DOI 10.4049/jimmunol.173.1.507; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Van Nhieu GT, 2003, NAT CELL BIOL, V5, P720, DOI 10.1038/ncb1021; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Wilk JN, 2005, IMMUNOL RES, V31, P151, DOI 10.1385/IR:31:2:151; Xue Y, 2008, J PROTEOME RES, V7, P3180, DOI 10.1021/pr800021a; Zhang YJ, 2006, MOL THER, V14, P336, DOI 10.1016/j.ymthe.2006.04.001	65	89	94	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22332	22343		10.1074/jbc.M901619200	http://dx.doi.org/10.1074/jbc.M901619200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19528242	hybrid, Green Published			2022-12-27	WOS:000268783700056
J	Singh, S; Padovani, D; Leslie, RA; Chiku, T; Banerjee, R				Singh, Sangita; Padovani, Dominique; Leslie, Rachel A.; Chiku, Taurai; Banerjee, Ruma			Relative Contributions of Cystathionine beta-Synthase and gamma-Cystathionase to H2S Biogenesis via Alternative Trans-sulfuration Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; AEROBIC CONTINUOUS-CULTURE; HYDROGEN-SULFIDE; SACCHAROMYCES-CEREVISIAE; LANTHIONINE KETIMINE; OXIDATIVE STRESS; REDOX REGULATION; BRAIN-TISSUE; HOMOCYSTEINE; YEAST	In mammals, the two enzymes in the trans-sulfuration pathway, cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CSE), are believed to be chiefly responsible for hydrogen sulfide (H2S) biogenesis. In this study, we report a detailed kinetic analysis of the human and yeast CBS-catalyzed reactions that result in H2S generation. CBS from both organisms shows a marked preference for H2S generation by beta-replacement of cysteine by homocysteine. The alternative H2S-generating reactions, i.e. beta-elimination of cysteine to generate serine or condensation of 2 mol of cysteine to generate lanthionine, are quantitatively less significant. The kinetic data were employed to simulate the turnover numbers of the various CBS-catalyzed reactions at physiologically relevant substrate concentrations. At equimolar concentrations of CBS and CSE, the simulations predict that H2S production by CBS would account for similar to 25-70% of the total H2S generated via the trans-sulfuration pathway depending on the extent of allosteric activation of CBS by S-adenosylmethionine. The relative contribution of CBS to H2S genesis is expected to decrease under hyperhomocysteinemic conditions. CBS is predicted to be virtually the sole source of lanthionine, and CSE, but not CBS, efficiently cleaves lanthionine. The insensitivity of the CBS-catalyzed H2S-generating reactions to the grade of hyperhomocysteinemia is in stark contrast to the responsiveness of CSE and suggests a previously unrecognized role for CSE in intracellular homocysteine management. Finally, our studies reveal that the profligacy of the trans-sulfuration pathway results not only in a multiplicity of H2S-yielding reactions but also yields novel thioether metabolites, thus increasing the complexity of the sulfur metabolome.	[Singh, Sangita; Padovani, Dominique; Leslie, Rachel A.; Chiku, Taurai; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Dominique, PADOVANI/EUS-9660-2022	PADOVANI, Dominique/0000-0003-1166-5801	National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Abe K, 1996, J NEUROSCI, V16, P1066; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; BORCSOK E, 1982, ARCH BIOCHEM BIOPHYS, V213, P695, DOI 10.1016/0003-9861(82)90600-2; BRAUNSTE.AE, 1971, BIOCHIM BIOPHYS ACTA, V242, P247, DOI 10.1016/0005-2744(71)90105-7; BRAUNSTEIN AE, 1969, BIOCHIM BIOPHYS ACTA, V171, P366, DOI 10.1016/0005-2744(69)90173-9; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Diwakar L, 2007, NEUROCHEM INT, V50, P418, DOI 10.1016/j.neuint.2006.09.014; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fontana M, 1997, NEUROCHEM RES, V22, P821, DOI 10.1023/A:1022083809994; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; GOODWIN LR, 1989, J ANAL TOXICOL, V13, P105, DOI 10.1093/jat/13.2.105; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; KERY V, 1994, J BIOL CHEM, V269, P25283; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; MCVEIGH I, 1972, MYCOPATH MYCOL APPL, V47, P135, DOI 10.1007/BF02126161; MITCHELL TW, 1993, J APPL TOXICOL, V13, P389, DOI 10.1002/jat.2550130605; MUDD SH, 1985, AM J HUM GENET, V37, P1; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; RICCI G, 1989, BIOCHIM BIOPHYS ACTA, V990, P211, DOI 10.1016/S0304-4165(89)80036-4; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; SAVAGE JC, 1990, J CHROMATOGR-BIOMED, V526, P540, DOI 10.1016/S0378-4347(00)82537-2; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Sohn HY, 2000, YEAST, V16, P1185, DOI 10.1002/1097-0061(20000930)16:13<1185::AID-YEA619>3.0.CO;2-W; Sohn HY, 2001, ARCH MICROBIOL, V176, P69, DOI 10.1007/s002030100295; Sohn HY, 2001, YEAST, V18, P125, DOI 10.1002/1097-0061(20010130)18:2<125::AID-YEA655>3.0.CO;2-9; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Taoka S, 2002, J BIOL CHEM, V277, P22421, DOI 10.1074/jbc.M202513200; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	39	464	475	2	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22457	22466		10.1074/jbc.M109.010868	http://dx.doi.org/10.1074/jbc.M109.010868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531479	hybrid, Green Published			2022-12-27	WOS:000268783700067
J	Vitour, D; Dabo, S; Pour, MA; Vilasco, M; Vidalain, PO; Jacob, Y; Mezel-Lemoine, M; Paz, S; Arguello, M; Lin, R; Tangy, F; Hiscott, J; Meurs, EF				Vitour, Damien; Dabo, Stephanie; Pour, Malek Ahmadi; Vilasco, Myriam; Vidalain, Pierre-Olivier; Jacob, Yves; Mezel-Lemoine, Mariana; Paz, Suzanne; Arguello, Meztli; Lin, Rongtuan; Tangy, Frederic; Hiscott, John; Meurs, Eliane F.			Polo-like Kinase 1 (PLK1) Regulates Interferon (IFN) Induction by MAVS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; KAPPA-B KINASE; RIG-I; BOX DOMAIN; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; IKK-EPSILON; HELICASE; CANCER; RECOGNITION	The mitochondria-bound adapter MAVS participates in IFN induction by recruitment of downstream partners such as members of the TRAF family, leading to activation of NF-kappa B, and the IRF3 pathways. A yeast two-hybrid search for MAVS-interacting proteins yielded the Polo-box domain (PBD) of the mitotic Polo-like kinase PLK1. We showed that PBD associates with two different domains of MAVS in both dependent and independent phosphorylation events. The phosphodependent association requires the phosphopeptide binding ability of PBD. It takes place downstream of the proline-rich domain of MAVS, within an STP motif, characteristic of the binding of PLK1 to its targets, where the central Thr(234) residue is phosphorylated. Its phosphoindependent association takes place at the C terminus of MAVS. PLK1 strongly inhibits the ability of MAVS to activate the IRF3 and NF-kappa B pathways and to induce IFN. Reciprocally, depletion of PLK1 can increase IFN induction in response to RIG-I/SeV or RIG-I/poly(I)-poly(C) treatments. This inhibition is dependent on the phosphoindependent association of PBD at the C terminus of MAVS where it disrupts the association of MAVS with its downstream partner TRAF3. IFN induction was strongly inhibited in cells arrested in G2/M by nocodazole, which provokes increased expression of endogenous PLK1. Interestingly, depletion of PLK1 from these nocodazole-treated cells could restore, at least partially, IFN induction. Altogether, these data demonstrate a new function for PLK1 as a regulator of IFN induction and provide the basis for the development of inhibitors preventing the PLK1/MAVS association to sustain innate immunity.	[Vitour, Damien; Dabo, Stephanie; Pour, Malek Ahmadi; Vilasco, Myriam; Meurs, Eliane F.] Inst Pasteur, Unit Hepacivirus & Innate Immun, F-75015 Paris, France; [Vidalain, Pierre-Olivier; Mezel-Lemoine, Mariana; Tangy, Frederic; Meurs, Eliane F.] Inst Pasteur, Lab Viral Genom & Vaccinat, F-75015 Paris, France; [Jacob, Yves] Inst Pasteur, Unit Genet Papillomavirus & Human Canc, F-75015 Paris, France; [Paz, Suzanne; Arguello, Meztli; Lin, Rongtuan; Hiscott, John] McGill Univ, Lady Davis Inst Med Res, Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Lady Davis Institute; McGill University	Meurs, EF (corresponding author), Inst Pasteur, 28 Rue Dr Roux, F-75724 Paris 15, France.	eliane.meurs@pasteur.fr	Vidalain, Pierre-Olivier/F-9778-2019; Lin, Rongtuan/A-1442-2008	Vidalain, Pierre-Olivier/0000-0003-3082-7407; Lin, Rongtuan/0000-0002-2238-3503; Jacob, Yves/0000-0001-9125-2374; Paz, Suzanne/0000-0002-0465-7144	Research Transversal Program; Pasteur Institute; Agence Nationale pour la Recherche contre le SIDA (ANRS)	Research Transversal Program; Pasteur Institute; Agence Nationale pour la Recherche contre le SIDA (ANRS)(ANRSFrench National Research Agency (ANR))	This work was supported in part by grants from a Research Transversal Program (186), from the Pasteur Institute, and by the Agence Nationale pour la Recherche contre le SIDA (ANRS) (to E. F. M.).	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bostik P, 2004, J VIROL, V78, P1464, DOI 10.1128/JVI.78.3.1464-1472.2004; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Chang F, 2004, MOL BIOL CELL, V15, P1793, DOI 10.1091/mbc.E03-09-0691; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; DICKSON RB, 1986, CANCER RES, V46, P1707; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garcia-Alvarez B, 2007, P NATL ACAD SCI USA, V104, P3107, DOI 10.1073/pnas.0609131104; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Patel D, 2004, CANCER RES, V64, P1299, DOI 10.1158/0008-5472.CAN-03-2917; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Reagan-Shaw S, 2005, FASEB J, V19, P611, DOI 10.1096/fj.04-2910fje; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Spankuch B, 2007, ONCOGENE, V26, P5793, DOI 10.1038/sj.onc.1210355; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Vilasco M, 2006, HEPATOLOGY, V44, P1635, DOI 10.1002/hep.21432; VITOUR D, 2007, SCI STKE, pPE20, DOI DOI 10.1126/STKE.38442007PE20; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	57	72	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21797	21809		10.1074/jbc.M109.018275	http://dx.doi.org/10.1074/jbc.M109.018275			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19546225	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000268783700004
J	Wyatt, AR; Yerbury, JJ; Wilson, MR				Wyatt, Amy R.; Yerbury, Justin J.; Wilson, Mark R.			Structural Characterization of Clusterin-Chaperone Client Protein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CHAPERONE; MOLECULAR CHAPERONES; AMYLOID FORMATION; CONFORMATIONAL DISEASE; TOXICITY; ALPHA(2)-MACROGLOBULIN; TEMPERATURE; SPECIFICITY; HAPTOGLOBIN; ALZHEIMERS	Clusterin (CLU) is a potent extracellular chaperone that inhibits protein aggregation and precipitation otherwise caused by physical or chemical stresses (e. g. heat, reduction). This action involves CLU forming soluble high molecular weight (HMW) complexes with the client protein. Other than their unquantified large size, the physical characteristics of these complexes were previously unknown. In this study, HMW CLU-citrate synthase (CS), HMW CLU-fibrinogen (FGN), and HMW CLU-glutathione S-transferase (GST) complexes were generated in vitro, and their structures studied using size exclusion chromatography (SEC), ELISA, SDS-PAGE, dynamic light scattering (DLS), bisANS fluorescence, and circular dichroism spectrophotometry (CD). Densitometry of Coomassie Blue-stained SDS-PAGE gels indicated that all three HMW CLU-client protein complexes had an approximate mass ratio of 1:2 (CLU: client protein). SEC indicated that all three clients formed complexes with CLU >= 4 x 10(7) Da; however, DLS estimated HMW CLU-FGN to have a diameter of 108.57 +/- 18.09 nm, while HMW CLU-CS and HMW CLU-GST were smaller with estimated diameters of 51.06 +/- 6.87 nm and 52.61 +/- 7.71 nm, respectively. Measurements of bisANS fluorescence suggest that the chaperone action of CLU involves preventing the exposure to aqueous solvent of hydrophobic regions that are normally exposed by the client protein during heat-induced unfolding. CD analysis indicated that, depending on the individual client protein, CLU may interact with a variety of intermediates on protein unfolding pathways with different amounts of native secondary structure. In vivo, soluble complexes like those studied here are likely to serve as vehicles to dispose of otherwise dangerous aggregation-prone misfolded extracellular proteins.	[Wyatt, Amy R.; Yerbury, Justin J.; Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia	University of Wollongong	Wilson, MR (corresponding author), Univ Wollongong, Sch Biol Sci, Northfields Ave, Wollongong, NSW 2522, Australia.	mrw@uow.edu.au	Yerbury, Justin/AAC-7054-2022; Wilson, Mark R/B-3254-2018	Yerbury, Justin/0000-0003-2528-7039; Wilson, Mark R/0000-0002-9551-7445; Wyatt, Amy/0000-0002-3650-2438	Australian Research Council [DP0773555]	Australian Research Council(Australian Research Council)	This work was supported in part by Grant DP0773555 from the Australian Research Council.	Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Freixes M, 2004, ACTA NEUROPATHOL, V108, P295, DOI 10.1007/s00401-004-0891-6; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; FRENCH LE, 1992, CLIN EXP IMMUNOL, V88, P389; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Heuer KH, 1996, BIOCHEMISTRY-US, V35, P9069, DOI 10.1021/bi952817o; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Ker Y. C., 1998, Lebensmittel-Wissenschaft and Technologie, V31, P107, DOI 10.1006/fstl.1997.0306; KUMAR KL, 1986, WESTERN J MED, V144, P753; Lakins JN, 2002, BIOCHEMISTRY-US, V41, P282, DOI 10.1021/bi0157666; McGugan E A, 2001, Emerg Med (Fremantle), V13, P116, DOI 10.1046/j.1442-2026.2001.00189.x; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Pape Magdalini, 2007, J Med Case Rep, V1, P154, DOI 10.1186/1752-1947-1-154; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; SALTIN B, 1966, J APPL PHYSIOL, V21, P1757, DOI 10.1152/jappl.1966.21.6.1757; Sasaki K, 2002, ACTA NEUROPATHOL, V104, P225, DOI 10.1007/s00401-002-0546-4; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; Stewart EM, 2007, BIOCHEMISTRY-US, V46, P1412, DOI 10.1021/bi062082v; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; WILSON MR, 1992, BIOCHIM BIOPHYS ACTA, V1159, P319, DOI 10.1016/0167-4838(92)90062-I; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	40	60	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21920	21927		10.1074/jbc.M109.033688	http://dx.doi.org/10.1074/jbc.M109.033688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19535339	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000268783700016
J	Chan, SL; Low, LY; Hsu, S; Li, S; Liu, T; Santelli, E; Le Negrate, G; Reed, JC; Woods, VL; Pascual, J				Chan, Siew Leong; Low, Lieh Yoon; Hsu, Simon; Li, Sheng; Liu, Tong; Santelli, Eugenio; Le Negrate, Gaelle; Reed, John C.; Woods, Virgil L., Jr.; Pascual, Jaime			Molecular Mimicry in Innate Immunity CRYSTAL STRUCTURE OF A BACTERIAL TIR DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL/INTERLEUKIN-1 RECEPTOR DOMAIN; AMIDE HYDROGEN/DEUTERIUM EXCHANGE; TOLL-LIKE RECEPTORS; MASS-SPECTROMETRY; PROTEIN; FAMILY; SYSTEM; MODEL; DIMER; TLR2	Macrophages detect pathogen infection via the activation of their plasma membrane-bound Toll-like receptor proteins (TLRs). The heterotypic interaction between the Toll/interleukin-1 receptor (TIR) domains of TLRs and adaptor proteins, like Myeloid differentiation primary response gene 88 (MyD88), is the first intracellular step in the signaling pathway of the mammalian innate immune response. The hetero-oligomerization of the TIRs of the receptor and adaptor brings about the activation of the transcription factor NF-kappa B, which regulates the synthesis of pro-inflammatory cytokines. Here, we report the first crystal structure of a bacterial TIR domain solved at 2.5 angstrom resolution. The three-dimensional fold of Paracoccus denitrificans TIR is identical to that observed for the TIR of human TLRs and MyD88 proteins. The structure shows a unique dimerization interface involving the DD-loop and EE-loop residues, whereas leaving the BB-loop highly exposed. Peptide amide hydrogen-deuterium exchange mass spectrometry also reveals that the same region is used for dimerization in solution and in the context of the full-length protein. These results, together with a functional interaction between P. denitrificans TIR and MyD88 visualized in a co-immunoprecipitation assay, further substantiate the model that bacterial TIR proteins adopt structural mimicry of the host active receptor TIR domains to interfere with the signaling of TLRs and their adaptors to decrease the inflammatory response.	[Chan, Siew Leong; Low, Lieh Yoon; Santelli, Eugenio; Le Negrate, Gaelle; Reed, John C.; Pascual, Jaime] Burnham Inst Med Res, Inflammat & Infect Dis Ctr, La Jolla, CA 92037 USA; [Chan, Siew Leong; Low, Lieh Yoon; Santelli, Eugenio; Le Negrate, Gaelle; Reed, John C.; Pascual, Jaime] Burnham Inst Med Res, Ctr Canc, La Jolla, CA 92037 USA; [Hsu, Simon; Li, Sheng; Liu, Tong; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Hsu, Simon; Li, Sheng; Liu, Tong; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad Program, San Diego, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Pascual, J (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pascual@burnham.org	Hsu, Simon/GXZ-6548-2022; pascual, jaime/D-4566-2009	Hsu, Simon/0000-0003-3780-294X; pascual, jaime/0000-0001-8992-7475	National Institutes of Health [P01AI055789, CA099835, CA118595, AI076961, R21AI065602]; NATIONAL CANCER INSTITUTE [R21CA099835, R21CA118595, R33CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076961, R21AI065602, P01AI055789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AI055789 (to J. C. R.), CA099835, CA118595, and AI076961 (to V. L. W.), and R21AI065602 (to J. P.).	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Davis CN, 2006, P NATL ACAD SCI USA, V103, P2953, DOI 10.1073/pnas.0510802103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; HAMURO Y, 2008, MASS SPECTROMETRY AN, P1; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kim YM, 2007, NAT IMMUNOL, V8, P674, DOI 10.1038/nio707-675; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li J, 2008, STRUCTURE, V16, P137, DOI 10.1016/j.str.2007.10.027; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Neill LAJ, 2008, NAT MED, V14, P370, DOI 10.1038/nm0408-370; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Woods VL, 2001, J CELL BIOCHEM, V84, P89, DOI 10.1002/jcb.10069; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zawadzki KM, 2003, PROTEIN SCI, V12, P1980, DOI 10.1110/ps.03166903	35	66	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21386	21392		10.1074/jbc.C109.007591	http://dx.doi.org/10.1074/jbc.C109.007591			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535337	Green Published, hybrid			2022-12-27	WOS:000268564400033
J	Tang, RH; Rosen, SD				Tang, Renhong; Rosen, Steven D.			Functional Consequences of the Subdomain Organization of the Sulfs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SULFATASE DEFICIENCY; HEPARAN-SULFATE; HEPATOCELLULAR-CARCINOMA; PROPROTEIN CONVERTASES; ANCHORED PROTEINS; GENE-EXPRESSION; BREAST-CANCER; WNT PROTEINS; TUMOR-GROWTH; IN-VIVO	Sulf-1 and Sulf-2 are novel extracellular sulfatases that act on internal glucosamine 6-O-sulfate modifications within heparan sulfate proteoglycans and regulate their interactions with various signaling molecules, including Wnt ligands. Although the Sulfs are multidomain proteins, there is limited information available about how the subdomains contribute to their enzymatic and signaling activities. In this study, we found that both human Sulfs were synthesized as prepro-enzymes and cleaved by a furin-type proteinase to form disulfide-bond linked heterodimers of 75- and 50-kDa subunits. The mature Sulfs were secreted into conditioned medium, as well as retained on the cell membrane. Although the catalytic center resides in the N-terminal 75-kDa subunit, the C-terminal 50-kDa subunit was indispensable for both arylsufatase and glucosamine 6-O-sulfate-endosulfatase activity. We found that the hydrophilic regions of the Sulfs were essential for endosulfatase activity but not for arylsulfatase activity. Using Edman sequencing, we identified furin-type proteinase cleavage sites in Sulf-1 and Sulf-2. Deletion of these sequences resulted in uncleavable forms of Sulfs. The uncleavable Sulfs retained enzymatic activity. However, they were unable to potentiate Wnt signaling, which may be due to their defective localization into lipid rafts on the plasma membrane.	[Tang, Renhong; Rosen, Steven D.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rosen, SD (corresponding author), 513 Parnassus Ave, San Francisco, CA 94143 USA.	Steven.Rosen@ucsf.edu		Rosen, Steven/0000-0002-6245-701X	National Institutes of Health [P01 AI053194, R21 CA122025]; University of California [17RT-0117]; NATIONAL CANCER INSTITUTE [R21CA122025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AI053194 and R21 CA122025 (to S. D. R.). This work was also supported by Tobacco-related Disease Research Program of the University of California Grant 17RT-0117.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Ambasta RK, 2007, J BIOL CHEM, V282, P34492, DOI 10.1074/jbc.M706744200; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Garcia AL, 2005, J BIOL CHEM, V280, P41595, DOI 10.1074/jbc.M509122200; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; Hernandez-Guzman FG, 2003, J BIOL CHEM, V278, P22989, DOI 10.1074/jbc.M211497200; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; McMahon S, 2003, EXP CELL RES, V291, P326, DOI 10.1016/S0014-4827(03)00407-5; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nagase H, 2008, CONNECT TISSUE RES, V49, P169, DOI 10.1080/03008200802151698; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Parenti G, 1997, CURR OPIN GENET DEV, V7, P386, DOI 10.1016/S0959-437X(97)80153-0; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; Sharom FJ, 2002, BIOCHEM CELL BIOL, V80, P535, DOI 10.1139/O02-146; Siegfried G, 2003, CANCER RES, V63, P1458; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Uchimura K, 2006, METHOD ENZYMOL, V416, P243, DOI 10.1016/S0076-6879(06)16015-2; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Watanabe N, 2004, FASEB J, V18, P1013, DOI 10.1096/fj.03-1040fje; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	59	54	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21505	21514		10.1074/jbc.M109.028472	http://dx.doi.org/10.1074/jbc.M109.028472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520866	Green Published, hybrid			2022-12-27	WOS:000268564400045
J	Lopez, IA; Rosenblatt, MI; Kim, C; Galbraith, GC; Jones, SM; Kao, LY; Newman, D; Liu, WX; Yeh, S; Pushkin, A; Abuladze, N; Kurtz, I				Lopez, Ivan A.; Rosenblatt, Mark I.; Kim, Charles; Galbraith, Gary C.; Jones, Sherri M.; Kao, Liyo; Newman, Debra; Liu, Weixin; Yeh, Stacey; Pushkin, Alexander; Abuladze, Natalia; Kurtz, Ira			Slc4a11 Gene Disruption in Mice CELLULAR TARGETS OF SENSORINEURONAL ABNORMALITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY ENDOTHELIAL DYSTROPHY; MOUSE MODEL; INNER-EAR; AUDITORY IMPAIRMENT; PERCEPTIVE DEAFNESS; CORNEAL-DYSTROPHY; HARBOYAN-SYNDROME; MUTATIONS; TRANSPORTER; GROWTH	NaBC1 (the SLC4A11 gene) belongs to the SLC4 family of sodium-coupled bicarbonate (carbonate) transporter proteins and functions as an electrogenic sodium borate cotransporter. Mutations in SLC4A11 cause either corneal abnormalities (corneal hereditary dystrophy type 2) or a combined auditory and visual impairment (Harboyan syndrome). The role of NaBC1 in sensory systems is poorly understood, given the difficulty of studying patients with NaBC1 mutations. We report our findings in Slc4a11(-/-) mice generated to investigate the role of NaBC1 in sensorineural systems. In wild-type mice, specific NaBC1 immunoreactivity was detected in fibrocytes of the spiral ligament, from the basal to the apical portion of the cochlea. NaBC1 immunoreactivity was present in the vestibular labyrinth, in stromal cells underneath the non-immunoreactive sensory epithelia of the macula utricle, sacule, and crista ampullaris, and the membranous vestibular labyrinth was collapsed. Both auditory brain response and vestibular evoked potential waveforms were significantly abnormal in Slc4a11(-/-) mice. In the cornea, NaBC1 was highly expressed in the endothelial cell layer with less staining in epithelial cells. However, unlike humans, the corneal phenotype was mild with a normal slit lamp evaluation. Corneal endothelial cells were morphologically normal; however, both the absolute height of the corneal basal epithelial cells and the relative basal epithelial cell/total corneal thickness were significantly increased in Slc4a11(-/-) mice. Our results demonstrate for the first time the importance of NaBC1 in the audio-vestibular system and provide support for the hypothesis that SLC4A11 should be considered a potential candidate gene in patients with isolated sensorineural vestibular hearing abnormalities.	[Kao, Liyo; Newman, Debra; Liu, Weixin; Yeh, Stacey; Pushkin, Alexander; Abuladze, Natalia; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA; [Lopez, Ivan A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Head & Neck, Los Angeles, CA 90095 USA; [Rosenblatt, Mark I.; Kim, Charles] Weill Cornell Med Coll, Margaret M Dyson Vis Res Inst, New York, NY 10021 USA; [Jones, Sherri M.] E Carolina Univ, Dept Commun Sci & Disorders, Greenville, NC 27858 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; University of North Carolina; East Carolina University	Kurtz, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Room 7-155,Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	ikurtz@mednet.UCLA.edu	Lopez, Ivan A/U-2177-2019; lopez, ivan/GSM-8495-2022	Lopez, Ivan A/0000-0001-5205-7293; 	National Institutes of Health [EY015829, EY019561, DC006443, DK077162, DK058563, DK063125]; NATIONAL EYE INSTITUTE [K08EY015829, R21EY019561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R01DK063125, R01DK058563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants EY015829 and EY019561 (to M. R.); DC006443 (to S. J.); and DK077162, DK058563, and DK063125 (to I. K.)	Abramowicz MJ, 2002, J MED GENET, V39, P110, DOI 10.1136/jmg.39.2.110; Abuin A, 2007, Handb Exp Pharmacol, P129; Aldave AJ, 2007, CORNEA, V26, P896, DOI 10.1097/ICO.0b013e318074bb01; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; Delprat B, 2005, MOL CELL BIOL, V25, P847, DOI 10.1128/MCB.25.2.847-853.2005; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; Desir J, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-28; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; Galbraith G, 2006, J NEUROSCI METH, V153, P214, DOI 10.1016/j.jneumeth.2005.10.017; Gates P, 2005, INTERN MED J, V35, P488, DOI 10.1111/j.1445-5994.2005.00891.x; Handzel O, 2006, OTOL NEUROTOL, V27, P57, DOI 10.1097/01.mao.0000188658.36327.8f; Hemadevi B, 2008, ARCH OPHTHALMOL-CHIC, V126, P700, DOI 10.1001/archopht.126.5.700; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; Hequembourg S, 2001, JARO-J ASSOC RES OTO, V2, P118, DOI 10.1007/s101620010075; HUANG CM, 1977, BRAIN RES, V137, P291; Ishiyama Gail, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P332, DOI 10.1097/01.moo.0000244191.51560.22; Jiao XD, 2007, J MED GENET, V44, P64, DOI 10.1136/jmg.2006.044644; Jones SM., 2008, BALANCE FUNCTION ASS, P379; Jones T.A., 2007, AUDITORY EVOKED POTE, P622; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kumar A, 2007, MOL VIS, V13, P39; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; Lopez IA, 2005, DEV BRAIN RES, V160, P63, DOI 10.1016/j.devbrainres.2005.08.008; Magli A, 1997, OPHTHALMIC GENET, V18, P87, DOI 10.3109/13816819709057120; Megerian CA, 2008, HEARING RES, V237, P90, DOI 10.1016/j.heares.2008.01.002; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Mizuta K, 2008, NEUROSCI LETT, V434, P104, DOI 10.1016/j.neulet.2008.01.036; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Park M, 2005, CELL CYCLE, V4, P24, DOI 10.4161/cc.4.1.1394; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; Parker MD, 2001, BIOCHEM BIOPH RES CO, V282, P1103, DOI 10.1006/bbrc.2001.4692; PEYMAN GA, 1977, A GRAEF ARCH KLIN EX, V201, P257, DOI 10.1007/BF02385183; Ping JL, 2007, J NEUROSCI METH, V161, P11, DOI 10.1016/j.jneumeth.2006.10.001; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Ramprasad Vedam L, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9487; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Robertson NG, 2008, HUM MOL GENET, V17, P3426, DOI 10.1093/hmg/ddn236; Sultana A, 2007, MOL VIS, V13, P1327; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; TUFT SJ, 1986, INVEST OPHTH VIS SCI, V27, P1199; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028	44	57	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26882	26896		10.1074/jbc.M109.008102	http://dx.doi.org/10.1074/jbc.M109.008102			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19586905	Green Published, hybrid			2022-12-27	WOS:000269969600069
J	Ferreira, P; Hernandez-Ortega, A; Herguedas, B; Martinez, AT; Medina, M				Ferreira, Patricia; Hernandez-Ortega, Aitor; Herguedas, Beatriz; Martinez, Angel T.; Medina, Milagros			Aryl-alcohol Oxidase Involved in Lignin Degradation A MECHANISTIC STUDY BASED ON STEADY AND PRE-STEADY STATE KINETICS AND PRIMARY AND SOLVENT ISOTOPE EFFECTS WITH TWO ALCOHOL SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTALLOGRAPHY REVEALS; FUNGUS PLEUROTUS-ERYNGII; GLUCOSE-OXIDASE; CHOLINE OXIDASE; CRYSTAL-STRUCTURE; CHOLESTEROL OXIDASE; CATALYTIC MECHANISM; ASPERGILLUS-NIGER; CELLOBIOSE DEHYDROGENASE; BETAINE-ALDEHYDE	Aryl-alcohol oxidase (AAO) is a FAD-containing enzyme in the GMC (glucose-methanol-choline oxidase) family of oxidoreductases. AAO participates in fungal degradation of lignin, a process of high ecological and biotechnological relevance, by providing the hydrogen peroxide required by ligninolytic peroxidases. In the Pleurotus species, this peroxide is generated in the redox cycling of p-anisaldehyde, an extracellular fungal metabolite. In addition to p-anisyl alcohol, the enzyme also oxidizes other polyunsaturated primary alcohols. Its reaction mechanism was investigated here using p-anisyl alcohol and 2,4-hexadien-1-ol as two AAO model substrates. Steady state kinetic parameters and enzyme-monitored turnover were consistent with a sequential mechanism in which O-2 reacts with reduced AAO before release of the aldehyde product. Pre-steady state analysis revealed that the AAO reductive half-reaction is essentially irreversible and rate limiting during catalysis. Substrate and solvent kinetic isotope effects under steady and presteady state conditions (the latter showing similar to 9-fold slower enzyme reduction when alpha-bideuterated substrates were used, and similar to 13-fold slower reduction when both substrate and solvent effects were simultaneously evaluated) revealed a synchronous mechanism in which hydride transfer from substrate alpha-carbon to FAD and proton abstraction from hydroxyl occur simultaneously. This significantly differs from the general mechanism proposed for other members of the GMC oxidoreductase family that implies hydride transfer from a previously stabilized substrate alkoxide.	[Martinez, Angel T.] CSIC, CIB, E-28040 Madrid, Spain; [Ferreira, Patricia; Herguedas, Beatriz; Medina, Milagros] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Ferreira, Patricia; Herguedas, Beatriz; Medina, Milagros] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos, E-50009 Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Zaragoza; University of Zaragoza	Martinez, AT (corresponding author), CSIC, CIB, Ramiro Maeztu 9, E-28040 Madrid, Spain.	atmartinez@cib.csic.es; mmedina@unizar.es	Herguedas, Beatriz/AAB-8665-2022; Martínez, Angel T/G-7284-2017; Neila, Patricia Ferreira/Y-4803-2019; Medina, Milagros/F-8310-2012	Martínez, Angel T/0000-0002-1584-2863; Medina, Milagros/0000-0001-8743-0182; Ferreira Neila, Patricia/0000-0003-4076-6118; Herguedas, Beatriz/0000-0003-2044-4795	Spanish Projects [BIO2005-03569, BIO2007-65890-C02-01, BIO2008-01533]; BIORENEW Project of the European Union [NMP2-CT-2006-026456]	Spanish Projects(Spanish Government); BIORENEW Project of the European Union(European Commission)	This work was supported by the Spanish Projects BIO2005-03569, BIO2007-65890-C02-01, and BIO2008-01533, and the BIORENEW Project of the European Union (Contract NMP2-CT-2006-026456).	Bannwarth M, 2004, BIOCHEMISTRY-US, V43, P11683, DOI 10.1021/bi048609q; BRIGHT HJ, 1967, J BIOL CHEM, V242, P994; CLELAND WW, 1982, METHOD ENZYMOL, V87, P625; Dreveny I, 2001, STRUCTURE, V9, P803, DOI 10.1016/S0969-2126(01)00639-6; Fan F, 2005, J AM CHEM SOC, V127, P2067, DOI 10.1021/ja044541q; Fan F, 2006, BIOCHEMISTRY-US, V45, P1979, DOI 10.1021/bi0517537; Ferreira P, 2005, BIOCHEM J, V389, P731, DOI 10.1042/BJ20041903; Ferreira P, 2006, FEBS J, V273, P4878, DOI 10.1111/j.1742-4658.2006.05488.x; Fraaije MW, 1997, J BIOL CHEM, V272, P18111, DOI 10.1074/jbc.272.29.18111; FREDERICK KR, 1990, J BIOL CHEM, V265, P3793; Gadda G, 2003, BBA-PROTEINS PROTEOM, V1650, P4, DOI 10.1016/S1570-9639(03)00188-2; Gadda G, 2003, BBA-PROTEINS PROTEOM, V1646, P112, DOI 10.1016/S1570-9639(03)00003-7; Gadda G, 2008, BIOCHEMISTRY-US, V47, P13745, DOI 10.1021/bi801994c; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Ghanem M, 2003, BIOCHEMISTRY-US, V42, P15179, DOI 10.1021/bi035435o; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; GUILLEN F, 1994, APPL ENVIRON MICROB, V60, P2811; GUILLEN F, 1992, EUR J BIOCHEM, V209, P603, DOI 10.1111/j.1432-1033.1992.tb17326.x; GUTIERREZ A, 1994, APPL ENVIRON MICROB, V60, P1783; Hallberg BM, 2002, J MOL BIOL, V315, P421, DOI 10.1006/jmbi.2001.5246; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Hernandez-Ortega A, 2008, FLAVINS FLAVOPROTEIN, P303; Kass IJ, 1998, BIOORG MED CHEM LETT, V8, P2663, DOI 10.1016/S0960-894X(98)00478-8; Kass IJ, 1998, BIOCHEMISTRY-US, V37, P17990, DOI 10.1021/bi982115+; Lario PI, 2003, J MOL BIOL, V326, P1635, DOI 10.1016/S0022-2836(03)00054-8; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lyubimov AY, 2006, NAT CHEM BIOL, V2, P259, DOI 10.1038/nchembio784; MARTINEZ AT, 1994, FEMS MICROBIOL REV, V13, P265, DOI 10.1016/0168-6445(94)90084-1; Martinez AT, 2005, INT MICROBIOL, V8, P195; MASSEY V, 1995, FASEB J, V9, P473, DOI 10.1096/fasebj.9.7.7737454; MASSEY V, 1969, J BIOL CHEM, V244, P3999; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; MENON V, 1995, BIOORG CHEM, V23, P42, DOI 10.1006/bioo.1995.1004; MULLER F, 1969, J BIOL CHEM, V244, P4007; Quaye O, 2008, BIOCHEMISTRY-US, V47, P243, DOI 10.1021/bi7017943; Romero E, 2009, BBA-PROTEINS PROTEOM, V1794, P689, DOI 10.1016/j.bbapap.2008.11.013; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Rotsaert FAJ, 2003, BIOCHEMISTRY-US, V42, P4049, DOI 10.1021/bi027092k; Ruiz-Duenas FJ, 2006, PROTEIN EXPRES PURIF, V45, P191, DOI 10.1016/j.pep.2005.06.003; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; Varela E, 2000, BBA-PROTEIN STRUCT M, V1481, P202, DOI 10.1016/S0167-4838(00)00127-8; Varela E, 1999, BIOCHEM J, V341, P113, DOI 10.1042/0264-6021:3410113; Witt S, 2000, BIOCHEM J, V347, P553, DOI 10.1042/0264-6021:3470553	44	49	49	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24840	24847		10.1074/jbc.M109.011593	http://dx.doi.org/10.1074/jbc.M109.011593			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19574215	Green Published, hybrid			2022-12-27	WOS:000269734000018
J	Ichinose, H; Fujimoto, Z; Honda, M; Harazono, K; Nishimoto, Y; Uzura, A; Kaneko, S				Ichinose, Hitomi; Fujimoto, Zui; Honda, Mariko; Harazono, Koichi; Nishimoto, Yukifumi; Uzura, Atsuko; Kaneko, Satoshi			A beta-L-Arabinopyranosidase from Streptomyces avermitilis Is a Novel Member of Glycoside Hydrolase Family 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABINOGALACTAN-PROTEINS; MOLECULAR GRAPHICS; CAJANUS-INDICUS; L-ARABINOSIDASE; BINDING MODULE; NBRC14893; XYLANASE; GLYCOPROTEINS; CRYSTALS; ARABINAN	Arabinogalactan proteins (AGPs) are a family of plant cell surface proteoglycans and are considered to be involved in plant growth and development. Because AGPs are very complex molecules, glycoside hydrolases capable of degrading AGPs are powerful tools for analyses of the AGPs. We previously reported such enzymes from Streptomyces avermitilis. Recently, a beta-L-arabinopyranosidase was purified from the culture supernatant of the bacterium, and its corresponding gene was identified. The primary structure of the protein revealed that the catalytic module was highly similar to that of glycoside hydrolase family 27 (GH27) alpha-D-galactosidases. The recombinant protein was successfully expressed as a secreted 64-kDa protein using a Streptomyces expression system. The specific activity toward p-nitrophenyl-beta-L-arabinopyranoside was 18 mu mol of arabinose/min/mg, which was 67 times higher than that toward p-nitrophenyl-alpha-D-galactopyranoside. The enzyme could remove 0.1 and 45% L-arabinose from gum arabic or larch arabinogalactan, respectively. X-ray crystallographic analysis reveals that the protein had a GH27 catalytic domain, an antiparallel beta-domain containing Greek key motifs, another antiparallel beta-domain forming a jellyroll structure, and a carbohydrate-binding module family 13 domain. Comparison of the structure of this protein with that of alpha-D-galactosidase showed a single amino acid substitution (aspartic acid to glutamic acid) in the catalytic pocket of beta-L-arabinopyranosidase, and a space for the hydroxymethyl group on the C-5 carbon of D-galactose bound to alpha-galactosidase was changed in beta-L-arabinopyranosidase. Mutagenesis study revealed that the residue is critical for modulating the enzyme activity. This is the first report in which beta-L-arabinopyranosidase is classified as a new member of the GH27 family.	[Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Fujimoto, Zui] Natl Inst Agrobiol Sci, Prot Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Harazono, Koichi; Nishimoto, Yukifumi; Uzura, Atsuko] Nagase & Co Ltd, Ctr Res & Dev, Nishi Ku, Kobe, Hyogo 6512241, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Agrobiological Sciences - Japan; Nagase & Co., Ltd.	Kaneko, S (corresponding author), Natl Food Res Inst, Food Biotechnol Div, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	sakaneko@affrc.go.jp		Fujimoto, Zui/0000-0002-3551-6854	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grand-in-aid for scientific research from the Japan Society for the Promotion of Science.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aspinall G O, 1969, Adv Carbohydr Chem Biochem, V24, P333; Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103; Boraston AB, 2000, BIOCHEM J, V350, P933, DOI 10.1042/0264-6021:3500933; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; DEY PM, 1973, BIOCHIM BIOPHYS ACTA, V302, P393, DOI 10.1016/0005-2744(73)90167-8; DEY PM, 1983, BIOCHIM BIOPHYS ACTA, V746, P8, DOI 10.1016/0167-4838(83)90003-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINCHER GB, 1974, BIOCHEM J, V139, P535, DOI 10.1042/bj1390535; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Fujimoto Z, 2002, J MOL BIOL, V316, P65, DOI 10.1006/jmbi.2001.5338; Fujimoto Z, 2009, ACTA CRYSTALLOGR F, V65, P632, DOI 10.1107/S1744309109017230; Gaspar Y, 2001, PLANT MOL BIOL, V47, P161, DOI 10.1023/A:1010683432529; Goodrum LJ, 2000, PHYTOCHEMISTRY, V54, P99, DOI 10.1016/S0031-9422(00)00043-1; Hatanaka T, 2008, PROTEIN EXPRES PURIF, V62, P244, DOI 10.1016/j.pep.2008.09.001; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; Ichinose H, 2008, APPL MICROBIOL BIOT, V80, P399, DOI 10.1007/s00253-008-1551-x; Ichinose H, 2008, APPL ENVIRON MICROB, V74, P2379, DOI 10.1128/AEM.01733-07; Ichinose H, 2006, BIOSCI BIOTECH BIOCH, V70, P2745, DOI 10.1271/bbb.60365; Ito S, 2004, J BIOTECHNOL, V110, P137, DOI 10.1016/j.jbiotec.2004.01.014; KNOX JP, 1995, FASEB J, V9, P1004, DOI 10.1096/fasebj.9.11.7544308; Kotake T, 2004, BIOCHEM J, V377, P749, DOI 10.1042/bj20031145; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ODONMAZIG P, 1994, CARBOHYD RES, V252, P317, DOI 10.1016/0008-6215(94)90028-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yang H, 2006, FOOD SCI TECHNOL RES, V12, P43, DOI 10.3136/fstr.12.43; Yao M, 2004, ACTA CRYSTALLOGR D, V60, P39, DOI 10.1107/S0907444903021188; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689	37	43	44	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25097	25106		10.1074/jbc.M109.022723	http://dx.doi.org/10.1074/jbc.M109.022723			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19608743	hybrid, Green Published			2022-12-27	WOS:000269734000044
J	Loque, D; Mora, SI; Andrade, SLA; Pantoja, O; Frommer, WB				Loque, Dominique; Mora, Silvia I.; Andrade, Susana L. A.; Pantoja, Omar; Frommer, Wolf B.			Pore Mutations in Ammonium Transporter AMT1 with Increased Electrogenic Ammonium Transport Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PLASMA-MEMBRANE; NEUROTRANSMITTER TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS ROOTS; CHANNEL AMTB; NH4+; MECHANISM; REVEALS	AMT/Mep ammonium transporters mediate high affinity ammonium/ammonia uptake in bacteria, fungi, and plants. The Arabidopsis AMT1 proteins mediate uptake of the ionic form of ammonium. AMT transport activity is controlled allosterically via a highly conserved cytosolic C terminus that interacts with neighboring subunits in a trimer. The C terminus is thus capable of modulating the conductivity of the pore. To gain insight into the underlying mechanism, pore mutants suppressing the inhibitory effect of mutations in the C-terminal trans-activation domain were characterized. AMT1; 1 carrying the mutation Q57H in transmembrane helix I (TMH I) showed increased ammonium uptake but reduced capacity to take up methylammonium. To explore whether the transport mechanism was altered, the AMT1; 1-Q57H mutant was expressed in Xenopus oocytes and analyzed electrophysiologically. AMT1; 1-Q57H was characterized by increased ammonium-induced and reduced methylammonium-induced currents. AMT1; 1-Q57H possesses a 100x lower affinity for ammonium (K-m) and a 10-fold higher V-max as compared with the wild type form. To test whether the trans-regulatory mechanism is conserved in archaeal homologs, AfAmt-2 from Archaeoglobus fulgidus was expressed in yeast. The transport function of AfAmt-2 also depends on trans-activation by the C terminus, and mutations in pore-residues corresponding to Q57H of AMT1; 1 suppress nonfunctional AfAmt-2 mutants lacking the activating C terminus. Altogether, our data suggest that bacterial and plant AMTs use a conserved allosteric mechanism to control ammonium flux, potentially using a gating mechanism that limits flux to protect against ammonium toxicity.	Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Loque, Dominique] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Mora, Silvia I.; Pantoja, Omar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico; [Andrade, Susana L. A.] Univ Freiburg, Dept Biochem, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	Carnegie Institution for Science; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Universidad Nacional Autonoma de Mexico; University of Freiburg	Frommer, WB (corresponding author), 260 Panama St, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Loque, Dominique/A-8153-2008; Frommer, Wolf B/A-8256-2008; Andrade, Susana L. A./D-5119-2012; Frommer, Wolf B/K-5042-2017; Pantoja, Omar/H-5981-2012	Frommer, Wolf B/0000-0001-6465-0115; Andrade, Susana L. A./0000-0003-2267-8499; Frommer, Wolf B/0000-0001-6465-0115; Pantoja, Omar/0000-0002-6538-9059	National Science Foundation Arabidopsis 2010 Program [MCB-0618402]	National Science Foundation Arabidopsis 2010 Program(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Arabidopsis 2010 Program Grant MCB-0618402 (to W. B. F.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gouaux E, 2009, PHILOS T R SOC B, V364, P149, DOI 10.1098/rstb.2008.0181; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; ILESS DC, 2006, PLOS BIOL, V4, pE351; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; Loque D, 2006, PLANT J, V48, P522, DOI 10.1111/j.1365-313X.2006.02887.x; Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; Mizuno Y, 2007, BIOCHEMISTRY-US, V46, P1477, DOI 10.1021/bi062149e; Nakhoul NL, 2001, AM J PHYSIOL-RENAL, V281, pF255, DOI 10.1152/ajprenal.2001.281.2.F255; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Tremblay PL, 2009, MOL MICROBIOL, V71, P12, DOI 10.1111/j.1365-2958.2008.06514.x; WANG MY, 1994, PLANT PHYSIOL, V104, P899, DOI 10.1104/pp.104.3.899; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	39	40	43	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24988	24995		10.1074/jbc.M109.020842	http://dx.doi.org/10.1074/jbc.M109.020842			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19581303	Green Published, hybrid			2022-12-27	WOS:000269734000034
J	Seong, C; Colavito, S; Kwon, Y; Sung, P; Krejci, L				Seong, Changhyun; Colavito, Sierra; Kwon, Youngho; Sung, Patrick; Krejci, Lumir			Regulation of Rad51 Recombinase Presynaptic Filament Assembly via Interactions with the Rad52 Mediator and the Srs2 Anti-recombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; ATP HYDROLYSIS; REPAIR; MUTATIONS; DAMAGE; BREAK	Homologous recombination represents an important means for the error-free elimination of DNA double-strand breaks and other deleterious DNA lesions from chromosomes. The Rad51 recombinase, a member of the RAD52 group of recombination proteins, catalyzes the homologous recombination reaction in the context of a helical protein polymer assembled on single-stranded DNA (ssDNA) that is derived from the nucleolytic processing of a primary lesion. The assembly of the Rad51-ssDNA nucleoprotein filament, often referred to as the presynaptic filament, is prone to interference by the single-strand DNA-binding factor replication protein A (RPA). The Saccharomyces cerevisiae Rad52 protein facilitates presynaptic filament assembly by helping to mediate the displacement of RPA from ssDNA. On the other hand, disruption of the presynaptic filament by the Srs2 helicase leads to a net exchange of Rad51 for RPA. To understand the significance of protein-protein interactions in the control of Rad52- or Srs2-mediated presynaptic filament assembly or disassembly, we have examined two rad51 mutants, rad51 Y388H and rad51 G393D, that are simultaneously ablated for Rad52 and Srs2 interactions and one, rad51 A320V, that is differentially inactivated for Rad52 binding for their biochemical properties and also for functional interactions with Rad52 or Srs2. We show that these mutant rad51 proteins are impervious to the mediator activity of Rad52 or the disruptive function of Srs2 in concordance with their protein interaction defects. Our results thus provide insights into the functional significance of the Rad51-Rad52 and Rad51-Srs2 complexes in the control of presynaptic filament assembly and disassembly. Moreover, our biochemical studies have helped identify A320V as a separation-of-function mutation in Rad51 with regards to a differential ablation of Rad52 interaction.	[Seong, Changhyun; Colavito, Sierra; Kwon, Youngho; Sung, Patrick; Krejci, Lumir] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Dept Biol, Brno 62500, Czech Republic	Yale University; Masaryk University Brno	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St,C130 Sterling Hall Med, New Haven, CT 06520 USA.	patrick.sung@yale.edu; lkrejci@chemi.muni.cz	Colavito, Sierra A/AAE-3957-2019; Krejci, Lumir/B-7842-2009; Classen, Scott/AAY-8176-2020	Krejci, Lumir/0000-0002-4732-1405; Colavito, Sierra/0000-0002-2814-4853	National Institutes of Health [RO1 ES07061, RO1 GM57814, PO1 CA92584]; Wellcome International Senior Research Fellowship [WT076476]; GACR [301/09/317 a 203/09/H046]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome International Senior Research Fellowship; GACR(Grant Agency of the Czech Republic); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 ES07061, RO1 GM57814, and PO1 CA92584. This work was also supported by Wellcome International Senior Research Fellowship WT076476 and GACR 301/09/317 a 203/09/H046.	AGUILERA A, 1988, GENETICS, V119, P779; Bianco P R, 1998, Front Biosci, V3, pD570; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Chi P, 2006, J BIOL CHEM, V281, P26268, DOI 10.1074/jbc.M602983200; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; SCHIESTL RH, 1990, GENETICS, V124, P817; SCHILD D, 1995, GENETICS, V140, P115; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	33	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24363	24371		10.1074/jbc.M109.032953	http://dx.doi.org/10.1074/jbc.M109.032953			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19605344	Green Published, hybrid			2022-12-27	WOS:000269380200049
J	Chen, YL; Liu, B; Zhou, ZN; Hu, RY; Fei, C; Xie, ZH; Ding, XY				Chen, Yue-Lei; Liu, Bin; Zhou, Zhen-Ning; Hu, Rui-Ying; Fei, Cong; Xie, Zhi-Hui; Ding, Xiaoyan			Smad6 Inhibits the Transcriptional Activity of Tbx6 by Mediating Its Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX GENES; PRESOMITIC MESODERM; DOMAIN PROTEIN; EXPRESSION; WNT; DIFFERENTIATION; BINDING; DOWNSTREAM; ACTIVATION; MUTATIONS	Members of the bone morphogenetic protein (BMP) and T-box gene families play several critical roles in the early embryonic development and tissue homeostasis. Although BMP proteins are the upstream regulators of T-box genes, few studies have investigated the molecular mechanisms between these two protein families. Here, we report that Tbx6 interacts directly with Smad6, an inhibitory Smad that antagonizes the BMP signal. This interaction is mediated through the Mad homology 2 (MH2) domain of Smad6 and residues 90 - 180 of Tbx6. We demonstrate that Smad6 facilitates the degradation of Tbx6 protein through recruitment of Smurf1, a ubiquitin E3 ligase. Consequently, Smad6 reduces Tbx6-mediated Myf-5 gene activation. Furthermore, specific knockdown of endogenous Smad6 and Smurf1 by small interfering RNA increases the protein levels of Tbx6 and enhance the expression of Tbx6 target genes. Collectively, these findings reveal that Smad6 serves as a critical mediator of BMP signal via a functional interaction with Tbx6, thus regulating the activation of Tbx6 downstream genes during cell differentiation.	[Chen, Yue-Lei; Liu, Bin; Zhou, Zhen-Ning; Hu, Rui-Ying; Fei, Cong; Xie, Zhi-Hui; Ding, Xiaoyan] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Grad Sch,Lab Mol Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ding, XY (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Grad Sch,Lab Mol Cell Biol, Shanghai 200031, Peoples R China.	xyding@sunm.shcnc.ac.cn			National Basic Research Program of China [2005CB522704, 2007CB947903, 2009CB941101]; National Natural Science Foundation of China [30623003, 30771077,, 30871411]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 2005CB522704, 2007CB947903, and 2009CB941101 from the National Basic Research Program of China and Grants 30623003, 30771077, and 30871411 from the National Natural Science Foundation of China ( to X. D.).	Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bai ST, 2002, J BIOL CHEM, V277, P4176, DOI 10.1074/jbc.M105105200; Chapman DL, 2003, MECH DEVELOP, V120, P837, DOI 10.1016/S0925-4773(03)00066-2; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen Y, 2003, BIOCHEM BIOPH RES CO, V310, P121, DOI 10.1016/j.bbrc.2003.08.127; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Hamaguchi T, 2004, DEV BIOL, V265, P355, DOI 10.1016/j.ydbio.2003.09.034; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; He Z, 2005, BIOCHEM BIOPH RES CO, V335, P676, DOI 10.1016/j.bbrc.2005.07.129; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Lin GF, 2003, DEV DYNAM, V226, P51, DOI 10.1002/dvdy.10215; Lou X, 2006, CELL RES, V16, P771, DOI 10.1038/sj.cr.7310093; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Mayer RJ, 2000, NAT REV MOL CELL BIO, V1, P145; Mei WY, 2001, FEBS LETT, V505, P47, DOI 10.1016/S0014-5793(01)02688-6; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reshef R, 1998, GENE DEV, V12, P290, DOI 10.1101/gad.12.3.290; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Shen R, 2006, J BIOL CHEM, V281, P3569, DOI 10.1074/jbc.M506761200; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Szeto DR, 2004, DEVELOPMENT, V131, P3751, DOI 10.1242/dev.01236; Uchiyama H, 2001, DEV GROWTH DIFFER, V43, P657; Wang Q, 2007, J BIOL CHEM, V282, P10742, DOI 10.1074/jbc.M610997200; White PH, 2005, GENESIS, V42, P193, DOI 10.1002/gene.20140; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103	43	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23481	23490		10.1074/jbc.M109.007864	http://dx.doi.org/10.1074/jbc.M109.007864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561075	Green Published, hybrid			2022-12-27	WOS:000269180000033
J	Li, N; Brun, T; Cnop, M; Cunha, DA; Eizirik, DL; Maechler, P				Li, Ning; Brun, Thierry; Cnop, Miriam; Cunha, Daniel A.; Eizirik, Decio L.; Maechler, Pierre			Transient Oxidative Stress Damages Mitochondrial Machinery Inducing Persistent beta-Cell Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT DIABETES-MELLITUS; INS-1E INSULINOMA CELLS; PANCREATIC-ISLETS; UNCOUPLING PROTEIN-2; GENE-EXPRESSION; COMPLEX-I; SECRETION; MOUSE; MUTATIONS	Transient exposure of beta-cells to oxidative stress interrupts the transduction of signals normally coupling glucose metabolism to insulin secretion. We investigated putative persistence of effects induced by one transient oxidative stress (200 mu M H2O2, 10 min) on insulin secreting cells following recovery periods of days and weeks. Three days after oxidative stress INS-1E cells and rat islets exhibited persistent dysfunction. In particular, the secretory response to 15 mM glucose was reduced by 40% in INS-1E cells stressed 3 days before compared with naive cells. Compared with non-stressed INS-1E cells, we observed reduced oxygen consumption (-43%) and impaired glucose-induced ATP generation (-46%). These parameters correlated with increased mitochondrial reactive oxygen species formation (+60%) accompanied with down-regulation of subunits of the respiratory chain and decreased expression of genes responsible for mitochondrial biogenesis (TFAM, -24%; PGC-1 alpha, -67%). Three weeks after single oxidative stress, both mitochondrial respiration and secretory responses were recovered. Moreover, such recovered INS-1E cells exhibited partial resistance to a second transient oxidative stress and up-regulation of UCP2 (+78%) compared with naive cells. In conclusion, one acute oxidative stress induces beta-cell dysfunction lasting over days, explained by persistent damages in mitochondrial components.	[Maechler, Pierre] Univ Geneva, Dept Cell Physiol & Metab, Fac Med, Univ Med Ctr, CH-1211 Geneva 4, Switzerland; [Cnop, Miriam; Cunha, Daniel A.; Eizirik, Decio L.] Univ Libre Bruxelles, Erasmus Hosp, Expt Med Lab, B-1070 Brussels, Belgium; [Cnop, Miriam] Univ Libre Bruxelles, Erasmus Hosp, Div Endocrinol, B-1070 Brussels, Belgium	University of Geneva; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Maechler, P (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Fac Med, Univ Med Ctr, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	Pierre.Maechler@unige.ch		Maechler, Pierre/0000-0002-2005-1433; Cnop, Miriam/0000-0002-5112-1692; LI, Ning/0000-0002-1626-5519; BRUN, Thierry/0000-0002-1659-4283	Swiss National Science Foundation; Bristol-Myers Squibb Company; Hans Wilsdorf Foundation, Geneva, Switzerland; Research Foundation of the European Association for the study of Diabetes, the European Union Integrated Project EuroDia [LSHM-CT2006-518153]; Belgium Fonds National de la Recherche Scientifique-Recherche Scientifique Medicale	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Hans Wilsdorf Foundation, Geneva, Switzerland; Research Foundation of the European Association for the study of Diabetes, the European Union Integrated Project EuroDia; Belgium Fonds National de la Recherche Scientifique-Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by the Swiss National Science Foundation ( to P. M.), the European Foundation for the Study of Diabetes (EFSD) through an EFSD fellowship supported by Bristol-Myers Squibb Company (to N.L.), a fellowship from the Hans Wilsdorf Foundation, Geneva, Switzerland (to N.L.), the Research Foundation of the European Association for the study of Diabetes, the European Union Integrated Project EuroDia LSHM-CT2006-518153 in the Framework Programme 6 of the European Community ( to M. C. and D. L. E.), and the Belgium Fonds National de la Recherche Scientifique-Recherche Scientifique Medicale ( to M. C. and D. L. E.).	Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Boengler K, 2007, J MOL CELL CARDIOL, V43, P610, DOI 10.1016/j.yjmcc.2007.08.004; Brun T, 2007, ONCOGENE, V26, P4261, DOI 10.1038/sj.onc.1210205; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Carobbio S, 2004, DIABETOLOGIA, V47, P266, DOI 10.1007/s00125-003-1306-2; Cottrell D A, 2000, Curr Opin Clin Nutr Metab Care, V3, P473, DOI 10.1097/00075197-200011000-00009; de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9; Delgado EHB, 2006, NEUROCHEM RES, V31, P1021, DOI 10.1007/s11064-006-9111-1; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; EIZIRIK DL, 1988, DIABETES, V37, P916, DOI 10.2337/diabetes.37.7.916; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; Li N, 2008, BIOCHEM SOC T, V36, P930, DOI 10.1042/BST0360930; Li WG, 2001, J BIOL CHEM, V276, P29251, DOI 10.1074/jbc.M102124200; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Maechler P, 2006, BIOCHEM SOC T, V34, P824, DOI 10.1042/BST0340824; Maechler P, 2002, CELL MOL LIFE SCI, V59, P1803, DOI 10.1007/PL00012507; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; MOREIRA JE, 1991, VIRCHOWS ARCH B, V60, P337, DOI 10.1007/BF02899565; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Produit-Zengaffinen N, 2007, DIABETOLOGIA, V50, P84, DOI 10.1007/s00125-006-0499-6; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.3.CO;2-M; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; SANDLER S, 1989, ENDOCRINOLOGY, V124, P1492, DOI 10.1210/endo-124-3-1492; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Tampo Y, 2003, CIRC RES, V92, P56, DOI 10.1161/01.RES.0000048195.15637.AC; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WELSH N, 1995, MOL MED, V1, P806, DOI 10.1007/BF03401895; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	47	67	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23602	23612		10.1074/jbc.M109.024323	http://dx.doi.org/10.1074/jbc.M109.024323			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19546218	hybrid, Green Published			2022-12-27	WOS:000269180000046
J	Lin, YP; Greenwood, A; Nicholson, LK; Sharma, Y; McDonough, SP; Chang, YF				Lin, Yi-Pin; Greenwood, Alex; Nicholson, Linda K.; Sharma, Yogendra; McDonough, Sean P.; Chang, Yung-Fu			Fibronectin Binds to and Induces Conformational Change in a Disordered Region of Leptospiral Immunoglobulin-like Protein B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM; BORRELIA-BURGDORFERI; SECONDARY STRUCTURE; INTERROGANS; SPECTRA; LIGB; RELAXATION; EXPRESSION; ADHERENCE; MSCRAMM	Leptospira interrogans is a pathogenic spirochete that causes disease in both humans and animals. LigB (Leptospiral immunoglobulin-like protein B) contributes to the binding of Leptospira to extracellular matrix proteins such as fibronectin (Fn), fibrinogen, laminin, and collagen. A high affinity Fn-binding region of LigB has been recently localized to Lig-BCen2, which contains the partial eleventh and full twelfth immunoglobulin-like repeats (LigBCen2R) and 47 amino acids of the non-repeat region (LigBCen2NR) of LigB. In this study, LigBCen2NR was shown to bind to the N-terminal domain (NTD) of Fn (K-D = 379 nM) by an enzyme-linked immunosorbent assay and isothermal titration calorimetry. Interestingly, this sequence was not observed to adopt secondary structure by far UV circular dichroism or by differential scanning calorimetry, in agreement with computer-based secondary structure predictions. A low partition coefficient (K-av) measured with gel permeation chromatography, a high hydrodynamic radius (R-h) measured with dynamic light scattering, and the insensitivity of the intrinsic viscosity to guanidine hydrochloride treatment all suggest that LigBCen2NR possesses an extended and disordered structure. Two-dimensional N-15-H-1 HSQC NMR spectra of intact LigBCen2 in the absence and presence of NTD are consistent with these observations, suggesting the presence of both a beta-rich region and an unstructured region in LigBCen2 and that the latter of these selectively interacts with NTD. Upon binding to NTD, LigBCen2NR was observed by CD to adopt a beta-strand-rich structure, suggestive of the known beta-zipper mode of NTD binding.	[Lin, Yi-Pin; Chang, Yung-Fu] Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Dept Biomed Sci, Coll Vet Med, Ithaca, NY 14853 USA; [Greenwood, Alex; Nicholson, Linda K.] Cornell Univ, Coll Agr & Life Sci, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Sharma, Yogendra] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Cornell University; Cornell University; Cornell University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chang, YF (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA.	yc42@cornell.edu	Greenwood, Alex/GWU-8292-2022		National Institutes of Health biophysics training grant; Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Biotechnology Research and Development Corporation (BRDC); National Science Foundation [MCB-0641582]	National Institutes of Health biophysics training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Biotechnology Research and Development Corporation (BRDC); National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by a National Institutes of Health biophysics training grant (to A.G.). This work was also supported in part by the Harry M. Zweig Memorial Fund for Equine Research, the New York State Science and Technology Foundation (CAT), the Biotechnology Research and Development Corporation (BRDC), and National Science Foundation Grant MCB-0641582 (to L.K.N.).	Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Berezov A, 2001, J MED CHEM, V44, P2565, DOI 10.1021/jm000527m; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; EIGEN M, 1963, ADV ENZYMOL REL S BI, V25, P1; FAINE S, 1999, LEPTOSPIRA LEPTOSPIR, P67; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; Jayaraman B, 2007, BIOCHEMISTRY-US, V46, P12174, DOI 10.1021/bi701281e; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; ODERMATT E, 1982, J MOL BIOL, V159, P109, DOI 10.1016/0022-2836(82)90034-1; OHNO H, 1986, BIOCHEM J, V235, P553, DOI 10.1042/bj2350553; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; STEVENS ES, 1987, J MOL BIOL, V197, P743, DOI 10.1016/0022-2836(87)90481-5; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; TANFORD C, 1967, J AM CHEM SOC, V89, P5023, DOI 10.1021/ja00995a034; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; WELSH EJ, 1983, BIOPOLYMERS, V22, P821, DOI 10.1002/bip.360220305; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62	51	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23547	23557		10.1074/jbc.M109.031369	http://dx.doi.org/10.1074/jbc.M109.031369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581300	Green Published, hybrid			2022-12-27	WOS:000269180000040
J	Manohar, M; Mooney, AM; North, JA; Nakkula, RJ; Picking, JW; Edon, A; Fishel, R; Poirier, MG; Ottesen, JJ				Manohar, Mridula; Mooney, Alex M.; North, Justin A.; Nakkula, Robin J.; Picking, Jonathan W.; Edon, Annick; Fishel, Richard; Poirier, Michael G.; Ottesen, Jennifer J.			Acetylation of Histone H3 at the Nucleosome Dyad Alters DNA-Histone Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; TIME-OF-FLIGHT; CHROMATIN-STRUCTURE; TARGET SITES; EQUILIBRIUM ACCESSIBILITY; SACCHAROMYCES-CEREVISIAE; RECOMBINANT HISTONES; SIN MUTATIONS; IDENTIFICATION; SEQUENCE	Histone post-translational modifications are essential for regulating and facilitating biological processes such as RNA transcription and DNA repair. Fifteen modifications are located in the DNA-histone dyad interface and include the acetylation of H3-K115 (H3-K115Ac) and H3-K122 (H3-K122Ac), but the functional consequences of these modifications are unknown. We have prepared semisynthetic histone H3 acetylated at Lys-115 and/or Lys-122 by expressed protein ligation and incorporated them into single nucleosomes. Competitive reconstitution analysis demonstrated that the acetylation of H3-K115 and H3-K122 reduces the free energy of histone octamer binding. Restriction enzyme kinetic analysis suggests that these histone modifications do not alter DNA accessibility near the sites of modification. However, acetylation of H3-K122 increases the rate of thermal repositioning. Remarkably, Lys -> Gln substitution mutations, which are used to mimic Lys acetylation, do not fully duplicate the effects of the H3-K115Ac or H3-K122Ac modifications. Our results are consistent with the conclusion that acetylation in the dyad interface reduces DNA-histone interaction(s), which may facilitate nucleosome repositioning and/or assembly/disassembly.	[Manohar, Mridula; Picking, Jonathan W.; Edon, Annick; Poirier, Michael G.; Ottesen, Jennifer J.] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Mooney, Alex M.; North, Justin A.; Nakkula, Robin J.; Picking, Jonathan W.; Poirier, Michael G.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University	Poirier, MG (corresponding author), 191 W Woodruff, Columbus, OH 43210 USA.	mpoirier@mps.ohio-state.edu; ottesen.1@osu.edu	Poirier, Michael Guy/B-5378-2012	Ottesen, Jennifer/0000-0003-3323-6290	National Institutes of Health [CA067007, GM062556, GM083055]; American Heart Association Predoctoral Fellowship [0815460D]; Burroughs Wellcome; NATIONAL CANCER INSTITUTE [R01CA067007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080176, R01GM083055, R01GM062556] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Burroughs Wellcome(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA067007 and GM062556 (to R. F.) and GM083055 (to M. P. and J.O.). This work was also supported by American Heart Association Predoctoral Fellowship 0815460D (to J.A.N.) and a Career Award in the Basic Biomedical Sciences from Burroughs Wellcome (to M. P.).	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Cocklin RR, 2003, J PROTEIN CHEM, V22, P327, DOI 10.1023/A:1025334006014; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Flaus A, 2004, EMBO J, V23, P343, DOI 10.1038/sj.emboj.7600047; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurumizaka H, 1997, MOL CELL BIOL, V17, P6953, DOI 10.1128/MCB.17.12.6953; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Maier VK, 2008, BIOL CHEM, V389, P345, DOI 10.1515/BC.2008.040; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Mersfelder EL, 2006, NUCLEIC ACIDS RES, V34, P2653, DOI 10.1093/nar/gkl338; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Muthurajan UM, 2004, EMBO J, V23, P260, DOI 10.1038/sj.emboj.7600046; Ottesen JJ, 2008, BIOPOLYMERS, V90, P406, DOI 10.1002/bip.20810; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Widlund HR, 2000, BIOCHEMISTRY-US, V39, P3835, DOI 10.1021/bi991957l; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	46	100	105	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23312	23321		10.1074/jbc.M109.003202	http://dx.doi.org/10.1074/jbc.M109.003202			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19520870	Green Published, hybrid			2022-12-27	WOS:000269180000016
J	Nojima, T; Yoshida, M				Nojima, Tatsuya; Yoshida, Masasuke			Probing Open Conformation of GroEL Rings by Cross-linking Reveals Single and Double Open Ring Structures of GroEL in ADP and ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN GROEL; IN-VIVO; POLYPEPTIDE BINDING; CRYSTAL-STRUCTURE; REACTION CYCLE; PROTEIN; COMPLEXES; MECHANISM; RESIDUES; RELEASE	Two heptamer rings of chaperonin GroEL undergo opening-closing conformational transition in the reaction cycle with the aid of GroES and ATP. We introduced Cys into the GroEL subunit at Ala-384 and Ser-509, which are very close between adjacent GroEL subunits in the open heptamer ring but far apart in the closed heptamer ring. The open ring-specific inter-subunit cross-linking between these Cys indicated that the number of rings in open conformation in GroEL was two in ATP (Gro-ELOO), one in ADP (GroEL(O)), and none in the absence of nucleotide. ADP showed an inhibitory effect on ATP-induced generation of GroEL(OO). The isolated GroEL(O) and GroEL(OO), which lost any bound nucleotide, could bind GroES to form a bullet-shaped 1:1 GroEL-GroES complex and a football-shaped 1: 2 GroEL-GroES complex, respectively, even without the addition of any nucleotide. Substrate protein was unable to form a stable complex with GroEL(OO) and did not stimulate ATPase activity of GroEL. These results favor a model of the GroEL reaction cycle that includes a football complex as a critical intermediate.	[Nojima, Tatsuya; Yoshida, Masasuke] Tokyo Inst Technol, Chem Resources Lab R1 7, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Yoshida, M (corresponding author), Tokyo Inst Technol, Chem Resources Lab R1 7, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	myoshida@res.titech.ac.jp	Nojima, Tatsuya/S-4325-2019; Nojima, Tatsuya/E-9741-2017	Nojima, Tatsuya/0000-0002-0422-0225; Nojima, Tatsuya/0000-0002-0422-0225	Japanese Society for the Promotion of Science for Young Scientists	Japanese Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported by research fellowships from the Japanese Society for the Promotion of Science for Young Scientists.	Aoki K, 2000, J BIOL CHEM, V275, P13755, DOI 10.1074/jbc.275.18.13755; AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Hayer-Hartl MK, 1999, BIOL CHEM, V380, P531, DOI 10.1515/BC.1999.068; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Nojima T, 2008, J BIOL CHEM, V283, P18385, DOI 10.1074/jbc.M709825200; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	32	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22834	22839		10.1074/jbc.M109.020057	http://dx.doi.org/10.1074/jbc.M109.020057			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19520865	hybrid, Green Published			2022-12-27	WOS:000268963100037
J	Liebau, E; Dawood, KF; Fabrini, R; Fischer-Riepe, L; Perbandt, M; Stella, L; Pedersen, JZ; Bocedi, A; Petrarca, P; Federici, G; Ricci, G				Liebau, Eva; Dawood, Kutayba F.; Fabrini, Raffaele; Fischer-Riepe, Lena; Perbandt, Markus; Stella, Lorenzo; Pedersen, Jens Z.; Bocedi, Alessio; Petrarca, Patrizia; Federici, Giorgio; Ricci, Giorgio			Tetramerization and Cooperativity in Plasmodium falciparum Glutathione S-Transferase Are Mediated by Atypic Loop 113-119	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITE; NITRIC-OXIDE; ERYTHROCYTES; ENZYME; IDENTIFICATION; METABOLISM; EXPRESSION; CLONING; CELLS; RAT	Glutathione S-transferase of Plasmodium falciparum (PfGST) displays a peculiar dimer to tetramer transition that causes full enzyme inactivation and loss of its ability to sequester parasitotoxic hemin. Furthermore, binding of hemin is modulated by a cooperative mechanism. Site-directed mutagenesis, steady-state kinetic experiments, and fluorescence anisotropy have been used to verify the possible involvement of loop 113-119 in the tetramerization process and in the cooperative phenomenon. This protein segment is one of the most prominent structural differences between PfGST and other GST isoenzymes. Our results demonstrate that truncation, increased rigidity, or even a simple point mutation of this loop causes a dramatic change in the tetramerization kinetics that becomes at least 100 times slower than in the native enzyme. All of the mutants tested have lost the positive cooperativity for hemin binding, suggesting that the integrity of this peculiar loop is essential for intersubunit communication. Interestingly, the tetramerization process of the native enzyme that occurs rapidly when GSH is removed is prevented not only by GSH but even by oxidized glutathione. This result suggests that protection by PfGST against hemin is independent of the redox status of the parasite cell. Because of the importance of this unique segment in the function/structure of PfGST, it could be a new target for the development of antimalarial drugs.	[Liebau, Eva; Fischer-Riepe, Lena] Univ Munster, Inst Anim Physiol, Munster, Germany; [Dawood, Kutayba F.; Fabrini, Raffaele; Stella, Lorenzo; Ricci, Giorgio] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Pedersen, Jens Z.; Petrarca, Patrizia] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Perbandt, Markus] Univ Lubeck, Ctr Struct & Cell Biol, Inst Biochem, D-23538 Lubeck, Germany; [Perbandt, Markus] DESY, Lab Struct Biol Infect & Inflammat, D-22603 Hamburg, Germany; [Bocedi, Alessio] Univ Rome Roma Tre, Dept Biol, I-00146 Rome, Italy; [Bocedi, Alessio] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Federici, Giorgio] Childrens Hosp Bambin Gesu, I-00165 Rome, Italy	University of Munster; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Lubeck; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Roma Tre University; Duke University; IRCCS Bambino Gesu	Ricci, G (corresponding author), Via Ric Sci 1, I-00133 Rome, Italy.	riccig@uniroma2.it	Perbandt, Markus/K-7603-2018; Stella, Lorenzo/A-7996-2010; Dawood, Kutayba/E-1505-2019	Stella, Lorenzo/0000-0002-5489-7381; Dawood, Kutayba/0000-0002-0762-9632; Ricci, Giorgio/0000-0002-7108-2846				Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Atamna H, 1997, EUR J BIOCHEM, V250, P670, DOI 10.1111/j.1432-1033.1997.00670.x; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Board PG, 1997, BIOCHEM J, V328, P929; BOARD PG, 1987, BIOCHEM J, V248, P937, DOI 10.1042/bj2480937; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Campanale N, 2003, J BIOL CHEM, V278, P27354, DOI 10.1074/jbc.M303634200; Deponte M, 2005, METHOD ENZYMOL, V401, P241, DOI 10.1016/S0076-6879(05)01015-3; Fritz-Wolf K, 2003, P NATL ACAD SCI USA, V100, P13821, DOI 10.1073/pnas.2333763100; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Harwaldt P, 2002, BIOL CHEM, V383, P821, DOI 10.1515/BC.2002.086; Hiller N, 2006, PROTEIN SCI, V15, P281, DOI 10.1110/ps.051891106; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Liebau E, 2005, J BIOL CHEM, V280, P26121, DOI 10.1074/jbc.M503889200; Liebau E, 2002, MOL BIOCHEM PARASIT, V124, P85, DOI 10.1016/S0166-6851(02)00160-3; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; Luersen K, 2000, BIOCHEM J, V346, P545, DOI 10.1042/0264-6021:3460545; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Meierjohann S, 2002, BIOCHEM J, V368, P761, DOI 10.1042/BJ20020962; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; Perbandt M, 2004, J BIOL CHEM, V279, P1336, DOI 10.1074/jbc.M309663200; ROSS VL, 1993, BIOCHEM J, V294, P373, DOI 10.1042/bj2940373; Salinas AE, 1999, CURR MED CHEM, V6, P279; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Tripathi T, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-67	29	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22133	22139		10.1074/jbc.M109.015198	http://dx.doi.org/10.1074/jbc.M109.015198			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531494	Green Published, hybrid			2022-12-27	WOS:000268783700037
J	Alvares, K; Dixit, SN; Lux, E; Veis, A				Alvares, Keith; Dixit, Saryu N.; Lux, Elizabeth; Veis, Arthur			Echinoderm Phosphorylated Matrix Proteins UTMP16 and UTMP19 Have Different Functions in Sea Urchin Tooth Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYTECHINUS-VARIEGATUS; BIOMINERALIZATION; TEETH; DOMAIN; EXPRESSION; PREDICTION	Studies of mineralization of embryonic spicules and of the sea urchin genome have identified several putative mineralization-related proteins. These predicted proteins have not been isolated or confirmed in mature mineralized tissues. Mature Lyte-chinus variegatus teeth were demineralized with 0.6 N HCl after prior removal of non-mineralized constituents with 4.0 M guanidinium HCl. The HCl-extracted proteins were fractionated on ceramic hydroxyapatite and separated into bound and unbound pools. Gel electrophoresis compared the protein distributions. The differentially present bands were purified and digested with trypsin, and the tryptic peptides were separated by high pressure liquid chromatography. NH2-terminal sequences were determined by Edman degradation and compared with the genomic sequence bank data. Two of the putative mineralization-related proteins were found. Their complete amino acid sequences were cloned from our L. variegatus cDNA library. Apatite-binding UTMP16 was found to be present in two isoforms; both isoforms had a signal sequence, a Ser-Asp-rich extracellular matrix domain, and a transmembrane and cytosolic insertion sequence. UTMP19, although rich in Glu and Thr did not bind to apatite. It had neither signal peptide nor transmembrane domain but did have typical nuclear localization and nuclear exit signal sequences. Both proteins were phosphorylated and good substrates for phosphatase. Immunolocalization studies with anti-UTMP16 show it to concentrate at the syncytial membranes in contact with the mineral. On the basis of our TOF-SIMS analyses of magnesium ion and Asp mapping of the mineral phase composition, we speculate that UTMP16 may be important in establishing the high magnesium columns that fuse the calcite plates together to enhance the mechanical strength of the mineralized tooth.	[Alvares, Keith; Dixit, Saryu N.; Lux, Elizabeth; Veis, Arthur] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Veis, A (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	aveis@northwestern.edu		Alvares, Keith/0000-0003-3710-4367	National Institutes of Health [DE 001374]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE001374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE001374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 001374 (to A. V.).	Alvares K, 2007, J EXP ZOOL PART B, V308B, P357, DOI 10.1002/jez.b.21159; Ameye L, 1999, J HISTOCHEM CYTOCHEM, V47, P1189, DOI 10.1177/002215549904700911; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cheers MS, 2005, DEV BIOL, V283, P384, DOI 10.1016/j.ydbio.2005.02.037; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Illies MR, 2002, DEV GENES EVOL, V212, P419, DOI 10.1007/s00427-002-0261-0; KNIPRATH E, 1974, CALC TISS RES, V14, P211, DOI 10.1007/BF02060296; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; MARKEL K, 1986, ZOOMORPHOLOGY, V106, P232, DOI 10.1007/BF00312044; Massa LF, 2005, HISTOCHEM CELL BIOL, V124, P197, DOI 10.1007/s00418-005-0009-9; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Ritchie HH, 2000, BBA-GENE STRUCT EXPR, V1493, P27, DOI 10.1016/S0167-4781(00)00150-0; Robach JS, 2006, J STRUCT BIOL, V155, P87, DOI 10.1016/j.jsb.2006.03.002; Robach JS, 2005, J STRUCT BIOL, V151, P18, DOI 10.1016/j.jsb.2005.04.001; SMITH AB, 1988, MOL BIOL EVOL, V5, P345; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Veis A., 2004, P365, DOI 10.1201/9780203970881.ch60; Veis A, 2002, MICROSC RES TECHNIQ, V59, P342, DOI 10.1002/jemt.10216; VEIS A, 2007, P 9 INT S BIOM, P329; VEIS DJ, 1986, J EXP ZOOL, V240, P35, DOI 10.1002/jez.1402400106; Wang RZ, 1997, PHILOS T R SOC B, V352, P469, DOI 10.1098/rstb.1997.0034; Wilt FH, 1999, J STRUCT BIOL, V126, P216, DOI 10.1006/jsbi.1999.4105	26	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26149	26160		10.1074/jbc.M109.024018	http://dx.doi.org/10.1074/jbc.M109.024018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19596854	Green Published, hybrid			2022-12-27	WOS:000269738000070
J	Broer, S; Schneider, HP; Broer, A; Deitmer, JW				Broeer, Stefan; Schneider, Hans-Peter; Broeer, Angelika; Deitmer, Joachim W.			Mutation of Asparagine 76 in the Center of Glutamine Transporter SNAT3 Modulates Substrate-induced Conductances and Na+ Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN HOMOLOGY DETECTION; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; MOLECULAR-BASIS; AMINO-ACIDS; MECHANISM; NEUROTRANSMITTER; SYSTEM; SUPERFAMILY; EXPRESSION	The glutamine transporter SLC38A3 (SNAT3) plays an important role in the release of glutamine from brain astrocytes and the uptake of glutamine into hepatocytes. It is related to the vesicular GABA (gamma-aminobutyric acid) transporter and the SLC36 family of proton-amino acid cotransporters. The transporter carries out electroneutral Na+-glutamine cotransport-H+ antiport. In addition, substrate-induced uncoupled cation currents are observed. Mutation of asparagine 76 to glutamine or histidine in predicted transmembrane helix 1 abolished all substrate-induced currents. Mutation of asparagine 76 to aspartate rendered the transporter Na+-independent and resulted in a gain of a large substrate-induced chloride conductance in the absence of Na+. Thus, a single residue is critical for coupled and uncoupled ion flows in the glutamine transporter SNAT3. Homology modeling of SNAT3 along the structure of the related benzyl-hydantoin permease from Microbacterium liquefaciens reveals that Asn-76 is likely to be located in the center of the membrane close to the translocation pore and forms part of the predicted Na+-binding site.	[Broeer, Stefan; Broeer, Angelika] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Schneider, Hans-Peter; Deitmer, Joachim W.] Tech Univ Kaiserslautern, Fachbereich Biol, Abt Allgemeine Zool, D-67653 Kaiserslautern, Germany	Australian National University; University of Kaiserslautern	Broer, A (corresponding author), Australian Natl Univ, Res Sch Biol, Bldg 41, Canberra, ACT 0200, Australia.	stefan.broeer@anu.edu.au; deitmer@biologie.uni-kl.de	Broer, Stefan/A-1286-2008	Broer, Stefan/0000-0002-8040-1634	Deutsche Forschungsgemeinschaft [De 231/16-2]; Landesschwerpunkt "Membrantransport"; Australian Research Council [LX0881952]; National Health and Medical Research Council [366713]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesschwerpunkt "Membrantransport"; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Deutsche Forschungsgemeinschaft Grant De 231/16-2 and a grant from the Landesschwerpunkt "Membrantransport" (to J. W. D.), by Australian Research Council Grant LX0881952 (to J. W. D. and S. B.), and by National Health and Medical Research Council Grant 366713 (to S. B.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; Albers A, 2001, PFLUG ARCH EUR J PHY, V443, P92, DOI 10.1007/s004240100663; Blakely RD, 2005, PHYSIOLOGY, V20, P225, DOI 10.1152/physiol.00013.2005; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Broer A, 2000, BIOCHEM J, V346, P705, DOI 10.1042/0264-6021:3460705; Broer A, 2002, J PHYSIOL-LONDON, V539, P3, DOI 10.1013/jphysiol.2001.013303; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Broer Stefan, 2003, Methods Mol Biol, V227, P245, DOI 10.1385/1-59259-387-9:245; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FANG Y, 2009, NATURE IN PRESS; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; Gammelsaeter R, 2009, BIOCHEM BIOPH RES CO, V381, P378, DOI 10.1016/j.bbrc.2009.02.062; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Granseth E, 2006, BIOINFORMATICS, V22, pE191, DOI 10.1093/bioinformatics/btl206; Haussinger D, 2001, J NUTR, V131, p2509S, DOI 10.1093/jn/131.9.2509S; HAUSSINGER D, 2001, J NUTR S9, V131, P2523; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Liu YJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE380, DOI 10.1152/ajpendo.00008.2003; Lolkema JS, 1998, FEMS MICROBIOL REV, V22, P305, DOI 10.1016/S0168-6445(98)00018-7; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Metzner L, 2008, BBA-BIOMEMBRANES, V1778, P1042, DOI 10.1016/j.bbamem.2007.12.026; MUNSCH T, 1994, J PHYSIOL-LONDON, V474, P43, DOI 10.1113/jphysiol.1994.sp020001; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider HP, 2007, J BIOL CHEM, V282, P3788, DOI 10.1074/jbc.M609452200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991; Zhang Z, 2008, J BIOL CHEM, V283, P12284, DOI 10.1074/jbc.M706774200; Zhang Z, 2007, BIOPHYS J, V92, P2621, DOI 10.1529/biophysj.106.100776; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	56	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25823	25831		10.1074/jbc.M109.031013	http://dx.doi.org/10.1074/jbc.M109.031013			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19596860	Green Published, hybrid			2022-12-27	WOS:000269738000040
J	Halvey, EJ; Vernon, J; Roy, B; Garthwaite, J				Halvey, Edward J.; Vernon, Jeffrey; Roy, Brijesh; Garthwaite, John			Mechanisms of Activity-dependent Plasticity in Cellular Nitric Oxide-cGMP Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLATE-CYCLASE; VASCULAR SMOOTH-MUSCLE; PROTEIN-KINASE; CYCLIC-GMP; CEREBELLAR CELLS; IN-VIVO; ACTIVATION; DESENSITIZATION; RECEPTOR; BINDING	Cellular responsiveness to nitric oxide (NO) is shaped by past history of NO exposure. The mechanisms behind this plasticity were explored using rat platelets in vitro, specifically to determine the relative contributions made by desensitization of NO receptors, which couple to cGMP formation, and by phosphodiesterase-5 (PDE5), which is activated by cGMP and also hydrolyzes it. Repeated delivery of brief NO pulses (50 nM peak) at 1-min intervals resulted in a progressive loss of the associated cGMP responses, which was the combined consequence of receptor desensitization and PDE5 activation, with the former dominating. Delivery of pulses of differing amplitude showed that NO stimulated and desensitized receptors with similar potency (EC50 = 10 - 20 nM). PDE5 activation was highly sensitive to NO, with a single pulse peaking at 2 nM being sufficient to evoke a 50% loss of response to a subsequent near-maximal NO pulse. However, the activated state of the PDE subsided quickly after removal of NO, the half-time for recovery being 25 s. In contrast, receptor desensitization reverted much more slowly, the half-time being 16 min. Accordingly, with long (20-min) exposures, NO concentrations as low as 600 pM provoked significant desensitization. The results indicate that PDE5 activation and receptor desensitization subserve distinct short term and longer term roles as mediators of plasticity in NO-cGMP signaling. A kinetic model explicitly describing the complex interplay between NO concentration, cGMP synthesis, PDE5 activation, and the resulting cGMP accumulation successfully simulated the present and previous data.	[Halvey, Edward J.; Vernon, Jeffrey; Roy, Brijesh; Garthwaite, John] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Garthwaite, J (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	john.garthwaite@ucl.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by a Programme grant from The Wellcome Trust.	AXELSSON KL, 1983, EUR J PHARMACOL, V88, P71, DOI 10.1016/0014-2999(83)90393-X; Bellamy TC, 2000, P NATL ACAD SCI USA, V97, P2928, DOI 10.1073/pnas.97.6.2928; Bellamy TC, 2002, P NATL ACAD SCI USA, V99, P507, DOI 10.1073/pnas.012368499; Bellamy TC, 2001, MOL PHARMACOL, V59, P54, DOI 10.1124/mol.59.1.54; Bellamy TC, 2001, J BIOL CHEM, V276, P4287, DOI 10.1074/jbc.M006677200; Blount MA, 2004, MOL PHARMACOL, V66, P144, DOI 10.1124/mol.66.1.144; Brandes RP, 2000, HYPERTENSION, V35, P231, DOI 10.1161/01.HYP.35.1.231; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; Bruder S, 2006, J BIOL CHEM, V281, P19969, DOI 10.1074/jbc.M603374200; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Clark DE, 1999, J PHARM SCI-US, V88, P807, DOI 10.1021/js9804011; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Fernandes D, 2006, MOL PHARMACOL, V69, P983, DOI 10.1124/mol.105.015479; Filippov G, 1997, J CLIN INVEST, V100, P942, DOI 10.1172/JCI119610; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Garthwaite G, 2006, J NEUROSCI, V26, P7730, DOI 10.1523/JNEUROSCI.1528-06.2006; Garthwaite J, 2005, FRONT BIOSCI-LANDMRK, V10, P1868; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gibson A, 2001, EUR J PHARMACOL, V411, P1, DOI 10.1016/S0014-2999(00)00824-4; GOLD ME, 1990, P NATL ACAD SCI USA, V87, P4430, DOI 10.1073/pnas.87.12.4430; Griffiths C, 2003, MOL PHARMACOL, V64, P1349, DOI 10.1124/mol.64.6.1349; HATAKEYAMA K, 1992, J BIOL CHEM, V267, P20734; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; HORIE M, 1989, J PHYSIOL-LONDON, V408, P313, DOI 10.1113/jphysiol.1989.sp017461; Hussain MB, 1999, BRIT J PHARMACOL, V128, P1082, DOI 10.1038/sj.bjp.0702874; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; MARTIN W, 1985, J PHARMACOL EXP THER, V232, P708; Mo E, 2004, J BIOL CHEM, V279, P26149, DOI 10.1074/jbc.M400916200; MONCADA S, 1991, P NATL ACAD SCI USA, V88, P2166, DOI 10.1073/pnas.88.6.2166; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mullershausen F, 2004, MOL BIOL CELL, V15, P4023, DOI 10.1091/mbc.E03-12-0890; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; Mullershausen F, 2001, J CELL BIOL, V155, P271, DOI 10.1083/jcb.200107001; Murthy KS, 2004, NEUROCHEM INT, V45, P845, DOI 10.1016/j.neuint.2004.03.014; Murthy KS, 2001, BIOCHEM J, V360, P199, DOI 10.1042/0264-6021:3600199; Okada D, 2002, BIOCHEMISTRY-US, V41, P9672, DOI 10.1021/bi025727+; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; RAND MJ, 1995, ANNU REV PHYSIOL, V57, P659; Roy B, 2008, BRIT J PHARMACOL, V153, P1495, DOI 10.1038/sj.bjp.0707687; Roy B, 2008, J BIOL CHEM, V283, P18841, DOI 10.1074/jbc.M801712200; Roy B, 2006, P NATL ACAD SCI USA, V103, P12185, DOI 10.1073/pnas.0602544103; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Scott WS, 1998, J SURG RES, V79, P66, DOI 10.1006/jsre.1998.5382; UJIIE K, 1994, J PHARMACOL EXP THER, V270, P761; WALDMAN SA, 1986, BIOCHEM PHARMACOL, V35, P3525, DOI 10.1016/0006-2952(86)90622-2; Wyatt TA, 1998, AM J PHYSIOL-HEART C, V274, pH448, DOI 10.1152/ajpheart.1998.274.2.H448; Wykes V, 2002, J NEUROCHEM, V83, P37, DOI 10.1046/j.1471-4159.2002.01106.x; Yamashita T, 2000, HYPERTENSION, V36, P97, DOI 10.1161/01.HYP.36.1.97; Zhou ZM, 2008, ARTERIOSCL THROM VAS, V28, P1803, DOI 10.1161/ATVBAHA.108.165043	56	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25630	25641		10.1074/jbc.M109.030338	http://dx.doi.org/10.1074/jbc.M109.030338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19605352	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000269738000021
J	Kindler, S; Dieterich, DC; Schutt, J; Sahin, J; Karpova, A; Mikhaylova, M; Schob, C; Gundelfinger, ED; Kreienkamp, HJ; Kreutz, MR				Kindler, Stefan; Dieterich, Daniela C.; Schuett, Janin; Sahin, Jale; Karpova, Anna; Mikhaylova, Marina; Schob, Claudia; Gundelfinger, Eckart D.; Kreienkamp, Hans-Juergen; Kreutz, Michael R.			Dendritic mRNA Targeting of Jacob and N-Methyl-D-aspartate-induced Nuclear Translocation after Calpain-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS; SPINE MORPHOGENESIS; EXPRESSION; TRANSPORT; IDENTIFICATION; GENE; FMRP; TRANSLATION; CALDENDRIN; PLASTICITY	Jacob is a recently identified plasticity-related protein that couples N-methyl-D-aspartate receptor activity to nuclear gene expression. An expression analysis by Northern blot and in situ hybridization shows that Jacob is almost exclusively present in brain, in particular in the cortex and the limbic system. Alternative splicing gives rise to multiple mRNA variants, all of which exhibit a prominent dendritic localization in the hippocampus. Functional analysis in primary hippocampal neurons revealed that a predominant cis-acting dendritic targeting element in the 3'-untranslated region of Jacob mRNAs is responsible for dendritic mRNA localization. In the mouse brain, Jacob transcripts are associated with both the fragile X mental retardation protein, a well described trans-acting factor regulating dendritic mRNA targeting and translation, and the kinesin family member 5C motor complex, which is known to mediate dendritic mRNA transport. Jacob is susceptible to rapid protein degradation in a Ca2+- and Calpain-dependent manner, and Calpain-mediated clipping of the myristoylated N terminus of Jacob is required for its nuclear translocation after N-methyl-D-aspartate receptor activation. Our data suggest that local synthesis in dendrites may be necessary to replenish dendritic Jacob pools after truncation of the N-terminal membrane anchor and concomitant translocation of Jacob to the nucleus.	[Dieterich, Daniela C.; Sahin, Jale; Karpova, Anna; Mikhaylova, Marina; Kreutz, Michael R.] Leibniz Inst Neurobiol, Project Grp Neuroplast, D-39118 Magdeburg, Germany; [Dieterich, Daniela C.] Leibniz Inst Neurobiol, Emmy Noether Res Grp, D-39118 Magdeburg, Germany; [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem Mol Biol, D-39118 Magdeburg, Germany; [Kindler, Stefan; Schuett, Janin; Schob, Claudia; Kreienkamp, Hans-Juergen] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); University of Hamburg; University Medical Center Hamburg-Eppendorf	Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, Project Grp Neuroplast, Brenneckestr 6, D-39118 Magdeburg, Germany.	Kreutz@ifn-magdeburg.de	Mikhaylova, Marina/AAM-4368-2020	Mikhaylova, Marina/0000-0001-7646-1346; Dieterich, Daniela C./0000-0002-9880-1214	Bundesministerium fur Bildung und Forschung [GZ 01GA505]; Deutsche Forschungsgemeinschaft [SFB779, TPB8, Ki488/2-6, KR1321/4-1, GRK 1167]; Fonds der Chemische Industrie; Land Saxony-Anhalt/European Union [C1-TP4, C2-TP5]; Schram Foundation; Thyssen-Stiftung Grant Az. [10.05.2.185]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemische Industrie; Land Saxony-Anhalt/European Union(European Commission); Schram Foundation; Thyssen-Stiftung Grant Az.	This work was supported by Bundesministerium fur Bildung und Forschung Grant GZ 01GA505 (to M. R. K. and E. D. G.); Deutsche Forschungsgemeinschaft Grants SFB779, TPB8 (to M. R. K.), Ki488/2-6 (to S. K.), and KR1321/4-1 (to H.-J.K. and S. K.); the Fonds der Chemische Industrie (to E. D. G.); Land Saxony-Anhalt/European Union Grant C1-TP4 and C2-TP5 (to M. R. K.); the Schram Foundation (to M. R. K.); and Thyssen-Stiftung Grant Az. 10.05.2.185 (to S. K.).; Supported by Deutsche Forschungsgemeinschaft Stipend GRK 1167.	Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Iacoangeli A, 2008, P NATL ACAD SCI USA, V105, P734, DOI 10.1073/pnas.0803737105; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kindler S, 2004, MOL BRAIN RES, V126, P14, DOI 10.1016/j.molbrainres.2004.03.014; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Laube G, 2002, MOL CELL NEUROSCI, V19, P459, DOI 10.1006/mcne.2001.1078; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Ronesi JA, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.15pe6; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008	32	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25431	25440		10.1074/jbc.M109.022137	http://dx.doi.org/10.1074/jbc.M109.022137			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19608740	Green Published, hybrid			2022-12-27	WOS:000269734000075
J	Ma, SL; Yang, YS; Wang, CM; Hui, N; Gu, LH; Zhong, HJ; Cai, ZJ; Wang, QQ; Zhang, QH; Li, N; Cao, XT				Ma, Shenglin; Yang, Yunshan; Wang, Chunmei; Hui, Ning; Gu, Linhui; Zhong, Haijun; Cai, Zhijian; Wang, Qingqing; Zhang, Qinghua; Li, Nan; Cao, Xuetao			Endogenous Human CaMKII Inhibitory Protein Suppresses Tumor Growth by Inducing Cell Cycle Arrest and Apoptosis through Down-regulation of the Phosphatidylinositide 3-Kinase/Akt/HDM2 Pathway (Publication with Expression of Concern. See vol. 295, pg. 8882, 2020) (Withdrawn Publication. See vol. 296, 2021) (Withdrawn Publication. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							KINASE-II INHIBITOR; HUMAN HEPATOCELLULAR-CARCINOMA; PHOSPHOINOSITIDE 3-KINASE; ACTIVATION; AKT; SURVIVAL; MDM2; PHOSPHORYLATION; PROLIFERATION; PROGRESSION	Inhibition of calcium/calmodulin-dependent protein kinase II (CaMKII) results in hypophosphorylation of CaMKII substrates and in some cases suppresses cell growth. We previously presented the first report of the human CaMKII inhibitory protein, hCaMKIIN beta. Here we report the functional characterization of hCaMKIIN beta in ovarian cancer cells. We showed that hCaMKIIN beta was highly expressed in normal ovarian tissues but was not detected in human ovarian adenocarcinoma, indicating that decreased expression of hCaMKIIN beta may be involved in the pathogenesis of human ovarian adenocarcinoma. As an endogenous CaMKII inhibitor, hCaMKIIN beta could significantly inhibit the growth of human ovarian cancer cells in vitro. In vivo, hCaMKIIN beta decreased the tumorigenicity and growth of HO-8910PM human ovarian cancer cells and prolonged the survival of tumor-bearing mice. hCaMKIIN beta blocked cell cycle progression and induced apoptosis of HO-8910PM cells, which was correlated with the up-regulation of p21, p53, and Bax and the down-regulation of cyclin A, cyclin D1, cyclin E, CDK2, phosphorylated retinoblastoma, and Bcl-2. We further demonstrated that hCaMKIIN beta-mediated CaMKII inhibition suppressed Akt activation, leading to the down-regulation of HDM2, which was responsible for the up-regulation of p53 and p21 in human ovarian cancer cells. The tumor-suppressive effect and the negative expression in human ovarian cancer tissues suggest that hCaMKIIN beta may play an important role in the regulation of tumor cell growth, possibly contributing to the development of new therapeutic strategies for ovarian cancer.	[Ma, Shenglin; Yang, Yunshan; Gu, Linhui; Zhong, Haijun] Zhejiang Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China; [Wang, Chunmei; Zhang, Qinghua; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Changhai Hosp, Shanghai 200433, Peoples R China; [Wang, Chunmei; Zhang, Qinghua; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Changhai Hosp, Shanghai 200433, Peoples R China; [Hui, Ning] Second Mil Med Univ, Dept Obstet & Gynecol, Changhai Hosp, Shanghai 200433, Peoples R China; [Cai, Zhijian; Wang, Qingqing] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Naval Medical University; Naval Medical University; Naval Medical University; Zhejiang University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	caoxt@public3.sta.net.cn			National Natural Science Foundation of China [30371629, 30772504, 30721091]; Shanghai Committee of Science and Technology [06DJ14011, 05DZ22106]; National High Biotechnology Development Program of China [2006AA02A305, 2009ZX09503-003]; Foundation for the Author of National Excellent Doctoral Dissertation of China [200462]; Zhejiang Provincial Program for the Cultivation of High Level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National High Biotechnology Development Program of China(National High Technology Research and Development Program of China); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Zhejiang Provincial Program for the Cultivation of High Level Innovative Health Talents	This work was supported by National Natural Science Foundation of China Grants 30371629, 30772504, and 30721091, Shanghai Committee of Science and Technology Grants 06DJ14011 and 05DZ22106, National High Biotechnology Development Program of China Grants 2006AA02A305 and 2009ZX09503-003, the Foundation for the Author of National Excellent Doctoral Dissertation of China Grant 200462, and Zhejiang Provincial Program for the Cultivation of High Level Innovative Health Talents ( to S. M.).	Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Coffer PJ, 1998, BIOCHEM J, V335, P1; Colomer J., 2007, V45, P169; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; Ducibella T, 2006, SEMIN CELL DEV BIOL, V17, P324, DOI 10.1016/j.semcdb.2006.02.010; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Idres N, 2001, CANCER RES, V61, P700; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Ma W, 2007, J BIOL CHEM, V282, P13351, DOI 10.1074/jbc.M611522200; MINAMI H, 1994, BIOCHEM BIOPH RES CO, V199, P241, DOI 10.1006/bbrc.1994.1220; Moll UM, 2003, MOL CANCER RES, V1, P1001; Moore SM, 1998, CANCER RES, V58, P5239; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qi RZ, 2003, CANCER RES, V63, P8323; RASMUSSEN G, 1995, BIOCHEM CELL BIOL, V73, P201, DOI 10.1139/o95-024; Rodriguez-Mora OG, 2006, CANCER BIOL THER, V5, P1022, DOI 10.4161/cbt.5.8.2910; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shenhua X, 1999, J EXP CLIN CANC RES, V18, P233; TAKUWA N, 1993, J BIOL CHEM, V268, P138; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Wang CM, 2008, J BIOL CHEM, V283, P11565, DOI 10.1074/jbc.M800436200; Wang XJ, 2004, J BIOL CHEM, V279, P45855, DOI 10.1074/jbc.M405147200; Wen Y, 2001, CANCER RES, V61, P7142; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200; Yang BF, 2003, J BIOL CHEM, V278, P7043, DOI 10.1074/jbc.M211278200; Yang LJ, 2004, J BIOL CHEM, V279, P11639, DOI 10.1074/jbc.M312895200; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhang J, 2001, BIOCHEM BIOPH RES CO, V285, P229, DOI 10.1006/bbrc.2001.5175	40	34	36	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24773	24782		10.1074/jbc.M109.028621	http://dx.doi.org/10.1074/jbc.M109.028621			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19586909	Green Published, hybrid			2022-12-27	WOS:000269734000012
J	Tumbale, P; Brew, K				Tumbale, Percy; Brew, Keith			Characterization of a Metal-independent CAZy Family 6 Glycosyltransferase from Bacteroides ovatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP-B; GROUP-A; STRUCTURAL BASIS; GENE; ALPHA-1,3-GALACTOSYLTRANSFERASE; SPECIFICITY; BINDING; GALACTOSYLTRANSFERASE; CLASSIFICATION; CONVERGENCE	The myriad functions of complex carbohydrates include modulating interactions between bacteria and their eukaryotic hosts. In humans and other vertebrates, variations in the activity of glycosyltransferases of CAZy family 6 generate antigenic variation between individuals and species that facilitates resistance to pathogens. The well characterized vertebrate glycosyltransferases of this family are multidomain membrane proteins with C-terminal catalytic domains. Genes for proteins homologous with their catalytic domains are found in at least nine species of anaerobic commensal bacteria and a cyanophage. Although the bacterial proteins are strikingly similar in sequence to the catalytic domains of their eukaryotic relatives, a metal-binding Asp-X-Asp sequence, present in a wide array of metal ion-dependent glycosyltransferases, is replaced by Asn-X-Asn. We have cloned and expressed one of these proteins from Bacteroides ovatus, a bacterium that is linked to inflammatory bowel disease. Functional characterization shows it to be a metal-independent glycosyltransferase with a 200-fold preference for UDP-GalNAc as substrate relative to UDP-Gal. It efficiently catalyzes the synthesis of oligosaccharides similar to human blood group A and may participate in the synthesis of the bacterial O-antigen. The kinetics for GalNAc transfer to 2'-fucosyl lactose are characteristic of a sequential mechanism, as observed previously for this family. Mutational studies indicate that despite the lack of a metal cofactor, there are pronounced similarities in structure-function relationships between the bacterial and vertebrate family 6 glycosyltransferases. These two groups appear to provide an example of horizontal gene transfer involving vertebrates and prokaryotes.	[Tumbale, Percy; Brew, Keith] Florida Atlantic Univ, Dept Basic Sci, Charles E Schmidt Coll Biomed Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Brew, K (corresponding author), Florida Atlantic Univ, Dept Biomed Sci, 777 Glades Rd, Boca Raton, FL 33431 USA.	kbrew@fau.edu	Brew, Keith/W-1643-2019; Brew, Keith/A-6746-2009	Brew, Keith/0000-0003-1306-1032	National Institutes of Health [AR40994]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR40994.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; GALILI U, 1988, J BIOL CHEM, V263, P17755; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Heissigerova H, 2003, GLYCOBIOLOGY, V13, P377, DOI 10.1093/glycob/cwg042; HENION TR, 1994, GLYCOBIOLOGY, V4, P193, DOI 10.1093/glycob/4.2.193; Hol W G, 1985, Adv Biophys, V19, P133, DOI 10.1016/0065-227X(85)90053-X; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Kona F, 2007, BIOCHEMISTRY-US, V46, P4532, DOI 10.1021/bi6024879; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Pak JE, 2006, J BIOL CHEM, V281, P26693, DOI 10.1074/jbc.M603534200; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; Persson M, 2007, J BIOL CHEM, V282, P9564, DOI 10.1074/jbc.M610998200; Rosch JW, 2009, MOL MICROBIOL, V72, P12, DOI 10.1111/j.1365-2958.2009.06638.x; Saitoh S, 2002, CLIN DIAGN LAB IMMUN, V9, P54, DOI 10.1128/CDLI.9.1.54-59.2002; Seto NOL, 1999, EUR J BIOCHEM, V259, P770, DOI 10.1046/j.1432-1327.1999.00086.x; Shulami S, 2004, J BIOL CHEM, V279, P45110, DOI 10.1074/jbc.M404561200; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Tumbale P, 2008, BIOCHEMISTRY-US, V47, P8711, DOI 10.1021/bi800852a; Tumbale P, 2008, GLYCOBIOLOGY, V18, P1036, DOI 10.1093/glycob/cwn083; Turcot-Dubois AL, 2007, GLYCOBIOLOGY, V17, P516, DOI 10.1093/glycob/cwm016; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Xu HJ, 1999, J BIOL CHEM, V274, P29390, DOI 10.1074/jbc.274.41.29390; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y; Yi W, 2008, J AM CHEM SOC, V130, P14420, DOI 10.1021/ja805844y; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhang YN, 2003, BIOCHEMISTRY-US, V42, P13512, DOI 10.1021/bi035430r; Zhang YN, 2004, GLYCOBIOLOGY, V14, P1295, DOI 10.1093/glycob/cwh119; Zhang YN, 2001, J BIOL CHEM, V276, P11567, DOI 10.1074/jbc.M006530200	41	8	8	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25126	25134		10.1074/jbc.M109.033878	http://dx.doi.org/10.1074/jbc.M109.033878			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19622749	Green Published			2022-12-27	WOS:000269734000047
J	Chiu, WC; Chang, CP; Wang, CC				Chiu, Wen-Chih; Chang, Chia-Pei; Wang, Chien-Chia			Evolutionary Basis of Converting a Bacterial tRNA Synthetase into a Yeast Cytoplasmic or Mitochondrial Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONYL-TRANSFER-RNA; ELONGATION FACTOR-I; SACCHAROMYCES-CEREVISIAE; BINDING DOMAIN; MULTISYNTHETASE COMPLEX; RABBIT LIVER; GENE ENCODES; AMINOACYLATION; TRANSLATION; FEATURES	Previous studies showed that cytoplasmic and mitochondrial forms of yeast valyl-tRNA synthetase (ValRS) are specified by the VAS1 gene through alternative initiation of translation. Sequence comparison suggests that the yeast cytoplasmic (or mature mitochondrial) ValRS contains an N-terminal appendage that acts in cis as a nonspecific tRNA-binding domain (TRBD) and is absent from its bacterial relatives. We show here that Escherichia coli ValRS can substitute for the mitochondrial and cytoplasmic functions of VAS1 by fusion of a mitochondrial targeting signal and a TRBD, respectively. In addition, the bacterial ValRS gene can be converted into a dual functional yeast gene encoding both cytoplasmic and mitochondrial activities by fusion of a DNA sequence specifying both the mitochondrial targeting signal and TRBD. In vitro assays suggested that fusion of a nonspecific TRBD to the bacterial enzyme significantly enhanced its yeast tRNA-binding and aminoacylation activities. These results not only underscore the necessity of retaining a TRBD for functioning of a tRNA synthetase in yeast cytoplasm, but also provide insights into the evolution of tRNA synthetase genes.	[Chiu, Wen-Chih; Chang, Chia-Pei; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Jhongli 32001, Taiwan	National Central University	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Jhongli 32001, Taiwan.	dukewang@cc.ncu.edu.tw			National Science Council, Taipei, Taiwan [NSC97-2311-B-008-002-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC97-2311-B-008-002-MY3 from the National Science Council, Taipei, Taiwan ( to C.-C.W.).	BEC G, 1994, J BIOL CHEM, V269, P2086; BEC G, 1989, J BIOL CHEM, V264, P21131; BEC G, 1989, J BIOL CHEM, V264, P21138; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang Chia-Pei, 2008, J Biol Chem, V283, P30699, DOI 10.1074/jbc.M805339200; Chang KJ, 2006, J BIOL CHEM, V281, P7775, DOI 10.1074/jbc.M511265200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Chen SJ, 2009, J BIOL CHEM, V284, P818, DOI 10.1074/jbc.M804378200; DIETRICH A, 1992, ANNU REV CELL BIOL, V8, P115, DOI 10.1146/annurev.cb.08.110192.000555; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Francin M, 2006, BIOCHEMISTRY-US, V45, P10153, DOI 10.1021/bi0606905; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; MARTINIS SA, 1996, ESCHERICHIA COLI SAL, P887; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; MIRANDE M, 1992, EUR J BIOCHEM, V203, P459, DOI 10.1111/j.1432-1033.1992.tb16570.x; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; MOTORIN YA, 1991, EUR J BIOCHEM, V201, P325, DOI 10.1111/j.1432-1033.1991.tb16289.x; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Pelchat M, 1999, BIOCHEM CELL BIOL, V77, P343, DOI 10.1139/bcb-77-4-343; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Schimmel P, 1999, TRENDS BIOCHEM SCI, V24, P127, DOI 10.1016/S0968-0004(99)01369-9; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Simos G, 1998, MOL CELL, V1, P235, DOI 10.1016/S1097-2765(00)80024-6; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; VENEMA RC, 1991, J BIOL CHEM, V266, P12574; Wang CC, 2000, J BIOL CHEM, V275, P17180, DOI 10.1074/jbc.M001057200; Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c; Wang CC, 1999, J BIOL CHEM, V274, P16508, DOI 10.1074/jbc.274.23.16508	38	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23954	23960		10.1074/jbc.M109.031047	http://dx.doi.org/10.1074/jbc.M109.031047			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574213	Green Published, hybrid			2022-12-27	WOS:000269380200009
J	Hill, KK; Roemer, SC; Jones, DNM; Churchill, MEA; Edwards, DP				Hill, Krista K.; Roemer, Sarah C.; Jones, David N. M.; Churchill, Mair E. A.; Edwards, Dean P.			A Progesterone Receptor Co-activator (JDP2) Mediates Activity through Interaction with Residues in the Carboxyl-terminal Extension of the DNA Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING FINGER PROTEIN; ESTROGEN RELATED RECEPTOR-2; STEROID-HORMONE RECEPTORS; NMR CHEMICAL-SHIFTS; INTRINSIC DISORDER; ANDROGEN RECEPTOR; NUCLEAR RECEPTORS; STRUCTURAL BASIS; IN-VITRO; TRANSCRIPTIONAL-ACTIVATION	Progesterone receptor (PR) belongs to the nuclear receptor family of ligand-dependent transcription factors and mediates the major biological effects of progesterone. Transcriptional coactivators that are recruited by PR through the carboxyl-terminal ligand binding domain have been studied extensively. Much less is known about co-activators that interact with other regions of receptors. Jun dimerization protein 2 (JDP2) is a PR co-activator that enhances the transcriptional activity of the amino-terminal domain by increasing the alpha-helical content and stability of the intrinsically disordered amino-terminal domain. To gain insights into the mechanism of JDP2 co-activation of PR, the structural basis of JDP2-PR interaction was analyzed using NMR. The smallest regions of each protein needed for efficient protein interaction were used for NMR and included the basic region plus leucine zipper (bZIP) domain of JDP2 and the core zinc modules of the PR DNA binding domain plus the intrinsically disordered carboxyl-terminal extension (CTE) of the DNA binding domain. Chemical shift changes in PR upon titration with JDP2 revealed that most of the residues involved in binding of JDP2 reside within the CTE. The importance of the CTE for binding JDP2 was confirmed by peptide competition and mutational analyses. Point mutations within CTE sites identified by NMR and a CTE domain swapping experiment also confirmed the functional importance of JDP2 interaction with the CTE for enhancement of PR transcriptional activity. These studies provide insights into the role and functional importance of the CTE for co-activator interactions.	[Hill, Krista K.; Jones, David N. M.; Churchill, Mair E. A.] Univ Colorado Denver, Program Mol Biol, Sch Med, Aurora, CO 80045 USA; [Roemer, Sarah C.; Jones, David N. M.; Churchill, Mair E. A.] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Edwards, Dean P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Edwards, Dean P.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor College of Medicine; Baylor College of Medicine	Churchill, MEA (corresponding author), Univ Colorado Denver, Program Mol Biol, Sch Med, 12801 E,17th Ave,POB 6511,MS 8303, Aurora, CO 80045 USA.	mair.churchill@ucdenver.edu	Jones, David N/C-5764-2013; Churchill, Mair E. A./C-5549-2014	Churchill, Mair E. A./0000-0003-0862-235X	NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059456, R01GM079154] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA046934] Funding Source: Medline; NIGMS NIH HHS [R01 GM059456, R01 GM079154, R01 GM079154-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Berjanskii MV, 2007, NUCLEIC ACIDS RES, V35, pW531, DOI 10.1093/nar/gkm328; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Choudhry MA, 2006, MOL ENDOCRINOL, V20, P2052, DOI 10.1210/me.2005-0486; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; Das D, 2004, MOL ENDOCRINOL, V18, P2616, DOI 10.1210/me.2004-0125; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dow LK, 2000, BIOCHEMISTRY-US, V39, P9725, DOI 10.1021/bi000723v; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edwards DP, 2002, J STEROID BIOCHEM, V83, P173, DOI 10.1016/S0960-0760(02)00265-0; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P219, DOI 10.1007/s10858-005-7944-6; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Gearhart MD, 2003, J MOL BIOL, V327, P819, DOI 10.1016/S0022-2836(03)00183-9; Goddard T. D., SPARKY 3; GRONEMEYER H, 1995, NATURE, V375, P190, DOI 10.1038/375190a0; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hsieh JC, 1999, BIOCHEMISTRY-US, V38, P16347, DOI 10.1021/bi9916574; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Ko L, 2002, MOL CELL BIOL, V22, P357, DOI 10.1128/MCB.22.1.357-369.2002; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2004, BIOCHEMISTRY-US, V43, P3008, DOI 10.1021/bi035934p; Lavery DN, 2006, BIOCHEM SOC T, V34, P1054, DOI 10.1042/BST0341054; LEE MS, 1993, SCIENCE, V260, P1117, DOI 10.1126/science.8388124; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Li XT, 2003, J BIOL CHEM, V278, P39261, DOI 10.1074/jbc.R300024200; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Loven MA, 2004, MOL ENDOCRINOL, V18, P2649, DOI 10.1210/me.2003-0195; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McEwan Iain J, 2007, Nucl Recept Signal, V5, pe001; Meinke G, 1999, NAT STRUCT BIOL, V6, P471; Melvin VS, 2004, J BIOL CHEM, V279, P14763, DOI 10.1074/jbc.M313335200; Melvin VS, 2002, J BIOL CHEM, V277, P25115, DOI 10.1074/jbc.M110400200; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Miotto B, 2006, MOL CELL BIOL, V26, P5969, DOI 10.1128/MCB.00696-06; Moilanen AM, 1998, MOL CELL BIOL, V18, P5128, DOI 10.1128/MCB.18.9.5128; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Peterson BR, 1996, P NATL ACAD SCI USA, V93, P13671, DOI 10.1073/pnas.93.24.13671; Poukka H, 2000, J CELL SCI, V113, P2991; Poukka H, 2000, J BIOL CHEM, V275, P571, DOI 10.1074/jbc.275.1.571; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Roemer SC, 2008, NUCLEIC ACIDS RES, V36, P3655, DOI 10.1093/nar/gkn249; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Romine LE, 1998, MOL ENDOCRINOL, V12, P664, DOI 10.1210/me.12.5.664; Schultz-Norton JR, 2007, NUCLEIC ACIDS RES, V35, P5028, DOI 10.1093/nar/gkm533; Sem DS, 1997, J BIOL CHEM, V272, P18038, DOI 10.1074/jbc.272.29.18038; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Verrier CS, 1997, MOL ENDOCRINOL, V11, P1009, DOI 10.1210/me.11.8.1009; Verrijdt G, 2002, BIOCHEM J, V361, P97, DOI 10.1042/0264-6021:3610097; Wardell SE, 2005, MOL CELL BIOL, V25, P8792, DOI 10.1128/MCB.25.20.8792-8808.2005; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Warnmark A, 2003, MOL ENDOCRINOL, V17, P1901, DOI 10.1210/me.2002-0384; Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; Wood JR, 2001, MOL ENDOCRINOL, V15, P1114, DOI 10.1210/me.15.7.1114; Zhang CC, 1999, MOL ENDOCRINOL, V13, P632, DOI 10.1210/me.13.4.632; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; Zhao Q, 2000, J MOL BIOL, V296, P509, DOI 10.1006/jmbi.1999.3457; ZILLIACUS J, 1995, MOL ENDOCRINOL, V9, P389, DOI 10.1210/me.9.4.389	74	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24415	24424		10.1074/jbc.M109.003244	http://dx.doi.org/10.1074/jbc.M109.003244			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19553667	Green Published, hybrid			2022-12-27	WOS:000269380200054
J	Miesbauer, M; Pfeiffer, NV; Rambold, AS; Muller, V; Kiachopoulos, S; Winklhofer, KF; Tatzelt, J				Miesbauer, Margit; Pfeiffer, Natalie V.; Rambold, Angelika S.; Mueller, Veronika; Kiachopoulos, Sophia; Winklhofer, Konstanze F.; Tatzelt, Joerg			alpha-Helical Domains Promote Translocation of Intrinsically Disordered Polypeptides into the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; SCRAPIE PRION PROTEIN; C-TERMINAL DOMAIN; SIGNAL SEQUENCES; QUALITY-CONTROL; RIBOSOME; DISEASE; CELLS; GLYCOSYLATION; CONFORMATION	Co-translational import into the endoplasmic reticulum (ER) is primarily controlled by N-terminal signal sequences that mediate targeting of the ribosome-nascent chain complex to the Sec61/translocon and initiate the translocation process. Here we show that after targeting to the translocon the secondary structure of the nascent polypeptide chain can significantly modulate translocation efficiency. ER-targeted polypeptides dominated by unstructured domains failed to efficiently translocate into the ER lumen and were subjected to proteasomal degradation via a co-translocational/preemptive pathway. Productive ER import could be reinstated by increasing the amount of alpha-helical domains, whereas more effective ER signal sequences had only a minor effect on ER import efficiency of unstructured polypeptides. ER stress and overexpression of p58(IPK) promoted the co-translocational degradation pathway. Moreover polypeptides with unstructured domains at their N terminus were specifically targeted to proteasomal degradation under these conditions. Our study indicates that extended unstructured domains are signals to dispose ER-targeted proteins via a co-translocational, preemptive quality control pathway.	[Tatzelt, Joerg] Univ Munich, Deutsch Zentrum Neurodegenerat Erkrankungen, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich	Tatzelt, J (corresponding author), Univ Munich, Deutsch Zentrum Neurodegenerat Erkrankungen, Schillerstr 44, D-80336 Munich, Germany.	Joerg.Tatzelt@med.uni-muenchen.de		Winklhofer, Konstanze/0000-0002-7256-8231; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft [SFB 596]; Max Planck Society; Bundesministerium fur Bildung und Forschung [DIP5.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 596), the Max Planck Society, and the Bundesministerium fur Bildung und Forschung (BioDisc, DIP5.1).	Blochberger TC, 1997, PROTEIN ENG, V10, P1465, DOI 10.1093/protein/10.12.1465; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Daniel CJ, 2008, J BIOL CHEM, V283, P20864, DOI 10.1074/jbc.M803517200; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Eberl H, 2002, BIOPHYS CHEM, V96, P293, DOI 10.1016/S0301-4622(02)00015-7; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gallo M, 2005, INT J IMMUNOPATH PH, V18, P95, DOI 10.1177/039463200501800111; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Heller U, 2003, J BIOL CHEM, V278, P36139, DOI 10.1074/jbc.M304002200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kiachopoulos S, 2005, J BIOL CHEM, V280, P9320, DOI 10.1074/jbc.M412525200; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Rutkowski DT, 2003, J BIOL CHEM, V278, P30365, DOI 10.1074/jbc.M302117200; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Uelhoff A, 2005, J BIOL CHEM, V280, P5137, DOI 10.1074/jbc.C400560200; von Bergen M, 2006, NEURODEGENER DIS, V3, P197, DOI 10.1159/000095257; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Wildegger G, 1999, NAT STRUCT BIOL, V6, P550, DOI 10.1038/9323; Winklhofer KF, 2000, BIOL CHEM, V381, P463, DOI 10.1515/BC.2000.061; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2	53	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24384	24393		10.1074/jbc.M109.023135	http://dx.doi.org/10.1074/jbc.M109.023135			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561072	Green Published, hybrid			2022-12-27	WOS:000269380200051
J	Smirnovas, V; Kim, JI; Lu, XJ; Atarashi, R; Caughey, B; Surewicz, WK				Smirnovas, Vytautas; Kim, Jae-Il; Lu, Xiaojun; Atarashi, Ryuichiro; Caughey, Byron; Surewicz, Witold K.			Distinct Structures of Scrapie Prion Protein (PrPSc)-seeded Versus Spontaneous Recombinant Prion Protein Fibrils Revealed by Hydrogen/Deuterium Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; AMYLOID FIBRILS; EMERGING PRINCIPLES; CONVERSION; RESISTANT; CORE; FORM; INFECTIVITY; DOMAIN; INHERITANCE	The detailed structures of prion disease-associated, partially protease-resistant forms of prion protein (e. g. PrPSc) are largely unknown. PrPSc appears to propagate itself by autocatalyzing the conformational conversion and oligomerization of normal prion protein (PrPC). One manifestation of PrPSc templating activity is its ability, in protein misfolding cyclic amplification reactions, to seed the conversion of recombinant prion protein (rPrP) into aggregates that more closely resemble PrPSc than spontaneously nucleated rPrP amyloids in terms of proteolytic fragmentation and infrared spectra. The absence of posttranslational modifications makes these rPrP aggregates more amenable to detailed structural analyses than bona fide PrPSc. Here, we compare the structures of PrPSc-seeded and spontaneously nucleated aggregates of hamster rPrP by using H/D exchange coupled with mass spectrometry. In spontaneously formed fibrils, very slow H/D exchange in region similar to 163-223 represents a systematically H-bonded cross-beta amyloid core structure. PrPSc-seeded aggregates have a subpopulation of molecules in which this core region extends N-terminally as far as to residue similar to 145, and there is a significant degree of order within residues similar to 117-133. The formation of tightly H-bonded structures by these more N-terminal residues may account partially for the generation of longer protease-resistant regions in the PrPSc-seeded rPrP aggregates; however, part of the added protease resistance is dependent on the presence of SDS during proteolysis, emphasizing the multifactorial influences on proteolytic fragmentation patterns. These results demonstrate that PrPSc has a distinct templating activity that induces ordered, systematically H-bonded structure in regions that are dynamic and poorly defined in spontaneously formed aggregates of rPrP.	[Smirnovas, Vytautas; Kim, Jae-Il; Lu, Xiaojun; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Atarashi, Ryuichiro; Caughey, Byron] NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA	Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu	Smirnovas, Vytautas/O-6270-2018	Smirnovas, Vytautas/0000-0002-1829-5455; Lu, Xiaojun/0000-0001-5251-4343	National Institutes of Health [NS44158, AG14359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or part, by National Institutes of Health Grants NS44158 and AG14359.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2001, TRENDS BIOCHEM SCI, V26, P235, DOI 10.1016/S0968-0004(01)01792-3; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; KASCSAK RJ, 1993, DEV BIOL STAND, V80, P141; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; Kheterpal I, 2006, ACCOUNTS CHEM RES, V39, P584, DOI 10.1021/ar050057w; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nazabal A, 2005, J BIOL CHEM, V280, P13220, DOI 10.1074/jbc.M413185200; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; RUBENSTEIN R, 1994, ARCH VIROL, V139, P301, DOI 10.1007/BF01310793; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104; Wickner RB, 2008, BIOESSAYS, V30, P955, DOI 10.1002/bies.20821	48	64	65	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24233	24241		10.1074/jbc.M109.036558	http://dx.doi.org/10.1074/jbc.M109.036558			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19596861	hybrid, Green Published			2022-12-27	WOS:000269380200037
J	Guttilla, IK; White, BA				Guttilla, Irene K.; White, Bruce A.			Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION; PROSTATE-CANCER; FKHR FOXO1; PHOSPHORYLATION; MICRORNAS; EXPRESSION; GROWTH; TRANSACTIVATION	The FOXO1 transcription factor orchestrates the regulation of genes involved in the apoptotic response, cell cycle checkpoints, and cellular metabolism. FOXO1 is a putative tumor suppressor, and the expression of this gene is dysregulated in some cancers, including prostate and endometrial cancers. However, the molecular mechanism resulting in aberrant expression of human FOXO1 in cancer cells is poorly understood. We show here that FOXO1 mRNA is down-regulated in breast tumor samples as compared with normal breast tissue. Silencing of the microRNA processing enzymes, Drosha and Dicer, led to an increase in FOXO1 expression. We also identified functional and specific microRNA target sites in the FOXO1 3'-untranslated region for miR-27a, miR-96, and miR-182, microRNAs that have previously been linked to oncogenic transformation. The three microRNAs, miR-27a, miR-96 and miR-182, were observed to be highly expressed in MCF-7 breast cancer cells, in which the level of FOXO1 protein is very low. Antisense inhibitors to each of these microRNAs led to a significant increase in endogenous FOXO1 expression and to a decrease in cell number in a manner that was blocked by FOXO1 siRNA. Overexpression of FOXO1 resulted in decreased cell viability because of inhibition of cell cycle traverse and induction of cell death. We have identified a novel mechanism of FOXO1 regulation, and targeting of FOXO1 by microRNAs may contribute to transformation or maintenance of an oncogenic state in breast cancer cells.	[White, Bruce A.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA; [Guttilla, Irene K.; White, Bruce A.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	White, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	bwhite@nso2.uchc.edu		Guttilla Reed, Irene/0000-0002-6617-1465				Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Goto T, 2008, BRIT J CANCER, V98, P1068, DOI 10.1038/sj.bjc.6604279; Goto T, 2008, ONCOGENE, V27, P9, DOI 10.1038/sj.onc.1210626; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lengyel F, 2007, STEROIDS, V72, P422, DOI 10.1016/j.steroids.2007.03.001; Li R, 2007, HUM PATHOL, V38, P1501, DOI 10.1016/j.humpath.2007.02.016; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Loscher CJ, 2008, EXP EYE RES, V87, P529, DOI 10.1016/j.exer.2008.08.016; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mazumdar A, 2003, FEBS LETT, V535, P6, DOI 10.1016/S0014-5793(02)03846-2; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200	40	491	523	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23204	23216		10.1074/jbc.M109.031427	http://dx.doi.org/10.1074/jbc.M109.031427			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574223	Green Published, hybrid			2022-12-27	WOS:000269180000005
J	Boniface, A; Parquet, C; Arthur, M; Mengin-Lecreulx, D; Blanot, D				Boniface, Audrey; Parquet, Claudine; Arthur, Michel; Mengin-Lecreulx, Dominique; Blanot, Didier			The Elucidation of the Structure of Thermotoga maritima Peptidoglycan Reveals Two Novel Types of Cross-link	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL PEPTIDOGLYCAN; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; ALANINE LIGASE; CELL-WALLS; BIOSYNTHESIS; ACID; DIFFERENTIATION; EXPRESSION; MONOMER	Thermotoga maritima is a Gram-negative, hyperthermophilic bacterium whose peptidoglycan contains comparable amounts of L-and D-lysine. We have determined the fine structure of this cell-wall polymer. The muropeptides resulting from the digestion of peptidoglycan by mutanolysin were separated by high-performance liquid chromatography and identified by amino acid analysis after acid hydrolysis, dinitrophenylation, enzymatic determination of the configuration of the chiral amino acids, and mass spectrometry. The high-performance liquid chromatography profile contained four main peaks, two monomers, and two dimers, plus a few minor peaks corresponding to anhydro forms. The first monomer was the D-lysine-containing disaccharide-tripeptide in which the D-Glu-D-Lys bond had the unusual gamma ->epsilon arrangement (Glc-NAc- MurNAc-L-Ala-gamma-D-Glu-epsilon-D-Lys). The second monomer was the conventional disaccharide-tetrapeptide (Glc-NAc-MurNAc-L-Ala-gamma-D-Glu-L-Lys-D-Ala). The first dimer contained a disaccharide-L-Ala as the acyl donor cross-linked to the alpha-amine of D-Lys in a tripeptide acceptor stem with the sequence of the first monomer. In the second dimer, donor and acceptor stems with the sequences of the second and first monomers, respectively, were connected by a D-Ala(4)-alpha-D-Lys(3) cross-link. The cross-linking index was 10 with an average chain length of 30 disaccharide units. The structure of the peptidoglycan of T. maritima revealed for the first time the key role of D-Lys in peptidoglycan synthesis, both as a surrogate of L-Lys or meso-diaminopimelic acid at the third position of peptide stems and in the formation of novel cross-links of the L-Ala(1)(alpha ->alpha)D-Lys(3) and D-Ala(4)(alpha ->alpha)D-Lys(3) types.	[Boniface, Audrey; Parquet, Claudine; Mengin-Lecreulx, Dominique; Blanot, Didier] Univ Paris 11, CNRS, Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, F-91405 Orsay, France; [Arthur, Michel] Univ Paris 06, Lab Rech Mol Antibiot, Ctr Rech Cordeliers, UMR S 872, F-75006 Paris, France; [Arthur, Michel] Univ Paris 05, UMR S 872, F-75006 Paris, France; [Arthur, Michel] INSERM, U872, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Blanot, D (corresponding author), Univ Paris 11, CNRS, Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, Batiment 430, F-91405 Orsay, France.	didier.blanot@u-psud.fr	Arthur, Michel/G-3680-2013	Arthur, Michel/0000-0003-1007-636X; MENGIN-LECREULX, Dominique/0000-0003-3205-0275	CNRS [UMR 8619]; Delegation Generale pour l'Armement [036000104, 056000030]; European Union EUR-INTAFAR Project [LSHMCT2004-512138]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Delegation Generale pour l'Armement; European Union EUR-INTAFAR Project	This work was supported by grants from the CNRS (UMR 8619), the Delegation Generale pour l'Armement (Contrats Jeune Chercheur 036000104 and 056000030 to A. B.) and the European Union EUR-INTAFAR Project (LSHMCT2004-512138).	Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Atrih A, 1998, J BACTERIOL, V180, P4603, DOI 10.1128/JB.180.17.4603-4612.1998; Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Boniface A, 2006, J BIOL CHEM, V281, P15680, DOI 10.1074/jbc.M506311200; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; DEROSA M, 1988, J CHEM SOC CHEM COMM, P1300, DOI 10.1039/c39880001300; GHUYSEN JM, 1968, BIOCHEMISTRY-US, V7, P1450, DOI 10.1021/bi00844a030; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; GUINAND M, 1969, BIOCHEMISTRY-US, V8, P200, DOI 10.1021/bi00829a029; HAMMES WP, 1977, ARCH MICROBIOL, V115, P95, DOI 10.1007/BF00427851; Horsburgh GJ, 2003, J BACTERIOL, V185, P3813, DOI 10.1128/JB.185.13.3813-3820.2003; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; HUBER R, 1992, PROKARYOTES HDB BIOL, V4, P3809; KLAIC B, 1985, CARBOHYD RES, V138, P65, DOI 10.1016/0008-6215(85)85223-X; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Mainard JL, 2002, J BIOL CHEM, V277, P35801, DOI 10.1074/jbc.M204319200; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Mengin-Lecreulx D, 1999, J BACTERIOL, V181, P5909, DOI 10.1128/JB.181.19.5909-5914.1999; Offant J, 2006, BBA-PROTEINS PROTEOM, V1764, P1036, DOI 10.1016/j.bbapap.2006.03.012; QUINTELA JC, 1995, FEMS MICROBIOL LETT, V125, P95, DOI 10.1016/0378-1097(94)00479-B; QUINTELA JC, 1995, J BACTERIOL, V177, P4947, DOI 10.1128/jb.177.17.4947-4962.1995; Rogers H.J., 1980, MICROBIAL CELL WALK, P190; Sato M, 2005, J BIOSCI BIOENG, V99, P623, DOI 10.1263/jbb.99.623; Sato M, 2006, BIOSCI BIOTECH BIOCH, V70, P2790, DOI 10.1271/bbb.60307; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Spraggon G, 2004, PROTEINS, V55, P1078, DOI 10.1002/prot.20034; Stetter KO, 1999, FEBS LETT, V452, P22, DOI 10.1016/S0014-5793(99)00663-8; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x	33	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21856	21862		10.1074/jbc.M109.034363	http://dx.doi.org/10.1074/jbc.M109.034363			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542229	Green Published, hybrid			2022-12-27	WOS:000268783700009
J	Chakraborty, K; Maity, PC; Sil, AK; Takeda, Y; Das, S				Chakraborty, Krishnendu; Maity, Palash Chandra; Sil, Alok Kumar; Takeda, Yoshifumi; Das, Santasabuj			cAMP Stringently Regulates Human Cathelicidin Antimicrobial Peptide Expression in the Mucosal Epithelial Cells by Activating cAMP-response Element-binding Protein, AP-1, and Inducible cAMP Early Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASIVE BACTERIAL-INFECTION; GENE-EXPRESSION; SIGNALING PATHWAYS; T-CELLS; TRANSCRIPTIONAL ATTENUATION; DEPENDENT MECHANISM; HUMAN KERATINOCYTES; HUMAN LUNG; C-FOS; LL-37	Little is known about the regulation of the innate host defense peptide cathelicidin at the mucosal surfaces. Expression is believed to be transcriptionally regulated, and several cis-acting elements have been identified in the cathelicidin putative promoter. However, the trans-acting factors have not been clearly defined. We have recently reported that bacterial exotoxins suppress cathelicidin expression in sodium butyrate-differentiated intestinal epithelial cells (ECs), and this may be mediated through inducible cAMP early repressor. Here we have shown that cAMP-signaling pathways transcriptionally regulate cathelicidin expression in various ECs. cAMP-response element-binding protein (CREB) and AP-1 (activator protein-1) bind to the cathelicidin putative promoter in vitro. Additionally, transcriptional complexes containing CREB, AP-1, and cathelicidin upstream regulatory sequences are formed within ECs. We have also shown that these complexes may activate cathelicidin promoter and are required for its inducible expression in ECs. This is underscored by the fact that silencing of CREB and AP-1 results in failure of ECs to up-regulate cathelicidin, and hepatitis B virus X protein may use CREB to induce cathelicidin. On the other hand, inducible cAMP early repressor competes with CREB and AP-1 for binding to the cathelicidin promoter and represses transcription, thus functioning as a counter-regulatory mechanism. Finally, both CREB and AP-1 were shown to play major roles in the regulation of cathelicidin in sodium butyrate-differentiated HT-29 cells. This is the first report of a detailed mechanistic study of inducible cathelicidin expression in the mucosal ECs. At the same time, it describes a novel immunomodulatory function of cAMP.	[Chakraborty, Krishnendu; Das, Santasabuj] Natl Inst Cholera & Enter Dis, Dept Clin Med, Kolkata 700010, India; [Maity, Palash Chandra; Sil, Alok Kumar] Univ Calcutta, Dept Microbiol, Kolkata 700019, W Bengal, India; [Takeda, Yoshifumi] Okayama Univ Infect Dis, Natl Inst Cholera & Enter Dis, Collaborat Res Ctr, Kolkata 700010, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of Calcutta; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Okayama University	Das, S (corresponding author), Natl Inst Cholera & Enter Dis, Dept Clin Med, P-33 CIT Rd,Scheme XM, Kolkata 700010, India.	santasabujdas@yahoo.com	Maity, Palash Chandra/ABD-9970-2021	/0000-0001-5632-2904; Maity, Palash Chandra/0000-0003-3295-5859	Program of Funding Research Center for Emerging and Reemerging Infectious Diseases; Ministry of Education, Culture, Sports, Science and Technology of Japan; Indian Council of Medical Research [2006-05630]	Program of Funding Research Center for Emerging and Reemerging Infectious Diseases; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported in part by Program of Funding Research Center for Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology of Japan and extramural funds from Indian Council of Medical Research Grant IRIS ID 2006-05630.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Barabitskaja O, 2006, J LEUKOCYTE BIOL, V79, P378, DOI 10.1189/jlb.0505255; BARBER JR, 1987, MOL CELL BIOL, V7, P2201, DOI 10.1128/MCB.7.6.2201; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bergamaschi A, 2006, CELL SIGNAL, V18, P1679, DOI 10.1016/j.cellsig.2006.01.006; Bergman P, 2005, CELL MICROBIOL, V7, P1009, DOI 10.1111/j.1462-5822.2005.00530.x; Bodor J, 1998, J BIOL CHEM, V273, P9544, DOI 10.1074/jbc.273.16.9544; Bodor J, 2007, EUR J IMMUNOL, V37, P884, DOI 10.1002/eji.200636510; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Dommett R, 2005, MOL IMMUNOL, V42, P903, DOI 10.1016/j.molimm.2004.12.004; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Elloumi HZ, 2008, MOL IMMUNOL, V45, P204, DOI 10.1016/j.molimm.2007.04.023; Erdag G, 2002, ANN SURG, V235, P113, DOI 10.1097/00000658-200201000-00015; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gerdin Matthew J, 2007, Sci STKE, V2007, ppe15; Getzenberg RH, 1997, UROLOGY, V50, P999, DOI 10.1016/S0090-4295(97)00408-1; Gombart AF, 2007, J STEROID BIOCHEM, V103, P552, DOI 10.1016/j.jsbmb.2006.12.095; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Harfi I, 2004, J IMMUNOL, V173, P4154, DOI 10.4049/jimmunol.173.6.4154; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Hu YH, 2008, J BIOL CHEM, V283, P9328, DOI 10.1074/jbc.M705110200; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Iwahashi H, 2000, J IMMUNOL, V164, P5403, DOI 10.4049/jimmunol.164.10.5403; KACICH RL, 1988, MOL ENDOCRINOL, V2, P73, DOI 10.1210/mend-2-1-73; Kallay E, 2005, CARCINOGENESIS, V26, P1581, DOI 10.1093/carcin/bgi124; Karlsson J, 2008, J LEUKOCYTE BIOL, V84, P1279, DOI 10.1189/jlb.0607437; Kida Y, 2006, MOL IMMUNOL, V43, P1972, DOI 10.1016/j.molimm.2005.11.014; Kwei KA, 2004, NEOPLASIA, V6, P440, DOI 10.1593/neo.04127; LALLI E, 1994, J BIOL CHEM, V269, P17359; Larrick JW, 1996, FEBS LETT, V398, P74, DOI 10.1016/S0014-5793(96)01199-4; Lau YE, 2006, AM J RESP CELL MOL, V34, P399, DOI 10.1165/rcmb.2005-0170OC; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lorenowicz MJ, 2007, ARTERIOSCL THROM VAS, V27, P1014, DOI 10.1161/ATVBAHA.106.132282; Lycke N, 1997, RES IMMUNOL, V148, P504, DOI 10.1016/S0923-2494(98)80144-2; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; MASQUILIER D, 1992, J BIOL CHEM, V267, P22460; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; NAKAMURA T, 1990, J BIOL CHEM, V265, P22011; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Niyonsaba F, 2005, J DERMATOL SCI, V40, P157, DOI 10.1016/j.jdermsci.2005.07.009; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Portis T, 2003, J VIROL, V77, P105, DOI 10.1128/JVI.77.1.105-114.2003; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; Royaee AR, 2006, MOL IMMUNOL, V43, P1267, DOI 10.1016/j.molimm.2005.07.008; Royaee AR, 2006, MOL IMMUNOL, V43, P702, DOI 10.1016/j.molimm.2005.03.014; Rutberg SE, 1999, ONCOGENE, V18, P1569, DOI 10.1038/sj.onc.1202463; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; SASSONECORSI P, 1994, EMBO J, V13, P4717, DOI 10.1002/j.1460-2075.1994.tb06797.x; Schauber J, 2004, MOL IMMUNOL, V41, P847, DOI 10.1016/j.molimm.2004.05.005; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Schwab M, 2007, MOL IMMUNOL, V44, P2107, DOI 10.1016/j.molimm.2006.09.016; Schwartz JH, 2001, P NATL ACAD SCI USA, V98, P13482, DOI 10.1073/pnas.251533998; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tamai KT, 1997, RECENT PROG HORM RES, V52, P121; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476; Termen S, 2008, MOL IMMUNOL, V45, P3947, DOI 10.1016/j.molimm.2008.06.020; Trocme C, 2001, J NEUROSCI RES, V65, P91, DOI 10.1002/jnr.1132.abs; VERMA IM, 1990, CIBA F SYMP, V150, P128; Wang GS, 2008, ANTIMICROB AGENTS CH, V52, P3438, DOI 10.1128/AAC.00452-08; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weinberg A, 1998, CRIT REV ORAL BIOL M, V9, P399, DOI 10.1177/10454411980090040201; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	87	43	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21810	21827		10.1074/jbc.M109.001180	http://dx.doi.org/10.1074/jbc.M109.001180			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531482	hybrid, Green Published			2022-12-27	WOS:000268783700005
J	Tsvetkov, P; Reuven, N; Prives, C; Shaul, Y				Tsvetkov, Peter; Reuven, Nina; Prives, Carol; Shaul, Yosef			Susceptibility of p53 Unstructured N Terminus to 20 S Proteasomal Degradation Programs the Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; UBIQUITIN-INDEPENDENT DEGRADATION; TRANSACTIVATION DOMAIN; PROTEIN-DEGRADATION; NEGATIVE REGULATOR; RAPID DEGRADATION; MDM2 ONCOPROTEIN; MAMMALIAN-CELLS; MOLECULAR-BASIS; C-TERMINUS	The N-terminal transcription activation domain of p53 is intrinsically unstructured. We show in vitro and in vivo that this domain initiates p53 degradation by the 20 S proteasome in a ubiquitin-independent fashion. The decay of metabolically labeled p53 follows biphasic kinetics with an immediate fast phase that is ubiquitin-independent and a second slower phase that is ubiquitin-dependent. The 20 S proteasome executes the first phase by default, whereas the second phase requires the 26 S proteasome. p53 N-terminal binding proteins, such as Hdmx, can selectively block the first phase of degradation. Remarkably, gamma-irradiation inhibits both p53 decay phases, whereas UV selectively negates the second phase, giving rise to discrete levels of p53 accumulation. Our data of a single protein experiencing double mode degradation mechanisms each with unique kinetics provide the mechanistic basis for programmable protein homeostasis (proteostasis).	[Tsvetkov, Peter; Reuven, Nina; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Weizmann Institute of Science; Columbia University	Shaul, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yosef.shaul@weizmann.ac.il	Reuven, Nina/AAM-8711-2020; Tsvetkov, Peter/J-9878-2019; Tsvetkov, Peter/D-6458-2011	Reuven, Nina/0000-0003-1569-3818; Tsvetkov, Peter/0000-0002-7577-2342; 	Samuel Waxman Cancer Research Foundation; Israel Science Foundation; Federal German Ministry for Education and Research; Journal of Cell Science student travel fellowship	Samuel Waxman Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation); Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Journal of Cell Science student travel fellowship	This work was supported by grants from the Samuel Waxman Cancer Research Foundation, from the Israel Science Foundation, and from the Minerva Foundation with funding from the Federal German Ministry for Education and Research and Journal of Cell Science student travel fellowship.	Alvarez-Castelao B, 2005, FEBS LETT, V579, P4797, DOI 10.1016/j.febslet.2005.07.060; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cain C, 2000, J BIOL CHEM, V275, P39944, DOI 10.1074/jbc.M002509200; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elliott E, 2007, J BIOL CHEM, V282, P37276, DOI 10.1074/jbc.M706379200; Finch RA, 2002, CANCER RES, V62, P3221; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hegyi H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000017; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8; Jayaraman L, 1997, METHOD ENZYMOL, V283, P245; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Kroll M, 1997, ONCOGENE, V15, P1841, DOI 10.1038/sj.onc.1201560; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prives C, 1999, J PATHOL, V187, P112; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Stad R, 2000, J BIOL CHEM, V275, P28039; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Tsvetkov P, 2005, P NATL ACAD SCI USA, V102, P5535, DOI 10.1073/pnas.0501828102; Tsvetkov P, 2008, PROTEINS, V70, P1357, DOI 10.1002/prot.21614; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WHEATLEY DN, 1980, CELL BIOL INT REP, V4, P1081, DOI 10.1016/0309-1651(80)90045-4; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200	63	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26234	26242		10.1074/jbc.M109.040493	http://dx.doi.org/10.1074/jbc.M109.040493			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19617345	Green Published, hybrid			2022-12-27	WOS:000269969600003
J	Fullerton, MD; Hakimuddin, F; Bonen, A; Bakovic, M				Fullerton, Morgan D.; Hakimuddin, Fatima; Bonen, Arend; Bakovic, Marica			The Development of a Metabolic Disease Phenotype in CTP: Phosphoethanolamine Cytidylyltransferase-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; ISOLATED RAT HEPATOCYTES; LIVER CELL-CULTURE; PROTEIN-KINASE-C; SKELETAL-MUSCLE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PHOSPHATIDYLETHANOLAMINE SYNTHESIS; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SYNTHESIS; EMBRYONIC LETHALITY	Phosphatidylethanolamine (PE) is an important inner membrane phospholipid mostly synthesized de novo via the PE-Kennedy pathway and by the decarboxylation of phosphatidylserine. CTP:phosphoethanolamine cytidylyltransferase (Pcyt2) catalyzes the formation of CDP-ethanolamine, which is often the rate regulatory step in the PE-Kennedy pathway. In the current investigation, we show that the reduced CDP-ethanolamine formation in Pcyt2(+/-) mice limits the rate of PE synthesis and increases the availability of diacylglycerol. This results in the increased formation of triglycerides, which is facilitated by stimulated de novo fatty acid synthesis and increased uptake of pre-existing fatty acids. Pcyt2(+/-) mice progressively accumulate more diacylglycerol and triglycerides with age and have modified fatty acid composition, predominantly in PE and triglycerides. Pcyt2(+/-) additionally have an inherent blockage in fatty acid utilization as energy substrate and develop impaired tolerance to glucose and insulin at an older age. Accordingly, gene expression analyses demonstrated the up-regulation of the main lipogenic genes and down-regulation of mitochondrial fatty acid beta-oxidation genes. These data demonstrate for the first time that to preserve membrane PE phospholipids, Pcyt2 deficiency generates compensatory changes in triglyceride and energy substrate metabolism, resulting in a progressive development of liver steatosis, hypertriglyceridemia, obesity, and insulin resistance, the main features of the metabolic syndrome.	[Fullerton, Morgan D.; Hakimuddin, Fatima; Bonen, Arend; Bakovic, Marica] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Bakovic, M (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Anim Sci & Nutr Bldg,Rm 346, Guelph, ON N1G 2W1, Canada.	mbakovic@uoguelph.ca			Ontario Graduate Scholarship; Canadian Institutes of Health Research [MOP-68962, 410-2007-86448]	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an Ontario Graduate Scholarship ( to M. D. F.) and Operating Grants MOP-68962 and 410-2007-86448 from the Canadian Institutes of Health Research ( to M.B.)	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; ARTHUR G, 1991, BIOCHEM J, V273, P121, DOI 10.1042/bj2730121; Bakovic M, 2007, BIOCHEM CELL BIOL, V85, P283, DOI 10.1139/O07-006; Bladergroen BA, 1999, BIOCHEM J, V343, P107, DOI 10.1042/0264-6021:3430107; Bleijerveld OB, 2007, J BIOL CHEM, V282, P28362, DOI 10.1074/jbc.M703786200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; BORKENHAGEN LF, 1961, J BIOL CHEM, V236, P28; Caviglia JM, 2004, J LIPID RES, V45, P1500, DOI 10.1194/jlr.M400079-JLR200; Denomme J, 2005, J NUTR, V135, P206, DOI 10.1093/jn/135.2.206; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; HOUWELING M, 1992, BIOCHEM J, V283, P55, DOI 10.1042/bj2830055; IGAL A, 1994, INT J BIOCHROMATOGR, V1, P137; Igal RA, 2001, J LIPID RES, V42, P88; Igal RA, 1998, J LIPID RES, V39, P31; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; JAMIL H, 1992, J BIOL CHEM, V267, P1752; Jiang Joy, 2008, Metabolic Syndrome and Related Disorders, V6, P1, DOI 10.1089/met.2007.0026; Johnson CA, 2005, BBA-MOL CELL BIOL L, V1735, P230, DOI 10.1016/j.bbalip.2005.06.002; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P926; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; Linden D, 2006, FASEB J, V20, P434, DOI 10.1096/fj.05-4568com; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; McFarland MJ, 2004, PHARMACOL THERAPEUT, V104, P117, DOI 10.1016/j.pharmthera.2004.07.008; MENON AK, 1992, J BIOL CHEM, V267, P15277; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; MinSeok R, 1996, J BIOCHEM, V120, P1040; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Nakashima A, 1997, J BIOL CHEM, V272, P9567; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Poloumienko A, 2004, GENE, V325, P145, DOI 10.1016/j.gene.2003.10.005; Schmitz-Peiffer C, 2002, ANN NY ACAD SCI, V967, P146; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; STALS HK, 1994, FEBS LETT, V343, P99, DOI 10.1016/0014-5793(94)80615-2; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; SUNDLER R, 1974, FEBS LETT, V43, P303, DOI 10.1016/0014-5793(74)80667-8; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; TIJBURG LBM, 1989, BIOCHEM J, V257, P645, DOI 10.1042/bj2570645; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; VOELKER DR, 1986, J BIOL CHEM, V261, P1002; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200	55	67	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25704	25713		10.1074/jbc.M109.023846	http://dx.doi.org/10.1074/jbc.M109.023846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19625253	hybrid, Green Published			2022-12-27	WOS:000269738000028
J	Jones, RPO; Wang, MC; Jowitt, TA; Ridley, C; Mellody, KT; Howard, M; Wang, T; Bishop, PN; Lotery, AJ; Kielty, CM; Baldock, C; Trump, D				Jones, Richard P. O.; Wang, Ming-Chuan; Jowitt, Thomas A.; Ridley, Caroline; Mellody, Kieran T.; Howard, Marjorie; Wang, Tao; Bishop, Paul N.; Lotery, Andrew J.; Kielty, Cay M.; Baldock, Clair; Trump, Dorothy			Fibulin 5 Forms a Compact Dimer in Physiological Solutions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; CUTIS LAXA; IN-VIVO; HYDRODYNAMIC PROPERTIES; MACULAR DEGENERATION; PROTEIN INTERACTIONS; BINDING-PROTEIN; DOMAIN; DANCE/FIBULIN-5; FIBULIN-5/DANCE	Fibulin 5 is a 52-kDa calcium-binding epidermal growth factor (cbEGF)-rich extracellular matrix protein that is essential for the formation of elastic tissues. Missense mutations in fibulin 5 cause the elastin disorder cutis laxa and have been associated with age-related macular degeneration, a leading cause of blindness. We investigated the structure, hydrodynamics, and oligomerization of fibulin 5 using small angle x-ray scattering, EM, light scattering, circular dichroism, and sedimentation. Compact structures for the monomer were determined by small angle x-ray scattering and EM, and are supported by close agreement between the theoretical sedimentation of the structures and the experimental sedimentation of the monomer in solution. EM showed that monomers associate around a central cavity to form a dimer. Light scattering and equilibrium sedimentation demonstrated that the equilibrium between the monomer and the dimer is dependent upon NaCl and Ca2+ concentrations and that the dimer is dominant under physiological conditions. The dimerization of fragments containing just the cbEGF domains suggests that intermolecular interactions between cbEGFs cause dimerization of fibulin 5. It is possible that fibulin 5 functions as a dimer during elastinogenesis or that dimerization may provide a method for limiting interactions with binding partners such as tropoelastin.	[Jones, Richard P. O.; Wang, Tao; Bishop, Paul N.; Trump, Dorothy] Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England; [Wang, Ming-Chuan; Jowitt, Thomas A.; Ridley, Caroline; Mellody, Kieran T.; Howard, Marjorie; Bishop, Paul N.; Kielty, Cay M.; Baldock, Clair] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PL, Lancs, England; [Lotery, Andrew J.] Univ Southampton, Clin Neurosci Div, Southampton SO17 1BJ, Hants, England	University of Manchester; University of Manchester; University of Southampton	Trump, D (corresponding author), Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Oxford Rd, Manchester M13 9WL, Lancs, England.	dorothy.trump@manchester.ac.uk		Baldock, Clair/0000-0003-3497-1959; Jowitt, Thomas/0000-0002-4045-0933; Lotery, Andrew/0000-0001-5541-4305; Ridley, Caroline/0000-0002-5483-0320; Bishop, Paul/0000-0001-7937-7932; Mellody, Kieran/0000-0002-8164-9148	Wellcome Trust [123364, 072291]; VIP award; National Institute for Health Research, Manchester Biomedical Research Centre; Medical Research Council [G0200246] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10094] Funding Source: researchfish; MRC [G0200246] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); VIP award; National Institute for Health Research, Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grants 123364 (to D. T., A. J. L., P. N. B., C. M. K., R. P. O. J., and C. R.), 072291 (to C. B. and M. C. W.), and VIP award (to R. P. O. J., and D. T.), and the National Institute for Health Research, Manchester Biomedical Research Centre.	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; Claus S, 2008, J INVEST DERMATOL, V128, P1442, DOI 10.1038/sj.jid.5701211; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; de la Torre JG, 2001, EUR BIOPHYS J BIOPHY, V30, P457, DOI 10.1007/s002490100176; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; FRANK J, 1981, ULTRAMICROSCOPY, V6, P343, DOI 10.1016/S0304-3991(81)80236-7; Freeman LJ, 2005, BIOCHEM J, V388, P1, DOI 10.1042/BJ20050368; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Hayes D, 1995, PROGRAM SEDNTERP SED; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; HOPE RA, 1993, OXFORD HDB CLIN MED; JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214; Kapetanopoulos A, 2002, MOL GENET GENOMICS, V267, P440, DOI 10.1007/s00438-002-0673-6; Kielty CM, 2002, J CELL SCI, V115, P2817; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Lewis MS, 2000, METHOD ENZYMOL, V321, P136; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; Lotery AJ, 2006, HUM MUTAT, V27, P568, DOI 10.1002/humu.20344; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Markova D, 2003, AM J HUM GENET, V72, P998, DOI 10.1086/373940; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	47	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25938	25943		10.1074/jbc.M109.011627	http://dx.doi.org/10.1074/jbc.M109.011627			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617354	Green Published, hybrid			2022-12-27	WOS:000269738000050
J	Jang, SW; Liu, X; Fu, H; Rees, H; Yepes, M; Levey, A; Ye, KQ				Jang, Sung-Wuk; Liu, Xia; Fu, Haian; Rees, Howard; Yepes, Manuel; Levey, Allan; Ye, Keqiang			Interaction of Akt-phosphorylated SRPK2 with 14-3-3 Mediates Cell Cycle and Cell Death in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; DEPENDENT KINASE INHIBITORS; ALZHEIMERS-DISEASE BRAIN; PROTEIN-SPECIFIC KINASE; RNA SPLICING FACTORS; MAMMALIAN-CELLS; SYMPATHETIC NEURONS; SUBCELLULAR-LOCALIZATION; POSTMITOTIC NEURONS; PROMOTE SURVIVAL	Terminally differentiated neurons are unable to reenter the cell cycle. Aberrant cell cycle activation provokes neuronal cell death, whereas cell cycle inhibition elevates neuronal survival. However, the molecular mechanism regulating the cell cycle and cell death in mature neurons remains elusive. Here we show that SRPK2, a protein kinase specific for the serine/arginine (SR) family of splicing factors, triggers cell cycle progression in neurons and induces apoptosis through regulation of nuclear cyclin D1. Akt phosphorylates SRPK2 on Thr-492 and promotes its nuclear translocation leading to cyclin D1 up-regulation, cell cycle reentry, and neuronal apoptosis. In addition, SRPK2 phosphorylates SC35 and, thus, inactivates p53, resulting in cyclin D1 up-regulation. 14-3-3 binding to SRPK2, regulated by Akt phosphorylation, inhibits these events. We find that SRPK2 is phosphorylated in ischemia-attacked brain, correlating with the observed increase in cyclin D1 levels. Hence, phosphatidylinositol 3-kinase/Akt mediates the cell cycle and cell death machinery in the nervous system through phosphorylation of SRPK2.	[Jang, Sung-Wuk; Liu, Xia; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Fu, Haian] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Rees, Howard; Yepes, Manuel; Levey, Allan] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Rees, Howard; Yepes, Manuel; Levey, Allan] Emory Univ, Sch Med, Ctr Neurol Dis, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, 615 Michael St, Atlanta, GA 30322 USA.	kye@emory.edu	Yepes, Manuel/C-3576-2011; Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X	National Institutes of Health [RO1 NS060680]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS060680 (to K. Y.).	Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Appert-Collin A, 2006, LIFE SCI, V79, P484, DOI 10.1016/j.lfs.2006.01.032; Arendt T, 1996, NEUROREPORT, V7, P3047; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Busser J, 1998, J NEUROSCI, V18, P2801; CANMAN CE, 1994, COLD SPRING HARB SYM, V59, P277, DOI 10.1101/SQB.1994.059.01.032; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Farinelli SE, 1996, J NEUROSCI, V16, P1150, DOI 10.1523/jneurosci.16-03-01150.1996; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Hsu SY, 1997, MOL ENDOCRINOL, V11, P1858, DOI 10.1210/me.11.12.1858; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Jang SW, 2008, CANCER RES, V68, P4559, DOI 10.1158/0008-5472.CAN-08-0021; Jin YH, 2000, J BIOL CHEM, V275, P30256, DOI 10.1074/jbc.M001902200; Kamachi M, 2002, J EXP MED, V196, P1213, DOI 10.1084/jem.20021167; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kuroyanagi N, 1998, BIOCHEM BIOPH RES CO, V242, P357, DOI 10.1006/bbrc.1997.7913; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; McShea A, 1997, AM J PATHOL, V150, P1933; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Okamoto Y, 1998, BIOCHEM BIOPH RES CO, V249, P872, DOI 10.1006/bbrc.1998.9247; Park DS, 2000, NEUROBIOL AGING, V21, P771, DOI 10.1016/S0197-4580(00)00220-7; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SMITH TW, 1995, J NEUROPATH EXP NEUR, V54, P297, DOI 10.1097/00005072-199505000-00002; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Vincent I, 1997, J NEUROSCI, V17, P3588; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wen Y, 2005, FEBS LETT, V579, P4591, DOI 10.1016/j.febslet.2005.07.028; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang Y, 2007, BBA-MOL BASIS DIS, V1772, P457, DOI 10.1016/j.bbadis.2006.10.002	50	90	100	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24512	24525		10.1074/jbc.M109.026237	http://dx.doi.org/10.1074/jbc.M109.026237			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592491	hybrid, Green Published			2022-12-27	WOS:000269380200063
J	Kapoor, N; Bartoszewski, R; Qadri, YJ; Bebok, Z; Bubien, JK; Fuller, CM; Benos, DJ				Kapoor, Niren; Bartoszewski, Rafal; Qadri, Yawar J.; Bebok, Zsuzsanna; Bubien, James K.; Fuller, Catherine M.; Benos, Dale J.			Knockdown of ASIC1 and Epithelial Sodium Channel Subunits Inhibits Glioblastoma Whole Cell Current and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; SENSITIVE NA+ CHANNELS; MALIGNANT GLIOMA; FLUID ABSORPTION; ENAC; PHOSPHORYLATION; CONTRIBUTES; TERMINI; SITES; LUNG	High grade gliomas such as glioblastoma multiforme express multiple members of the epithelial sodium channel (ENaC)/Degenerin family, characteristically displaying a basally active amiloride-sensitive cation current not seen in normal human astrocytes or lower grade gliomas. Using quantitative real time PCR, we have shown higher expression of ASIC1, alpha ENaC, and gamma ENaC in D54-MG human glioblastoma multiforme cells compared with primary human astrocytes. We hypothesize that this glioma current is mediated by a hybrid channel composed of a mixture of ENaC and acid-sensing ion channel (ASIC) subunits. To test this hypothesis we made dominant negative cDNAs for ASIC1, alpha ENaC, gamma ENaC, and delta ENaC. D54-MG cells transfected with the dominant negative constructs for ASIC1, alpha ENaC, or gamma ENaC showed reduced protein expression and a significant reduction in the amiloride-sensitive whole cell current as compared with untransfected D54-MG cells. Knocking down alpha ENaC or gamma ENaC also abolished the high P-K(+)/P-Na(+) of D54-MG cells. Knocking down gamma ENaC in D54-MG cells reduced delta ENaC protein expression but had no effect on either the whole cell current or K+ permeability. Using coimmunoprecipitation we show interactions between ASIC1, alpha ENaC, and gamma ENaC, consistent with these subunits interacting with each other to form an ion channel in glioma cells. We also found a significant inhibition of D54-MG cell migration after ASIC1, alpha ENaC, or gamma ENaC knockdown, consistent with the hypothesis that ENaC/Degenerin subunits play an important role in glioma cell biology.	[Kapoor, Niren; Benos, Dale J.] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; [Bartoszewski, Rafal; Bebok, Zsuzsanna; Benos, Dale J.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Qadri, Yawar J.; Bubien, James K.; Fuller, Catherine M.; Benos, Dale J.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama, Dept Neurobiol, 1918 Univ Blvd, Birmingham, AL 35294 USA.	Benos@uab.edu	Fuller, Cathy/B-4046-2011; Bartoszewski, Rafal A/D-6311-2011	Bartoszewski, Rafal A/0000-0002-2864-6757; Qadri, Yawar/0000-0003-2138-4018	National Institutes of Health [CA101952, DK37206]; NATIONAL CANCER INSTITUTE [R01CA101952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037206, R01DK037206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported, in whole or in part, by National Institutes of Health Grant CA101952 and DK37206.	Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Bashari E, 2009, AM J PHYSIOL-CELL PH, V296, pC372, DOI 10.1152/ajpcell.00200.2008; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; Berdiev BK, 2007, J BIOL CHEM, V282, P36481, DOI 10.1074/jbc.M708089200; Berdiev BK, 2009, MOL BIOSYST, V5, P123, DOI 10.1039/b810471a; Berdiev BK, 2003, J BIOL CHEM, V278, P15023, DOI 10.1074/jbc.M300991200; Brockway LM, 2002, AM J PHYSIOL-CELL PH, V283, pC126, DOI 10.1152/ajpcell.00457.2001; Bubien JK, 2004, AM J PHYSIOL-CELL PH, V287, pC1282, DOI 10.1152/ajpcell.00077.2004; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Chigaev A, 2001, AM J PHYSIOL-RENAL, V280, pF1030, DOI 10.1152/ajprenal.2001.280.6.F1030; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Edinger RS, 2006, J BIOL CHEM, V281, P9110, DOI 10.1074/jbc.M509232200; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Ettaiche M, 2004, J NEUROSCI, V24, P1005, DOI 10.1523/JNEUROSCI.4698-03.2004; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Folkesson HG, 2008, AM J PHYSIOL-LUNG C, V294, pL399, DOI 10.1152/ajplung.00523.2007; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Grunder S, 2000, NEUROREPORT, V11, P1607; Guggino WB, 2000, P NATL ACAD SCI USA, V97, P9827, DOI 10.1073/pnas.97.18.9827; Hegde M, 2004, J PHARMACOL EXP THER, V310, P67, DOI 10.1124/jpet.103.065029; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Immke D C, 2001, ScientificWorldJournal, V1, P510; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V245, P589, DOI 10.1006/bbrc.1998.8483; ISMAILOV II, 1994, J BIOL CHEM, V269, P22193; Jahr H, 2005, BIOCHEM BIOPH RES CO, V337, P349, DOI 10.1016/j.bbrc.2005.09.054; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jernigan NL, 2006, AM J PHYSIOL-RENAL, V291, pF1184, DOI 10.1152/ajprenal.00177.2006; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kleyman TR, 2006, KIDNEY INT, V70, P1391, DOI 10.1038/sj.ki.5001860; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lin WH, 2002, J NEUROPHYSIOL, V88, P133, DOI 10.1152/jn.2002.88.1.133; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Matalon S, 2002, J APPL PHYSIOL, V93, P1852, DOI 10.1152/japplphysiol.01241.2001; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Naves LA, 2005, BRAZ J MED BIOL RES, V38, P1561, DOI 10.1590/S0100-879X2005001100001; O'Brodovich H, 2008, AM J PHYSIOL-LUNG C, V294, pL401, DOI 10.1152/ajplung.00431.2007; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Ross SB, 2007, AM J PHYSIOL-CELL PH, V293, pC1181, DOI 10.1152/ajpcell.00066.2007; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Schwab A, 2001, NEWS PHYSIOL SCI, V16, P29, DOI 10.1152/physiologyonline.2001.16.1.29; Shi HK, 2002, EUR J BIOCHEM, V269, P4551, DOI 10.1046/j.1432-1033.2002.03154.x; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Swift Pauline A, 2004, Am J Pharmacogenomics, V4, P161, DOI 10.2165/00129785-200404030-00003; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200	58	96	97	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24526	24541		10.1074/jbc.M109.037390	http://dx.doi.org/10.1074/jbc.M109.037390			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561078	Green Published, hybrid			2022-12-27	WOS:000269380200064
J	Liu, WC; Ouyang, XS; Yang, JJ; Liu, JG; Li, QS; Gu, YP; Fukata, M; Lin, T; He, JC; Abreu, M; Unkeless, JC; Mayer, L; Xiong, HB				Liu, Weicheng; Ouyang, Xinshou; Yang, Jianjun; Liu, Jianguo; Li, Qingshan; Gu, Yongpeng; Fukata, Masayuki; Lin, Tony; He, John Cijiang; Abreu, Maria; Unkeless, Jay C.; Mayer, Lloyd; Xiong, Huabao			AP-1 Activated by Toll-like Receptors Regulates Expression of IL-23 p19	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; AUTOIMMUNE INFLAMMATION; DENDRITIC CELLS; ADAPTIVE IMMUNITY; CROHNS-DISEASE; P40 EXPRESSION; C-REL; IL-12	Interleukin (IL)-23, a new member of the IL-12 family, plays a central role in the Th17 immune response and in autoimmune diseases. It is clear that activated macrophages and dendritic cells produce IL-23, but the molecular mechanisms whereby inflammatory signals stimulate IL-23 expression are not fully understood. We demonstrate that induction of IL-23 p19 gene expression by LPS depends on the TLR4 and MyD88 pathways. All three MAPK pathways (ERK, JNK, and p38) that are activated by lipopolysaccharide (LPS) stimulation were shown to exert a positive effect on p19 expression. We cloned a 1.3-kb putative p19 promoter and defined its transcription initiation sites by the 5'-rapid amplification of cDNA ends method. By analyzing IL-23 p19 promoter mutants, we have identified a promoter region (-413 to + 10) that contains several important elements, including NF-kappa B and AP-1. In addition to NF-kappa B, we have demonstrated that the proximal AP-1 site is important for p19 promoter activation. Mutation of the AP-1 site resulted in the loss of p19 promoter activation. Electrophoretic mobility shift assay (EMSA) analysis showed that c-Jun and c-Fos bind to the AP-1 site, which was confirmed by a chromatin immunoprecipitation assay. Furthermore, co-transfection of c-Jun and ATF2 synergistically induced p19 promoter activation, and c-Jun and ATF2 formed a protein complex, demonstrated by co-immunoprecipitation. Finally, LPS-stimulated peritoneal macrophages from IL-10-deficient mice expressed significantly higher IL-23 p19 than macrophages from wild type mice, and the addition of recombinant IL-10 strongly inhibited LPS-induced p19 expression. Thus, this study suggests that MyD88-dependent Toll-like receptor signaling induces IL-23 p19 gene expression through both MAPKs and NF-kappa B.	[Liu, Weicheng; Ouyang, Xinshou; Yang, Jianjun; Li, Qingshan; Gu, Yongpeng; Fukata, Masayuki; Lin, Tony; Abreu, Maria; Unkeless, Jay C.; Mayer, Lloyd; Xiong, Huabao] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [He, John Cijiang] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Liu, Jianguo] St Louis Univ, Sch Med, Dept Med, Div Immunobiol, St Louis, MO 63104 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Saint Louis University	Xiong, HB (corresponding author), Mt Sinai Sch Med, Inst Immunol, Box 1630,1 Gustave L Levy Pl, New York, NY 10029 USA.	Huabao.Xiong@mssm.edu	yang, jian/HIK-0188-2022; liu, weicheng/D-4173-2013		National Institutes of Health [P01 DK072201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DK072201 ( to H. X.).	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Belladonna ML, 2002, J IMMUNOL, V168, P5448, DOI 10.4049/jimmunol.168.11.5448; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Feng GJ, 1999, J IMMUNOL, V163, P6403; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Masumi A, 2002, FEBS LETT, V531, P348, DOI 10.1016/S0014-5793(02)03556-1; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muhlbauer M, 2008, J BIOL CHEM, V283, P14182, DOI 10.1074/jbc.M709029200; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Xiong HB, 2003, J BIOL CHEM, V278, P2271, DOI 10.1074/jbc.M209583200; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	42	104	112	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24006	24016		10.1074/jbc.M109.025528	http://dx.doi.org/10.1074/jbc.M109.025528			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592489	Green Published, hybrid			2022-12-27	WOS:000269380200015
J	Cheng, SB; Amici, SA; Ren, XQ; Mckay, SB; Treuil, MW; Lindstrom, JM; Rao, J; Anand, R				Cheng, Shi-Bin; Amici, Stephanie A.; Ren, Xiao-Qin; McKay, Susan B.; Treuil, Magdalen W.; Lindstrom, Jon M.; Rao, Jayaraman; Anand, Rene			Presynaptic Targeting of alpha 4 beta 2 Nicotinic Acetylcholine Receptors Is Regulated by Neurexin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT SUBSTANTIA-NIGRA; ALPHA-NEUREXINS; SYNAPSE FORMATION; INHIBITORY SYNAPSES; CELL-ADHESION; CA2+ CHANNELS; MICE LACKING; NEUROLIGIN; SUBUNIT	The mechanisms involved in the targeting of neuronal nicotinic acetylcholine receptors (AChRs), critical for their functional organization at neuronal synapses, are not well understood. We have identified a novel functional association between alpha 4 beta 2 AChRs and the presynaptic cell adhesion molecule, neurexin-1 beta. In non-neuronal tsA 201 cells, recombinant neurexin-1 beta and mature alpha 4 beta 2 AChRs form complexes. alpha 4 beta 2 AChRs and neurexin-1 beta also coimmunoprecipitate from rat brain lysates. When exogenous alpha 4 beta 2 AChRs and neurexin-1 beta are coexpressed in hippocampal neurons, they are robustly targeted to hemi-synapses formed between these neurons and cocultured tsA 201 cells expressing neuroligin-1, a postsynaptic binding partner of neurexin-1 beta. The extent of synaptic targeting is significantly reduced in similar experiments using a mutant neurexin-1 beta lacking the extracellular domain. Additionally, when alpha 4 beta 2 AChRs, alpha 7 AChRs, and neurexin-1 beta are coexpressed in the same neuron, only the alpha 4 beta 2 AChR colocalizes with neurexin-1 beta at presynaptic terminals. Collectively, these data suggest that neurexin-1 beta targets alpha 4 beta 2 AChRs to presynaptic terminals, which mature by trans-synaptic interactions between neurexins and neuroligins. Interestingly, human neurexin-1 gene dysfunctions have been implicated in nicotine dependence and in autism spectrum disorders. Our results provide novel insights as to possible mechanisms by which dysfunctional neurexins, through downstream effects on alpha 4 beta 2 AChRs, may contribute to the etiology of these neurological disorders.	[Amici, Stephanie A.; McKay, Susan B.; Anand, Rene] Ohio State Univ, Coll Med, Dept Pharmacol, Columbus, OH 43210 USA; [Treuil, Magdalen W.; Rao, Jayaraman] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, New Orleans, LA 70112 USA; [Cheng, Shi-Bin; Ren, Xiao-Qin] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; [Lindstrom, Jon M.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Pennsylvania	Anand, R (corresponding author), Ohio State Univ, Coll Med, Dept Pharmacol, 796 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	anand.20@osu.edu			National Institutes of Health [RO1 DA019675, RO1 NS011323]; Millennium Trust Health Excellence Fund HEF [(2002-2007)-SCP-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA026240, R01DA019675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millennium Trust Health Excellence Fund HEF; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DA019675 (to R. A.) and RO1 NS011323 (to J.M.L.). This work was also supported by the Millennium Trust Health Excellence Fund HEF (2002-2007)-SCP-01 (to R. A. and J.R.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; ANAND R, 1991, J BIOL CHEM, V266, P11192; Arroyo-Jimenez MD, 1999, J NEUROSCI, V19, P6475; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Charpantier E, 1998, NEUROREPORT, V9, P3097, DOI 10.1097/00001756-199809140-00033; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Conroy WG, 2007, DEV BIOL, V307, P79, DOI 10.1016/j.ydbio.2007.04.017; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; ELLENA JF, 1983, BIOCHEMISTRY-US, V22, P5523, DOI 10.1021/bi00293a012; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Goslin K., 1998, CULTURING NERVE CELL, P339; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; Hata Y, 1996, J NEUROSCI, V16, P2488; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Martin-Ruiz CM, 2004, MOL BRAIN RES, V123, P81, DOI 10.1016/j.molbrainres.2004.01.003; Marubio LM, 2003, EUR J NEUROSCI, V17, P1329, DOI 10.1046/j.1460-9568.2003.02564.x; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; Perry EK, 2001, AM J PSYCHIAT, V158, P1058, DOI 10.1176/appi.ajp.158.7.1058; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Ross BS, 2008, DEV NEUROBIOL, V68, P409, DOI 10.1002/dneu.20598; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WHITING PJ, 1988, J NEUROSCI, V8, P3395; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	54	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23251	23259		10.1074/jbc.M109.017384	http://dx.doi.org/10.1074/jbc.M109.017384			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19567877	Green Published, hybrid			2022-12-27	WOS:000269180000010
J	Schonauer, MS; Kastaniotis, AJ; Kursu, VAS; Hiltunen, JK; Dieckmann, CL				Schonauer, Melissa S.; Kastaniotis, Alexander J.; Kursu, V. A. Samuli; Hiltunen, J. Kalervo; Dieckmann, Carol L.			Lipoic Acid Synthesis and Attachment in Yeast Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOATE-PROTEIN LIGASE; ACYL CARRIER PROTEIN; PYRUVATE-DEHYDROGENASE COMPLEX; ALPHA-KETOGLUTARATE DEHYDROGENASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; BOVINE LIVER; GENE	Lipoic acid is a sulfur-containing cofactor required for the function of several multienzyme complexes involved in the oxidative decarboxylation of alpha-keto acids and glycine. Mechanistic details of lipoic acid metabolism are unclear in eukaryotes, despite two well defined pathways for synthesis and covalent attachment of lipoic acid in prokaryotes. We report here the involvement of four genes in the synthesis and attachment of lipoic acid in Saccharomyces cerevisiae. LIP2 and LIP5 are required for lipoylation of all three mitochondrial target proteins: Lat1 and Kgd2, the respective E2 subunits of pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, and Gcv3, the H protein of the glycine cleavage enzyme. LIP3, which encodes a lipoate-protein ligase homolog, is necessary for lipoylation of Lat1 and Kgd2, and the enzymatic activity of Lip3 is essential for this function. Finally, GCV3, encoding the H protein target of lipoylation, is itself absolutely required for lipoylation of Lat1 and Kgd2. We show that lipoylated Gcv3, and not glycine cleavage activity per se, is responsible for this function. Demonstration that a target of lipoylation is required for lipoylation is a novel result. Through analysis of the role of these genes in protein lipoylation, we conclude that only one pathway for de novo synthesis and attachment of lipoic acid exists in yeast. We propose a model for protein lipoylation in which Lip2, Lip3, Lip5, and Gcv3 function in a complex, which may be regulated by the availability of acetyl-CoA, and which in turn may regulate mitochondrial gene expression.	[Dieckmann, Carol L.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Schonauer, Melissa S.; Dieckmann, Carol L.] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Kastaniotis, Alexander J.; Kursu, V. A. Samuli; Hiltunen, J. Kalervo] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Kastaniotis, Alexander J.; Kursu, V. A. Samuli; Hiltunen, J. Kalervo] Univ Oulu, Bioctr, FI-90014 Oulu, Finland	University of Arizona; University of Arizona; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Dieckmann, CL (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, POB 210106, Tucson, AZ 85721 USA.	dieckman@u.arizona.edu		Hiltunen, Kalervo/0000-0002-3073-9602; Kastaniotis, Alexander/0000-0003-3624-9214	National Institutes of Health [GM34893, T3208659]; National Science Foundation Integrative Graduate Education and Research Traineeship Program in Evolutionary, Functional, and Computational Genomics, University of Arizona; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Integrative Graduate Education and Research Traineeship Program in Evolutionary, Functional, and Computational Genomics, University of Arizona; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34893 (to C. L. D.).; Supported by National Institutes of Health Grant T3208659 (Graduate Training in Biochemistry and Molecular Biology) and a fellowship from the National Science Foundation Integrative Graduate Education and Research Traineeship Program in Evolutionary, Functional, and Computational Genomics, University of Arizona.	Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Booker SJ, 2004, CHEM BIOL, V11, P10, DOI 10.1016/j.chembiol.2004.01.002; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; FUJIWARA K, 1994, J BIOL CHEM, V269, P16605; Fujiwara K, 1999, EUR J BIOCHEM, V260, P761, DOI 10.1046/j.1432-1327.1999.00204.x; Fujiwara K, 2005, J BIOL CHEM, V280, P33645, DOI 10.1074/jbc.M505010200; Fujiwara K, 2001, J BIOL CHEM, V276, P28819, DOI 10.1074/jbc.M101748200; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; HAYDEN MA, 1993, BIOCHEMISTRY-US, V32, P3778, DOI 10.1021/bi00065a033; HERBERT A. A., 1970, Methods in Enzymology, V18A, P269, DOI 10.1016/0076-6879(71)18314-0; HERBERT AA, 1975, ARCH MICROBIOL, V106, P259, DOI 10.1007/BF00446532; HERBERT AA, 1968, J GEN MICROBIOL, V53, P363, DOI 10.1099/00221287-53-3-363; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Jordan SW, 2003, J BACTERIOL, V185, P1582, DOI 10.1128/JB.185.5.1582-1589.2003; Kang SG, 2007, GENE, V393, P53, DOI 10.1016/j.gene.2007.01.011; Kim DJ, 2005, J BIOL CHEM, V280, P38081, DOI 10.1074/jbc.M507284200; KRESZE GB, 1981, EUR J BIOCHEM, V119, P573, DOI 10.1111/j.1432-1033.1981.tb05646.x; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; Marvin ME, 2001, FEMS MICROBIOL LETT, V199, P131, DOI 10.1016/S0378-1097(01)00170-7; MCGRAW P, 1983, J BIOL CHEM, V258, P9459; McManus E, 2006, J MOL BIOL, V356, P625, DOI 10.1016/j.jmb.2005.11.057; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; Morikawa T, 2001, FEBS LETT, V498, P16, DOI 10.1016/S0014-5793(01)02469-3; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Nagarajan L, 1997, J BIOL CHEM, V272, P4444, DOI 10.1074/jbc.272.7.4444; Nesbitt NM, 2005, PROTEIN EXPRES PURIF, V39, P269, DOI 10.1016/j.pep.2004.10.021; Onder O, 2006, MOL CELL PROTEOMICS, V5, P1426, DOI 10.1074/mcp.M600099-MCP200; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Piper MD, 2000, J BIOL CHEM, V275, P30987, DOI 10.1074/jbc.M004248200; Reche PA, 2000, PROTEIN SCI, V9, P1922, DOI 10.1110/ps.9.10.1922; REED LJ, 1990, J BIOL CHEM, V265, P8971; REMES AM, 1992, PEDIATRICS, V89, P730; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; SULO P, 1993, J BIOL CHEM, V268, P17634; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Zhao X, 2005, BIOCHEMISTRY-US, V44, P16737, DOI 10.1021/bi051865y; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	51	92	95	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23234	23242		10.1074/jbc.M109.015594	http://dx.doi.org/10.1074/jbc.M109.015594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570983	hybrid, Green Published			2022-12-27	WOS:000269180000008
J	Carafoli, F; Clout, NJ; Hohenester, E				Carafoli, Federico; Clout, Naomi J.; Hohenester, Erhard			Crystal Structure of the LG1-3 Region of the Laminin alpha 2 Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITES; DYSTROGLYCAN-BINDING; INTEGRIN-BINDING; CELL-ADHESION; GLOBULAR DOMAIN; MOLECULAR DISSECTION; TERTIARY STRUCTURE; LIGAND-BINDING; LG MODULES; LONG-ARM	Laminins are large heterotrimeric glycoproteins with many essential functions in basement membrane assembly and function. Cell adhesion to laminins is mediated by a tandem of five laminin G-like (LG) domains at the C terminus of the alpha chain. Integrin binding requires an intact LG1-3 region, as well as contributions from the coiled coil formed by the alpha, beta, and gamma chains. We have determined the crystal structure at 2.8-angstrom resolution of the LG1-3 region of the laminin alpha 2 chain (alpha 2LG1-3). The three LG domains adopt typical beta-sandwich folds, with canonical calcium binding sites in LG1 and LG2. LG2 and LG3 interact through a substantial interface, but LG1 is completely dissociated from the LG2-3 pair. We suggest that the missing gamma chain tail may be required to stabilize the interaction between LG1 and LG2-3 in the biologically active conformation. A global analysis of N-linked glycosylation sites shows that the beta-sandwich faces of LG1 are free of carbohydrate modifications in all five laminin alpha chains, suggesting that these surfaces may harbor the integrin binding site. The alpha 2LG1-3 structure provides the first atomic view of the integrin binding region of laminins.	[Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Hohenester, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Dept Life Sci, Prince Consort Rd, London SW7 2AZ, England.	e.hohenester@imperial.ac.uk			Wellcome Trust Senior Research Fellowship; BBSRC [BB/D524840/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524840/1] Funding Source: researchfish	Wellcome Trust Senior Research Fellowship(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Senior Research Fellowship (to E.H.) (Refs. 054334 and 083942).	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BRUCH M, 1989, EUR J BIOCHEM, V185, P271, DOI 10.1111/j.1432-1033.1989.tb15112.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; DEUTZMANN R, 1990, EUR J BIOCHEM, V191, P513, DOI 10.1111/j.1432-1033.1990.tb19151.x; Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2006, MATRIX BIOL, V25, P112, DOI 10.1016/j.matbio.2005.10.003; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kikkawa Y, 2006, DEV BIOL, V296, P265, DOI 10.1016/j.ydbio.2006.04.463; Kim JM, 2005, EXP CELL RES, V304, P317, DOI 10.1016/j.yexcr.2004.11.009; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; Kunneken K, 2004, J BIOL CHEM, V279, P5184, DOI 10.1074/jbc.M310424200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Navdaev Alexei, 2008, Exp Cell Res, V314, P489, DOI 10.1016/j.yexcr.2007.10.027; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Shang ML, 2001, J BIOL CHEM, V276, P33045, DOI 10.1074/jbc.M100798200; Shen KC, 2008, STRUCTURE, V16, P422, DOI 10.1016/j.str.2008.01.005; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; Stetefeld J, 2004, STRUCTURE, V12, P503, DOI 10.1016/j.str.2004.02.001; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Talts JF, 1999, FEBS LETT, V458, P319, DOI 10.1016/S0014-5793(99)01180-1; Talts JF, 1998, FEBS LETT, V426, P71, DOI 10.1016/S0014-5793(98)00312-3; Taniguchi Y, 2009, J BIOL CHEM, V284, P7820, DOI 10.1074/jbc.M809332200; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yu H, 2003, BIOCHEM J, V371, P289, DOI 10.1042/BJ20021500	54	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22786	22792		10.1074/jbc.M109.026658	http://dx.doi.org/10.1074/jbc.M109.026658			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553699	Green Published, hybrid			2022-12-27	WOS:000268963100032
J	Taulet, N; Comunale, F; Favard, C; Charrasse, S; Bodin, S; Gauthier-Rouviere, C				Taulet, Nicolas; Comunale, Franck; Favard, Cyril; Charrasse, Sophie; Bodin, Stephane; Gauthier-Rouviere, Cecile			N-cadherin/p120 Catenin Association at Cell-Cell Contacts Occurs in Cholesterol-rich Membrane Domains and Is Required for RhoA Activation and Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; P120 CATENIN; BETA-CATENIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ACTIN CYTOSKELETON; C2C12 MYOBLASTS; ALPHA-CATENIN; ADHESION; P120-CATENIN; JUNCTIONS	p120 catenin is a major regulator of cadherin stability at cell-cell contacts and a modulator of Rho GTPase activities. In C2C12 myoblasts, N-cadherin is stabilized at cell contacts through its association with cholesterol-rich membrane domains or lipid rafts (LR) and acts as an adhesion-activated receptor that activates RhoA, an event required for myogenesis induction. Here, we report that association of p120 catenin with N-cadherin at cell contacts occurs specifically in LR. We demonstrate that interaction of p120 catenin with N-cadherin is required for N-cadherin association with LR and for its stabilization at cell contacts. LR disruption inhibits myogenesis induction and N-cadherin-dependent RhoA activation as does the perturbation of the N-cadherin-p120 catenin complex after p120 catenin knockdown. Finally, we observe an N-cadherin-dependent accumulation of RhoA at phosphatidylinositol 4,5-bisphosphate- enriched cell contacts which is lost after LR disruption. Thus, a functional N-cadherin-catenin complex occurs in cholesterol-rich membrane microdomains which allows the recruitment of RhoA and the regulation of its activity during myogenesis induction.	[Taulet, Nicolas; Comunale, Franck; Charrasse, Sophie; Bodin, Stephane; Gauthier-Rouviere, Cecile] Univ Montpellier 2, CNRS, UMR 5237, Ctr Rech Biochim Macromol,Inst Federatif Rech 122, F-34293 Montpellier, France; [Taulet, Nicolas; Comunale, Franck; Charrasse, Sophie; Bodin, Stephane; Gauthier-Rouviere, Cecile] Univ Montpellier 1, CNRS, UMR 5237, Ctr Rech Biochim Macromol,Inst Federatif Rech 122, F-34293 Montpellier, France; [Favard, Cyril] Domaine Univ St Jerome, Inst Fresnel, F-13397 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite	Gauthier-Rouviere, C (corresponding author), Univ Montpellier 2, CNRS, UMR 5237, Ctr Rech Biochim Macromol,Inst Federatif Rech 122, 1919 Route Mende, F-34293 Montpellier, France.	cecile.gauthier@crbm.cnrs.fr	Favard, Cyril/P-6392-2016	Favard, Cyril/0000-0002-8304-2980; Comunale, Franck/0000-0001-8838-2151	Ligue Nationale contre le Cancer (Equipe labellisee); Association Francaise contre les Myopathies; Agence Nationale de la Recherche; Association Francaise pour la Recherche contre le Cancer	Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise pour la Recherche contre le Cancer	This work was supported in part by the Ligue Nationale contre le Cancer (Equipe labellisee), Association Francaise contre les Myopathies, Agence Nationale de la Recherche, and Association Francaise pour la Recherche contre le Cancer.	Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Bodin S, 2001, BIOCHEMISTRY-US, V40, P15290, DOI 10.1021/bi0109313; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Carnac G, 1998, MOL BIOL CELL, V9, P1891, DOI 10.1091/mbc.9.7.1891; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Comunale F, 2007, BIOL CELL, V99, P503, DOI 10.1042/BC20070011; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; El Sayegh TY, 2007, MOL BIOL CELL, V18, P3026, DOI 10.1091/mbc.E06-12-1159; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kanno M, 2008, EXP CELL RES, V314, P1683, DOI 10.1016/j.yexcr.2008.01.031; Knudsen KA, 1990, CURR OPIN CELL BIOL, V2, P902, DOI 10.1016/0955-0674(90)90090-2; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; Liu H, 2007, CELL STRUCT FUNCT, V32, P127, DOI 10.1247/csf.07023; Lovett FA, 2006, J CELL SCI, V119, P4828, DOI 10.1242/jcs.03278; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; STADDON JM, 1995, J CELL BIOL, V130, P369, DOI 10.1083/jcb.130.2.369; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	40	38	38	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23137	23145		10.1074/jbc.M109.017665	http://dx.doi.org/10.1074/jbc.M109.017665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546217	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000268963100065
J	Ahmed, K; Tunaru, S; Langhans, CD; Hanson, J; Michalski, CW; Kolker, S; Jones, PM; Okun, JG; Offermanns, S				Ahmed, Kashan; Tunaru, Sorin; Langhans, Claus-Dieter; Hanson, Julien; Michalski, Christoph W.; Koelker, Stefan; Jones, Patricia M.; Okun, Juergen G.; Offermanns, Stefan			Deorphanization of GPR109B as a Receptor for the beta-Oxidation Intermediate 3-OH-octanoic Acid and Its Role in the Regulation of Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHLY SELECTIVE AGONISTS; PROTEIN-COUPLED RECEPTOR; 3-HYDROXY FATTY-ACIDS; NICOTINIC-ACID; MOLECULAR-IDENTIFICATION; PUMA-G; HM74; ADIPOCYTES; PATHWAY; OBESITY	The orphan G-protein-coupled receptor GPR109B is the result of a recent gene duplication of the nicotinic acid and ketone body receptor GPR109A being found in humans but not in rodents. Like GPR109A, GPR109B is predominantly expressed in adipocytes and is supposed to mediate antilipolytic effects. Here we show that GPR109B serves as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid, which has antilipolytic activity on human but not on murine adipocytes. GPR109B is coupled toG(i)-type G-proteins and is activated by 2- and 3-OH-octanoic acid with EC50 values of about 4 and 8 mu M, respectively. Interestingly, 3-OH-octanoic acid plasma concentrations reach micromolar concentrations under conditions of increased beta-oxidation rates, like in diabetic ketoacidosis or under a ketogenic diet. These data suggest that the ligand receptor pair 3-OH-octanoic acid/GPR109B mediates in humans a negative feedback regulation of adipocyte lipolysis to counteract prolipolytic influences under conditions of physiological or pathological increases in beta-oxidation rates.	[Ahmed, Kashan; Tunaru, Sorin; Hanson, Julien; Offermanns, Stefan] Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; [Langhans, Claus-Dieter; Koelker, Stefan; Okun, Juergen G.] Univ Childrens Hosp Heidelberg, Div Inherited Metab Dis, Dept Gen Pediat, D-69120 Heidelberg, Germany; [Hanson, Julien] Univ Liege, Dept Med Chem, Ctr Interfac Rech Med, B-4000 Liege, Belgium; [Michalski, Christoph W.] Tech Univ Munich, Dept Surg, D-81675 Munich, Germany; [Jones, Patricia M.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Dept Pathol, Dallas, TX 75235 USA; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Liege; Technical University of Munich; University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society	Offermanns, S (corresponding author), Heidelberg Univ, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	stefan.offermanns@mpi-bn.mpg.de	Tunaru, Sorin/G-8516-2011; Michalski, Christoph/U-9167-2019; Hanson, Julien/A-8242-2008; Offermanns, Stefan/L-3313-2017	Tunaru, Sorin/0000-0002-6005-1737; Hanson, Julien/0000-0001-7063-7590; Offermanns, Stefan/0000-0001-8676-6805	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	This work was supported in part by a grant from the German Research Foundation.	Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Costa CG, 1998, CLIN CHEM, V44, P463; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; HAGENFELDT L, 1990, J PEDIATR-US, V116, P387, DOI 10.1016/S0022-3476(05)82826-4; HOSHI M, 1973, J NEUROCHEM, V21, P709, DOI 10.1111/j.1471-4159.1973.tb06017.x; Irukayama-Tomobe Y, 2009, P NATL ACAD SCI USA, V106, P3930, DOI 10.1073/pnas.0811844106; Jones JM, 2000, J BIOL CHEM, V275, P12590, DOI 10.1074/jbc.275.17.12590; Jones PM, 2000, J INHERIT METAB DIS, V23, P745, DOI 10.1023/A:1005643201489; Jones PM, 2002, CLIN CHEM, V48, P176; KISHIMOTO Y, 1963, J LIPID RES, V4, P139; Knowles HJ, 2006, BIOCHEM PHARMACOL, V71, P646, DOI 10.1016/j.bcp.2005.11.019; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Nordli DR, 1992, MEDICAL TREATMENT EP, P455; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; RODBELL M, 1964, J BIOL CHEM, V239, P375; Semple G, 2006, J MED CHEM, V49, P1227, DOI 10.1021/jm051099t; SENIOR B, 1968, NATURE, V219, P83, DOI 10.1038/219083a0; Skinner PJ, 2007, BIOORG MED CHEM LETT, V17, P6619, DOI 10.1016/j.bmcl.2007.09.058; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Westman Eric C, 2003, Curr Atheroscler Rep, V5, P476, DOI 10.1007/s11883-003-0038-6; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zellner C, 2005, HUM MUTAT, V25, P18, DOI 10.1002/humu.20121	31	63	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21928	21933		10.1074/jbc.M109.019455	http://dx.doi.org/10.1074/jbc.M109.019455			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19561068	Green Published, hybrid			2022-12-27	WOS:000268783700017
J	Guilliere, F; Peixeiro, N; Kessler, A; Raynal, B; Desnoues, N; Keller, J; Delepierre, M; Prangishvili, D; Sezonov, G; Guijarro, JI				Guilliere, Florence; Peixeiro, Nuno; Kessler, Alexandra; Raynal, Bertrand; Desnoues, Nicole; Keller, Jenny; Delepierre, Muriel; Prangishvili, David; Sezonov, Guennadi; Guijarro, J. Inaki			Structure, Function, and Targets of the Transcriptional Regulator SvtR from the Hyperthermophilic Archaeal Virus SIRV1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; ROD-SHAPED VIRUS; CRYSTAL-STRUCTURE; BACKBONE DYNAMICS; OPERATOR COMPLEX; NMR EXPERIMENTS; PLASMID PRN1; PROTEIN; GENOMES; SPECTROSCOPY	We have characterized the structure and the function of the 6.6-kDa protein SvtR (formerly called gp08) from the rod-shaped virus SIRV1, which infects the hyperthermophilic archaeon Sulfolobus islandicus that thrives at 85 degrees C in hot acidic springs. The protein forms a dimer in solution. The NMR solution structure of the protein consists of a ribbon-helix-helix (RHH) fold between residues 13 and 56 and a disordered N-terminal region (residues 1-12). The structure is very similar to that of bacterial RHH proteins despite the low sequence similarity. We demonstrated that the protein binds DNA and uses its beta-sheet face for the interaction like bacterial RHH proteins. To detect all the binding sites on the 32.3-kb SIRV1 linear genome, we designed and performed a global genome-wide search of targets based on a simplified electrophoretic mobility shift assay. Four targets were recognized by the protein. The strongest binding was observed with the promoter of the gene coding for a virion structural protein. When assayed in a host reconstituted in vitro transcription system, the protein SvtR (Sulfolobus virus transcription regulator) repressed transcription from the latter promoter, as well as from the promoter of its own gene.	[Guilliere, Florence; Delepierre, Muriel; Guijarro, J. Inaki] Inst Pasteur, Unite RMN Biomol, CNRS, URA 2185, F-75015 Paris, France; [Peixeiro, Nuno; Kessler, Alexandra; Desnoues, Nicole; Prangishvili, David; Sezonov, Guennadi] Inst Pasteur, Unite Biol Mol Gene Chez Extremophiles, F-75015 Paris, France; [Keller, Jenny] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, CNRS, IFR115,UMR 8619, F-91405 Orsay, France; [Sezonov, Guennadi] Univ Paris 06, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Sezonov, G (corresponding author), Inst Pasteur, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	guennadi.sezonov@pasteur.fr; inaki.guijarro@pasteur.fr	Guijarro, J. Inaki/E-6438-2019; Sezonov, Guennadi/ABB-5734-2020	Guijarro, J. Inaki/0000-0002-3826-5245; Sezonov, Guennadi/0000-0002-2016-6126; raynal, Bertrand/0000-0001-5634-0408; GUILLIERE, Florence/0000-0002-4025-2988	Institut Pasteur; CNRS [CNRS URA 2185]; Region Ile de France	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Ile de France(Region Ile-de-France)	The work was supported in part by the Institut Pasteur and the CNRS (CNRS URA 2185). The 600-MHz spectrometer was funded by the Region Ile de France and the Institut Pasteur.	Abella M, 2007, NUCLEIC ACIDS RES, V35, P6788, DOI 10.1093/nar/gkm782; Arnold HP, 2000, VIROLOGY, V267, P252, DOI 10.1006/viro.1999.0105; Bell SD, 2005, TRENDS MICROBIOL, V13, P262, DOI 10.1016/j.tim.2005.03.015; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Berkner S, 2007, J BACTERIOL, V189, P1711, DOI 10.1128/JB.01586-06; Blum H, 2001, VIROLOGY, V281, P6, DOI 10.1006/viro.2000.0776; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Garvie CW, 2000, STRUCTURE, V8, P905, DOI 10.1016/S0969-2126(00)00182-9; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Gomis-Ruth FX, 1998, EMBO J, V17, P7404, DOI 10.1093/emboj/17.24.7404; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; GRZESIEK S, 1995, J AM CHEM SOC, V117, P5312, DOI 10.1021/ja00124a014; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jerschow A, 1997, J MAGN RESON, V125, P372, DOI 10.1006/jmre.1997.1123; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kessler A, 2004, J BACTERIOL, V186, P7745, DOI 10.1128/JB.186.22.7745-7753.2004; Kessler A, 2006, NUCLEIC ACIDS RES, V34, P4837, DOI 10.1093/nar/gkl502; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Larson JD, 2006, PROTEIN SCI, V15, P2630, DOI 10.1110/ps.062425706; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawrence CM, 2009, J BIOL CHEM, V284, P12599, DOI 10.1074/jbc.R800078200; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lipps G, 2004, BIOCHEM SOC T, V32, P240, DOI 10.1042/BST0320240; Lipps G, 2001, NUCLEIC ACIDS RES, V29, P904, DOI 10.1093/nar/29.4.904; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MARION D, 1988, J MAGN RESON, V80, P528, DOI 10.1016/0022-2364(88)90250-8; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Pelta MD, 1998, MAGN RESON CHEM, V36, P706, DOI 10.1002/(SICI)1097-458X(199810)36:10<706::AID-OMR363>3.0.CO;2-W; Peng X, 2004, MOL MICROBIOL, V54, P366, DOI 10.1111/j.1365-2958.2004.04287.x; Peng X, 2001, VIROLOGY, V291, P226, DOI 10.1006/viro.2001.1190; Peterson SN, 2007, J MOL BIOL, V369, P1307, DOI 10.1016/j.jmb.2007.04.023; Popescu A, 2005, PROTEINS, V59, P303, DOI 10.1002/prot.20406; Prangishvili D, 2004, BIOCHEM SOC T, V32, P204, DOI 10.1042/BST0320204; Prangishvili D, 2001, TRENDS MICROBIOL, V9, P39, DOI 10.1016/S0966-842X(00)01910-7; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Prangishvill D, 2006, VIRUS RES, V117, P52, DOI 10.1016/j.virusres.2006.01.007; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Schildbach JF, 1999, P NATL ACAD SCI USA, V96, P811, DOI 10.1073/pnas.96.3.811; Schreiter ER, 2003, NAT STRUCT BIOL, V10, P794, DOI 10.1038/nsb985; Schreiter ER, 2007, NAT REV MICROBIOL, V5, P710, DOI 10.1038/nrmicro1717; Schreiter ER, 2006, P NATL ACAD SCI USA, V103, P13676, DOI 10.1073/pnas.0606247103; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Steinmetz NF, 2008, ADV FUNCT MATER, V18, P3478, DOI 10.1002/adfm.200800711; TORSVIK T, 1974, NATURE, V248, P680, DOI 10.1038/248680a0; Vestergaard G, 2005, VIROLOGY, V336, P83, DOI 10.1016/j.virol.2005.02.025; Vestergaard G, 2008, J BACTERIOL, V190, P6837, DOI 10.1128/JB.00795-08; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Zeeb M, 2004, J MOL BIOL, V336, P227, DOI 10.1016/j.jmb.2003.12.003; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	72	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22222	22237		10.1074/jbc.M109.029850	http://dx.doi.org/10.1074/jbc.M109.029850			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19535331	Green Published, hybrid			2022-12-27	WOS:000268783700047
J	Villar, VM; Jones, JE; Armando, I; Palmes-Saloma, C; Yu, PY; Pascua, AM; Keever, L; Arnaldo, FB; Wang, Z; Luo, YJ; Felder, RA; Jose, PA				Villar, Van Anthony M.; Jones, John E.; Armando, Ines; Palmes-Saloma, Cynthia; Yu, Peiying; Pascua, Annabelle M.; Keever, Lindsay; Arnaldo, Francis B.; Wang, Zheng; Luo, Yingjin; Felder, Robin A.; Jose, Pedro A.			G Protein-coupled Receptor Kinase 4 (GRK4) Regulates the Phosphorylation and Function of the Dopamine D-3 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; SPONTANEOUSLY HYPERTENSIVE-RATS; BLOOD-PRESSURE; FLUORESCENCE COMPLEMENTATION; ADENYLATE-CYCLASE; LIPID RAFTS; DIFFERENTIAL EXPRESSION; SIGNALING COMPONENTS; TYPE-1 RECEPTOR; SPLICE VARIANTS	During conditions of moderate sodium excess, the dopaminergic system regulates blood pressure and water and electrolyte balance by engendering natriuresis. Dopamine exerts its effects on dopamine receptors, including the dopamine D-3 receptor. G protein-coupled receptor kinase 4 (GRK4), whose gene locus (4p16.3) is linked to essential hypertension, desensitizes the D-1 receptor, another dopamine receptor. This study evaluated the role of GRK4 on D-3 receptor function in human proximal tubule cells. D-3 receptor co-segregated in lipid rafts and co-immunoprecipitated and co-localized in human proximal tubule cells and in proximal and distal tubules and glomeruli of kidneys of Wistar Kyoto rats. Bimolecular fluorescence complementation and confocal microscopy revealed that agonist activation of the receptor initiated the interaction between D-3 receptor and GRK4 at the cell membrane and promoted it intracellularly, presumably en route to endosomal trafficking. Of the four GRK4 splice variants, GRK4-gamma and GRK4-alpha mediated a 3- and 2-fold increase in the phosphorylation of agonist-activated D-3 receptor, respectively. Inhibition of GRK activity with heparin or knockdown of GRK4 expression via RNA interference completely abolished p44/42 phosphorylation and mitogenesis induced by D-3 receptor stimulation. These data demonstrate that GRK4, specifically the GRK4-gamma and GRK4-alpha isoforms, phosphorylates the D-3 receptor and is crucial for its signaling in human proximal tubule cells.	[Villar, Van Anthony M.] Childrens Natl Med Ctr, Ctr Mol Physiol Res, Childrens Res Inst, Washington, DC 20010 USA; Univ Philippines, Natl Inst Mol Biol & Biotechnol, Quezon City 1101, Philippines; [Felder, Robin A.] Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA 22908 USA	Children's National Health System; University of the Philippines System; University of the Philippines Diliman; University of Virginia	Villar, VM (corresponding author), Childrens Natl Med Ctr, Ctr Mol Physiol Res, Childrens Res Inst, Suite 5340, Washington, DC 20010 USA.	vvillar@cnmc.org			National Institutes of Health [HL023081, HL074940, DK039308, HL092196, HL068686]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074940, R01HL023081, R01HL092196, P01HL068686, R37HL023081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL023081, HL074940, DK039308, HL092196, and HL068686.	Allayee H, 2001, HYPERTENSION, V38, P773, DOI 10.1161/hy1001.092617; ALOUSI AA, 1991, FASEB J, V5, P2300, DOI 10.1096/fasebj.5.9.1650314; Asico LD, 1998, J CLIN INVEST, V102, P493, DOI 10.1172/JCI3685; Bek MJ, 2001, KIDNEY INT, V60, P890, DOI 10.1046/j.1523-1755.2001.060003890.x; BENOVIC JL, 1989, J BIOL CHEM, V264, P6707; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; Binda AV, 2002, MOL PHARMACOL, V62, P507, DOI 10.1124/mol.62.3.507; Brenninkmeijer CBAP, 1999, J ENDOCRINOL, V162, P401, DOI 10.1677/joe.0.1620401; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; CASARI G, 1995, HYPERTENSION, V25, P320, DOI 10.1161/01.HYP.25.3.320; CHIO CL, 1994, MOL PHARMACOL, V45, P51; Cussac D, 1999, MOL PHARMACOL, V56, P1025, DOI 10.1124/mol.56.5.1025; FELDER CC, 1993, AM J PHYSIOL, V264, pF1032, DOI 10.1152/ajprenal.1993.264.6.F1032; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Gildea JJ, 2008, HYPERTENSION, V51, P360, DOI 10.1161/HYPERTENSIONAHA.107.100099; Griffon N, 1997, J NEUROCHEM, V68, P1; Han JY, 2007, J CELL PHYSIOL, V211, P486, DOI 10.1002/jcp.20956; Han WX, 2008, HYPERTENSION, V51, P481, DOI 10.1161/HYPERTENSIONAHA.107.103275; Hisatomi O, 1998, FEBS LETT, V424, P159, DOI 10.1016/S0014-5793(98)00162-8; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hussain T, 2003, EXP BIOL MED, V228, P134, DOI 10.1177/153537020322800202; Hussain T, 1997, AM J PHYSIOL-RENAL, V272, pF339, DOI 10.1152/ajprenal.1997.272.3.F339; Ilani T, 2002, CELL MOL NEUROBIOL, V22, P47, DOI 10.1023/A:1015341712166; Insel PA, 2005, BIOCHEM SOC T, V33, P1131, DOI 10.1042/BST0331131; Jose PA, 2003, CURR OPIN NEPHROL HY, V12, P189, DOI 10.1097/00041552-200303000-00010; KANEKO S, 1992, AM J PHYSIOL, V263, pR631, DOI 10.1152/ajpregu.1992.263.3.R631; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kim KM, 2005, J BIOL CHEM, V280, P12774, DOI 10.1074/jbc.M408901200; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Krueger KM, 1997, J BIOL CHEM, V272, P5; LECONIAT M, 1991, HUM GENET, V87, P618, DOI 10.1007/BF00209024; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Narkar VA, 2001, J AM SOC NEPHROL, V12, P1844, DOI 10.1681/ASN.V1291844; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Newman-Tancredi A, 1999, MOL PHARMACOL, V55, P564; Nurnberger A, 2004, J HISTOCHEM CYTOCHEM, V52, P1647, DOI 10.1369/jhc.4A6359.2004; O'Connell DP, 1998, HYPERTENSION, V32, P886, DOI 10.1161/01.HYP.32.5.886; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; Obadiah J, 1999, CELL MOL NEUROBIOL, V19, P653, DOI 10.1023/A:1006988603199; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Pettersson-Fernholm KJ, 2004, NEPHROL DIAL TRANSPL, V19, P1432, DOI 10.1093/ndt/gfh174; PILON C, 1994, EUR J PHARM-MOLEC PH, V268, P129, DOI 10.1016/0922-4106(94)90182-1; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Rice T, 2002, HYPERTENSION, V39, P1037, DOI 10.1161/01.HYP.0000018911.46067.6E; Robinson SW, 1997, MOL PHARMACOL, V52, P508, DOI 10.1124/mol.52.3.508; Sallese M, 1997, J BIOL CHEM, V272, P10188; Sanada H, 2006, HYPERTENSION, V47, P1131, DOI 10.1161/01.HYP.0000222004.74872.17; Shin Y, 2003, J HYPERTENS, V21, P199, DOI 10.1097/00004872-200301000-00030; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Soma Masayoshi, 2002, Med Sci Monit, V8, pCR1; SOMERS RL, 1984, SCIENCE, V226, P182, DOI 10.1126/science.6091271; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Virlon B, 1998, ENDOCRINOLOGY, V139, P2784, DOI 10.1210/en.139.6.2784; Watts VJ, 1997, MOL PHARMACOL, V52, P181, DOI 10.1124/mol.52.2.181; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Yu P, 2006, KIDNEY INT, V70, P1072, DOI 10.1038/sj.ki.5001708; Yu PY, 2004, KIDNEY INT, V66, P2167, DOI 10.1111/j.1523-1755.2004.66007.x; Zeng CY, 2008, HYPERTENSION, V51, P1449, DOI 10.1161/HYPERTENSIONAHA.107.096487; Zeng CY, 2006, CIRC RES, V99, P494, DOI 10.1161/01.RES.0000240500.96746.ec; Zeng CY, 2003, HYPERTENSION, V42, P787, DOI 10.1161/01.HYP.0000085334.34963.4E	72	51	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21425	21434		10.1074/jbc.M109.003665	http://dx.doi.org/10.1074/jbc.M109.003665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520868	Green Published, hybrid			2022-12-27	WOS:000268564400037
J	Wouters, MM; Roeder, JL; Tharayil, VS; Stanich, JE; Strege, PR; Lei, S; Bardsley, MR; Ordog, T; Gibbons, SJ; Farrugia, G				Wouters, Mira M.; Roeder, Jaime L.; Tharayil, Vivek S.; Stanich, Jennifer E.; Strege, Peter R.; Lei, Sha; Bardsley, Michael R.; Ordog, Tamas; Gibbons, Simon J.; Farrugia, Gianrico			Protein Kinase C gamma Mediates Regulation of Proliferation by the Serotonin 5-Hydroxytryptamine Receptor 2B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTROINTESTINAL STROMAL TUMORS; SMOOTH-MUSCLE-CELLS; HYPERTROPHIC PYLORIC-STENOSIS; RAT STOMACH FUNDUS; INTERSTITIAL-CELLS; DIABETIC GASTROPARESIS; MURINE INTESTINE; 5-HT2B RECEPTOR; ENTERIC NEURONS; DENTATE GYRUS	Activation of the 5-hydroxytryptamine receptor 2B (5-HT2B), a G(q/11) protein-coupled receptor, results in proliferation of various cell types. The 5-HT2B receptor is also expressed on the pacemaker cells of the gastrointestinal tract, the interstitial cells of Cajal (ICC), where activation triggers ICC proliferation. The goal of this study was to characterize the mitogenic signal transduction cascade activated by the 5-HT2B receptor. All of the experiments were performed on mouse small intestine primary cell cultures. Activation of the 5-HT2B receptor by its agonist BW723C86 induced proliferation of ICC. Inhibition of phosphatidylinositol 3-kinase by LY294002 decreased base-line proliferation but had no effect on 5-HT2B receptor-mediated proliferation. Proliferation of ICC through the 5-HT2B receptor was inhibited by the phospholipase C inhibitor U73122 and by the inositol 1,4,5-trisphosphate receptor inhibitor Xestospongin C. Calphostin C, the alpha, beta, gamma , and mu protein kinase C (PKC) inhibitor Go6976, and the alpha, beta, gamma, delta, and zeta PKC inhibitor Go6983 inhibited 5-HT2B receptor-mediated proliferation, indicating the involvement of PKC alpha, beta, or gamma. Of all the PKC isoforms blocked by Go6976, PKC gamma and mu mRNAs were found by single- cell PCR to be expressed in ICC. 5-HT2B receptor activation in primary cell cultures obtained from PKC gamma(-/-) mice did not result in a proliferative response, further indicating the requirement for PKC gamma in the proliferative response to 5-HT2B receptor activation. The data demonstrate that the 5-HT2B receptor-induced proliferative response of ICC is through phospholipase C, [Ca2+](t), and PKC gamma, implicating this PKC isoform in the regulation of cellular proliferation.	[Farrugia, Gianrico] Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Div Gastroenterol & Hepatol, Enter Neurosci Program, Rochester, MN 55905 USA; Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Farrugia, G (corresponding author), Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Div Gastroenterol & Hepatol, Enter Neurosci Program, 200 1st St SW, Rochester, MN 55905 USA.	farrugia.gianrico@mayo.edu	Wouters, Mira/K-1371-2013	Wouters, Mira/0000-0002-3438-1919; Harrington, Jon/0000-0003-1293-5201; Lei, Sha/0000-0002-6985-9193; Strege, Peter/0000-0003-4571-2207	National Institutes of Health [DK52766, DK57061]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052766, R01DK057061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52766 and DK57061.	Abdouh M, 2004, BRAIN BEHAV IMMUN, V18, P24, DOI 10.1016/S0889-1591(03)00088-6; Bagowski CP, 1999, EMBO J, V18, P5567, DOI 10.1093/emboj/18.20.5567; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Bertrand PP, 2006, J PHYSIOL-LONDON, V577, P689, DOI 10.1113/jphysiol.2006.117804; Bhasin N, 2004, ANAT EMBRYOL, V208, P135, DOI 10.1007/s00429-004-0380-7; Blay P, 2004, CLIN CANCER RES, V10, P4089, DOI 10.1158/1078-0432.CCR-04-0630; CATTANEO MG, 1995, EUR J PHARM-MOLEC PH, V291, P209, DOI 10.1016/0014-2999(95)90106-X; Cerda SR, 2006, ONCOGENE, V25, P3123, DOI 10.1038/sj.onc.1209360; Chen H, 2002, GUT, V51, P793, DOI 10.1136/gut.51.6.793; Choi KM, 2007, NEUROGASTROENT MOTIL, V19, P585, DOI 10.1111/j.1365-2982.2007.00936.x; Choi KM, 2008, GASTROENTEROLOGY, V135, P2055, DOI 10.1053/j.gastro.2008.09.003; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; COX DA, 1995, J PHARMACOL EXP THER, V272, P143; De Lucchini S, 2005, MOL CELL NEUROSCI, V29, P299, DOI 10.1016/j.mcn.2005.03.008; De Lucchini S, 2003, MOL BRAIN RES, V115, P196, DOI 10.1016/S0169-328X(03)00173-6; ERSPAMER V, 1954, PHARMACOL REV, V6, P425; Feldstein AE, 2003, J PEDIATR GASTR NUTR, V36, P492, DOI 10.1097/00005176-200304000-00016; Finniss Susan, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P1004; Forster J, 2005, J GASTROINTEST SURG, V9, P102, DOI 10.1016/j.gassur.2004.10.001; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Furness JB, 2006, HISTOCHEM CELL BIOL, V126, P537, DOI 10.1007/s00418-006-0190-5; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; He CL, 2000, GASTROENTEROLOGY, V118, P14, DOI 10.1016/S0016-5085(00)70409-4; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Huang GJ, 2005, NEUROSCIENCE, V135, P803, DOI 10.1016/j.neuroscience.2005.05.056; Hurd C, 2002, ONCOGENE, V21, P2154, DOI 10.1038/sj.onc.1205290; Iino S, 2004, J PHYSIOL-LONDON, V556, P521, DOI 10.1113/jphysiol.2003.058792; JULIUS D, 1990, P NATL ACAD SCI USA, V87, P928, DOI 10.1073/pnas.87.3.928; Keenan C, 1997, FEBS LETT, V415, P101, DOI 10.1016/S0014-5793(97)01104-6; Kenny SE, 1998, J PEDIATR SURG, V33, P94, DOI 10.1016/S0022-3468(98)90370-0; KURSAR JD, 1992, MOL PHARMACOL, V42, P549; LANGER JC, 1995, J PEDIATR SURG, V30, P1535, DOI 10.1016/0022-3468(95)90151-5; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Narita M, 2004, EUR J NEUROSCI, V19, P479, DOI 10.1111/j.0953-816X.2003.03119.x; Nebigil CG, 2003, CIRCULATION, V107, P3223, DOI 10.1161/01.CIR.0000074224.57016.01; Nebigil CG, 2003, FASEB J, V17, P1373, DOI 10.1096/fj.02-1122fje; Ou WB, 2008, ONCOGENE, V27, P5624, DOI 10.1038/onc.2008.177; Ou Y, 2002, NEUROGASTROENT MOTIL, V14, P477, DOI 10.1046/j.1365-2982.2002.00348.x; Poole DP, 2004, HISTOCHEM CELL BIOL, V121, P21, DOI 10.1007/s00418-003-0602-8; Radley JJ, 2002, BRAIN RES, V955, P264, DOI 10.1016/S0006-8993(02)03477-7; Rich A, 2003, AM J PHYSIOL-GASTR L, V284, pG313, DOI 10.1152/ajpgi.00093.2002; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Sempere T, 2004, NEUROIMMUNOMODULAT, V11, P307, DOI 10.1159/000079411; Shatos MA, 2009, INVEST OPHTH VIS SCI, V50, P614, DOI 10.1167/iovs.08-2467; Strege PR, 2003, AM J PHYSIOL-CELL PH, V284, pC60, DOI 10.1152/ajpcell.00532.2001; Szurszewski JH, 2004, NEUROGASTROENT MOTIL, V16, P81, DOI 10.1111/j.1743-3150.2004.00480.x; Thuneberg L, 2001, ANAT REC, V262, P110; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P279, DOI 10.1053/gast.1996.v111.pm8690192; Verbeek DS, 2008, J CELL SCI, V121, P2339, DOI 10.1242/jcs.027698; Vigorito E, 2006, CELL SIGNAL, V18, P1455, DOI 10.1016/j.cellsig.2005.11.008; Wagner LM, 2001, MOL VIS, V7, P57; Wang XY, 2003, AM J PHYSIOL-GASTR L, V285, pG593, DOI 10.1152/ajpgi.00421.2002; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; Ward SM, 1998, GASTROENTEROLOGY, V115, P314, DOI 10.1016/S0016-5085(98)70198-2; Wouters MM, 2007, NEUROGASTROENT MOTIL, V19, P5, DOI 10.1111/j.1365-2982.2007.00963.x; Wouters MM, 2007, GASTROENTEROLOGY, V133, P897, DOI 10.1053/j.gastro.2007.06.017; Wu TT, 2008, J CELL BIOCHEM, V103, P9, DOI 10.1002/jcb.21378; Yamamoto M, 2000, AM J PHYSIOL-CELL PH, V279, pC587, DOI 10.1152/ajpcell.2000.279.3.C587; Zarate N, 2003, GUT, V52, P966, DOI 10.1136/gut.52.7.966	62	22	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21177	21184		10.1074/jbc.M109.015859	http://dx.doi.org/10.1074/jbc.M109.015859			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531484	Green Published, hybrid			2022-12-27	WOS:000268564400010
J	Savino, C; Montemiglio, LC; Sciara, G; Miele, AE; Kendrew, SG; Jemth, P; Gianni, S; Vallone, B				Savino, Carmelinda; Montemiglio, Linda C.; Sciara, Giuliano; Miele, Adriana E.; Kendrew, Steven G.; Jemth, Per; Gianni, Stefano; Vallone, Beatrice			Investigating the Structural Plasticity of a Cytochrome P450 THREE-DIMENSIONAL STRUCTURES OF P450 EryK AND BINDING TO ITS PHYSIOLOGICAL SUBSTRATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SUBSTRATE-BINDING; DRUG-INTERACTIONS; C-12 HYDROXYLASE; LIGAND-BINDING; NA+ BINDING; MECHANISM; KINETICS; DOMAIN; ERYK	Cytochrome P450s are heme-containing proteins that catalyze the oxidative metabolism of many physiological endogenous compounds. Because of their unique oxygen chemistry and their key role in drug and xenobiotic metabolism, particular attention has been devoted in elucidating their mechanism of substrate recognition. In this work, we analyzed the three-dimensional structures of a monomeric cytochrome P450 from Saccharopolyspora erythraea, commonly called EryK, and the binding kinetics to its physiological ligand, erythromycin D. Three different structures of EryK were obtained: two ligand-free forms and one in complex with its substrate. Analysis of the substrate-bound structure revealed the key structural determinants involved in substrate recognition and selectivity. Interestingly, the ligand-free structures of EryK suggested that the protein may explore an open and a closed conformation in the absence of substrate. In an effort to validate this hypothesis and to investigate the energetics between such alternative conformations, we performed stopped-flow absorbance experiments. Data demonstrated that EryK binds erythromycin D via a mechanism involving at least two steps. Contrary to previously characterized cytochrome P450s, analysis of double jump mixing experiments confirmed that this complex scenario arises from a pre-existing equilibrium between the open and closed subpopulations of EryK, rather than from an induced-fit type mechanism.	[Gianni, Stefano] CNR, Inst Mol Biol & Pathol, Dept Biochem Sci, I-00185 Rome, Italy; [Savino, Carmelinda; Montemiglio, Linda C.; Sciara, Giuliano; Miele, Adriana E.; Gianni, Stefano; Vallone, Beatrice] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Kendrew, Steven G.] Biot Technol Ltd, Saffron Walden CB10 1XL, Essex, England; [Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Uppsala University	Gianni, S (corresponding author), CNR, Inst Mol Biol & Pathol, Dept Biochem Sci, Ple Aldo Moro 5, I-00185 Rome, Italy.	Stefano.gianni@uniroma1.it; beatrice.vallone@uniroma1.it	Miele, Adriana E./F-4083-2011; gianni, stefano/C-8536-2009; Vallone, Beatrice/F-4174-2012; sciara, giuliano/AAL-4478-2020	Miele, Adriana E./0000-0002-4637-2606; VALLONE, Beatrice/0000-0003-0058-9049; SAVINO, CARMELINDA/0000-0002-1602-4838; Gianni, Stefano/0000-0003-1653-1925	Italian MIUR FIRB2003 [RBLA03B3KC_004]; CNR [RSTL2007-856]	Italian MIUR FIRB2003(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); CNR(Consiglio Nazionale delle Ricerche (CNR))	The work was supported by Italian MIUR FIRB2003 Grants RBLA03B3KC_004 and CNR RSTL2007-856.	Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell SG, 2006, BIOCHEM BIOPH RES CO, V342, P191, DOI 10.1016/j.bbrc.2006.01.133; Bell SG, 2008, J MOL BIOL, V383, P561, DOI 10.1016/j.jmb.2008.08.033; Chen Y, 2008, APPL ENVIRON MICROB, V74, P1820, DOI 10.1128/AEM.02770-07; Cheng G, 2005, NUCLEIC ACIDS RES, V33, P5861, DOI 10.1093/nar/gki894; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Davydov DR, 2005, BIOCHEMISTRY-US, V44, P13902, DOI 10.1021/bi0509346; Davydov DR, 2004, BIOCHEMISTRY-US, V43, P6475, DOI 10.1021/bi036260l; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Desai RP, 2004, BIOTECHNOL PROGR, V20, P1660, DOI 10.1021/bp0497435; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gianni S, 2007, BIOPHYS CHEM, V131, P111, DOI 10.1016/j.bpc.2007.09.009; GOTOH O, 1992, J BIOL CHEM, V267, P83; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Heringa J, 1999, PROTEINS, V37, P44, DOI 10.1002/(SICI)1097-0134(19991001)37:1<44::AID-PROT5>3.0.CO;2-F; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lamb DC, 2007, CURR OPIN BIOTECH, V18, P504, DOI 10.1016/j.copbio.2007.09.010; LAMBALOT RH, 1995, BIOCHEMISTRY-US, V34, P1858, DOI 10.1021/bi00006a006; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; LI HY, 1995, ACTA CRYSTALLOGR D, V51, P21, DOI 10.1107/S0907444994009194; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacey MS, 1998, J ANTIBIOT, V51, P1029, DOI 10.7164/antibiotics.51.1029; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 2005, CYTOCHROME P450S STR, P377; Pylypenko O, 2004, ANNU REV BIOCHEM, V73, P991, DOI 10.1146/annurev.biochem.73.011303.073711; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Ruan X, 1997, J BACTERIOL, V179, P6416, DOI 10.1128/jb.179.20.6416-6425.1997; Savino C, 2008, PROTEIN PEPTIDE LETT, V15, P1138, DOI 10.2174/092986608786071201; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; STASSI D, 1993, J BACTERIOL, V175, P182, DOI 10.1128/JB.175.1.182-189.1993; Vagin A, 1998, ACTA CRYSTALLOGR D, V54, P400, DOI 10.1107/S0907444997014923; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; WRECKREICHHART D, 2000, GENOME BIOL, V3003, P1; Yun CH, 1996, J BIOL CHEM, V271, P31312, DOI 10.1074/jbc.271.49.31312	48	62	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29170	29179		10.1074/jbc.M109.003590	http://dx.doi.org/10.1074/jbc.M109.003590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19625248	hybrid, Green Published			2022-12-27	WOS:000270678900072
J	El Kaderi, B; Medler, S; Raghunayakula, S; Ansari, A				El Kaderi, Belal; Medler, Scott; Raghunayakula, Sarita; Ansari, Athar			Gene Looping Is Conferred by Activator-dependent Interaction of Transcription Initiation and Termination Machineries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; YEAST; REINITIATION; TFIIB; MECHANISM; PROMOTER; RELEASE; REGIONS; COMPLEX	Gene looping juxtaposes the promoter and terminator regions of RNA polymerase II-transcribed genes in yeast and mammalian cells. Here we report an activator-dependent interaction of transcription initiation and termination factors during gene looping in budding yeast. Chromatin analysis revealed that MET16, INO1, and GAL1p-BUD3 are in a stable looped configuration during activated transcription. Looping was nearly abolished in the absence of transcription activators Met28, Ino2, and Gal4 of MET16, INO1, and GAL1p-BUD3 genes, respectively. The activator-independent increase in transcription was not accompanied by loop formation, thereby suggesting an essential role for activators in gene looping. The activators did not facilitate loop formation directly because they did not exhibit an interaction with the 3' end of the genes. Instead, activators physically interacted with the general transcription factor TFIIB when the genes were activated and in a looped configuration. TFIIB cross-linked to both the promoter and the terminator regions during the transcriptionally activated state of a gene. The presence of TFIIB on the terminator was dependent on the Rna15 component of CF1 3' end processing complex. Coimmunoprecipitation revealed a physical interaction of Rna15 with TFIIB. We propose that the activators facilitate gene looping through their interaction with TFIIB during transcriptional activation of genes.	[El Kaderi, Belal; Medler, Scott; Raghunayakula, Sarita; Ansari, Athar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Ansari, A (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	bb2749@wayne.edu	Ansari, Athar/AEK-0223-2022	Ansari, Athar/0000-0003-2806-421X	Wayne State University	Wayne State University	This work was supported by start-up funds from Wayne State University.	AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; FEDOR MJ, 1989, MOL CELL BIOL, V9, P1721, DOI 10.1128/MCB.9.4.1721; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Jansa P, 2001, NUCLEIC ACIDS RES, V29, P423, DOI 10.1093/nar/29.2.423; JIANG Y, 1993, MOL CELL BIOL, V13, P4572, DOI 10.1128/MCB.13.8.4572; Keaveney M, 1998, MOL CELL, V1, P917, DOI 10.1016/S1097-2765(00)80091-X; KULKENS T, 1992, EMBO J, V11, P4665, DOI 10.1002/j.1460-2075.1992.tb05568.x; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; MARAIA RJ, 1994, MOL CELL BIOL, V14, P2147, DOI 10.1128/MCB.14.3.2147; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; MCNEIL JB, 1985, MOL CELL BIOL, V5, P3545, DOI 10.1128/MCB.5.12.3545; O'Reilly D, 2007, GENOMICS, V90, P407, DOI 10.1016/j.ygeno.2007.04.010; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; WACH A, 1994, YEAST, V10, P1808; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Yochum GS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-102; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603	31	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25015	25025		10.1074/jbc.M109.007948	http://dx.doi.org/10.1074/jbc.M109.007948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19602510	Green Published, hybrid			2022-12-27	WOS:000269734000037
J	Huang, XJ; Beullens, M; Zhang, JH; Zhou, Y; Nicolaescu, E; Lesage, B; Hu, Q; Wu, JH; Bollen, M; Shi, YY				Huang, Xiaojuan; Beullens, Monique; Zhang, Jiahai; Zhou, Yi; Nicolaescu, Emilia; Lesage, Bart; Hu, Qi; Wu, Jihui; Bollen, Mathieu; Shi, Yunyu			Structure and Function of the Two Tandem WW Domains of the Pre-mRNA Splicing Factor FBP21 (Formin-binding Protein 21)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND RECOGNITION; PROTEOMIC ANALYSIS; BACKBONE DYNAMICS; DIPOLAR COUPLINGS; MAMMALIAN-CELLS; CHEMICAL-SHIFT; GROUP-II/III; SH2 DOMAINS; NMR; COMPLEX	Human FBP21 (formin-binding protein 21) contains a matrin-type zinc finger and two tandem WW domains. It is a component of the spliceosomes and interacts with several established splicing factors. Here we demonstrate for the first time that FBP21 is an activator of pre-mRNA splicing in vivo and that its splicing activation function and interaction with the splicing factor SIPP1 (splicing factor that interacts with PQBP1 and PP1) are both mediated by the two tandem WW domains of group III. We determined the solution structure of the tandem WW domains of FBP21 and found that the WW domains recognize peptide ligands containing either group II (PPLP) or group III (PPR) motifs. The binding interfaces involve both the XP and XP2 grooves of the two WW domains. Significantly, the tandem WW domains of FBP21 are connected by a highly flexible region, enabling their simultaneous interaction with two proline-rich motifs of SIPP1. The strong interaction between SIPP1 and FBP21 can be explained by the conjugation of two low affinity interactions with the tandem WW domains. Our study provides a structural basis for understanding the molecular mechanism underlying the functional implication of FBP21 and the biological specificity of tandem WW domains.	[Beullens, Monique; Nicolaescu, Emilia; Lesage, Bart; Bollen, Mathieu] Katholieke Univ Leuven, Lab Biosignaling & Therapeut, Dept Mol Cell Biol, Fac Med, B-3000 Louvain, Belgium; [Huang, Xiaojuan; Zhang, Jiahai; Zhou, Yi; Hu, Qi; Wu, Jihui; Shi, Yunyu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci, Microscale & Sch Life Sci, Hefei 230026, Anhui, Peoples R China	KU Leuven; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Bollen, M (corresponding author), Katholieke Univ Leuven, Lab Biosignaling & Therapeut, Dept Mol Cell Biol, Fac Med, B-3000 Louvain, Belgium.	Mathieu.Bollen@med.kuleuven.be; yyshi@ustc.edu.cn	Zhou, Yi/P-1039-2015; hu, qi/K-1462-2014; Shi, Yunyu/B-3240-2009	Zhou, Yi/0000-0002-1650-4591; Shi, Yunyu/0000-0002-1348-4759	Chinese National Natural Science Foundation [30670426]; Chinese National Fundamental Research Project [2006CB806507, 2006CB910201]; Chinese National High Tech R D Program [2006AA02A315]; Fund for Scientific Research-Flanders [G.0670.09N]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese National Fundamental Research Project; Chinese National High Tech R D Program(National High Technology Research and Development Program of China); Fund for Scientific Research-Flanders(FWO)	This work was supported by Chinese National Natural Science Foundation Grant 30670426, Chinese National Fundamental Research Project Grants 2006CB806507 and 2006CB910201, the Chinese National High Tech R & D Program Grant 2006AA02A315, and the Fund for Scientific Research-Flanders Grant G.0670.09N.	Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Babini E, 2006, STRUCTURE, V14, P1029, DOI 10.1016/j.str.2006.04.004; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Braddock DT, 2001, J AM CHEM SOC, V123, P8634, DOI 10.1021/ja016234f; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cramer P, 2001, FEBS LETT, V498, P179, DOI 10.1016/S0014-5793(01)02485-1; Dancheck B, 2008, BIOCHEMISTRY-US, V47, P12346, DOI 10.1021/bi801308y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Favaro PMB, 2003, BIOCHEM BIOPH RES CO, V311, P365, DOI 10.1016/j.bbrc.2003.10.012; Fedoroff OY, 2004, J BIOL CHEM, V279, P34991, DOI 10.1074/jbc.M404987200; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Itani OA, 2003, AM J PHYSIOL-RENAL, V285, pF916, DOI 10.1152/ajprenal.00203.2003; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kato Y, 2006, PROTEINS, V63, P227, DOI 10.1002/prot.20880; Kato Y, 2006, J BIOL CHEM, V281, P40321, DOI 10.1074/jbc.M609321200; Katoh M, 2004, INT J MOL MED, V13, P473; Kim S, 2001, BIOCHEMISTRY-US, V40, P6776, DOI 10.1021/bi002700m; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Llorian M, 2004, BIOCHEM J, V378, P229, DOI 10.1042/BJ20030950; Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Meiyappan M, 2007, J MOL BIOL, V372, P970, DOI 10.1016/j.jmb.2007.06.064; Nasim MT, 2006, NAT PROTOC, V1, P1022, DOI 10.1038/nprot.2006.148; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; OPELLA SJ, 1994, METHOD ENZYMOL, V239, P536; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Pires JR, 2001, J MOL BIOL, V314, P1147, DOI 10.1006/jmbi.2000.5199; Pires JR, 2005, J MOL BIOL, V348, P399, DOI 10.1016/j.jmb.2005.02.056; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Ramirez-Espain X, 2007, J MOL BIOL, V373, P1255, DOI 10.1016/j.jmb.2007.08.052; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Wiesner S, 2002, J MOL BIOL, V324, P807, DOI 10.1016/S0022-2836(02)01145-2; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	58	36	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25375	25387		10.1074/jbc.M109.024828	http://dx.doi.org/10.1074/jbc.M109.024828			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592703	hybrid, Green Published			2022-12-27	WOS:000269734000070
J	Carr, HS; Cai, CL; Keinanen, K; Frost, JA				Carr, Heather S.; Cai, Chunlin; Keinanen, Kari; Frost, Jeffrey A.			Interaction of the RhoA Exchange Factor Net1 with Discs Large Homolog 1 Protects It from Proteasome-mediated Degradation and Potentiates Net1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; PDZ DOMAIN; MESENCHYMAL TRANSITIONS; SIGNALING PATHWAYS; FAMILY GTPASES; TGF-BETA; COMPLEX; BINDING; PROTEINS; CADHERIN	Net1 is a nuclear Rho guanine nucleotide exchange factor that is specific for the RhoA subfamily of small G proteins. Truncated forms of Net1 are transforming in NIH3T3 cells, and this activity requires cytoplasmic localization of Net1 as well as the presence of a COOH-terminal PDZ binding site. We have previously shown that Net1 interacts with PDZ domain-containing proteins within the Discs Large (Dlg) family and relocalizes them to the nucleus. In the present work, we demonstrate that Net1 binds directly to the first two PDZ domains of Dlg1 and that both PDZ domains are required for maximal interaction in cells. Furthermore, we show that Net1 is an unstable protein in MCF7 breast epithelial cells and that interaction with Dlg1 significantly enhances Net1 stability. Stabilization by Dlg1 significantly increases the ability of Net1 to stimulate RhoA activation in cells. The stability of endogenous Net1 is strongly enhanced by cell-cell contact, and this correlates with a dramatic increase in the interaction between Net1 and Dlg1. Importantly, disruption of E-cadherin-mediated cell contacts, either by depletion of external calcium or by treatment with transforming growth factor beta, leads to a rapid loss of the interaction between Net1 and Dlg1 and a subsequent increase in the ubiquitylation of Net1. These results indicate that Net1 requires interaction with PDZ domain proteins, such as Dlg1, to protect it from proteasome-mediated degradation and to maximally stimulate RhoA and that this interaction is regulated by cell-cell contact.	[Carr, Heather S.; Frost, Jeffrey A.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Cai, Chunlin; Keinanen, Kari] Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland	University of Texas System; University of Texas Health Science Center Houston; University of Helsinki	Frost, JA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	Jeffrey.a.frost@uth.tmc.edu	Keinanen, Kari/E-9122-2010	Frost, Jeffrey/0000-0001-9722-1536	National Institutes of Health [5R01CA116356-02]; Susan G. Komen Breast Cancer Foundation Award [BCTR123806]; Academy of Finland [110900]; NATIONAL CANCER INSTITUTE [R01CA116356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation Award(Susan G. Komen Breast Cancer Foundation); Academy of Finland(Academy of Finland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01CA116356-02 (to J. A. F.). This work was also supported by Susan G. Komen Breast Cancer Foundation Award BCTR123806 (to J. A. F.) and by Academy of Finland Grant 110900 (to K. K.).	Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; BOGGS B, 1987, MOL CELL BIOL, V7, P2700, DOI 10.1128/MCB.7.8.2700; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Burbelo PD, 1999, P NATL ACAD SCI USA, V96, P9083, DOI 10.1073/pnas.96.16.9083; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Chan AML, 1996, ONCOGENE, V12, P1259; Dobrosotskaya IY, 2001, BIOCHEM BIOPH RES CO, V283, P969, DOI 10.1006/bbrc.2001.4880; Erasmus JC, 2006, METHOD ENZYMOL, V406, P402, DOI 10.1016/S0076-6879(06)06029-0; Garcia-Mata R, 2007, MOL CELL BIOL, V27, P8683, DOI 10.1128/MCB.00157-07; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gilcrease MZ, 2009, CANCER EPIDEM BIOMAR, V18, P80, DOI 10.1158/1055-9965.EPI-08-0842; Harris BZ, 2001, J CELL SCI, V114, P3219; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Mzali R, 2005, FASEB J, V19, P1911, DOI 10.1096/fj.05-4030fje; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Peiretti F, 2003, J CELL SCI, V116, P1949, DOI 10.1242/jcs.00415; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Reiter LT, 2006, HUM MOL GENET, V15, P2825, DOI 10.1093/hmg/ddl225; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Surena AL, 2009, BBA-MOL CELL RES, V1793, P264, DOI 10.1016/j.bbamcr.2008.09.005; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wu XC, 2006, BIOCHEM BIOPH RES CO, V351, P328, DOI 10.1016/j.bbrc.2006.09.172; Yamaguchi K, 2008, BIOL CHEM, V389, P405, DOI 10.1515/BC.2008.036; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	44	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24269	24280		10.1074/jbc.M109.029439	http://dx.doi.org/10.1074/jbc.M109.029439			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586902	Green Published, hybrid			2022-12-27	WOS:000269380200040
J	Choudhury, R; McGovern, A; Ridley, C; Cain, SA; Baldwin, A; Wang, MC; Guo, C; Mironov, A; Drymoussi, Z; Trump, D; Shuttleworth, A; Baldock, C; Kielty, CM				Choudhury, Rawshan; McGovern, Amanda; Ridley, Caroline; Cain, Stuart A.; Baldwin, Andrew; Wang, Ming-Chuan; Guo, Chun; Mironov, Aleksandr, Jr.; Drymoussi, Zoe; Trump, Dorothy; Shuttleworth, Adrian; Baldock, Clair; Kielty, Cay M.			Differential Regulation of Elastic Fiber Formation by Fibulin-4 and-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; RECESSIVE CUTIS LAXA; SMOOTH-MUSCLE-CELLS; LYSYL-OXIDASE; FIBRILLIN-1 INTERACTIONS; HUMAN TROPOELASTIN; IN-VIVO; TISSUE LOCALIZATION; DEPENDENT MANNER; HYBRID DOMAIN	Fibulin-4 and -5 are extracellular glycoproteins with essential non-compensatory roles in elastic fiber assembly. We have determined how they interact with tropoelastin, lysyl oxidase, and fibrillin-1, thereby revealing how they differentially regulate assembly. Strong binding between fibulin-4 and lysyl oxidase enhanced the interaction of fibulin-4 with tropoelastin, forming ternary complexes that may direct elastin cross-linking. In contrast, fibulin-5 did not bind lysyl oxidase strongly but bound tropoelastin in terminal and central regions and could concurrently bind fibulin-4. Both fibulins differentially bound N-terminal fibrillin-1, which strongly inhibited their binding to lysyl oxidase and tropoelastin. Knockdown experiments revealed that fibulin-5 controlled elastin deposition on microfibrils, although fibulin-4 can also bind fibrillin-1. These experiments provide a molecular account of the distinct roles of fibulin-4 and -5 in elastic fiber assembly and how they act in concert to chaperone cross-linked elastin onto microfibrils.	[Choudhury, Rawshan; McGovern, Amanda; Cain, Stuart A.; Baldwin, Andrew; Wang, Ming-Chuan; Guo, Chun; Mironov, Aleksandr, Jr.; Drymoussi, Zoe; Shuttleworth, Adrian; Baldock, Clair; Kielty, Cay M.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Ridley, Caroline; Trump, Dorothy] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Kielty, CM (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	cay.kielty@manchester.ac.uk	Guo, Chun/AAM-5894-2020; Cain, Stuart A/G-2836-2017	Guo, Chun/0000-0002-1540-3166; Mironov, Aleksandr/0000-0002-1497-328X; Drymoussi, Zoe/0000-0001-6683-9114; Baldwin, Andrew/0000-0002-8331-6769; Baldock, Clair/0000-0003-3497-1959; Ridley, Caroline/0000-0002-5483-0320; Cain, Stuart/0000-0001-8417-1058; McGovern, Amanda/0000-0001-7727-3283	Wellcome Trust [081930, 072291]; Medical Research Council [G0200246]; European Union [LSHM-CT-2005-018960]; MRC [G0200246] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grants 081930 and 072291, Medical Research Council Grant G0200246, and European Union Grant LSHM-CT-2005-018960.	Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Bax DV, 2007, J CELL SCI, V120, P1383, DOI 10.1242/jcs.003954; BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Cain SA, 2008, J BIOL CHEM, V283, P27017, DOI 10.1074/jbc.M803373200; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d; Dasouki M, 2007, AM J MED GENET A, V143A, P2635, DOI 10.1002/ajmg.a.31980; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; FORNIERI C, 1987, J CELL BIOL, V105, P1463, DOI 10.1083/jcb.105.3.1463; Freeman LJ, 2005, BIOCHEM J, V388, P1, DOI 10.1042/BJ20050368; Fu L, 2007, HUM MOL GENET, V16, P2411, DOI 10.1093/hmg/ddm198; Gheduzzi D, 2005, MATRIX BIOL, V24, P15, DOI 10.1016/j.matbio.2004.12.001; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Hu QR, 2006, J INVEST DERMATOL, V126, P283, DOI 10.1038/sj.jid.5700047; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Mellody KT, 2006, J BIOL CHEM, V281, P31854, DOI 10.1074/jbc.M602743200; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Nonaka R, 2009, CLIN BIOCHEM, V42, P713, DOI 10.1016/j.clinbiochem.2008.12.020; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Rahn DD, 2009, AM J PATHOL, V174, P206, DOI 10.2353/ajpath.2009.080212; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060; Spencer JA, 2005, P NATL ACAD SCI USA, V102, P2946, DOI 10.1073/pnas.0500058102; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200; Tu YD, 2008, BIOMACROMOLECULES, V9, P1739, DOI 10.1021/bm7013153; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zheng Q, 2007, MOL CELL BIOL, V27, P1083, DOI 10.1128/MCB.01330-06	55	89	93	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24553	24567		10.1074/jbc.M109.019364	http://dx.doi.org/10.1074/jbc.M109.019364			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19570982	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000269380200066
J	Grobe, N; Zhang, B; Fisinger, U; Kutchan, TM; Zenk, MH; Guengerich, FP				Grobe, Nadja; Zhang, Baichen; Fisinger, Ursula; Kutchan, Toni M.; Zenk, Meinhart H.; Guengerich, F. Peter			Mammalian Cytochrome P450 Enzymes Catalyze the Phenol-coupling Step in Endogenous Morphine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS SYNTHESIZE MORPHINE; RAT-LIVER; BENZYLISOQUINOLINE ALKALOIDS; BERBERIS-STOLONIFERA; CYP2D6 MODULATION; MOLECULAR-CLONING; O-DEMETHYLATION; HUMAN BRAIN; SALUTARIDINE; CODEINE	A cytochrome P450 (P450) enzyme in porcine liver that catalyzed the phenol-coupling reaction of the substrate (R)-reticuline to salutaridine was previously purified to homogeneity (Amann, T., Roos, P. H., Huh, H., and Zenk, M. H. (1995) Heterocycles 40, 425-440). This reaction was found to be catalyzed by human P450s 2D6 and 3A4 in the presence of (R)-reticuline and NADPH to yield not a single product, but rather (-)-isoboldine, (-)-corytuberine, (-)-pallidine, and salutaridine, the paraortho coupled established precursor of morphine in the poppy plant and most likely also in mammals. (S)-Reticuline, a substrate of both P450 enzymes, yielded the phenol-coupled alkaloids (-)-isoboldine, (-)-corytuberine, (-)-pallidine, and sinoacutine; none of these serve as a morphine precursor. Catalytic efficiencies were similar for P450 2D6 and P450 3A4 in the presence of cytochrome b(5) with (R)-reticuline as substrate. The mechanism of phenol coupling is not yet established; however, we favor a single cycle of iron oxidation to yield salutaridine and the three other alkaloids from (R)-reticuline. The total yield of salutaridine formed can supply the 10 nM concentration of morphine found in human neuroblastoma cell cultures and in brain tissues of mice.	[Grobe, Nadja; Zhang, Baichen; Kutchan, Toni M.; Zenk, Meinhart H.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Fisinger, Ursula] Univ Munich, Lehrstuhl Pharmazeut Biol, D-80333 Munich, Germany; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Donald Danforth Plant Science Center; University of Munich; Vanderbilt University; Vanderbilt University	Zenk, MH (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	mhzenk@danforthcenter.org	Kutchan, Toni/L-4625-2013		National Institutes of Health [R21 DA0224418, R37 CA090426]; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DA0224418 and R37 CA090426 and the Deutsche Forschungsgemeinschaft.	Agarwal V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002337; AMANN T, 1991, TETRAHEDRON LETT, V32, P3675, DOI 10.1016/S0040-4039(00)79765-6; AMANN T, 1995, HETEROCYCLES, V40, P425; Barton DHR, 1957, SOME BIOGENETIC ASPE; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Boettcher C, 2006, J IMMUNOL, V176, P5703, DOI 10.4049/jimmunol.176.10.5703; Boettcher C, 2005, P NATL ACAD SCI USA, V102, P8495, DOI 10.1073/pnas.0503244102; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; DAYER P, 1988, BIOCHEM BIOPH RES CO, V152, P411, DOI 10.1016/S0006-291X(88)80729-0; DONNERER J, 1986, P NATL ACAD SCI USA, V83, P4566, DOI 10.1073/pnas.83.12.4566; Eichhorn J, 1998, PHYTOCHEMISTRY, V49, P1037, DOI 10.1016/S0031-9422(97)01024-8; GERARDY R, 1993, PHYTOCHEMISTRY, V32, P79, DOI 10.1016/0031-9422(92)80111-Q; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2002, J BIOL CHEM, V277, P33711, DOI 10.1074/jbc.M205146200; Hanna IH, 2001, J BIOL CHEM, V276, P39553, DOI 10.1074/jbc.M106841200; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hiroi T, 1998, BIOCHEM BIOPH RES CO, V249, P838, DOI 10.1006/bbrc.1998.9232; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; KAMETANI T, 1977, BIOORG CHEM, V6, P249, DOI 10.1016/0045-2068(77)90026-8; KAMETANI T, 1980, HETEROCYCLES, V14, P963, DOI 10.3987/R-1980-07-0963; KODAIRA H, 1988, P NATL ACAD SCI USA, V85, P1267, DOI 10.1073/pnas.85.4.1267; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; MEIER UH, 1997, TETRAHEDRON LETT, V38, P7357; MIKUS G, 1991, XENOBIOTICA, V21, P1501, DOI 10.3109/00498259109044400; Muller A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001641; Nasreen A, 1996, TETRAHEDRON LETT, V37, P8161, DOI 10.1016/0040-4039(96)01852-7; Oscarson M, 1997, MOL PHARMACOL, V52, P1034, DOI 10.1124/mol.52.6.1034; Poeaknapo C, 2004, P NATL ACAD SCI USA, V101, P14091, DOI 10.1073/pnas.0405430101; Raith K, 2003, J AM SOC MASS SPECTR, V14, P1262, DOI 10.1016/S1044-0305(03)00539-7; Rueffer M, 1998, FEBS LETT, V438, P111, DOI 10.1016/S0014-5793(98)01282-4; RUEFFER M, 1987, TETRAHEDRON LETT, V28, P5307, DOI 10.1016/S0040-4039(00)96715-7; Sagner S, 1998, PHYTOCHEMISTRY, V47, P375, DOI 10.1016/S0031-9422(97)00590-6; Siegle I, 2001, PHARMACOGENETICS, V11, P237, DOI 10.1097/00008571-200104000-00007; STADLER R, 1993, J BIOL CHEM, V268, P823; WEITZ CJ, 1987, NATURE, V330, P674, DOI 10.1038/330674a0; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Yu AM, 2002, J PHARMACOL EXP THER, V303, P1291, DOI 10.1124/jpet.102.039891; Yue QY, 1997, EUR J CLIN PHARMACOL, V52, P41, DOI 10.1007/s002280050247; ZENK MH, 1994, PURE APPL CHEM, V66, P2023, DOI 10.1351/pac199466102023; ZENK MH, 1989, J CHEM SOC CHEM COMM, P1725, DOI 10.1039/c39890001725; Zhu W, 2005, J IMMUNOL, V175, P7357, DOI 10.4049/jimmunol.175.11.7357	41	39	39	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24425	24431		10.1074/jbc.M109.011320	http://dx.doi.org/10.1074/jbc.M109.011320			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561069	Green Published, hybrid			2022-12-27	WOS:000269380200055
J	Ito, T; Suzuki, S; Kanaji, S; Shiraishi, H; Ohta, S; Arima, K; Tanaka, G; Tamada, T; Honjo, E; Garcia, KC; Kuroki, R; Izuhara, K				Ito, Takachika; Suzuki, Shoichi; Kanaji, Sachiko; Shiraishi, Hiroshi; Ohta, Shoichiro; Arima, Kazuhiko; Tanaka, Go; Tamada, Taro; Honjo, Eijiro; Garcia, K. Christopher; Kuroki, Ryota; Izuhara, Kenji			Distinct Structural Requirements for Interleukin-4 (IL-4) and IL-13 Binding to the Shared IL-13 Receptor Facilitate Cellular Tuning of Cytokine Responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION	Both interleukin-4 (IL-4) and IL-13 can bind to the shared receptor composed of the IL-4 receptor alpha chain and the IL-13 receptor alpha 1 chain (IL-13R alpha 1); however, the mechanisms by which these ligands bind to the receptor chains are different, enabling the principal functions of these ligands to be different. We have previously shown that the N-terminal Ig-like domain in IL-13R alpha 1, called the D1 domain, is the specific and critical binding unit for IL-13. However, it has still remained obscure which amino acid has specific binding capacity to IL-13 and why the D1 domain acts as the binding site for IL-13, but not IL-4. To address these questions, in this study we performed mutational analyses for the D1 domain, combining the structural data to identify the amino acids critical for binding to IL-13. Mutations of Lys-76, Lys-77, or Ile-78 in c' strand in which the crystal structure showed interaction with IL-13, and those of Trp-65 and Ala-79 adjacent to the interacting site, resulted in significant impairment of IL-13 binding, demonstrating that these amino acids generate the binding site. Furthermore, mutations of Val-35, Leu-38, or Val-42 at the N-terminal beta-strand also resulted in loss of IL-13 binding, probably from decreased structural stability. None of the mutations employed here affected IL-4 binding. These results demonstrate that the D1 domain of IL-13R alpha 1 acts as an affinity converter, through direct cytokine interactions, that allows the shared receptor to respond differentially to IL-4 and IL-13.	[Ito, Takachika; Suzuki, Shoichi; Kanaji, Sachiko; Shiraishi, Hiroshi; Arima, Kazuhiko; Tanaka, Go; Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga 8498501, Japan; [Ito, Takachika] Saga Med Sch, Dept Emergency Med, Saga 8498501, Japan; [Ohta, Shoichiro; Izuhara, Kenji] Saga Med Sch, Dept Lab Med, Saga 8498501, Japan; [Tamada, Taro; Honjo, Eijiro; Kuroki, Ryota] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Neutron Sci Res Ctr, Mol Struct Biol Grp, Tokai, Ibaraki 3191195, Japan; [Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Saga University; Saga University; Saga University; Japan Atomic Energy Agency; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Izuhara, K (corresponding author), Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga 8498501, Japan.	kizuhara@cc.saga-u.ac.jp	Arima, Kazuhiko/I-8962-2014	Arima, Kazuhiko/0000-0002-0607-8787; Tamada, Taro/0000-0003-1419-8022	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grant-in-aids for scientific research from the Japan Society for the Promotion of Science.	Andrews AL, 2002, J BIOL CHEM, V277, P46073, DOI 10.1074/jbc.M209560200; Arima K, 2005, J BIOL CHEM, V280, P24915, DOI 10.1074/jbc.M502571200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Honjo E, 2008, PROTEIN EXPRES PURIF, V60, P25, DOI 10.1016/j.pep.2008.03.020; Izuhara K, 2006, CURR MED CHEM, V13, P2291, DOI 10.2174/092986706777935140; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Madhankumar AB, 2002, J BIOL CHEM, V277, P43194, DOI 10.1074/jbc.M205047200; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Tamada T, 2006, P NATL ACAD SCI USA, V103, P3135, DOI 10.1073/pnas.0511264103; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x	18	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24289	24296		10.1074/jbc.M109.007286	http://dx.doi.org/10.1074/jbc.M109.007286			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586918	hybrid, Green Published			2022-12-27	WOS:000269380200042
J	Lee-Young, RS; Griffee, SR; Lynes, SE; Bracy, DP; Ayala, JE; McGuinness, OP; Wasserman, DH				Lee-Young, Robert S.; Griffee, Susan R.; Lynes, Sara E.; Bracy, Deanna P.; Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.			Skeletal Muscle AMP-activated Protein Kinase Is Essential for the Metabolic Response to Exercise in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; NITRIC-OXIDE RELEASE; GLUCOSE-TRANSPORT; DOSE-RESPONSE; MOUSE MODEL; BLOOD-FLOW; CONTRACTION; TISSUES; NNOS; MICE	AMP-activated protein kinase (AMPK) has been postulated as a super-metabolic regulator, thought to exert numerous effects on skeletal muscle function, metabolism, and enzymatic signaling. Despite these assertions, little is known regarding the direct role(s) of AMPK in vivo, and results obtained in vitro or in situ are conflicting. Using a chronically catheterized mouse model (carotid artery and jugular vein), we show that AMPK regulates skeletal muscle metabolism in vivo at several levels, with the result that a deficit in AMPK activity markedly impairs exercise tolerance. Compared with wild-type littermates at the same relative exercise capacity, vascular glucose delivery and skeletal muscle glucose uptake were impaired; skeletal muscle ATP degradation was accelerated, and arterial lactate concentrations were increased in mice expressing a kinase-dead AMPK alpha 2 subunit (alpha 2-KD) in skeletal muscle. Nitric-oxide synthase (NOS) activity was significantly impaired at rest and in response to exercise in alpha 2-KD mice; expression of neuronal NOS (NOS mu) was also reduced. Moreover, complex I and IV activities of the electron transport chain were impaired 32 +/- 8 and 50 +/- 7%, respectively, in skeletal muscle of alpha 2-KD mice (p < 0.05 versus wild type), indicative of impaired mitochondrial function. Thus, AMPK regulates neuronal NOS mu expression, NOS activity, and mitochondrial function in skeletal muscle. In addition, these results clarify the role of AMPK in the control of muscle glucose uptake during exercise. Collectively, these findings demonstrate that AMPK is central to substrate metabolism in vivo, which has important implications for exercise tolerance in health and certain disease states characterized by impaired AMPK activation in skeletal muscle.	[Lee-Young, Robert S.; Griffee, Susan R.; Lynes, Sara E.; Bracy, Deanna P.; Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.] Vanderbilt Univ, Sch Med, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Lee-Young, RS (corresponding author), 823 Light Hall,2200 Pierce Ave, Nashville, TN 37232 USA.	robert.s.lee-young@vanderbilt.edu		Lee, Robert/0000-0002-8166-142X	National Institutes of Health Grants [U24 DK-59637, R01 DK-54902]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054902, U24DK059637] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants U24 DK-59637 and R01 DK-54902 (to D. H. W.).	Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Ayala JE, 2007, DIABETES, V56, P1025, DOI 10.2337/db06-0883; BALON TW, 1994, J APPL PHYSIOL, V77, P2519, DOI 10.1152/jappl.1994.77.6.2519; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; De Filippis E, 2008, AM J PHYSIOL-ENDOC M, V294, pE607, DOI 10.1152/ajpendo.00729.2007; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2007, DIABETES RES CLIN PR, V77, pS92, DOI 10.1016/j.diabres.2007.01.040; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hirschfield W, 2000, AM J PHYSIOL-REG I, V278, pR95, DOI 10.1152/ajpregu.2000.278.1.R95; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Jorgensen SB, 2008, FRONT BIOSCI-LANDMRK, V13, P5589; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Klein DK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1242, DOI 10.1152/ajpendo.00382.2007; KNIGHT DR, 1992, J APPL PHYSIOL, V73, P1114, DOI 10.1152/jappl.1992.73.3.1114; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Lau KS, 2000, PHYSIOL GENOMICS, V2, P21, DOI 10.1152/physiolgenomics.2000.2.1.21; Lee-Young RS, 2006, AM J PHYSIOL-ENDOC M, V291, pE566, DOI 10.1152/ajpendo.00023.2006; Lefort N, 2008, AM J PHYSIOL-ENDOC M, V295, pE1447, DOI 10.1152/ajpendo.90362.2008; Maxwell AJ, 1998, CIRCULATION, V98, P369, DOI 10.1161/01.CIR.98.4.369; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miura S, 2009, AM J PHYSIOL-ENDOC M, V296, pE47, DOI 10.1152/ajpendo.90690.2008; MORGAN CR, 1965, DIABETES, V14, P669, DOI 10.2337/diab.14.10.669; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Mu J, 2003, BIOCHEM SOC T, V31, P236, DOI 10.1042/bst0310236; Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Ross RM, 2007, DIABETES, V56, P2885, DOI 10.2337/db07-0745; Rottman JN, 2003, J AM SOC ECHOCARDIOG, V16, P1150, DOI 10.1067/S0894-7317(03)00471-1; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Schild L, 2005, FASEB J, V19, P145, DOI 10.1096/fj.05-3898fje; Shearer J, 2004, DIABETES, V53, P1429, DOI 10.2337/diabetes.53.6.1429; Shearer J, 2008, LIPIDS, V43, P703, DOI 10.1007/s11745-008-3183-4; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Soraru G, 2007, NEUROPATH APPL NEURO, V33, P204, DOI 10.1111/j.1365-2990.2006.00791.x; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Stephens TJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE688, DOI 10.1152/ajpendo.00101.2001; VALLANCE P, 1989, LANCET, V2, P997; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P1110, DOI 10.1016/j.bbabio.2006.06.004; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; Zwetsloot KA, 2008, J PHYSIOL-LONDON, V586, P6021, DOI 10.1113/jphysiol.2008.159871	57	109	112	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23925	23934		10.1074/jbc.M109.021048	http://dx.doi.org/10.1074/jbc.M109.021048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19525228	Green Published, hybrid			2022-12-27	WOS:000269380200006
J	Kim, MH; Sasaki, K; Imai, R				Kim, Myung-Hee; Sasaki, Kentaro; Imai, Ryozo			Cold Shock Domain Protein 3 Regulates Freezing Tolerance in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING PROTEIN; MESSENGER-RNA; TRANSCRIPTIONAL ADAPTER; ESCHERICHIA-COLI; STRESS TOLERANCE; GENE-EXPRESSION; LOW-TEMPERATURE; CSPA FAMILY; ACCLIMATION; ACID	In response to cold, Escherichia coli produces cold shock proteins (CSPs) that have essential roles in cold adaptation as RNA chaperones. Here, we demonstrate that Arabidopsis cold shock domain protein 3 (AtCSP3), which shares a cold shock domain with bacterial CSPs, is involved in the acquisition of freezing tolerance in plants. AtCSP3 complemented a cold-sensitive phenotype of the E. coli CSP quadruple mutant and displayed nucleic acid duplex melting activity, suggesting that AtCSP3 also functions as an RNA chaperone. Promoter-GUS transgenic plants revealed tissue-specific expression of AtCSP3 in shoot and root apical regions. When exposed to low temperature, GUS activity was extensively induced in a broader region of the roots. In transgenic plants expressing an AtCSP3-GFP fusion, GFP signals were detected in both the nucleus and cytoplasm. An AtCSP3 knock-out mutant (atcsp3-2) was sensitive to freezing compared with wild-type plants under non-acclimated and cold-acclimated conditions, whereas expression of C-repeat-binding factors and their downstream genes during cold acclimation was not altered in the atcsp3-2 mutant. Overexpression of AtCSP3 in transgenic plants conferred enhanced freezing tolerance over wild-type plants. Together, the data demonstrated an essential role of RNA chaperones for cold adaptation in higher plants.	[Kim, Myung-Hee; Sasaki, Kentaro; Imai, Ryozo] Natl Agr Res Ctr Hokkaido Reg, Crop Cold Tolerance Res Team, Toyohira Ku, Sapporo, Hokkaido 0628555, Japan	National Agriculture & Food Research Organization - Japan	Imai, R (corresponding author), Natl Agr Res Ctr Hokkaido Reg, Crop Cold Tolerance Res Team, Toyohira Ku, Hitsujigaoka 1, Sapporo, Hokkaido 0628555, Japan.	rzi@affrc.go.jp			Japan Society for the Promotion of Science [19380063]; National Agriculture and Food Research Organization (NARO)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Agriculture and Food Research Organization (NARO)	This work was supported in part by Grants from Japan Society for the Promotion of Science (KAKENHI Scientific Research B 19380063) and National Agriculture and Food Research Organization (NARO) ( Development of Innovative Crops through the Molecular Analysis of Useful Genes 3202) ( to R. I. and K. S., respectively).	[Anonymous], 2012, FROST SURVIVAL PLANT, DOI DOI 10.1002/joc.4518; Castiglioni P, 2008, PLANT PHYSIOL, V147, P446, DOI 10.1104/pp.108.118828; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CURTIS OF, 1930, AM J BOT, V17, P1047; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; Fusaro AF, 2007, PLANTA, V225, P1339, DOI 10.1007/s00425-006-0444-4; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; GILMOUR SJ, 1992, PLANT MOL BIOL, V18, P13, DOI 10.1007/BF00018452; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Higashi K, 2003, J BIOL CHEM, V278, P5156, DOI 10.1074/jbc.M208724200; Hunger K, 2006, J BACTERIOL, V188, P240, DOI 10.1128/JB.188.1.240-248.2006; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Karlson D, 2003, PLANT PHYSIOL, V131, P12, DOI 10.1104/pp.014472; Karlson D, 2002, J BIOL CHEM, V277, P35248, DOI 10.1074/jbc.M205774200; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; Lasham A, 2003, J BIOL CHEM, V278, P35516, DOI 10.1074/jbc.M303920200; LIN CT, 1992, PLANT PHYSIOL, V99, P519, DOI 10.1104/pp.99.2.519; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nakaminami K, 2005, FEBS LETT, V579, P4887, DOI 10.1016/j.febslet.2005.07.074; Nakaminami K, 2006, P NATL ACAD SCI USA, V103, P10122, DOI 10.1073/pnas.0603168103; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Phadtare S, 2002, J BIOL CHEM, V277, P46706, DOI 10.1074/jbc.M208118200; Pisarev AV, 2002, J BIOL CHEM, V277, P15445, DOI 10.1074/jbc.M111954200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Sasaki K, 2007, BIOCHEM BIOPH RES CO, V364, P633, DOI 10.1016/j.bbrc.2007.10.059; SCHWABE WW, 1954, J EXP BOT, V5, P389, DOI 10.1093/jxb/5.3.389; Sommerville J, 1999, BIOESSAYS, V21, P319, DOI 10.1002/(SICI)1521-1878(199904)21:4<319::AID-BIES8>3.3.CO;2-V; Stockinger EJ, 2001, NUCLEIC ACIDS RES, V29, P1524, DOI 10.1093/nar/29.7.1524; Takahashi H, 1997, J PLANT RES, V110, P163, DOI 10.1007/BF02509304; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Vlachonasios KE, 2003, PLANT CELL, V15, P626, DOI 10.1105/tpc.007922; Weber MHW, 2002, NUCLEIC ACIDS RES, V30, P375, DOI 10.1093/nar/30.1.375; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101	46	85	95	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23454	23460		10.1074/jbc.M109.025791	http://dx.doi.org/10.1074/jbc.M109.025791			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19556243	hybrid, Green Published			2022-12-27	WOS:000269180000030
J	Porayette, P; Gallego, MJ; Kaltcheva, MM; Bowen, RL; Meethal, SV; Atwood, CS				Porayette, Prashob; Gallego, Miguel J.; Kaltcheva, Maria M.; Bowen, Richard L.; Meethal, Sivan Vadakkadath; Atwood, Craig S.			Differential Processing of Amyloid-beta Precursor Protein Directs Human Embryonic Stem Cell Proliferation and Differentiation into Neuronal Precursor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; ALZHEIMERS-DISEASE; TRANSGENIC MICE; DISINTEGRIN METALLOPROTEASE; SECRETASE CLEAVAGE; AGING CHANGES; EXPRESSION; PEPTIDES; BRAIN; TAU	The amyloid-beta precursor protein (A beta PP) is a ubiquitously expressed transmembrane protein whose cleavage product, the amyloid-beta(A beta) protein, is deposited in amyloid plaques in neurodegenerative conditions such as Alzheimer disease, Down syndrome, and head injury. We recently reported that this protein, normally associated with neurodegenerative conditions, is expressed by human embryonic stem cells (hESCs). We now report that the differential processing of A beta PP via secretase enzymes regulates the proliferation and differentiation of hESCs. hESCs endogenously produce amyloid-beta, which when added exogenously in soluble and fibrillar forms but not oligomeric forms markedly increased hESC proliferation. The inhibition of A beta PP cleavage by beta-secretase inhibitors significantly suppressed hESC proliferation and promoted nestin expression, an early marker of neural precursor cell (NPC) formation. The induction of NPC differentiation via the non-amyloidogenic pathway was confirmed by the addition of secreted A beta PP alpha, which suppressed hESC proliferation and promoted the formation of NPCs. Together these data suggest that differential processing of A beta PP is normally required for embryonic neurogenesis.	[Porayette, Prashob; Gallego, Miguel J.; Kaltcheva, Maria M.; Meethal, Sivan Vadakkadath; Atwood, Craig S.] Univ Wisconsin, Dept Med, Sect Geriatr & Gerontol, Madison, WI 53705 USA; [Porayette, Prashob; Gallego, Miguel J.; Kaltcheva, Maria M.; Meethal, Sivan Vadakkadath; Atwood, Craig S.] Vet Affairs Hosp, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA; [Bowen, Richard L.] OTB Res, Raleigh, NC 27615 USA; [Atwood, Craig S.] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA; [Atwood, Craig S.] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Joondalup, WA 6027, Australia	University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; Case Western Reserve University; Edith Cowan University	Atwood, CS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Wm S Middleton Mem Vet Affairs Hosp GRECC 11G, 2500 Overlook Terrace, Madison, WI 53705 USA.	csa@medicine.wisc.edu	, Craig/AAB-3963-2022; Porayette, Prashob/N-5034-2018	Porayette, Prashob/0000-0001-9078-5128				Arai Y, 1997, BRAIN DEV-JPN, V19, P290, DOI 10.1016/S0387-7604(97)00559-7; Atwood CS, 2001, ALZHEIMER'S DISEASE, P341, DOI 10.1002/0470846453.ch32; Berezovska O, 1997, J NEUROPATH EXP NEUR, V56, P40, DOI 10.1097/00005072-199701000-00004; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Calafiore M, 2006, NEUROBIOL AGING, V27, P606, DOI 10.1016/j.neurobiolaging.2005.03.019; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Doetsch F, 1997, J NEUROSCI, V17, P5046; Esh C, 2005, BIOCHEMISTRY-US, V44, P13807, DOI 10.1021/bi051213+; Gallego MJ, 2009, STEM CELLS DEV, V18, P737, DOI 10.1089/scd.2008.0190; GALLEGO MJ, 2008, NAT PRECEDINGS; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hay DC, 2007, CLONING STEM CELLS, V9, P51, DOI 10.1089/clo.2006.0045; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Heo C, 2007, J NEUROCHEM, V102, P493, DOI 10.1111/j.1471-4159.2007.04499.x; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Kaether C, 2006, NEURODEGENER DIS, V3, P275, DOI 10.1159/000095267; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Kuhn HG, 1999, BIOESSAYS, V21, P625, DOI 10.1002/(SICI)1521-1878(199908)21:8<625::AID-BIES1>3.0.CO;2-6; Kwak YD, 2006, STEM CELLS DEV, V15, P381, DOI 10.1089/scd.2006.15.381; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LI QX, 1995, J BIOL CHEM, V270, P14140, DOI 10.1074/jbc.270.23.14140; Li XJ, 2006, METH MOL B, V331, P169; Liu TB, 2004, J NEUROCHEM, V88, P554, DOI 10.1046/j.1471-4159.2003.02196.x; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; McCulloch DR, 2004, CLIN CANCER RES, V10, P314, DOI 10.1158/1078-0432.CCR-0846-3; McPhie DL, 2003, J NEUROSCI, V23, P6914; MILLER FD, 1987, J CELL BIOL, V105, P3065, DOI 10.1083/jcb.105.6.3065; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; MIYAZONO M, 1993, ACTA NEUROPATHOL, V86, P236, DOI 10.1007/BF00304137; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; MULLER F, 1985, ANAT EMBRYOL, V172, P157, DOI 10.1007/BF00319598; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Shea KS, 1999, ANAT RECORD, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; PALMERT MR, 1990, NEUROLOGY, V40, P1028, DOI 10.1212/WNL.40.7.1028; Porayette P, 2007, BIOCHEM BIOPH RES CO, V364, P522, DOI 10.1016/j.bbrc.2007.10.021; Raina AK, 2000, J NEUROSCI RES, V61, P128, DOI 10.1002/1097-4547(20000715)61:2<128::AID-JNR2>3.3.CO;2-8; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; TAKASHIMA S, 1990, BRAIN DEV-JPN, V12, P367, DOI 10.1016/S0387-7604(12)80066-0; Tang K, 2006, J NEUROL SCI, V240, P53, DOI 10.1016/j.jns.2005.09.002; Troy CM, 2000, J NEUROSCI, V20, P1386; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wei WL, 2002, J BIOL CHEM, V277, P17649, DOI 10.1074/jbc.M111704200; Wen JY, 2007, J CELL BIOCHEM, V102, P149, DOI 10.1002/jcb.21285; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YOSHIKAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P204, DOI 10.1016/0006-291X(90)91377-5; Zhang SC, 2003, J HEMATOTH STEM CELL, V12, P625, DOI 10.1089/15258160360732650	57	54	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23806	23817		10.1074/jbc.M109.026328	http://dx.doi.org/10.1074/jbc.M109.026328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19542221	Green Published, hybrid			2022-12-27	WOS:000269180000064
J	Naranuntarat, A; Jensen, LT; Pazicni, S; Penner-Hahn, JE; Culotta, VC				Naranuntarat, Amornrat; Jensen, Laran T.; Pazicni, Samuel; Penner-Hahn, James E.; Culotta, Valeria C.			The Interaction of Mitochondrial Iron with Manganese Superoxide Dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOSYNTHESIS; PROTEIN; BIOGENESIS; SCAFFOLD; TRANSPORTER; GENE; ISCU; SPECIFICITY; CELLS; SITE	Superoxide dismutase 2 (SOD2) is one of the rare mitochondrial enzymes evolved to use manganese as a cofactor over the more abundant element iron. Although mitochondrial iron does not normally bind SOD2, iron will misincorporate into Saccharomyces cerevisiae Sod2p when cells are starved for manganese or when mitochondrial iron homeostasis is disrupted by mutations in yeast grx5, ssq1, and mtm1. We report here that such changes in mitochondrial manganese and iron similarly affect cofactor selection in a heterologously expressed Escherichia coli Mn-SOD, but not a highly homologous Fe-SOD. By x-ray absorption near edge structure and extended x-ray absorption fine structure analyses of isolated mitochondria, we find that misincorporation of iron into yeast Sod2p does not correlate with significant changes in the average oxidation state or coordination chemistry of bulk mitochondrial iron. Instead, small changes in mitochondrial iron are likely to promote iron-SOD2 interactions. Iron binds Sod2p in yeast mutants blocking late stages of iron-sulfur cluster biogenesis (grx5, ssq1, and atm1), but not in mutants defective in the upstream Isu proteins that serve as scaffolds for iron-sulfur biosynthesis. In fact, we observed a requirement for the Isu proteins in iron inactivation of yeast Sod2p. Sod2p activity was restored in mtm1 and grx5 mutants by depleting cells of Isu proteins or using a dominant negative Isu1p predicted to stabilize iron binding to Isu1p. In all cases where disruptions in iron homeostasis inactivated Sod2p, we observed an increase in mitochondrial Isu proteins. These studies indicate that the Isu proteins and the iron-sulfur pathway can donate iron to Sod2p.	[Culotta, Valeria C.] Johns Hopkins Univ, Dept Environm Hlth Sci, Div Toxicol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Pazicni, Samuel; Penner-Hahn, James E.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Michigan System; University of Michigan	Culotta, VC (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Div Toxicol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	vculotta@jhsph.edu	Jensen, Amornrat/AAO-3411-2020; Penner-Hahn, James/GYD-3750-2022	Jensen, Amornrat/0000-0003-2528-8795; Penner-Hahn, James/0000-0003-0314-1274; Pazicni, Samuel/0000-0002-4775-7794; Jensen, Laran/0000-0003-3199-1743	National Institutes of Health [ES-08996, GM-38047]; Johns Hopkins University NIEHS Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008996, P30ES003819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038047, R29GM038047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University NIEHS Center(Johns Hopkins University); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES-08996 (to V.C.C.) and GM-38047 (awarded to J.E.P.-H.) and the Johns Hopkins University NIEHS Center.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Agar JN, 2000, J AM CHEM SOC, V122, P2136, DOI 10.1021/ja9944195; Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Balzan R, 1999, BIOCHEM BIOPH RES CO, V256, P63, DOI 10.1006/bbrc.1999.0285; Bekri S, 2000, BLOOD, V96, P3256; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; BEYER WF, 1991, J BIOL CHEM, V266, P303; CARLIOZ A, 1988, J BIOL CHEM, V263, P1555; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Duttaroy A, 2003, GENETICS, V165, P2295; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Hudder BN, 2007, J BIOL INORG CHEM, V12, P1029, DOI 10.1007/s00775-007-0275-1; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Jensen LT, 2004, J BIOL CHEM, V279, P29938, DOI 10.1074/jbc.M402795200; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knieszner H, 2005, J BIOL CHEM, V280, P28966, DOI 10.1074/jbc.M503031200; Laliberte J, 2004, J BIOL CHEM, V279, P28744, DOI 10.1074/jbc.M403426200; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lesuisse E, 2005, GENETICS, V169, P107, DOI 10.1534/genetics.104.035873; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; NILSSON R, 2009, CELL METAB IN PRESS; Popescu BFG, 2007, J INORG BIOCHEM, V101, P957, DOI 10.1016/j.jinorgbio.2007.03.004; PRIVALLE CT, 1992, J BIOL CHEM, V267, P9140; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; SIKORSKI RS, 1989, GENETICS, V122, P19; Tobin DA, 2003, J AM CHEM SOC, V125, P9962, DOI 10.1021/ja035927o; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Vance CK, 2001, BIOCHEMISTRY-US, V40, P13079, DOI 10.1021/bi0113317; Vance CK, 1998, J AM CHEM SOC, V120, P461, DOI 10.1021/ja972060j; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Weng TC, 2005, J SYNCHROTRON RADIAT, V12, P506, DOI 10.1107/S0909049504034193; Whittaker JW, 2003, BIOCHEM SOC T, V31, P1318; Wintjens R, 2004, J BIOL CHEM, V279, P9248, DOI 10.1074/jbc.M312329200; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	49	56	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22633	22640		10.1074/jbc.M109.026773	http://dx.doi.org/10.1074/jbc.M109.026773			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561359	Green Published, hybrid			2022-12-27	WOS:000268963100016
J	Stockbridge, RB; Wolfenden, R				Stockbridge, Randy B.; Wolfenden, Richard			The Intrinsic Reactivity of ATP and the Catalytic Proficiencies of Kinases Acting on Glucose, N-Acetylgalactosamine, and Homoserine A THERMODYNAMIC ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST HEXOKINASE; TRANSITION-STATE; METAL-IONS; STABILITY-CONSTANTS; KINETIC MECHANISM; PHOSPHATE ESTERS; ADENOSINE DI; HYDROLYSIS; SUBSTRATE; TRIPHOSPHATE	To evaluate the rate enhancements produced by representative kinases and their thermodynamic basis, rate constants were determined as a function of changing temperature for 1) the spontaneous methanolysis of ATP and 2) reactions catalyzed by kinases to which different mechanisms of action have been ascribed. For each of these enzymes, the minor effects of changing viscosity indicate that k(cat)/K-m is governed by the central chemical events in the enzyme-substrate complex rather than by enzyme-substrate encounter. Individual Arrhenius plots, obtained at intervals between pH 4.8 and 11.0, yielded Delta H-double dagger and T Delta S-double dagger for the nonenzymatic methanolysis of ATP(2-), ATP(3-), and ATP(4-) in the absence of Mg2+. The addition of Mg2+ led to partly compensating changes in Delta H-double dagger and T Delta S-double dagger, accelerating the nonenzymatic methanolysis of ATP 11-fold at pH 7 and 25 degrees C. The rate enhancements produced by yeast hexokinase, homoserine kinase, and N-acetylgalactosamine kinase (obtained by comparison of their k(cat)/K-m values in the presence of saturating phosphoryl acceptor with the second order rate constant for methanolysis of MgATP) ranged between 10(12)- and 10(14)-fold. Their nominal affinities for the altered substrates in the transition state were 2.1 x 10(-16) M for N-acetylgalactosamine kinase, 7.4 x 10(-17) M for homoserine kinase, and 6.4 x 10(-18) M for hexokinase. Compared with nonenzymatic phosphoryl transfer, all three kinases were found to produce major reductions in the entropy of activation, in accord with the likelihood that substrate juxtaposition and desolvation play prominent roles in their catalytic action.	[Stockbridge, Randy B.; Wolfenden, Richard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Wolfenden, R (corresponding author), 120 Mason Farm Rd,Genet Med Suite 3010, Chapel Hill, NC 27599 USA.	water@med.unc.edu	Wolfenden, Richard/CAH-1293-2022	Stockbridge, Randy/0000-0001-8848-3032	National Institutes of Health [GM 18325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018325, R01GM018325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 18325.	ADMIRAAL SJ, 1995, CHEM BIOL, V2, P729, DOI 10.1016/1074-5521(95)90101-9; ALBERTY RA, 1951, J BIOL CHEM, V193, P425; BAILEY JM, 1968, J BIOL CHEM, V243, P4827; BUNTON CA, 1958, J CHEM SOC, P3574, DOI 10.1039/jr9580003574; BUTCHER WW, 1955, J AM CHEM SOC, V77, P2420, DOI 10.1021/ja01614a018; Cleland WW, 1995, FASEB J, V9, P1585, DOI 10.1096/fasebj.9.15.8529838; COHN M, 1962, J BIOL CHEM, V237, P176; DANENBERG KD, 1975, BIOCHEMISTRY-US, V14, P28, DOI 10.1021/bi00672a006; DANENBERG PV, 1977, BIOCHIM BIOPHYS ACTA, V480, P351, DOI 10.1016/0005-2744(77)90027-4; DARZYNKIEWICZ E, 1985, BIOCHEMISTRY-US, V24, P1701, DOI 10.1021/bi00328a020; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; DISABATO G, 1961, J AM CHEM SOC, V83, P4400, DOI 10.1021/ja01482a025; EDSALL JT, 1958, BIOPHYSICAL CHEM, P452; FELDMAN I, 1978, BIOCHEMISTRY-US, V17, P1541, DOI 10.1021/bi00601a029; GLONEK T, 1992, INT J BIOCHEM, V24, P1533, DOI 10.1016/0020-711X(92)90171-V; JONES JP, 1991, BIOCHEMISTRY-US, V30, P3634, DOI 10.1021/bi00229a007; KIRBY AJ, 1967, J AM CHEM SOC, V89, P415, DOI 10.1021/ja00978a044; KORNBERG A, 1951, J BIOL CHEM, V193, P481; KOSHLAND DE, 1951, J AM CHEM SOC, V73, P4103, DOI 10.1021/ja01153a016; Krishna SS, 2001, BIOCHEMISTRY-US, V40, P10810, DOI 10.1021/bi010851z; Lad C, 2003, P NATL ACAD SCI USA, V100, P5607, DOI 10.1073/pnas.0631607100; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; MAPLE SR, 1987, J AM CHEM SOC, V109, P3168, DOI 10.1021/ja00244a063; MARAT K, 1999, SPINWORKS VERSION 2; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; OSCARSON JL, 1995, J SOLUTION CHEM, V24, P171, DOI 10.1007/BF00972840; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pastuszak I, 1996, J BIOL CHEM, V271, P20776, DOI 10.1074/jbc.271.34.20776; SARVAZYAN AP, 1980, J PHYS CHEM-US, V84, P692, DOI 10.1021/j100444a002; Scheffzek K, 1996, BIOCHEMISTRY-US, V35, P9716, DOI 10.1021/bi960642s; Schroeder GK, 2007, BIOCHEMISTRY-US, V46, P4037, DOI 10.1021/bi602600p; SEM DS, 1991, BIOCHEMISTRY-US, V30, P4978, DOI 10.1021/bi00234a020; SHAMES SL, 1984, ARCH BIOCHEM BIOPHYS, V235, P359, DOI 10.1016/0003-9861(84)90209-1; Sharma PK, 2005, BIOCHEMISTRY-US, V44, P11307, DOI 10.1021/bi0509806; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; SMITH RM, 1956, J AM CHEM SOC, V78, P2376, DOI 10.1021/ja01592a009; SMITH RM, 1991, PURE APPL CHEM, V63, P1015, DOI 10.1351/pac199163071015; TETAS M, 1963, BIOCHEMISTRY-US, V2, P350, DOI 10.1021/bi00902a030; Thoden JB, 2005, J BIOL CHEM, V280, P32784, DOI 10.1074/jbc.M505730200; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; TRIBOLET R, 1987, EUR J BIOCHEM, V163, P353, DOI 10.1111/j.1432-1033.1987.tb10807.x; Trobro S, 2006, BIOCHEMISTRY-US, V45, P7049, DOI 10.1021/bi0605383; VIOLA RE, 1978, BIOCHEMISTRY-US, V17, P4111, DOI 10.1021/bi00613a001; Wang KJ, 2005, ORIGINS LIFE EVOL B, V35, P187, DOI 10.1007/s11084-005-0657-8; Wang P, 1995, J SOLUTION CHEM, V24, P989, DOI 10.1007/BF00973517; Wang PM, 1996, J PHYS CHEM-US, V100, P9556, DOI 10.1021/jp960559e; WELCH M, 1995, BIOCHEMISTRY-US, V34, P385, DOI 10.1021/bi00002a001; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002; Wolfenden R, 1999, J AM CHEM SOC, V121, P7419, DOI 10.1021/ja991280p	49	43	45	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22747	22757		10.1074/jbc.M109.017806	http://dx.doi.org/10.1074/jbc.M109.017806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531469	Green Published, hybrid			2022-12-27	WOS:000268963100029
J	Sommerfeld, A; Reinehr, R; Haussinger, D				Sommerfeld, Annika; Reinehr, Roland; Haeussinger, Dieter			Bile Acid-induced Epidermal Growth Factor Receptor Activation in Quiescent Rat Hepatic Stellate Cells Can Trigger Both Proliferation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-INDUCED APOPTOSIS; HEPATOCYTE APOPTOSIS; LIVER-INJURY; TYROSINE PHOSPHORYLATION; CD95 LIGAND; KINASE; JNK; MECHANISMS; FIBROSIS; FAS	Bile acids have been reported to induce epidermal growth factor receptor (EGFR) activation and subsequent proliferation of activated hepatic stellate cells (HSC), but the underlying mechanisms and whether quiescent HSC are also a target for bile acid-induced proliferation or apoptosis remained unclear. Therefore, primary rat HSC were cultured for up to 48 h and analyzed for their proliferative/apoptotic responses toward bile acids. Hydrophobic bile acids, i.e. taurolithocholate 3-sulfate, taurochenodeoxycholate, and glycochenodeoxycholate, but not taurocholate or tauroursodeoxycholate, induced Yes-dependent EGFR phosphorylation. Simultaneously, hydrophobic bile acids induced phosphorylation of the NADPH oxidase subunit p47(phox) and formation of reactive oxygen species (ROS). ROS production was sensitive to inhibition of acidic sphingomyelinase, protein kinase C zeta, and NADPH oxidases. All maneuvers which prevented bile acid-induced ROS formation also prevented Yes and subsequent EGFR phosphorylation. Taurolithocholate 3-sulfate-induced EGFR activation was followed by extracellular signal-regulated kinase 1/2, but not c-Jun N-terminal kinase (JNK) activation, and stimulated HSC proliferation. When, however, a JNK signal was induced by coadministration of cycloheximide or hydrogen peroxide (H2O2), activated EGFR associated with CD95 and triggered EGFR-mediated CD95-tyrosine phosphorylation and subsequent formation of the death-inducing signaling complex. In conclusion, hydrophobic bile acids lead to a NADPH oxidase-driven ROS generation followed by a Yes-mediated EGFR activation in quiescent primary rat HSC. This proliferative signal shifts to an apoptotic signal when a JNK signal simultaneously comes into play.	[Sommerfeld, Annika; Reinehr, Roland; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016					Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Cariers A, 2002, CELL PHYSIOL BIOCHEM, V12, P179, DOI 10.1159/000066277; Chieco P, 1997, HISTOCHEM J, V29, P875, DOI 10.1023/A:1026446008712; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Fischer R, 2002, GASTROENTEROLOGY, V123, P845, DOI 10.1053/gast.2002.35384; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Gressner AM, 1998, CELL TISSUE RES, V292, P447, DOI 10.1007/s004410051073; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2007, J BIOL CHEM, V282, P19029, DOI 10.1074/jbc.M703112200; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; Poppleton HM, 1999, ARCH BIOCHEM BIOPHYS, V363, P227, DOI 10.1006/abbi.1998.1095; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Reinehr R, 2004, GASTROENTEROLOGY, V127, P1540, DOI 10.1053/j.gastro.2004.08.056; Reinehr R, 2004, J BIOL CHEM, V279, P10364, DOI 10.1074/jbc.M311997200; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Reinehr R, 2008, GASTROENTEROLOGY, V134, P1494, DOI 10.1053/j.gastro.2008.02.021; SAWITZA I, 2009, HEPATOLOGY IN PRESS; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V291, pG575, DOI 10.1152/ajpgi.00102.2006; Svegliati-Baroni G, 2005, GASTROENTEROLOGY, V128, P1042, DOI 10.1053/j.gastro.2005.01.007; Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115; Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702	36	37	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22173	22183		10.1074/jbc.M109.005355	http://dx.doi.org/10.1074/jbc.M109.005355			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553664	Green Published, hybrid			2022-12-27	WOS:000268783700042
J	Zhou, LJ; Deepa, SS; Etzler, JC; Ryu, JY; Mao, XM; Fang, QC; Liu, DD; Torres, JM; Jia, WP; Lechleiter, JD; Liu, F; Dong, LQ				Zhou, Lijun; Deepa, Sathyaseelan S.; Etzler, Julie C.; Ryu, Jiyoon; Mao, Xuming; Fang, Qichen; Liu, Dianna D.; Torres, Jesus M.; Jia, Weiping; Lechleiter, James D.; Liu, Feng; Dong, Lily Q.			Adiponectin Activates AMP-activated Protein Kinase in Muscle Cells via APPL1/LKB1-dependent and Phospholipase C/Ca2+/Ca2+/Calmodulin-dependent Protein Kinase Kinase-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; GLUCOSE-UPTAKE; C-ZETA; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; TUMOR-SUPPRESSOR; CYCLE ARREST; RAT-BRAIN	The binding of the adaptor protein APPL1 to adiponectin receptors is necessary for adiponectin-induced AMP-activated protein kinase (AMPK) activation in muscle, yet the underlying molecular mechanism remains unknown. Here we show that in muscle cells adiponectin and metformin induce AMPK activation by promoting APPL1-dependent LKB1 cytosolic translocation. APPL1 mediates adiponectin signaling by directly interacting with adiponectin receptors and enhances LKB1 cytosolic localization by anchoring this kinase in the cytosol. Adiponectin also activates another AMPK upstream kinase Ca2+/calmodulin-dependent protein kinase kinase by activating phospholipase C and subsequently inducing Ca2+ release from the endoplasmic reticulum, which plays a minor role in AMPK activation. Our results show that in muscle cells adiponectin is able to activate AMPK via two distinct mechanisms as follows: a major pathway (the APPL1/LKB1-dependent pathway) that promotes the cytosolic localization of LKB1 and a minor pathway (the phospholipase C/Ca2+/Ca2+ Ca2+/calmodulin-dependent protein kinase kinase-dependent pathway) that stimulates Ca2+ release from intracellular stores.	[Deepa, Sathyaseelan S.; Etzler, Julie C.; Ryu, Jiyoon; Liu, Dianna D.; Lechleiter, James D.; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Zhou, Lijun; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Mao, Xuming; Liu, Feng; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Liu, Feng; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA; [Fang, Qichen; Jia, Weiping] Jiao Tong Univ, Affiliated Hosp 6, Shanghai Diabet Inst, Shanghai 200233, Peoples R China; [Torres, Jesus M.] Univ Granada, Fac Med, Dept Biochem & Mol Biol, Granada 18012, Spain	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University; University of Granada	Dong, LQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	dongq@uthscsa.edu	Zhou, Lijun/H-2229-2011; Ryu, Jiyoon/M-8573-2019; Torres, Jesus M/B-3634-2011	Ryu, Jiyoon/0000-0001-7365-0555; Deepa, Sathyaseelan/0000-0002-3669-4820	National Institutes of Health [RO1 DK69930, RO1 DK76902, AG021890, AG19316]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076902, R01DK069930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316, T32AG021890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK69930 (to L. Q. D.), RO1 DK76902 (to F. L.), T32 AG021890 (to J. C. E.), and PPG AG19316 (to J. D. L.). This work was also supported by a career development award from the American Diabetes Association (to L. Q. D.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; CAMACHO P, 1993, SCIENCE, V260, P226, DOI 10.1126/science.8385800; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hattori Y, 2008, FEBS LETT, V582, P1719, DOI 10.1016/j.febslet.2008.04.037; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hue L, 2007, ESSAYS BIOCHEM, V43, P121, DOI 10.1042/bse0430121; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Imai K, 2006, BIOCHEM BIOPH RES CO, V351, P595, DOI 10.1016/j.bbrc.2006.10.056; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2008, FRONT BIOSCI-LANDMRK, V13, P5589; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kuoppamaa H, 2008, DIABETES-METAB RES, V24, P554, DOI 10.1002/dmrr.883; Lee ES, 2008, REGUL PEPTIDES, V151, P71, DOI 10.1016/j.regpep.2008.05.001; Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mao XM, 2006, MINI-REV MED CHEM, V6, P1331, DOI 10.2174/138955706778992978; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; MIKOSHIBA K, 2000, SCI STKE, V51, pPE1; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Sakagami H, 1998, MOL BRAIN RES, V54, P311, DOI 10.1016/S0169-328X(97)00362-8; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Smith DP, 2001, HUM MOL GENET, V10, P2869, DOI 10.1093/hmg/10.25.2869; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vinet J, 2003, MOL BRAIN RES, V111, P216, DOI 10.1016/S0169-328X(02)00698-8; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200	60	166	175	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22426	22435		10.1074/jbc.M109.028357	http://dx.doi.org/10.1074/jbc.M109.028357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520843	Green Published, hybrid			2022-12-27	WOS:000268783700064
J	Dengl, S; Cramer, P				Dengl, Stefan; Cramer, Patrick			Torpedo Nuclease Rat1 Is Insufficient to Terminate RNA Polymerase II in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES TRANSCRIPTION TERMINATION; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; POLY(A) SIGNAL; YEAST GENE; EXORIBONUCLEASE; ELONGATION; PROTEIN; PURIFICATION; SITE	Termination of RNA polymerase (pol) II transcription in vivo requires the 5'-RNA exonuclease Rat1. It was proposed that Rat1 degrades RNA from the 5'-end that is created by transcript cleavage, catches up with elongating pol II, and acts like a Torpedo that removes pol II from DNA. Here we test the Torpedo model in an in vitro system based on bead-coupled pol II elongation complexes (ECs). Recombinant Rat1 complexes with Rai1, and with Rai1 and Rtt103, degrade RNA extending from the EC until they reach the polymerase surface but fail to terminate pol II. Instead, the EC retains an similar to 18-nucleotide RNA that remains with its 3'-end at the active site and can be elongated. Thus, pol II termination apparently requires a factor or several factors in addition to Rat1, Rai1, and Rtt103, post-translational modifications of these factors, or unusual reaction conditions.	[Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de			Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [SFB646]; Transregio; Nanosystems Initiative Munich NIM; Elitenetzwerk Bayern; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Transregio; Nanosystems Initiative Munich NIM; Elitenetzwerk Bayern; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich SFB646, the Transregio 5, the Nanosystems Initiative Munich NIM, the Elitenetzwerk Bayern, and the Fonds der Chemischen Industrie.	AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Aranda A, 1999, MOL CELL BIOL, V19, P1251; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; BATEMAN E, 1988, CELL, V54, P985, DOI 10.1016/0092-8674(88)90113-4; Birse CE, 1997, EMBO J, V16, P3633, DOI 10.1093/emboj/16.12.3633; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; DISEGNI G, 1993, MOL CELL BIOL, V13, P3424, DOI 10.1128/MCB.13.6.3424; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; El Hage A, 2008, GENE DEV, V22, P1069, DOI 10.1101/gad.463708; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; HENDERSON SL, 1989, GENE DEV, V3, P212, DOI 10.1101/gad.3.2.212; Jasiak AJ, 2008, J BIOL CHEM, V283, P26423, DOI 10.1074/jbc.M803237200; Johnson AW, 2001, METHOD ENZYMOL, V342, P260, DOI 10.1016/S0076-6879(01)42550-X; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; LARIMER FW, 1992, GENE, V120, P51, DOI 10.1016/0378-1119(92)90008-D; LARIMER FW, 1990, GENE, V95, P85, DOI 10.1016/0378-1119(90)90417-P; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Lykke-Andersen S, 2007, BIOCHIMIE, V89, P1177, DOI 10.1016/j.biochi.2007.05.007; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Poole T L, 1995, Nucleic Acids Symp Ser, P79; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Reeder RH, 1997, TRENDS BIOCHEM SCI, V22, P473, DOI 10.1016/S0968-0004(97)01133-X; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; STEVENS A, 1978, BIOCHEM BIOPH RES CO, V81, P656, DOI 10.1016/0006-291X(78)91586-3; STEVENS A, 1980, J BIOL CHEM, V255, P3080; STEVENS A, 1987, ARCH BIOCHEM BIOPHYS, V252, P339, DOI 10.1016/0003-9861(87)90040-3; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Tran DP, 2001, MOL CELL BIOL, V21, P7495, DOI 10.1128/MCB.21.21.7495-7508.2001; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Verma-Gaur J, 2008, EUKARYOT CELL, V7, P1009, DOI 10.1128/EC.00057-08; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Xue Y, 2000, MOL CELL BIOL, V20, P4006, DOI 10.1128/MCB.20.11.4006-4015.2000	55	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21270	21279		10.1074/jbc.M109.013847	http://dx.doi.org/10.1074/jbc.M109.013847			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535338	Green Published, hybrid			2022-12-27	WOS:000268564400021
J	Chen, BC; Chang, HM; Hsu, MJ; Shih, CM; Chiu, YH; Chiu, WT; Lin, CH				Chen, Bing-Chang; Chang, Huey-Mei; Hsu, Ming-Jen; Shih, Chwen-Ming; Chiu, Yi-Hua; Chiu, Wen-Ta; Lin, Chien-Huang			Peptidoglycan Induces Cyclooxygenase-2 Expression in Macrophages by Activating the Neutral Sphingomyelinase-Ceramide Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; N-TERMINAL KINASE; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; STAPHYLOCOCCUS-AUREUS; PROTEIN-KINASES; TRANSCRIPTION; INVOLVEMENT; INTERLEUKIN-1	The sphingomyelin signal transduction pathway is known to play a role in mediating the action of various cytokines. Herein, we examined the role of neutral sphingomyelinase (nSMase)/ceramide in peptidoglycan (PGN)-induced NF-kappa B activation and cyclooxygenase-2 (COX-2) expression in macrophages. PGN-induced COX-2 expression was attenuated by an nSMase inhibitor (3-O-methyl-sphingomyeline, 3-OMS) and ceramidase, but not by an acidic SMase inhibitor (imipramine). C2-ceramide, bacterial SMase (which mimics cellular SMase activity), and a ceramidase inhibitor (N-oleoyl-ethanolamine) individually had no effect on COX-2 expression; however, they markedly enhanced PGN-induced COX-2 expression. PGN activated nSMase, but not acidic SMase, resulting in increased ceramide generation. PGN-induced nSMase activation and ceramide formation were inhibited by 3-OMS, but not by imipramine. PGN-induced COX-2 expression was inhibited by a p38 MAPK inhibitor (SB 203580) and dominant negative mutants of MAPK kinase (MKK) 3, MKK6, and p38 MAPK alpha. 3-OMS selectively inhibited PGN-induced p38 MAPK and MKK3/6 activation, but not JNK or ERK1/2. C2-ceramide, bacterial SMase, and N-oleoyl-ethanolamine all induced p38 MAPK or MKK3/6 activation. The PGN-mediated increases in kappa B-luciferase activity were also inhibited by 3-OMS and the p38 MAPK alpha DN, but not by imipramine. Furthermore, C2-ceramide caused an increase in kappa B-luciferase activity. Our data demonstrate for the first time that PGN activates the nSMase/ceramide pathway to induce MKK3/6/p38 MAPK activation, which in turn initiates NF-kappa B activation and ultimately induces COX-2 expression in macrophages. The nSMase/ceramide pathway is required but might not be sufficient for COX-2 expression induced by PGN.	[Chen, Bing-Chang] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei 110, Taiwan; [Chang, Huey-Mei; Hsu, Ming-Jen; Shih, Chwen-Ming; Lin, Chien-Huang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Hsu, Ming-Jen] Taipei Med Univ, Coll Med, Dept Pharmacol, Taipei 110, Taiwan; [Shih, Chwen-Ming] Taipei Med Univ, Coll Med, Dept Biochem, Taipei 110, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Coll Med, Sch Med, Taipei 110, Taiwan; [Chiu, Yi-Hua] Taipei Med Univ, Instrument Ctr, Off Res & Dev, Taipei 110, Taiwan; [Chiu, Wen-Ta; Lin, Chien-Huang] Taipei Med Univ, Shuang Ho Hosp, Taipei 235, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Wang Fang Hosp, Taipei 116, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Lin, CH (corresponding author), 250 Wu Hsing St, Taipei 110, Taiwan.	chlin@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737; Hsu, Ming-Jen/0000-0001-9688-8494	National Science Council of Taiwan [NSC 96-2320-B-038-029-MY3]; Center of Excellence for Clinical Trial and Research in Neurology and Neurosurgery [DOH-TD-B-111-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Center of Excellence for Clinical Trial and Research in Neurology and Neurosurgery	This work was supported by National Science Council of Taiwan Grant NSC 96-2320-B-038-029-MY3 and Center of Excellence for Clinical Trial and Research in Neurology and Neurosurgery Grant DOH-TD-B-111-002.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198; ALBOUZ S, 1986, LIFE SCI, V38, P357, DOI 10.1016/0024-3205(86)90083-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BONE RC, 1994, ARCH INTERN MED, V154, P26, DOI 10.1001/archinte.154.1.26; Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681; Chen BC, 2004, J IMMUNOL, V173, P5219, DOI 10.4049/jimmunol.173.8.5219; Chen BC, 2004, J BIOL CHEM, V279, P20889, DOI 10.1074/jbc.M311279200; Chen BC, 2001, J LEUKOCYTE BIOL, V69, P280; Chen CC, 2001, MOL PHARMACOL, V59, P493, DOI 10.1124/mol.59.3.493; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Cho YH, 2003, MOL PHARMACOL, V63, P512, DOI 10.1124/mol.63.3.512; Delogu G, 1999, CRIT CARE MED, V27, P2413, DOI 10.1097/00003246-199911000-00015; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Kirtikara K, 1998, MOL CELL BIOCHEM, V181, P41; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KRIVAN HC, 1988, P NATL ACAD SCI USA, V85, P6157, DOI 10.1073/pnas.85.16.6157; Lin CH, 2001, BRIT J PHARMACOL, V134, P543, DOI 10.1038/sj.bjp.0704290; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; Marcinkowska E, 1997, BIOCHEM BIOPH RES CO, V241, P419, DOI 10.1006/bbrc.1997.7832; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; MITCHELL JA, 1995, BIOCHEM PHARMACOL, V50, P1535, DOI 10.1016/0006-2952(95)00212-X; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pahan K, 1998, J BIOL CHEM, V273, P2591, DOI 10.1074/jbc.273.5.2591; Palaniyar N, 2002, IMMUNOBIOLOGY, V205, P575, DOI 10.1078/0171-2985-00156; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; Tonnetti L, 1999, J EXP MED, V189, P1581, DOI 10.1084/jem.189.10.1581; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Wang ZM, 2000, J BIOL CHEM, V275, P20260, DOI 10.1074/jbc.M909168199; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Xu ZJ, 2001, J IMMUNOL, V167, P6975, DOI 10.4049/jimmunol.167.12.6975; Zeng C, 2005, J NEUROCHEM, V94, P703, DOI 10.1111/j.1471-4159.2005.03217.x; Zhang P, 1997, J BIOL CHEM, V272, P9609	43	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20562	20573		10.1074/jbc.M109.028084	http://dx.doi.org/10.1074/jbc.M109.028084			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19531467	Green Published, hybrid			2022-12-27	WOS:000268316100018
J	Petschnigg, J; Wolinski, H; Kolb, D; Zellnig, G; Kurat, CF; Natter, K; Kohlwein, SD				Petschnigg, Julia; Wolinski, Heimo; Kolb, Dagmar; Zellnig, Guenther; Kurat, Christoph F.; Natter, Klaus; Kohlwein, Sepp D.			Good Fat, Essential Cellular Requirements for Triacylglycerol Synthesis to Maintain Membrane Homeostasis in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN-RESPONSE; MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; ENDOPLASMIC-RETICULUM MEMBRANE; GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE; LIPID PARTICLES; ACID SYNTHESIS; PHOSPHOLIPID-SYNTHESIS; TRANSCRIPTION FACTOR; PATHWAY	Storage triacylglycerols (TAG) and membrane phospholipids share common precursors, i.e. phosphatidic acid and diacylglycerol, in the endoplasmic reticulum. In addition to providing a biophysically rather inert storage pool for fatty acids, TAG synthesis plays an important role to buffer excess fatty acids (FA). The inability to incorporate exogenous oleic acid into TAG in a yeast mutant lacking the acyltransferases Lro1p, Dga1p, Are1p, and Are2p contributing to TAG synthesis results in dysregulation of lipid synthesis, massive proliferation of intracellular membranes, and ultimately cell death. Carboxypeptidase Y trafficking from the endoplasmic reticulum to the vacuole is severely impaired, but the unfolded protein response is only moderately up-regulated, and dispensable for membrane proliferation, upon exposure to oleic acid. FA-induced toxicity is specific to oleic acid and much less pronounced with palmitoleic acid and is not detectable with the saturated fatty acids, palmitic and stearic acid. Palmitic acid supplementation partially suppresses oleic acid-induced lipotoxicity and restores carboxypeptidase Y trafficking to the vacuole. These data show the following: (i) FA uptake is not regulated by the cellular lipid requirements; (ii) TAG synthesis functions as a crucial intracellular buffer for detoxifying excess unsaturated fatty acids; (iii) membrane lipid synthesis and proliferation are responsive to and controlled by a balanced fatty acid composition.	[Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Zellnig, Guenther] Graz Univ, Inst Plant Sci, A-8010 Graz, Austria	University of Graz; University of Graz	Kohlwein, SD (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-11, A-8010 Graz, Austria.	sepp.kohlwein@uni-graz.at		Wolinski, Heimo/0000-0002-1583-6092; Kurat, Christoph/0000-0003-0962-3258; Kohlwein, Sepp Dieter/0000-0002-1030-0598	Federal Ministry for Science and Research; Austrian Science Fund [F3005]; Austrian Science Fund (FWF) [F 3005, W 901] Funding Source: researchfish	Federal Ministry for Science and Research; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by grants from the Federal Ministry for Science and Research (Project GOLD, Genomics of Lipid-associated Disorders, in the framework of the GEN-AU Program) and the Austrian Science Fund Project SFB Lipotox F3005 (to S. D. K.).	Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chang HJ, 2002, GENETICS, V162, P29; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Collins RN, 2006, CELL, V124, P464, DOI 10.1016/j.cell.2006.01.017; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huyer G, 2004, MOL BIOL CELL, V15, P908, DOI 10.1091/mbc.E03-07-0546; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; KOHLWEIN SD, 1984, BIOCHIM BIOPHYS ACTA, V792, P310, DOI 10.1016/0005-2760(84)90198-X; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Larson LL, 2002, YEAST, V19, P373, DOI 10.1002/yea.839; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; MECHLER B, 1987, EMBO J, V6, P2157, DOI 10.1002/j.1460-2075.1987.tb02483.x; Menzel R, 1997, YEAST, V13, P1211, DOI 10.1002/(SICI)1097-0061(199710)13:13<1211::AID-YEA168>3.0.CO;2-8; MORRISON WR, 1964, J LIPID RES, V5, P600; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schneiter R, 1997, CELL, V88, P431, DOI 10.1016/S0092-8674(00)81882-6; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Skoneczny M, 1996, BIOCHIMIE, V78, P95, DOI 10.1016/0300-9084(96)82639-3; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sorger D, 2003, APPL MICROBIOL BIOT, V61, P289, DOI 10.1007/s00253-002-1212-4; Stroobants AK, 1999, FEBS LETT, V453, P210, DOI 10.1016/S0014-5793(99)00721-8; Tatzer V, 2002, MOL BIOL CELL, V13, P4429, DOI 10.1091/mbc.E02-04-0196; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Trotter PJ, 2001, ANNU REV NUTR, V21, P97, DOI 10.1146/annurev.nutr.21.1.97; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; WATERHAM HR, 1994, J CELL BIOL, V127, P737, DOI 10.1083/jcb.127.3.737; Wolinski H, 2009, J PROTEOME RES, V8, P20, DOI 10.1021/pr800782n; Wolinski Heimo, 2008, V457, P151, DOI 10.1007/978-1-59745-261-8_11; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	74	149	154	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30981	30993		10.1074/jbc.M109.024752	http://dx.doi.org/10.1074/jbc.M109.024752			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19608739	Green Published, hybrid			2022-12-27	WOS:000271378400028
J	Cendron, L; Trovato, A; Seno, F; Folli, C; Alfieri, B; Zanotti, G; Berni, R				Cendron, Laura; Trovato, Antonio; Seno, Flavio; Folli, Claudia; Alfieri, Beatrice; Zanotti, Giuseppe; Berni, Rodolfo			Amyloidogenic Potential of Transthyretin Variants INSIGHTS FROM STRUCTURAL AND COMPUTATIONAL ANALYSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; 2.5 ANGSTROM RESOLUTION; RAT TRANSTHYRETIN; CRYSTAL-STRUCTURE; FIBRIL FORMATION; NATIVE-STATE; KINETIC STABILIZATION; AGGREGATION-PRONE; DENATURATION; PROTEINS	Human transthyretin (TTR) is an amyloidogenic protein whose mild amyloidogenicity is enhanced by many point mutations affecting considerably the amyloid disease phenotype. To ascertain whether the high amyloidogenic potential of TTR variants may be explained on the basis of the conformational change hypothesis, an aim of this work was to determine structural alterations for five amyloidogenic TTR variants crystallized under native and/or destabilizing (moderately acidic pH) conditions. While at acidic pH structural changes may be more significant because of a higher local protein flexibility, only limited alterations, possibly representing early events associated with protein destabilization, are generally induced by mutations. This study was also aimed at establishing to what extent wildtype TTR and its amyloidogenic variants are intrinsically prone to beta-aggregation. We report the results of a computational analysis predicting that wild-type TTR possesses a very high intrinsic beta-aggregation propensity which is on average not enhanced by amyloidogenic mutations. However, when located in beta-strands, most of these mutations are predicted to destabilize the native beta-structure. The analysis also shows that rat and murine TTR have a lower intrinsic beta-aggregation propensity and a similar native beta-structure stability compared with human TTR. This result is consistent with the lack of in vitro amyloidogenicity found for both murine and rat TTR. Collectively, the results of this study support the notion that the high amyloidogenic potential of human pathogenic TTR variants is determined by the destabilization of their native structures, rather than by a higher intrinsic v-aggregation propensity.	[Cendron, Laura; Zanotti, Giuseppe] Univ Padua, Dept Biol Chem, I-35121 Padua, Italy; [Cendron, Laura; Zanotti, Giuseppe] Ist Chim Biomol, Sect Padua, I-35121 Padua, Italy; [Trovato, Antonio; Seno, Flavio] Univ Padua, Dept Phys G Galilei, I-35131 Padua, Italy; [Trovato, Antonio; Seno, Flavio] Univ Padua, Consorzio Nazl Interuniv Sci Fis Mat, I-35131 Padua, Italy; [Folli, Claudia; Alfieri, Beatrice; Berni, Rodolfo] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Cendron, Laura; Zanotti, Giuseppe] Venetian Inst Mol Med, I-35129 Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); University of Padua; University of Padua; University of Parma; Veneto Institute Molecular Medicine	Zanotti, G (corresponding author), Univ Padua, Dept Biol Chem, Viale G Colombo, I-35121 Padua, Italy.	giuseppe.zanotti@unipd.it; rodolfo.berni@unipr.it	cendron, Laura/A-5202-2014; Trovato, Antonio/A-3471-2009	Trovato, Antonio/0000-0002-1596-9477; Seno, Flavio/0000-0002-9095-4726; Cendron, Laura/0000-0002-0125-0461; Zanotti, Giuseppe/0000-0002-0945-6501; Berni, Rodolfo/0000-0002-1839-0479	University of Padua and Progetto di Ateneo [CPDA083702]; University of Parma; PRIN [2007B57EAB]	University of Padua and Progetto di Ateneo; University of Parma; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the University of Padua and Progetto di Ateneo n. CPDA083702, by the University of Parma and by the PRIN Project 2007 No. 2007B57EAB.	Altland K, 2007, ELECTROPHORESIS, V28, P2053, DOI 10.1002/elps.200600840; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Bonifacio MJ, 1996, BBA-MOL BASIS DIS, V1316, P35, DOI 10.1016/0925-4439(96)00014-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Damas AM, 1996, ACTA CRYSTALLOGR D, V52, P966, DOI 10.1107/S0907444996003307; Dobson CM, 2004, SCIENCE, V304, P1259, DOI 10.1126/science.1093078; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandez-Busquets X, 2008, CURR MED CHEM, V15, P1336, DOI 10.2174/092986708784534938; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; HAMILTON JA, 1993, J BIOL CHEM, V268, P2416; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hoang TX, 2006, P NATL ACAD SCI USA, V103, P6883, DOI 10.1073/pnas.0601824103; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; HURSHMAN BAR, 2008, BIOCHEMISTRY-US, V47, P6969; Jenne DE, 1996, P NATL ACAD SCI USA, V93, P6302, DOI 10.1073/pnas.93.13.6302; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu K, 2000, NAT STRUCT BIOL, V7, P754; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; MCCUTCHEN SL, 1993, BIOCHEMISTRY-US, V32, P12119, DOI 10.1021/bi00096a024; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naylor HM, 1999, BIOCHEMISTRY-US, V38, P2647, DOI 10.1021/bi982291i; Neto-Silva RM, 2005, ACTA CRYSTALLOGR D, V61, P333, DOI 10.1107/S0907444904034316; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Pasquato N, 2007, J MOL BIOL, V366, P711, DOI 10.1016/j.jmb.2006.11.076; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; Quintas A, 1997, FEBS LETT, V418, P297, DOI 10.1016/S0014-5793(97)01398-7; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Reixach N, 2008, J BIOL CHEM, V283, P2098, DOI 10.1074/jbc.M708028200; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schormann N, 1998, AMYLOID, V5, P175, DOI 10.3109/13506129809003843; Sebastiao MP, 1998, J BIOL CHEM, V273, P24715, DOI 10.1074/jbc.273.38.24715; Sebastiao MP, 2001, J MOL BIOL, V306, P733, DOI 10.1006/jmbi.2000.4415; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shnyrov VL, 2000, BIOPHYS CHEM, V88, P61, DOI 10.1016/S0301-4622(00)00199-X; Tajiri T, 2002, CLIN CHIM ACTA, V323, P129, DOI 10.1016/S0009-8981(02)00179-1; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/285221; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wojtczak A, 1997, ACTA BIOCHIM POL, V44, P505, DOI 10.18388/abp.1997_4400; Wojtczak A, 2001, ACTA CRYSTALLOGR D, V57, P1061, DOI 10.1107/S0907444901007235; Zanotti G, 2008, FEBS J, V275, P5841, DOI 10.1111/j.1742-4658.2008.06705.x	65	37	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25832	25841		10.1074/jbc.M109.017657	http://dx.doi.org/10.1074/jbc.M109.017657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19602727	Green Published, hybrid			2022-12-27	WOS:000269738000041
J	Khotskaya, YB; Dai, YM; Ritchie, JP; MacLeod, V; Yang, Y; Zinn, K; Sanderson, RD				Khotskaya, Yekaterina B.; Dai, Yuemeng; Ritchie, Joseph P.; MacLeod, Veronica; Yang, Yang; Zinn, Kurt; Sanderson, Ralph D.			Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BONE-MARROW MICROENVIRONMENT; MULTIPLE-MYELOMA; MONOCLONAL-ANTIBODY; SOLUBLE SYNDECAN-1; CELL-SURFACE; CANCER-CELLS; ROUND-TABLE; ANGIOGENESIS; STIMULATION	Myeloma tumors are characterized by high expression of syndecan-1 (CD138), a heparan sulfate proteoglycan present on the myeloma cell surface and shed into the tumor microenvironment. High levels of shed syndecan-1 in the serum of patients are an indicator of poor prognosis, and numerous studies have implicated syndecan-1 in promoting the growth and progression of this cancer. In the present study we directly addressed the role of syndecan-1 in myeloma by stable knockdown of its expression using RNA interference. Knockdown cells that were negative for syndecan-1 expression became apoptotic and failed to grow in vitro. Knockdown cells expressing syndecan-1 at similar to 28% or similar to 14% of normal levels survived and grew well in vitro but formed fewer and much smaller subcutaneous tumors in mice compared with tumors formed by cells expressing normal levels of syndecan-1. When injected intravenously into mice (experimental metastasis model), knockdown cells formed very few metastases as compared with controls. This indicates that syndecan-1 may be required for the establishment of multi-focal metastasis, a hallmark of this cancer. One mechanism of syndecan-1 action occurs via stimulation of tumor angiogenesis because tumors formed by knockdown cells exhibited diminished levels of vascular endothelial growth factor and impaired development of blood vessels. Together, these data indicate that the effects of syndecan-1 on myeloma survival, growth, and dissemination are due, at least in part, to its positive regulation of tumor-host interactions that generate an environment capable of sustaining robust tumor growth.	[Khotskaya, Yekaterina B.; Ritchie, Joseph P.; Yang, Yang; Zinn, Kurt; Sanderson, Ralph D.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Zinn, Kurt] Univ Alabama, Dept Radiol, Birmingham, AL 35294 USA; [Zinn, Kurt] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Yang, Yang; Sanderson, Ralph D.] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Ritchie, Joseph P.; Yang, Yang; Sanderson, Ralph D.] Univ Alabama, Ctr Metab Bone Dis, Birmingham, AL 35294 USA; [Dai, Yuemeng; MacLeod, Veronica] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Dai, Yuemeng] Univ Arkansas Med Sci, Dept Otolaryngol, Little Rock, AR 72205 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Sanderson, RD (corresponding author), Univ Alabama, Dept Pathol, 814 SHEL,1530 3rd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu		Zinn, Kurt/0000-0001-7463-4741	National Institutes of Health [CA055819]; Comprehensive Cancer Center [P30CA013148]; University of Alabama at Birmingham Multi-Purpose Arthritis and Musculoskeletal Center [P30AR48311]; Institutional Training Grant [T32-AR047512]; NATIONAL CANCER INSTITUTE [P01CA055819, P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR047512, P30AR048311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center; University of Alabama at Birmingham Multi-Purpose Arthritis and Musculoskeletal Center; Institutional Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA055819 (to R. D. S.). This work was also supported by Comprehensive Cancer Center Core Support Grant P30CA013148 (to R. D. S.), University of Alabama at Birmingham Multi-Purpose Arthritis and Musculoskeletal Center Grant P30AR48311 (Flow Cytometry Core), and Institutional Training Grant Predoctoral Grant T32-AR047512 (to J. P. R.).	Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Anderson KC, 2002, MOL CANCER THER, V1, P1361; Anderson KC, 2007, EXP HEMATOL, V35, P155, DOI 10.1016/j.exphem.2007.01.024; Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Barlogie B, 2006, WILLIAMS HEMATOLOGY, P1501; Bartlett AH, 2007, MOL CELLS, V24, P153; Bayer-Garner IB, 2001, MODERN PATHOL, V14, P1052, DOI 10.1038/modpathol.3880435; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Borset M, 2000, BLOOD, V96, P2528; Broek IV, 2008, CLIN EXP METASTAS, V25, P325, DOI 10.1007/s10585-007-9108-4; Caers J, 2008, B CANCER, V95, P301, DOI 10.1684/bdc.2008.0600; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Dalton W, 2006, CLIN CANCER RES, V12, P6603, DOI 10.1158/1078-0432.CCR-06-1489; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Jourdan M, 1998, BRIT J HAEMATOL, V100, P637, DOI 10.1046/j.1365-2141.1998.00623.x; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Maeda T, 2004, CANCER RES, V64, P612, DOI 10.1158/0008-5472.CAN-03-2439; Mahtouk K, 2006, ONCOGENE, V25, P7180, DOI 10.1038/sj.onc.1209699; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Perez LE, 2008, J IMMUNOL, V180, P1545, DOI 10.4049/jimmunol.180.3.1545; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Ribatti D, 2006, ONCOGENE, V25, P4257, DOI 10.1038/sj.onc.1209456; Ribatti D, 2008, GENES NUTR, V3, P29, DOI 10.1007/s12263-008-0076-3; Roodman GD, 2002, J BONE MINER RES, V17, P1921, DOI 10.1359/jbmr.2002.17.11.1921; Sanderson RD, 2008, CLIN EXP METASTAS, V25, P149, DOI 10.1007/s10585-007-9125-3; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; Seidel C, 2000, BLOOD, V96, P3139, DOI 10.1182/blood.V96.9.3139.h8003139_3139_3146; Vacca A, 2003, HAEMATOLOGICA, V88, P176; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x; Witzig TE, 1996, CYTOMETRY, V26, P113, DOI 10.1002/(SICI)1097-0320(19960615)26:2<113::AID-CYTO3>3.0.CO;2-H; Yaccoby S, 1999, BLOOD, V94, P3576, DOI 10.1182/blood.V94.10.3576.422k01_3576_3582; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200	39	72	72	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26085	26095		10.1074/jbc.M109.018473	http://dx.doi.org/10.1074/jbc.M109.018473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19596856	hybrid, Green Published			2022-12-27	WOS:000269738000064
J	Shi, LH; Ko, ML; Ko, GYP				Shi, Liheng; Ko, Michael L.; Ko, Gladys Y. -P.			Rhythmic Expression of MicroRNA-26a Regulates the L-type Voltage-gated Calcium Channel alpha 1C Subunit in Chicken Cone Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYLALKYLAMINE N-ACETYLTRANSFERASE; MAMMALIAN CIRCADIAN CLOCK; MELATONIN SYNTHESIS; GENE-EXPRESSION; MESSENGER-RNA; PINEAL-GLAND; C-ELEGANS; CAMP; KINASE; RETINA	MicroRNAs (miRNAs) modulate gene expression by degrading or inhibiting translation of messenger RNAs (mRNAs). Here, we demonstrated that chicken microRNA-26a (gga-mir-26a) is a key posttranscriptional regulator of photoreceptor L-type voltage-gated calcium channel alpha 1C subunit (L-VGCC alpha 1C) expression, and its own expression has a diurnal rhythm, thereby explaining the rhythmic nature of L-VGCC alpha 1Cs. Circadian oscillators in retinal photoreceptors provide a mechanism that allows photoreceptors to anticipate daily illumination changes. In photoreceptors, L-VGCC activities are under circadian control, which are higher at night and lower during the day. Interestingly, the mRNA level of VGCC alpha 1D oscillates, but those for VGCC alpha 1C do not. However, the protein expression of both VGCC alpha 1C and alpha 1D are higher at night in cone photoreceptors. The underlying mechanism regulating L-VGCC alpha 1C protein expression was not clear until now. In vitro targeting reporter assays verified that gga-mir-26a specifically targeted the L-VGCC alpha 1C 3'-untranslated region, and gga-mir-26a expression in the retina peaked during the day. After transfection with gga-mir-26a, L-VGCC alpha 1C protein expression and L-VGCC current density decreased. Therefore, the rhythmic expression of gga-mir-26a regulated the protein expression of the L-VGCC alpha 1C subunit. Additionally, both CLOCK (circadian locomoter output cycles kaput) and CREB (cAMP-response element-binding protein-1) activated gga-mir-26a expression in vitro. This result implies that gga-mir-26a might be a downstream target of circadian oscillators. Our work has uncovered new functional roles for miRNAs in the regulation of circadian rhythms in cone photoreceptors. Circadian regulated miRNAs could serve as the link between the core oscillator and output signaling that further govern biological functions.	[Shi, Liheng; Ko, Michael L.; Ko, Gladys Y. -P.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Ko, GYP (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, 4458 TAMU, College Stn, TX 77843 USA.	gko@cvm.tamu.edu			National Institutes of Health [RO1EY017452]; Department of Veterinary Integrative Bioscience programmatic development minigrant; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022532] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004917, P30ES009106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterinary Integrative Bioscience programmatic development minigrant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1EY017452 ( to G. K.). This work was also supported by a Department of Veterinary Integrative Bioscience programmatic development minigrant ( to G. K.).	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Altamirano J, 2007, CIRC RES, V101, P590, DOI 10.1161/CIRCRESAHA.107.152322; Bailey MJ, 2004, J BIOL CHEM, V279, P52247, DOI 10.1074/jbc.M405679200; Baler R, 1997, J BIOL CHEM, V272, P6979, DOI 10.1074/jbc.272.11.6979; Banerjee D, 2005, DEV CELL, V8, P287, DOI 10.1016/j.devcel.2004.12.006; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bengert P, 2005, BRIEF BIOINFORM, V6, P72, DOI 10.1093/bib/6.1.72; Berger EM, 2005, IN VITRO CELL DEV-AN, V41, P12; Bernard M, 1997, J NEUROCHEM, V68, P213; Boden G, 1996, AM J PHYSIOL-ENDOC M, V271, pE246, DOI 10.1152/ajpendo.1996.271.2.E246; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; Chae KS, 2007, INVEST OPHTH VIS SCI, V48, P901, DOI 10.1167/iovs.06-0824; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng HYM, 2007, CELL CYCLE, V6, P3034, DOI 10.4161/cc.6.24.5106; Chong NW, 2000, J BIOL CHEM, V275, P32991, DOI 10.1074/jbc.M005671200; Chong NW, 2003, J NEUROCHEM, V85, P851, DOI 10.1046/j.1471-4159.2003.01723.x; Dijk DJ, 2005, J BIOL RHYTHM, V20, P279, DOI 10.1177/0748730405278292; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Eide EJ, 2005, METHOD ENZYMOL, V393, P408, DOI 10.1016/S0076-6879(05)93019-X; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Huang KM, 2008, MAMM GENOME, V19, P510, DOI 10.1007/s00335-008-9127-8; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Ivanova TN, 2003, BRAIN RES, V973, P56, DOI 10.1016/S0006-8993(03)02540-X; Ivanova TN, 2003, BRAIN RES, V991, P96, DOI 10.1016/j.brainres.2003.08.003; Jakubcakova V, 2007, NEURON, V54, P831, DOI 10.1016/j.neuron.2007.04.031; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kim WY, 2003, P NATL ACAD SCI USA, V100, P4933, DOI 10.1073/pnas.0736949100; Ko GYP, 2004, J NEUROSCI, V24, P1296, DOI 10.1523/JNEUROSCI.3560-03.2004; Ko GYP, 2003, J NEUROSCI, V23, P3145; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Ko ML, 2009, J NEUROCHEM, V108, P1607, DOI 10.1111/j.1471-4159.2009.05931.x; Kuss AW, 2008, CURR NEUROL NEUROSCI, V8, P190, DOI 10.1007/s11910-008-0031-0; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Mao DL, 1998, MOL ENDOCRINOL, V12, P492, DOI 10.1210/me.12.4.492; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; O'Neill JS, 2007, CURR BIOL, V17, pR760, DOI 10.1016/j.cub.2007.07.001; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; REME C, 1986, BRAIN RES, V369, P356, DOI 10.1016/0006-8993(86)90550-0; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Ryan D, 2006, MOL VIS, V12, P1175; Sambrook J., 2001, MOL CLONING LAB MANU; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Shi L, 2009, J BIOL CHEM, V284, P3966, DOI 10.1074/jbc.M806333200; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Spiwoks-Becker I, 2004, EUR J NEUROSCI, V19, P1559, DOI 10.1111/j.1460-9568.2004.03198.x; TOHSE N, 1992, CIRC RES, V71, P376, DOI 10.1161/01.RES.71.2.376; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Xu SP, 2009, CHINESE J STRUC CHEM, V28, P87; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200	69	33	37	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25791	25803		10.1074/jbc.M109.033993	http://dx.doi.org/10.1074/jbc.M109.033993			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19608742	hybrid, Green Published			2022-12-27	WOS:000269738000037
J	Leitch, JM; Yick, PJ; Culotta, VC				Leitch, Jeffry M.; Yick, Priscilla J.; Culotta, Valeria C.			The Right to Choose: Multiple Pathways for Activating Copper, Zinc Superoxide Dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; CHAPERONE CCS; CU,ZN-SUPEROXIDE DISMUTASE; POSTTRANSLATIONAL MODIFICATIONS; INTERMEMBRANE SPACE; SOD1; MITOCHONDRIA; METAL; YEAST; PROTEIN	Since the discovery of SOD1 in 1969, there have been numerous achievements made in our understanding of the enzyme's biochemical reactivity and its role in oxidative stress protection and as a genetic determinant in amyotrophic lateral sclerosis. Many recent advances have also been made in understanding the "activation" of SOD1, i.e. the process by which an inert polypeptide is converted to a mature active enzyme through post-translational modifications. To date, two such activation pathways have been identified: one requiring the CCS copper chaperone and one that works independently of CCS to insert copper and activate SOD1 through oxidation of an intramolecular disulfide. Depending on an organism's lifestyle and complexity, different eukaryotes have evolved to favor one pathway over the other. Some organisms rely solely on CCS for activating SOD1, and others can only activate SOD1 independently of CCS, whereas the majority of eukaryotes appear to have evolved to use both pathways. In this minireview, we shall highlight recent advances made in understanding the mechanisms by which the CCS-dependent and CCS-independent pathways control the activity, structure, and intracellular localization of copper, zinc superoxide dismutase, with relevance to amyotrophic lateral sclerosis and an emphasis on evolutionary biology.	[Leitch, Jeffry M.; Yick, Priscilla J.; Culotta, Valeria C.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Culotta, VC (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	vculotta@jhsph.edu			Johns Hopkins University NIEHS Center; National Institutes of Health [GM 50016]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819, T35ES007308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087904, R01GM050016, R37GM050016] Funding Source: NIH RePORTER	Johns Hopkins University NIEHS Center(Johns Hopkins University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Johns Hopkins University NIEHS Center and by National Institutes of Health Grant GM 50016 (to V.C.C.). This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chu CC, 2005, PLANT PHYSIOL, V139, P425, DOI 10.1104/pp.105.065284; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cozzolino M, 2009, ANTIOXID REDOX SIGN, V11, P1547, DOI 10.1089/ARS.2009.2545; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DJINOVIC K, 1992, J MOL BIOL, V225, P791, DOI 10.1016/0022-2836(92)90401-5; Eisses JF, 2000, BIOCHEMISTRY-US, V39, P7337, DOI 10.1021/bi000690j; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FORMAN HJ, 1973, J BIOL CHEM, V248, P2645; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Kawamata H, 2008, HUM MOL GENET, V17, P3303, DOI 10.1093/hmg/ddn226; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Laliberte J, 2004, J BIOL CHEM, V279, P28744, DOI 10.1074/jbc.M403426200; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; Lin SJ, 1997, J BIOL CHEM, V272, P9215; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Reddehase S, 2009, J MOL BIOL, V385, P331, DOI 10.1016/j.jmb.2008.10.088; ROE JA, 1988, BIOCHEMISTRY-US, V27, P950, DOI 10.1021/bi00403a017; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosenzweig AC, 2000, CURR OPIN CHEM BIOL, V4, P140, DOI 10.1016/S1367-5931(99)00066-6; Rothstein JD, 1999, J NEUROCHEM, V72, P422, DOI 10.1046/j.1471-4159.1999.0720422.x; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; SEETHARAMAN SV, 2009, EXP BIOL ME IN PRESS; Son M, 2008, J BIOL CHEM, V283, P12267, DOI 10.1074/jbc.M708523200; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Son M, 2009, NEUROBIOL DIS, V34, P155, DOI 10.1016/j.nbd.2009.01.005; Stasser JP, 2007, BIOCHEMISTRY-US, V46, P11845, DOI 10.1021/bi700566h; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Trumbull KA, 2009, ANTIOXID REDOX SIGN, V11, P1627, DOI 10.1089/ARS.2009.2574; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Zhu HN, 2000, BIOCHEMISTRY-US, V39, P5413, DOI 10.1021/bi992727+	50	80	81	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24679	24683		10.1074/jbc.R109.040410	http://dx.doi.org/10.1074/jbc.R109.040410			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19586921	hybrid, Green Published			2022-12-27	WOS:000269734000002
J	Spiering, D; Schmolke, M; Ohnesorge, N; Schmidt, M; Goebeler, M; Wegener, J; Wixler, V; Ludwig, S				Spiering, Desiree; Schmolke, Mirco; Ohnesorge, Nils; Schmidt, Marc; Goebeler, Matthias; Wegener, Joachim; Wixler, Viktor; Ludwig, Stephan			MEK5/ERK5 Signaling Modulates Endothelial Cell Migration and Focal Contact Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; GENE-EXPRESSION; ADHESION KINASE; ERK5; MICE; P130(CAS); BMK1/ERK5; ACTIN; TRANSCRIPTION	The formation of new blood vessels from pre-existing ones requires highly coordinated restructuring of endothelial cells (EC) and the surrounding extracellular matrix. Directed EC migration is a central step in this process and depends on cellular signaling cascades that initiate and control the structural rearrangements. On the basis of earlier findings that ERK5 deficiency in mouse EC results in massive defects in vessel architecture, we focused on the impact of the MEK5/ERK5 signaling pathway on EC migration. Using a retroviral gene transfer approach, we found that constitutive activation of MEK5/ERK5 signaling strongly inhibits EC migration and results in massive morphological changes. The area covered by spread EC was dramatically enlarged, accompanied by an increase in focal contacts and altered organization of actin filaments. Consequently, cells were more rigid and show reduced motility. This phenotype was most likely based on decreased focal contact turnover caused by reduced expression of p130Cas, a key player in directed cell migration. We demonstrate for the first time that ERK5 signaling not only is involved in EC survival and stress response but also controls migration and morphology of EC.	[Wixler, Viktor; Ludwig, Stephan] Univ Klinikum Muenster, IMV, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany; [Wixler, Viktor; Ludwig, Stephan] Univ Klinikum Muenster, Interdisciplinary Ctr Med Res IZKF, D-48149 Munster, Germany; [Ohnesorge, Nils; Schmidt, Marc; Goebeler, Matthias] Univ Heidelberg, Dept Dermatol, Univ Med Ctr Mannheim, D-68167 Mannheim, Germany; [Ohnesorge, Nils; Schmidt, Marc; Goebeler, Matthias] Univ Giessen, Dept Dermatol, D-35392 Giessen, Germany; [Wegener, Joachim] Univ Regensburg, Inst Analyt Chem, Chemo & Biosensors Grp, D-93040 Regensburg, Germany	University of Munster; University of Munster; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; University of Regensburg	Ludwig, S (corresponding author), Univ Klinikum Muenster, IMV, Ctr Mol Biol Inflammat ZMBE, von Esmarch Str 56, D-48149 Munster, Germany.	ludwigs@uni-muenster.de	Wegener, Joachim/AAR-3641-2020; Schmolke, Mirco/AAI-9081-2020; Schmidt, Marc/E-8821-2010; Goebeler, Matthias/F-7118-2013; Wegener, Joachim/A-1234-2011; Goebeler, Matthias/P-3612-2019	Schmolke, Mirco/0000-0002-2491-3029; Schmidt, Marc/0000-0002-8643-1615; Ludwig, Stephan/0000-0003-4490-3052				Abassi YA, 2003, J BIOL CHEM, V278, P35636, DOI 10.1074/jbc.M306438200; Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; GIAEVER I, 1986, IEEE T BIO-MED ENG, V33, P242, DOI 10.1109/TBME.1986.325896; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Goebeler M, 2001, BLOOD, V97, P46, DOI 10.1182/blood.V97.1.46; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Johnson TR, 2008, MOL CANCER RES, V6, P1639, DOI 10.1158/1541-7786.MCR-08-0052; Kaneda T, 2008, CANCER LETT, V270, P354, DOI 10.1016/j.canlet.2008.05.042; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lindemann D, 1997, MOL MED, V3, P466, DOI 10.1007/BF03401693; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mauriz JL, 2008, J PHARM SCI-US, V97, P4129, DOI 10.1002/jps.21286; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Pi XC, 2004, CIRC RES, V94, P362, DOI 10.1161/01.RES.0000112406.27800.6F; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schramp M, 2008, J CELL BIOL, V181, P1195, DOI 10.1083/jcb.200801078; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Villa-Moruzzi E, 2007, BIOCHEM J, V408, P7, DOI 10.1042/BJ20070058; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	37	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24972	24980		10.1074/jbc.M109.042911	http://dx.doi.org/10.1074/jbc.M109.042911			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605361	Green Published, hybrid			2022-12-27	WOS:000269734000032
J	Gesell, A; Rolf, M; Ziegler, J; Chavez, MLD; Huang, FC; Kutchan, TM				Gesell, Andreas; Rolf, Megan; Ziegler, Joerg; Chavez, Maria Luisa Diaz; Huang, Fong-Chin; Kutchan, Toni M.			CYP719B1 Is Salutaridine Synthase, the C-C Phenol-coupling Enzyme of Morphine Biosynthesis in Opium Poppy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450 REDUCTASES; COPTIS-JAPONICA CELLS; PAPAVER-SOMNIFERUM; MOLECULAR-CLONING; HETEROLOGOUS EXPRESSION; BENZYLISOQUINOLINE ALKALOIDS; METHYLENEDIOXY BRIDGE; BERBERIS-STOLONIFERA; GENE TRANSCRIPT; CULTURES	Morphine is a powerful analgesic natural product produced by the opium poppy Papaver somniferum. Although formal syntheses of this alkaloid have been reported, the morphine molecule contains five stereocenters and a C-C phenol linkage that to date render a total synthesis of morphine commercially unfeasible. The C-C phenol-coupling reaction along the biosynthetic pathway to morphine in opium poppy is catalyzed by the cytochrome P450-dependent oxygenase salutaridine synthase. We report herein on the identification of salutaridine synthase as a member of the CYP719 family of cytochromes P450 during a screen of recombinant cytochromes P450 of opium poppy functionally expressed in Spodoptera frugiperda Sf9 cells. Recombinant CYP719B1 is a highly stereo-and regioselective enzyme; of forty-one compounds tested as potential substrates, only (R)reticuline and (R)-norreticuline resulted in formation of a product (salutaridine and norsalutaridine, respectively). To date, CYP719s have been characterized catalyzing only the formation of a methylenedioxy bridge in berberine biosynthesis (canadine synthase, CYP719A1) and in benzo[c]phenanthridine biosynthesis (stylopine synthase, CYP719A14). Previously identified phenol-coupling enzymes of plant alkaloid biosynthesis belong only to the CYP80 family of cytochromes. CYP719B1 therefore is the prototype for a new family of plant cytochromes P450 that catalyze formation of a phenol-couple.	[Rolf, Megan; Chavez, Maria Luisa Diaz; Kutchan, Toni M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Gesell, Andreas; Ziegler, Joerg; Chavez, Maria Luisa Diaz; Kutchan, Toni M.] Leibniz Inst Pflanzenbiochem, D-06120 Halle, Saale, Germany; [Huang, Fong-Chin; Kutchan, Toni M.] Univ Munich, Mol Biol Lab, D-80333 Munich, Germany	Donald Danforth Plant Science Center; Leibniz Institut fur Pflanzenbiochemie; University of Munich	Kutchan, TM (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	tmkutchan@danforthcenter.org	Ziegler, Jörg/W-7645-2019; Kutchan, Toni/L-4625-2013	Gesell, Andreas/0000-0002-9614-7079; Augustin, Megan/0000-0002-8430-6466	Deutsche Forschungsgemeinschaft, Bonn, Germany; Fonds der Chemischen Industrie, Frankfurt, Germany; Mallinckrodt Foundation, St. Louis, MO	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Fonds der Chemischen Industrie, Frankfurt, Germany(Fonds der Chemischen Industrie); Mallinckrodt Foundation, St. Louis, MO	This work was supported in part by the Deutsche Forschungsgemeinschaft, Bonn, Germany, Fonds der Chemischen Industrie, Frankfurt, Germany, and the Mallinckrodt Foundation, St. Louis, MO.	Bak S, 1997, PLANT J, V11, P191, DOI 10.1046/j.1365-313X.1997.11020191.x; BARTON DHR, 1967, J CHEM SOC C, P128, DOI 10.1039/j39670000128; BJORKLUND JA, 1995, J AM CHEM SOC, V117, P1533, DOI 10.1021/ja00110a009; Davin LB, 2005, CURR OPIN BIOTECH, V16, P398, DOI 10.1016/j.copbio.2005.06.010; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; EILERT U, 1985, J PLANT PHYSIOL, V119, P65, DOI 10.1016/S0176-1617(85)80216-9; GERARDY R, 1993, PHYTOCHEMISTRY, V32, P79, DOI 10.1016/0031-9422(92)80111-Q; GOTOH O, 1992, J BIOL CHEM, V267, P83; Grobe N, 2009, J BIOL CHEM, V284, P24425, DOI 10.1074/jbc.M109.011320; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; HOLTON TA, 1993, NATURE, V366, P276, DOI 10.1038/366276a0; Huang FC, 2000, PHYTOCHEMISTRY, V53, P555, DOI 10.1016/S0031-9422(99)00600-7; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; KAMETANI T, 1971, J CHEM SOC C, P1021, DOI 10.1039/j39710001021; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; KUTCHAN TM, 1994, PHYTOCHEMISTRY, V35, P353, DOI 10.1016/S0031-9422(00)94763-0; KUTCHAN TM, 1998, ALKALOIDS, V50, P257; Lewis NG, 1999, CURR OPIN PLANT BIOL, V2, P153, DOI 10.1016/S1369-5266(99)80030-2; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Niemetz R, 2005, PHYTOCHEMISTRY, V66, P2001, DOI 10.1016/j.phytochem.2005.01.009; Novak BH, 2000, CURR ORG CHEM, V4, P343, DOI 10.2174/1385272003376292; OKEEFE DP, 1989, PLANT PHYSIOL, V89, P1141, DOI 10.1104/pp.89.4.1141; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pauli HH, 1998, PLANT J, V13, P793, DOI 10.1046/j.1365-313X.1998.00085.x; Rosco A, 1997, ARCH BIOCHEM BIOPHYS, V348, P369, DOI 10.1006/abbi.1997.0374; RUEFFER M, 1994, PHYTOCHEMISTRY, V36, P1219, DOI 10.1016/S0031-9422(00)89640-5; Rupasinghe Sanjeewa, 2006, Phytochemistry Reviews, V5, P473, DOI 10.1007/s11101-006-9028-y; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STADLER R, 1993, J BIOL CHEM, V268, P823; SZANTAY C, 1982, J ORG CHEM, V47, P594, DOI 10.1021/jo00342a051; UMEMOTO N, 1993, FEBS LETT, V330, P169, DOI 10.1016/0014-5793(93)80266-W; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; ZENK MH, 1989, J CHEM SOC CHEM COMM, P1725, DOI 10.1039/c39890001725; Ziegler J, 2005, PLANTA, V222, P458, DOI 10.1007/s00425-005-1550-4; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5	40	106	121	4	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24432	24442		10.1074/jbc.M109.033373	http://dx.doi.org/10.1074/jbc.M109.033373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19567876	hybrid, Green Published			2022-12-27	WOS:000269380200056
J	Guan, HP; Goldstein, JL; Brown, MS; Liang, G				Guan, Hong-Ping; Goldstein, Joseph L.; Brown, Michael S.; Liang, Guosheng			Accelerated Fatty Acid Oxidation in Muscle Averts Fasting-induced Hepatic Steatosis in SJL/J Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-SYNTHESIS; CHOLESTEROL; DEFICIENCY; METABOLISM; INSULIN; SCAP	The accumulation of triglycerides (TG) in the liver, designated hepatic steatosis, is characteristically associated with obesity and insulin resistance, but it can also develop after fasting. Here, we show that fasting-induced hepatic steatosis is under genetic control in inbred mice. After a 24-h fast, C57BL/6J mice and SJL/J mice both lost more than 20% of body weight and similar to 60% of total body TG. In C57BL/6J mice, TG accumulated in liver, producing frank steatosis. In striking contrast, SJL/J mice failed to accumulate any hepatic TG even though they lost nearly as much adipose tissue mass as the C57BL/6J mice. Mice from five other inbred strains developed fasting-induced steatosis like the C57BL/6J mice. Measurements of the uptake of free fatty acids (FA) in vivo and in vitro demonstrated that SJL/J mice were protected from steatosis because their heart and skeletal muscle took up and oxidized twice as much FA as compared with C57BL/6J mice. As a result of this muscle diversion, serum-free FA and ketone bodies rose much less after fasting in SJL/J mice as compared with C57BL/6J mice. When livers of SJL/J and C57BL/6J mice were perfused with similar concentrations of FA, the livers took up and esterified similar amounts. We conclude that SJL/J mice express one or more variant genes that lead to enhanced FA uptake and oxidation in muscle, thereby sparing the liver from FA overload in the fasting state.	[Guan, Hong-Ping; Goldstein, Joseph L.; Brown, Michael S.; Liang, Guosheng] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu		Guan, Hong-Ping/0000-0002-2282-3193	National Institutes of Health [HL20948, DK81182]; Moss Heart Foundation; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Foundation; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported, in whole or in part, by Grants HL20948 and DK81182 from the National Institutes of Health. This work was also supported by the Moss Heart Foundation and Perot Family Foundation.	Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; CRISPENS CG, 1973, LAB ANIM SCI, V23, P408; Cui YX, 2004, MOL CELL BIOL, V24, P258, DOI 10.1128/MCB.24.1.258-269.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Havel RJ, 1997, P NUTR SOC, V56, P659, DOI 10.1079/PNS19970065; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lin XB, 2005, AM J PHYSIOL-GASTR L, V288, pG1179, DOI 10.1152/ajpgi.00411.2004; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; MCGARRY JD, 1971, J BIOL CHEM, V246, P1149; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Vafiadaki E, 2001, NEUROREPORT, V12, P625, DOI 10.1097/00001756-200103050-00039; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097	22	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24644	24652		10.1074/jbc.M109.034397	http://dx.doi.org/10.1074/jbc.M109.034397			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19581301	Green Published, hybrid			2022-12-27	WOS:000269380200073
J	Hsu, YH; Burke, JE; Li, S; Woods, VL; Dennis, EA				Hsu, Yuan-Hao; Burke, John E.; Li, Sheng; Woods, Virgil L., Jr.; Dennis, Edward A.			Localizing the Membrane Binding Region of Group VIA Ca2+-independent Phospholipase A(2) Using Peptide Amide Hydrogen/Deuterium Exchange Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUTERIUM-EXCHANGE; CRYSTAL-STRUCTURE; PROTEIN-KINASE; EXPRESS GROUP; CONFORMATIONAL-CHANGES; HYDROGEN-EXCHANGE; PANCREATIC-ISLETS; C2 DOMAIN; PSI-BLAST; CELLS	The Group VIA-2 Ca2+-independent phospholipase A(2) (GVIA-2 iPLA(2)) is composed of seven consecutive N-terminal ankyrin repeats, a linker region, and a C-terminal phospholipase catalytic domain. No structural information exists for this enzyme, and no information is known about the membrane binding surface. We carried out deuterium exchange experiments with the GVIA-2 iPLA(2) in the presence of both phospholipid substrate and the covalent inhibitor methyl arachidonoyl fluorophosphonate and located regions in the protein that change upon lipid binding. No changes were seen in the presence of only methyl arachidonoyl fluorophosphonate. The region with the greatest change upon lipid binding was region 708-730, which showed a >70% decrease in deuteration levels at numerous time points. No decreases in exchange due to phospholipid binding were seen in the ankyrin repeat domain of the protein. To locate regions with changes in exchange on the enzyme, we constructed a computational homology model based on homologous structures. This model was validated by comparing the deuterium exchange results with the predicted structure. Our model combined with the deuterium exchange results in the presence of lipid substrate have allowed us to propose the first structural model of GVIA-2 iPLA(2) as well as the interfacial lipid binding region.	[Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hsu, Yuan-Hao; Burke, John E.; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Hsu, Yuan-Hao; Burke, John E.; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Woods, VL (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; edennis@ucsd.edu	hsu, yuan-hao/B-5744-2009; Burke, John/A-5659-2013; Burke, John/H-3922-2019; Dennis, Edward A./M-5554-2019	Burke, John/0000-0003-1668-2109; Burke, John/0000-0001-7904-9859; Dennis, Edward A./0000-0003-3738-3140	National Institutes of Health [GM20501, CA099835, CA118595, AI076961]; NATIONAL CANCER INSTITUTE [R21CA118595, R33CA099835, R21CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020501, R01GM020501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM20501 (to E. A. D.) and CA099835, CA118595, and AI076961 (to V. L. W.).	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Balsinde J, 2006, BBA-MOL CELL BIOL L, V1761, P1344, DOI 10.1016/j.bbalip.2006.07.013; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Forsell PKAL, 1999, EUR J BIOCHEM, V262, P575, DOI 10.1046/j.1432-1327.1999.00418.x; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Y, 2002, J MOL BIOL, V321, P703, DOI 10.1016/S0022-2836(02)00419-9; Hemmer W, 1997, J BIOL CHEM, V272, P16946, DOI 10.1074/jbc.272.27.16946; Hochrein JM, 2006, PROTEIN SCI, V15, P65, DOI 10.1110/ps.051782206; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Hsu YH, 2008, J BIOL CHEM, V283, P36397, DOI 10.1074/jbc.M805581200; Kim MY, 2002, PROTEIN SCI, V11, P1320, DOI 10.1110/ps.3140102; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Ramanadham S, 2008, AM J PATHOL, V172, P868, DOI 10.2353/ajpath.2008.070756; Roshak AK, 2000, J BIOL CHEM, V275, P35692, DOI 10.1074/jbc.M002273200; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312; Yan XG, 2002, PROTEIN SCI, V11, P2113, DOI 10.1110/ps.0204402; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang ZQ, 1996, BIOCHEMISTRY-US, V35, P779, DOI 10.1021/bi952227q	44	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23652	23661		10.1074/jbc.M109.021857	http://dx.doi.org/10.1074/jbc.M109.021857			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19556238	hybrid, Green Published			2022-12-27	WOS:000269180000051
J	Johnson, MP; Ruban, AV				Johnson, Matthew P.; Ruban, Alexander V.			Photoprotective Energy Dissipation in Higher Plants Involves Alteration of the Excited State Energy of the Emitting Chlorophyll(s) in the Light Harvesting Antenna II (LHCII)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED PEA THYLAKOIDS; PHOTOSYSTEM-II; EXCITATION-ENERGY; A FLUORESCENCE; XANTHOPHYLL CYCLE; MOLECULAR-MECHANISM; ALPHA-FLUORESCENCE; ABSORBENCY CHANGES; CRYSTAL-STRUCTURE; CATION FORMATION	Non-photochemical quenching (NPQ), a mechanism of energy dissipation in higher plants protects photosystem II ( PSII) reaction centers from damage by excess light. NPQ involves a reduction in the chlorophyll excited state lifetime in the PSII harvesting antenna (LHCII) by a quencher. Yet, little is known about the effect of the quencher on chlorophyll excited state energy and dynamics. Application of picosecond time-resolved fluorescence spectroscopy demonstrated that NPQ involves a red-shift (60 +/- 5 cm(-1)) and slight enhancement of the vibronic satellite of the main PSII lifetime component present in intact chloroplasts. Whereas this fluorescence red-shift was enhanced by the presence of zeaxanthin, it was not dependent upon it. The red-shifted fluorescence of intact chloroplasts in the NPQ state was accompanied by red-shifted chlorophyll a absorption. Nearly identical absorption and fluorescence changes were observed in isolated LHCII complexes quenched in a low detergent media, suggesting that the mechanism of quenching is the same in both systems. In both cases, the extent of the fluorescence red-shift was shown to correlate with the lifetime of a component. The alteration in the energy of the emitting chlorophyll(s) in intact chloroplasts and isolated LHCII was also accompanied by changes in lutein 1 observed in their 77K fluorescence excitation spectra. We suggest that the characteristic red-shifted fluorescence emission reflects an altered environment of the emitting chlorophyll( s) in LHCII brought about by their closer interaction with lutein 1 in the quenching locus.	[Johnson, Matthew P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London; Queen Mary University London	Ruban, AV (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd,Fogg Bldg, London E1 4NS, England.	a.ruban@qmul.ac.uk		Johnson, Matthew/0000-0002-1663-0205	UKBBSRC; Royal Society	UKBBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London)	This work was supported by grants (to A. V. R.) from UKBBSRC and The Royal Society.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; BILGER W, 1994, PLANTA, V193, P238, DOI 10.1007/BF00192536; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; Broess K, 2006, BIOPHYS J, V91, P3776, DOI 10.1529/biophysj.106.085068; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Croce R, 1998, BIOCHEMISTRY-US, V37, P17355, DOI 10.1021/bi9813227; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Engelmann ECM, 2005, BBA-BIOENERGETICS, V1706, P276, DOI 10.1016/j.bbabio.2004.11.009; GILMORE AM, 1995, P NATL ACAD SCI USA, V92, P2273, DOI 10.1073/pnas.92.6.2273; Gilmore AM, 1998, BIOCHEMISTRY-US, V37, P13582, DOI 10.1021/bi981384x; Gilmore AM, 1996, PHOTOSYNTH RES, V48, P171, DOI 10.1007/BF00041007; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Holzwarth AR, 2008, PHOTOSYNTHESIS ENERG, P77; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ilioaia C, 2008, J BIOL CHEM, V283, P29505, DOI 10.1074/jbc.M802438200; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Melkozernov AN, 2001, PHOTOSYNTH RES, V70, P129, DOI 10.1023/A:1017909325669; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Moise N, 2004, BBA-BIOENERGETICS, V1657, P47, DOI 10.1016/j.bbabio.2004.04.003; MULLINEAUX CW, 1993, BIOCHIM BIOPHYS ACTA, V1141, P23, DOI 10.1016/0005-2728(93)90184-H; NOCTOR G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P339, DOI 10.1016/0005-2728(93)90237-A; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pieper J, 1999, J PHYS CHEM A, V103, P2422, DOI 10.1021/jp983958d; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; QUICK WP, 1984, P ROY SOC LOND B BIO, V226, P237; REES D, 1992, PHOTOSYNTH RES, V31, P11, DOI 10.1007/BF00049532; Richter M, 1999, BIOCHEMISTRY-US, V38, P12718, DOI 10.1021/bi983009a; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; RUBAN AV, 1994, PLANT PHYSIOL, V104, P227, DOI 10.1104/pp.104.1.227; Ruban AV, 2002, J BIOL CHEM, V277, P7785, DOI 10.1074/jbc.M110693200; RUBAN AV, 1991, BIOCHIM BIOPHYS ACTA, V1059, P355, DOI 10.1016/S0005-2728(05)80221-X; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; RUBAN AV, 1993, PLANT PHYSIOL, V102, P741, DOI 10.1104/pp.102.3.741; SCHREIBER U, 1986, PHOTOSYNTH RES, V9, P261, DOI 10.1007/BF00029749; Scott M, 2006, BIOCHEMISTRY-US, V45, P8952, DOI 10.1021/bi060767p; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; van Oort B, 2007, FEBS LETT, V581, P3528, DOI 10.1016/j.febslet.2007.06.070; van Oort B, 2007, J PHYS CHEM B, V111, P7631, DOI 10.1021/jp070573z; Vasil'ev S, 1998, BIOCHEMISTRY-US, V37, P11046, DOI 10.1021/bi9806854; Vasilev S, 1997, BIOCHEMISTRY-US, V36, P7503, DOI 10.1021/bi9625253; Veerman J, 2007, PLANT PHYSIOL, V145, P997, DOI 10.1104/pp.107.106872; Wagner B, 1996, J PHOTOCH PHOTOBIO B, V36, P339, DOI 10.1016/S1011-1344(96)07391-5; Yan HC, 2007, BIOCHEM BIOPH RES CO, V355, P457, DOI 10.1016/j.bbrc.2007.01.172	56	78	78	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23592	23601		10.1074/jbc.M109.013557	http://dx.doi.org/10.1074/jbc.M109.013557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19567871	hybrid, Green Published			2022-12-27	WOS:000269180000045
J	Maegawa, GHB; Tropak, MB; Buttner, JD; Rigat, BA; Fuller, M; Pandit, D; Tang, LI; Kornhaber, GJ; Hamuro, Y; Clarke, JTR; Mahuran, DJ				Maegawa, Gustavo H. B.; Tropak, Michael B.; Buttner, Justin D.; Rigat, Brigitte A.; Fuller, Maria; Pandit, Deepangi; Tang, Liangiie; Kornhaber, Gregory J.; Hamuro, Yoshitomo; Clarke, Joe T. R.; Mahuran, Don J.			Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BETA-GLUCOSIDASE; LYSOSOMAL STORAGE DISORDERS; MASS-SPECTROMETRY; PHARMACOLOGICAL CHAPERONES; ISOFAGOMINE INCREASES; ENDOPLASMIC-RETICULUM; CHEMICAL CHAPERONES; GM2 GANGLIOSIDOSIS; H/D EXCHANGE; TAY-SACHS	Gaucher disease (GD), the most prevalent lysosomal storage disease, is caused by a deficiency of glucocerebrosidase (GCase). The identification of small molecules acting as agents for enzyme enhancement therapy is an attractive approach for treating different forms of GD. A thermal denaturation assay utilizing wild type GCase was developed to screen a library of 1,040 Food and Drug Administration-approved drugs. Ambroxol (ABX), a drug used to treat airway mucus hypersecretion and hyaline membrane disease in newborns, was identified and found to be a pH-dependent, mixed-type inhibitor of GCase. Its inhibitory activity was maximal at neutral pH, found in the endoplasmic reticulum, and undetectable at the acidic pH of lysosomes. The pH dependence of ABX to bind and stabilize the enzyme was confirmed by monitoring the rate of hydrogen/deuterium exchange at increasing guanidine hydrochloride concentrations. ABX treatment significantly increased N370S and F213I mutant GCase activity and protein levels in GD fibroblasts. These increases were primarily confined to the lysosome-enriched fraction of treated cells, a finding confirmed by confocal immunofluorescence microscopy. Additionally, enhancement of GCase activity and a reduction in glucosylceramide storage was verified in ABX-treated GD lymphoblasts (N370S/N370S). Hydrogen/deuterium exchange mass spectrometry revealed that upon binding of ABX, amino acid segments 243-249, 310-312, and 386-400 near the active site of GCase are stabilized. Consistent with its mixed-type inhibition of GCase, modeling studies indicated that ABX interacts with both active and non-active site residues. Thus, ABX has the biochemical characteristics of a safe and effective enzyme enhancement therapy agent for the treatment of patients with the most common GD genotypes.	[Maegawa, Gustavo H. B.; Tropak, Michael B.; Buttner, Justin D.; Rigat, Brigitte A.; Clarke, Joe T. R.; Mahuran, Don J.] Hosp Sick Children, Res Inst, Genet & Genome Biol Program, Toronto, ON M5G 1X8, Canada; [Maegawa, Gustavo H. B.; Clarke, Joe T. R.] Hosp Sick Children, Res Inst, Dept Paediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Maegawa, Gustavo H. B.; Clarke, Joe T. R.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Fuller, Maria] Univ Adelaide, Lysosomal Dis Res Unit, SA Pathol Womens & Childrens Hosp, Adelaide, SA 5005, Australia; [Fuller, Maria] Univ Adelaide, Dept Pediat, Adelaide, SA 5005, Australia; [Pandit, Deepangi; Tang, Liangiie; Kornhaber, Gregory J.; Hamuro, Yoshitomo] ExSar Corp, Monmouth Jct, NJ 08852 USA; [Mahuran, Don J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; SA Pathology; University of Adelaide; University of Adelaide; University of Toronto	Mahuran, DJ (corresponding author), Hosp Sick Children, Res Inst, Genet & Genome Biol Program, Rm 9146A,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hex@sickkids.ca		Maegawa, Gustavo/0000-0001-6933-4138	David M. C. Ju Foundation; Life for Luke Foundation; Canadian Institutes of Health Research Team Grant [CTP-82944]	David M. C. Ju Foundation; Life for Luke Foundation; Canadian Institutes of Health Research Team Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by the David M. C. Ju Foundation ( to B. R.), the Life for Luke Foundation (to G. M.), and Canadian Institutes of Health Research Team Grant CTP-82944 (to D. M.).	Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Bembi B, 2008, ACTA PAEDIATR, V97, P81, DOI 10.1111/j.1651-2227.2008.00643.x; BIANCHI M, 1990, AGENTS ACTIONS, V31, P275, DOI 10.1007/BF01997619; Boston-Howes W, 2008, EXP NEUROL, V213, P229, DOI 10.1016/j.expneurol.2008.06.010; BROWN CA, 1993, AM J HUM GENET, V53, P497; Chang HH, 2006, FEBS J, V273, P4082, DOI 10.1111/j.1742-4658.2006.05410.x; COLOMBO L, 1990, J CHROMATOGR-BIOMED, V530, P141, DOI 10.1016/S0378-4347(00)82313-0; Copeland RA., 2000, ENZYME PRACTICAL INT, P266, DOI 10.1002/0471220639.ch8; COUET W, 1989, INT J CLIN PHARM TH, V27, P467; Cox TM, 2008, J INHERIT METAB DIS, V31, P319, DOI 10.1007/s10545-008-0779-z; Cox TM, 2003, J INHERIT METAB DIS, V26, P513, DOI 10.1023/A:1025902113005; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fuller M, 2008, MOL GENET METAB, V93, P437, DOI 10.1016/j.ymgme.2007.11.011; Gan-Or Z, 2008, NEUROLOGY, V70, P2277, DOI 10.1212/01.wnl.0000304039.11891.29; Goker-Alpan O, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028019; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Goker-Alpan O, 2008, ARCH NEUROL-CHICAGO, V65, P1353, DOI 10.1001/archneur.65.10.1353; Grabowski GA, 2008, EXPERT OPIN EMERG DR, V13, P197, DOI [10.1517/14728214.13.1.197, 10.1517/14728214.13.1.197 ]; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Hein LK, 2007, MOL GENET METAB, V92, P336, DOI 10.1016/j.ymgme.2007.08.001; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; JONSSON LMV, 1987, EUR J BIOCHEM, V164, P171, DOI 10.1111/j.1432-1033.1987.tb11008.x; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Kornhaber GJ, 2008, CHEMBIOCHEM, V9, P2643, DOI 10.1002/cbic.200800249; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Lee HJ, 2004, PHARMACOL RES, V49, P93, DOI 10.1016/j.phrs.2003.07.011; Leonova T, 2000, MOL GENET METAB, V70, P281, DOI 10.1006/mgme.2000.3035; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lin H, 2004, BBA-MOL BASIS DIS, V1689, P219, DOI 10.1016/j.bbadis.2004.03.007; Liu C., 2003, ADV MED STAT, P1051, DOI DOI 10.1142/9789812388759_0028; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; Malerba M, 2008, EXPERT OPIN DRUG MET, V4, P1119, DOI 10.1517/17425255.4.8.1119 ; Martin DR, 2008, MOL GENET METAB, V94, P212, DOI 10.1016/j.ymgme.2008.02.004; Masuda N, 2008, NEUROBIOL DIS, V30, P293, DOI 10.1016/j.nbd.2008.01.014; Meijer LA, 2004, J VET PHARMACOL THER, V27, P219, DOI 10.1111/j.1365-2885.2004.00584.x; Molina G, 2004, AM J OBSTET GYNECOL, V191, P2177, DOI 10.1016/j.ajog.2004.07.043; OOSTERHUIS B, 1993, EUR J CLIN PHARMACOL, V44, P237, DOI 10.1007/BF00271364; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Porto C, 2009, MOL THER, V17, P964, DOI 10.1038/mt.2009.53; Powell KD, 2003, BIOCHEMISTRY-US, V42, P4962, DOI 10.1021/bi034096w; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Rigat B, 2009, MOL GENET METAB, V96, P225, DOI 10.1016/j.ymgme.2008.12.008; Rojpibulstit M, 2003, CLIN DRUG INVEST, V23, P273, DOI 10.2165/00044011-200323040-00007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Shen JS, 2008, BIOCHEM BIOPH RES CO, V369, P1071, DOI 10.1016/j.bbrc.2008.02.125; Sidransky E, 1997, J MED GENET, V34, P876, DOI 10.1136/jmg.34.10.876-a; Sidransky E, 1997, Adv Pediatr, V44, P73; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Tang LJ, 2007, ANAL CHEM, V79, P8728, DOI 10.1021/ac071380a; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Tropak MB, 2008, CHEMBIOCHEM, V9, P2650, DOI 10.1002/cbic.200800304; Tropak MB, 2007, FEBS J, V274, P4951, DOI 10.1111/j.1742-4658.2007.06040.x; Tropak MB, 2007, CHEM BIOL, V14, P153, DOI 10.1016/j.chembiol.2006.12.006; TSAI P, 1992, PEDIATR RES, V31, P503, DOI 10.1203/00006450-199205000-00019; Wang HY, 2007, EUR J NEUROSCI, V26, P633, DOI 10.1111/j.1460-9568.2007.05663.x; Wauer R R, 1989, Eur Respir J Suppl, V3, p57S; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Weiser T, 2008, CNS NEUROSCI THER, V14, P17, DOI 10.1111/j.1527-3458.2007.00032.x; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Yang B, 2002, EUR RESPIR J, V19, P952, DOI 10.1183/09031936.02.00253302; Yu ZQ, 2007, FEBS J, V274, P4944, DOI 10.1111/j.1742-4658.2007.06042.x; Yu ZQ, 2007, J MED CHEM, V50, P94, DOI 10.1021/jm060677i; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhao H, 2002, CELL MOL LIFE SCI, V59, P694, DOI 10.1007/s00018-002-8458-y; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104; Zimmer KP, 1999, J PATHOL, V188, P407	72	214	226	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23502	23516		10.1074/jbc.M109.012393	http://dx.doi.org/10.1074/jbc.M109.012393			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19578116	Green Published, hybrid			2022-12-27	WOS:000269180000035
J	Frayne, J; Taylor, A; Cameron, G; Hadfield, AT				Frayne, Jan; Taylor, Abby; Cameron, Gus; Hadfield, Andrea T.			Structure of Insoluble Rat Sperm Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) via Heterotetramer Formation with Escherichia coli GAPDH Reveals Target for Contraceptive Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CHLOROHYDRIN; ANTIFERTILITY COMPOUNDS; RESOLUTION STRUCTURE; GLYCOLYTIC ENZYME; MOTILITY; SPERMATOZOA; INHIBITION; (S)-ALPHA-CHLOROHYDRIN; METABOLISM; MOUSE	Sperm glyceraldehyde-3-phosphate dehydrogenase has been shown to be a successful target for a non-hormonal contraceptive approach, but the agents tested to date have had unacceptable side effects. Obtaining the structure of the sperm-specific isoform to allow rational inhibitor design has therefore been a goal for a number of years but has proved intractable because of the insoluble nature of both native and recombinant protein. We have obtained soluble recombinant sperm glyceraldehyde-3-phosphate dehydrogenase as a heterotetramer with the Escherichia coli glyceraldehyde-3- phosphate dehydrogenase in a ratio of 1:3 and have solved the structure of the heterotetramer which we believe represents a novel strategy for structure determination of an insoluble protein. A structure was also obtained where glyceraldehyde 3-phosphate binds in the P-s pocket in the active site of the sperm enzyme subunit in the presence of NAD. Modeling and comparison of the structures of human somatic and sperm-specific glyceraldehyde-3-phosphate dehydrogenase revealed few differences at the active site and hence rebut the long presumed structural specificity of 3-chlorolactaldehyde for the sperm isoform. Thecontraceptive activity of alpha-chlorohydrin and its apparent specificity for the sperm isoform in vivo are likely to be due to differences in metabolism to 3-chlorolactaldehyde in spermatozoa and somatic cells. However, further detailed analysis of the sperm glyceraldehyde-3-phosphate dehydrogenase structure revealed sites in the enzyme that do show significant difference compared with published somatic glyceraldehyde-3- phosphate dehydrogenase structures that could be exploited by structure-based drug design to identify leads for novel male contraceptives.	[Frayne, Jan; Taylor, Abby; Cameron, Gus; Hadfield, Andrea T.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Frayne, J (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	jan.frayne@bristol.ac.uk; a.t.hadfield@bristol.ac.uk		Frayne, Jan/0000-0002-1113-7761	Biotechnology and Biological Sciences Research Council; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Biotechnology and Biological Sciences Research Council.	Aronov AM, 1999, P NATL ACAD SCI USA, V96, P4273, DOI 10.1073/pnas.96.8.4273; Aronov AM, 1998, J MED CHEM, V41, P4790, DOI 10.1021/jm9802620; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakker BM, 2000, MOL BIOCHEM PARASIT, V106, P1, DOI 10.1016/S0166-6851(99)00197-8; BIESECKER G, 1977, NATURE, V266, P328, DOI 10.1038/266328a0; Bone W, 2001, J ANDROL, V22, P464; Bone W, 2000, INT J ANDROL, V23, P284; Bressi JC, 2001, J MED CHEM, V44, P2080, DOI 10.1021/jm000472o; BROWNWOODMAN PDC, 1978, BIOCHEM J, V170, P23, DOI 10.1042/bj1700023; Bunch DO, 1998, BIOL REPROD, V58, P834, DOI 10.1095/biolreprod58.3.834; COPPOLA JA, 1969, LIFE SCI PT 1 PHYSI, V8, P43, DOI 10.1016/0024-3205(69)90291-4; Cowan-Jacob SW, 2003, ACTA CRYSTALLOGR D, V59, P2218, DOI 10.1107/S0907444903020493; Duee E, 1996, J MOL BIOL, V257, P814, DOI 10.1006/jmbi.1996.0204; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERICSSON RJ, 1970, J REPROD FERTIL, V22, P213; FORD WCL, 1981, J REPROD FERTIL, V63, P75; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; FORD WCL, 1982, J REPROD FERTIL, V65, P177; FORD WCL, 1981, CONTRACEPTION, V24, P577, DOI 10.1016/0010-7824(81)90061-5; FORD WCL, 1983, J REPROD FERTIL, V69, P147; Ismail SA, 2005, ACTA CRYSTALLOGR D, V61, P1508, DOI 10.1107/S0907444905026740; Jelks K, 2001, REPROD TOXICOL, V15, P11; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; JONES AR, 1983, EXPERIENTIA, V39, P784, DOI 10.1007/BF01990326; KIRTON KT, 1970, J REPROD FERTIL, V21, P275; KOCHMAN M, 1974, FEBS LETT, V41, P104, DOI 10.1016/0014-5793(74)80964-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MARKOVICH DS, 1975, FEBS LETT, V58, P138, DOI 10.1016/0014-5793(75)80243-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; MORAS D, 1975, J BIOL CHEM, V250, P9137; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OBERLANDER G, 1994, J REPROD FERTIL, V100, P551; OSBORNE HH, 1975, BIOCHEM J, V151, P37, DOI 10.1042/bj1510037; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rossman M.G., 1975, ENZYMES, P62; SEGAL HL, 1953, J BIOL CHEM, V204, P265; SETTY BS, 1970, INDIAN J EXP BIOL, V8, P49; STEVENSON D, 1984, INT J ANDROL, V7, P79, DOI 10.1111/j.1365-2605.1984.tb00762.x; STEVENSON D, 1985, J REPROD FERTIL, V74, P157; Suresh S, 2001, J MOL BIOL, V309, P423, DOI 10.1006/jmbi.2001.4588; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VANCALENBERGH S, 1995, J MED CHEM, V38, P3838, DOI 10.1021/jm00019a014; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; VERLINDE CLMJ, 1994, J MED CHEM, V37, P3605, DOI 10.1021/jm00047a017; WANG CC, 1995, ANNU REV PHARMACOL, V35, P93, DOI 10.1146/annurev.pa.35.040195.000521; WATSON HC, 1972, NATURE-NEW BIOL, V240, P130, DOI 10.1038/newbio240130a0; WELCH JE, 1992, BIOL REPROD, V46, P869, DOI 10.1095/biolreprod46.5.869; Welch JE, 2006, MOL REPROD DEV, V73, P1052, DOI 10.1002/mrd.20235; Welch JE, 2000, J ANDROL, V21, P328; Westhoff D, 1997, J CELL SCI, V110, P1821; Williams AC, 2001, J ANDROL, V22, P680	53	27	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22703	22712		10.1074/jbc.M109.004648	http://dx.doi.org/10.1074/jbc.M109.004648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542219	hybrid, Green Published			2022-12-27	WOS:000268963100025
J	Hanna, M; Liu, HB; Amir, J; Sun, Y; Morris, SW; Siddiqui, MAQ; Lau, LF; Chaqour, B				Hanna, Mary; Liu, Haibo; Amir, Jawaria; Sun, Yi; Morris, Stephan W.; Siddiqui, M. A. Q.; Lau, Lester F.; Chaqour, Brahim			Mechanical Regulation of the Proangiogenic Factor CCN1/CYR61 Gene Requires the Combined Activities of MRTF-A and CREB-binding Protein Histone Acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MUSCLE-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR-B; IMMEDIATE-EARLY GENE; CCN FAMILY; DEPENDENT TRANSCRIPTION; ANGIOGENIC FACTOR; MYOCARDIN; ACTIN; CYR61	Smooth muscle-rich tissues respond to mechanical overload by an adaptive hypertrophic growth combined with activation of angiogenesis, which potentiates their mechanical overload-bearing capabilities. Neovascularization is associated with mechanical strain-dependent induction of angiogenic factors such as CCN1, an immediate-early gene-encoded matricellular molecule critical for vascular development and repair. Here we have demonstrated that mechanical strain-dependent induction of the CCN1 gene involves signaling cascades through RhoA-mediated actin remodeling and the p38 stress-activated protein kinase (SAPK). Actin signaling controls serum response factor (SRF) activity via SRF interaction with the myocardin-related transcriptional activator (MRTF)-A and tethering to a single CArG box sequence within the CCN1 promoter. Such activity was abolished in mechanically stimulated mouse MRTF-A(-/)-cells or upon inhibition of CREB-binding protein (CBP) histone acetyltransferase (HAT) either pharmacologically or by siRNAs. Mechanical strain induced CBP-mediated acetylation of histones 3 and 4 at the SRF-binding site and within the CCN1 gene coding region. Inhibition of p38 SAPK reduced CBP HAT activity and its recruitment to the SRF.MRTF-A complex, whereas enforced induction of p38 by upstream activators (e. g. MKK3 and MKK6) enhanced both CBP HAT and CCN1 promoter activities. Similarly, mechanical over-load-induced CCN1 gene expression in vivo was associated with nuclear localization of MRTF-A and enrichment of the CCN1 promoter with both MRTF-A and acetylated histone H3. Taken together, these data suggest that signal-controlled activation of SRF, MRTF-A, and CBP provides a novel connection between mechanical stimuli and angiogenic gene expression.	[Hanna, Mary; Liu, Haibo; Amir, Jawaria; Siddiqui, M. A. Q.; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Sun, Yi; Morris, Stephan W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Lau, Lester F.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; St Jude Children's Research Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chaqour, B (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	bchaqour@downstate.edu	Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324; Lau, Lester/0000-0002-4364-2914	National Institutes of Health [R56DK60572, R21DK068483, R01CA 87064, Core Grant 21765]; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [R01CA087064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK060572, R21DK068483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R56DK60572 and R21DK068483 (to B. C.), R01CA 87064, and Core Grant 21765. This work was also supported by the American Lebanese Syrian Associated Charities, St. Jude Children's Research Hospital (to Y. S. and S. W. M.).	Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Camoretti-Mercado B, 2006, J BIOL CHEM, V281, P20383, DOI 10.1074/jbc.M602748200; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Chaqour B, 2002, AM J PHYSIOL-ENDOC M, V283, pE765, DOI 10.1152/ajpendo.00131.2002; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen J, 2008, NEUROGASTROENT MOTIL, V20, P829, DOI 10.1111/j.1365-2982.2008.01149.x; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Fataccioli V, 2002, HUM GENE THER, V13, P1461, DOI 10.1089/10430340260185094; Grote K, 2004, J BIOL CHEM, V279, P55675, DOI 10.1074/jbc.M406532200; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Gusterson RJ, 2003, J BIOL CHEM, V278, P6838, DOI 10.1074/jbc.M211762200; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Han JH, 1997, FEBS LETT, V403, P19, DOI 10.1016/S0014-5793(97)00021-5; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; Hilfiker-Kleiner D, 2004, CIRCULATION, V109, P2227, DOI 10.1161/01.CIR.0000127952.90508.9D; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hirayama M, 2008, J CELL BIOCHEM, V104, P1297, DOI 10.1002/jcb.21708; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63; Kim KH, 2003, J BIOL CHEM, V278, P13847, DOI 10.1074/jbc.M210128200; Kivela R, 2007, J APPL PHYSIOL, V103, P1395, DOI 10.1152/japplphysiol.00531.2007; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; LATINKIC BV, 1991, NUCLEIC ACIDS RES, V19, P3261, DOI 10.1093/nar/19.12.3261; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Morawietz H, 1999, CIRC RES, V84, P678, DOI 10.1161/01.RES.84.6.678; Nakagawa K, 2005, GENES CELLS, V10, P835, DOI 10.1111/j.1365-2443.2005.00880.x; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Sano Masanori, 2008, Nihon Rinsho, V66, P1013; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yang W, 2008, BUILD RES INF, V36, P1, DOI 10.1080/09613210701702883; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoshida Y, 2007, BIOCHEM BIOPH RES CO, V355, P611, DOI 10.1016/j.bbrc.2007.01.195; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200	58	86	88	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23125	23136		10.1074/jbc.M109.019059	http://dx.doi.org/10.1074/jbc.M109.019059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542562	hybrid, Green Published			2022-12-27	WOS:000268963100064
J	Lu, HS; Murata-Kamiya, N; Saito, Y; Hatakeyama, M				Lu, Huaisheng; Murata-Kamiya, Naoko; Saito, Yasuhiro; Hatakeyama, Masanori			Role of Partitioning-defective 1/Microtubule Affinity-regulating Kinases in the Morphogenetic Activity of Helicobacter pylori CagA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; NUCLEOTIDE EXCHANGE FACTOR; FOCAL ADHESION KINASE; C-ELEGANS EMBRYOS; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; IV SECRETION; POLARITY; DYNAMICS; MICROTUBULES	Helicobacter pylori CagA plays a key role in gastric carcinogenesis. Upon delivery into gastric epithelial cells, CagA binds and deregulates SHP-2 phosphatase, a bona fide oncoprotein, thereby causing sustained ERK activation and impaired focal adhesions. CagA also binds and inhibits PAR1b/MARK2, one of the four members of the PAR1 family of kinases, to elicit epithelial polarity defect. In nonpolarized gastric epithelial cells, CagA induces the hummingbird phenotype, an extremely elongated cell shape characterized by a rear retraction defect. This morphological change is dependent on CagA-deregulated SHP-2 and is thus thought to reflect the oncogenic potential of CagA. In this study, we investigated the role of the PAR1 family of kinases in the hummingbird phenotype. We found that CagA binds not only PAR1b but also other PAR1 isoforms, with order of strength as follows: PAR1b > PAR1d >= PAR1a > PAR1c. Binding of CagA with PAR1 isoforms inhibits the kinase activity. This abolishes the ability of PAR1 to destabilize microtubules and thereby promotes disassembly of focal adhesions, which contributes to the hummingbird phenotype. Consistently, PAR1 knockdown potentiates induction of the hummingbird phenotype by CagA. The morphogenetic activity of CagA was also found to be augmented through inhibition of non-muscle myosin II. Because myosin II is functionally associated with PAR1, perturbation of PAR1-regulated myosin II by CagA may underlie the defect of rear retraction in the hummingbird phenotype. Our findings reveal that CagA systemically inhibits PAR1 family kinases and indicate that malfunctioning of microtubules and myosin II by CagA-mediated PAR1 inhibition cooperates with deregulated SHP-2 in the morphogenetic activity of CagA.	[Lu, Huaisheng; Murata-Kamiya, Naoko; Saito, Yasuhiro; Hatakeyama, Masanori] Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Kita Ku, Sapporo, Hokkaido 0600815, Japan; [Murata-Kamiya, Naoko; Hatakeyama, Masanori] Hokkaido Univ, Inst Med Genet, Ctr Infect Associated Canc, Sapporo, Hokkaido 0600815, Japan; [Hatakeyama, Masanori] Univ Tokyo, Grad Sch Med, Dept Microbiol, Tokyo 1130033, Japan	Hokkaido University; Hokkaido University; University of Tokyo	Hatakeyama, M (corresponding author), Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	mhata@igm.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Azuma T, 2004, J INFECT DIS, V189, P820, DOI 10.1086/381782; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Bourzac KM, 2007, INFECT IMMUN, V75, P1203, DOI 10.1128/IAI.01702-06; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2006, INT J CANCER, V119, P1217, DOI 10.1002/ijc.21831; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Higuchi M, 2004, CANCER SCI, V95, P442, DOI 10.1111/j.1349-7006.2004.tb03229.x; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kwan KM, 2005, DEVELOPMENT, V132, P4599, DOI 10.1242/dev.02041; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; PALAZZO AF, 2002, SCI STKE, V139, pPE31; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; PARSA I, 1988, CANCER RES, V48, P2265; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Trinczek B, 2004, J BIOL CHEM, V279, P5915, DOI 10.1074/jbc.M304528200; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Zeaiter Z, 2008, CELL MICROBIOL, V10, P781, DOI 10.1111/j.1462-5822.2007.01084.x; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200	71	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23024	23036		10.1074/jbc.M109.001008	http://dx.doi.org/10.1074/jbc.M109.001008			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553659	Green Published, hybrid			2022-12-27	WOS:000268963100055
J	Tsai, YC; Qi, HY; Lin, CP; Lin, RK; Kerrigan, JE; Rzuczek, SG; LaVoie, EJ; Rice, JE; Pilch, DS; Lyu, YL; Liu, LF				Tsai, Yuan-Chin; Qi, Haiyan; Lin, Chao-Po; Lin, Ren-Kuo; Kerrigan, John E.; Rzuczek, Suzanne G.; LaVoie, Edmond J.; Rice, Joseph E.; Pilch, Daniel S.; Lyu, Yi Lisa; Liu, Leroy F.			A G-quadruplex Stabilizer Induces M-phase Cell Cycle Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A; IN-VITRO; SMALL-MOLECULE; MACROCYCLIC HEXAOXAZOLE; TELOMERASE INHIBITION; KINETOCHORE FUNCTION; ANTITUMOR-ACTIVITY; INTERACTIVE AGENT; TUMOR-CELLS; DNA	G-quadruplex stabilizers such as telomestatin and HXDV bind with exquisite specificity to G-quadruplexes, but not to triplex, duplex, or single-stranded DNAs. Studies have suggested that the antiproliferative and possibly anti-tumor activities of these compounds are linked to their inhibitory effect on telomerase and/or telomere function. In the current studies, we show that HXDV, a synthetic analog of telomestatin, exhibits antiproliferative activity against both telomerase-positive and -negative cells and induces robust apoptosis within 16 h of treatment, suggesting a mode of action independent of telomerase. HXDV was also shown to inhibit cell cycle progression causing M-phase cell cycle arrest, as evidenced by accumulation of cells with 4 N DNA content, increased mitotic index, separated centrosomes, elevated histone H3 phosphorylation at Ser-10 (an M-phase marker), and defective chromosome alignment and spindle fiber assembly (revealed by time-lapse microscopy). The M-phase arrest caused by HXDV paralleled with reduction in the expression level of the major M-phase checkpoint regulator Aurora A. All these cellular effects appear to depend on the G-quadruplex binding activity of HXDV as its non-G-quadruplex binding analog, TXTLeu, is completely devoid of all these effects. In the aggregate, our results suggest that HXDV, which exhibits anti-proliferative and apoptotic activities, is also a novel M-phase blocker, with a mode of action dependent on its G-quadruplex binding activity.	[Tsai, Yuan-Chin; Qi, Haiyan; Lin, Chao-Po; Lin, Ren-Kuo; Pilch, Daniel S.; Lyu, Yi Lisa; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Kerrigan, John E.] Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Rzuczek, Suzanne G.; LaVoie, Edmond J.; Rice, Joseph E.] Rutgers State Univ, Dept Med Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick	Liu, LF (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.	lliu@umdnj.edu		Liu, Leroy/0000-0001-9396-763X; Pilch, Daniel/0000-0002-0113-0849; Lin, Chao-Po/0000-0002-1457-1635	National Institutes of Health [CA039662, CA102463.]; NATIONAL CANCER INSTITUTE [R01CA102463, R01CA039662, T32CA108455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA039662 and CA102463.	Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Barbieri CM, 2007, NUCLEIC ACIDS RES, V35, P3272, DOI 10.1093/nar/gkm188; Binz N, 2005, EUR J CANCER, V41, P2873, DOI 10.1016/j.ejca.2005.08.025; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chang CC, 2006, ANAL CHEM, V78, P2810, DOI 10.1021/ac052218f; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Doi T, 2006, ORG LETT, V8, P4165, DOI 10.1021/ol061793i; Evans R, 2008, LEUKEMIA LYMPHOMA, V49, P559, DOI 10.1080/10428190701824544; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Gowan SM, 2002, MOL PHARMACOL, V61, P1154, DOI 10.1124/mol.61.5.1154; Hars ES, 2006, CANCER RES, V66, P8975, DOI 10.1158/0008-5472.CAN-06-1724; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heit R, 2006, BIOCHEM CELL BIOL, V84, P605, DOI 10.1139/O06-080; HOFFMANN I, 1994, J CELL SCI, P75; Horard B, 2008, NAT CELL BIOL, V10, P113, DOI 10.1038/ncb0208-113; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Ke YW, 2003, CELL RES, V13, P69, DOI 10.1038/sj.cr.7290152; Kim MY, 2003, CANCER RES, V63, P3247; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Mikami-Terao Y, 2008, CANCER LETT, V261, P226, DOI 10.1016/j.canlet.2007.11.017; Minhas GS, 2006, BIOORG MED CHEM LETT, V16, P3891, DOI 10.1016/j.bmcl.2006.05.038; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; O'Loughlin C, 2000, EUR J CANCER, V36, P1149, DOI 10.1016/S0959-8049(00)00071-X; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Phatak P, 2007, BRIT J CANCER, V96, P1223, DOI 10.1038/sj.bjc.6603691; Pilch DS, 2008, BIOCHIMIE, V90, P1233, DOI 10.1016/j.biochi.2008.03.011; Qi HY, 2006, CANCER RES, V66, P11808, DOI 10.1158/0008-5472.CAN-06-1225; Rzuczek SG, 2008, BIOORG MED CHEM LETT, V18, P913, DOI 10.1016/j.bmcl.2007.12.048; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Satyanarayana M, 2008, BIOORG MED CHEM LETT, V18, P3802, DOI 10.1016/j.bmcl.2008.05.032; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Tauchi T, 2006, ONCOGENE, V25, P5719, DOI 10.1038/sj.onc.1209577; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847	52	41	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22535	22543		10.1074/jbc.M109.020230	http://dx.doi.org/10.1074/jbc.M109.020230			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531483	Green Published, hybrid			2022-12-27	WOS:000268963100006
J	Cottrell, GS; Padilla, BE; Amadesi, S; Poole, DP; Murphy, JE; Hardt, M; Roosterman, D; Steinhoff, M; Bunnett, NW				Cottrell, Graeme S.; Padilla, Benjamin E.; Amadesi, Silvia; Poole, Daniel P.; Murphy, Jane E.; Hardt, Markus; Roosterman, Dirk; Steinhoff, Martin; Bunnett, Nigel W.			Endosomal Endothelin-converting Enzyme-1 A REGULATOR OF beta-ARRESTIN-DEPENDENT ERK SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT GASTROINTESTINAL-TRACT; PROTEIN-COUPLED RECEPTORS; SUBSTANCE-P; NEUROKININ-1 RECEPTOR; NEUTRAL ENDOPEPTIDASE; KINASE ACTIVATION; MAMMALIAN-CELLS; MAP KINASES; NEURONS; ENDOCYTOSIS	Neuropeptide signaling at the cell surface is regulated by metalloendopeptidases, which degrade peptides in the extracellular fluid, and beta-arrestins, which interact with G protein-coupled receptors (GPCRs) to mediate desensitization. beta-Arrestins also recruit GPCRs and mitogen-activated protein kinases to endosomes to allow internalized receptors to continue signaling, but the mechanisms regulating endosomal signaling are unknown. We report that endothelin-converting enzyme-1 (ECE-1) degrades substance P (SP) in early endosomes of epithelial cells and neurons to destabilize the endosomal mitogen-activated protein kinase signalosome and terminate signaling. ECE-1 inhibition caused endosomal retention of the SP neurokinin 1 receptor, beta-arrestins, and Src, resulting in markedly sustained ERK2 activation in the cytosol and nucleus, whereas ECE-1 overexpression attenuated ERK2 activation. ECE-1 inhibition also enhanced SP-induced expression and phosphorylation of the nuclear death receptor Nur77, resulting in cell death. Thus, endosomal ECE-1 attenuates ERK2-mediated SP signaling in the nucleus to prevent cell death. We propose that agonist availability in endosomes, here regulated by ECE-1, controls beta-arrestin-dependent signaling of endocytosed GPCRs.	[Cottrell, Graeme S.; Padilla, Benjamin E.; Amadesi, Silvia; Poole, Daniel P.; Murphy, Jane E.; Bunnett, Nigel W.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Cottrell, Graeme S.; Padilla, Benjamin E.; Amadesi, Silvia; Poole, Daniel P.; Murphy, Jane E.; Bunnett, Nigel W.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Hardt, Markus] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Roosterman, Dirk] Univ Hosp Munster, Dept Internal Med D, D-48149 Munster, Germany; [Steinhoff, Martin] Univ Munster, Dept Dermatol, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany; [Steinhoff, Martin] Univ Munster, Ludwig Boltzmann Inst Cell Biol & Immunobiol Skin, D-48149 Munster, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Munster; University of Munster; University of Munster	Bunnett, NW (corresponding author), Univ Calif San Francisco, Dept Surg, 513 Parnassus Ave, San Francisco, CA 94143 USA.	nigel.bunnett@ucsf.edu	Poole, Daniel/AET-6645-2022; Steinhoff, Martin/F-6312-2013; Hardt, Markus/M-8569-2019	Poole, Daniel/0000-0002-6168-8422; Hardt, Markus/0000-0002-2300-216X; Bunnett, Nigel W./0000-0003-3367-0644; Cottrell, Graeme/0000-0001-9098-7627; Steinhoff, Martin/0000-0002-7090-2187	National Institutes of Health [DK43207, DK39957]; British Heart Foundation [FS/08/017/25027]; CJ Martin Fellowship [454858]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039957, R56DK043207, R01DK043207, R37DK039957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43207 and DK39957 (to N. W. B. and B. E. P.). This work was also supported by British Heart Foundation Grant FS/08/017/25027 (to G. S. C.) and CJ Martin Fellowship 454858 (to D. P. P.).	Ahn K, 1998, BIOCHEM BIOPH RES CO, V243, P184, DOI 10.1006/bbrc.1998.8081; Al-Sarraj A, 2002, NEUROSCI LETT, V332, P111, DOI 10.1016/S0304-3940(02)00939-4; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Anselmi L, 2005, NEUROPEPTIDES, V39, P349, DOI 10.1016/j.npep.2004.12.023; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Castro-Obregon S, 2004, J BIOL CHEM, V279, P17543, DOI 10.1074/jbc.M312363200; Cottrell GS, 2007, J BIOL CHEM, V282, P12260, DOI 10.1074/jbc.M606338200; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Doyle CA, 1999, NEUROSCIENCE, V89, P17, DOI 10.1016/S0306-4522(98)00276-0; DRAPEAU G, 1987, NEUROPEPTIDES, V10, P43, DOI 10.1016/0143-4179(87)90088-6; DUGGAN AW, 1992, BRAIN RES, V579, P261, DOI 10.1016/0006-8993(92)90059-I; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grady EF, 1996, J NEUROSCI, V16, P6975, DOI 10.1523/jneurosci.16-21-06975.1996; Jafri F, 2006, J BIOL CHEM, V281, P19346, DOI 10.1074/jbc.M512643200; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Johnson GD, 1999, J BIOL CHEM, V274, P4053, DOI 10.1074/jbc.274.7.4053; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Li HS, 2005, TRAFFIC, V6, P324, DOI 10.1111/j.1600-0854.2005.00274.x; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu HT, 1999, P NATL ACAD SCI USA, V96, P12096, DOI 10.1073/pnas.96.21.12096; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; McConalogue K, 1998, MOL BIOL CELL, V9, P2305, DOI 10.1091/mbc.9.8.2305; OKAMOTO A, 1994, BIOCHEM J, V299, P683, DOI 10.1042/bj2990683; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; Poole DP, 2002, AUTON NEUROSCI-BASIC, V101, P39, DOI 10.1016/S1566-0702(02)00179-0; Robinson S, 2008, PROTEOMICS, V8, P435, DOI 10.1002/pmic.200700680; Roosterman D, 2008, ENDOCRINOLOGY, V149, P2200, DOI 10.1210/en.2007-1628; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001; Slagsvold HH, 2002, BIOCHEM BIOPH RES CO, V291, P1146, DOI 10.1006/bbrc.2002.6579; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Umekawa K, 2000, JPN J PHARMACOL, V84, P7, DOI 10.1254/jjp.84.7; Willoughby EA, 2005, J BIOL CHEM, V280, P25651, DOI 10.1074/jbc.M501926200; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Zachrisson O, 1998, MOL BRAIN RES, V60, P291, DOI 10.1016/S0169-328X(98)00191-0	49	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22411	22425		10.1074/jbc.M109.026674	http://dx.doi.org/10.1074/jbc.M109.026674			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531493	hybrid, Green Published			2022-12-27	WOS:000268783700063
J	Morgan, AH; Dioszeghy, V; Maskrey, BH; Thomas, CP; Clark, SR; Mathie, SA; Lloyd, CM; Kuhn, H; Topley, N; Coles, BC; Taylor, PR; Jones, SA; O'Donnell, VB				Morgan, Alwena H.; Dioszeghy, Vincent; Maskrey, Benjamin H.; Thomas, Christopher P.; Clark, Stephen R.; Mathie, Sara A.; Lloyd, Clare M.; Kuehn, Hartmut; Topley, Nicholas; Coles, Barbara C.; Taylor, Philip R.; Jones, Simon A.; O'Donnell, Valerie B.			Phosphatidylethanolamine-esterified Eicosanoids in the Mouse TISSUE LOCALIZATION AND INFLAMMATION-DEPENDENT FORMATION IN Th-2 DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; 15-LIPOXYGENASE EXPRESSION; IN-VIVO; 12/15-LIPOXYGENASE; CELLS; MACROPHAGES; MICE; LIPOXYGENASE; INFLAMMATION; MONOCYTES	In this study, murine peritoneal macrophages from naive lavage were found to generate four phospholipids that contain 12-hydroxyeicosatetraenoic acid (12-HETE). They comprise three plasmalogen and one diacyl phosphatidylethanolamines (PEs) (16:0p, 18:1p, 18:0p, and 18:0a at sn-1) and are absent in macrophages from 12/15-lipoxygenase (12/15-LOX)-deficient mice. They are generated acutely in response to calcium mobilization, are primarily cell-associated, and are detected on the outside of the plasma membrane. Levels of 12-HETE-PEs in naive lavage are in a similar range to those of free 12-HETE (5.5 +/- 0.2 ng or 18.5 +/- 1.03 ng/lavage for esterified versus free, respectively). In healthy mice, 12/15-LOX-derived 12-HETE-PEs are found in the peritoneal cavity, peritoneal membrane, lymph node, and intestine, with a similar distribution to 12/15-LOX- derived 12-HETE. In vivo generation of 12-HETE-PEs occurs in a Th2-dependent model of murine lung inflammation associated with interleukin-4/interleukin-13 expression. In contrast, in Toll receptor-dependent peritonitis mediated either by live bacteria or bacterial products, 12-HETE-PEs are rapidly cleared during the acute phase then reappear during resolution. The human homolog, 18:0a/15-HETE-PE inhibited human monocyte generation of cytokines in response to lipopolysaccharide. In summary, a new family of lipid mediators generated by murine macrophages during Th2 inflammation are identified and structurally characterized. The studies suggest a new paradigm for lipids generated by 12/15-LOX in inflammation involving formation of esterified eicosanoids.	[Morgan, Alwena H.; Dioszeghy, Vincent; Maskrey, Benjamin H.; Thomas, Christopher P.; Clark, Stephen R.; Topley, Nicholas; Coles, Barbara C.; Taylor, Philip R.; Jones, Simon A.; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, S Glam, Wales; [Mathie, Sara A.; Lloyd, Clare M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Kuehn, Hartmut] Humboldt Univ, Inst Biochem, D-10117 Berlin, Germany	Cardiff University; Imperial College London; Humboldt University of Berlin	O'Donnell, VB (corresponding author), Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Tenovus Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	o-donnellvb@cardiff.ac.uk	Thomas, Christopher P/R-5243-2016; Clark, Stephen/N-6242-2014; O'Donnell, Valerie/C-6948-2012; Jones, Simon Arnett/Q-7017-2018	Thomas, Christopher P/0000-0001-5840-8613; Clark, Stephen/0000-0001-5907-9671; Lloyd, Clare/0000-0001-8977-6726; Jones, Simon Arnett/0000-0001-7297-9711; Taylor, Philip/0000-0003-0163-1421; /0000-0003-4089-8460	Medical Research Council [G0601617] Funding Source: Medline; Wellcome Trust [087618, 057704] Funding Source: Medline; MRC [G0601617] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andersson CK, 2008, AM J RESP CELL MOL, V39, P648, DOI 10.1165/rcmb.2007-0443OC; BRASH AR, 1986, PROSTAG LEUKOTR ESS, V23, P149, DOI 10.1016/0262-1746(86)90178-2; Brinckmann R, 1997, ADV EXP MED BIOL, V400, P599; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Hajek AR, 2008, J ALLERGY CLIN IMMUN, V122, P633, DOI 10.1016/j.jaci.2008.06.021; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; MACKENZIE RK, 1991, J INFECT DIS, V163, P837, DOI 10.1093/infdis/163.4.837; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; Middleton MK, 2006, J IMMUNOL, V176, P265, DOI 10.4049/jimmunol.176.1.265; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Schnurr K, 1999, FASEB J, V13, P143, DOI 10.1096/fasebj.13.1.143; SESSIONS A, 1983, BIOCHIM BIOPHYS ACTA, V728, P103, DOI 10.1016/0005-2736(83)90442-X; Shankaranarayanan P, 2003, J IMMUNOL, V170, P887, DOI 10.4049/jimmunol.170.2.887; Shappell SB, 2001, CANCER RES, V61, P497; von Schlieffen E, 2009, ARTERIOSCL THROM VAS, V29, P356, DOI 10.1161/ATVBAHA.108.173799; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; Zhao L, 2002, J BIOL CHEM, V277, P35350, DOI 10.1074/jbc.M205738200	26	65	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21185	21191		10.1074/jbc.M109.021634	http://dx.doi.org/10.1074/jbc.M109.021634			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531470	Green Published, hybrid			2022-12-27	WOS:000268564400011
J	Klein, IK; Predescu, DN; Sharma, T; Knezevic, I; Malik, AB; Predescu, S				Klein, Irene K.; Predescu, Dan N.; Sharma, Tiffany; Knezevic, Ivana; Malik, Asrar B.; Predescu, Sanda			Intersectin-2L Regulates Caveola Endocytosis Secondary to Cdc42-mediated Actin Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; DBL HOMOLOGY DOMAIN; ENDOTHELIAL-CELLS; PROTEIN INTERSECTIN; ARP2/3 COMPLEX; CDC42; MEMBRANE; GTPASES; FAMILY; INTERNALIZATION	Here we addressed the role of intersectin-2L (ITSN-2L), a guanine nucleotide exchange factor for the Rho GTPase Cdc42, in the mechanism of caveola endocytosis in endothelial cells (ECs). Immunoprecipitation and co-localization studies showed that ITSN-2L associates with members of the Cdc42-WASp-Arp2/3 actin polymerization pathway. Expression of Dbl homology-pleckstrin homology (DH-PH) region of ITSN-2L (DH-PHITSN-2L) induced specific activation of Cdc42, resulting in formation of extensive filopodia, enhanced cortical actin, as well as a shift from G-actin to F-actin. The "catalytically dead" DH-PH domain reversed these effects and induced significant stress fiber formation, without a detectable shift in actin pools. A biotin assay for caveola internalization indicated a significant decrease in the uptake of biotinylated proteins in DH-PHITSN-2L-transfected cells compared with control and 1 mu M jasplakinolide-treated cells. ECs depleted of ITSN-2L by small interfering RNA, however, showed decreased Cdc42 activation and actin remodeling similar to the defective DH-PH, resulting in 62% increase in caveola-mediated uptake compared with controls. Thus, ITSN-2L, a guanine nucleotide exchange factor for Cdc42, regulates different steps of caveola endocytosis in ECs by controlling the temporal and spatial actin polymerization and remodeling sub-adjacent to the plasma membrane.	[Predescu, Dan N.; Knezevic, Ivana; Predescu, Sanda] Rush Univ, Dept Pharmacol, Med Ctr, Chicago, IL USA; [Klein, Irene K.; Sharma, Tiffany; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Predescu, S (corresponding author), 1750 W Harrison St, Chicago, IL 60612 USA.	sanda_predescu@rush.edu		Malik, Asrar/0000-0002-8205-7128; Predescu, Sanda/0000-0002-9386-6756	National Institutes of Health [R01 HL089462, HL007829]; American Heart Association [SDG 0635175N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007829, R01HL089462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL089462 (to S. P.) and HL007829 (to A. B. M.). This work was supported by American Heart Association Grant SDG 0635175N (to S. P.).	Bayless KJ, 2002, J CELL SCI, V115, P1123; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Malacombe M, 2006, EMBO J, V25, P3494, DOI 10.1038/sj.emboj.7601247; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Predescu SA, 2005, J BIOL CHEM, V280, P37130, DOI 10.1074/jbc.M505659200; Predescu SA, 2003, MOL BIOL CELL, V14, P4997, DOI 10.1091/mbc.e03-01-0041; Predescu SA, 2007, J BIOL CHEM, V282, P17166, DOI 10.1074/jbc.M608996200; Pruitt WM, 2003, BBA-MOL CELL RES, V1640, P61, DOI 10.1016/S0167-4889(03)00002-8; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Pucharcos C, 2001, BBA-GENE STRUCT EXPR, V1521, P1, DOI 10.1016/S0167-4781(01)00276-7; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sun XJ, 2007, CELL MICROBIOL, V9, P1672, DOI 10.1111/j.1462-5822.2007.00900.x; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668	30	41	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25953	25961		10.1074/jbc.M109.035071	http://dx.doi.org/10.1074/jbc.M109.035071			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19622753	Green Published, hybrid			2022-12-27	WOS:000269738000052
J	Ye, B; Nerbonne, JM				Ye, Bin; Nerbonne, Jeanne M.			Proteolytic Processing of HCN2 and Co-assembly with HCN4 in the Generation of Cardiac Pacemaker Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT-NEGATIVE SUPPRESSION; NUCLEOTIDE-GATED CHANNELS; VENTRICULAR MYOCYTES; SINOATRIAL NODE; EXPRESSION; HEART; TERMINUS; CURRENTS; DOMAIN; MICE	In sino-atrial and atrio-ventricular nodal cells, hyperpolarization-activated cyclic nucleotide-gated (HCN) inward current carrying cationic channels, I-f, are expressed that contribute importantly to the diastolic depolarization critical for cardiac pacemaker activity. Although previous studies have demonstrated myocardial expression of both the HCN2 and HCN4 subunits, the specific roles of these subunits in the generation of functional myo-cardial I-f channels remain unclear. To explore the molecular compositions of functional cardiac I-f channels, antibodies targeted against specific C- and N-terminal sequences in HCN2 and HCN4 were exploited to examine HCN2 and HCN4 subunit expression in adult (mouse) heart and to immunoprecipitate endogenous HCN-encoded cardiac I-f channel complexes. Western blot experiments revealed that although the full-length HCN2 (105 kDa) and HCN4 (160 kDa) proteins are readily detected in transiently transfected HEK-293 cells and in adult (mouse) brain, the molecular mass of the HCN2 protein in the myocardium is similar to 60 kDa. In addition, the myocardial 60-kDa HCN2 protein lacks the C terminus, which contains the cAMP binding domain. In heterologous cells, the C-terminal-truncated HCN2 protein co-assembles with HCN4 to form functional heteromeric HCN channels, which activate faster than homomeric HCN2 or homomeric HCN4 channels, and display properties similar to endogenous myocardial I-f channels Taken together, these results suggest that functional myocardial I-f channels reflect the heteromeric assembly of HCN2 and HCN4 subunits and further that the HCN4 subunit underlies the cAMP-mediated regulation of cardiac I-f channels.	[Ye, Bin] Univ Wisconsin, Div Cardiovasc Med, Dept Med, Madison, WI 53706 USA; [Nerbonne, Jeanne M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Ye, B (corresponding author), Univ Wisconsin, Div Cardiovasc Med, Dept Med & Publ Hlth, Rm 24,1300 Univ Ave, Madison, WI 53706 USA.	bye@medicine.wisc.edu			National Institutes of Health, NHLBI [R01 HL034161]; Scientist Development [0435030N]; American Heart Association National Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Scientist Development; American Heart Association National Center(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health, NHLBI, Grant R01 HL034161 (to J.M.N.) and by Scientist Development Grant 0435030N (to B.Y.) from the American Heart Association National Center.	Altomare C, 2003, J PHYSIOL-LONDON, V549, P347, DOI 10.1113/jphysiol.2002.027698; Barbuti A, 2008, ANN NY ACAD SCI, V1123, P213, DOI 10.1196/annals.1420.024; Cerbai E, 1996, CIRCULATION, V94, P1674, DOI 10.1161/01.CIR.94.7.1674; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Han W, 2002, CIRC RES, V91, P790, DOI 10.1161/01.RES.0000039534.18114.D9; Herrmann S, 2007, EMBO J, V26, P4423, DOI 10.1038/sj.emboj.7601868; Herrmann S, 2007, PFLUG ARCH EUR J PHY, V454, P517, DOI 10.1007/s00424-007-0224-4; Hoppe UC, 1998, CIRCULATION, V97, P55, DOI 10.1161/01.CIR.97.1.55; Jiang M, 2004, CIRCULATION, V109, P1783, DOI 10.1161/01.CIR.0000124225.43852.50; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Nagatomo T, 1998, AM J PHYSIOL-HEART C, V275, pH2016, DOI 10.1152/ajpheart.1998.275.6.H2016; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Proenza C, 2002, J BIOL CHEM, V277, P29634, DOI 10.1074/jbc.M200504200; Qu JH, 2002, PFLUG ARCH EUR J PHY, V444, P597, DOI 10.1007/s00424-002-0860-7; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Tran N, 2002, J BIOL CHEM, V277, P43588, DOI 10.1074/jbc.M208477200; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Verkerk AO, 2007, EUR HEART J, V28, P2472, DOI 10.1093/eurheartj/ehm339; Viscomi C, 2001, J BIOL CHEM, V276, P29930, DOI 10.1074/jbc.M103971200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Whitaker GM, 2007, J BIOL CHEM, V282, P22900, DOI 10.1074/jbc.M610978200; Xue T, 2002, CIRC RES, V90, P1267, DOI 10.1161/01.RES.0000024390.97889.C6; Ye B, 2003, PHYSIOL GENOMICS, V12, P187, DOI 10.1152/physiolgenomics.00117.2002; Ye B, 2008, BIOCHEMISTRY-US, V47, P12312, DOI 10.1021/bi8009295; Zicha S, 2005, CARDIOVASC RES, V66, P472, DOI 10.1016/j.cardiores.2005.02.011	32	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25553	25559		10.1074/jbc.M109.007583	http://dx.doi.org/10.1074/jbc.M109.007583			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19574228	hybrid, Green Published			2022-12-27	WOS:000269738000012
J	Abid, K; Rochat, B; Lassahn, PG; Stocklin, R; Michalet, S; Brakch, N; Aubert, JF; Vatansever, B; Tella, P; De Meester, I; Grouzmann, E				Abid, Karim; Rochat, Bertrand; Lassahn, Paul-Gerhard; Stoecklin, Reto; Michalet, Sophie; Brakch, Noureddine; Aubert, Jean-Francois; Vatansever, Bilgin; Tella, Patricia; De Meester, Ingrid; Grouzmann, Eric			Kinetic Study of Neuropeptide Y (NPY) Proteolysis in Blood and Identification of NPY3-35 A NEW PEPTIDE GENERATED BY PLASMA KALLIKREIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PROTEINASE-INHIBITOR; ISOTOPE-DILUTION ASSAY; FEEDING-BEHAVIOR; AMINOPEPTIDASE-P; BENZOATE METHANESULFONATE; DIPEPTIDYLPEPTIDASE-IV; RECEPTOR; SYSTEM; ACTIVATION; THROMBIN	There is little information on how neuropeptide Y (NPY) proteolysis by peptidases occurs in serum, in part because reliable techniques are lacking to distinguish different NPY immunoreactive forms and also because the factors affecting the expression of these enzymes have been poorly studied. In the present study, LC-MS/MS was used to identify and quantify NPY fragments resulting from peptidolytic cleavage of NPY1-36 upon incubation with human serum. Kinetic studies indicated that NPY1-36 is rapidly cleaved in serum into 3 main fragments with the following order of efficacy: NPY3-36 >> NPY3-35 >> NPY2-36. Trace amounts of additional NPY forms were identified by accurate mass spectrometry. Specific inhibitors of dipeptidyl peptidase IV, kallikrein, and aminopeptidase P prevented the production of NPY3-36, NPY3-35, and NPY2-36, respectively. Plasma kallikrein at physiological concentrations converted NPY3-36 into NPY3-35. Receptor binding assays revealed that NPY3-35 is unable to bind to NPY Y1, Y2, and Y5 receptors; thus NPY3-35 may represent the major metabolic clearance product of the Y2/Y5 agonist, NPY3-36.	[Abid, Karim; Vatansever, Bilgin; Tella, Patricia; Grouzmann, Eric] CHUV, Div Clin Pharmacol & Toxicol, CH-1011 Lausanne, Switzerland; [Rochat, Bertrand] CHUV, Quantitat Mass Spectrometry Facil, CH-1011 Lausanne, Switzerland; [Brakch, Noureddine; Aubert, Jean-Francois] CHUV, Div Angiol, CH-1011 Lausanne, Switzerland; [Lassahn, Paul-Gerhard] ThermoFisher Sci, CH-4127 Birsfelden, Switzerland; [Stoecklin, Reto; Michalet, Sophie] Atheris Labs, CH-1233 Bernex, Switzerland; [De Meester, Ingrid] Univ Antwerp, Med Biochem Lab, B-2610 Antwerp, Belgium	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Antwerp	Grouzmann, E (corresponding author), Hop Beaumont, 29 Rue Beaumont, CH-1011 Lausanne, Switzerland.	Eric.Grouzmann@chuv.ch	De Meester, Ingrid/A-6881-2017	De Meester, Ingrid/0000-0002-3421-0124; Abid, Karim/0000-0003-0025-7335	Swiss National Science Foundation [3100 AO-101999]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 3100 AO-101999 (to E. G.).	Abdel-Samad D, 2007, PEPTIDES, V28, P281, DOI 10.1016/j.peptides.2006.09.028; ALLEN JM, 1984, REGUL PEPTIDES, V8, P61, DOI 10.1016/0167-0115(84)90029-6; Almeida PC, 2000, BBA-PROTEIN STRUCT M, V1479, P83, DOI 10.1016/S0167-4838(00)00049-2; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Bitran M, 1999, BRAIN RES, V851, P87, DOI 10.1016/S0006-8993(99)02123-X; Busso N, 2005, AM J PATHOL, V166, P433, DOI 10.1016/S0002-9440(10)62266-3; Cardin A D, 1986, Adv Exp Med Biol, V198 Pt A, P195; Cavadas C, 2006, P NATL ACAD SCI USA, V103, P10497, DOI 10.1073/pnas.0600913103; CORDER R, 1985, PEPTIDES, V6, P1195, DOI 10.1016/0196-9781(85)90450-4; DE MI, 2003, ADV EXP MED BIOL, V524, P3; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Frerker N, 2007, PEPTIDES, V28, P257, DOI 10.1016/j.peptides.2006.09.027; Grouzmann E, 2002, FASEB J, V16, P1132, DOI 10.1096/fj.01-0939fje; Grouzmann E, 1997, J BIOL CHEM, V272, P7699, DOI 10.1074/jbc.272.12.7699; GROUZMANN E, 1989, J CLIN ENDOCR METAB, V68, P808, DOI 10.1210/jcem-68-4-808; ICHINOSE A, 1986, J BIOL CHEM, V261, P3486; Jackson DN, 2005, J PHYSIOL-LONDON, V568, P573, DOI 10.1113/jphysiol.2005.092700; Khan IU, 2007, BIOPOLYMERS, V88, P182, DOI 10.1002/bip.20666; Kippen AD, 1997, J BIOL CHEM, V272, P12513, DOI 10.1074/jbc.272.19.12513; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; LEDUC R, 1990, LIFE SCI, V46, P1427, DOI 10.1016/0024-3205(90)90458-4; LUNDBERG JM, 1985, BIOCHEM BIOPH RES CO, V133, P30, DOI 10.1016/0006-291X(85)91837-6; Malis DD, 1999, BRIT J PHARMACOL, V126, P989, DOI 10.1038/sj.bjp.0702388; MEDEIROS MD, 1994, ENDOCRINOLOGY, V134, P2088, DOI 10.1210/en.134.5.2088; Mentlein R, 1996, PEPTIDES, V17, P709, DOI 10.1016/0196-9781(96)00066-6; MENTLEIN R, 1993, REGUL PEPTIDES, V49, P133, DOI 10.1016/0167-0115(93)90435-B; METTERS KM, 1988, J BIOL CHEM, V263, P12543; Michel MC, 1998, PHARMACOL REV, V50, P143; Moser C, 2000, CAN J PHYSIOL PHARM, V78, P134, DOI 10.1139/cjpp-78-2-134; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; OHNO H, 1980, THROMB RES, V19, P579, DOI 10.1016/0049-3848(80)90030-4; OHNO H, 1981, THROMB RES, V24, P445, DOI 10.1016/0049-3848(81)90078-5; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Peek M, 2002, J BIOL CHEM, V277, P47804, DOI 10.1074/jbc.M209778200; Pons Jennifer, 2004, Curr Opin Investig Drugs, V5, P957; Prechel MM, 1995, J PHARMACOL EXP THER, V275, P1136; SAHU A, 1993, TRENDS ENDOCRIN MET, V4, P217, DOI 10.1016/1043-2760(93)90125-X; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; Schmaier AH, 2008, INT IMMUNOPHARMACOL, V8, P161, DOI 10.1016/j.intimp.2007.08.022; Silva AP, 2003, REGUL PEPTIDES, V116, P71, DOI 10.1016/S0167-0115(03)00191-5; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Stocklin R, 1997, DIABETES, V46, P44, DOI 10.2337/diabetes.46.1.44; THEODORSSONNORHEIM E, 1985, SCAND J CLIN LAB INV, V45, P355, DOI 10.3109/00365518509161019; Veloso D, 2003, SCAND J CLIN LAB INV, V63, P279, DOI 10.1080/00365510310001735; WAHLESTEDT C, 1985, J PHARMACOL EXP THER, V234, P735; WALKER P, 1991, TRENDS PHARMACOL SCI, V12, P111, DOI 10.1016/0165-6147(91)90518-W; WESTFALL TC, 1987, J CARDIOVASC PHARM, V10, P716, DOI 10.1097/00005344-198712000-00016; Wiest R, 2006, J HEPATOL, V44, P512, DOI 10.1016/j.jhep.2005.08.023; YARON A, 1968, BIOCHEM BIOPH RES CO, V32, P658, DOI 10.1016/0006-291X(68)90289-1	49	53	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24715	24724		10.1074/jbc.M109.035253	http://dx.doi.org/10.1074/jbc.M109.035253			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19620246	Green Published, hybrid			2022-12-27	WOS:000269734000006
J	Branham, MT; Bustos, MA; De Blas, GA; Rehmann, H; Zarelli, VEP; Trevino, CL; Darszon, A; Mayorga, LS; Tomes, CN				Branham, Maria T.; Bustos, Matias A.; De Blas, Gerardo A.; Rehmann, Holger; Zarelli, Valeria E. P.; Trevino, Claudia L.; Darszon, Alberto; Mayorga, Luis S.; Tomes, Claudia N.			Epac Activates the Small G Proteins Rap1 and Rab3A to Achieve Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SOLUBLE ADENYLYL-CYCLASE; GTP-BINDING PROTEIN; CA2+-INDUCED CA2+ RELEASE; PHOSPHOLIPASE-C-EPSILON; EXCHANGE FACTOR; ACROSOMAL EXOCYTOSIS; SPERM ACROSOME; ZONA-PELLUCIDA; CYCLIC-AMP; SIGNAL-TRANSDUCTION	Exocytosis of the acrosome (the acrosome reaction) relies on cAMP production, assembly of a proteinaceous fusion machinery, calcium influx from the extracellular medium, and mobilization from inositol 1,4,5-trisphosphate-sensitive intracellular stores. Addition of cAMP to human sperm suspensions bypasses some of these requirements and elicits exocytosis in a protein kinase A-and extracellular calcium-independent manner. The relevant cAMP target is Epac, a guanine nucleotide exchange factor for the small GTPase Rap. We show here that a soluble adenylyl cyclase synthesizes the cAMP required for the acrosome reaction. Epac stimulates the exchange of GDP for GTP on Rap1, upstream of a phospholipase C. The Epac-selective cAMP analogue 8-pCPT-2'-O-Me-cAMP induces a phospholipase C-dependent calcium mobilization in human sperm suspensions. In addition, our studies identify a novel connection between cAMP and Rab3A, a secretory granule-associated protein, revealing that the latter functions downstream of soluble adenylyl cyclase/cAMP/Epac but not of Rap1. Challenging sperm with calcium or 8-pCPT-2'-O-Me-cAMP boosts the exchange of GDP for GTP on Rab3A. Recombinant Epac does not release GDP from Rab3A in vitro, suggesting that the Rab3A-GEF activation by cAMP/Epac in vivo is indirect. We propose that Epac sits at a critical point during the exocytotic cascade after which the pathway splits into two limbs, one that assembles the fusion machinery into place and another that elicits intracellular calcium release.	[Mayorga, Luis S.; Tomes, Claudia N.] Univ Nacl Cuyo, Lab Biol Celular & Mol, Inst Histol & Embriol, Consejo Nacl Invest Cient & Tecn,Fac Ciencias Med, RA-5500 Mendoza, Argentina; [Rehmann, Holger] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Rehmann, Holger] Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; [De Blas, Gerardo A.; Trevino, Claudia L.; Darszon, Alberto] Univ Nacl Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Universidad Nacional Autonoma de Mexico	Tomes, CN (corresponding author), Univ Nacl Cuyo, Lab Biol Celular & Mol, Inst Histol & Embriol, Consejo Nacl Invest Cient & Tecn,Fac Ciencias Med, CC 56, RA-5500 Mendoza, Argentina.	ctomes@fcm.uncu.edu.ar		Trevino, Claudia L/0000-0002-7281-0534; Mayorga, Luis S/0000-0002-5995-0671; Bustos, Matias A./0000-0001-9625-1127; Darszon, Alberto/0000-0002-2502-0505	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 5951]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT2006-1036]; Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) [49113, 42605]; PAPIIT [IN204109, IN211809]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work was supported in part by Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP 5951, Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT2006-1036, Argentina (to C.N.T.), Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) Grants 49113 (to A.D.) and 42605 (to C.L.T.), and PAPIIT Grants IN204109 ( to C.L.T.) and IN211809 (to A.D.).	Aivatiadou E, 2007, MOL BIOL CELL, V18, P1530, DOI 10.1091/mbc.E06-10-0902; Amano R, 2007, J REPROD DEVELOP, V53, P127, DOI 10.1262/jrd.18077; Balasubramanian L, 2008, PFLUG ARCH EUR J PHY, V456, P747, DOI 10.1007/s00424-007-0371-7; Bedford JM, 1998, BIOL REPROD, V59, P1275, DOI 10.1095/biolreprod59.6.1275; Belmonte SA, 2005, DEV BIOL, V285, P393, DOI 10.1016/j.ydbio.2005.07.001; Beltran C, 2007, BIOCHEM BIOPH RES CO, V358, P1128, DOI 10.1016/j.bbrc.2007.05.061; Berruti G, 2003, CELL MOL BIOL, V49, P381; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Chin EC, 2004, J ENDOCRINOL, V183, P51, DOI 10.1677/joe.1.05550; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; D'Silva NJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1667, DOI 10.1152/ajpcell.1998.274.6.C1667; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Garde J, 1996, FEBS LETT, V391, P263, DOI 10.1016/0014-5793(96)00749-1; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Han H, 2005, J EXP MED, V202, P353, DOI 10.1084/jem.20050778; Handley MTW, 2007, J CELL SCI, V120, P973, DOI 10.1242/jcs.03406; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Hatakeyama H, 2007, J PHYSIOL-LONDON, V582, P1087, DOI 10.1113/jphysiol.2007.135228; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Iida H, 1999, DEV BIOL, V211, P144, DOI 10.1006/dbio.1999.9302; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kang GX, 2005, J PHYSIOL-LONDON, V566, P173, DOI 10.1113/jphysiol.2005.087510; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kinukawa M, 2006, FEBS LETT, V580, P1515, DOI 10.1016/j.febslet.2006.01.078; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kowluru A, 1997, BIOCHEM PHARMACOL, V54, P1097, DOI 10.1016/S0006-2952(97)00314-6; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Kwan EP, 2007, DIABETES, V56, P2579, DOI 10.2337/db06-1207; Lang Thorsten, 2008, V184, P107; LEISER M, 1995, ENDOCRINOLOGY, V136, P2521, DOI 10.1210/en.136.6.2521; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Nakagaki I, 2000, PFLUG ARCH EUR J PHY, V440, P828, DOI 10.1007/s004240000372; Nomikos M, 2005, J BIOL CHEM, V280, P31011, DOI 10.1074/jbc.M500629200; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Ohnishi H, 1997, J CLIN INVEST, V100, P3044, DOI 10.1172/JCI119859; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; PRYDE JG, 1986, BIOCHEM J, V233, P525, DOI 10.1042/bj2330525; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; REGAZZI R, 2007, MOL MECH EXOCYTOSIS, P28; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Sakane A, 2006, P NATL ACAD SCI USA, V103, P10029, DOI 10.1073/pnas.0600304103; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Sedej S, 2005, J PHYSIOL-LONDON, V567, P799, DOI 10.1113/jphysiol.2005.090381; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Szaszak M, 2008, CELL SIGNAL, V20, P590, DOI 10.1016/j.cellsig.2007.10.020; Tomes Claudia Nora, 2007, Soc Reprod Fertil Suppl, V65, P275; Tomes CN, 1996, MOL REPROD DEV, V43, P196, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;196::AID-MRD9&gt;3.0.CO;2-M; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Ward CR, 1999, MOL REPROD DEV, V53, P413, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;413::AID-MRD7&gt;3.0.CO;2-W; Wuttke M S, 2001, JOP, V2, P154; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zheng Yi, 2003, EMBO Reports, V4, P463, DOI 10.1038/sj.embor.embor831	102	76	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24825	24839		10.1074/jbc.M109.015362	http://dx.doi.org/10.1074/jbc.M109.015362			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19546222	Green Published, hybrid			2022-12-27	WOS:000269734000017
J	Cho, YD; Yoon, WJ; Woo, KM; Baek, JH; Lee, G; Cho, JY; Ryoo, HM				Cho, Young-Dan; Yoon, Won-Joon; Woo, Kyung-Mi; Baek, Jeong-Hwa; Lee, Gene; Cho, Je-Yoel; Ryoo, Hyun-Mo			Molecular Regulation of Matrix Extracellular Phosphoglycoprotein Expression by Bone Morphogenetic Protein-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT HYPOPHOSPHATEMIC RICKETS; ALKALINE-PHOSPHATASE EXPRESSION; OSTEOBLAST DIFFERENTIATION; HOMEODOMAIN PROTEINS; SIBLING PROTEINS; GENE-EXPRESSION; MEPE; RUNX2; DLX5; BINDING	Matrix extracellular phosphoglycoprotein (MEPE) is mainly expressed in mineralizing tissues, and its C-terminal proteolytic cleavage product is an acidic-serine-asparate-rich-MEPE-associated motif (ASARM) that is a strong regulator of body phosphate metabolism and mineralization. There is sufficient data supporting a role for MEPE protein function in mineralization, however, little is known about the regulation of MEPE gene expression. As bone morphogenetic protein-2 (BMP-2) is one of the most important signals for calvarial mineralization and MEPE expression is higher in mineralized tissues, we attempted to uncover a regulatory circuit between BMP-2 and MEPE expression. Mepe expression is very low in proliferating MC3T3-E1 cells, but is dramatically increased in the mineralization stage and is strongly stimulated by treatment with BMP-2, even in proliferating cells. Overexpression and knockdown experiments of Smads, Dlx5, and Runx2 indicated that they are indispensable mediators of BMP-2-induced Mepe expression. In contrast, Msx2 showed strong inhibition of Mepe transcription. PHEX is an enzyme that prevents the release of the ASARM motif, a mineralization inhibitor, from the MEPE molecule. Thus, the MEPE/PHEX ratio may be a good indicator of mineralization progression because we found that the mRNA ratio and protein levels were low when osteoblasts were actively differentiating to the mineralization stage and the ratio was high when the cells reached the mineralization stage when it is assumed that osteocytes may protect themselves and make a space to survive from the mineralized matrix by releasing the ASARM motif. Collectively, MEPE expression is bone cell-specific and induced by the BMP-2 signaling pathway. In addition, the MEPE/PHEX ratio of the cell could be a very important barometer indicating the progression of tissue mineralization.	[Cho, Young-Dan; Yoon, Won-Joon; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Dept Cell & Dev Biol, Seoul 100749, South Korea; [Lee, Gene] Seoul Natl Univ, Dept Biochem, Sch Dent, Seoul 100749, South Korea; [Lee, Gene] Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 100749, South Korea; [Cho, Je-Yoel] Kyungpook Natl Univ, Dept Biochem, Sch Dent, Taegu 700422, South Korea; [Cho, Je-Yoel] Kyungpook Natl Univ, Skeletal Dis Genome Res Ctr, Taegu 700422, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University; Kyungpook National University	Ryoo, HM (corresponding author), 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Cho, Young-Dan/AAR-4573-2021; Baek, Jeong-Hwa/A-8628-2012; Woo, Kyung Mi/A-2793-2009; Ryoo, Hyun-Mo/D-5839-2012	Woo, Kyung Mi/0000-0002-2782-1189; Ryoo, Hyun-Mo/0000-0001-6769-8341	Ministry of Health and Welfare [A010252]; Korean Government (MOEHRD) [KRF-2006-I00680A]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare Project A010252, and a Korea Research Foundation grant funded by Korean Government (MOEHRD) Grant KRF-2006-I00680A.	Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Argiro L, 2001, GENOMICS, V74, P342, DOI 10.1006/geno.2001.6553; Barnes GL, 2003, CANCER RES, V63, P2631; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Cho JY, 2006, GENE, V372, P71, DOI 10.1016/j.gene.2005.12.010; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Choi KY, 2005, DEV DYNAM, V233, P115, DOI 10.1002/dvdy.20323; Dodig M, 1996, J BIOL CHEM, V271, P16422, DOI 10.1074/jbc.271.27.16422; Econs MJ, 1997, J CLIN INVEST, V100, P2653, DOI 10.1172/JCI119809; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; HOFFMANN HM, 1994, P NATL ACAD SCI USA, V91, P12887, DOI 10.1073/pnas.91.26.12887; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Liu H, 2004, J DENT RES, V83, P496, DOI 10.1177/154405910408300612; MARTIN A, 2007, J BONE MINER RES, V22, pF1118; Nagel DE, 2004, J CELL BIOCHEM, V93, P1107, DOI 10.1002/jcb.20249; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Petersen DN, 2000, J BIOL CHEM, V275, P36172, DOI 10.1074/jbc.M003622200; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rowe PSN, 2004, CRIT REV ORAL BIOL M, V15, P264, DOI 10.1177/154411130401500503; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Six N, 2007, J DENT RES, V86, P780, DOI 10.1177/154405910708600818; Sprowson AP, 2008, J ORTHOP RES, V26, P1256, DOI 10.1002/jor.20606; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; White KE, 2006, ENDOCR REV, V27, P221, DOI 10.1210/er.2005-0019; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Yoon WJ, 2008, J BIOL CHEM, V283, P32751, DOI 10.1074/jbc.M803183200; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	37	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25230	25240		10.1074/jbc.M109.008391	http://dx.doi.org/10.1074/jbc.M109.008391			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617624	Green Published, hybrid			2022-12-27	WOS:000269734000057
J	Corda, D; Kudo, T; Zizza, P; Iurisci, C; Kawai, E; Kato, N; Yanaka, N; Mariggio, S				Corda, Daniela; Kudo, Takahiro; Zizza, Pasquale; Iurisci, Cristiano; Kawai, Eri; Kato, Norihisa; Yanaka, Noriyuki; Mariggio, Stefania			The Developmentally Regulated Osteoblast Phosphodiesterase GDE3 Is Glycerophosphoinositol-specific and Modulates Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE; MEMBRANE-PROTEIN; PHOSPHOINOSITIDE METABOLITE; ESCHERICHIA-COLI; THYROID-CELLS; DIFFERENTIATION; 4-PHOSPHATE; TRANSPORTER; PROMOTES	The glycerophosphodiester phosphodiesterase enzyme family involved in the hydrolysis of glycerophosphodiesters has been characterized in bacteria and recently identified in mammals. Here, we have characterized the activity and function of GDE3, one of the seven mammalian enzymes. GDE3 is up-regulated during osteoblast differentiation and can affect cell morphology. We show that GDE3 is a glycerophosphoinositol (GroPIns) phosphodiesterase that hydrolyzes GroPIns, producing inositol 1-phosphate and glycerol, and thus suggesting specific roles for this enzyme in GroPIns metabolism. Substrate specificity analyses show that wild-type GDE3 selectively hydrolyzes GroPIns over glycerophosphocholine, glycerophosphoethanolamine, and glycerophosphoserine. A single point mutation in the catalytic domain of GDE3 (GDE3R231A) leads to loss of GroPIns enzymatic hydrolysis, identifying an arginine residue crucial for GDE3 activity. After heterologous GDE3 expression in HEK293T cells, phosphodiesterase activity is detected in the extracellular medium, with no effect on the intracellular GroPIns pool. Together with the millimolar concentrations of calcium required for GDE3 activity, this predicts an enzyme topology with an extracellular catalytic domain. Interestingly, GDE3 ectocellular activity is detected in a stable clone from a murine osteoblast cell line, further confirming the activity of GDE3 in a more physiological context. Finally, overexpression of wild-type GDE3 in osteoblasts promotes disassembly of actin stress fibers, decrease in growth rate, and increase in alkaline phosphatase activity and calcium content, indicating a role for GDE3 in induction of differentiation. Thus, we have identified the GDE3 substrate GroPIns as a candidate mediator for osteoblast proliferation, in line with the GroPIns activity observed previously in epithelial cells.	[Corda, Daniela; Zizza, Pasquale; Iurisci, Cristiano; Mariggio, Stefania] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy; [Kudo, Takahiro; Kato, Norihisa; Yanaka, Noriyuki] Hiroshima Univ, Dept Mol & Appl Biosci, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Kawai, Eri] Mitsubishi Tanabe Pharma Corp, Adv Med Res Dept, Yodogawa Ku, Osaka 5328505, Japan	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Hiroshima University; Mitsubishi Tanabe Pharma Corporation	Corda, D (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy.	corda@negrisud.it; yanaka@hiroshima-u.ac.jp; mariggio@negrisud.it	Yanaka, Noriyuki/P-9096-2016; Corda, Daniela/K-6385-2016; Mariggio', Stefania/H-5467-2015; Zizza, Pasquale/K-3292-2018	Corda, Daniela/0000-0002-3614-751X; Mariggio', Stefania/0000-0002-6397-3016; Zizza, Pasquale/0000-0001-7281-6090	Telethon Italia (Italy); Italian Association for Cancer Research (AIRC, Milan, Italy); MIUR (Italy)	Telethon Italia (Italy)(Fondazione Telethon); Italian Association for Cancer Research (AIRC, Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); MIUR (Italy)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Telethon Italia (Italy), the Italian Association for Cancer Research (AIRC, Milan, Italy), and the MIUR (Italy).	Ahren IL, 2001, MICROB PATHOGENESIS, V31, P151, DOI 10.1006/mpat.2001.0456; Berrie CP, 2007, METHOD ENZYMOL, V434, P187, DOI 10.1016/S0076-6879(07)34011-1; Chang PA, 2008, MOL MEMBR BIOL, V25, P557, DOI 10.1080/09687680802537605; CLARKE NG, 1981, BIOCHEM J, V195, P301, DOI 10.1042/bj1950301; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; Corda D, 2009, CELL MOL LIFE SCI, V66, P3449, DOI 10.1007/s00018-009-0113-4; Datta NS, 2005, J BONE MINER RES, V20, P1051, DOI 10.1359/JBMR.050106; Dragani LK, 2004, J CHROMATOGR B, V802, P283, DOI 10.1016/j.jchromb.2003.12.002; Filippi BM, 2008, BBA-MOL CELL RES, V1783, P2311, DOI 10.1016/j.bbamcr.2008.07.021; LARSON TJ, 1983, J BIOL CHEM, V258, P5428; Mancini R, 2003, MOL BIOL CELL, V14, P503, DOI 10.1091/mbc.E02-04-0179; Mariggio S, 2007, CANCER RES, V67, P11769, DOI 10.1158/0008-5472.CAN-07-1997; Mariggio S, 2006, FEBS LETT, V580, P6789, DOI 10.1016/j.febslet.2006.11.039; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; Ogasawara T, 2004, MOL CELL BIOL, V24, P6560, DOI 10.1128/mcb.24.15.6560-6568.2004; Patrussi L, 2007, CELL SIGNAL, V19, P2351, DOI 10.1016/j.cellsig.2007.07.014; Patton-Vogt JL, 1998, GENETICS, V149, P1707; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Sowa H, 2002, J BONE MINER RES, V17, P1190, DOI 10.1359/jbmr.2002.17.7.1190; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; VALITUTTI S, 1991, CELL SIGNAL, V3, P321, DOI 10.1016/0898-6568(91)90061-X; Waite M, 1999, BBA-MOL CELL BIOL L, V1439, P187, DOI 10.1016/S1388-1981(99)00094-3; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100	27	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24848	24856		10.1074/jbc.M109.035444	http://dx.doi.org/10.1074/jbc.M109.035444			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19596859	Green Published, hybrid			2022-12-27	WOS:000269734000019
J	Hiroi, M; Mori, K; Sekine, K; Sakaeda, Y; Shimada, J; Ohmori, Y				Hiroi, Miki; Mori, Kazumasa; Sekine, Keisuke; Sakaeda, Yoshiichi; Shimada, Jun; Ohmori, Yoshihiro			Mechanisms of Resistance to Interferon-gamma-mediated Cell Growth Arrest in Human Oral Squamous Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; MESSENGER-RNA STABILITY; C-MYC EXPRESSION; FACTOR-KAPPA-B; IFN-GAMMA; MELANOMA-CELLS; PROTEIN-KINASE; INHIBITOR P21(WAF1/CIP1); TARGETED DISRUPTION; SIGNAL TRANSDUCER	Interferon-gamma (IFN gamma) has an antiproliferative effect on a variety of tumor cells. However, many tumor cells resist treatment with IFNs. Here, we show that IFN gamma fails to inhibit the growth of some types of oral squamous cell carcinoma (OSCC) cells that possess a fully functional IFN gamma/STAT1 (signal transducer and activator of transcription-1) signaling pathway. IFN gamma inhibited the growth of the HSC-2, HSC-3, and HSC-4 OSCC cell lines. However, Ca9-22 cells were resistant to IFN gamma despite having intact STAT1-dependent signaling, such as normal tyrosine phosphorylation, DNA binding activity, and transcriptional activity of STAT1. The growth inhibition of HSC-2 cells resulted from S-phase arrest of the cell cycle. IFN gamma inhibited cyclin A2 (CcnA2)-associated kinase activity, which correlated with the IFN gamma-mediated down-regulation of CcnA2 and Cdk2 expression at both the transcriptional and post-transcriptional level in HSC-2 cells but not in Ca9-22 cells. RNAi-mediated knockdown of CcnA2 and Cdk2 resulted in growth inhibition in both cell lines. These results indicate that the resistance of OSCC to IFN gamma is not due simply to the deficiency in STAT1-dependent signaling but results from a defect in the signaling component that mediates this IFN gamma-induced down-regulation of CcnA2 and Cdk2 expression at the transcriptional and post-transcriptional levels.	[Mori, Kazumasa; Shimada, Jun] Meikai Univ, Div Oral & Maxillofacial Surg, Dept Diagnost & Therapeut Sci, Sch Dent, Sakado, Saitama 3500283, Japan; Meikai Univ, Div Microbiol & Immunol, Dept Oral Biol & Tissue Engn, Sch Dent, Sakado, Saitama 3500283, Japan	Meikai University; Meikai University		ohmori@dent.meikai.ac.jp		Ohmori, Yoshihiro/0000-0002-6069-357X; Sekine, Keisuke/0000-0001-5133-0876	Ministry of Education, Science, and Culture of Japan; Meikai University School of Dentistry	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Meikai University School of Dentistry	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan and from the Meikai University School of Dentistry.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Asao H, 2000, J BIOL CHEM, V275, P867, DOI 10.1074/jbc.275.2.867; BENNETT MR, 1994, BIOCHEM J, V302, P701, DOI 10.1042/bj3020701; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Chawla-Sarkar M, 2002, J INTERF CYTOK RES, V22, P603, DOI 10.1089/10799900252982089; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Clifford JL, 2002, CLIN CANCER RES, V8, P2067; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dovhey SE, 2000, CANCER RES, V60, P5789; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; EL DW, 1993, CELL, V75, P817; Fang P, 2006, EXP CELL RES, V312, P1229, DOI 10.1016/j.yexcr.2005.12.011; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Gooch JL, 2000, CELL GROWTH DIFFER, V11, P335; HARPER JW, 1993, CELL, V75, P805; Harvat BL, 1996, CELL GROWTH DIFFER, V7, P289; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Hiroi M, 2003, BIOCHEM J, V376, P393, DOI 10.1042/BJ20030842; JONAK GJ, 1984, P NATL ACAD SCI-BIOL, V81, P1747, DOI 10.1073/pnas.81.6.1747; KAMATA N, 1986, CANCER RES, V46, P1648; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kominsky S, 1998, ONCOGENE, V17, P2973, DOI 10.1038/sj.onc.1202217; Kortylewski M, 2004, J INVEST DERMATOL, V122, P414, DOI 10.1046/j.0022-202X.2004.22237.x; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; Lei HQ, 2005, CANCER BIOL THER, V4, P709, DOI 10.4161/cbt.4.7.1767; Mandal M, 1998, ONCOGENE, V16, P217, DOI 10.1038/sj.onc.1201529; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Ohmori Y, 1997, J IMMUNOL, V159, P5474; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Sangfelt O, 1997, ONCOGENE, V14, P415, DOI 10.1038/sj.onc.1200832; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Shiffman D, 1996, J BIOL CHEM, V271, P12199, DOI 10.1074/jbc.271.21.12199; Sibinga NES, 1999, J BIOL CHEM, V274, P12139, DOI 10.1074/jbc.274.17.12139; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Sun WH, 1998, BLOOD, V91, P570, DOI 10.1182/blood.V91.2.570.570_570_576; Vivo C, 2001, ONCOGENE, V20, P1085, DOI 10.1038/sj.onc.1204199; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; XU B, 1994, BLOOD, V84, P1942; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928	55	7	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24869	24880		10.1074/jbc.M109.025932	http://dx.doi.org/10.1074/jbc.M109.025932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19596857	Green Published, hybrid			2022-12-27	WOS:000269734000021
J	Srivastava, S; Hamouda, AK; Pandhare, A; Duddempudi, PK; Sanghvi, M; Cohen, JB; Blanton, MP				Srivastava, Shouryadeep; Hamouda, Ayman K.; Pandhare, Akash; Duddempudi, Phaneendra K.; Sanghvi, Mitesh; Cohen, Jonathan B.; Blanton, Michael P.			[H-3]Epibatidine Photolabels Non-equivalent Amino Acids in the Agonist Binding Site of Torpedo and alpha 4 beta 2 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CURARIFORM ANTAGONISTS BIND; DIFFERENT ORIENTATIONS; MOLECULAR DOCKING; LIGAND; PROTEIN; DOMAIN; IDENTIFICATION; CONFORMATIONS; STOICHIOMETRY; PHARMACOLOGY	Nicotinic acetylcholine receptor (nAChR) agonists, such as epibatidine and its molecular derivatives, are potential therapeutic agents for a variety of neurological disorders. In order to identify determinants for subtype-selective agonist binding, it is important to determine whether an agonist binds in a common orientation in different nAChR subtypes. To compare the mode of binding of epibatidine in a muscle and a neuronal nAChR, we photolabeled Torpedo alpha(2)beta gamma delta and expressed human alpha 4 beta 2 nAChRs with [H-3]epibatidine and identified by Edman degradation the photolabeled amino acids. Irradiation at 254 nm resulted in photolabeling of alpha Tyr(198) in agonist binding site Segment C of the principal (+) face in both alpha subunits and of gamma Leu(109) and gamma Tyr(117) in Segment E of the complementary (-) face, with no labeling detected in the delta subunit. For affinity-purified alpha 4 beta 2 nAChRs, [H-3]epibatidine photolabeled alpha 4Tyr(195) (equivalent to Torpedo alpha Tyr(190)) in Segment C as well as beta 2Val(111) and beta 2Ser(113) in Segment E (equivalent to Torpedo gamma Leu(109) and gamma Tyr(111), respectively). Consideration of the location of the photolabeled amino acids in homology models of the nAChRs based upon the acetylcholine-binding protein structure and the results of ligand docking simulations suggests that epibatidine binds in a single preferred orientation within the alpha-gamma transmitter binding site, whereas it binds in two distinct orientations in the alpha 4 beta 2 nAChR.	[Srivastava, Shouryadeep; Pandhare, Akash; Duddempudi, Phaneendra K.; Sanghvi, Mitesh; Blanton, Michael P.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Sch Med, Lubbock, TX 79430 USA; [Srivastava, Shouryadeep; Pandhare, Akash; Duddempudi, Phaneendra K.; Sanghvi, Mitesh; Blanton, Michael P.] Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Sch Med, Lubbock, TX 79430 USA; [Hamouda, Ayman K.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Harvard University; Harvard Medical School	Blanton, MP (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Sch Med, 3601 4th St, Lubbock, TX 79430 USA.	michael.blanton@ttuhsc.edu	Pandhare, Akash/M-1827-2016; Duddempudi, Phaneendra/AAL-8015-2020; Sanghvi, Mitesh/C-6740-2013	Duddempudi, Phaneendra/0000-0002-2625-8179; Hamouda, Ayman/0000-0001-7819-3074	National Institutes of Health [GM-58448]; American Heart Association South Central [0755029Y]; South Plains Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association South Central(American Heart Association); South Plains Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-58448 (to J. B. C.). This work was also supported in part by American Heart Association South Central Affiliate Grant-in-Aid 0755029Y (to M. P. B.) and the South Plains Foundation (to M. P. B.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cashin AL, 2007, BIOCHEMISTRY-US, V46, P630, DOI 10.1021/bi061638b; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; Chiara DC, 1998, FEBS LETT, V423, P223, DOI 10.1016/S0014-5793(98)00093-3; Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; Erickson JA, 2004, J MED CHEM, V47, P45, DOI 10.1021/jm030209y; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Gao F, 2003, J BIOL CHEM, V278, P23020, DOI 10.1074/jbc.M301151200; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HAMOUDA AK, 2008, BIOPHYS J, V94, pA1418; Hamouda AK, 2007, BIOCHEMISTRY-US, V46, P13837, DOI 10.1021/bi701705r; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; NEUBIG RR, 1979, BIOCHEMISTRY-US, V18, P5464, DOI 10.1021/bi00591a032; Nirthanan S, 2005, BIOCHEMISTRY-US, V44, P13447, DOI 10.1021/bi051209y; OHKURA K, 1989, TETRAHEDRON LETT, V30, P3433, DOI 10.1016/S0040-4039(00)99264-5; PEDERSEN SE, 1986, J BIOL CHEM, V261, P3735; Prince RJ, 1998, J BIOL CHEM, V273, P7843, DOI 10.1074/jbc.273.14.7843; Song XZ, 2003, BIOCHEMISTRY-US, V42, P4197, DOI 10.1021/bi027405b; Tomizawa M, 2008, P NATL ACAD SCI USA, V105, P1728, DOI 10.1073/pnas.0711724105; Tomizawa M, 2007, BIOCHEMISTRY-US, V46, P8798, DOI 10.1021/bi700667v; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vodovozova EL, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1, DOI 10.1134/S0006297907010014; Wang HL, 2003, J BIOL CHEM, V278, P32284, DOI 10.1074/jbc.M304366200; Wells GB, 2008, FRONT BIOSCI-LANDMRK, V13, P5479, DOI 10.2741/3094; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITTEN DG, 1976, PHOTOCHEMISTRY HETER, P524; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhang J, 2003, BRAIN RES, V959, P98, DOI 10.1016/S0006-8993(02)03733-2; ZOLTEWICZ JA, 1983, J ORG CHEM, V48, P4214, DOI 10.1021/jo00171a012	46	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24939	24947		10.1074/jbc.M109.019083	http://dx.doi.org/10.1074/jbc.M109.019083			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19620239	Green Published, hybrid			2022-12-27	WOS:000269734000028
J	Zhang, M; Wang, FC; Kou, ZH; Zhang, Y; Gao, SR				Zhang, Miao; Wang, Fengchao; Kou, Zhaohui; Zhang, Yu; Gao, Shaorong			Defective Chromatin Structure in Somatic Cell Cloned Mouse Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; STEM-CELLS; NUCLEAR TRANSFER; TRICHOSTATIN-A; DONOR CELLS; CLONING; PLURIPOTENCY; PROTEIN; OCT4	Epigenetic reprogramming plays a central role in the development of cloned embryos generated by somatic cell nuclear transfer, and it is believed that aberrant reprogramming leads to the abnormal development of most cloned embryos. Recent studies show that trimethylation of H3K27 (H3K27me3) contributes to the maintenance of embryonic stem cell pluripotency because the differentiation genes are always occupied by nucleosomes trimethylated at H3K27, which represses gene expression. Here, we provide evidence that differential H3K27me3 modification exists between normal fertilization-produced blastocysts and somatic cell nuclear transfer cloned blastocysts; H3K27me3 was specifically found in cells of the inner cell mass (ICM) of normal blastocysts, whereas there was no modification of H3K27me3 in the ICM of cloned blastocysts. Subsequently, we demonstrated that the differentiation-related genes, which are marked by H3K27me3 in embryonic stem cells, were expressed at significantly higher levels in cloned embryos than in normal embryos. The polycomb repressive complex 2 (PRC2) component genes (Eed, Ezh2, and Suz12), which are responsible for the generation of H3K27me3, were expressed at lower levels in the cloned embryos. Our results suggest that reduced expression of PRC2 component genes in cloned embryos results in defective modification of H3K27me3 to the differentiation-related genes in pluripotent ICM cells. This results in premature expression of developmental genes and death of somatic cloned embryos shortly after implantation. Taken together, these studies suggest that H3K27me3 might be an important epigenetic marker with which to evaluate the developmental potential of cloned embryos.	[Zhang, Miao; Wang, Fengchao; Kou, Zhaohui; Zhang, Yu; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China	National Institute of Biological Sciences, Beijing; China Agricultural University	Gao, SR (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	gaoshaorong@nibs.ac.cn			Ministry of Science and Technology of China [2008AA022311, 2009CB941100]; National Natural Science Foundation [30670302]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 2008AA022311 and 2009CB941100 from the Ministry of Science and Technology of China and Grant 30670302 from the National Natural Science Foundation.	Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Faust C, 1998, DEVELOPMENT, V125, P4495; Gao SR, 2003, BIOL REPROD, V69, P48, DOI 10.1095/biolreprod.102.014522; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamazaki Y, 2006, MOL REPROD DEV, V73, P180, DOI 10.1002/mrd.20411; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	36	52	59	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24981	24987		10.1074/jbc.M109.011973	http://dx.doi.org/10.1074/jbc.M109.011973			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19602512	hybrid, Green Published			2022-12-27	WOS:000269734000033
J	Argiriadi, MA; Xiang, T; Wu, CB; Ghayur, T; Borhani, DW				Argiriadi, Maria A.; Xiang, Tao; Wu, Chengbin; Ghayur, Tariq; Borhani, David W.			Unusual Water-mediated Antigenic Recognition of the Proinflammatory Cytokine Interleukin-18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-GAMMA; LIGAND-BINDING; T-CELLS; PROTEIN; IL-18; REFINEMENT; ANTIBODY; IDENTIFICATION; MOLECULES; RESIDUES	The unique cytokine interleukin-18 (IL-18) acts synergistically with IL-12 to regulate T-helper 1 and 2 lymphocytes and, as such, seems to underlie the pathogenesis of various autoimmune and allergic diseases. Several anti-IL-18 agents are in clinical development, including the recombinant human antibody ABT-325, which is entering trials for autoimmune diseases. Given competing cytokine/receptor and cytokine/receptor decoy interactions, understanding the structural basis for recognition is critical for effective development of anti-cytokine therapies. Here we report three crystal structures: the murine antibody 125-2H Fab fragment bound to human IL-18, at 1.5 angstrom resolution; the 125-2H Fab (2.3 angstrom); and the ABT-325 Fab (1.5 angstrom). These structures, along with human/mouse IL-18 chimera binding data, allow us to make three key observations relevant to the biology and antigenic recognition of IL-18 and related cytokines. First, several IL-18 residues shift dramatically (> 10 angstrom) upon binding 125-2H, compared with unbound IL-18 (Kato, Z., Jee, J., Shikano, H., Mishima, M., Ohki, I., Ohnishi, H., Li, A., Hashimoto, K., Matsukuma, E., Omoya, K., Yamamoto, Y., Yoneda, T., Hara, T., Kondo, N., and Shirakawa, M. (2003) Nat. Struct. Biol. 10, 966-971). IL-18 thus exhibits plasticity that may be common to its interactions with other receptors. Related cytokines may exhibit similar plasticity. Second, ABT-325 and 125-2H differ significantly in combining site character and architecture, thus explaining their ability to bind IL-18 simultaneously at distinct epitopes. These data allow us to define the likely ABT-325 epitope and thereby explain the distinct neutralizing mechanisms of both antibodies. Third, given the high 125-2H potency, 10 well ordered water molecules are trapped upon complex formation in a cavity between two IL-18 loops and all six 125-2H complementarity-determining regions. Thus, counterintuitively, tight and specific antibody binding may in some cases be water-mediated.	[Argiriadi, Maria A.; Xiang, Tao; Borhani, David W.] Abbott Labs, Dept Biochem, Worcester, MA 01605 USA; [Argiriadi, Maria A.; Xiang, Tao; Borhani, David W.] Abbott Labs, Dept Chem, Worcester, MA 01605 USA; [Wu, Chengbin; Ghayur, Tariq] Abbott Labs, Dept Biol, Worcester, MA 01605 USA	Abbott Laboratories; Abbott Laboratories; Abbott Laboratories	Argiriadi, MA (corresponding author), Abbott Labs, Dept Biochem, 100 Res Dr, Worcester, MA 01605 USA.	maria.argiriadi@abbott.com	Borhani, David/O-2692-2019	Borhani, David/0000-0002-8486-8792				Azam T, 2003, J IMMUNOL, V171, P6574, DOI 10.4049/jimmunol.171.12.6574; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; Binkowski TA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-45; Bombardieri M, 2007, EXPERT OPIN BIOL TH, V7, P31, DOI 10.1517/14712598.7.1.31; Brady KD, 1998, BIOCHEMISTRY-US, V37, P8508, DOI 10.1021/bi9803325; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cohen GH, 2005, ACTA CRYSTALLOGR D, V61, P628, DOI 10.1107/S0907444905007870; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DeLano W.L, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; EVANS PR, 1997, JOINT CCP4 ESF EACBM, V33; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GHAYUR T, 2005, Patent No. 2005047307; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karni A, 2002, J NEUROIMMUNOL, V125, P134, DOI 10.1016/S0165-5728(02)00018-8; Kato Z, 2003, NAT STRUCT BIOL, V10, P966, DOI 10.1038/nsb993; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Kim SH, 2002, J BIOL CHEM, V277, P10998, DOI 10.1074/jbc.M108311200; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Krumm B, 2008, P NATL ACAD SCI USA, V105, P20711, DOI 10.1073/pnas.0809086106; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LESLIE AGW, 1992, CCP4 ESF EACMB NEWSL, V26; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Losy J, 2001, ACTA NEUROL SCAND, V104, P171, DOI 10.1034/j.1600-0404.2001.00356.x; Ludwiczek O, 2005, EUR CYTOKINE NETW, V16, P27; Mazza G, 1999, J MOL BIOL, V287, P773, DOI 10.1006/jmbi.1999.2645; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plater-Zyberk C, 2001, J CLIN INVEST, V108, P1825, DOI 10.1172/JCI200112097; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Taniguchi M, 1997, J IMMUNOL METHODS, V206, P107, DOI 10.1016/S0022-1759(97)00094-X; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu CB, 2003, J IMMUNOL, V170, P5571, DOI 10.4049/jimmunol.170.11.5571; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Yamamoto Y, 2004, BIOCHEM BIOPH RES CO, V317, P181, DOI 10.1016/j.bbrc.2004.03.024; Yamamura M, 2001, ARTHRITIS RHEUM, V44, P275, DOI 10.1002/1529-0131(200102)44:2<275::AID-ANR44>3.3.CO;2-2; Yoshimoto T, 1998, J IMMUNOL, V161, P3400	60	23	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24478	24489		10.1074/jbc.M109.023887	http://dx.doi.org/10.1074/jbc.M109.023887			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19553661	Green Published, hybrid			2022-12-27	WOS:000269380200060
J	He, DH; Su, YL; Usatyuk, PV; Spannhake, EW; Kogut, P; Solway, J; Natarajan, V; Zhao, YT				He, Donghong; Su, Yanlin; Usatyuk, Peter V.; Spannhake, Ernst Wm.; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong			Lysophosphatidic Acid Enhances Pulmonary Epithelial Barrier Integrity and Protects Endotoxin-induced Epithelial Barrier Disruption and Lung Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; AIRWAY SMOOTH-MUSCLE; KAPPA-B ACTIVATION; KINASE-C-DELTA; E-CADHERIN; CELL-ADHESION; INTERLEUKIN-8 SECRETION; INDUCED TRANSACTIVATION; IL-13 RECEPTOR-ALPHA-2; MOLECULAR-CLONING	Lysophosphatidic acid (LPA), a bioactive phospholipid, induces a wide range of cellular effects, including gene expression, cytoskeletal rearrangement, and cell survival. We have previously shown that LPA stimulates secretion of pro-and anti-inflammatory cytokines in bronchial epithelial cells. This study provides evidence that LPA enhances pulmonary epithelial barrier integrity through protein kinase C (PKC) delta- and zeta-mediated E-cadherin accumulation at cell-cell junctions. Treatment of human bronchial epithelial cells (HBEpCs) with LPA increased transepithelial electrical resistance (TER) by similar to 2.0-fold and enhanced accumulation of E-cadherin to the cell-cell junctions through G alpha(i)-coupled LPA receptors. Knockdown of E-cadherin with E-cadherin small interfering RNA or pretreatment with EGTA (0.1 mM) prior to LPA (1 mu M) treatment attenuated LPA-induced increases in TER in HBEpCs. Furthermore, LPA induced tyrosine phosphorylation of focal adhesion kinase (FAK) and overexpression of the FAK inhibitor, and FAK-related non-kinase-attenuated LPA induced increases in TER and E-cadherin accumulation at cell-cell junctions. Overexpression of dominant negative protein kinase delta and zeta attenuated LPA-induced phosphorylation of FAK, accumulation of E-cadherin at cell-cell junctions, and an increase in TER. Additionally, lipopolysaccharide decreased TER and induced E-cadherin relocalization from cell-cell junctions to cytoplasm in a dose-dependent fashion, which was restored by LPA post-treatment in HBEpCs. Intratracheal post-treatment with LPA (5 mu M) reduced LPS-induced neutrophil influx, protein leak, and E-cadherin shedding in bronchoalveolar lavage fluids in a murine model of acute lung injury. These data suggest a protective role of LPA in airway inflammation and remodeling.	[He, Donghong; Su, Yanlin; Usatyuk, Peter V.; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Spannhake, Ernst Wm.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 20215 USA	University of Chicago; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhao, YT (corresponding author), 929 E 57th St,Ctr Integrat Sci Bldg,Rm W403M, Chicago, IL 60637 USA.	yzhao@medicine.bsd.uchicago.edu	Solway, Julian/B-1116-2008	Solway, Julian/0000-0002-0898-8530	National Institutes of Health [RO1 HL091916, RO1 HL079396]; American Cancer Society-Institutional Research [58-044-47]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091916, R01HL079396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-Institutional Research(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL091916 (to Y. Z.) and RO1 HL079396 (to V. N.). This work was also supported by American Cancer Society-Institutional Research Grant 58-044-47 (to Y. Z.).	Amerongen GPV, 2000, ARTERIOSCL THROM VAS, V20, pE127, DOI 10.1161/01.ATV.20.12.e127; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1997, BIOCHEM BIOPH RES CO, V231, P619, DOI 10.1006/bbrc.1997.6150; Budinger GRS, 2006, CLIN CHEST MED, V27, P655, DOI 10.1016/j.ccm.2006.06.007; Bush KT, 2000, AM J PHYSIOL-RENAL, V278, pF847, DOI 10.1152/ajprenal.2000.278.5.F847; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; COLLARESBUZATO CB, 1994, BBA-MOL CELL RES, V1222, P147, DOI 10.1016/0167-4889(94)90163-5; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; Eckert JJ, 2005, DEV BIOL, V288, P234, DOI 10.1016/j.ydbio.2005.09.037; Ediger TL, 2000, J PHARMACOL EXP THER, V294, P1076; Ediger TL, 2002, AM J PHYSIOL-LUNG C, V282, pL91, DOI 10.1152/ajplung.2002.282.1.L91; Eutamene H, 2005, EUR RESPIR J, V25, P789, DOI 10.1183/09031936.05.00064704; Evans SM, 2002, AM J RESP CELL MOL, V27, P446, DOI 10.1165/rcmb.4776; Fan H, 2008, MOL MED, V14, P422, DOI 10.2119/2007-00106.Fan; Georas SN, 2007, CLIN EXP ALLERGY, V37, P311, DOI 10.1111/j.1365-2222.2006.02626.x; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Goto Y, 2000, AM J RESP CELL MOL, V23, P712, DOI 10.1165/ajrcmb.23.6.4031; Gourgoulianis KI, 1999, MEDIAT INFLAMM, V8, P261, DOI 10.1080/09629359990432; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hashimoto T, 2003, J PHARMACOL SCI, V91, P8, DOI 10.1254/jphs.91.8; He DH, 2008, BIOCHEM J, V412, P153, DOI 10.1042/BJ20071649; HULSMANN AR, 1994, AM J RESP CRIT CARE, V149, P519, DOI 10.1164/ajrccm.149.2.8306055; Huntley GW, 2002, NEUROSCIENTIST, V8, P221, DOI 10.1177/1073858402008003008; Hybertson BM, 1997, J APPL PHYSIOL, V82, P226, DOI 10.1152/jappl.1997.82.1.226; Im DS, 2000, MOL PHARMACOL, V57, P753, DOI 10.1124/mol.57.4.753; Jaggi M, 2005, CANCER RES, V65, P483; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; OTTO T, 1993, UROL RES, V21, P359, DOI 10.1007/BF00296837; Postma FR, 2001, CURR BIOL, V11, P121, DOI 10.1016/S0960-9822(01)00030-6; Poynter ME, 2003, J IMMUNOL, V170, P6257, DOI 10.4049/jimmunol.170.12.6257; Rubenfeld J, 2006, AM J PHYSIOL-LUNG C, V290, pL66, DOI 10.1152/ajplung.00473.2004; Saatian B, 2006, BIOCHEM J, V393, P657, DOI 10.1042/BJ20050791; Sugiura T, 2002, J LIPID RES, V43, P2049, DOI 10.1194/jlr.M200242-JLR200; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takuwa Y, 2002, J BIOCHEM, V131, P767, DOI 10.1093/oxfordjournals.jbchem.a003163; Thiery JP, 2003, CURR OPIN GENET DEV, V13, P365, DOI 10.1016/S0959-437X(03)00088-1; Toews ML, 1997, J APPL PHYSIOL, V83, P1216, DOI 10.1152/jappl.1997.83.4.1216; Tokumura A, 2002, BBA-MOL CELL BIOL L, V1582, P18, DOI 10.1016/S1388-1981(02)00133-6; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Vernooy JHJ, 2001, AM J RESP CELL MOL, V24, P569, DOI 10.1165/ajrcmb.24.5.4156; Wang LX, 2003, J BIOL CHEM, V278, P39931, DOI 10.1074/jbc.M302896200; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Westermann AM, 1998, ANN ONCOL, V9, P437, DOI 10.1023/A:1008217129273; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Yin F, 2005, INVEST OPHTH VIS SCI, V46, P1927, DOI 10.1167/iovs.04-1256; Zabner J, 2003, J APPL PHYSIOL, V95, P394, DOI 10.1152/japplphysiol.01134.2002; Zhao YT, 2005, BIOCHEM J, V385, P493, DOI 10.1042/BJ20041160; Zhao YT, 2007, CELL SIGNAL, V19, P2329, DOI 10.1016/j.cellsig.2007.07.005; Zhao YT, 2007, J BIOL CHEM, V282, P10172, DOI 10.1074/jbc.M611210200; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200; Zhao Y, 2009, AM J RESP CELL MOL, V40, P19, DOI 10.1165/rcmb.2008-0105OC	60	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24123	24132		10.1074/jbc.M109.007393	http://dx.doi.org/10.1074/jbc.M109.007393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586906	Green Published, hybrid			2022-12-27	WOS:000269380200026
J	Kim, J; Park, SI; Ahn, C; Kim, H; Yim, J				Kim, Jaekwang; Park, Sang Ick; Ahn, Chiyoung; Kim, Heuijong; Yim, Jeongbin			Guanine Deaminase Functions as Dihydropterin Deaminase in the Biosynthesis of Aurodrosopterin, a Minor Red Eye Pigment of Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE; DIHYDRONEOPTERIN TRIPHOSPHATE; POLYACRYLAMIDE-GEL; MELANOGASTER; IDENTIFICATION; PURIFICATION; PTERIDINES; SYNTHASE; SEPIAPTERIN; PROTEINS	Dihydropterin deaminase, which catalyzes the conversion of 7,8-dihydropterin to 7,8-dihydrolumazine, was purified 5850-fold to apparent homogeneity from Drosophila melanogaster. Its molecular mass was estimated to be 48 kDa by gel filtration and SDS-PAGE, indicating that it is a monomer under native conditions. The pI value, temperature, and optimal pH of the enzyme were 5.5, 40 degrees C, and 7.5, respectively. Interestingly the enzyme had much higher activity for guanine than for 7,8-dihydropterin. The specificity constant (k(cat)/K-m) for guanine (8.6 x 10(6) M-1.s(-1)) was 860-fold higher than that for 7,8-dihydropterin (1.0 x 10(4) M-1.s(-1)). The structural gene of the enzyme was identified by matrix- assisted laser desorption/ionization time-offlight mass spectrometry analysis as CG18143, located at region 82A1 on chromosome 3R. The cloned and expressed CG18143 exhibited both 7,8-dihydropterin and guanine deaminase activities. Flies with mutations in CG18143, SUPor-P/Df(3R)A321R1 transheterozygotes, had severely decreased activities in both deaminases compared with the wild type. Among several red eye pigments, the level of aurodrosopterin was specifically decreased in the mutant, and the amount of xanthine and uric acid also decreased considerably to 76 and 59% of the amounts in the wild type, respectively. In conclusion, dihydropterin deaminase encoded by CG18143 plays a role in the biosynthesis of aurodrosopterin by providing one of its precursors, 7,8-dihydrolumazine, from 7,8-dihydropterin. Dihydropterin deaminase also functions as guanine deaminase, an important enzyme for purine metabolism.	[Kim, Jaekwang; Kim, Heuijong; Yim, Jeongbin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Park, Sang Ick] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Seoul 122701, South Korea; [Ahn, Chiyoung] Korea Food & Drug Adm, Adv Therapy Prod Div, Biopharmaceut & Herbal Med Bur, Seoul 122704, South Korea	Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science	Yim, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	jyim@snu.ac.kr		Kim, Jaekwang/0000-0002-7312-4077	Korean Government (Ministry of Education and Human Resources Development) [KRF-2008313-E00068]; Brain Korea 21 project	Korean Government (Ministry of Education and Human Resources Development)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Brain Korea 21 project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by Korea Research Foundation Grant KRF-2008313-E00068 funded by the Korean Government (Ministry of Education and Human Resources Development) and by the second stage of the Brain Korea 21 project in 2009.	Arnott D, 1998, ANAL BIOCHEM, V258, P1, DOI 10.1006/abio.1998.2566; AWDEH ZL, 1968, NATURE, V219, P66, DOI 10.1038/219066a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canbolat O, 1996, BREAST CANCER RES TR, V37, P189, DOI 10.1007/BF01806500; FAN CL, 1976, BIOCHEM GENET, V14, P271, DOI 10.1007/BF00484766; FARKAS WR, 1978, SCIENCE, V199, P786, DOI 10.1126/science.622568; FORREST HS, 1960, HELV CHIM ACTA, V43, P1005, DOI 10.1002/hlca.19600430408; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; GUPTA NK, 1985, ARCH BIOCHEM BIOPHYS, V236, P266, DOI 10.1016/0003-9861(85)90626-5; HILLIKER AJ, 1992, P NATL ACAD SCI USA, V89, P4343, DOI 10.1073/pnas.89.10.4343; KAUFMAN S, 1967, J BIOL CHEM, V242, P3934; Kim J, 2006, BIOCHEM J, V398, P451, DOI 10.1042/BJ20060424; KIM NS, 1996, GENETICS, V42, P1157; KRIVI GG, 1979, BIOCHEM GENET, V17, P371, DOI 10.1007/BF00498976; KUZMITS R, 1980, ENZYME, V25, P148, DOI 10.1159/000459240; Lederer E, 1940, BIOL REV CAMB PHILOS, V15, P273; Liaw SH, 2004, J BIOL CHEM, V279, P35479, DOI 10.1074/jbc.M405304200; MACKAY WJ, 1983, GENETICS, V105, P35; MASSIE HR, 1991, EXP GERONTOL, V26, P609, DOI 10.1016/0531-5565(91)90078-Z; Park D, 2000, BBA-GENE STRUCT EXPR, V1492, P247, DOI 10.1016/S0167-4781(00)00084-1; PARK YS, 1990, BIOCHIM BIOPHYS ACTA, V1038, P186, DOI 10.1016/0167-4838(90)90203-R; REMBOLD H, 1971, BIOCHIM BIOPHYS ACTA, V230, P117, DOI 10.1016/0304-4165(71)90059-6; REMBOLD H, 1972, ANGEW CHEM INT EDIT, V11, P1061, DOI 10.1002/anie.197210611; ROSEMAN RR, 1995, GENETICS, V141, P1061; ROSSI CA, 1978, BIOCHIM BIOPHYS ACTA, V526, P235, DOI 10.1016/0005-2744(78)90308-X; SCHWINCK I, 1971, Genetics, V68, pS59; SCHWINCK I, 1973, Archiv fuer Genetik, V46, P41; TAKIKAWA SI, 1983, INSECT BIOCHEM, V13, P361, DOI 10.1016/0020-1790(83)90018-5; TARAS MJ, 1981, STANDARD METHODS EXA, P350; THEOBALD N, 1978, CHEM BER-RECL, V111, P3385, DOI 10.1002/cber.19781111013; VISCONTINI M, 1957, HELV CHIM ACTA, V40, P579, DOI 10.1002/hlca.19570400311; WIEDERRECHT GJ, 1984, J BIOL CHEM, V259, P2195; YIM JB, 1993, HELV CHIM ACTA, V76, P1970, DOI 10.1002/hlca.19930760516; YIM JJ, 1976, J BIOL CHEM, V251, P5087; YIM JJ, 1981, INSECT BIOCHEM, V11, P363, DOI 10.1016/0020-1790(81)90069-X; YIM JJ, 1977, SCIENCE, V198, P1168, DOI 10.1126/science.412253	36	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23426	23435		10.1074/jbc.M109.016493	http://dx.doi.org/10.1074/jbc.M109.016493			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19567870	Green Published, hybrid			2022-12-27	WOS:000269180000027
J	Ribeiro, FM; Ferreira, LT; Paquet, M; Cregan, T; Ding, QM; Gros, R; Ferguson, SSG				Ribeiro, Fabiola M.; Ferreira, Lucimar T.; Paquet, Maryse; Cregan, Tamara; Ding, Qingming; Gros, Robert; Ferguson, Stephen S. G.			Phosphorylation-independent Regulation of Metabotropic Glutamate Receptor 5 Desensitization and Internalization by G Protein-coupled Receptor Kinase 2 in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED INTERNALIZATION; DOMINANT-NEGATIVE MUTANT; BETA(2)-ADRENERGIC RECEPTOR; BETA-ARRESTIN; SYNERGISTIC REGULATION; SELECTIVE REGULATION; HOMOLOGY DOMAIN; SEQUESTRATION; GRK2; 1A	The uncoupling of metabotropic glutamate receptors (mGluRs) from heterotrimeric G proteins represents an essential feedback mechanism that protects neurons against receptor overstimulation that may ultimately result in damage. The desensitization of mGluR signaling is mediated by both second messenger-dependent protein kinases and G protein-coupled receptor kinases (GRKs). Unlike mGluR1, the attenuation of mGluR5 signaling in HEK 293 cells is reported to be mediated by a phosphorylation-dependent mechanism. However, the mechanisms regulating mGluR5 signaling and endocytosis in neurons have not been investigated. Here we show that a 2-fold overexpression of GRK2 leads to the attenuation of endogenous mGluR5-mediated inositol phosphate (InsP) formation in striatal neurons and siRNA knockdown of GRK2 expression leads to enhanced mGluR5-mediated InsP formation. Expression of a catalytically inactive GRK2-K220R mutant also effectively attenuates mGluR5 signaling, but the expression of a GRK2-D110A mutant devoid in G alpha(q/11) binding increases mGluR5 signaling in response to agonist stimulation. Taken together, these results indicate that the attenuation of mGluR5 responses in striatal neurons is phosphorylation-independent. In addition, we find that mGluR5 does not internalize in response to agonist treatment in striatal neuron, but is efficiently internalized in cortical neurons that have higher levels of endogenous GRK2 protein expression. When overexpressed in striatal neurons, GRK2 promotes agonist-stimulated mGluR5 internalization. Moreover, GRK2-mediated promotion of mGluR5 endocytosis does not require GRK2 catalytic activity. Thus, we provide evidence that GRK2 mediates phosphorylation-independent mGluR5 desensitization and internalization in neurons.	[Ferguson, Stephen S. G.] Univ Western Ontario, Robarts Res Inst, Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, London, ON N6A 5K8, Canada; [Ding, Qingming; Gros, Robert] Univ Western Ontario, Robarts Res Inst, Vasc Biol Res Grp, London, ON N6A 5K8, Canada; [Gros, Robert; Ferguson, Stephen S. G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Ferguson, SSG (corresponding author), Univ Western Ontario, Robarts Res Inst, Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, 100 Perth Dr, London, ON N6A 5K8, Canada.	ferguson@robarts.ca	Gros, Robert/AAV-2237-2020; Ribeiro, Fabiola/E-8831-2013; Gros, Robert/A-3010-2009	Gros, Robert/0000-0002-3667-8011; Ribeiro, Fabiola/0000-0001-7042-9433; Gros, Robert/0000-0002-3667-8011	Canadian Institutes of Health Research (CIHR) [MA-15506, MOP82756]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research (CIHR) Grant MA-15506 ( to S. S. G. F.) and CIHR Grant MOP82756 ( to R. G.).	Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Baig AH, 2002, ENDOCR RES, V28, P281, DOI 10.1081/ERC-120016798; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen ZG, 2004, MOL PHARMACOL, V66, P377; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; Dhami GK, 2005, J BIOL CHEM, V280, P24420, DOI 10.1074/jbc.M501650200; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Gros R, 2006, CIRC RES, V99, P845, DOI 10.1161/01.RES.0000245189.21703.c0; Iacovelli L, 2003, J BIOL CHEM, V278, P12433, DOI 10.1074/jbc.M203992200; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; KONG GH, 1994, J BIOL CHEM, V269, P13084; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Mangmool S, 2006, J BIOL CHEM, V281, P31940, DOI 10.1074/jbc.M602832200; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Mundell SJ, 2004, BIOCHEMISTRY-US, V43, P7541, DOI 10.1021/bi0359022; Mundell SJ, 2003, J NEUROCHEM, V84, P294, DOI 10.1046/j.1471-4159.2003.01515.x; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nijboer CHA, 2008, J NEUROSCI, V28, P3324, DOI 10.1523/JNEUROSCI.4769-07.2008; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Ribeiro FM, 2007, EUR J NEUROSCI, V26, P3437, DOI 10.1111/j.1460-9568.2007.05967.x; RuizGomez A, 1997, J BIOL CHEM, V272, P9601; Sallese M, 2000, FASEB J, V14, P2569, DOI 10.1096/fj.00-0072com; Schlador ML, 1997, J BIOL CHEM, V272, P18882, DOI 10.1074/jbc.272.30.18882; Shiina T, 2001, J BIOL CHEM, V276, P33019, DOI 10.1074/jbc.M100140200; Sorensen SD, 2003, NEUROPHARMACOLOGY, V44, P699, DOI 10.1016/S0028-3908(03)00053-4; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; TSUGA H, 1994, J BIOL CHEM, V269, P32522; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082	42	56	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23444	23453		10.1074/jbc.M109.000778	http://dx.doi.org/10.1074/jbc.M109.000778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19564331	hybrid, Green Published			2022-12-27	WOS:000269180000029
J	Zhao, H; Sagert, J; Hwang, DS; Waite, JH				Zhao, Hua; Sagert, Jason; Hwang, Dong Soo; Waite, J. Herbert			Glycosylated Hydroxytryptophan in a Mussel Adhesive Protein from Perna viridis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-ANALYSIS; C-MANNOSYLATION; PROTECTIVE-COATINGS; CROSS-LINKING; GREEN MUSSEL; TRYPTOPHAN; 5-HYDROXYTRYPTOPHAN; LINKAGE; MIMICS	The 3,4-dihydroxyphenyl-L-alanine (Dopa)-containing proteins of mussel byssus play a critical role in wet adhesion and have inspired versatile new synthetic strategies for adhesives and coatings. Apparently, however, not all mussel adhesive proteins are beholden to Dopa chemistry. The cDNA-deduced sequence of Pvfp-1, a highly aromatic and redox active byssal coating protein in the green mussel Perna viridis, suggests that Dopa may be replaced by a post-translational modification of tryptophan. The N-terminal tryptophan-rich domain of Pvfp-1 contains 42 decapeptide repeats with the consensus sequences ATPKPW(1)TAW(2)K and APPPAW(1)TAW(2)K. A small collagen domain (18 Gly-X-Y repeats) is also present. Tandem mass spectrometry of isolated tryptic decapeptides has detected both C-2-hexosylated tryptophan(W-1) and C-2-hexosylated hydroxytryptophan (W-2), the latter of which is redox active. The UV absorbance spectrum of W-2 is consistent with 7-hydroxytryptophan, which represents an intriguing new theme for bioinspired opportunistic wet adhesion.	[Sagert, Jason; Hwang, Dong Soo; Waite, J. Herbert] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Zhao, Hua] ASTAR, Inst Chem & Engn Sci, Ind Biotechnol Dept, Singapore 627833, Singapore	University of California System; University of California Santa Barbara; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Sustainability for Chemicals, Energy & Environment (ISCE2)	Waite, JH (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	waite@lifesci.ucsb.edu	Hwang, Dong Soo/C-7291-2011	Hwang, Dong Soo/0000-0002-2487-2255	National Institutes of Health [R01 DE018468]; National Science Foundation [MRSEC DMR05-20415]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE018468. This work was also supported by National Science Foundation Grant MRSEC DMR05-20415.	Benson AJ, 2001, J SHELLFISH RES, V20, P21; Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8; EK A, 1953, J AM CHEM SOC, V75, P500, DOI 10.1021/ja01098a519; Furmanek A, 2000, ACTA BIOCHIM POL, V47, P781, DOI 10.18388/abp.2000_3996; Gutsche B, 1999, BIOCHEM J, V343, P11, DOI 10.1042/0264-6021:3430011; Hofsteenge J, 1999, J BIOL CHEM, V274, P32786, DOI 10.1074/jbc.274.46.32786; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; HOFSTEENGE J, 1996, TECH PROTEIN CHEM, V8, P163; Holten-Andersen N, 2008, J DENT RES, V87, P701, DOI 10.1177/154405910808700808; Holten-Andersen N, 2007, NAT MATER, V6, P669, DOI 10.1038/nmat1956; Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012; HUGLI TE, 1972, J BIOL CHEM, V247, P2828; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; KNIGHT JA, 1983, CLIN CHEM, V29, P1969; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Li JSS, 2005, J BIOL CHEM, V280, P38513, DOI 10.1074/jbc.M508449200; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Liu J, 2004, P NATL ACAD SCI USA, V101, P16156, DOI 10.1073/pnas.0405319101; Manabe S, 2003, CHEM-EUR J, V9, P1435, DOI 10.1002/chem.200390163; MAVES KK, 1993, IMMUNOL RES, V12, P233, DOI 10.1007/BF02918255; MAYS C, 1981, BIOCHEMISTRY-US, V20, P2810, DOI 10.1021/bi00513a016; Munte CE, 2008, FEBS J, V275, P1163, DOI 10.1111/j.1742-4658.2008.06277.x; Nicholson Shaun, 2003, Mar Pollut Bull, V46, P1040, DOI 10.1016/S0025-326X(03)00152-8; Ohkawa K, 2004, BIOFOULING, V20, P101, DOI 10.1080/08927010410001681246; PEREDO AG, 2002, MOL CELL PROTEOMICS, V1, P11; Sagert J, 2006, BIOLOGICAL ADHESIVES, P125, DOI 10.1007/978-3-540-31049-5_7; SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936; Tsuda M, 2005, J NAT PROD, V68, P1277, DOI 10.1021/np050076e; Waite J.H., 1992, Results and Problems in Cell Differentiation, V19, P27; WAITE JH, 1991, ANAL BIOCHEM, V192, P429, DOI 10.1016/0003-2697(91)90560-G; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; WAITE JH, 1981, ANAL BIOCHEM, V111, P131, DOI 10.1016/0003-2697(81)90240-2; Westwood G, 2007, MACROMOLECULES, V40, P3960, DOI 10.1021/ma0703002; Wu Z, 1996, BIOORG CHEM, V24, P127, DOI 10.1006/bioo.1996.0012; Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z; Zhang ZW, 2004, P NATL ACAD SCI USA, V101, P8882, DOI 10.1073/pnas.0307029101	41	39	42	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23344	23352		10.1074/jbc.M109.022517	http://dx.doi.org/10.1074/jbc.M109.022517			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19584055	Green Published, hybrid			2022-12-27	WOS:000269180000019
J	Albet-Torres, N; Bloemink, MJ; Barman, T; Candau, R; Frolander, K; Geeves, MA; Golker, K; Herrmann, C; Lionne, C; Piperio, C; Schmitz, S; Veigel, C; Mansson, A				Albet-Torres, Nuria; Bloemink, Marieke J.; Barman, Tom; Candau, Robin; Frolander, Kerstin; Geeves, Michael A.; Golker, Kerstin; Herrmann, Christian; Lionne, Corinne; Piperio, Claudia; Schmitz, Stephan; Veigel, Claudia; Mansson, Alf			Drug Effect Unveils Inter-head Cooperativity and Strain-dependent ADP Release in Fast Skeletal Actomyosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE-VELOCITY RELATIONSHIP; DICTYOSTELIUM MYOSIN-II; SMOOTH-MUSCLE MYOSIN; RABBIT PSOAS MUSCLE; RAPID-FLOW-QUENCH; 2,3-BUTANEDIONE MONOXIME; BLEBBISTATIN INHIBITION; MYOFIBRILLAR ATPASES; SHORTENING VELOCITY; INORGANIC-PHOSPHATE	Amrinone is a bipyridine compound with characteristic effects on the force-velocity relationship of fast skeletal muscle, including a reduction in the maximum shortening velocity and increased maximum isometric force. Here we performed experiments to elucidate the molecular mechanisms for these effects, with the additional aim to gain insight into the molecular mechanisms underlying the force-velocity relationship. In vitro motility assays established that amrinone reduces the sliding velocity of heavy meromyosin-propelled actin filaments by 30% at different ionic strengths of the assay solution. Stopped-flow studies of myofibrils, heavy meromyosin and myosin subfragment 1, showed that the effects on sliding speed were not because of a reduced rate of ATP-induced actomyosin dissociation because the rate of this process was increased by amrinone. Moreover, optical tweezers studies could not detect any amrinone-induced changes in the working stroke length. In contrast, the ADP affinity of acto-heavy meromyosin was increased about 2-fold by 1 mM amrinone. Similar effects were not observed for acto-subfragment 1. Together with the other findings, this suggests that the amrinone-induced reduction in sliding velocity is attributed to inhibition of a strain-dependent ADP release step. Modeling results show that such an effect may account for the amrinone-induced changes of the force-velocity relationship. The data emphasize the importance of the rate of a strain-dependent ADP release step in influencing the maximum sliding velocity in fast skeletal muscle. The data also lead us to discuss the possible importance of cooperative interactions between the two myosin heads in muscle contraction.	[Albet-Torres, Nuria; Frolander, Kerstin; Golker, Kerstin; Mansson, Alf] Univ Kalmar, Sch Pure Appl Nat Sci, SE-39182 Kalmar, Sweden; [Bloemink, Marieke J.; Geeves, Michael A.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; [Barman, Tom; Herrmann, Christian; Lionne, Corinne] Univ Montpellier I, CNRS, UMR 5236, Inst Biol, F-34000 Montpellier, France; [Candau, Robin] Univ Montpellier I, INRA, UMR 866, F-34060 Montpellier, France; [Piperio, Claudia; Schmitz, Stephan; Veigel, Claudia] Natl Inst Med Res, London NW7 1AA, England	Linnaeus University; University of Kalmar; University of Kent; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; INRAE; Universite de Montpellier; MRC National Institute for Medical Research	Mansson, A (corresponding author), Univ Kalmar, Sch Pure Appl Nat Sci, SE-39182 Kalmar, Sweden.	alf.mansson@hik.se	Mansson, Alf/ABC-6271-2021; Geeves, Michael/F-7583-2011; LIONNE, Corinne/AFV-1826-2022	Mansson, Alf/0000-0002-5889-7792; Geeves, Michael/0000-0002-9364-8898; LIONNE, Corinne/0000-0002-6348-5311; Bloemink, Marieke Johanna/0000-0001-9441-2783; candau, robin/0000-0002-5930-8750	The Swedish Research Council [621-2004-3449, 621-2007-6137]; The Carl Trygger Foundation; The Knowledge Foundation (KK-stiftelsen); The Crafoord Foundation; Faculty of Natural Sciences and Engineering at the University of Kalmar; Wellcome Trust [070021]; Biotechnology and Biological Sciences Research Council and Medical Research Council (United Kingdom)	The Swedish Research Council(Swedish Research Council); The Carl Trygger Foundation; The Knowledge Foundation (KK-stiftelsen); The Crafoord Foundation; Faculty of Natural Sciences and Engineering at the University of Kalmar; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council and Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Medical Research Council UK (MRC))	This work was supported in part by The Swedish Research Council Projects 621-2004-3449 and 621-2007-6137 (to A. M.), The Carl Trygger Foundation, The Knowledge Foundation (KK-stiftelsen), The Crafoord Foundation, Faculty of Natural Sciences and Engineering at the University of Kalmar (to A. M. and N.A.-T.), Program Grant 070021 from the Wellcome Trust (to M. A. G. and M.J.B.), and Biotechnology and Biological Sciences Research Council and Medical Research Council (United Kingdom) (to C. P., S. S., and C. V.).	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Amitani I, 2001, BIOPHYS J, V80, P379, DOI 10.1016/S0006-3495(01)76022-5; BAGNI MA, 1992, J MUSCLE RES CELL M, V13, P516, DOI 10.1007/BF01737994; Balaz M, 2007, BIOCHEMISTRY-US, V46, P7233, DOI 10.1021/bi700211u; BARMAN TE, 1985, METHOD BIOCHEM ANAL, V31, P1, DOI 10.1002/9780470110522.ch1; Batters C, 2004, EMBO J, V23, P1433, DOI 10.1038/sj.emboj.7600169; Berger CEM, 2001, J BIOL CHEM, V276, P23240, DOI 10.1074/jbc.M100524200; BIOSCA JA, 1984, BIOCHEMISTRY-US, V23, P1947, DOI 10.1021/bi00304a010; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; BOTTINELLI R, 1993, J MUSCLE RES CELL M, V14, P110; BRENNER B, 1986, BIOPHYS J, V50, P685, DOI 10.1016/S0006-3495(86)83509-3; Capitanio M, 2006, P NATL ACAD SCI USA, V103, P87, DOI 10.1073/pnas.0506830102; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Conibear PB, 1998, BIOPHYS J, V75, P926, DOI 10.1016/S0006-3495(98)77581-2; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DANTZIG JA, 1991, J PHYSIOL-LONDON, V432, P639, DOI 10.1113/jphysiol.1991.sp018405; Duke T, 2000, PHILOS T ROY SOC B, V355, P529, DOI 10.1098/rstb.2000.0594; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P2770, DOI 10.1073/pnas.96.6.2770; EDMAN KAP, 1988, J PHYSIOL-LONDON, V404, P301, DOI 10.1113/jphysiol.1988.sp017291; Edman KAP, 1997, J PHYSIOL-LONDON, V503, P141, DOI 10.1111/j.1469-7793.1997.141bi.x; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gollub J, 1996, NAT STRUCT BIOL, V3, P796, DOI 10.1038/nsb0996-796; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; HERRMANN C, 1992, BIOCHEMISTRY-US, V31, P12227, DOI 10.1021/bi00163a036; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HORIUTI K, 1988, J MUSCLE RES CELL M, V9, P156, DOI 10.1007/BF01773737; HOUADJETO M, 1992, BIOCHEMISTRY-US, V31, P1564, DOI 10.1021/bi00120a038; Howard J., 2001, MECH MOTOR PROTEINS; Iwamoto H, 2007, J MOL BIOL, V369, P249, DOI 10.1016/j.jmb.2007.03.031; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Klinth J, 2003, J MUSCLE RES CELL M, V24, P15, DOI 10.1023/A:1024894130989; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; MA YZ, 1994, BIOPHYS J, V66, P1542, DOI 10.1016/S0006-3495(94)80945-2; Mansson A, 2007, LECT NOTES PHYS, V711, P385; MANSSON A, 1984, ACTA PHYSIOL SCAND, V120, P473, DOI 10.1111/j.1748-1716.1984.tb07409.x; MANSSON A, 1989, ACTA PHYSIOL SCAND, V136, P37, DOI 10.1111/j.1748-1716.1989.tb08627.x; Mansson A, 2003, ANAL BIOCHEM, V314, P281, DOI 10.1016/S0003-2697(02)00610-3; MANSSON A, 1985, ACTA PHYSIOL SCAND, V125, P481, DOI 10.1111/j.1748-1716.1985.tb07745.x; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MCKILLOP DFA, 1994, J MUSCLE RES CELL M, V15, P309; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Patterson B, 1997, J BIOL CHEM, V272, P27612, DOI 10.1074/jbc.272.44.27612; REIMANN EM, 1978, BIOCHIM BIOPHYS ACTA, V523, P516, DOI 10.1016/0005-2744(78)90054-2; Sasaki N, 1998, ADV BIOPHYS, V35, P1; Shaw MA, 2003, BIOCHEMISTRY-US, V42, P6128, DOI 10.1021/bi026964f; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SLEEP JA, 1980, BIOCHEMISTRY-US, V19, P1276, DOI 10.1021/bi00548a002; SMITH DA, 1995, BIOPHYS J, V69, P524, DOI 10.1016/S0006-3495(95)79926-X; Stehle R, 1998, J MUSCLE RES CELL M, V19, P381, DOI 10.1023/A:1005397620720; Stehle R, 2000, BIOCHEMISTRY-US, V39, P7508, DOI 10.1021/bi0004753; Stehle R, 2000, BIOPHYS J, V78, P1458, DOI 10.1016/S0006-3495(00)76699-9; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sundberg M, 2006, LANGMUIR, V22, P7302, DOI 10.1021/la060365i; Suzuki Y, 1997, BIOCHEM BIOPH RES CO, V234, P701, DOI 10.1006/bbrc.1997.6671; TRENTHAM DR, 1976, Q REV BIOPHYS, V9, P217, DOI 10.1017/S0033583500002419; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Woledge RC., 1985, ENERGETIC ASPECTS MU	71	41	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22926	22937		10.1074/jbc.M109.019232	http://dx.doi.org/10.1074/jbc.M109.019232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19520847	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000268963100046
J	Hung, KH; Titus, M; Chiang, SC; Stumph, WE				Hung, Ko-Hsuan; Titus, Mitchell; Chiang, Shu-Chi; Stumph, William E.			A Map of Drosophila melanogaster Small Nuclear RNA-activating Protein Complex (DmSNAPc) Domains Involved in Subunit Assembly and DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL-SEQUENCE-ELEMENT; TRANSCRIPTION FACTOR; POLYMERASE-II; GENE-TRANSCRIPTION; IN-VITRO; U6 GENES; SNAP(C); PROMOTER; TBP; U1	Transcription of genes coding for the small nuclear RNAs (snRNAs) is dependent upon a unique transcription factor known as the small nuclear RNA-activating protein complex (SNAPc). SNAPc binds to an essential proximal sequence element located about 40-65 base pairs upstream of the snRNA transcription start site. In the fruit fly Drosophila melanogaster, DmSNAPc contains three distinct polypeptides (DmSNAP190, DmSNAP50, and DmSNAP43) that are stably associated with each other and bind to the DNA as a complex. We have used mutational analysis to identify domains within each subunit that are involved in complex formation with the other two subunits in vivo. We have also identified domains in each subunit required for sequence-specific DNA binding. With one exception, domains required for subunit-subunit interactions lie in the most evolutionarily conserved regions of the proteins. However, DNA binding by DmSNAPc is dependent not only upon the conserved regions but is also highly dependent upon domains outside the conserved regions. Comparison with functional domains identified in human SNAPc indicates many parallels but also reveals significant differences in this ancient yet rapidly evolving system.	[Hung, Ko-Hsuan; Titus, Mitchell; Chiang, Shu-Chi; Stumph, William E.] San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA; [Hung, Ko-Hsuan; Chiang, Shu-Chi] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Titus, Mitchell; Stumph, William E.] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University	Stumph, WE (corresponding author), San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA.	wstumph@sciences.sdsu.edu			National Science Foundation [MCB-0641350, MCB-0842770]; California Metabolic Research Foundation; Div Of Molecular and Cellular Bioscience [0842770] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); California Metabolic Research Foundation; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-0641350 and MCB-0842770 and the California Metabolic Research Foundation.	Bai L, 1996, MOL CELL BIOL, V16, P5419; Barakat NH, 2008, FEBS LETT, V582, P2413, DOI 10.1016/j.febslet.2008.06.003; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; Das A, 2003, P NATL ACAD SCI USA, V100, P80, DOI 10.1073/pnas.262609399; Hanzlowsky A, 2006, PROTEIN EXPRES PURIF, V48, P215, DOI 10.1016/j.pep.2006.02.015; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; Henry RW, 1996, EMBO J, V15, P7129, DOI 10.1002/j.1460-2075.1996.tb01104.x; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Hernandez G, 2007, NUCLEIC ACIDS RES, V35, P21, DOI 10.1093/nar/gkl982; Hinkley CS, 2003, J BIOL CHEM, V278, P18649, DOI 10.1074/jbc.M204247200; Jawdekar GW, 2006, J BIOL CHEM, V281, P31050, DOI 10.1074/jbc.M603810200; Lai HT, 2008, FEBS LETT, V582, P3734, DOI 10.1016/j.febslet.2008.09.059; Li C, 2004, MOL CELL BIOL, V24, P1897, DOI 10.1128/MCB.24.5.1897-1906.2004; Ma B, 2001, J BIOL CHEM, V276, P5027, DOI 10.1074/jbc.M009301200; Ma BC, 2002, MOL CELL BIOL, V22, P8067, DOI 10.1128/MCB.22.22.8067-8078.2002; Mittal V, 1999, GENE DEV, V13, P1807, DOI 10.1101/gad.13.14.1807; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; Schimanski B, 2005, MOL CELL BIOL, V25, P7303, DOI 10.1128/MCB.25.16.7303-7313.2005; Su Y, 1997, EUR J BIOCHEM, V248, P231, DOI 10.1111/j.1432-1033.1997.t01-1-00231.x; WALDSCHMIDT R, 1991, EMBO J, V10, P2595, DOI 10.1002/j.1460-2075.1991.tb07801.x; WANANDI I, 1993, J BIOL CHEM, V268, P6629; Wang Y, 1998, MOL CELL BIOL, V18, P1570, DOI 10.1128/MCB.18.3.1570; Wong MW, 1998, MOL CELL BIOL, V18, P368, DOI 10.1128/MCB.18.1.368; Yoon JB, 1996, MOL CELL BIOL, V16, P1; YOON JB, 1995, MOL CELL BIOL, V15, P2019; ZAMROD Z, 1993, MOL CELL BIOL, V13, P5918, DOI 10.1128/MCB.13.9.5918	28	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22568	22579		10.1074/jbc.M109.027961	http://dx.doi.org/10.1074/jbc.M109.027961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19556241	Green Published, hybrid			2022-12-27	WOS:000268963100010
J	Ehlen, HWA; Sengle, G; Klatt, AR; Talke, A; Muller, S; Paulsson, M; Wagener, R				Ehlen, Harald W. A.; Sengle, Gerhard; Klatt, Andreas R.; Talke, Anja; Mueller, Stefan; Paulsson, Mats; Wagener, Raimund			Proteolytic Processing Causes Extensive Heterogeneity of Tissue Matrilin Forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; MULTIPLE EPIPHYSEAL DYSPLASIA; AT-AC INTRON; EXTRACELLULAR-MATRIX; FILAMENTOUS NETWORK; MOLECULAR-STRUCTURE; CARTILAGE; PROTEIN; EXPRESSION; ADAMTS-4	The matrilins are a family of multidomain extracellular matrix proteins with adapter functions. The oligomeric proteins have a bouquet-like structure and bind to a variety of different ligands whereby the avidity of their interactions is dependent on the number of subunits and domains present. Here we show the contribution of post-translational proteolytic processing to the heterogeneity of matrilins seen in tissue extracts and cell culture supernatants. A cleavage site after two glutamate residues in the hinge region close to the C-terminal coiled-coil oligomerization domain is conserved among the matrilins. Cleavage at this site yields molecules that lack almost complete subunits. The processing is least pronounced in matrilin-1 and particularly complex in matrilin-2, which contains additional cleavage sites. Replacement of the hinge region in matrilin-4 by the matrilin-1 hinge region had no marked effect on the processing. A detailed study revealed that matrilin-4 is processed already in the secretory pathway and that the activation of the responsible enzymes is dependent on proprotein convertase activity. Matrilin-3 and -4, but not matrilin-1 subunits present in matrilin-1/-3 heterooligomers, were identified as substrates for ADAMTS4 and ADAMTS5, whereas ADAMTS1 did not cleave any matrilin. A neo-epitope antibody raised against the N terminus of the C-terminal cleavage product of matrilin-4 detected processed matrilin-4 in cultures of primary chondrocytes as well as on cartilage sections showing that the conserved cleavage site is used in vivo.	[Wagener, Raimund] Univ Cologne, Inst Biochem 2, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Mueller, Stefan; Paulsson, Mats] Univ Cologne, CMMC, D-50931 Cologne, Germany; Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Ehlen, Harald W. A.] Univ Duisburg Essen, Dept Biol & Geog, ZMB, Ctr Med Biotechnol, D-45117 Essen, Germany; [Klatt, Andreas R.] Cologne Univ Hosp, Inst Clin Chem, D-50924 Cologne, Germany; [Talke, Anja] Invitek GmbH, D-13125 Berlin, Germany	University of Cologne; University of Cologne; University of Cologne; University of Duisburg Essen; University of Cologne	Wagener, R (corresponding author), Univ Cologne, Inst Biochem 2, Fac Med, Ctr Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	raimund.wagener@uni-koeln.de			Deutsche Forschungsgemeinschaft [WA 1338/2-6]; Medical Faculty of the University of Cologne	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the University of Cologne	This work was supported by Deutsche Forschungsgemeinschaft Grant WA 1338/2-6 and the Koln Fortune program of the Medical Faculty of the University of Cologne.	Aszodi A, 1996, EUR J BIOCHEM, V236, P970, DOI 10.1111/j.1432-1033.1996.00970.x; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borochowitz ZU, 2004, J MED GENET, V41, P366, DOI 10.1136/jmg.2003.013342; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; CHEN Q, 1995, MOL BIOL CELL, V6, P1743, DOI 10.1091/mbc.6.12.1743; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Deak F, 1997, J BIOL CHEM, V272, P9268; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hauser N, 1996, J BIOL CHEM, V271, P32247, DOI 10.1074/jbc.271.50.32247; HAUSER N, 1994, J BIOL CHEM, V269, P25747; Hills R, 2007, J BIOL CHEM, V282, P11101, DOI 10.1074/jbc.M611588200; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Klatt AR, 2001, J BIOL CHEM, V276, P17267, DOI 10.1074/jbc.M100587200; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; Mann HH, 2007, MATRIX BIOL, V26, P167, DOI 10.1016/j.matbio.2006.10.010; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Min JL, 2006, ANN RHEUM DIS, V65, P1060, DOI 10.1136/ard.2005.045153; Mostert AK, 2003, AM J MED GENET A, V120A, P490, DOI 10.1002/ajmg.a.20034; Muratoglu S, 2000, CYTOGENET CELL GENET, V90, P323, DOI 10.1159/000056797; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; PAULSSON M, 1979, BIOCHEM J, V183, P539, DOI 10.1042/bj1830539; Piecha D, 1999, J BIOL CHEM, V274, P13353, DOI 10.1074/jbc.274.19.13353; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Sengle G, 2003, J BIOL CHEM, V278, P50240, DOI 10.1074/jbc.M307794200; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Wagener R, 1998, FEBS LETT, V438, P165, DOI 10.1016/S0014-5793(98)01293-9; Wagener R, 2000, MAMM GENOME, V11, P85, DOI 10.1007/s003350010018; Wagener R, 1997, FEBS LETT, V413, P129, DOI 10.1016/S0014-5793(97)00895-8; Wagener R, 1998, FEBS LETT, V436, P123, DOI 10.1016/S0014-5793(98)01111-9; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Will Horst, 2005, J Biomol Tech, V16, P459; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	45	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21545	21556		10.1074/jbc.M109.016568	http://dx.doi.org/10.1074/jbc.M109.016568			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531486	hybrid, Green Published			2022-12-27	WOS:000268564400049
J	Wareski, P; Vaarmann, A; Choubey, V; Safiulina, D; Liiv, J; Kuum, M; Kaasik, A				Wareski, Przemyslaw; Vaarmann, Annika; Choubey, Vinay; Safiulina, Dzhamilja; Liiv, Joanna; Kuum, Malle; Kaasik, Allen			PGC-1 alpha and PGC-1 beta Regulate Mitochondrial Density in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUNTINGTONS-DISEASE; ENERGY-METABOLISM; MUTANT HUNTINGTIN; OXIDATIVE STRESS; RECEPTOR-ALPHA; IN-VIVO; SIRT1; COACTIVATORS; MODULATION	Recent studies indicate that regulation of cellular oxidative capacity through enhancing mitochondrial biogenesis may be beneficial for neuronal recovery and survival in human neurodegenerative disorders. The peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) has been shown to be a master regulator of mitochondrial biogenesis and cellular energy metabolism in muscle and liver. The aim of our study was to establish whether PGC-1 alpha and PGC-1 beta control mitochondrial density also in neurons and if these coactivators could be up-regulated by deacetylation. The results demonstrate that PGC-1 alpha and PGC-1 beta control mitochondrial capacity in an additive and independent manner. This effect was observed in all studied subtypes of neurons, in cortical, midbrain, and cerebellar granule neurons. We also observed that endogenous neuronal PGC-1 alpha but not PGC-1 beta could be activated through its repressor domain by suppressing it. Results demonstrate also that overexpression of SIRT1 deacetylase or suppression of GCN5 acetyltransferase activates transcriptional activity of PGC-1 alpha in neurons and increases mitochondrial density. These effects were mediated exclusively via PGC-1 alpha, since overexpression of SIRT1 or suppression of GCN5 was ineffective where PGC-1 alpha was suppressed by short hairpin RNA. Moreover, the results demonstrate that overexpression of PGC-1 beta or PGC-1 alpha or activation of the latter by SIRT1 protected neurons from mutant alpha-synuclein-or mutant huntingtin-induced mitochondrial loss. These evidences demonstrate that activation or overexpression of the PGC-1 family of coactivators could be used to compensate for neuronal mitochondrial loss and suggest that therapeutic agents activating PGC-1 would be valuable for treating neurodegenerative diseases in which mitochondrial dysfunction and oxidative damage play an important pathogenic role.	[Wareski, Przemyslaw; Vaarmann, Annika; Choubey, Vinay; Safiulina, Dzhamilja; Liiv, Joanna; Kuum, Malle; Kaasik, Allen] Univ Tartu, Dept Pharmacol, EE-51014 Tartu, Estonia	University of Tartu	Kaasik, A (corresponding author), Univ Tartu, Dept Pharmacol, Ravila 19, EE-51014 Tartu, Estonia.	allen.kaasik@ut.ee	Safiulina, Dzamilja/I-7336-2015; Choubey, Vinay/H-3170-2015; Kaasik, Allen/I-2738-2015; Vaarmann, Annika/AAH-7289-2021	Choubey, Vinay/0000-0002-1953-5692; Vaarmann, Annika/0000-0003-0296-8325	Estonian Science Foundation [6227, 7175]; European Community; European Regional Development Fund	Estonian Science Foundation; European Community(European Commission); European Regional Development Fund(European Commission)	This work was supported by Estonian Science Foundation Grants 6227 and for mitochondrial loss. 7175, European Community Projects BRAIN BIOENERGETICS and ESTBIOREG, and the European Regional Development Fund.	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hasholt L, 2003, J GENE MED, V5, P528, DOI 10.1002/jgm.378; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; JENKINS BG, 1993, NEUROLOGY, V43, P2689, DOI 10.1212/WNL.43.12.2689; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Leenders K L, 1986, Mov Disord, V1, P69, DOI 10.1002/mds.870010110; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Reeve Amy K., 2008, Biotechnology Journal, V3, P750, DOI 10.1002/biot.200800066; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Srivastava S, 2007, HUM MOL GENET, V16, P993, DOI 10.1093/hmg/ddm045; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000	33	231	240	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21379	21385		10.1074/jbc.M109.018911	http://dx.doi.org/10.1074/jbc.M109.018911			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19542216	hybrid, Green Published			2022-12-27	WOS:000268564400032
J	Bundschuh, FA; Hannappel, A; Anderka, O; Ludwig, B				Bundschuh, Freya A.; Hannappel, Achim; Anderka, Oliver; Ludwig, Bernd			Surf1, Associated with Leigh Syndrome in Humans, Is a Heme-binding Protein in Bacterial Oxidase Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; PARACOCCUS-DENITRIFICANS; MITOCHONDRIAL COX1P; COFACTOR INSERTION; TERMINAL OXIDASES; ESCHERICHIA-COLI; MEMBRANE; YEAST; EXPRESSION; DEFICIENCY	Biogenesis of mitochondrial cytochrome c oxidase (COX) relies on a large number of assembly factors, among them the transmembrane protein Surf1. The loss of human Surf1 function is associated with Leigh syndrome, a fatal neurodegenerative disorder caused by severe COX deficiency. In the bacterium Paracoccus denitrificans, two homologous proteins, Surf1c and Surf1q, were identified, which we characterize in the present study. When coexpressed in Escherichia coli together with enzymes for heme a synthesis, the bacterial Surf1 proteins bind heme a in vivo. Using redox difference spectroscopy and isothermal titration calorimetry, the binding of the heme cofactor to purified apo-Surf1c and apo-Surf1q is quantified: Each of the Paracoccus proteins binds heme a in a 1:1 stoichiometry and with K-d values in the submicromolar range. In addition, we identify a conserved histidine as a residue crucial for heme binding. Contrary to most earlier concepts, these data support a direct role of Surf1 in heme a cofactor insertion into COX subunit I by providing a protein-bound heme a pool.	[Bundschuh, Freya A.; Hannappel, Achim; Anderka, Oliver; Ludwig, Bernd] Goethe Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Ludwig, Bernd] Cluster Excellence Macromol Complexes Frankfurt M, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Ludwig, B (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	ludwig@em.uni-frankfurt.de			Deutsche Forschungsgemeinschaft [SFB 472]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 472, Cluster of Excellence Macromolecular Complexes Project EXC 115, and the Center of Membrane Proteomics Frankfurt.	Anderka O, 2008, BIOCHEMISTRY-US, V47, P4683, DOI 10.1021/bi702397d; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Belevich I, 2008, ANTIOXID REDOX SIGN, V10, P1, DOI 10.1089/ars.2007.1705; Bundschuh FA, 2008, BBA-BIOENERGETICS, V1777, P1336, DOI 10.1016/j.bbabio.2008.05.448; DEGIER JWL, 1994, MOL MICROBIOL, V13, P183, DOI 10.1111/j.1365-2958.1994.tb00414.x; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; DUTTA C, 1990, ANAL BIOCHEM, V184, P96, DOI 10.1016/0003-2697(90)90018-5; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Gibney BR, 2000, BIOCHEMISTRY-US, V39, P11041, DOI 10.1021/bi000925r; Greiner P, 2008, BBA-BIOENERGETICS, V1777, P904, DOI 10.1016/j.bbabio.2008.04.003; HENDLER RW, 1991, BIOPHYS J, V60, P415, DOI 10.1016/S0006-3495(91)82067-7; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Holdgate GA, 2001, BIOTECHNIQUES, V31, P164; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Khalimonchuk E, 2005, MITOCHONDRION, V5, P363, DOI 10.1016/j.mito.2005.08.002; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUDWIG B, 1980, P NATL ACAD SCI-BIOL, V77, P196, DOI 10.1073/pnas.77.1.196; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MOGI T, 1994, MOL MICROBIOL, V14, P391, DOI 10.1111/j.1365-2958.1994.tb02174.x; Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Poyau A, 1999, FEBS LETT, V462, P416, DOI 10.1016/S0014-5793(99)01571-9; Smith D, 2005, J BIOL CHEM, V280, P17652, DOI 10.1074/jbc.C500061200; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Wang ZH, 2009, J BIOL CHEM, V284, P839, DOI 10.1074/jbc.M804167200; WEINSTEIN JD, 1983, J BIOL CHEM, V258, P6799; WILLIAMS JN, 1964, ARCH BIOCHEM BIOPHYS, V107, P537, DOI 10.1016/0003-9861(64)90313-3; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	43	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25735	25741		10.1074/jbc.M109.040295	http://dx.doi.org/10.1074/jbc.M109.040295			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19625251	Green Published, hybrid			2022-12-27	WOS:000269738000031
J	Nicke, A; Kuan, YH; Masin, M; Rettinger, J; Marquez-Klaka, B; Bender, O; Gorecki, DC; Murrell-Lagnado, RD; Soto, F				Nicke, Annette; Kuan, Yung-Hui; Masin, Marianela; Rettinger, Juergen; Marquez-Klaka, Benjamin; Bender, Olaf; Gorecki, Dariusz C.; Murrell-Lagnado, Ruth D.; Soto, Florentina			A Functional P2X7 Splice Variant with an Alternative Transmembrane Domain 1 Escapes Gene Inactivation in P2X7 Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(7) RECEPTOR FUNCTION; PERMEABILITY DYNAMICS; LARGE-PORE; ATP; CHANNELS; SUBUNITS; CELLS; BRAIN; IDENTIFICATION; POLYMORPHISM	The ATP-activated P2X7 receptor channel is involved in immune function and inflammatory pain and represents an important drug target. Here we describe a new P2X7 splice variant (P2X7(k)), containing an alternative intracellular N terminus and first transmembrane domain encoded by a novel exon 1 in the rodent P2rx7 gene. Whole cell patch clamp recordings of the rat isoform expressed in HEK293 cells revealed an 8-fold higher sensitivity to the agonist Bz-ATP and much slower deactivation kinetics when compared with the P2X7(a) receptor. Permeability measurements in Xenopus oocytes show a high permeability for N-methyl-D-glucamine immediately upon activation, suggesting that the P2X7(k) channel is constitutively dilated upon opening. The rates of agonist-induced dye uptake and membrane blebbing in HEK cells were also increased. PCR analyses and biochemical analysis by SDS-PAGE and BN-PAGE indicate that the P2X7(k) variant escapes gene deletion in one of the available P2X7(-/-) mice strains and is strongly expressed in the spleen. Taken together, we describe a novel P2X7 isoform with distinct functional properties that contributes to the diversity of P2X7 receptor signaling. Its presence in one of the P2X7(-/-) strains has important implications for our understanding of the role of this receptor in health and disease.	[Nicke, Annette; Kuan, Yung-Hui; Marquez-Klaka, Benjamin; Bender, Olaf] Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; [Masin, Marianela; Soto, Florentina] MPI Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Masin, Marianela; Murrell-Lagnado, Ruth D.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Rettinger, Juergen] MPI Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; [Gorecki, Dariusz C.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England	Max Planck Society; University of Cambridge; Max Planck Society; University of Portsmouth	Nicke, A (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany.	anicke@gwdg.de		Murrell-Lagnado, Ruth/0000-0003-2743-7977; Nicke, Annette/0000-0001-6798-505X; Gorecki, Dariusz/0000-0003-3584-1654	Deutsche Forschungsgemeinschaft [NI 592/4, NI 592/5]; German Israeli Foundation; Interreg IV; Biotechnology and Biological Sciences and Research Council [BB/F001320/1]; Biotechnology and Biological Sciences Research Council [BB/F001320/1] Funding Source: researchfish; BBSRC [BB/F001320/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Interreg IV; Biotechnology and Biological Sciences and Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Deutsche Forschungsgemeinschaft (Grants NI 592/4 and NI 592/5 to A. N.), the German Israeli Foundation (to F. S.), the Interreg IV (AdMiN) (to D. C. G.), and the Biotechnology and Biological Sciences and Research Council (Grant BB/F001320/1to R. M.-L.).	Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Chaumont S, 2008, P NATL ACAD SCI USA, V105, P12063, DOI 10.1073/pnas.0803008105; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hong SY, 2009, J IMMUNOL, V183, P578, DOI 10.4049/jimmunol.0900120; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kim M, 2001, J BIOL CHEM, V276, P23262, DOI 10.1074/jbc.M102253200; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Masin M, 2006, J BIOL CHEM, V281, P4100, DOI 10.1074/jbc.M507735200; MCINNES IB, 2007, AM COLL RHEUMATOL; Nicke A, 2005, J NEUROCHEM, V92, P925, DOI 10.1111/j.1471-4159.2004.02939.x; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ohlendorff SD, 2007, PHARMACOGENET GENOM, V17, P555, DOI 10.1097/FPC.0b013e3280951625; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Paukert M, 2002, FEBS LETT, V513, P253, DOI 10.1016/S0014-5793(02)02324-4; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Sanchez-Nogueiro J, 2005, FEBS LETT, V579, P3783, DOI 10.1016/j.febslet.2005.05.073; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Sharp AJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-33; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Taylor SRJ, 2009, J LEUKOCYTE BIOL, V85, P978, DOI 10.1189/jlb.0408251; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Vial C, 2004, BIOCHEM J, V382, P101, DOI 10.1042/BJ20031910; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059	49	146	148	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25813	25822		10.1074/jbc.M109.033134	http://dx.doi.org/10.1074/jbc.M109.033134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19546214	Green Published, hybrid			2022-12-27	WOS:000269738000039
J	Chen, YH; Wendt-Pienkoski, E; Rajski, SR; Shen, B				Chen, Yihua; Wendt-Pienkoski, Evelyn; Rajski, Scott R.; Shen, Ben			In Vivo Investigation of the Roles of FdmM and FdmM1 in Fredericamycin Biosynthesis Unveiling a New Family of Oxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-GRISEUS; GENE-CLUSTER; IDENTIFICATION; ANTIBIOTICS; OXIDATION; COFACTOR; PATHWAY; CLONING	Fredericamycin (FDM) A, a highly oxidized aromatic penta-decaketide natural product, exhibits potent cytotoxicity and has been studied as a new anticancer drug lead. The FDM biosynthetic gene cluster has been previously cloned from Streptomyces griseus ATCC 49344 and successfully expressed in the heterologous host Streptomyces albus J1074. The fdmM and fdmM1 genes code for two proteins with high sequence homology to each other but unknown function. In-frame deletion of each of the genes from the fdm cluster was accomplished in the S. albus host. Each mutant failed to produce FDM A and the key biosynthetic intermediate FDM E but produced various new metabolites, the titers of which were dramatically increased via overexpression of an fdm pathway-specific activator fdmR1. The Delta fdmM mutant strain accumulated three new compounds FDM M-1, FDM M-2, and FDM M-3, whereas the Delta fdmM1 mutant strain produced one new compound FDM M1-1. Isolation and structural characterization of these compounds enable us to propose that FdmM and FdmM1 catalyze the C-6 and C-8 hydroxylations for FDM biosynthesis, respectively. Homologs of FdmM and FdmM1 can be found in biosynthetic gene clusters of many other aromatic polyketides, ranging from dodecaketides to pentadecaketides, but to date all of them were annotated as proteins of unknown function. Based on the findings reported here for FdmM and FdmM1, we now propose similar functions for those proteins, and FdmM and FdmM1 therefore represent an emerging family of novel oxygenases responsible for hydroxylation of aromatic polyketide natural products.	[Chen, Yihua; Wendt-Pienkoski, Evelyn; Rajski, Scott R.; Shen, Ben] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, B (corresponding author), 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu	Chen, Yihua/B-3550-2012		National Institutes of Health [CA113297]; NATIONAL CANCER INSTITUTE [U19CA113297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113297.	Beinker P, 2006, J MOL BIOL, V359, P728, DOI 10.1016/j.jmb.2006.03.060; BOCKHOLT H, 1994, J ORG CHEM, V59, P2064, DOI 10.1021/jo00087a021; BYRNE KM, 1985, BIOCHEMISTRY-US, V24, P478, DOI 10.1021/bi00323a035; Chen Y, 2008, J BACTERIOL, V190, P5587, DOI 10.1128/JB.00592-08; Chen YH, 2008, J NAT PROD, V71, P431, DOI 10.1021/np070664n; Fetzner S, 2002, APPL MICROBIOL BIOT, V60, P243, DOI 10.1007/s00253-002-1123-4; Funa N, 2005, J BIOL CHEM, V280, P14514, DOI 10.1074/jbc.M500190200; Gatti DL, 1996, BIOCHEMISTRY-US, V35, P567, DOI 10.1021/bi951344i; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Jansson A, 2005, J BIOL CHEM, V280, P3636, DOI 10.1074/jbc.M412095200; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim BC, 2007, J MICROBIOL BIOTECHN, V17, P830; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Li AY, 2002, CHEM BIOL, V9, P1017, DOI 10.1016/S1074-5521(02)00223-5; Martin R, 2001, J ANTIBIOT, V54, P239, DOI 10.7164/antibiotics.54.239; MISRA R, 1982, J AM CHEM SOC, V104, P4478, DOI 10.1021/ja00380a025; Niemi J, 1999, BBA-PROTEIN STRUCT M, V1430, P57, DOI 10.1016/S0167-4838(98)00265-9; PANDEY RC, 1981, J ANTIBIOT, V34, P1389, DOI 10.7164/antibiotics.34.1389; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schenk A, 2007, ANGEW CHEM INT EDIT, V46, P7035, DOI 10.1002/anie.200702033; SHEN B, 1993, BIOCHEMISTRY-US, V32, P6656, DOI 10.1021/bi00077a019; Sontag B, 2004, J ANTIBIOT, V57, P823, DOI 10.7164/antibiotics.57.823; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Widboom PF, 2007, NATURE, V447, P342, DOI 10.1038/nature05702; Xu Z, 2007, J AM CHEM SOC, V129, P6022, DOI 10.1021/ja069045b	25	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24735	24743		10.1074/jbc.M109.014191	http://dx.doi.org/10.1074/jbc.M109.014191			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19620242	Green Published, hybrid			2022-12-27	WOS:000269734000008
J	Pores-Fernando, AT; Ranaghan, MYD; Zweifach, A				Pores-Fernando, Arun T.; Ranaghan, Michelle Y. D.; Zweifach, Adam			No Specific Subcellular Localization of Protein Kinase C Is Required for Cytotoxic T Cell Granule Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPRAMOLECULAR ACTIVATION CLUSTERS; PKC-THETA; SECRETORY LYSOSOMES; ANTIGEN RECEPTOR; IL-2 PROMOTER; CD8(+) CTL; DELTA; LYMPHOCYTES; SUBSTRATE; SIGNAL	Cytotoxic T cells kill virus-infected cells and tumor cells by releasing lytic granules that contain cell-killing contents. Exocytosis requires calcium influx and protein kinase C (PKC) activation. Here, we extend our previous finding regarding the lack of isoform specificity of PKCs in the granule release step, showing that mutant constitutively active PKC delta can substitute for phorbol esters and support exocytosis. PKC delta, a novel PKC isoform, was recently shown to play a role in lytic granule reorientation. Surprisingly, however, our results suggested that mutant PKC delta did not localize to the plasma membrane (PM). To test directly whether PKC has to be in the PM to drive exocytosis, we generated mutants of various PKC isoforms that were tethered either to the outer mitochondrial membrane or to the PM. Tethered mutant PKC delta s were able to promote exocytosis as effectively as the untethered version. The substrates of PKCs involved in lytic granule exocytosis are currently unknown, but subcellular localization is believed to be a critical factor in determining PKC accessibility to substrates. That there is no requirement for specific PKC localization in lytic granule exocytosis may have important implications for the identity of PKC substrates.	[Pores-Fernando, Arun T.; Ranaghan, Michelle Y. D.; Zweifach, Adam] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Zweifach, A (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT 06269 USA.	adam.zweifach@uconn.edu			National Institutes of Health [R01 AI054839]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI054839 (to A. Z.).	Altman A, 2000, IMMUNOL TODAY, V21, P567, DOI 10.1016/S0167-5699(00)01749-7; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Fierro AF, 2004, J BIOL CHEM, V279, P25646, DOI 10.1074/jbc.M400296200; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Grybko MJ, 2007, J LEUKOCYTE BIOL, V81, P509, DOI 10.1189/jlb.0206109; HIRAI S, 1994, EMBO J, V13, P2331, DOI 10.1002/j.1460-2075.1994.tb06517.x; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Ma JSY, 2008, J IMMUNOL, V181, P4716, DOI 10.4049/jimmunol.181.7.4716; Ma JSY, 2007, J IMMUNOL, V178, P7814, DOI 10.4049/jimmunol.178.12.7814; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mochly-Rosen D, 1998, FASEB J, V12, P35; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Pardo J, 2003, INT IMMUNOL, V15, P1441, DOI 10.1093/intimm/dxg141; Pores-Fernando AT, 2008, BIOCHEM BIOPH RES CO, V371, P630, DOI 10.1016/j.bbrc.2008.04.028; Pores-Fernando AT, 2005, J PHYSIOL-LONDON, V567, P891, DOI 10.1113/jphysiol.2005.089565; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Puente LG, 2000, J IMMUNOL, V165, P6865, DOI 10.4049/jimmunol.165.12.6865; Puente LG, 2006, EUR J IMMUNOL, V36, P1009, DOI 10.1002/eji.200535277; Puente LG, 2005, MOL IMMUNOL, V42, P1177, DOI 10.1016/j.molimm.2004.11.012; Radoja S, 2006, CRIT REV IMMUNOL, V26, P265, DOI 10.1615/CritRevImmunol.v26.i3.40; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Rybin VO, 2006, AM J PHYSIOL-CELL PH, V290, pC750, DOI 10.1152/ajpcell.00395.2005; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Wan QJ, 2000, J BIOL CHEM, V275, P12136, DOI 10.1074/jbc.275.16.12136; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101	33	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25107	25115		10.1074/jbc.M109.011866	http://dx.doi.org/10.1074/jbc.M109.011866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592494	hybrid, Green Published			2022-12-27	WOS:000269734000045
J	Shewmaker, F; McGlinchey, RP; Thurber, KR; McPhie, P; Dyda, F; Tycko, R; Wickner, RB				Shewmaker, Frank; McGlinchey, Ryan P.; Thurber, Kent R.; McPhie, Peter; Dyda, Fred; Tycko, Robert; Wickner, Reed B.			The Functional Curli Amyloid Is Not Based on In-register Parallel beta-Sheet Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; HET-S PRION; NUCLEAR-MAGNETIC-RESONANCE; THIN AGGREGATIVE FIMBRIAE; ESCHERICHIA-COLI; EXPERIMENTAL CONSTRAINTS; SALMONELLA-ENTERITIDIS; SECONDARY STRUCTURE; FIBRILS; PROTEIN	The extracellular curli proteins of Enterobacteriaceae form fibrous structures that are involved in biofilm formation and adhesion to host cells. These curli fibrils are considered a functional amyloid because they are not a consequence of misfolding, but they have many of the properties of protein amyloid. We confirm that fibrils formed by CsgA and CsgB, the primary curli proteins of Escherichia coli, possess many of the hallmarks typical of amyloid. Moreover we demonstrate that curli fibrils possess the cross-beta structure that distinguishes protein amyloid. However, solid state NMR experiments indicate that curli structure is not based on an in-register parallel beta-sheet architecture, which is common to many human disease-associated amyloids and the yeast prion amyloids. Solid state NMR and electron microscopy data are consistent with a beta-helix-like structure but are not sufficient to establish such a structure definitively.	[Wickner, Reed B.] NIDDK, Lab Biochem & Genet, Natl Inst Hlth, Bethesda, MD 20892 USA; [Thurber, Kent R.; Tycko, Robert] NIDDK, Labs Chem Phys, Natl Inst Hlth, Bethesda, MD 20892 USA; [Dyda, Fred] NIDDK, Labs Mol Biol, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wickner, RB (corresponding author), NIDDK, Lab Biochem & Genet, Natl Inst Hlth, Bldg 8,Rm 207,8 Ctr Dr, Bethesda, MD 20892 USA.	wickner@helix.nih.gov			NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024950, Z01DK024964, ZIADK024964, Z01DK024949, ZIADK024948, ZIADK024949, ZIADK075031, ZIADK075018] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Program of the NIDDK, National Institutes of Health.	Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Baxa U, 2005, J STRUCT BIOL, V150, P170, DOI 10.1016/j.jsb.2005.02.007; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Baxa U, 2006, ADV PROTEIN CHEM, V73, P125, DOI 10.1016/S0065-3233(06)73005-4; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Collinson SK, 1999, J MOL BIOL, V290, P741, DOI 10.1006/jmbi.1999.2882; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Ishii Y, 2001, CHEM PHYS, V266, P231, DOI 10.1016/S0301-0104(01)00250-6; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Mackay JP, 2001, STRUCTURE, V9, P83, DOI 10.1016/S0969-2126(00)00559-1; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; McPhie P, 2001, ANAL BIOCHEM, V293, P109, DOI 10.1006/abio.2001.5113; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044; Podrabsky JE, 2001, AM J PHYSIOL-REG I, V280, pR123, DOI 10.1152/ajpregu.2001.280.1.R123; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Siemer AB, 2006, J AM CHEM SOC, V128, P13224, DOI 10.1021/ja063639x; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tycko R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437194; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Virchow R, 1853, CR HEBD ACAD SCI, V37, P860; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; White AP, 2001, J MOL BIOL, V311, P735, DOI 10.1006/jmbi.2001.4876; Wickner RB, 2008, BIOESSAYS, V30, P955, DOI 10.1002/bies.20821; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	53	100	104	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25065	25076		10.1074/jbc.M109.007054	http://dx.doi.org/10.1074/jbc.M109.007054			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19574225	Green Published, hybrid			2022-12-27	WOS:000269734000041
J	Xu, Q; Traag, BA; Willemse, J; McMullan, D; Miller, MD; Elsliger, MA; Abdubek, P; Astakhova, T; Axelrod, HL; Bakolitsa, C; Carlton, D; Chen, C; Chiu, HJ; Chruszcz, M; Clayton, T; Das, D; Deller, MC; Duan, L; Ellrott, K; Ernst, D; Farr, CL; Feuerhelm, J; Grant, JC; Grzechnik, A; Grzechnik, SK; Han, GW; Jaroszewski, L; Jin, KK; Klock, HE; Knuth, MW; Kozbial, P; Krishna, SS; Kumar, A; Marciano, D; Minor, W; Mommaas, AM; Morse, AT; Nigoghossian, E; Nopakun, A; Okach, L; Oommachen, S; Paulsen, J; Puckett, C; Reyes, R; Rife, CL; Sefcovic, N; Tien, HJ; Trame, CB; van den Bedem, H; Wang, SR; Weekes, D; Hodgson, KO; Wooley, J; Deacon, AM; Godzik, A; Lesley, SA; Wilson, IA; Wezel, GP				Xu, Qingping; Traag, Bjorn A.; Willemse, Joost; McMullan, Daniel; Miller, Mitchell D.; Elsliger, Marc-Andre; Abdubek, Polat; Astakhova, Tamara; Axelrod, Herbert L.; Bakolitsa, Constantina; Carlton, Dennis; Chen, Connie; Chiu, Hsiu-Ju; Chruszcz, Maksymilian; Clayton, Thomas; Das, Debanu; Deller, Marc C.; Duan, Lian; Ellrott, Kyle; Ernst, Dustin; Farr, Carol L.; Feuerhelm, Julie; Grant, Joanna C.; Grzechnik, Anna; Grzechnik, Slawomir K.; Han, Gye Won; Jaroszewski, Lukasz; Jin, Kevin K.; Klock, Heath E.; Knuth, Mark W.; Kozbial, Piotr; Krishna, S. Sri; Kumar, Abhinav; Marciano, David; Minor, Wladek; Mommaas, A. Mieke; Morse, Andrew T.; Nigoghossian, Edward; Nopakun, Amanda; Okach, Linda; Oommachen, Silvya; Paulsen, Jessica; Puckett, Christina; Reyes, Ron; Rife, Christopher L.; Sefcovic, Natasha; Tien, Henry J.; Trame, Christine B.; van den Bedem, Henry; Wang, Shuren; Weekes, Dana; Hodgson, Keith O.; Wooley, John; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.; van Wezel, Gilles P.			Structural and Functional Characterizations of SsgB, a Conserved Activator of Developmental Cell Division in Morphologically Complex Actinomycetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-COELICOLOR A3(2); PROTEIN; SPORULATION; GENE; EXPRESSION; GROWTH; FTSZ; LOCALIZATION; INTEGRATION; CRYSTALS	SsgA-like proteins (SALPs) are a family of homologous cell division-related proteins that occur exclusively in morphologically complex actinomycetes. We show that SsgB, a subfamily of SALPs, is the archetypal SALP that is functionally conserved in all sporulating actinomycetes. Sporulation-specific cell division of Streptomyces coelicolor ssgB mutants is restored by introduction of distant ssgB orthologues from other actinomycetes. Interestingly, the number of septa (and spores) of the complemented null mutants is dictated by the specific ssgB orthologue that is expressed. The crystal structure of the SsgB from Thermobifida fusca was determined at 2.6 angstrom resolution and represents the first structure for this family. The structure revealed similarities to a class of eukaryotic "whirly" single-stranded DNA/RNA-binding proteins. However, the electro-negative surface of the SALPs suggests that neither SsgB nor any of the other SALPs are likely to interact with nucleotide substrates. Instead, we show that a conserved hydrophobic surface is likely to be important for SALP function and suggest that proteins are the likely binding partners.	[Wilson, Ian A.] Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; [Xu, Qingping; McMullan, Daniel; Miller, Mitchell D.; Elsliger, Marc-Andre; Abdubek, Polat; Astakhova, Tamara; Axelrod, Herbert L.; Bakolitsa, Constantina; Carlton, Dennis; Chen, Connie; Chiu, Hsiu-Ju; Clayton, Thomas; Das, Debanu; Deller, Marc C.; Duan, Lian; Ellrott, Kyle; Ernst, Dustin; Farr, Carol L.; Feuerhelm, Julie; Grant, Joanna C.; Grzechnik, Anna; Grzechnik, Slawomir K.; Han, Gye Won; Jaroszewski, Lukasz; Jin, Kevin K.; Klock, Heath E.; Knuth, Mark W.; Kozbial, Piotr; Krishna, S. Sri; Kumar, Abhinav; Marciano, David; Morse, Andrew T.; Nigoghossian, Edward; Nopakun, Amanda; Okach, Linda; Oommachen, Silvya; Paulsen, Jessica; Puckett, Christina; Reyes, Ron; Rife, Christopher L.; Sefcovic, Natasha; Tien, Henry J.; Trame, Christine B.; van den Bedem, Henry; Weekes, Dana; Hodgson, Keith O.; Wooley, John; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Xu, Qingping; Miller, Mitchell D.; Axelrod, Herbert L.; Chiu, Hsiu-Ju; Das, Debanu; Jin, Kevin K.; Kumar, Abhinav; Oommachen, Silvya; Reyes, Ron; Rife, Christopher L.; Trame, Christine B.; van den Bedem, Henry; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Traag, Bjorn A.; Willemse, Joost; van Wezel, Gilles P.] Leiden Univ, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands; [McMullan, Daniel; Abdubek, Polat; Chen, Connie; Ernst, Dustin; Feuerhelm, Julie; Grant, Joanna C.; Klock, Heath E.; Knuth, Mark W.; Nigoghossian, Edward; Okach, Linda; Paulsen, Jessica; Puckett, Christina; Lesley, Scott A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Astakhova, Tamara; Duan, Lian; Ellrott, Kyle; Grzechnik, Slawomir K.; Jaroszewski, Lukasz; Krishna, S. Sri; Morse, Andrew T.; Wooley, John; Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Bakolitsa, Constantina; Jaroszewski, Lukasz; Kozbial, Piotr; Krishna, S. Sri; Sefcovic, Natasha; Weekes, Dana; Godzik, Adam] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Chruszcz, Maksymilian; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Chruszcz, Maksymilian; Minor, Wladek; Wang, Shuren] Leiden Univ, Med Ctr, Midwest Ctr Struct Genom, NL-2300 RC Leiden, Netherlands; [Mommaas, A. Mieke] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Sect Elect Microscopy, NL-2300 RC Leiden, Netherlands	Scripps Research Institute; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Leiden University; Leiden University - Excl LUMC; Novartis; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of Virginia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Wilson, IA (corresponding author), Scripps Res Inst, Joint Ctr Struct Genom, BCC206,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu; g.wezel@chem.leidenuniv.nl	Han, Gye Won/GLQ-8724-2022; Godzik, Adam/AAW-1467-2020; subramanian, srikrishna/D-5004-2009; subramanian, srikrishna/N-3018-2019; Godzik, Adam/A-7279-2009; Han, Gye Won/GLQ-8673-2022; Minor, Wladek/F-3096-2014; Chruszcz, Maksymilian/E-6407-2011; Han, Gye Won/GLT-1531-2022; Willemse, Joost/B-1861-2008; van Wezel, Gilles/ABC-7854-2021	Han, Gye Won/0000-0003-4107-835X; Godzik, Adam/0000-0002-2425-852X; subramanian, srikrishna/0000-0002-3263-1048; subramanian, srikrishna/0000-0002-3263-1048; Godzik, Adam/0000-0002-2425-852X; Minor, Wladek/0000-0001-7075-7090; Chruszcz, Maksymilian/0000-0001-7521-5485; Willemse, Joost/0000-0001-9312-6021; van Wezel, Gilles/0000-0003-0341-1561; Miller, Mitchell/0000-0003-1626-4943; Bakolitsa, Constantina/0000-0002-6980-9831; Marciano, David/0000-0001-8868-2138; Deller, Marc/0000-0001-8070-6502; Elsliger, Marc Andre/0000-0002-1989-7626	National Institutes of Health, NIGMS [U54 GM074898, U54 GM074942]; Netherlands Council for Scientific Research ECHO [700.54.002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942, U54GM074898] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Netherlands Council for Scientific Research ECHO; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grants U54 GM074898 and U54 GM074942 (to the Protein Structure Initiative, which supported the structural genomics project) and Netherlands Council for Scientific Research ECHO Grant 700.54.002 (to G. P. v. W.).	Autret S, 2001, DEV CELL, V1, P10, DOI 10.1016/S1534-5807(01)00014-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bramhill D, 1997, ANNU REV CELL DEV BI, V13, P395, DOI 10.1146/annurev.cellbio.13.1.395; Chater KF, 2006, FEMS MICROBIOL REV, V30, P651, DOI 10.1111/j.1574-6976.2006.00033.x; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; CHATER KF, 1972, J GEN MICROBIOL, V72, P9, DOI 10.1099/00221287-72-1-9; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Del Sol R, 2006, J BACTERIOL, V188, P1540, DOI 10.1128/JB.188.4.1540-1550.2006; Desveaux D, 2002, NAT STRUCT BIOL, V9, P512, DOI 10.1038/nsb814; Elliot MA, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P419; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Flardh K, 2000, MOL MICROBIOL, V38, P737, DOI 10.1046/j.1365-2958.2000.02177.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hopwood DA, 2007, STREPTOMYCES NATURE; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; JANSSEN GR, 1993, GENE, V124, P133, DOI 10.1016/0378-1119(93)90774-W; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Kawamoto S, 1997, MICROBIOL-UK, V143, P1077, DOI 10.1099/00221287-143-4-1077; Keijser BJF, 2003, FEMS MICROBIOL LETT, V225, P59, DOI 10.1016/S0378-1097(03)00481-6; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kormanec J, 2002, MOL GENET GENOMICS, V267, P536, DOI 10.1007/200438-002-0687-0; LARSON JL, 1986, PLASMID, V15, P199, DOI 10.1016/0147-619X(86)90038-7; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2004, ANNU REV BIOPH BIOM, V33, P177, DOI 10.1146/annurev.biophys.33.110502.132647; LYDIATE DJ, 1985, GENE, V35, P223, DOI 10.1016/0378-1119(85)90001-0; Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Mazza P, 2006, MOL MICROBIOL, V60, P838, DOI 10.1111/j.1365-2958.2006.05134.x; MCCORMICK JR, 1994, MOL MICROBIOL, V14, P243, DOI 10.1111/j.1365-2958.1994.tb01285.x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Noens EEE, 2005, MOL MICROBIOL, V58, P929, DOI 10.1111/j.1365-2958.2005.04883.x; Noens EE, 2007, MOL MICROBIOL, V64, P1244, DOI 10.1111/j.1365-2958.2007.05732.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Traag BA, 2008, ANTON LEEUW INT J G, V94, P85, DOI 10.1007/s10482-008-9225-3; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van Wezel GP, 2000, J BACTERIOL, V182, P5653, DOI 10.1128/JB.182.20.5653-5662.2000; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WILDERMUTH H, 1970, J GEN MICROBIOL, V60, P51, DOI 10.1099/00221287-60-1-51; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	55	19	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25268	25279		10.1074/jbc.M109.018564	http://dx.doi.org/10.1074/jbc.M109.018564			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19567872	Green Published, hybrid			2022-12-27	WOS:000269734000060
J	Yang, QY; Low, CB; Karthik, BC; Wang, Y; Ryo, A; Yao, SQ; Yang, DW; Liou, YC				Yang, Qiaoyun; Low, Choon Bing; Karthik, Balakrishna Chandrababu; Wang, Yu; Ryo, Akihide; Yao, Shao Q.; Yang, Daiwen; Liou, Yih-Cherng			Pin1 Catalyzes Conformational Changes of Thr-187 in p27(Kip1) and Mediates Its Stability through a Polyubiquitination Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL-ISOMERASE PIN1; CELL-CYCLE PROGRESSION; DEPENDENT KINASES; CDK INHIBITORS; S-PHASE; PHOSPHORYLATION; P27; CANCER; TRANSFORMATION; LOCALIZATION	The cis-trans peptidylprolyl isomerase Pin1 plays a critical role in regulating a subset of phosphoproteins by catalyzing conformational changes on the phosphorylated Ser/Thr-Pro motifs. The phosphorylation-directed ubiquitination is one of the major mechanisms to regulate the abundance of p27(Kip1). In this study, we demonstrate that Pin1 catalyzes the cis-trans conformational changes of p27(Kip1) and further mediates its stability through the polyubiquitination mechanism. Our results show that the phosphorylated Thr-187-Pro motif in p27(Kip1) is a key Pin1-binding site. In addition, NMR analyses show that this phosphorylated Thr-187-Pro site undergoes conformational change catalyzed by Pin1. Moreover, in Pin1 knock-out mouse embryonic fibroblasts, p27(Kip1) has a shorter lifetime and displays a higher degree of polyubiquitination than in Pin1 wildtype mouse embryonic fibroblasts, suggesting that Pin1 plays a critical role in regulating p27(Kip1) degradation. Additionally, Pin1 dramatically reduces the interaction between p27(Kip1) and Cks1, possibly via isomerizing the cis-trans conformation of p27(Kip1). Our study thus reveals a novel regulatory mechanism for p27(Kip1) stability and sheds new light on the biological function of Pin1 as a general regulator of protein stability.	[Yang, Qiaoyun; Low, Choon Bing; Karthik, Balakrishna Chandrababu; Wang, Yu; Ryo, Akihide; Yao, Shao Q.; Yang, Daiwen; Liou, Yih-Cherng] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Yao, Shao Q.] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Ryo, Akihide] Natl Inst Infect Dis 1, AIDS Res Ctr, Res Grp 1, Tokyo 2080011, Japan	National University of Singapore; National University of Singapore; National Institute of Infectious Diseases (NIID)	Liou, YC (corresponding author), 14 Sci Dr 4, Singapore 117543, Singapore.	dbslyc@nus.edu.sg	Yao, Shao Q/B-8825-2008; yang, daiwen/H-8408-2012	yang, daiwen/0000-0002-6804-0071	Biomedical Research Council, the Agency for Science, Research, and Technology [06/1/21/19/473]; National University of Singapore [R-154-000-403-112]	Biomedical Research Council, the Agency for Science, Research, and Technology(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	This work was supported by Grant 06/1/21/19/473 from the Biomedical Research Council, the Agency for Science, Research, and Technology, and in part by Facility Research Council Grant R-154-000-403-112 from the National University of Singapore ( to Y.C.L.).	Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Borriello A, 2007, CELL CYCLE, V6, P1053, DOI 10.4161/cc.6.9.4142; Brenkman AB, 2008, CANCER RES, V68, P7597, DOI 10.1158/0008-5472.CAN-08-1059; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Jeong SJ, 2009, BIOCHEM BIOPH RES CO, V381, P294, DOI 10.1016/j.bbrc.2009.02.024; Kaldis P, 2007, CELL, V128, P241, DOI 10.1016/j.cell.2007.01.006; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Reed SI, 2002, CELL CYCLE, V1, P389, DOI 10.4161/cc.1.6.261; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Ryo A, 2007, J BIOL CHEM, V282, P36671, DOI 10.1074/jbc.M704145200; Ryo A, 2009, TRENDS BIOCHEM SCI, V34, P162, DOI 10.1016/j.tibs.2008.12.004; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Seeliger MA, 2003, NAT STRUCT BIOL, V10, P718, DOI 10.1038/nsb962; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sun HY, 2008, ANGEW CHEM INT EDIT, V47, P1698, DOI 10.1002/anie.200703473; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Timmerbeul I, 2006, P NATL ACAD SCI USA, V103, P14009, DOI 10.1073/pnas.0606316103; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; You H, 2002, J CELL BIOCHEM, V84, P211, DOI 10.1002/jcb.10037; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	61	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23980	23988		10.1074/jbc.M109.022814	http://dx.doi.org/10.1074/jbc.M109.022814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19584057	hybrid, Green Published			2022-12-27	WOS:000269380200012
J	Barth, S; Edlich, F; Berchner-Pfannschmidt, U; Gneuss, S; Jahreis, G; Hasgall, PA; Fandrey, J; Wenger, RH; Camenisch, G				Barth, Sandra; Edlich, Frank; Berchner-Pfannschmidt, Utta; Gneuss, Silke; Jahreis, Guenther; Hasgall, Philippe A.; Fandrey, Joachim; Wenger, Roland H.; Camenisch, Gieri			Hypoxia-inducible Factor Prolyl-4-hydroxylase PHD2 Protein Abundance Depends on Integral Membrane Anchoring of FKBP38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYLASE DOMAIN PROTEIN-2; BCL-2 REGULATOR FKBP38; PROLYL-HYDROXYLASE; HIF-ALPHA; NITRIC-OXIDE; TRANSCRIPTIONAL ACTIVITY; ORNITHINE-DECARBOXYLASE; PROTEASOMAL DEGRADATION; RESPONSIVE ELEMENT; OXYGEN	Prolyl-4-hydroxylase domain (PHD) proteins are 2-oxoglutarate and dioxygen-dependent enzymes that mediate the rapid destruction of hypoxia-inducible factor alpha subunits. Whereas PHD1 and PHD3 proteolysis has been shown to be regulated by Siah2 ubiquitin E3 ligase-mediated polyubiquitylation and proteasomal destruction, protein regulation of the main oxygen sensor responsible for hypoxia-inducible factor alpha regulation, PHD2, remained unknown. We recently reported that the FK506-binding protein (FKBP) 38 specifically interacts with PHD2 and determines PHD2 protein stability in a peptidylprolyl cis-trans isomerase-independent manner. Using peptide array binding assays, fluorescence spectroscopy, and fluorescence resonance energy transfer analysis, we defined a minimal linear glutamate-rich PHD2 binding domain in the N-terminal part of FKBP38 and showed that this domain forms a high affinity complex with PHD2. Vice versa, PHD2 interacted with a non-linear N-terminal motif containing the MYND (myeloid, Nervy, and DEAF-1)-type Zn2+ finger domain with FKBP38. Biochemical fractionation and immunofluorescence analysis demonstrated that PHD2 subcellular localization overlapped with FKBP38 in the endoplasmic reticulum and mitochondria. An additional fraction of PHD2 was found in the cytoplasm. In cellulo PHD2/FKBP38 association, as well as regulation of PHD2 protein abundance by FKBP38, is dependent on membrane-anchored FKBP38 localization mediated by the C-terminal transmembrane domain. Mechanistically our data indicate that PHD2 protein stability is regulated by a ubiquitin-independent proteasomal pathway involving FKBP38 as adaptor protein that mediates proteasomal interaction. We hypothesize that FKBP38-bound PHD2 is constantly degraded whereas cytosolic PHD2 is stable and able to function as an active prolyl-4-hydroxylase.	[Barth, Sandra; Hasgall, Philippe A.; Wenger, Roland H.; Camenisch, Gieri] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Barth, Sandra; Hasgall, Philippe A.; Wenger, Roland H.; Camenisch, Gieri] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Edlich, Frank; Jahreis, Guenther] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; [Berchner-Pfannschmidt, Utta; Gneuss, Silke; Fandrey, Joachim] Univ Duisburg Essen, Inst Physiol, D-45122 Essen, Germany	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Max Planck Society; University of Duisburg Essen	Camenisch, G (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	gieri.camenisch@access.uzh.ch	Wenger, Roland H./B-7953-2009; Fandrey, Joachim/AAA-3524-2021	Wenger, Roland H./0000-0001-7592-4839; Fandrey, Joachim/0000-0001-9585-0531	European Commission/State Secretariat for Education and Research (SER) [EUROXY LSHC-CT-2003-502932/SBF 03.0647-2]; Swiss National Science Foundation [3100A0-104219]; Deutsche Forschungsgemeinschaft [FA 225/19-3]	European Commission/State Secretariat for Education and Research (SER)(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Forschungskredit der Universitat Zurrich (to G. C.), the Sassella-Stiftung (to G. C. and S. B.), the Hartmann Muller-Stiftung (to G. C.), the Krebsliga des Kanton Zurrich (to G. C.), the Olga Mayenfisch Stiftung (to G. C.), 6th Framework Programme of the European Commission/State Secretariat for Education and Research (SER) Grant EUROXY LSHC-CT-2003-502932/SBF 03.0647-2 (to R. H. W.), Swiss National Science Foundation Grant 3100A0-104219 (to R. H. W. and G. C.), and Deutsche Forschungsgemeinschaft Grant FA 225/19-3 (to J. F.).	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Bader N, 2006, BIOL CHEM, V387, P1351, DOI 10.1515/BC.2006.169; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Berchner-Pfannschmidt U, 2008, EUR RESPIR J, V32, P210, DOI 10.1183/09031936.00013408; Berchner-Pfannschmidt U, 2008, J BIOL CHEM, V283, P31745, DOI 10.1074/jbc.M804390200; Berchner-Pfannschmidt U, 2007, J BIOL CHEM, V282, P1788, DOI 10.1074/jbc.M607065200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; Camenisch G, 1999, FASEB J, V13, P81, DOI 10.1096/fasebj.13.1.81; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Choi KO, 2005, MOL PHARMACOL, V68, P1803, DOI 10.1124/mol.105.015271; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Ju DH, 2008, MOL CELL BIOL, V28, P1404, DOI 10.1128/MCB.01787-07; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Khan Z, 2006, AM J PATHOL, V169, P1251, DOI 10.2353/ajpath.2006.060360; Knowles HJ, 2003, CANCER RES, V63, P1764; Koivunen P, 2007, J BIOL CHEM, V282, P30544, DOI 10.1074/jbc.M704988200; Ladendorff NE, 2001, ONCOGENE, V20, P125, DOI 10.1038/sj.onc.1204048; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lausen J, 2004, J BIOL CHEM, V279, P49281, DOI 10.1074/jbc.M407239200; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Moller A, 2009, ONCOGENE, V28, P289, DOI 10.1038/onc.2008.382; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Soilleux EJ, 2005, HISTOPATHOLOGY, V47, P602, DOI 10.1111/j.1365-2559.2005.02280.x; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tarcsa E, 2000, J BIOL CHEM, V275, P20295, DOI 10.1074/jbc.M001555200; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wirthner R, 2007, METHOD ENZYMOL, V435, P43, DOI 10.1016/S0076-6879(07)35003-9; Wotzlaw C, 2007, FASEB J, V21, P700, DOI 10.1096/fj.06-6280com; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	78	56	56	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23046	23058		10.1074/jbc.M109.032631	http://dx.doi.org/10.1074/jbc.M109.032631			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546213	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000268963100057
J	Qin, YB; Li, L; Pan, WJ; Wu, DQ				Qin, Yuanbo; Li, Lin; Pan, Weijun; Wu, Dianqing			Regulation of Phosphatidylinositol Kinases and Metabolism by Wnt3a and Dvl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDES; PHOSPHORYLATION; MECHANISM; DISEASE; AXIN	Wnt signaling plays important roles in various physiological and pathophysiological processes. The pathway that leads to beta-catenin stabilization is initiated by Wnt binding to its cell surface receptors, which induces the formation of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) via activation of phosphatidylinositol 4-phosphate 5-kinase (PIP5K) type I. Here, we show that Wnt also stimulated the production of phosphatidylinositol 4-phosphate (PtdIns(4)P), which depended on Frizzled (Fz), Dishevelled (Dvl), and phosphatidylinositol 4-kinase (PI4K) type II alpha in HEK293T cells. Dvl directly interacted with and activated PI4KII alpha by increasing its V-max for ATP and PtdIns. In addition, Dvl regulated PI4KII alpha and PIP5KI via different domains. Moreover, Dvl, PI4KII alpha, and PIP5KI appeared to form a ternary complex upon Wnt3a stimulation. This complex may allow efficient production of PtdIns(4,5)P-2 from PtdIns, which is far more abundant than PtdIns(4)P in cells. Therefore, this study provides new insights into the mechanism by which Wnt3a regulates the production of PtdIns(4,5)P-2.	[Qin, Yuanbo; Pan, Weijun; Wu, Dianqing] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Qin, Yuanbo; Pan, Weijun; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Qin, Yuanbo; Li, Lin] Chinese Acad Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Qin, Yuanbo; Li, Lin] Chinese Acad Sci, Ctr Cell Signaling, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Yale University; Yale University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Pan, WJ (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, 333 Cedar St, New Haven, CT 06520 USA.	weijun.pan@yale.edu; dan.wu@yale.edu			National Institutes of Health; NSFC; NATIONAL CANCER INSTITUTE [R01CA139395, R01CA132317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health grants (to D. W.). This work was also supported by NSFC grants (to L. L.).	Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Clarke JH, 2007, BIOCHEM SOC SYMP, V74, P149, DOI 10.1042/BSS2007c14; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	22	55	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22544	22548		10.1074/jbc.M109.014399	http://dx.doi.org/10.1074/jbc.M109.014399			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561074	Green Published, hybrid			2022-12-27	WOS:000268963100007
J	Bhunia, A; Mohanram, H; Domadia, PN; Torres, J; Bhattacharjya, S				Bhunia, Anirban; Mohanram, Harini; Domadia, Prerna N.; Torres, Jaume; Bhattacharjya, Surajit			Designed beta-Boomerang Antiendotoxic and Antimicrobial Peptides STRUCTURES AND ACTIVITIES IN LIPOPOLYSACCHARIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; ANTI-ENDOTOXIC ACTIVITY; MEMBRANE PROTEIN PHOE; OUTER-MEMBRANE; ESCHERICHIA-COLI; POLYMYXIN-B; INFLUENZA HEMAGGLUTININ; BINDING-PROTEIN; FUSION DOMAIN; SPECTROSCOPY	Lipopolysaccharide (LPS), an integral part of the outer membrane of Gram-negative bacteria, is involved in a variety of biological processes including inflammation, septic shock, and resistance to host-defense molecules. LPS also provides an environment for folding of outer membrane proteins. In this work, we describe the structure-activity correlation of a series of 12-residue peptides in LPS. NMR structures of the peptides derived in complex with LPS reveal boomerang-like beta-strand conformations that are stabilized by intimate packing between the two aromatic residues located at the 4 and 9 positions. This structural feature renders these peptides with a high ability to neutralize endotoxicity, >80% at 10 nM concentration, of LPS. Replacements of these aromatic residues either with Ala or with Leu destabilizes the boomerang structure with the concomitant loss of antiendotoxic and antimicrobial activities. Furthermore, the aromatic packing stabilizing the beta-boomerang structure in LPS is found to be maintained even in a truncated octapeptide, defining a structured LPS binding motif. The mode of action of the active designed peptides correlates well with their ability to perturb LPS micelle structures. Fourier transform infrared spectroscopy studies of the peptides delineate beta-type conformations and immobilization of phosphate head groups of LPS. Trp fluorescence studies demonstrated selective interactions with LPS and the depth of insertion into the LPS bilayer. Our results demonstrate the requirement of LPS-specific structures of peptides for endotoxin neutralizations. In addition, we propose that structures of these peptides may be employed to design proteins for the outer membrane.	[Bhunia, Anirban; Mohanram, Harini; Domadia, Prerna N.; Torres, Jaume; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Bhattacharjya, S (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore 637551, Singapore.	surajit@ntu.edu.sg	Bhattacharjya, SURAJIT/A-2183-2011; Torres, Jaume/A-2179-2011; Torres, Jaume/AAJ-4510-2020; Mohanram, Harini/L-9207-2019	Torres, Jaume/0000-0002-1282-9727; Mohanram, Harini/0000-0002-8179-2665; Bhunia, Anirban/0000-0002-8752-2842	A*Star BMRC Singapore [06/1/22/19/446]	A*Star BMRC Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Grant 06/1/22/19/446 from A*Star BMRC Singapore.	Bhattacharjya S, 1997, BIOPOLYMERS, V41, P251, DOI 10.1002/(SICI)1097-0282(199703)41:3<251::AID-BIP2>3.0.CO;2-R; Bhattacharjya S, 2007, BIOCHEMISTRY-US, V46, P5864, DOI 10.1021/bi6025159; Bhunia A, 2008, BIOCHEM BIOPH RES CO, V369, P853, DOI 10.1016/j.bbrc.2008.02.105; Bhunia A, 2007, BBA-BIOMEMBRANES, V1768, P3282, DOI 10.1016/j.bbamem.2007.07.017; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Brandenburg K, 1997, BBA-BIOMEMBRANES, V1329, P183, DOI 10.1016/S0005-2736(97)00109-0; Bulieris PV, 2003, J BIOL CHEM, V278, P9092, DOI 10.1074/jbc.M211177200; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Chen X, 2007, BBA-BIOMEMBRANES, V1768, P2421, DOI 10.1016/j.bbamem.2007.05.001; Chen XM, 2006, J MED CHEM, V49, P7754, DOI 10.1021/jm0610447; Clements A, 2007, J BIOL CHEM, V282, P15569, DOI 10.1074/jbc.M701454200; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; David SA, 2001, J MOL RECOGNIT, V14, P370, DOI 10.1002/jmr.549; de Cock H, 1999, J BIOL CHEM, V274, P5114, DOI 10.1074/jbc.274.8.5114; deCock H, 1996, EMBO J, V15, P5567, DOI 10.1002/j.1460-2075.1996.tb00941.x; Ding L, 2003, BIOCHEMISTRY-US, V42, P12251, DOI 10.1021/bi035130+; Dings RPM, 2008, BIOCHEM J, V414, P143, DOI 10.1042/BJ20080506; Dings RPM, 2007, ACCOUNTS CHEM RES, V40, P1057, DOI 10.1021/ar700086k; DOFFERHOFF ASM, 1995, DIFFERENTIAL RELEASE, P11; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2000, STRUCTURE, V8, P585; FINK PF, 1990, SEPSIS SYNDROME HDB, P619; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gutsmann T, 2000, J MEMBRANE BIOL, V176, P223, DOI 10.1007/s002320001092; Hallock KJ, 2002, BIOPHYS J, V83, P1004, DOI 10.1016/S0006-3495(02)75226-0; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Hardaway RM, 2000, AM SURGEON, V66, P22; Hirakura Y, 2002, BBA-BIOMEMBRANES, V1562, P32, DOI 10.1016/S0005-2736(02)00358-9; Howe J, 2007, BIOPHYS J, V92, P2796, DOI 10.1529/biophysj.106.095711; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Jerala R, 2004, CURR TOP MED CHEM, V4, P1173, DOI 10.2174/1568026043388079; Kondejewski LH, 1999, J BIOL CHEM, V274, P13181, DOI 10.1074/jbc.274.19.13181; Lai AL, 2007, J BIOL CHEM, V282, P23946, DOI 10.1074/jbc.M704008200; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; Mares J, 2009, J BIOL CHEM, V284, P11498, DOI 10.1074/jbc.M806587200; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mueller M, 2004, J BIOL CHEM, V279, P26307, DOI 10.1074/jbc.M401231200; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; Pristovsek P, 2005, J MED CHEM, V48, P1666, DOI 10.1021/jm049217k; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; RUSTICI A, 1993, SCIENCE, V259, P361, DOI 10.1126/science.8420003; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Srimal S, 1996, BIOCHEM J, V315, P679, DOI 10.1042/bj3150679; STRAIN SM, 1983, J BIOL CHEM, V258, P3466; Tack BF, 2002, EUR J BIOCHEM, V269, P1181, DOI 10.1046/j.0014-2956.2002.02751.x; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Wang W, 2008, ANGEW CHEM INT EDIT, V47, P9870, DOI 10.1002/anie.200803474; WUTHRICH K, 1986, NMR PROTEINS NUC ACI; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; Zhang LJ, 2000, BIOCHEMISTRY-US, V39, P14504, DOI 10.1021/bi0011173; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	73	90	90	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21991	22004		10.1074/jbc.M109.013573	http://dx.doi.org/10.1074/jbc.M109.013573			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520860	Green Published, hybrid			2022-12-27	WOS:000268783700023
J	Faye, C; Chautard, E; Olsen, BR; Ricard-Blum, S				Faye, Clement; Chautard, Emilie; Olsen, Bjorn R.; Ricard-Blum, Sylvie			The First Draft of the Endostatin Interaction Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOGENESIS INHIBITOR ENDOSTATIN; HEPARIN/HEPARAN SULFATE BINDING; A-BETA TOXICITY; ALZHEIMERS-DISEASE; COLLAGEN-XVIII; TISSUE TRANSGLUTAMINASE; MATRICELLULAR PROTEINS; EXTRACELLULAR-MATRIX; FIBRIL FORMATION; HEPARAN-SULFATE	Endostatin is a C-terminal proteolytic fragment of collagen XVIII that is localized in vascular basement membrane zones in various organs. It binds to heparin/heparan sulfate and to a number of proteins, but its molecular mechanisms of action are not fully elucidated. We have used surface plasmon resonance (SPR) arrays to identify new partners of endostatin, and to give further insights on its molecular mechanism of action. New partners of endostatin include glycosaminoglycans (chondroitin and dermatan sulfate), matricellular proteins (thrombospondin-1 and SPARC), collagens (I, IV, and VI), the amyloid peptide A beta-(1-42), and transglutaminase-2. The biological functions of the endostatin network involve a number of extracellular proteins containing epidermal growth factor and epidermal growth factor-like domains, and able to bind calcium. Depending on the trigger event, and on the availability of its members in a given tissue at a given time, the endostatin network might be involved either in the control of angiogenesis, and tumor growth, or in neurogenesis and neurodegenerative diseases.	[Faye, Clement; Chautard, Emilie; Ricard-Blum, Sylvie] Univ Lyon 1, CNRS, IFR Biosci Gerland Lyon Sud 128, Inst Biol & Chim Prot,UMR 5086, F-69367 Lyon 07, France; [Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Olsen, Bjorn R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School	Ricard-Blum, S (corresponding author), Univ Lyon 1, CNRS, IFR Biosci Gerland Lyon Sud 128, Inst Biol & Chim Prot,UMR 5086, 7 Passage Vercors, F-69367 Lyon 07, France.	s.ricard-blum@ibcp.fr	Chautard, Emilie/C-7836-2011	Chautard, Emilie/0000-0003-1456-5347; RICARD-BLUM, Sylvie/0000-0001-9263-1851	National Institutes of Health [36820]; Association pour la Recherche contre le Cancer [3652]; INSERM [A04115SP]; CPER Rhone-Alpes; Institut Rhone-Alpin des Systemes Complexes; Emergence Research Program Region Rhone-Alpes; University Lyon-1	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CPER Rhone-Alpes(Region Auvergne-Rhone-Alpes); Institut Rhone-Alpin des Systemes Complexes; Emergence Research Program Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); University Lyon-1	This work was supported, in whole or in part, by National Institutes of Health Grant 36820 (to B.O.). This work was also supported by Association pour la Recherche contre le Cancer Grant 3652 (to S. R. B.), GIS Maladies Rares INSERM Grant A04115SP (to S. R. B.), grants from the CPER Rhone-Alpes (to C. F., E. C., and S. R. B.), Institut Rhone-Alpin des Systemes Complexes (to C. F., E. C., and S. R. B.), the Emergence Research Program Region Rhone-Alpes (to S. R. B.), and a Bonus Qualite Recherche grant from the University Lyon-1 (to S. R. B.).	Abdollahi A, 2003, CANCER RES, V63, P8890; Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bix G, 2008, MICROSC RES TECHNIQ, V71, P339, DOI 10.1002/jemt.20562; Bocci G, 2003, P NATL ACAD SCI USA, V100, P12917, DOI 10.1073/pnas.2135406100; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; BUEE L, 1992, AM J PATHOL, V141, P783; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Cao Y, 2008, ADV CANCER RES, V100, P113, DOI 10.1016/S0065-230X(08)00004-3; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Celik I, 2005, CANCER RES, V65, P11044, DOI 10.1158/0008-5472.CAN-05-2617; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Chlenski A, 2006, INT J CANCER, V118, P310, DOI 10.1002/ijc.21357; Chlenski A, 2002, CANCER RES, V62, P7357; Dardik R, 2006, EXP CELL RES, V312, P2973, DOI 10.1016/j.yexcr.2006.05.019; Deininger MH, 2002, J NEUROSCI, V22, P10621; Digtyar AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P235, DOI 10.1134/S0006297907030017; DURBIN R, 1994, COMPUTATIONAL METHODS IN GENOME RESEARCH, P45; FAYE C, 2009, J BIOL CHEM IN PRESS; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Javaherian K, 2002, J BIOL CHEM, V277, P45211, DOI 10.1074/jbc.M206358200; Karumanchi SA, 2001, MOL CELL, V7, P811, DOI 10.1016/S1097-2765(01)00225-8; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Kiuchi Y, 2002, LIFE SCI, V70, P1555, DOI 10.1016/S0024-3205(01)01528-4; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Li CY, 2005, BIOCHEM BIOPH RES CO, V329, P873, DOI 10.1016/j.bbrc.2005.02.055; Lourenco GJ, 2006, BREAST CANCER RES TR, V100, P335, DOI 10.1007/s10549-006-9259-z; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; Miosge N, 1999, FASEB J, V13, P1743, DOI 10.1096/fasebj.13.13.1743; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Morgan C, 2002, PEPTIDES, V23, P1229, DOI 10.1016/S0196-9781(02)00058-X; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Osada Y, 2005, J BIOL CHEM, V280, P8596, DOI 10.1074/jbc.M413340200; Pufe T, 2004, MATRIX BIOL, V23, P267, DOI 10.1016/j.matbio.2004.06.003; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Ricard-Blum S, 2006, ANAL BIOCHEM, V352, P252, DOI 10.1016/j.ab.2006.02.011; Ricard-Blum S, 2006, J BIOL CHEM, V281, P25195, DOI 10.1074/jbc.M603096200; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Sasaki T, 1999, EMBO J, V18, P6240, DOI 10.1093/emboj/18.22.6240; Schmidt A, 2004, DEV DYNAM, V230, P468, DOI 10.1002/dvdy.20072; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIJN RMT, 2006, CANCER GENE THER, V13, P619; St Croix B, 2000, SCIENCE, V289, P1197; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang DS, 2008, INT J CLIN EXP PATHO, V1, P5; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414	57	70	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22041	22047		10.1074/jbc.M109.002964	http://dx.doi.org/10.1074/jbc.M109.002964			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542224	Green Published, hybrid			2022-12-27	WOS:000268783700028
J	Sung, I; Kwak, JH; Na, HJ; Kim, JK; Ding, Y; Choi, ME				Kim, Sung Il; Kwak, Joon Hyeok; Na, Hee-Jun; Kim, Jin Kuk; Ding, Yan; Choi, Mary E.			Transforming Growth Factor-beta (TGF-beta 1) Activates TAK1 via TAB1-mediated Autophosphorylation, Independent of TGF-beta Receptor Kinase Activity in Mesangial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; IL-1 SIGNALING PATHWAY; KAPPA-B; FIBRONECTIN SYNTHESIS; EPITHELIAL-CELLS; GENE-EXPRESSION; SMAD PROTEINS; JNK PATHWAY; I RECEPTOR; P38 MAPK	Transforming growth factor-beta 1 (TGF-beta 1) is a multifunctional cytokine that signals through the interaction of type I (T beta RI) and type II (T beta RII) receptors to activate distinct intracellular pathways. TAK1 is a serine/threonine kinase that is rapidly activated by TGF-beta 1. However, the molecular mechanism of TAK1 activation is incompletely understood. Here, we propose a mechanism whereby TAK1 is activated by TGF-beta 1 in primary mouse mesangial cells. Under unstimulated conditions, endogenous TAK1 is stably associated with T beta RI. TGF-beta 1 stimulation causes rapid dissociation from the receptor and induces TAK1 phosphorylation. Deletion mutant analysis indicates that the juxtamembrane region including the GS domain of T beta RI is crucial for its interaction with TAK1. Both T beta RI-mediated TAK1 phosphorylation and TGF-beta 1-induced TAK1 phosphorylation do not require kinase activity of T beta RI. Moreover, T beta RI-mediated TAK1 phosphorylation correlates with the degree of its association with T beta RI and requires kinase activity of TAK1. TAB1 does not interact with TGF-beta receptors, but TAB1 is indispensable for TGF-beta 1-induced TAK1 activation. We also show that TRAF6 and TAB2 are required for the interaction of TAK1 with T beta RI and TGF-beta 1-induced TAK1 activation in mouse mesangial cells. Taken together, our data indicate that TGF-beta 1-induced interaction of T beta RI and T beta RII triggers dissociation of TAK1 from T beta RI, and subsequently TAK1 is phosphorylated through TAB1-mediated autophosphorylation and not by the receptor kinase activity of T beta RI.	[Kim, Sung Il; Kwak, Joon Hyeok; Na, Hee-Jun; Kim, Jin Kuk; Ding, Yan; Choi, Mary E.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Renal Div, Boston, MA 02115 USA; [Kim, Jin Kuk] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon 420767, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Soonchunhyang University	Choi, ME (corresponding author), Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Renal Div, 4 Blackfan Circle,HIM 5, Boston, MA 02115 USA.	mchoi@rics.bwh.harvard.edu			National Institutes of Health [R01DK57661]; American Society of Nephrology; American Heart Association [0665379U]; National Kidney Foundation of the Alleghenies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; American Heart Association(American Heart Association); National Kidney Foundation of the Alleghenies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK57661 (NIDDK). This work was also supported by an M. James Scherbenske grant from the American Society of Nephrology (to M. E. C.) and Beginning Grant-in-Aid 0665379U from the American Heart Association and the National Kidney Foundation of the Alleghenies (to S. I. K.).	Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Cheng JF, 2002, EXP BIOL MED, V227, P943, DOI 10.1177/153537020222701102; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Choi ME, 1999, AM J PHYSIOL-RENAL, V276, pF88, DOI 10.1152/ajprenal.1999.276.1.F88; Choo MK, 2006, MOL CANCER THER, V5, P2970, DOI 10.1158/1535-7163.MCT-06-0379; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hocevar BA, 2005, J BIOL CHEM, V280, P25920, DOI 10.1074/jbc.M501150200; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hoffmann A, 2005, J BIOL CHEM, V280, P27271, DOI 10.1074/jbc.M503368200; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kim SI, 2008, J BIOL CHEM, V283, P10753, DOI 10.1074/jbc.M801263200; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mucsi I, 1996, J BIOL CHEM, V271, P16567, DOI 10.1074/jbc.271.28.16567; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Ono K, 2003, BIOCHEM BIOPH RES CO, V307, P332, DOI 10.1016/S0006-291X(03)01207-5; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Terada Y, 1999, KIDNEY INT, V56, P1378, DOI 10.1046/j.1523-1755.1999.00665.x; Thiefes A, 2005, J BIOL CHEM, V280, P27728, DOI 10.1074/jbc.M411657200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Watkins SJ, 2006, CARDIOVASC RES, V69, P432, DOI 10.1016/j.cardiores.2005.11.007; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133	71	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22285	22296		10.1074/jbc.M109.007146	http://dx.doi.org/10.1074/jbc.M109.007146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19556242	hybrid, Green Published			2022-12-27	WOS:000268783700052
J	Sauve, V; Roversi, P; Leath, KJ; Garman, EF; Antrobus, R; Lea, SM; Berks, BC				Sauve, Veronique; Roversi, Pietro; Leath, Kirstin J.; Garman, Elspeth F.; Antrobus, Robin; Lea, Susan M.; Berks, Ben C.			Mechanism for the Hydrolysis of a Sulfur-Sulfur Bond Based on the Crystal Structure of the Thiosulfohydrolase SoxB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI 5'-NUCLEOTIDASE; PARACOCCUS-PANTOTROPHUS GB17; BENDING DOMAIN ROTATION; GLYOXALASE-II; THIOBACILLUS-ACIDOPHILUS; TETRATHIONATE HYDROLASE; 3-DIMENSIONAL STRUCTURE; OXIDIZING BACTERIA; ENZYME-SYSTEM; GENE-CLUSTER	SoxB is an essential component of the bacterial Sox sulfur oxidation pathway. SoxB contains a di-manganese(II) site and is proposed to catalyze the release of sulfate from a protein-bound cysteine S-thiosulfonate. A direct assay for SoxB activity is described. The structure of recombinant Thermus thermophilus SoxB was determined by x-ray crystallography to a resolution of 1.5 angstrom. Structures were also determined for SoxB in complex with the substrate analogue thiosulfate and in complex with the product sulfate. A mechanistic model for SoxB is proposed based on these structures.	[Roversi, Pietro; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	susan.lea@path.ox.ac.uk; ben.berks@bioch.ox.ac.uk	Roversi, Pietro/F-8925-2011; Roversi, Pietro/AAK-4241-2021; Lea, Susan M/B-7678-2009	Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437; Lea, Susan M/0000-0001-9287-8053; Berks, Ben/0000-0001-9685-4067; Garman, Elspeth/0000-0001-8329-5665	Biotechnology and Biological Sciences Research Council [P15195]; Medical Research Council [G0400775]; Engineering and Physical Sciences Research Council [EP/D032210/1] Funding Source: researchfish; EPSRC [EP/D032210/1] Funding Source: UKRI; MRC [G0400775] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant P15195 and Medical Research Council Grant G0400775.	Antonyuk SV, 2000, CRYSTALLOGR REP+, V45, P105, DOI 10.1134/1.171145; APOSTOL I, 1995, PROTEIN SCI, V4, P2616, DOI 10.1002/pro.5560041219; Appia-Ayme C, 2001, J BACTERIOL, V183, P6107, DOI 10.1128/JB.183.20.6107-6118.2001; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Beller HR, 2006, J BACTERIOL, V188, P1473, DOI 10.1128/JB.188.4.1473-1488.2006; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; *BRUK AXS INC, 2000, SMART SAINT SADABS X; BUILDER S, 1998, Patent No. 5808006; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; CAMMACK R, 1989, FEBS LETT, V253, P239, DOI 10.1016/0014-5793(89)80967-6; CHEARY RW, 1996, CCP4 POWDER DIFFRACT; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Dahl C., 2007, MICROBIAL SULFUR MET; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; DeJong GAH, 1997, EUR J BIOCHEM, V243, P678; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Di Costanzo L, 2005, P NATL ACAD SCI USA, V102, P13058, DOI 10.1073/pnas.0504027102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epel B, 2005, J BIOL INORG CHEM, V10, P636, DOI 10.1007/s00775-005-0015-3; Fan QR, 2000, J BIOL CHEM, V275, P23700, DOI 10.1074/jbc.M003318200; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; Garman E, 1999, STRUCT FOLD DES, V7, pR291, DOI 10.1016/S0969-2126(00)88335-5; Garman EF, 2005, PROG BIOPHYS MOL BIO, V89, P173, DOI 10.1016/j.pbiomolbio.2004.09.005; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GRIME GW, 1991, NUCL INSTRUM METH B, V54, P52, DOI 10.1016/0168-583X(91)95490-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Johansson S. A. E., 1995, PARTICLE INDUCED XRA; Kanao T, 2007, J BIOTECHNOL, V132, P16, DOI 10.1016/j.jbiotec.2007.08.030; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Knofel T, 2001, J MOL BIOL, V309, P255, DOI 10.1006/jmbi.2001.4657; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lengeler J. W., 1999, BIOL PROKARYOTES; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; Liu DL, 2005, P NATL ACAD SCI USA, V102, P11882, DOI 10.1073/pnas.0505255102; LU WP, 1983, J GEN MICROBIOL, V129, P3549; Marasinghe GPK, 2005, J BIOL CHEM, V280, P40668, DOI 10.1074/jbc.M509748200; McMillen L, 2003, BIOCHEM J, V372, P625, DOI 10.1042/BJ20021800; MEULENBERG R, 1992, EUR J BIOCHEM, V209, P367, DOI 10.1111/j.1432-1033.1992.tb17298.x; Meyer B, 2007, ENVIRON MICROBIOL, V9, P2957, DOI 10.1111/j.1462-2920.2007.01407.x; Mukhopadhyaya PN, 2000, J BACTERIOL, V182, P4278, DOI 10.1128/JB.182.15.4278-4287.2000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogawa T, 2008, J BACTERIOL, V190, P6097, DOI 10.1128/JB.00634-08; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petri R, 2001, FEMS MICROBIOL LETT, V197, P171, DOI 10.1111/j.1574-6968.2001.tb10600.x; Quentmeier A, 2001, FEBS LETT, V503, P168, DOI 10.1016/S0014-5793(01)02727-2; Rother D, 2001, J BACTERIOL, V183, P4499, DOI 10.1128/JB.183.15.4499-4508.2001; Rzhepishevska OI, 2007, APPL ENVIRON MICROB, V73, P7367, DOI 10.1128/AEM.01497-07; Sambrook J, 2001, MOL CLONING LAB MANU; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Schilling O, 2003, BIOCHEMISTRY-US, V42, P11777, DOI 10.1021/bi034672o; Schultz-Heienbrok R, 2005, BIOCHEMISTRY-US, V44, P2244, DOI 10.1021/bi047989c; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Williams RJP, 2000, COORDIN CHEM REV, V200, P247, DOI 10.1016/S0010-8545(00)00324-6; Winn MD, 2002, ACTA CRYSTALLOGR D, V58, P1929, DOI 10.1107/S0907444902016116; Wodara C, 1997, J BACTERIOL, V179, P5014, DOI 10.1128/jb.179.16.5014-5023.1997	64	27	27	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21707	21718		10.1074/jbc.M109.002709	http://dx.doi.org/10.1074/jbc.M109.002709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535341	hybrid, Green Published			2022-12-27	WOS:000268564400063
J	Sy, SMH; Huen, MSY; Chen, JJ				Sy, Shirley M. -H.; Huen, Michael S. Y.; Chen, Junjie			MRG15 Is a Novel PALB2-interacting Factor Involved in Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMO DOMAIN; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLATION; DNA-DAMAGE; REPAIR; BRCA2; PALB2; CONSERVATION; PARTNER; DIRECTS	PALB2 is an integral component of the BRCA complex important for recombinational DNA repair. However, exactly how this activity is regulated in vivo remains unexplored. Here we provide evidence to show that MRG15 is a novel PALB2-associated protein that ensures regulated recombination events. We found that the direct interaction between MRG15 and PALB2 is mediated by an evolutionarily conserved region on PALB2. Intriguingly, although damage-induced RAD51 foci formation and mitomycin C sensitivity appeared normal in MRG15-binding defective PALB2 mutants, these cells exhibited a significant increase in gene conversion rates. Consistently, we found that abrogation of the PALB2-MRG15 interaction resulted in elevated sister chromatid exchange frequencies. Our results suggest that loss of the PALB2-MRG15 interaction relieved the cells with the suppression of sister chromatid exchange and therefore led to a hyper-recombination phenotype in the gene conversion assay. Together, our study indicated that although PALB2 is required for proficient homologous recombination, it could also govern the choice of templates used in homologous recombination repair.	[Sy, Shirley M. -H.; Huen, Michael S. Y.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd,Unit 66,Rm Y3-6006, Houston, TX 77030 USA.	jchen8@mdanderson.org	Huen, Michael Shing Yan/E-9862-2010	Sy, Ming Hui/0000-0002-2731-6692	National Institutes of Health [CA089239, CA092312, CA100109]; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA089239, R01CA100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312 and CA100109 (to J.C.).	Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bertram MJ, 2001, GENE, V266, P111, DOI 10.1016/S0378-1119(01)00372-9; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Garcia SN, 2007, FEBS LETT, V581, P5275, DOI 10.1016/j.febslet.2007.10.017; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Sy SMH, 2009, J BIOL CHEM, V284, P18302, DOI 10.1074/jbc.M109.016717; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	19	54	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21127	21131		10.1074/jbc.C109.023937	http://dx.doi.org/10.1074/jbc.C109.023937			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19553677	Green Published, hybrid			2022-12-27	WOS:000268564400005
J	Noubhani, A; Bunoust, O; Bonini, BM; Thevelein, JM; Devin, A; Rigoulet, M				Noubhani, Abdelmajid; Bunoust, Odile; Bonini, Beatriz Monge; Thevelein, Johan M.; Devin, Anne; Rigoulet, Michel			The Trehalose Pathway Regulates Mitochondrial Respiratory Chain Content through Hexokinase 2 and cAMP in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TREHALOSE-6-PHOSPHATE SYNTHASE; OXIDATIVE-PHOSPHORYLATION; GLYCOLYTIC-ENZYMES; MOLECULAR-CLONING; GROWTH DEFECT; WILD-TYPE; YEAST; GLUCOSE; GENE	In yeast, trehalose is synthesized by a multimeric enzymatic complex: TPS1 encodes trehalose 6-phosphate synthase, which belongs to a complex that is composed of at least three other subunits, including trehalose 6-phosphate phosphatase Tps2 and the redundant regulatory subunits Tps3 and Tsl1. The product of the TPS1 gene plays an essential role in the control of the glycolytic pathway by restricting the influx of glucose into glycolysis. In this paper, we investigated whether the trehalose synthesis pathway could be involved in the control of the other energy-generating pathway: oxidative phosphorylation. We show that the different mutants of the trehalose synthesis pathway (tps1 Delta, tps2 Delta, and tps1,2 Delta) exhibit modulation in the amount of respiratory chains, in terms of cytochrome content and maximal respiratory activity. Furthermore, these variations in mitochondrial enzymatic content are positively linked to the intracellular concentration in cAMP that is modulated by Tps1p through hexokinase2. This is the first time that a pathway involved in sugar storage, i.e. trehalose, is shown to regulate the mitochondrial enzymatic content.	[Noubhani, Abdelmajid; Bunoust, Odile; Devin, Anne; Rigoulet, Michel] CNRS, UMR5095, Inst Biochim & Genet Cellulaire, F-33077 Bordeaux, France; [Noubhani, Abdelmajid; Bunoust, Odile; Devin, Anne; Rigoulet, Michel] Univ Bordeaux 2, F-33076 Bordeaux, France; [Bonini, Beatriz Monge; Thevelein, Johan M.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Flanders, Belgium; [Bonini, Beatriz Monge; Thevelein, Johan M.] VIB, Dept Mol Microbiol, B-3001 Louvain, Flanders, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; KU Leuven; Flanders Institute for Biotechnology (VIB)	Rigoulet, M (corresponding author), CNRS, UMR5095, Inst Biochim & Genet Cellulaire, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	Michel.Rigoulet@ibgc.u-bordeaux2.fr	Thevelein, Johan M./AAK-4203-2021; Thevelein, Johan M./A-7897-2013	Thevelein, Johan M./0000-0002-2626-0180	Agence Nationale pour la Recherche [05-BLAN-0339-01]; Conseil Regional d'Aquitaine	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This work was supported by Agence Nationale pour la Recherche 05-BLAN-0339-01 and the Conseil Regional d'Aquitaine.	BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x; Bell W, 1998, J BIOL CHEM, V273, P33311, DOI 10.1074/jbc.273.50.33311; BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; BLAZQUEZ MA, 1994, CURR GENET, V25, P89, DOI 10.1007/BF00309531; Bonini BM, 2003, BBA-BIOENERGETICS, V1606, P83, DOI 10.1016/S0005-2728(03)00086-0; BoyMarcotte E, 1996, MICROBIOL-UK, V142, P459, DOI 10.1099/13500872-142-3-459; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Dejean L, 2002, BBA-BIOENERGETICS, V1554, P159, DOI 10.1016/S0005-2728(02)00240-2; Dejean L, 2002, BIOCHEM BIOPH RES CO, V293, P1383, DOI 10.1016/S0006-291X(02)00391-1; Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200; DEVIRGILIO C, 1993, EUR J BIOCHEM, V212, P315; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; ESTEVEZ AM, 1995, FEBS LETT, V374, P100, DOI 10.1016/0014-5793(95)01085-S; Gancedo C., 1989, YEASTS, V3, P205; GONZALEZ MI, 1992, YEAST, V8, P183, DOI 10.1002/yea.320080304; HOHMANN S, 1993, CURR GENET, V23, P281, DOI 10.1007/BF00310888; Hohmann S, 1996, MOL MICROBIOL, V20, P981, DOI 10.1111/j.1365-2958.1996.tb02539.x; Larsson C, 1997, J BACTERIOL, V179, P7243, DOI 10.1128/jb.179.23.7243-7250.1997; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; NAVAS MA, 1993, P NATL ACAD SCI USA, V90, P1290, DOI 10.1073/pnas.90.4.1290; NAVON G, 1979, BIOCHEMISTRY-US, V18, P4487, DOI 10.1021/bi00588a006; Noubhani A, 2000, EUR J BIOCHEM, V267, P4566, DOI 10.1046/j.1432-1327.2000.01511.x; ONISHI T, 1967, EUR J BIOCHEM, V1, P301, DOI 10.1111/j.1432-1033.1967.tb00074.x; Portela P, 2003, FEMS YEAST RES, V3, P119, DOI 10.1111/j.1567-1364.2003.tb00147.x; Rossell S, 2005, FEMS YEAST RES, V5, P611, DOI 10.1016/j.femsyr.2004.11.003; SCHAAFF I, 1989, YEAST, V5, P285, DOI 10.1002/yea.320050408; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; THEVELEIN JM, 1987, J GEN MICROBIOL, V133, P2191; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Van Vaeck C, 2001, BIOCHEM J, V353, P157; VANAELST L, 1993, MOL MICROBIOL, V8, P927; VANAELST L, 1991, EMBO J, V10, P2095, DOI 10.1002/j.1460-2075.1991.tb07742.x; VANNESTE WH, 1966, BIOCHEMISTRY-US, V5, P838, DOI 10.1021/bi00867a005; VUORIO OE, 1993, EUR J BIOCHEM, V216, P849, DOI 10.1111/j.1432-1033.1993.tb18207.x	38	23	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27229	27234		10.1074/jbc.M109.029454	http://dx.doi.org/10.1074/jbc.M109.029454			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19620241	Green Published, hybrid			2022-12-27	WOS:000270232300023
J	Fuchs, P; Zorer, M; Reipert, S; Rezniczek, GA; Propst, F; Walko, G; Fischer, I; Bauer, J; Leschnik, MW; Luscher, B; Thalhammer, JG; Lassmann, H; Wiche, G				Fuchs, Peter; Zoerer, Michael; Reipert, Siegfried; Rezniczek, Guenther A.; Propst, Friedrich; Walko, Gernot; Fischer, Irmgard; Bauer, Jan; Leschnik, Michael W.; Luescher, Bernhard; Thalhammer, Johann G.; Lassmann, Hans; Wiche, Gerhard			Targeted Inactivation of a Developmentally Regulated Neural Plectin Isoform (Plectin 1c) in Mice Leads to Reduced Motor Nerve Conduction Velocity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTONIA-MUSCULORUM MICE; NEUROLOGIC DEGENERATION; EPIDERMOLYSIS-BULLOSA; STRATIFIED EPITHELIA; LINKER PROTEIN; GENE; SYSTEM; EXPRESSION; CYTOSKELETON; ACTIN	Cytolinker proteins stabilize cells mechanically, regulate cytoskeleton dynamics, and provide scaffolds for signaling molecules. For plectin, the prototype of these proteins, an unusual diversity of isoforms has been reported, which show distinct expression patterns, subcellular localizations, and functions. Plectin has been shown to have important functions in skin and muscle, but little is known about its role in neural cells. To address this issue, we generated two knock-out mouse lines, one which was selectively lacking plectin 1c (P1c), the major isoform expressed in neural cells, and another in which plectin was conditionally deleted in neuronal precursor cells. Using isoform-specific antibodies, we found P1c to be expressed late in development and to associate with postsynaptic dendrites of central nervous system neurons, motorneurons of spinal cord, sciatic nerve axons, and Schwann cells. Motor nerve conduction velocity was found significantly reduced in sciatic nerve from P1c-deficient as well as from conditional knock-out mice. This defect was traceable to an increased number of motor nerve fibers with small cross-sectional areas; the thicknesses of axons and of myelin sheaths were unaffected. This is the first report demonstrating an important role of plectin in a major nerve function.	[Fuchs, Peter; Zoerer, Michael; Reipert, Siegfried; Rezniczek, Guenther A.; Propst, Friedrich; Walko, Gernot; Fischer, Irmgard; Wiche, Gerhard] Univ Vienna, Max F Perutz Labs, Dept Biochem & Cell Biol, A-1030 Vienna, Austria; [Bauer, Jan; Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Dept Neuroimmunol, A-1090 Vienna, Austria; [Leschnik, Michael W.; Thalhammer, Johann G.] Univ Vet Med Vienna, Clin Internal Med & Infect Dis, A-1210 Vienna, Austria; [Luescher, Bernhard] Rhein Westfael TH Aachen Univ, Fac Med, Div Biochem & Mol Biol, D-52074 Aachen, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Veterinary Medicine Vienna; RWTH Aachen University	Wiche, G (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Biochem & Cell Biol, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	gerhard.wiche@univie.ac.at	Lassmann, Hans/Z-2269-2019; WICHE, Gerhard/AAA-3227-2021; Rezniczek, Günther/A-1493-2014; Bauer, Jan/F-5429-2011; Rezniczek, Günther/Q-9318-2016; Rezniczek, Günther/AAO-2963-2020; Reipert, Siegfried/A-4406-2014; Luscher, Bernhard/A-7330-2011	Lassmann, Hans/0000-0001-8617-5052; Rezniczek, Günther/0000-0002-0852-6002; Bauer, Jan/0000-0001-5802-8047; Rezniczek, Günther/0000-0002-0852-6002; Rezniczek, Günther/0000-0002-0852-6002; Wiche, Gerhard/0000-0001-9550-5463; Fuchs, Peter/0000-0003-3933-7674; Reipert, Siegfried/0000-0002-2043-3562; Luscher, Bernhard/0000-0002-9622-8709; Walko, Gernot/0000-0002-8504-1738	Austrian Science Research Fund [SFB 006/611, P17862-B09, P20744-B11]	Austrian Science Research Fund(Austrian Science Fund (FWF))	This work was supported by Austrian Science Research Fund Grants SFB 006/611, P17862-B09, and P20744-B11.	Abrahamsberg C, 2005, P NATL ACAD SCI USA, V102, P18449, DOI 10.1073/pnas.0505380102; Ackerl R, 2007, J CELL SCI, V120, P2435, DOI 10.1242/jcs.004481; Andra K, 2003, J INVEST DERMATOL, V120, P189, DOI 10.1046/j.1523-1747.2003.12027.x; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; Bernier G, 1995, MOL CELL NEUROSCI, V6, P509, DOI 10.1006/mcne.1995.0003; Bernier G, 1998, DEVELOPMENT, V125, P2135; Bernier G, 2000, DEV DYNAM, V219, P216, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1041>3.0.CO;2-O; Bernier G, 1998, DEV GENET, V22, P160, DOI 10.1002/(SICI)1520-6408(1998)22:2<160::AID-DVG5>3.0.CO;2-4; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; Dowling J, 1997, DEV BIOL, V187, P131, DOI 10.1006/dbio.1997.8567; Duchen L W, 1976, Adv Neurol, V14, P353; Elliott CE, 1997, GENOMICS, V42, P115, DOI 10.1006/geno.1997.4724; ERRANTE LD, 1994, J NEUROSCI RES, V37, P515, DOI 10.1002/jnr.490370411; FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; Fuchs P, 2005, CELL MOL NEUROBIOL, V25, P1141, DOI 10.1007/s10571-005-7826-1; Giorda R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012260; Gregor M, 2006, J CELL SCI, V119, P1864, DOI 10.1242/jcs.02891; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HERRMANN H, 1987, J BIOL CHEM, V262, P1320; Hogan B, 1994, MANIPULATING MOUSE E; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Kriz J, 2000, BRAIN RES, V885, P32, DOI 10.1016/S0006-8993(00)02899-7; Lesniewicz K, 2005, GENOMICS, V86, P38, DOI 10.1016/j.ygeno.2005.03.009; Lie AA, 1998, ACTA NEUROPATHOL, V96, P215, DOI 10.1007/s004010050885; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Osmanagic-Myers S, 2004, J BIOL CHEM, V279, P18701, DOI 10.1074/jbc.M312382200; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Pfendner E, 2005, EXP DERMATOL, V14, P241, DOI 10.1111/j.0906-6705.2005.00324.x; Rao MV, 2002, J CELL BIOL, V158, P681, DOI 10.1083/jcb.200202037; Rezniczek GA, 2004, METHOD CELL BIOL, V78, P721; Rezniczek GA, 2003, HUM MOL GENET, V12, P3181, DOI 10.1093/hmg/ddg345; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Takei Y, 1997, J CELL BIOL, V137, P1615, DOI 10.1083/jcb.137.7.1615; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Waikar SS, 1996, BRAIN RES, V721, P91, DOI 10.1016/0006-8993(96)00165-5; WICHE G, 1982, EXP CELL RES, V138, P15, DOI 10.1016/0014-4827(82)90086-6; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5	49	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26502	26509		10.1074/jbc.M109.018150	http://dx.doi.org/10.1074/jbc.M109.018150			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19625254	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000269969600031
J	Tamehiro, N; Mujawar, Z; Zhou, SP; Zhuang, DZ; Hornemann, T; von Eckardstein, A; Fitzgerald, ML				Tamehiro, Norimasa; Mujawar, Zahedi; Zhou, Suiping; Zhuang, Debbie Z.; Hornemann, Thorsten; von Eckardstein, Arnold; Fitzgerald, Michael L.			Cell Polarity Factor Par3 Binds SPTLC1 and Modulates Monocyte Serine Palmitoyltransferase Activity and Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; APOE-DEFICIENT MICE; E-KNOCKOUT MICE; CHOLESTEROL EFFLUX; SPHINGOLIPID METABOLISM; SPHINGOMYELIN SYNTHESIS; PERMEABILITY BARRIER; PLASMA SPHINGOMYELIN; INHIBITOR MYRIOCIN; ATHEROSCLEROSIS	Elevated sphingolipids have been associated with increased cardiovascular disease. Conversely, atherosclerosis is reduced in mice by blocking de novo synthesis of sphingolipids catalyzed by serine palmitoyltransferase (SPT). The SPT enzyme is composed of the SPTLC1 and -2 subunits, and here we describe a novel protein-protein interaction between SPTLC1 and the PDZ protein Par3 (partitioning defective protein 3). Mammalian SPTLC1 orthologs have a highly conserved C terminus that conforms to a type II PDZ protein interaction motif, and by screening PDZ domain protein arrays with an SPTLC1 C-terminal peptide, we found it bound the third PDZ domain of Par3. Overlay and immuno-precipitation assays confirmed this interaction and indicate Par3 is able to associate with the SPTLC1/2 holoenzyme by binding the C-terminal SPTLC1 PDZ motif. The physiologic existence of the SPTLC1/2-Par3 complex was detected in mouse liver and macrophages, and short interfering RNA inhibition of Par3 in human THP-1 monocytes significantly reduced SPT activity and de novo ceramide synthesis by nearly 40%. Given monocyte recruitment into inflamed vessels is thought to promote atherosclerosis, and because Par3 and sphingolipids have been associated with polarized cell migration, we tested whether the ability of THP-1 monocytes to migrate toward MCP- 1 (monocyte chemoattractant protein 1) depended upon Par3 and SPTLC1 expression. Knockdown of Par3 significantly reduced MCP1-induced chemotaxis of THP-1 monocytes, as did knockdown of SPTLC1, and this Par3 effect depended upon SPT activity and was blunted by ceramide treatment. In conclusion, protein arrays were used to identify a novel SPTLC1-Par3 interaction that associates with increased monocyte serine palmitoyltransferase activity and chemotaxis toward inflammatory signals.	[Fitzgerald, Michael L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit,Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Hornemann, Thorsten; von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Zurich; University Zurich Hospital	Fitzgerald, ML (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit,Ctr Computat & Integrat Biol, 185 Cambridge St, Boston, MA 02114 USA.	mfitzgerald@ccib.mgh.harvard.edu			NHLBI [HL074136]; American Heart Association [09GRNT2260352]; Uehara Memorial Foundation; Nagai Foundation of Tokyo; Japan Heart Foundation; American Heart Association; Massachusetts Biomedical Research Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074136] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Uehara Memorial Foundation(Uehara Memorial Foundation); Nagai Foundation of Tokyo; Japan Heart Foundation; American Heart Association(American Heart Association); Massachusetts Biomedical Research Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by National Institutes of Health Grant HL074136 from NHLBI (to M.L.F.). This work was also supported by an American Heart Association Grant-in-Aid 09GRNT2260352 to M.L.F.) and by fellowship training grants from the Uehara Memorial Foundation, the Nagai Foundation of Tokyo, and the Japan Heart Foundation (to N.T.), the American Heart Association (to Z.M.), and the Massachusetts Biomedical Research Corporation (to S.Z.).	Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; Fitzgerald ML, 2004, J BIOL CHEM, V279, P48477, DOI 10.1074/jbc.M409848200; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Glaros EN, 2008, J LIPID RES, V49, P1677, DOI 10.1194/jlr.E800005-JLR200; Glaros EN, 2007, BIOCHEM PHARMACOL, V73, P1340, DOI 10.1016/j.bcp.2006.12.023; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Herget T, 2000, J BIOL CHEM, V275, P30344, DOI 10.1074/jbc.M000714200; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jeong TS, 1998, J CLIN INVEST, V101, P905, DOI 10.1172/JCI870; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Krishnamurthy K, 2007, J BIOL CHEM, V282, P3379, DOI 10.1074/jbc.M607779200; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Park TS, 2008, PHARMACOL RES, V58, P45, DOI 10.1016/j.phrs.2008.06.005; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Stevenson NJ, 2004, J IMMUNOL, V173, P3243, DOI 10.4049/jimmunol.173.5.3243; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tamehiro N, 2008, BIOCHEMISTRY-US, V47, P6138, DOI 10.1021/bi800182t; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang G, 2008, J NEUROCHEM, V106, P718, DOI 10.1111/j.1471-4159.2008.05451.x; Wei J, 2009, BBA-MOL CELL BIOL L, V1791, P746, DOI 10.1016/j.bbalip.2009.03.016; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922; Zuo Y, 2008, J BIOL CHEM, V283, P36624, DOI 10.1074/jbc.M807377200	45	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24881	24890		10.1074/jbc.M109.014365	http://dx.doi.org/10.1074/jbc.M109.014365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592499	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000269734000022
J	Taylor, AI; Beavil, RL; Sutton, BJ; Calvert, RA				Taylor, Alexander I.; Beavil, Rebecca L.; Sutton, Brian J.; Calvert, Rosaleen A.			A Monomeric Chicken IgY Receptor Binds IgY with 2:1 Stoichiometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-ALPHA-RI; CRYSTAL-STRUCTURES; IMMUNE-RESPONSES; COMPLEX; FRAGMENT; LIGAND; CELLS; GLYCOSYLATION; ANTIBODY; DISTINCT	IgY is the principal serum antibody in birds and reptiles, and an IgY-like molecule was the evolutionary precursor of both mammalian IgG and IgE. A receptor for IgY on chicken monocytes, chicken leukocyte receptor AB1 (CHIR-AB1), lies in the avian leukocyte receptor cluster rather than the classical Fc receptor cluster where the genes for mammalian IgE and IgG receptors are found. IgG and IgE receptors bind to the lower hinge region of their respective antibodies with 1:1 stoichiometry, whereas the myeloid receptor for IgA, Fc alpha RI, and the IgG homeostasis receptor, FcRn, which are found in the mammalian leukocyte receptor cluster, bind with 2:1 stoichiometry between the heavy chain constant domains 2 and 3 of each heavy chain. In this paper, the extracellular domain of CHIRAB1 was expressed in a soluble form and shown to be a monomer that binds to IgY-Fc with 2:1 stoichiometry. The two binding sites have similar affinities:K-a1 = 7.22 +/- 0.22 x 10(5) M-1 and K-a2 = 3.63 +/- 1.03 x 10(6) M-1 (comparable with the values reported for IgA binding to its receptor). The affinity constants for IgY and IgY-Fc binding to immobilized CHIR-AB1 are 9.07 +/- 0.07 x 10(7) and 6.11 +/- 0.02 x 10(8) M-1, respectively, in agreement with values obtained for IgY binding to chicken monocyte cells and comparable with reported values for human IgA binding to neutrophils. Although the binding site for CHIRAB1 on IgY is not known, the data reported here with a monomeric receptor binding to IgY at two sites with low affinity suggest an IgA-like interaction.	[Taylor, Alexander I.; Beavil, Rebecca L.; Sutton, Brian J.; Calvert, Rosaleen A.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London	Calvert, RA (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	rosy.calvert@kcl.ac.uk		Taylor, Alexander/0000-0001-7684-1437	Wellcome Trust VIP; Biotechnology and Biological Sciences Research Council (UK); BBSRC [BB/D011418/1] Funding Source: UKRI; MRC [G0501494] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011418/1] Funding Source: researchfish; Medical Research Council [G0400503B, G0501494] Funding Source: researchfish	Wellcome Trust VIP(Wellcome Trust); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a Wellcome Trust VIP award and by the Biotechnology and Biological Sciences Research Council (UK).	Arnon TI, 2008, J MOL BIOL, V381, P1012, DOI 10.1016/j.jmb.2008.06.082; Bakema JE, 2008, J IMMUNOL, V181, P4080, DOI 10.4049/jimmunol.181.6.4080; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Davison TF, 2003, BRIT POULTRY SCI, V44, P6, DOI 10.1080/0007166031000085364; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; FAITH RE, 1973, IMMUNOLOGY, V25, P151; Fayngerts SA, 2007, IMMUNOGENETICS, V59, P493, DOI 10.1007/s00251-007-0208-8; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geng J, 2006, PROTEIN EXPRES PURIF, V48, P142, DOI 10.1016/j.pep.2006.01.021; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; HUMMEL JP, 1962, BIOCHIM BIOPHYS ACTA, V63, P530, DOI 10.1016/0006-3002(62)90124-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laun K, 2006, PLOS GENET, V2, P707, DOI 10.1371/journal.pgen.0020073; Martin WL, 1999, BIOCHEMISTRY-US, V38, P12639, DOI 10.1021/bi9913505; McDonnell JM, 2001, NAT STRUCT BIOL, V8, P437, DOI 10.1038/87603; Miah SMS, 2008, J IMMUNOL, V180, P2922; Nice EC, 1999, BIOESSAYS, V21, P339, DOI 10.1002/(SICI)1521-1878(199904)21:4<339::AID-BIES11>3.0.CO;2-C; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; QURESHI MA, 1990, VET IMMUNOL IMMUNOP, V26, P237, DOI 10.1016/0165-2427(90)90094-9; RAYCHAUDHURI G, 1985, MOL IMMUNOL, V22, P1009, DOI 10.1016/0161-5890(85)90104-X; Sanchez LM, 1999, BIOCHEMISTRY-US, V38, P9471, DOI 10.1021/bi9907330; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Suzuki N, 2004, GLYCOBIOLOGY, V14, P275, DOI 10.1093/glycob/cwh031; Taylor AI, 2008, J BIOL CHEM, V283, P16384, DOI 10.1074/jbc.M801321200; Taylor AI, 2009, BIOCHEMISTRY-US, V48, P558, DOI 10.1021/bi8019993; Taylor AI, 2007, IMMUNOGENETICS, V59, P323, DOI 10.1007/s00251-007-0195-9; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Viertboeck BC, 2009, J IMMUNOL, V182, P1533, DOI 10.4049/jimmunol.182.3.1533; Viertlboeck BC, 2007, P NATL ACAD SCI USA, V104, P11718, DOI 10.1073/pnas.0702011104; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; YOUNG RJ, 1995, PROTEIN ENG, V8, P193, DOI 10.1093/protein/8.2.193	36	13	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24168	24175		10.1074/jbc.M109.020263	http://dx.doi.org/10.1074/jbc.M109.020263			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592496	Green Published, hybrid			2022-12-27	WOS:000269380200030
J	Areste, C; Mutocheluh, M; Blackbourn, DJ				Areste, Cristina; Mutocheluh, Mohamed; Blackbourn, David J.			Identification of Caspase-mediated Decay of Interferon Regulatory Factor-3, Exploited by a Kaposi Sarcoma-associated Herpesvirus Immunoregulatory Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; INNATE ANTIVIRAL RESPONSE; KAPPA-B KINASE; VIRUS-INFECTION; IMMUNE MODULATION; BETA ENHANCEOSOME; IRF-3 ACTIVATION; CELL-DEATH; APOPTOSIS; PHOSPHORYLATION	Upon virus infection, the cell mounts an innate type I interferon (IFN) response to limit the spread. This response is orchestrated by the constitutively expressed IFN regulatory factor (IRF)-3 protein, which becomes post-translationally activated. Although the activation events are understood in detail, the negative regulation of this innate response is less well understood. Many viruses, including Kaposi sarcoma-associated herpesvirus (KSHV), have evolved defense strategies against this IFN response. Thus, KSHV encodes a viral IRF (vIRF)-2 protein, sharing homology with cellular IRFs and is a known inhibitor of the innate IFN response. Here, we show that vIRF-2 mediates IRF-3 inactivation by a mechanism involving caspase-3, although vIRF-2 itself is not pro-apoptotic. Importantly, we also show that caspase-3 participates in normal IRF-3 turnover in the absence of vIRF-2, during the antiviral response induced by poly(I:C) transfection. These data provide unprecedented insight into negative regulation of IRF-3 following activation of the type I IFN antiviral response and the mechanism by which KSHV vIRF-2 inhibits this innate response.	[Areste, Cristina; Mutocheluh, Mohamed; Blackbourn, David J.] Univ Birmingham, Canc Res UK Canc Ctr, Sch Canc Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England	Cancer Research UK; University of Birmingham	Blackbourn, DJ (corresponding author), Univ Birmingham, Canc Res UK Canc Ctr, Sch Canc Sci, Coll Med & Dent Sci, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	d.j.blackbourn@bham.ac.uk		Blackbourn, David/0000-0002-6703-4497; Mutocheluh, Mohamed/0000-0002-1396-5085	Medical Research Council [G0400408]; Cancer Research UK [C7934]; MRC [G0400408] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (Grant G0400408) and Cancer Research UK (Grant C7934) (to D. J. B.). Author's Choice -Final version full access.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Alexander L, 2000, J VIROL, V74, P3388, DOI 10.1128/JVI.74.7.3388-3398.2000; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Areste C, 2009, TRENDS MICROBIOL, V17, P119, DOI 10.1016/j.tim.2008.12.001; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Burysek L, 1999, J HUMAN VIROL, V2, P19; Burysek L, 2001, J VIROL, V75, P2345, DOI 10.1128/JVI.75.5.2345-2352.2001; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Cunningham C, 2003, J GEN VIROL, V84, P1471, DOI 10.1099/vir.0.19015-0; Dragan AI, 2008, J MOL BIOL, V384, P335, DOI 10.1016/j.jmb.2008.09.015; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Fuld S, 2006, J VIROL, V80, P3092, DOI 10.1128/JVI.80.6.3092-3097.2006; Goubau D, 2009, EUR J IMMUNOL, V39, P527, DOI 10.1002/eji.200838832; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kelly GL, 2005, J VIROL, V79, P10709, DOI 10.1128/JVI.79.16.10709-10717.2005; Kirchhoff S, 2002, J IMMUNOL, V168, P1226, DOI 10.4049/jimmunol.168.3.1226; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rezaee SAR, 2006, J GEN VIROL, V87, P1781, DOI 10.1099/vir.0.81919-0; Rosado JA, 2006, J CELL PHYSIOL, V209, P142, DOI 10.1002/jcp.20715; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Saira K, 2007, J VIROL, V81, P3077, DOI 10.1128/JVI.02064-06; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Searles RP, 1999, J VIROL, V73, P3040, DOI 10.1128/JVI.73.4.3040-3053.1999; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Wilhelm S, 1998, EUR J IMMUNOL, V28, P891, DOI 10.1002/(SICI)1521-4141(199803)28:03<891::AID-IMMU891>3.3.CO;2-O; Wu WF, 2006, J BIOL CHEM, V281, P10682, DOI 10.1074/jbc.M511759200; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	53	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23272	23285		10.1074/jbc.M109.033290	http://dx.doi.org/10.1074/jbc.M109.033290			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19553679	Green Published, hybrid			2022-12-27	WOS:000269180000012
J	Deng, Y; Guo, Y; Watson, H; Au, WC; Shakoury-Elizeh, M; Basrai, MA; Bonifacino, JS; Philpott, CC				Deng, Yi; Guo, Yan; Watson, Hadiya; Au, Wei-Chun; Shakoury-Elizeh, Minoo; Basrai, Munira A.; Bonifacino, Juan S.; Philpott, Caroline C.			Gga2 Mediates Sequential Ubiquitin-independent and Ubiquitin-dependent Steps in the Trafficking of ARN1 from the trans-Golgi Network to the Vacuole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEINS; EPSIN-RELATED PROTEINS; SACCHAROMYCES-CEREVISIAE; FERRICHROME TRANSPORTER; MULTIVESICULAR BODY; STRUCTURAL BASIS; SORTING-SIGNAL; ENTH DOMAIN; YEAST; RECOGNITION	In Saccharomyces cerevisiae, ARN1 encodes a transporter for the uptake of ferrichrome, an important nutritional source of iron. In the absence of ferrichrome, Arn1p is sorted directly from the trans-Golgi network (TGN) to the vacuolar lumen via the vacuolar protein-sorting pathway. Arn1p is mis-sorted to the plasma membrane in cells lacking Gga2p, a monomeric clathrin-adaptor protein involved in vesicular transport from the TGN. Although Ggas have been characterized as ubiquitin receptors, we show here that ubiquitin binding by Gga2 was not required for the TGN-to-endosome trafficking of Arn1, but it was required for subsequent sorting of Arn1 into the multivesicular body. In a ubiquitin-binding mutant of Gga2, Arn1p accumulated on the vacuolar membrane in a ubiquitinated form. The yeast epsins Ent3p and Ent4p were also involved in TGN-to-vacuole sorting of Arn1p. Amino-terminal sequences of Arn1p were required for vacuolar protein sorting, as mutation of ubiquitinatable lysine residues resulted in accumulation on the vacuolar membrane, and mutation of either a THN or YGL sequence resulted in mis-sorting to the plasma membrane. These studies suggest that Gga2 is involved in sorting at both the TGN and multivesicular and that the first step can occur without ubiquitin binding.	[Deng, Yi; Guo, Yan; Shakoury-Elizeh, Minoo; Philpott, Caroline C.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Watson, Hadiya; Bonifacino, Juan S.] Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Au, Wei-Chun; Basrai, Munira A.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Philpott, CC (corresponding author), Bldg 10,Rm 9B-16,10 Ctr Dr,MSC 1800, Bethesda, MD 20892 USA.	carolinep@intra.niddk.nih.gov	Basrai, Munira/AAV-4422-2020	Deng, Yi/0000-0003-1378-015X; Bonifacino, Juan S./0000-0002-5673-6370	National Institutes of Health Intramural Research Programs of the NIDDK; Eunice Kennedy Shriver NICHD; NCI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010822, ZIABC010822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054512, Z01DK054512] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Programs of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Programs of the NIDDK (to Y.D., Y.G., M.S.-E., and C.C.P.), the Eunice Kennedy Shriver NICHD (to H.W.and J.S.B.), and the NCI (to W.-C.A.and M.B.).	Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Boman AL, 2002, MOL BIOL CELL, V13, P3078, DOI 10.1091/mbc.E02-02-0078; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708; Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000; Costaguta G, 2006, MOL BIOL CELL, V17, P3907, DOI 10.1091/mbc.E06-05-0410; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Eugster A, 2004, MOL BIOL CELL, V15, P3031, DOI 10.1091/mbc.e03-11-0793; Froissard M, 2007, TRAFFIC, V8, P1601, DOI 10.1111/j.1600-0854.2007.00627.x; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Heymann P, 2000, BIOMETALS, V13, P65, DOI 10.1023/A:1009250017785; Hirst J, 2001, MOL BIOL CELL, V12, P3573, DOI 10.1091/mbc.12.11.3573; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; KAISER CA, 2002, GUIDE YEAST GENETICS; Kawasaki M, 2005, GENES CELLS, V10, P639, DOI 10.1111/j.1365-2443.2005.00865.x; Kim Y, 2005, EMBO J, V24, P952, DOI 10.1038/sj.emboj.7600579; Kim Y, 2002, EMBO J, V21, P3632, DOI 10.1093/emboj/cdf382; Kim Y, 2007, MOL BIOL CELL, V18, P1790, DOI 10.1091/mbc.E06-09-0861; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Mattera R, 2004, J BIOL CHEM, V279, P31409, DOI 10.1074/jbc.M402183200; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Moore RE, 2003, P NATL ACAD SCI USA, V100, P5664, DOI 10.1073/pnas.1030323100; Mullins C, 2001, MOL CELL BIOL, V21, P7981, DOI 10.1128/MCB.21.23.7981-7994.2001; Pelham HRB, 2004, CURR BIOL, V14, pR357, DOI 10.1016/j.cub.2004.04.027; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; Philpott CC, 1998, EMBO J, V17, P5026, DOI 10.1093/emboj/17.17.5026; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; SHERMAN F, 1991, P3; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a; Shiba Y, 2004, J BIOL CHEM, V279, P7105, DOI 10.1074/jbc.M311702200; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Takata K, 2008, HISTOCHEM CELL BIOL, V130, P197, DOI 10.1007/s00418-008-0457-0; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383; Yun CW, 2001, J BIOL CHEM, V276, P10218, DOI 10.1074/jbc.M010065200	54	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23830	23841		10.1074/jbc.M109.030015	http://dx.doi.org/10.1074/jbc.M109.030015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574226	Green Published, hybrid			2022-12-27	WOS:000269180000066
J	Dong, XC; Yang, B; Li, YJ; Zhong, C; Ding, JP				Dong, Xianchi; Yang, Bei; Li, Yingjie; Zhong, Chen; Ding, Jianping			Molecular Basis of the Acceleration of the GDP-GTP Exchange of Human Ras Homolog Enriched in Brain by Human Translationally Controlled Tumor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; NUCLEOTIDE EXCHANGE; STRUCTURAL BASIS; BINDING PARTNER; DIRECT TARGET; RHEB GTPASE; MTOR; TCTP; RAPTOR; COMPLEX	Ras homolog enriched in brain (Rheb), a small GTPase, positively regulates the mTORC1 pathway. The GDP-GTP exchange of Rheb has been suggested to be facilitated by translationally controlled tumor protein (TCTP). Here we demonstrate that human TCTP (hTCTP) interacts with human Rheb (hRheb) and accelerates its GDP release in vitro and that hTCTP activates the mTORC1 pathway in vivo. To investigate the underlying mechanism, we built structure models of GDP-and GTP-bound hRheb in complexes with hTCTP and performed molecular dynamics simulations of the models, which predict key residues involved in the interactions and region of hRheb undergoing conformational change during the GDP-GTP exchange. These results are verified with site-directed mutagenesis and in vitro biochemical and in vivo cell biological analyses. Furthermore, a crystal structure of the E12V mutant hTCTP, which lacks the guanine nucleotide exchange factor activity, shows that the deficiency appears to be caused by loss of a salt-bridging interaction with Lys-45 of hRheb. These data collectively provide insights into the molecular mechanisms of how hTCTP interacts with hRheb and activates the mTORC1 pathway.	[Dong, Xianchi; Yang, Bei; Li, Yingjie; Zhong, Chen; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Dong, Xianchi; Yang, Bei; Li, Yingjie; Zhong, Chen; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Res Ctr Struct Biol, Shanghai 200031, Peoples R China; [Dong, Xianchi; Yang, Bei; Li, Yingjie] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Zhong, C (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	czhong@sibs.ac.cn; jpding@sibs.ac.cn	Dong, Xianchi/C-1393-2015; Yang, Bei/AAD-9831-2021	Dong, Xianchi/0000-0001-5121-1236; Yang, Bei/0000-0001-5389-3859; ding, jian ping/0000-0001-7029-7346	Ministry of Science and Technology of China [2006CB806501, 2006AA02Z112, 2006AA02A313, 2007CB914302]; National Natural Science Foundation of China [30770480, 30730028, 90713046]; Chinese Academy of Sciences [KSCX2-YW-R-107, SIBS2007KIP202, SIBS2008002]; Science and Technology Commission of Shanghai Municipality [07XD14032, 08QA14076]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Ministry of Science and Technology of China (Grants 2006CB806501, 2006AA02Z112, 2006AA02A313, and 2007CB914302), the National Natural Science Foundation of China (Grants 30770480, 30730028, and 90713046), the Chinese Academy of Sciences (Grants KSCX2-YW-R-107, SIBS2007KIP202, and SIBS2008002), and the Science and Technology Commission of Shanghai Municipality (Grants 07XD14032 and 08QA14076).	Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Itzen A, 2006, EMBO J, V25, P1445, DOI 10.1038/sj.emboj.7601044; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; MAKRIDES S, 1988, NUCLEIC ACIDS RES, V16, P2349, DOI 10.1093/nar/16.5.2349; MONTAGNE J, 2001, SCI STKE, pPE36; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Szilagyi A, 2005, PHYS BIOL, V2, pS1, DOI 10.1088/1478-3975/2/2/S01; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yoon T, 2000, ARCH BIOCHEM BIOPHYS, V384, P379, DOI 10.1006/abbi.2000.2108; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	45	48	54	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23754	23764		10.1074/jbc.M109.012823	http://dx.doi.org/10.1074/jbc.M109.012823			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570981	Green Published, hybrid			2022-12-27	WOS:000269180000060
J	Li, JX; Qian, XG; Hu, JB; Sha, BD				Li, Jingzhi; Qian, Xinguo; Hu, Junbin; Sha, Bingdong			Molecular Chaperone Hsp70/Hsp90 Prepares the Mitochondrial Outer Membrane Translocon Receptor Tom71 for Preprotein Loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTOR; PROTEIN IMPORT; CRYSTAL-STRUCTURE; TPR DOMAIN; IDENTIFICATION; RECOGNITION; CHIP	The preproteins targeted to the mitochondria are transported through the translocase of the outer membrane complex. Tom70/Tom71 is a major surface receptor of the translocase of the outer membrane complex for mitochondrial preproteins. The preproteins are escorted to Tom70/Tom71 by molecular chaperones Hsp70 and Hsp90. Here we present the high resolution crystal structures of Tom71 and the protein complexes between Tom71 and the Hsp70/Hsp90 C terminus. The crystal structures indicate that Tom70/Tom71 may exhibit two distinct states. In the closed state, the N-terminal domain of Tom70/Tom71 partially blocks the preprotein-binding pocket. In the open state, the N-terminal domain moves away, and the preprotein-binding pocket is fully exposed. The complex formation between the C-terminal EEVD motif of Hsp70/Hsp90 and Tom71 could lock Tom71 in the open state where the preprotein-binding pocket of Tom71 is ready to receive preproteins. The interactions between Hsp70/Hsp90 and Tom71 N-terminal domain generate conformational changes that may increase the volume of the preprotein-binding pocket. The complex formation of Hsp70/Hsp90 and Tom71 also generates significant domain rearrangement within Tom71, which may position the preprotein-binding pocket closer to Hsp70/Hsp90 to facilitate the preprotein transfer from the molecular chaperone to Tom71. Therefore, molecular chaperone Hsp70/Hsp90 may function to prepare the mitochondrial outer membrane receptor Tom71 for preprotein loading.	[Li, Jingzhi; Qian, Xinguo; Hu, Junbin; Sha, Bingdong] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Sha, BD (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, MCLM 364,1918 Univ Blvd, Birmingham, AL 35294 USA.	bdsha@uab.edu			National Institutes of Health [R01 DK56203, R01 GM65959]; Army Research Office [51894LS]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080261, R01GM065959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK56203 and R01 GM65959. This work was also supported by Army Research Office Grant 51894LS.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beddoe T, 2004, J BIOL CHEM, V279, P46448, DOI 10.1074/jbc.M405639200; Beddoe T, 2002, BBA-MOL CELL RES, V1592, P35, DOI 10.1016/S0167-4889(02)00262-8; Bomer U, 1996, FEBS LETT, V382, P153, DOI 10.1016/0014-5793(96)00156-1; Brix J, 2000, J MOL BIOL, V303, P479, DOI 10.1006/jmbi.2000.4120; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Koh JY, 2001, MOL CELL BIOL, V21, P7576, DOI 10.1128/MCB.21.22.7576-7586.2001; Kondo-Okamoto N, 2008, EMBO REP, V9, P63, DOI 10.1038/sj.embor.7401113; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	31	57	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23852	23859		10.1074/jbc.M109.023986	http://dx.doi.org/10.1074/jbc.M109.023986			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581297	hybrid, Green Published			2022-12-27	WOS:000269180000068
J	Torrado, M; Revuelta, J; Gonzalez, C; Corzana, F; Bastida, A; Asensio, JL				Torrado, Mario; Revuelta, Julia; Gonzalez, Carlos; Corzana, Francisco; Bastida, Agatha; Luis Asensio, Juan			Role of Conserved Salt Bridges in Homeodomain Stability and DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK PROTEIN; RESIDUES; RESOURCE; THERMOSTABILITY; STABILIZATION; SPECTROSCOPY; RECOGNITION; SPECIFICITY; MUTATIONS; DYNAMICS	The sequence information available for homeodomains reveals that salt bridges connecting pairs 19/30, 31/42, and 17/52 are frequent, whereas aliphatic residues at these sites are rare and mainly restricted to proteins from homeotherms. We have analyzed the influence of salt and hydrophobic bridges at these sites on the stability and DNA binding properties of human Hesx-1 homeodomain. Regarding the protein stability, our analysis shows that hydrophobic side chains are clearly preferred at positions 19/30 and 31/42. This stabilizing influence results from the more favorable packing of the aliphatic side chains with the protein core, as illustrated by the three-dimensional solution structure of a thermostable variant, herein reported. In contrast only polar side chains seem to be tolerated at positions 17/52. Interestingly, despite the significant influence of pairs 19/30 and 31/42 on the stability of the homeodomain, their effect on DNA binding ranges from modest to negligible. The observed lack of correlation between binding strength and conformational stability in the analyzed variants suggests that salt/hydrophobic bridges at these specific positions might have been employed by evolution to independently modulate both properties.	[Torrado, Mario; Revuelta, Julia; Bastida, Agatha; Luis Asensio, Juan] CSIC, Inst Quim Organ Gen, Dept Quim Organ Biol, E-28006 Madrid, Spain; [Gonzalez, Carlos] CSIC, Inst Quim Fis Rocasolano, Grp RMN, E-28006 Madrid, Spain; [Corzana, Francisco] Univ La Rioja, Dept Quim, Unidad Asociada, CSIC, E-26006 Logrono, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de La Rioja	Asensio, JL (corresponding author), CSIC, Inst Quim Organ Gen, Dept Quim Organ Biol, Juan Cierva 3, E-28006 Madrid, Spain.	iqoa110@iqog.csic.es	Bastida, Agatha/K-1607-2014; Gonzalez, Carlos/A-4734-2013; Asensio, Juan L./J-1996-2015; Corzana, Francisco/B-1310-2015	Bastida, Agatha/0000-0002-5141-9595; Gonzalez, Carlos/0000-0001-8796-1282; Asensio, Juan L./0000-0001-7536-5221; Corzana, Francisco/0000-0001-5597-8127; Revuelta, Julia/0000-0001-6225-7336	Spanish "Plan Nacional" (Ministerio de Ciencia y Technologia) [CTQ2007-67403/BQU, CTQ2004-04994/BQU]	Spanish "Plan Nacional" (Ministerio de Ciencia y Technologia)	This work was supported by Spanish "Plan Nacional" (Ministerio de Ciencia y Technologia) Research Grants CTQ2007-67403/BQU and CTQ2004-04994/BQU.	Banerjee-Basu S, 2003, NUCLEIC ACIDS RES, V31, P304, DOI 10.1093/nar/gkg118; Banerjee-Basu S, 2000, NUCLEIC ACIDS RES, V28, P329, DOI 10.1093/nar/28.1.329; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P291, DOI 10.1093/nar/29.1.291; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Billeter M, 1996, PROG BIOPHYS MOL BIO, V66, P211, DOI 10.1016/S0079-6107(97)00006-0; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; Cillo C, 1999, EXP CELL RES, V248, P1, DOI 10.1006/excr.1999.4451; CLARKE ND, 1995, PROTEIN SCI, V4, P2269, DOI 10.1002/pro.5560041104; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dahiyat BI, 1997, P NATL ACAD SCI USA, V94, P10172, DOI 10.1073/pnas.94.19.10172; de la Mata I, 2002, CHEMBIOCHEM, V3, P726, DOI 10.1002/1439-7633(20020802)3:8<726::AID-CBIC726>3.0.CO;2-C; Fodor E, 2005, BIOCHEMISTRY-US, V44, P12480, DOI 10.1021/bi050835s; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Gonzalez M, 2001, BIOCHEMISTRY-US, V40, P4923, DOI 10.1021/bi0022341; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; LIM WA, 1991, J MOL BIOL, V219, P359, DOI 10.1016/0022-2836(91)90570-V; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Marti DN, 2000, BIOCHEMISTRY-US, V39, P12804, DOI 10.1021/bi001242e; Marti DN, 2003, J MOL BIOL, V330, P621, DOI 10.1016/S0022-2836(03)00623-5; Martin A, 2002, J MOL BIOL, V318, P1341, DOI 10.1016/S0022-2836(02)00243-7; Max KEA, 2007, J MOL BIOL, V369, P1087, DOI 10.1016/j.jmb.2007.04.016; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Perl D, 2000, NAT STRUCT BIOL, V7, P380; Rios MAD, 2005, BIOCHEMISTRY-US, V44, P1243, DOI 10.1021/bi0484441; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHEEK RM, 1989, METHOD ENZYMOL, V177, P204; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stollar EJ, 2003, J BIOL CHEM, V278, P43699, DOI 10.1074/jbc.M308029200; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wunderlich M, 2005, J MOL BIOL, V347, P1063, DOI 10.1016/j.jmb.2005.02.014; WYMAN J, 1948, ADV PROTEIN CHEM, V4, P407, DOI 10.1016/S0065-3233(08)60011-X; Yang QS, 1996, PROG BIOCHEM BIOPHYS, V23, P29	39	9	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23765	23779		10.1074/jbc.M109.012054	http://dx.doi.org/10.1074/jbc.M109.012054			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561080	Green Published, hybrid			2022-12-27	WOS:000269180000061
J	Enoki, S; Watanabe, R; Iino, R; Noji, H				Enoki, Sawako; Watanabe, Rikiya; Iino, Ryota; Noji, Hiroyuki			Single-molecule Study on the Temperature-sensitive Reaction of F-1-ATPase with a Hybrid F-1 Carrying a Single beta(E190D)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1-ATPASE; ATP SYNTHASE; BETA-SUBUNIT; CATALYTIC SUBUNITS; ROTATION; MECHANISM; MOTOR; RESOLUTION	F-1-ATPase is a rotary molecular motor in which the gamma-subunit rotates against the alpha(3)beta(3) cylinder. The unitary gamma-rotation is a 120 degrees step comprising 80 and 40 degrees substeps, each of these initiated by ATP binding and ADP release and by ATP hydrolysis and inorganic phosphate release, respectively. In our previous study on gamma-rotation at low temperatures, a highly temperature-sensitive (TS) reaction step of F-1-ATPase from thermophilic Bacillus PS3 was found below 9 degrees C as an intervening pause before the 80 substep at the same angle for ATP binding and ADP release. However, it remains unclear as to which reaction step the TS reaction corresponds. In this study, we found that the mutant F-1(beta E190D) from thermophilic Bacillus PS3 showed a clear pause of the TS reaction below 18 degrees C. In an attempt to identify the catalytic state of the TS reaction, the rotation of the hybrid F-1, carrying a single copy of beta E190D, was observed at 18 degrees C. The hybrid F-1 showed a pause of the TS reaction at the same angle as for the ATP binding of the incorporated beta E190D, although kinetic analysis revealed that the TS reaction is not the ATP binding step. These findings suggest that the TS reaction is a structural rearrangement of beta before or after ATP binding.	[Enoki, Sawako; Watanabe, Rikiya; Iino, Ryota; Noji, Hiroyuki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Osaka University	Noji, H (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.	hnoji@sanken.osaka-u.ac.jp	Watanabe, Rikiya/AAO-1390-2021; Iino, Ryota/B-7746-2011	Watanabe, Rikiya/0000-0001-7146-2745; Iino, Ryota/0000-0003-0110-5704				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; AMANO T, 1994, FEBS LETT, V348, P93, DOI 10.1016/0014-5793(94)00588-5; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cross RL, 2000, BBA-BIOENERGETICS, V1458, P270, DOI 10.1016/S0005-2728(00)00079-7; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OHTSUBO M, 1987, BIOCHEM BIOPH RES CO, V146, P705, DOI 10.1016/0006-291X(87)90586-9; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; PARK MY, 1994, J BIOCHEM-TOKYO, V116, P1139, DOI 10.1093/oxfordjournals.jbchem.a124640; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	24	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23169	23176		10.1074/jbc.M109.026401	http://dx.doi.org/10.1074/jbc.M109.026401			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561076	Green Published, hybrid			2022-12-27	WOS:000268963100068
J	Hornemann, S; von Schroetter, C; Damberger, FF; Wuthrich, K				Hornemann, Simone; von Schroetter, Christine; Damberger, Fred F.; Wuethrich, Kurt			Prion Protein-Detergent Micelle Interactions Studied by NMR in Solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; LIPID-MEMBRANES; TRANSMEMBRANE FORM; ENDOPLASMIC-RETICULUM; CHEMICAL-SHIFTS; DISEASE; PEPTIDE; DOMAIN; CONVERSION; TOPOLOGY	Cellular prion proteins, PrPC, carrying the amino acid substitutions P102L, P105L, or A117V, which confer increased susceptibility to human transmissible spongiform encephalopathies, are known to form structures that include transmembrane polypeptide segments. Herein, we investigated the interactions between dodecylphosphocholine micelles and the polypeptide fragments 90-231 of the recombinant mouse PrP variants carrying the amino acid replacements P102L, P105L, A117V, A113V/A115V/A118V, K110I/H111I, M129V, P105L/M129V, and A117V/M129V. Wild-type mPrP-(90-231) and mPrP [M129V]-(91-231) showed only weak interactions with dodecylphosphocholine micelles in aqueous solution at pH 7.0, whereas discrete interaction sites within the polypeptide segment 102-127 were identified for all other aforementioned mPrP variants by NMR chemical shift mapping. These model studies thus provide evidence that amino acid substitutions within the polypeptide segment 102-127 affect the interactions of PrPC with membranous structures, which might in turn modulate the physiological function of the protein in health and disease.	[Hornemann, Simone; von Schroetter, Christine; Damberger, Fred F.; Wuethrich, Kurt] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hornemann, S (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	simone.hornemann@usz.ch	Damberger, Fred F/A-8938-2011	Damberger, Fred F/0000-0002-8457-3409; Wuthrich, Kurt/0000-0001-8739-6965	Swiss National Science Foundation; ETH Zurich through the National Center of Competence in Research "Structural Biology,"; European Union	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich through the National Center of Competence in Research "Structural Biology,"(Swiss National Science Foundation (SNSF)); European Union(European Commission)	This project was supported by the Swiss National Science Foundation and the ETH Zurich through the National Center of Competence in Research "Structural Biology," and by a grant from the European Union.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Arora A, 2001, CURR OPIN STRUC BIOL, V11, P540, DOI 10.1016/S0959-440X(00)00246-3; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Beswick V, 1996, BIOCHEMISTRY-US, V35, P14717, DOI 10.1021/bi961710d; Boettcher JM, 2007, BIOMOL NMR ASSIGM, V1, P167, DOI 10.1007/s12104-007-9063-7; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; DeMarco ML, 2009, J NEUROCHEM, V109, P60, DOI 10.1111/j.1471-4159.2009.05892.x; Dupiereux I, 2005, BIOCHEM BIOPH RES CO, V331, P894, DOI 10.1016/j.bbrc.2005.04.012; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Harris B, 2003, CLIO MED, V71, P85; Harrison CF, 2007, J NEUROCHEM, V103, P1709, DOI 10.1111/j.1471-4159.2007.04936.x; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, MOL CELL, V2, P85, DOI 10.1016/S1097-2765(00)80116-1; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; HILLER S, 2006, THESIS ETH ZURICH, P98; Hiller S, 2008, ANGEW CHEM INT EDIT, V47, P977, DOI 10.1002/anie.200703367; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Keller R., 2004, COMPUTER AIDED RESON, V1; KITAMOTO T, 1994, J PHILOS T R SOC L B, V343, P391; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; LUGINBUHL P, 1995, J MAGN RESON SER B, V109, P229, DOI 10.1006/jmrb.1995.0016; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Malmendal A, 2005, BIOCHEMISTRY-US, V44, P6502, DOI 10.1021/bi050088z; Mishra RS, 2002, J BIOL CHEM, V277, P24554, DOI 10.1074/jbc.M200213200; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Ott CM, 2007, J BIOL CHEM, V282, P11163, DOI 10.1074/jbc.M607660200; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Pillot T, 1997, J MOL BIOL, V274, P381, DOI 10.1006/jmbi.1997.1382; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Ruan KH, 2002, BIOCHEM J, V368, P721, DOI 10.1042/BJ20021001; Rymer DL, 2000, J NEUROCHEM, V75, P2536, DOI 10.1046/j.1471-4159.2000.0752536.x; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; So SP, 2000, J BIOL CHEM, V275, P40679, DOI 10.1074/jbc.M005752200; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Stewart RS, 2001, J BIOL CHEM, V276, P2212, DOI 10.1074/jbc.M006763200; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Weissmann C, 2002, P NATL ACAD SCI USA, V99, P16378, DOI 10.1073/pnas.172403799; Weissmann C, 1999, J BIOL CHEM, V274, P3, DOI 10.1074/jbc.274.1.3; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	59	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22713	22721		10.1074/jbc.M109.000430	http://dx.doi.org/10.1074/jbc.M109.000430			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546219	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000268963100026
J	Putcha, BDK; Fernandez, EJ				Putcha, Balananda-Dhurjati K.; Fernandez, Elias J.			Direct Interdomain Interactions Can Mediate Allosterism in the Thyroid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; ESTROGEN RESPONSE ELEMENTS; NUCLEAR HORMONE-RECEPTORS; LIGAND-BINDING DOMAIN; ANDROGEN RECEPTOR; DNA-BINDING; COREGULATOR INTERACTIONS; STRUCTURAL DETERMINANTS; COACTIVATOR RECRUITMENT; ALPHA	The thyroid (TR) and retinoid X receptors (RXR) belong to the nuclear receptor (NR) superfamily of ligand-mediated transcription factors. At the molecular level, TR activity is specifically modulated by interactions with the ligand 3,3',5 triiodo-L-thyronine (T3), RXR, DNA, and co-activators such as SRC1, occurring in concert or sequentially. Although binding sites for DNA and coregulators such as SRC1 are distinct and at distal regions of these receptors, cell-based and EMSA studies have suggested that these molecules can regulate binding of each other to the receptor. We present evidence of direct, DNA-dependent, communication between the DNA and ligand binding domains (DBD and LBD) that can allosterically regulate interactions with SRC1 and DNA, respectively, using isothermal titration calorimetry (ITC) and cell-based assays. Additionally, we note that interdomain communication is affected by RXR in RXR:TR. We also noticed a DNA-dependent cross-talk between RXR and TR within RXR:TR. Finally, we suggest that differences in transactivation on different TRE may be the consequence of different affinities between TRE and RXR:TR.	[Putcha, Balananda-Dhurjati K.; Fernandez, Elias J.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Fernandez, EJ (corresponding author), M407, Knoxville, TN 37996 USA.	elias.fernandez@utk.edu	Fernandez, Elias/AAX-8405-2021	Fernandez, Elias/0000-0003-4374-0669	National Institutes of Health [DK066394]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK066394 (to E.J.F.).	Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Castillo AI, 2004, MOL CELL BIOL, V24, P502, DOI 10.1128/MCB.24.2.502-513.2004; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Claret FX, 1996, MOL CELL BIOL, V16, P219; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Diallo EM, 2005, PROTEIN EXPRES PURIF, V40, P292, DOI 10.1016/j.pep.2005.01.007; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Gonzalez MI, 2001, J BIOL CHEM, V276, P6420, DOI 10.1074/jbc.M008689200; Greenspan NS, 1999, NAT BIOTECHNOL, V17, P936, DOI 10.1038/13590; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Herdick M, 2000, MOL PHARMACOL, V57, P1206; Ikeda M, 1996, J BIOL CHEM, V271, P23096, DOI 10.1074/jbc.271.38.23096; Kahlen JP, 1997, NUCLEIC ACIDS RES, V25, P4307, DOI 10.1093/nar/25.21.4307; Kersten S, 1997, J BIOL CHEM, V272, P12771, DOI 10.1074/jbc.272.19.12771; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; LEHMANN JM, 1993, MOL CELL BIOL, V13, P7698, DOI 10.1128/MCB.13.12.7698; Lin BC, 1997, MOL CELL BIOL, V17, P6131, DOI 10.1128/MCB.17.10.6131; Makowski A, 2003, MOL ENDOCRINOL, V17, P273, DOI 10.1210/me.2002-0310; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Meijsing SH, 2007, MOL CELL BIOL, V27, P2442, DOI 10.1128/MCB.01570-06; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mengeling BJ, 2008, MOL CELL ENDOCRINOL, V280, P47, DOI 10.1016/j.mce.2007.09.011; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Moore JMR, 2005, MOL CELL PROTEOMICS, V4, P475, DOI 10.1074/mcp.R500001-MCP200; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Mouchon A, 1999, MOL CELL BIOL, V19, P3073; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200; Wood JR, 1998, MOL CELL BIOL, V18, P1927, DOI 10.1128/MCB.18.4.1927; Wright E, 2007, BIOCHEMISTRY-US, V46, P862, DOI 10.1021/bi061627i; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	40	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22517	22524		10.1074/jbc.M109.026682	http://dx.doi.org/10.1074/jbc.M109.026682			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561066	Green Published, hybrid			2022-12-27	WOS:000268963100004
J	Yuan, K; Li, N; Jiang, K; Zhu, TG; Huo, YD; Wang, C; Lu, J; Shaw, A; Thomas, K; Zhang, JC; Mann, D; Liao, J; Jin, CJ; Yao, XB				Yuan, Kai; Li, Na; Jiang, Kai; Zhu, Tongge; Huo, Yuda; Wang, Chong; Lu, Jing; Shaw, Andrew; Thomas, Kelwyn; Zhang, Jiancun; Mann, David; Liao, Jian; Jin, Changjiang; Yao, Xuebiao			PinX1 Is a Novel Microtubule-binding Protein Essential for Accurate Chromosome Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; MITOTIC CHECKPOINT; CENP-E; SPINDLE MICROTUBULES; NDC80 COMPLEX; IMPORTIN-BETA; KINETOCHORE; ATTACHMENT; LOCALIZATION; CENTROMERE	Mitosis is an orchestration of dynamic interactions between spindle microtubules and chromosomes, which is mediated by protein structures that include the kinetochores, and other protein complexes present on chromosomes. PinX1 is a potent telomerase inhibitor in interphase; however, its function in mitosis is not well documented. Here we show that PinX1 is essential for faithful chromosome segregation. Deconvolution microscopic analyses show that PinX1 localizes to nucleoli and telomeres in interphase and relocates to the periphery of chromosomes and the outer plate of the kinetochores in mitosis. Our deletion analyses mapped the kinetochore localization domain of PinX1 to the central region and its chromosome periphery localization domain to the C terminus. Interestingly, the kinetochore localization of PinX1 is dependent on Hec1 and CENP-E. Our biochemical characterization revealed that PinX1 is a novel microtubule-binding protein. Our real time imaging analyses show that suppression of PinX1 by small interference RNA abrogates faithful chromosome segregation and results in anaphase chromatid bridges in mitosis and micronuclei in interphase, suggesting an essential role of PinX1 in chromosome stability. Taken together, the results indicate that PinX1 plays an important role in faithful chromosome segregation in mitosis.	[Yuan, Kai; Li, Na; Jiang, Kai; Zhu, Tongge; Huo, Yuda; Wang, Chong; Lu, Jing; Zhang, Jiancun; Liao, Jian; Jin, Changjiang; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Yuan, Kai; Li, Na; Jiang, Kai; Zhu, Tongge; Huo, Yuda; Wang, Chong; Lu, Jing; Zhang, Jiancun; Liao, Jian; Jin, Changjiang; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Yuan, Kai; Jiang, Kai; Shaw, Andrew; Mann, David] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Thomas, Kelwyn] Morehouse Sch Med, Dept Biochem, Atlanta, GA 30310 USA; [Zhang, Jiancun] Guangzhou Inst Biomed & Hlth, Guangzhou 510663, Guangdong, Peoples R China	Morehouse School of Medicine; Morehouse School of Medicine; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Jin, CJ (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	jincj@ustc.edu.cn; yaoxb@ustc.edu.cn	Yuan, Kai/A-1294-2009; Yao, Xuebiao/P-5771-2014; Yuan, Kai/ABH-2688-2020	Yuan, Kai/0000-0001-7002-5703; 	National Institutes of Health [DK-56292, CA89019, CA92080, CA118948]; Chinese Academy of Science [KSCX1-YW-R65, KSCX2-YW-H10]; Chinese 973 [2002CB713700, 2010CB912103, 2007CB914503, 2006CB943600]; Chinese 863 [2006AA02A247]; Chinese Natural Science Foundation [30270654, 30070349, 90508002, 30121001]; China National Key Projects for Infectious Disease [2008ZX10002021]; American Cancer Society [RPG-99-173-01]; Georgia Cancer Coalition Breast Cancer; Atlanta Clinical and Translational Science Award Chemical Biology; NATIONAL CANCER INSTITUTE [P50CA089019, U56CA092080, U54CA118948] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973(National Basic Research Program of China); Chinese 863(National High Technology Research and Development Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China National Key Projects for Infectious Disease; American Cancer Society(American Cancer Society); Georgia Cancer Coalition Breast Cancer; Atlanta Clinical and Translational Science Award Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292, CA89019, CA92080, and CA118948. This work was also supported by Chinese Academy of Science Grants KSCX1-YW-R65 and KSCX2-YW-H10, Chinese 973 Projects 2002CB713700, 2010CB912103, 2007CB914503, and 2006CB943600, Chinese 863 Project 2006AA02A247, Chinese Natural Science Foundation Grants 30270654, 30070349, 90508002, and 30121001, China National Key Projects for Infectious Disease Grant 2008ZX10002021, American Cancer Society Grant RPG-99-173-01, a Georgia Cancer Coalition Breast Cancer research grant, and an Atlanta Clinical and Translational Science Award Chemical Biology grant (to X. Y.).	Banik SSR, 2004, J BIOL CHEM, V279, P51745, DOI 10.1074/jbc.M408131200; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Chan GKT, 2000, NAT CELL BIOL, V2, P944, DOI 10.1038/35046598; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dou Z, 2004, FEBS LETT, V572, P51, DOI 10.1016/j.febslet.2004.06.092; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Lin J, 2004, GENE DEV, V18, P387, DOI 10.1101/gad.1171804; Lin J, 2007, BIOCHEM BIOPH RES CO, V353, P946, DOI 10.1016/j.bbrc.2006.12.123; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Mazumdar M, 2005, TRENDS CELL BIOL, V15, P349, DOI 10.1016/j.tcb.2005.05.006; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Oh BK, 2007, GENE, V400, P35, DOI 10.1016/j.gene.2007.05.015; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; Sakita-Suto S, 2007, MOL BIOL CELL, V18, P1107, DOI 10.1091/mbc.E06-11-1021; Tahara K, 2008, J CELL BIOL, V180, P493, DOI 10.1083/jcb.200708003; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wright K, 1998, ONCOGENE, V17, P1185, DOI 10.1038/sj.onc.1202028; Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	40	37	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23072	23082		10.1074/jbc.M109.001990	http://dx.doi.org/10.1074/jbc.M109.001990			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553660	Green Published, hybrid			2022-12-27	WOS:000268963100059
J	Davis, JH; Baker, TA; Sauer, RT				Davis, Joseph H.; Baker, Tania A.; Sauer, Robert T.			Engineering Synthetic Adaptors and Substrates for Controlled ClpXP Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PLUS PROTEASE; SPECIFICITY-ENHANCING FACTOR; ATP-DEPENDENT PROTEASES; ZINC-BINDING DOMAIN; DIHYDROFOLATE-REDUCTASE; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; RECOGNITION SIGNALS; STRUCTURAL BASIS; SSPB ADAPTER	Facile control of targeted intracellular protein degradation has many potential uses in basic science and biotechnology. One promising approach to this goal is to redesign adaptor proteins, which can regulate proteolytic specificity by tethering substrates to energy-dependent AAA + proteases. Using the ClpXP protease, we have probed the minimal biochemical functions required for adaptor function by designing and characterizing variant substrates, adaptors, and ClpX enzymes. We find that substrate tethering mediated by heterologous interaction domains and a small bridging molecule mimics substrate delivery by the wild-type system. These results show that simple tethering is sufficient for synthetic adaptor function. In our engineered system, tethering and proteolysis depend on the presence of the macrolide rapamycin, providing a foundation for engineering highly specific degradation of target proteins in cells. Importantly, this degradation is regulated by a small molecule without the need for new adaptor or enzyme biosynthesis.	[Davis, Joseph H.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Davis, Joseph H./0000-0002-8858-8907; Sauer, Robert/0000-0002-1719-5399	National Institutes of Health [AI-16892, GM-48224]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049224, R01GM048224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-16892 and GM-48224.	Abdelhakim AH, 2008, MOL CELL, V30, P39, DOI 10.1016/j.molcel.2008.02.013; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Farrell CM, 2007, MOL CELL, V25, P161, DOI 10.1016/j.molcel.2006.11.018; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FLEMING MP, 1972, BMJ-BRIT MED J, V1, P726, DOI 10.1136/bmj.1.5802.726; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Krahn JM, 2007, BIOCHEMISTRY-US, V46, P14878, DOI 10.1021/bi701532r; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Levchenko I, 2005, NAT STRUCT MOL BIOL, V12, P520, DOI 10.1038/nsmb934; Levchenko I, 2003, MOL CELL, V12, P365, DOI 10.1016/j.molcel.2003.08.014; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; McGinness KE, 2007, J BIOL CHEM, V282, P11465, DOI 10.1074/jbc.M610671200; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Park EY, 2007, J MOL BIOL, V367, P514, DOI 10.1016/j.jmb.2007.01.003; PATTISHALL KH, 1977, J BIOL CHEM, V252, P2319; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; SMITH SL, 1979, J BIOL CHEM, V254, P6222; Song HK, 2003, MOL CELL, V12, P75, DOI 10.1016/S1097-2765(03)00271-5; STONE D, 1979, J BIOL CHEM, V254, P857; Thibault G, 2006, EMBO J, V25, P3367, DOI 10.1038/sj.emboj.7601223; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Walsh DP, 2006, CHEM REV, V106, P2476, DOI 10.1021/cr0404141; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200	46	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21848	21855		10.1074/jbc.M109.017624	http://dx.doi.org/10.1074/jbc.M109.017624			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19549779	Green Published, hybrid			2022-12-27	WOS:000268783700008
J	Gao, BL; Boeglin, WE; Zheng, YX; Schneider, C; Brash, AR				Gao, Benlian; Boeglin, William E.; Zheng, Yuxiang; Schneider, Claus; Brash, Alan R.			Evidence for an Ionic Intermediate in the Transformation of Fatty Acid Hydroperoxide by a Catalase-related Allene Oxide Synthase from the Cyanobacterium Acaryochloris marina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOXYGENASE FUSION PROTEIN; LIVER MICROSOMAL CYTOCHROME-P-450; HEME-LINKED IONIZATION; RESONANCE RAMAN; LINOLEIC-ACID; HORSERADISH-PEROXIDASE; VALPROIC ACID; COMPOUND-II; IDENTIFICATION; EXPRESSION	Allene oxides are reactive epoxides biosynthesized from fatty acid hydroperoxides by specialized cytochrome P450s or by catalase-related hemoproteins. Here we cloned, expressed, and characterized a gene encoding a lipoxygenase-catalase/peroxidase fusion protein from Acaryochloris marina. We identified novel allene oxide synthase (AOS) activity and a by-product that provides evidence of the reaction mechanism. The fatty acids 18.4 omega 3 and 18.3 omega 3 are oxygenated to the 12R-hydroperoxide by the lipoxygenase domain and converted to the corresponding 12R,13-epoxy allene oxide by the catalase-related domain. Linoleic acid is oxygenated to its 9R-hydroperoxide and then, surprisingly, converted similar to 70% to an epoxyalcohol identified spectroscopically and by chemical synthesis as 9R, 10S-epoxy-13S-hydroxyoctadeca-11E-enoic acid and only similar to 30% to the 9R, 10-epoxy allene oxide. Experiments using oxygen-18-labeled 9R-hydroperoxide substrate and enzyme incubations conducted in (H2O)-O-18 indicated that similar to 72% of the oxygen in the epoxyalcohol 13S-hydroxyl arises from water, a finding that points to an ionic intermediate (epoxy allylic carbocation) during catalysis. AOS and epoxyalcohol synthase activities are mechanistically related, with a reacting intermediate undergoing a net hydrogen abstraction or hydroxylation, respectively. The existence of epoxy allylic carbocations in fatty acid transformations is widely implicated although for AOS reactions, without direct experimental support. Our findings place together in strong association the reactions of allene oxide synthesis and an ionic reaction intermediate in the AOS-catalyzed transformation.	[Brash, Alan R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, 23rd Ave S Pierce, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			National Institutes of Health [GM-074888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-074888.	Anton R, 1998, J INVEST DERMATOL, V110, P303, DOI 10.1046/j.1523-1747.1998.00159.x; BAKER BJ, 1985, J AM CHEM SOC, V107, P2976, DOI 10.1021/ja00296a026; BLEE E, 1993, J BIOL CHEM, V268, P1708; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; BRASH AR, 1988, P NATL ACAD SCI USA, V85, P3382, DOI 10.1073/pnas.85.10.3382; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; Bylund J, 1998, ANAL BIOCHEM, V265, P55, DOI 10.1006/abio.1998.2897; CHUANG WJ, 1989, J BIOL CHEM, V264, P14209; CROMBIE L, 1991, J CHEM SOC PERK T 1, P581, DOI 10.1039/p19910000581; de Montellano P. R. O., 1995, CYTCOCHROME P450 STR, P245; FALCK JR, 1984, J AM CHEM SOC, V106, P3334, DOI 10.1021/ja00323a046; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Gao B, 2008, ARCH BIOCHEM BIOPHYS, V477, P285, DOI 10.1016/j.abb.2008.07.011; Garscha U, 2008, BIOCHEM BIOPH RES CO, V373, P579, DOI 10.1016/j.bbrc.2008.06.060; Garscha U, 2009, J BIOL CHEM, V284, P13755, DOI 10.1074/jbc.M808665200; Gerwick WH, 1996, LIPIDS, V31, P1215, DOI 10.1007/BF02587906; GIBIAN MJ, 1987, ANAL BIOCHEM, V163, P343, DOI 10.1016/0003-2697(87)90234-X; Grechkin AN, 2006, BBA-MOL CELL BIOL L, V1761, P1419, DOI 10.1016/j.bbalip.2006.09.002; GRECHKIN AN, 1991, BIOCHIM BIOPHYS ACTA, V1086, P317, DOI 10.1016/0005-2760(91)90176-I; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P413, DOI 10.1021/tx00022a003; Hamberg M, 2005, BIOCHEM BIOPH RES CO, V338, P169, DOI 10.1016/j.bbrc.2005.08.117; HAMBERG M, 1986, BIOCHIM BIOPHYS ACTA, V879, P410, DOI 10.1016/0005-2760(86)90233-X; HASHIMOTO S, 1986, P NATL ACAD SCI USA, V83, P2417, DOI 10.1073/pnas.83.8.2417; HASHIMOTO S, 1986, J BIOL CHEM, V261, P1110; HEIMBROOK DC, 1981, BIOCHEM BIOPH RES CO, V99, P530, DOI 10.1016/0006-291X(81)91777-0; IMAI T, 1993, J BIOL CHEM, V268, P19681; KIKUCHI H, 1982, TETRAHEDRON LETT, V23, P5171, DOI 10.1016/S0040-4039(00)85788-3; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; KORZEKWA KR, 1990, DRUG METAB DISPOS, V18, P974; Laethem RM, 1996, DRUG METAB DISPOS, V24, P664; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; MACDONALD TL, 1982, BIOCHEM BIOPH RES CO, V104, P620, DOI 10.1016/0006-291X(82)90682-9; Mayer JM, 2004, ANNU REV PHYS CHEM, V55, P363, DOI 10.1146/annurev.physchem.55.091602.094446; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; NAGATA K, 1986, DRUG METAB DISPOS, V14, P559; Niisuke K, 2009, J LIPID RES, V50, P1448, DOI 10.1194/jlr.M900025-JLR200; NORDBLOM GD, 1976, ARCH BIOCHEM BIOPHYS, V175, P524, DOI 10.1016/0003-9861(76)90541-5; OERTLING WA, 1988, BIOCHEMISTRY-US, V27, P5395, DOI 10.1021/bi00415a002; Ohashi S, 2008, PHOTOSYNTH RES, V98, P141, DOI 10.1007/s11120-008-9383-1; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Oliw EH, 2002, PROSTAG OTH LIPID M, V68-9, P313, DOI 10.1016/S0090-6980(02)00037-0; Ortiz de Montellano PR, 1986, CYTOCHROME P450 STRU, P217; PEERS KE, 1983, CHEM PHYS LIPIDS, V32, P49, DOI 10.1016/0009-3084(83)90069-5; Proshlyakov DA, 1996, BIOSPECTROSCOPY, V2, P317, DOI 10.1002/(SICI)1520-6343(1996)2:5<317::AID-BSPY5>3.0.CO;2-1; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Rector CL, 2007, CHEM RES TOXICOL, V20, P1582, DOI 10.1021/tx700120r; RETTIE AE, 1987, SCIENCE, V235, P890, DOI 10.1126/science.3101178; RETTIE AE, 1995, BIOCHEMISTRY-US, V34, P7889, DOI 10.1021/bi00024a013; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; SONG WC, 1993, J BIOL CHEM, V268, P6293; Stumpe Michael, 2006, Phytochemistry Reviews, V5, P347, DOI 10.1007/s11101-006-9038-9; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; Tosha T, 2006, J BIOL CHEM, V281, P12610, DOI 10.1074/jbc.M600061200; ULLRICH V, 1994, ANGEW CHEM INT EDIT, V33, P1911, DOI 10.1002/anie.199419111; Ullrich V, 2003, ARCH BIOCHEM BIOPHYS, V409, P45, DOI 10.1016/S0003-9861(02)00410-1; VELDINK GA, 1970, FEBS LETT, V7, P188, DOI 10.1016/0014-5793(70)80153-3; WANG RW, 1991, ARCH BIOCHEM BIOPHYS, V290, P355, DOI 10.1016/0003-9861(91)90551-S; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200; Ziegler J, 1999, LIPIDS, V34, P1005, DOI 10.1007/s11745-999-0451-z	67	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22087	22098		10.1074/jbc.M109.013151	http://dx.doi.org/10.1074/jbc.M109.013151			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531485	Green Published, hybrid			2022-12-27	WOS:000268783700033
J	MacDonald, CJ; Cheng, RYS; Roberts, DD; Wink, DA; Yeh, GC				MacDonald, Christopher J.; Cheng, Robert Y. S.; Roberts, David D.; Wink, David A.; Yeh, Grace Chao			Modulation of Carcinogen Metabolism by Nitric Oxide-Aspirin 2 Is Associated with Suppression of DNA Damage and DNA Adduct Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; POLYCYCLIC AROMATIC-HYDROCARBONS; IN-VITRO; DONATING ASPIRIN; CARDIOVASCULAR EVENTS; MECHANISTIC ASSAYS; TRADITIONAL NSAIDS; CANCER-CELLS; MICE LACKING; CHO-CELLS	Nitric oxide (NO)-donating non-steroidal anti-inflammatory drugs (NSAIDs) represent a promising new class of drugs developed to provide a safer alternative than their conventional NSAID counterparts in chemoprevention. We tested the effects of NO-aspirin 2 on Phase I and Phase II carcinogen-metabolizing enzymes. In HepG2 human hepatoma cells and in LS180 colonic adenocarcinoma cells, NO-aspirin 2 inhibited 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD)-induced cytochrome P450 (CYP) enzyme activity and CYP1A1 and CYP1A2 mRNA expression. These effects were further characterized as being mediated through transcriptional regulation: NO-aspirin 2 inhibited binding of ligand (TCDD)-activated aryl hydrocarbon receptor to the CYP1A1 enhancer sequence; additionally, NO-aspirin 2 suppressed carcinogen-induced expression of CYP1A heterogeneous nuclear RNA. The fate of carcinogen metabolites depends not only on activation by CYP enzymes but also detoxification by Phase II enzymes. Both HepG2 and LS180 cells treated with NO-aspirin 2 showed an increase in glutathione S-transferase-P1 (GST-P1), glutamate-cysteine ligase (GCL), and NAD(P)H:quinone oxidoreductase-1 (NQO1) expression. Compared with two other NO-releasing compounds, diethylenetriamine-NO and the organic nitrate, isosorbide dinitrate, the inhibitory effects of NO-aspirin 2 on TCDD-induced CYP activity and mRNA expression were considerably more potent. Furthermore, aspirin alone had no inhibitory effect on TCDD-induced CYP activity, nor did aspirin up-regulate GCL, GST-P1, or NQO1 expression. Consequent to the effects on carcinogen-metabolizing enzymes, NO-aspirin 2 inhibited [H-3] benzo[ a] pyrene-DNA adduct formation and DNA damage elicited by TCDD or benzo[a] pyrene. Our results demonstrate that NO-aspirin 2 may be an effective chemopreventive agent by favorably affecting the inhibitory and enhancing effects of Phase I and Phase II carcinogen metabolism, thereby protecting DNA from carcinogenic insult.	[MacDonald, Christopher J.; Cheng, Robert Y. S.; Yeh, Grace Chao] NCI, Cellular Def & Carcinogenesis Sect, Lab Metab, NIH, Frederick, MD 21702 USA; [Roberts, David D.] NCI, Pathol Lab, NIH, Frederick, MD 21702 USA; [Wink, David A.] NCI, Radiat Biol Branch, Ctr Canc Res, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yeh, GC (corresponding author), NCI, NIH, Bldg 31,Rm 3A11,31 Ctr Dr, Bethesda, MD 20892 USA.	yeh@ncifcrf.gov	Roberts, David D./A-9699-2008; Cheng, Robert/E-9799-2013	Roberts, David D./0000-0002-2481-2981; Azad, Mahan/0000-0002-8633-3513; Cheng, Robert/0000-0003-0287-6439; Wink, David/0000-0002-5652-7480	NATIONAL CANCER INSTITUTE [Z01SC009174, ZIASC009174, ZIABC000155, Z01BC000155, ZIABC010899, Z01BC010899] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AWASTHI YC, 1994, INT J BIOCHEM, V26, P295, DOI 10.1016/0020-711X(94)90050-7; Balu N, 2004, CHEM RES TOXICOL, V17, P827, DOI 10.1021/tx034207s; Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Bjorkman David J., 1999, American Journal of Medicine, V107, p3S; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; BROWN JF, 1993, AM J PHYSIOL, V265, pG418, DOI 10.1152/ajpgi.1993.265.3.G418; Burczynski ME, 2000, CANCER RES, V60, P908; CAVALIERI EL, 1995, XENOBIOTICA, V25, P677, DOI 10.3109/00498259509061885; Cirino G, 1996, BRIT J PHARMACOL, V117, P1421, DOI 10.1111/j.1476-5381.1996.tb15301.x; CONNEY AH, 1982, CANCER RES, V42, P4875; Dale YR, 2006, MOL PHARMACOL, V70, P1481, DOI 10.1124/mol.106.027474; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050, DOI 10.1016/0016-5085(94)90229-1; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Flowers L, 1997, BIOCHEMISTRY-US, V36, P8640, DOI 10.1021/bi970367p; Fujihara CK, 1998, AM J PHYSIOL-RENAL, V274, pF573, DOI 10.1152/ajprenal.1998.274.3.F573; Gao JJ, 2006, CARCINOGENESIS, V27, P803, DOI 10.1093/carcin/bgi262; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hu X, 1997, INT J CANCER, V73, P897, DOI 10.1002/(SICI)1097-0215(19971210)73:6<897::AID-IJC23>3.0.CO;2-0; Hulsman N, 2007, J MED CHEM, V50, P2424, DOI 10.1021/jm061371e; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kashfi K, 2005, J PHARMACOL EXP THER, V312, P978, DOI 10.1124/jpet.104.075994; Kashfi K, 2002, J PHARMACOL EXP THER, V303, P1273, DOI 10.1124/jpet.102.042754; Kashfi K, 2007, BIOCHEM BIOPH RES CO, V358, P1096, DOI 10.1016/j.bbrc.2007.05.038; Konturek PC, 2006, J PHYSIOL PHARMACOL, V57, P15; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; MacDonald CJ, 2004, CANCER RES, V64, P429, DOI 10.1158/0008-5472.CAN-03-0974; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; McCoull KD, 1999, CHEM RES TOXICOL, V12, P237, DOI 10.1021/tx980182z; Melendez-Colon VJ, 1999, CARCINOGENESIS, V20, P1885, DOI 10.1093/carcin/20.10.1885; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Muscara MN, 1998, LIFE SCI, V62, pPL235, DOI 10.1016/S0024-3205(98)00072-1; O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3; Park JH, 2006, CHEM RES TOXICOL, V19, P719, DOI 10.1021/tx0600245; Patten EJ, 1999, CANCER LETT, V147, P95, DOI 10.1016/S0304-3835(99)00282-7; PELKONEN O, 1982, PHARMACOL REV, V34, P189; Rao CV, 2004, CURR CANCER DRUG TAR, V4, P29, DOI 10.2174/1568009043481632; Rigas B, 2004, TRENDS MOL MED, V10, P324, DOI 10.1016/j.molmed.2004.05.004; ROBERTSON IGC, 1986, CANCER RES, V46, P2220; Rosetti M, 2006, APOPTOSIS, V11, P1321, DOI 10.1007/s10495-006-6986-x; Ryu DY, 1996, MOL PHARMACOL, V50, P443; Schoonen WGEJ, 2005, TOXICOL IN VITRO, V19, P491, DOI 10.1016/j.tiv.2005.01.002; Schoonen WGEJ, 2005, TOXICOL IN VITRO, V19, P505, DOI 10.1016/j.tiv.2005.01.003; SEGASOTHY M, 1994, AM J KIDNEY DIS, V24, P17, DOI 10.1016/S0272-6386(12)80155-7; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; SIMS P, 1974, NATURE, V252, P326, DOI 10.1038/252326a0; Singh G, 1999, J RHEUMATOL, V26, P18; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SINGHAL SS, 1992, BIOCHIM BIOPHYS ACTA, V1171, P19, DOI 10.1016/0167-4781(92)90135-M; Soll Andrew, 1998, American Journal of Medicine, V105, p10S, DOI 10.1016/S0002-9343(98)00275-7; Stefano F, 2007, CURR TOP MED CHEM, V7, P277, DOI 10.2174/156802607779941350; Sundberg K, 2002, CHEM RES TOXICOL, V15, P170, DOI 10.1021/tx015546t; Talalay P, 2003, ADV ENZYME REGUL, V43, P121, DOI 10.1016/S0065-2571(02)00038-9; Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Wallace JL, 2002, NAT REV DRUG DISCOV, V1, P375, DOI 10.1038/nrd794; Wen X, 2005, CARCINOGENESIS, V26, P803, DOI 10.1093/carcin/bgi015; Williams JL, 2001, CANCER RES, V61, P3285; Yeh RK, 2004, BIOCHEM PHARMACOL, V67, P2197, DOI 10.1016/j.bcp.2004.02.027	63	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22099	22107		10.1074/jbc.M109.021063	http://dx.doi.org/10.1074/jbc.M109.021063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542225	Green Published, hybrid			2022-12-27	WOS:000268783700034
J	Neumann, M; Mittelstadt, G; Seduk, F; Iobbi-Nivol, C; Leimkuhler, S				Neumann, Meina; Mittelstaedt, Gerd; Seduk, Farida; Iobbi-Nivol, Chantal; Leimkuehler, Silke			MocA Is a Specific Cytidylyltransferase Involved in Molybdopterin Cytosine Dinucleotide Biosynthesis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; DIMETHYL-SULFOXIDE REDUCTASE; XANTHINE DEHYDROGENASE; GUANINE DINUCLEOTIDE; CRYSTAL-STRUCTURE; GENE; MECHANISM; MOBA; OXIDOREDUCTASE; PURIFICATION	We have purified and characterized a specific CTP: molybdopterin cytidylyltransferase for the biosynthesis of the molybdopterin (MPT) cytosine dinucleotide (MCD) cofactor in Escherichia coli. The protein, named MocA, shows 22% amino acid sequence identity to E. coli MobA, the specific GTP: molybdopterin guanylyltransferase for molybdopterin guanine dinucleotide biosynthesis. MocA is essential for the activity of the MCD-containing enzymes aldehyde oxidoreductase Yag-TSR and the xanthine dehydrogenases XdhABC and XdhD. Using a fully defined in vitro assay, we showed that MocA, Mo-MPT, CTP, and MgCl2 are required and sufficient for MCD biosynthesis in vitro. The activity of MocA is specific for CTP; other nucleotides such as ATP and GTP were not utilized. In the defined in vitro system a turnover number of 0.37 +/- 0.01 min(-1) was obtained. A1:1 binding ratio of MocA to Mo-MPT and CTP was determined to monomeric MocA with dissociation constants of 0.23 +/- 0.02 mu M for CTP and 1.17 +/- 0.18 mu M for Mo-MPT. We showed that MocA was also able to convert MPT to MCD in the absence of molybdate, however, with only one catalytic turnover. The addition of molybdate after one turnover gave rise to a higher MCD production, revealing that MCD remains bound to MocA in the absence of molybdate. This work presents the first characterization of a specific enzyme involved in MCD biosynthesis in bacteria.	[Neumann, Meina; Mittelstaedt, Gerd; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Seduk, Farida; Iobbi-Nivol, Chantal] CNRS, IFR88, Chim Bacterienne Lab, F-13402 Marseille 20, France	University of Potsdam; Centre National de la Recherche Scientifique (CNRS)	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de	Neumann-Schaal, Meina/AAM-6389-2021	Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [LE1171/3-3]; DAAD PROCOPE	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD PROCOPE(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Deutsche Forschungsgemeinschaft Grant LE1171/3-3. The exchange of researchers among laboratories involved in the work was funded by the DAAD PROCOPE program (to C. I.-N. and S. L.).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Genest O, 2008, J BIOL CHEM, V283, P21433, DOI 10.1074/jbc.M802954200; Guse A, 2003, J BIOL CHEM, V278, P25302, DOI 10.1074/jbc.M302639200; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hanzelmann P, 1998, EUR J BIOCHEM, V255, P755, DOI 10.1046/j.1432-1327.1998.2550755.x; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; JOHNSON JL, 1991, J BIOL CHEM, V266, P12140; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; Joshi MS, 1996, J BACTERIOL, V178, P4310, DOI 10.1128/jb.178.14.4310-4312.1996; Lake MW, 2000, J BIOL CHEM, V275, P40211, DOI 10.1074/jbc.M007406200; LEVINE RA, 1982, J BACTERIOL, V149, P923, DOI 10.1128/JB.149.3.923-930.1982; Loschi L, 2004, J BIOL CHEM, V279, P50391, DOI 10.1074/jbc.M408876200; McLuskey K, 2003, J BIOL CHEM, V278, P23706, DOI 10.1074/jbc.M301485200; MILLER JB, 1987, J BACTERIOL, V169, P1853, DOI 10.1128/jb.169.5.1853-1860.1987; Miller JH, 1972, EXPT MOL GENETICS, P201; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Neumann M, 2009, FEBS J, V276, P2762, DOI 10.1111/j.1742-4658.2009.07000.x; Nichols JD, 2007, BIOCHEMISTRY-US, V46, P78, DOI 10.1021/bi061551q; Nichols JD, 2005, J BIOL CHEM, V280, P7817, DOI 10.1074/jbc.M413783200; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; PALMER T, 1994, EUR J BIOCHEM, V222, P687, DOI 10.1111/j.1432-1033.1994.tb18913.x; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; RAJAGOPALAN KV, 1996, ESCHERICHIA COLI SAL, P674; Sachelaru P, 2006, APPL ENVIRON MICROB, V72, P5126, DOI 10.1128/AEM.00437-06; SCHUBEL U, 1995, J BACTERIOL, V177, P2197, DOI 10.1128/jb.177.8.2197-2203.1995; SMITH ST, 1967, J BIOL CHEM, V242, P4108; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Temple CA, 2000, J BIOL CHEM, V275, P40202, DOI 10.1074/jbc.M007407200; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000	34	44	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21891	21898		10.1074/jbc.M109.008565	http://dx.doi.org/10.1074/jbc.M109.008565			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542235	Green Published, hybrid			2022-12-27	WOS:000268783700013
J	Umeda, M; Murata-Kamiya, N; Saito, Y; Ohba, Y; Takahashi, M; Hatakeyama, M				Umeda, Mayumi; Murata-Kamiya, Naoko; Saito, Yasuhiro; Ohba, Yusuke; Takahashi, Masayuki; Hatakeyama, Masanori			Helicobacter pylori CagA Causes Mitotic Impairment and Induces Chromosomal Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; C-ELEGANS EMBRYOS; MAMMALIAN-CELLS; TYROSINE PHOSPHORYLATION; INCREASED RISK; PROTEIN; SPINDLE; KINASES; CANCER; ADENOCARCINOMA	Infection with cagA-positive Helicobacter pylori is the strongest risk factor for the development of gastric carcinoma. The cagA gene product CagA, which is delivered into gastric epithelial cells, specifically binds to and aberrantly activates SHP-2 oncoprotein. CagA also interacts with and inhibits partitioning-defective 1 (PAR1)/MARK kinase, which phosphorylates microtubule-associated proteins to destabilize microtubules and thereby causes epithelial polarity defects. In light of the notion that microtubules are not only required for polarity regulation but also essential for the formation of mitotic spindles, we hypothesized that CagA-mediated PAR1 inhibition also influences mitosis. Here, we investigated the effect of CagA on the progression of mitosis. In the presence of CagA, cells displayed a delay in the transition from prophase to metaphase. Furthermore, a fraction of the CagA-expressing cells showed spindle misorientation at the onset of anaphase, followed by chromosomal segregation with abnormal division axis. The effect of CagA on mitosis was abolished by elevated PAR1 expression. Conversely, inhibition of PAR1 kinase elicited mitotic delay similar to that induced by CagA. Thus, CagA-mediated inhibition of PAR1, which perturbs microtubule stability and thereby causes microtubule-based spindle dysfunction, is involved in the prophase/metaphase delay and subsequent spindle misorientation. Consequently, chronic exposure of cells to CagA induces chromosomal instability. Our findings reveal a bifunctional role of CagA as an oncoprotein: CagA elicits uncontrolled cell proliferation by aberrantly activating SHP-2 and at the same time induces chromosomal instability by perturbing the microtubule-based mitotic spindle. The dual function of CagA may cooperatively	[Hatakeyama, Masanori] Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Kita Ku, Sapporo, Hokkaido 0600815, Japan; [Umeda, Mayumi; Murata-Kamiya, Naoko; Takahashi, Masayuki; Hatakeyama, Masanori] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600815, Japan; [Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido 0600815, Japan; [Hatakeyama, Masanori] Univ Tokyo, Grad Sch Med, Dept Microbiol, Tokyo 1130033, Japan	Hokkaido University; Hokkaido University; Hokkaido University; University of Tokyo	Hatakeyama, M (corresponding author), Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	mhata@igm.hokudai.ac.jp	Ohba, Yusuke/E-7944-2011; Takahashi, Masayuki/D-8079-2012	Takahashi, Masayuki/0000-0002-5923-2813	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; BLASER MJ, 1995, CANCER RES, V55, P2111; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; IZUMI M, 1991, EXP CELL RES, V197, P229, DOI 10.1016/0014-4827(91)90427-V; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; MARSHALL BJ, 1984, LANCET, V1, P1311; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nomura AMY, 2002, J INFECT DIS, V186, P1138, DOI 10.1086/343808; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; PREUSS U, 1995, MOL BIOL CELL, V6, P1397, DOI 10.1091/mbc.6.10.1397; Rudi J, 1997, DIGEST DIS SCI, V42, P1652, DOI 10.1023/A:1018849112533; Rugge M, 1999, CANCER-AM CANCER SOC, V85, P2506, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2506::AID-CNCR3>3.3.CO;2-9; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Shimoyama T, 1998, J CLIN PATHOL, V51, P225, DOI 10.1136/jcp.51.3.225; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Torres J, 1998, INT J CANCER, V78, P298, DOI 10.1002/(SICI)1097-0215(19981029)78:3&lt;298::AID-IJC6&gt;3.0.CO;2-Q; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; VANDRE DD, 1991, J CELL SCI, V98, P577; Varmark H, 2004, J CELL BIOCHEM, V91, P904, DOI 10.1002/jcb.20013; Watts JL, 1996, DEVELOPMENT, V122, P3133; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Yamazaki S, 2003, J INFECT DIS, V187, P334, DOI 10.1086/367807	48	51	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22166	22172		10.1074/jbc.M109.035766	http://dx.doi.org/10.1074/jbc.M109.035766			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19546211	Green Published, hybrid			2022-12-27	WOS:000268783700041
J	Giles, LM; Li, L; Chin, LS				Giles, Lisa M.; Li, Lian; Chin, Lih-Shen			Printor, a Novel TorsinA-interacting Protein Implicated in Dystonia Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN AGGREGATION; KELCH-REPEAT SUPERFAMILY; TRANSGENIC MOUSE MODEL; ACTIN-BINDING PROTEIN; EARLY-ONSET DYSTONIA; AAA PLUS PROTEIN; NUCLEAR-ENVELOPE; DYT1 DYSTONIA; DOMAIN PROTEINS; ENDOSOMAL TRAFFICKING	Early onset generalized dystonia (DYT1) is an autosomal dominant neurological disorder caused by deletion of a single glutamate residue (torsinA Delta E) in the C-terminal region of the AAA(+) (ATPases associated with a variety of cellular activities) protein torsinA. The pathogenic mechanism by which torsinA Delta E mutation leads to dystonia remains unknown. Here we report the identification and characterization of a 628-amino acid novel protein, printor, that interacts with torsinA. Printor co-distributes with torsinA in multiple brain regions and colocalizes with torsinA in the endoplasmic reticulum. Interestingly, printor selectively binds to the ATP-free form but not to the ATP-bound form of torsinA, supporting a role for printor as a cofactor rather than a substrate of torsinA. The interaction of printor with torsinA is completely abolished by the dystonia-associated torsinA Delta E mutation. Our findings suggest that printor is a new component of the DYT1 pathogenic pathway and provide a potential molecular target for therapeutic intervention in dystonia.	[Giles, Lisa M.; Li, Lian; Chin, Lih-Shen] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Li, L (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	lianli@pharm.emory.edu; chinl@pharm.emory.edu		Li, Lian/0000-0003-4700-1134; Chin, Lih-Shen/0000-0002-0817-0368	National Institutes of Health [NS054334, NS050650, ES015813, GM082828]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, R01NS050650, F31NS054334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054334 (to L. M. G.), NS050650 (to L.-S.C.), and ES015813 and GM082828 (to L. L.).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Augood SJ, 2003, BRAIN RES, V986, P12, DOI 10.1016/S0006-8993(03)03164-0; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Bressman SB, 2001, ARCH NEUROL-CHICAGO, V58, P681, DOI 10.1001/archneur.58.4.681; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Caldwell Guy A, 2004, Adv Neurol, V94, P79; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; CHEN W, 1995, MOL CELL BIOL, V15, P3424; Chin LS, 2002, J BIOL CHEM, V277, P35071, DOI 10.1074/jbc.M203300200; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Clarimon J, 2005, ANN NEUROL, V57, P765, DOI 10.1002/ana.20485; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; GEARING M, 1993, J NEUROPATH EXP NEUR, V52, P22, DOI 10.1097/00005072-199301000-00004; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Giles LM, 2009, AUTOPHAGY, V5, P82, DOI 10.4161/auto.5.1.7173; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Grundmann K, 2007, NEUROBIOL DIS, V27, P190, DOI 10.1016/j.nbd.2007.04.015; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hernandez MC, 1997, J NEUROSCI, V17, P3038; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Kim TA, 1998, J CELL BIOL, V141, P553, DOI 10.1083/jcb.141.3.553; Kirk E, 2006, J CELL SCI, V119, P4689, DOI 10.1242/jcs.03249; Klein C, 2002, ANN NEUROL, V52, P675, DOI 10.1002/ana.10358; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; Konakova M, 2001, BRAIN RES, V922, P1, DOI 10.1016/S0006-8993(01)03014-1; Kwong J, 2000, J CELL SCI, V113, P2273; Lee JT, 2008, HUM MOL GENET, V17, P906, DOI 10.1093/hmg/ddm363; Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111; Li YK, 2002, J BIOL CHEM, V277, P28212, DOI 10.1074/jbc.M111612200; Li YK, 2001, J BIOL CHEM, V276, P40824, DOI 10.1074/jbc.M106141200; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Rostasy K, 2003, NEUROBIOL DIS, V12, P11, DOI 10.1016/S0969-9961(02)00010-4; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Shashidharan P, 2000, BRAIN RES, V853, P197, DOI 10.1016/S0006-8993(99)02232-5; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Walker RH, 2002, NEUROLOGY, V58, P120, DOI 10.1212/WNL.58.1.120; Walker RH, 2001, BRAIN RES, V900, P348, DOI 10.1016/S0006-8993(01)02302-2; WAY M, 1995, J CELL BIOL, V128, P51, DOI 10.1083/jcb.128.1.51; Webber E, 2008, J MOL BIOL, V382, P638, DOI 10.1016/j.jmb.2008.07.045; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Xiao HF, 2004, DEV BRAIN RES, V152, P47, DOI 10.1016/j.devbrainres.2004.05.012; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015	72	20	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21765	21775		10.1074/jbc.M109.004838	http://dx.doi.org/10.1074/jbc.M109.004838			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535332	Green Published, hybrid			2022-12-27	WOS:000268564400068
J	Hughes, BT; Nwosu, CC; Espenshade, PJ				Hughes, Bridget T.; Nwosu, Christine C.; Espenshade, Peter J.			Degradation of Sterol Regulatory Element-binding Protein Precursor Requires the Endoplasmic Reticulum-associated Degradation Components Ubc7 and Hrd1 in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; SCHIZOSACCHAROMYCES-POMBE; UBIQUITIN-LIGASE; QUALITY-CONTROL; SREBP; GENE; CHOLESTEROL; EXPRESSION; AGENT; SCAP	Sre1, the fission yeast sterol regulatory element-binding protein (SREBP), is an endoplasmic reticulum (ER) membrane-bound transcription factor that is a principal regulator of hypoxic gene expression. Under low oxygen, Sre1 is cleaved from its inactive ER precursor form to generate an active nuclear transcription factor that up-regulates genes required for low oxygen growth. To maintain a constant supply of Sre1, Sre1 precursor synthesis must be regulated to replenish Sre1 precursor lost to proteolytic cleavage under low oxygen. In this study, we investigated the mechanisms controlling Sre1 precursor levels. We found that positive feedback regulation at the sre1(+) promoter increases the synthesis of the Sre1 precursor under low oxygen and that this regulation is required for maximal Sre1 activation and target gene expression. We also demonstrate that the Sre1 precursor is rapidly degraded by the proteasome in the absence of its binding partner Scp1, which is required for oxygen-regulated Sre1 cleavage. Degradation of Sre1 in the absence of Scp1 requires the ER-associated degradation (ERAD) components Ubc7, an E2 ubiquitin conjugating enzyme, and Hrd1, an E3 ubiquitin ligase. We conclude that positive feedback regulation to up-regulate Sre1 precursor synthesis under low oxygen is essential for Sre1 function and propose that excess Sre1 precursor is removed by ERAD to ensure complex formation between Sre1 and its binding partner Scp1. Thus, Sre1 is a new example of an endogenous ERAD substrate, establishing fission yeast as an organism for the study of this important degradative pathway.	[Hughes, Bridget T.; Nwosu, Christine C.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu			National Institutes of Health [HL-077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-077588.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Braun S, 2007, EMBO REP, V8, P1176, DOI 10.1038/sj.embor.7401105; Brauweiler A, 2007, ONCOGENE, V26, P2263, DOI 10.1038/sj.onc.1210017; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nielsen IS, 2002, EUKARYOT CELL, V1, P613, DOI 10.1128/EC1.4.613-625.2002; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006	29	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20512	20521		10.1074/jbc.M109.002436	http://dx.doi.org/10.1074/jbc.M109.002436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19520858	Green Published, hybrid			2022-12-27	WOS:000268316100012
J	Tomshine, JC; Severson, SR; Wigle, DA; Sun, ZF; Beleford, DAT; Shridhar, V; Horazdovsky, BF				Tomshine, Jin C.; Severson, Sandra R.; Wigle, Dennis A.; Sun, Zhifu; Beleford, Daniah A. T.; Shridhar, Vijayalakshmi; Horazdovsky, Bruce F.			Cell Proliferation and Epidermal Growth Factor Signaling in Non-small Cell Lung Adenocarcinoma Cell Lines Are Dependent on Rin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TUMOR-SUPPRESSOR GENE; FACTOR RECEPTOR; EGF RECEPTOR; TRANSDUCTION PATHWAYS; MULTIVESICULAR BODIES; DOWN-REGULATION; EARLY ENDOSOMES; ENDOCYTOSIS; RAB5	Rin1 is a Rab5 guanine nucleotide exchange factor that plays an important role in Ras-activated endocytosis and growth factor receptor trafficking in fibroblasts. In this study, we show that Rin1 is expressed at high levels in a large number of non-small cell lung adenocarcinoma cell lines, including Hop62, H650, HCC4006, HCC827, EKVX, HCC2935, and A549. Rin1 depletion from A549 cells resulted in a decrease in cell proliferation that was correlated to a decrease in epidermal growth factor receptor (EGFR) signaling. Expression of wild type Rin1 but not the Rab5 guanine nucleotide exchange factor-deficient Rin1 (Rin1 Delta) complemented the Rin1 depletion effects, and overexpression of Rin1 Delta had a dominant negative effect on cell proliferation. Rin1 depletion stabilized the cell surface levels of EGFR, suggesting that internalization was necessary for robust signaling in A549 cells. In support of this conclusion, introduction of either dominant negative Rab5 or dominant negative dynamin decreased A549 proliferation and EGFR signaling. These data demonstrate that proper internalization and endocytic trafficking are critical for EGFR-mediated signaling in A549 cells and suggest that up-regulation of Rin1 in A549 cell lines may contribute to their proliferative nature.	[Tomshine, Jin C.; Severson, Sandra R.; Horazdovsky, Bruce F.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wigle, Dennis A.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA; [Beleford, Daniah A. T.; Shridhar, Vijayalakshmi] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Sun, Zhifu] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Horazdovsky, BF (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	horazdovsky.bruce@mayo.edu		Sun, Zhifu/0000-0001-8461-7523				Balbis A, 2007, ENDOCRINOLOGY, V148, P2944, DOI 10.1210/en.2006-1674; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Barbieri MA, 2004, EUR J CELL BIOL, V83, P305, DOI 10.1078/0171-9335-00381; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Burd CG, 1996, MOL CELL BIOL, V16, P2369; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; Clague MJ, 2001, J CELL SCI, V114, P3075; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FOX CF, 1979, J SUPRAMOL STR CELL, V12, P517, DOI 10.1002/jss.400120411; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gill DJ, 2007, BIOCHEM SOC SYMP, V74, P47, DOI 10.1042/BSS2007c05; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; HAN LM, 1995, MOL CELL BIOL, V15, P1318; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Hu HL, 2008, MOL CELL BIOL, V28, P1573, DOI 10.1128/MCB.01087-07; Hunker CM, 2006, EXP CELL RES, V312, P1106, DOI 10.1016/j.yexcr.2005.12.021; Hunker CM, 2006, ANTICANCER RES, V26, P905; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; Milstein M, 2007, CANCER RES, V67, P11510, DOI 10.1158/0008-5472.CAN-07-1147; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NESTEROV A, 1994, ARCH BIOCHEM BIOPHYS, V313, P351, DOI 10.1006/abbi.1994.1398; Oksvold MP, 2000, J HISTOCHEM CYTOCHEM, V48, P21, DOI 10.1177/002215540004800103; PARTON RG, 1992, J CELL SCI, V103, P335; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; RACHWAL WJ, 1995, BRIT J CANCER, V72, P56, DOI 10.1038/bjc.1995.277; Senda K, 2007, ONCOL REP, V17, P1171; Shuster MI, 2000, GENE CHROMOSOME CANC, V28, P153, DOI 10.1002/(SICI)1098-2264(200006)28:2<153::AID-GCC4>3.0.CO;2-9; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Witters L, 1999, BREAST CANCER RES TR, V53, P41, DOI 10.1023/A:1006127527107; Zainabadi K, 2005, GENOMICS, V85, P704, DOI 10.1016/j.ygeno.2005.02.014; Zhang M, 2004, ACTA PHARMACOL SIN, V25, P61	46	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26331	26339		10.1074/jbc.M109.033514	http://dx.doi.org/10.1074/jbc.M109.033514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19570984	Green Published, hybrid			2022-12-27	WOS:000269969600013
J	Hardy, JA; Wells, JA				Hardy, Jeanne A.; Wells, James A.			Dissecting an Allosteric Switch in Caspase-7 Using Chemical and Mutational Probes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE INHIBITORS; STRUCTURAL BASIS; CELL-DEATH; ACTIVATION; APOPTOSIS; MECHANISM; SITE; SPECIFICITY; SUBSTRATE; PURIFICATION	Apoptotic caspases, such as caspase-7, are stored as inactive protease zymogens, and when activated, lead to a fate-determining switch to induce cell death. We previously discovered small molecule thiol-containing inhibitors that when tethered revealed an allosteric site and trapped a conformation similar to the zymogen form of the enzyme. We noted three structural transitions that the compounds induced: (i) breaking of an interaction between Tyr-223 and Arg-187 in the allosteric site, which prevents proper ordering of the catalytic cysteine; (ii) pinning the L2' loop over the allosteric site, which blocks critical interactions for proper ordering of the substrate-binding groove; and (iii) a hinge-like rotation at Gly-188 positioned after the catalytic Cys-186 and Arg-187. Here we report a systematic mutational analysis of these regions to dissect their functional importance to mediate the allosteric transition induced by these compounds. Mutating the hinge Gly-188 to the restrictive proline causes a massive similar to 6000-fold reduction in catalytic efficiency. Mutations in the Arg-187-Tyr-223 couple have a far less dramatic effect (3-20-fold reductions). Interestingly, although the allosteric couple mutants still allow binding and allosteric inhibition, they partially relieve the mutual exclusivity of binding between inhibitors at the active and allosteric sites. These data highlight a small set of residues critical for mediating the transition from active to inactive zymogen-like states.	[Hardy, Jeanne A.; Wells, James A.] Sunesis Pharmaceut, San Francisco, CA 94080 USA		Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Box 2552, San Francisco, CA 94143 USA.	jim.wells@ucsf.edu	Wells, Jim A/O-9854-2016	Hardy, Jeanne/0000-0002-3406-7997	National Institutes of Health [GM65048]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM065048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Postdoctoral Fellowship GM65048 (to J. H.).	Agniswamy J, 2007, FEBS J, V274, P4752, DOI 10.1111/j.1742-4658.2007.05994.x; ASBOTH B, 1985, BIOCHEMISTRY-US, V24, P606, DOI 10.1021/bi00324a010; Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chereau D, 2003, BIOCHEMISTRY-US, V42, P4151, DOI 10.1021/bi020593l; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; Denault JB, 2002, CHEM REV, V102, P4489, DOI 10.1021/cr010183n; Denault JB, 2006, MOL CELL, V23, P523, DOI 10.1016/j.molcel.2006.06.020; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Nuttall ME, 2001, DRUG DISCOV TODAY, V6, P85, DOI 10.1016/S1359-6446(00)01601-9; OBrien T, 2009, CRC ENZYM INHIB SER, P1; Reed JC, 2000, CURR OPIN BIOTECH, V11, P586, DOI 10.1016/S0958-1669(00)00148-8; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Romanowski MJ, 2004, STRUCTURE, V12, P1361, DOI 10.1016/j.str.2004.05.010; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Scheer JM, 2005, PROTEIN EXPRES PURIF, V41, P148, DOI 10.1016/j.pep.2005.01.008; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; Yeretssian G, 2008, CYTOKINE, V43, P380, DOI 10.1016/j.cyto.2008.07.015	31	36	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26063	26069		10.1074/jbc.M109.001826	http://dx.doi.org/10.1074/jbc.M109.001826			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19581639	hybrid, Green Published			2022-12-27	WOS:000269738000062
J	Warfel, JM; D'Agnillo, F				Warfel, Jason M.; D'Agnillo, Felice			Anthrax Lethal Toxin Enhances I kappa B Kinase Activation and Differentially Regulates Pro-inflammatory Genes in Human Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-ANTHRACIS; PROTECTIVE ANTIGEN; TNF-ALPHA; INHALATIONAL ANTHRAX; SIGNALING PATHWAYS; VCAM-1 EXPRESSION; MESSENGER-RNA; MAP KINASES; IKK-BETA; T-CELLS	Anthrax lethal toxin (LT) was previously shown to enhance transcriptional activity of NF-kappa B in tumor necrosis factor-alpha-activated primary human endothelial cells. Here we show that this LT-mediated increase in NF-kappa B activation is associated with the enhanced degradation of the inhibitory proteins I kappa B alpha and I kappa B beta but not I kappa B epsilon. Moreover, this was accompanied by enhanced activation of the I kappa B kinase complex (IKK), which is responsible for targeting I kappa B proteins for degradation. Importantly, LT enhancement of I kappa B alpha degradation was completely blocked by a selective IKK beta inhibitor, whereas I kappa B beta degradation was attenuated, suggesting a mechanistic link. Consistent with the above data, LT-cotreated cells show elevated phosphorylation of two IKK substrates, I kappa B alpha and p65, both of which were blocked by incubation with the IKK beta inhibitor. Consistent with NF-kappa B activation, LT increased transcription of the NF-kappa B regulated gene CD40. Conversely, LT inhibited transcription of another NF-kappa B-regulated gene, CCL2. This inhibition was linked to the LT-mediated suppression of another CCL2-regulating transcription factor, AP-1 (activator protein-1). These data suggest that LT-mediated enhancement of NF-kappa B is IKK-dependent, but importantly, the net effect of LT on the transcription of proinflammatory genes is driven by the cumulative effect of LT on the particular set of transcription factors that regulate a given promoter. Together, these findings provide new mechanistic insight on how LT may disrupt the host response to anthrax.	[Warfel, Jason M.; D'Agnillo, Felice] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Lab Biochem & Vasc Biol, Bethesda, MD 20892 USA; [Warfel, Jason M.] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20007 USA	US Food & Drug Administration (FDA); Georgetown University	D'Agnillo, F (corresponding author), 29 Lincoln Dr,Bldg 29,Rm 129, Bethesda, MD 20892 USA.	felice.dagnillo@fda.hhs.gov	Warfel, Jason M/D-2557-2011		National Institutes of Health-Georgetown University Graduate Partnership Program; Oak Ridge Institute for Science and Education	National Institutes of Health-Georgetown University Graduate Partnership Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Ridge Institute for Science and Education(General Electric)	This work was supported, in whole or in part, by the National Institutes of Health-Georgetown University Graduate Partnership Program ( to J. M. W.) and by the Research Fellowship Program administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the United States Department of Energy and United States Food and Drug Administration.	Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Boyer AE, 2007, ANAL CHEM, V79, P8463, DOI 10.1021/ac701741s; Budde LM, 2002, MOL BIOL CELL, V13, P4179, DOI 10.1091/mbc.01-07-0373; Chakrabarti S, 2007, J BIOL CHEM, V282, P18307, DOI 10.1074/jbc.M700211200; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005; Dal Molin F, 2008, TOXICON, V52, P824, DOI 10.1016/j.toxicon.2008.08.011; DeBusk LM, 2008, CANCER RES, V68, P10223, DOI 10.1158/0008-5472.CAN-08-1833; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Deshpande A, 2006, FEBS LETT, V580, P4172, DOI 10.1016/j.febslet.2006.06.070; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; Gupta RA, 2001, J BIOL CHEM, V276, P31059, DOI 10.1074/jbc.M104141200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Johnson DR, 1996, J BIOL CHEM, V271, P16317, DOI 10.1074/jbc.271.27.16317; Kang ZG, 2009, J MOL BIOL, V389, P595, DOI 10.1016/j.jmb.2009.04.030; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Krzesz R, 1999, FEBS LETT, V453, P191, DOI 10.1016/S0014-5793(99)00683-3; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Kupfer R, 2002, J IMMUNOL METHODS, V266, P155, DOI 10.1016/S0022-1759(02)00146-1; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Mabry R, 2006, CLIN VACCINE IMMUNOL, V13, P671, DOI 10.1128/CVI.00023-06; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moss NC, 2007, AM J PHYSIOL-HEART C, V293, pH2248, DOI 10.1152/ajpheart.00776.2007; Mourez M, 2005, REV PHYSIOL BIOCH P, V152, P135, DOI 10.1007/s10254-004-0028-2; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Park SK, 2004, NEPHROL DIAL TRANSPL, V19, P312, DOI 10.1093/ndt/gfg583; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Ramirez DM, 2002, J IND MICROBIOL BIOT, V28, P232, DOI 10.1038/sj/jim/700239; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; Shieh WJ, 2003, AM J PATHOL, V163, P1901, DOI 10.1016/S0002-9440(10)63548-1; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Spiecker M, 2000, J IMMUNOL, V164, P3316, DOI 10.4049/jimmunol.164.6.3316; Steele AD, 2005, BIOCHEM BIOPH RES CO, V337, P1249, DOI 10.1016/j.bbrc.2005.09.180; Strnad J, 2007, TRENDS PHARMACOL SCI, V28, P142, DOI 10.1016/j.tips.2007.01.005; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Wagner AH, 2002, BLOOD, V99, P520, DOI 10.1182/blood.V99.2.520; Walsh JJ, 2007, CLIN INFECT DIS, V44, P968, DOI 10.1086/512372; Warfel JM, 2008, J IMMUNOL, V180, P7516, DOI 10.4049/jimmunol.180.11.7516; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Winsauer G, 2008, CELL SIGNAL, V20, P2107, DOI 10.1016/j.cellsig.2008.08.004; Winsauer G, 2007, THROMB HAEMOSTASIS, V97, P364, DOI 10.1160/TH06-08-0473; Wu C, 2003, J BIOL CHEM, V278, P31980, DOI 10.1074/jbc.M304278200; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	71	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25761	25771		10.1074/jbc.M109.036970	http://dx.doi.org/10.1074/jbc.M109.036970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19620708	Green Published, hybrid			2022-12-27	WOS:000269738000034
J	Ravindra, KC; Selvi, BR; Arif, M; Reddy, BAA; Thanuja, GR; Agrawal, S; Pradhan, SK; Nagashayana, N; Dasgupta, D; Kundu, TK				Ravindra, Kodihalli C.; Selvi, B. Ruthrotha; Arif, Mohammed; Reddy, B. A. Ashok; Thanuja, Gali R.; Agrawal, Shipra; Pradhan, Suman Kalyan; Nagashayana, Natesh; Dasgupta, Dipak; Kundu, Tapas K.			Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, Plumbagin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P300 HISTONE ACETYLTRANSFERASE; ENHANCED RAMAN-SPECTROSCOPY; GLOBAL GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; CANCER CELLS; CHROMATIN TRANSCRIPTION; PROTEIN ACETYLATION; SMALL MOLECULES; HUMAN-DISEASE; DNA-DAMAGE	Lysine acetyltransferases (KATs), p300 (KAT3B), and its close homologue CREB-binding protein (KAT3A) are probably the most widely studied KATs with well documented roles in various cellular processes. Hence, the dysfunction of p300 may result in the dysregulation of gene expression leading to the manifestation of many disorders. The acetyltransferase activity of p300/CREB-binding protein is therefore considered as a target for new generation therapeutics. We describe here a natural compound, plumbagin (RTK1), isolated from Plumbago rosea root extract, that inhibits histone acetyltransferase activity potently in vivo. Interestingly, RTK1 specifically inhibits the p300-mediated acetylation of p53 but not the acetylation by another acetyltransferase, p300/CREB-binding protein-associated factor, PCAF, in vivo. RTK1 inhibits p300 histone acetyltransferase activity in a noncompetitive manner. Docking studies and site-directed mutagenesis of the p300 histone acetyltransferase domain suggest that a single hydroxyl group of RTK1 makes a hydrogen bond with the lysine 1358 residue of this domain. In agreement with this, we found that indeed the hydroxyl group-substituted plumbagin derivatives lost the acetyltransferase inhibitory activity. This study describes for the first time the chemical entity (hydroxyl group) required for the inhibition of acetyltransferase activity.	[Ravindra, Kodihalli C.; Selvi, B. Ruthrotha; Arif, Mohammed; Reddy, B. A. Ashok; Thanuja, Gali R.; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bangalore 560064, Karnataka, India; [Agrawal, Shipra] Int Technol Pk Bangalore, Inst Bioinformat & Appl Biotechnol, Bangalore 560066, Karnataka, India; [Nagashayana, Natesh] Cent Govt Hlth Scheme Dispensary 3, Bangalore 560004, Karnataka, India; [Pradhan, Suman Kalyan; Dasgupta, Dipak] Saha Inst Nucl Phys, Div Biophys, Kolkata 700064, W Bengal, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Saha Institute of Nuclear Physics	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in	B.A.Reddy, Ashok/AAD-2839-2021; Pradhan, Suman/O-4518-2015; Gali Ramamoorthy, Thanuja/AFV-8484-2022	Gali Ramamoorthy, Thanuja/0000-0003-3314-0352; Bharathavikru, Ruthrotha Selvi/0000-0002-3096-7461; Kundu, Tapas/0000-0001-7790-214X; MOHAMMED, ARIF/0000-0003-1300-5081	Department of Biotechnology, Government of India,; Jawaharlal Nehru Centre for Advanced Scientific Research	Department of Biotechnology, Government of India,(Department of Biotechnology (DBT) India); Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology, Government of India, and Jawaharlal Nehru Centre for Advanced Scientific Research.	Acharya BR, 2008, BIOCHEMISTRY-US, V47, P7838, DOI 10.1021/bi800730q; Arif M, 2009, J MED CHEM, V52, P267, DOI 10.1021/jm800657z; Arif M, 2007, J PHYS CHEM B, V111, P11877, DOI 10.1021/jp0762931; Bai X, 2008, J CANCER RES CLIN, V134, P83, DOI 10.1007/s00432-007-0252-7; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; Batta Kiran, 2007, Subcell Biochem, V41, P193; Biel M, 2004, ANGEW CHEM INT EDIT, V43, P3974, DOI 10.1002/anie.200453879; Chan HM, 2001, J CELL SCI, V114, P2363; Choi KC, 2009, CANCER RES, V69, P583, DOI 10.1158/0008-5472.CAN-08-2442; Davidson SM, 2005, CHEMBIOCHEM, V6, P162, DOI 10.1002/cbic.200400246; DINDA B, 1995, INDIAN J CHEM B, V34, P525; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Gomathinayagam R, 2008, ANTICANCER RES, V28, P785; Goodman RH, 2000, GENE DEV, V14, P1553; Grant PA, 1999, SEMIN CELL DEV BIOL, V10, P169, DOI 10.1006/scdb.1999.0298; Heery DM, 2007, DRUG DISCOV TODAY, V12, P88, DOI 10.1016/j.drudis.2006.11.012; Hsu YL, 2006, J PHARMACOL EXP THER, V318, P484, DOI 10.1124/jpet.105.098863; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Mantelingu K, 2007, J PHYS CHEM B, V111, P4527, DOI 10.1021/jp067655s; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Sarli V, 2007, CHEM BIOL, V14, P605, DOI 10.1016/j.chembiol.2007.06.001; Stimson L, 2005, MOL CANCER THER, V4, P1521, DOI 10.1158/1535-7163.MCT-05-0135; SWAMINATHAN V, 2007, CHROMATIN DIS, V41, P397; Varier RA, 2006, CURR PHARM DESIGN, V12, P1975, DOI 10.2174/138161206777442092; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	36	97	98	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24453	24464		10.1074/jbc.M109.023861	http://dx.doi.org/10.1074/jbc.M109.023861			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19570987	Green Published, hybrid			2022-12-27	WOS:000269380200058
J	Verstak, B; Nagpal, K; Bottomley, SP; Golenbock, DT; Hertzog, PJ; Mansell, A				Verstak, Brett; Nagpal, Kamalpreet; Bottomley, Stephen P.; Golenbock, Douglas T.; Hertzog, Paul J.; Mansell, Ashley			MyD88 Adapter-like (Mal)/TIRAP Interaction with TRAF6 Is Critical for TLR2-and TLR4-mediated NF-kappa B Proinflammatory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; SIGNAL-TRANSDUCTION; CUTTING EDGE; TIR-DOMAIN; ACTIVATION; TLR4; MOLECULE; PATHWAY; TRIF; TOLL-LIKE-RECEPTOR-4	Toll/interleukin-1 (TIR)receptor-containing adapters are critical in orchestrating the different signal transduction pathways following Toll-like receptor (TLR) activation. MyD88 adapter-like (Mal), also termed TIRAP, is involved in bridging MyD88 to the receptor complex for TLR-2 and TLR4 signaling in response to bacterial infection. We have previously reported an interaction between Mal and tumor necrosis factor receptor-associated factor 6 (TRAF6) via a TRAF6-binding motif, the disruption of which inhibited TLR-mediated NF-kappa B-luciferase reporter activity. Given the recent report of intracellular TRAM localization promoting sequential signaling in TLR4 responses, we further characterized Mal interaction with TRAF6, the cellular localization, and the outcomes of disrupting this association on TLR inflammatory responses. We found that Mal and TRAF6 directly interact in response to TLR2 and TLR4 stimulation, although membrane localization is not necessary to facilitate interaction. Critically, reconstitution of murine Mal-deficient macrophages with MalE190A, containing a mutation within the TRAF6-binding motif, fails to reconstitute the proinflammatory response to TLR2 and TLR4 ligands compared with wild type Mal. Furthermore, Mal interaction with TRAF6 mediates Ser phosphorylation of the p65 subunit of NF-kappa B and thus controls transcriptional activation but not nuclear translocation of NF-kappa B. This study characterizes the novel role for Mal in facilitating the direct recruitment of TRAF6 to the plasma membrane, which is necessary for TLR2- and TLR4-induced transactivation of NF-kappa B and regulation of the subsequent pro-inflammatory response.	[Verstak, Brett; Hertzog, Paul J.; Mansell, Ashley] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Verstak, Brett] Univ Massachusetts, Sch Med, Cooperat Res Ctr Chron Inflammatory Dis, Worcester, MA 01605 USA; [Nagpal, Kamalpreet; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA 01605 USA; [Bottomley, Stephen P.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Monash University	Mansell, A (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.	ashley.mansell@med.monash.edu.au	Hertzog, Paul J/G-6734-2013; Mansell, Ashley/B-9553-2008; Hertzog, Paul J/I-7053-2013	Hertzog, Paul J/0000-0002-1373-8472; Mansell, Ashley/0000-0002-6540-1281; Hertzog, Paul J/0000-0002-1373-8472				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Watts C, 2008, NAT IMMUNOL, V9, P343, DOI 10.1038/ni0408-343; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	33	156	164	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24192	24203		10.1074/jbc.M109.023044	http://dx.doi.org/10.1074/jbc.M109.023044			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592497	Green Published, hybrid			2022-12-27	WOS:000269380200033
J	Maxwell, SA; Li, ZG; Jaya, D; Ballard, S; Ferrell, J; Fu, HA				Maxwell, Steve A.; Li, Zenggang; Jaya, David; Ballard, Scott; Ferrell, Jay; Fu, Haian			14-3-3 zeta Mediates Resistance of Diffuse Large B Cell Lymphoma to an Anthracycline-based Chemotherapeutic Regimen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER CELLS; P53-MEDIATED APOPTOSIS; MITOTIC CATASTROPHE; GENE-EXPRESSION; PROTEINS; SURVIVAL; BAD; 14-3-3-PROTEINS; IDENTIFICATION; CARCINOMA	Patients presenting with diffuse large B cell lymphoma (DLBCL) are treated with a standard anthracycline-based chemotherapeutic mixture consisting of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Half of DLBCL patients will develop chemo-refractory tumors due to the emergence of CHOP-resistant DLBCL cells. We isolated DLBCL cells that were resistant to CHOP as a model system to investigate the molecular basis of CHOP resistance. Resistant cells emerged from CHOP-sensitive DLBCL populations after repeated cycles of on-off exposure to stepwise increased dosages of CHOP. A proteomic analysis of CHOP-sensitive and -resistant DLBCL cells identified the zeta isoform of the 14-3-3 family as a differentially expressed protein. CHOP-sensitive cells showed reduced expression of 14-3-3 zeta protein in the presence of high-dose CHOP relative to control cells. In contrast, CHOP-resistant cells expressed markedly higher levels of 14-3-3 zeta regardless the presence of high-dose CHOP. Because 14-3-3 zeta is known to exert anti-apoptotic influences and chemoresistance in lung, colon, and prostate carcinoma, we hypothesized that 14-3-3 zeta promotes survival of DLBCL cells in CHOP. In support of our hypothesis, knockdown of 14-3-3 zeta by small interfering RNA restored the sensitivity of resistant DLBCL to CHOP-induce apoptosis. In addition, 14-3-3 zeta expression was highly up-regulated in a resected DLBCL lymph node relative to a normal lymph node by Western blot analysis. Furthermore, more than half of 35 DLBCL tissues showed elevated 14-3-3 zeta expression relative to normal lymph tissue by immunohistochemical analysis. Our study implicates 14-3-3 zeta in the pathogenesis of DLBCL and suggests a promising combination strategy with a 14-3-3 inhibitor for the treatment of refractory DLBCL.	[Maxwell, Steve A.; Ballard, Scott; Ferrell, Jay] Texas A&M Syst Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77840 USA; [Li, Zenggang; Jaya, David; Fu, Haian] Emory Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Emory University	Maxwell, SA (corresponding author), Texas A&M Syst Hlth Sci Ctr, Dept Mol & Cellular Med, Rm 440,Reynolds Med Bldg, College Stn, TX 77840 USA.	smaxwell@medicine.tamhsc.edu		jaye, david/0000-0001-7977-6909				Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Chatterjee D, 2004, INT J ONCOL, V25, P503; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Chumsri S, 2008, CURR OPIN MOL THER, V10, P323; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Coiffier B, 2002, ANTI-CANCER DRUG, V13, pS43, DOI 10.1097/00001813-200211002-00007; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Dong S, 2008, LEUKEMIA, V22, P572, DOI 10.1038/sj.leu.2405064; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Huber E, 2004, J VIROL, V78, P7478, DOI 10.1128/JVI.78.14.7478-7489.2004; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kumar AP, 2003, CARCINOGENESIS, V24, P209, DOI 10.1093/carcin/24.2.209; Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Liou JY, 2007, CANCER RES, V67, P3185, DOI 10.1158/0008-5472.CAN-06-3431; Lossos IS, 2004, CLIN LYMPHOMA, V5, P128, DOI 10.1016/S1526-9655(11)70069-0; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Matta A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-169; Maxwell SA, 2000, APOPTOSIS, V5, P277, DOI 10.1023/A:1009660714216; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; Muslin AJ, 2005, CURR TOP DEV BIOL, V65, P211; Ng AK, 2007, SEMIN RADIAT ONCOL, V17, P169, DOI 10.1016/j.semradonc.2007.02.002; Ngan CY, 2008, CANCER SCI, V99, P129, DOI 10.1111/j.1349-7006.2007.00637.x; Niemantsverdriet M, 2008, ONCOGENE, V27, P1315, DOI 10.1038/sj.onc.1210742; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Qi WQ, 2007, MOL CARCINOGEN, V46, P847, DOI 10.1002/mc.20314; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Qi WQ, 2003, RADIAT RES, V160, P217, DOI 10.1667/RR3038; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; REFF ME, 1994, BLOOD, V83, P435; Rivera A, 2006, CELL MOL LIFE SCI, V63, P1425, DOI 10.1007/s00018-006-5521-5; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Shoji Masahiro, 1994, Human Antibodies and Hybridomas, V5, P123; Sinha P, 2000, ELECTROPHORESIS, V21, P3048, DOI 10.1002/1522-2683(20000801)21:14<3048::AID-ELPS3048>3.0.CO;2-W; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Zang L, 2004, J PROTEOME RES, V3, P604, DOI 10.1021/pr034131l; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	49	48	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22379	22389		10.1074/jbc.M109.022418	http://dx.doi.org/10.1074/jbc.M109.022418			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19525224	hybrid, Green Published			2022-12-27	WOS:000268783700060
J	Pruitt, RN; Chagot, B; Cover, M; Chazin, WJ; Spiller, B; Lacy, DB				Pruitt, Rory N.; Chagot, Benjamin; Cover, Michael; Chazin, Walter J.; Spiller, Ben; Lacy, D. Borden			Structure-Function Analysis of Inositol Hexakisphosphate-induced Autoprocessing in Clostridium difficile Toxin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE DOMAIN; RTX TOXIN; CLEAVAGE; CELLS; GLUCOSYLATION; SITE	The action of Clostridium difficile toxins A and B depends on inactivation of host small G-proteins by glucosylation. Cellular inositol hexakisphosphate (InsP6) induces an autocatalytic cleavage of the toxins, releasing an N-terminal glucosyltransferase domain into the host cell cytosol. We have defined the cysteine protease domain (CPD) responsible for autoprocessing within toxin A (TcdA) and report the 1.6 angstrom x-ray crystal structure of the domain bound to InsP6. InsP6 is bound in a highly basic pocket that is separated from an unusual active site by a beta-flap structure. Functional studies confirm an intramolecular mechanism of cleavage and highlight specific residues required for InsP6-induced TcdA processing. Analysis of the structural and functional data in the context of sequences from similar and diverse origins highlights a C-terminal extension and a pi-cation interaction within the beta-flap that appear to be unique among the large clostridial cytotoxins.	[Pruitt, Rory N.; Cover, Michael; Spiller, Ben; Lacy, D. Borden] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Chagot, Benjamin; Chazin, Walter J.; Lacy, D. Borden] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Spiller, Ben] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Lacy, DB (corresponding author), A-5301 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	borden.lacy@vanderbilt.edu	Chagot, Benjamin/AAC-6495-2019; Lacy, D. Borden/AFQ-2203-2022; Chagot, Benjamin/H-3258-2011	Chagot, Benjamin/0000-0002-9153-0060; Lacy, Borden/0000-0003-2273-8121; Cover, Michael/0000-0003-4136-3599	National Institutes of Health [RO1 GM075156]; Cellular and Molecular Microbiology Training; Germs and Defense Summer Science Academy; Vanderbilt University Medical Center development; United States Department of Energy; Office of Science; Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Microbiology Training; Germs and Defense Summer Science Academy; Vanderbilt University Medical Center development; United States Department of Energy(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM075156 (to W. J. C.). This work was also supported by a Cellular and Molecular Microbiology Training Grant (to R. N. P.), the Germs and Defense Summer Science Academy (to M. C.), and Vanderbilt University Medical Center development funds. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Gerhard R, 2008, J MED MICROBIOL, V57, P765, DOI 10.1099/jmm.0.47769-0; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; MCFARLAND LV, 1986, AM J INFECT CONTROL, V14, P99, DOI 10.1016/0196-6553(86)90018-0; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2009, PROTEIN SCI, V18, P856, DOI 10.1002/pro.78; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	29	89	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21934	21940		10.1074/jbc.M109.018929	http://dx.doi.org/10.1074/jbc.M109.018929			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553670	Green Published, hybrid			2022-12-27	WOS:000268783700018
J	Carpena, X; Vidossich, P; Schroettner, K; Calisto, BM; Banerjee, S; Stampler, J; Soudi, M; Furtmuller, PG; Rovira, C; Fita, I; Obinger, C				Carpena, Xavier; Vidossich, Pietro; Schroettner, Klarissa; Calisto, Barbara M.; Banerjee, Srijib; Stampler, Johanna; Soudi, Monika; Furtmueller, Paul G.; Rovira, Carme; Fita, Ignacio; Obinger, Christian			Essential Role of Proximal Histidine-Asparagine Interaction in Mammalian Peroxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; HUMAN MYELOPEROXIDASE; LINKAGE; REDOX; HEME; SUPERFAMILY; REACTIVITY; EVOLUTION; OXIDATION; BINDING	In heme enzymes belonging to the peroxidase-cyclooxygenase superfamily the proximal histidine is in close interaction with a fully conserved asparagine. The crystal structure of a mixture of glycoforms of myeloperoxidase (MPO) purified from granules of human leukocytes prompted us to revise the orientation of this asparagine and the protonation status of the proximal histidine. The data we present contrast with previous MPO structures, but are strongly supported by molecular dynamics simulations. Moreover, comprehensive analysis of published lactoperoxidase structures suggest that the described proximal heme architecture is a general structural feature of animal heme peroxidases. Its importance is underlined by the fact that the MPO variant N421D, recombinantly expressed in mammalian cell lines, exhibited modified spectral properties and diminished catalytic activity compared with wild-type recombinant MPO. It completely lost its ability to oxidize chloride to hypochlorous acid, which is a characteristic feature of MPO and essential for its role in host defense. The presented crystal structure of MPO revealed further important differences compared with the published structures including the extent of glycosylation, interaction between light and heavy polypeptides, as well as heme to protein covalent bonds. These data are discussed with respect to biosynthesis and post-translational maturation of MPO as well as to its peculiar biochemical and biophysical properties.	[Banerjee, Srijib; Stampler, Johanna; Soudi, Monika; Furtmueller, Paul G.; Obinger, Christian] Univ Nat Resources & Appl Life Sci, Div Biochem, Dept Chem, Metalloprot Res Grp, A-1190 Vienna, Austria; [Carpena, Xavier; Schroettner, Klarissa; Calisto, Barbara M.; Fita, Ignacio] Inst Res Biomed, Barcelona 08028, Spain; [Carpena, Xavier; Schroettner, Klarissa; Calisto, Barbara M.; Fita, Ignacio] CSIC, IBMB, Inst Mol Biol, E-08028 Barcelona, Spain; [Vidossich, Pietro; Rovira, Carme] CoSMoLab, Lab Simulacio Computac & Modelitzacio, Barcelona 08028, Spain; [Vidossich, Pietro; Rovira, Carme] Inst Quim Teor & Computac IQTCUB, Barcelona 08028, Spain; [Rovira, Carme] ICREA, Barcelona 08028, Spain	University of Natural Resources & Life Sciences, Vienna; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona; ICREA	Obinger, C (corresponding author), Univ Nat Resources & Appl Life Sci, Div Biochem, Dept Chem, Metalloprot Res Grp, Muthgasse 18, A-1190 Vienna, Austria.	christian.obinger@boku.ac.at	Carpena, Xavi/J-5877-2017; Rovira, Carme/K-5195-2014; Furtmüller, Paul G./Y-5819-2018; Obinger, Christian/AAV-3173-2021; Fita, Ignasi/R-4515-2019	Carpena, Xavi/0000-0002-8646-0440; Rovira, Carme/0000-0003-1477-5010; Furtmüller, Paul G./0000-0002-1199-2469; Fita, Ignasi/0000-0002-7521-2679; Obinger, Christian/0000-0002-7133-3430; Calisto, Barbara/0000-0003-1732-571X	Spanish Ministerio de Educacion y Ciencia [FIS2008-03845, BIO2005-08686-C02-01]; Generalitat de Catalunya [2005SGR-00112, 2005SGR-00036]; Austrian Science Fund [P20664]; Spanish Research Council; ICREA Funding Source: Custom	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Austrian Science Fund(Austrian Science Fund (FWF)); Spanish Research Council; ICREA(ICREA)	This work was supported by Spanish Ministerio de Educacion y Ciencia Grants FIS2008-03845 and BIO2005-08686-C02-01, Generalitat de Catalunya Grants 2005SGR-00112 and 2005SGR-00036, and Austrian Science Fund FWF project P20664 (to P. G. F.). This work was also supported by a grant from the I3P program of the Spanish Research Council (to X. C.).	Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Doerge DR, 1997, ANAL BIOCHEM, V250, P10, DOI 10.1006/abio.1997.2191; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2001, FEBS LETT, V503, P147, DOI 10.1016/S0014-5793(01)02725-9; GLEICH GJ, 1989, INT ARCH ALLER A IMM, V88, P59, DOI 10.1159/000234749; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; JOHNSON KR, 1987, NUCLEIC ACIDS RES, V15, P2013, DOI 10.1093/nar/15.5.2013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KETTLE AJ, 1988, BIOCHIM BIOPHYS ACTA, V957, P185, DOI 10.1016/0167-4838(88)90271-3; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHLSSON PI, 1983, ACTA CHEM SCAND B, V37, P917, DOI 10.3891/acta.chem.scand.37b-0917; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oxvig C, 1999, J BIOL CHEM, V274, P16953, DOI 10.1074/jbc.274.24.16953; Passardi F, 2007, GENOMICS, V89, P567, DOI 10.1016/j.ygeno.2007.01.006; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Taurog A, 1970, Recent Prog Horm Res, V26, P189; THOMAS EL, 1999, PEROXIDASES CHEM BIO, P1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Welinder KG., 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [10.1016/0959-440x(92)90230-5, DOI 10.1016/0959-440X(92)90230-5]; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zederbauer M, 2007, J BIOL CHEM, V282, P17041, DOI 10.1074/jbc.M610685200; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	41	62	64	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25929	25937		10.1074/jbc.M109.002154	http://dx.doi.org/10.1074/jbc.M109.002154			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19608745	Green Published, hybrid			2022-12-27	WOS:000269738000049
J	Hankins, JV; Trent, MS				Hankins, Jessica V.; Trent, M. Stephen			Secondary Acylation of Vibrio cholerae Lipopolysaccharide Requires Phosphorylation of Kdo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-MANNO-OCTULOSONIC ACID TRANSFERASE; LIPID-A BIOSYNTHESIS; COLI-MSBB GENE; ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; HELICOBACTER-PYLORI; SALMONELLA-TYPHIMURIUM; CHEMICAL-STRUCTURE; ACYL CHAINS; VIRULENCE	The lipopolysaccharide of Vibrio cholerae has been reported to contain a single 3-deoxy-D-manno-octulosonic acid (Kdo) residue that is phosphorylated. The phosphorylated Kdo sugar further links the hexa-acylated V. cholerae lipid A domain to the core oliogosaccharide and O-antigen. In this report, we confirm that V. cholerae possesses the enzymatic machinery to synthesize a phosphorylated Kdo residue. Further, we have determined that the presence of the phosphate group on the Kdo residue is necessary for secondary acylation in V. cholerae. The requirement for a secondary substituent on the Kdo residue (either an additional Kdo sugar or a phosphate group) was also found to be critical for secondary acylation catalyzed by LpxL proteins from Bordetella pertussis, Escherichia coli, and Haemophilus influenzae. Although three putative late acyltransferase orthologs have been identified in the V. cholerae genome (Vc0212, Vc0213, and Vc1577), only Vc0213 appears to be functional. Vc0213 functions as a myristoyl transferase acylating lipid A at the 2'-position of the glucosamine disaccharide. Generally acyl-ACPs serve as fatty acyl donors for the acyltransferases required for lipopolysaccharide biosynthesis; however, in vitro assays indicate that Vc0213 preferentially utilizes myristoyl-CoA as an acyl donor. This is the first report to biochemically characterize enzymes involved in the biosynthesis of the V. cholerae Kdo-lipid A domain.	[Trent, M. Stephen] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Trent, M. Stephen] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Hankins, Jessica V.] Med Coll Georgia, Dept Mol Biochem & Biochem, Augusta, GA 30912 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University System of Georgia; Augusta University	Trent, MS (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA.	strent@mail.utexas.edu			National Institutes of Health [AI076322, AI064184]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076322, R01AI064184, R01AI076322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI076322 and AI064184 ( to M. S. T.).	BELUNIS CJ, 1995, J BIOL CHEM, V270, P27646, DOI 10.1074/jbc.270.46.27646; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Boutonnier A, 2001, INFECT IMMUN, V69, P3488, DOI 10.1128/IAI.69.5.3488-3493.2001; Brabetz W, 2000, J BIOL CHEM, V275, P34954, DOI 10.1074/jbc.M005204200; BRADE H, 1985, J BACTERIOL, V161, P795, DOI 10.1128/JB.161.2.795-798.1985; BROADY KW, 1981, EUR J BIOCHEM, V115, P463; BROZEK KA, 1992, METHOD ENZYMOL, V209, P476; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; Caroff M, 2001, J ENDOTOXIN RES, V7, P63, DOI 10.1177/09680519010070011101; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; HELANDER IM, 1988, EUR J BIOCHEM, V177, P483, DOI 10.1111/j.1432-1033.1988.tb14398.x; Hood DW, 2001, MOL MICROBIOL, V39, P341, DOI 10.1046/j.1365-2958.2001.02204.x; Isobe T, 1999, J BACTERIOL, V181, P2648, DOI 10.1128/JB.181.8.2648-2651.1999; Jones BD, 1997, INFECT IMMUN, V65, P4778, DOI 10.1128/IAI.65.11.4778-4783.1997; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; MOHAN S, 1994, J BACTERIOL, V176, P6944, DOI 10.1128/JB.176.22.6944-6951.1994; Nichols WA, 1997, J ENDOTOXIN RES, V4, P163, DOI 10.1177/096805199700400301; PHILLIPS NJ, 1992, BIOCHEMISTRY-US, V31, P4515, DOI 10.1021/bi00133a019; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; SIX DA, 2008, BIOCHEMISTRY-US, V65, P4778; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Somerville JE, 1999, INFECT IMMUN, V67, P6583; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Stead CM, 2008, J BACTERIOL, V190, P7012, DOI 10.1128/JB.00667-08; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tran AX, 2006, J BACTERIOL, V188, P4531, DOI 10.1128/JB.00146-06; Tran AX, 2004, J BIOL CHEM, V279, P55780, DOI 10.1074/jbc.M406480200; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; Villeneuve S, 2000, P NATL ACAD SCI USA, V97, P8433, DOI 10.1073/pnas.060022997; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; White KA, 1997, J BIOL CHEM, V272, P16555, DOI 10.1074/jbc.272.26.16555; White KA, 1999, J BIOL CHEM, V274, P31391, DOI 10.1074/jbc.274.44.31391	42	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25804	25812		10.1074/jbc.M109.022772	http://dx.doi.org/10.1074/jbc.M109.022772			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617350	Green Published, hybrid			2022-12-27	WOS:000269738000038
J	Cui, YX; Freedman, JH				Cui, Yuxia; Freedman, Jonathan H.			Cadmium Induces Retinoic Acid Signaling by Regulating Retinoic Acid Metabolic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAROTENE 15,15'-DIOXYGENASE ACTIVITY; INDUCED LIMB DEFECTS; BETA-CAROTENE; CAENORHABDITIS-ELEGANS; 15,15'-MONOOXYGENASE GENE; MATERNAL EXPOSURE; SPECIAL EMPHASIS; MOUSE EMBRYOS; PROVITAMIN-A; WISTAR RAT	The transition metal cadmium is an environmental teratogen. In addition, cadmium and retinoic acid can act synergistically to induce forelimb malformations. The molecular mechanism underlying the teratogenicity of cadmium and the synergistic effect with retinoic acid has not been addressed. An evolutionarily conserved gene, beta,beta-carotene 15,15'-monooxygenase (BCMO), which is involved in retinoic acid biosynthesis, was studied in both Caenorhabditis elegans and murine Hepa 1-6 cells. In C. elegans, bcmo-1 was expressed in the intestine and was cadmium inducible. Similarly, in Hepa 1-6 cells, Bcmo1 was induced by cadmium. Retinoic acid-mediated signaling increased after 24-h exposures to 5 and 10 mu M cadmium in Hepa 1-6 cells. Examination of gene expression demonstrated that the induction of retinoic acid signaling by cadmium may be mediated by overexpression of Bcmo1. Furthermore, cadmium inhibited the expression of Cyp26a1 and Cyp26b1, which are involved in retinoic acid degradation. These results indicate that cadmium-induced teratogenicity may be due to the ability of the metal to increase the levels of retinoic acid by disrupting the expression of retinoic acid-metabolizing genes.	[Cui, Yuxia; Freedman, Jonathan H.] NIEHS, Comparat Genom Grp, Mol Toxicol Lab, Natl Inst Hlth, Durham, NC 27709 USA; [Cui, Yuxia] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Freedman, JH (corresponding author), NIEHS, Mol Toxicol Lab, NIH, Mail Drop E1-05,POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	freedma1@niehs.nih.gov			National Institutes of Health [U19ES011375, R01ES009949]; NIH; NIEHS [Z01ES102045]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES011375, ZIAES102045, Z01ES102045, R01ES009949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant U19ES011375 and R01ES009949 (to J. H. F.) and by the Intramural Research Program of NIH and NIEHS (Grant Z01ES102045).	*AG TOX SUBST DIS, 2007, CERCLA PRIOR LIST HA; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; DE SK, 1990, TOXICOLOGY, V64, P89, DOI 10.1016/0300-483X(90)90102-M; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; During A, 1998, BIOCHEM BIOPH RES CO, V249, P467, DOI 10.1006/bbrc.1998.9160; During A, 2000, BRIT J NUTR, V84, P117; Elsaid AF, 2007, MOL GENET METAB, V92, P258, DOI 10.1016/j.ymgme.2007.05.018; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Franssen-van Hal NLW, 2005, ARCH BIOCHEM BIOPHYS, V439, P32, DOI 10.1016/j.abb.2005.05.001; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; GOYER RA, 1991, FUND APPL TOXICOL, V16, P22, DOI 10.1016/0272-0590(91)90130-V; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; HOLT D, 1987, ARCH TOXICOL, V59, P443, DOI 10.1007/BF00316212; Hovland DN, 1999, TERATOLOGY, V60, P13, DOI 10.1002/(SICI)1096-9926(199907)60:1<13::AID-TERA6>3.0.CO;2-B; Hovland DN, 2000, GENOMICS, V63, P193, DOI 10.1006/geno.1999.6069; IARC Working Group on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, 1993, BER CADM MERC EXP GL; Jin TY, 1998, NEUROTOXICOLOGY, V19, P529; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Koizumi S, 2003, J OCCUP HEALTH, V45, P331, DOI 10.1539/joh.45.331; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; LAYTON WM, 1979, TERATOLOGY, V19, P229, DOI 10.1002/tera.1420190213; Lee GS, 2006, BIRTH DEFECTS RES A, V76, P19, DOI 10.1002/bdra.20201; LEVIN AA, 1987, TERATOLOGY, V36, P163, DOI 10.1002/tera.1420360203; Liao XY, 2007, TOXICOL APPL PHARM, V225, P47, DOI 10.1016/j.taap.2007.06.005; MAHALIK MP, 1995, TOXICOL LETT, V76, P195, DOI 10.1016/0378-4274(95)80003-V; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; MESSERLE K, 1982, TERATOLOGY, V25, P61, DOI 10.1002/tera.1420250109; MILAIRE J, 1985, TERATOLOGY, V32, P433, DOI 10.1002/tera.1420320313; Mostbock S, 2002, GEN PHYSIOL BIOPHYS, V21, P443; Nishijo M, 2002, OCCUP ENVIRON MED, V59, P394, DOI 10.1136/oem.59.6.394; PADMANABHAN R, 1990, REPROD TOXICOL, V4, P291, DOI 10.1016/0890-6238(90)90041-S; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Perlmann T, 2002, NAT GENET, V31, P7, DOI 10.1038/ng877; Piasek M, 2001, REPROD TOXICOL, V15, P673, DOI 10.1016/S0890-6238(01)00174-5; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; RAMSEY FL, 2002, STAT SLEUTH COURSE M, P162; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; Ronco AM, 2005, BIOMETALS, V18, P233, DOI 10.1007/s10534-005-0583-2; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Scott WJ, 2005, REPROD TOXICOL, V19, P479, DOI 10.1016/j.reprotox.2004.11.013; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Soukupova D, 1991, Funct Dev Morphol, V1, P3; Stiernagle Theresa, 2006, WormBook, P1; SULSTON J, 1988, NEMATODE CAENORHABDI, P123; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sunderman F W Jr, 1992, IARC Sci Publ, P249; Takeda A, 2003, J NUTR SCI VITAMINOL, V49, P69, DOI 10.3177/jnsv.49.69; Takitani K, 2006, EUR J NUTR, V45, P320, DOI 10.1007/s00394-006-0601-3; Thompson J, 2001, TERATOLOGY, V64, P87, DOI 10.1002/tera.1050; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WAALKES MP, 1992, CRIT REV TOXICOL, V22, P175, DOI 10.3109/10408449209145323; White RJ, 2008, DEV DYNAM, V237, P2775, DOI 10.1002/dvdy.21695; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Wyss A, 2004, J NUTR, V134, p246S, DOI 10.1093/jn/134.1.246S	62	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24925	24932		10.1074/jbc.M109.026609	http://dx.doi.org/10.1074/jbc.M109.026609			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19556237	Green Published, hybrid			2022-12-27	WOS:000269734000026
J	Freeman, L; Buisson, M; Tarbouriech, N; Van der Heyden, A; Labbe, P; Burmeister, WP				Freeman, Lucy; Buisson, Marlyse; Tarbouriech, Nicolas; Van der Heyden, Angeline; Labbe, Pierre; Burmeister, Wim P.			The Flexible Motif V of Epstein-Barr Virus Deoxyuridine 5 '-Triphosphate Pyrophosphatase Is Essential for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FELINE IMMUNODEFICIENCY VIRUS; DUTP PYROPHOSPHATASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; ESCHERICHIA-COLI; NUCLEOTIDE COMPLEXES; MONOMERIC DUTPASE; MECHANISM; TRIPHOSPHATE; PHOSPHATE	Deoxyuridine 5'-triphosphate pyrophosphatases (dUTPases) are ubiquitous enzymes essential for hydrolysis of dUTP, thus preventing its incorporation into DNA. Although Epstein-Barr virus (EBV) dUTPase is monomeric, it has a high degree of similarity with the more frequent trimeric form of the enzyme. In both cases, the active site is composed of five conserved sequence motifs. Structural and functional studies of mutants based on the structure of EBV dUTPase gave new insight into the mechanism of the enzyme. A first mutant allowed us to exclude a role in enzymatic activity for the disulfide bridge involving the beginning of the disordered C terminus. Sequence alignments revealed two groups of dUTPases, based on the position in sequence of a conserved aspartic acid residue close to the active site. Single mutants of this residue in EBV dUTPase showed a highly impaired catalytic activity, which could be partially restored by a second mutation, making EBV dUTPase more similar to the second group of enzymes. Deletion of the flexible C-terminal tail carrying motif V resulted in a protein completely devoid of enzymatic activity, crystallizing with unhydrolyzed Mg2+-dUTP complex in the active site. Point mutations inside motif V highlighted the essential role of lid residue Phe(273). Magnesium appears to play a role mainly in substrate binding, since in absence of Mg2+, the K-m of the enzyme is reduced, whereas the k(cat) is less affected.	[Burmeister, Wim P.] Univ Grenoble, UVHCI, CNRS, UMI3265,UJF,EMBL, F-38042 Grenoble 9, France; [Van der Heyden, Angeline; Labbe, Pierre] Univ Grenoble, Dept Chim Mol, F-38042 Grenoble 9, France; [Burmeister, Wim P.] Inst Univ France, F-75005 Paris, France; [Buisson, Marlyse] Hop Michallon, Virol Lab, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut Universitaire de France; CHU Grenoble Alpes	Burmeister, WP (corresponding author), Univ Grenoble, UVHCI, CNRS, UMI3265,UJF,EMBL, BP 181, F-38042 Grenoble 9, France.	wpb@embl.fr		tarbouriech, nicolas/0000-0002-0206-3959; Burmeister, Wim/0000-0003-0876-6118; VAN DER HEYDEN, Angeline/0000-0003-0369-3765	Region Rhone-Alpes	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	Supported by the Region Rhone-Alpes via the "Cluster 10 Infectiologie."	Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851; Bajaj M, 2007, ACTA CRYSTALLOGR F, V63, P409, DOI 10.1107/S1744309107016004; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; Bergman AC, 1998, FEBS LETT, V441, P327, DOI 10.1016/S0014-5793(98)01575-0; CEDERGRENZEPPEZAUER ES, 1992, NATURE, V355, P740, DOI 10.1038/355740a0; Chan S, 2004, J MOL BIOL, V341, P503, DOI 10.1016/j.jmb.2004.06.028; Dauter Z, 1999, J MOL BIOL, V285, P655, DOI 10.1006/jmbi.1998.2332; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HALENBECK R, 1989, BIO-TECHNOL, V7, P710, DOI 10.1038/nbt0789-710; Harkiolaki M, 2004, STRUCTURE, V12, P41, DOI 10.1016/j.str.2003.11.016; HUANG SL, 1982, BIOCHEMISTRY-US, V21, P951, DOI 10.1021/bi00534a021; Kovari J, 2008, PROTEINS, V71, P308, DOI 10.1002/prot.21757; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, INT CCP4 ESF EACMB N, V26; MCGEOCH DJ, 1990, NUCLEIC ACIDS RES, V18, P4105, DOI 10.1093/nar/18.14.4105; Mol CD, 1996, STRUCTURE, V4, P1077, DOI 10.1016/S0969-2126(96)00114-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustafi D, 2003, P NATL ACAD SCI USA, V100, P5670, DOI 10.1073/pnas.1031504100; Nemeth-Pongracz V, 2007, NUCLEIC ACIDS RES, V35, P495, DOI 10.1093/nar/gkl1074; Palmen LG, 2008, BIOCHEMISTRY-US, V47, P7863, DOI 10.1021/bi800325j; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prasad GS, 1996, PROTEIN SCI, V5, P2429, DOI 10.1002/pro.5560051205; Prasad GS, 2000, ACTA CRYSTALLOGR D, V56, P1100, DOI 10.1107/S0907444900009197; Quesada-Soriano I, 2008, BBA-PROTEINS PROTEOM, V1784, P1347, DOI 10.1016/j.bbapap.2008.05.014; Samal A, 2007, ACTA CRYSTALLOGR D, V63, P571, DOI 10.1107/S0907444907007871; Tarbouriech N, 2005, STRUCTURE, V13, P1299, DOI 10.1016/j.str.2005.06.009; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Vertessy BG, 1998, FEBS LETT, V421, P83, DOI 10.1016/S0014-5793(97)01545-7; Whittingham JL, 2005, STRUCTURE, V13, P329, DOI 10.1016/j.str.2004.11.015	35	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25280	25289		10.1074/jbc.M109.019315	http://dx.doi.org/10.1074/jbc.M109.019315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19586911	hybrid, Green Published			2022-12-27	WOS:000269734000061
J	Gafni, J; Cong, X; Chen, SF; Gibson, BW; Ellerby, LM				Gafni, Juliette; Cong, Xin; Chen, Sylvia F.; Gibson, Bradford W.; Ellerby, Lisa M.			Calpain-1 Cleaves and Activates Caspase-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTIN REDUCES TOXICITY; CELL-DEATH; GRANZYME-B; EXECUTIONER CASPASE-3; THYMOCYTE APOPTOSIS; NEURONAL DAMAGE; INHIBITION; PROTEASES; GLUTAMATE; LOCALIZATION	Caspase-7 is an executioner caspase that plays a key role in apoptosis, cancer, and a number of neurodegenerative diseases. The mechanism of caspase-7 activation by granzyme B and caspase-3 has been well characterized. However, whether other proteases such as calpains activate or inactivate caspase-7 is not known. Here, we present that recombinant caspase-7 is directly cleaved by calpain-1 within the large subunit of caspase-7 to produce two novel products, large subunit p18 and p17. This new form of caspase-7 has a 6-fold increase in V-max when compared with the previously characterized p20/p12 form. Zymography revealed that the smaller caspase-7 product (p17) is 18-fold more active than either the caspase-3-cleaved product (p20) or the larger calpain-1 product of caspase-7 (p18). Mass spectrometry and site-directed mutagenesis identified the calpain cleavage sites within the caspase-7 large subunit at amino acid 36 and 45/47. These proteolysis events occur in vivo as indicated by the accumulation of caspase-7 p18 and p17 subunits in cortical neurons undergoing Ca2+ dysregulation. Further, cleavage at amino acid 45/47 of caspase-7 by calpain results in a reduction in nuclear localization when compared with the caspase-3 cleavage product of caspase-7 (p20). Our studies suggest the calpain-activated form of caspase-7 has unique enzymatic activity, localization, and binding affinity when compared with the caspase-activated form.	[Gafni, Juliette; Cong, Xin; Chen, Sylvia F.; Gibson, Bradford W.; Ellerby, Lisa M.] Buck Inst Age Res, Novato, CA 94945 USA	Buck Institute for Research on Aging	Ellerby, LM (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	lellerby@buckinstitute.org			National Institutes of Health [NS40251A]; Nathan Shock [P30 AG025708]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG025708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nathan Shock; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant NS40251A and Nathan Shock Grant P30 AG025708.	Altznauer F, 2004, J BIOL CHEM, V279, P5947, DOI 10.1074/jbc.M308576200; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Chaitanya GV, 2008, NEUROCHEM RES, V33, P2178, DOI 10.1007/s11064-007-9567-7; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Del Rio P, 2008, NEUROCHEM RES, V33, P1475, DOI 10.1007/s11064-008-9612-1; Del Rio P, 2008, EXP NEUROL, V212, P179, DOI 10.1016/j.expneurol.2008.03.023; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Hayashi N, 2006, NEUROSCI LETT, V397, P5, DOI 10.1016/j.neulet.2005.11.057; HONG SC, 1994, BRAIN RES, V661, P43, DOI 10.1016/0006-8993(94)91178-9; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kato M, 2000, J BIOCHEM, V127, P297, DOI 10.1093/oxfordjournals.jbchem.a022607; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; Moore JD, 2002, BRIT J PHARMACOL, V135, P1069, DOI 10.1038/sj.bjp.0704538; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Ray SK, 2006, NEUROSCIENCE, V139, P577, DOI 10.1016/j.neuroscience.2005.12.057; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; RODRIGUEZTARDUCHY G, 1990, EMBO J, V9, P2997, DOI 10.1002/j.1460-2075.1990.tb07492.x; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shikama Y, 2001, EXP CELL RES, V264, P315, DOI 10.1006/excr.2000.5153; Squier MKT, 1997, J IMMUNOL, V158, P3690; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; Thornberry NA, 1999, CELL DEATH DIFFER, V6, P1023, DOI 10.1038/sj.cdd.4400607; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wu J, 2006, CELL MOL LIFE SCI, V63, P949, DOI 10.1007/s00018-005-5565-6; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278; Yaoita Y, 2002, BIOCHEM BIOPH RES CO, V291, P79, DOI 10.1006/bbrc.2002.6408; Zhivotovsky B, 2004, CELL CYCLE, V3, P64; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536; ZHIVOTOVSKY B, 1994, BIOCHEM BIOPH RES CO, V202, P120, DOI 10.1006/bbrc.1994.1901; Zhou Q, 1997, BIOCHEM J, V324, P361, DOI 10.1042/bj3240361	43	44	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25441	25449		10.1074/jbc.M109.038174	http://dx.doi.org/10.1074/jbc.M109.038174			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617626	Green Published, hybrid			2022-12-27	WOS:000269734000076
J	Koski, MK; Hieta, R; Hirsila, M; Ronka, A; Myllyharju, J; Wierenga, RK				Koski, M. Kristian; Hieta, Reija; Hirsila, Maija; Ronka, Anna; Myllyharju, Johanna; Wierenga, Rik K.			The Crystal Structure of an Algal Prolyl 4-Hydroxylase Complexed with a Proline-rich Peptide Reveals a Novel Buried Tripeptide Binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETOGLUTARATE DIOXYGENASE; ANGSTROM RESOLUTION; KEY ENZYMES; HIF-ALPHA; HYPOXIA; HYDROXYPROLINE; RECOGNITION; REFINEMENT; COLLAGENS; MECHANISM	Plant and algal prolyl 4-hydroxylases (P4Hs) are key enzymes in the synthesis of cell wall components. These monomeric enzymes belong to the 2-oxoglutarate dependent superfamily of enzymes characterized by a conserved jelly-roll framework. This algal P4H has high sequence similarity to the catalytic domain of the vertebrate, tetrameric collagen P4Hs, whereas there are distinct sequence differences with the oxygen-sensing hypoxia-inducible factor P4H subfamily of enzymes. We present here a 1.98-angstrom crystal structure of the algal Chlamydomonas reinhardtii P4H-1 complexed with Zn2+ and a proline-rich (SerPro)(5) substrate. This ternary complex captures the competent mode of binding of the peptide substrate, being bound in a left handed (poly) L-proline type II conformation in a tunnel shaped by two loops. These two loops are mostly disordered in the absence of the substrate. The importance of these loops for the function is confirmed by extensive mutagenesis, followed up by enzyme kinetic characterizations. These loops cover the central Ser-Pro-Ser tripeptide of the substrate such that the hydroxylation occurs in a highly buried space. This novel mode of binding does not depend on stacking interactions of the proline side chains with aromatic residues. Major conformational changes of the two peptide binding loops are predicted to be a key feature of the catalytic cycle. These conformational changes are probably triggered by the conformational switch of Tyr(140), as induced by the hydroxylation of the proline residue. The importance of these findings for understanding the specific binding and hydroxylation of (X-Pro-Gly)(n) sequences by collagen P4Hs is also discussed.	[Hieta, Reija; Hirsila, Maija; Ronka, Anna; Myllyharju, Johanna; Wierenga, Rik K.] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Koski, M. Kristian; Wierenga, Rik K.] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; [Hieta, Reija; Hirsila, Maija; Ronka, Anna; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland	University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Wierenga, RK (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, POB 3000, FIN-90014 Oulu, Finland.	rik.wierenga@oulu.fi		Hieta, Reija/0000-0001-5724-6253	Academy of Finland [200966, 115124, 1114344, 1211128]; Sigrid Juselius Foundation and Fibrogen Inc.	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation and Fibrogen Inc.(Sigrid Juselius Foundation)	This work was supported by the Academy of Finland Grants 200966 (to R. K. W.), 115124 (to M. K. K.), and 1114344 and 1211128 (to J.M.) and by the Sigrid Juselius Foundation and Fibrogen Inc. (to J.M.).	Adair W.S., 1990, P15; Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Bollinger JM, 2005, EUR J INORG CHEM, P4245, DOI 10.1002/ejic.200500476; Bourenkov GP, 2006, ACTA CRYSTALLOGR D, V62, P58, DOI 10.1107/S0907444905033998; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; Chowdhury R, 2008, CHEM SOC REV, V37, P1308, DOI 10.1039/b701676j; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Ferris PJ, 2001, BIOCHEMISTRY-US, V40, P2978, DOI 10.1021/bi0023605; Flashman E, 2008, J BIOL CHEM, V283, P3808, DOI 10.1074/jbc.M707411200; Gorres KL, 2008, BIOCHEMISTRY-US, V47, P9447, DOI 10.1021/bi8009373; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KASKA DD, 1987, BIOCHEM J, V241, P483, DOI 10.1042/bj2410483; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; Loenarz C, 2009, ANGEW CHEM INT EDIT, V48, P1784, DOI 10.1002/anie.200805427; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McDonough MA, 2005, J BIOL CHEM, V280, P41101, DOI 10.1074/jbc.M507528200; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; O'Brien JR, 2003, BIOCHEMISTRY-US, V42, P5547, DOI 10.1021/bi0341096; Okuyama K, 2004, BIOPOLYMERS, V76, P367, DOI 10.1002/bip.20107; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Schumacher M, 2005, J BIOL CHEM, V280, P20397, DOI 10.1074/jbc.M501453200; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Zhang ZH, 2002, FEBS LETT, V517, P7, DOI 10.1016/S0014-5793(02)02520-6	48	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25290	25301		10.1074/jbc.M109.014050	http://dx.doi.org/10.1074/jbc.M109.014050			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19553701	Green Published, hybrid			2022-12-27	WOS:000269734000062
J	Podust, LM; Ouellet, H; von Kries, JP; de Montellano, PRO				Podust, Larissa M.; Ouellet, Hugues; von Kries, Jens P.; de Montellano, Paul R. Ortiz			Interaction of Mycobacterium tuberculosis CYP130 with Heterocyclic Arylamines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC MICROSOMAL CYTOCHROME; ANTIMYCOBACTERIAL ACTIVITY; AZOLE ANTIFUNGALS; CRYSTAL-STRUCTURE; DRUG INTERACTION; IN-VITRO; IDENTIFICATION; DERIVATIVES; COMPLEXES; BINDING	The Mycobacterium tuberculosis P450 enzymes are of interest for their pharmacological development potential, as evidenced by their susceptibility to inhibition by antifungal azole drugs that normally target sterol 14 alpha-demethylase (CYP51). Although antifungal azoles show promise, direct screening of compounds against M. tuberculosis P450 enzymes may identify novel, more potent, and selective inhibitory scaffolds. Here we report that CYP130 from M. tuberculosis has a natural propensity to bind primary arylamines with particular chemical architectures. These compounds were identified via a high throughput screen of CYP130 with a library of synthetic organic molecules. As revealed by subsequent x-ray structure analysis, selected compounds bind in the active site by Fe-coordination and hydrogen bonding of the arylamine group to the carbonyl oxygen of Gly(243). As evidenced by the binding of structural analogs, the primary arylamine group is indispensable, but synergism due to hydrophobic contacts between the rest of the molecule and protein amino acid residues is responsible for a binding affinity comparable with that of the antifungal azole drugs. The topology of the CYP130 active site favors angular coordination of the arylamine group over the orthogonal coordination of azoles. Upon substitution of Gly(243) by an alanine, the binding mode of azoles and some arylamines reverted from type II to type I because of hydrophobic and steric interactions with the alanine side chain. We suggest a role for the conserved Ala(Gly)(243)-Gly(244) motif in the I-helix in modulating both the binding affinity of the axial water ligand and the ligand selectivity of cytochrome P450 enzymes.	[Podust, Larissa M.; Ouellet, Hugues; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [von Kries, Jens P.] Leibniz Inst Mol Pharmacol, Screening Unit, D-13125 Berlin, Germany	University of California System; University of California San Francisco; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu	Podust, Larissa/ABB-7940-2020	Podust, Larissa/0000-0002-8537-8760	National Institutes of Health [AI07824, GM25515, GM078553]; X-Mtb Consortium Bundesministerium fuer Bildung und Forschung/Projekttraeger Juelich (BMBF/PTJ) [BIO/0312992A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025515, R37GM025515, R01GM078553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); X-Mtb Consortium Bundesministerium fuer Bildung und Forschung/Projekttraeger Juelich (BMBF/PTJ)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants AI07824 and GM25515 (to P.O.d.M.) and GM078553 (to L. M. P.). This work was also supported by Grants BIO/0312992A (to J.P.K.) from the X-Mtb Consortium Bundesministerium fuer Bildung und Forschung/Projekttraeger Juelich (BMBF/PTJ).	Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Ahmad Z, 2006, FEMS MICROBIOL LETT, V258, P200, DOI 10.1111/j.1574-6968.2006.00224.x; Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Banfi E, 2006, J ANTIMICROB CHEMOTH, V58, P76, DOI 10.1093/jac/dkl182; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Byrne ST, 2007, J MED MICROBIOL, V56, P1047, DOI 10.1099/jmm.0.47058-0; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chen CK, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000372; DeLano W.L, PYMOL MOL GRAPHICS S; FRANKLIN MR, 1976, CHEM-BIOL INTERACT, V14, P337, DOI 10.1016/0009-2797(76)90112-5; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hlavica P, 2006, BBA-PROTEINS PROTEOM, V1764, P645, DOI 10.1016/j.bbapap.2006.01.013; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Keilin D, 1943, NATURE, V151, P390, DOI 10.1038/151390a0; Kim D, 2005, ANNU REV PHARMACOL, V45, P27, DOI 10.1146/annurev.pharmtox.45.120403.100010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; MANSUY D, 1978, EUR J BIOCHEM, V86, P573, DOI 10.1111/j.1432-1033.1978.tb12341.x; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Podust LM, 2007, ANTIMICROB AGENTS CH, V51, P3915, DOI 10.1128/AAC.00311-07; Recchi C, 2003, J BIOL CHEM, V278, P33763, DOI 10.1074/jbc.M305963200; REMMER H, 1966, MOL PHARMACOL, V2, P187; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; Sheehan DJ, 1999, CLIN MICROBIOL REV, V12, P40, DOI 10.1128/CMR.12.1.40; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454	32	25	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25211	25219		10.1074/jbc.M109.017632	http://dx.doi.org/10.1074/jbc.M109.017632			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605350	Green Published, hybrid			2022-12-27	WOS:000269734000055
J	Small, TW; Pickering, JG				Small, Theodore W.; Pickering, J. Geoffrey			Nuclear Degradation of Wilms Tumor 1-associating Protein and Survivin Splice Variant Switching Underlie IGF-1-mediated Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-I; PRE-MESSENGER-RNA; DROSOPHILA-MELANOGASTER; PROTEOMIC ANALYSIS; FL(2)D GENE; APOPTOSIS; RECEPTOR; ACTIVATION; EXPRESSION	WTAP (Wilms tumor 1-associating protein) is a recently identified nuclear protein that is essential for mouse embryo development. The Drosophila homolog of WTAP, Fl(2)d, regulates pre-mRNA splicing; however, the role of WTAP in mammalian cells is uncertain. To elucidate a context for WTAP action, we screened growth and survival factors for their effects on WTAP expression in vascular smooth muscle cells (SMCs), a cell type previously found to express WTAP dynamically. This revealed that insulin-like growth factor-1 (IGF-1) uniquely reduced WTAP abundance. This decline in WTAP proved to be necessary for IGF-1 to confer its antiapoptotic properties, which were blocked by transducing the WTAP gene into SMCs. WTAP down-regulation by IGF-1 was mediated by an IGF-1 receptor-phosphatidylinositol 3-kinase-Akt signaling axis that directed WTAP degradation via a nuclear 26 S proteasome. Moreover, by promoting the degradation of WTAP, IGF-1 shifted the pre-mRNA splicing program for the survival factor, survivin, to reduce expression of survivin-2B, which is proapoptotic, and increase expression of survivin, which is antiapoptotic. Knockdown of survivin-2B rescued the ability of IGF-1 to promote survival when WTAP was overexpressed. These data uncover a novel regulatory cascade for human SMC survival based on adjusting the nuclear abundance of WTAP to define the splice variant balance among survivin isoforms.	[Small, Theodore W.; Pickering, J. Geoffrey] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada; [Pickering, J. Geoffrey] Univ Western Ontario, London Hlth Sci Ctr, London, ON N6A 5K8, Canada; [Pickering, J. Geoffrey] Univ Western Ontario, Dept Med Cardiol, London, ON N6A 5K8, Canada; [Small, Theodore W.; Pickering, J. Geoffrey] Univ Western Ontario, Dept Biochem, London, ON N6A 5K8, Canada; [Pickering, J. Geoffrey] Univ Western Ontario, Dept Med Biophys, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Pickering, JG (corresponding author), London Hlth Sci Ctr, 339 Windermere Rd, London, ON N6A 5A5, Canada.	gpickering@robarts.ca	Pickering, J. Geoffrey/G-3341-2011	Pickering, J. Geoffrey/0000-0001-6474-3274	Canadian Institutes of Health Research [FRN-11715]; Heart and Stroke Foundation of Canada [T5675]; Krembil Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Krembil Foundation	This work was supported by Canadian Institutes of Health Research Grant FRN-11715, Heart and Stroke Foundation of Canada Grant T5675, and the Krembil Foundation.	Allard D, 2008, J BIOL CHEM, V283, P19739, DOI 10.1074/jbc.M710098200; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Bai HZ, 1999, CIRC RES, V85, P229, DOI 10.1161/01.RES.85.3.229; Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Blanc-Brude OP, 2002, NAT MED, V8, P987, DOI 10.1038/nm750; Burnette JM, 1999, GENETICS, V151, P1517; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Cregan SP, 1999, J NEUROSCI, V19, P7860; Dupont J, 2003, RECENT PROG HORM RES, V58, P325, DOI 10.1210/rp.58.1.325; Fukusumi Y, 2008, DEV DYNAM, V237, P618, DOI 10.1002/dvdy.21444; Gable KL, 2006, MOL CANCER THER, V5, P1079, DOI 10.1158/1535-7163.MCT-05-0397; GENG YJ, 1995, AM J PATHOL, V147, P251; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; GRANADINO B, 1990, EMBO J, V9, P2597, DOI 10.1002/j.1460-2075.1990.tb07441.x; Granadino B, 1996, MOL GEN GENET, V253, P26, DOI 10.1007/s004380050292; Henricks DM, 1998, BIOL REPROD, V59, P330, DOI 10.1095/biolreprod59.2.330; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Jones G, 2000, J BIOL CHEM, V275, P22157, DOI 10.1074/jbc.M000369200; Li CY, 2004, CELL RES, V14, P473, DOI 10.1038/sj.cr.7290250; Li SH, 1999, CIRC RES, V85, P338, DOI 10.1161/01.RES.85.4.338; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; Li YX, 2003, ARTERIOSCL THROM VAS, V23, P2178, DOI 10.1161/01.ATV.0000099788.31333.DB; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Ling X, 2007, J BIOL CHEM, V282, P27204, DOI 10.1074/jbc.M705161200; Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914; Mahotka C, 1999, CANCER RES, V59, P6097; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Okura Y, 2001, J MOL CELL CARDIOL, V33, P1777, DOI 10.1006/jmcc.2001.1441; Ortega A, 2003, J BIOL CHEM, V278, P3040, DOI 10.1074/jbc.M210737200; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Patel VA, 2001, CIRC RES, V88, P895, DOI 10.1161/hh0901.090305; Penalva LOF, 2000, GENETICS, V155, P129; Penn JKM, 2008, GENETICS, V178, P737, DOI 10.1534/genetics.107.081679; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Rockel TD, 2002, J STRUCT BIOL, V140, P189; Rocnik EF, 2002, J BIOL CHEM, V277, P38571, DOI 10.1074/jbc.M206689200; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Small TW, 2007, TRENDS CARDIOVAS MED, V17, P230, DOI 10.1016/j.tcm.2007.08.002; Small TW, 2006, CIRC RES, V99, P1338, DOI 10.1161/01.RES.0000252289.79841.d3; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; van der Veer E, 2005, CIRC RES, V97, P25, DOI 10.1161/01.RES.0000173298.38808.27; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	48	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24684	24695		10.1074/jbc.M109.034629	http://dx.doi.org/10.1074/jbc.M109.034629			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605357	hybrid, Green Published			2022-12-27	WOS:000269734000003
J	Oussaief, L; Hippocrate, A; Ramirez, V; Rampanou, A; Zhang, W; Meyers, D; Cole, P; Khelifa, R; Joab, I				Oussaief, Lassad; Hippocrate, Aurelie; Ramirez, Vanessa; Rampanou, Aurore; Zhang, Wei; Meyers, David; Cole, Philip; Khelifa, Ridha; Joab, Irene			Phosphatidylinositol 3-Kinase/Akt Pathway Targets Acetylation of Smad3 through Smad3/CREB-binding Protein Interaction CONTRIBUTION TO TRANSFORMING GROWTH FACTOR beta 1-INDUCED EPSTEIN-BARR VIRUS REACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; TGF-BETA; ACTIVATION; CELLS; EXPRESSION; GENE; INHIBITORS; 5-BROMODEOXYURIDINE; PHOSPHORYLATION; TRANSACTIVATION	Epstein-Barr virus, a ubiquitous human herpesvirus, is associated with the development of carcinomas and lymphomas. We previously showed that transforming growth factor beta 1 (TGF-beta 1) mediated the virus to enter the lytic cycle, which is triggered by expression of Z Epstein-Barr virus replication activator (ZEBRA), through the ERK 1/2 MAPK signaling pathway. We report here that Akt, activated downstream from ERK 1/2, was required for TGF-beta 1-induced ZEBRA expression and enabled Smad3, a mediator of TGF-beta 1 signaling, to be acetylated by direct interaction with the co-activator CREB-binding protein and then to regulate TGF-beta 1-induced ZEBRA expression.	[Oussaief, Lassad; Hippocrate, Aurelie; Rampanou, Aurore; Joab, Irene] Univ Paris 11, INSERM, Hop Paul Brousse, UMR542, F-94807 Villejuif, France; [Oussaief, Lassad; Khelifa, Ridha] Habib Thameur Hosp, Viral & Mol Tumor Diagnost Unit, Tunis 1008, Tunisia; [Ramirez, Vanessa] Univ Costa Rica, Invest Heath Inst, San Jose 1000, Costa Rica; [Zhang, Wei] INSERM, U716, F-75010 Paris, France; [Meyers, David; Cole, Philip] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Tunis-El-Manar; Hopital Habib Thameur; Universidad Costa Rica; Institut National de la Sante et de la Recherche Medicale (Inserm); Johns Hopkins University	Joab, I (corresponding author), Univ Paris 11, INSERM, Hop Paul Brousse, UMR542, Batiment Andre Lwoff,14 Ave Paul Vaillant Couturi, F-94807 Villejuif, France.	irene.joab@inserm.fr			French network Herpesviruses and Cancer, Association pour la Recherche sur le Cancer Grant [3572]; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Tunisian Ministry of Higher Education, Research and Technology; INSERM; Institut Francilien de Recherche en Nephrologie et Transplantation; Association Nouvelles Recherches Biomedicales; Association pour l'Utilisation du Rein Artificiel; Naturalia and Biologia	French network Herpesviruses and Cancer, Association pour la Recherche sur le Cancer Grant; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Tunisian Ministry of Higher Education, Research and Technology; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Francilien de Recherche en Nephrologie et Transplantation; Association Nouvelles Recherches Biomedicales; Association pour l'Utilisation du Rein Artificiel; Naturalia and Biologia	This work was supported by the French network Herpesviruses and Cancer, Association pour la Recherche sur le Cancer Grant 3572, Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), Tunisian Ministry of Higher Education, Research and Technology, INSERM, Institut Francilien de Recherche en Nephrologie et Transplantation, Association Nouvelles Recherches Biomedicales, Association pour l'Utilisation du Rein Artificiel, and Naturalia and Biologia.	Arbach H, 2006, J VIROL, V80, P845, DOI 10.1128/JVI.80.2.845-853.2006; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Desgranges C, 1975, IARC Sci Publ, P191; El Mchichi B, 2007, CELL DEATH DIFFER, V14, P1826, DOI 10.1038/sj.cdd.4402187; Fahmi H, 2000, J VIROL, V74, P5810, DOI 10.1128/JVI.74.13.5810-5818.2000; Fukagawa Y, 2008, ELECTROPHORESIS, V29, P3192, DOI 10.1002/elps.200800086; GERBER P, 1972, P NATL ACAD SCI USA, V69, P83, DOI 10.1073/pnas.69.1.83; Gruffat H, 2002, EMBO REP, V3, P141, DOI 10.1093/embo-reports/kvf031; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; HAMPAR B, 1972, P NATL ACAD SCI USA, V69, P78, DOI 10.1073/pnas.69.1.78; HENLE W, 1971, J INFECT DIS, V124, P58, DOI 10.1093/infdis/124.1.58; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Iwakiri D, 2004, J IMMUNOL, V172, P1561, DOI 10.4049/jimmunol.172.3.1561; KIEFF, 2007, EPSTEIN BARR VIRUS I; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Liang CL, 2002, J BIOL CHEM, V277, P23345, DOI 10.1074/jbc.M107420200; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; PALLESEN G, 1991, LANCET, V337, P320, DOI 10.1016/0140-6736(91)90943-J; Ragoczy T, 1999, J VIROL, V73, P9858, DOI 10.1128/JVI.73.12.9858-9866.1999; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Touitou R, 2003, J GEN VIROL, V84, P949, DOI 10.1099/vir.0.18687-0; TOVEY MG, 1978, NATURE, V276, P270, DOI 10.1038/276270a0; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; ZURHAUSEN H, 1978, NATURE, V272, P373	38	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23912	23924		10.1074/jbc.M109.036483	http://dx.doi.org/10.1074/jbc.M109.036483			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19589780	Green Published, hybrid			2022-12-27	WOS:000269380200005
J	Patel, A; Dharmarajan, V; Vought, VE; Cosgrove, MS				Patel, Anamika; Dharmarajan, Venkatasubramanian; Vought, Valarie E.; Cosgrove, Michael S.			On the Mechanism of Multiple Lysine Methylation by the Human Mixed Lineage Leukemia Protein-1 (MLL1) Core Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 LYSINE-4; H3-LYS(4) METHYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; MOLECULAR REGULATION; PRODUCT SPECIFICITY; CATALYTIC MECHANISM; FUNCTIONAL-ANALYSIS; MASS-SPECTROMETRY; TRITHORAX FAMILY; STRUCTURAL BASIS	Transcription in eukaryotic genomes depends on enzymes that regulate the degree of histone H3 lysine 4 (H3K4) methylation. The mixed lineage leukemia protein-1 (MLL1) is a member of the SET1 family of H3K4 methyltransferases and is frequently rearranged in acute leukemias. Despite sequence comparisons that predict that SET1 family enzymes should only monomethylate their substrates, mono-, di-, and trimethylation of H3K4 has been attributed to SET1 family complexes in vivo and in vitro. To better understand this paradox, we have biochemically reconstituted and characterized a five-component 200-kDa MLL1 core complex containing human MLL1, WDR5, RbBP5, Ash2L, and DPY-30. We demonstrate that the isolated MLL1 SET domain is a slow monomethyltransferase and that tyrosine 3942 of MLL1 prevents di- and trimethylation of H3K4. In contrast, a complex containing the MLL1 SET domain, WDR5, RbBP5, Ash2L, and DPY-30, displays a marked similar to 600-fold increase in enzymatic activity but only to the dimethyl form of H3K4. Single turnover kinetic experiments reveal that the reaction leading to H3K4 dimethylation involves the transient accumulation of a monomethylated species, suggesting that the MLL1 core complex uses a non-processive mechanism to catalyze multiple lysine methylation. We have also discovered that the non-SET domain components of the MLL1 core complex possess a previously unrecognized methyltransferase activity that catalyzes H3K4 dimethylation within the MLL1 core complex. Our results suggest that the mechanism of multiple lysine methylation by the MLL1 core complex involves the sequential addition of two methyl groups at two distinct active sites within the complex.	[Patel, Anamika; Dharmarajan, Venkatasubramanian; Vought, Valarie E.; Cosgrove, Michael S.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Cosgrove, MS (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	mscosgro@syr.edu			March of Dimes Birth Defects Foundation [5-FY06-585]; Leukemia Research Foundation [RSG-09-245-01-DMC]; American Cancer Society; Syracuse University; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); Leukemia Research Foundation; American Cancer Society(American Cancer Society); Syracuse University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by research grants from the March of Dimes Birth Defects Foundation (Grant 5-FY06-585), from the Leukemia Research Foundation, a Research Scholar Grant (RSG-09-245-01-DMC) from the American Cancer Society (to M. S. C.), and by funds from Syracuse University.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dirk LMA, 2007, BIOCHEMISTRY-US, V46, P3905, DOI 10.1021/bi6023644; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fersht A., 1999, STRUCTURE MECH PROTE, P143; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Gross JW, 2000, BIOCHEMISTRY-US, V39, P13633, DOI 10.1021/bi001963d; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Houston CT, 2000, ANAL CHEM, V72, P3311, DOI 10.1021/ac991499m; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; JONES RS, 1993, MOL CELL BIOL, V13, P6357, DOI 10.1128/MCB.13.10.6357; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Laue T. M., 1992, ANAL ULTRACENTRIFUGA, P19; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P26; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; STASSEN MJ, 1995, MECH DEVELOP, V52, P209, DOI 10.1016/0925-4773(95)00402-M; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; van Dijk K, 2005, PLANT CELL, V17, P2439, DOI 10.1105/tpc.105.034165; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	64	155	169	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24242	24256		10.1074/jbc.M109.014498	http://dx.doi.org/10.1074/jbc.M109.014498			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19556245	hybrid, Green Published			2022-12-27	WOS:000269380200038
J	Cammer, M; Gevrey, JC; Lorenz, M; Dovas, A; Condeelis, J; Cox, D				Cammer, Michael; Gevrey, Jean-Claude; Lorenz, Mike; Dovas, Athanassios; Condeelis, John; Cox, Dianne			The Mechanism of CSF-1-induced Wiskott-Aldrich Syndrome Protein Activation in Vivo A ROLE FOR PHOSPHATIDYLINOSITOL 3-KINASE AND Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP FAMILY PROTEINS; TUMOR-CELL MIGRATION; N-WASP; ACTIN POLYMERIZATION; ARP2/3 COMPLEX; N-WASP-ARP2/3 COMPLEX; MAMMARY-TUMORS; MACROPHAGES; CDC42; PHOSPHORYLATION	A role for Wiskott-Aldrich syndrome protein (WASP) in chemotaxis to various agents has been demonstrated in monocyte-derived cell types. Although WASP has been shown to be activated by multiple mechanisms in vitro, it is unclear how WASP is regulated in vivo. A WASP biosensor (WASPbs), which uses intramolecular fluorescence resonance energy transfer to report WASP activation in vivo, was constructed, and following transfection of macrophages, activation of WASPbs upon treatment with colony-stimulating factor-1 (CSF-1) was detected globally as early as 30 s and remained localized to protrusive regions at later time points. Similar results were obtained when endogenous WASP activation was determined using conformation-sensitive antibodies. In vivo CSF-1-induced WASP activation was fully Cdc42-dependent. Activation of WASP in response to treatment with CSF-1 was also shown to be phosphatidylinositol 3-kinase-dependent. However, treatment with the Src family kinase inhibitors PP2 or SU6656 or disruption of the major tyrosine phosphorylation site of WASPbs (Y291F mutation) did not reduce the level of CSF-1-induced WASP activation. Our results indicate that WASP activation downstream of CSF-1R is phosphatidylinositol 3-kinase- and Cdc42-dependent consistent with an involvement of these molecules in macrophage migration. However, although tyrosine phosphorylation of WASP has been proposed to stimulate WASP activity, we found no evidence to indicate that this occurs in vivo.	[Cammer, Michael; Gevrey, Jean-Claude; Lorenz, Mike; Dovas, Athanassios; Condeelis, John; Cox, Dianne] Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Cox, Dianne] Yeshiva Univ, Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Cammer, Michael; Condeelis, John] Yeshiva Univ, Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cox, D (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave,MRRC306, Bronx, NY 10461 USA.	dcox@aecom.yu.edu		Cox, Dianne/0000-0002-0591-9767; Cammer, Michael/0000-0003-4930-1739	National Institutes of Health [RO1 GM071828, GM38511, P01 CA100324]; NATIONAL CANCER INSTITUTE [P01CA100324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071828, R01GM038511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM071828 (to D. C.), GM38511 (to J. C.), and P01 CA100324 (to	Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Aharinejad Seyedhossein, 2007, Methods Mol Biol, V361, P227; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Allen WE, 1997, J CELL SCI, V110, P707; Badolato R, 1998, J IMMUNOL, V161, P1026; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Calle Y, 2004, J PATHOL, V204, P460, DOI 10.1002/path.1651; Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Guinamard R, 1998, FEBS LETT, V434, P431, DOI 10.1016/S0014-5793(98)01016-3; Jones GE, 2003, EXP CELL RES, V290, P120, DOI 10.1016/S0014-4827(03)00318-5; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; Kato M, 1999, J BIOL CHEM, V274, P27225, DOI 10.1074/jbc.274.38.27225; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Pivniouk VI, 2003, INT IMMUNOL, V15, P1431, DOI 10.1093/intimm/dxg148; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ridley AJ, 2001, FEBS LETT, V498, P168, DOI 10.1016/S0014-5793(01)02481-4; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Sukumvanich P, 2004, CELL MOTIL CYTOSKEL, V59, P141, DOI 10.1002/cm.20030; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Ward ME, 2004, P NATL ACAD SCI USA, V101, P970, DOI 10.1073/pnas.0306258101; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	53	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23302	23311		10.1074/jbc.M109.036384	http://dx.doi.org/10.1074/jbc.M109.036384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561083	hybrid, Green Published			2022-12-27	WOS:000269180000015
J	Lee, S; Bowrin, K; Hamad, AR; Chakravarti, S				Lee, Seakwoo; Bowrin, Kyle; Hamad, Abdel Rahim; Chakravarti, Shukti			Extracellular Matrix Lumican Deposited on the Surface of Neutrophils Promotes Migration by Binding to beta(2) Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; LEUCINE-RICH PROTEOGLYCANS; CELL-ADHESION; RECEPTOR; COLLAGEN; DECORIN; LIGAND; MICE; ALPHA-2-BETA-1; FIBROMODULIN	During inflammation, circulating polymorphonuclear neutrophils (PMNs) receive signals to cross the endothelial barrier and migrate through the extracellular matrix (ECM) to reach the injured site. Migration requires complex and poorly understood interactions of chemokines, chemokine receptors, ECM molecules, integrins, and other receptors. Here we show that the ECM protein lumican regulates PMN migration through interactions with specific integrin receptors. Lumican-deficient (Lum(-/-)) mice manifest connective tissue defects, impaired innate immune response, and poor wound healing with reduced PMN infiltration. Lum(-/-) PMNs exhibit poor chemotactic migration that is restored with exogenous recombinant lumican and inhibited by anti-lumican antibody, confirming a role for lumican inPMNmigration. Treatment of PMNs with antibodies that block beta(2), beta(1), and alpha(M) integrin subunits inhibits lumican-mediated migration. Furthermore, immunohistochemical and biochemical approaches indicate binding of lumican to beta(2), alpha(M), and alpha(L) integrin subunits. Thus, lumican may regulate PMN migration mediated by MAC-1 (alpha(M)/beta(2)) and LFA-1 (alpha(L)/beta(2)), the two major PMN surface integrins. We detected lumican on the surface of peritoneal PMNs and not bone marrow or peripheral blood PMNs. This suggests that PMNs must acquire lumican during or after crossing the endothelial barrier as they exit circulation. We also found that peritoneal PMNs do not express lumican, whereas endothelial cells do. Taken together these observations suggest a novel endothelial lumican-mediated paracrine regulation of neutrophils early on in their migration path.	[Lee, Seakwoo; Bowrin, Kyle; Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Hamad, Abdel Rahim] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Chakravarti, S (corresponding author), Johns Hopkins Sch Med, Dept Med, 935 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	schakra1@jhmi.edu			NEI [EY11654]; Crohn's and Colitis Foundation of America [1559]; NATIONAL EYE INSTITUTE [R01EY011654, R56EY011654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064388] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Crohn's and Colitis Foundation of America; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant EY11654 from NEI (to S. C.). This work was also supported by Senior Investigator Researcher Award 1559 from the Crohn's and Colitis Foundation of America (to S. C.).	BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P20613; BOHNSACK JF, 1990, J EXP MED, V171, P1221, DOI 10.1084/jem.171.4.1221; BREZILLON S, 2009, CANC LETT IN PRESS; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Chakravarti S, 2002, GLYCOCONJUGATE J, V19, P287, DOI 10.1023/A:1025348417078; CHAKRAVARTI S, 1995, GENOMICS, V27, P481, DOI 10.1006/geno.1995.1080; D'Onofrio MF, 2008, BIOCHEM BIOPH RES CO, V365, P266, DOI 10.1016/j.bbrc.2007.10.155; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Frieser M, 1996, EUR J IMMUNOL, V26, P3127, DOI 10.1002/eji.1830261245; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P24773; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gresham HD, 1996, J BIOL CHEM, V271, P30587, DOI 10.1074/jbc.271.48.30587; HEIT B, 2003, SCI STKE, pPL5; HEMLER ME, 1990, CELL DIFFER DEV, V32, P229, DOI 10.1016/0922-3371(90)90035-U; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Ley K, 2002, IMMUNOL REV, V186, P8, DOI 10.1034/j.1600-065X.2002.18602.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LUO Y, 2001, CURR PROTOC IMMUNOL; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; OQUENDO P, 1989, J BIOL CHEM, V264, P4133; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Sixt M, 2001, J BIOL CHEM, V276, P18878, DOI 10.1074/jbc.M010898200; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; WALZOG B, 1995, EXP CELL RES, V218, P28, DOI 10.1006/excr.1995.1127; Werr J, 2000, J LEUKOCYTE BIOL, V68, P553; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200	42	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23662	23669		10.1074/jbc.M109.026229	http://dx.doi.org/10.1074/jbc.M109.026229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19531489	Green Published, hybrid			2022-12-27	WOS:000269180000052
J	Castro, BM; Silva, LC; Fedorov, A; de Almeida, RFM; Prieto, M				Castro, Bruno M.; Silva, Liana C.; Fedorov, Alexander; de Almeida, Rodrigo F. M.; Prieto, Manuel			Cholesterol-rich Fluid Membranes Solubilize Ceramide Domains IMPLICATIONS FOR THE STRUCTURE AND DYNAMICS OF MAMMALIAN INTRACELLULAR AND PLASMA MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME-RESOLVED FLUORESCENCE; RESISTANT CANCER-CELLS; LIPID RAFTS; CHEMICAL ACTIVITY; ORDERED DOMAINS; PHASE; SPHINGOMYELIN; BILAYER; PHOSPHATIDYLCHOLINE; MIXTURES	A uniquely sensitive method for ceramide domain detection allowed us to study in detail cholesterol-ceramide interactions in lipid bilayers with low (physiological) ceramide concentrations, ranging from low or no cholesterol (a situation similar to intracellular membranes, such as endoplasmic reticulum) to high cholesterol (similar to mammalian plasma membrane). Diverse fluorescence spectroscopy and microscopy experiments were conducted showing that for low cholesterol amounts ceramide segregates into gel domains that disappear upon increasing cholesterol levels. This was observed in different raft (sphingomyelin/cholesterol-containing) and non-raft (sphingomyelin-absent) membranes, i.e. mimicking different types of cell membranes. Cholesterol-ceramide interactions have been described mainly as raft sphingomyelin-dependent. Here sphingomyelin independence is demonstrated. In addition, ceramide-rich domains re-appear when either cholesterol is converted by cholesterol oxidase to cholestenone or the temperature is decreased. Ceramide is more soluble in cholesterol-rich fluid membranes than in cholesterol-poor ones, thereby increasing the chemical potential of cholesterol. Ceramide solubility depends on the average gel-fluid transition temperature of the remaining membrane lipids. The inability of cholestenone-rich membranes to dissolve ceramide gel domains shows that the cholesterol ordering and packing properties are fundamental to the mixing process. We also show that the solubility of cholesterol in ceramide domains is low. The results are rationalized by a ternary phospholipid/ceramide/cholesterol phase diagram, providing the framework for the better understanding of biochemical phenomena modulated by cholesterol-ceramide interactions such as cholesterol oxidase activity, lipoprotein metabolism, and lipid targeting in cancer therapy. It also suggests that the lipid compositions of different organelles are such that ceramide gel domains are not formed unless a stress or pathological situation occurs.	[de Almeida, Rodrigo F. M.] Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, P-1749016 Lisbon, Portugal; [Castro, Bruno M.; Silva, Liana C.; Fedorov, Alexander; Prieto, Manuel] Inst Super Tecn, Ctr Quim Fis Mol, P-1049001 Lisbon, Portugal; [Castro, Bruno M.; Silva, Liana C.; Fedorov, Alexander; Prieto, Manuel] Inst Super Tecn, Inst Nanosci & Nanotechnol, P-1049001 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	de Almeida, RFM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, Ed C8, P-1749016 Lisbon, Portugal.	rodrigo.almeida@fc.ul.pt	de Almeida, Rodrigo/D-8629-2012; Silva, Liana C./A-3025-2011; Prieto, Manuel/N-4448-2013; iMed.ULisboa, InTraCellADD/B-4826-2014	de Almeida, Rodrigo/0000-0002-9748-7083; Silva, Liana C./0000-0003-1311-0770; Prieto, Manuel/0000-0003-3012-6598; Castro, Bruno/0000-0003-1055-3859; fedorov, alexander/0000-0003-2454-6908	Fundacao para a Ciencia e Tecnologia, Portugal [POCTI/QUI/68151/2006];  [BD/36635/2007];  [BPD/30289/2006]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); ; 	This work was supported in part by Fundacao para a Ciencia e Tecnologia, Portugal, Research Grant POCTI/QUI/68151/2006 (to R. F. M. de A.), and Fellowships BD/36635/2007 (to B. M. C.) and BPD/30289/2006 (to L. C. S.).	Alanko SMK, 2005, BBA-BIOMEMBRANES, V1715, P111, DOI 10.1016/j.bbamem.2005.08.002; Ali MR, 2006, BIOCHEMISTRY-US, V45, P12629, DOI 10.1021/bi060610x; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Bjorkqvist YJE, 2005, BIOPHYS J, V88, P4054, DOI 10.1529/biophysj.104.054718; Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; Bunge A, 2008, BIOPHYS J, V94, P2680, DOI 10.1529/biophysj.107.112904; Castro BM, 2007, BIOPHYS J, V93, P1639, DOI 10.1529/biophysj.107.107714; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; Davis JH, 2009, BIOPHYS J, V96, P521, DOI 10.1016/j.bpj.2008.09.042; de Almeida RFM, 2005, J MOL BIOL, V346, P1109, DOI 10.1016/j.jmb.2004.12.026; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; de Almeida RFM, 2002, BIOPHYS J, V82, P823, DOI 10.1016/S0006-3495(02)75444-1; de Almeida RFM, 2007, BIOPHYS J, V93, P539, DOI 10.1529/biophysj.106.098822; de Almeida RFM, 2009, CHEM PHYS LIPIDS, V157, P61, DOI 10.1016/j.chemphyslip.2008.07.011; Fidorra M, 2006, BIOPHYS J, V90, P4437, DOI 10.1529/biophysj.105.077107; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gouaze V, 2004, MOL CANCER THER, V3, P633; Grassme H, 2005, J BIOL CHEM, V280, P26256, DOI 10.1074/jbc.M500835200; HACKENBROCK CR, 1976, BIOCHIM BIOPHYS ACTA, V455, P466, DOI 10.1016/0005-2736(76)90318-7; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holopainen JM, 1997, CHEM PHYS LIPIDS, V88, P1, DOI 10.1016/S0009-3084(97)00040-6; Hsueh YW, 2002, BIOPHYS J, V82, P3089, DOI 10.1016/S0006-3495(02)75650-6; Ito J, 2000, J LIPID RES, V41, P894; Johnston I, 2006, LANGMUIR, V22, P11284, DOI 10.1021/la061636s; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lavie Y, 1999, LIPIDS, V34, pS57, DOI 10.1007/BF02562229; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Massey JB, 2001, BBA-BIOMEMBRANES, V1510, P167, DOI 10.1016/S0005-2736(00)00344-8; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Pinto SN, 2008, BIOPHYS J, V95, P2867, DOI 10.1529/biophysj.108.129858; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Scheffer L, 2007, CHEMBIOCHEM, V8, P2286, DOI 10.1002/cbic.200700482; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; SHAH J, 1995, J LIPID RES, V36, P1936; Sietsma H, 2001, J MEMBRANE BIOL, V181, P153, DOI 10.1007/s00232-001-0033-1; Silva L, 2006, MOL MEMBR BIOL, V23, P137, DOI 10.1080/09687860500439474; Silva LC, 2007, BIOPHYS J, V92, P502, DOI 10.1529/biophysj.106.091876; Silva LC, 2009, BIOPHYS J, V96, P3210, DOI 10.1016/j.bpj.2008.12.3923; Silvius JR, 1996, BIOCHEMISTRY-US, V35, P15198, DOI 10.1021/bi9615506; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; Stockl M, 2008, J BIOL CHEM, V283, P30828, DOI 10.1074/jbc.M801418200; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; THEWALT JL, 1992, BIOPHYS J, V63, P1176, DOI 10.1016/S0006-3495(92)81681-8; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Yu CJ, 2005, J LIPID RES, V46, P1678, DOI 10.1194/jlr.M500060-JLR200	61	110	111	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22978	22987		10.1074/jbc.M109.026567	http://dx.doi.org/10.1074/jbc.M109.026567			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19520848	Green Published, hybrid			2022-12-27	WOS:000268963100051
J	Danko, S; Daiho, T; Yamasaki, K; Liu, XY; Suzuki, H				Danko, Stefania; Daiho, Takashi; Yamasaki, Kazuo; Liu, Xiaoyu; Suzuki, Hiroshi			Formation of the Stable Structural Analog of ADP-sensitive Phosphoenzyme of Ca2+-ATPase with Occluded Ca2+ by Beryllium Fluoride STRUCTURAL CHANGES DURING PHOSPHORYLATION AND ISOMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CALCIUM-PUMP; INSENSITIVE PHOSPHOENZYME; BINDING-SITES; ADENOSINE-TRIPHOSPHATASE; CONFORMATIONAL-CHANGES; REACTION-MECHANISM; CATALYTIC SITE; PHOSPHOSERINE PHOSPHATASE; CRYSTAL-STRUCTURE	As a stable analog for ADP-sensitive phosphorylated intermediate of sarcoplasmic reticulum Ca2+-ATPase E1PCa(2)center dot Mg, a complex of E1Ca(2)center dot BeFx, was successfully developed by addition of beryllium fluoride and Mg2+ to the Ca2+-bound state, E1Ca(2). In E1Ca(2)center dot BeFx, most probably E1Ca(2)center dot BeF3-, two Ca2+ are occluded at high affinity transport sites, its formation required Mg2+ binding at the catalytic site, and ADP decomposed it to E1Ca(2), as in E1PCa(2)center dot Mg. Organization of cytoplasmic domains in E1Ca(2)center dot BeFx was revealed to be intermediate between those in E1Ca(2)center dot AlF4- ADP (transition state of E1PCa(2) formation) and E2 center dot BeF3-(ADP-insensitive phosphorylated intermediate E2P center dot Mg). Trinitrophenyl-AMP (TNP-AMP) formed a very fluorescent (superfluorescent) complex with E1Ca(2)center dot BeFx in contrast to no superfluorescence of TNP-AMP bound to E1Ca(2)center dot AlFx. E1Ca(2)center dot BeFx with bound TNP-AMP slowly decayed to E1Ca(2), being distinct from the superfluorescent complex of TNP-AMP with E2 center dot BeF3-, which was stable. Tryptophan fluorescence revealed that the transmembrane structure of E1Ca(2)center dot BeFx mimics E1PCa(2)center dot Mg, and between those of E1Ca(2)center dot AlF4-center dot ADP and E2 center dot BeF3-. E1Ca(2)center dot BeFx at low 50-100 mu M Ca2+ was converted slowly to E2 center dot BeF3- releasing Ca2+, mimicking E1PCa(2)center dot Mg -> E2P center dot Mg + 2Ca(2+)center dot Ca2+ replacement of Mg2+ at the catalytic site at approximately millimolar high Ca2+ decomposed E1Ca(2)center dot BeFx to E1Ca(2). Notably, E1Ca(2)center dot BeFx was perfectly stabilized for at least 12 days by 0.7 mM lumenal Ca2+ with 15 mM Mg2+. Also, stable E1Ca(2)center dot BeFx was produced from E2 center dot BeF3- at 0.7 mM lumenal Ca2+ by binding two Ca2+ to lumenally oriented low affinity transport sites, as mimicking the reverse conversion E2P center dot Mg + 2Ca(2+) -> E1PCa(2)center dot Mg.	[Danko, Stefania; Daiho, Takashi; Yamasaki, Kazuo; Liu, Xiaoyu; Suzuki, Hiroshi] Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College		hisuzuki@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research (B) (to H. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; CHAMPEIL P, 1986, FEBS LETT, V206, P93, DOI 10.1016/0014-5793(86)81347-3; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; de Meis L, 1974, Biochemistry, V13, P2057, DOI 10.1021/bi00707a009; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DUPONT Y, 1982, BIOCHEM BIOPH RES CO, V106, P1272, DOI 10.1016/0006-291X(82)91250-5; DUPONT Y, 1978, NATURE, V273, P396, DOI 10.1038/273396a0; DUPONT Y, 1983, FEBS LETT, V156, P93, DOI 10.1016/0014-5793(83)80255-5; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Gonzalez DA, 2006, BIOPHYS CHEM, V124, P27, DOI 10.1016/j.bpc.2006.05.025; HASSELBACH W, 1981, FED PROC, V40, P2657; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; HIRATSUKA T, 1982, BIOCHIM BIOPHYS ACTA, V719, P509, DOI 10.1016/0304-4165(82)90240-9; Holdensen AN, 2009, J BIOL CHEM, V284, P12258, DOI 10.1074/jbc.M900977200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; KANAZAWA T, 1975, J BIOL CHEM, V250, P113; KANAZAWA T, 1973, J BIOL CHEM, V248, P3163; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KUBOTA T, 1993, BIOCHIM BIOPHYS ACTA, V1163, P131, DOI 10.1016/0167-4838(93)90174-P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKOWITZ JR, 1983, PRINCIPLES FLUORESCE; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; Meissner G, 1974, Methods Enzymol, V32, P475; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MURPHY AJ, 1993, J BIOL CHEM, V268, P23307; MYUNG J, 1994, BIOCHEMISTRY-US, V33, P8775, DOI 10.1021/bi00195a020; NAKAMOTO RK, 1984, J BIOL CHEM, V259, P2961; NAKAMURA S, 1994, J BIOL CHEM, V269, P16015; OBARA M, 1988, J BIOL CHEM, V263, P3690; OGURUSU T, 1991, J BIOCHEM-TOKYO, V109, P472, DOI 10.1093/oxfordjournals.jbchem.a123406; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Peeraer Y, 2004, EUR J BIOCHEM, V271, P3421, DOI 10.1111/j.0014-2956.2004.04277.x; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Stokes DL, 2003, ANNU REV BIOPH BIOM, V32, P445, DOI 10.1146/annurev.biophys.32.110601.142433; SUZUKI H, 1995, J BIOL CHEM, V270, P3089, DOI 10.1074/jbc.270.7.3089; SUZUKI H, 1994, BIOCHEMISTRY-US, V33, P8240, DOI 10.1021/bi00193a010; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; WAKABAYASHI S, 1987, J BIOL CHEM, V262, P11524; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; WATANABE T, 1982, J BIOL CHEM, V257, P1510; WEBB MR, 1981, J BIOL CHEM, V256, P4884; Webb RJ, 2000, J BIOL CHEM, V275, P977, DOI 10.1074/jbc.275.2.977; YAMADA S, 1980, J BIOL CHEM, V255, P3108; YAMAMOTO T, 1968, J BIOCHEM-TOKYO, V64, P137, DOI 10.1093/oxfordjournals.jbchem.a128873; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093	74	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22722	22735		10.1074/jbc.M109.029702	http://dx.doi.org/10.1074/jbc.M109.029702			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561071	Green Published, hybrid			2022-12-27	WOS:000268963100027
J	Puri, R; Suzuki, T; Yamakawa, K; Ganesh, S				Puri, Rajat; Suzuki, Toshimitsu; Yamakawa, Kazuhiro; Ganesh, Subramaniam			Hyperphosphorylation and Aggregation of Tau in Laforin-deficient Mice, an Animal Model for Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; GLYCOGEN-SYNTHASE KINASE-3-BETA; DUAL-SPECIFICITY PHOSPHATASE; PAIRED HELICAL FILAMENTS; ACTIVATED PROTEIN-KINASE; INCLUSION-BODY MYOSITIS; ALZHEIMERS-DISEASE; EPM2A GENE; ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES	Lafora progressive myoclonous epilepsy (Lafora disease; LD) is caused by mutations in the EPM2A gene encoding a dual specificity protein phosphatase named laforin. Our analyses on the Epm2a gene knock-out mice, which developed most of the symptoms of LD, reveal the presence of hyperphosphorylated Tau protein (Ser(396) and Ser(202)) as neurofibrillary tangles (NFTs) in the brain. Intriguingly, NFTs were also observed in the skeletal muscle tissues of the knock-out mice. The hyperphosphorylation of Tau was associated with increased levels of the active form of GSK3 beta. The observations on Tau protein were replicated in cell lines using laforin overexpression and knockdown approaches. We also show here that laforin and Tau proteins physically interact and that the interaction was limited to the phosphatase domain of laforin. Finally, our in vitro and in vivo assays demonstrate that laforin dephosphorylates Tau, and therefore laforin is a novel Tau phosphatase. Taken together, our study suggests that laforin is one of the critical regulators of Tau protein, that the NFTs could underlie some of the symptoms seen in LD, and that laforin can contribute to the NFT formation in Alzheimer disease and other tauopathies.	[Puri, Rajat; Ganesh, Subramaniam] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Suzuki, Toshimitsu; Yamakawa, Kazuhiro] RIKEN, Brain Sci Inst, Neurogenet Lab, Wako, Saitama 3510198, Japan	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; RIKEN	Ganesh, S (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	sganesh@iitk.ac.in	PURI, RAJAT/H-6369-2019; Puri, Rajat/A-9960-2016; Yamakawa, Kazuhiro/N-5050-2015	PURI, RAJAT/0000-0002-8690-278X; Yamakawa, Kazuhiro/0000-0002-1478-4390; Suzuki, Toshimitsu/0000-0003-0585-5692	Life Science Research Board; Department of Science Technology; Japan Society of the Promotion of Science; RIKEN Brain Science Institute; Council of Scientific and Industrial Research student fellowship; Company of Biologists traveling fellowship	Life Science Research Board; Department of Science Technology(Department of Science & Technology (India)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Brain Science Institute; Council of Scientific and Industrial Research student fellowship; Company of Biologists traveling fellowship	This work was supported in part by sponsored research grants from the Life Science Research Board and the Department of Science & Technology (to S.G.), the Japan Society of the Promotion of Science and the RIKEN Brain Science Institute (to K.Y.), and a Council of Scientific and Industrial Research student fellowship and a Company of Biologists traveling fellowship (to R.P.)	ASKANAS V, 1994, AM J PATHOL, V144, P177; BANCHER C, 1991, BRAIN RES, V539, P11, DOI 10.1016/0006-8993(91)90681-K; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dubey D, 2008, HUM MOL GENET, V17, P3010, DOI 10.1093/hmg/ddn199; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2004, BIOCHEM BIOPH RES CO, V313, P1101, DOI 10.1016/j.bbrc.2003.12.043; Ganesh S, 2003, HUM MOL GENET, V12, P2359, DOI 10.1093/hmg/ddg253; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Ganesh S, 2001, BIOCHEM BIOPH RES CO, V283, P1046, DOI 10.1006/bbrc.2001.4914; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Goebel Hans H, 2006, Semin Pediatr Neurol, V13, P96, DOI 10.1016/j.spen.2006.06.005; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GREENE V, 1987, J NEUROPATH EXP NEUR, V46, P345, DOI 10.1097/00005072-198705000-00048; Imahori K, 1997, J BIOCHEM, V121, P179; IQBAL K, 1991, MOL NEUROBIOL, V5, P399, DOI 10.1007/BF02935561; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; KATO S, 1990, ACTA NEUROPATHOL, V81, P125, DOI 10.1007/BF00334500; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Loberg RD, 2003, HYPERTENSION, V41, P898, DOI 10.1161/01.HYP.0000061762.58873.2F; Machado-Salas J, 2005, EPILEPSIA, V46, P75; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Mirabella M, 1996, J NEUROPATH EXP NEUR, V55, P774, DOI 10.1097/00005072-199607000-00003; Mittal S, 2007, HUM MOL GENET, V16, P753, DOI 10.1093/hmg/ddm006; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; PERRY G, 1987, J NEUROSCI, V7, P3736; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; VANHEYCOP DE, 1963, EPILEPSIA, V4, P95; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YAMAMOTO T, 1986, NEUROPATH APPL NEURO, V12, P3, DOI 10.1111/j.1365-2990.1986.tb00677.x; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	51	43	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22657	22663		10.1074/jbc.M109.009688	http://dx.doi.org/10.1074/jbc.M109.009688			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542233	Green Published, hybrid			2022-12-27	WOS:000268963100019
J	Pastor, MD; Garcia-Yebenes, I; Fradejas, N; Perez-Ortiz, JM; Mora-Lee, S; Tranque, P; Moro, MA; Pende, M; Calvo, S				Dolores Pastor, Maria; Garcia-Yebenes, Isaac; Fradejas, Noelia; Manuel Perez-Ortiz, Jose; Mora-Lee, Silvia; Tranque, Pedro; Angeles Moro, Maria; Pende, Mario; Calvo, Soledad			mTOR/S6 Kinase Pathway Contributes to Astrocyte Survival during Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; IN-VITRO MODELS; S6 KINASE; PROTEIN-SYNTHESIS; CELL-SURVIVAL; MAMMALIAN TARGET; GENE-EXPRESSION; MESSENGER-RNAS; P70S6 KINASE; GROWTH	Neurons are highly dependent on astrocyte survival during brain damage. To identify genes involved in astrocyte function during ischemia, we performed mRNA differential display in astrocytes after oxygen and glucose deprivation (OGD). We detected a robust down-regulation of S6 kinase 1 (S6K1) mRNA that was accompanied by a sharp decrease in protein levels and activity. OGD-induced apoptosis was increased by the combined deletion of S6K1 and S6K2 genes, as well as by treatment with rapamycin that inhibits S6K1 activity by acting on the upstream regulator mTOR (mammalian target of rapamycin). Astrocytes lacking S6K1 and S6K2 (S6K1;S6K2(-/-)) displayed a defect in BAD phosphorylation and in the expression of the antiapoptotic factors Bcl-2 and Bcl-xL. Furthermore reactive oxygen species were increased while translation recovery was impaired in S6K-deficient astrocytes following OGD. Rescue of either S6K1 or S6K2 expression by adenoviral infection revealed that protective functions were specifically mediated by S6K1, because this isoform selectively promoted resistance to OGD and reduction of ROS levels. Finally, "in vivo" effects of S6K suppression were analyzed in the permanent middle cerebral artery occlusion model of ischemia, in which absence of S6K expression increased mortality and infarct volume. In summary, this article uncovers a protective role for astrocyte S6K1 against brain ischemia, indicating a functional pathway that senses nutrient and oxygen levels and may be beneficial for neuronal survival.	[Calvo, Soledad] Univ Castilla La Mancha, Fac Med, Sch Med, Dept Med Sci, Albacete 02006, Spain; [Garcia-Yebenes, Isaac; Angeles Moro, Maria] Univ Complutense Madrid, Dept Pharmacol, Sch Med, E-28040 Madrid, Spain; [Pende, Mario] Univ Paris 05, INSERM, U845, F-75015 Paris, France	Universidad de Castilla-La Mancha; Complutense University of Madrid; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Calvo, S (corresponding author), Univ Castilla La Mancha, Fac Med, Sch Med, Dept Med Sci, Avda Almansa 14, Albacete 02006, Spain.	soledad.calvo@uclm.es	Moro, María Ángeles/K-6396-2014; Pende, Mario/AFR-1348-2022; PÉREZ-ORTIZ, JOSÉ M./R-5379-2019	Moro, María Ángeles/0000-0003-1010-8237; Pende, Mario/0000-0002-7864-8937; PÉREZ-ORTIZ, JOSÉ M./0000-0002-3588-6273; Pastor, Maria Dolores/0000-0003-2736-0447; Tranque Gomez, Pedro Antonio/0000-0003-1072-7337; Fradejas-Villar, Noelia/0000-0003-3418-0743	Spanish Ministry of Education and Science [BFU2006-14267]; Junta de Comunidades de Castilla-La Mancha [PAI05-017, PCI-08-0101-8639]	Spanish Ministry of Education and Science(Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha)	This work was supported by the Spanish Ministry of Education and Science (Grant BFU2006-14267) and Junta de Comunidades de Castilla-La Mancha (Grants PAI05-017 and PCI-08-0101-8639) (to S. C.).	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Alliouachene S, 2008, J CLIN INVEST, V118, P3629, DOI 10.1172/JCI35237; Althausen S, 2001, J NEUROCHEM, V78, P779, DOI 10.1046/j.1471-4159.2001.00462.x; Bambrick L, 2004, NEUROCHEM RES, V29, P601, DOI 10.1023/B:NERE.0000014830.06376.e6; Benavides A, 2005, GLIA, V52, P261, DOI 10.1002/glia.20242; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chen XQ, 2005, J NEUROSCI RES, V79, P798, DOI 10.1002/jnr.20396; de la Vega CM, 2001, BIOCHEM J, V357, P819; DeGracia DJ, 2004, J NEUROSCI RES, V77, P771, DOI 10.1002/jnr.20225; Desagher S, 1996, J NEUROSCI, V16, P2553; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dugan LL, 2004, J BIOENERG BIOMEMBR, V36, P317, DOI 10.1023/B:JOBB.0000041761.61554.44; Gingras AC, 2001, GENE DEV, V15, P2852; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jamison JT, 2008, NEUROSCIENCE, V154, P504, DOI 10.1016/j.neuroscience.2008.03.057; Janelidze S, 2001, NEUROBIOL DIS, V8, P147, DOI 10.1006/nbdi.2000.0325; Jonassen AK, 2004, BIOCHEM BIOPH RES CO, V315, P160, DOI 10.1016/j.bbrc.2004.01.029; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mengesdorf T, 2002, EXP NEUROL, V177, P538, DOI 10.1006/exnr.2002.8002; Mieulet V, 2007, AM J PHYSIOL-CELL PH, V293, pC712, DOI 10.1152/ajpcell.00499.2006; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Patel S, 2002, J BIOL CHEM, V277, P9889, DOI 10.1074/jbc.M109870200; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pende Mario, 2006, Bull Cancer, V93, pE39; Perez-Asenio FJ, 2005, NEUROBIOL DIS, V18, P375, DOI 10.1016/j.nbd.2004.10.018; Perez-Ortiz JM, 2004, J BIOL CHEM, V279, P8976, DOI 10.1074/jbc.M308518200; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Voloboueva LA, 2008, J CEREBR BLOOD F MET, V28, P1009, DOI 10.1038/sj.jcbfm.9600600; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010	47	76	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22067	22078		10.1074/jbc.M109.033100	http://dx.doi.org/10.1074/jbc.M109.033100			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19535330	Green Published, hybrid			2022-12-27	WOS:000268783700031
J	Gonzalez-Guerrero, M; Hong, D; Arguello, JM				Gonzalez-Guerrero, Manuel; Hong, Deli; Argueello, Jose M.			Chaperone-mediated Cu+ Delivery to Cu+ Transport ATPases REQUIREMENT OF NUCLEOTIDE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; ARCHAEOGLOBUS-FULGIDUS; SARCOPLASMIC-RETICULUM; COPPER TRAFFICKING; STRUCTURAL BASIS; CALCIUM-TRANSPORT; DISEASE PROTEIN; TERMINAL DOMAIN; ATP BINDING; PUMP	Cu+-ATPases drive the efflux of Cu+ from the cell cytoplasm. During their catalytic/transport cycle, cytoplasmic Cu+-chaperones deliver the metal to the two transmembrane metal-binding sites (TM-MBSs) responsible for Cu+ translocation. Here, using Archaeoglobus fulgidus Cu+-ATPase CopA and the C-terminal Cu+-chaperone domain of CopZ (Ct-CopZ), we describe the mechanism of Cu+ transfer to both TM-MBSs. In absence of other ligands, Ct-CopZ transfers Cu+ to wild-type CopA and to various CopA constructs lacking or having mutated cytoplasmic metal-binding domains, in a fashion consistent with occupancy of a single TM-MBS. Similar experiments performed in the presence of 2.5 mM ADP-Mg2+, stabilizing an E1.ADP, lead to full occupancy of both TM-MBSs. In both cases, the transfer is largely stoichiometric, i.e. equimolar amounts of Ct-CopZ center dot Cu+ saturated the TM-MBSs. Experiments performed with CopA mutants lacking either TM-MBS showed that both sites are loaded independently, and nucleotide binding does not affect their availability. The nucleotide-induced E2 -> E1 transition is structurally characterized by a large displacement of the A and N domains opening the cytoplasmic region of P-type ATPases. Then, it is apparent that, whereas the first Cu+-chaperone can bind an ATPase form available in the absence of ligands, the second requires the E1.nucleotide intermediary to interact and deliver the metal. Interestingly, independent of TM-MBS Cu+ loading, nucleotide binding also prevents the regulatory interaction of the N-terminal cytoplasmic metal-binding domain with the nucleotide binding domain.	[Gonzalez-Guerrero, Manuel; Hong, Deli; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Hong, Deli/AAG-2565-2021; Gonzalez-Guerrero, Manuel/N-2281-2019; Gonzalez-Guerrero, Manuel/E-7338-2011; Arguello, Jose/D-1997-2012	Gonzalez-Guerrero, Manuel/0000-0001-7334-5286; Gonzalez-Guerrero, Manuel/0000-0001-7334-5286; Arguello, Jose/0000-0003-3940-6297	National Science Foundation [MCB-0235165]	National Science Foundation(National Science Foundation (NSF))	This work was supported, by National Science Foundation Grant MCB-0235165 (to J.M.A.).	Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2008, STRUCTURE, V16, P833, DOI 10.1016/j.str.2008.05.002; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Banci L, 2001, BIOCHEMISTRY-US, V40, P15660, DOI 10.1021/bi0112715; Bird AJ, 2008, ADV MICROB PHYSIOL, V53, P231, DOI 10.1016/SO065-2911(07)53004-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; FAGAN MJ, 1994, J MOL EVOL, V38, P57; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Frausto da Silva J, 2001, BIOL CHEM ELEMENTS, P418; Glynn I M, 1984, Soc Gen Physiol Ser, V38, P33; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Hussain F, 2008, P NATL ACAD SCI USA, V105, P11158, DOI 10.1073/pnas.0802928105; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mandal AK, 2004, J BIOL CHEM, V279, P54802, DOI 10.1074/jbc.M410854200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; POST RL, 1972, J BIOL CHEM, V247, P6530; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Sazinsky MH, 2007, J BIOL CHEM, V282, P25950, DOI 10.1074/jbc.M703311200; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Solioz M, 2003, FEMS MICROBIOL REV, V27, P183, DOI 10.1016/S0168-6445(03)00053-6; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P386, DOI 10.1016/S0753-3322(03)00012-X; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Voskoboinik N, 1999, J BIOL CHEM, V274, P22008, DOI 10.1074/jbc.274.31.22008; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350	47	45	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20804	20811		10.1074/jbc.M109.016329	http://dx.doi.org/10.1074/jbc.M109.016329			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19525226	Green Published, hybrid			2022-12-27	WOS:000268316100043
J	Pochynyuk, O; Kucher, V; Boiko, N; Mironova, E; Staruschenko, A; Karpushev, AV; Tong, QS; Hendron, E; Stockand, J				Pochynyuk, Oleh; Kucher, Volodymyr; Boiko, Nina; Mironova, Elena; Staruschenko, Alexander; Karpushev, Alexey V.; Tong, Qiusheng; Hendron, Eunan; Stockand, James			Intrinsic Voltage Dependence of the Epithelial Na+ Channel Is Masked by a Conserved Transmembrane Domain Tryptophan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; CORTICAL COLLECTING TUBULE; M2 PROTON CHANNEL; INFLUENZA-A VIRUS; ION CHANNELS; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; MOLECULAR MECHANISMS; STRUCTURAL BASIS; SODIUM-CHANNEL; MEMBRANE	Tryptophan residues critical to function are frequently located at the lipid-water interface of transmembrane domains. All members of the epithelial Na+ channel (ENaC)/Degenerin (Deg) channel superfamily contain an absolutely conserved Trp at the base of their first transmembrane domain. Here, we test the importance of this conserved Trp to ENaC/Deg function. Targeted substitution of this Trp in mouse ENaC and rat ASIC subunits decrease channel activity. Differential substitution with distinct amino acids in alpha-mENaC shows that it is loss of this critical Trp rather than introduction of residues having novel properties that changes channel activity. Surprisingly, Trp substitution unmasks voltage sensitivity. Mutant ENaC has increased steady-state activity at hyperpolarizing compared with depolarizing potentials associated with transient activation and deactivation times, respectively. The times of activation and deactivation change 1 ms/mV in a linear manner with rising and decreasing slopes, respectively. Increases in macroscopic currents at hyperpolarizing potentials results from a voltage-dependent increase in open probability. Voltage sensitivity is not influenced by divalent cations; however, it is Na+-dependentwitha 63-mV decrease in voltage required to reach half-maximal activity per log increase in [Na+]. Mutant channels are particularly sensitive to intracellular [Na+] for removing this sodium abolishes voltage dependence. We conclude that the conserved Trp at the base of TM1 in ENaC/Deg channels protects against voltage by masking an inhibitory allosteric or pore block mechanism, which decreases activity in response to intracellular Na+.	[Pochynyuk, Oleh; Kucher, Volodymyr; Boiko, Nina; Mironova, Elena; Tong, Qiusheng; Hendron, Eunan; Stockand, James] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Staruschenko, Alexander; Karpushev, Alexey V.] Med Coll Wisconsin, Dept Physiol, Kidney Dis Ctr, Milwaukee, WI 53226 USA	University of Texas System; University of Texas Health San Antonio; Medical College of Wisconsin	Stockand, J (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	stockand@uthscsa.edu	Karpushev, Alexey/K-5371-2014	Karpushev, Alexey/0000-0001-8437-6424; Staruschenko, Alexander/0000-0002-5190-8356; Stockand, James/0000-0002-3817-4319	National Institutes of Health [R01DK70571]; AHA [0640054N, 0730111N]; Carl W. Gottschalk Research Scholar; American Heart Association [0825062F]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Carl W. Gottschalk Research Scholar; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK70571 and AHA Grants 0640054N ( to J.D.S.) and 0730111N. This work was also supported by a Carl W. Gottschalk Research Scholar Grant ( American Society of Nephrology) ( to A. S.) and 0825062F ( American Heart Association) ( to O.P.).	Awayda MS, 1999, AM J PHYSIOL-CELL PH, V277, pC216, DOI 10.1152/ajpcell.1999.277.2.C216; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Bonny O, 2000, KIDNEY INT, V57, P1313, DOI 10.1046/j.1523-1755.2000.00968.x; Booth RE, 2003, AM J PHYSIOL-RENAL, V284, pF938, DOI 10.1152/ajprenal.00373.2002; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Haney EF, 2007, BBA-BIOMEMBRANES, V1768, P2355, DOI 10.1016/j.bbamem.2007.04.018; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2006, J BIOL CHEM, V281, P30455, DOI 10.1074/jbc.M604615200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loussouarn G, 2002, TRENDS CARDIOVAS MED, V12, P253, DOI 10.1016/S1050-1738(02)00170-6; MACDONALD JF, 1990, TRENDS PHARMACOL SCI, V11, P167, DOI 10.1016/0165-6147(90)90070-O; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Oezdirekcan S, 2008, BIOPHYS J, V94, P1315, DOI 10.1529/biophysj.106.101782; Palmer LG, 1996, J GEN PHYSIOL, V107, P35, DOI 10.1085/jgp.107.1.35; PALMER LG, 1988, J GEN PHYSIOL, V92, P121, DOI 10.1085/jgp.92.1.121; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Pochynyuk O, 2005, J BIOL CHEM, V280, P37565, DOI 10.1074/jbc.M509071200; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; SILVER RB, 1993, AM J PHYSIOL, V264, pF557, DOI 10.1152/ajprenal.1993.264.3.F557; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2007, DEV NEUROBIOL, V67, P97, DOI 10.1002/dneu.20338; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tang P, 2002, P NATL ACAD SCI USA, V99, P16035, DOI 10.1073/pnas.252522299; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Williamson IM, 2003, CELL MOL LIFE SCI, V60, P1581, DOI 10.1007/s00018-003-3172-y; Witter R, 2008, J AM CHEM SOC, V130, P918, DOI 10.1021/ja0754305; Xiang F, 2007, J PHYS CHEM B, V111, P12282, DOI 10.1021/jp073883q; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	41	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25512	25521		10.1074/jbc.M109.015917	http://dx.doi.org/10.1074/jbc.M109.015917			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19620245	hybrid, Green Published			2022-12-27	WOS:000269738000008
J	Roman, AC; Carvajal-Gonzalez, JM; Rico-Leo, EM; Fernandez-Salguero, PM				Carlos Roman, Angel; Carvajal-Gonzalez, Jose M.; Rico-Leo, Eva M.; Fernandez-Salguero, Pedro M.			Dioxin Receptor Deficiency Impairs Angiogenesis by a Mechanism Involving VEGF-A Depletion in the Endothelium and Transforming Growth Factor-beta Overexpression in the Stroma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; MOUSE EMBRYO FIBROBLASTS; TGF-BETA; NULL MICE; BRANCHING MORPHOGENESIS; CONSTITUTIVE EXPRESSION; TUMOR MICROENVIRONMENT; VASCULAR DEVELOPMENT; TRANSCRIPTION FACTOR; CARDIAC-HYPERTROPHY	Angiogenesis has key roles in development and in the progression of human diseases such as cancer. Consequently, identifying the novel markers and regulators of angiogenesis is a critical task. The dioxin receptor (AhR) contributes to vascular homeostasis and to the endothelial response to toxins, although the mechanisms involved are largely uncharacterized. Here, we show that AhR-null mice (AhR(-/-)) have impaired angiogenesis in vivo that compromises tumor xenograft growth. Aortic rings emigration experiments and RNA interference indicated that AhR(-/-) endothelial cells failed to branch and to form tube-like structures. Such a phenotype was found to be vascular endothelial growth factor (VEGF)-dependent, as AhR(-/-) aortic endothelial cells (MAECs) secreted lower amounts of active VEGF-A and their treatment with VEGF-A rescued angiogenesis in culture and in vivo. Further, the addition of anti-VEGF antibody to AhR(-/-) MAECs reduced angiogenesis. Treatment under hypoxic conditions with 2-methoxyestradiol suggested that HIF-1 alpha modulates endothelial VEGF expression in an AhR-dependent manner. Importantly, AhR-null stromal myofibroblasts produced increased transforming growth factor-beta (TGF beta) activity, which inhibited angiogenesis in human endothelial cells (HMECs) and AhR(-/-) mice, whereas the co-culture of HMECs with AhR(-/-) myofibroblasts or with their conditioned medium inhibited branching, which was restored by an anti-TGF beta antibody. Moreover, VEGF and TGF beta activities cooperated in modulating angiogenesis, as the addition of TGF beta to AhR(-/-) MAECs further reduced their low basal VEGF-A activity. Thus, AhR modulates angiogenesis through a mechanism requiring VEGF activation in the endothelium and TGF beta inactivation in the stroma. These data highlight the role of AhR in cardiovascular homeostasis and suggest that this receptor can be a novel regulator of angiogenesis during tumor development.	[Carlos Roman, Angel; Carvajal-Gonzalez, Jose M.; Rico-Leo, Eva M.; Fernandez-Salguero, Pedro M.] Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, E-06071 Badajoz, Spain	Universidad de Extremadura	Fernandez-Salguero, PM (corresponding author), Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, Ave Elvas S-N, E-06071 Badajoz, Spain.	pmfersal@unex.es	Fernandez-Salguero, Pedro M./J-8437-2014; Carvajal-Gonzalez, Jose Maria/ABC-6780-2020	Fernandez-Salguero, Pedro M./0000-0003-2839-5027; Carvajal-Gonzalez, Jose Maria/0000-0001-6576-830X	Spanish Ministry of Science and Innovation [SAF2008-00462]; Junta de Extremadura [GRU08012, GRU09001]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06/0020/1016]; European Union FEDER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Extremadura; Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); European Union FEDER(European Commission)	This work was supported by grants from the Spanish Ministry of Science and Innovation (SAF2008-00462), the Junta de Extremadura (GRU08012 and GRU09001), and the Red Tematica de Investigacion Cooperativa en Cancer (RTICC) (RD06/0020/1016, Fondo de Investigaciones Sanitarias (FIS), Carlos III Institute, Spanish Ministry of Health) (to P.M.F.-S.). All Spanish funding was co-sponsored by the European Union FEDER program.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Bohnsack BL, 2004, CELL CYCLE, V3, P1506, DOI 10.4161/cc.3.12.1334; Bove PF, 2008, J BIOL CHEM, V283, P17919, DOI 10.1074/jbc.M709914200; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carvajal-Gonzalez JM, 2009, J CELL SCI, V122, P1823, DOI 10.1242/jcs.047274; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Chan WK, 1999, J BIOL CHEM, V274, P12115, DOI 10.1074/jbc.274.17.12115; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Childs S, 2002, DEVELOPMENT, V129, P973; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Corchero J, 2004, INT J EXP PATHOL, V85, P295, DOI 10.1111/j.0959-9673.2004.00397.x; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dor Y, 2003, TRENDS CELL BIOL, V13, P131, DOI 10.1016/S0962-8924(03)00022-9; Elizondo G, 2000, MOL PHARMACOL, V57, P1056; Feng Y, 2009, NEUROSCIENCE, V158, P823, DOI 10.1016/j.neuroscience.2008.10.024; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gomez-Duran A, 2006, J CELL BIOCHEM, V97, P380, DOI 10.1002/jcb.20637; Gomez-Duran A, 2008, J MOL BIOL, V380, P1, DOI 10.1016/j.jmb.2008.04.056; GOMEZDURAN A, 2008, BIOCH PHARM; Guo JH, 2004, TOXICOL APPL PHARM, V194, P79, DOI 10.1016/j.taap.2003.09.002; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc; Ichihara S, 2007, ARTERIOSCL THROM VAS, V27, P1297, DOI 10.1161/ATVBAHA.106.138701; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Kundu JK, 2008, CANCER LETT, V269, P243, DOI 10.1016/j.canlet.2008.03.057; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lloyd RV, 2003, MICROSC RES TECHNIQ, V60, P244, DOI 10.1002/jemt.10263; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Lund AK, 2006, TOXICOL APPL PHARM, V212, P127, DOI 10.1016/j.taap.2005.07.005; Lund AK, 2003, TOXICOL APPL PHARM, V193, P177, DOI 10.1016/j.taap.2003.08.008; Mallet C, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0494; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Moennikes O, 2004, CANCER RES, V64, P4707, DOI 10.1158/0008-5472.CAN-03-0875; Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Peng L, 2008, TOXICOLOGY, V246, P242, DOI 10.1016/j.tox.2008.01.002; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271; Pollenz RS, 1999, MOL PHARMACOL, V56, P1127, DOI 10.1124/mol.56.6.1127; Puga A, 2005, BIOCHEM PHARMACOL, V69, P199, DOI 10.1016/j.bcp.2004.06.043; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Roman AC, 2008, P NATL ACAD SCI USA, V105, P1632, DOI 10.1073/pnas.0708366105; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Santiago-Josefat B, 2004, J CELL SCI, V117, P849, DOI 10.1242/jcs.00932; Takeuchi A, 2009, INVEST OPHTH VIS SCI, V50, P3410, DOI 10.1167/iovs.08-2299; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tomanek RJ, 2001, DEV DYNAM, V221, P265, DOI 10.1002/dvdy.1137; Vasquez Alejandro, 2003, Cardiovasc Toxicol, V3, P153, DOI 10.1385/CT:3:2:153; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313; Zhang QZ, 2005, MOL CANCER THER, V4, P1465, DOI 10.1158/1535-7163.MCT-05-0198; Zhang ZH, 2008, BLOOD, V111, P1980, DOI 10.1182/blood-2007-06-094680	73	57	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25135	25148		10.1074/jbc.M109.013292	http://dx.doi.org/10.1074/jbc.M109.013292			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617630	hybrid, Green Published			2022-12-27	WOS:000269734000048
J	Martens, EC; Koropatkin, NM; Smith, TJ; Gordon, JI				Martens, Eric C.; Koropatkin, Nicole M.; Smith, Thomas J.; Gordon, Jeffrey I.			Complex Glycan Catabolism by the Human Gut Microbiota: The Bacteroidetes Sus-like Paradigm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OUTER-MEMBRANE PROTEINS; PLANT POLYSACCHARIDES; BINDING SITES; IN-VIVO; STARCH; SYMBIONT; THETAIOTAOMICRON; BACTERIA; GENES; BIOSYNTHESIS	Trillions of microbes inhabit the distal gut of adult humans. They have evolved to compete efficiently for nutrients, including a wide array of chemically diverse, complex glycans present in our diets, secreted by our intestinal mucosa, and displayed on the surfaces of other gut microbes. Here, we review how members of the Bacteroidetes, one of two dominant gut-associated bacterial phyla, process complex glycans using a series of similarly patterned, cell envelope-associated multiprotein systems. These systems provide insights into how gut, as well as terrestrial and aquatic, Bacteroidetes survive in highly competitive ecosystems.	[Martens, Eric C.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; [Koropatkin, Nicole M.; Smith, Thomas J.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Washington University (WUSTL); Donald Danforth Plant Science Center	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@wustl.edu	Smith, Thomas J/K-9086-2013	Smith, Thomas J/0000-0003-3528-6793	National Institutes of Health [DK30292, GM078800, HD07409, AI073060]; Missouri Life Sciences Trust Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007409, F32HD007409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI073060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Missouri Life Sciences Trust Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK30292, GM078800, HD07409, and AI073060. This work was also supported by the Missouri Life Sciences Trust Fund. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; ANDERSON KL, 1989, J BACTERIOL, V171, P3192, DOI 10.1128/jb.171.6.3192-3198.1989; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; DElla JN, 1996, J BACTERIOL, V178, P7173; Della JN, 1996, J BACTERIOL, V178, P7180; Ferguson AD, 2002, BBA-BIOMEMBRANES, V1565, P318, DOI 10.1016/S0005-2736(02)00578-3; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; Kitamura M, 2008, J BIOL CHEM, V283, P36328, DOI 10.1074/jbc.M806115200; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; McBride MJ, 2003, J BACTERIOL, V185, P6648, DOI 10.1128/JB.185.22.6648-6657.2003; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997; SALYERS AA, 1977, APPL ENVIRON MICROB, V34, P529, DOI 10.1128/AEM.34.5.529-533.1977; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Salyers AA, 2000, METHODS, V20, P35, DOI 10.1006/meth.1999.0903; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; TANCULA E, 1992, J BACTERIOL, V174, P5609, DOI 10.1128/JB.174.17.5609-5616.1992; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; VALENTINE PJ, 1992, APPL ENVIRON MICROB, V58, P1541, DOI 10.1128/AEM.58.5.1541-1548.1992; WHITEHEAD TR, 1995, BBA-GEN SUBJECTS, V1244, P239, DOI 10.1016/0304-4165(95)00051-C; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; York WS, 2008, CURR OPIN PLANT BIOL, V11, P258, DOI 10.1016/j.pbi.2008.02.007	39	408	422	5	93	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24673	24677		10.1074/jbc.R109.022848	http://dx.doi.org/10.1074/jbc.R109.022848			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19553672	Green Published, hybrid			2022-12-27	WOS:000269734000001
J	O'Leary, B; Rao, SK; Kim, J; Plaxton, WC				O'Leary, Brendan; Rao, Srinath K.; Kim, Julia; Plaxton, William C.			Bacterial-type Phosphoenolpyruvate Carboxylase (PEPC) Functions as a Catalytic and Regulatory Subunit of the Novel Class-2 PEPC Complex of Vascular Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASTOR-OIL SEEDS; ALGA SELENASTRUM-MINUTUM; MICROALGA CHLAMYDOMONAS-REINHARDTII; MOLECULAR-MASS ISOFORMS; FATTY-ACID SYNTHESIS; UNRELATED POLYPEPTIDES; ARABIDOPSIS-THALIANA; EXPRESSION ANALYSIS; KINETIC-PROPERTIES; PHOSPHORYLATION	Phosphoenolpyruvate carboxylase (PEPC) is a tightly regulated anaplerotic enzyme situated at a major branch point of the plant C metabolism. Two distinct oligomeric classes of PEPC occur in the triglyceride-rich endosperm of developing castor oil seeds (COS). Class-1 PEPC is a typical homotetramer composed of identical 107-kDa plant-type PEPC (PTPC) subunits (encoded by RcPpc3), whereas the novel Class-2 PEPC 910-kDa hetero-octameric complex arises from a tight interaction between Class-1 PEPC and distantly related 118-kDa bacterial-type PEPC (BTPC) polypeptides (encoded by RcPpc4). Here, COS BTPC was expressed from full-length RcPpc4 cDNA in Escherichia coli as an active PEPC that exhibited unusual properties relative to PTPCs, including a tendency to form large aggregates, enhanced thermal stability, a high K-m(PEP), and insensitivity to metabolite effectors. A chimeric 900-kDa Class-2 PEPC hetero-octamer having a 1:1 stoichiometry of BTPC: PTPC subunits was isolated from a mixture of clarified extracts containing recombinant RcPPC4 and an Arabidopsis thaliana Class-1 PEPC (the PTPC, AtPPC3). The purified Class-2 PEPC exhibited biphasic PEP saturation kinetics with high and low affinity sites attributed to its AtPPC3 and RcPPC4 subunits, respectively. The RcPPC4 subunits: (i) catalyzed the majority of the Class-2 PEPC V-max, particularly in the presence of the inhibitor L-malate, and (ii) also functioned as Class-2 PEPC regulatory subunits by modulating PEP binding and catalytic potential of its AtPPC3 subunits. BTPCs appear to associate with PTPCs to form stable Class-2 PEPC complexes in vivo that are hypothesized to maintain high flux from PEP under physiological conditions that would otherwise inhibit Class-1 PEPCs.	[O'Leary, Brendan; Rao, Srinath K.; Kim, Julia; Plaxton, William C.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Plaxton, William C.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Plaxton, WC (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	plaxton@queensu.ca	O'Leary, Brendan M/C-4680-2014; Plaxton, William C/O-3353-2013	O'Leary, Brendan M/0000-0002-8770-155X; Plaxton, William C/0000-0002-8447-7249	Natural Sciences and Engineering Research Council of Canada (NSERC); Queen's Research Chairs program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen's Research Chairs program	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Queen's Research Chairs program (to W.C. P.).	Blonde JD, 2003, J BIOL CHEM, V278, P11867, DOI 10.1074/jbc.M211269200; BROOKS SPJ, 1992, BIOTECHNIQUES, V13, P906; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Eastmond PJ, 1997, PLANT PHYSIOL, V114, P851, DOI 10.1104/pp.114.3.851; Gennidakis S, 2007, PLANT J, V52, P839, DOI 10.1111/j.1365-313X.2007.03274.x; Gousset-Dupont A, 2005, PLANT SCI, V169, P1096, DOI 10.1016/j.plantsci.2005.07.014; Grafahrend-Belau E, 2009, PLANT PHYSIOL, V149, P585, DOI 10.1104/pp.108.129635; Gregory AL, 2009, BIOCHEM J, V420, P57, DOI 10.1042/BJ20082397; Izui K, 2004, ANNU REV PLANT BIOL, V55, P69, DOI 10.1146/annurev.arplant.55.031903.141619; Kai Y, 2003, ARCH BIOCHEM BIOPHYS, V414, P170, DOI 10.1016/S0003-9861(03)00170-X; Kim M, 2007, PROTEIN EXPRES PURIF, V52, P230, DOI 10.1016/j.pep.2006.11.003; Law RD, 1997, EUR J BIOCHEM, V247, P642, DOI 10.1111/j.1432-1033.1997.00642.x; Mamedov TG, 2005, PLANT J, V42, P832, DOI 10.1111/j.1365-313X.2005.02416.x; Moellering ER, 2007, FEBS LETT, V581, P4871, DOI 10.1016/j.febslet.2007.09.015; Moraes TF, 2000, EUR J BIOCHEM, V267, P4465, DOI 10.1046/j.1432-1327.2000.01495.x; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; PLAXTON WC, 1989, EUR J BIOCHEM, V181, P443, DOI 10.1111/j.1432-1033.1989.tb14745.x; Rivoal J, 1996, ARCH BIOCHEM BIOPHYS, V332, P47, DOI 10.1006/abbi.1996.0315; Rivoal J, 1998, BIOCHEM J, V331, P201, DOI 10.1042/bj3310201; Rivoal J, 2002, PLANT CELL PHYSIOL, V43, P785, DOI 10.1093/pcp/pcf092; Rivoal J, 2001, J BIOL CHEM, V276, P12588, DOI 10.1074/jbc.M010150200; Sanchez R, 2006, PLANTA, V223, P901, DOI 10.1007/s00425-005-0144-5; Sanchez R, 2003, PLANT PHYSIOL, V132, P949, DOI 10.1104/pp.102.019653; SMITH RG, 1992, PLANT PHYSIOL, V98, P1233, DOI 10.1104/pp.98.4.1233; Sullivan S, 2004, PLANT PHYSIOL, V135, P2078, DOI 10.1104/pp.104.042762; Takahashi-Terada A, 2005, J BIOL CHEM, V280, P11798, DOI 10.1074/jbc.M408768200; Thomas JG, 1997, PROTEIN EXPRES PURIF, V11, P289, DOI 10.1006/prep.1997.0796; Tripodi KE, 2005, PLANT PHYSIOL, V139, P969, DOI 10.1104/pp.105.066647; Uhrig RG, 2008, J BIOL CHEM, V283, P29650, DOI 10.1074/jbc.M806102200; Uhrig RG, 2008, PLANT PHYSIOL, V146, P1346, DOI 10.1104/pp.107.110361; Xu WX, 2006, J BIOL CHEM, V281, P17238, DOI 10.1074/jbc.M602299200; Yuan JP, 2006, PHOTOSYNTH RES, V88, P73, DOI 10.1007/s11120-005-9032-x	32	46	46	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24797	24805		10.1074/jbc.M109.022863	http://dx.doi.org/10.1074/jbc.M109.022863			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605358	Green Published, hybrid			2022-12-27	WOS:000269734000014
J	Zaborske, JM; Narasimhan, J; Jiang, L; Wek, SA; Dittmar, KA; Freimoser, F; Pan, T; Wek, RC				Zaborske, John M.; Narasimhan, Jana; Jiang, Li; Wek, Sheree A.; Dittmar, Kimberly A.; Freimoser, Florien; Pan, Tao; Wek, Ronald C.			Genome-wide Analysis of tRNA Charging and Activation of the eIF2 Kinase Gcn2p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAEMOPHILUS-INFLUENZAE YBAK; UNCHARGED TRANSFER-RNA; AMINO-ACID STARVATION; FACTOR 2-ALPHA KINASE; TRANSLATIONAL CONTROL; PROTEIN-KINASE; GENE-EXPRESSION; EIF2-ALPHA KINASE; SYNAPTIC PLASTICITY; SACCHAROMYCES-CEREVISIAE	When cells are subjected to nutritional stress, uncharged tRNAs accumulate and activate Gcn2p phosphorylation of eukaryotic initiation factor-2 (eIF2) and the general amino acid control pathway. The Gcn2p regulatory domain homologous to histidyl-tRNA synthetases is proposed to bind to uncharged tRNA, directly contributing to activation of Gcn2p. Here we apply a microarray technology to analyze genome-wide changes in tRNA charging in yeast upon activation of Gcn2p in response to amino acid starvation and high salinity, a stress not directly linked to nutritional deficiency. This microarray technology is applicable for all eukaryotic cells. Strains were starved for histidine, leucine, or tryptophan and shown to rapidly induce Gcn2p phosphorylation of eIF2. The relative charging level of all tRNAs was measured before and after starvation, and Gcn2p activation and the intracellular levels of the starved amino acid correlate with the observed decrease in tRNA charging. Interestingly, in some cases, tRNAs not charged with the starved amino acid became deacylated more rapidly than tRNAs charged with the starved amino acid. This increase in uncharged tRNA levels occurred although the intracellular levels for these non-starved amino acids remained unchanged. Additionally, treatment of a wild-type strain with high salinity stress showed transient changes in the charging of several different tRNAs. These results suggest that Gcn2p can be activated by many different tRNA species in the cell. These results also depict a complex cellular relationship between tRNA charging, amino acid availability, and non-nutrient stress. These relationships are best revealed by simultaneous monitoring of the charging level of all tRNAs.	[Zaborske, John M.; Dittmar, Kimberly A.; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Narasimhan, Jana; Jiang, Li; Wek, Sheree A.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Freimoser, Florien] ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland	University of Chicago; Indiana University System; Indiana University-Purdue University Indianapolis; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pan, T (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.	taopan@uchicago.edu; rwek@iupui.edu	Freimoser, Florian/A-6152-2014	Freimoser, Florian/0000-0001-7607-3108	National Institutes of Health [R01GM49164, T32GM007183-33]; Ajinomoto Inc., Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, T32GM007183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ajinomoto Inc., Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM49164 (to R. C. W.) from the National Institutes of Health and National Institutes of Health Training Grant T32GM007183-33) (to J.Z.). This work was also supported by a grant from Ajinomoto Inc., Japan (to T. P.)	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Beebe K, 2004, P NATL ACAD SCI USA, V101, P5958, DOI 10.1073/pnas.0401530101; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Feller A, 1999, EUR J BIOCHEM, V261, P163, DOI 10.1046/j.1432-1327.1999.00262.x; Garriz A, 2009, MOL CELL BIOL, V29, P1592, DOI 10.1128/MCB.01446-08; Goossens A, 2001, J BIOL CHEM, V276, P30753, DOI 10.1074/jbc.M102960200; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kaiser C. S., 1994, METHODS YEAST GENETI, P207; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mascarenhas C, 2008, MOL BIOL CELL, V19, P2995, DOI 10.1091/mbc.E07-11-1173; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; MESSENGUY F, 1980, EUR J BIOCHEM, V108, P439, DOI 10.1111/j.1432-1033.1980.tb04740.x; MIRANDE M, 1983, EUR J BIOCHEM, V131, P163, DOI 10.1111/j.1432-1033.1983.tb07244.x; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Palmer LK, 2002, GENETICS, V161, P563; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; Qiu HF, 2002, GENE DEV, V16, P1271, DOI 10.1101/gad.979402; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2004, TOP CURR GENET, V7, P171; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	56	93	97	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25254	25267		10.1074/jbc.M109.000877	http://dx.doi.org/10.1074/jbc.M109.000877			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19546227	hybrid, Green Published			2022-12-27	WOS:000269734000059
J	Miyata, M; Rikitake, Y; Takahashi, M; Nagamatsu, Y; Yamauchi, Y; Ogita, H; Hirata, K; Takai, Y				Miyata, Muneaki; Rikitake, Yoshiyuki; Takahashi, Motonori; Nagamatsu, Yuichi; Yamauchi, Yusuke; Ogita, Hisakazu; Hirata, Ken-ichi; Takai, Yoshimi			Regulation by Afadin of Cyclical Activation and Inactivation of Rap1, Rac1, and RhoA Small G Proteins at Leading Edges of Moving NIH3T3 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN STRESS FIBERS; NECL-5/POLIOVIRUS RECEPTOR; CELLULAR MORPHOLOGY; FOCAL COMPLEXES; BINDING PROTEIN; JUNCTIONS; ADHESION; CDC42; AF-6; INTERACTS	Cyclical activation and inactivation of Rho family small G proteins, such as Rho, Rac, and Cdc42, are needed for moving cells to form leading edge structures in response to chemoattractants. However, the mechanisms underlying the dynamic regulation of their activities are not fully understood. We recently showed that another small G protein, Rap1, plays a crucial role in the platelet-derived growth factor (PDGF)-induced formation of leading edge structures and activation of Rac1 in NIH3T3 cells. We showed here that knockdown of afadin, an actin-binding protein, in NIH3T3 cells resulted in a failure to develop leading edge structures in association with an impairment of the activation of Rap1 and Rac1 and inactivation of RhoA in response to PDGF. Overexpression of a constitutively active mutant of Rap1 (Rap1-CA) and knockdown of SPA-1, a Rap1 GTPase-activating protein that was negatively regulated by afadin by virtue of binding to it, in afadin-knockdown NIH3T3 cells restored the formation of leading edge structures and the reduction of the PDGF-induced activation of Rac1 and inactivation of RhoA, suggesting that the inactivation of Rap1 by SPA-1 is responsible for inhibition of the formation of leading edge structures. The effect of Rap1-CA on the restoration of the formation of leading edge structures and RhoA inactivation was diminished by additional knockdown of ARAP1, a Rap-activated Rho GAP, which localized at the leading edges of moving NIH3T3 cells. These results indicate that afadin regulates the cyclical activation and inactivation of Rap1, Rac1, and RhoA through SPA-1 and ARAP1.	[Miyata, Muneaki; Rikitake, Yoshiyuki; Takahashi, Motonori; Nagamatsu, Yuichi; Yamauchi, Yusuke; Ogita, Hisakazu; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan; [Rikitake, Yoshiyuki; Takahashi, Motonori; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan	Kobe University; Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Yamauchi, Yusuke/D-2780-2015; Ogita, Hisakazu/AAE-4416-2020	Yamauchi, Yusuke/0000-0001-7854-927X; Ogita, Hisakazu/0000-0001-6750-1668	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Foundation for Applied Enzymology	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology	This work was supported by grants-in-aid for Scientific Research and for Cancer Research and, in part, by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2006-2008) and a research grant from the Japan Foundation for Applied Enzymology.	Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuhara T, 2004, J CELL BIOL, V166, P393, DOI 10.1083/jcb.200401093; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Ikeda W, 2001, ONCOGENE, V20, P3457, DOI 10.1038/sj.onc.1204463; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Nagamatsu Y, 2008, J BIOL CHEM, V283, P14532, DOI 10.1074/jbc.M801647200; Nakahara H, 2003, GENES CELLS, V8, P1019, DOI 10.1111/j.1365-2443.2003.00695.x; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Su L, 2003, J BIOL CHEM, V278, P15232, DOI 10.1074/jbc.M211888200; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3; Zhang ZC, 2005, J BIOL CHEM, V280, P33200, DOI 10.1074/jbc.M505057200	33	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24595	24609		10.1074/jbc.M109.016436	http://dx.doi.org/10.1074/jbc.M109.016436			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19589776	Green Published, hybrid			2022-12-27	WOS:000269380200069
J	Yamaji, N; Little, MJ; Nishio, H; Billen, B; Villegas, E; Nishiuchi, Y; Tytgat, J; Nicholson, GM; Corzo, G				Yamaji, Nahoko; Little, Michelle J.; Nishio, Hideki; Billen, Bert; Villegas, Elba; Nishiuchi, Yuji; Tytgat, Jan; Nicholson, Graham M.; Corzo, Gerardo			Synthesis, Solution Structure, and Phylum Selectivity of a Spider delta-Toxin That Slows Inactivation of Specific Voltage-gated Sodium Channel Subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCORPION ALPHA-TOXINS; LETHAL NEUROTOXIN; PEPTIDE TOXINS; ATRAX-ROBUSTUS; RAT-BRAIN; MOLECULAR-MECHANISMS; MISSULENA-BRADLEYI; MEMBRANE PATCHES; BINDING; INSECT	Magi 4, now renamed delta-hexatoxin-Mg1a, is a 43-residue neurotoxic peptide from the venom of the hexathelid Japanese funnel-web spider (Macrothele gigas) with homology to delta-hexatoxins from Australian funnel-web spiders. It binds with high affinity to receptor site 3 on insect voltage-gated sodium (Na-V) channels but, unlike delta-hexatoxins, does not compete for the related site 3 in rat brain despite being previously shown to be lethal by intracranial injection. To elucidate differences in Na-V channel selectivity, we have undertaken the first characterization of a peptide toxin on a broad range of mammalian and insect Na-V channel subtypes showing that delta-hexatoxin-Mg1a selectively slows channel inactivation of mammalian Na(V)1.1, Na(V)1.3, and Na(V)1.6 but more importantly shows higher affinity for insect Na(V)1 (para) channels. Consequently, delta-hexatoxin-Mg1a induces tonic repetitive firing of nerve impulses in insect neurons accompanied by plateau potentials. In addition, we have chemically synthesized and folded delta-hexatoxin-Mg1a, ascertained the bonding pattern of the four disulfides, and determined its three-dimensional solution structure using NMR spectroscopy. Despite modest sequence homology, we show that key residues important for the activity of scorpion alpha-toxins and delta-hexatoxins are distributed in a topologically similar manner in delta-hexatoxin-Mg1a. However, subtle differences in the toxin surfaces are important for the novel selectivity of delta-hexatoxin-Mg1a for certain mammalian and insect Na-V channel subtypes. As such, delta-hexatoxin-Mg1a provides us with a specific tool with which to study channel structure and function and determinants for phylum-and tissue-specific activity.	[Little, Michelle J.; Nicholson, Graham M.] Univ Technol Sydney, Dept Med & Mol Biosci, Neurotoxin Res Grp, Sydney, NSW 2007, Australia; [Yamaji, Nahoko] Suntory Inst Bioorgan Res, Osaka 6188503, Japan; [Nishio, Hideki; Nishiuchi, Yuji] Peptide Inst Inc, Prot Res Fdn, Osaka 5628686, Japan; [Billen, Bert; Tytgat, Jan] Univ Leuven, Toxicol Lab, B-3000 Leuven, Belgium; [Villegas, Elba] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca 62210, Morelos, Mexico; [Corzo, Gerardo] Univ Nacl Autonoma Mexico, Inst Biotecnologia, Cuernavaca 62210, Morelos, Mexico	University of Technology Sydney; Suntory Holdings Ltd; KU Leuven; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico	Nicholson, GM (corresponding author), Univ Technol Sydney, Dept Med & Mol Biosci, Neurotoxin Res Grp, Sydney, NSW 2007, Australia.	Graham.Nicholson@uts.edu.au; corzo@ibt.unam.mx	Corzo, Gerardo/B-3778-2014; Nicholson, Graham M/E-8136-2010; Tytgat, Jan/F-1560-2010	Corzo, Gerardo/0000-0002-9513-1622; Nicholson, Graham M/0000-0002-4277-4296; Tytgat, Jan/0000-0003-1778-6022; Villegas Villarreal, Elba Cristina/0000-0003-1795-0427	Direccion General de Asuntos del Personal Academico [IN220809-3]; CONACyT [49773/24968]; Australian Research Council Discovery [DP0559396]; Australian postgraduate award [G.0330.06, OT-05-64, UA p6/31]	Direccion General de Asuntos del Personal Academico; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Australian Research Council Discovery(Australian Research Council); Australian postgraduate award(Australian Government)	This work was supported in part by Direccion General de Asuntos del Personal Academico Grants IN220809-3 and CONACyT 49773/24968 (to G. C.), Australian Research Council Discovery Grant DP0559396 (to G. M. N.), an Australian postgraduate award (to M. J. L.), Grants G.0330.06 (F. W. O. Vlaanderen), OT-05-64 (Katholieke Universiteit Leuven), and UA p6/31 (Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policy) (to B. B. and J. T.).	Birinyi-Strachan LC, 2005, NEUROPHARMACOLOGY, V49, P669, DOI 10.1016/j.neuropharm.2005.04.024; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Cierpicki T, 2000, PROTEIN SCI, V9, P976, DOI 10.1110/ps.9.5.976; Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5; DeLano W.L, PYMOL MOL GRAPHICS S; FERNANDEZ JM, 1984, J PHYSIOL-LONDON, V356, P565, DOI 10.1113/jphysiol.1984.sp015483; Fletcher JI, 1997, STRUCTURE, V5, P1525, DOI 10.1016/S0969-2126(97)00301-8; Gilles N, 2002, EUR J BIOCHEM, V269, P1500, DOI 10.1046/j.1432-1033.2002.02799.x; Gilles N, 2000, J NEUROCHEM, V75, P1735, DOI 10.1046/j.1471-4159.2000.0751735.x; Gilles N, 1999, J NEUROSCI, V19, P8730, DOI 10.1523/JNEUROSCI.19-20-08730.1999; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; Gordon Dalia, 1997, Invertebrate Neuroscience, V3, P103, DOI 10.1007/BF02480365; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Grolleau F, 2000, J EXP BIOL, V203, P1633; Grolleau F, 2001, J EXP BIOL, V204, P711; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunning SJ, 2008, FEBS J, V275, P4045, DOI 10.1111/j.1742-4658.2008.06545.x; Gunning SJ, 2003, FEBS LETT, V554, P211, DOI 10.1016/S0014-5793(03)01175-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOUSSET D, 1994, J MOL BIOL, V238, P88, DOI 10.1006/jmbi.1994.1270; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; Karbat I, 2007, FEBS J, V274, P1918, DOI 10.1111/j.1742-4658.2007.05737.x; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krimm I, 1999, J MOL BIOL, V285, P1749, DOI 10.1006/jmbi.1998.2418; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leipold E, 2004, MOL PHARMACOL, V65, P685, DOI 10.1124/mol.65.3.685; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Little MJ, 1998, FEBS LETT, V439, P246, DOI 10.1016/S0014-5793(98)01378-7; Little MJ, 1998, J BIOL CHEM, V273, P27076, DOI 10.1074/jbc.273.42.27076; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; NICHOLSON GM, 1994, PFLUG ARCH EUR J PHY, V428, P400, DOI 10.1007/BF00724524; Nicholson GM, 1998, PFLUG ARCH EUR J PHY, V436, P117, DOI 10.1007/s004240050612; Nicholson GM, 2004, TOXICON, V43, P587, DOI 10.1016/j.toxicon.2004.02.006; Nicholson GM, 2002, EUR J PHARMACOL, V452, P35, DOI 10.1016/S0014-2999(02)02239-2; Oliveira JS, 2004, J BIOL CHEM, V279, P33323, DOI 10.1074/jbc.M404344200; Ostman JAR, 2008, J PHYSIOL-LONDON, V586, P1077, DOI 10.1113/jphysiol.2007.147942; Pallaghy PK, 1997, FEBS LETT, V419, P191, DOI 10.1016/S0014-5793(97)01452-X; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; PARDI A, 1983, EUR J BIOCHEM, V137, P445, DOI 10.1111/j.1432-1033.1983.tb07848.x; Rash LD, 2000, BRIT J PHARMACOL, V130, P1817, DOI 10.1038/sj.bjp.0703494; ROY ML, 1992, J NEUROSCI, V12, P2104; SCHREIBMAYER W, 1987, BIOCHIM BIOPHYS ACTA, V901, P273, DOI 10.1016/0005-2736(87)90124-6; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHEUMACK DD, 1985, FEBS LETT, V181, P154, DOI 10.1016/0014-5793(85)81132-7; STRICHARTZ GR, 1986, J GEN PHYSIOL, V88, P413, DOI 10.1085/jgp.88.3.413; Szeto TH, 2000, FEBS LETT, V470, P293, DOI 10.1016/S0014-5793(00)01339-9; Tugarinov V, 1997, BIOCHEMISTRY-US, V36, P2414, DOI 10.1021/bi961497l; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Waxman SG, 2002, NOVART FDN SYMP, V241, P34; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479; Wuthrich K, 1986, NMR PROTEINS NUCL AC	58	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24568	24582		10.1074/jbc.M109.030841	http://dx.doi.org/10.1074/jbc.M109.030841			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592486	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000269380200067
J	Poor, CB; Chen, PR; Duguid, E; Rice, PA; He, C				Poor, Catherine B.; Chen, Peng R.; Duguid, Erica; Rice, Phoebe A.; He, Chuan			Crystal Structures of the Reduced, Sulfenic Acid, and Mixed Disulfide Forms of SarZ, a Redox Active Global Regulator in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS OHRR; OXIDATION-SENSING MECHANISM; PSEUDOMONAS-AERUGINOSA; MARR FAMILY; ORGANIC HYDROPEROXIDES; BIOFILM FORMATION; VIRULENCE GENES; PEROXIDE SENSOR; REPRESSOR; PROTEINS	SarZ is a global transcriptional regulator that uses a single cysteine residue, Cys(13), to sense peroxide stress and control metabolic switching and virulence in Staphylococcus aureus. SarZ belongs to the single-cysteine class of OhrR-MgrA proteins that play key roles in oxidative resistance and virulence regulation in various bacteria. We present the crystal structures of the reduced form, sulfenic acid form, and mixed disulfide form of SarZ. Both the sulfenic acid and mixed disulfide forms are structurally characterized for the first time for this class of proteins. The Cys(13) sulfenic acid modification is stabilized through two hydrogen bonds with surrounding residues, and the overall DNA-binding conformation is retained. A further reaction of the Cys(13) sulfenic acid with an external thiol leads to formation of a mixed disulfide bond, which results in an allosteric change in the DNA-binding domains, disrupting DNA binding. Thus, the crystal structures of SarZ in three different states provide molecular level pictures delineating the mechanism by which this class of redox active regulators undergoes activation. These structures help to understand redox-mediated virulence regulation in S. aureus and activation of the MarR family proteins in general.	[Poor, Catherine B.; Chen, Peng R.; Duguid, Erica; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Duguid, Erica; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 929 E 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu		Duguid, Erica/0000-0003-4319-1030	National Institutes of Health [AI074658]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; National Science Foundation Graduate Research Fellowship; United States Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074658 (to C. H.). This work was also supported by a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award, a National Science Foundation Graduate Research Fellowship (to C. B. P.), and by funds from the National Institutes of Health and the United States Department of Energy (to Beamlines 23-ID-B, 19BM, and 14BM).	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Ballal A, 2009, J BACTERIOL, V191, P1656, DOI 10.1128/JB.01555-08; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W.L, PYMOL MOL GRAPHICS S; delCardayre SB, 1998, J BIOL CHEM, V273, P5744, DOI 10.1074/jbc.273.10.5744; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Hochgrafe F, 2007, J BIOL CHEM, V282, P25981, DOI 10.1074/jbc.C700105200; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Ingavale S, 2005, INFECT IMMUN, V73, P1423, DOI 10.1128/IAI.73.3.1423-1431.2005; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Luong TT, 2003, J BACTERIOL, V185, P3703, DOI 10.1128/JB.185.13.3703-3710.2003; Manna AC, 2003, INFECT IMMUN, V71, P343, DOI 10.1128/IAI.71.1.343-353.2003; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Soonsanga S, 2008, J BACTERIOL, V190, P5738, DOI 10.1128/JB.00576-08; Soonsanga S, 2008, MOL MICROBIOL, V68, P978, DOI 10.1111/j.1365-2958.2008.06200.x; Soonsanga S, 2007, J BACTERIOL, V189, P7069, DOI 10.1128/JB.00879-07; Tamber S, 2009, INFECT IMMUN, V77, P419, DOI 10.1128/IAI.00859-08; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Truong-Bolduc QC, 2005, J BACTERIOL, V187, P2395, DOI 10.1128/JB.187.7.2395-2405.2005; Wang L, 2008, J INFECT DIS, V197, P1254, DOI 10.1086/586714; Wilke MS, 2008, P NATL ACAD SCI USA, V105, P14832, DOI 10.1073/pnas.0805489105; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	48	74	75	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23517	23524		10.1074/jbc.M109.015826	http://dx.doi.org/10.1074/jbc.M109.015826			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19586910	Green Published, hybrid			2022-12-27	WOS:000269180000036
J	Blindauer, CA; Harvey, I; Bunyan, KE; Stewart, AJ; Sleep, D; Harrison, DJ; Berezenko, S; Sadler, PJ				Blindauer, Claudia A.; Harvey, Ian; Bunyan, Kerry E.; Stewart, Alan J.; Sleep, Darrell; Harrison, David J.; Berezenko, Stephen; Sadler, Peter J.			Structure, Properties, and Engineering of the Major Zinc Binding Site on Human Albumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM-ALBUMIN; NUCLEAR-MAGNETIC-RESONANCE; TO-BASE TRANSITION; CRYSTAL-STRUCTURE; METAL-BINDING; CONFORMATIONAL-CHANGE; EQUILIBRIUM DIALYSIS; IN-VITRO; PROTEIN; ACID	Most blood plasma zinc is bound to albumin, but the structure of the binding site has not been determined. Zn K-edge extended x-ray absorption fine structure spectroscopy and modeling studies show that the major Zn2+ site on albumin is a 5-coordinate site with average Zn-O/N distances of 1.98 angstrom and a weak sixth O/N bond of 2.48 angstrom, consistent with coordination to His(67) and Asn(99) from domain I, His(247) and Asp(249) from domain II (residues conserved in all sequenced mammalian albumins), plus a water ligand. The dynamics of the domain I/II interface, thought to be important to biological function, are affected by Zn2+ binding, which induces cooperative allosteric effects related to those of the pH-dependent neutral-to-base transition. N99D and N99H mutations enhance Zn2+ binding but alter protein stability, whereas mutation of His67 to alanine removes an interdomain H-bond and weakens Zn2+ binding. Both wildtype and mutant albumins promote the safe management of high micromolar zinc concentrations for cells in cultures.	[Blindauer, Claudia A.; Sadler, Peter J.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Harvey, Ian] Res Councils Daresbury Lab, Council Cent Lab, Warrington WA4 4AD, Cheshire, England; [Bunyan, Kerry E.; Harrison, David J.] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh EH4 2XR, Midlothian, Scotland; [Stewart, Alan J.] Univ St Andrews, Bute Med Sch, St Andrews KY16 9TS, Fife, Scotland; [Sleep, Darrell; Berezenko, Stephen] Novozymes Biopharma Ltd, Nottingham NG7 1FD, England	University of Warwick; STFC Daresbury Laboratory; University of Edinburgh; University of St Andrews; Novozymes	Blindauer, CA (corresponding author), Univ Warwick, Dept Chem, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	c.blindauer@warwick.ac.uk	Blindauer, Claudia/G-3237-2011; Stewart, Alan J/B-6569-2008	Blindauer, Claudia/0000-0001-8396-9332; Stewart, Alan J/0000-0003-4580-1840; Sleep, Darrell/0000-0001-8287-9538	Biotechnology and Biological Sciences Research Council; Novozymes Biopharma, Ltd.; European Community Marie Curie Fellowship; Wellcome Trust; Wolfson Foundation; Olga Kennard Fellowship from the Royal Society	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Novozymes Biopharma, Ltd.; European Community Marie Curie Fellowship(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Wolfson Foundation; Olga Kennard Fellowship from the Royal Society	This work was supported by the Biotechnology and Biological Sciences Research Council (Collaborative Award in Science and Engineering) (to A. J. S.), Novozymes Biopharma, Ltd., a European Community Marie Curie Fellowship (to C. A. B.), the Council for the Central Laboratory of the Research Councils (synchrotron beam time), the Wellcome Trust (Edinburgh Protein Interaction Centre), the Wolfson Foundation, and an Olga Kennard Fellowship from the Royal Society (to C. A. B.).	Bal W, 1998, J INORG BIOCHEM, V70, P33, DOI 10.1016/S0162-0134(98)00010-5; BOS OJM, 1989, J BIOL CHEM, V264, P953; Cario E, 2000, EUR J CLIN INVEST, V30, P419; CAROLI S, 1994, CRIT REV ANAL CHEM, V24, P363, DOI 10.1080/10408349408048824; CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704; CHRISTODOULOU J, 1994, EUR J BIOCHEM, V225, P363, DOI 10.1111/j.1432-1033.1994.00363.x; CHRISTODOULOU J, 1997, THESIS U LONDON; COUSINS RJ, 1986, CLIN PHYSIOL BIOCH, V4, P20; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Ferrer ML, 2001, BIOPHYS J, V80, P2422, DOI 10.1016/S0006-3495(01)76211-X; FISCHER MJE, 1993, BIOCHEM PHARMACOL, V45, P2411, DOI 10.1016/0006-2952(93)90221-H; Ford D, 2004, P NUTR SOC, V63, P21, DOI 10.1079/PNS2003320; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Giroux E.L., 1973, BIOINORG CHEM, V2, P125, DOI [10.1016/s0006-3061(00)80156-8, DOI 10.1016/S0006-3061(00)80156-8, DOI 10.1016/50006-3061(00)80156-8]; GOUMAKOS W, 1991, BIOCHEM CELL BIOL, V69, P809, DOI 10.1139/o91-121; Guo ML, 2003, J BIOL CHEM, V278, P2490, DOI 10.1074/jbc.M208776200; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harford C, 1997, ACCOUNTS CHEM RES, V30, P123, DOI 10.1021/ar9501535; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HORIE T, 1988, AM J PHYSIOL, V254, pG465, DOI 10.1152/ajpgi.1988.254.4.G465; Hsin K, 2008, J APPL CRYSTALLOGR, V41, P963, DOI 10.1107/S002188980802476X; JANSSEN LHM, 1981, BIOCHIM BIOPHYS ACTA, V669, P244, DOI 10.1016/0005-2795(81)90247-6; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; LABRO JFA, 1986, BIOCHIM BIOPHYS ACTA, V873, P267, DOI 10.1016/0167-4838(86)90054-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin SZ, 2005, NEUROREPORT, V16, P1461, DOI 10.1097/01.wnr.0000176523.34594.98; LIPSCOMB WN, 1980, P NATL ACAD SCI-BIOL, V77, P3875, DOI 10.1073/pnas.77.7.3875; Lu J, 2008, BIOCHEM SOC T, V36, P1317, DOI 10.1042/BST0361317; Ma SF, 2005, DRUG METAB DISPOS, V33, P1911, DOI 10.1124/dmd.105.006163; MARTINS EO, 1982, INORG CHIM A-BIOINOR, V67, P71, DOI 10.1016/S0020-1693(00)85042-2; MASUOKA J, 1994, J BIOL CHEM, V269, P25557; McCall KA, 2004, BIOCHEMISTRY-US, V43, P3979, DOI 10.1021/bi0498914; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Ohyoshi E, 1999, J INORG BIOCHEM, V75, P213, DOI 10.1016/S0162-0134(99)00090-2; Okeson CD, 2004, TOXICOL IN VITRO, V18, P673, DOI 10.1016/j.tiv.2004.03.006; Oz GL, 1998, BIOCHEM CELL BIOL, V76, P223, DOI 10.1139/bcb-76-2-3-223; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Peters T., 1995, ALL ALBUMIN BIOCH GE, P9, DOI [10.1016/B978-012552110-9/50004-0, DOI 10.1016/B978-012552110-9/50004-0]; Petersen CE, 2002, PROTEINS, V47, P116, DOI 10.1002/prot.10068; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; PETTIT G, 1993, IUPAC STABILITY CONS; REED RG, 1989, J BIOL CHEM, V264, P9867; Rowe DJ, 2000, P SOC EXP BIOL MED, V224, P178, DOI 10.1046/j.1525-1373.2000.22418.x; Rudolf E, 2003, BIOMETALS, V16, P295, DOI 10.1023/A:1020603110255; Sadler PJ, 1996, INORG CHEM, V35, P4490, DOI 10.1021/ic951005d; Stewart AJ, 2005, FEBS J, V272, P353, DOI 10.1111/j.1742-4658.2004.04474.x; Stewart AJ, 2003, P NATL ACAD SCI USA, V100, P3701, DOI 10.1073/pnas.0436576100; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TICHANE RM, 1957, J AM CHEM SOC, V79, P1293, DOI 10.1021/ja01563a009; Turk BE, 2004, NAT STRUCT MOL BIOL, V11, P60, DOI 10.1038/nsmb708; WANG X, 2009, SPECTROCHIM A A 0424; WILTING J, 1980, J BIOL CHEM, V255, P3032; Yamasaki K, 1999, BBA-PROTEIN STRUCT M, V1432, P313, DOI 10.1016/S0167-4838(99)00098-9	56	106	116	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23116	23124		10.1074/jbc.M109.003459	http://dx.doi.org/10.1074/jbc.M109.003459			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19520864	hybrid, Green Published			2022-12-27	WOS:000268963100063
J	Fu, AG; Aluru, M; Rodermel, SR				Fu, Aigen; Aluru, Maneesha; Rodermel, Steven R.			Conserved Active Site Sequences in Arabidopsis Plastid Terminal Oxidase (PTOX) IN VITRO AND IN PLANTA MUTAGENESIS STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ALTERNATIVE OXIDASE; CYANIDE-RESISTANT OXIDASE; CHLOROPLAST BIOGENESIS; IMMUTANS; THALIANA; ENZYME; GENE; CHLORORESPIRATION; DIFFERENTIATION; PHOTOSYNTHESIS	The plastid terminal oxidase (PTOX) is distantly related to the mitochondrial alternative oxidase (AOX). Both are members of the diiron carboxylate quinol oxidase (DOX) class of proteins. PTOX and AOX contain 20 highly conserved amino acids, six of which are Fe-binding ligands. We have previously used in vitro and in planta activity assays to examine the functional importance of the Fe-binding sites. In this report, we conduct alanine-scanning mutagenesis on the 14 other conserved sites using our in vitro and in planta assay procedures. We found that the 14 sites fall into three classes: (i) Ala-139, Pro-142, Glu-171, Asn-174, Leu-179, Pro-216, Ala-230, Asp-287, and Arg-293 are dispensable for activity; (ii) Tyr-234 and Asp-295 are essential for activity; and (iii) Leu-135, His-151, and Tyr-212 are important but not essential for activity. Our data are consistent with the proposed role of some of these residues in active site conformation, substrate binding, and/or catalysis. Titration experiments showed that down-regulation of PTOX to similar to 3% of wild-type levels did not compromise plant growth, at least under ambient growth conditions. This suggests that PTOX is normally in excess, especially early in thylakoid membrane biogenesis.	[Fu, Aigen; Aluru, Maneesha; Rodermel, Steven R.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA	Iowa State University	Rodermel, SR (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, 253 Bessey Hall, Ames, IA 50011 USA.	rodermel@iastate.edu						Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Ajayi WU, 2002, J BIOL CHEM, V277, P8187, DOI 10.1074/jbc.M111477200; Albury MS, 1998, J BIOL CHEM, V273, P30301, DOI 10.1074/jbc.273.46.30301; Albury MS, 2002, J BIOL CHEM, V277, P1190, DOI 10.1074/jbc.M109853200; Aluru MR, 2006, J EXP BOT, V57, P1871, DOI 10.1093/jxb/erj008; Aluru MR, 2001, PLANT PHYSIOL, V127, P67, DOI 10.1104/pp.127.1.67; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; Atteia A, 2004, GENE, V330, P143, DOI 10.1016/j.gene.2004.01.015; Baerr JN, 2005, PHYSIOL PLANTARUM, V124, P390, DOI 10.1111/j.1399-3054.2005.00506.x; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Berthold DA, 2003, ANNU REV PLANT BIOL, V54, P497, DOI 10.1146/annurev.arplant.54.031902.134915; Berthold DA, 2002, J BIOL CHEM, V277, P43608, DOI 10.1074/jbc.M206724200; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cournac L, 2000, PHILOS T ROY SOC B, V355, P1447, DOI 10.1098/rstb.2000.0705; Finnegan PM, 2003, FEBS LETT, V555, P425, DOI 10.1016/S0014-5793(03)01309-7; Fu AG, 2005, J BIOL CHEM, V280, P42489, DOI 10.1074/jbc.M508940200; Joet T, 2002, J BIOL CHEM, V277, P31623, DOI 10.1074/jbc.M203538200; Josse EM, 2000, PLANT PHYSIOL, V123, P1427, DOI 10.1104/pp.123.4.1427; Josse EM, 2003, EUR J BIOCHEM, V270, P3787, DOI 10.1046/j.1432-1033.2003.03766.x; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; McDonald AE, 2003, PLANT MOL BIOL, V53, P865, DOI 10.1023/B:PLAN.0000023669.79465.d2; McDonald AE, 2008, FUNCT PLANT BIOL, V35, P535, DOI 10.1071/FP08025; MOORE AL, 1995, J BIOENERG BIOMEMBR, V27, P367, DOI 10.1007/BF02109999; Moore AL, 2008, BIOCHEM SOC T, V36, P1022, DOI 10.1042/BST0361022; Nakamura K, 2005, BIOCHEM BIOPH RES CO, V334, P593, DOI 10.1016/j.bbrc.2005.06.131; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; PERRY SE, 1991, METHOD CELL BIOL, V34, P327; PURVIS AC, 1993, PHYSIOL PLANTARUM, V88, P712, DOI 10.1111/j.1399-3054.1993.tb01393.x; Purvis AC, 2001, J PLANT PHYSIOL, V158, P159, DOI 10.1078/0176-1617-00128; REDEI GP, 1963, SCIENCE, V139, P767, DOI 10.1126/science.139.3556.767; Rizhsky L, 2002, PLANT J, V32, P329, DOI 10.1046/j.1365-313X.2002.01427.x; Rosso D, 2006, PLANT PHYSIOL, V142, P574, DOI 10.1104/pp.106.085886; Shahbazi M, 2007, PLANT PHYSIOL, V145, P691, DOI 10.1104/pp.107.106336; SIEDOW JN, 1995, FEBS LETT, V362, P10, DOI 10.1016/0014-5793(95)00196-G; Siedow JN, 2000, BBA-BIOENERGETICS, V1459, P432, DOI 10.1016/S0005-2728(00)00181-X; Stenmark P, 2003, FEBS LETT, V552, P189, DOI 10.1016/S0014-5793(03)00920-7; Umbach AL, 2000, ARCH BIOCHEM BIOPHYS, V378, P234, DOI 10.1006/abbi.2000.1834; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; WETZEL CM, 1994, PLANT J, V6, P161, DOI 10.1046/j.1365-313X.1994.6020161.x; Wu DY, 1999, PLANT CELL, V11, P43, DOI 10.1105/tpc.11.1.43; Yip JYH, 2001, PHYSIOL PLANTARUM, V112, P327, DOI 10.1034/j.1399-3054.2001.1120305.x	44	16	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22625	22632		10.1074/jbc.M109.017905	http://dx.doi.org/10.1074/jbc.M109.017905			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542226	Green Published, hybrid			2022-12-27	WOS:000268963100015
J	Hwang, HW; Lee, JR; Chou, KY; Suen, CS; Hwang, MJ; Chen, C; Shieh, RC; Chau, LY				Hwang, Hsuan-Wen; Lee, Jay-Ron; Chou, Kuan-Yu; Suen, Ching-Shu; Hwang, Ming-Jing; Chen, Chinpan; Shieh, Ru-Chi; Chau, Lee-Young			Oligomerization Is Crucial for the Stability and Function of Heme Oxygenase-1 in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE ALPHA-HELICES; MEMBRANE-PROTEINS; CYTOCHROME-P450 REDUCTASE; DRIVE ASSOCIATION; CRYSTAL-STRUCTURE; COILED COILS; RESIDUES; MOTIF; DIMERIZATION; DEGRADATION	Heme oxygenase-1 (HO-1), a stress-inducible enzyme anchored in the endoplasmic reticulum (ER) by a single transmembrane segment (TMS) located at the C terminus, interacts with NADPH cytochrome P450 reductase and biliverdin reductase to catalyze heme degradation to biliverdin and its metabolite, bilirubin. Previous studies suggested that HO-1 functions as a monomer. Using chemical cross-linking, co-immunoprecipitation, and fluorescence resonance energy transfer (FRET) experiments, here we showed that HO-1 forms dimers/oligomers in the ER. However, oligomerization was not observed with a truncated HO-1 lacking the C-terminal TMS (amino acids 266-285), which exhibited cytosolic and nuclear localization, indicating that the TMS is essential for the self-assembly of HO-1 in the ER. To identify the interface involved in the TMS-TMS interaction, residue Trp-270, predicted by molecular modeling as a potential interfacial residue of TMS alpha-helices, was mutated, and the effects on protein subcellular localization and activity assessed. The results showed that the W270A mutant was present exclusively in the ER and formed oligomers with similar activity to those of the wild type HO-1. Interestingly, the W270N mutant was localized not only in the ER, but also in the cytosol and nucleus, suggesting it is susceptible to proteolytic cleavage. Moreover, the microsomal HO activity of the W270N mutant was significantly lower than that of the wild type. The W270N mutation appears to interfere with the oligomeric state, as revealed by a lower FRET efficiency. Collectively, these data suggest that oligomerization, driven by TMS-TMS interactions, is crucial for the stabilization and function of HO-1 in the ER.	[Hwang, Hsuan-Wen; Lee, Jay-Ron; Chou, Kuan-Yu; Suen, Ching-Shu; Hwang, Ming-Jing; Chen, Chinpan; Shieh, Ru-Chi; Chau, Lee-Young] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan	Shieh, RC (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	ruchi@ibms.sinica.edu.tw; lyc@ibms.sinica.edu.tw	Hwang, Ming-jing/E-9210-2012; Chen, Chinpan/O-4202-2018; Chau, Lee-Young/N-7659-2018	Hwang, Ming-jing/0000-0002-9657-5663; Chau, Lee-Young/0000-0002-6316-2328	National Science Council of Taiwan [NSC-95-2320-B-001-028-MY3, NSC-952320-B-001-008]; Academia Sinica Investigatorship	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica Investigatorship(Academia Sinica - Taiwan)	This work was supported in parts by grants from the National Science Council of Taiwan (to R.-C.S., NSC-95-2320-B-001-028-MY3; to L.-Y.C., NSC-952320- B-001-008), and an Academia Sinica Investigatorship (to L.-Y.C.).	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Arkin IT, 2002, BBA-BIOMEMBRANES, V1565, P347, DOI 10.1016/S0005-2736(02)00580-1; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Higashimoto Y, 2008, BIOCHEM BIOPH RES CO, V367, P852, DOI 10.1016/j.bbrc.2008.01.016; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huber WJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI 10.1021/bi701496z; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Lin PH, 2008, BBA-MOL CELL RES, V1783, P1826, DOI 10.1016/j.bbamcr.2008.05.008; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Yang NC, 2004, J BIOMED SCI, V11, P799, DOI 10.1159/000081827; YOSHIDA T, 1991, EUR J BIOCHEM, V199, P729, DOI 10.1111/j.1432-1033.1991.tb16177.x; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	31	43	43	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22672	22679		10.1074/jbc.M109.028001	http://dx.doi.org/10.1074/jbc.M109.028001			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19556236	Green Published, hybrid			2022-12-27	WOS:000268963100021
J	Iguchi, Y; Katsuno, M; Niwa, J; Yamada, S; Sone, J; Waza, M; Adachi, H; Tanaka, F; Nagata, K; Arimura, N; Watanabe, T; Kaibuchi, K; Sobue, G				Iguchi, Yohei; Katsuno, Masahisa; Niwa, Jun-ichi; Yamada, Shin-ichi; Sone, Jun; Waza, Masahiro; Adachi, Hiroaki; Tanaka, Fumiaki; Nagata, Koh-ichi; Arimura, Nariko; Watanabe, Takashi; Kaibuchi, Kozo; Sobue, Gen			TDP-43 Depletion Induces Neuronal Cell Damage through Dysregulation of Rho Family GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PROTEIN GERANYLGERANYLATION; TARDBP MUTATIONS; INHIBITION; APOPTOSIS; SURVIVAL; KINASE; CDC42; PHOSPHORYLATION	The 43-kDa TAR DNA-binding protein (TDP-43) is known to be a major component of the ubiquitinated inclusions characteristic of amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positive inclusions. Although TDP-43 is a nuclear protein, it disappears from the nucleus of affected neurons and glial cells, implicating TDP-43 loss of function in the pathogenesis of neurodegeneration. Here we show that the knockdown of TDP-43 in differentiated Neuro-2a cells inhibited neurite outgrowth and induced cell death. In knockdown cells, the Rho family members RhoA, Rac1, and Cdc42 GTPases were inactivated, and membrane localization of these molecules was reduced. In addition, TDP-43 depletion significantly suppressed protein geranylgeranylation, a key regulating factor of Rho family activity and intracellular localization. In contrast, overexpression of TDP-43 mitigated the cellular damage caused by pharmacological inhibition of geranylgeranylation. Furthermore administration of geranylgeranyl pyrophosphate partially restored cell viability and neurite outgrowth in TDP-43 knockdown cells. In summary, our data suggest that TDP-43 plays a key role in the maintenance of neuronal cell morphology and survival possibly through protein geranylgeranylation of Rho family GTPases.	[Iguchi, Yohei; Katsuno, Masahisa; Yamada, Shin-ichi; Sone, Jun; Waza, Masahiro; Adachi, Hiroaki; Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Watanabe, Takashi; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Katsuno, Masahisa; Watanabe, Takashi] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Niwa, Jun-ichi] Aichi Med Univ, Stroke Ctr, Aichi 4801195, Japan; [Nagata, Koh-ichi] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Aichi 4800838, Japan; [Arimura, Nariko] Tamagawa Univ, Brain Sci Inst, Tokyo 1948610, Japan	Nagoya University; Nagoya University; Nagoya University; Aichi Medical University	Sobue, G (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sobueg@med.nagoya-u.ac.jp	KATSUNO, MASAHISA/I-7502-2014; Sone, Jun/M-5027-2014; Adachi, Hiroaki/AAM-7812-2020	KATSUNO, MASAHISA/0000-0001-9453-9311; Sone, Jun/0000-0002-9057-7609; Adachi, Hiroaki/0000-0002-9302-4663; Watanabe, Takashi/0000-0002-9015-5246	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Japan Intractable Diseases Research Foundation; Special Coordination Funds for Promoting Science and Technology	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Intractable Diseases Research Foundation; Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Center-of-Excellence grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan; grants from the Ministry of Health, Labor and Welfare of Japan; a grant from the Japan Intractable Diseases Research Foundation; and the Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned by the Ministry of Education, Culture, Sports, Science and Technology.	ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Ahmed I, 2006, MOL CELL BIOCHEM, V281, P17, DOI 10.1007/s11010-006-0165-9; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Ericsson J, 1998, J LIPID RES, V39, P1731; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2006, J NEUROSCI, V26, P12106, DOI 10.1523/JNEUROSCI.3032-06.2006; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; Loucks FA, 2006, J NEUROCHEM, V97, P957, DOI 10.1111/j.1471-4159.2006.03802.x; Meske V, 2003, EUR J NEUROSCI, V17, P93, DOI 10.1046/j.1460-9568.2003.02433.x; MOOMAW JF, 1992, J BIOL CHEM, V267, P17438; Nakagawa M, 2001, J CELL SCI, V114, P1829; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Saito M, 2005, ALCOHOL CLIN EXP RES, V29, P1374, DOI 10.1097/01.alc.0000175011.22307.61; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Sueyoshi N, 2001, J LIPID RES, V42, P1197; Tanaka T, 2000, J NEUROSCI, V20, P2852; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Xia Z, 2001, LEUKEMIA, V15, P1398, DOI 10.1038/sj.leu.2402196; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhou KM, 1998, J BIOL CHEM, V273, P16782, DOI 10.1074/jbc.273.27.16782	44	76	81	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22059	22066		10.1074/jbc.M109.012195	http://dx.doi.org/10.1074/jbc.M109.012195			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19535326	Green Published, hybrid			2022-12-27	WOS:000268783700030
J	Mazar, J; Thomas, M; Bezrukov, L; Chanturia, A; Pekkurnaz, G; Yin, SR; Kuznetsov, SA; Robey, PG; Zimmerberg, J				Mazar, Julia; Thomas, Molly; Bezrukov, Ludmila; Chanturia, Alexander; Pekkurnaz, Gulcin; Yin, Shurong; Kuznetsov, Sergei A.; Robey, Pamela G.; Zimmerberg, Joshua			Cytotoxicity Mediated by the Fas Ligand (FasL)-activated Apoptotic Pathway in Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW CELLS; IMMUNE PRIVILEGE; IN-VITRO; LYMPHOCYTE-PROLIFERATION; T-CELLS; DIFFERENTIATION; DONOR; MECHANISM; SURVIVAL; LEUKEMIA	Whereas it is now clear that human bone marrow stromal cells (BMSCs) can be immunosuppressive and escape cytotoxic lymphocytes (CTLs) in vitro and in vivo, the mechanisms of this phenomenon remain controversial. Here, we test the hypothesis that BMSCs suppress immune responses by Fas-mediated apoptosis of activated lymphocytes and find both Fas and FasL expression by primary BMSCs. Jurkat cells or activated lymphocytes were each killed by BMSCs after 72 h of co-incubation. In comparison, the cytotoxic effect of BMSCs on non-activated lymphocytes and on caspase-8(-/-) Jurkat cells was extremely low. Fas/Fc fusion protein strongly inhibited BMSC-induced lymphocyte apoptosis. Although we detected a high level of Fas expression in BMSCs, stimulation of Fas with anti-Fas antibody did not result in the expected BMSC apoptosis, regardless of concentration, suggesting a disruption of the Fas activation pathway. Thus BMSCs may have an endogenous mechanism to evade Fas-mediated apoptosis. Cumulatively, these data provide a parallel between adult stem/progenitor cells and cancer cells, consistent with the idea that stem/progenitor cells can use FasL to prevent lymphocyte attack by inducing lymphocyte apoptosis during the regeneration of injured tissues.	[Mazar, Julia; Thomas, Molly; Bezrukov, Ludmila; Chanturia, Alexander; Pekkurnaz, Gulcin; Yin, Shurong; Zimmerberg, Joshua] NICHD, Program Phys Biol, Bethesda, MD 20892 USA; [Kuznetsov, Sergei A.; Robey, Pamela G.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zimmerberg, J (corresponding author), NICHD, Program Phys Biol, Bethesda, MD 20892 USA.	joshz@helix.nih.gov	Robey, Pamela Gehron/H-1429-2011	Robey, Pamela Gehron/0000-0002-5316-5576; Pekkurnaz, Gulcin/0000-0002-7388-6178	NICHD; NIDCR; Department of Health and Human Services and Breast Cancer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001409] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000380] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Department of Health and Human Services and Breast Cancer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health intramural programs of the NICHD and NIDCR. This work was also supported by Department of Health and Human Services and Breast Cancer Stamp funds.	Abrahams VM, 2003, CANCER RES, V63, P5573; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Benvenuto F, 2007, STEM CELLS, V25, P1753, DOI 10.1634/stemcells.2007-0068; Ceccatelli S, 2004, TOXICOL LETT, V149, P59, DOI 10.1016/j.toxlet.2003.12.060; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; George JF, 1998, NAT MED, V4, P333, DOI 10.1038/nm0398-333; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Griffith TS, 1997, IMMUNOL TODAY, V18, P240, DOI 10.1016/S0167-5699(97)81663-5; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kemp KC, 2005, LEUKEMIA LYMPHOMA, V46, P1531, DOI 10.1080/10428190500215076; Lacombe F, 1996, HEMATOL CELL THER, V38, P495, DOI 10.1007/s00282-996-0495-9; Lee ST, 2002, BRIT J HAEMATOL, V118, P1128, DOI 10.1046/j.1365-2141.2002.03767.x; Liu J, 2004, TRANSPL P, V36, P3272, DOI 10.1016/j.transproceed.2004.11.090; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Medana I, 2001, J IMMUNOL, V167, P674, DOI 10.4049/jimmunol.167.2.674; O'Connell J, 2001, NAT MED, V7, P271, DOI 10.1038/85395; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; Oh SH, 2000, BIOCHEM BIOPH RES CO, V279, P500, DOI 10.1006/bbrc.2000.3985; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019; Robey PG, 2006, J AM DENT ASSOC, V137, P961, DOI 10.14219/jada.archive.2006.0317; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sanchez A, 2004, HEPATOLOGY, V40, P590, DOI 10.1002/hep.20363; Studeny M, 2002, CANCER RES, V62, P3603; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001	30	38	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22022	22028		10.1074/jbc.M109.032235	http://dx.doi.org/10.1074/jbc.M109.032235			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531476	Green Published, hybrid			2022-12-27	WOS:000268783700026
J	Cook, KM; Hilton, ST; Mecinovic, J; Motherwell, WB; Figg, WD; Schofield, CJ				Cook, Kristina M.; Hilton, Stephen T.; Mecinovic, Jasmin; Motherwell, William B.; Figg, William D.; Schofield, Christopher J.			Epidithiodiketopiperazines Block the Interaction between Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) and p300 by a Zinc Ejection Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; STRUCTURAL BASIS; METAL-COMPLEXES; IN-VIVO; GLIOTOXIN; TRANSCRIPTION; SPORIDESMIN; CELLS; INHIBITOR; PATHWAY	The hypoxic response in humans is regulated by the hypoxia-inducible transcription factor system; inhibition of hypoxia-inducible factor (HIF) activity has potential for the treatment of cancer. Chetomin, a member of the epidithiodiketopiperazine (ETP) family of natural products, inhibits the interaction between HIF-alpha and the transcriptional coactivator p300. Structure-activity studies employing both natural and synthetic ETP derivatives reveal that only the structurally unique ETP core is required and sufficient to block the interaction of HIF-1 alpha and p300. In support of both cell-based and animal work showing that the cytotoxic effect of ETPs is reduced by the addition of Zn2+ through an unknown mechanism, our mechanistic studies reveal that ETPs react with p300, causing zinc ion ejection. Cell studies with both natural and synthetic ETPs demonstrated a decrease in vascular endothelial growth factor and antiproliferative effects that were abrogated by zinc supplementation. The results have implications for the design of selective ETPs and for the interaction of ETPs with other zinc ion-binding protein targets involved in gene expression.	[Cook, Kristina M.; Figg, William D.] NCI, NIH, Bethesda, MD 20814 USA; [Cook, Kristina M.; Mecinovic, Jasmin; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Cook, Kristina M.; Mecinovic, Jasmin; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England; [Hilton, Stephen T.] Univ London, Sch Pharm, Dept Pharmaceut & Biol Chem, London WC1N 1AX, England; [Motherwell, William B.] UCL, Dept Chem, London WC1H 0AJ, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Oxford; University of London; University College London; University of London School of Pharmacy; University of London; University College London	Figg, WD (corresponding author), 10 Ctr Dr,9000 Rockville Pike,Bldg 10,Rm 5A01, Bethesda, MD 20892 USA.	wdfigg@helix.nih.gov	Cook, Kristina/B-8012-2008; Figg, William D/M-2411-2016; Hilton, Stephen/C-2699-2008; Mecinovic, Jasmin/F-9694-2015; Hilton, Stephen/AAM-6617-2020; Hilton, Stephen/P-4493-2019	Hilton, Stephen/0000-0001-8782-4499; Mecinovic, Jasmin/0000-0002-5559-3822; Hilton, Stephen/0000-0001-8782-4499; Cook, Kristina/0000-0002-0503-7166; Schofield, Christopher/0000-0002-0290-6565	National Institutes of Health [Z01SC 006538]; Cancer Research UK; The Wellcome Trust; Biochemical and Biotechnology Research Council; NATIONAL CANCER INSTITUTE [ZIASC006538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); The Wellcome Trust(Wellcome TrustEuropean Commission); Biochemical and Biotechnology Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Grant Z01SC 006538. This work was also supported by grants from Cancer Research UK, The Wellcome Trust, and the Biochemical and Biotechnology Research Council.	Aliev AE, 2006, TETRAHEDRON LETT, V47, P2387, DOI 10.1016/j.tetlet.2006.01.156; Bernardo PH, 2003, J BIOL CHEM, V278, P46549, DOI 10.1074/jbc.M304825200; Chai CLL, 2000, REDOX REP, V5, P257, DOI 10.1179/135100000101535799; Choi HS, 2007, BIOCHEM BIOPH RES CO, V359, P523, DOI 10.1016/j.bbrc.2007.05.139; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; DELANO WL, 2002, PYMOL VERSION 99 PYM; Duncan EJ, 2005, TOXICOL LETT, V159, P164, DOI 10.1016/j.toxlet.2005.05.005; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Fox EM, 2008, FUNGAL GENET BIOL, V45, P671, DOI 10.1016/j.fgb.2007.10.005; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; FUKUYAMA T, 1981, TETRAHEDRON, V37, P2045, DOI 10.1016/S0040-4020(01)97960-8; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Goodman RH, 2000, GENE DEV, V14, P1553; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hilton ST, 2004, SYNLETT, P2609, DOI 10.1055/s-2004-834823; Hilton ST, 2005, BIOORG MED CHEM LETT, V15, P2239, DOI 10.1016/j.bmcl.2005.03.022; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; JIANG H, 1993, AUST J CHEM, V46, P1743, DOI 10.1071/CH9931743; JORDAN TW, 1986, J CELL SCI, V85, P33; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lienard BMR, 2007, CHEMMEDCHEM, V2, P175, DOI 10.1002/cmdc.200600250; Loo JA, 1996, J MED CHEM, V39, P4313, DOI 10.1021/jm960253w; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Selevsek N, 2006, J AM SOC MASS SPECTR, V17, P1000, DOI 10.1016/j.jasms.2006.03.010; SEYA H, 1986, J CHEM SOC PERK T 1, P109, DOI 10.1039/p19860000109; SHIGEMATSU N, 1994, J ANTIBIOT, V47, P311, DOI 10.7164/antibiotics.47.311; Staab A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-213; Tibodeau JD, 2009, ANTIOXID REDOX SIGN, V11, P1097, DOI 10.1089/ARS.2008.2318; Vigushin DM, 2004, MED ONCOL, V21, P21, DOI 10.1385/MO:21:1:21; Woodcock JC, 2001, J INORG BIOCHEM, V85, P187, DOI 10.1016/S0162-0134(01)00193-3; Woodcock JC, 2001, J INORG BIOCHEM, V84, P225, DOI 10.1016/S0162-0134(01)00173-8	40	136	148	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26831	26838		10.1074/jbc.M109.009498	http://dx.doi.org/10.1074/jbc.M109.009498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19589782	Green Published, hybrid			2022-12-27	WOS:000269969600064
J	Fallas, JA; Gauba, V; Hartgerink, JD				Fallas, Jorge A.; Gauba, Varun; Hartgerink, Jeffrey D.			Solution Structure of an ABC Collagen Heterotrimer Reveals a Single-register Helix Stabilized by Electrostatic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; NATURAL BREAK; BINDING-SITE; NMR; PEPTIDE; MODEL; CONFORMATION; SEQUENCE	Collagen, known for its structural role in tissues and also for its participation in the regulation of homeostatic and pathological processes in mammals, is assembled from triple helices that can be either homotrimers or heterotrimers. High resolution structural information for natural collagens has been difficult to obtain because of their size and the heterogeneity of their native environment. For this reason, peptides that self-assemble into collagen-like triple helices are used to gain insight into the structure, stability, and biochemistry of this important protein family. Although many of the most common collagens in humans are heterotrimers, almost all studies of collagen helices have been on homotrimers. Here we report the first structure of a collagen heterotrimer. Our structure, obtained by solution NMR, highlights the role of electrostatic interactions as stabilizing factors within the triple helical folding motif. This addresses an issue that has been actively researched because of the predominance of charged residues in the collagen family. We also find that it is possible to selectively form a collagen heterotrimer with a well defined composition and register of the peptide chains within the helix, based on information encoded solely in the collagenous domain. Globular domains are implicated in determining the composition of several collagen types, but it is unclear what their role in controlling register may be. We show that is possible to design peptides that not only selectively choose a composition but also a specific register without the assistance of other protein constructs. This mechanism may be used in nature as well.	[Fallas, Jorge A.; Gauba, Varun; Hartgerink, Jeffrey D.] Rice Univ, Dept Chem & Bioengn, Houston, TX 77005 USA	Rice University	Hartgerink, JD (corresponding author), 6100 Main St,MS-60, Houston, TX 77005 USA.	jdh@rice.edu	Hartgerink, Jeffrey D/G-4275-2016	Hartgerink, Jeffrey D/0000-0002-3186-5395	Robert A. Welch Foundation Research [C1557]; National Science Foundation [DMR-0645474]; Camille Dreyfus Teacher Scholar Awards Program	Robert A. Welch Foundation Research(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Camille Dreyfus Teacher Scholar Awards Program	This work was supported in part by Robert A. Welch Foundation Research Grant C1557, National Science Foundation Career Award DMR-0645474, and the Camille Dreyfus Teacher Scholar Awards Program.	ARCHER SJ, 1991, J MAGN RESON, V95, P636, DOI 10.1016/0022-2364(91)90182-S; Baum J, 1997, FOLD DES, V2, pR53, DOI 10.1016/S1359-0278(97)00028-X; Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Brodsky B, 2008, NATURE, V453, P998, DOI 10.1038/453998a; Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2; GAUBA V, 2007, J AM CHEM SOC, V129, P15304; Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; GODDARD TD, 2008, SPARKY 3 VERSION 3 1; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; Madhan B, 2008, J AM CHEM SOC, V130, P13520, DOI 10.1021/ja805496v; Melacini G, 2000, J MOL BIOL, V300, P1041, DOI 10.1006/jmbi.2000.3919; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; MUHANDIRAM DR, 1993, J BIOMOL NMR, V3, P463; Nagarajan V, 1999, J BIOCHEM-TOKYO, V125, P310, DOI 10.1093/oxfordjournals.jbchem.a022288; OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7; Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; POWERS R, 1993, BIOCHEMISTRY-US, V32, P6744, DOI 10.1021/bi00077a030; Slatter DA, 2006, J MOL BIOL, V359, P289, DOI 10.1016/j.jmb.2006.02.071; Slatter DA, 2003, J MOL BIOL, V329, P175, DOI 10.1016/S0022-2836(03)00380-2; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; TUCKWELL DS, 1994, J CELL SCI, V107, P993; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024	47	69	71	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26851	26859		10.1074/jbc.M109.014753	http://dx.doi.org/10.1074/jbc.M109.014753			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19625247	hybrid, Green Published			2022-12-27	WOS:000269969600066
J	Di Pasquale, E; Brivanlou, AH				Di Pasquale, Elisa; Brivanlou, Ali H.			Bone Morphogenetic Protein 15 (BMP15) Acts as a BMP and Wnt Inhibitor during Early Embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; PREMATURE OVARIAN FAILURE; INCREASED OVULATION RATE; XENOPUS-EMBRYOS; NEURAL INDUCTION; TGF-BETA; PREIMPLANTATION EMBRYOS; GENE-EXPRESSION; MOUSE OOCYTES; STEM-CELLS	Bone morphogenetic protein 15 (BMP15) belongs to an unusual subgroup of the transforming growth factor beta (TGF beta)superfamily of signaling ligands as it lacks a key cysteine residue in the mature region required for proper intermolecular dimerization. Naturally occurring BMP15 mutation leads to early ovarian failure in humans, and BMP15 has been shown to activate the Smad1/5/8 pathway in that context. Despite its important role in germ cell specification, the embryological function of BMP15 remains unknown. Surprisingly, we find that during early Xenopus embryogenesis BMP15 acts solely as an inhibitor of the Smad1/5/8 pathway and the Wnt pathway. BMP15 gain-of-function leads to embryos with secondary ectopic heads and to direct neural induction in intact explants. BMP15 inhibits BMP4-mediated epidermal induction in dissociated explants. BMP15 strongly inhibits BRE response induced by BMP4 and blocks phosphorylation and activation of Smad1/5/8 MH2-domain. Mechanistically, BMP15 protein specifically interacts with BMP4 protein, suggesting inhibition upstream of receptor binding. Loss-of-function experiments using morpholinos or a naturally occurring human BMP15 dominant-negative mutant (BMP15-Y235C) leads to embryos lacking head. BMP15-Y235C also eliminates the inhibitory activity of BMP15 on BRE (BMP-responsive element). Finally, we show that BMP15 inhibits the canonical branch of the Wnt pathway, upstream of beta-catenin. We, thus, demonstrate that BMP15 is necessary and sufficient for the specification of dorso-anterior structures and highlight novel mechanisms of BMP15 function that strongly suggest a reinterpretation of its function in ovaries specially for ovarian failure.	[Di Pasquale, Elisa; Brivanlou, Ali H.] Rockefeller Univ, Mol Embryol Lab, New York, NY 10065 USA	Rockefeller University	Brivanlou, AH (corresponding author), Rockefeller Univ, Mol Embryol Lab, New York, NY 10065 USA.	brvnlou@rockefeller.edu	Di Pasquale, Elisa/ABI-6252-2020; Di Pasquale, Elisa/A-4751-2014; Di Pasquale, Elisa/ABI-6210-2020	Di Pasquale, Elisa/0000-0003-2373-5635; Di Pasquale, Elisa/0000-0003-2373-5635; 	National Institutes of Health [HD32105]; Rockefeller University Women and Science Fellowship Program; University of Milan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032105, R55HD032105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University Women and Science Fellowship Program; University of Milan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD32105 (to A. H. B.).; Supported by funds from the Rockefeller University Women and Science Fellowship Program and from the University of Milan, Department of Medical Science, Laboratory of Experimental Endocrinology (Istituto Auxologico Italiano). Present address: Multimedica IRCCS-MultiLab, Via Fantoli 16/15, 20138 Milan, Italy.	Aaltonen J, 1999, J CLIN ENDOCR METAB, V84, P2744, DOI 10.1210/jc.84.8.2744; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Branford WW, 2002, CURR BIOL, V12, P2136, DOI 10.1016/S0960-9822(02)01360-X; BRIVANLOU AH, 1989, DEVELOPMENT, V106, P611; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; GRUNZ H, 1989, CELL DIFFER DEV, V28, P211, DOI 10.1016/0922-3371(89)90006-3; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Laissue P, 2006, EUR J ENDOCRINOL, V154, P739, DOI 10.1530/eje.1.02135; Laitinen M, 1998, MECH DEVELOP, V78, P135, DOI 10.1016/S0925-4773(98)00161-0; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; McNatty KP, 2005, MOL CELL ENDOCRINOL, V234, P57, DOI 10.1016/j.mce.2004.08.013; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Pennetier S, 2004, BIOL REPROD, V71, P1359, DOI 10.1095/biolreprod.104.030288; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Sharov AA, 2003, EMBO J, V22, P2992, DOI 10.1093/emboj/cdg291; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Vonica A, 2000, DEV BIOL, V217, P230, DOI 10.1006/dbio.1999.9551; Vonica A, 2007, DEV BIOL, V303, P281, DOI 10.1016/j.ydbio.2006.09.039; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zeng FY, 2003, BIOL REPROD, V68, P31, DOI 10.1095/biolreprod.102.007674	40	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26127	26136		10.1074/jbc.M109.036608	http://dx.doi.org/10.1074/jbc.M109.036608			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19553676	Green Published, hybrid			2022-12-27	WOS:000269738000068
J	Uranishi, H; Zolotukhin, AS; Lindtner, S; Warming, S; Zhang, GM; Bear, J; Copeland, NG; Jenkins, NA; Pavlakis, GN; Felber, BK				Uranishi, Hiroaki; Zolotukhin, Andrei S.; Lindtner, Susan; Warming, Soren; Zhang, Gen-Mu; Bear, Jenifer; Copeland, Neal G.; Jenkins, Nancy A.; Pavlakis, George N.; Felber, Barbara K.			The RNA-binding Motif Protein 15B (RBM15B/OTT3) Acts as Cofactor of the Nuclear Export Receptor NXF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA EYE DEVELOPMENT; TRANSPORT ELEMENT RTE; HNRNP-LIKE PROTEINS; MESSENGER-RNA; SPLIT-ENDS; MENTAL-RETARDATION; SIGNALING PATHWAY; GENETIC SCREEN; FAMILY-MEMBERS; TARGET GENES	The human SPEN family proteins SHARP, RBM15/OTT1, and RBM15B/OTT3 share the structural domain architecture but show distinct functional properties. Here, we examined the function of OTT3 and compared it with its paralogues RBM15 and SHARP. We found that OTT3, like RBM15, has post-transcriptional regulatory activity, whereas SHARP does not, supporting a divergent role of RBM15 and OTT3. OTT3 shares with RBM15 the association with the splicing factor compartment and the nuclear envelope as well as the binding to mRNA export factors NXF1 and Aly/REF. Mutational analysis revealed direct interaction of OTT3 and RBM15 with NXF1 via their C-terminal regions. Biochemical and subcellular localization studies showed that OTT3 and RBM15 also interact with each other in vivo, further supporting a shared function. Genetic knockdown of RBM15 in mouse is embryonically lethal, indicating that OTT3 cannot compensate for the RBM15 loss, which supports the notion that these proteins, in addition to sharing similar activities, likely have distinct biological roles.	[Uranishi, Hiroaki; Lindtner, Susan; Pavlakis, George N.] NCI, Human Retrovirus Sect, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Zolotukhin, Andrei S.; Zhang, Gen-Mu; Bear, Jenifer; Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Warming, Soren; Copeland, Neal G.; Jenkins, Nancy A.] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Felber, BK (corresponding author), POB B,Bldg 535,Rm 209, Frederick, MD 21702 USA.	felberb@mail.nih.gov	Warming, Soren/ABD-5729-2021	Warming, Soren/0000-0002-5721-0741	National Institutes of Health Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC010750, Z01BC010334, Z01BC010750, ZIABC010334] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program.	Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bear J, 1999, MOL CELL BIOL, V19, P6306; Braun IC, 2001, J BIOL CHEM, V276, P20536, DOI 10.1074/jbc.M100400200; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chang JL, 2008, DEV BIOL, V314, P100, DOI 10.1016/j.ydbio.2007.11.023; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Doroquez DB, 2007, MECH DEVELOP, V124, P792, DOI 10.1016/j.mod.2007.05.002; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Golovanov AP, 2006, RNA, V12, P1933, DOI 10.1261/rna.212106; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; Hansen A, 2007, NAT METHODS, V4, P35, DOI 10.1038/NMETH977; Hautbergue GM, 2008, P NATL ACAD SCI USA, V105, P5154, DOI 10.1073/pnas.0709167105; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; Jemc J, 2006, GENETICS, V173, P279, DOI 10.1534/genetics.106.055558; Jun L, 2001, CURR BIOL, V11, P1381, DOI 10.1016/S0960-9822(01)00419-5; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kuang B, 2000, DEVELOPMENT, V127, P1517; Kuersten S, 2004, MOL CELL, V14, P599, DOI 10.1016/j.molcel.2004.05.004; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lai DM, 2006, RNA, V12, P1446, DOI 10.1261/rna.94306; Lin HV, 2003, DEVELOPMENT, V130, P3125, DOI 10.1242/dev.00527; Lindtner S, 2006, J BIOL CHEM, V281, P36915, DOI 10.1074/jbc.M608745200; Ma XY, 2007, MOL CELL BIOL, V27, P3056, DOI 10.1128/MCB.01339-06; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Nappi F, 2001, J VIROL, V75, P4558, DOI 10.1128/JVI.75.10.4558-4569.2001; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Raffel GD, 2007, P NATL ACAD SCI USA, V104, P6001, DOI 10.1073/pnas.0609041104; Raffel GD, 2009, MOL CELL BIOL, V29, P333, DOI 10.1128/MCB.00370-08; Rebay I, 2000, GENETICS, V154, P695; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Saito K, 2004, BIOCHEM BIOPH RES CO, V321, P291, DOI 10.1016/j.bbrc.2004.06.140; Schreiber SL, 2002, GENESIS, V33, P141, DOI 10.1002/gene.10102; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Shmulevich I., 2002, COMPUTATIONAL STAT A, V1st, P125; Smulevitch S, 2005, J VIROL, V79, P2356, DOI 10.1128/JVI.79.4.2356-2365.2005; Smulevitch S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-6; Stauber RH, 1998, BIOTECHNIQUES, V24, P462, DOI 10.2144/98243rr01; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Tabernero C, 1996, J VIROL, V70, P5998, DOI 10.1128/JVI.70.9.5998-6011.1996; Takano K, 2007, NUCLEIC ACIDS RES, V35, P2513, DOI 10.1093/nar/gkm125; Tan W, 2005, NUCLEIC ACIDS RES, V33, P3855, DOI 10.1093/nar/gki706; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-309; Yabe D, 2007, GENESIS, V45, P300, DOI 10.1002/dvg.20296; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zolotukhin AS, 2008, VIROLOGY, V377, P88, DOI 10.1016/j.virol.2008.04.002	56	37	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26106	26116		10.1074/jbc.M109.040113	http://dx.doi.org/10.1074/jbc.M109.040113			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19586903	Green Published, hybrid			2022-12-27	WOS:000269738000066
J	Pechlivanis, M; Samol, A; Kerkhoff, E				Pechlivanis, Markos; Samol, Annette; Kerkhoff, Eugen			Identification of a Short Spir Interaction Sequence at the C-terminal End of Formin Subgroup Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCALIZED MESSENGER-RNA; ACTIN; CAPPUCCINO; SPINDLE; DOMAINS	The actin nucleation factors Spire and Cappuccino interact with each other and regulate essential cellular events during Drosophila oogenesis in a cooperative fashion. The interaction blocks formin actin nucleation activity and enhances the Spire activity. Analogous to Spire and Cappuccino, the mammalian homologs Spir-1 and formin-2 show a regulatory interaction. To get an understanding of the nature of the Spir-formin cooperation, we have analyzed the interaction biochemically and biophysically. Our data shows that the association of Spir-1 and formin-2 is not significantly mediated by binding of the Spir-1-KIND domain to the formin FH2 core domain. Instead, a short sequence motif C-terminal adjacent to the formin-2-FH2 domain could be characterized that mediates the interaction and is conserved among the members of the Fmn subgroup of formins. In line with this, we found that both mammalian Spir proteins, Spir-1 and Spir-2, interact with mammalian Fmn subgroup proteins formin-1 and formin-2.	[Pechlivanis, Markos; Samol, Annette; Kerkhoff, Eugen] Univ Regensburg, Bavarian Genome Res Network BayGene Cell Struct &, Inst Funct Genom, D-93053 Regensburg, Germany	University of Regensburg	Kerkhoff, E (corresponding author), Univ Regensburg, Bavarian Genome Res Network BayGene Cell Struct &, Inst Funct Genom, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	Eugen.Kerkhoff@klinik.uni-regensburg.de			Bavarian Genome Research Network (Bay-Gene); Deutsche Forschungsgemeinschaft [SPP 1150, KE 447/4-3]	Bavarian Genome Research Network (Bay-Gene); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Bavarian Genome Research Network (Bay-Gene) and the Deutsche Forschungsgemeinschaft (SPP 1150, KE 447/4-3).	Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Le Goff C, 2006, BIOL CELL, V98, P697, DOI 10.1042/BC20050095; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Satou Y, 1997, DEV BIOL, V192, P467, DOI 10.1006/dbio.1997.8730; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Schumacher N, 2004, GENE EXPR PATTERNS, V4, P249, DOI 10.1016/j.modgep.2003.11.006; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Wellington A, 1999, DEVELOPMENT, V126, P5267	22	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25324	25333		10.1074/jbc.M109.030320	http://dx.doi.org/10.1074/jbc.M109.030320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605360	Green Published, hybrid			2022-12-27	WOS:000269734000065
J	Harada, S; Uchida, M; Shimizu, N				Harada, Seiyu; Uchida, Masafumi; Shimizu, Noriaki			Episomal High Copy Number Maintenance of Hairpin-capped DNA Bearing a Replication Initiation Region in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE AMPLIFICATION; INVERTED REPEATS; HUMAN CANCER; S-PHASE; BREAKS; TRANSCRIPTION; CHROMOSOMES; PALINDROME; PLASMIDS; REPLICON	We previously found that a plasmid bearing a replication initiation region efficiently initiates gene amplification in mammalian cells and that it generates extrachromosomal double minutes and/or chromosomal homogeneously staining regions. During analysis of the underlying mechanism, we serendipitously found that hairpin-capped linear DNA was stably maintained as numerous extrachromosomal tiny episomes for more than a few months in a human cancer cell line. Generation of such episomes depended on the presence of the replication initiation region in the original plasmid. Despite extrachromosomal maintenance, episomal gene expression was epigenetically suppressed. The Southern blot analysis of the DNA of cloned cells revealed that the region around the hairpin end was diversified between the clones. Furthermore, the bisulfite-modified PCR and the sequencing analyses revealed that the palindrome sequence that derived from the original hairpin end or its end-resected structure were well preserved during clonal long term growth. From these data, we propose a model that explains the formation and maintenance of these episomes, in which replication of the hairpin-capped DNA and cruciform formation and its resolution play central roles. Our findings may be relevant for the dissection of mammalian replicator sequences.	[Harada, Seiyu; Uchida, Masafumi; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398521, Japan	Hiroshima University	Shimizu, N (corresponding author), 1-7-1 Kagamiyama, Higashihiroshima 7398521, Japan.	shimizu@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [17370002]; Ministry of Education, Science, Sports and Culture of Japan [19038016]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (B) 17370002 from the Japan Society for the Promotion of Science (to N. S.) and Grant-in-Aid for Scientific Research on Priority Areas, Nuclear Dynamics 19038016 from the Ministry of Education, Science, Sports and Culture of Japan (to N. S.).	Aladjem MI, 2004, EMBO REP, V5, P686, DOI 10.1038/sj.embor.7400185; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; CARROLL SM, 1988, MOL CELL BIOL, V8, P1525, DOI 10.1128/MCB.8.4.1525; Cote AG, 2008, MOL CELL, V31, P800, DOI 10.1016/j.molcel.2008.08.025; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; Haber JE, 2006, CELL, V125, P1237, DOI 10.1016/j.cell.2006.06.012; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Jenke ACW, 2004, P NATL ACAD SCI USA, V101, P11322, DOI 10.1073/pnas.0401355101; Lobachev KS, 2007, FRONT BIOSCI-LANDMRK, V12, P4208, DOI 10.2741/2381; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Myllykangas S, 2006, CANCER LETT, V232, P79, DOI 10.1016/j.canlet.2005.07.045; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Rattray AJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh143; Schaarschmidt D, 2004, EMBO J, V23, P191, DOI 10.1038/sj.emboj.7600029; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2004, J CELL SCI, V117, P5303, DOI 10.1242/jcs.01414; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2001, EXP CELL RES, V268, P201, DOI 10.1006/excr.2001.5286; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Tanaka H, 2002, P NATL ACAD SCI USA, V99, P8772, DOI 10.1073/pnas.132275999; Tanaka H, 2007, MOL CELL BIOL, V27, P1993, DOI 10.1128/MCB.01313-06; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; VONHOFF DD, 1988, P NATL ACAD SCI USA, V85, P4804	31	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24320	24327		10.1074/jbc.M109.008128	http://dx.doi.org/10.1074/jbc.M109.008128			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19617622	Green Published, hybrid			2022-12-27	WOS:000269380200045
J	Malhotra, S; Kovats, S; Zhang, WG; Coggeshall, KM				Malhotra, Shikha; Kovats, Susan; Zhang, Weiguo; Coggeshall, K. Mark			B Cell Antigen Receptor Endocytosis and Antigen Presentation to T Cells Require Vav and Dynamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TYROSINE PHOSPHORYLATION; COSTIMULATORY MOLECULES; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; ADAPTER MOLECULE; HUMORAL IMMUNITY; LIPID RAFTS; RHO GTPASES; IN-VIVO	Antigen binding to the B cell antigen receptor (BCR) initiates an array of signaling events. These include endocytosis of ligand-receptor complexes via clathrin-coated pits, trafficking of the internalized ligand to lysosomes, degradation of the associated proteins to peptides, and peptide presentation on nascent major histocompatibility complex class II to T cells. The signal transduction events supporting BCR internalization are not well understood. We have identified a pathway supporting BCR internalization that includes the Vav1 and/or Vav3 isoforms and the GTPase dynamin. Vav1 and -3 are not required for B cell development and maturation, nor for a variety of BCR-induced signaling events nor for BCR signaling leading to major histocompatibility complex class II and CD80 expression, but Vav1 and/or -3 are absolutely required for BCR endocytosis and BCR-induced Rac-GTP loading. This is the first demonstration of a link between Vav and Rac in BCR internalization leading to antigen presentation to T cells.	[Malhotra, Shikha; Coggeshall, K. Mark] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Malhotra, Shikha; Coggeshall, K. Mark] Univ Oklahoma, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Kovats, Susan] Oklahoma Med Res Fdn, Arthrit & Immunol Program, Oklahoma City, OK 73104 USA; [Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; Duke University	Coggeshall, KM (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	mark-coggeshall@omrf.ouhsc.edu		Kovats, Susan/0000-0001-5479-9952	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056156] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI056156] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Arai C, 2003, EUR J IMMUNOL, V33, P1806, DOI 10.1002/eji.200324018; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brauweiler A, 2000, J EXP MED, V191, P1545, DOI 10.1084/jem.191.9.1545; Brown BK, 2001, TRAFFIC, V2, P414, DOI 10.1034/j.1600-0854.2001.002006414.x; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; CHALUPNY NJ, 1993, EMBO J, V12, P2691, DOI 10.1002/j.1460-2075.1993.tb05930.x; Charvet C, 2006, J IMMUNOL, V177, P5024, DOI 10.4049/jimmunol.177.8.5024; Cooney DS, 2001, J IMMUNOL, V167, P844, DOI 10.4049/jimmunol.167.2.844; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Goncalves L, 2004, VIROLOGY, V326, P20, DOI 10.1016/j.virol.2004.04.042; Graham DB, 2006, J IMMUNOL, V177, P2349, DOI 10.4049/jimmunol.177.4.2349; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Hayney MS, 1997, VACCINE, V15, P3, DOI 10.1016/S0264-410X(96)00133-8; He YY, 2006, ONCOGENE, V25, P1521, DOI 10.1038/sj.onc.1209184; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Jacob A, 1999, J BIOL CHEM, V274, P13704, DOI 10.1074/jbc.274.19.13704; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KRUSKALL MS, 1992, J EXP MED, V175, P495, DOI 10.1084/jem.175.2.495; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; MARSHALL LS, 1993, J CLIN IMMUNOL, V13, P165, DOI 10.1007/BF00919969; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Mutch CM, 2007, INT IMMUNOL, V19, P19, DOI 10.1093/intimm/dxl118; Natarajan K, 2001, J IMMUNOL, V167, P114, DOI 10.4049/jimmunol.167.1.114; Neumann-Haefelin C, 2007, GENES IMMUN, V8, P181, DOI 10.1038/sj.gene.6364368; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Onabajo OO, 2008, J IMMUNOL, V180, P6685, DOI 10.4049/jimmunol.180.10.6685; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Phee H, 2001, MOL CELL BIOL, V21, P8615, DOI 10.1128/MCB.21.24.8615-8625.2001; Poland GA, 2008, VACCINE, V26, P6183, DOI 10.1016/j.vaccine.2008.06.057; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; SHASTRI N, 1986, J IMMUNOL, V137, P911; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; SONG WX, 1995, J IMMUNOL, V155, P4255; Stephenson LM, 2006, J IMMUNOL, V177, P8620, DOI 10.4049/jimmunol.177.12.8620; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Swat W, 2003, INT IMMUNOL, V15, P215, DOI 10.1093/intimm/dxg021; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WEBB CF, 1989, J IMMUNOL, V143, P3934; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zuckerman JN, 1996, J MED VIROL, V50, P283, DOI 10.1002/(SICI)1096-9071(199612)50:4&lt;283::AID-JMV1&gt;3.0.CO;2-4	61	48	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24088	24097		10.1074/jbc.M109.014209	http://dx.doi.org/10.1074/jbc.M109.014209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586920	Green Published, hybrid			2022-12-27	WOS:000269380200022
J	Wort, SJ; Ito, M; Chou, PC; Mc Master, SK; Badiger, R; Jazrawi, E; de Souza, P; Evans, TW; Mitchell, JA; Pinhu, L; Ito, K; Adcock, IM				Wort, Stephen J.; Ito, Misako; Chou, Pai-Chien; Mc Master, Shaun K.; Badiger, Rekha; Jazrawi, Elen; de Souza, Patricia; Evans, Timothy W.; Mitchell, Jane A.; Pinhu, Liao; Ito, Kaz; Adcock, Ian M.			Synergistic Induction of Endothelin-1 by Tumor Necrosis Factor alpha and Interferon gamma Is due to Enhanced NF-kappa B Binding and Histone Acetylation at Specific kappa B Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PREPROENDOTHELIN-1 GENE-EXPRESSION; REGULATORY FACTOR-I; PULMONARY-HYPERTENSION; TNF-ALPHA; TRANSCRIPTIONAL REGULATION; ARTERY; RELEASE; PROMOTER; INTERLEUKIN-1	Endothelin-1 (ET-1) is a potent vasoconstrictor and co-mitogen for vascular smooth muscle and is implicated in pulmonary vascular remodeling and the development of pulmonary arterial hypertension. Vascular smooth muscle is an important source of ET-1. Here we demonstrate synergistic induction of preproET-1 message RNA and release of mature peptide by a combination of tumor necrosis factor alpha(TNF alpha) and interferon gamma(IFN gamma) in primary human pulmonary artery smooth muscle cells. This induction was prevented by pretreatment with the histone acetyltransferase inhibitor anacardic acid. TNF alpha induced a rapid and prolonged pattern of nuclear factor (NF)-kappa B p65 subunit activation and binding to the native preproET-1 promoter. In contrast, IFN gamma induced a delayed activation of interferon regulatory factor-1 without any effect on NF-kappa B p65 nuclear localization or consensus DNA binding. However, we found cooperative p65 binding and histone H4 acetylation at distinct kappa B sites in the preproET-1 promoter after stimulation with both TNF alpha and IFN gamma. This was associated with enhanced recruitment of RNA polymerase II to the ATG start site and read-through of the ET-1 coding region. Understanding such mechanisms is crucial in determining the key control points in ET-1 release. This has particular relevance to developing novel treatments targeted at the inflammatory component of pulmonary vascular remodeling.	[Wort, Stephen J.; Mc Master, Shaun K.; Badiger, Rekha; Jazrawi, Elen; de Souza, Patricia; Evans, Timothy W.; Mitchell, Jane A.; Pinhu, Liao] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Crit Care, London SW3 6LY, England; [Ito, Misako; Chou, Pai-Chien; Ito, Kaz; Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis Sect, London SW3 6LY, England	Imperial College London; Imperial College London	Wort, SJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Crit Care, Dovehouse St, London SW3 6LY, England.	s.wort@imperial.ac.uk	Adcock, Ian/L-3217-2019; Ito, Kazuhiro/AAF-5994-2019; Mitchell, Jane A/A-1991-2009	Adcock, Ian/0000-0003-2101-8843	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Adcock IM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-21; Aziz SM, 1997, CELL BIOL INT, V21, P801, DOI 10.1006/cbir.1997.0200; BOBIK A, 1990, AM J PHYSIOL, V258, pC408, DOI 10.1152/ajpcell.1990.258.3.C408; CASLIN AW, 1990, HISTOPATHOLOGY, V16, P9, DOI 10.1111/j.1365-2559.1990.tb01054.x; Casola A, 2002, AM J PHYSIOL-LUNG C, V283, pL1280, DOI 10.1152/ajplung.00162.2002; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fujita M, 2001, AM J PHYSIOL-LUNG C, V280, pL39, DOI 10.1152/ajplung.2001.280.1.L39; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; INOUE A, 1989, J BIOL CHEM, V264, P14954; Ito K, 2001, J BIOL CHEM, V276, P30208, DOI 10.1074/jbc.M103604200; JAHNKE A, 1995, IMMUNOBIOLOGY, V193, P305, DOI 10.1016/S0171-2985(11)80559-0; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Karin Michael, 2005, Proc Am Thorac Soc, V2, P386, DOI 10.1513/pats.200504-034SR; Keslacy S, 2007, MOL PHARMACOL, V71, P609, DOI 10.1124/mol.106.030171; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kubo K, 1998, RESP PHYSIOL, V111, P301, DOI 10.1016/S0034-5687(98)00006-1; Langleben D, 2007, CLIN CHEST MED, V28, P117, DOI 10.1016/j.ccm.2006.11.002; LEE ME, 1990, J BIOL CHEM, V265, P10446; LEE ME, 1991, J BIOL CHEM, V266, P19034; Lesprit P, 1998, AM J RESP CRIT CARE, V157, P907, DOI 10.1164/ajrccm.157.3.9707095; MARSDEN PA, 1992, AM J PHYSIOL, V262, pC854, DOI 10.1152/ajpcell.1992.262.4.C854; Molet S, 2000, J ALLERGY CLIN IMMUN, V105, P333, DOI 10.1016/S0091-6749(00)90084-8; Negi S, 2008, CHEM-EUR J, V14, P3236, DOI 10.1002/chem.200701320; Paludan SR, 2000, J LEUKOCYTE BIOL, V67, P18, DOI 10.1002/jlb.67.1.18; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; Quehenberger P, 2000, DIABETES, V49, P1561, DOI 10.2337/diabetes.49.9.1561; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; Sawa Y, 1997, CIRCULATION, V96, P280; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; SUGIURA M, 1989, BIOCHEM BIOPH RES CO, V161, P1220, DOI 10.1016/0006-291X(89)91372-7; Tau G, 1999, ALLERGY, V54, P1233, DOI 10.1034/j.1398-9995.1999.00099.x; Tchekneva E, 2000, AM J PHYSIOL-LUNG C, V278, pL813, DOI 10.1152/ajplung.2000.278.4.L813; Tchekneva E, 1998, J CLIN INVEST, V101, P1389, DOI 10.1172/JCI622; Upton PD, 2001, AM J RESP CELL MOL, V24, P170, DOI 10.1165/ajrcmb.24.2.4210; Voelkel NF, 1995, EUR RESPIR J, V8, P2129, DOI 10.1183/09031936.95.08122129; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Woods M, 2003, MOL PHARMACOL, V64, P923, DOI 10.1124/mol.64.4.923; Wort SJ, 2002, MOL PHARMACOL, V62, P1147, DOI 10.1124/mol.62.5.1147; Wort SJ, 2001, AM J RESP CELL MOL, V25, P104, DOI 10.1165/ajrcmb.25.1.4331; Wort SJ, 2000, J CARDIOVASC PHARM, V36, pS410; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YOSHIZUMI M, 1990, BIOCHEM BIOPH RES CO, V166, P324, DOI 10.1016/0006-291X(90)91948-R	45	58	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24297	24305		10.1074/jbc.M109.032524	http://dx.doi.org/10.1074/jbc.M109.032524			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592490	hybrid, Green Published			2022-12-27	WOS:000269380200043
J	Houde, N; Chamoux, E; Bisson, M; Roux, S				Houde, Nicolas; Chamoux, Estelle; Bisson, Martine; Roux, Sophie			Transforming Growth Factor-beta 1 (TGF-beta 1) Induces Human Osteoclast Apoptosis by Up-regulating Bim	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; GIANT-CELL TUMOR; P38 MAP KINASE; TGF-BETA; (TGF-BETA)-INDUCED APOPTOSIS; EPITHELIAL-CELLS; BONE; EXPRESSION; SMAD; RECEPTOR	Transforming growth factor-beta 1 (TGF-beta 1) is the most abundant TGF-beta isoform detected in bone and is an important functional modulator of osteoclasts. TGF-beta 1 can induce osteoclast apoptosis; however, the apoptotic pathways involved in this process are not known. We show here that human osteoclasts express both type-I and type-II TGF-beta receptors. In the absence of survival factors, TGF-beta 1 (1 ng/ml) induced osteoclast apoptosis. The expression of activated caspase-9, but not that of caspase-8, was increased by TGF-beta 1 stimulation, and the rate of TGF-beta 1-induced apoptosis was significantly lower in the presence of a caspase-9 inhibitor. To study further the mechanisms involved in TGF-beta 1-induced osteoclast apoptosis, we investigated TGF-beta 1 signaling, which primarily involves the Smad pathway, but also other pathways that may interfere with intracellular modulators of apoptosis, such as mitogen-activated protein (MAP) kinases and Bcl2 family members. We show here that early events consisted of a trend toward increased expression of extracellular signal-regulated kinase (ERK), and then TGF-beta 1 significantly induced the activation of p38 and Smad2 in a time-dependent manner. These signaling cascades may activate the intrinsic apoptosis pathway, which involves Bim, the expression of which was increased in the presence of TGF-beta 1. Furthermore, the rate of TGF-beta 1-induced osteoclast apoptosis was lower when Bim expression was suppressed, and inhibiting the Smad pathway abolished Bim up-regulation following TGF-beta stimulation. This could correspond to a regulatory mechanism involved in the inhibition of osteoclast activity by TGF-beta 1.	[Houde, Nicolas; Chamoux, Estelle; Bisson, Martine; Roux, Sophie] Univ Sherbrooke, Fac Med, Div Rheumatol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Roux, S (corresponding author), 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	sophie.roux@usherbrooke.ca			Arthritis Society	Arthritis Society	This study was funded by grants from the Arthritis Society (to S. R.).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunetti G, 2007, ANN NY ACAD SCI, V1116, P316, DOI 10.1196/annals.1402.011; Chamoux E, 2008, J CELL PHYSIOL, V216, P536, DOI 10.1002/jcp.21430; CHENU C, 1988, P NATL ACAD SCI USA, V85, P5683, DOI 10.1073/pnas.85.15.5683; Colucci S, 2007, APOPTOSIS, V12, P1623, DOI 10.1007/s10495-007-0095-3; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Fox SW, 2008, BIOCHEM BIOPH RES CO, V366, P123, DOI 10.1016/j.bbrc.2007.11.120; Franchi A, 2001, APPL IMMUNOHISTO M M, V9, P170, DOI 10.1097/00022744-200106000-00010; Fuller K, 2000, J CELL SCI, V113, P2445; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Karsdal MA, 2003, J BIOL CHEM, V278, P44975, DOI 10.1074/jbc.M303905200; Karsdal MA, 2001, J BIOL CHEM, V276, P39350, DOI 10.1074/jbc.M008738200; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; ORCEL P, 1990, J CELL PHYSIOL, V142, P293, DOI 10.1002/jcp.1041420211; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Reffey SB, 2001, J BIOL CHEM, V276, P26542, DOI 10.1074/jbc.M100331200; Riggs BL, 2005, J BONE MINER RES, V20, P177, DOI 10.1359/JBMR.041114; Roux S, 1996, J CELL PHYSIOL, V168, P489, DOI 10.1002/(SICI)1097-4652(199609)168:3<489::AID-JCP1>3.3.CO;2-R; Roux S, 2005, BIOCHEM BIOPH RES CO, V333, P42, DOI 10.1016/j.bbrc.2005.05.092; ROUX S, 2007, CELL APOPTOTIC SIGNA, P163; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091; Teramoto T, 1998, BIOCHEM BIOPH RES CO, V251, P56, DOI 10.1006/bbrc.1998.9411; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Yu J, 2008, J CELL PHYSIOL, V215, P422, DOI 10.1002/jcp.21325; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; ZHENG MH, 1994, AM J PATHOL, V145, P1095	40	54	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23397	23404		10.1074/jbc.M109.019372	http://dx.doi.org/10.1074/jbc.M109.019372			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574221	Green Published, hybrid			2022-12-27	WOS:000269180000024
J	Moriarty, TJ; Chaconas, G				Moriarty, Tara J.; Chaconas, George			Identification of the Determinant Conferring Permissive Substrate Usage in the Telomere Resolvase, ResT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAR PLASMID PROPHAGE; BORRELIA-BURGDORFERI; CRYSTAL-STRUCTURE; HAIRPIN TELOMERES; VIBRIO-HARVEYI; CLUSTAL-W; DNA; PROTEIN; SEQUENCE; GENOME	Linear genome stability requires specialized telomere replication and protection mechanisms. A common solution to this problem in non-eukaryotes is the formation of hairpin telomeres by telomere resolvases (also known as protelomerases). These enzymes perform a two-step transesterification on replication intermediates to generate hairpin telomeres using an active site similar to that of tyrosine recombinases and type IB topoisomerases. Unlike phage telomere resolvases, the telomere resolvase from the Lyme disease pathogen Borrelia burgdorferi (ResT) is a permissive enzyme that resolves several types of telomere in vitro. However, the ResT region and residues mediating permissive substrate usage have not been identified. The relapsing fever Borrelia hermsii ResT exhibits a more restricted substrate usage pattern than B. burgdorferi ResT and cannot efficiently resolve a Type 2 telomere. In this study, we determined that all relapsing fever ResTs process Type 2 telomeres inefficiently. Using a library of chimeric and mutant B. hermsii/B. burgdorferi ResTs, we mapped the determinants in B. burgdorferi ResT conferring the ability to resolve multiple Type 2 telomeres. Type 2 telomere resolution was dependent on a single proline in the ResT catalytic region that was conserved in all Lyme disease but not relapsing fever ResTs and that is part of a 2-amino acid insertion absent from phage telomere resolvase sequences. The identification of a permissive substrate usage determinant explains the ability of B. burgdorferi ResT to process the 19 unique telomeres found in its segmented genome and will aid further studies on the structure and function of this essential enzyme.	[Moriarty, Tara J.; Chaconas, George] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Chaconas, George] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Chaconas, G (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	chaconas@ucalgary.ca	Moriarty, Tara J./K-1684-2016	Moriarty, Tara J./0000-0002-1751-5145	Canadian Institutes of Health Research (CIHR) [MOP-53086]; Canada Research Chairs (CRC) Program; Alberta Heritage Foundation for Medical Research (AHFMR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs (CRC) Program(Canada Research Chairs); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (Grant MOP-53086), the Canada Research Chairs (CRC) Program, and the Alberta Heritage Foundation for Medical Research (AHFMR).	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; Casjens S, 1999, CURR OPIN MICROBIOL, V2, P529, DOI 10.1016/S1369-5274(99)00012-0; Casjens SR, 2004, J BACTERIOL, V186, P1818, DOI 10.1128/JB.186.6.1818-1832.2004; Chaconas G, 2005, MOL MICROBIOL, V58, P625, DOI 10.1111/j.1365-2958.2005.04872.x; Chaconas G, 2001, EMBO J, V20, P3229, DOI 10.1093/emboj/20.12.3229; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; COTMORE SF, 1987, ADV VIRUS RES, V33, P91, DOI 10.1016/S0065-3527(08)60317-6; Davis NA, 1999, J MOL BIOL, V291, P249, DOI 10.1006/jmbi.1999.2947; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Deneke J, 2004, J BIOL CHEM, V279, P53699, DOI 10.1074/jbc.M409001200; Deneke J, 2002, J BIOL CHEM, V277, P10410, DOI 10.1074/jbc.M111769200; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Glockner G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-211; GONZALEZ A, 1986, NUCLEIC ACIDS RES, V14, P6835, DOI 10.1093/nar/14.17.6835; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hertwig S, 2003, MOL MICROBIOL, V48, P989, DOI 10.1046/j.1365-2958.2003.03458.x; HINNEBUSCH J, 1991, J BACTERIOL, V173, P7233, DOI 10.1128/jb.173.22.7233-7239.1991; HIROCHIKA H, 1982, PLASMID, V7, P59, DOI 10.1016/0147-619X(82)90027-0; Huang WM, 2004, J BACTERIOL, V186, P4134, DOI 10.1128/JB.186.13.4134-4141.2004; Huang WM, 2004, J MOL BIOL, V337, P77, DOI 10.1016/j.jmb.2004.01.012; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kobryn K, 2005, MOL CELL, V17, P783, DOI 10.1016/j.molcel.2005.02.025; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Kobryn K, 2009, MOL MICROBIOL, V71, P1117, DOI 10.1111/j.1365-2958.2008.06584.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; LIN YS, 1993, MOL MICROBIOL, V10, P923, DOI 10.1111/j.1365-2958.1993.tb00964.x; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Malinin A Iu, 1992, Mol Gen Mikrobiol Virusol, P19; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; MELLADO RP, 1980, VIROLOGY, V104, P84, DOI 10.1016/0042-6822(80)90367-0; Mouw KW, 2007, MOL MICROBIOL, V63, P1319, DOI 10.1111/j.1365-2958.2007.05586.x; Oakey HJ, 2000, J APPL MICROBIOL, V89, P702, DOI 10.1046/j.1365-2672.2000.01169.x; Oakey HJ, 2002, J APPL MICROBIOL, V93, P1089, DOI 10.1046/j.1365-2672.2002.01776.x; PATEL DJ, 1985, BIOCHEMISTRY-US, V24, P936, DOI 10.1021/bi00325a019; Picardeau M, 1998, MICROBIOL-UK, V144, P1981, DOI 10.1099/00221287-144-7-1981; PLASTERK RHA, 1985, NATURE, V318, P257, DOI 10.1038/318257a0; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rybchin VN, 1999, MOL MICROBIOL, V33, P895, DOI 10.1046/j.1365-2958.1999.01533.x; SAVILAHTI H, 1993, J VIROL, V67, P4696, DOI 10.1128/JVI.67.8.4696-4703.1993; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tourand Y, 2003, MOL MICROBIOL, V48, P901, DOI 10.1046/j.1365-2958.2003.03485.x; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; Tourand Y, 2006, J BACTERIOL, V188, P7378, DOI 10.1128/JB.00760-06; Tourand Y, 2009, J BIOL CHEM, V284, P7264, DOI 10.1074/jbc.M808918200; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	56	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23293	23301		10.1074/jbc.M109.023549	http://dx.doi.org/10.1074/jbc.M109.023549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561077	Green Published, hybrid			2022-12-27	WOS:000269180000014
J	Tsalkova, T; Blumenthal, DK; Mei, FC; White, MA; Cheng, XD				Tsalkova, Tamara; Blumenthal, Donald K.; Mei, Fang C.; White, Mark A.; Cheng, Xiaodong			Mechanism of Epac Activation STRUCTURAL AND FUNCTIONAL ANALYSES OF Epac2 HINGE MUTANTS WITH CONSTITUTIVE AND REDUCED ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; EXCHANGE FACTOR EPAC; CYCLIC-AMP; CRYSTAL-STRUCTURE; CAMP; RAP1; PKA; NUCLEOTIDES; SUBUNIT; COMPLEX	Epac2 is a member of the family of exchange proteins directly activated by cAMP (Epac). Our previous studies suggest a model of Epac activation in which cAMP binding to the enzyme induces a localized "hinge" motion that reorients the regulatory lobe relative to the catalytic lobe without inducing large conformational changes within individual lobes. In this study, we identified the location of the major hinge in Epac2 by normal mode motion correlation and structural alignment analyses. Targeted mutagenesis was then performed to test the functional importance of hinge bending for Epac activation. We show that substitution of the conserved residue phenylalanine 435 with glycine (F435G) facilitates the hinge bending and leads to a constitutively active Epac2 capable of stimulating nucleotide exchange in the absence of cAMP. In contrast, substitution of the same residue with a bulkier side chain, tryptophan (F435W), impedes the hinge motion and results in a dramatic decrease in Epac2 catalytic activity. Structural parameters determined by small angle x-ray scattering further reveal that whereas the F435G mutant assumes a more extended conformation in the absence of cAMP, the F435W mutant is incapable of adopting the fully extended and active conformation in the presence of cAMP. These findings demonstrate the importance of hinge motion in Epac activation. Our study also suggests that phenylalanine at position 435 is the optimal size side chain to keep Epac closed and inactive in the absence of cAMP while still allowing the proper hinge motion for full Epac extension and activation in the presence of cAMP.	[Tsalkova, Tamara; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Tsalkova, Tamara; Mei, Fang C.; White, Mark A.; Cheng, Xiaodong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Utah System of Higher Education; University of Utah	Cheng, XD (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	xcheng@utmb.edu	White, Mark Andrew/B-1723-2012; Cheng, Xiaodong/O-8176-2019	White, Mark Andrew/0000-0003-1057-4203; Cheng, Xiaodong/0000-0002-3479-1694; Blumenthal, Donald/0000-0002-8614-1167	National Institutes of Health, NIGMS [GM066170]; American Heart Association [0755049Y]; NIEHS Center [ES006676]; United States Department of Energy [DE-FG02-05ER64026]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant GM066170, American Heart Association Grant-in-Aid 0755049Y, and NIEHS Center Grant ES006676. X-ray scattering data were collected at the University of Utah using facilities that are supported by United States Department of Energy Grant DE-FG02-05ER64026 ( to Jill Trewhella).	Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Brock M, 2007, J BIOL CHEM, V282, P32256, DOI 10.1074/jbc.M706231200; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DeLano W.L, PYMOL MOL GRAPHICS S; Flores SC, 2008, PROTEINS, V73, P299, DOI 10.1002/prot.22060; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; SVERGUN DI, 1988, ACTA CRYSTALLOGR A, V44, P244, DOI 10.1107/S0108767387011255; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x	24	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23644	23651		10.1074/jbc.M109.024950	http://dx.doi.org/10.1074/jbc.M109.024950			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19553663	Green Published, hybrid			2022-12-27	WOS:000269180000050
J	Li, M; Smith, CJ; Walker, MT; Smith, TJ				Li, Ming; Smith, Christopher J.; Walker, Matthew T.; Smith, Thomas J.			Novel Inhibitors Complexed with Glutamate Dehydrogenase ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIFUNCTIONAL AFFINITY LABEL; HYPERINSULINISM/HYPERAMMONEMIA SYNDROME; INSULIN-SECRETION; REDUCED COENZYME; AMINO-ACIDS; L-LEUCINE; MECHANISM; ADP; BINDING; SITE	Mammalian glutamate dehydrogenase (GDH) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of L-glutamate to 2-oxoglutarate using NAD(P)(+) as coenzyme. Unlike its counterparts from other animal kingdoms, mammalian GDH is regulated by a host of ligands. The recently discovered hyperinsulinism/hyperammonemia disorder showed that the loss of allosteric inhibition of GDH by GTP causes excessive secretion of insulin. Subsequent studies demonstrated that wild-type and hyperinsulinemia/hyperammonemia forms of GDH are inhibited by the green tea polyphenols, epigallocatechin gallate and epicatechin gallate. This was followed by high throughput studies that identified more stable inhibitors, including hexachlorophene, GW5074, and bithionol. Shown here are the structures of GDH complexed with these three compounds. Hexachlorophene forms a ring around the internal cavity in GDH through aromatic stacking interactions between the drug and GDH as well as between the drug molecules themselves. In contrast, GW5074 and bithionol both bind as pairs of stacked compounds at hexameric 2-fold axes between the dimers of subunits. The internal core of GDH contracts when the catalytic cleft closes during enzymatic turnover. None of the drugs cause conformational changes in the contact residues, but all bind to key interfaces involved in this contraction process. Therefore, it seems likely that the drugs inhibit enzymatic turnover by inhibiting this transition. Indeed, this expansion/contraction process may play a major role in the inter-subunit communication and allosteric regulation observed in GDH.	[Li, Ming; Smith, Christopher J.; Walker, Matthew T.; Smith, Thomas J.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Smith, TJ (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	tsmith@danforthcenter.org	Smith, Thomas J/K-9086-2013	Smith, Thomas J/0000-0003-3528-6793	National Institutes of Health [DK072171]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK072171 (to T. J. S.).	Allen A, 2004, BIOCHEMISTRY-US, V43, P14431, DOI 10.1021/bi048817i; BAILEY J, 1982, J BIOL CHEM, V257, P5579; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; Banerjee S, 2003, BIOCHEMISTRY-US, V42, P3446, DOI 10.1021/bi0206917; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DIETER H, 1981, EUR J BIOCHEM, V115, P217; DOMBROWSKI KE, 1992, BIOCHEMISTRY-US, V31, P3785, DOI 10.1021/bi00130a008; DOMBROWSKI KE, 1989, ARCH BIOCHEM BIOPHYS, V275, P302, DOI 10.1016/0003-9861(89)90377-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGEL PC, 1969, BIOCHEM J, V115, P621, DOI 10.1042/bj1150621; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; FAHIEN LA, 1981, ARCH BIOCHEM BIOPHYS, V212, P247, DOI 10.1016/0003-9861(81)90364-7; FLOCCO MM, 1994, J MOL BIOL, V235, P709, DOI 10.1006/jmbi.1994.1022; FRIEDEN C, 1965, J BIOL CHEM, V240, P2028; FRIEDEN C, 1959, J BIOL CHEM, V234, P809; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hsu BYL, 2001, J PEDIATR-US, V138, P383, DOI 10.1067/mpd.2001.111818; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; IWATSUBO M, 1967, B SOC CHIM BIOL, V49, P1563; KOBERSTEIN R, 1973, EUR J BIOCHEM, V36, P545, DOI 10.1111/j.1432-1033.1973.tb02942.x; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li M, 2007, BIOCHEMISTRY-US, V46, P15089, DOI 10.1021/bi7018783; MacMullen C, 2001, J CLIN ENDOCR METAB, V86, P1782, DOI 10.1210/jc.86.4.1782; MARKAU K, 1972, FEBS LETT, V24, P32, DOI 10.1016/0014-5793(72)80819-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAL PK, 1975, BIOCHEMISTRY-US, V14, P707, DOI 10.1021/bi00675a010; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; PROUGH RA, 1973, J BIOL CHEM, V248, P8528; SCHMIDT JA, 1984, J BIOL CHEM, V259, P4515; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; SMITH EL, 1975, ENZYMES, P293; SMITH T, 1982, BIOCHEMISTRY-US, V21, P733, DOI 10.1021/bi00533a023; Smith TJ, 2008, TRENDS BIOCHEM SCI, V33, P557, DOI 10.1016/j.tibs.2008.07.007; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; TOMKINS GM, 1962, J BIOL CHEM, V237, P1704; Vazquez JA, 2003, LETT APPL MICROBIOL, V37, P365, DOI 10.1046/j.1472-765X.2003.01408.x; YIELDING KL, 1961, P NATL ACAD SCI USA, V47, P983, DOI 10.1073/pnas.47.7.983; YIELDING KL, 1960, BIOCHEM BIOPH RES CO, V2, P303, DOI 10.1016/0006-291X(60)90189-3; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9	49	59	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22988	23000		10.1074/jbc.M109.020222	http://dx.doi.org/10.1074/jbc.M109.020222			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531491	hybrid, Green Published			2022-12-27	WOS:000268963100052
J	Sabeh, F; Li, XY; Saunders, TL; Rowe, RG; Weiss, SJ				Sabeh, Farideh; Li, Xiao-Yan; Saunders, Thomas L.; Rowe, R. Grant; Weiss, Stephen J.			Secreted Versus Membrane-anchored Collagenases RELATIVE ROLES IN FIBROBLAST-DEPENDENT COLLAGENOLYSIS AND INVASION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; EXTRACELLULAR-MATRIX; 1-MATRIX METALLOPROTEINASE; CELL-MIGRATION; DEFICIENT MICE; GELATINASE-A; SUBSTRATE DEGRADATION; CYSTEINE PROTEINASES; MEDIATED INHIBITION; TARGETED MUTATION	Fibroblasts degrade type I collagen, the major extracellular protein found in mammals, during events ranging from bulk tissue resorption to invasion through the three-dimensional extracellular matrix. Current evidence suggests that type I collagenolysis is mediated by secreted as well as membrane-anchored members of the matrix metalloproteinase (MMP) gene family. However, the roles played by these multiple and possibly redundant, degradative systems during fibroblast-mediated matrix remodeling is undefined. Herein, we use fibroblasts isolated from Mmp13(-/-), Mmp8(-/-), Mmp2(-/-), Mmp9(-/-), Mmp14(-/-) and Mmp16(-/-) mice to define the functional roles for secreted and membrane-anchored collagenases during collagen-resorptive versus collagen-invasive events. In the presence of a functional plasminogen activator-plasminogen axis, secreted collagenases arm cells with a redundant collagenolytic potential that allows fibroblasts harboring single deficiencies for either MMP-13, MMP-8, MMP-2, or MMP-9 to continue to degrade collagen comparably to wild-type fibroblasts. Likewise, Mmp14(-/-) or Mmp16(-/-) fibroblasts retain near-normal collagenolytic activity in the presence of plasminogen via the mobilization of secreted collagenases, but only Mmp14 (MT1-MMP) plays a required role in the collagenolytic processes that support fibroblast invasive activity. Furthermore, by artificially tethering a secreted collagenase to the surface of Mmp14(-/-) fibroblasts, we demonstrate that localized pericellular collagenolytic activity differentiates the collagen-invasive phenotype from bulk collagen degradation. Hence, whereas secreted collagenases arm fibroblasts with potent matrix-resorptive activity, only MT1-MMP confers the focal collagenolytic activity necessary for supporting the tissue-invasive phenotype.	[Sabeh, Farideh; Li, Xiao-Yan; Weiss, Stephen J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sabeh, Farideh; Li, Xiao-Yan; Saunders, Thomas L.; Rowe, R. Grant; Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Biomed Res Core Facil, Ann Arbor, MI 48109 USA; [Rowe, R. Grant] Univ Michigan, Cell & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weiss, SJ (corresponding author), Univ Michigan, Inst Life Sci, 5000 LSI,210 Washtenaw, Ann Arbor, MI 48109 USA.	sjweiss@umich.edu		Saunders, Thom/0000-0003-2015-101X	National Institutes of Health [R01 CA071699, CA088308]; NATIONAL CANCER INSTITUTE [R01CA088308, R01CA071699, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA071699 and CA088308 (to S. J. W.).	Almholt Kasper, 2008, P203, DOI 10.1007/978-0-387-69057-5_11; Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Atkinson SJ, 2001, FEBS LETT, V491, P222, DOI 10.1016/S0014-5793(01)02204-9; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; Bank RA, 1999, ANN RHEUM DIS, V58, P35, DOI 10.1136/ard.58.1.35; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Beare AHM, 2003, J INVEST DERMATOL, V120, P153, DOI 10.1046/j.1523-1747.2003.12019.x; Benbow U, 1999, J BIOL CHEM, V274, P25371, DOI 10.1074/jbc.274.36.25371; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; BIRKEDALHANSEN H, 1987, METHOD ENZYMOL, V144, P140; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Carmeliet P, 1998, THROMB RES, V91, P255, DOI 10.1016/S0049-3848(98)00122-4; Costea DE, 2006, AM J PATHOL, V168, P1889, DOI 10.2353/ajpath.2006.050843; Cox SW, 2006, ORAL DIS, V12, P34, DOI 10.1111/j.1601-0825.2005.01153.x; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Creemers LB, 1997, BIOTECHNIQUES, V22, P656, DOI 10.2144/97224bm19; Creemers LB, 1998, MATRIX BIOL, V16, P575, DOI 10.1016/S0945-053X(98)90068-3; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Davis GE, 2006, J INVEST DERM SYMP P, V11, P44, DOI 10.1038/sj.jidsymp.5650008; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Green KA, 2008, J INVEST DERMATOL, V128, P2092, DOI 10.1038/jid.2008.54; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holopainen JM, 2003, INVEST OPHTH VIS SCI, V44, P2550, DOI 10.1167/iovs.02-1190; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Itoh T, 1998, CANCER RES, V58, P1048; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jiang XL, 2005, J CELL PHYSIOL, V202, P723, DOI 10.1002/jcp.20162; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Kerkvliet EHM, 1999, MATRIX BIOL, V18, P373, DOI 10.1016/S0945-053X(99)00032-3; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Knauper V, 2002, FEBS LETT, V532, P127, DOI 10.1016/S0014-5793(02)03654-2; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Lee HJ, 2006, MOL BIOL CELL, V17, P4812, DOI 10.1091/mbc.E06-06-0486; Li SH, 2000, J BIOL CHEM, V275, P35384, DOI 10.1074/jbc.M005139200; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Lin M, 2008, AM J PATHOL, V173, P144, DOI 10.2353/ajpath.2008.080081; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; Liu Z, 1998, J EXP MED, V188, P475, DOI 10.1084/jem.188.3.475; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Milner JM, 2001, ARTHRITIS RHEUM-US, V44, P2084, DOI 10.1002/1529-0131(200109)44:9<2084::AID-ART359>3.0.CO;2-R; Mohan R, 1998, J BIOL CHEM, V273, P25903, DOI 10.1074/jbc.273.40.25903; Morris MJ, 2009, BIOCHEMISTRY-US, V48, P5313, DOI 10.1021/bi900498z; Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Netzel-Arnett S, 2002, J BIOL CHEM, V277, P45154, DOI 10.1074/jbc.M206354200; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; Nyalendo C, 2008, CARCINOGENESIS, V29, P1655, DOI 10.1093/carcin/bgn159; O'Reilly PJ, 2008, CURR OPIN PHARMACOL, V8, P242, DOI 10.1016/j.coph.2008.02.003; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Runger TM, 2007, J INVEST DERMATOL, V127, P293, DOI 10.1038/sj.jid.5700535; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Saunders WB, 2005, J CELL SCI, V118, P2325, DOI 10.1242/jcs.02360; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Wu NJ, 2002, MATRIX BIOL, V21, P149, DOI 10.1016/S0945-053X(01)00192-5; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zhang YH, 2007, J IMMUNOL, V179, P3297, DOI 10.4049/jimmunol.179.5.3297; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	92	118	119	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23001	23011		10.1074/jbc.M109.002808	http://dx.doi.org/10.1074/jbc.M109.002808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542530	hybrid, Green Published			2022-12-27	WOS:000268963100053
J	Zhang, AS; Yang, F; Wang, JH; Tsukamoto, H; Enns, CA				Zhang, An-Sheng; Yang, Fan; Wang, Jiaohong; Tsukamoto, Hidekazu; Enns, Caroline A.			Hemojuvelin-Neogenin Interaction Is Required for Bone Morphogenic Protein-4-induced Hepcidin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-METABOLISM; JUVENILE HEMOCHROMATOSIS; PROTEIN CORECEPTOR; SOLUBLE HEMOJUVELIN; RECEPTOR NEOGENIN; MOUSE-LIVER; OVERLOAD; DRAGON; CELLS; BMP6	Hemojuvelin (HJV) is a glycosylphosphatidylinositol-linked protein and binds both bone morphogenic proteins (BMPs) and neogenin. Cellular HJV acts as aBMP co-receptor to enhance the transcription of hepcidin, a key iron regulatory hormone secreted predominantly by liver hepatocytes. In this study we characterized the role of neogenin in HJV-regulated hepcidin expression. Both HJV and neogenin were expressed in liver hepatocytes. Knockdown of neogenin decreased BMP4-induced hepcidin mRNA levels by 16-fold in HJV-expressing HepG2 cells but only by about 2-fold in cells transfected with either empty vector or G99V mutant HJV that does not bind BMPs. Further studies indicated that disruption of the HJV-neogenin interaction is responsible for a marked suppression of hepcidin expression. Moreover, in vivo studies showed that hepatic hepcidin mRNA could be significantly suppressed by blocking the interaction of HJV with full-length neogenin with a soluble fragment of neogenin in mice. Together, these results suggest that the HJV-neogenin interaction is required for the BMP-mediated induction of hepcidin expression when HJV is expressed. Combined with our previous studies, our results support that hepatic neogenin possesses two functions, mediation of cellular HJV release, and stimulation of HJV-enhanced hepcidin expression.	[Zhang, An-Sheng; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Yang, Fan] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Wang, Jiaohong; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Tsukamoto, Hidekazu] Greater Los Angeles Healthcare Syst, Dept Vet Affairs, Los Angeles, CA 90073 USA	Oregon Health & Science University; California Institute of Technology; University of Southern California	Zhang, AS (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu	Zhu, Ren-Yuan/V-8966-2019; Yang, Fan/GYU-4249-2022	Zhu, Ren-Yuan/0000-0003-3091-7461; 	National Institutes of Health [DK080765, P50AA11199, R24AA12885]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080765 (to A.-S.Z.), P50AA11199 (to H.T.), and R24AA12885 (to H.T.).	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Camaschella C, 2002, SEMIN HEMATOL, V39, P242, DOI 10.1053/shem.2002.35635; Conrad S, 2007, J BIOL CHEM, V282, P16423, DOI 10.1074/jbc.M610901200; Davies PS, 2004, J BIOL CHEM, V279, P25085, DOI 10.1074/jbc.M400537200; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; De Gobbi M, 2002, BRIT J HAEMATOL, V117, P973, DOI 10.1046/j.1365-2141.2002.03509.x; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng YF, 2005, MOL CELL BIOL, V25, P4010, DOI 10.1128/MCB.25.10.4010-4022.2005; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Goldschneider D, 2008, MOL CELL BIOL, V28, P4068, DOI 10.1128/MCB.02114-07; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; LUXON BA, 2000, LIVER DIS DIAGNOSIS, P3; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Schaffar G, 2008, J NEUROCHEM, V107, P418, DOI 10.1111/j.1471-4159.2008.05621.x; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Xia Y, 2005, ENDOCRINOLOGY, V146, P3614, DOI 10.1210/en.2004-1676; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zhang AS, 2008, J BIOL CHEM, V283, P17494, DOI 10.1074/jbc.M710527200; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200	40	64	65	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22580	22589		10.1074/jbc.M109.027318	http://dx.doi.org/10.1074/jbc.M109.027318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19564337	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000268963100011
J	Leitch, JM; Jensen, LT; Bouldin, SD; Outten, CE; Hart, PJ; Culotta, VC				Leitch, Jeffry M.; Jensen, Laran T.; Bouldin, Samantha D.; Outten, Caryn E.; Hart, P. John; Culotta, Valeria C.			Activation of Cu,Zn-Superoxide Dismutase in the Absence of Oxygen and the Copper Chaperone CCS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC SUPEROXIDE-DISMUTASE; PROTEIN DISULFIDE-ISOMERASE; SACCHAROMYCES-CEREVISIAE; PHYSIOLOGICAL-ROLE; OXIDATIVE DAMAGE; ACTIVE-SITE; IN-VIVO; SOD1; METAL; THIOREDOXIN	Eukaryotic Cu,Zn-superoxide dismutases (SOD1s) are generally thought to acquire the essential copper cofactor and intramolecular disulfide bond through the action of the CCS copper chaperone. However, several metazoan SOD1s have been shown to acquire activity in vivo in the absence of CCS, and the Cu, Zn-SOD from Caenorhabditis elegans has evolved complete independence from CCS. To investigate SOD1 activation in the absence of CCS, we compared and contrasted the CCS-independent activation of C. elegans and human SOD1 to the strict CCS-dependent activation of Saccharomyces cerevisiae SOD1. Using a yeast expression system, both pathways were seen to acquire copper derived from cell surface transporters and compete for the same intracellular pool of copper. Like CCS, CCS-independent activation occurs rapidly with a preexisting pool of apo-SOD1 without the need for new protein synthesis. The two pathways, however, strongly diverge when assayed for the SOD1 disulfide. SOD1 molecules that are activated without CCS exhibit disulfide oxidation in vivo without oxygen and under copper-depleted conditions. The strict requirement for copper, oxygen, and CCS in disulfide bond oxidation appears exclusive to yeast SOD1, and we find that a unique proline at position 144 in yeast SOD1 is responsible for this disulfide effect. CCS-dependent and -independent pathways also exhibit differential requirements for molecular oxygen. CCS activation of SOD1 requires oxygen, whereas the CCS-independent pathway is able to activate SOD1s even under anaerobic conditions. In this manner, Cu, Zn-SOD from metazoans may retain activity over a wide range of physiological oxygen tensions.	[Leitch, Jeffry M.; Jensen, Laran T.; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Bouldin, Samantha D.; Outten, Caryn E.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Xray Crystallog Core Lab, San Antonio, TX 78229 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Culotta, VC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, 615 N Wolfe St,Rm E7626, Baltimore, MD 21205 USA.	vculotta@jhsph.edu	Outten, Caryn E./I-9433-2019	Outten, Caryn E./0000-0003-0335-6531; Jensen, Laran/0000-0003-3199-1743	National Institutes of Health [GM 50016, ES 13780, NS 39112]; Johns Hopkins University National Institutes of Environmental Health Sciences Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819, K22ES013780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050016, R01GM050016, F32GM087904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University National Institutes of Environmental Health Sciences Center(Johns Hopkins University); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 50016 (to V. C. C.) and ES 13780 (to C. E. O.) and National Institutes of Health, NINDS, Grant NS 39112 (to P. J. H.). This work was also supported by the Johns Hopkins University National Institutes of Environmental Health Sciences Center.	Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Brune B, 2007, CARDIOVASC RES, V75, P275, DOI 10.1016/j.cardiores.2007.03.005; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; EMERIT J, 1982, SEM HOP PARIS, V58, P2670; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Jensen LT, 2002, J MOL BIOL, V318, P251, DOI 10.1016/S0022-2836(02)00093-1; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Kirby LG, 2008, J NEUROSCI, V28, P12927, DOI 10.1523/JNEUROSCI.2887-08.2008; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lapinskas PJ, 1996, MOL MICROBIOL, V21, P519, DOI 10.1111/j.1365-2958.1996.tb02561.x; Lin SJ, 1996, MOL CELL BIOL, V16, P6303; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; LIU XF, 1992, J BIOL CHEM, V267, P18298; LOFERER H, 1995, J BIOL CHEM, V270, P26178, DOI 10.1074/jbc.270.44.26178; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; Mason JT, 2006, BIOCHEMISTRY-US, V45, P13409, DOI 10.1021/bi061136y; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; PANTOLIANO MW, 1982, J INORG BIOCHEM, V17, P325, DOI 10.1016/S0162-0134(00)80093-8; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; Sherman F., 1974, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197	52	56	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21863	21871		10.1074/jbc.M109.000489	http://dx.doi.org/10.1074/jbc.M109.000489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542232	Green Published, hybrid			2022-12-27	WOS:000268783700010
J	Neil, JR; Tian, MZ; Schiemann, WP				Neil, Jason R.; Tian, Maozhen; Schiemann, William P.			X-linked Inhibitor of Apoptosis Protein and Its E3 Ligase Activity Promote Transforming Growth Factor-beta-mediated Nuclear Factor-kappa B Activation during Breast Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; CELL-PROLIFERATION; SIGNALING PATHWAYS; UP-REGULATION; XIAP; EXPRESSION; INVASION; RECEPTOR; TAK1	The precise sequence of events that enable mammary tumorigenesis to convert transforming growth factor-beta (TGF-beta) from a tumor suppressor to a tumor promoter remains incompletely understood. We show here that X-linked inhibitor of apoptosis protein (xIAP) is essential for the ability of TGF-beta to stimulate nuclear factor-kappa B (NF-kappa B) in metastatic 4T1 breast cancer cells. Indeed whereas TGF-beta suppressed NF-kappa B activity in normal mammary epithelial cells, those engineered to overexpress xIAP demonstrated activation of NF-kappa B when stimulated with TGF-beta. Additionally up-regulated xIAP expression also potentiated the basal and TGF-beta-stimulated transcriptional activities of Smad2/3 and NF-kappa B. Mechanistically xIAP (i) interacted physically with the TGF-beta type I receptor, (ii) mediated the ubiquitination of TGF-beta-activated kinase 1 (TAK1), and (iii) facilitated the formation of complexes between TAK1-binding protein 1 (TAB1) and I kappa B kinase beta that enabled TGF-beta to activate p65/Re1A and to induce the expression of prometastatic (i.e. cyclooxygenase-2 and plasminogen activator inhibitor-1) and prosurvival (i.e. survivin) genes. We further observed that inhibiting the E3 ubiquitin ligase function of xIAP or expressing a mutant ubiquitin protein (i.e. K63R-ubiquitin) was capable of blocking xIAP- and TGF-beta-mediated activation of NF-kappa B. Functionally xIAP deficiency dramatically reduced the coupling of TGF-beta to Smad2/3 in NMuMG cells as well as inhibited their expression of mesenchymal markers in response to TGF-beta. More importantly, xIAP deficiency also abrogated the formation of TAB1.I kappa B kinase beta complexes in 4T1 breast cancer cells, thereby diminishing their activation of NF-kappa B, their expression of prosurvival/metastatic genes, their invasion through synthetic basement membranes, and their growth in soft agar. Collectively our findings have defined a novel role for xIAP in mediating oncogenic signaling by TGF-beta in breast cancer cells.	[Neil, Jason R.; Tian, Maozhen; Schiemann, William P.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Schiemann, WP (corresponding author), Univ Colorado Denver, Dept Pharmacol, MS 8303,Anschutz Med Campus,RC1 S Tower,Rm L18-61, Aurora, CO 80045 USA.	Bill.Schiemann@ucdenver.edu	tian, maozhen/F-5457-2010		National Institutes of Health [CA114039, CA129359]; Komen Foundation; NATIONAL CANCER INSTITUTE [R01CA114039, R01CA129359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA114039 and CA129359 (to W. P. S.). This work was also supported by the Komen Foundation (to W. P. S.).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Bruno T, 2008, CELL DEATH DIFFER, V15, P515, DOI 10.1038/sj.cdd.4402284; Cheung HH, 2006, CLIN CANCER RES, V12, P3238, DOI 10.1158/1078-0432.CCR-06-0817; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Danson S, 2007, CURR CANCER DRUG TAR, V7, P785, DOI 10.2174/156800907783220471; Farina AR, 1998, INT J CANCER, V75, P721; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Hwang C, 2008, CELL DEATH DIFFER, V15, P831, DOI 10.1038/cdd.2008.15; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lacasse EC, 2005, ANN NY ACAD SCI, V1058, P215, DOI 10.1196/annals.1359.032; LaCasse EC, 2006, CLIN CANCER RES, V12, P5231, DOI 10.1158/1078-0432.CCR-06-0608; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Lopez-Rovira T, 2000, J BIOL CHEM, V275, P28937, DOI 10.1074/jbc.M909923199; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Ma L, 1998, ONCOGENE, V17, P1321, DOI 10.1038/sj.onc.1202058; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Neil JR, 2008, CARCINOGENESIS, V29, P2227, DOI 10.1093/carcin/bgn202; Neil JR, 2008, CANCER RES, V68, P1462, DOI 10.1158/0008-5472.CAN-07-3094; Olayioye MA, 2005, CELL DEATH DIFFER, V12, P87, DOI 10.1038/sj.cdd.4401524; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Reffey SB, 2001, J BIOL CHEM, V276, P26542, DOI 10.1074/jbc.M100331200; Schiemann WP, 2007, EXPERT REV ANTICANC, V7, P609, DOI 10.1586/14737140.7.5.609; Schiemann WP, 1999, BLOOD, V94, P2854, DOI 10.1182/blood.V94.8.2854.420k07_2854_2861; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Sokol JP, 2005, BREAST CANCER RES, V7, pR844, DOI 10.1186/bcr1312; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; SUMIYOSHI K, 1991, THROMB RES, V63, P59, DOI 10.1016/0049-3848(91)90270-7; Sun Y, 2003, CANCER BIOL THER, V2, P623; Syed NA, 2006, APOPTOSIS, V11, P2147, DOI 10.1007/s10495-006-0197-3; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yan SR, 2005, ONCOGENE, V24, P6482, DOI 10.1038/sj.onc.1208810; Yie SM, 2006, CLIN EXP METASTAS, V23, P279, DOI 10.1007/s10585-006-9037-7; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	54	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21209	21217		10.1074/jbc.M109.018374	http://dx.doi.org/10.1074/jbc.M109.018374			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531477	Green Published, hybrid			2022-12-27	WOS:000268564400014
J	Shirakawa, R; Fukai, S; Kawato, M; Higashi, T; Kondo, H; Ikeda, T; Nakayama, E; Okawa, K; Nureki, O; Kimura, T; Kita, T; Horiuchi, H				Shirakawa, Ryutaro; Fukai, Shuya; Kawato, Mitsunori; Higashi, Tomohito; Kondo, Hirokazu; Ikeda, Tomoyuki; Nakayama, Ei; Okawa, Katsuya; Nureki, Osamu; Kimura, Takeshi; Kita, Toru; Horiuchi, Hisanori			Tuberous Sclerosis Tumor Suppressor Complex-like Complexes Act as GTPase-activating Proteins for Ral GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TSC2 GAP ACTIVITY; CELLULAR-TRANSFORMATION; DEPENDENT MANNER; DIRECT TARGET; RAIA GTPASE; RHEB; EFFECTOR; EXOCYST; CANCER	The small GTPases RalA and RalB are multifunctional proteins regulating a variety of cellular processes. Like other GTPases, the activity of Ral is regulated by the opposing effects of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Although several RalGEFs have been identified and characterized, the molecular identity of RalGAP remains unknown. Here, we report the first molecular identification of RalGAPs, which we have named RalGAP1 and RalGAP2. They are large heterodimeric complexes, each consisting of a catalytic alpha 1 or alpha 2 subunit and a common beta subunit. These RalGAP complexes share structural and catalytic similarities with the tuberous sclerosis tumor suppressor complex, which acts as a GAP for Rheb. In vitro GTPase assays revealed that recombinant RalGAP1 accelerates the GTP hydrolysis rate of RalA by 280,000-fold. Heterodimerization was required for this GAP activity. In PC12 cells, knockdown of the beta subunit led to sustained Ral activation upon epidermal growth factor stimulation, indicating that the RalGAPs identified here are critical for efficient termination of Ral activation induced by extracellular stimuli. Our identification of RalGAPs will enable further understanding of Ral signaling in many biological and pathological processes.	[Nakayama, Ei; Kimura, Takeshi; Kita, Toru; Horiuchi, Hisanori] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Kyoto 6068507, Japan; [Fukai, Shuya] Univ Tokyo, Struct Biol Lab, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan; [Fukai, Shuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Nureki, Osamu] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Tokyo 1088639, Japan	Kyoto University; Kyoto University; University of Tokyo; University of Tokyo; University of Tokyo	Horiuchi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan.	horiuchi@kuhp.kyoto-u.ac.jp	Fukai, Shuya/X-4838-2018; Higashi, Tomohito/AHE-7942-2022; NUREKI, OSAMU/G-4960-2014	Fukai, Shuya/0000-0002-1241-1443; Higashi, Tomohito/0000-0001-5616-1477	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15081206, 20013201, 07J08426]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Research Grants 15081206 and 20013201 (to H. H.) and 07J08426 (to R. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Takeda Science Foundation (to H. H.) This work was also supported in part by Global COE Program "Center for Frontier Medicine" from the Ministry of Education, Culture, Sports, Science, and Technology.	ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Ceriani M, 2007, EXP CELL RES, V313, P2293, DOI 10.1016/j.yexcr.2007.03.016; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; de Bruyn KMT, 2000, J BIOL CHEM, V275, P29761, DOI 10.1074/jbc.M001160200; EMKEY R, 1991, J BIOL CHEM, V266, P9703; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gridley S, 2006, CELL SIGNAL, V18, P1626, DOI 10.1016/j.cellsig.2006.01.002; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rebhun JF, 2000, J BIOL CHEM, V275, P13406, DOI 10.1074/jbc.C000085200; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Schwarzbraun T, 2004, GENOMICS, V84, P577, DOI 10.1016/j.ygeno.2004.04.013; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Shao HP, 2000, J BIOL CHEM, V275, P26914; Smith SC, 2007, CLIN CANCER RES, V13, P3803, DOI 10.1158/1078-0432.CCR-06-2419; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Wolthuis RMF, 1997, EMBO J, V16, P6748, DOI 10.1093/emboj/16.22.6748; Wolthuis RMF, 1996, ONCOGENE, V13, P353; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	50	50	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21580	21588		10.1074/jbc.M109.012112	http://dx.doi.org/10.1074/jbc.M109.012112			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520869	Green Published, hybrid			2022-12-27	WOS:000268564400052
J	Kim, J; Roeder, RG				Kim, Jaehoon; Roeder, Robert G.			Direct Bre1-Paf1 Complex Interactions and RING Finger-independent Bre1-Rad6 Interactions Mediate Histone H2B Ubiquitylation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; LIGASE ACTIVITY; RAD6 PROTEIN; HUMAN-CELLS; MONOUBIQUITINATION; TRANSCRIPTION; METHYLATION; CATALYSIS	Recent yeast genetic studies have implicated the ubiquitin-conjugating enzyme and ubiquitin ligase functions of yRad6 and yBre1, respectively, in H2B ubiquitylation. However, there have been no corresponding biochemical analyses demonstrating intrinsic enzyme activities of yRad6 and yBre1 or related mechanistic details. Here, we describe a robust in vitro chromatin ubiquitylation assay that involves purified H2B ubiquitylation factors and natural nucleosomes. Our results indicate that yRad6 has an in vitro ability to nonspecifically ubiquitylate all core histones in the absence of an ubiquitin ligase but that yBre1 functions, through direct interactions with yRad6, to direct the ubiquitin conjugating activity of yRad6 toward the physiological H2B ubiquitylation site. Moreover, a yRad6 domain mapping analysis shows that an intact UBC domain is required for binding to yBre1, whereas the C-terminal acidic tail domain that is not required for a stable yBre1-yRad6 interaction is necessary for full enzyme activity of yRad6. We also find that, analogous to heteromeric complex formation by BRE1 paralogues in other organisms, yBre1 forms a homo-multimeric complex. Of special significance, our detailed biochemical analyses further show that the yBre1 RING finger domain is essential for H2B ubiquitylation but, surprisingly, dispensable for interaction of yBre1 with yRad6. In further support of the genetically identified requirement of the RNA polymerase II-associated yPaf1 complex for H2B ubiquitylation, protein interaction studies reveal that a purified yPaf1 complex directly and selectively interacts with yBre1 and thus serves to link the H2B ubiquitylation and general transcription machineries. These studies provide a more detailed mechanistic basis for H2B ubiquitylation in yeast.	[Kim, Jaehoon; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University	Roeder, RG (corresponding author), 1230 York Ave, New York, NY 10065 USA.	roeder@mail.rockefeller.edu	Kim, Jaehoon/G-2711-2011	Kim, Jaehoon/0000-0003-4035-0438	National Institutes of Health [CA129325, DK071900]; Starr Foundation; NATIONAL CANCER INSTITUTE [R01CA129325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129325 and DK071900 ( to R. G. R.). This work was also supported by a Leukemia and Lymphoma Society Specialized Centers of Research grant and by the Starr Foundation.	Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Cao Y, 2008, PLANT CELL, V20, P2586, DOI 10.1105/tpc.108.062760; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2002, J BIOL CHEM, V277, P24530, DOI 10.1074/jbc.M201612200; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shi XM, 1996, MOL CELL BIOL, V16, P669; SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Utley RT, 1996, METHOD ENZYMOL, V274, P276; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zofall M, 2007, J BIOL CHEM, V282, P14065, DOI 10.1074/jbc.M700292200	35	79	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20582	20592		10.1074/jbc.M109.017442	http://dx.doi.org/10.1074/jbc.M109.017442			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19531475	Green Published, hybrid			2022-12-27	WOS:000268316100020
J	Pelaez, R; Herrero, P; Moreno, F				Pelaez, Rafael; Herrero, Pilar; Moreno, Fernando			Nuclear Export of the Yeast Hexokinase 2 Protein Requires the Xpo1 (Crm1)-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIG1 GLUCOSE REPRESSOR; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION; LOCALIZATION; SIGNALS; SITE; PII; MUTATIONS; COMPLEXES; CYTOPLASM	Hexokinase 2 (Hxk2) from Saccharomyces cerevisiae was one of the first metabolic enzymes described as a multifunctional protein. Hxk2 has a double subcellular localization; it functions as a glycolytic enzyme in the cytoplasm and as a regulator of gene transcription of several Mig1-regulated genes in the nucleus. However, the mechanism by which Hxk2 enters and leaves the nucleus is still unknown. In low glucose conditions, Hxk2 is phosphorylated at serine 14, but how this phosphorylation may affect glucose signaling is also unknown at the moment. Here we report that the Hxk2 protein is an export substrate of the carrier protein Xpo1 (Crm1). We also show that the Hxk2 nuclear export and the binding of Hxk2 and Xpo1 involve two leucine-rich nuclear export signals (NES) located between leucine 23 and isoleucine 33 (NES1) and between leucine 310 and leucine 318 (NES2). We also show that the Hxk2 phosphorylation at serine 14 promotes Hxk2 export by facilitating the association of Hxk2 with Xpo1. Our study uncovers a new cargo for the Xpo1 yeast exportin and identifies Hxk2 phosphorylation at serine 14 as a regulatory mechanism that controls its nuclear exit in function of the glucose levels.	[Pelaez, Rafael; Herrero, Pilar; Moreno, Fernando] Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	University of Oviedo	Pelaez, R (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, Campus El Cristo, E-33006 Oviedo, Spain.	fmoreno@uniovi.es	Peláez, Rafael/R-9458-2019	Peláez, Rafael/0000-0002-4047-6017	Ministerio de Educacion y Ciencia - Direccion General de Investigacion (Spain) [BFU2007-66063-C02-02]	Ministerio de Educacion y Ciencia - Direccion General de Investigacion (Spain)(Spanish Government)	This work was supported by Ministerio de Educacion y Ciencia - Direccion General de Investigacion (Spain) Grant BFU2007-66063-C02-02.	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Benzeno S, 2006, ONCOGENE, V25, P6291, DOI 10.1038/sj.onc.1209644; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; GASCON S, 1968, J BIOL CHEM, V243, P1567; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Heidrich K, 1997, BIOCHEMISTRY-US, V36, P1960, DOI 10.1021/bi9623643; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; KADOWAKI H, 1989, GENE, V76, P161, DOI 10.1016/0378-1119(89)90018-8; KRIEGEL TM, 1994, BIOCHEMISTRY-US, V33, P148, DOI 10.1021/bi00167a019; Kunzler M, 2000, MOL CELL BIOL, V20, P4295, DOI 10.1128/MCB.20.12.4295-4308.2000; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; MA H, 1986, MOL CELL BIOL, V6, P4046, DOI 10.1128/MCB.6.11.4046; Maurer P, 2001, MOL BIOL CELL, V12, P539, DOI 10.1091/mbc.12.3.539; Mayordomo I, 2001, YEAST, V18, P923, DOI 10.1002/yea.737; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Moreno F, 2002, FEMS MICROBIOL REV, V26, P83, DOI 10.1111/j.1574-6976.2002.tb00600.x; Neufeld KL, 2000, P NATL ACAD SCI USA, V97, P12085, DOI 10.1073/pnas.220401797; Ostling J, 1996, MOL CELL BIOL, V16, P753; Quan XX, 2007, BBA-MOL CELL RES, V1773, P1052, DOI 10.1016/j.bbamcr.2007.04.014; Randez-Gil F, 1998, FEBS LETT, V425, P475, DOI 10.1016/S0014-5793(98)00289-0; Randez-Gil F, 1998, MOL CELL BIOL, V18, P2940, DOI 10.1128/MCB.18.5.2940; Riera A, 2008, BIOCHEM J, V415, P233, DOI 10.1042/BJ20080797; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6	34	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20548	20555		10.1074/jbc.M109.013730	http://dx.doi.org/10.1074/jbc.M109.013730			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19525230	Green Published, hybrid			2022-12-27	WOS:000268316100016
J	Takei, N; Kawamura, M; Ishizuka, Y; Kakiya, N; Inamura, N; Namba, H; Nawa, H				Takei, Nobuyuki; Kawamura, Mihoko; Ishizuka, Yuta; Kakiya, Naomasa; Inamura, Naoko; Namba, Hisaaki; Nawa, Hiroyuki			Brain-derived Neurotrophic Factor Enhances the Basal Rate of Protein Synthesis by Increasing Active Eukaryotic Elongation Factor 2 Levels and Promoting Translation Elongation in Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERM SYNAPTIC PLASTICITY; FACTOR-II; MAMMALIAN TARGET; KINASE; BDNF; EXPRESSION; INITIATION; MEMORY; PHOSPHORYLATION; RECEPTORS	The constitutive and activity-dependent components of protein synthesis are both critical for neural function. Although the mechanisms controlling extracellularly induced protein synthesis are becoming clear, less is understood about the molecular networks that regulate the basal translation rate. Here we describe the effects of chronic treatment with various neurotrophic factors and cytokines on the basal rate of protein synthesis in primary cortical neurons. Among the examined factors, brain-derived neurotrophic factor (BDNF) showed the strongest effect. The rate of protein synthesis increased in the cortical tissues of BDNF transgenic mice, whereas it decreased in BDNF knock-out mice. BDNF specifically increased the level of the active, unphosphorylated form of eukaryotic elongation factor 2 (eEF2). The levels of active eEF2 increased and decreased in BDNF transgenic and BDNF knock-out mice, respectively. BDNF decreased kinase activity and increased phosphatase activity against eEF2 in vitro. Additionally, BDNF shortened the ribosomal transit time, an index of translation elongation. In agreement with these results, overexpression of eEF2 enhanced protein synthesis. Taken together, our results demonstrate that the increased level of active eEF2 induced by chronic BDNF stimulation enhances translational elongation processes and increases the total rate of protein synthesis in neurons.	[Takei, Nobuyuki; Kawamura, Mihoko; Ishizuka, Yuta; Kakiya, Naomasa; Inamura, Naoko; Namba, Hisaaki; Nawa, Hiroyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata 9518585, Japan	Niigata University	Takei, N (corresponding author), Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Asahimachi 1, Niigata 9518585, Japan.	nobtak@bri.niigata-u.ac.jp	Ishizuka, Yuta/ACN-8245-2022; Ishizuka, Yuta/AAB-9170-2019	Ishizuka, Yuta/0000-0002-2036-902X; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of science; Japan Science and Technology Corporation (Core Research for Evolutional Science and Technology, CREST); Niigata University Research project	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Corporation (Core Research for Evolutional Science and Technology, CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Niigata University Research project	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (a grant-in-aid for Priority Area (RNA Network), the Japan Society for the Promotion of science (a grant-in-aid for Scientific Research B), the Japan Science and Technology Corporation (Core Research for Evolutional Science and Technology, CREST), and a grant for the promotion of the Niigata University Research project.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Carroll M, 2004, J NEUROCHEM, V90, P1464, DOI 10.1111/j.1471-4159.2004.02634.x; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Croll SD, 1999, NEUROSCIENCE, V93, P1491, DOI 10.1016/S0306-4522(99)00296-1; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; GSCHWENDT M, 1989, FEBS LETT, V257, P357, DOI 10.1016/0014-5793(89)81571-6; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inamura N, 2005, J NEUROCHEM, V95, P1438, DOI 10.1111/j.1471-4159.2005.03466.x; Inamura N, 2003, MOL BRAIN RES, V111, P165, DOI 10.1016/S0169-328X(03)00027-5; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; MATHEWS MB, 2000, TRANSLATIONAL CONTRO, P719; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Meyuhas O, 2000, COLD SPRING HARBOR M, V39, P671; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Namba H, 2006, MOL CELL NEUROSCI, V31, P628, DOI 10.1016/j.mcn.2005.12.002; NAWA H, 1995, EUR J NEUROSCI, V7, P1527, DOI 10.1111/j.1460-9568.1995.tb01148.x; Nawa H, 2001, TRENDS NEUROSCI, V24, P683, DOI 10.1016/S0166-2236(00)01955-X; NIELSEN PJ, 1980, J CELL PHYSIOL, V104, P269, DOI 10.1002/jcp.1041040302; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Proud C, 2000, COLD SPRING HARBOR M, V39, P719; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; REDPATH NT, 1990, BIOCHEM J, V272, P175, DOI 10.1042/bj2720175; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1991, FEBS LETT, V285, P170, DOI 10.1016/0014-5793(91)80798-8; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Sossin WS, 2008, PROG BRAIN RES, V169, P3, DOI 10.1016/S0079-6123(07)00001-5; Takei N, 1998, J BIOL CHEM, V273, P27620, DOI 10.1074/jbc.273.42.27620; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tokunaga C, 2004, BIOCHEM BIOPH RES CO, V313, P443, DOI 10.1016/j.bbrc.2003.07.019; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	46	37	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26340	26348		10.1074/jbc.M109.023010	http://dx.doi.org/10.1074/jbc.M109.023010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19625250	hybrid, Green Published			2022-12-27	WOS:000269969600014
J	Kerr, ID; Lee, JH; Farady, CJ; Marion, R; Rickert, M; Sajid, M; Pandey, KC; Caffrey, CR; Legac, J; Hansell, E; McKerrow, JH; Craik, CS; Rosenthal, PJ; Brinen, LS				Kerr, Iain D.; Lee, Ji H.; Farady, Christopher J.; Marion, Rachael; Rickert, Mathias; Sajid, Mohammed; Pandey, Kailash C.; Caffrey, Conor R.; Legac, Jennifer; Hansell, Elizabeth; McKerrow, James H.; Craik, Charles S.; Rosenthal, Philip J.; Brinen, Linda S.			Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE INHIBITORS; PLASMODIUM-FALCIPARUM; TRYPANOSOMA-CRUZI; MOLECULAR REPLACEMENT; PARASITIC DISEASES; CHAGAS-DISEASE; IN-VITRO; SUBSTRATE; HEMOGLOBIN; SPECIFICITY	Cysteine proteases of the papain superfamily are implicated in a number of cellular processes and are important virulence factors in the pathogenesis of parasitic disease. These enzymes have therefore emerged as promising targets for antiparasitic drugs. We report the crystal structures of three major parasite cysteine proteases, cruzain, falcipain-3, and the first reported structure of rhodesain, in complex with a class of potent, small molecule, cysteine protease inhibitors, the vinyl sulfones. These data, in conjunction with comparative inhibition kinetics, provide insight into the molecular mechanisms that drive cysteine protease inhibition by vinyl sulfones, the binding specificity of these important proteases and the potential of vinyl sulfones as antiparasitic drugs.	[Kerr, Iain D.; Lee, Ji H.; Marion, Rachael; Rickert, Mathias; Brinen, Linda S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Farady, Christopher J.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Sajid, Mohammed; Caffrey, Conor R.; Hansell, Elizabeth; McKerrow, James H.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Sajid, Mohammed; Caffrey, Conor R.; Hansell, Elizabeth; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94143 USA; [Pandey, Kailash C.; Legac, Jennifer; Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Brinen, LS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, QB3 Byers Hall 508C,1700 4th St, San Francisco, CA 94158 USA.	brinen@cmp.ucsf.edu	Pandey, Kailash/H-5048-2011		National Institutes of Health [AI35707, AI35800]; Sandler Foundation; Medicines for Malaria Venture; Charles E. Culpeper Biomedical Pilot Initiative Award; Dept. of Energy, Office of Biological and Environmental Research; National Center for Research Resources, Biomedical Technology Program, NIH; NIGMS, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI035800, R56AI035800, R01AI035800, P01AI035707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Foundation; Medicines for Malaria Venture; Charles E. Culpeper Biomedical Pilot Initiative Award; Dept. of Energy, Office of Biological and Environmental Research; National Center for Research Resources, Biomedical Technology Program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI35707 and AI35800 (to C. R. C.). This work was also supported by the Sandler Foundation, the Medicines for Malaria Venture, and a Charles E. Culpeper Biomedical Pilot Initiative Award ( to C. R. C.). Part of this research was performed at SSRL, a national user facility operated by Stanford University on behalf of the U. S. Dept. of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Dept. of Energy, Office of Biological and Environmental Research, and by the National Center for Research Resources, Biomedical Technology Program, NIH, and NIGMS, NIH.	BALAKRISHNAN I, 2002, PRINCIPLES PRACTICE, P91; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Brinen LS, 2000, STRUCT FOLD DES, V8, P831, DOI 10.1016/S0969-2126(00)00173-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caffrey C. R., 2000, Current Drug Targets, V1, P155, DOI 10.2174/1389450003349290; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; Chen YT, 2008, BIOORG MED CHEM LETT, V18, P5860, DOI 10.1016/j.bmcl.2008.06.012; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Docampo R, 2003, PARASITOL RES, V90, pS10, DOI 10.1007/s00436-002-0752-y; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; EAKIN AE, 1993, J BIOL CHEM, V268, P6115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel JC, 1998, J CELL SCI, V111, P597; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Engel JC, 1999, MEDICINA-BUENOS AIRE, V59, P171; Ettari R, 2008, J MED CHEM, V51, P988, DOI 10.1021/jm701141u; Evans W, 1997, CHEM BRIT, V33, P22; Fujii N, 2005, BIOORG MED CHEM LETT, V15, P121, DOI 10.1016/j.bmcl.2004.10.023; Gillmor SA, 1997, PROTEIN SCI, V6, P1603, DOI 10.1002/pro.5560060801; Gonzalez FV, 2007, BIOORG MED CHEM LETT, V17, P6697, DOI 10.1016/j.bmcl.2007.10.056; Greenbaum DC, 2004, J MED CHEM, V47, P3212, DOI 10.1021/jm030549j; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Huang L, 2003, BIOORGAN MED CHEM, V11, P21, DOI 10.1016/S0968-0896(02)00427-3; Jacobsen W, 2000, DRUG METAB DISPOS, V28, P1343; Jaishankar P, 2008, BIOORG MED CHEM LETT, V18, P624, DOI 10.1016/j.bmcl.2007.11.070; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; Laufer MK, 2007, AM J TROP MED HYG, V77, P160, DOI 10.4269/ajtmh.2007.77.160; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKerrow JH, 2008, CURR OPIN INFECT DIS, V21, P668, DOI 10.1097/QCO.0b013e328315cca9; McPherson A, 1982, PREPARATION ANAL PRO; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nkemngu NJ, 2003, INT J ANTIMICROB AG, V22, P155, DOI 10.1016/S0924-8579(03)00096-7; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellette M, 2001, TROP MED INT HEALTH, V6, P874, DOI 10.1046/j.1365-3156.2001.00777.x; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102; Pandey KC, 2004, J BIOL CHEM, V279, P3484, DOI 10.1074/jbc.M310536200; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Rosenthal PJ, 1996, ANTIMICROB AGENTS CH, V40, P1600, DOI 10.1128/AAC.40.7.1600; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Schulz F, 2007, CHEMMEDCHEM, V2, P1214, DOI 10.1002/cmdc.200700070; Shenai BR, 2003, ANTIMICROB AGENTS CH, V47, P154, DOI 10.1128/AAC.47.1.154-160.2003; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Steverding D, 2006, MINI-REV MED CHEM, V6, P1025, DOI 10.2174/138955706778195207; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vicik R, 2006, BIOORG MED CHEM LETT, V16, P2753, DOI 10.1016/j.bmcl.2006.02.026; Wang SX, 2007, STRUCTURE, V15, P535, DOI 10.1016/j.str.2007.03.012; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; Zhang YC, 1998, DRUG METAB DISPOS, V26, P360	58	197	197	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25697	25703		10.1074/jbc.M109.014340	http://dx.doi.org/10.1074/jbc.M109.014340			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19620707	Green Published, hybrid			2022-12-27	WOS:000269738000027
J	Thompson, CH; Olivetti, PR; Fuller, MD; Freeman, CS; McMaster, D; French, RJ; Pohl, J; Kubanek, J; Mccarty, NA				Thompson, Christopher H.; Olivetti, Pedro R.; Fuller, Matthew D.; Freeman, Cody S.; McMaster, Denis; French, Robert J.; Pohl, Jan; Kubanek, Julia; Mccarty, Nael A.			Isolation and Characterization of a High Affinity Peptide Inhibitor of ClC-2 Chloride Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEIURUS-QUINQUESTRIATUS-HEBRAEUS; SCORPION TOXINS; CHARYBDOTOXIN BLOCK; POTASSIUM CHANNEL; MOLECULAR-BASIS; VOLTAGE; VENOM; PURIFICATION; INVOLVEMENT; SELECTIVITY	The ClC protein family includes voltage-gated chloride channels and chloride/proton exchangers. In eukaryotes, ClC proteins regulate membrane potential of excitable cells, contribute to epithelial transport, and aid in lysosomal acidification. Although structure/function studies of ClC proteins have been aided greatly by the available crystal structures of a bacterial ClC chloride/proton exchanger, the availability of useful pharmacological tools, such as peptide toxin inhibitors, has lagged far behind that of their cation channel counterparts. Here we report the isolation, from Leiurus quinquestriatus hebraeus venom, of a peptide toxin inhibitor of the ClC-2 chloride channel. This toxin, GaTx2, inhibits ClC-2 channels with a voltage-dependent apparent K-D of similar to 20 pM, making it the highest affinity inhibitor of any chloride channel. GaTx2 slows ClC-2 activation by increasing the latency to first opening by nearly 8-fold but is unable to inhibit open channels, suggesting that this toxin inhibits channel activation gating. Finally, GaTx2 specifically inhibits ClC-2 channels, showing no inhibitory effect on a battery of other major classes of chloride channels and voltage-gated potassium channels. GaTx2 is the first peptide toxin inhibitor of any ClC protein. The high affinity and specificity displayed by this toxin will make it a very powerful pharmacological tool to probe ClC-2 structure/function.	[Thompson, Christopher H.; Olivetti, Pedro R.; Fuller, Matthew D.; Freeman, Cody S.; Kubanek, Julia; Mccarty, Nael A.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Fuller, Matthew D.] Emory Univ, Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA; [Pohl, Jan] Emory Univ, Microchem & Prote Facil, Atlanta, GA 30322 USA; [Mccarty, Nael A.] Emory Univ, Childrens Healthcare Atlanta & Dept Pediat, Atlanta, GA 30322 USA; [McMaster, Denis; French, Robert J.] Univ Calgary, Peptide Synth Core Facil, Calgary, AB T2N 4N1, Canada; [French, Robert J.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Kubanek, Julia] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; University of Calgary; University of Calgary; University System of Georgia; Georgia Institute of Technology	Mccarty, NA (corresponding author), 2015 Uppergate Dr, Atlanta, GA 30322 USA.	namccar@emory.edu		Kubanek, Julia/0000-0003-4482-1831	National Institutes of Health [DK066409]; Canadian Institutes of Health Research; Cystic Fibrosis Foundation; Children's Healthcare of Atlanta, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK066409, R01DK056481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Children's Healthcare of Atlanta, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK066409. This work was also supported by the National Institutes of Health National Center for Research Resources, the Canadian Institutes of Health Research, the Cystic Fibrosis Foundation, and Children's Healthcare of Atlanta, Inc.	Abdel-Mottaleb Y, 2006, FEBS LETT, V580, P6254, DOI 10.1016/j.febslet.2006.10.029; Accardi A, 2003, J GEN PHYSIOL, V122, P277, DOI 10.1085/jgp.200308834; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; Blanc E, 1996, PROTEINS, V24, P359, DOI 10.1002/(SICI)1097-0134(199603)24:3&lt;359::AID-PROT9&gt;3.0.CO;2-B; Buisine E, 1997, J PEPT RES, V49, P545; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; Cheng G, 2007, CARDIOVASC RES, V73, P198, DOI 10.1016/j.cardiores.2006.10.012; CHICCHI GG, 1988, J BIOL CHEM, V263, P10192; Clark S, 1998, J PHYSIOL-LONDON, V506, P665, DOI 10.1111/j.1469-7793.1998.665bv.x; Cuppoletti J, 2004, AM J PHYSIOL-CELL PH, V287, pC1173, DOI 10.1152/ajpcell.00528.2003; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de Santiago JA, 2005, J GEN PHYSIOL, V126, P591, DOI 10.1085/jgp.200509310; DEBIN JA, 1993, AM J PHYSIOL, V264, pC361, DOI 10.1152/ajpcell.1993.264.2.C361; Donough Mc, 2003, CALCIUM CHANNEL PHAR; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Fahlke C, 2001, AM J PHYSIOL-RENAL, V280, pF748, DOI 10.1152/ajprenal.2001.280.5.F748; Fuller MD, 2007, J BIOL CHEM, V282, P37545, DOI 10.1074/jbc.M708079200; Fuller MD, 2004, AM J PHYSIOL-CELL PH, V287, pC1328, DOI 10.1152/ajpcell.00162.2004; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Hui KY, 2003, J GEN PHYSIOL, V122, P63, DOI 10.1085/jgp.200308842; Jentsch TJ, 2005, CURR OPIN NEUROBIOL, V15, P319, DOI 10.1016/j.conb.2005.05.002; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kharrat R, 1996, EUR J BIOCHEM, V242, P491, DOI 10.1111/j.1432-1033.1996.0491r.x; Matulef K, 2008, ACS CHEM BIOL, V3, P419, DOI 10.1021/cb800083a; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Picollo A, 2007, J MEMBRANE BIOL, V216, P73, DOI 10.1007/s00232-007-9034-z; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Thompson CH, 2005, J MEMBRANE BIOL, V208, P65, DOI 10.1007/s00232-005-0818-8; Zdebik AA, 2004, J BIOL CHEM, V279, P22276, DOI 10.1074/jbc.M309899200; Zerrouk H, 1996, INT J PEPT PROT RES, V48, P514	40	33	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26051	26062		10.1074/jbc.M109.031724	http://dx.doi.org/10.1074/jbc.M109.031724			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19574231	hybrid, Green Published			2022-12-27	WOS:000269738000061
J	Avila-Perez, M; Vreede, J; Tang, YF; Bende, O; Losi, A; Gartner, W; Hellingwerf, K				Avila-Perez, Marcela; Vreede, Jocelyne; Tang, Yifen; Bende, Onno; Losi, Aba; Gaertner, Wolfgang; Hellingwerf, Klaas			In Vivo Mutational Analysis of YtvA from Bacillus subtilis MECHANISM OF LIGHT ACTIVATION OF THE GENERAL STRESS RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVIRONMENTAL SIGNALING PATHWAY; TRANSCRIPTION FACTOR SIGMA(B); NTP-BINDING-PROPERTIES; ARABIDOPSIS NPH1; KINASE-ACTIVITY; RECEPTOR YTVA; PROTEIN YTVA; DOMAIN; PHOTORECEPTOR; PHOSPHORYLATION	The general stress response of Bacillus subtilis can be activated by stimuli such as the addition of salt or ethanol and with blue light. In the latter response, YtvA activates sigma(B) through a cascade of Rsb proteins, organized in stressosomes. YtvA is composed of an N-terminal LOV (light, oxygen, and voltage) domain and a C-terminal STAS (sulfate transporter and anti-sigma factor) domain and shows light-modulated GTP binding in vitro. Here, we examine the mechanism of YtvA-mediated activation of sigma(B) in vivo with site-directed mutagenesis. Constitutive off and constitutive on mutations have been identified. Disruption of GTP binding in the STAS domain eliminates light activation of sigma(B). In contrast, modification of sites relevant for phosphorylation of STAS domains does not affect the stress response significantly. The data obtained are integrated into a model for the structure of full-length YtvA, which presumably functions as a dimer.	[Avila-Perez, Marcela; Bende, Onno; Hellingwerf, Klaas] Swammerdam Inst Life Sci, NL-1018 WV Amsterdam, Netherlands; [Vreede, Jocelyne] Univ Amsterdam, Computat Chem & Phys Grp, Vant Hoff Inst Mol Sci, NL-1018 WV Amsterdam, Netherlands; [Tang, Yifen; Losi, Aba; Gaertner, Wolfgang] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany	University of Amsterdam; University of Amsterdam; Max Planck Society	Hellingwerf, K (corresponding author), Swammerdam Inst Life Sci, Nieuwe Achtergracht 166, NL-1018 WV Amsterdam, Netherlands.	K.J.Hellingwerf@uva.nl	Vreede, Jocelyne/G-4525-2010; Losi, Aba/M-8709-2015	Losi, Aba/0000-0003-0497-2723; Gartner, Wolfgang/0000-0002-6898-7011				Akbar S, 2001, J BACTERIOL, V183, P1329, DOI 10.1128/JB.183.4.1329-1338.2001; Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bongers RS, 2005, APPL ENVIRON MICROB, V71, P8818, DOI 10.1128/AEM.71.12.8818-8824.2005; BOYLAN SA, 1992, J BACTERIOL, V174, P3695, DOI 10.1128/JB.174.11.3695-3706.1992; Buttani V, 2007, EUR BIOPHYS J BIOPHY, V36, P831, DOI 10.1007/s00249-007-0155-1; Buttani V, 2006, FEBS LETT, V580, P3818, DOI 10.1016/j.febslet.2006.06.007; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; Delumeau O, 2004, J BIOL CHEM, V279, P40927, DOI 10.1074/jbc.M405464200; Delumeau O, 2006, J BACTERIOL, V188, P7885, DOI 10.1128/JB.00892-06; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kang CM, 1998, MOL MICROBIOL, V30, P189, DOI 10.1046/j.1365-2958.1998.01052.x; KENNEY TJ, 1987, J BACTERIOL, V169, P3329, DOI 10.1128/jb.169.7.3329-3339.1987; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Losi A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1145, DOI 10.1562/2005-05-25-RA-541; Losi A, 2004, PHOTOCHEM PHOTOBIOL, V80, P150, DOI 10.1562/2004-03-17-RC-116.1; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; Marles-Wright J, 2007, CURR OPIN STRUC BIOL, V17, P755, DOI 10.1016/j.sbi.2007.08.004; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; NAJAFI SMA, 1995, J BACTERIOL, V177, P2912, DOI 10.1128/jb.177.10.2912-2913.1995; Najafi SMA, 1996, J BACTERIOL, V178, P6632, DOI 10.1128/jb.178.22.6632-6634.1996; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Quin M, 2008, ACTA CRYSTALLOGR F, V64, P196, DOI 10.1107/S1744309108003849; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Suzuki N, 2007, J GEN APPL MICROBIOL, V53, P81, DOI 10.2323/jgam.53.81; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT	48	61	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24958	24964		10.1074/jbc.M109.033316	http://dx.doi.org/10.1074/jbc.M109.033316			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19581299	Green Published, hybrid			2022-12-27	WOS:000269734000030
J	Eisenberg, S; Korza, G; Carson, J; Liachko, I; Tye, BK				Eisenberg, Shlomo; Korza, George; Carson, John; Liachko, Ivan; Tye, Bik-Kwoon			Novel DNA Binding Properties of the Mcm10 Protein from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTONOMOUSLY REPLICATING SEQUENCES; SEQUENTIAL BINDING; ESCHERICHIA-COLI; POLYMERASE-ALPHA; MCM2-7 COMPLEX; ORIGIN; PURIFICATION; CDC45; CHROMOSOME; INTERACTS	The Mcm10 protein is essential for chromosomal DNA replication in eukaryotic cells. We purified the Saccharomyces cerevisiae Mcm10 (ScMcm10) and characterized its DNA binding properties. Electrophoretic mobility shift assays and surface plasmon resonance analysis showed that ScMcm10 binds stably to both double strand (ds) DNA and single strand (ss) DNA. On short DNA templates of 25 or 50 bp, surface plasmon resonance analysis showed a similar to 1:1 stoichiometry of ScMcm10 to dsDNA. On longer dsDNA templates, however, multiple copies of ScMcm10 cooperated in the rapid assembly of a large, stable nucleoprotein complex. The amount of protein bound was directly proportional to the length of the DNA, with an average occupancy spacing of 21-24 bp. This tight spacing is consistent with a nucleoprotein structure in which ScMcm10 is aligned along the helical axis of the dsDNA. In contrast, the stoichiometry of ScMcm10 bound to ssDNA of 20-50 nucleotides was similar to 3:1 suggesting that interaction with ssDNA induces the assembly of a multisubunit ScMcm10 complex composed of at least three subunits. The tight packing of ScMcm10 on dsDNA and the assembly of a multisubunit complex on ssDNA suggests that, in addition to protein-DNA, protein-protein interactions may be involved in forming the nucleoprotein complex. We propose that these DNA binding properties have an important role in (i) initiation of DNA replication and (ii) formation and maintenance of a stable replication fork during the elongation phase of chromosomal DNA replication.	Univ Connecticut, Sch Med, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA; [Liachko, Ivan; Tye, Bik-Kwoon] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	University of Connecticut; Cornell University	Eisenberg, S (corresponding author), 263 Farmington Ave, Farmington, CT 06030 USA.	seisenberg@nso2.uchc.edu			National Institutes of Health [GM072557, NS15190, RR022232]; National Science Foundation [MCB-0453773]; University of Connecticut Health Center Research Advisorey Council Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015190, R56NS015190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Connecticut Health Center Research Advisorey Council Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072557 (to B. K. T.) and NS15190 and RR022232 (to J.H.C.). This work was also supported by National Science Foundation Grant MCB-0453773 (to B. K. T.) and by the University of Connecticut Health Center Research Advisorey Council Fund (to S. E.).	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; DIFFLEY JFX, 1988, P NATL ACAD SCI USA, V85, P2120, DOI 10.1073/pnas.85.7.2120; DUMAS LB, 1982, MOL GEN GENET, V187, P42, DOI 10.1007/BF00384381; EISENBERG S, 1976, P NATL ACAD SCI USA, V73, P1594, DOI 10.1073/pnas.73.5.1594; EISENBERG S, 1988, P NATL ACAD SCI USA, V85, P743, DOI 10.1073/pnas.85.3.743; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fien K, 2006, J BIOL CHEM, V281, P22248, DOI 10.1074/jbc.M512997200; Fisher Robert J., 1994, Methods (Orlando), V6, P121, DOI 10.1006/meth.1994.1015; FRANCESCONI SC, 1989, MOL CELL BIOL, V9, P2906, DOI 10.1128/MCB.9.7.2906; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Homesley L, 2000, GENE DEV, V14, P913; Houchens CR, 2008, J BIOL CHEM, V283, P30216, DOI 10.1074/jbc.M802649200; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; Lei M, 2001, J CELL SCI, V114, P1447; Liachko I, 2009, GENETICS, V181, P379, DOI 10.1534/genetics.108.099101; MAINE GT, 1984, GENETICS, V106, P365; Margulies C, 1996, J BIOL CHEM, V271, P17035, DOI 10.1074/jbc.271.29.17035; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; PALZKILL TG, 1988, CELL, V53, P441, DOI 10.1016/0092-8674(88)90164-X; Raychaudhuri S, 1997, NUCLEIC ACIDS RES, V25, P5057, DOI 10.1093/nar/25.24.5057; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Sawyer SL, 2004, J MOL BIOL, V340, P195, DOI 10.1016/j.jmb.2004.04.066; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; SWEDER KS, 1988, J BIOL CHEM, V263, P17270; WALKER SS, 1990, P NATL ACAD SCI USA, V87, P4665, DOI 10.1073/pnas.87.12.4665; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	36	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25412	25420		10.1074/jbc.M109.033175	http://dx.doi.org/10.1074/jbc.M109.033175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605346	Green Published, hybrid			2022-12-27	WOS:000269734000073
J	Ikonomov, OC; Sbrissa, D; Ijuin, T; Takenawa, T; Shisheva, A				Ikonomov, Ognian C.; Sbrissa, Diego; Ijuin, Takeshi; Takenawa, Tadaomi; Shisheva, Assia			Sac3 Is an Insulin-regulated Phosphatidylinositol 3,5-Bisphosphate Phosphatase GAIN IN INSULIN RESPONSIVENESS THROUGH Sac3 DOWN-REGULATION IN ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GLUT4 STORAGE-VESICLES; 3T3-L1 ADIPOCYTES; REVERSIBLE OXIDATION; LIPID PHOSPHATASES; MAMMALIAN ORTHOLOG; PIKFYVE; KINASE; PTEN; INSIGHTS	Insulin-regulated stimulation of glucose entry and mobilization of fat/muscle-specific glucose transporter GLUT4 onto the cell surface require the phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2) pathway for optimal performance. The reduced insulin responsiveness observed under ablation of the PtdIns(3,5)P-2-synthesizing PIKfyve and its associated activator ArPIKfyve in 3T3L1 adipocytes suggests that dysfunction of the PtdIns(3,5)P-2-specific phosphatase Sac3 may yield the opposite effect. Paradoxically, as uncovered recently, in addition to turnover Sac3 also supports PtdIns(3,5)P-2 biosynthesis by allowing optimal PIKfyve-ArPIKfyve association. These opposing inputs raise the key question as to whether reduced Sac3 protein levels and/or hydrolyzing activity will produce gain in insulin responsiveness. Here we report that small interfering RNA-mediated knockdown of endogenous Sac3 by similar to 60%, which resulted in a slight but significant elevation of PtdIns(3,5)P-2 in 3T3L1 adipocytes, increased GLUT4 translocation and glucose entry in response to insulin. In contrast, ectopic expression of Sac3(WT), but not phosphatase-deficient Sac3(D488A), reduced GLUT4 surface abundance in the presence of insulin. Endogenous Sac3 physically assembled with PIKfyve and ArPIKfyve in both membrane and soluble fractions of 3T3L1 adipocytes, but this remained insulin-insensitive. Importantly, acute insulin markedly reduced the in vitro C8-PtdIns(3,5)P-2 hydrolyzing activity of Sac3. The insulin-sensitive Sac3 pool likely controls a discrete PtdIns(3,5)P-2 subfraction as the high pressure liquid chromatography-measurable insulin-dependent elevation in total [H-3] inositol-PtdIns(3,5)P-2 was minor. Together, our data identify Sac3 as an insulin-sensitive phosphatase whose down-regulation increases insulin responsiveness, thus implicating Sac3 as a novel drug target in insulin resistance.	[Ikonomov, Ognian C.; Sbrissa, Diego; Shisheva, Assia] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Ijuin, Takeshi; Takenawa, Tadaomi] Kobe Univ, Sch Med, Dept Lipid Biochem, Kobe, Hyogo 6500017, Japan	Wayne State University; Kobe University	Shisheva, A (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.	ashishev@med.wayne.edu	Ijuin, Takeshi/H-7016-2017	Ijuin, Takeshi/0000-0002-0618-1776	National Institutes of Health Grant [DK58058]; American Diabetes Association Grant [1-05-RA-120]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Grant(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58058) ( to A. S.). This work was also supported by American Diabetes Association Grant 1-05-RA-120.	Astle MV, 2007, BIOCHEM SOC SYMP, V74, P161, DOI 10.1042/BSS2007c15; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Ijuin T, 2008, MOL CELL BIOL, V28, P5184, DOI 10.1128/MCB.01990-06; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2009, BIOCHEM BIOPH RES CO, V382, P566, DOI 10.1016/j.bbrc.2009.03.063; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Larance M, 2008, MOL ENDOCRINOL, V22, P226, DOI 10.1210/me.2007-0282; Lazar DF, 2006, NAT REV DRUG DISCOV, V5, P333, DOI 10.1038/nrd2007; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Pattaranit Ratchada, 2008, Science Progress, V91, P285, DOI 10.3184/003685008X361343; Pilch PF, 2008, ACTA PHYSIOL, V192, P89, DOI 10.1111/j.1748-1716.2007.01788.x; Sasaoka T, 2006, PHARMACOL THERAPEUT, V112, P799, DOI 10.1016/j.pharmthera.2006.06.001; Sbrissa D, 2005, J BIOL CHEM, V280, P7883, DOI 10.1074/jbc.M412729200; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shisheva A, 2001, J BIOL CHEM, V276, P11859, DOI 10.1074/jbc.M008437200; SHISHEVA A, 1993, ENDOCRINOLOGY, V133, P1562, DOI 10.1210/en.133.4.1562; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Shisheva A, 2008, AM J PHYSIOL-ENDOC M, V295, pE536, DOI 10.1152/ajpendo.90353.2008; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Vinciguerra Manlio, 2006, Archives of Physiology and Biochemistry, V112, P89, DOI 10.1080/13813450600711359; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723	42	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23961	23971		10.1074/jbc.M109.025361	http://dx.doi.org/10.1074/jbc.M109.025361			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19578118	hybrid, Green Published			2022-12-27	WOS:000269380200010
J	Kunkel, MT; Garcia, EL; Kajimoto, T; Hall, RA; Newton, AC				Kunkel, Maya T.; Garcia, Erin L.; Kajimoto, Taketoshi; Hall, Randy A.; Newton, Alexandra C.			The Protein Scaffold NHERF-1 Controls the Amplitude and Duration of Localized Protein Kinase D Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODED FLUORESCENT REPORTER; PDZ DOMAIN; RECEPTOR-ACTIVITY; BETA-CATENIN; PHOSPHORYLATION; BINDING; ASSOCIATION; FAMILY; EXCHANGER; EBP50	Protein kinase D (PKD) transduces an abundance of signals downstream of diacylglycerol production. The mammalian PKD family consists of three isoforms, PKD1, PKD2, and PKD3; of these PKD1 and PKD2 contain PDZ-binding motifs at their carboxyl termini. Here we show that membrane-localized NHERF scaffold proteins provide a nexus for tightly controlled PKD signaling via a PDZ domain interaction. Using a proteomic array containing 96 purified PDZ domains, we have identified the first PDZ domain of NHERF-1 as an interaction partner for the PDZ-binding motifs of both PKD1 and PKD2. A fluorescence resonance energy transfer-based translocation assay reveals a transient association of PKD1 and PKD2 with NHERF-1 in live cells that is triggered by phorbol ester stimulation and, importantly, differs strikingly from the sustained translocation to plasma membrane. Targeting a fluorescence resonance energy transfer-based kinase activity reporter for PKD to NHERF scaffolds reveals a unique signature of PKD activation at the scaffold that is distinct from that of general cytosolic or plasma membrane activity. Specifically, agonist-evoked activation of PKD at the scaffold is rapid and sustained but blunted in magnitude when compared with cytosolic PKD. Thus, live cell imaging of PKD activity demonstrates ultrasensitive control of kinase signaling at the scaffold compared with bulk activity in the cytosol or at the plasma membrane.	[Kunkel, Maya T.; Kajimoto, Taketoshi; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Garcia, Erin L.; Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	University of California System; University of California San Diego; Emory University	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu		Hall, Randy/0000-0002-8318-8728	National Institutes of Health [P01 DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DK54441 (to A. C. N.).	Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; De Kimpe L, 2009, CELL SIGNAL, V21, P253, DOI 10.1016/j.cellsig.2008.10.015; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Georgescu MM, 2008, CURR MOL MED, V8, P459, DOI 10.2174/156652408785748031; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Lopez-Lluch G, 2001, BIOCHEM J, V357, P39, DOI 10.1042/0264-6021:3570039; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Rochdi MD, 2002, J BIOL CHEM, V277, P40751, DOI 10.1074/jbc.M207910200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Tan MQ, 2003, J BIOL CHEM, V278, P2824, DOI 10.1074/jbc.M211523200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	47	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24653	24661		10.1074/jbc.M109.024547	http://dx.doi.org/10.1074/jbc.M109.024547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19581308	Green Published, hybrid			2022-12-27	WOS:000269380200074
J	Kawano, S; Ikeda, W; Kishimoto, M; Ogita, H; Takai, Y				Kawano, Satoshi; Ikeda, Wataru; Kishimoto, Megumi; Ogita, Hisakazu; Takai, Yoshimi			Silencing of ErbB3/ErbB2 Signaling by Immunoglobulin-like Necl-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; TUMOR-SUPPRESSOR TSLC1; MALE-INFERTILITY; RECEPTOR; GENE; SUPERFAMILY; ERBB2; HETERODIMERIZATION; IDENTIFICATION; LOCALIZATION	ErbB2 and ErbB3, members of the EGF receptor/ErbB family, form a heterodimer upon binding of a ligand, inducing the activation of Rac small G protein and Akt protein kinase for cell movement and survival, respectively. The enhanced ErbB3/ErbB2 signaling causes tumorigenesis, invasion, and metastasis. We found here that the ErbB3/ErbB2 signaling is regulated by immunoglobulin-like Necl-2, which is down-regulated in various cancer cells and serves as a tumor suppressor. The extracellular region of ErbB3, but not ErbB2, interacted in cis with that of Necl-2. This interaction reduced the ligand-induced, ErbB2-catalyzed tyrosine phosphorylation of ErbB3 and inhibited the consequent ErbB3-mediated activation of Rac and Akt, resulting in the inhibition of cancer cell movement and survival. These inhibitory effects of Necl-2 were mediated by the protein-tyrosine phosphatase PTPN13 which interacted with the cytoplasmic tail of Necl-2. We describe here this novel mechanism for silencing of the ErbB3/ErbB2 signaling by Necl-2.	[Kawano, Satoshi; Ikeda, Wataru; Kishimoto, Megumi; Ogita, Hisakazu; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan	Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Ogita, Hisakazu/AAE-4416-2020; Ikeda, Wataru/V-8531-2019	Ikeda, Wataru/0000-0002-6907-9058; Ogita, Hisakazu/0000-0001-6750-1668	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research and for Cancer Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2007, 2008).	Abaan OD, 2008, CANCER METAST REV, V27, P205, DOI 10.1007/s10555-008-9114-2; Amann J, 2005, CANCER RES, V65, P226; Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; CHADENEAU C, 1994, J BIOL CHEM, V269, P15601; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; de Bono JS, 2002, TRENDS MOL MED, V8, pS19, DOI 10.1016/S1471-4914(02)02306-7; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Fujita E, 2006, MOL CELL BIOL, V26, P718, DOI 10.1128/MCB.26.2.718-726.2006; Fukami T, 2002, GENE, V295, P7, DOI 10.1016/S0378-1119(02)00835-1; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Mao XL, 2003, CANCER RES, V63, P7979; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Murakami Y, 2002, ONCOGENE, V21, P6936, DOI 10.1038/sj.onc.1205825; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; van der Weyden L, 2006, MOL CELL BIOL, V26, P3595, DOI 10.1128/MCB.26.9.3595-3609.2006; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Yageta M, 2002, CANCER RES, V62, P5129; Yamada D, 2006, MOL CELL BIOL, V26, P3610, DOI 10.1128/MCB.26.9.3610-3624.2006; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yip YL, 2002, CANCER IMMUNOL IMMUN, V50, P569, DOI 10.1007/s002620100226; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	47	45	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23793	23805		10.1074/jbc.M109.025155	http://dx.doi.org/10.1074/jbc.M109.025155			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561085	hybrid, Green Published			2022-12-27	WOS:000269180000063
J	Kim, Y; Deshpande, A; Dai, YS; Kim, JJ; Lindgren, A; Conway, A; Clark, AT; Wong, DT				Kim, Yong; Deshpande, Amit; Dai, Yanshan; Kim, Jeffrey J.; Lindgren, Anne; Conway, Anne; Clark, Amander T.; Wong, David T.			Cyclin-dependent Kinase 2-associating Protein 1 Commits Murine Embryonic Stem Cell Differentiation through Retinoblastoma Protein Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; GROWTH SUPPRESSOR; FAMILY PROTEINS; G(1) CONTROL; DNA-DAMAGE; ES CELLS; PRB; PLURIPOTENCY; ACTIVATION; EXPRESSION	Mouse embryonic stem cells (mESCs) maintain pluripotency and indefinite self-renewal through yet to be defined molecular mechanisms. Leukemia inhibitory factor has been utilized to maintain the symmetrical self-renewal and pluripotency of mESCs in culture. It has been suggested that molecules with significant cellular effects on retinoblastoma protein (pRb) or its related pathways should have functional impact on mESC proliferation and differentiation. However, the involvement of pRb in pluripotent differentiation of mESCs has not been extensively elaborated. In this paper, we present novel experimental data indicating that Cdk2ap1 (cyclin-dependent kinase 2-associating protein 1), an inhibitor of G(1)/S transition through down-regulation of CDK2 and an essential gene for early embryonic development, confers competency for mESC differentiation. Targeted disruption of Cdk2ap1 in mESCs resulted in abrogation of leukemia inhibitory factor withdrawal-induced differentiation, along with altered pRb phosphorylation. The differentiation competency of the Cdk2ap1(-/-) mESCs was restored upon the ectopic expression of Cdk2ap1 or a non-phosphorylatable pRb mutant (mouse Ser(788)-> Ala), suggesting that the CDK2AP1-mediated differentiation of mESCs was elicited through the regulation of pRb. Further analysis on mESC maintenance or differentiation-related gene expression supports the phosphorylation at serine 788 in pRb plays a significant role for the CDK2AP1-mediated differentiation of mESCs. These data clearly demonstrate that CDK2AP1 is a competency factor in the proper differentiation of mESCs by modulating the phosphorylation level of pRb. This sheds light on the role of the establishment of the proper somatic cell type cell cycle regulation for mESCs to enter into the differentiation process.	[Kim, Yong; Deshpande, Amit; Dai, Yanshan; Kim, Jeffrey J.; Wong, David T.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA; [Kim, Yong; Deshpande, Amit; Dai, Yanshan; Kim, Jeffrey J.; Wong, David T.] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90095 USA; [Kim, Yong; Wong, David T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Wong, David T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Wong, David T.] Univ Calif Los Angeles, Div Head & Neck Surgery Otolaryngol, Los Angeles, CA 90095 USA; [Lindgren, Anne; Conway, Anne; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Coll Letters & Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kim, Y (corresponding author), Univ Calif Los Angeles, Sch Dent, 10833 Le Conte Ave,73-017 CHS, Los Angeles, CA 90095 USA.	thadyk@ucla.edu; dtww@ucla.edu	Dai, Yanshan/B-8577-2009	Dai, Yanshan/0000-0001-5048-7417	National Institutes of Health Public Service [T32 DE 007296-08, R01 DE 14857]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007296, R01DE014857] Funding Source: NIH RePORTER	National Institutes of Health Public Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Public Service Grants T32 DE 007296-08 (to Y.K.) and R01 DE 14857 (to D. T. W.).	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Deshpande AM, 2009, J BIOL CHEM, V284, P6043, DOI 10.1074/jbc.C800158200; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Ernst M, 1999, J BIOL CHEM, V274, P9729, DOI 10.1074/jbc.274.14.9729; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hu MG, 2004, CANCER RES, V64, P490, DOI 10.1158/0008-5472.CAN-03-2284; Jori FP, 2007, MOL CELL NEUROSCI, V34, P299, DOI 10.1016/j.mcn.2006.11.009; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kim Y, 2005, J BIOL CHEM, V280, P23273, DOI 10.1074/jbc.M412929200; Kim Y, 2005, ONCOGENE, V24, P407, DOI 10.1038/sj.onc.1208222; Kim Y, 2001, INT J ORAL BIOL  DEC, V2001, P87; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004518; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; LeCouter JE, 1996, ONCOGENE, V12, P1433; Lee S, 2003, MOL REPROD DEV, V64, P405, DOI 10.1002/mrd.10232; Matsuo K, 2000, FASEB J, V14, P1318, DOI 10.1096/fj.14.10.1318; McLear JA, 2006, MOL CELL NEUROSCI, V33, P260, DOI 10.1016/j.mcn.2006.07.012; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Shea KS, 1999, ANAT RECORD, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2; Prost S, 1998, FEBS LETT, V425, P499, DOI 10.1016/S0014-5793(98)00296-8; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Savatier P, 1996, ONCOGENE, V12, P309; SAVATIER P, 1994, ONCOGENE, V9, P809; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Shintani S, 2001, CLIN CANCER RES, V7, P2776; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Sidle A, 1996, CRIT REV BIOCHEM MOL, V31, P237, DOI 10.3109/10409239609106585; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Tsuji T, 1998, J BIOL CHEM, V273, P6704, DOI 10.1074/jbc.273.12.6704; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0	44	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23405	23414		10.1074/jbc.M109.026088	http://dx.doi.org/10.1074/jbc.M109.026088			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19564334	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000269180000025
J	Park, JW; Mieyal, JJ; Rhee, SG; Chock, PB				Park, Ji Won; Mieyal, John J.; Rhee, Sue Goo; Chock, P. Boon			Deglutathionylation of 2-Cys Peroxiredoxin Is Specifically Catalyzed by Sulfiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; MAMMALIAN PEROXIREDOXIN; REDUCE PEROXIDES; ACTIVE-SITE; GLUTATHIONYLATION; THIOREDOXIN; PROTEINS; IDENTIFICATION	Reversible protein glutathionylation plays a key role in cellular regulation and cell signaling and protects protein thiols from hyperoxidation. Sulfiredoxin (Srx), an enzyme that catalyzes the reduction of Cys-sulfinic acid derivatives of 2-Cys peroxiredoxins (2-Cys Prxs), has been shown to catalyze the deglutathionylation of actin. We show that deglutathionylation of 2-Cys Prx, a family of peroxidases, is specifically catalyzed by Srx. Using the ubiquitously expressed member of 2-Cys Prx, Prx I, we revealed the following. (i) Among its four Cys residues, Cys(52), Cys(83), and Cys(173) can be glutathionylated in vitro. Deglutathionylation with Cys mutants showed that Cys(83) and Cys(173) were preferentially catalyzed by Srx, with glutathionylated Srx as the reaction intermediate, whereas glutaredoxin I was more favorable for deglutathionylating Cys(52). (ii) Studies using site-directed mutagenesis coupled with binding and deglutathionylation activities revealed that Pro(174) and Pro(179) of Prx I and Tyr(92) of Srx are essential for both activities. Furthermore, relative to glutaredoxin I, Srx exhibited negligible deglutathionylation activity for glutathionylated cysteine and glutathionylated BSA. These results indicate that Srx is specific for deglutathionylating Prx I due to its favorable affinity for Prx I. To assess the biological relevance of these observations, we showed that Prx I is glutathionylated in A549 and HeLa cells under modest levels of H2O2. In addition, the level of glutathionylated Prx I was substantially elevated in small interfering RNA-mediated Srx-knocked down cells, whereas the reverse was observed in Srx-overexpressing cells. However, glutathionylation of Prx V, not known to bind to Srx, was not affected by the change in Srx expression levels.	[Rhee, Sue Goo] Ewha Womans Univ, Ctr Cell Signaling Res, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Park, Ji Won; Chock, P. Boon] NHLBI, Biochem Lab, Biochem & Biophys Ctr, Div Intramural Res,NIH, Bethesda, MD 20892 USA; [Mieyal, John J.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Mieyal, John J.] Louis B Stokes Cleveland Vet Affairs Med Res Ctr, Cleveland, OH 44106 USA	Ewha Womans University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Rhee, SG (corresponding author), Ewha Womans Univ, Ctr Cell Signaling Res, Div Life & Pharmaceut Sci, 210 Sci Ctr Bldg,Block C,Dae Hyun Dong 11, Seoul 120750, South Korea.	rheesg@ewha.ac.kr; chockp@mail.nih.gov			National Institutes of Health [2 PO1 AG 15885]; NHLBI; Intramural Research Program; Brain Korea21; Korean Science and Engineering Foundation; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program; Brain Korea21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Korean Science and Engineering Foundation(Korea Science and Engineering Foundation); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health, NHLBI, Intramural Research Program and by National Institutes of Health Research Grant 2 PO1 AG 15885 (to J.J.M.). This study was also supported in part by a Brain Korea21 grant (to J.W.P.), by BioR and D Program grants of Korean Science and Engineering Foundation (to S. G. R.), and by a Merit Review research grant from the Department of Veterans Affairs (to J.J.M.).	Andoh T, 2002, J BIOL CHEM, V277, P9655, DOI 10.1074/jbc.M110701200; APFFEL A, 1995, J CHROMATOGR A, V712, P177, DOI 10.1016/0021-9673(95)00175-M; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chae HZ, 1999, METHOD ENZYMOL, V300, P219; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chock P. B., 1996, PRINCIPLES MED BIOL, P201; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Gravina Mieyal S.A, 1995, BIOTHIOLS HLTH DIS, P305; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Lee DY, 2006, BIOCHEMISTRY-US, V45, P15301, DOI 10.1021/bi061824h; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	39	93	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23364	23374		10.1074/jbc.M109.021394	http://dx.doi.org/10.1074/jbc.M109.021394			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561357	Green Published, hybrid			2022-12-27	WOS:000269180000021
J	Everett, KL; Bunney, TD; Yoon, YD; Rodrigues-Lima, F; Harris, R; Driscoll, PC; Abe, K; Fuchs, H; de Angelis, MH; Yu, P; Cho, WW; Katan, M				Everett, Katy L.; Bunney, Tom D.; Yoon, Youngdae; Rodrigues-Lima, Fernando; Harris, Richard; Driscoll, Paul C.; Abe, Koichiro; Fuchs, Helmut; de Angelis, Martin Hrabe; Yu, Philipp; Cho, Wohnwa; Katan, Matilda			Characterization of Phospholipase C gamma Enzymes with Gain-of-Function Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; BRUTONS TYROSINE KINASE; B-CELL; CRYSTAL-STRUCTURE; C-GAMMA-1; ACTIVATION; RAC; PHOSPHORYLATION; STIMULATION; CARCINOMAS	Phospholipase C gamma isozymes (PLC gamma 1 and PLC gamma 2) have a crucial role in the regulation of a variety of cellular functions. Both enzymes have also been implicated in signaling events underlying aberrant cellular responses. Using N-ethyl-N-nitrosourea (ENU) mutagenesis, we have recently identified single point mutations in murine PLC gamma 2 that lead to spontaneous inflammation and autoimmunity. Here we describe further, mechanistic characterization of two gain-of-function mutations, D993G and Y495C, designated as ALI5 and ALI14. The residue Asp-993, mutated in ALI5, is a conserved residue in the catalytic domain of PLC enzymes. Analysis of PLC gamma 1 and PLC gamma 2 with point mutations of this residue showed that removal of the negative charge enhanced PLC activity in response to EGF stimulation or activation by Rac. Measurements of PLC activity in vitro and analysis of membrane binding have suggested that ALI5-type mutations facilitate membrane interactions without compromising substrate binding and hydrolysis. The residue mutated in ALI14 (Tyr-495) is within the spPH domain. Replacement of this residue had no effect on folding of the domain and enhanced Rac activation of PLC gamma 2 without increasing Rac binding. Importantly, the activation of the ALI14-PLC gamma 2 and corresponding PLC gamma 1 variants was enhanced in response to EGF stimulation and bypassed the requirement for phosphorylation of critical tyrosine residues. ALI5- and ALI14-type mutations affected basal activity only slightly; however, their combination resulted in a constitutively active PLC. Based on these data, we suggest that each mutation could compromise auto-inhibition in the inactive PLC, facilitating the activation process; in addition, ALI5-type mutations could enhance membrane interaction in the activated state.	[Everett, Katy L.; Bunney, Tom D.; Katan, Matilda] Inst Canc Res, Chester Beatty Labs, Sect Cell & Mol Biol, London SW3 6JB, England; [Yoon, Youngdae; Cho, Wohnwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Rodrigues-Lima, Fernando] Univ Paris 07, Lab Responses Mol & Cellulaires Xenobiot, CNRS, Unite Biol Fonct & Adaptat,EAC 7059, F-75013 Paris, France; [Harris, Richard; Driscoll, Paul C.] UCL, Inst Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Driscoll, Paul C.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Abe, Koichiro; Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Lehrstuhl Expt Genet, D-85350 Freising Weihenstephan, Germany; [Abe, Koichiro] Tokai Univ, Sch Med, Div Basic Med Sci & Mol Med, Kanagawa 2591193, Japan; [Yu, Philipp] Univ Marburg, Inst Immunol, D-35032 Marburg, Germany	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of London; Birkbeck University London; University College London; MRC National Institute for Medical Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Tokai University; Philipps University Marburg	Katan, M (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Cell & Mol Biol, London SW3 6JB, England.	matilda.katan@icr.ac.uk	de Angelis, Martin Hrabe/F-5531-2012; Driscoll, Paul C/B-8007-2010; Fuchs, Helmut/M-7347-2014	de Angelis, Martin Hrabe/0000-0002-7898-2353; Driscoll, Paul C/0000-0002-4124-6950; Fuchs, Helmut/0000-0002-5143-2677; Harris, Richard/0000-0001-7459-1745; Bunney, Tom/0000-0002-0281-8813	Cancer Research UK; Association pour la Recherche sur le Cancer (ARC); Association Francaise contre les Myopathies (AFM); MRC; Medical Research Council [MC_U117574559] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Cancer Research UK (to M. K.), the Association pour la Recherche sur le Cancer (ARC) and Association Francaise contre les Myopathies (AFM) (to F. R. L.), and the MRC (to K. L. E.).	ARTEAGA CL, 1991, P NATL ACAD SCI USA, V88, P10435, DOI 10.1073/pnas.88.23.10435; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; DeBell K, 2007, MOL CELL BIOL, V27, P854, DOI 10.1128/MCB.01400-06; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Dunbrack RL, 1999, PROTEINS, P81; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Fuchs H, 2000, MAMM GENOME, V11, P528, DOI 10.1007/s003350010101; Guo SL, 2004, P NATL ACAD SCI USA, V101, P14180, DOI 10.1073/pnas.0405878101; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Jones NP, 2007, MOL CELL BIOL, V27, P5790, DOI 10.1128/MCB.00778-07; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Katan M, 2003, ADV ENZYME REGUL, V43, P77, DOI 10.1016/S0065-2571(02)00027-4; Katan Matilda, 2005, Biochem J, V391, pe7; KOHDA D, 1993, CELL, V72, P953, DOI 10.1016/0092-8674(93)90583-C; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; NOMOTO K, 1995, MOL CARCINOGEN, V12, P146, DOI 10.1002/mc.2940120306; PASCAL SM, 1994, CELL, V77, P461, DOI 10.1016/0092-8674(94)90160-0; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; Sekiya F, 2004, J BIOL CHEM, V279, P32181, DOI 10.1074/jbc.M405116200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wells A, 2000, ADV CANCER RES, V78, P31; Wen WY, 2006, J BIOL CHEM, V281, P12060, DOI 10.1074/jbc.M600336200; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018	38	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23083	23093		10.1074/jbc.M109.019265	http://dx.doi.org/10.1074/jbc.M109.019265			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531496	Green Published, hybrid			2022-12-27	WOS:000268963100060
J	Fatma, N; Kubo, E; Takamura, Y; Ishihara, K; Garcia, C; Beebe, DC; Singh, DP				Fatma, Nigar; Kubo, Eri; Takamura, Yoshihiro; Ishihara, Keiichi; Garcia, Claudia; Beebe, David C.; Singh, Dhirendra P.			Loss of NF-kappa B Control and Repression of Prdx6 Gene Transcription by Reactive Oxygen Species-driven SMAD3-mediated Transforming Growth Factor beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELENIUM GLUTATHIONE-PEROXIDASE; LENS EPITHELIAL-CELLS; MICE LACKING SMAD3; TGF-BETA; OXIDATIVE STRESS; C-MYC; PROTEIN TRANSDUCTION; TARGETED DISRUPTION; ANTIOXIDANT DEFENSE; 1-CYS PEROXIREDOXIN		[Fatma, Nigar; Takamura, Yoshihiro; Ishihara, Keiichi; Singh, Dhirendra P.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA; [Kubo, Eri] Univ Fukui, Dept Ophthalmol, Fukui 9101193, Japan; [Garcia, Claudia; Beebe, David C.] Washington Univ, St Louis, MO 63110 USA	University of Nebraska System; University of Nebraska Medical Center; University of Fukui; Washington University (WUSTL)	Singh, DP (corresponding author), Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, 985840 Nebraska Med Ctr, Omaha, NE 68198 USA.	dpsingh@unmc.edu	Ishihara, Keiichi/M-5743-2019		National Institutes of Health, NEI [EY-13394, EY017613]; Research for Preventing Blindness; NATIONAL EYE INSTITUTE [R01EY017613, R01EY013394] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research for Preventing Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grants EY-13394 and EY017613 (to D.P.S.). This work was also supported by a grant from Research for Preventing Blindness (to R.P.B.).	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; Baker JC, 1997, CURR OPIN GENET DEV, V7, P467, DOI 10.1016/S0959-437X(97)80072-X; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Chang XZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1789; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; Chu SH, 2003, PHARMACOLOGY, V69, P12, DOI 10.1159/000071244; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Datto MB, 1999, MOL CELL BIOL, V19, P2495; de Iongh RU, 2005, CELLS TISSUES ORGANS, V179, P43, DOI 10.1159/000084508; Desaint S, 2004, J BIOL CHEM, V279, P31157, DOI 10.1074/jbc.M401888200; Dunker N, 2003, CELL TISSUE RES, V313, P1, DOI 10.1007/s00441-003-0761-x; Dwivedi DJ, 2006, AM J PATHOL, V168, P69, DOI 10.2353/ajpath.2006.041089; Fatma N, 2005, CELL DEATH DIFFER, V12, P734, DOI 10.1038/sj.cdd.4401597; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Fatma N, 2008, BRAIN RES, V1233, P63, DOI 10.1016/j.brainres.2008.07.076; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Frank S, 1997, ONCOGENE, V14, P915, DOI 10.1038/sj.onc.1200905; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gallagher BM, 2007, FREE RADICAL BIO MED, V42, P1270, DOI 10.1016/j.freeradbiomed.2007.01.023; Gentry JJ, 2000, J BIOL CHEM, V275, P7558, DOI 10.1074/jbc.275.11.7558; Herrera B, 2004, FREE RADICAL BIO MED, V36, P16, DOI 10.1016/j.freeradbiomed.2003.09.020; HIGUCHI M, 1992, J IMMUNOTHER, V12, P41, DOI 10.1097/00002371-199207000-00005; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hua XX, 2000, J BIOL CHEM, V275, P33205, DOI 10.1074/jbc.C000568200; Iakoubova OA, 1997, GENOMICS, V42, P474, DOI 10.1006/geno.1997.4762; Jin G, 1997, J BIOL CHEM, V272, P26620, DOI 10.1074/jbc.272.42.26620; Kawabata M, 1999, J BIOCHEM, V125, P9, DOI 10.1093/oxfordjournals.jbchem.a022273; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; KERR LD, 1988, J BIOL CHEM, V263, P16999; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Koli K, 2001, MICROSC RES TECHNIQ, V52, P354, DOI 10.1002/1097-0029(20010215)52:4<354::AID-JEMT1020>3.0.CO;2-G; Kretz-Remy C, 2001, J BIOL CHEM, V276, P43723, DOI 10.1074/jbc.M010821200; Kubo E, 2006, MECH AGEING DEV, V127, P249, DOI 10.1016/j.mad.2005.10.003; Kubo E, 2004, BIOCHEM BIOPH RES CO, V314, P1050, DOI 10.1016/j.bbrc.2004.01.002; Kubo E, 2008, AM J PHYSIOL-CELL PH, V294, pC842, DOI 10.1152/ajpcell.00540.2007; Kumin A, 2007, J CELL BIOL, V179, P747, DOI 10.1083/jcb.200706090; Kumin A, 2006, AM J PATHOL, V169, P1194, DOI 10.2353/ajpath.2006.060119; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lovicu FJ, 2002, BRIT J OPHTHALMOL, V86, P220, DOI 10.1136/bjo.86.2.220; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Maruno Kevin A, 2002, Clin Exp Optom, V85, P76; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mostert V, 1999, FEBS LETT, V460, P23, DOI 10.1016/S0014-5793(99)01298-3; Munz B, 1997, BIOCHEM J, V326, P579, DOI 10.1042/bj3260579; Nakai M, 2000, J NEUROCHEM, V74, P647, DOI 10.1046/j.1471-4159.2000.740647.x; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Pak JH, 2006, EXP EYE RES, V82, P899, DOI 10.1016/j.exer.2005.10.017; Park CK, 2008, J CANCER RES CLIN, V134, P255, DOI 10.1007/s00432-007-0282-1; Phelan SA, 2003, FREE RADICAL BIO MED, V35, P1110, DOI 10.1016/S0891-5849(03)00462-3; Piette J, 1997, BIOL CHEM, V378, P1237; Power JHT, 2002, AM J PATHOL, V161, P885, DOI 10.1016/S0002-9440(10)64249-6; Roberts AB, 1999, MICROBES INFECT, V1, P1265, DOI 10.1016/S1286-4579(99)00258-0; RUPEC RA, 1995, EUR J BIOCHEM, V234, P632, DOI 10.1111/j.1432-1033.1995.632_b.x; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sharma P, 2003, J BIOL CHEM, V278, P20037, DOI 10.1074/jbc.M212016200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Sparling NE, 2003, REDOX REP, V8, P87, DOI 10.1179/135100003125001404; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Uberti D, 2004, BIOCHEM PHARMACOL, V67, P1743, DOI 10.1016/j.bcp.2004.01.012; Wang XS, 2004, ATHEROSCLEROSIS, V177, P61, DOI 10.1016/j.atherosclerosis.2004.06.007; Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200; Wang Y, 2006, ANTIOXID REDOX SIGN, V8, P229, DOI 10.1089/ars.2006.8.229; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	92	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22758	22772		10.1074/jbc.M109.016071	http://dx.doi.org/10.1074/jbc.M109.016071			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553668	Green Published, hybrid			2022-12-27	WOS:000268963100030
J	Liu, J; Wang, ZK; Jiang, K; Zhang, LY; Zhao, LL; Hua, SS; Yan, F; Yang, Y; Wang, DM; Fu, CH; Ding, X; Guo, Z; Yao, XB				Liu, Jing; Wang, Zhikai; Jiang, Kai; Zhang, Liangyu; Zhao, Lingli; Hua, Shasha; Yan, Feng; Yang, Yong; Wang, Dongmei; Fu, Chuanhai; Ding, Xia; Guo, Zhen; Yao, Xuebiao			PRC1 Cooperates with CLASP1 to Organize Central Spindle Plasticity in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC PARIETAL-CELLS; MITOTIC SPINDLE; CHROMOSOMAL PASSENGERS; MICROTUBULE DYNAMICS; CYTOKINESIS; PROTEIN; CHECKPOINT; PHOSPHORYLATION; KINETOCHORES; CENTROMERES	During cell division, chromosome segregation is governed by the interaction of spindle microtubules with the kinetochore. A dramatic remodeling of interpolar microtubules into an organized central spindle between the separating chromatids is required for the initiation and execution of cytokinesis. Central spindle organization requires mitotic kinesins, microtubule-bundling protein PRC1, and Aurora B kinase complex. However, the precise role of PRC1 in central spindle organization has remained elusive. Here we show that PRC1 recruits CLASP1 to the central spindle at early anaphase onset. CLASP1 belongs to a conserved microtubule-binding protein family that mediates the stabilization of overlapping microtubules of the central spindle. PRC1 physically interacts with CLASP1 and specifies its localization to the central spindle. Repression of CLASP1 leads to sister-chromatid bridges and depolymerization of spindle midzone microtubules. Disruption of PRC1-CLASP1 interaction by a membrane-permeable peptide abrogates accurate chromosome segregation, resulting in sister chromatid bridges. These findings reveal a key role for the PRC1-CLASP1 interaction in achieving a stable anti-parallel microtubule organization essential for faithful chromosome segregation. We propose that PRC1 forms a link between stabilization of CLASP1 association with central spindle microtubules and anti-parallel microtubule elongation.	[Ding, Xia] Beijing Univ Chinese Med, Dept Med, Beijing 100086, Peoples R China; [Liu, Jing; Wang, Zhikai; Jiang, Kai; Zhang, Liangyu; Zhao, Lingli; Hua, Shasha; Yan, Feng; Wang, Dongmei; Guo, Zhen; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Liu, Jing; Wang, Zhikai; Jiang, Kai; Zhang, Liangyu; Zhao, Lingli; Hua, Shasha; Yan, Feng; Wang, Dongmei; Guo, Zhen; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Jiang, Kai; Yan, Feng; Yang, Yong; Fu, Chuanhai; Guo, Zhen] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA	Beijing University of Chinese Medicine; Morehouse School of Medicine	Ding, X (corresponding author), Beijing Univ Chinese Med, Dept Med, Beijing 100086, Peoples R China.	xiading@yahoo.com; zhenguo@ustc.edu.cn; yaoxb@ustc.edu.cn	Yang, Yong/U-4781-2019; Yang, Yong/P-8322-2018; Fu, Chuanhai/G-8303-2016; Zhang, Liangyu/ABE-4868-2021; Yao, Xuebiao/P-5771-2014	Fu, Chuanhai/0000-0003-4354-3796; Zhang, Liangyu/0000-0002-2701-0773	National Institutes of Health [DK-56292, CA89019, CA92080]; Chinese 973 Projects [2002CB713700, 2010CB912103, 2007CB914503, 2009CB861703]; Chinese Academy of Science [KSCX1-YW-R65, KSCX2-YW-H-10]; Chinese Natural Science Foundation [39925018, 90508002, 30870990]; China National Key Projects for Infectious Disease [2008ZX10002-021]; Anhui Province Chemical Biology [08040102005]; Atlanta Clinical ant Translation Science Institute; NATIONAL CANCER INSTITUTE [U56CA092080, P50CA089019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Projects(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China National Key Projects for Infectious Disease; Anhui Province Chemical Biology; Atlanta Clinical ant Translation Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292, CA89019, and CA92080 (to X. Y.). This work was also supported by Chinese 973 Projects 2002CB713700, 2010CB912103, 2007CB914503, and 2009CB861703, Chinese Academy of Science Grants KSCX1-YW-R65 and KSCX2-YW-H-10, Chinese Natural Science Foundation Grants 39925018 and 90508002 (to X. Y.) and 30870990 (to X. D.), China National Key Projects for Infectious Disease Grant 2008ZX10002-021, a Georgia Cancer Coalition Breast Cancer research grant, Anhui Province Chemical Biology Key Project Grant 08040102005, and an Atlanta Clinical ant Translation Science Institute research grant.	Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Fu CH, 2007, CELL RES, V17, P449, DOI 10.1038/cr.2007.32; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Hannak E, 2006, J CELL BIOL, V172, P19, DOI 10.1083/jcb.200508180; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mimori-Kiyosue Y, 2006, GENES CELLS, V11, P845, DOI 10.1111/j.1365-2443.2006.00990.x; Mollinari C, 2005, MOL BIOL CELL, V16, P1043, DOI 10.1091/mbc.E04-04-0346; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Smertenko AP, 2006, J CELL SCI, V119, P3227, DOI 10.1242/jcs.03051; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; YAO XB, 1993, AM J PHYSIOL, V265, pC36, DOI 10.1152/ajpcell.1993.265.1.C36; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	35	43	43	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23059	23071		10.1074/jbc.M109.009670	http://dx.doi.org/10.1074/jbc.M109.009670			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561070	Green Published, hybrid			2022-12-27	WOS:000268963100058
J	Noland, RC; Koves, TR; Seiler, SE; Lum, H; Lust, RM; Ilkayeva, O; Stevens, RD; Hegardt, FG; Muoio, DM				Noland, Robert C.; Koves, Timothy R.; Seiler, Sarah E.; Lum, Helen; Lust, Robert M.; Ilkayeva, Olga; Stevens, Robert D.; Hegardt, Fausto G.; Muoio, Deborah M.			Carnitine Insufficiency Caused by Aging and Overnutrition Compromises Mitochondrial Performance and Metabolic Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-L-CARNITINE; SKELETAL-MUSCLE MITOCHONDRIA; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ARTIFICIAL SELECTION; DIABETES-MELLITUS; GLUCOSE DISPOSAL; UP-REGULATION; BIOSYNTHESIS; DEFICIENCY	In addition to its essential role in permitting mitochondrial import and oxidation of long chain fatty acids, carnitine also functions as an acyl group acceptor that facilitates mitochondrial export of excess carbons in the form of acylcarnitines. Recent evidence suggests carnitine requirements increase under conditions of sustained metabolic stress. Accordingly, we hypothesized that carnitine insufficiency might contribute to mitochondrial dysfunction and obesity-related impairments in glucose tolerance. Consistent with this prediction whole body carnitine dimunition was identified as a common feature of insulin-resistant states such as advanced age, genetic diabetes, and diet-induced obesity. In rodents fed a lifelong (12 month) high fat diet, compromised carnitine status corresponded with increased skeletal muscle accumulation of acylcarnitine esters and diminished hepatic expression of carnitine biosynthetic genes. Diminished carnitine reserves in muscle of obese rats was accompanied by marked perturbations in mitochondrial fuel metabolism, including low rates of complete fatty acid oxidation, elevated incomplete beta-oxidation, and impaired substrate switching from fatty acid to pyruvate. These mitochondrial abnormalities were reversed by 8 weeks of oral carnitine supplementation, in concert with increased tissue efflux and urinary excretion of acetylcarnitine and improvement of whole body glucose tolerance. Acetylcarnitine is produced by the mitochondrial matrix enzyme, carnitine acetyltransferase (CrAT). A role for this enzyme in combating glucose intolerance was further supported by the finding that CrAT overexpression in primary human skeletal myocytes increased glucose uptake and attenuated lipid-induced suppression of glucose oxidation. These results implicate carnitine insufficiency and reduced CrAT activity as reversible components of the metabolic syndrome.	[Noland, Robert C.; Koves, Timothy R.; Seiler, Sarah E.; Lum, Helen; Ilkayeva, Olga; Stevens, Robert D.; Muoio, Deborah M.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Koves, Timothy R.; Muoio, Deborah M.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Muoio, Deborah M.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Lust, Robert M.] E Carolina Univ, Dept Physiol, Greenville, NC 27834 USA; [Hegardt, Fausto G.] Univ Barcelona, Sch Pharm, Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, E-08028 Barcelona, Spain	Duke University; Duke University; Duke University; University of North Carolina; East Carolina University; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona	Muoio, DM (corresponding author), 4321 Med Pk Dr, Durham, NC 27704 USA.	Muoio@duke.edu	Koves, Tim/I-4806-2012; Noland, Robert/N-1982-2017; Muoio, Debbie Marie/E-1147-2012	Koves, Tim/0000-0001-8763-5866; Muoio, Deborah/0000-0003-3760-9277; Noland, Robert/0000-0001-5543-3450	National Institutes of Health [P30-AG028716, R01-AG028930, F32-DK080609]; American Diabetes Association; John A. Hartford Duke Center for Excellence Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK080609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028930, P30AG028716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); John A. Hartford Duke Center for Excellence Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-AG028716 and R01-AG028930 (to D. M. M.) and F32-DK080609 (to R. N.). This work was also supported by the American Diabetes Association (to D. M. M.) and a John A. Hartford Duke Center for Excellence Award (to T. R. K).	Ames BN, 2004, ANN NY ACAD SCI, V1033, P108, DOI 10.1196/annals.1320.010; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Arrigoni-Martelli E, 2001, DRUG EXP CLIN RES, V27, P27; Aureli T, 1999, EUR J BIOCHEM, V263, P287, DOI 10.1046/j.1432-1327.1999.00524.x; BECKER TC, 1994, J BIOL CHEM, V269, P21234; BHUIYAN AKMJ, 1988, BIOCHEM J, V253, P337, DOI 10.1042/bj2530337; Brass EP, 2003, CLIN PHARMACOL THER, V73, P338, DOI 10.1016/S0009-9236(02)17636-3; BRASS EP, 1995, CLIN THER, V17, P176, DOI 10.1016/0149-2918(95)80017-4; CAPALDO B, 1991, DIABETES RES CLIN PR, V14, P191, DOI 10.1016/0168-8227(91)90020-E; CEDERBLAD G, 1987, AM J CLIN NUTR, V45, P725, DOI 10.1093/ajcn/45.4.725; CHASE JFA, 1967, BIOCHEM J, V104, P510, DOI 10.1042/bj1040510; Citak EC, 2006, PEDIATR HEMAT ONCOL, V23, P381, DOI 10.1080/08880010600646704; DAVIS AT, 1986, J NUTR, V116, P760, DOI 10.1093/jn/116.5.760; Dhitavat S, 2002, NEUROCHEM RES, V27, P501, DOI 10.1023/A:1019800703683; Farkas V, 1996, BIOCHEM PHARMACOL, V52, P1429, DOI 10.1016/S0006-2952(96)00507-2; FARRELL S, 1986, BIOCHIM BIOPHYS ACTA, V876, P175, DOI 10.1016/0005-2760(86)90332-2; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; Fischer GM, 2000, BBA-MOL BASIS DIS, V1501, P200, DOI 10.1016/S0925-4439(00)00023-5; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Haqq AM, 2005, CONTEMP CLIN TRIALS, V26, P616, DOI 10.1016/j.cct.2005.09.003; Huang W, 1999, BIOCHEM PHARMACOL, V58, P1361, DOI 10.1016/S0006-2952(99)00219-1; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Kaido M, 1997, EUR NEUROL, V38, P302, DOI 10.1159/000113399; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Koch A, 2008, EXP BIOL MED, V233, P356, DOI 10.3181/0706-RM-168; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; LligonaTrulla L, 1997, J LIPID RES, V38, P1454; Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; MIKHAIL MM, 1976, CLIN CHIM ACTA, V71, P207, DOI 10.1016/0009-8981(76)90532-5; Mingrone G, 1999, J AM COLL NUTR, V18, P77, DOI 10.1080/07315724.1999.10718830; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Nalecz Katarzyna A., 2004, Molecular Aspects of Medicine, V25, P551; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; Okamoto Maya, 2006, J Clin Forensic Med, V13, P26, DOI 10.1016/j.jcfm.2005.05.004; Okudaira N, 2001, PHARMACEUT RES, V18, P439, DOI 10.1023/A:1011042008169; Otsuka M, 1999, J NUTR SCI VITAMINOL, V45, P163, DOI 10.3177/jnsv.45.163; PIEKLIK JR, 1975, J BIOL CHEM, V250, P4445; Power RA, 2007, DIABETOLOGIA, V50, P824, DOI 10.1007/s00125-007-0605-4; Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004; Rahbar AR, 2005, EUR J CLIN NUTR, V59, P592, DOI 10.1038/sj.ejcn.1602109; RANDLE PJ, 1963, LANCET, V1, P785; REBOUCHE CJ, 1986, J NUTR, V116, P751; Ricciolini R, 1998, J NEUROCHEM, V71, P2510; ROE CR, 1983, ARCH DIS CHILD, V58, P916, DOI 10.1136/adc.58.11.916; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Tein I, 2003, J INHERIT METAB DIS, V26, P147, DOI 10.1023/A:1024481016187; Thyfault JP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1076, DOI 10.1152/ajpendo.00177.2004; UZIEL G, 1988, MUSCLE NERVE, V11, P720, DOI 10.1002/mus.880110708; van Vlies N, 2007, BBA-BIOENERGETICS, V1767, P1134, DOI 10.1016/j.bbabio.2007.07.001; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Winter SC, 2003, J INHERIT METAB DIS, V26, P171, DOI 10.1023/A:1024433100257; Wood JC, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e19	63	235	244	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22840	22852		10.1074/jbc.M109.032888	http://dx.doi.org/10.1074/jbc.M109.032888			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553674	Green Published, hybrid			2022-12-27	WOS:000268963100038
J	Sebag, JA; Hinkle, PM				Sebag, Julien A.; Hinkle, Patricia M.			Opposite Effects of the Melanocortin-2 (MC2) Receptor Accessory Protein MRAP on MC2 and MC5 Receptor Dimerization and Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE COMPLEMENTATION; EXPRESSION; VISUALIZATION; DEFICIENCY; TISSUES; MEMBERS; FAMILY; TYPE-2; ROLES; GAMMA	MC2 (ACTH) receptors require MC2 receptor accessory protein (MRAP) to reach the cell surface. In this study, we show that MRAP has the opposite effect on the closely related MC5 receptor. In enzyme-linked immunosorbent assay and microscopy experiments, MC2 receptor was retained in the endoplasmic reticulum in the absence of MRAP and targeted to the plasma membrane with MRAP. MC5 receptor was at the plasma membrane in the absence of MRAP, but trapped intracellularly when expressed with MRAP. Using bimolecular fluorescence complementation, where one fragment of yellow fluorescent protein (YFP) was fused to receptors and another to MRAP, we showed that MC2 receptor-MRAP dimers were present at the plasma membrane, whereas MC5 receptor-MRAP dimers were intracellular. Both MC2 and MC5 receptors co-precipitated with MRAP. MRAP did not alter expression of beta 2-adrenergic receptors or co-precipitate with them. To determine if MRAP affects formation of receptor oligomers, we co-expressed MC2 receptors fused to YFP fragments in the presence or absence of MRAP. YFP fluorescence, reporting MC2 receptor homodimers, was readily detectable with or without MRAP. In contrast, MC5 receptor homodimers were visible in the absence of MRAP, but little fluorescence was observed by microscopic analysis when MRAP was co-expressed. Co-precipitation of differentially tagged receptors confirmed that MRAP blocks MC5 receptor dimerization. The regions of MRAP required for its effects on MC2 and MC5 receptors differed. These results establish that MRAP forms stable complexes with two different melanocortin receptors, facilitating surface expression of MC2 receptor but disrupting dimerization and surface localization of MC5 receptor.	[Sebag, Julien A.; Hinkle, Patricia M.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Hinkle, PM (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Box 711, Rochester, NY 14642 USA.	Patricia_Hinkle@urmc.rochetser.edu	sebag, julien/AAU-2142-2020	sebag, julien/0000-0002-8366-312X	National Institutes of Health [DK19974]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK19974 (to P.M.H.).	Abdel-Malek ZA, 2001, CELL MOL LIFE SCI, V58, P434, DOI 10.1007/PL00000868; Baron A, 2009, GEN COMP ENDOCR, V161, P13, DOI 10.1016/j.ygcen.2008.11.026; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Boston BA, 1996, ENDOCRINOLOGY, V137, P2043, DOI 10.1210/en.137.5.2043; Boston BA, 1999, ANN NY ACAD SCI, V885, P75; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Chen M, 2007, J BIOL CHEM, V282, P21712, DOI 10.1074/jbc.M702285200; Chen M, 2009, BIOCHEM PHARMACOL, V77, P114, DOI 10.1016/j.bcp.2008.09.023; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Grieco P, 2002, J PEPT RES, V59, P203, DOI 10.1034/j.1399-3011.2002.01966.x; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Mandrika I, 2005, BIOCHEM BIOPH RES CO, V326, P349, DOI 10.1016/j.bbrc.2004.11.036; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Morgan C, 2006, BEHAV GENET, V36, P291, DOI 10.1007/s10519-005-9024-9; Nickolls SA, 2006, PEPTIDES, V27, P380, DOI 10.1016/j.peptides.2004.12.037; Nimura M, 2006, ANAT EMBRYOL, V211, P109, DOI 10.1007/s00429-005-0066-9; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Webb TR, 2009, ENDOCRINOLOGY, V150, P720, DOI 10.1210/en.2008-0941; Zanna PT, 2008, BIOCHEM BIOPH RES CO, V368, P211, DOI 10.1016/j.bbrc.2008.01.060	27	71	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22641	22648		10.1074/jbc.M109.022400	http://dx.doi.org/10.1074/jbc.M109.022400			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19535343	Green Published, hybrid			2022-12-27	WOS:000268963100017
J	Chernyavsky, AI; Arredondo, J; Qian, J; Galitovskiy, V; Grando, SA				Chernyavsky, Alexander I.; Arredondo, Juan; Qian, Jing; Galitovskiy, Valentin; Grando, Sergei A.			Coupling of Ionic Events to Protein Kinase Signaling Cascades upon Activation of alpha 7 Nicotinic Receptor COOPERATIVE REGULATION OF alpha(2)-INTEGRIN EXPRESSION AND Rho KINASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TOBACCO TOXICITY; CONFORMATIONALLY RESTRICTED ANALOG; ADRENAL CHROMAFFIN CELLS; ACETYLCHOLINE-RECEPTOR; CA2+ INFLUX; CATECHOLAMINE SECRETION; HUMAN KERATINOCYTES; ORAL KERATINOCYTES; DIRECTIONAL MIGRATION; CHOLINERGIC CONTROL	Defining the signaling mechanisms and effector proteins mediating phenotypic and mechanical plasticity of keratinocytes (KCs) during wound epithelialization is one of the major goals in epithelial cell biology. The acetylcholine (ACh)-gated ion channels, or nicotinic ACh receptors (nAChRs), mediate the nicotinergic signaling that controls crawling locomotion of KCs. To elucidate relative contributions of the ionic and protein kinase-mediated events elicited due to activation of alpha 7 nAChRs, we quantitated expression of alpha(2)-integrin gene at the mRNA and protein levels and also measured Rho kinase activity in KCs stimulated with the alpha 7 agonist AR-R17779 while blocking the Na+ or Ca2+ entry and/or inhibiting signaling kinases. The results demonstrated the existence of the two-component signaling systems coupling the ionic events and protein kinase signaling cascades downstream of alpha 7 nAChR to simultaneous upregulation of alpha(2)-integrin expression and activation of Rho kinase. The Raf/MEK1/ERK1/2 cascade up-regulating alpha(2)-integrin was activated due to both Ca2+-dependent recruitment of Ca2+/calmodulin-dependent protein kinase II and protein kinase C and Ca2+-independent activation of Ras. Likewise the phosphatidylinositol 3-kinase-mediated activation of Rho kinase was elicited due to both Ca2+ entry-dependent involvement of Ca2+/calmodulin-dependent protein kinase II and Ca2+-independent activation of Jak2. Thus, although the initial signals emanating from activated alpha 7 nAChR are different in nature the pathways intersect at common effector molecules providing for a common end point effect. This novel paradigm of nAChR-mediated coordination of the ionic and metabolic signaling events can allow an auto/paracrine ACh to simultaneously alter gene expression and induce reciprocal changes in the cytoskeleton and contractile system of KCs required to compete a particular step of wound epithelialization.	[Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Grando, SA (corresponding author), Univ Calif Irvine, Dept Dermatol, 134 Sprague Hall, Irvine, CA 92697 USA.	sgrando@uci.edu			National Institutes of Health [GM62136, DE14173, ES014384]; Institute for Science and Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Science and Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62136, DE14173, and ES014384 (to S. A. G.). This work was also supported by a research grant from the Institute for Science and Health (to S. A. G.).	Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Arredondo J, 2005, AM J PATHOL, V166, P597, DOI 10.1016/S0002-9440(10)62281-X; Arredondo J, 2008, FASEB J, V22, P1356, DOI 10.1096/fj.07-9965.com; Arredondo J, 2007, LIFE SCI, V80, P2191, DOI 10.1016/j.lfs.2007.01.013; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; Arredondo J, 2006, FASEB J, V20, P2093, DOI 10.1096/fj.06-6191com; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Chernyavsky AI, 2005, J BIOL CHEM, V280, P39220, DOI 10.1074/jbc.M504407200; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Chernyavsky AI, 2008, J BIOL CHEM, V283, P3401, DOI 10.1074/jbc.M704956200; Chernyavsky AI, 2007, EXP CELL RES, V313, P3542, DOI 10.1016/j.yexcr.2007.07.011; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; Dasgupta P, 2006, J CLIN INVEST, V116, P2208, DOI 10.1172/JCI28164; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Denda M, 2006, EXP DERMATOL, V15, P455, DOI 10.1111/j.0906-6705.2006.00430.x; Ferrand A, 2004, EXP CELL RES, V301, P128, DOI 10.1016/j.yexcr.2004.07.037; Fischer H, 2005, J NEUROSCI, V25, P3571, DOI 10.1523/JNEUROSCI.4971-04.2005; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Genersch E, 2000, J CELL SCI, V113, P4319; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grando SA, 2006, EXP DERMATOL, V15, P265, DOI 10.1111/j.0906-6705.2006.00410.x; GRANDO SA, 1995, J INVEST DERMATOL, V105, P774, DOI 10.1111/1523-1747.ep12325606; Grando SA, 1996, J INVEST DERMATOL, V107, P412, DOI 10.1111/1523-1747.ep12363399; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; HARA M, 1993, P NATL ACAD SCI USA, V90, P2281, DOI 10.1073/pnas.90.6.2281; HOCHSTRATE P, 1995, GLIA, V15, P43, DOI 10.1002/glia.440150106; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Koshi R, 2007, J PERIODONTAL RES, V42, P518, DOI 10.1111/j.1600-0765.2007.00976.x; Kumar P, 2005, J BIOL CHEM, V280, P25928, DOI 10.1074/jbc.M502435200; Kurzen H, 2004, J INVEST DERMATOL, V123, P937, DOI 10.1111/j.0022-202X.2004.23425.x; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Leabu M, 2005, J CELL PHYSIOL, V202, P754, DOI 10.1002/jcp.20163; Ma W, 2007, J BIOL CHEM, V282, P13351, DOI 10.1074/jbc.M611522200; Macor JE, 2004, J ORG CHEM, V69, P6493, DOI 10.1021/jo049404q; Mullen G, 2000, J MED CHEM, V43, P4045, DOI 10.1021/jm000249r; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 2000, J DENT RES, V79, P939; NUTTER TJ, 1995, J GEN PHYSIOL, V105, P701, DOI 10.1085/jgp.105.6.701; Palma E, 1998, P NATL ACAD SCI USA, V95, P10246, DOI 10.1073/pnas.95.17.10246; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sgard F, 2002, MOL PHARMACOL, V61, P150, DOI 10.1124/mol.61.1.150; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Singh G S, 1975, Recent Adv Stud Cardiac Struct Metab, V7, P401; SORENSON RL, 1995, ENDOCRINOLOGY, V136, P4092, DOI 10.1210/en.136.9.4092; SORIMACHI M, 1994, JPN J PHYSIOL, V44, P343, DOI 10.2170/jjphysiol.44.343; STEINBACH JH, 1990, CIBA F SYMP, V152, P53; Szasz BK, 2005, NEUROPHARMACOLOGY, V49, P400, DOI 10.1016/j.neuropharm.2005.03.023; TACHIKAWA E, 1994, NEUROSCI LETT, V177, P155, DOI 10.1016/0304-3940(94)90890-7; Taylor SC, 2000, J NEUROCHEM, V75, P1583, DOI 10.1046/j.1471-4159.2000.0751583.x; Tournier JM, 2006, AM J PATHOL, V168, P55, DOI 10.2353/ajpath.2006.050333; vanHoek ML, 1997, BIOCHEM J, V326, P271, DOI 10.1042/bj3260271; Wang K, 2004, J BIOL CHEM, V279, P8779, DOI 10.1074/jbc.M309652200; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wityak J, 2004, BIOORG MED CHEM LETT, V14, P1483, DOI 10.1016/j.bmcl.2004.01.012; Zia SH, 2000, J PHARMACOL EXP THER, V293, P973	60	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22140	22148		10.1074/jbc.M109.011395	http://dx.doi.org/10.1074/jbc.M109.011395			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19549780	Green Published, hybrid			2022-12-27	WOS:000268783700038
J	Xu, SL; Huo, JX; Gunawan, M; Su, IH; Lam, KP				Xu, Shengli; Huo, Jianxin; Gunawan, Merry; Su, I-Hsin; Lam, Kong-Peng			Activated Dectin-1 Localizes to Lipid Raft Microdomains for Signaling and Activation of Phagocytosis and Cytokine Production in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCANS; RECEPTOR; RECOGNITION; MACROPHAGES; INDUCTION; COLOCALIZATION; CHOLESTEROL; INFECTION; MEMBRANES; IMMUNITY	Lipid rafts are plasma membrane microdomains that are enriched in cholesterol, glycosphingolipids, and glycosylphosphatidylinositol-anchored proteins and play an important role in the signaling of ITAM-bearing lymphocyte antigen receptors. Dectin-1 is a C-type lectin receptor (CLR) that recognizes beta-glucan in the cell walls of fungi and triggers signal transduction via its cytoplasmic hemi-ITAM. However, it is not known if similar to antigen receptors, Dectin-1 would also signal via lipid rafts and if the integrity of lipid raft microdomains is important for the physiological functions mediated by Dectin-1. We demonstrate here using sucrose gradient ultracentrifugation and confocal microscopy that Dectin-1 translocates to lipid rafts upon stimulation of dendritic cells (DCs) with the yeast derivative zymosan or beta-glucan. In addition, two key signaling molecules, Syk and PLC gamma 2 are also recruited to lipid rafts upon the activation of Dectin-1, suggesting that lipid raft microdomains facilitate Dectin-1 signaling. Disruption of lipid raft integrity with the synthetic drug, methyl-beta-cyclodextrin (beta mD) leads to reduced intracellular Ca2+ flux and defective Syk and ERK phosphorylation in Dectin-1-activated DCs. Furthermore, beta mD-treated DCs have significantly attenuated production of IL-2, IL-10, and TNF alpha upon Dectin-1 engagement, and they also exhibit impaired phagocytosis of zymosan particles. Taken together, the data indicate that Dectin-1 and perhaps also other CLRs are recruited to lipid rafts upon activation and that the integrity of lipid rafts is important for the signaling and cellular functions initiated by this class of innate receptors.	[Xu, Shengli; Huo, Jianxin; Lam, Kong-Peng] Agcy Sci Technol & Res, Immunol Lab, Bioproc Technol Inst, Singapore 138668, Singapore; [Lam, Kong-Peng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 119074, Singapore; [Gunawan, Merry; Su, I-Hsin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Xu, SL (corresponding author), Agcy Sci Technol & Res, Immunol Lab, Bioproc Technol Inst, 20 Biopolis Way,06-01 Ctr, Singapore 138668, Singapore.	xu_shengli@bti.a-star.edu.sg; lam_kong_peng@bti.a-star.edu.sg	Su, I-hsin/A-2207-2011; Lam, Kong-Peng/G-5374-2012; HUO, JIANXIN/GXH-0232-2022	Su, I-hsin/0000-0002-5894-9580; HUO, JIANXIN/0000-0003-2913-6537; Lam, Kong-Peng/0000-0002-1316-4333	Biomedical Research Council of A*STAR	Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of A*STAR.	Aman MJ, 2001, J BIOL CHEM, V276, P46371, DOI 10.1074/jbc.M104069200; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; He HT, 2005, SEMIN IMMUNOL, V17, P23, DOI 10.1016/j.smim.2004.09.001; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Kondadasula SV, 2008, BLOOD, V111, P4173, DOI 10.1182/blood-2007-01-068908; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lang ML, 2002, BIOCHEM J, V364, P517, DOI 10.1042/BJ20011696; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Locke D, 2002, J BIOL CHEM, V277, P18801, DOI 10.1074/jbc.M111520200; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Seminario MC, 2003, IMMUNOL REV, V192, P80, DOI 10.1034/j.1600-065X.2003.00013.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Vamosi G, 2004, P NATL ACAD SCI USA, V101, P11082, DOI 10.1073/pnas.0403916101; Vereb G, 2000, P NATL ACAD SCI USA, V97, P6013, DOI 10.1073/pnas.97.11.6013; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005	33	57	59	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22005	22011		10.1074/jbc.M109.009076	http://dx.doi.org/10.1074/jbc.M109.009076			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19525229	Green Published, hybrid			2022-12-27	WOS:000268783700024
J	Zmijewski, JW; Banerjee, S; Abraham, E				Zmijewski, Jaroslaw W.; Banerjee, Sami; Abraham, Edward			S-Glutathionylation of the Rpn2 Regulatory Subunit Inhibits 26 S Proteasomal Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PROTEIN-DEGRADATION; KAPPA-B ACTIVATION; OXIDATIVE STRESS; NEUTROPHIL ACTIVATION; HYDROGEN-PEROXIDE; LUNG INJURY; SIGNAL-TRANSDUCTION; REDOX REGULATION; 20S PROTEASOME; NITRIC-OXIDE	Although increased intracellular concentrations of hydrogen peroxide (H2O2) are associated with inhibition of 26 S proteasomal activity, the mechanisms responsible for such effects have not been well delineated. In the present studies, we found that direct exposure of purified 26 S proteasomes to H2O2 had negligible effects on their activity, whereas incubation with glutathione and H2O2 produced >80% decrease in chymotrypsin-like and trypsin-like activities. Rpn1 and Rpn2, which are subunits of the 19 S regulatory particle, undergo S-glutathionylation after exposure of purified 26 S proteasomes to glutathione and H2O2, as well as in HEK 293 cells and neutrophils incubated with H2O2. Increased oxidation of Rpn1 and Rpn2 cysteine thiols was also found in lung extracts from mice in which catalase was inactivated, a condition associated with augmented intracellular concentrations of H2O2 and diminished 26 S proteasomal activity. Although unoxidized Rpn2 enhanced 20 S proteolytic function in vitro, such potentiation was not found when the 20 S core particle was incubated with oxidized Rpn2. The composition of 26 S proteasomes was not altered after exposure to glutathione and H2O2, with similar amounts of Rpn1 and Rpn2 in control or oxidized 26 S proteasomal complexes. These findings identify S-glutathionylation of Rpn2 as a contributory mechanism for H2O2-induced inhibition of 26 S proteasomal function.	[Abraham, Edward] Univ Alabama, Sch Med, Dept Med, Birmingham, AL 35294 USA; [Zmijewski, Jaroslaw W.; Abraham, Edward] Univ Alabama, Ctr Free Radical Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Abraham, E (corresponding author), Univ Alabama, Sch Med, Dept Med, BDB 420,1530 3rd Ave S, Birmingham, AL 35294 USA.	eabraham@uab.edu			National Institutes of Health [HL62221, GM87748]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62221 and GM87748.	Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Barlow CA, 2008, APOPTOSIS, V13, P681, DOI 10.1007/s10495-008-0203-z; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Chen C, 2002, J BIOCHEM MOL TOXIC, V16, P227, DOI 10.1002/jbt.10043; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choi KS, 2006, PREP BIOCHEM BIOTECH, V36, P65, DOI 10.1080/10826060500388520; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Demasi M, 2003, J BIOL CHEM, V278, P679, DOI 10.1074/jbc.M209282200; Demasi M, 2001, ARCH BIOCHEM BIOPHYS, V389, P254, DOI 10.1006/abbi.2001.2332; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Farout L, 2006, ANTIOXID REDOX SIGN, V8, P205, DOI 10.1089/ars.2006.8.205; Fink MP, 2002, CURR OPIN CLIN NUTR, V5, P167, DOI 10.1097/00075197-200203000-00009; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hosler MR, 2003, INT J BIOCHEM CELL B, V35, P685, DOI 10.1016/S1357-2725(02)00397-7; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; KOECHLING UM, 1994, ALCOHOL, V11, P235, DOI 10.1016/0741-8329(94)90036-1; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Kotamraju S, 2005, METHOD ENZYMOL, V396, P526, DOI 10.1016/S0076-6879(05)96044-8; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lu SC, 2000, CURR TOP CELL REGUL, V36, P95; Macdonald J, 2003, BRIT J ANAESTH, V90, P221, DOI 10.1093/bja/aeg034; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Meiners S, 2008, MED RES REV, V28, P309, DOI 10.1002/med.20111; MINHAS HS, 1995, BIOCHEM PHARMACOL, V49, P1475, DOI 10.1016/0006-2952(94)00518-Q; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; Pajonk F, 2002, FREE RADICAL BIO MED, V32, P536, DOI 10.1016/S0891-5849(02)00743-8; Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; SCHMITT J, 1993, MOL BIOL REP, V18, P223, DOI 10.1007/BF01674434; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shelton MD, 2008, MOL CELLS, V25, P332; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang QE, 2005, MOL CARCINOGEN, V42, P53, DOI 10.1002/mc.20065; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014; de Pina MZ, 2008, J BIOL CHEM, V283, P12373, DOI 10.1074/jbc.M706832200; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC; Zmijewski JW, 2009, AM J PHYSIOL-LUNG C, V296, pL624, DOI DOI 10.1152/ajplung.90522.2008	67	51	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22213	22221		10.1074/jbc.M109.028902	http://dx.doi.org/10.1074/jbc.M109.028902			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19549781	hybrid, Green Published			2022-12-27	WOS:000268783700046
J	Wang, JR; Whiteman, MW; Lian, HQ; Wang, GX; Singh, A; Huang, DY; Denmark, T				Wang, Jianrong; Whiteman, Mary W.; Lian, Huiqin; Wang, Guangxin; Singh, Amit; Huang, Dongyang; Denmark, Ted			A Non-canonical MEK/ERK Signaling Pathway Regulates Autophagy via Regulating Beclin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR; MAMMALIAN-CELLS; GOLGI FRAGMENTATION; TUBEROUS SCLEROSIS; HT-29 CELLS; C-ELEGANS; LIFE-SPAN; IN-VIVO; INDUCTION	Autophagy-essential proteins are the molecular basis of protective or destructive autophagy machinery. However, little is known about the signaling mechanisms governing these proteins and the opposing consequences of autophagy in mammals. Here we report that a non-canonical MEK/ERK module, which is positioned downstream of AMP-activated protein kinase (AMPK) and upstream of tuberous sclerosis complex (TSC), regulates autophagy by regulating Beclin 1. Depletion of ERK partially inhibited autophagy, whereas specific inhibition on MEK completely inhibited autophagy. MEK could bypass ERK to promote autophagy. Basal MEK/ERK activity conferred basal Beclin 1 by preventing disassembly of mammalian target of rapamycin complex 1 (mTORC1) and mTORC2. Activation of MEK/ERK by AMPK upon autophagy stimuli disassembled mTORC1 via binding to and activating TSC but disassembled mTORC2 independently of TSC. Inhibition of mTORC1 or mTORC2 by transiently or moderately activated MEK/ERK caused moderately enhanced Beclin 1 resulting in cytoprotective autophagy, whereas inhibition of both mTORC1 and mTORC2 by sustained MEK/ERK activation caused strongly pronounced Beclin 1 leading to cytodestructive autophagy. Our findings thus propose that the AMPK-MEK/ERK-TSC-mTOR pathway regulation of Beclin 1 represents different thresholds responsible for a protective or destructive autophagy.	[Wang, Jianrong; Whiteman, Mary W.; Lian, Huiqin; Wang, Guangxin; Singh, Amit; Denmark, Ted] Treman Res Inst, Ithaca, NY 14850 USA; Shantou Univ, Coll Med, Shantou 515041, Guangdong, Peoples R China	Shantou University	Wang, JR (corresponding author), Treman Res Inst, Ithaca, NY 14850 USA.	jrwang@stu.edu.cn			Shantou University; Unimed Foundation	Shantou University; Unimed Foundation	This work was supported by grants from Shantou University and the Unimed Foundation.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Colanzi A, 2000, J CELL BIOL, V149, P331, DOI 10.1083/jcb.149.2.331; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Subramaniam S, 2006, NEUROSCIENCE, V138, P1055, DOI 10.1016/j.neuroscience.2005.12.013; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vellai T, 2008, AUTOPHAGY, V4, P507, DOI 10.4161/auto.5670; Wang JR, 2008, AUTOPHAGY, V4, P947, DOI 10.4161/auto.6787; Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Xu J, 2006, J BIOL CHEM, V281, P982, DOI 10.1074/jbc.M505484200; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	61	259	270	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21412	21424		10.1074/jbc.M109.026013	http://dx.doi.org/10.1074/jbc.M109.026013			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520853	Green Published, hybrid			2022-12-27	WOS:000268564400036
J	Xu, M; Bai, L; Gong, Y; Xie, W; Hang, HY; Jiang, T				Xu, Min; Bai, Lin; Gong, Yong; Xie, Wei; Hang, Haiying; Jiang, Tao			Structure and Functional Implications of the Human Rad9-Hus1-Rad1 Cell Cycle Checkpoint Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSOR RAD9-RAD1-HUS1 INTERACTS; DNA-POLYMERASE-BETA; REPAIR; CLAMP; PCNA; DAMAGE; RAD9; GLYCOSYLASE; PROTEINS; CRYSTALLOGRAPHY	Cellular DNA lesions are efficiently countered by DNA repair in conjunction with delays in cell cycle progression. Previous studies have demonstrated that Rad9, Hus1, and Rad1 can form a heterotrimeric complex (the 9-1-1 complex) that plays dual roles in cell cycle checkpoint activation and DNA repair in eukaryotic cells. Although the 9-1-1 complex has been proposed to form a toroidal structure similar to proliferating cell nuclear antigen (PCNA), which plays essential roles in DNA replication and repair, the structural basis by which it performs different functions has not been elucidated. Here we report the crystal structure of the human 9-1-1 complex at 3.2 angstrom resolution. The crystal structure, together with biochemical assays, reveals that the interdomain connecting loops (IDC loop) of hRad9, hHus1, and hRad1 are largely divergent, and further cocrystallization study indicates that a PCNA-interacting box (PIP box)-containing peptide derived from hFen1 binds tightly to the interdomain connecting loop of hRad1, providing the molecular basis for the damage repair-specific activity of the 9-1-1 complex in contrast to PCNA. Furthermore, structural comparison with PCNA reveals other unique structural features of the 9-1-1 complex that are proposed to contribute to DNA damage recognition.	[Xu, Min; Bai, Lin; Gong, Yong; Xie, Wei; Hang, Haiying; Jiang, Tao] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Xu, Min; Bai, Lin; Xie, Wei] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hang, HY (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	hh91@ibp.ac.cn; tjiang@ibp.ac.cn	bai, lin/J-2502-2015	bai, lin/0000-0002-7535-7819; Xie, Wei/0000-0002-4550-6211; Xu, Min/0000-0002-6589-061X	National Key Basic Research Program [2006CB910902]; National Natural Science Foundation of China [30770435, 30721003, 30530180]; National High Technology Research and Development Program of China [2006AA02A319]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This research was financially supported by the National Key Basic Research Program (Grant 2006CB910902), the National Natural Science Foundation of China (Grants 30770435, 30721003, and 30530180), the National High Technology Research and Development Program of China (Grant 2006AA02A319), and the National Natural Science Foundation of China (Grant 30530180).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bessho T, 2000, J BIOL CHEM, V275, P7451, DOI 10.1074/jbc.275.11.7451; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DORE AS, 2009, MOL CELL IN PRESS; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; He W, 2008, NUCLEIC ACIDS RES, V36, P6406, DOI 10.1093/nar/gkn686; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker AE, 1998, J BIOL CHEM, V273, P18332, DOI 10.1074/jbc.273.29.18332; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Rauen M, 2000, J BIOL CHEM, V275, P29767, DOI 10.1074/jbc.M005782200; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zhu DY, 2005, ACTA CRYSTALLOGR D, V61, P772, DOI 10.1107/S0907444904028768; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	36	65	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20457	20461		10.1074/jbc.C109.022384	http://dx.doi.org/10.1074/jbc.C109.022384			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19535328	Green Published, hybrid			2022-12-27	WOS:000268316100006
J	Ameyar-Zazoua, M; Souidi, M; Fritsch, L; Robin, P; Thomas, A; Hamiche, A; Percipalle, P; Ait-Si-Ali, S; Harel-Bellan, A				Ameyar-Zazoua, Maya; Souidi, Mouloud; Fritsch, Lauriane; Robin, Philippe; Thomas, Audrey; Hamiche, Ali; Percipalle, Piergiorgio; Ait-Si-Ali, Slimane; Harel-Bellan, Annick			Physical and Functional Interaction between Heterochromatin Protein 1 alpha and the RNA-binding Protein Heterogeneous Nuclear Ribonucleoprotein U	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HNRNP-U/SAF-A; SAF-A; MAMMALIAN HETEROCHROMATIN; POLYMERASE-II; IN-VIVO; HP1; DNA; TRANSCRIPTION; METHYLATION; DROSOPHILA	By combining biochemical purification and mass spectrometry, we identified proteins associated with human heterochromatin protein 1 alpha (HP1 alpha) both in the nucleoplasm and in chromatin. Some of these are RNA-binding proteins, and among them is the protein heterogeneous nuclear ribonucleoprotein U (hnRNP U)/SAF-A, which is linked to chromatin organization and transcriptional regulation. Here, we demonstrate that hnRNP U is a bona fide HP1 alpha-interacting molecule. More importantly, hnRNP U depletion reduces HP1 alpha-dependent gene silencing and disturbs HP1 alpha subcellular localization. Thus, our data demonstrate that hnRNP U is involved in HP1 alpha function, shedding new light on the mode of action of HP1 alpha and on the function of hnRNP U.	[Ameyar-Zazoua, Maya; Souidi, Mouloud; Fritsch, Lauriane; Robin, Philippe; Thomas, Audrey; Hamiche, Ali; Ait-Si-Ali, Slimane; Harel-Bellan, Annick] CNRS, IAL, FRE 2944, F-94800 Villejuif, France; [Ameyar-Zazoua, Maya; Souidi, Mouloud; Fritsch, Lauriane; Robin, Philippe; Thomas, Audrey; Hamiche, Ali; Ait-Si-Ali, Slimane; Harel-Bellan, Annick] Univ Paris 11, F-94801 Villejuif, France; [Percipalle, Piergiorgio] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet	Harel-Bellan, A (corresponding author), CNRS, IAL, FRE 2944, 7 Rue Guy Moquet, F-94800 Villejuif, France.	ahbellan@vjf.cnrs.fr	Harel-Bellan, Annick/M-9795-2015; SOUIDI, Mouloud/ABI-1444-2020	Harel-Bellan, Annick/0000-0002-2339-153X	CNRS; European Union 6th Framework Programme TRANS-REG [LSHG-CT-2004-502950]; SIROCCO [LSHG-CT-2006-037900]	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union 6th Framework Programme TRANS-REG(European Commission); SIROCCO	This work was supported by CNRS and by European Union 6th Framework Programme TRANS-REG Grant LSHG-CT-2004-502950 and SIROCCO Grant LSHG-CT-2006-037900.	Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Fackelmayer FO, 2005, J BIOL CHEM, V280, P1720, DOI 10.1074/jbc.C400531200; FACKELMAYER FO, 1994, BBA-GENE STRUCT EXPR, V1217, P232, DOI 10.1016/0167-4781(94)90044-2; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Gohring F, 1997, BIOCHEMISTRY-US, V36, P8276, DOI 10.1021/bi970480f; Helbig R, 2003, CHROMOSOMA, V112, P173, DOI 10.1007/s00412-003-0258-0; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Malyavantham KS, 2008, J CELL BIOCHEM, V105, P391, DOI 10.1002/jcb.21834; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Sugimoto K, 2001, CELL STRUCT FUNCT, V26, P705, DOI 10.1247/csf.26.705; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Yugami M, 2007, FEBS LETT, V581, P1, DOI 10.1016/j.febslet.2006.11.062; Zofall M, 2006, COLD SPRING HARB SYM, V71, P487, DOI 10.1101/sqb.2006.71.059	24	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27974	27979		10.1074/jbc.M109.037929	http://dx.doi.org/10.1074/jbc.M109.037929			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19617346	hybrid, Green Published			2022-12-27	WOS:000270676300025
J	Johnsen, U; Dambeck, M; Zaiss, H; Fuhrer, T; Soppa, J; Sauer, U; Schonheit, P				Johnsen, Ulrike; Dambeck, Michael; Zaiss, Henning; Fuhrer, Tobias; Soppa, Joerg; Sauer, Uwe; Schoenheit, Peter			D-Xylose Degradation Pathway in the Halophilic Archaeon Haloferax volcanii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE PATHWAY; EVOLUTIONARY INSIGHT; DEHYDROGENASE; METABOLISM; PURIFICATION; GLUCOSE; IDENTIFICATION; CONSTRUCTION; DEHYDRATASE; EXPRESSION	The pathway of D-xylose degradation in archaea is unknown. In a previous study we identified in Haloarcula marismortui the first enzyme of xylose degradation, an inducible xylose dehydrogenase (Johnsen, U., and Schonheit, P. (2004) J. Bacteriol. 186, 6198-6207). Here we report a comprehensive study of the complete D-xylose degradation pathway in the halophilic archaeon Haloferax volcanii. The analyses include the following: (i) identification of the degradation pathway in vivo following C-13-labeling patterns of proteinogenic amino acids after growth on [C-13]xylose; (ii) identification of xylose-induced genes by DNA microarray experiments; (iii) characterization of enzymes; and (iv) construction of in-frame deletion mutants and their functional analyses in growth experiments. Together, the data indicate that D-xylose is oxidized exclusively to the tricarboxylic acid cycle intermediate alpha-ketoglutarate, involving D-xylose dehydrogenase (HVO_B0028), a novel xylonate dehydratase (HVO_B0038A), 2-keto-3-deoxyxylonate dehydratase (HVO_B0027), and alpha-ketoglutarate semialdehyde dehydrogenase (HVO_B0039). The functional involvement of these enzymes in xylose degradation was proven by growth studies of the corresponding in-frame deletion mutants, which all lost the ability to grow on D-xylose, but growth on glucose was not significantly affected. This is the first report of an archaeal D-xylose degradation pathway that differs from the classical D-xylose pathway in most bacteria involving the formation of xylulose 5-phosphate as an intermediate. However, the pathway shows similarities to proposed oxidative pentose degradation pathways to alpha-ketoglutarate in few bacteria, e.g. Azospirillum brasilense and Caulobacter crescentus, and in the archaeon Sulfolobus solfataricus.	[Johnsen, Ulrike; Zaiss, Henning; Schoenheit, Peter] Univ Kiel, Inst Allgemeine Mikrobiol, D-24118 Kiel, Germany; [Dambeck, Michael; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Fuhrer, Tobias; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Kiel; Goethe University Frankfurt; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schonheit, P (corresponding author), Univ Kiel, Inst Allgemeine Mikrobiol, Bot Garten 1-9, D-24118 Kiel, Germany.	peter.schoenheit@ifam.uni-kiel.de	Sauer, Uwe/Y-3556-2019; Fuhrer, Tobias/B-5667-2013	Fuhrer, Tobias/0000-0001-5006-6874; Soppa, Jorg/0000-0002-6132-5840				Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Bonete MJ, 1996, FEBS LETT, V383, P227, DOI 10.1016/0014-5793(96)00235-9; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Chen CN, 2008, J MOL BIOL, V384, P604, DOI 10.1016/j.jmb.2008.09.055; Connaris H, 1999, BIOTECHNOL BIOENG, V64, P38, DOI 10.1002/(SICI)1097-0290(19990705)64:1<38::AID-BIT4>3.0.CO;2-7; Dauner M, 2000, BIOTECHNOL PROGR, V16, P642, DOI 10.1021/bp000058h; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Hammelmann M, 2008, J MICROBIOL METH, V75, P201, DOI 10.1016/j.mimet.2008.05.029; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Johnsen U, 2001, ARCH MICROBIOL, V175, P52, DOI 10.1007/s002030000237; Lamble FJ, 2004, FEBS LETT, V576, P133, DOI 10.1016/j.febslet.2004.08.074; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Moore RA, 2004, INFECT IMMUN, V72, P4172, DOI 10.1128/IAI.72.7.4172-4187.2004; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Soppa J, 2008, ARCH MICROBIOL, V190, P197, DOI 10.1007/s00203-008-0376-4; SOPPA J, 1994, SYST APPL MICROBIOL, V16, P725; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van de Werken Harmen J. G., 2008, P71; Wanner C, 2002, J BACTERIOL, V184, P3114, DOI 10.1128/JB.184.11.3114-3121.2002; Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200; Watanabe S, 2007, J BIOL CHEM, V282, P6685, DOI 10.1074/jbc.M611057200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Watanabe S, 2006, J BIOL CHEM, V281, P28876, DOI 10.1074/jbc.M602585200; Zaigler A, 2003, MOL MICROBIOL, V48, P1089, DOI 10.1046/j.1365-2958.2003.03497.x	29	76	86	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27290	27303		10.1074/jbc.M109.003814	http://dx.doi.org/10.1074/jbc.M109.003814			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19584053	hybrid, Green Published			2022-12-27	WOS:000270232300030
J	Boniecki, MT; Rho, SB; Tukalo, M; Hsu, JL; Romero, EP; Martinis, SA				Boniecki, Michal T.; Rho, Seung Bae; Tukalo, Mikhail; Hsu, Jennifer L.; Romero, Eliana P.; Martinis, Susan A.			Leucyl-tRNA Synthetase-dependent and -independent Activation of a Group I Intron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST MITOCHONDRIA; MATURASE DEFICIENCY; SPLICING FUNCTION; DNA ENDONUCLEASE; CATALYTIC CORE; P4-P6 DOMAIN; PROTEIN; BINDING; CONNECTIONS; MUTATIONS	Leucyl-tRNA synthetase (LeuRS) is an essential RNA splicing factor for yeast mitochondrial introns. Intracellular experiments have suggested that it works in collaboration with a maturase that is encoded within the bI4 intron. RNA deletion mutants of the large bI4 intron were constructed to identify a competently folded intron for biochemical analysis. The minimized bI4 intron was active in RNA splicing and contrasts with previous proposals that the canonical core of the bI4 intron is deficient for catalysis. The activity of the minimized bI4 intron was enhanced in vitro by the presence of the bI4 maturase or LeuRS.	[Boniecki, Michal T.; Rho, Seung Bae; Tukalo, Mikhail; Hsu, Jennifer L.; Romero, Eliana P.; Martinis, Susan A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	martinis@uiuc.edu		Martinis, Susan/0000-0001-5730-8346; Tukalo, Michael/0000-0002-0982-2372	National Institutes of Health [GM63107]; Human Frontiers Science Program; Robert A. Welch Foundation; American Chemical Society Petroleum Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063107, R01GM063789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Robert A. Welch Foundation(The Welch Foundation); American Chemical Society Petroleum Research Fund(American Chemical Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63107. This work was also supported by grants from The Human Frontiers Science Program, The Robert A. Welch Foundation, and the American Chemical Society Petroleum Research Fund.	AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; Bassi GS, 2002, P NATL ACAD SCI USA, V99, P128, DOI 10.1073/pnas.012579299; Caprara MG, 1996, J MOL BIOL, V257, P512, DOI 10.1006/jmbi.1996.0182; Caprara MG, 1996, CELL, V87, P1135, DOI 10.1016/S0092-8674(00)81807-3; Caprara MG, 2001, J MOL BIOL, V308, P165, DOI 10.1006/jmbi.2001.4581; Chen X, 2000, J MOL BIOL, V301, P265, DOI 10.1006/jmbi.2000.3963; CHERNIACK AD, 1990, CELL, V62, P745, DOI 10.1016/0092-8674(90)90119-Y; DELAHODDE A, 1989, CELL, V56, P431, DOI 10.1016/0092-8674(89)90246-8; GAMPEL A, 1987, MOL CELL BIOL, V7, P2545, DOI 10.1128/MCB.7.7.2545; GOGUEL V, 1992, MOL CELL BIOL, V12, P696, DOI 10.1128/MCB.12.2.696; GUO QB, 1991, J BIOL CHEM, V266, P1809; Houman F, 2000, P NATL ACAD SCI USA, V97, P13743, DOI 10.1073/pnas.240465597; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; KAMPER U, 1992, MOL CELL BIOL, V12, P499; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; LABOUESSE M, 1987, EMBO J, V6, P713, DOI 10.1002/j.1460-2075.1987.tb04812.x; LABOUESSE M, 1985, CELL, V41, P133, DOI 10.1016/0092-8674(85)90068-6; LAMBOWITZ AM, 1999, RNA WORLD, V2, P451; Li GY, 1996, MOL GEN GENET, V252, P667, DOI 10.1007/BF02173972; Martinis SA, 2007, CHEM BIOL, V14, P1307, DOI 10.1016/j.chembiol.2007.12.001; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOHR G, 1994, NATURE, V370, P147, DOI 10.1038/370147a0; Mohr G, 2001, J MOL BIOL, V307, P75, DOI 10.1006/jmbi.2000.4460; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pathak HB, 2002, J BIOL CHEM, V277, P31551, DOI 10.1074/jbc.M204408200; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Paukstelis PJ, 2005, MOL CELL, V17, P417, DOI 10.1016/j.molcel.2004.12.026; Rangan P, 2003, J MOL BIOL, V329, P229, DOI 10.1016/S0022-2836(03)00430-3; Rho SB, 2002, EMBO J, V21, P6874, DOI 10.1093/emboj/cdf671; Rho SB, 2000, RNA, V6, P1882, DOI 10.1017/S1355838200001254; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; TANNER NK, 1995, J MOL BIOL, V252, P583; WENZLAU JM, 1989, CELL, V56, P421, DOI 10.1016/0092-8674(89)90245-6; Westhof E, 1996, FOLD DES, V1, pR78, DOI 10.1016/S1359-0278(96)00037-5	36	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26243	26250		10.1074/jbc.M109.031179	http://dx.doi.org/10.1074/jbc.M109.031179			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19622748	Green Published, hybrid			2022-12-27	WOS:000269969600004
J	McGill, MA; Dho, SE; Weinmaster, G; McGlade, CJ				McGill, Melanie A.; Dho, Sascha E.; Weinmaster, Gerry; McGlade, C. Jane			Numb Regulates Post-endocytic Trafficking and Degradation of Notch1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFY CELL FATE; MAMMALIAN NUMB; LIGAND ENDOCYTOSIS; UBIQUITIN LIGASE; DOWN-REGULATION; ASYMMETRIC LOCALIZATION; ALPHA-ADAPTIN; PROTEIN; RECEPTOR; ACTIVATION	Notch is a transmembrane receptor that controls cell fate decisions during development and tissue homeostasis. Both activation and attenuation of the Notch signal are tightly regulated by endocytosis. The adaptor protein Numb acts as an inhibitor of Notch and is known to function within the intracellular trafficking pathways. However, a role for Numb in regulating Notch trafficking has not been defined. Here we show that mammalian Notch1 is constitutively internalized and trafficked to both recycling and late endosomal compartments, and we demonstrate that changes in Numb expression alter the dynamics of Notch1 trafficking. Overexpression of Numb promotes sorting of Notch1 through late endosomes for degradation, whereas depletion of Numb facilitates Notch1 recycling. Numb mutants that do not interact with the ubiquitin-protein isopeptide ligase, Itch, or that lack motifs important for interaction with endocytic proteins fail to promote Notch1 degradation. Our data suggest that Numb inhibits Notch1 activity by regulating post-endocytic sorting events that lead to Notch1 degradation.	[McGill, Melanie A.; Dho, Sascha E.; McGlade, C. Jane] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [McGill, Melanie A.; McGlade, C. Jane] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; [Weinmaster, Gerry] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	McGlade, CJ (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jmcglade@sickkids.ca			Canadian Cancer Society [016125]; National Institutes of Health [R37 NS031885]; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031885] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Canadian Cancer Society Grant 016125 (to C. J. M.) and, in whole or in part, by National Institutes of Health Grant R37 NS031885 from NINDS (to G. W.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Commisso C, 2007, MOL BIOL CELL, V18, P1, DOI 10.1091/mbc.E06-08-0753; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Dho SE, 2006, MOL BIOL CELL, V17, P4142, DOI 10.1091/mbc.E06-02-0097; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gomez MR, 1997, DEVELOPMENT, V124, P4857; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Klueg KM, 1999, J CELL SCI, V112, P3289; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Nilsson L, 2008, GENETICS, V179, P375, DOI 10.1534/genetics.108.087247; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; Olswang-Kutz Y, 2009, J CELL SCI, V122, P471, DOI 10.1242/jcs.038521; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Shaye DD, 2005, DEVELOPMENT, V132, P5081, DOI 10.1242/dev.02076; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; SHEN Q, 2002, SCI STKE, pPE52; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3489; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Wilkin MB, 2005, MOL MEMBR BIOL, V22, P279, DOI 10.1080/09687860500129778; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Yeh E, 2001, CURR BIOL, V11, P1675, DOI 10.1016/S0960-9822(01)00527-9; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	76	159	164	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26427	26438		10.1074/jbc.M109.014845	http://dx.doi.org/10.1074/jbc.M109.014845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19567869	Green Published, hybrid			2022-12-27	WOS:000269969600024
J	Gao, J; He, JH; Zhai, YG; Wada, TR; Xie, W				Gao, Jie; He, Jinhan; Zhai, Yonggong; Wada, Taira; Xie, Wen			The Constitutive Androstane Receptor Is an Anti-obesity Nuclear Receptor That Improves Insulin Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X-RECEPTOR; MEDIATED GLUCOSE-METABOLISM; ALPHA-DEPENDENT INDUCTION; FREE FATTY-ACIDS; CROSS-TALK; DRUG-METABOLISM; HEPATIC STEATOSIS; ENHANCER MODULE; TARGET GENES; CAR	Obesity and type 2 diabetes are related metabolic disorders of high prevalence. The constitutive androstane receptor (CAR) was initially characterized as a xenobiotic receptor regulating the responses of mammals to xenotoxicants. In this study, we have uncovered an unexpected role of CAR in preventing obesity and alleviating type 2 diabetes. Using a high fat diet (HFD)-induced obesity model, we showed that treatment of wild type mice with the CAR agonist 1,4-bis[2-(3,5 dichloropyridyloxy)] benzene (TCPOBOP) efficiently prevented obesity from happening or reversed preinduced obesity. Treatment with TCPOBOP improved insulin sensitivity in both the HFD-induced type 2 diabetic model and the ob/ob mice. In contrast, CAR null mice maintained on a chow diet showed spontaneous insulin insensitivity, which cannot be relieved by TOPOBOP treatment. The hepatic steatosis in HFD-treated mice and ob/ob mice was markedly reduced by the TCPOBOP treatment. The metabolic benefits of CAR activation may have resulted from the combined effect of inhibition of lipogenesis, very low density lipoprotein secretion and export of triglycerides, and gluconeogenesis as well as increases in brown adipose tissue energy expenditure and peripheral fat mobilization. Moreover, the skeletal muscle of CAR-activated mice showed a decreased incomplete oxidation, despite having a lower expression level of peroxisome proliferator-activated receptor alpha and its target genes involved in fatty acid oxidation. In summary, our results have revealed an important metabolic function of CAR and may establish this "xenobiotic receptor" as a novel therapeutic target for the prevention and treatment of obesity and type 2 diabetes.	[Gao, Jie; He, Jinhan; Zhai, Yonggong; Wada, Taira; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Gao, Jie; He, Jinhan; Zhai, Yonggong; Wada, Taira; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Xie, Wen] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xie, W (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, 633 Salk Hall, Pittsburgh, PA 15261 USA.	wex6@pitt.edu	Xie, Wen/M-1768-2016; Gao, Jie/C-1520-2017		National Institutes of Health [ES012479, CA107011]; NATIONAL CANCER INSTITUTE [R01CA107011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES012479 and CA107011 (to W. X.).	Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Dong BN, 2009, HEPATOLOGY, V50, P622, DOI 10.1002/hep.23025; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; HANSON ES, 1995, J NEUROENDOCRINOL, V7, P273, DOI 10.1111/j.1365-2826.1995.tb00757.x; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; HOOVERPLOW J, 1985, J NUTR, V115, P303, DOI 10.1093/jn/115.3.303; Huang WD, 2004, J CLIN INVEST, V113, P137, DOI 10.1172/JCI200418385; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; LAHTELA JT, 1984, RES COMMUN CHEM PATH, V44, P215; LAHTELA JT, 1985, DIABETES, V34, P911, DOI 10.2337/diabetes.34.9.911; Lee JH, 2008, ENDOCRINOLOGY, V149, P3778, DOI 10.1210/en.2007-1605; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; RANDLE PJ, 1963, LANCET, V1, P785; Roth A, 2008, PHARMACOGENET GENOM, V18, P325, DOI 10.1097/FPC.0b013e3282f706e0; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sugatani J, 2001, HEPATOLOGY, V33, P1232, DOI 10.1053/jhep.2001.24172; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; VENKATESAN N, 1994, METABOLISM, V43, P348, DOI 10.1016/0026-0495(94)90103-1; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wieneke N, 2007, FEBS LETT, V581, P5617, DOI 10.1016/j.febslet.2007.11.011; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	38	167	180	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25984	25992		10.1074/jbc.M109.016808	http://dx.doi.org/10.1074/jbc.M109.016808			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617349	Green Published, hybrid			2022-12-27	WOS:000269738000055
J	Clarkson, NG; Brown, MH				Clarkson, Nicholas G.; Brown, Marion H.			Inhibition and Activation by CD244 Depends on CD2 and Phospholipase C-gamma 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; LINKED LYMPHOPROLIFERATIVE DISEASE; HUMAN NK CELLS; RECEPTOR 2B4 CD244; T-CELL; CYTOPLASMIC DOMAIN; CUTTING EDGE; SIGNAL-TRANSDUCTION; INFECTED-CELLS; SH3 DOMAIN	Regulation by the NK and T cell surface receptor CD244 in mice and humans depends both on engagement at the cell surface by CD48 and intracellular interactions with SAP and EAT-2. Relevance to human disease by manipulating CD244 in mouse models is complicated by rodent CD2 also binding CD48. We distinguish between contributions of mouse CD244 and CD2 on engagement of CD48 in a mouse T cell hybridoma. CD2 and CD244 both contribute positively to the immune response as mutation of proline-rich motifs or tyrosine motifs in the tails of CD2 and CD244, respectively, result in a decrease in antigen-specific interleukin-2 production. Inhibitory effects of mouse CD244 are accounted for by competition with CD2 at the cell surface for CD48. In humans CD2 and CD244 are engaged separately at the cell surface but biochemical data suggest a potential conserved intracellular link between the two receptors through FYN kinase. We identify a novel signaling mechanism for CD244 through its potential to recruit phospholipase C-gamma 1 via the conserved phosphorylated tyrosine motif in the tail of the adaptor protein EAT-2, which we show is important for function.	[Clarkson, Nicholas G.; Brown, Marion H.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Brown, MH (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	marion.brown@path.ox.ac.uk			Medical Research Council [G0400808]; MRC [G0400808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0400808.	BELL GM, 1992, MOL CELL BIOL, V12, P5548, DOI 10.1128/MCB.12.12.5548; Bell GM, 1996, J EXP MED, V183, P169, DOI 10.1084/jem.183.1.169; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Boles KS, 1999, TISSUE ANTIGENS, V54, P27, DOI 10.1034/j.1399-0039.1999.540103.x; BROWN MH, 1988, EUR J IMMUNOL, V18, P1223, DOI 10.1002/eji.1830180812; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; CARMO AM, 1993, EUR J IMMUNOL, V23, P2196, DOI 10.1002/eji.1830230922; Carreno BM, 2000, J IMMUNOL, V165, P1352, DOI 10.4049/jimmunol.165.3.1352; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; CHANG HC, 1990, J EXP MED, V172, P351, DOI 10.1084/jem.172.1.351; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Chlewicki LK, 2008, J IMMUNOL, V180, P8159, DOI 10.4049/jimmunol.180.12.8159; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; Clarkson NG, 2007, J BIOL CHEM, V282, P25385, DOI 10.1074/jbc.M704483200; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dupre L, 2005, BLOOD, V105, P4383, DOI 10.1182/blood-2004-08-3269; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Eissmann P, 2006, J IMMUNOL, V177, P3170, DOI 10.4049/jimmunol.177.5.3170; Endt J, 2007, EUR J IMMUNOL, V37, P193, DOI 10.1002/eji.200636341; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Freund C, 2002, EMBO J, V21, P5985, DOI 10.1093/emboj/cdf602; Fukai I, 2000, EUR J IMMUNOL, V30, P3507, DOI 10.1002/1521-4141(2000012)30:12<3507::AID-IMMU3507>3.0.CO;2-O; GARNIWAGNER BA, 1993, J IMMUNOL, V151, P60; Graham DSC, 2008, GENES IMMUN, V9, P93, DOI 10.1038/sj.gene.6364453; Gu CP, 2006, P NATL ACAD SCI USA, V103, P14447, DOI 10.1073/pnas.0606624103; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; HE Q, 1988, CELL, V54, P979, DOI 10.1016/0092-8674(88)90112-2; Hofmann G, 2005, BIOCHEMISTRY-US, V44, P13043, DOI 10.1021/bi050814y; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Li CJ, 2009, CELL SIGNAL, V21, P111, DOI 10.1016/j.cellsig.2008.09.014; Li J, 1998, EMBO J, V17, P7320, DOI 10.1093/emboj/17.24.7320; Lin HM, 1998, J BIOL CHEM, V273, P19914, DOI 10.1074/jbc.273.31.19914; Morra M, 2001, EMBO J, V20, P5840, DOI 10.1093/emboj/20.21.5840; Nakajima H, 1999, EUR J IMMUNOL, V29, P1676, DOI 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Nishizawa K, 1998, P NATL ACAD SCI USA, V95, P14897, DOI 10.1073/pnas.95.25.14897; OHNO H, 1991, J IMMUNOL, V147, P2100; PANCHAMOORTHY G, 1994, MOL CELL BIOL, V14, P6372, DOI 10.1128/MCB.14.9.6372; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Schleinitz N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003278; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Stepp SE, 1999, EUR J IMMUNOL, V29, P2392, DOI 10.1002/(SICI)1521-4141(199908)29:08<2392::AID-IMMU2392>3.3.CO;2-I; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Tangye SG, 2000, MOL IMMUNOL, V37, P493, DOI 10.1016/S0161-5890(00)00076-6; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tangye SG, 1999, J IMMUNOL, V162, P6981; Tassi I, 2005, J IMMUNOL, V175, P7996, DOI 10.4049/jimmunol.175.12.7996; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Upshaw JL, 2005, J IMMUNOL, V175, P213, DOI 10.4049/jimmunol.175.1.213; VALIANTE NM, 1993, J EXP MED, V178, P1397, DOI 10.1084/jem.178.4.1397; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Watzl C, 2000, J IMMUNOL, V165, P3545, DOI 10.4049/jimmunol.165.7.3545; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200	65	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24725	24734		10.1074/jbc.M109.028209	http://dx.doi.org/10.1074/jbc.M109.028209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19586919	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000269734000007
J	Kajander, T; Sachs, JN; Goldman, A; Regan, L				Kajander, Tommi; Sachs, Jonathan N.; Goldman, Adrian; Regan, Lynne			Electrostatic Interactions of Hsp-organizing Protein Tetratricopeptide Domains with Hsp70 and Hsp90 COMPUTATIONAL ANALYSIS AND PROTEIN ENGINEERING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY; BINDING; DESIGN; RECOGNITION; INHIBITORS; STABILITY; DYNAMICS; INSIGHTS; MODELS	The Hsp-organizing protein (HOP) binds to the C termini of the chaperones Hsp70 and Hsp90, thus bringing them together so that substrate proteins can be passed from Hsp70 to Hsp90. Because Hsp90 is essential for the correct folding and maturation of many oncogenic proteins, it has become a significant target for anti-cancer drug design. HOP binds to Hsp70 and Hsp90 via two independent tetratricopeptide (TPR) domains, TPR1 and TPR2A, respectively. We have analyzed ligand binding using Poisson-Boltzmann continuum electrostatic calculations, free energy perturbation, molecular dynamics simulations, and site-directed mutagenesis to delineate the contribution of different interactions to the affinity and specificity of the TPR-peptide interactions. We found that continuum electrostatic calculations could be used to guide protein design by removing unfavorable interactions to increase binding affinity, with an 80-fold increase in affinity for TPR2A. Contributions at buried charged residues, however, were better predicted by free energy perturbation calculations. We suggest using a combination of the two approaches for increasing the accuracy of results, with free energy perturbation calculations used only at selected buried residues of the ligand binding pocket. Finally we present the crystal structure of TPR2A in complex with its non-cognate Hsp70 ligand, which provides insight on the origins of specificity in TPR domain-peptide recognition.	[Kajander, Tommi; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, FIN-00014 Helsinki, Finland; [Kajander, Tommi; Regan, Lynne] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Regan, Lynne] Yale Univ, Dept Chem, New Haven, CT 06511 USA; [Sachs, Jonathan N.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Helsinki; Yale University; Yale University; University of Minnesota System; University of Minnesota Twin Cities	Kajander, T (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, POB 65, FIN-00014 Helsinki, Finland.	tommi.kajander@helsinki.fi		Kajander, Tommi/0000-0002-5094-227X; Goldman, Adrian/0000-0001-8032-9700	Helsingin Sanomat Centennial foundation, Finland; National Research Service Award [5F32GM071134]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071134] Funding Source: NIH RePORTER	Helsingin Sanomat Centennial foundation, Finland; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported partly by a post doctoral Fellowship from the Helsingin Sanomat Centennial foundation, Finland.; Supported by National Research Service Award Grant 5F32GM071134.	BEUTLER TC, 1994, CHEM PHYS LETT, V222, P529, DOI 10.1016/0009-2614(94)00397-1; BHANDARKAR M, 2003, NAMD USERS GUIDE VER; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chipot C, 2008, J CHEM THEORY COMPUT, V4, P2150, DOI 10.1021/ct800313k; Cortajarena AL, 2008, ACS CHEM BIOL, V3, P161, DOI 10.1021/cb700260z; Cortajarena AL, 2006, PROTEIN SCI, V15, P1193, DOI 10.1110/ps.062092506; Cortajarena AL, 2004, PROTEIN ENG DES SEL, V17, P399, DOI 10.1093/protein/gzh047; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILSON MK, 1987, NATURE, V330, P84, DOI 10.1038/330084a0; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Havranek JJ, 1999, P NATL ACAD SCI USA, V96, P11145, DOI 10.1073/pnas.96.20.11145; Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381; Henin J, 2005, J AM CHEM SOC, V127, P8478, DOI 10.1021/ja050581y; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lu ND, 2004, J COMPUT CHEM, V25, P28, DOI 10.1002/jcc.10369; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Morozov AV, 2003, J PHYS CHEM B, V107, P2075, DOI 10.1021/jp0267555; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 1998, ACTA CRYSTALLOGR D, V54, P817, DOI 10.1107/S0907444997019434; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Selzer T, 1999, J MOL BIOL, V287, P409, DOI 10.1006/jmbi.1999.2615; Sham YY, 1998, BIOPHYS J, V74, P1744, DOI 10.1016/S0006-3495(98)77885-3; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; Simonson T, 2001, CURR OPIN STRUC BIOL, V11, P243, DOI 10.1016/S0959-440X(00)00197-4; Spector S, 2000, BIOCHEMISTRY-US, V39, P872, DOI 10.1021/bi992091m; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Yi F, 2008, ACS CHEM BIOL, V3, P645, DOI 10.1021/cb800162x; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	42	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25364	25374		10.1074/jbc.M109.033894	http://dx.doi.org/10.1074/jbc.M109.033894			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19586912	hybrid, Green Published			2022-12-27	WOS:000269734000069
J	Little, GH; Saw, A; Bai, Y; Dow, J; Marjoram, P; Simkhovich, B; Leeka, J; Kedes, L; Kloner, RA; Poizat, C				Little, Gillian H.; Saw, Aman; Bai, Yan; Dow, Joan; Marjoram, Paul; Simkhovich, Boris; Leeka, Justin; Kedes, Larry; Kloner, Robert A.; Poizat, Coralie			Critical Role of Nuclear Calcium/Calmodulin-dependent Protein Kinase II delta B in Cardiomyocyte Survival in Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATA-4 TRANSCRIPTION FACTOR; CARDIAC-MUSCLE-CELLS; APOPTOSIS IN-VIVO; HEART-FAILURE; CAM KINASE; INHIBITION PROTECTS; GENE-EXPRESSION; HISTONE DEACETYLASE-4; RAT-HEART; DOXORUBICIN	Calcium/calmodulin-dependent protein kinase II (CaMKII) plays a central role in cardiac contractility and heart disease. However, the specific role of alternatively spliced variants of CaMKII in cardiac disease and apoptosis remains poorly explored. Here we report that the delta B subunit of CaMKII (CaMKII delta B), which is the predominant nuclear isoform of calcium/calmodulin- dependent protein kinases in heart muscle, acts as an anti-apoptotic factor and is a novel target of the antineoplastic and cardiomyopathic drug doxorubicin (Dox(adriamycin)). Hearts of rats that develop cardiomyopathy following chronic treatment with Dox also show down-regulation of CaMKII delta B mRNA, which correlates with decreased cardiac function in vivo, reduced expression of sarcomeric proteins, and increased tissue damage associated with Dox cardiotoxicity. Overexpression of CaMKII delta B in primary cardiac cells inhibits Dox-mediated apoptosis and prevents the loss of the antiapoptotic protein Bcl-2. Specific silencing of CaMKII delta B by small interfering RNA prevents the formation of organized sarcomeres and decreases the expression of Bcl-2, which all mimic the effect of Dox. CaMKII delta B is required for GATA-4-mediated co-activation and binding to the Bcl-2 promoter. These results reveal that CaMKII delta B plays an essential role in cardiomyocyte survival and provide a mechanism for the protective role of CaMKII delta B. These results suggest that selective targeting of CaMKII in the nuclear compartment might represent a strategy to regulate cardiac apoptosis and to reduce Dox-mediated cardiotoxicity.	[Little, Gillian H.; Saw, Aman; Bai, Yan; Kedes, Larry; Poizat, Coralie] Univ So Calif, Inst Med Genet, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA; [Dow, Joan; Simkhovich, Boris; Leeka, Justin; Kloner, Robert A.] Univ So Calif, Dept Med, Inst Heart, Good Samaritan Hosp,Keck Sch Med, Los Angeles, CA 90017 USA; [Dow, Joan; Simkhovich, Boris; Leeka, Justin; Kloner, Robert A.] Univ So Calif, Div Cardiovasc Med, Inst Heart, Good Samaritan Hosp,Keck Sch Med, Los Angeles, CA 90017 USA; [Marjoram, Paul] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90017 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Poizat, C (corresponding author), Univ So Calif, Inst Med Genet, Dept Biochem & Mol Biol, Keck Sch Med, 2250 Alcazar St, Los Angeles, CA 90033 USA.	poizat@usc.edu			National Institutes of Health; NATIONAL CANCER INSTITUTE [C06CA062528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014514, C06RR010600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health grants (to L.K.).	Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Arola OJ, 2000, CANCER RES, V60, P1789; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; BALTAS LG, 1995, FEBS LETT, V373, P71, DOI 10.1016/0014-5793(95)00981-E; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; BROCKE L, 1995, J NEUROSCI, V15, P6797; Chen B, 2007, CARDIOVASC TOXICOL, V7, P114, DOI 10.1007/s12012-007-0005-5; Chen MH, 2008, CIRCULATION, V118, P84, DOI 10.1161/CIRCULATIONAHA.108.776831; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; Hagemann D, 1999, J CELL BIOCHEM, V74, P202; Heckman CA, 2000, J BIOL CHEM, V275, P6499, DOI 10.1074/jbc.275.9.6499; ITO H, 1990, P NATL ACAD SCI USA, V87, P4275, DOI 10.1073/pnas.87.11.4275; Kang YJ, 2000, J BIOL CHEM, V275, P13690, DOI 10.1074/jbc.275.18.13690; Kawamura T, 2004, BIOCHEM BIOPH RES CO, V315, P733, DOI 10.1016/j.bbrc.2004.01.105; Khan M, 2006, J CARDIOVASC PHARM, V47, P9, DOI 10.1097/01.fjc.0000191520.48404.27; Kim Y, 2003, MOL PHARMACOL, V63, P368, DOI 10.1124/mol.63.2.368; Kitta K, 2003, J BIOL CHEM, V278, P4705, DOI 10.1074/jbc.M211616200; Kitta K, 2001, BIOCHEM J, V359, P375, DOI 10.1042/0264-6021:3590375; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Maeda A, 1997, CLIN EXP PHARMACOL P, V24, P720, DOI 10.1111/j.1440-1681.1997.tb02119.x; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mishra S, 2003, AM J PHYSIOL-HEART C, V284, pH876, DOI 10.1152/ajpheart.00266.2002; Netticadan T, 2000, CIRC RES, V86, P596, DOI 10.1161/01.RES.86.5.596; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Ramirez MT, 1997, J BIOL CHEM, V272, P31203, DOI 10.1074/jbc.272.49.31203; Reeve JLV, 2007, J CELL MOL MED, V11, P509, DOI 10.1111/j.1582-4934.2007.00042.x; Rodriguez-Mora OG, 2006, CANCER BIOL THER, V5, P1022, DOI 10.4161/cbt.5.8.2910; Schwarz ER, 1998, CARDIOVASC RES, V39, P216, DOI 10.1016/S0008-6363(98)00009-1; Simichovich BZ, 2003, ARCH BIOCHEM BIOPHYS, V420, P268, DOI 10.1016/j.abb.2003.06.001; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Singer HA, 1997, J BIOL CHEM, V272, P9393; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Ueno M, 2006, J PHARMACOL SCI, V101, P151, DOI 10.1254/jphs.FP0050980; Venkatakrishnan CD, 2006, AM J PHYSIOL-HEART C, V291, pH2680, DOI 10.1152/ajpheart.00395.2006; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wright SC, 1997, FASEB J, V11, P843, DOI 10.1096/fasebj.11.11.9285482; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhang T, 2004, RECENT PROG HORM RES, V59, P141, DOI 10.1210/rp.59.1.141; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326	56	51	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24857	24868		10.1074/jbc.M109.003186	http://dx.doi.org/10.1074/jbc.M109.003186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19602725	Green Published, hybrid			2022-12-27	WOS:000269734000020
J	Al-Zahrani, AS; Kondabagil, K; Gao, S; Kelly, N; Ghosh-Kumar, M; Rao, VB				Al-Zahrani, Abdulrahman S.; Kondabagil, Kiran; Gao, Song; Kelly, Noreen; Ghosh-Kumar, Manjira; Rao, Venigalla B.			The Small Terminase, gp16, of Bacteriophage T4 Is a Regulator of the DNA Packaging Motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; LARGE SUBUNIT; ATPASE CENTER; COMPARATIVE GENOMICS; NUCLEOTIDE EXCHANGE; PROTEIN GP17; PHAGE-T4; MECHANISM; GENES; SITE	Tailed bacteriophages and herpes viruses use powerful molecular motors to translocate DNA into a preassembled prohead and compact the DNA to near crystalline density. The phage T4 motor, a pentamer of 70-kDa large terminase, gp17, is the fastest and most powerful motor reported to date. gp17 has an ATPase activity that powers DNA translocation and a nuclease activity that cuts concatemeric DNA and generates the termini of viral genome. An 18-kDa small terminase, gp16, is also essential, but its role in DNA packaging is poorly understood. gp16 forms oligomers, most likely octamers, exhibits no enzymatic activities, but stimulates the gp17-ATPase activity, and inhibits the nuclease activity. Extensive mutational and biochemical analyses show that gp16 contains three domains, a central oligomerization domain, and N- and C-terminal domains that are essential for ATPase stimulation. Stimulation occurs not by nucleotide exchange or enhanced ATP binding but by triggering hydrolysis of gp17-bound ATP, a mechanism reminiscent of GTPase-activating proteins. gp16 does not have an arginine finger but its interaction with gp17 seems to position a gp17 arginine finger into the catalytic pocket. gp16 inhibits DNA translocation when gp17 is associated with the prohead. gp16 restricts gp17-nuclease such that the putative packaging initiation cut is made but random cutting is inhibited. These results suggest that the phage T4 packaging machine consists of a motor (gp17) and a regulator (gp16). The gp16 regulator is essential to coordinate the gp17 motor ATPase, translocase, and nuclease activities, otherwise it could be suicidal to the virus.	[Al-Zahrani, Abdulrahman S.; Kondabagil, Kiran; Gao, Song; Kelly, Noreen; Ghosh-Kumar, Manjira; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Catholic University of America	Rao, VB (corresponding author), Catholic Univ Amer, Dept Biol, 620 Michigan Ave NE, Washington, DC 20064 USA.	rao@cua.edu		Rao, Venigalla/0000-0002-0777-6587	National Science Foundation [MCB-423528, MCB-0923873]	National Science Foundation(National Science Foundation (NSF))	This work was supported by Grants MCB-423528 and MCB-0923873 (to V. B. R.) from the National Science Foundation.	Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; ALZAHRANI A, 2006, THESIS CATHOLIC U AM; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; BECKER A, 1978, P NATL ACAD SCI USA, V75, P4199, DOI 10.1073/pnas.75.9.4199; Black LW, 2006, J BIOL CHEM, V281, P25635, DOI 10.1074/jbc.M602093200; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Camacho AG, 2003, J BIOL CHEM, V278, P23251, DOI 10.1074/jbc.M301805200; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019; Feiss Michael, 2005, P5; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Goetzinger KR, 2003, J MOL BIOL, V331, P139, DOI 10.1016/S0022-2836(03)00636-3; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hwang Y, 1996, J MOL BIOL, V261, P524, DOI 10.1006/jmbi.1996.0480; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; Kondabagil KR, 2006, J MOL BIOL, V363, P786, DOI 10.1016/j.jmb.2006.08.054; Kondabagil KR, 2006, J MOL BIOL, V358, P67, DOI 10.1016/j.jmb.2006.01.078; Kuebler D, 1998, J MOL BIOL, V281, P803, DOI 10.1006/jmbi.1998.1952; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Lin H, 1997, J BIOL CHEM, V272, P3495, DOI 10.1074/jbc.272.6.3495; Lin HC, 1998, VIROLOGY, V242, P118, DOI 10.1006/viro.1997.9019; LUFTIG RB, 1972, J VIROL, V10, P545, DOI 10.1128/JVI.10.3.545-554.1972; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mitchell MS, 2006, J BIOL CHEM, V281, P518, DOI 10.1074/jbc.M507719200; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Miyazaki Satoshi, 2002, Journal of Structural and Functional Genomics, V2, P37, DOI 10.1023/A:1014418700858; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Nemecek D, 2008, J MOL BIOL, V383, P494, DOI 10.1016/j.jmb.2008.08.050; RAO VB, 1988, J MOL BIOL, V200, P475, DOI 10.1016/0022-2836(88)90537-2; Rao VB, 2001, J MOL BIOL, V314, P401, DOI 10.1006/jmbi.2001.5169; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Rentas FJ, 2003, J MOL BIOL, V334, P37, DOI 10.1016/j.jmb.2003.09.028; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; SKORUPSKI K, 1992, J MOL BIOL, V223, P977, DOI 10.1016/0022-2836(92)90256-J; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; STREISIN.G, 1967, P NATL ACAD SCI USA, V57, P292, DOI 10.1073/pnas.57.2.292; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUMNERSMITH M, 1981, VIROLOGY, V111, P642, DOI 10.1016/0042-6822(81)90363-9; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wieden HJ, 2002, J BIOL CHEM, V277, P6032, DOI 10.1074/jbc.M110888200; YANG Q, 2005, BIOCHEMISTRY-US, V38, P14238; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609	55	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24490	24500		10.1074/jbc.M109.025007	http://dx.doi.org/10.1074/jbc.M109.025007			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561086	Green Published, hybrid			2022-12-27	WOS:000269380200061
J	Arredondo, SA; Chen, TF; Riggs, AF; Gilbert, HF; Georgiou, G				Arredondo, Silvia A.; Chen, Tiffany F.; Riggs, Austen F.; Gilbert, Hiram F.; Georgiou, George			Role of Dimerization in the Catalytic Properties of the Escherichia coli Disulfide Isomerase DsbC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOND FORMATION; CRYSTAL-STRUCTURE; ACTIVE-SITE; REDOX STATES; PROTEIN; THIOREDOXIN; EXPRESSION; ISOMERIZATION; SUBUNITS; COMPLEX	The bacterial protein-disulfide isomerase DsbC is a homodimeric V-shaped enzyme that consists of a dimerization domain, two alpha-helical linkers, and two opposing thioredoxin fold catalytic domains. The functional significance of the two catalytic domains of DsbC is not well understood yet. We have engineered heterodimer-like DsbC derivatives covalently linked via (Gly(3)-Ser) flexible linkers. We either inactivated one of the catalytic sites (CGYC), or entirely removed one of the catalytic domains while maintaining the putative binding area intact. Variants having a single active catalytic site display significant levels of isomerase activity. Furthermore, mDsbC[H45D]-dim[D53H], a DsbC variant lacking an entire catalytic domain but with an intact dimerization domain, also showed isomerase activity, albeit at lower levels. In addition, the absence of the catalytic domain allowed this protein to catalyze in vivo oxidation. Our results reveal that two catalytic domains in DsbC are not essential for disulfide bond isomerization and that a determining feature in isomerization is the availability of a substrate binding domain.	[Arredondo, Silvia A.; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Chen, Tiffany F.; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Riggs, Austen F.; Georgiou, George] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Riggs, Austen F.] Univ Texas Austin, Neurobiol Sect, Sch Biol Sci, Austin, TX 78712 USA; [Gilbert, Hiram F.] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Baylor College of Medicine	Georgiou, G (corresponding author), 1 Univ Stn Stop C0400, Austin, TX 78712 USA.	gg@che.utexas.edu			National Institutes of Health Grant [GM55090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55090.	Arredondo S, 2008, J BIOL CHEM, V283, P31469, DOI 10.1074/jbc.M803346200; Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; BIZUB D, 1991, J BIOL CHEM, V266, P4951; Callaway KA, 2006, BIOCHEMISTRY-US, V45, P13719, DOI 10.1021/bi0610451; Chen J, 1999, J BIOL CHEM, V274, P19601, DOI 10.1074/jbc.274.28.19601; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; Ke HM, 2006, BIOCHEMISTRY-US, V45, P15100, DOI 10.1021/bi061511m; KISHIGAMI S, 1995, FEBS LETT, V364, P55, DOI 10.1016/0014-5793(95)00354-C; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; KORTT AA, 1994, EUR J BIOCHEM, V221, P151, DOI 10.1111/j.1432-1033.1994.tb18724.x; Kurokawa Y, 2001, J BIOL CHEM, V276, P14393, DOI 10.1074/jbc.M100132200; LIANG H, 1993, P NATL ACAD SCI USA, V90, P7010, DOI 10.1073/pnas.90.15.7010; Liu XQ, 2001, J BIOL CHEM, V276, P1146, DOI 10.1074/jbc.M004929200; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; LYLES MM, 1994, J BIOL CHEM, V269, P30946; MARTINEZGALISTEO E, 1993, BIOCHIMIE, V75, P803, DOI 10.1016/0300-9084(93)90131-B; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; PREDKI PF, 1995, BIOCHEMISTRY-US, V34, P9834, DOI 10.1021/bi00031a003; Qiu J, 1998, APPL ENVIRON MICROB, V64, P4891; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Robinson CR, 1996, BIOCHEMISTRY-US, V35, P109, DOI 10.1021/bi9521194; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Segatori L, 2004, P NATL ACAD SCI USA, V101, P10018, DOI 10.1073/pnas.0403003101; Sun XX, 2000, J BIOL CHEM, V275, P22743, DOI 10.1074/jbc.M002406200; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Todorovska A, 2001, J IMMUNOL METHODS, V248, P47, DOI 10.1016/S0022-1759(00)00342-2; VUORI K, 1992, J BIOL CHEM, V267, P7211; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Yeh SM, 2007, ACTA CRYSTALLOGR D, V63, P465, DOI 10.1107/S0907444907003320; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016; Zhang Z, 2002, PROTEIN EXPRES PURIF, V26, P218, DOI 10.1016/S1046-5928(02)00502-8; Zhu H, 1996, J BIOL CHEM, V271, P30007, DOI 10.1074/jbc.271.47.30007	53	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23972	23979		10.1074/jbc.M109.010199	http://dx.doi.org/10.1074/jbc.M109.010199			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19581640	hybrid, Green Published			2022-12-27	WOS:000269380200011
J	Tsunaka, Y; Toga, J; Yamaguchi, H; Tate, S; Hirose, S; Morikawa, K				Tsunaka, Yasuo; Toga, Junko; Yamaguchi, Hiroto; Tate, Shin-ichi; Hirose, Susumu; Morikawa, Kosuke			Phosphorylated Intrinsically Disordered Region of FACT Masks Its Nucleosomal DNA Binding Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; GROUP BOX PROTEIN; TRANSCRIPTION ELONGATION; CK2 PHOSPHORYLATES; CRYSTAL-STRUCTURE; CORE PARTICLE; GAGA FACTOR; SSRP1; CHROMATIN; DOMAIN	FACT is a heterodimer of SPT16 and SSRP1, which each contain several conserved regions in the primary structure. The interaction of FACT with nucleosomes induces chromatin remodeling through the combinatorial action of its distinct functional protein regions. However, there is little mechanistic insight into how these regions cooperatively contribute to FACT functions, particularly regarding the recognition of nucleosomal DNA. Here, we report the identification of novel phosphorylation sites of Drosophila melanogaster FACT (dFACT) expressed in Sf9 cells. These sites are densely concentrated in the acidic intrinsically disordered (ID) region of the SSRP1 subunit and control nucleosomal DNA binding by dFACT. This region and the adjacent segment of the HMG domain form weak electrostatic intramolecular interactions, which is reinforced by the phosphorylation, thereby blocking DNA binding competitively. Importantly, this control mechanism appears to support rapid chromatin transactions during early embryogenesis through the dephosphorylation of some sites in the maternally transmitted dSSRP1.	[Tsunaka, Yasuo; Toga, Junko; Yamaguchi, Hiroto; Morikawa, Kosuke] Osaka Univ, Inst Prot Res, Takara Bio Endowed Lab, Osaka 5650874, Japan; [Tsunaka, Yasuo] JSPS, Chiyoda Ku, Tokyo 1028472, Japan; [Tate, Shin-ichi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Hirose, Susumu] Natl Inst Genet, Dept Dev Genet, Mishima, Shizuoka 4118540, Japan; [Morikawa, Kosuke] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Japan Society for the Promotion of Science; Hiroshima University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST)	Morikawa, K (corresponding author), Osaka Univ, Inst Prot Res, Takara Bio Endowed Lab, 6-2-3 Furuedai, Osaka 5650874, Japan.	morikako@protein.osaka-u.ac.jp	Hirose, Susumu/I-8865-2019; Tate, Shin-ichi/E-3057-2015	Tate, Shin-ichi/0000-0002-5556-7712; Tsunaka, Yasuo/0000-0002-7366-7610	Japan Society for the Promotion of Science (JSPS) [18GS0316]; Mitsubishi Foundation; MEXT Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation; MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by the Japan Society for the Promotion of Science (JSPS), by the Mitsubishi Foundation, by a Grant-in-Aid for Basic Scientific Research (S) from MEXT Japan, by the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST), and by a Grant-in-Aid for Creative Scientific Research Program (18GS0316) from JSPS.	AIZAWA S, 1994, BIOCHEMISTRY-US, V33, P14690, DOI 10.1021/bi00253a006; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; CAVANAGH J, 1996, PROTEIN NMR SPECTROS, P411; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Gariglio M, 1997, EXP CELL RES, V236, P472, DOI 10.1006/excr.1997.3742; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Grasser KD, 1998, TRENDS PLANT SCI, V3, P260, DOI 10.1016/S1360-1385(98)01259-X; Grasser KD, 2003, PLANT MOL BIOL, V53, P281, DOI 10.1023/B:PLAN.0000007002.99408.ba; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kasai N, 2005, J BIOMOL NMR, V32, P83, DOI 10.1007/s10858-005-3662-3; Kawabata T, 2002, NUCLEIC ACIDS RES, V30, P294, DOI 10.1093/nar/30.1.294; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Krohn NM, 2003, J BIOL CHEM, V278, P12710, DOI 10.1074/jbc.M300250200; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Li YP, 2005, J BIOL CHEM, V280, P11869, DOI 10.1074/jbc.M413944200; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MILES J, 1992, P NATL ACAD SCI USA, V89, P1276, DOI 10.1073/pnas.89.4.1276; Miyagi A, 2008, CHEMPHYSCHEM, V9, P1859, DOI 10.1002/cphc.200800210; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nakayama T, 2007, GENE DEV, V21, P552, DOI 10.1101/gad.1503407; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rickards B, 2007, MOL CELL BIOL, V27, P937, DOI 10.1128/MCB.01584-06; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Schlesinger MB, 2000, GENETICS, V155, P1593; Shimojima T, 2003, GENE DEV, V17, P1605, DOI 10.1101/gad.1086803; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Thomsen MS, 2004, BIOCHEMISTRY-US, V43, P8029, DOI 10.1021/bi0499009; Tsunaka Y, 2005, NUCLEIC ACIDS RES, V33, P3424, DOI 10.1093/nar/gki663; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Watson M, 2007, J MOL BIOL, V374, P1286, DOI 10.1016/j.jmb.2007.09.075; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	53	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24610	24621		10.1074/jbc.M109.001958	http://dx.doi.org/10.1074/jbc.M109.001958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19605348	Green Published, hybrid			2022-12-27	WOS:000269380200070
J	Chien, YC; Masica, DL; Gray, JJ; Nguyen, S; Vali, H; Mckee, MD				Chien, Yung-Ching; Masica, David L.; Gray, Jeffrey J.; Nguyen, Sarah; Vali, Hojatollah; Mckee, Marc D.			Modulation of Calcium Oxalate Dihydrate Growth by Selective Crystal-face Binding of Phosphorylated Osteopontin and Polyaspartate Peptide Showing Occlusion by Sectoral (Compositional) Zoning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL EPITHELIAL-CELLS; KIDNEY-STONE FORMATION; INTRACRYSTALLINE PROTEINS; IN-VITRO; MONOHYDRATE CRYSTALS; MEMBRANE INTERACTION; BONE SIALOPROTEIN; URINARY CRYSTALS; ACIDIC PROTEINS; EXPRESSION	Calcium oxalate dihydrate (COD) mineral and the urinary protein osteopontin/uropontin (OPN) are commonly found in kidney stones. To investigate the effects of OPN on COD growth, COD crystals were grown with phosphorylated OPN or a polyaspartic acid-rich peptide of OPN (DDLDDDDD, poly-Asp(86-93)). Crystals grown with OPN showed increased dimensions of the {110} prismatic faces attributable to selective inhibition at this crystallographic face. At high concentrations of OPN, elongated crystals with dominant {110} faces were produced, often with intergrown, interpenetrating twin crystals. Poly-Asp(86-93) dose-dependently elongated crystal morphology along the {110} faces in a manner similar to OPN. In crystal growth studies using fluorescently tagged poly-Asp(86-93) followed by imaging of crystal interiors using confocal microscopy, sectoral (compositional) zoning in COD was observed resulting from selective binding and incorporation (occlusion) of peptide exclusively into {110} crystal sectors. Computational modeling of poly-Asp(86-93) adsorption to COD {110} and {101} surfaces also suggests increased stabilization of the COD {110} surface and negligible change to the natively stable {101} surface. Ultrastructural, colloidal-gold immunolocalization of OPN by transmission electron microscopy in human stones confirmed an intracrystalline distribution of OPN. In summary, OPN and its poly-Asp(86-93) sequence similarly affect COD mineral growth; the {110} crystallographic faces become enhanced and dominant attributable to {110} face inhibition by the protein/peptide, and peptides can incorporate into the mineral phase. We, thus, conclude that the poly-Asp(86-93) domain is central to the OPN ability to interact with the {110} faces of COD, where it binds to inhibit crystal growth with subsequent intracrystalline incorporation (occlusion).	[Chien, Yung-Ching; Nguyen, Sarah; Vali, Hojatollah; Mckee, Marc D.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada; [Masica, David L.; Gray, Jeffrey J.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Vali, Hojatollah; Mckee, Marc D.] McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	McGill University; Johns Hopkins University; Johns Hopkins University; McGill University	Mckee, MD (corresponding author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	marc.mckee@mcgill.ca	Vali, Hojatollah/F-3511-2012; McKee, Marc D/E-2187-2011; Gray, Jeffrey J./B-5682-2008	Vali, Hojatollah/0000-0003-3464-9943; McKee, Marc D/0000-0001-8349-965X; Gray, Jeffrey J./0000-0001-6380-2324	Canadian Institutes of Health Research [MT11360]; Arnold and Mabel Beckman Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [0846324] Funding Source: National Science Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Arnold and Mabel Beckman Foundation; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by Canadian Institutes of Health Research Grant MT11360 (to M. D. M.) and by the Arnold and Mabel Beckman Foundation.	ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; AIZENBERG J, 1995, FASEB J, V9, P262, DOI 10.1096/fasebj.9.2.7781928; Albeck S, 1996, CONNECT TISSUE RES, V35, P365, DOI 10.3109/03008209609029213; Asplin JR, 1998, KIDNEY INT, V53, P194, DOI 10.1046/j.1523-1755.1998.00739.x; BARTHOLOMEW RS, 1979, AM J OPHTHALMOL, V88, P1026, DOI 10.1016/0002-9394(79)90410-0; BERG W, 1979, EUR UROL, V5, P136; BERG W, 1976, European Urology, V2, P92; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; BROWN LF, 1992, MOL BIOL CELL, V3, P1169, DOI 10.1091/mbc.3.10.1169; Cerini C, 1999, KIDNEY INT, V55, P1776, DOI 10.1046/j.1523-1755.1999.00426.x; Chauvet MC, 2005, J STRUCT BIOL, V151, P12, DOI 10.1016/j.jsb.2005.04.005; Chien YC, 2008, J STRUCT BIOL, V163, P84, DOI 10.1016/j.jsb.2008.04.008; Chutipongtanate S, 2005, J CLIN INVEST, V115, P3613, DOI 10.1172/JCI25342; DAUDON M, 2008, 2 INT UR RES S; Daudon Michel, 2004, Rev Med Suisse Romande, V124, P455; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Dowty E., 2002, SHAPE WINDOWS PROFES; DOYLE IR, 1991, CLIN CHEM, V37, P1589; Durrbaum D, 2001, UROL RES, V29, P83, DOI 10.1007/s002400000163; Elhadj S, 2006, P NATL ACAD SCI USA, V103, P19237, DOI 10.1073/pnas.0605748103; Elhadj S, 2006, CRYST GROWTH DES, V6, P197, DOI 10.1021/cg050288+; ELLIOT JS, 1980, J UROLOGY, V123, P324, DOI 10.1016/S0022-5347(17)55918-2; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Fleming DE, 2003, J BONE MINER RES, V18, P1282, DOI 10.1359/jbmr.2003.18.7.1282; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; GIBSON RI, 1974, AM MINERAL, V59, P1177; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Grover PK, 2008, AM J PHYSIOL-RENAL, V294, pF355, DOI 10.1152/ajprenal.00529.2007; Hoyer JR, 2001, KIDNEY INT, V60, P77, DOI 10.1046/j.1523-1755.2001.00772.x; Hunter GK, 2009, CELLS TISSUES ORGANS, V189, P44, DOI 10.1159/000151430; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Khan SR, 1997, WORLD J UROL, V15, P236, DOI 10.1007/BF01367661; Kim IW, 2006, CRYST GROWTH DES, V6, P5, DOI 10.1021/cg0502183; Kleinman Jack G., 2004, Nephron Physiology, V98, pP43, DOI 10.1159/000080263; KOHRI K, 1993, J BIOL CHEM, V268, P15180; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Koul HK, 1999, J AM SOC NEPHROL, V10, pS417; Langdon A, 2009, CALCIFIED TISSUE INT, V84, P240, DOI 10.1007/s00223-008-9215-5; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LEPAGE L, 1982, J PHARM SCI, V71, P1059, DOI 10.1002/jps.2600710927; LEWIS RD, 1974, ARCH PATHOL, V98, P149; Lieske JC, 1999, J AM SOC NEPHROL, V10, pS422; Lieske JC, 1997, KIDNEY INT, V52, P1291, DOI 10.1038/ki.1997.454; Lieske JC, 1996, CALCIFIED TISSUE INT, V58, P195, DOI 10.1007/BF02526887; LOPEZ CA, 1993, LAB INVEST, V69, P355; Makrodimitris K, 2007, J AM CHEM SOC, V129, P13713, DOI 10.1021/ja074602v; MANDEL N, 1994, J AM SOC NEPHROL, V5, pS37; MANDEL NS, 1987, J UROLOGY, V138, P557, DOI 10.1016/S0022-5347(17)43258-7; MANDEL NS, 1989, J UROLOGY, V142, P1516, DOI 10.1016/S0022-5347(17)39145-0; Masica DL, 2009, BIOPHYS J, V96, P3082, DOI 10.1016/j.bpj.2009.01.033; MCKEE MD, 1995, MICROSC RES TECHNIQ, V31, P44, DOI 10.1002/jemt.1070310105; MCKEE MD, 1995, J BONE MINER RES, V10, P1913; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; O'Young J, 2009, CELLS TISSUES ORGANS, V189, P51, DOI 10.1159/000151724; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Palmer D., 2005, CRYSTAL MAKER; Pampena DA, 2004, BIOCHEM J, V378, P1083, DOI 10.1042/BJ20031150; Pedraza CE, 2008, J CELL BIOCHEM, V103, P1379, DOI 10.1002/jcb.21515; Pokroy B, 2006, J STRUCT BIOL, V155, P96, DOI 10.1016/j.jsb.2006.03.008; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; REEDER RJ, 1987, GEOCHIM COSMOCHIM AC, V51, P187, DOI 10.1016/0016-7037(87)90230-4; Rittling SR, 1999, EXP NEPHROL, V7, P103; Ryall RL, 2005, BJU INT, V96, P654, DOI 10.1111/j.1464-410X.2005.05701.x; RYALL RL, 1985, UROL RES, V13, P285; Ryall RL, 2001, J STRUCT BIOL, V134, P5, DOI 10.1006/jsbi.2001.4363; Ryall RL, 2007, UROL RES, V35, P1, DOI 10.1007/s00240-007-0078-4; Sheng XX, 2005, P NATL ACAD SCI USA, V102, P267, DOI 10.1073/pnas.0406835101; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SORENSEN ES, 1993, J DAIRY RES, V60, P189, DOI 10.1017/S0022029900027503; Stephenson AE, 2008, SCIENCE, V322, P724, DOI 10.1126/science.1159417; Taller A, 2007, BIOPHYS J, V93, P1768, DOI 10.1529/biophysj.106.101881; Tawada T, 1999, UROL RES, V27, P238, DOI 10.1007/s002400050116; TAZZOLI V, 1980, AM MINERAL, V65, P327; Thurgood LA, 2008, UROL RES, V36, P103, DOI 10.1007/s00240-008-0139-3; Touryan LA, 2001, J CRYST GROWTH, V233, P380, DOI 10.1016/S0022-0248(01)01441-5; Verkoelen CF, 2000, KIDNEY INT, V57, P1072, DOI 10.1046/j.1523-1755.2000.00934.x; Wang LJ, 2006, LANGMUIR, V22, P7279, DOI 10.1021/la060897z; WERNESS PG, 1981, J CRYST GROWTH, V53, P166, DOI 10.1016/0022-0248(81)90063-4; Wesson JA, 1998, KIDNEY INT, V53, P952, DOI 10.1111/j.1523-1755.1998.00839.x; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; Wesson JA, 2006, CURR OPIN NEPHROL HY, V15, P386, DOI 10.1097/01.mnh.0000232879.50716.6f; Wesson Jeffrey A., 1996, Scanning Microscopy, V10, P415; WIESSNER JH, 1986, J UROLOGY, V135, P835, DOI 10.1016/S0022-5347(17)45871-X; Worcester EM, 1996, SEMIN NEPHROL, V16, P474; Xie YS, 2001, KIDNEY INT, V60, P1645, DOI 10.1046/j.1523-1755.2001.00032.x; Yasui T, 2001, UROL RES, V29, P50, DOI 10.1007/s002400000152	87	58	60	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23491	23501		10.1074/jbc.M109.021899	http://dx.doi.org/10.1074/jbc.M109.021899			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581305	Green Published, hybrid			2022-12-27	WOS:000269180000034
J	Gonzalez, V; Guo, KX; Hurley, L; Sun, D				Gonzalez, Veronica; Guo, Kexiao; Hurley, Laurence; Sun, Daekyu			Identification and Characterization of Nucleolin as a c-myc G-quadruplex-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEASE HYPERSENSITIVE ELEMENT; INTRAMOLECULAR G-QUADRUPLEX; PROXIMAL PROMOTER REGION; PRE-RIBOSOMAL-RNA; POLYMERASE-I TRANSCRIPTION; REMODELING COMPLEX NORC; RELEVANT G-QUADRUPLEX; HUMAN TELOMERIC DNA; GENE-EXPRESSION; MESSENGER-RNA	myc is a proto-oncogene that plays an important role in the promotion of cellular growth and proliferation. Understanding the regulation of c-myc is important in cancer biology, as it is overexpressed in a wide variety of human cancers, including most gynecological, breast, and colon cancers. We previously demonstrated that a guanine-rich region upstream of the P1 promoter of c-myc that controls 85-90% of the transcriptional activation of this gene can form an intramolecular G-quadruplex (G4) that functions as a transcriptional repressor element. In this study, we used an affinity column to purify proteins that selectively bind to the human c-myc G-quadruplex. We found that nucleolin, a multifunctional phosphoprotein, binds in vitro to the c-myc G-quadruplex structure with high affinity and selectivity when compared with other known quadruplex structures. In addition, we demonstrate that upon binding, nucleolin facilitates the formation and increases the stability of the c-myc G-quadruplex structure. Furthermore, we provide evidence that nucleolin overexpression reduces the activity of a c-myc promoter in plasmid presumably by inducing and stabilizing the formation of the c-myc G-quadruplex. Finally, we show that nucleolin binds to the c-myc promoter in HeLa cells, which indicates that this interaction occurs in vivo. In summary, nucleolin may induce c-myc G4 formation in vivo.	[Hurley, Laurence] BIO5 Inst, Tucson, AZ 85721 USA; [Gonzalez, Veronica; Hurley, Laurence; Sun, Daekyu] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA; [Guo, Kexiao] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Hurley, Laurence] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; Arizona Center Cancer Care; University of Arizona	Hurley, L (corresponding author), BIO5 Inst, 1657 E Helen St, Tucson, AZ 85721 USA.	hurley@pharmacy.arizona.edu; sun@pharmacy.arizona.edu			National Institutes of Health [GM085585, CA94166, CA95060]; NATIONAL CANCER INSTITUTE [P30CA023074, P50CA095060, R01CA094166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM085585 and CA94166 and CA95060 (Under-represented Minority Supplements).	Alarcon-Vargas D, 2004, J BIOL CHEM, V279, P5008, DOI 10.1074/jbc.M312054200; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; Allain FHT, 2000, J MOL BIOL, V303, P227, DOI 10.1006/jmbi.2000.4118; Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; BERBERICH SJ, 1995, ONCOGENE, V10, P2343; Bouvet P, 1997, EMBO J, V16, P5235, DOI 10.1093/emboj/16.17.5235; Bouvet P, 2001, J MOL BIOL, V309, P763, DOI 10.1006/jmbi.2001.4691; BRYS A, 1994, P NATL ACAD SCI USA, V91, P4915, DOI 10.1073/pnas.91.11.4915; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Chang CC, 2004, ANAL CHEM, V76, P4490, DOI 10.1021/ac049510s; Chang CC, 2003, ANAL CHEM, V75, P6177, DOI 10.1021/ac034789i; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Cheng M, 1999, J BIOL CHEM, V274, P6553, DOI 10.1074/jbc.274.10.6553; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; DANG CV, 1995, C MYC FUNCTION NEOPL, P85; DAVIS TL, 1989, P NATL ACAD SCI USA, V86, P9682, DOI 10.1073/pnas.86.24.9682; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Dempsey LA, 1998, J BIOL CHEM, V273, P29224, DOI 10.1074/jbc.273.44.29224; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Dexheimer TS, 2009, MOL CANCER THER, V8, P1363, DOI 10.1158/1535-7163.MCT-08-1093; DRYGIN D, 2008, P 99 ANN M AM ASS CA; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; FAHRLANDER PD, 1985, P NATL ACAD SCI USA, V82, P3746, DOI 10.1073/pnas.82.11.3746; Fry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4336, DOI 10.2741/2391; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; Ginisty H, 2000, J BIOL CHEM, V275, P18845, DOI 10.1074/jbc.M002350200; Ginisty H, 1999, J CELL SCI, V112, P761; Grinstein E, 2002, J EXP MED, V196, P1067, DOI 10.1084/jem.20011053; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Guo K, 2007, J AM CHEM SOC, V129, P10220, DOI 10.1021/ja072185g; Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Khateb S, 2004, NUCLEIC ACIDS RES, V32, P4145, DOI 10.1093/nar/gkh745; Khateb S, 2007, NUCLEIC ACIDS RES, V35, P5775, DOI 10.1093/nar/gkm636; Kim MY, 2003, CANCER RES, V63, P3247; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; Langst G, 1997, EMBO J, V16, P760, DOI 10.1093/emboj/16.4.760; Langst G, 1998, EMBO J, V17, P3135, DOI 10.1093/emboj/17.11.3135; Lemarteleur T, 2004, BIOCHEM BIOPH RES CO, V323, P802, DOI 10.1016/j.bbrc.2004.08.150; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nasi S, 2001, FEBS LETT, V490, P153, DOI 10.1016/S0014-5793(01)02118-4; Nemeth A, 2004, NUCLEIC ACIDS RES, V32, P4091, DOI 10.1093/nar/gkh732; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Phan AT, 2002, NUCLEIC ACIDS RES, V30, P4618, DOI 10.1093/nar/gkf597; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Roger B, 2003, CHROMOSOMA, V111, P399, DOI 10.1007/s00412-002-0221-5; Scaggiante B, 2006, FEBS J, V273, P1350, DOI 10.1111/j.1742-4658.2006.05143.x; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Seri M, 2000, NAT GENET, V26, P103; Serin G, 1996, BIOCHIMIE, V78, P530, DOI 10.1016/0300-9084(96)84759-6; Shammas MA, 2004, CLIN CANCER RES, V10, P770, DOI 10.1158/1078-0432.CCR-0793-03; Shin-ya K, 2001, J AM CHEM SOC, V123, P1262, DOI 10.1021/ja005780q; Shiue CN, 2009, ONCOGENE, V28, P1833, DOI 10.1038/onc.2009.21; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; SPENCER CA, 1991, ADV CANCER RES, V56, P1; Strohner R, 2004, MOL CELL BIOL, V24, P1791, DOI 10.1128/MCB.24.4.1791-1798.2004; Sun D, 2008, MOL CANCER THER, V7, P880, DOI 10.1158/1535-7163.MCT-07-2119; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806	97	219	224	3	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23622	23635		10.1074/jbc.M109.018028	http://dx.doi.org/10.1074/jbc.M109.018028			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581307	hybrid, Green Published			2022-12-27	WOS:000269180000048
J	Steed, PR; Fillingame, RH				Steed, P. Ryan; Fillingame, Robert H.			Aqueous Accessibility to the Transmembrane Regions of Subunit c of the Escherichia coli F1F0 ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTARY MOTOR; ACCESS PATHWAYS; CARBOXYL GROUP; CROSS-LINKING; ROTOR RING; K+ CHANNEL; MEMBRANE; CYSTEINE; BINDING; HELICES	Rotary catalysis in F1F0 ATP synthase is powered by proton translocation through the membrane-embedded F-0 sector. Proton binding and release occur in the middle of the membrane at Asp-61 on transmembrane helix (TMH) 2 of subunit c. Previously the reactivity of Cys substituted into TMH2 revealed extensive aqueous access at the cytoplasmic side as probed with Ag+ and other thiolate-directed reagents. The analysis of aqueous accessibility of membrane-embedded regions in subunit c was extended here to TMH1 and the periplasmic side of TMH2. The Ag+ sensitivity of Cys substitutions was more limited on the periplasmic versus cytoplasmic side of TMH2. In TMH1, Ag+ sensitivity was restricted to a pocket of four residues lying directly behind Asp-61. Aqueous accessibility was also probed using Cd2+, a membrane-impermeant soft metal ion with properties similar to Ag+. Cd2+ inhibition was restricted to the I28C substitution in TMH1 and residues surrounding Asp-61 in TMH2. The overall pattern of inhibition, by all of the reagents tested, indicates highest accessibility on the cytoplasmic side of TMH2 and in a pocket of residues around Asp-61, including proximal residues in TMH1. Additionally subunit a was shown to mediate access to this region by the membrane-impermeant probe 2-(trimethylammonium) ethyl methanethiosulfonate. Based upon these results and other information, a pocket of aqueous accessible residues, bordered by the peripheral surface of TMH4 of subunit a, is proposed to extend from the cytoplasmic side of cTMH2 to Asp-61 in the center of the membrane.	[Steed, P. Ryan; Fillingame, Robert H.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu		Steed, Ryan/0000-0001-5445-0080	United States Public Health Service [GM23105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM23105 from the United States Public Health Service.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; AYLETT BJ, 1979, CHEM BIOCH BIOL CADM, V2, P1; Barik S, 1996, Methods Mol Biol, V57, P203; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev OY, 2001, J BIOL CHEM, V276, P27449, DOI 10.1074/jbc.M100762200; FILLINGAME RH, 1991, J BIOL CHEM, V266, P20934; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Harrington MA, 1999, J BIOL CHEM, V274, P27536, DOI 10.1074/jbc.274.39.27536; HOPPE J, 1984, BIOCHIM BIOPHYS ACTA, V768, P1, DOI 10.1016/0304-4173(84)90005-3; HOPPE J, 1980, EUR J BIOCHEM, V112, P17, DOI 10.1111/j.1432-1033.1980.tb04981.x; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Jones PC, 2001, J BACTERIOL, V183, P1524, DOI 10.1128/JB.183.5.1524-1530.2001; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kwaw I, 2001, BIOCHEMISTRY-US, V40, P10491, DOI 10.1021/bi010866x; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Penefsky H S, 1979, Methods Enzymol, V56, P527; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; von Ballmoos C, 2002, EUR J BIOCHEM, V269, P5581, DOI 10.1046/j.1432-1033.2002.03264.x; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	43	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23243	23250		10.1074/jbc.M109.002501	http://dx.doi.org/10.1074/jbc.M109.002501			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19542218	Green Published, hybrid			2022-12-27	WOS:000269180000009
J	Tzatsos, A				Tzatsos, Alexandros			Raptor Binds the SAIN (Shc and IRS-1 NPXY Binding) Domain of Insulin Receptor Substrate-1 (IRS-1) and Regulates the Phosphorylation of IRS-1 at Ser-636/639 by mTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; DEPENDENT PHOSPHORYLATION; SERINE PHOSPHORYLATION; PROTEIN-KINASE; S6 KINASE; TOS MOTIF; RAPAMYCIN; PATHWAY; AKT/PKB; DEGRADATION	In normal physiological states mTOR phosphorylates and activates Akt. However, under diabetic-mimicking conditions mTOR inhibits phosphatidylinositol (PI) 3-kinase/Akt signaling by phosphorylating insulin receptor substrate-1 (IRS-1) at Ser-636/639. The molecular basis for the differential effect of mTOR signaling on Akt is poorly understood. Here, it has been shown that knockdown of mTOR, Raptor, and mLST8, but not Rictor and mSin1, suppresses insulin-stimulated phosphorylation of IRS-1 at Ser-636/639 and stabilizes IRS-1 after long term insulin stimulation. This phosphorylation depends on the PI 3-kinase/PDK1 axis but is Akt-independent. At the molecular level, Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of IRS-1 and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR. IRS-1 lacking the SAIN domain does not interact with Raptor, is not phosphorylated at Ser-636/639, and favorably interacts with PI 3-kinase. Overall, these data provide new insights in the molecular mechanisms by which mTORC1 inhibits PI 3-kinase/Akt signaling at the level of IRS-1 and suggest that mTOR signaling toward Akt is scaffold-dependent.	Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Tzatsos, A (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Simches Res Bldg,CPZN 4100,185 Cambridge St, Boston, MA 02114 USA.	atzatsos@partners.org		Tzatsos, Alexandros/0000-0002-8476-4328	E. Nestora	E. Nestora	This work was supported by E. Nestora.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rodgers BD, 2001, J ENDOCRINOL, V168, P325, DOI 10.1677/joe.0.1680325; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002	39	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22525	22534		10.1074/jbc.M109.027748	http://dx.doi.org/10.1074/jbc.M109.027748			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561084	Green Published, hybrid			2022-12-27	WOS:000268963100005
J	Amat, R; Planavila, A; Chen, SL; Iglesias, R; Giralt, M; Villarroya, F				Amat, Ramon; Planavila, Anna; Chen, Shen Liang; Iglesias, Roser; Giralt, Marta; Villarroya, Francesc			SIRT1 Controls the Transcription of the Peroxisome Proliferator-activated Receptor-gamma Co-activator-1 alpha (PGC-1 alpha) Gene in Skeletal Muscle through the PGC-1 alpha Autoregulatory Loop and Interaction with MyoD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-FUNCTION; COACTIVATOR PGC-1-ALPHA; PROTEIN; EXPRESSION; ALPHA; DIFFERENTIATION; DEACETYLASE; INCREASES; OXIDATION; EXERCISE	Peroxisome proliferator activated receptor-gamma co-activator-1 alpha (PGC-1 alpha) is a transcriptional co-activator that coordinately regulates the expression of distinct sets of metabolism-related genes in different tissues. Here we show that PGC-1 alpha expression is reduced in skeletal muscles from mice lacking the sirtuin family deacetylase SIRT1. Conversely, SIRT1 activation or overexpression in differentiated C2C12 myotubes increased PGC-1 alpha mRNA expression. The transcription-promoting effects of SIRT1 occurred through stimulation of PGC-1 alpha promoter activity and were enhanced by co-transfection of myogenic factors, such as myocyte enhancer factor 2 (MEF2) and, especially, myogenic determining factor (MyoD). SIRT1 bound to the proximal promoter region of the PGC-1 alpha gene, an interaction potentiated by MEF2C or MyoD, which also interact with this region. In the presence of MyoD, SIRT1 promoted a positive autoregulatory PGC-1 alpha expression loop, such that overexpression of PGC-1 alpha increased PGC-1 alpha promoter activity in the presence of co-expressed MyoD and SIRT1. Chromatin immunoprecipitation showed that SIRT1 interacts with PGC-1 alpha promoter and increases PGC-1 alpha recruitment to its own promoter region. Immunoprecipitation assays further showed that SIRT1-PGC-1 alpha interactions are enhanced by MyoD. Collectively, these data indicate that SIRT1 controls PGC-1 alpha gene expression in skeletal muscle and that MyoD is a key mediator of this action. The involvement of MyoD in SIRT1-dependent PGC-1 alpha expression may help to explain the ability of SIRT1 to drive muscle-specific gene expression and metabolism. Autoregulatory control of PGC-1 alpha gene transcription seems to be a pivotal mechanism for conferring a transcription-activating response to SIRT1 in skeletal muscle.	[Amat, Ramon; Planavila, Anna; Iglesias, Roser; Giralt, Marta; Villarroya, Francesc] Univ Barcelona, Dept Bioquim & Biol Mol, Inst Biomed, E-08028 Barcelona, Spain; [Amat, Ramon; Planavila, Anna; Iglesias, Roser; Giralt, Marta; Villarroya, Francesc] CIBER Fisiopatol Obesidad & Nutr, Barcelona 08028, Spain; [Chen, Shen Liang] Natl Cent Univ, Dept Life Sci, Jhongli 32054, Taiwan	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; National Central University	Villarroya, F (corresponding author), Univ Barcelona, Dept Bioquim & Biol Mol, Inst Biomed, Avda Diagonal 645, E-08028 Barcelona, Spain.	fvillarroya@ub.edu	Giralt, Marta/A-4756-2013; Iglesias, Roser/C-5561-2017; Amat, Ramon/F-2681-2010; Villarroya, Francesc/K-4357-2014	Giralt, Marta/0000-0001-7968-4190; Iglesias, Roser/0000-0002-7107-8097; Amat, Ramon/0000-0001-8284-2540; Anna, Planavila Porta/0000-0001-5474-4724; Villarroya, Francesc/0000-0003-1266-9142	Ministerio de Ciencia e Innovacion, Spain [SAF2008-01896]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work is supported by Grant SAF2008-01896 from the Ministerio de Ciencia e Innovacion, Spain.	Amat R, 2007, J BIOL CHEM, V282, P34066, DOI 10.1074/jbc.M707114200; AMRI EZ, 1995, J BIOL CHEM, V270, P2367, DOI 10.1074/jbc.270.5.2367; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675; Baldan A, 2004, NUCLEIC ACIDS RES, V32, P4742, DOI 10.1093/nar/gkh806; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Chang JH, 2006, ENDOCRINOLOGY, V147, P3093, DOI 10.1210/en.2005-1317; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Nadal A, 2002, BIOCHEM J, V366, P289, DOI 10.1042/BJ20020598; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pilegaard H, 2003, DIABETES, V52, P657, DOI 10.2337/diabetes.52.3.657; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Solanes G, 2000, FASEB J, V14, P2141; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017	31	166	171	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21872	21880		10.1074/jbc.M109.022749	http://dx.doi.org/10.1074/jbc.M109.022749			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553684	Green Published, hybrid			2022-12-27	WOS:000268783700011
J	Finger, LD; Blanchard, MS; Theimer, CA; Sengerova, B; Singh, P; Chavez, V; Liu, F; Grasby, JA; Shen, BH				Finger, L. David; Blanchard, M. Suzette; Theimer, Carla A.; Sengerova, Blanka; Singh, Purnima; Chavez, Valerie; Liu, Fei; Grasby, Jane A.; Shen, Binghui			The 3 '-Flap Pocket of Human Flap Endonuclease 1 Is Critical for Substrate Binding and Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; DNA-POLYMERASE-I; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS; OKAZAKI FRAGMENTS; ESCHERICHIA-COLI; STRUCTURAL BASIS; PCNA BINDING; HUMAN FEN1; EXONUCLEASE	Flap endonuclease 1 (FEN1) proteins, which are present in all kingdoms of life, catalyze the sequence-independent hydrolysis of the bifurcated nucleic acid intermediates formed during DNA replication and repair. How FEN1s have evolved to preferentially cleave flap structures is of great interest especially in light of studies wherein mice carrying a catalytically deficient FEN1 were predisposed to cancer. Structural studies of FEN1s from phage to human have shown that, although they share similar folds, the FEN1s of higher organisms contain a 3'-extrahelical nucleotide (3'-flap) binding pocket. When presented with 5'-flap substrates having a 3'-flap, archaeal and eukaryotic FEN1s display enhanced reaction rates and cleavage site specificity. To investigate the role of this interaction, a kinetic study of human FEN1 (hFEN1) employing well defined DNA substrates was conducted. The presence of a 3'-flap on substrates reduced K-m and increased multiple- and single turnover rates of endonucleolytic hydrolysis at near physiological salt concentrations. Exonucleolytic and fork-gap-endonucleolytic reactions were also stimulated by the presence of a 3'-flap, and the absence of a 3'-flap from a 5'-flap substrate was more detrimental to hFEN1 activity than removal of the 5'-flap or introduction of a hairpin into the 5'-flap structure. hFEN1 reactions were predominantly rate-limited by product release regardless of the presence or absence of a 3'-flap. Furthermore, the identity of the stable enzyme product species was deduced from inhibition studies to be the 5'-phosphorylated product. Together the results indicate that the presence of a 3'-flap is the critical feature for efficient hFEN1 substrate recognition and catalysis.	[Finger, L. David; Singh, Purnima; Chavez, Valerie; Shen, Binghui] City Hope Natl Med Ctr, Div Radiat Biol, Duarte, CA 91010 USA; [Chavez, Valerie] City Hope Natl Med Ctr, Grad Sch Biol Sci, Duarte, CA 91010 USA; [Chavez, Valerie] Beckman Res Inst, Duarte, CA 91010 USA; [Theimer, Carla A.; Liu, Fei] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Sengerova, Blanka; Grasby, Jane A.] Univ Sheffield, Krebs Inst, Dept Chem, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England	City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Sheffield	Finger, LD (corresponding author), Kaplan Black Bldg,1500 E Duarte Rd, Duarte, CA 91010 USA.	lfingerjr@coh.org; bshen@coh.org	Collis, Blanka/ABB-6858-2020	Shen, Binghui/0000-0002-4408-407X; Singh, Purnima/0000-0002-4968-7398; Finger, L. David/0000-0002-2342-9569	National Institutes of Health [NCI F32CA117236, R01CA073764]; Biotechnology and Biological Sciences and Research Council [B20079, F0147321]; BBSRC [BB/F014732/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [B20079, BB/F014732/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [F32CA117236, R01CA073764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences and Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants NCI F32CA117236 (to L. D. F.) and R01CA073764 (to B.Sh.). This work was also supported by Biotechnology and Biological Sciences and Research Council Grants B20079 and F0147321 (to J.A.G.).	Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Cook P. F., 2007, ENZYME KINETICS MECH, P121; Correll CC, 2008, RSC BIOMOL SCI, P1, DOI 10.1039/9781847558268-00001; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; DUXIN JP, 2009, MOL CELL BIOL   0101; Fersht A., 1985, ENZYME STRUCTURE MEC; Frank G, 1998, J BIOL CHEM, V273, P33064, DOI 10.1074/jbc.273.49.33064; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Friedrich-Heineken E, 2004, NUCLEIC ACIDS RES, V32, P2520, DOI 10.1093/nar/gkh576; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hastie Tj, 1991, STAT MODELS S, P95; Hosfield DJ, 1998, J BIOL CHEM, V273, P27154, DOI 10.1074/jbc.273.42.27154; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Kaiser MW, 1999, J BIOL CHEM, V274, P21387, DOI 10.1074/jbc.274.30.21387; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Larsen E, 2008, CANCER RES, V68, P4571, DOI 10.1158/0008-5472.CAN-08-0168; LEATHERBARROW RJ, 1990, TRENDS BIOCHEM SCI, V15, P455, DOI 10.1016/0968-0004(90)90295-M; LILLEY DMJ, 1995, NUCLEIC ACIDS RES, V23, P3363, DOI 10.1093/nar/23.17.3363; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; LYAMICHEV V, 1993, SCIENCE, V260, P778, DOI 10.1126/science.7683443; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Matsui E, 2002, J BIOL CHEM, V277, P37840, DOI 10.1074/jbc.M205235200; McMurray CT, 2008, DNA REPAIR, V7, P1121, DOI 10.1016/j.dnarep.2008.03.013; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Park C, 2003, BIOCHEMISTRY-US, V42, P3509, DOI 10.1021/bi026076k; Park C, 2001, J AM CHEM SOC, V123, P11472, DOI 10.1021/ja0164834; Patel D, 2002, J MOL BIOL, V320, P1025, DOI 10.1016/S0022-2836(02)00547-8; Pinheiro J, 2001, MIXED EFFECTS MODELS; Qiu JZ, 2004, J BIOL CHEM, V279, P24394, DOI 10.1074/jbc.M401464200; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; ROBINS P, 1994, J BIOL CHEM, V269, P28535; RUDOLPH FB, 1982, CONT ENZYME KINETICS, P207; Ruggiero BL, 2004, J BIOL CHEM, V279, P23088, DOI 10.1074/jbc.M313170200; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sambrook J., 2001, MOL CLONING LAB MANU; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sayers JR, 1998, NAT STRUCT BIOL, V5, P668, DOI 10.1038/1358; SEGEL IH, 1975, BIOCH CALCULATIONS, P208; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shen BH, 1998, TRENDS BIOCHEM SCI, V23, P171, DOI 10.1016/S0968-0004(98)01199-2; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Team RC., 2022, LANG ENV STAT COMP; Theimer CA, 1998, J MOL BIOL, V279, P545, DOI 10.1006/jmbi.1998.1812; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Williams R, 2007, J MOL BIOL, V371, P34, DOI 10.1016/j.jmb.2007.04.063; Wu HH, 2005, METHOD ENZYMOL, V394, P525, DOI 10.1016/S0076-6879(05)94022-6; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xu Y, 1997, J MOL BIOL, V268, P284, DOI 10.1006/jmbi.1997.0967; Xu Y, 2001, J BIOL CHEM, V276, P30167, DOI 10.1074/jbc.M100985200; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yoshizawa S, 1997, BIOCHEMISTRY-US, V36, P4761, DOI 10.1021/bi961738p; Zheng L, 2002, BIOCHEMISTRY-US, V41, P10323, DOI 10.1021/bi025841s; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	75	43	44	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22184	22194		10.1074/jbc.M109.015065	http://dx.doi.org/10.1074/jbc.M109.015065			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19525235	Green Published, hybrid			2022-12-27	WOS:000268783700043
J	Kumasaka, T; Aritake, K; Ago, H; Irikura, D; Tsurumura, T; Yamamoto, M; Miyano, M; Urade, Y; Hayaishi, O				Kumasaka, Takashi; Aritake, Kosuke; Ago, Hideo; Irikura, Daisuke; Tsurumura, Toshiharu; Yamamoto, Masaki; Miyano, Masashi; Urade, Yoshihiro; Hayaishi, Osamu			Structural Basis of the Catalytic Mechanism Operating in Open-Closed Conformers of Lipocalin Type Prostaglandin D Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBROSPINAL-FLUID; BETA-TRACE; TRICHROMATIC CONCEPT; SELECTIVE INHIBITOR; D SYNTHETASE; ACTIVE-SITE; BINDING; PROTEIN; IDENTIFICATION; MICE	Lipocalin type prostaglandin D synthase (L-PGDS) is a multifunctional protein acting as a somnogen (PGD(2))-producing enzyme, an extracellular transporter of various lipophilic ligands, and an amyloid-beta chaperone in human cerebrospinal fluid. In this study, we determined the crystal structures of two different conformers of mouse L-PGDS, one with an open cavity of the beta-barrel and the other with a closed cavity due to the movement of the flexible E-F loop. The upper compartment of the central large cavity contains the catalytically essential Cys(65) residue and its network of hydrogen bonds with the polar residues Ser(45), Thr(67), and Ser(81), whereas the lower compartment is composed of hydrophobic amino acid residues that are highly conserved among other lipocalins. SH titration analysis combined with site-directed mutagenesis revealed that the Cys(65) residue is activated by its interaction with Ser(45) and Thr(67) and that the S45A/T67A/S81A mutant showed less than 10% of the L-PGDS activity. The conformational change between the open and closed states of the cavity indicates that the mobile calyx contributes to the multiligand binding ability of L-PGDS.	[Kumasaka, Takashi; Ago, Hideo; Irikura, Daisuke; Yamamoto, Masaki; Miyano, Masashi] RIKEN SPring 8 Ctr, Harima Inst, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan; [Aritake, Kosuke; Irikura, Daisuke; Tsurumura, Toshiharu; Urade, Yoshihiro; Hayaishi, Osamu] Osaka Biosci Inst, Dept Mol & Behav Biol, Osaka 5650874, Japan	RIKEN	Miyano, M (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan.	miyano@spring8.or.jp	Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Miyano, Masashi/R-2785-2016	Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Miyano, Masashi/0000-0003-2253-6175; Ago, Hideo/0000-0002-9040-488X	JAXA, Takeda Foundation; Takeda Pharmaceutical Co., Ltd; Ono Pharmaceutical Co., Ltd; Japan Society for the Promotion of Science [19590094]; Japan Foundation for Applied Enzymology; Osaka City	JAXA, Takeda Foundation(Takeda Science Foundation (TSF)); Takeda Pharmaceutical Co., Ltd(Takeda Pharmaceutical Company Ltd); Ono Pharmaceutical Co., Ltd(Ono Pharmaceutical Co Ltd); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology; Osaka City	This work was supported in part by a grant from the JAXA, Takeda Foundation (to Y.U.), a grant from Takeda Pharmaceutical Co., Ltd. Ono Pharmaceutical Co., Ltd. (to O.H.), Japan Society for the Promotion of Science Grant 19590094 (to K.A.), a grant from the Japan Foundation for Applied Enzymology (to K.A.), and a grant from Osaka City.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aritake K, 2006, J BIOL CHEM, V281, P15277, DOI 10.1074/jbc.M506431200; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Inoue K, 2009, J BIOCHEM, V145, P169, DOI 10.1093/jb/mvn154; Irikura D, 2003, J BIOCHEM, V133, P29, DOI 10.1093/jb/mvg006; Irikura D, 2009, J BIOL CHEM, V284, P7623, DOI 10.1074/jbc.M808593200; Jemth P, 2000, J BIOL CHEM, V275, P8618, DOI 10.1074/jbc.275.12.8618; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kumasaka T, 2002, STRUCTURE, V10, P1205, DOI 10.1016/S0969-2126(02)00830-4; Liu JF, 2008, BIOCHIMIE, V90, P1637, DOI 10.1016/j.biochi.2008.06.003; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; NEWCOMER ME, 1993, STRUCTURE, V1, P7, DOI 10.1016/0969-2126(93)90004-Z; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinzar E, 2000, P NATL ACAD SCI USA, V97, P4903, DOI 10.1073/pnas.090093997; Pinzar E, 2000, J BIOL CHEM, V275, P31239, DOI 10.1074/jbc.M000750200; Pregel MJ, 1997, J BIOL CHEM, V272, P23552, DOI 10.1074/jbc.272.38.23552; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Shimamoto S, 2007, J BIOL CHEM, V282, P31373, DOI 10.1074/jbc.M700123200; Tanaka R, 2009, BIOCHEM BIOPH RES CO, V378, P851, DOI 10.1016/j.bbrc.2008.11.152; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; URADE Y, 1989, J BIOL CHEM, V264, P1041; URADE Y, 1985, J BIOL CHEM, V260, P2410; URADE Y, 1995, J BIOL CHEM, V270, P1422, DOI 10.1074/jbc.270.3.1422; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; URADE Y, 2006, FUNCTIONAL STRUCTURA, P135; Urade Y., 2006, LIPOCALINS, V9, P99; WATANABE K, 1994, BIOCHEM BIOPH RES CO, V203, P1110, DOI 10.1006/bbrc.1994.2297; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738	50	34	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22344	22352		10.1074/jbc.M109.018341	http://dx.doi.org/10.1074/jbc.M109.018341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19546224	hybrid, Green Published			2022-12-27	WOS:000268783700057
J	Sakai, K; Nakamura, T; Matsumoto, K; Nakamura, T				Sakai, Katsuya; Nakamura, Takahiro; Matsumoto, Kunio; Nakamura, Toshikazu			Angioinhibitory Action of NK4 Involves Impaired Extracellular Assembly of Fibronectin Mediated by Perlecan-NK4 Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; HEPARAN-SULFATE; GEFITINIB RESISTANCE; 4-KRINGLE ANTAGONIST; VASCULAR DEVELOPMENT; MOUSE EMBRYOS; TUMOR-GROWTH; G(1) PHASE; MATRIX; CELL	NK4, a fragment of hepatocyte growth factor (HGF), exerts bifunctional action as a competitive antagonist against HGF and its receptor c-Met and an angiogenesis inhibitor. Here we studied the anti-angiogenic mechanism of NK4. In cultured human endothelial cells, NK4 inhibited DNA synthesis induced not only by HGF but also by either basic fibroblast growth factor or vascular endothelial growth factor. Even if c-Met expression was diminished by small interference RNA, NK4 inhibited basic fibroblast growth factor-induced DNA synthesis, indicating that anti-angiogenic action of NK4 is c-Met-independent. Affinity purification with NK4-immobilized beads revealed that NK4 binds to perlecan. Consistent with this, NK4 colocalized with perlecan in endothelial cells. Perlecan is a multidomain heparan sulfate proteoglycan that interacts with basement membrane components such as fibronectin. NK4 inhibited extracellular assembly of fibronectin, by which fibronectin-dependent endothelial cell spreading was inhibited by NK4. Knockdown of perlecan expression by small interference RNA significantly abrogated the inhibitory effect of NK4 on fibronectin assembly and cell spreading. In NK4-treated endothelial cells, tyrosine phosphorylation of focal adhesion kinase and Rac activation were reduced, whereas overexpression of activated Rac recovered the DNA synthesis in NK4-treated endothelial cells. These results indicate that the association between NK4 and perlecan impairs fibronectin assembly, thereby inhibiting anchorage-dependent signaling. The identified mechanism for angiostatic action provides further proof of significance for NK4 in the treatment of cancer and potentially for vascular regulation as well.	[Sakai, Katsuya; Nakamura, Toshikazu] Osaka Univ, Ctr Adv Sci & Innovat, Kringle Pharma Joint Res Div Regenerat Drug Disco, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Nakamura, Takahiro; Matsumoto, Kunio] Kanazawa Univ, Canc Res Inst, Div Tumor Dynam & Regulat, Kanazawa, Ishikawa 9200934, Japan	Osaka University; Kanazawa University	Nakamura, T (corresponding author), Osaka Univ, Ctr Adv Sci & Innovat, Kringle Pharma Joint Res Div Regenerat Drug Disco, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	nakamura@casi.osaka-u.ac.jp	Matsumoto, Kunio/D-8441-2015	Matsumoto, Kunio/0000-0002-6532-4482; Sakai, Katsuya/0000-0002-0443-1786	Ministry of Education, Culture, Science, Sports, and Technology of Japan [18013031, 18015031]; 21st Century Global Center of Excellence program; National Institute of Biomedical Innovation	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century Global Center of Excellence program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by Ministry of Education, Culture, Science, Sports, and Technology of Japan Grants 18013031 (to To. N.) and 18015031 (to K. M.), by the 21st Century Global Center of Excellence program (to T. N.), and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation.	Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chung CY, 1997, J CELL SCI, V110, P1413; CLARK RAF, 1982, J INVEST DERMATOL, V79, P269, DOI 10.1111/1523-1747.ep12500076; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; Date K, 1998, ONCOGENE, V17, P3045, DOI 10.1038/sj.onc.1202231; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; HEREMANS A, 1990, J BIOL CHEM, V265, P8716; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; ISEMURA M, 1987, J BIOL CHEM, V262, P8926; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Klass CM, 2000, J CELL SCI, V113, P493; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; Kuba K, 2000, CANCER RES, V60, P6737; Kuba K, 2000, BIOCHEM BIOPH RES CO, V279, P846, DOI 10.1006/bbrc.2000.4034; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Matsumoto K, 2005, BIOCHEM BIOPH RES CO, V333, P316, DOI 10.1016/j.bbrc.2005.05.131; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; Mercurius KO, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-18; Merkulova-Rainon T, 2003, J BIOL CHEM, V278, P37400, DOI 10.1074/jbc.M212768200; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura T, 1997, CANCER RES, V57, P3305; NICOSIA RF, 1987, AM J PATHOL, V128, P78; Pozzi M, 1998, J CELL BIOL, V142, P587; Qiao DH, 2003, J BIOL CHEM, V278, P16045, DOI 10.1074/jbc.M211259200; Raymond WW, 2006, J BIOL CHEM, V281, P1489, DOI 10.1074/jbc.M511154200; Tomioka D, 2001, CANCER RES, V61, P7518; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643	45	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22491	22499		10.1074/jbc.M109.025148	http://dx.doi.org/10.1074/jbc.M109.025148			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553700	hybrid, Green Published			2022-12-27	WOS:000268783700070
J	You, DW; Hong, J; Rong, MQ; Yu, HN; Liang, SP; Ma, YF; Yang, HL; Wu, J; Lin, DH; Lai, R				You, Dewen; Hong, Jing; Rong, Mingqiang; Yu, Haining; Liang, Songping; Ma, Yufang; Yang, Hailong; Wu, Jing; Lin, Donghai; Lai, Ren			The First Gene-encoded Amphibian Neurotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIDER SELENOCOSMIA-HUWENA; TOAD BOMBINA-MAXIMA; ANTIMICROBIAL PEPTIDES; SODIUM-CHANNEL; SKIN SECRETIONS; NA+-CHANNELS; TETRODOTOXIN; MUSCLE; VENOM; PURIFICATION	Many gene-encoded neurotoxins with various functions have been discovered in fish, reptiles, and mammals. A novel 60-residue neurotoxin peptide (anntoxin) that inhibited tetrodotoxin-sensitive (TTX-S) voltage-gated sodium channel (VGSC) was purified and characterized from the skin secretions of the tree frog Hyla annectans (Jerdon). This is the first gene-encoded neurotoxin found in amphibians. The IC50 of anntoxin for the TTX-S channel was about 3.4 mu M. Anntoxin shares sequence homology with Kunitz-type toxins but contains only two of three highly conserved cysteine bridges, which are typically found in these small, basic neurotoxin modules, i.e. snake dendrotoxins. Anntoxin showed an inhibitory ability against trypsin with an inhibitory constant (K-i) of 0.025 mu M. Anntoxin was distributed in skin, brain, stomach, and liver with a concentration of 25, 7, 3, and 2 mu g/g wet tissue, respectively. H. annectans lives on trees or other plants for its entire life cycle, and its skin contains the largest amount of anntoxin, which possibly helps defend against various aggressors or predators. A low dose of anntoxin was found to induce lethal toxicity for several potential predators, including the insect, snake, bird, and mouse. The tissue distribution and functional properties of the current toxin may provide insights into the ecological adaptation of tree-living amphibians.	[Hong, Jing; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [You, Dewen; Ma, Yufang; Yang, Hailong; Wu, Jing; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming 650223, Yunnan, Peoples R China; [Rong, Mingqiang; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha 410081, Peoples R China; [Yu, Haining] Hebei Normal Univ, Coll Life Sci, Shijiazhuang 050016, Hebei, Peoples R China; [You, Dewen; Hong, Jing; Ma, Yufang; Yang, Hailong; Wu, Jing] Chinese Acad Sci, Grad Sch, Beijing 100009, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Hunan Normal University; Hebei Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lin, DH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.	dhlin@mail.shcnc.ac.cn; rlai@mail.kiz.ac.cn	yang, hailong/GXH-9625-2022		Chinese National Natural Science Foundation [30830021]; Chinese Academy of Sciences [KSCXZ-YW-R-088, KSCX2-YW-G-024]; Ministry of Science [2007AA02Z192, 2007AA100602]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported in part by the Chinese National Natural Science Foundation (30830021), Chinese Academy of Sciences (KSCXZ-YW-R-088, KSCX2-YW-G-024), and the Ministry of Science (2007AA02Z192, 2007AA100602).	Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chahine M, 1998, BIOPHYS J, V75, P236, DOI 10.1016/S0006-3495(98)77510-1; Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045; Conlon JM, 1997, PEPTIDES, V18, P361, DOI 10.1016/S0196-9781(96)00339-7; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; DALY JW, 1984, TOXICON, V22, P905, DOI 10.1016/0041-0101(84)90182-X; DALY JW, 1987, TOXICON, V25, P1023, DOI 10.1016/0041-0101(87)90265-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duda TF, 2002, MOL BIOL EVOL, V19, P858, DOI 10.1093/oxfordjournals.molbev.a004143; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Imredy JP, 1998, BIOCHEMISTRY-US, V37, P14867, DOI 10.1021/bi980929k; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; Lai R, 2001, BIOCHEM BIOPH RES CO, V286, P259, DOI 10.1006/bbrc.2001.5359; Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee WH, 2005, EUR J IMMUNOL, V35, P1220, DOI 10.1002/eji.200425615; Li JX, 2007, FASEB J, V21, P2466, DOI 10.1096/fj.06-7966com; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Li JX, 2006, BIOCHEM BIOPH RES CO, V350, P983, DOI 10.1016/j.bbrc.2006.09.150; Li RK, 2000, J BIOL CHEM, V275, P27551; Li YF, 2006, PROTEIN EXPRES PURIF, V47, P498, DOI 10.1016/j.pep.2005.10.022; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liu XH, 2007, PEPTIDES, V28, P1540, DOI 10.1016/j.peptides.2007.07.006; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; MEIER J, 1986, TOXICON, V24, P395, DOI 10.1016/0041-0101(86)90199-6; Mignogna G, 1997, PEPTIDES, V18, P367, DOI 10.1016/S0196-9781(96)00342-7; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V17, P275; NARAHASHI T, 1960, AM J PHYSIOL, V198, P934, DOI 10.1152/ajplegacy.1960.198.5.934; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; POH CH, 1991, COMP BIOCHEM PHYS B, V99, P793, DOI 10.1016/0305-0491(91)90143-2; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; ROY ML, 1992, J NEUROSCI, V12, P2104; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Shon KJ, 1998, J NEUROSCI, V18, P4473; Strachan LC, 1999, J PHARMACOL EXP THER, V288, P379; Wechselberger C, 1998, FEBS LETT, V429, P41, DOI 10.1016/S0014-5793(98)00545-6; Whittington CM, 2008, GENOME RES, V18, P986, DOI 10.1101/gr.7149808; Xiao YC, 2004, J BIOL CHEM, V279, P26220, DOI 10.1074/jbc.M401387200; Xiao YC, 2003, TOXICON, V41, P643, DOI 10.1016/S0041-0101(02)00280-5; YASUHARA T, 1979, CHEM PHARM BULL, V27, P486; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	47	48	53	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22079	22086		10.1074/jbc.M109.013276	http://dx.doi.org/10.1074/jbc.M109.013276			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19535333	hybrid, Green Published			2022-12-27	WOS:000268783700032
J	Cole, DK; Yuan, F; Rizkallah, PJ; Miles, JJ; Gostick, E; Price, DA; Gao, GF; Jakobsen, BK; Sewell, AK				Cole, David K.; Yuan, Fang; Rizkallah, Pierre J.; Miles, John J.; Gostick, Emma; Price, David A.; Gao, George F.; Jakobsen, Bent K.; Sewell, Andrew K.			Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; TUMOR-REACTIVE CTL; PEPTIDE VACCINES; STRUCTURAL BASIS; ANTIGEN; ALPHA; IMMUNOGENICITY; AFFINITY; CHAIN; USAGE	CD8(+) T-cells specific for MART-1-(26-35), a dominant melanoma epitope restricted by human leukocyte antigen (HLA)A* 0201, are exceptionally common in the naive T-cell repertoire. Remarkably, the TRAV12-2 gene is used to encode the T-cell receptor alpha(TCR alpha) chain in > 87% of these T-cells. Here, the molecular basis for this genetic bias is revealed from the structural and thermodynamic properties of an archetypal TRAV12-2-encoded TCR complexed to the clinically relevant heteroclitic peptide, ELAGIGILTV, bound to HLA-A*0201 (A2ELA). Unusually, the TRAV12-2 germ line-encoded regions of the TCR dominate the major atomic contacts with the peptide at the TCR/A2-ELA interface. This "innate" pattern of antigen recognition probably explains the unique characteristics and extraordinary frequencies of CD8(+) T-cell responses to this epitope.	[Cole, David K.; Rizkallah, Pierre J.; Miles, John J.; Gostick, Emma; Price, David A.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Yuan, Fang] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Rizkallah, Pierre J.] STFC Daresbury Lab, Warrington WA4 4AD, Cheshire, England; [Miles, John J.] Univ Queensland, Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia; [Gao, George F.] Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China; [Jakobsen, Bent K.] Immunocore Ltd, Abingdon OX14 4RX, Oxon, England	Cardiff University; University of Oxford; STFC Daresbury Laboratory; QIMR Berghofer Medical Research Institute; University of Queensland; Chinese Academy of Sciences; Institute of Microbiology, CAS	Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	sewellak@cardiff.ac.uk	Cole, David/C-8387-2012; Miles, John/H-4975-2011; Sewell, Andrew/GPT-4220-2022; Price, David A/C-7876-2013; Rizkallah, Pierre J/A-5367-2012; Gao, George Fu/ABD-5229-2021; Miles, John J/ABC-1105-2020	Sewell, Andrew/0000-0003-3194-3135; Price, David A/0000-0001-9416-2737; Rizkallah, Pierre J/0000-0002-9290-0369; Miles, John J/0000-0001-5506-6304; Cole, David/0000-0003-0028-9396	Cardiff University Link Chair Scheme; Biotechnology and Biological Sciences Research Council (BBSRC) UK [BB/H001085/1]; MRC [G0501963] Funding Source: UKRI; Medical Research Council [G0501963] Funding Source: researchfish	Cardiff University Link Chair Scheme; Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Cardiff University Link Chair Scheme and by Biotechnology and Biological Sciences Research Council (BBSRC) UK Grant BB/H001085/1, which enabled the establishment of protein crystallography at Cardiff University School of Medicine.	Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bins A, 2007, J IMMUNOTHER, V30, P234, DOI 10.1097/01.cji.0000211333.06762.47; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chen Qiyuan, 2005, Cancer Immun, V5, P5; Chodorowski Zygmunt, 2007, Przegl Lek, V64, P380; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; DeLano W.L, PYMOL MOL GRAPHICS S; Dietrich PY, 2003, J IMMUNOL, V170, P5103, DOI 10.4049/jimmunol.170.10.5103; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Kawakami Y, 1997, Int Rev Immunol, V14, P173, DOI 10.3109/08830189709116851; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; KRAUSA P, 1995, TISSUE ANTIGENS, V45, P223, DOI 10.1111/j.1399-0039.1995.tb02444.x; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meidenbauer N, 2003, J IMMUNOL, V170, P2161, DOI 10.4049/jimmunol.170.4.2161; Miles JJ, 2006, CURR MED CHEM, V13, P2725, DOI 10.2174/092986706778521959; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pittet MJ, 2002, TRENDS IMMUNOL, V23, P325, DOI 10.1016/S1471-4906(02)02244-5; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Speiser DE, 2002, EUR J IMMUNOL, V32, P731, DOI 10.1002/1521-4141(200203)32:3<731::AID-IMMU731>3.0.CO;2-H; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Trautmann L, 2002, EUR J IMMUNOL, V32, P3181, DOI 10.1002/1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Valmori D, 2000, J IMMUNOL, V165, P533, DOI 10.4049/jimmunol.165.1.533; Valmori D, 1998, J IMMUNOL, V160, P1750; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Voelter V, 2008, INT IMMUNOL, V20, P1087, DOI 10.1093/intimm/dxn066; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Yoshioka T, 1997, J IMMUNOL METHODS, V201, P145, DOI 10.1016/S0022-1759(96)00221-9; Yuan F, 2007, ACTA CRYSTALLOGR F, V63, P758, DOI 10.1107/S1744309107037244	50	110	111	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27281	27289		10.1074/jbc.M109.022509	http://dx.doi.org/10.1074/jbc.M109.022509			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19605354	Green Published, hybrid			2022-12-27	WOS:000270232300029
J	Yuan, W; Wang, Y; Heinecke, JW; Fu, XY				Yuan, Wei; Wang, Yi; Heinecke, Jay W.; Fu, Xiaoyun			Hypochlorous Acid Converts the gamma-Glutamyl Group of Glutathione Disulfide to 5-Hydroxybutyrolactam, a Potential Marker for Neutrophil Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE-CHLORIDE; MYELOPEROXIDASE-DERIVED OXIDANTS; OXIDATIVE CROSS-LINKING; AMINO-ACIDS; RESPIRATORY BURST; THIOLS; INFLAMMATION; SULFONAMIDE; MECHANISM; ALDEHYDES	In healthy cells, glutathione disulfide (GSSG) is rapidly reduced back to glutathione (GSH) by glutathione reductase to maintain redox status. The ratio of GSH/GSSG has been used as an indicator of oxidative stress. However, hypochlorous acid (HOCl) generated by the myeloperoxidase-H2O2-Cl- system of neutrophils converts GSH to irreversible oxidation products. Although several such products have been identified, yields of these compounds are very low in biological systems, and they cannot account quantitatively for thiol loss. In the current studies, we use liquid chromatography-mass spectrometry (LC-MS) to demonstrate that HOCl and chloramines oxidize GSSG to two irreversible products in high yield. The products, termed M-45 and M-90, are, respectively, 45 or 90 atomic mass units lighter than GSSG. The reaction pathway involves chloramine and aldehyde intermediates, and converts the gamma-glutamyl residues of GSSG to 5-hydroxybutyrolactam. Importantly, M-45 and M-90 were resistant to reduction by glutathione reductase. Moreover, the monohydroxylbutyrolactam M-45 accounted for >90% of the endogenous GSH oxidation products generated by activated neutrophils. Because the reaction pathway involves chlorinating intermediates, hydroxylbutyrolactams are likely to be specific products of HOCl, which is generated only by myeloperoxidase. Therefore, our observations implicate M-45 as a potential biomarker for myeloperoxidase activity in vivo.	[Yuan, Wei; Heinecke, Jay W.; Fu, Xiaoyun] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Wang, Yi; Fu, Xiaoyun] Puget Sound Blood Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Puget Sound Blood Center	Fu, XY (corresponding author), 921 Terry Ave, Seattle, WA 98104 USA.	xyfu@psbcresearch.org	Wang, Yi/C-2871-2013; Yuan, Wei/C-4938-2012		National Institutes of Health [HL075381]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL075381.	Anderson MM, 2003, DIABETES, V52, P2137, DOI 10.2337/diabetes.52.8.2137; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Andreoli R, 2003, RAPID COMMUN MASS SP, V17, P637, DOI 10.1002/rcm.960; Ashfaq S, 2006, J AM COLL CARDIOL, V47, P1005, DOI 10.1016/j.jacc.2005.09.063; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Carr AC, 1997, BIOCHEM J, V327, P275, DOI 10.1042/bj3270275; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P273, DOI 10.1006/abbi.1994.1167; Chesney JA, 1996, J BACTERIOL, V178, P2131, DOI 10.1128/jb.178.7.2131-2135.1996; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; den Hartog GJM, 2002, BIOL CHEM, V383, P709; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Fu XY, 2004, J BIOL CHEM, V279, P6209, DOI 10.1074/jbc.C300506200; Fu XY, 2002, BIOCHEMISTRY-US, V41, P1293, DOI 10.1021/bi015777z; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Harwood DT, 2008, CHEM RES TOXICOL, V21, P1011, DOI 10.1021/tx800050n; Harwood DT, 2006, BIOCHEM J, V399, P161, DOI 10.1042/BJ20060978; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hazen SL, 1998, J BIOL CHEM, V273, P4997, DOI 10.1074/jbc.273.9.4997; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; HUGHES MN, 1968, J CHEM SOC A, V2, P450; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kleinman WA, 2000, BIOCHEM PHARMACOL, V60, P19, DOI 10.1016/S0006-2952(00)00293-8; Lang CA, 2000, J LAB CLIN MED, V135, P402, DOI 10.1067/mlc.2000.105977; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Nagy P, 2007, CHEM RES TOXICOL, V20, P79, DOI 10.1021/tx060184g; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ogino T, 1997, FREE RADICAL BIO MED, V23, P445, DOI 10.1016/S0891-5849(97)00115-9; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; Prutz WA, 1996, ARCH BIOCHEM BIOPHYS, V332, P110, DOI 10.1006/abbi.1996.0322; Pullar JM, 2001, J BIOL CHEM, V276, P22120, DOI 10.1074/jbc.M102088200; Queralt JJ, 2002, CHEM PHYS, V280, P1, DOI 10.1016/S0301-0104(02)00487-1; Rabenstein D.L., 1989, COENZYMES COFACTORS, V3, P67; Rodes J, 2007, TXB HEPATOLOGY BASIC; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Serru V, 2001, CLIN CHEM, V47, P1321; Staubmann R, 1999, PHYTOCHEMISTRY, V50, P337, DOI 10.1016/S0031-9422(98)00531-7; Thomas E L, 1986, Methods Enzymol, V132, P569; Vaisar Tomas, 2007, Curr Atheroscler Rep, V9, P417, DOI 10.1007/s11883-007-0054-z; Winterbourn CC, 1997, BIOCHEM J, V326, P87, DOI 10.1042/bj3260087; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489	45	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26908	26917		10.1074/jbc.M109.005496	http://dx.doi.org/10.1074/jbc.M109.005496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19584048	hybrid, Green Published			2022-12-27	WOS:000269969600071
J	Abboud, N; De Jesus, M; Nakouzi, A; Cordero, RJB; Pujato, M; Fiser, A; Rivera, J; Casadevall, A				Abboud, Nareen; De Jesus, Magdia; Nakouzi, Antonio; Cordero, Radames J. B.; Pujato, Mario; Fiser, Andras; Rivera, Johanna; Casadevall, Arturo			Identification of Linear Epitopes in Bacillus anthracis Protective Antigen Bound by Neutralizing Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; TOXIN; RESPONSES; PROTEINS; RECEPTOR; CHANNEL; BINDING; MICE	Protective antigen (PA), the binding subunit of anthrax toxin, is the major component in the current anthrax vaccine, but the fine antigenic structure of PA is not well defined. To identify linear neutralizing epitopes of PA, 145 overlapping peptides covering the entire sequence of the protein were synthesized. Six monoclonal antibodies (mAbs) and antisera from mice specific for PA were tested for their reactivity to the peptides by enzyme-linked immunosorbent assays. Three major linear immunodominant B-cell epitopes were mapped to residues Leu(156) to Ser(170), Val(196) to Ile(210), and Ser(312) to Asn(326) of the PA protein. Two mAbs with toxin-neutralizing activity recognized two different epitopes in close proximity to the furin cleavage site in domain 1. The three-dimensional complex structure of PA and its neutralizing mAbs 7.5G and 19D9 were modeled using the molecular docking method providing models for the interacting epitope and paratope residues. For both mAbs, LeTx neutralization was associated with interference with furin cleavage, but they differed in effectiveness depending on whether they bound on the N- or C-terminal aspect of the cleaved products. The two peptides containing these epitopes that include amino acids Leu(156)-Ser(170) and Val(196)-Ile(210) were immunogenic and elicited neutralizing antibody responses to PA. These results identify the first linear neutralizing epitopes of PA and show that peptides containing epitope sequences can elicit neutralizing antibody responses, a finding that could be exploited for vaccine design.	[Rivera, Johanna; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA; [Pujato, Mario; Fiser, Andras] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Casadevall, A (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	casadeva@aecom.yu.edu	Cordero, Radamés JB/F-6912-2011	Cordero, Radamés JB/0000-0002-3026-7094	National Institutes of Health [2U54AI057158-06]; Department of Defense [DOD-071640041-002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 2U54AI057158-06. This work was also supported by Department of Defense Grant DOD-071640041-002.	Abboud N, 2008, CLIN VACCINE IMMUNOL, V15, P1115, DOI 10.1128/CVI.00015-08; Baillie L, 2004, FEMS IMMUNOL MED MIC, V42, P267, DOI 10.1016/j.femsim.2004.05.011; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Beavis RC, 1996, METHOD ENZYMOL, V270, P519; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Brossier F, 2004, INFECT IMMUN, V72, P6313, DOI 10.1128/IAI.72.11.6313-6317.2004; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; De Jesus M, 2009, EUKARYOT CELL, V8, P96, DOI 10.1128/EC.00331-08; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; Flick-Smith HC, 2002, INFECT IMMUN, V70, P1653, DOI 10.1128/IAI.70.3.1653-1656.2002; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gubbins MJ, 2006, FEMS IMMUNOL MED MIC, V47, P436, DOI 10.1111/j.1574-695X.2006.00114.x; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laffly E, 2005, ANTIMICROB AGENTS CH, V49, P3414, DOI 10.1128/AAC.49.8.3414-3420.2005; Moayeri M, 2007, INFECT IMMUN, V75, P5175, DOI 10.1128/IAI.00719-07; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Peterson JW, 2007, INFECT IMMUN, V75, P3414, DOI 10.1128/IAI.00352-07; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Reed DS, 2002, CYTOMETRY, V49, P1, DOI 10.1002/cyto.10134; Rivera J, 2006, INFECT IMMUN, V74, P4149, DOI 10.1128/IAI.00150-06; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Subramanian GM, 2005, CLIN INFECT DIS, V41, P12, DOI 10.1086/430708; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Zhang J, 2006, BIOCHEM BIOPH RES CO, V341, P1164, DOI 10.1016/j.bbrc.2006.01.080	29	32	37	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25077	25086		10.1074/jbc.M109.022061	http://dx.doi.org/10.1074/jbc.M109.022061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617628	Green Published, hybrid			2022-12-27	WOS:000269734000042
J	Motshwene, PG; Moncrieffe, MC; Grossmann, JG; Kao, C; Ayaluru, M; Sandercock, AM; Robinson, CV; Latz, E; Gay, NJ				Motshwene, Precious G.; Moncrieffe, Martin C.; Grossmann, J. Guenter; Kao, Cheng; Ayaluru, Murali; Sandercock, Alan M.; Robinson, Carol V.; Latz, Eicke; Gay, Nicholas J.			An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH DOMAIN; STRUCTURAL BASIS; MASS-SPECTROMETRY; INNATE IMMUNITY; HIGH-RESOLUTION; TIR-DOMAIN; COMPLEX; PROTEIN; SCATTERING; REGULATOR	Toll-like receptors (TLRs) mediate responses to pathogen-associated molecules as part of the vertebrate innate immune response to infection. Receptor dimerization is coupled to downstream signal transduction by the recruitment of a post-receptor complex containing the adaptor protein MyD88 and the IRAK protein kinases. In this work, we show that the death domains of human MyD88 and IRAK-4 assemble into closed complexes having unusual stoichiometries of 7:4 and 8:4, the Myddosome. Formation of the Myddosome is likely to be a key event for TLR4 signaling in vivo as we show here that pathway activation requires that the receptors cluster into lipid rafts. Taken together, these findings indicate that TLR activation causes the formation of a highly oligomeric signaling platform analogous to the death-inducing signaling complex of the Fas receptor pathway.	[Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Grossmann, J. Guenter] Univ Liverpool, Mol Biophys Grp, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Sandercock, Alan M.; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Kao, Cheng; Ayaluru, Murali] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Latz, Eicke] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01655 USA	University of Cambridge; University of Liverpool; University of Cambridge; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Worcester	Gay, NJ (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	njg11@cam.ac.uk	Murali, Ayaluru/G-3401-2014; Latz, Eicke/H-3951-2014	Murali, Ayaluru/0000-0001-6406-6840; Latz, Eicke/0000-0003-1488-5666; Motshwene, Precious/0000-0002-0230-9410; robinson, carol/0000-0001-7829-5505	UK Medical Research Council; Biotechnology and Biological Science Research Council; South African National Research Foundation; BBSRC [BB/G009295/1] Funding Source: UKRI; MRC [G0400007] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G009295/1] Funding Source: researchfish; Medical Research Council [G0400007] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); South African National Research Foundation(National Research Foundation - South Africa); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the UK Medical Research Council and Biotechnology and Biological Science Research Council (to N.G.).; Supported by the South African National Research Foundation.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Benesch JLP, 2009, J AM SOC MASS SPECTR, V20, P341, DOI 10.1016/j.jasms.2008.11.014; Beutler E, 2001, BLOOD CELL MOL DIS, V27, P728, DOI 10.1006/bcmd.2001.0441; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Zhande R, 2007, MOL CELL BIOL, V27, P7394, DOI 10.1128/MCB.00600-07; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	41	246	261	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25404	25411		10.1074/jbc.M109.022392	http://dx.doi.org/10.1074/jbc.M109.022392			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592493	Green Published, hybrid			2022-12-27	WOS:000269734000072
J	Wiley, DJ; Shrestha, N; Yang, J; Atis, N; Dayton, K; Schesser, K				Wiley, David J.; Shrestha, Niraj; Yang, Jing; Atis, Nadege; Dayton, Kevin; Schesser, Kurt			The Activities of the Yersinia Protein Kinase A (YpkA) and Outer Protein J (YopJ) Virulence Factors Converge on an eIF2 alpha Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED EIF-2-ALPHA KINASE; FACTOR 2-ALPHA KINASE; NF-KAPPA-B; SCHIZOSACCHAROMYCES-POMBE; SIGNAL-TRANSDUCTION; EFFECTOR YOPJ; FISSION YEAST; ACTIVATION; PHOSPHORYLATION; EXPRESSION	The Yersinia protein kinase A (YpkA) and outer protein J (YopJ) are co-expressed from a single transcript and are injected directly into eukaryotic cells by the plague bacterium Yersinia pestis. When overexpressed in vertebrate or yeast cells, YpkA disrupts the actin-based cytoskeletal system by an unknown mechanism, whereas YopJ obstructs inductive chemokine expression by inhibiting MAPK and NF-kappa B signaling. Previously, we showed that the fission yeast Schizosaccharomyces pombe was sensitive to the kinase activity of YpkA. Here, we screened yeast for cellular processes important for YpkA activity and found that the eIF2 alpha kinases mollify the toxicity imparted by the kinase activity of YpkA. Specifically, strains lacking the eIF2 alpha kinase Hri2 were particularly sensitive to YpkA. Unexpectedly, the activity of YopJ, which conferred a phenotype consistent with its inhibitory effect on MAPK signaling, was also found to be dependent on Hri2. When expressed in S. pombe, YopJ sensitized cells to osmotic and oxidative stresses through a Hri2-dependent mechanism. However, when co-expressed with YpkA, YopJ protected cells from YpkA-mediated toxicity, and this protection was entirely dependent on Hri2. In contrast, YopJ did not confer protection against the toxic effects of the Yersinia virulence factor YopE. These findings are the first to functionally link YpkA and YopJ and suggest that eIF2 alpha kinases, which are critically important in antiviral defenses and protection against environmental stresses, also play a role in bacterial virulence.	[Wiley, David J.; Shrestha, Niraj; Yang, Jing; Atis, Nadege; Dayton, Kevin; Schesser, Kurt] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	University of Miami	Schesser, K (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, 1600 NW 10th Ave, Miami, FL 33136 USA.	kschesser@med.miami.edu			NIAID; National Institutes of Health Public Health Service [AI53459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053459] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Public Health Service Grant AI53459.	BARTRA S, 2001, BMC MICROBIOL, V1, pE22; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Bauer BN, 2001, BIOCHEMISTRY-US, V40, P11543, DOI 10.1021/bi010983s; Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Dunand-Sauthier I, 2005, EUKARYOT CELL, V4, P1785, DOI 10.1128/EC.4.11.1785-1793.2005; FAGARD R, 1981, P NATL ACAD SCI-BIOL, V78, P866, DOI 10.1073/pnas.78.2.866; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Juris SJ, 2006, FEBS LETT, V580, P179, DOI 10.1016/j.febslet.2005.11.071; KEENEY JB, 1994, GENETICS, V136, P849; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Meijer LK, 2000, CELL MICROBIOL, V2, P231, DOI 10.1046/j.1462-5822.2000.00049.x; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Nejedlik L, 2004, YEAST, V21, P759, DOI 10.1002/yea.1135; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Uma S, 1998, EXP CELL RES, V238, P273, DOI 10.1006/excr.1997.3860; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Yoon S, 2003, J BIOL CHEM, V278, P2131, DOI 10.1074/jbc.M209905200; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443; Zhan K, 2002, MOL CELL BIOL, V22, P7134, DOI 10.1128/MCB.22.20.7134-7146.2002; Zhou GF, 2004, J BIOL CHEM, V279, P46595, DOI 10.1074/jbc.M408320200	46	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24744	24753		10.1074/jbc.M109.010140	http://dx.doi.org/10.1074/jbc.M109.010140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19553678	hybrid, Green Published			2022-12-27	WOS:000269734000009
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Identification of Residues in the Drug Translocation Pathway of the Human Multidrug Resistance P-glycoprotein by Arginine Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED ATPASE ACTIVITY; 1ST TRANSMEMBRANE SEGMENT; BINDING SITE; CROSS-LINKING; MUTATIONAL ANALYSIS; PROMOTE MATURATION; CYSTIC-FIBROSIS; MOLECULAR-BASIS; HUMAN MDR1; TRANSPORTER	P-glycoprotein (P-gp, ATP-binding cassette B1) is a drug pump that extracts toxic drug substrates from the plasma membrane and catalyzes their ATP-dependent efflux. To map the residues in the drug translocation pathway, we performed arginine-scanning mutagenesis on all transmembrane (TM) segments (total = 237 residues) of a P-gp processing mutant (G251V) defective in folding (15% maturation efficiency) (glycosylation state used to monitor folding). The rationale was that arginines introduced into the drug-binding sites would mimic drug rescue and enhance maturation of wild-type or processing mutants of P-gp. It was found that 38 of the 89 mutants that matured had enhanced maturation. Enhancer mutations were found in 11 of the 12 TM segments with the largest number found in TMs 6 and 12 (seven in each), TMs that are critical for P-gp-drug substrate interactions. Modeling of the TM segments showed that the enhancer arginines were found on the hydrophilic face, whereas inhibitory arginines were located on a hydrophobic face that may be in contact with the lipid bilayer. It was found that many of the enhancer arginines caused large alterations in P-gp-drug interactions in ATPase assays. For example, mutants A302R (TM5), L339R (TM6), G872R (TM10), F942R (TM11), Q946R (TM11), V982R (TM12), and S993R (TM12) reduced the apparent affinity for verapamil by similar to 10-fold, whereas the F336R (TM6) and M986R (TM12) mutations caused at least a 10-fold increase in apparent affinity for rhodamine B. The results suggest that P-gp contains a large aqueous-filled drug translocation pathway with multiple drug-binding sites that can accommodate the bulky arginine side chains to promote folding of the protein.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Canadian Cancer Society [19074]; Canadian Institutes of Health Research [25043]; Cystic Fibrosis Foundation [CLARKE-08GO]	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by Canadian Cancer Society Grant 19074, Canadian Institutes of Health Research Grant 25043, and Cystic Fibrosis Foundation Grant CLARKE-08GO.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Becker JP, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-3; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dey S, 1999, BIOCHEMISTRY-US, V38, P6630, DOI 10.1021/bi983038l; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Gannon MK, 2009, J MED CHEM, V52, P3328, DOI 10.1021/jm900253g; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; LOO TW, 1994, J BIOL CHEM, V269, P7750; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; Loo TW, 1996, J BIOL CHEM, V271, P15414, DOI 10.1074/jbc.271.26.15414; Muller M, 1996, J BIOL CHEM, V271, P1877; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Qu Q, 2002, BIOCHEMISTRY-US, V41, P4744, DOI 10.1021/bi0120897; Qu Q, 2001, BIOCHEMISTRY-US, V40, P1413, DOI 10.1021/bi002035h; Rothnie A, 2005, FEBS LETT, V579, P3984, DOI 10.1016/j.febslet.2005.06.030; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; Stockner T, 2009, FEBS J, V276, P964, DOI 10.1111/j.1742-4658.2008.06832.x; Storm J, 2007, BIOCHEMISTRY-US, V46, P9899, DOI 10.1021/bi700447p; TANGWAI DF, 1995, BIOCHEMISTRY-US, V34, P32, DOI 10.1021/bi00001a005; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926	52	66	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24074	24087		10.1074/jbc.M109.023267	http://dx.doi.org/10.1074/jbc.M109.023267			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19581304	Green Published, hybrid			2022-12-27	WOS:000269380200021
J	Martianez, T; Frances, S; Lopez, JM				Martianez, Tania; Frances, Silvia; Lopez, Jose M.			Generation of Digital Responses in Stress Sensors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; CELLULAR-ENERGY; POSITIVE-FEEDBACK; XENOPUS OOCYTES; CYTOCHROME-C; JNK; APOPTOSIS; PHOSPHORYLATION; PATHWAY	Ultrasensitivity, hysteresis (a form of biochemical memory), and all-or-none (digital) responses are important signaling properties for the control of irreversible processes and are well characterized in the c-Jun N-terminal kinase (JNK)system using Xenopus oocytes. Our aim was to study these properties in the AMP-activated protein kinase (AMPK) signaling system under stress conditions that could engage a cell death program, and compare them to the JNK responses. After characterization of Xenopus AMPK, we show here that the response to antimycin (nonapoptotic) was slightly cooperative and graded (analog) in individual oocytes, whereas the response to sorbitol (which induced cytochrome c release and caspase activation) was ultra-sensitive, digital in single cells, and without hysteresis, hallmarks of a monostable system. Moreover, initial graded responses of AMPK and JNK turned into digital during a critical period for the execution of the cell death program, although single cell analysis did not show complete correlation between AMPK or JNK activation and cytochrome c release. We propose a model where the life or death decision in the cell is made by integration of multiple digital signals from stress sensors.	[Lopez, Jose M.] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Bioquim, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Barcelona	Lopez, JM (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici M,Campus Bellaterra, E-08193 Barcelona, Spain.	josemanuel.lopez@uab.es	Lopez, Jose M/D-1654-2011; Lopez, Jose/AAF-3798-2020	Lopez, Jose M/0000-0002-4104-6262; Lopez, Jose/0000-0002-4104-6262	Fondo de Investigaciones Sanitarias (FIS) [PI 05/1748]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III)	This work was supported by Grant PI 05/1748 from Fondo de Investigaciones Sanitarias (FIS).	Aleu J, 2003, J PHYSIOL-LONDON, V547, P209, DOI 10.1113/jphysiol.2002.029660; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Bagowski CP, 2001, J BIOL CHEM, V276, P1459, DOI 10.1074/jbc.M008050200; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; KIRBY KS, 1965, BIOCHEM J, V96, P266, DOI 10.1042/bj0960266; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; RIESKE JS, 1967, J BIOL CHEM, V242, P4888; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sehy JV, 2004, MAGN RESON MED, V52, P239, DOI 10.1002/mrm.20132; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tran TH, 2007, J BIOL CHEM, V282, P20340, DOI 10.1074/jbc.M702210200; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhang L, 2007, AM J PHYSIOL-HEART C, V293, pH457, DOI 10.1152/ajpheart.00002.2007	36	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23902	23911		10.1074/jbc.M109.026054	http://dx.doi.org/10.1074/jbc.M109.026054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19570986	Green Published, hybrid			2022-12-27	WOS:000269380200004
J	Sanghani, PC; Davis, WI; Fears, SL; Green, SL; Zhai, LM; Tang, YP; Martin, E; Bryan, NS; Sanghani, SP				Sanghani, Paresh C.; Davis, Wilhelmina I.; Fears, Sharry L.; Green, Scheri-Lyn; Zhai, Lanmin; Tang, Yaoping; Martin, Emil; Bryan, Nathan S.; Sanghani, Sonal P.			Kinetic and Cellular Characterization of Novel Inhibitors of S-Nitrosoglutathione Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LIVER ALCOHOL-DEHYDROGENASE; DEPENDENT FORMALDEHYDE DEHYDROGENASE; BIOTIN-SWITCH ASSAY; NITRIC-OXIDE; GUANYLATE-CYCLASE; NITROSYLATION; NITROSOTHIOLS; BINDING; ACTIVATION	S-Nitrosoglutathione reductase (GSNOR) is an alcohol dehydrogenase involved in the regulation of S-nitrosothiols (SNOs) in vivo. Knock-out studies in mice have shown that GSNOR regulates the smooth muscle tone in airways and the function of beta-adrenergic receptors in lungs and heart. GSNOR has emerged as a target for the development of therapeutic approaches for treating lung and cardiovascular diseases. We report three compounds that exclude GSNOR substrate, S-nitrosoglutathione (GSNO) from its binding site in GSNOR and cause an accumulation of SNOs inside the cells. The new inhibitors selectively inhibit GSNOR among the alcohol dehydrogenases. Using the inhibitors, we demonstrate that GSNOR limits nitric oxide-mediated suppression of NF-kappa B and activation of soluble guanylyl cyclase. Our findings reveal GSNOR inhibitors to be novel tools for regulating nitric oxide bioactivity and assessing the role of SNOs in vivo.	[Sanghani, Paresh C.; Davis, Wilhelmina I.; Fears, Sharry L.; Green, Scheri-Lyn; Zhai, Lanmin; Sanghani, Sonal P.] Indiana Univ Purdue Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Tang, Yaoping; Martin, Emil; Bryan, Nathan S.] Univ Texas Houston Hlth Sci Ctr, Brown Fdn Inst Mol Med, Houston, TX 77030 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health Science Center Houston	Sanghani, PC (corresponding author), Indiana Univ Purdue Univ, Dept Biochem & Mol Biol, L3-316,1345 W 16th St, Indianapolis, IN 46202 USA.	psanghan@iupui.edu			National Institutes of Health [R21HL087816, R01HL088128]; Showalter Research trust; American Heart Association-National; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL087816, R01HL088128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Research trust; American Heart Association-National(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21HL087816 (to P. C. S. and S. P. S.) and R01HL088128 (to E. M.). This work was also supported by the Showalter Research trust (to P. C. S. and S. P. S.), the Research Support Funds Grant (to P. C. S.), and the American Heart Association-National (to N. S. B.).	ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; CHADHA VK, 1983, J MED CHEM, V26, P916, DOI 10.1021/jm00360a024; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; EKLUND H, 1990, EUR J BIOCHEM, V193, P303, DOI 10.1111/j.1432-1033.1990.tb19337.x; ENGELAND K, 1993, P NATL ACAD SCI USA, V90, P2491, DOI 10.1073/pnas.90.6.2491; ESTONIUS M, 1994, BIOCHEMISTRY-US, V33, P15080, DOI 10.1021/bi00254a017; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; IGNARRO LJ, 1980, FEBS LETT, V110, P275, DOI 10.1016/0014-5793(80)80091-3; Jaffrey SR, 2005, METHOD ENZYMOL, V396, P105, DOI 10.1016/S0076-6879(05)96011-4; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Johnson MA, 2001, J BIOL CHEM, V276, P39872, DOI 10.1074/jbc.M102781200; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Marshall HE, 2004, P NATL ACAD SCI USA, V101, P8841, DOI 10.1073/pnas.0403034101; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Martin E, 2001, P NATL ACAD SCI USA, V98, P12938, DOI 10.1073/pnas.231486198; MATHEWS WR, 1993, J PHARMACOL EXP THER, V267, P1529; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Samouilov A, 1998, ANAL BIOCHEM, V258, P322, DOI 10.1006/abio.1998.2609; Sanghani PC, 2002, BIOCHEMISTRY-US, V41, P15189, DOI 10.1021/bi026705q; Sanghani PC, 2002, BIOCHEMISTRY-US, V41, P10778, DOI 10.1021/bi0257639; Sanghani PC, 2000, BIOCHEMISTRY-US, V39, P10720, DOI 10.1021/bi9929711; SARMA RH, 1972, BIOCHEMISTRY-US, V11, P170, DOI 10.1021/bi00752a006; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Wang XD, 2008, FREE RADICAL BIO MED, V44, P1362, DOI 10.1016/j.freeradbiomed.2007.12.032; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Wink DA, 1997, J BIOL CHEM, V272, P11147; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P874, DOI 10.1016/j.freeradbiomed.2004.12.012; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101	38	58	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24354	24362		10.1074/jbc.M109.019919	http://dx.doi.org/10.1074/jbc.M109.019919			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19596685	hybrid, Green Published			2022-12-27	WOS:000269380200048
J	Dang, YJ; Low, WK; Xu, J; Gehring, NH; Dietz, HC; Romo, D; Liu, JO				Dang, Yongjun; Low, Woon-Kai; Xu, Jing; Gehring, Niels H.; Dietz, Harry C.; Romo, Daniel; Liu, Jun O.			Inhibition of Nonsense-mediated mRNA Decay by the Natural Product Pateamine A through Eukaryotic Initiation Factor 4AIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXON-JUNCTION COMPLEX; ZEALAND MARINE SPONGE; TRANSLATION INITIATION; CAENORHABDITIS-ELEGANS; UPF1 PHOSPHORYLATION; MAMMALIAN-CELLS; QUALITY-CONTROL; PROTEIN-KINASE; CORE COMPLEX; HUMAN SMG-1	Nonsense-mediated mRNA decay (NMD) in mammalian cells is a key mechanism for the removal of mRNA containing premature stop codons and is mediated by the coordinated function of numerous proteins that dynamically associate with the exon junction complex. The information communicated by these interactions and the functional consequences from a mechanistic perspective, however, are not completely documented. Herein, we report that the natural product pateamine A ( PatA) is capable of inhibiting NMD through direct interaction with eIF4AIII, which is independent of its inhibition of translation initiation. Furthermore, we have characterized the mechanisms by which PatA and cycloheximide modulate NMD. Unlike CHX, PatA was found to inhibit NMD by a novel mechanism that is independent of the phosphorylation of Up-frameshift protein 1.	[Dang, Yongjun; Low, Woon-Kai; Xu, Jing; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Gehring, Niels H.] Univ Heidelberg, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Gehring, Niels H.] European Mol Biol Lab, D-69120 Heidelberg, Germany; [Gehring, Niels H.] Univ Heidelberg, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Romo, Daniel] Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Texas A&M University System; Texas A&M University College Station	Liu, JO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	joliu@jhu.edu	dang, yongjun/A-8095-2011; dang, yongjun/M-6531-2016	dang, yongjun/0000-0001-7237-1132; Xu, Jing/0000-0002-3307-2719	National Institutes of Health from the NCI [CA 100211]; Keck Foundation; NATIONAL CANCER INSTITUTE [R01CA100211] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 100211 from the NCI. This work was also supported by the Keck Foundation.	Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen ZZ, 2005, GENETICS, V171, P403, DOI 10.1534/genetics.105.045674; Chiu SY, 2003, RNA, V9, P77, DOI 10.1261/rna.2137903; Clement SL, 2006, NAT STRUCT MOL BIOL, V13, P299, DOI 10.1038/nsmb0406-299; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Grimson A, 2004, MOL CELL BIOL, V24, P7483, DOI 10.1128/MCB.24.17.7483-7490.2004; Holbrook JA, 2006, EMBO REP, V7, P722, DOI 10.1038/sj.embor.7400721; Hood KA, 2001, APOPTOSIS, V6, P207, DOI 10.1023/A:1011340827558; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Low WK, 2007, CHEM BIOL, V14, P715, DOI 10.1016/j.chembiol.2007.05.012; Lykke-Andersen J, 2004, NAT STRUCT MOL BIOL, V11, P305, DOI 10.1038/nsmb0404-305; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Morita T, 2007, J BIOL CHEM, V282, P7799, DOI 10.1074/jbc.M610159200; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; NORTHCOTE PT, 1991, TETRAHEDRON LETT, V32, P6411, DOI 10.1016/0040-4039(91)80182-6; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Page MF, 1999, MOL CELL BIOL, V19, P5943; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Romo D, 2004, J AM CHEM SOC, V126, P10582, DOI 10.1021/ja040065s; Sarnow P, 2005, BIOCHEM SOC T, V33, P1479, DOI 10.1042/BST0331479; Shibuya T, 2006, RNA, V12, P360, DOI 10.1261/rna.2190706; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Singh G, 2007, MOL CELL, V27, P780, DOI 10.1016/j.molcel.2007.06.030; Stroupe ME, 2006, J MOL BIOL, V360, P743, DOI 10.1016/j.jmb.2006.05.049; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; Wang J, 2002, J BIOL CHEM, V277, P18489, DOI 10.1074/jbc.M111781200; Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002; West LM, 2000, J ORG CHEM, V65, P445, DOI 10.1021/jo991296y; Wilkinson MF, 2005, TRENDS GENET, V21, P143, DOI 10.1016/j.tig.2005.01.007; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002	58	54	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23613	23621		10.1074/jbc.M109.009985	http://dx.doi.org/10.1074/jbc.M109.009985			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570977	Green Published, hybrid			2022-12-27	WOS:000269180000047
J	Fukuda, A; Nakadai, T; Shimada, M; Hisatake, K				Fukuda, Aya; Nakadai, Tomoyoshi; Shimada, Miho; Hisatake, Koji			Heterogeneous Nuclear Ribonucleoprotein R Enhances Transcription from the Naturally Configured c-fos Promoter in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SERUM RESPONSE FACTOR; HBV-ENCODED COACTIVATOR; TERMINAL REPEAT DOMAIN; MAP KINASE PATHWAY; MEDIATOR COMPLEX; FUNCTIONAL-ANALYSIS; PROTEIN CBP; ACTIVATION; CREB	Transcription of a proto-oncogene c-fos is induced rapidly to high levels by various extracellular stimuli. To explore the molecular mechanism of c-fos gene induction, we established a defined in vitro transcription system for the c-fos promoter that consists of purified activators (SRF, Elk-1, cAMP-responsive element-binding protein, and ATF1), general transcription factors, and RNA polymerase II. In this reconstituted transcription system, activation of c-fos transcription was highly dependent upon coactivators such as PC4 and Mediator, indicating a very weak activation potential of the activators in the context of an unaltered promoter structure. This heightened coactivator dependence, however, allowed us to identify from HeLa nuclear extract a coactivator-like activity termed transcriptional regulator of c-fos (TREF) that enhanced c-fos transcription but not GAL4-VP16-dependent transcription. TREF cooperated with Mediator to enhance c-fos transcription by similar to 60-fold over its basal level and, like Mediator, stimulated activator-independent (basal) transcription as well. Further purification of TREF revealed that it consists of at least three distinct components, one of which was purified to near homogeneity and identified as heterogeneous nuclear ribonucleoprotein R. Recombinant heterogeneous nuclear ribonucleoprotein R enhanced transcription from the c-fos promoter and displayed cooperativity with PC4 and Mediator, thus demonstrating its direct transcriptional activity.	[Fukuda, Aya; Hisatake, Koji] Univ Tsukuba, Dept Biochem, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Fukuda, Aya; Hisatake, Koji] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Nakadai, Tomoyoshi; Shimada, Miho] Saitama Med Univ, Fac Med, Dept Mol Biol, Saitama 3500495, Japan	University of Tsukuba; University of Tsukuba; Saitama Medical University	Hisatake, K (corresponding author), 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	kojihisa@md.tsukuba.ac.jp		Nishimura, Ken/0000-0002-0716-4142; Hisatake, Koji/0000-0002-5795-3115	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research ( to A. F. and K. H.) and Special Coordination Funds for Promoting Science and Technology ( to A. F.) of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; Carty SM, 2002, MOL CELL PROTEOMICS, V1, P598, DOI 10.1074/mcp.M200029-MCP200; Chan HM, 2001, J CELL SCI, V114, P2363; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Damania B, 1996, GENE DEV, V10, P1369, DOI 10.1101/gad.10.11.1369; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; Fukuda A, 2004, MOL CELL BIOL, V24, P6525, DOI 10.1128/MCB.24.14.6525-6535.2004; Fukuda A, 2002, P NATL ACAD SCI USA, V99, P1206, DOI 10.1073/pnas.251674198; Fukuda A, 2001, GENES CELLS, V6, P707, DOI 10.1046/j.1365-2443.2001.00456.x; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Hassfeld W, 1998, NUCLEIC ACIDS RES, V26, P439, DOI 10.1093/nar/26.2.439; Haviv I, 1998, MOL CELL BIOL, V18, P1562, DOI 10.1128/MCB.18.3.1562; Haviv I, 1996, EMBO J, V15, P3413, DOI 10.1002/j.1460-2075.1996.tb00707.x; Haviv I, 1998, GENE DEV, V12, P1217, DOI 10.1101/gad.12.8.1217; Henry NL, 1996, J BIOL CHEM, V271, P21842, DOI 10.1074/jbc.271.36.21842; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; Huang J, 2008, CELL MOL BIOL LETT, V13, P303, DOI 10.2478/s11658-008-0002-0; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lukac DM, 1997, J VIROL, V71, P7227, DOI 10.1128/JVI.71.10.7227-7239.1997; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; REASON AJ, 1992, J BIOL CHEM, V267, P16911; REINBERG D, 1987, J BIOL CHEM, V262, P3322; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5291, DOI 10.1073/pnas.89.12.5291	57	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23472	23480		10.1074/jbc.M109.013656	http://dx.doi.org/10.1074/jbc.M109.013656			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581295	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000269180000032
J	Griffon, N; Jin, WJ; Petty, TJ; Millar, J; Badellino, KO; Saven, JG; Marchadier, DH; Kempner, ES; Billheimer, J; Glick, JM; Rader, DJ				Griffon, Nathalie; Jin, Weijin; Petty, Thomas J.; Millar, John; Badellino, Karen O.; Saven, Jeffery G.; Marchadier, Dawn H.; Kempner, Ellis S.; Billheimer, Jeffrey; Glick, Jane M.; Rader, Daniel J.			Identification of the Active Form of Endothelial Lipase, a Homodimer in a Head-to-Tail Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LIPOPROTEIN-LIPASE; HUMAN HEPATIC LIPASE; RADIATION INACTIVATION; HEPARIN-BINDING; PROTEIN STRUCTURES; PANCREATIC LIPASE; SUBSTRATE-SPECIFICITY; CHIMERIC LIPASE; CATALYTIC SITE; HDL METABOLISM	Endothelial lipase (EL) is a member of a subfamily of lipases that act on triglycerides and phospholipids in plasma lipoproteins, which also includes lipoprotein lipase and hepatic lipase. EL has a tropism for high density lipoprotein, and its level of phospholipase activity is similar to its level of triglyceride lipase activity. Inhibition or loss-of-function of EL in mice results in an increase in high density lipoprotein cholesterol, making it a potential therapeutic target. Although hepatic lipase and lipoprotein lipase have been shown to function as homodimers, the active form of EL is not known. In these studies, the size and conformation of the active form of EL were determined. Immunoprecipitation experiments suggested oligomerization. Ultracentrifugation experiments showed that the active form of EL had a molecular weight higher than the molecular weight of a simple monomer but less than a dimer. A construct encoding a covalent head-to-tail homodimer of EL (EL-EL) was expressed and had similar lipolytic activity to EL. The functional molecular weights determined by radiation inactivation were similar for EL and the covalent homodimer EL-EL. We previously showed that EL could be cleaved by proprotein convertases, such as PC5, resulting in loss of activity. In cells overexpressing PC5, the covalent homodimeric EL-EL appeared to be more stable, with reduced cleavage and conserved lipolytic activity. A comparative model obtained using other lipase structures suggests a structure for the head-to-tail EL homodimer that is consistent with the experimental findings. These data confirm the hypothesis that EL is active as a homodimer in head-to-tail conformation.	[Griffon, Nathalie; Jin, Weijin; Millar, John; Marchadier, Dawn H.; Billheimer, Jeffrey; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Griffon, Nathalie; Jin, Weijin; Millar, John; Marchadier, Dawn H.; Billheimer, Jeffrey; Rader, Daniel J.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Glick, Jane M.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Kempner, Ellis S.] NIAMS, NIH, Bethesda, MD 20892 USA; [Petty, Thomas J.; Saven, Jeffery G.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Badellino, Karen O.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Pennsylvania; University of Pennsylvania	Rader, DJ (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, Cardiovasc Inst, 654 BRBII-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu	Petty, Tom/A-6758-2011	Petty, Tom/0000-0002-4007-6515	NHLBI [HL55323]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055323, R37HL055323] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL55323 from the NHLBI (to D.J.R.).	Badellino KO, 2004, CURR OPIN CARDIOL, V19, P392, DOI 10.1097/01.hco.0000130161.89169.02; BELFRAGE P, 1969, J LIPID RES, V10, P341; Ben-Zeev O, 1999, METH MOL B, V109, P257; BENGTSSON G, 1981, EUR J BIOCHEM, V113, P547, DOI 10.1111/j.1432-1033.1981.tb05097.x; Berryman DE, 1998, BBA-PROTEIN STRUCT M, V1382, P217, DOI 10.1016/S0167-4838(97)00150-7; BOURNE Y, 1994, J MOL BIOL, V238, P709, DOI 10.1006/jmbi.1994.1331; Broedl UC, 2004, FASEB J, V18, P1891, DOI 10.1096/fj.03-1307fje; Brown RJ, 2007, J LIPID RES, V48, P1132, DOI 10.1194/jlr.M600535-JLR200; DAVIS RC, 1992, J BIOL CHEM, V267, P21499; DICHEK HL, 1993, J LIPID RES, V34, P1393; DUGI KA, 1995, J BIOL CHEM, V270, P25396, DOI 10.1074/jbc.270.43.25396; DUGI KA, 1992, J BIOL CHEM, V267, P25086; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; GARFINKEL AS, 1983, J LIPID RES, V24, P775; Gauster M, 2005, J LIPID RES, V46, P977, DOI 10.1194/jlr.M400500-JLR200; Griffon N, 2006, J LIPID RES, V47, P1803, DOI 10.1194/jlr.M500552-JLR200; HARMON JT, 1985, METHOD ENZYMOL, V117, P65; Hill JS, 1998, J BIOL CHEM, V273, P30979, DOI 10.1074/jbc.273.47.30979; Hill JS, 1996, J BIOL CHEM, V271, P22931, DOI 10.1074/jbc.271.37.22931; IVERIUS PH, 1976, J BIOL CHEM, V251, P7791; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Keiper T, 2001, J LIPID RES, V42, P1180; KEMPNER ES, 1979, ANAL BIOCHEM, V92, P2, DOI 10.1016/0003-2697(79)90617-1; Kobayashi J, 1996, J BIOL CHEM, V271, P26296, DOI 10.1074/jbc.271.42.26296; Kobayashi Y, 2002, EUR J BIOCHEM, V269, P4701, DOI 10.1046/j.1432-1033.2002.03179.x; Lookene A, 1997, J BIOL CHEM, V272, P766, DOI 10.1074/jbc.272.2.766; Lutz EP, 2004, J BIOL CHEM, V279, P238, DOI 10.1074/jbc.M310559200; Lutz EP, 2001, J CLIN INVEST, V107, P1183, DOI 10.1172/JCI11774; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; McCoy MG, 2002, J LIPID RES, V43, P921; Miller GC, 2004, J LIPID RES, V45, P2080, DOI 10.1194/jlr.M400162-JLR200; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; OLIVECRONA T, 1985, J BIOL CHEM, V260, P6888; OSBORNE JC, 1985, BIOCHEMISTRY-US, V24, P5606, DOI 10.1021/bi00341a048; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schoonderwoerd K, 1996, BIOCHEM J, V318, P463, DOI 10.1042/bj3180463; Sendak RA, 1998, J LIPID RES, V39, P1310; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; WONG H, 1991, P NATL ACAD SCI USA, V88, P11290, DOI 10.1073/pnas.88.24.11290; Wong H, 1997, P NATL ACAD SCI USA, V94, P5594, DOI 10.1073/pnas.94.11.5594; Zhang LY, 2005, J BIOL CHEM, V280, P42580, DOI 10.1074/jbc.M507252200	47	34	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23322	23330		10.1074/jbc.M109.037002	http://dx.doi.org/10.1074/jbc.M109.037002			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19567873	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000269180000017
J	Song, WL; Paschos, G; Fries, S; Reilly, MP; Yu, Y; Rokach, J; Chang, CT; Patel, P; Lawson, JA; FitzGerald, GA				Song, Wen-Liang; Paschos, Georgios; Fries, Susanne; Reilly, Muredach P.; Yu, Ying; Rokach, Joshua; Chang, Chih-Tsung; Patel, Pranav; Lawson, John A.; FitzGerald, Garret A.			Novel Eicosapentaenoic Acid-derived F-3-isoprostanes as Biomarkers of Lipid Peroxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RANDOMIZED CONTROLLED-TRIAL; PROSTAGLANDIN F-2 ALPHA; N-3 FATTY-ACIDS; IN-VIVO; FISH-OIL; DOCOSAHEXAENOIC ACID; HUMAN URINE; MYOCARDIAL-INFARCTION; ISOPROSTANE; PLATELET	Isoprostanes (iPs) are prostaglandin (PG) isomers generated by free radical-catalyzed peroxidation of polyunsaturated fatty acids (PUFAs). Urinary F-2-iPs, PGF(2 alpha) isomers derived from arachidonic acid (AA) are used as indices of lipid peroxidation in vivo. We now report the characterization of two major F-3-iPs, 5-epi-8,12-iso-iPF(3 alpha)-VI and 8,12-iso-iPF(3 alpha)-VI, derived from the omega-3 fatty acid, eicosapentaenoic acid (EPA). Although the potential therapeutic benefits of EPA receive much attention, a shift toward a diet rich in omega-3 PUFAs may also predispose to enhanced lipid peroxidation. Urinary 5-epi-8,12-iso-iPF(3 alpha)-VI and 8,12-iso-iPF(3 alpha)-VI are highly correlated and unaltered by cyclooxygenase inhibition in humans. Fish oil dose-dependently elevates urinary F-3-iPs in mice and a shift in dietary omega-3/omega-6 PUFAs is reflected by an increasing slope [m] of the line relating urinary 8, 12-iso-iPF(3 alpha)-VI and 8,12-iso-iPF(2 alpha)-VI. Administration of bacterial lipopolysaccharide evokes a reversible increase in both urinary 8,12-iso-iPF(3 alpha)-VI and 8,12-iso-iPF(2 alpha)-VI in humans on an ad lib diet. However, while excretion of the iPs is highly correlated (R-2 median = 0.8), [m] varies by an order of magnitude, reflecting marked inter-individual variability in the relative peroxidation of omega-3 versus omega-6 substrates. Clustered analysis of F-2- and F-3-iPs refines assessment of the oxidant stress response to an inflammatory stimulus in vivo by integrating variability in dietary intake of omega-3/omega-6 PUFAs.	[Song, Wen-Liang; Paschos, Georgios; Fries, Susanne; Reilly, Muredach P.; Yu, Ying; Lawson, John A.; FitzGerald, Garret A.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Rokach, Joshua; Chang, Chih-Tsung; Patel, Pranav] Florida Inst Technol, Dept Chem, Melbourne, FL 32901 USA; [Rokach, Joshua; Chang, Chih-Tsung; Patel, Pranav] Florida Inst Technol, Claude Pepper Inst, Melbourne, FL 32901 USA	University of Pennsylvania; Florida Institute of Technology; Florida Institute of Technology	FitzGerald, GA (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, 153 Johnson Pavil,Hamilton Walk, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	Paschos, Georgios K/F-2802-2011; FitzGerald, Garret A/A-4222-2010	Reilly, Muredach/0000-0002-3035-9386; Rokach, Joshu/0000-0003-1814-7505; Song, Wenliang/0000-0002-1866-0635	National Institutes of Health [P01-HL62250, 1U54-RR-023567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250, R01HL081873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-HL62250 and 1U54-RR-023567 ( to G. A. F.) and HL-81873 ( to J.R.).	Audoly LP, 2000, CIRCULATION, V101, P2833, DOI 10.1161/01.CIR.101.24.2833; Brooks JD, 2008, J BIOL CHEM, V283, P12043, DOI 10.1074/jbc.M800122200; Brouwer IA, 2006, JAMA-J AM MED ASSOC, V295, P2613, DOI 10.1001/jama.295.22.2613; Brouwer IA, 2006, PROG LIPID RES, V45, P357, DOI 10.1016/j.plipres.2006.02.004; Chang CT, 2008, BIOORG MED CHEM LETT, V18, P5523, DOI 10.1016/j.bmcl.2008.09.008; Fam SS, 2002, J BIOL CHEM, V277, P36076, DOI 10.1074/jbc.M205638200; Feagan BG, 2008, JAMA-J AM MED ASSOC, V299, P1690, DOI 10.1001/jama.299.14.1690; Gao L, 2003, J BIOL CHEM, V278, P28479, DOI 10.1074/jbc.M303984200; Gao L, 2006, J BIOL CHEM, V281, P14092, DOI 10.1074/jbc.M601035200; Hoffman SW, 1997, STROKE, V28, P844, DOI 10.1161/01.STR.28.4.844; Jacobo SH, 2006, J ORG CHEM, V71, P1370, DOI 10.1021/jo051916x; Kinsella BT, 1997, J PHARMACOL EXP THER, V281, P957; KNAPP HR, 1986, NEW ENGL J MED, V314, P937, DOI 10.1056/NEJM198604103141501; KNAPP HR, 1989, NEW ENGL J MED, V320, P1037, DOI 10.1056/NEJM198904203201603; KULKARNI PS, 1986, PROSTAGLANDINS, V31, P1159, DOI 10.1016/0090-6980(86)90217-0; Kunapuli P, 1998, J BIOL CHEM, V273, P22442, DOI 10.1074/jbc.273.35.22442; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Lawson JA, 1998, J BIOL CHEM, V273, P29295, DOI 10.1074/jbc.273.45.29295; Lawson JA, 2006, J LIPID RES, V47, P2515, DOI 10.1194/jlr.M600327-JLR200; Leaf A, 2005, CIRCULATION, V112, P2762, DOI 10.1161/CIRCULATIONAHA.105.549527; Lee SH, 2006, CURR DRUG METAB, V7, P929; Li HW, 1999, P NATL ACAD SCI USA, V96, P13381, DOI 10.1073/pnas.96.23.13381; Makrides M, 2009, JAMA-J AM MED ASSOC, V301, P175, DOI 10.1001/jama.2008.945; Mallat Z, 1999, J CLIN INVEST, V103, P421, DOI 10.1172/JCI3985; McAdam BF, 2000, J CLIN INVEST, V105, P1473, DOI 10.1172/JCI9523; Minuz P, 1998, ARTERIOSCL THROM VAS, V18, P1248, DOI 10.1161/01.ATV.18.8.1248; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1992, PROSTAGLANDINS, V44, P155, DOI 10.1016/0090-6980(92)90077-7; Nilsen DWT, 2001, AM J CLIN NUTR, V74, P50; Nonaka-Sarukawa M, 2003, HEART, V89, P871, DOI 10.1136/heart.89.8.871; NouroozZadeh J, 1997, BIOCHEM BIOPH RES CO, V236, P467, DOI 10.1006/bbrc.1997.6869; O'Sullivan S, 1999, PROSTAG OTH LIPID M, V57, P149, DOI 10.1016/S0090-6980(98)00076-8; Pratico D, 1997, J CLIN INVEST, V100, P2028, DOI 10.1172/JCI119735; Pratico D, 1996, J BIOL CHEM, V271, P14916, DOI 10.1074/jbc.271.25.14916; Raitt MH, 2005, JAMA-J AM MED ASSOC, V293, P2884, DOI 10.1001/jama.293.23.2884; Reilly MP, 1998, CIRCULATION, V98, P2822, DOI 10.1161/01.CIR.98.25.2822; Reilly MP, 1997, CIRCULATION, V96, P3314; REIS GJ, 1990, AM J CARDIOL, V66, P1171, DOI 10.1016/0002-9149(90)91093-L; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Song WL, 2007, METHOD ENZYMOL, V433, P51, DOI 10.1016/S0076-6879(07)33003-6; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; TAKAHASHI K, 1992, J CLIN INVEST, V90, P136, DOI 10.1172/JCI115826; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; YIN K, 1994, J PHARMACOL EXP THER, V270, P1192	45	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23636	23643		10.1074/jbc.M109.024075	http://dx.doi.org/10.1074/jbc.M109.024075			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19520854	Green Published, hybrid			2022-12-27	WOS:000269180000049
J	Clifford, RJ; Kaplan, JH				Clifford, Rebecca J.; Kaplan, Jack H.			Regulation of Na,K-ATPase Subunit Abundance by Translational Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; BETA-SUBUNIT; ALPHA-SUBUNIT; MDCK CELLS; GENE-EXPRESSION; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; TRANSGENIC MICE; MESSENGER-RNA	The Na,K-ATPase is an alpha beta heterodimer responsible for maintaining fluid and electrolyte homeostasis in mammalian cells. We engineered Madin-Darby canine kidney cell lines expressing alpha(1)FLAG, beta(1)FLAG, or beta 2MYC subunits via a tetracycline-regulated promoter and a line expressing both stable beta 1MYC and tetracycline-regulated beta(1)FLAG to examine regulatory mechanisms of sodium pump subunit expression. When overexpression of exogenous beta(1)FLAG increased total beta subunit levels by > 200% without changes in alpha subunit abundance, endogenous beta(1) subunit (beta E-1) abundance decreased. beta E-1 down-regulation did not occur during beta 2MYC overexpression, indicating isoform specificity of the repression mechanism. Measurements of RNA stability and content indicated that decreased beta subunit expression was not accompanied by any change in mRNA levels. In addition, the degradation rate of beta subunits was not altered by beta(1)FLAG overexpression. Cells stably expressing beta 1MYC, when induced to express beta(1)FLAG subunits, showed reduced beta 1MYC and beta E-1 subunit abundance, indicating that these effects occur via the coding sequences of the down-regulated polypeptides. In a similar way, Madin-Darby canine kidney cells overexpressing exogenous beta(1)FLAG subunits exhibited a reduction of endogenous alpha(1) subunits (alpha E-1) with no change in alpha mRNA levels or beta subunits. The reduction in alpha E-1 compensated for alpha(1)FLAG subunit expression, resulting in unchanged total alpha subunit abundance. Thus, regulation of alpha subunit expression maintained its native level, whereas beta subunit was not as tightly regulated and its abundance could increase substantially over native levels. These effects also occurred in human embryonic kidney cells. These data are the first indication that cellular sodium pump subunit abundance is modulated by translational repression. This mechanism represents a novel, potentially important mechanism for regulation of Na,K-ATPase expression.	[Clifford, Rebecca J.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaplan, JH (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	kaplanj@uic.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [GM-39500]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-39500.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Barwe SP, 2007, J MOL BIOL, V365, P706, DOI 10.1016/j.jmb.2006.10.029; Beggah AT, 1997, J BIOL CHEM, V272, P10318; Beguin P, 2000, MOL BIOL CELL, V11, P1657, DOI 10.1091/mbc.11.5.1657; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BOWEN JW, 1987, AM J PHYSIOL, V252, pC179, DOI 10.1152/ajpcell.1987.252.2.C179; CAPLAN MJ, 1986, CELL, V46, P623, DOI 10.1016/0092-8674(86)90888-3; CAPLAN MJ, 1986, J BIOL CHEM, V261, P2860; Clifford RJ, 2008, AM J PHYSIOL-RENAL, V295, pF1314, DOI 10.1152/ajprenal.90406.2008; CORTHESYTHEULAZ I, 1991, AM J PHYSIOL, V261, pC124, DOI 10.1152/ajpcell.1991.261.1.C124; DEVARAJAN P, 1992, J BIOL CHEM, V267, P22435; Dickey CA, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-7; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; FARLEY RA, 1986, BIOCHIM BIOPHYS ACTA, V873, P136, DOI 10.1016/0167-4838(86)90199-8; Gatto C, 1998, J BIOL CHEM, V273, P10578, DOI 10.1074/jbc.273.17.10578; Gatto C, 2001, AM J PHYSIOL-CELL PH, V281, pC982, DOI 10.1152/ajpcell.2001.281.3.C982; GonzalezGaray ML, 1996, J CELL BIOL, V135, P1525, DOI 10.1083/jcb.135.6.1525; Grindstaff KK, 1996, J BIOL CHEM, V271, P23211, DOI 10.1074/jbc.271.38.23211; Harris ZL, 1996, EUR RESPIR J, V9, P472, DOI 10.1183/09031936.96.09030472; HAYASHI Y, 1983, BIOCHIM BIOPHYS ACTA, V748, P153, DOI 10.1016/0167-4838(83)90291-1; Henderson ER, 1996, J BIOL CHEM, V271, P4900; Hu YK, 2000, J BIOL CHEM, V275, P19185, DOI 10.1074/jbc.M000641200; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KYTE J, 1971, J BIOL CHEM, V246, P4157; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Laughery MD, 2007, AM J PHYSIOL-RENAL, V292, pF1718, DOI 10.1152/ajprenal.00360.2006; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; LUTSENKO S, 1994, J BIOL CHEM, V269, P4555; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; MILLER RP, 1988, BIOCHIM BIOPHYS ACTA, V954, P50, DOI 10.1016/0167-4838(88)90054-4; MIRCHEFF AK, 1992, AM J PHYSIOL, V262, pC470, DOI 10.1152/ajpcell.1992.262.2.C470; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; OHTSUBO M, 1990, BIOCHIM BIOPHYS ACTA, V1021, P157, DOI 10.1016/0005-2736(90)90028-M; Pontiggia L, 1997, BIOCHEM BIOPH RES CO, V231, P755, DOI 10.1006/bbrc.1997.6188; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; RUIZ A, 1995, GENE, V155, P179, DOI 10.1016/0378-1119(94)00812-7; Shao Y, 2004, AM J PHYSIOL-CELL PH, V286, pC580, DOI 10.1152/ajpcell.00117.2003; Shao Y, 2001, ARCH BIOCHEM BIOPHYS, V390, P78, DOI 10.1006/abbi.2001.2354; Shoshani L, 2005, MOL BIOL CELL, V16, P1071, DOI 10.1091/mbc.E04-03-0267; SWEADNER KJ, 1979, J BIOL CHEM, V254, P6060; TANG MJ, 1992, AM J PHYSIOL, V263, pC436, DOI 10.1152/ajpcell.1992.263.2.C436; THEODORAKIS NG, 1992, MOL CELL BIOL, V12, P791, DOI 10.1128/MCB.12.2.791; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Wang G, 2007, MOL CELL BIOCHEM, V294, P73, DOI 10.1007/s11010-006-9247-y; Weber P, 1998, J NEUROSCI, V18, P9192; Wendt CH, 2000, J BIOL CHEM, V275, P41396, DOI 10.1074/jbc.M004759200; Wendt CH, 1998, AM J PHYSIOL-CELL PH, V274, pC356, DOI 10.1152/ajpcell.1998.274.2.C356; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; YANG-FENG T L, 1988, Genomics, V2, P128, DOI 10.1016/0888-7543(88)90094-8; You LC, 2000, METAB ENG, V2, P210, DOI 10.1006/mben.1999.0139; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	56	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22905	22915		10.1074/jbc.M109.030536	http://dx.doi.org/10.1074/jbc.M109.030536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553675	Green Published, hybrid			2022-12-27	WOS:000268963100044
J	Zhang, W; Yang, J; Liu, YJ; Chen, X; Yu, TX; Jia, JH; Liu, CM				Zhang, Wen; Yang, Jun; Liu, Yajuan; Chen, Xi; Yu, Tianxin; Jia, Jianhang; Liu, Chunming			PR55 alpha, a Regulatory Subunit of PP2A, Specifically Regulates PP2A-mediated beta-Catenin Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; WNT SIGNALING PATHWAY; CRYSTAL-STRUCTURE; NAKED CUTICLE; PHOSPHORYLATION; HOLOENZYME; APC; IDENTIFICATION; DEGRADATION; REPRESSION	A central question in Wnt signaling is the regulation of beta-catenin phosphorylation and degradation. Multiple kinases, including CKI alpha and GSK3, are involved in beta-catenin phosphorylation. Protein phosphatases such as PP2A and PP1 have been implicated in the regulation of beta-catenin. However, which phosphatase dephosphorylates beta-catenin in vivo and how the specificity of beta-catenin dephosphorylation is regulated are not clear. In this study, we show that PP2A regulates beta-catenin phosphorylation and degradation in vivo. We demonstrate that PP2A is required for Wnt/beta-catenin signaling in Drosophila. Moreover, we have identified PR55 alpha as the regulatory subunit of PP2A that controls beta-catenin phosphorylation and degradation. PR55 alpha, but not the catalytic subunit, PP2Ac, directly interacts with beta-catenin. RNA interference knockdown of PR55 alpha elevates beta-catenin phosphorylation and decreases Wnt signaling, whereas overexpressing PR55 alpha enhances Wnt signaling. Taken together, our results suggest that PR55 alpha specifically regulates PP2A-mediated beta-catenin dephosphorylation and plays an essential role in Wnt signaling.	[Yang, Jun; Yu, Tianxin; Liu, Chunming] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Zhang, Wen; Liu, Yajuan; Chen, Xi; Jia, Jianhang; Liu, Chunming] Univ Kentucky, Lucille P Markey Canc Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Kentucky	Liu, CM (corresponding author), 741 S Limestone,B375 BBSRB, Lexington, KY 40506 USA.	chunming.liu@uky.edu	Yu, T.X./B-9806-2011	Jia, Jianhang/0000-0002-9313-3843	National Institutes of Health [R01GM079684, R01DK071976]; Charlotte Geyer Foundation; NATIONAL CANCER INSTITUTE [R21CA112007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charlotte Geyer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant R01GM079684.; Supported by National Institutes of Health Grant R01DK071976 and an award from the Charlotte Geyer Foundation.	Adams Deanna G., 2007, V365, P101; Bajpai R, 2004, DEVELOPMENT, V131, P1007, DOI 10.1242/dev.00980; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Creyghton MP, 2006, P NATL ACAD SCI USA, V103, P5397, DOI 10.1073/pnas.0507237103; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Ratcliffe MJ, 2000, J BIOL CHEM, V275, P35680, DOI 10.1074/jbc.C000639200; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Strovel ET, 2000, J BIOL CHEM, V275, P2399, DOI 10.1074/jbc.275.4.2399; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yamamoto H, 2001, J BIOL CHEM, V276, P26875, DOI 10.1074/jbc.M100443200; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006	33	81	84	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22649	22656		10.1074/jbc.M109.013698	http://dx.doi.org/10.1074/jbc.M109.013698			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19556239	Green Published, hybrid			2022-12-27	WOS:000268963100018
J	Gao, FR; Kwon, SW; Zhao, YM; Jin, Y				Gao, Furong; Kwon, Sung Won; Zhao, Yingming; Jin, Ying			PARP1 Poly(ADP-ribosyl)ates Sox2 to Control Sox2 Protein Levels and FGF4 Expression during Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR OCT-4; NANOG GENE-EXPRESSION; CARCINOMA-CELLS; SELF-RENEWAL; POSTTRANSLATIONAL MODIFICATION; REGULATORY ELEMENT; SYNERGISTIC ACTION; MOUSE DEVELOPMENT; ADP-RIBOSYLATION	Transcription factors Oct4 and Sox2 are key players in maintaining the pluripotent state of embryonic stem cells (ESCs). Small changes in their levels disrupt normal expression of their target genes. However, it remains elusive how protein levels of Oct4 and Sox2 and expression of their target genes are precisely controlled in ESCs. Here we identify PARP1, a DNA-binding protein with an NAD(+)-dependent enzymatic activity, as a cofactor of Oct4 and Sox2 to regulate expression of their target gene FGF4. We demonstrate for the first time that PARP1 binds the FGF4 enhancer to positively regulate FGF4 expression. Our data show that PARP1 interacts with and poly(ADP-ribosyl)ates Sox2 directly, which may be a step required for dissociation and degradation of inhibitory Sox2 proteins from the FGF4 enhancer. When PARP1 activity is inhibited or absent, poly(ADP-ribosyl)ation of Sox2 decreases and association of Sox2 with FGF4 enhancers increases, accompanied by an elevated level of Sox2 proteins and reduced expression of FGF4. Significantly, specific knockdown of Sox2 expression by RNA interference can considerably abrogate the inhibitory effect of the poly(ADPribose) polymerase inhibitor on FGF4 expression. Interestingly, PARP1 deficiency does not affect undifferentiated ESCs but compromises cell survival and/or growth when ESCs are induced into differentiation. Addition of FGF4 can partially rescue the phenotypes caused by PARP1 deficiency during ESC differentiation. Taken together, this study uncovers new mechanisms through which Sox2 protein levels and FGF4 expression are dynamically regulated during ESC differentiation and adds a new member to the family of proteins regulating the properties of ESCs.	[Gao, Furong; Jin, Ying] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Sch Med,Inst Hlth Sci,Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Gao, Furong; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Shanghai 200025, Peoples R China; [Kwon, Sung Won; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Gao, Furong] Chinese Acad Sci, Grad Sch, Beijing 100000, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Chicago; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Sch Med,Inst Hlth Sci,Key Lab Stem Cell Biol, 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn		, jin ying/0000-0003-0070-2048	National Natural Science Foundation of China [30730051]; Shanghai Science and Technology Developmental Foundation [08JC1413100]; National High Technology Research and Development Program of China [2006CB943901, 2007CB947904]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Developmental Foundation; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation of China Grant 30730051, Shanghai Science and Technology Developmental Foundation Grant 08JC1413100, National High Technology Research and Development Program of China Grants 2006CB943901 and 2007CB947904, and Shanghai Leading Academic Discipline Project S30201.	Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Boer B, 2006, J CELL PHYSIOL, V208, P97, DOI 10.1002/jcp.20635; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; FERRO AM, 1982, J BIOL CHEM, V257, P7808; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hemberger M, 2003, DEV BIOL, V257, P371, DOI 10.1016/S0012-1606(03)00097-6; Huang JY, 2006, NUCLEIC ACIDS RES, V34, P2398, DOI 10.1093/nar/gkl241; Johnson LR, 1998, MOL REPROD DEV, V50, P377; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kanai M, 2007, BIOCHEM BIOPH RES CO, V359, P426, DOI 10.1016/j.bbrc.2007.05.108; KASID UN, 1989, J BIOL CHEM, V264, P18687; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Luster TA, 2003, GENE, V323, P163, DOI 10.1016/j.gene.2003.09.019; Masutani M, 2001, MUTAT RES-FUND MOL M, V477, P111, DOI 10.1016/S0027-5107(01)00112-9; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; NISWANDER L, 1992, DEVELOPMENT, V114, P755; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olabisi OA, 2008, MOL CELL BIOL, V28, P2860, DOI 10.1128/MCB.01746-07; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; SCHOORLEMMER J, 1991, MECH DEVELOP, V36, P75, DOI 10.1016/0925-4773(91)90074-G; SCOVASSI AI, 1993, EXP CELL RES, V206, P177, DOI 10.1006/excr.1993.1135; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Smulson ME, 2000, ADV ENZYME REGUL, V40, P183, DOI 10.1016/S0065-2571(99)00024-2; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wacker David A, 2007, Subcell Biochem, V41, P45; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Yeom YI, 1996, DEVELOPMENT, V122, P881; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com	59	56	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22263	22273		10.1074/jbc.M109.033118	http://dx.doi.org/10.1074/jbc.M109.033118			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531481	Green Published, hybrid			2022-12-27	WOS:000268783700050
J	Jeong, J; Rao, AU; Xu, JL; Ogg, SL; Hathout, Y; Fenselau, C; Mather, IH				Jeong, Jaekwang; Rao, Anita U.; Xu, Jinling; Ogg, Sherry L.; Hathout, Yetrib; Fenselau, Catherine; Mather, Ian H.			The PRY/SPRY/B30.2 Domain of Butyrophilin 1A1 (BTN1A1) Binds to Xanthine Oxidoreductase IMPLICATIONS FOR THE FUNCTION OF BTN1A1 IN THE MAMMARY GLAND AND OTHER TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAT-GLOBULE-MEMBRANE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MILK PROTEIN BUTYROPHILIN; MAMMARY EPITHELIAL-CELLS; CLASS-I REGION; IMMUNOGLOBULIN SUPERFAMILY; BOVINE BUTYROPHILIN; POLYACRYLAMIDE-GELS; CYTOPLASMIC DOMAIN	Butyrophilin 1A1 (BTN1A1) and xanthine oxidoreductase (XOR) are highly expressed in the lactating mammary gland and are secreted into milk associated with the milk fat globule membrane (MFGM). Ablation of the genes encoding either protein causes severe defects in the secretion of milk lipid droplets, suggesting that the two proteins may function in the same pathway. Therefore, we determined whether BTN1A1 and XOR directly interact using protein binding assays, surface plasmon resonance analysis, and gel filtration. Bovine XOR bound with high affinity in a pH- and salt-sensitive manner (K-D = 101 +/- 31 nM in 10 mM HEPES, 150 mM NaCl, pH 7.4) to the PRY/SPRY/B30.2 domain in the cytoplasmic region of bovine BTN1A1. Binding was stoichiometric, with one XOR dimer binding to either two BTN1A1 monomers or one dimer. XOR bound to BTN1A1 orthologs from mice, humans, or cows but not to the cytoplasmic domains of the closely related human paralogs, BTN2A1 or BTN3A1, or to the B30.2 domain of human RoRet (TRIM 38), a protein in the TRIM family. Analysis of the protein composition of the MFGM of wild type and BTN1A1 null mice showed that most of the XOR in mice lacking BTN1A1 was released from the MFGM in a soluble form when the milk lipid droplets were disrupted to prepare membrane, compared with wild-type mice, in which most of the XOR remained membrane-bound. Thus BTN1A1 functions in vivo to stabilize the association of XOR with the MFGM by direct interactions through the PRY/SPRY/B30.2 domain. The potential significance of BTN1A1/XOR interactions in the mammary gland and other tissues is discussed.	[Jeong, Jaekwang; Rao, Anita U.; Xu, Jinling; Ogg, Sherry L.; Mather, Ian H.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Hathout, Yetrib; Fenselau, Catherine] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Mather, IH (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	imather@umd.edu			National Institutes of Health [R01 HD048588-01A1]; United States Department of Agriculture [NRI 0003264, 2005-04637]; Maryland Agricultural Experiment Station; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); Maryland Agricultural Experiment Station; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD048588-01A1. This work was also supported by United States Department of Agriculture Grants NRI 0003264 and 2005-04637 and the Maryland Agricultural Experiment Station (to I. H. M.).	ADACHI T, 1993, BIOCHEM J, V289, P523, DOI 10.1042/bj2890523; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Banghart LR, 1998, J BIOL CHEM, V273, P4171, DOI 10.1074/jbc.273.7.4171; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Breithaupt C, 2003, P NATL ACAD SCI USA, V100, P9446, DOI 10.1073/pnas.1133443100; BUCHHEIM W, 1982, NATURWISSENSCHAFTEN, V69, P505, DOI 10.1007/BF00365826; Compte E, 2004, EUR J IMMUNOL, V34, P2089, DOI 10.1002/eji.200425227; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; FRANKE WW, 1981, J CELL BIOL, V89, P485, DOI 10.1083/jcb.89.3.485; GARDINIER MV, 1992, J NEUROSCI RES, V33, P177, DOI 10.1002/jnr.490330123; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grutter C, 2006, FEBS LETT, V580, P99, DOI 10.1016/j.febslet.2005.11.076; Guggenmos J, 2004, J IMMUNOL, V172, P661, DOI 10.4049/jimmunol.172.1.661; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HEID HW, 1983, BIOCHIM BIOPHYS ACTA, V728, P228, DOI 10.1016/0005-2736(83)90476-5; Henry J, 1998, MOL BIOL EVOL, V15, P1696, DOI 10.1093/oxfordjournals.molbev.a025896; Ishii T, 1995, BBA-GEN SUBJECTS, V1245, P285, DOI 10.1016/0304-4165(95)00102-6; JACK LJW, 1990, J BIOL CHEM, V265, P14481; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; KEON BH, 1994, BBA-LIPID LIPID MET, V1215, P327, DOI 10.1016/0005-2760(94)90061-2; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Kuang ZH, 2009, J MOL BIOL, V386, P662, DOI 10.1016/j.jmb.2008.12.078; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; LINSLEY PS, 1994, PROTEIN SCI, V3, P1341, DOI 10.1002/pro.5560030820; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Malcherek G, 2007, J IMMUNOL, V179, P3804, DOI 10.4049/jimmunol.179.6.3804; Mana P, 2004, INT IMMUNOL, V16, P489, DOI 10.1093/intimm/dxh049; Martin HM, 2004, INFECT IMMUN, V72, P4933, DOI 10.1128/IAI.72.9.4933-4939.2004; Masters SL, 2006, NAT STRUCT MOL BIOL, V13, P77, DOI 10.1038/nsmb1034; Mather I. H., 1987, The mammary gland. Development, regulation, and function., P217; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McManaman JL, 2007, J MAMMARY GLAND BIOL, V12, P259, DOI 10.1007/s10911-007-9053-5; McManaman JL, 2002, J PHYSIOL-LONDON, V545, P567, DOI 10.1113/jphysiol.2002.027185; Meyer M, 2003, TISSUE ANTIGENS, V61, P63, DOI 10.1034/j.1399-0039.2003.610105.x; NEIRA LM, 1990, PROTOPLASMA, V159, P168, DOI 10.1007/BF01322599; Nguyen T, 2006, J IMMUNOL, V176, P7354, DOI 10.4049/jimmunol.176.12.7354; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; PAHL HL, 1994, BIOESSAYS, V16, P497, DOI 10.1002/bies.950160709; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Robenek H, 2006, P NATL ACAD SCI USA, V103, P10385, DOI 10.1073/pnas.0600795103; Ruddy DA, 1997, GENOME RES, V7, P441, DOI 10.1101/gr.7.5.441; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stefferl A, 2000, J IMMUNOL, V165, P2859, DOI 10.4049/jimmunol.165.5.2859; SULLIVAN CH, 1982, MOL CELL BIOCHEM, V44, P13, DOI 10.1007/BF00573841; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; VERNET C, 1993, J MOL EVOL, V37, P600; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; WOODWELL GM, 1977, MAR BIOL, V41, P1, DOI 10.1007/BF00390575	60	44	47	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22444	22456		10.1074/jbc.M109.020446	http://dx.doi.org/10.1074/jbc.M109.020446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531472	Green Published, hybrid			2022-12-27	WOS:000268783700066
J	Lorizate, M; Brugger, B; Akiyama, H; Glass, B; Muller, B; Anderluh, G; Wieland, FT; Krausslich, HG				Lorizate, Maier; Bruegger, Britta; Akiyama, Hisashi; Glass, Baerbel; Mueller, Barbara; Anderluh, Gregor; Wieland, Felix T.; Kraeusslich, Hans-Georg			Probing HIV-1 Membrane Liquid Order by Laurdan Staining Reveals Producer Cell-dependent Differences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; 2-PHOTON FLUORESCENCE MICROSCOPY; PORE-FORMING TOXIN; GIANT UNILAMELLAR VESICLES; CYTOLYSIN EQUINATOXIN-II; FREE STANDING BILAYERS; MURINE LEUKEMIA-VIRUS; LIPID RAFTS; PLASMA-MEMBRANE; SEA-ANEMONE	Viruses acquire their envelope by budding from a host cell membrane, but viral lipid composition may differ from that of the budding membrane. We have previously reported that the HIV-1 membrane is highly enriched in cholesterol, sphingolipids, and other raft lipids, suggesting that the virus may bud from pre-existing or virus-induced lipid rafts. Here, we employed the environmentally sensitive fluorescent dye Laurdan to study the membrane lateral structure of HIV-1 derived from different cell lines. Differences in viral membrane order detected by Laurdan staining were shown by mass spectrometry to be due to differences in lipid composition. Isogenic viruses from two different cell lines were both strongly enriched in raft lipids and displayed a liquid-ordered membrane, but these effects were significantly more pronounced for HIV-1 from the T-cell line MT-4 compared with virus from 293T cells. Host-dependent differences in the lipidomes predominantly affected the ratio of sphingomyelins (including dihydrosphingomyelin) to phosphatidylcholine, whereas cholesterol contents were similar. Accordingly, treatment of infectious HIV-1 with the sphingomyelin-binding toxins Equinatoxin-II or lysenin showed differential inhibition of infectivity. Liposomes consisting of lipids that had been extracted from viral particles exhibited slightly less liquid order than the respective viral membranes, which is likely to be due to absence of membrane proteins and to loss of lipid asymmetry. Synthetic liposomes consisting of a quaternary lipid mixture emulating the viral lipids showed a liquid order similar to liposomes derived from virion lipids. Thus, Laurdan staining represents a rapid and quantitative method to probe viral membrane liquid order and may prove useful in the search for lipid active drugs.	[Lorizate, Maier; Akiyama, Hisashi; Glass, Baerbel; Mueller, Barbara; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Virol, D-69120 Heidelberg, Germany; [Bruegger, Britta; Wieland, Felix T.] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Ljubljana	Krausslich, HG (corresponding author), Univ Klinikum Heidelberg, Dept Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	hans-georg.kraeusslich@med.uni-heidelberg.de	Anderluh, Gregor/C-6905-2014; Muller, Barbara/AAC-4483-2020; Lorizate, Maier/S-1151-2018	Anderluh, Gregor/0000-0002-9916-8465; Lorizate, Maier/0000-0001-8173-2788; Akiyama, Hisashi/0000-0001-9228-0465; Muller, Barbara/0000-0001-5726-5585				ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; AGY MB, 1990, VIROLOGY, V177, P251, DOI 10.1016/0042-6822(90)90478-A; ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; Bagatolli LA, 2003, CHEM PHYS LIPIDS, V122, P137, DOI 10.1016/S0009-3084(02)00184-6; Bagatolli LA, 2000, CHEM PHYS LIPIDS, V105, P135, DOI 10.1016/S0009-3084(00)00118-3; Bagatolli LA, 2000, BIOPHYS J, V79, P434, DOI 10.1016/S0006-3495(00)76305-3; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bonev BB, 2003, BIOPHYS J, V84, P2382, DOI 10.1016/S0006-3495(03)75044-9; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brugger B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-70; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; EMI N, 1991, J VIROL, V65, P1202, DOI 10.1128/JVI.65.3.1202-1207.1991; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Goni FM, 2008, BBA-MOL CELL BIOL L, V1781, P665, DOI 10.1016/j.bbalip.2008.09.002; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hatch SC, 2009, J VIROL, V83, P3496, DOI 10.1128/JVI.02249-08; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Izquierdo-Useros N, 2009, BLOOD, V113, P2732, DOI 10.1182/blood-2008-05-158642; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nguyen DH, 1999, MOL MICROBIOL, V33, P659, DOI 10.1046/j.1365-2958.1999.01518.x; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Oswald-Richter K, 2006, J VIROL, V80, P11767, DOI 10.1128/JVI.00213-06; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; PARASASSI T, 1994, BIOPHYS J, V66, P120, DOI 10.1016/S0006-3495(94)80763-5; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Sekizawa Y, 1997, GENE, V191, P97, DOI 10.1016/S0378-1119(97)00047-4; Shogomori H, 2008, BBA-GEN SUBJECTS, V1780, P612, DOI 10.1016/j.bbagen.2007.09.001; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021; Waheed AA, 2006, J BIOL CHEM, V281, P28699, DOI 10.1074/jbc.M603609200; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	61	66	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22238	22247		10.1074/jbc.M109.029256	http://dx.doi.org/10.1074/jbc.M109.029256			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553682	Green Published, hybrid			2022-12-27	WOS:000268783700048
J	Christensen, QH; Cronan, JE				Christensen, Quin H.; Cronan, John E.			The Thermoplasma acidophilum LplA-LplB Complex Defines a New Class of Bipartite Lipoate-protein Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; LIPOIC ACID; POSTTRANSLATIONAL MODIFICATION; CRYSTAL-STRUCTURE; MULTIFUNCTIONAL ENZYMES; CARRIER PROTEIN; SWINGING ARMS; EXPRESSION; GENES; SYSTEM	Lipoic acid is a covalently bound cofactor found throughout the domains of life that is required for aerobic metabolism of 2-oxoacids and for C-1 metabolism. Utilization of exogenous lipoate is catalyzed by a ligation reaction that proceeds via a lipoyl-adenylate intermediate to attach the cofactor to the epsilon-amino group of a conserved lysine residue of protein lipoyl domains. The lipoyl ligases of demonstrated function have a large N-terminal catalytic domain and a small C-terminal accessory domain. Half of the members of the LplA family detected in silico have only the large catalytic domain. Two x-ray structures of the Thermoplasma acidophilum LplA structure have been reported, although the protein was reported to lack ligase activity. McManus et al. (McManus, E., Luisi, B. F., and Perham, R. N. (2006) J. Mol. Biol. 356, 625-637) hypothesized that the product of an adjacent gene was also required for ligase activity. We have shown this to be the case and have named the second protein, LplB. We found that complementation of Escherichia coli strains lacking lipoate ligase with T. acidophilum LplA was possible only when LplB was also present. LplA had no detectable ligase activity in vitro in the absence of LplB. Moreover LplA and LplB were shown to interact and were purified as a heterodimer. LplB was required for lipoyl-adenylate formation but was not required for transfer of the lipoyl moiety of lipoyl-adenylate to acceptor proteins. Surveys of sequenced genomes show that most lipoyl ligases of the kingdom Archaea are heterodimeric. We propose that the presence of an accessory domain provides a diagnostic to distinguish lipoyl ligase homologues from other members of the lipoate/biotin attachment enzyme family.	[Cronan, John E.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Christensen, Quin H.; Cronan, John E.] Univ Illinois, Chem Biol Interface Training Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019		National Institutes of Health [5 T32 GM070421]; NIGMS; NIAID [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 T32 GM070421, a Ruth L. Kirschstein National Research Service Award from the NIGMS, and AI15650 from the NIAID.	AMARASINGHAM CR, 1965, J BIOL CHEM, V240, P3664; Chapman-Smith A, 2001, PROTEIN SCI, V10, P2608, DOI 10.1110/ps.ps.22401; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Engel N, 2007, PLANT PHYSIOL, V144, P1328, DOI 10.1104/pp.107.099317; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fujiwara K, 2005, J BIOL CHEM, V280, P33645, DOI 10.1074/jbc.M505010200; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; Glanville JG, 2007, NUCLEIC ACIDS RES, V35, pW27, DOI 10.1093/nar/gkm325; GREEN DE, 1995, BIOCHEM J, V309, P853, DOI 10.1042/bj3090853; GUEST JR, 1973, J GEN MICROBIOL, V75, P197, DOI 10.1099/00221287-75-1-197; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; JENCKS WP, 1957, BIOCHIM BIOPHYS ACTA, V24, P227, DOI 10.1016/0006-3002(57)90185-3; Kim DJ, 2005, J BIOL CHEM, V280, P38081, DOI 10.1074/jbc.M507284200; Kim DJ, 2008, PROTEINS, V70, P1620, DOI 10.1002/prot.21843; KOIKE M, 1960, J BIOL CHEM, V235, P1931; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; McManus E, 2006, J MOL BIOL, V356, P625, DOI 10.1016/j.jmb.2005.11.057; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Miller J. H., 1972, EXPT MOL GENETICS, P431; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Nesbitt NM, 2005, PROTEIN EXPRES PURIF, V39, P269, DOI 10.1016/j.pep.2004.10.021; PACKMAN LC, 1984, BIOCHEM J, V217, P219, DOI 10.1042/bj2170219; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Reche P, 1998, BIOCHEM J, V329, P589, DOI 10.1042/bj3290589; Reche P, 1999, EMBO J, V18, P2673, DOI 10.1093/emboj/18.10.2673; REED KE, 1994, P NATL ACAD SCI USA, V91, P3720, DOI 10.1073/pnas.91.9.3720; REED LJ, 1958, J BIOL CHEM, V232, P123; Streaker ED, 2006, PROTEIN SCI, V15, P1928, DOI 10.1110/ps.062187306; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Wycuff DR, 2000, ANAL BIOCHEM, V277, P67, DOI 10.1006/abio.1999.4385; XU Y, 1994, BIOCHEMISTRY-US, V33, P7354, DOI 10.1021/bi00189a041; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	39	27	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21317	21326		10.1074/jbc.M109.015016	http://dx.doi.org/10.1074/jbc.M109.015016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520844	Green Published, hybrid			2022-12-27	WOS:000268564400026
J	Khromov, A; Choudhury, N; Stevenson, AS; Somlyo, AV; Eto, M				Khromov, Alexander; Choudhury, Nandini; Stevenson, Andra S.; Somlyo, Avril V.; Eto, Masumi			Phosphorylation-dependent Autoinhibition of Myosin Light Chain Phosphatase Accounts for Ca2+ Sensitization Force of Smooth Muscle Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RHO-ASSOCIATED KINASE; GUINEA-PIG ILEUM; TARGETING SUBUNIT; BINDING SUBUNIT; PHOSPHOPROTEIN INHIBITOR; CALCIUM SENSITIVITY; ACTIN CYTOSKELETON; REGULATORY SUBUNIT; SKELETAL-MUSCLE	The reversible regulation of myosin light chain phosphatase (MLCP) in response to agonist stimulation and cAMP/cGMP signals plays an important role in the regulation of smooth muscle (SM) tone. Here, we investigated the mechanism underlying the inhibition of MLCP induced by the phosphorylation of myosin phosphatase targeting subunit (MYPT1), a regulatory subunit of MLCP, at Thr-696 and Thr-853 using glutathione S-transferase (GST)-MYPT1 fragments having the inhibitory phosphorylation sites. GST-MYPT1 fragments, including only Thr-696 and only Thr-853, inhibited purified MLCP (IC50 = 1.6 and 60 nM, respectively) when they were phosphorylated with RhoA-dependent kinase (ROCK). The activities of isolated catalytic subunits of type 1 and type 2A phosphatases (PP1 and PP2A) were insensitive to either fragment. Phospho-GST-MYPT1 fragments docked directly at the active site of MLCP, and this was blocked by a PP1/PP2A inhibitor microcystin (MC)-LR or by mutation of the active sites in PP1. GST-MYPT1 fragments induced a contraction of beta-escin-permeabilized ileum SM at constant pCa 6.3 (EC50 = 2 mu M), which was eliminated by Ala substitution of the fragment at Thr-696 or by ROCK inhibitors or 8Br-cGMP. GST-MYPT1-(697-880) was 5-times less potent than fragments including Thr-696. Relaxation induced by 8Br-cGMP was not affected by Ala substitution at Ser-695, a known phosphorylation site for protein kinase A/G. Thus, GST-MYPT1 fragments are phosphorylated by ROCK in permeabilized SM and mimic agonist-induced inhibition and cGMP-induced activation of MLCP. We propose a model in which MYPT1 phosphorylation at Thr-696 and Thr-853 causes an autoinhibition of MLCP that accounts for Ca2+ sensitization of smooth muscle force.	[Khromov, Alexander; Choudhury, Nandini; Stevenson, Andra S.; Somlyo, Avril V.] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Eto, Masumi] Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA; [Eto, Masumi] Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	University of Virginia; Jefferson University; Jefferson University	Eto, M (corresponding author), 1020 Locust St,436 Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	masumi.eto@jefferson.edu	Eto, Masumi/ABE-4700-2020	Eto, Masumi/0000-0002-0651-5836	National Institutes of Health [PO1 HL48807, PO1 HL19242, RO1 HL83261, PO1 48807]; Pennsylvania CURE grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048807, R01HL083261, P01HL019242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania CURE grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL48807, PO1 HL19242 (to A. V. S.), RO1 HL83261, and PO1 48807 (to M. E.). This work was also supported by a Pennsylvania CURE grant (to M. E.). A conflict of interest exists in Millipore products (for M. E.).	Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; Bonnevier J, 2004, J BIOL CHEM, V279, P28998, DOI 10.1074/jbc.M404259200; BRADLEY AB, 1987, J PHYSIOL-LONDON, V385, P437, DOI 10.1113/jphysiol.1987.sp016500; Choudhury N, 2004, J MUSCLE RES CELL M, V25, P657, DOI 10.1007/s10974-004-7807-x; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; Eto M, 1999, BIOCHEMISTRY-US, V38, P16952, DOI 10.1021/bi992030o; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Eto M, 2003, METHOD ENZYMOL, V366, P243; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2007, STRUCTURE, V15, P1591, DOI 10.1016/j.str.2007.10.014; Etter EF, 2001, J BIOL CHEM, V276, P34681, DOI 10.1074/jbc.M104737200; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; GONG MC, 1992, J BIOL CHEM, V267, P14662; Guilluy C, 2005, BRIT J PHARMACOL, V146, P1010, DOI 10.1038/sj.bjp.0706408; Guo ZH, 2003, J BIOL CHEM, V278, P1856, DOI 10.1074/jbc.M211075200; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hilgers RHP, 2007, J HYPERTENS, V25, P1687, DOI 10.1097/HJH.0b013e32816f778d; HIMPENS B, 1990, PFLUG ARCH EUR J PHY, V417, P21, DOI 10.1007/BF00370764; HIMPENS B, 1990, PFLUG ARCH EUR J PHY, V416, P28, DOI 10.1007/BF00370218; HIMPENS B, 1989, J PHYSIOL-LONDON, V413, P489, DOI 10.1113/jphysiol.1989.sp017665; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kitazawa T, 2003, J PHYSIOL-LONDON, V546, P879, DOI 10.1113/jphysiol.2002.029306; KITAZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P1291, DOI 10.1016/0006-291X(90)91589-K; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Koyama M, 2000, FEBS LETT, V475, P197, DOI 10.1016/S0014-5793(00)01654-9; Lee MR, 1997, J BIOL CHEM, V272, P5063, DOI 10.1074/jbc.272.8.5063; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MARTIN BI, 1994, PROTEIN EXPRES PURIF, V5, P211, DOI 10.1006/prep.1994.1033; Matsuzawa F, 2005, J BIOCHEM, V137, P633, DOI 10.1093/jb/mvi077; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Ohki SY, 2003, J MOL BIOL, V326, P1539, DOI 10.1016/S0022-2836(03)00048-2; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; REMBOLD CM, 1992, HYPERTENSION, V20, P129, DOI 10.1161/01.HYP.20.2.129; Richards CT, 2002, J BIOL CHEM, V277, P4422, DOI 10.1074/jbc.M111047200; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Sausbier M, 2000, CIRC RES, V87, P825, DOI 10.1161/01.RES.87.9.825; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; STEWART AA, 1983, EUR J BIOCHEM, V132, P289, DOI 10.1111/j.1432-1033.1983.tb07361.x; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Wang HL, 2008, BIOCHEMISTRY-US, V47, P4461, DOI 10.1021/bi702539e; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu J, 1996, BIOCHEMISTRY-US, V35, P13858, DOI 10.1021/bi961669e; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362	69	80	83	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21569	21579		10.1074/jbc.M109.019729	http://dx.doi.org/10.1074/jbc.M109.019729			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531490	hybrid, Green Published			2022-12-27	WOS:000268564400051
J	Guimond, SE; Puvirajesinghe, TM; Skidmore, MA; Kalus, I; Dierks, T; Yates, EA; Turnbull, JE				Guimond, Scott E.; Puvirajesinghe, Tania M.; Skidmore, Mark A.; Kalus, Ina; Dierks, Thomas; Yates, Edwin A.; Turnbull, Jeremy E.			Rapid Purification and High Sensitivity Analysis of Heparan Sulfate from Cells and Tissues TOWARD GLYCOMICS PROFILING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							6-O-ENDOSULFATASES; OLIGOSACCHARIDES; ELECTROPHORESIS; PROTEOGLYCANS; MICROANALYSIS; DISACCHARIDES; SEQUENCES; MICE; NMR; FGF	Studies on glycosaminoglycans and proteoglycans (PGs) have been hampered by difficulties in isolation and analysis by traditional methods that are laborious and lack sensitivity and throughput. Here we demonstrate a simple method for rapid isolation of proteoglycans (RIP) employing phenol/guanidine/chloroform reagent to purify heparan sulfate (HS) PGs quantitatively from various tissues and cells. We further show that this generic purification methodology, when applied in concert with a BODIPY (TM) fluorescent label, permits structural analyses on RIP-purified HS at similar to 1,000-fold higher sensitivity than standard UV detection methods and similar to 10-100-fold higher sensitivity than previous fluorescence detection methods. The utility of RIP-BODIPY methodology was demonstrated by rapid profiling of HS structural composition from small tissue samples, multiple mouse organs, and as little as a few thousand cultured cells. It was also used to generate novel insights into in vivo structural changes in HS from Sulf1 knock-out mice for the first time that differed significantly from previous observations limited to tissue culture experiments. RIP was also applied to purify HS for bioassay testing, exemplified by cell assays of fibroblast growth factor signaling activation; this generated data from 2-O-sulfotransferase knock-out mice and revealed an unexpected deficiency in fibroblast growth factor activation by HS from heterozygous mice. These data demonstrate that RIP will underpin emerging efforts to develop glycomics profiling strategies for HS and other glycosaminoglycans to explore their structure-function relationships in complex biological systems.	[Guimond, Scott E.; Puvirajesinghe, Tania M.; Skidmore, Mark A.; Yates, Edwin A.; Turnbull, Jeremy E.] Univ Liverpool, Sch Biol Sci, Ctr Glycobiol, Liverpool L69 7ZB, Merseyside, England; [Kalus, Ina; Dierks, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany	University of Liverpool; University of Bielefeld	Turnbull, JE (corresponding author), Univ Liverpool, Sch Biol Sci, Ctr Glycobiol, Crown St, Liverpool L69 7ZB, Merseyside, England.	j.turnbull@liverpool.ac.uk	Yates, Edwin A/I-4808-2013; Puvirajesinghe, Tania/AAD-9137-2020; Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339; Wang, Cong-Yi/0000-0001-7914-168X; Puvirajesinghe, Tania/0000-0002-8304-9824; Yates, Edwin/0000-0001-9365-5433; Guimond, Scott/0000-0002-5903-418X	Medical Research Council, UK; Wellcome Trust; Biotechnology and Biological Sciences Research Council; BBSRC [BB/D006325/1] Funding Source: UKRI; MRC [G117/423] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D006325/1] Funding Source: researchfish; Medical Research Council [G117/423] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Medical Research Council, UK (Senior Research Fellowship to J. E. T. and Ph. D. funding to T. P.), the Wellcome Trust (to E. A. Y., M. A. S., S. E. G., andJ. E. T.), and the Biotechnology and Biological Sciences Research Council (to E. A. Y., M. A. S., S. E. G., and J. E. T.).	Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brickman YG, 1998, GLYCOBIOLOGY, V8, P463, DOI 10.1093/glycob/8.5.463; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Drummond KJ, 2001, PROTEOMICS, V1, P304, DOI 10.1002/1615-9861(200102)1:2<304::AID-PROT304>3.0.CO;2-B; Ford-Perriss M, 2002, GLYCOBIOLOGY, V12, P721, DOI 10.1093/glycob/cwf072; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8; JASEJA M, 1989, CAN J CHEM, V67, P1449, DOI 10.1139/v89-221; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; KARIYA Y, 1992, COMP BIOCHEM PHYS B, V103, P473, DOI 10.1016/0305-0491(92)90323-J; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Militsopoullou M, 2003, BIOMED CHROMATOGR, V17, P39, DOI 10.1002/bmc.207; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Pratt T, 2006, J NEUROSCI, V26, P6911, DOI 10.1523/JNEUROSCI.0505-06.2006; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Rudd TR, 2009, GLYCOBIOLOGY, V19, P52, DOI 10.1093/glycob/cwn103; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Skidmore MA, 2006, J CHROMATOGR A, V1135, P52, DOI 10.1016/j.chroma.2006.09.064; Staples GO, 2009, PROTEOMICS, V9, P686, DOI 10.1002/pmic.200701008; Toyoda H, 1997, J CHROMATOGR B, V704, P19, DOI 10.1016/S0378-4347(97)00478-7; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; TURNBULL JE, 1988, BIOCHEM J, V251, P597, DOI 10.1042/bj2510597; Turnbull JE, 2007, NAT CHEM BIOL, V3, P74, DOI 10.1038/nchembio0207-74; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Yates EA, 1996, CARBOHYD RES, V294, P15	39	35	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25714	25722		10.1074/jbc.M109.032755	http://dx.doi.org/10.1074/jbc.M109.032755			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19596853	Green Published, hybrid			2022-12-27	WOS:000269738000029
J	Hailey, KL; Li, S; Andersen, MD; Roy, M; Woods, VL; Jennings, PA				Hailey, Kendra L.; Li, Sheng; Andersen, Mette D.; Roy, Melinda; Woods, Virgil L., Jr.; Jennings, Patricia A.			Pro-interleukin (IL)-1 beta Shares a Core Region of Stability as Compared with Mature IL-1 beta While Maintaining a Distinctly Different Configurational Landscape A COMPARATIVE HYDROGEN/DEUTERIUM EXCHANGE MASS SPECTROMETRY STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICALLY-ACTIVE INTERLEUKIN-1-BETA; NATIVE-STATE TOPOLOGY; HYDROGEN-EXCHANGE; PRECURSOR INTERLEUKIN-1-BETA; PROTEIN INTERLEUKIN-1-BETA; 3-DIMENSIONAL STRUCTURE; SECONDARY STRUCTURE; DEUTERIUM-EXCHANGE; UNFOLDED PROTEINS; NMR-SPECTROSCOPY	Interleukin-1 beta (IL-1 beta) is a master cytokine involved in initiating the innate immune response in vertebrates (Dinarello, C. A. (1994) FASEB J. 8, 1314-1325). It is first synthesized as an inactive 269-residue precursor (pro-interleukin-1 beta or pro-IL-1 beta). Pro-IL-1 beta requires processing by caspase-1 to generate the active, mature 153-residue cytokine. In this study, we combined hydrogen/deuterium exchange mass spectrometry, circular dichroism spectroscopy, and enzymatic digestion comparative studies to investigate the configurational landscape of pro-IL-1 beta and the role the N terminus plays in modulating the landscape. We find that the N terminus keeps pro-IL-1 beta in a protease-labile state while maintaining a core region of stability in the C-terminal region, the eventual mature protein. In mature IL-1 beta, this highly protected region maps back to the area protected earliest in the NMR studies characterizing an on-route kinetic refolding intermediate. This protected region also encompasses two important functional loops that participate in the IL-1 beta/receptor binding interface required for biological activity. We propose that the purpose of the N-terminal precursor region in pro-IL-1 beta is to suppress the function of the eventual mature region while keeping a structurally and also functionally important core region primed for the final folding into the native, active state of the mature protein. The presence of the self-inhibiting precursor region provides yet another layer of regulation in the life cycle of this important cytokine.	[Hailey, Kendra L.; Andersen, Mette D.; Roy, Melinda; Jennings, Patricia A.] Univ Calif, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif, Dept Med, La Jolla, CA 92093 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif, Biol Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Woods, VL (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; pajennin@ucsd.edu			National Institutes of Health [GM54038, CA099835, CA118595, AI076961, AI072106, AI068730, AI081982, GM037684, GM020501, GM066170]; University of California IUCRP Program; BiogenIdec; NATIONAL CANCER INSTITUTE [R21CA118595, R21CA099835, R33CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076961, P01AI068730, R01AI081982, R01AI072106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170, R01GM020501, R01GM054038, R01GM037684, F32GM020501, R29GM054038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California IUCRP Program(University of California System); BiogenIdec(Biogen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54038 (to P. A. J.) and CA099835, CA118595, AI076961, AI072106, AI068730, AI081982, GM037684, GM020501, and GM066170, and a Discovery Grant from the University of California IUCRP Program, BiogenIdec corporate sponsor (to V. L. W.).	Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Barbar E, 1999, BIOPOLYMERS, V51, P191, DOI 10.1002/(SICI)1097-0282(1999)51:3<191::AID-BIP3>3.0.CO;2-B; Bird S, 2002, J IMMUNOL, V168, P3329, DOI 10.4049/jimmunol.168.7.3329; BLACK RA, 1988, J BIOL CHEM, V263, P9437; Branden C., 1998, INTRO PROTEIN STRUCT, V2nd; Brock M, 2007, J BIOL CHEM, V282, P32256, DOI 10.1074/jbc.M706231200; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Capraro DT, 2008, P NATL ACAD SCI USA, V105, P14844, DOI 10.1073/pnas.0807812105; Chavez LL, 2006, P NATL ACAD SCI USA, V103, P10254, DOI 10.1073/pnas.0510110103; Clementi C, 2000, P NATL ACAD SCI USA, V97, P5871, DOI 10.1073/pnas.100547897; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P2315, DOI 10.1021/bi00223a005; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Covalt JC, 2005, PROTEIN EXPRES PURIF, V41, P45, DOI 10.1016/j.pep.2005.01.010; CRAIG S, 1989, INT J PEPT PROT RES, V33, P256; DeLano W.L, PYMOL MOL GRAPHICS S; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; DINARELLO CA, 1989, CRIT REV IMMUNOL, V9, P1; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; DRISCOLL PC, 1990, BIOCHEMISTRY-US, V29, P4668, DOI 10.1021/bi00471a023; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; Golynskiy M, 2007, J BIOL INORG CHEM, V12, P699, DOI 10.1007/s00775-007-0216-z; Gosavi S, 2006, J MOL BIOL, V357, P986, DOI 10.1016/j.jmb.2005.11.074; Gosavi S, 2008, P NATL ACAD SCI USA, V105, P10384, DOI 10.1073/pnas.0801343105; GRISHINA IB, 1994, FARADAY DISCUSS, V99, P245, DOI 10.1039/fd9949900245; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; HAZUDA D, 1989, J BIOL CHEM, V264, P1689; HAZUDA DJ, 1991, J BIOL CHEM, V266, P7081; HAZUDA DJ, 1990, J BIOL CHEM, V265, P6318; Heidary DK, 1997, NAT STRUCT BIOL, V4, P725, DOI 10.1038/nsb0997-725; Heidary DK, 2005, J MOL BIOL, V353, P1187, DOI 10.1016/j.jmb.2005.08.072; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; KAVITA U, 1995, J BIOL CHEM, V270, P27758, DOI 10.1074/jbc.270.46.27758; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kobayashi Y, 1997, J BIOCHEM-TOKYO, V121, P896; KOBAYASHI Y, 1991, CHEM PHARM BULL, V39, P1513; Koussounadis AI, 2004, CURR PHARM DESIGN, V10, P3857, DOI 10.2174/1381612043382585; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li RH, 1999, PROTEIN SCI, V8, P1571, DOI 10.1110/ps.8.8.1571; Linderstrom-Lang K., 1957, S PROT STRUCT, V9, P23; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Roy M, 2005, J MOL BIOL, V348, P335, DOI 10.1016/j.jmb.2005.02.059; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Shinde U, 2000, SEMIN CELL DEV BIOL, V11, P35, DOI 10.1006/scdb.1999.0349; Spraggon G, 2004, PROTEIN SCI, V13, P3187, DOI 10.1110/ps.04939904; Stevenson FT, 1997, P NATL ACAD SCI USA, V94, P508, DOI 10.1073/pnas.94.2.508; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; VARLEY P, 1993, SCIENCE, V260, P1110, DOI 10.1126/science.8493553; VEERAPANDIAN B, 1992, PROTEINS, V12, P10, DOI 10.1002/prot.340120103; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; WEISSMAN JS, 1992, CELL, V71, P841, DOI 10.1016/0092-8674(92)90559-U; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; YOUNG PR, 1989, PROTEIN ENG, V2, P545, DOI 10.1093/protein/2.7.545; Zhang Y.Z., 1995, THESIS U PENNSYLVANI	75	23	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26137	26148		10.1074/jbc.M109.027375	http://dx.doi.org/10.1074/jbc.M109.027375			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19592498	hybrid, Green Published			2022-12-27	WOS:000269738000069
J	Higgins, MA; Whitworth, GE; El Warry, N; Randriantsoa, M; Samain, E; Burke, RD; Vocadlo, DJ; Boraston, AB				Higgins, Melanie A.; Whitworth, Garrett E.; El Warry, Nahida; Randriantsoa, Mialy; Samain, Eric; Burke, Robert D.; Vocadlo, David J.; Boraston, Alisdair B.			Differential Recognition and Hydrolysis of Host Carbohydrate Antigens by Streptococcus pneumoniae Family 98 Glycoside Hydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; BINDING; IDENTIFICATION; PROTEIN; DIVERSITY; MODEL; INSIGHTS; REGIONS; CLONING; GENOME	The presence of a fucose utilization operon in the Streptococcus pneumoniae genome and its established importance in virulence indicates a reliance of this bacterium on the harvesting of host fucose-containing glycans. The identities of these glycans, however, and how they are harvested is presently unknown. The biochemical and high resolution x-ray crystallographic analysis of two family 98 glycoside hydrolases (GH98s) from distinctive forms of the fucose utilization operon that originate from different S. pneumoniae strains reveal that one enzyme, the predominant type among pneumococcal isolates, has a unique endo-beta-galactosidase activity on the Lewis(Y) antigen. Altered active site topography in the other species of GH98 enzyme tune its endo-beta-galactosidase activity to the blood group A and B antigens. Despite their different specificities, these enzymes, and by extension all family 98 glycoside hydrolases, use an inverting catalytic mechanism. Many bacterial and viral pathogens exploit host carbohydrate antigens for adherence as a precursor to colonization or infection. However, this is the first evidence of bacterial endoglycosidase enzymes that are known to play a role in virulence and are specific for distinct host carbohydrate antigens. The strain-specific distribution of two distinct types of GH98 enzymes further suggests that S. pneumoniae strains may specialize to exploit host-specific antigens that vary from host to host, a factor that may feature in whether a strain is capable of colonizing a host or establishing an invasive infection.	[Higgins, Melanie A.; El Warry, Nahida; Burke, Robert D.; Boraston, Alisdair B.] Univ Victoria, Victoria, BC V8W 3P6, Canada; [Whitworth, Garrett E.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Randriantsoa, Mialy; Samain, Eric] CNRS, CERMAV, F-38041 Grenoble 9, France	University of Victoria; Simon Fraser University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Boraston, AB (corresponding author), Univ Victoria, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Burke, Robert/0000-0001-5527-4410; Boraston, Alisdair/0000-0001-6417-0592	Canadian Institutes of Health Research [MOP 86610]; Natural Sciences and Engineering Research Council (NSERC) of Canada; Michael Smith Foundation for Health Research (MSFHR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Canadian Institutes of Health Research Grant MOP 86610 (to D. J. V. and A. B. B.).; Supported by doctoral fellowships from the Natural Sciences and Engineering Research Council (NSERC) of Canada and the Michael Smith Foundation for Health Research (MSFHR).; Supported by a doctoral fellowship from the NSERC.	Anderson KM, 2005, J BIOL CHEM, V280, P7720, DOI 10.1074/jbc.M414099200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barik S, 1996, Methods Mol Biol, V57, P203; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Calcutt MJ, 2002, FEMS MICROBIOL LETT, V214, P77, DOI 10.1111/j.1574-6968.2002.tb11327.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002950; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; CUNDELL DR, 1994, MICROB PATHOGENESIS, V17, P361, DOI 10.1006/mpat.1994.1082; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Doern GV, 1999, EMERG INFECT DIS, V5, P757, DOI 10.3201/eid0506.990603; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G, 2002, ACTA CRYSTALLOGR D, V58, P976, DOI 10.1107/S0907444902005486; Ficko-Blean E, 2005, ACTA CRYSTALLOGR F, V61, P834, DOI 10.1107/S1744309105024012; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gregg KJ, 2008, J BIOL CHEM, V283, P12604, DOI 10.1074/jbc.M709865200; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lillelund VH, 2002, CHEM REV, V102, P515, DOI 10.1021/cr000433k; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Ravn V, 2000, APMIS, V108, P1, DOI 10.1034/j.1600-0463.2000.d01-1.x; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rigden DJ, 2005, FEBS LETT, V579, P5466, DOI 10.1016/j.febslet.2005.09.011; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shaikh FA, 2008, BIOCHEM CELL BIOL, V86, P169, DOI 10.1139/O07-149; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tomasz A, 1999, AM J MED, V107, P55, DOI 10.1016/S0002-9343(99)00107-2; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Yuriev E, 2005, IMMUNOL CELL BIOL, V83, P709, DOI 10.1111/j.1440-1711.2005.01374.x	50	35	36	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26161	26173		10.1074/jbc.M109.024067	http://dx.doi.org/10.1074/jbc.M109.024067			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19608744	hybrid, Green Published			2022-12-27	WOS:000269738000071
J	Caceres, PS; Ares, GR; Ortiz, PA				Caceres, Paulo S.; Ares, Gustavo R.; Ortiz, Pablo A.			cAMP Stimulates Apical Exocytosis of the Renal Na+-K+-2Cl(-) Cotransporter NKCC2 in the Thick Ascending Limb ROLE OF PROTEIN KINASE A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY COLLECTING DUCT; RAT-KIDNEY; CA2+ MOBILIZATION; ADENYLYL-CYCLASE; CYCLIC-AMP; PHOSPHORYLATION; PKA; ACTIVATION; VASOPRESSIN; MECHANISM	The apical renal Na+-K+-2Cl(-) cotransporter NKCC2 mediates NaCl absorption by the thick ascending limb (TAL) of Henle's loop. cAMP stimulates NKCC2 by enhancing steady-state apical membrane levels of this protein; however, the trafficking and signaling mechanisms by which this occurs have not been studied. Here, we report that stimulation of endogenous cAMP levels with either forskolin/3-isobutyl-1-methylxanthine (IBMX) or the V2 receptor agonist [deamino-Cys(1),D-Arg(8)] vasopressin increases steady-state surface NKCC2 and that the protein kinase A (PKA) inhibitor H-89 blocks this effect. Confocal imaging of apical surface NKCC2 in isolated perfused TALs confirmed a stimulatory effect of cAMP on apical trafficking that was blocked by PKA inhibition. Selective stimulation of PKA with the agonist N-6-benzoyl-cAMP (500 mu M) stimulated steady-state surface NKCC2, whereas the Epac-selective agonist 8-p-chlorophenylthio-2'-O-methyl-cAMP (100 and 250 mu M) had no effect. To explore the trafficking mechanism by which cAMP increases apical NKCC2, we measured cumulative apical membrane exocytosis and NKCC2 exocytic insertion in TALs. By monitoring apical FM1-43 fluorescence, we observed rapid stimulation of apical exocytosis (2 min) by forskolin/IBMX. We also found constitutive exocytic insertion of NKCC2 in TALs over time, which was increased by 3-fold in the presence of forskolin/IBMX. PKA inhibition blunted cAMP-stimulated exocytic insertion but did not affect the rate of constitutive exocytosis. We conclude that cAMP stimulates steady-state apical surface NKCC2 by stimulating exocytic insertion and that this process is highly dependent on PKA but not Epac.	[Caceres, Paulo S.; Ares, Gustavo R.; Ortiz, Pablo A.] Henry Ford Hosp, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Caceres, Paulo S.; Ortiz, Pablo A.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	Ortiz, PA (corresponding author), Henry Ford Hosp, Hypertens & Vasc Res Div, E&R Bldg,Rm 7041,2799 W Grand Blvd, Detroit, MI 48202 USA.	portiz1@hfhs.org		Ortiz, Pablo/0000-0002-7512-7255; Caceres, Paulo/0000-0003-0197-8177	National Institutes of Health [R01 HL080409-05, P01 HL090550-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080409, P01HL090550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL080409-05 and P01 HL090550-01 (Subproject 2; to P. A. O.).	Ameen NA, 2003, AM J PHYSIOL-CELL PH, V284, pC429, DOI 10.1152/ajpcell.00261.2002; Ares GR, 2008, AM J PHYSIOL-RENAL, V295, pF877, DOI 10.1152/ajprenal.00449.2007; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Bhattacharya A, 2004, J BIOL CHEM, V279, P37291, DOI 10.1074/jbc.M403819200; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29, DOI 10.1152/ajprenal.2000.278.1.F29; Clayton A, 2005, J BIOL CHEM, V280, P23451, DOI 10.1074/jbc.M502242200; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Dilly KW, 2004, J BIOL CHEM, V279, P40778, DOI 10.1074/jbc.M406010200; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; GAPSTUR SM, 1988, AM J PHYSIOL, V255, pF292, DOI 10.1152/ajprenal.1988.255.2.F292; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; HEBERT SC, 1981, AM J PHYSIOL, V241, pF412, DOI 10.1152/ajprenal.1981.241.4.F412; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; Katsura T, 1997, Am J Physiol, V272, pF817; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Li Y, 2008, AM J PHYSIOL-RENAL, V295, pF525, DOI 10.1152/ajprenal.00448.2007; Liu Y, 2007, FEBS LETT, V581, P4318, DOI 10.1016/j.febslet.2007.07.083; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; MOLONY DA, 1987, AM J PHYSIOL, V252, pF177, DOI 10.1152/ajprenal.1987.252.1.F177; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Peng Y, 2001, AM J PHYSIOL-RENAL, V280, pF34, DOI 10.1152/ajprenal.2001.280.1.F34; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Yip KP, 2006, AM J PHYSIOL-RENAL, V291, pF882, DOI 10.1152/ajprenal.00411.2005; Yip KP, 2002, J PHYSIOL-LONDON, V538, P891, DOI 10.1113/jphysiol.2001.012606	38	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24965	24971		10.1074/jbc.M109.037135	http://dx.doi.org/10.1074/jbc.M109.037135			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592485	Green Published, hybrid			2022-12-27	WOS:000269734000031
J	Howell, JJ; Stoffel, M				Howell, Jessica J.; Stoffel, Markus			Nuclear Export-independent Inhibition of Foxa2 by Insulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE B; CAENORHABDITIS-ELEGANS; MEDIATED PHOSPHORYLATION; GLUCOSE-HOMEOSTASIS; FACTOR FKHR; C-ELEGANS; BINDING; MOUSE; SIGNALS	The Forkhead box A2 transcription factor (Foxa2/HNF-3 beta) has been shown to be a key regulator of genes involved in the maintenance of glucose and lipid homeostasis in the liver. It is constitutively inactivated in several hyperinsulinemic/obese mouse models, thereby enhancing their metabolic phenotypes. Foxa2 is activated under fasting conditions but is inhibited by insulin signaling via phosphatidylinositol 3-kinase/AKT in a phosphorylation-dependent manner, which results in its nuclear exclusion. However, the mechanism and relative importance of its nuclear export has not yet been elucidated. Here we show that Foxa2 contains a functional nuclear export signal and is excluded from the nucleus via a CRM1-dependent pathway in response to insulin signaling. Furthermore, direct evidence is provided that nuclear export-defective Foxa2 is phosphorylated and inactivated by insulin in vitro and in vivo. These data demonstrate for the first time that phosphorylation itself is the main event regulating the activity of Foxa2, suggesting that export-independent mechanisms have evolved to ensure inhibition of Foxa2 under conditions in which insulin signaling is present.	[Stoffel, Markus] ETH, Inst Mol Syst Biol, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland; Rockefeller Univ, New York, NY 10021 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Rockefeller University	Stoffel, M (corresponding author), ETH, Inst Mol Syst Biol, Swiss Fed Inst Technol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	stoffel@imsb.biol.ethz.ch		Stoffel, Markus/0000-0003-1304-5817; Howell, Jessica/0000-0002-9736-5211	SystemsX.ch (Swiss Initiative in Systems Biology)	SystemsX.ch (Swiss Initiative in Systems Biology)	This work was supported in part by a LiverX Grant from SystemsX.ch (Swiss Initiative in Systems Biology).	ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CALNAN DR, ONCOGENE, V27, P2276; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; FRENEAUX E, 1988, HEPATOLOGY, V8, P1056, DOI 10.1002/hep.1840080513; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; GOTTLIEB S, 1994, GENETICS, V137, P107; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Oberkofler H, 2009, J MOL MED, V87, P299, DOI 10.1007/s00109-008-0425-0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tsai WC, 2003, ENDOCRINOLOGY, V144, P5615, DOI 10.1210/en.2003-0481; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wolfrum C, 2008, J BIOL CHEM, V283, P16940, DOI 10.1074/jbc.M801930200; Yanai H, 2006, J VIROL, V80, P1121, DOI 10.1128/JVI.80.3.1121-1129.2006; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	40	25	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24816	24824		10.1074/jbc.M109.042135	http://dx.doi.org/10.1074/jbc.M109.042135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19589781	Green Published, hybrid			2022-12-27	WOS:000269734000016
J	Tortorella, MD; Tomasselli, AG; Mathis, KJ; Schnute, ME; Woodard, SS; Munie, G; Williams, JM; Caspers, N; Wittwer, AJ; Malfait, AM; Shieh, HS				Tortorella, Micky D.; Tomasselli, Alfredo G.; Mathis, Karl J.; Schnute, Mark E.; Woodard, Scott S.; Munie, Grace; Williams, Jennifer M.; Caspers, Nicole; Wittwer, Arthur J.; Malfait, Anne-Marie; Shieh, Huey-Sheng			Structural and Inhibition Analysis Reveals the Mechanism of Selectivity of a Series of Aggrecanase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAMTS-4 AGGRECANASE-1; ESCHERICHIA-COLI; CARTILAGE; OSTEOARTHRITIS; PURIFICATION; CLEAVAGE; CLONING; FAMILY; POTENT; MODEL	Several inhibitors of a series of cis-1(S)2(R)-amino-2-indanol-based compounds were reported to be selective for the aggrecanases, ADAMTS-4 and -5 over other metalloproteases. To understand the nature of this selectivity for aggrecanases, the inhibitors, along with the broad spectrum metalloprotease inhibitor marimastat, were independently bound to the catalytic domain of ADAMTS-5, and the corresponding crystal structures were determined. By comparing the structures, it was determined that the specificity of the relative inhibitors for ADAMTS-5 was not driven by a specific interaction, such as zinc chelation, hydrogen bonding, or charge interactions, but rather by subtle and indirect factors, such as water bridging, ring rigidity, pocket size, and shape, as well as protein conformation flexibility.	[Tortorella, Micky D.; Tomasselli, Alfredo G.; Mathis, Karl J.; Schnute, Mark E.; Woodard, Scott S.; Munie, Grace; Williams, Jennifer M.; Caspers, Nicole; Wittwer, Arthur J.; Malfait, Anne-Marie; Shieh, Huey-Sheng] Pfizer Global Res & Dev, St Louis, MO 63017 USA	Pfizer	Tortorella, MD (corresponding author), Pfizer Global Res & Dev, 700 Chesterfield Pkwy, Chesterfield, MO 63017 USA.	micky.d.tortorella@gmail.com; huey.s.shieh@pfizer.com		Tortorella, Micky/0000-0002-1010-0174; Malfait, Anne-Marie/0000-0003-1428-0384	Industrial Macromolecular Crystallography Association; Center for Advanced Radiation Sources at the University of Chicago	Industrial Macromolecular Crystallography Association; Center for Advanced Radiation Sources at the University of Chicago(University of Chicago)	Use of the IMCA-CAT beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Center for Advanced Radiation Sources at the University of Chicago.	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Felson DT, 2007, ARTHRITIS RHEUM-US, V56, P1378, DOI 10.1002/art.22526; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; HOOPER NM, 2005, ADAM FAMILY PROTEASE, V4; HUGHES CE, 1995, BIOCHEM J, V305, P799, DOI 10.1042/bj3050799; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Kuzmic P, 2000, ANAL BIOCHEM, V286, P45, DOI 10.1006/abio.2000.4685; LAGENTE V, 2008, MATRIX METALLOPROTEI, V11; MANKIN HJ, 1970, J BONE JOINT SURG AM, VA 52, P424, DOI 10.2106/00004623-197052030-00002; Pratt LM, 1998, BIOORG MED CHEM LETT, V8, P1359, DOI 10.1016/S0960-894X(98)00218-2; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; ROSENFELD SA, 1994, GENE, V139, P281, DOI 10.1016/0378-1119(94)90770-6; Shieh HS, 2008, J BIOL CHEM, V283, P1501, DOI 10.1074/jbc.M705879200; Tortorella MD, 2008, CURR PHARM BIOTECHNO, V9, P16, DOI 10.2174/138920108783497622; Tortorella MD, 2005, ARCH BIOCHEM BIOPHYS, V444, P34, DOI 10.1016/j.abb.2005.09.018; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Wittwer AJ, 2007, BIOCHEMISTRY-US, V46, P6393, DOI 10.1021/bi7000642; Yao WQ, 2002, BIOORG MED CHEM LETT, V12, P101, DOI 10.1016/S0960-894X(01)00704-1; Yao WQ, 2001, J MED CHEM, V44, P3347, DOI 10.1021/jm015533c; YEM AW, 1988, IMMUNOL INVEST, V17, P551, DOI 10.3109/08820138809030588	23	47	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24185	24191		10.1074/jbc.M109.029116	http://dx.doi.org/10.1074/jbc.M109.029116			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586907	hybrid, Green Published			2022-12-27	WOS:000269380200032
J	Cohen, L; Moran, Y; Sharon, A; Segal, D; Gordon, D; Gurevitz, M				Cohen, Lior; Moran, Yehu; Sharon, Amir; Segal, Daniel; Gordon, Dalia; Gurevitz, Michael			Drosomycin, an Innate Immunity Peptide of Drosophila melanogaster, Interacts with the Fly Voltage-gated Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCORPION BETA-TOXINS; NA+ CHANNELS; ANTIMICROBIAL PEPTIDE; ANTIFUNGAL PEPTIDES; FUNCTIONAL SURFACE; INSECT; SELECTIVITY; DIVERGENCE; EXPRESSION; EVOLUTION	Several peptide families, including insect antimicrobial peptides, plant protease inhibitors, and ion channel gating modifiers, as well as blockers from scorpions, bear a common CS alpha beta scaffold. The high structural similarity between two peptides containing this scaffold, drosomycin and a truncated scorpion beta-toxin, has prompted us to examine and compare their biological effects. Drosomycin is the most expressed antimicrobial peptide in Drosophila melanogaster immune response. A truncated scorpion beta-toxin is capable of binding and inducing conformational alteration of voltage-gated sodium channels. Here, we show that both peptides (i) exhibit anti-fungal activity at micromolar concentrations; (ii) enhance allosterically at nano-molar concentration the activity of Lqh alpha IT, a scorpion alpha toxin that modulates the inactivation of the D. melanogaster voltage-gated sodium channel (DmNa(v)1); and ( iii) inhibit the facilitating effect of the polyether brevetoxin-2 on DmNa(v)1 activation. Thus, the short CS alpha beta scaffold of drosomycin and the truncated scorpion toxin can maintain more than one bioactivity, and, in light of this new observation, we suggest that the biological role of peptides bearing this scaffold should be carefully examined. As for drosomycin, we discuss the intriguing possibility that it has additional functions in the fly, as implied by its tight interaction with DmNa(v)1.	[Cohen, Lior; Moran, Yehu; Sharon, Amir; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, Dept Plant Sci, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Segal, Daniel] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Cohen, L (corresponding author), Tel Aviv Univ, Dept Plant Sci, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel.	lcohen76@cc.huji.ac.il; mamgur@post.tau.ac.il		Segal, Daniel/0000-0002-6777-505X; Moran, Yehu/0000-0001-9928-9294	United States-Israel Binational Agricultural Research and Development [IS-3928-06, IS-4066-07]; Israeli Science Foundation [1008/05, 107/08]	United States-Israel Binational Agricultural Research and Development; Israeli Science Foundation(Israel Science Foundation)	This work was supported by the United States-Israel Binational Agricultural Research and Development Grants IS-3928-06 ( to M. G. and D. G.) and IS-4066-07 ( to D. G. and M. G.) and by Israeli Science Foundation Grants 1008/05 ( to D. G. and M. G.) and 107/08 ( to M. G. and D. G.).	Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2004, J BIOL CHEM, V279, P8206, DOI 10.1074/jbc.M307531200; Cohen L, 2008, J BIOL CHEM, V283, P15169, DOI 10.1074/jbc.M801229200; Cohen L, 2006, FASEB J, V20, P1933, DOI 10.1096/fj.05-5545fje; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Froy O, 1998, FASEB J, V12, P1793, DOI 10.1096/fasebj.12.15.1793; GORDON D, 1993, FEBS LETT, V315, P125, DOI 10.1016/0014-5793(93)81147-R; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; HOFFMANN JA, 1993, FEBS LETT, V325, P63, DOI 10.1016/0014-5793(93)81414-U; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Jiggins FM, 2005, GENETICS, V171, P1847, DOI 10.1534/genetics.105.045435; Karbat I, 2004, FASEB J, V18, P683, DOI 10.1096/fj.03-0733com; Karbat I, 2007, J MOL BIOL, V366, P586, DOI 10.1016/j.jmb.2006.10.085; Landon C, 1997, PROTEIN SCI, V6, P1878, DOI 10.1002/pro.5560060908; Lazzaro BP, 2005, GENETICS, V169, P2023, DOI 10.1534/genetics.104.034249; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Moran Y, 2007, BIOCHEM J, V406, P41, DOI 10.1042/BJ20070233; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; POLI MA, 1986, MOL PHARMACOL, V30, P129; Shichor I, 2002, J NEUROSCI, V22, P4364, DOI 10.1523/JNEUROSCI.22-11-04364.2002; Takagi Y, 1998, NEUROSCI LETT, V244, P149, DOI 10.1016/S0304-3940(98)00145-1; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Yang WY, 2006, GENE, V379, P26, DOI 10.1016/j.gene.2006.03.017; Zhu S, 2005, CELL MOL LIFE SCI, V62, P2257, DOI 10.1007/s00018-005-5200-6; Zilberberg N, 1996, BIOCHEMISTRY-US, V35, P10215, DOI 10.1021/bi9528309	27	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23558	23563		10.1074/jbc.M109.023358	http://dx.doi.org/10.1074/jbc.M109.023358			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574227	hybrid, Green Published			2022-12-27	WOS:000269180000041
J	Jin, Y; An, XJ; Ye, ZL; Cully, B; Wu, JP; Li, J				Jin, Yi; An, Xiaojin; Ye, Zelian; Cully, Brittany; Wu, Jiaping; Li, Jian			RGS5, a Hypoxia-inducible Apoptotic Stimulator in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR; GENE-EXPRESSION; ANGIOTENSIN-II; PROLIFERATION; REGULATOR; FAMILY; VEGF; DIFFERENTIATION; INDUCTION	Endothelial cells rapidly respond to changes in oxygen homeostasis by regulating gene expression. Regulator of G protein signaling 5 (RGS5) is a negative regulator of G protein-mediated signaling that is strongly expressed in vessels during angiogenesis; however, the role of RGS5 in hypoxia has not been fully understood. Under hypoxic conditions, we found that the expression of RGS5, but not other RGS, was induced in human umbilical vein endothelial cells (HUVEC). RGS5 mRNA was increased when HUVEC were incubated with chemicals that stabilized hypoxia-inducible factor-1 alpha (HIF-1 alpha), whereas hypoxia-stimulated RGS5 promoter activity was absent in HIF-1 beta(-/-) cells. Vascular endothelial growth factor (VEGF), which is regulated by HIF-1, did not appear to be involved in hypoxia-induced RGS5 expression; however, VEGF-mediated activation of p38 but not ERK1/2 was increased by RGS5. Overexpression of RGS5 in HUVEC exhibited a reduced growth rate without affecting the cell proliferation. Annexin V assay revealed that RGS5 induced apoptosis with significantly increased activation of caspase-3 and the Bax/Bcl-2 ratio. Small interfering RNA-specific for RGS5, caspase-3 inhibitor, and p38 inhibitor resulted in an attenuation of RGS5-stimulated apoptosis. Matrigel assay proved that RGS5 significantly impaired the angiogenic effect of VEGF and stimulated apoptosis in vivo. We concluded that RGS5 is a novel HIF-1-dependent, hypoxia-induced gene that is involved in the induction of endothelial apoptosis. Moreover, RGS5 antagonizes the angiogenic effect of VEGF by increasing the activation of p38 signaling, suggesting that RGS5 could be an important target for apoptotic therapy.	[Li, Jian] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiovasc Med,Ctr Life Sci, Boston, MA 02215 USA; [Jin, Yi; An, Xiaojin; Ye, Zelian; Li, Jian] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Peking University	Li, J (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiovasc Med,Ctr Life Sci, CLS 909,3 Blackfan Circle, Boston, MA 02215 USA.	jli@bidmc.harvard.edu		Jin, Yi/0000-0001-9704-973X	National Institutes of Health [HLR01082837]; American Heart Association [0265494T]; China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HLR01082837 (to J.L.). This work was also supported by American Heart Association Grant-in-aid 0265494T (to J.L.) and the China Scholarship Council (to J.Y. and X. A.).	Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Adams LD, 2000, CIRC RES, V87, P623, DOI 10.1161/01.RES.87.7.623; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bell SE, 2001, J CELL SCI, V114, P2755; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Brunelle JK, 2002, APOPTOSIS, V7, P475, DOI 10.1023/A:1020668923852; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cho H, 2003, BIOCHEM J, V371, P973, DOI 10.1042/BJ20021769; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Dulin NO, 2000, J BIOL CHEM, V275, P21317, DOI 10.1074/jbc.M910079199; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferrari G, 2006, P NATL ACAD SCI USA, V103, P17260, DOI 10.1073/pnas.0605556103; Furuya M, 2004, J PATHOL, V203, P551, DOI 10.1002/path.1543; Grant SL, 2000, MOL PHARMACOL, V57, P460, DOI 10.1124/mol.57.3.460; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Issbrucker K, 2002, FASEB J, V16, P262, DOI 10.1096/fj.02-0329fje; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kirsch T, 2001, BRAIN RES, V910, P106, DOI 10.1016/S0006-8993(01)02670-1; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Mandriota SJ, 2000, AM J PATHOL, V156, P2077, DOI 10.1016/S0002-9440(10)65079-1; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sodhi A, 2000, CANCER RES, V60, P4873; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Stempien-Otero A, 1999, J BIOL CHEM, V274, P8039, DOI 10.1074/jbc.274.12.8039; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yilmaz A, 2003, BIOCHEM BIOPH RES CO, V306, P730, DOI 10.1016/S0006-291X(03)01064-7; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200; Zeng HY, 2002, J BIOL CHEM, V277, P4003, DOI 10.1074/jbc.M110842200	43	45	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23436	23443		10.1074/jbc.M109.032664	http://dx.doi.org/10.1074/jbc.M109.032664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19564336	Green Published, hybrid			2022-12-27	WOS:000269180000028
J	Tse, KWK; Dang-Lawson, M; Lee, RL; Vong, D; Bulic, A; Buckbinder, L; Gold, MR				Tse, Kathy W. K.; Dang-Lawson, May; Lee, Rosaline L.; Vong, Doris; Bulic, Anica; Buckbinder, Leonard; Gold, Michael R.			B Cell Receptor-induced Phosphorylation of Pyk2 and Focal Adhesion Kinase Involves Integrins and the Rap GTPases and Is Required for B Cell Spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATES RAP1-INDUCED ADHESION; RICH TYROSINE KINASE-2; CYTOSKELETAL REARRANGEMENT; ACTIN POLYMERIZATION; INDUCED ACTIVATION; SYNAPSE FORMATION; SIGNALING EVENTS; MIGRATION; PROTEIN; LYMPHOCYTES	Signaling by the B cell receptor (BCR) promotes integrin-mediated adhesion and cytoskeletal reorganization. This results in B cell spreading, which enhances the ability of B cells to bind antigens and become activated. Proline-rich tyrosine kinase (Pyk2) and focal adhesion kinase (FAK) are related cytoplasmic tyrosine kinases that regulate cell adhesion, cell morphology, and cell migration. In this report we show that BCR signaling and integrin signaling collaborate to induce the phosphorylation of Pyk2 and FAK on key tyrosine residues, a modification that increases the kinase activity of Pyk2 and FAK. Activation of the Rap GTPases is critical for BCR-induced integrin activation as well as for BCR- and integrin-induced reorganization of the actin cytoskeleton. We now show that Rap activation is essential for BCR- induced phosphorylation of Pyk2 and for integrin-induced phosphorylation of Pyk2 and FAK. Moreover Rap-dependent phosphorylation of Pyk2 and FAK required an intact actin cytoskeleton as well as actin dynamics, suggesting that Rap regulates Pyk2 and FAK via its effects on the actin cytoskeleton. Importantly B cell spreading induced by BCR/integrin co-stimulation or by integrin engagement was inhibited by short hairpin RNA-mediated knockdown of either Pyk2 or FAK expression and by treatment with PF-431396, a chemical inhibitor that blocks the kinase activities of both Pyk2 and FAK. Thus Pyk2 and FAK are downstream targets of the Rap GTPases that play a key role in regulating B cell morphology.	[Tse, Kathy W. K.; Dang-Lawson, May; Lee, Rosaline L.; Vong, Doris; Bulic, Anica; Gold, Michael R.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Tse, Kathy W. K.; Dang-Lawson, May; Lee, Rosaline L.; Vong, Doris; Bulic, Anica; Gold, Michael R.] Univ British Columbia, Inst Life Sci, I3 Res Grp, Vancouver, BC V6T 1Z3, Canada; [Buckbinder, Leonard] Pfizer Global Res & Dev, Groton, CT 06340 USA; [Tse, Kathy W. K.; Dang-Lawson, May; Lee, Rosaline L.; Vong, Doris; Bulic, Anica; Gold, Michael R.] Univ British Columbia, Inst Life Sci, CELL Res Grp, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; Pfizer; University of British Columbia	Gold, MR (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mgold@interchange.ubc.ca	Gold, Michael/AAF-2081-2021	Gold, Michael/0000-0003-1222-3191	Canadian Institutes of Health Research Operating [68865]; Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research Operating(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institutes of Health Research Operating Grant 68865 (to M. R. G.) and by graduate student fellowships (to K. W. K. T.) from the Michael Smith Foundation for Health Research and the Natural Sciences and Engineering Research Council of Canada.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Ambrose HE, 2004, IMMUNOLOGY, V111, P400, DOI 10.1111/j.1365-2567.2004.01824.x; Andreev J, 1999, MOL CELL BIOL, V19, P2338; Astier A, 1997, J BIOL CHEM, V272, P228; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Cai XM, 2006, MOL CELL BIOL, V26, P2857, DOI 10.1128/MCB.26.7.2857-2868.2006; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Christian SL, 2003, J BIOL CHEM, V278, P41756, DOI 10.1074/jbc.M303180200; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Davey EJ, 1998, J IMMUNOL, V160, P5366; Durand CA, 2006, EUR J IMMUNOL, V36, P2235, DOI 10.1002/eji.200535004; Elenstrom C, 1989, GROWTH FACTORS, V2, P73, DOI 10.3109/08977198909069083; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; FREEDMAN AS, 1993, J IMMUNOL, V150, P1645; FREUNDLICH B, 1983, J IMMUNOL METHODS, V62, P31, DOI 10.1016/0022-1759(83)90107-2; Giannoni E, 2003, J BIOL CHEM, V278, P36763, DOI 10.1074/jbc.M302686200; Gismondi A, 2003, J IMMUNOL, V170, P3065, DOI 10.4049/jimmunol.170.6.3065; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Glodek AM, 2003, J EXP MED, V197, P461, DOI 10.1084/jem.20021477; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Manie SN, 1996, BLOOD, V87, P1855; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; Mlinaric-Rascan I, 2001, FEBS LETT, V498, P26, DOI 10.1016/S0014-5793(01)02474-7; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Robertson LK, 2005, J IMMUNOL, V175, P8138, DOI 10.4049/jimmunol.175.12.8138; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Rovida E, 2005, BIOL CHEM, V386, P919, DOI 10.1515/BC.2005.107; Ruusala A, 2008, MOL CELL BIOL, V28, P1802, DOI 10.1128/MCB.00201-07; SantosArgumedo L, 1997, IMMUNOLOGY, V90, P147, DOI 10.1046/j.1365-2567.1997.00126.x; Sarkar S, 2002, LEUKEMIA LYMPHOMA, V43, P1663, DOI 10.1080/1042819021000003009; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; van Buul JD, 2005, J BIOL CHEM, V280, P21129, DOI 10.1074/jbc.M500898200; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Westerberg L, 2001, BLOOD, V98, P1086, DOI 10.1182/blood.V98.4.1086; Xiong WC, 1998, J CELL SCI, V111, P1981; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049	68	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22865	22877		10.1074/jbc.M109.013169	http://dx.doi.org/10.1074/jbc.M109.013169			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561089	hybrid, Green Published			2022-12-27	WOS:000268963100040
J	Irimia, A; Eoff, RL; Guengerich, FP; Egli, M				Irimia, Adriana; Eoff, Robert L.; Guengerich, F. Peter; Egli, Martin			Structural and Functional Elucidation of the Mechanism Promoting Error-prone Synthesis by Human DNA Polymerase kappa Opposite the 7,8-Dihydro-8-oxo-2 '-deoxyguanosine Adduct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-DIFFRACTION DATA; LESION-BYPASS; SULFOLOBUS-SOLFATARICUS; TRANSLESION SYNTHESIS; CRYSTAL-STRUCTURE; MISMATCH EXTENSION; ESCHERICHIA-COLI; FINGER DOMAIN; FIDELITY; REPLICATION	Human polymerase kappa (hPol kappa) is one of four eukaryotic Y-class DNA polymerases and may be an important element in the cellular response to polycyclic aromatic hydrocarbons such as benzo[a] pyrene, which can lead to reactive oxygenated metabolite-mediated oxidative stress. Here, we present a detailed analysis of the activity and specificity of hPol kappa bypass opposite the major oxidative adduct 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-oxoG). Unlike its archaeal homolog Dpo4, hPol kappa bypasses this lesion in an error-prone fashion by inserting mainly dATP. Analysis of transient-state kinetics shows diminished "bursts" for dATP: 8-oxoG and dCTP: 8-oxoG incorporation, indicative of non-productive complex formation, but dATP: 8-oxoG insertion events that do occur are 2-fold more efficient than dCTP: G insertion events. Crystal structures of ternary hPol kappa complexes with adducted template-primer DNA reveal non-productive (dGTP and dATP) alignments of incoming nucleotide and 8-oxoG. Structural limitations placed upon the hPol kappa by interactions between the N-clasp and finger domains combined with stabilization of the syn-oriented template 8-oxoG through the side chain of Met-135 both appear to contribute to error-prone bypass. Mutating Leu-508 in the little finger domain of hPol kappa to lysine modulates the insertion opposite 8-oxoG toward more accurate bypass, similar to previous findings with Dpo4. Our structural and activity data provide insight into important mechanistic aspects of error-prone bypass of 8-oxoG by hPol kappa compared with accurate and efficient bypass of the lesion by Dpo4 and polymerase eta.	[Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 868A Robinson Res Bldg, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu			National Institutes of Health [P01 ES05355, P30 ES000267, R01 ES010375, F32 CA119776]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355, P30ES000267, R01ES010375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 ES05355 (to M. E.), P30 ES000267 (to F. P. G. and M. E.), R01 ES010375 (to F. P. G.), and F32 CA119776 (to R. L. E.). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlson KD, 2006, P NATL ACAD SCI USA, V103, P15776, DOI 10.1073/pnas.0605785103; Carlson KD, 2005, MOL CELL BIOL, V25, P2169, DOI 10.1128/MCB.25.6.2169-2176.2005; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DEGAN P, 1991, CARCINOGENESIS, V12, P865, DOI 10.1093/carcin/12.5.865; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; FRAGA CG, 1991, P NATL ACAD SCI USA, V88, P11003, DOI 10.1073/pnas.88.24.11003; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Garcia-Ortiz MV, 2007, FEBS J, V274, P3340, DOI 10.1111/j.1742-4658.2007.05868.x; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Hogg M, 2005, CURR OPIN STRUC BIOL, V15, P86, DOI 10.1016/j.sbi.2005.01.014; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lehmann AR, 2006, MOL CELL, V24, P493, DOI 10.1016/j.molcel.2006.10.021; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; MALINS DC, 1991, CANCER RES, V51, P5430; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Ohashi E, 2000, GENE DEV, V14, P1589; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potapova O, 2002, J BIOL CHEM, V277, P28157, DOI 10.1074/jbc.M202607200; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; SHIMODA R, 1994, CANCER RES, V54, P3171; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Uijon SN, 2004, STRUCTURE, V12, P1395, DOI 10.1016/j.str.2004.05.011; Vellieux FMD, 1997, METHOD ENZYMOL, V277, P18, DOI 10.1016/S0076-6879(97)77005-8; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	50	69	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22467	22480		10.1074/jbc.M109.003905	http://dx.doi.org/10.1074/jbc.M109.003905			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542228	hybrid, Green Published			2022-12-27	WOS:000268783700068
J	Dixon, DP; Edwards, R				Dixon, David P.; Edwards, Robert			Selective Binding of Glutathione Conjugates of Fatty Acid Derivatives by Plant Glutathione Transferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRITICUM-AESTIVUM L.; ARABIDOPSIS-THALIANA; S-TRANSFERASES; HERBICIDE DETOXIFICATION; STRUCTURAL-CHARACTERIZATION; LIPOXYGENASE PATHWAY; PROTEOMIC ANALYSIS; PURIFICATION; MAIZE; WHEAT	Proteomic studies with Arabidopsis thaliana have revealed that the plant-specific Tau (U) class glutathione transferases (GSTs) are selectively retained by S-hexylglutathione affinity supports. Overexpression of members of the Arabidopsis GST superfamily in Escherichia coli showed that 25 of the complement of 28 GSTUs caused the aberrant accumulation of acylated glutathione thioesters in vivo, a perturbation that was not observed with other GST classes. Each GSTU caused a specific group of fatty acyl derivatives to accumulate, which varied in chain length (C-6 to C-18), additional oxygen content (0 or 1), and desaturation (0 or 1). Thioesters bound tightly to recombinant GSTs (K-d similar to 1 mu M), explaining their accumulation. Transient expression of GSTUs in Nicotiana benthamiana followed by recovery by Strep-tag affinity chromatography allowed the respective plant ligands to be extracted and characterized. Again, each GST showed a distinct profile of recovered metabolites, notably glutathionylated oxophytodienoic acid and related oxygenated fatty acids. Similarly, the expression of the major Tau protein GSTU19 in the endogenous host Arabidopsis led to the selective binding of the glutathionylated oxophytodienoic acid-glutathione conjugate, with the enzyme able to catalyze the conjugation reaction. Additional ligands identified in planta included other fatty acid derivatives including divinyl ethers and glutathionylated chlorogenic acid. The strong and specific retention of various oxygenated fatty acids by each GSTU and the conservation in binding observed in the different hosts suggest that these proteins have selective roles in binding and conjugating these unstable metabolites in vivo.	[Dixon, David P.; Edwards, Robert] Univ Durham, Sch Biol & Biomed Sci, Ctr Bioact Chem, Durham DH1 3LE, England	Durham University	Edwards, R (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Ctr Bioact Chem, South Rd, Durham DH1 3LE, England.	Robert.Edwards@durham.ac.uk	Dixon, David P/B-5413-2008	Dixon, David P/0000-0003-4644-8399; Edwards, Robert/0000-0003-0809-5991	Biotechnology and Biological Sciences Research Council [BBC51227X1]; BBSRC [BB/G001766/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G001766/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council through Grant BBC51227X1 and a research development fellowship (to R. E.).	Alfenito MR, 1998, PLANT CELL, V10, P1135, DOI 10.1105/tpc.10.7.1135; Andrews CJ, 2005, PESTIC BIOCHEM PHYS, V82, P205, DOI 10.1016/j.pestbp.2004.11.009; Blackburn ML, 1997, CHEM RES TOXICOL, V10, P1364, DOI 10.1021/tx970087a; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cummins I, 1997, PESTIC BIOCHEM PHYS, V59, P35, DOI 10.1006/pest.1997.2308; Davoine C, 2006, PLANT PHYSIOL, V140, P1484, DOI 10.1104/pp.105.074690; Davoine C, 2005, ANAL CHEM, V77, P7366, DOI 10.1021/ac051155y; DeRidder BP, 2002, PLANT PHYSIOL, V130, P1497, DOI 10.1104/pp.010066; Dixon DP, 2008, J BIOL CHEM, V283, P20268, DOI 10.1074/jbc.M802026200; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 1998, CURR OPIN PLANT BIOL, V1, P258, DOI 10.1016/S1369-5266(98)80114-3; Dixon DP, 1998, PLANT MOL BIOL, V36, P75, DOI 10.1023/A:1005958711207; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Edwards R, 2005, Z NATURFORSCH C, V60, P307; EDWARDS R, 2000, HERBICIDES THEIR MEC, P38; Falck JR, 2007, BIOORGAN MED CHEM, V15, P1062, DOI 10.1016/j.bmc.2006.10.022; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Grechkin AN, 2002, PROSTAG OTH LIPID M, V68-9, P457, DOI 10.1016/S0090-6980(02)00048-5; HOLT DC, 1995, PLANTA, V196, P295, DOI 10.1007/BF00201388; Kordic S, 2002, ARCH BIOCHEM BIOPHYS, V399, P232, DOI 10.1006/abbi.2002.2772; Leventis R, 1997, BIOCHEMISTRY-US, V36, P5546, DOI 10.1021/bi963029h; Loutre C, 2003, PLANT J, V34, P485, DOI 10.1046/j.1365-313X.2003.01742.x; McGonigle B, 2000, PLANT PHYSIOL, V124, P1105, DOI 10.1104/pp.124.3.1105; MOZER TJ, 1983, BIOCHEMISTRY-US, V22, P1068, DOI 10.1021/bi00274a011; Panzella L, 2003, BIOORGAN MED CHEM, V11, P4797, DOI 10.1016/S0968-0896(03)00460-7; Pascal S, 1998, PLANT SCI, V134, P217, DOI 10.1016/S0168-9452(98)00067-3; Pensalfini A, 2008, FREE RADICAL BIO MED, V44, P1624, DOI 10.1016/j.freeradbiomed.2008.01.025; PEYROT DC, 2002, J AGR FOOD CHEM, V50, P4076; Reinemer P, 1996, J MOL BIOL, V255, P289, DOI 10.1006/jmbi.1996.0024; Sappl PG, 2004, PLANT MOL BIOL, V54, P205, DOI 10.1023/B:PLAN.0000028786.57439.b3; Smith AP, 2004, J BIOL CHEM, V279, P26098, DOI 10.1074/jbc.M402807200; TAKAHASHI Y, 1992, PLANT CELL PHYSIOL, V33, P779; Tapp EJ, 2008, J AGR FOOD CHEM, V56, P6623, DOI 10.1021/jf800793q; Thom R, 2002, BIOCHEMISTRY-US, V41, P7008, DOI 10.1021/bi015964x; Wang W, 1998, PHARMACOL REV, V50, P335	36	61	65	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21249	21256		10.1074/jbc.M109.020107	http://dx.doi.org/10.1074/jbc.M109.020107			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520850	Green Published, hybrid			2022-12-27	WOS:000268564400018
J	Manso, I; Torres, B; Andreu, JM; Menendez, M; Rivas, G; Alfonso, C; Diaz, E; Garcia, JL; Galan, B				Manso, Isabel; Torres, Begona; Manuel Andreu, Jose; Menendez, Margarita; Rivas, German; Alfonso, Carlos; Diaz, Eduardo; Luis Garcia, Jose; Galan, Beatriz			3-Hydroxyphenylpropionate and Phenylpropionate Are Synergistic Activators of the MhpR Transcriptional Regulator from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYBENZOATE HYDROXYLASE; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; CATABOLIC PATHWAY; PSEUDOMONAS-PUTIDA; PHENYLACETIC ACID; ERWINIA-CHRYSANTHEMI; DIFFERENT MODES; GENES; BINDING	The degradation of the aromatic compound phenylpropionate (PP) in Escherichia coli K-12 requires the activation of two different catabolic pathways coded by the hca and the mhp gene clusters involved in the mineralization of PP and 3-hydroxyphenylpropionate (3HPP), respectively. The compound 3-(2,3-dihydroxyphenyl) propionate (DHPP) is a common intermediate of both pathways which must be cleaved by the MhpB dioxygenase before entering into the primary cell metabolism. Therefore, the degradation of PP has to be controlled by both its specific regulator (HcaR) but also by the Mhp Rregulator of the mhp cluster. We have demonstrated that 3HPP and DHPP are the true and best activators of MhpR, whereas PP only induces no response. However, in vivo and in vitro transcription experiments have demonstrated that PP activates the MhpR regulator synergistically with the true inducers, representing the first case of such a peculiar synergistic effect described for a bacterial regulator. The three compounds enhanced the interaction of MhpR with its DNA operator in electrophoretic mobility shift assays. Inducer binding to MhpR is detected by circular dichroism and fluorescence spectroscopies. Fluorescence quenching measurements have revealed that the true inducers (3HPP and DHPP) and PP bind with similar affinities and independently to MhpR. This type of dual-metabolite synergy provides great potential for a rapid modulation of gene expression and represents an important feature of transcriptional control. The mhp regulatory system is an example of the high complexity achievable in prokaryotes.	[Manso, Isabel; Torres, Begona; Diaz, Eduardo; Luis Garcia, Jose; Galan, Beatriz] CSIC, Dept Mol Microbiol, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain; [Manuel Andreu, Jose; Rivas, German; Alfonso, Carlos] CSIC, Ctr Invest Biol, Dept Ciencia Prot, Madrid 28040, Spain; [Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Galan, B (corresponding author), CSIC, Dept Mol Microbiol, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain.	bgalan@cib.csic.es	Alfonso, Carlos/K-1316-2014; Menendez, Margarita/M-1795-2014; Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Garcia Lopez, Jose Luis/G-9139-2015; Diaz, Eduardo/F-8605-2016	Alfonso, Carlos/0000-0001-7165-4800; Menendez, Margarita/0000-0002-3267-4443; Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Galan, Beatriz/0000-0002-2596-6034; Andreu, Jose M/0000-0001-8064-6933; Garcia Lopez, Jose Luis/0000-0002-9238-2485; Diaz, Eduardo/0000-0002-9731-6524	Comision Interministerial de Ciencia y Tecnologia [GEN2006-27750-C5-3-E, BIO2006-05957, CSD200700005]; Comunidad Autonoma de Madrid [P-AMB-259-0505]	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Comunidad Autonoma de Madrid(Comunidad de Madrid)	This work was supported by Comision Interministerial de Ciencia y Tecnologia a Grants GEN2006-27750-C5-3-E, BIO2006-05957, and CSD200700005 and Comunidad Autonoma de Madrid Grant P-AMB-259-0505.	Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Bertani I, 2001, MICROBIOL-SGM, V147, P1611, DOI 10.1099/00221287-147-6-1611; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Bundy BM, 2002, P NATL ACAD SCI USA, V99, P7693, DOI 10.1073/pnas.102605799; BURLINGAME R, 1983, J BACTERIOL, V155, P424, DOI 10.1128/JB.155.1.424-426.1983; BURLINGAME RP, 1986, J BACTERIOL, V168, P55, DOI 10.1128/jb.168.1.55-64.1986; Carmona Manuel, 2008, P97; Cebolla A, 2001, NUCLEIC ACIDS RES, V29, P759, DOI 10.1093/nar/29.3.759; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Diaz E, 1998, J BACTERIOL, V180, P2915; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; DIMARCO AA, 1994, J BACTERIOL, V176, P4277, DOI 10.1128/jb.176.14.4277-4284.1994; DIMARCO AA, 1993, J BACTERIOL, V175, P4499, DOI 10.1128/JB.175.14.4499-4506.1993; Donald LJ, 2001, PROTEIN SCI, V10, P1370, DOI 10.1110/ps.780101; Eulberg D, 1998, ANTON LEEUW INT J G, V74, P71, DOI 10.1023/A:1001755928637; Ezezika OC, 2007, J MOL BIOL, V367, P616, DOI 10.1016/j.jmb.2006.09.090; Ferrandez A, 2000, J BIOL CHEM, V275, P12214, DOI 10.1074/jbc.275.16.12214; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Ferrandez A, 1997, J BACTERIOL, V179, P2573, DOI 10.1128/jb.179.8.2573-2581.1997; Gerischer U, 1998, J BACTERIOL, V180, P1512, DOI 10.1128/JB.180.6.1512-1524.1998; Gloss LM, 1997, BIOCHEMISTRY-US, V36, P5612, DOI 10.1021/bi970056e; Guazzaroni MAE, 2005, J BIOL CHEM, V280, P20887, DOI 10.1074/jbc.M500783200; Guazzaroni ME, 2007, J BIOL CHEM, V282, P16308, DOI 10.1074/jbc.M610032200; Guo Z, 1999, MOL MICROBIOL, V32, P253, DOI 10.1046/j.1365-2958.1999.01342.x; KASHKET ER, 1985, ANNU REV MICROBIOL, V39, P219, DOI 10.1146/annurev.mi.39.100185.001251; Kok RG, 1998, J BACTERIOL, V180, P5058, DOI 10.1128/JB.180.19.5058-5069.1998; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKOWICZ JR, 1995, BIOPHYS CHEM, V56, P263, DOI 10.1016/0301-4622(95)00040-5; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu Y, 1999, J BACTERIOL, V181, P2411, DOI 10.1128/JB.181.8.2411-2421.1999; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Marschall C, 1998, J MOL BIOL, V276, P339, DOI 10.1006/jmbi.1997.1533; Masai E, 2002, APPL ENVIRON MICROB, V68, P4416, DOI 10.1128/AEM.68.9.4416-4424.2002; Miller J. H, 1972, EXPT MOL GENETICS; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; NASSER W, 1992, MOL MICROBIOL, V6, P257, DOI 10.1111/j.1365-2958.1992.tb02007.x; Nomura K, 1998, P NATL ACAD SCI USA, V95, P14034, DOI 10.1073/pnas.95.24.14034; Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419; PACE CN, 1980, J BIOL CHEM, V255, P3862; PERKINS JD, 1993, J MOL BIOL, V232, P419, DOI 10.1006/jmbi.1993.1401; Popp R, 2002, J BACTERIOL, V184, P1988, DOI 10.1128/JB.184.7.1988-1997.2002; Prieto MA, 1997, FEBS LETT, V414, P293, DOI 10.1016/S0014-5793(97)01012-0; Prieto MA, 1997, BIOCHEM BIOPH RES CO, V232, P759, DOI 10.1006/bbrc.1997.6368; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; REVERCHON S, 1991, MOL MICROBIOL, V5, P2203, DOI 10.1111/j.1365-2958.1991.tb02150.x; Sambrook J., 2001, MOL CLONING LAB MANU; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Scott D, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P1, DOI 10.1039/9781847552617; Smith MA, 2003, APPL ENVIRON MICROB, V69, P524, DOI 10.1128/AEM.69.1.524-532.2003; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Torres B, 2003, J BIOL CHEM, V278, P27575, DOI 10.1074/jbc.M303245200; Turlin E, 2001, J MOL MICROB BIOTECH, V3, P127; Walker JR, 2006, J MOL BIOL, V358, P810, DOI 10.1016/j.jmb.2006.02.034; WEBER PC, 1995, ACTA CRYSTALLOGR D, V51, P590, DOI 10.1107/S0907444995001405; Yamamoto K, 2003, MOL MICROBIOL, V47, P183, DOI 10.1046/j.1365-2958.2003.03287.x; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200	61	25	25	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21218	21228		10.1074/jbc.M109.008243	http://dx.doi.org/10.1074/jbc.M109.008243			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520845	Green Published, hybrid			2022-12-27	WOS:000268564400015
J	Pohjoismaki, JLO; Goffart, S; Tyynismaa, H; Willcox, S; Ide, T; Kang, D; Suomalainen, A; Karhunen, PJ; Griffith, JD; Holt, IJ; Jacobs, HT				Pohjoismaki, Jaakko L. O.; Goffart, Steffi; Tyynismaa, Henna; Willcox, Smaranda; Ide, Tomomi; Kang, Dongchon; Suomalainen, Anu; Karhunen, Pekka J.; Griffith, Jack D.; Holt, Ian J.; Jacobs, Howard T.			Human Heart Mitochondrial DNA Is Organized in Complex Catenated Networks Containing Abundant Four-way Junctions and Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-A; ROLLING-CIRCLE REPLICATION; FIELD GEL-ELECTROPHORESIS; MOBILITY GROUP PROTEIN; STRAND-BREAK REPAIR; MTDNA COPY NUMBER; MOUSE L CELLS; HOMOLOGOUS RECOMBINATION; LINEAR-MOLECULES; MAMMALIAN-CELLS	Analysis of human heart mitochondrial DNA (mtDNA) by electron microscopy and agarose gel electrophoresis revealed a complete absence of the theta-type replication intermediates seen abundantly in mtDNA from all other tissues. Instead only Y- and X-junctional forms were detected after restriction digestion. Uncut heart mtDNA was organized in tangled complexes of up to 20 or more genome equivalents, which could be resolved to genomic monomers, dimers, and linear fragments by treatment with the decatenating enzyme topoisomerase IV plus the cruciform-cutting T7 endonuclease I. Human and mouse brain also contained a population of such mtDNA forms, which were absent, however, from mouse, rabbit, or pig heart. Overexpression in transgenic mice of two proteins involved in mtDNA replication, namely human mitochondrial transcription factor A or the mouse Twinkle DNA helicase, generated abundant four-way junctions in mtDNA of heart, brain, and skeletal muscle. The organization of mtDNA of human heart as well as of mouse and human brain in complex junctional networks replicating via a presumed non-theta mechanism is unprecedented in mammals.	[Pohjoismaki, Jaakko L. O.; Goffart, Steffi; Jacobs, Howard T.] Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland; [Pohjoismaki, Jaakko L. O.; Goffart, Steffi; Jacobs, Howard T.] Univ Tampere, Tampere Univ Hosp, FI-33014 Tampere, Finland; [Pohjoismaki, Jaakko L. O.; Karhunen, Pekka J.] Univ Tampere, Dept Forens Med, FI-33014 Tampere, Finland; [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FI-00290 Helsinki, Finland; [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Programme Mol Neurol, FI-00290 Helsinki, Finland; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan; [Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka 8128582, Japan; [Holt, Ian J.] MRC, Mitochondrial Biol Unit, Cambridge CB2 OXY, England	Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of North Carolina; University of North Carolina Chapel Hill; Kyushu University; Kyushu University	Jacobs, HT (corresponding author), Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland.	howard.t.jacobs@uta.fi	Goffart, Steffi/N-3597-2015; Tyynismaa, Henna/F-1428-2011; Jacobs, Howard T/G-2434-2011; Pohjoismaeki, Jaakko L. O./AAC-7995-2019	Goffart, Steffi/0000-0001-8491-1458; Pohjoismaeki, Jaakko L. O./0000-0002-1185-3610; Jacobs, Howard/0000-0003-1895-6003; holt, ian/0000-0001-5468-0193; Tyynismaa, Henna/0000-0002-2493-2422; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195	National Institutes of Health [GM31819]; Academy of Finland; Sigrid Juselius Foundation; Tampere University Hospital Medical Research Fund; Universities of Tampere and Helsinki; Yrjo Jahnsson Foundation; Elli and Elvi Oksanen Fund of the Pirkanmaa Fund; Finnish Cultural Foundation; Finnish Foundation for Cardiovascular Research; Helsinki Biomedical Graduate School; European Union; United Kingdom Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER; Medical Research Council [MC_U105663140] Funding Source: researchfish; MRC [MC_U105663140] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital Medical Research Fund; Universities of Tampere and Helsinki; Yrjo Jahnsson Foundation; Elli and Elvi Oksanen Fund of the Pirkanmaa Fund; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Foundation for Cardiovascular Research; Helsinki Biomedical Graduate School; European Union(European Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM31819. This work was also supported by the Academy of Finland, Sigrid Juselius Foundation, Tampere University Hospital Medical Research Fund, Universities of Tampere and Helsinki, Yrjo Jahnsson Foundation, Elli and Elvi Oksanen Fund of the Pirkanmaa Fund under the auspices of the Finnish Cultural Foundation, Finnish Foundation for Cardiovascular Research, Helsinki Biomedical Graduate School, European Union (EUMITOCOMBAT project), and the United Kingdom Medical Research Council.	AKINS RA, 1986, CELL, V47, P505, DOI 10.1016/0092-8674(86)90615-X; Backert S, 1996, MOL CELL BIOL, V16, P6285; Backert S, 2000, CURR GENET, V37, P304, DOI 10.1007/s002940050532; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Barthelemy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs; Bendich AJ, 1996, J MOL BIOL, V255, P564, DOI 10.1006/jmbi.1996.0048; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; CLAYTON DA, 1967, NATURE, V216, P652, DOI 10.1038/216652a0; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CLAYTON DA, 1968, NATURE, V220, P976, DOI 10.1038/220976a0; CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; DAVIS RW, 1968, P NATL ACAD SCI USA, V60, P243, DOI 10.1073/pnas.60.1.243; Drew ME, 2001, J CELL BIOL, V153, P735, DOI 10.1083/jcb.153.4.735; DRI AM, 1992, GENE, V120, P11, DOI 10.1016/0378-1119(92)90003-8; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Fouche N, 2006, NUCLEIC ACIDS RES, V34, P6044, DOI 10.1093/nar/gkl757; Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008; FUJIWARA Y, 1976, MUTAT RES, V37, P91, DOI 10.1016/0027-5107(76)90058-0; HAN ZY, 1994, CHROMOSOMA, V103, P162, DOI 10.1007/BF00368008; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; Hinz JM, 2006, NUCLEIC ACIDS RES, V34, P1358, DOI 10.1093/nar/gkl020; Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Hyvarinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Jacobs MA, 1996, CURR GENET, V30, P3, DOI 10.1007/s002940050093; Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233; Kamashev D, 2000, EMBO J, V19, P6527, DOI 10.1093/emboj/19.23.6527; Khazi FR, 2003, MOL GENET GENOMICS, V269, P454, DOI 10.1007/s00438-003-0859-6; KIRSCHNER RH, 1968, P NATL ACAD SCI USA, V60, P1466, DOI 10.1073/pnas.60.4.1466; Kogoma T, 1996, J BACTERIOL, V178, P1258, DOI 10.1128/jb.178.5.1258-1264.1996; Kong DC, 1996, EMBO J, V15, P2010, DOI 10.1002/j.1460-2075.1996.tb00552.x; Li SS, 1998, J BACTERIOL, V180, P3750, DOI 10.1128/JB.180.15.3750-3756.1998; Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06; MacAlpine DM, 1998, P NATL ACAD SCI USA, V95, P6739, DOI 10.1073/pnas.95.12.6739; MALESZKA R, 1991, EMBO J, V10, P3923, DOI 10.1002/j.1460-2075.1991.tb04962.x; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; Odahara M, 2007, GENES GENET SYST, V82, P43, DOI 10.1266/ggs.82.43; Ohno T, 2000, BIOCHEM BIOPH RES CO, V271, P492, DOI 10.1006/bbrc.2000.2656; Oldenburg DJ, 2004, J MOL BIOL, V335, P953, DOI 10.1016/j.jmb.2003.11.020; Oldenburg DJ, 2001, J MOL BIOL, V310, P549, DOI 10.1006/jmbi.2001.4783; Oldenburg DJ, 1996, PLANT CELL, V8, P447, DOI 10.1105/tpc.8.3.447; Pohjoismaki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200; ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810; ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737; SACCONE C, 1994, CURR OPIN GENET DEV, V4, P875, DOI 10.1016/0959-437X(94)90073-6; Sandler SJ, 1996, GENETICS, V143, P5; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; Smith KC, 2004, BIOESSAYS, V26, P1322, DOI 10.1002/bies.20109; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763; Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606	70	91	95	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21446	21457		10.1074/jbc.M109.016600	http://dx.doi.org/10.1074/jbc.M109.016600			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19525233	hybrid, Green Published			2022-12-27	WOS:000268564400039
J	Rigby, S; Huang, YX; Streubel, B; Chott, A; Du, MQ; Turner, SD; Bacon, CM				Rigby, Sue; Huang, Yuanxue; Streubel, Berthold; Chott, Andreas; Du, Ming-Qing; Turner, Suzanne D.; Bacon, Chris M.			The Lymphoma-associated Fusion Tyrosine Kinase ITK-SYK Requires Pleckstrin Homology Domain-mediated Membrane Localization for Activation and Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL; PROTEIN-KINASE; SIGNALING PATHWAYS; PLASMA-MEMBRANE; FAMILY KINASES; TEC KINASES; PHOSPHORYLATION; PROLIFERATION; INHIBITION; EXPRESSION	ITK-SYK, a novel fusion tyrosine kinase (FTK) resulting from a recurrent t(5; 9)(q33;q22), was recently identified in a poorly understood subset of peripheral T-cell lymphomas. However, the biochemical and functional properties of ITK-SYK are unknown. Here we demonstrate that ITK-SYK is a catalytically active tyrosine kinase that is sensitive to an established inhibitor of SYK. The expression of ITK-SYK, but not SYK, transformed NIH3T3 cells, inducing loss of contact inhibition and formation of anchorage-independent colonies in soft agar, in a kinase activity-dependent manner. ITK-SYK is unusual among FTKs in having an N-terminal phosphatidylinositol 3,4,5-trisphosphate-binding pleckstrin homology (PH) domain. Introduction of a well characterized loss-of-function mutation (R29C) into the PH domain of ITK-SYK inhibited its phosphorylation, markedly reduced its catalytic activity, and abrogated its ability to activate the ERK signaling pathway and to transform NIH3T3 cells. Although ITK-SYK was membrane-associated, ITK-SYK-R29C was not. However, each of these properties could be recovered by retargeting ITK-SYK-R29C back to the plasma membrane by the addition of an N-terminal myristylation sequence. Consistent with a model in which ITK-SYK requires PH domain-mediated binding to phosphatidylinositol 3,4,5-trisphosphate generated by phosphatidylinositol 3-kinase (PI3K), ITK-SYK activity was reduced by pharmacological inhibition of PI3K and increased by co-expression with a constitutively active form of PI3K. Together, these findings identify ITK-SYK as an active, transforming FTK dependent upon PH domain-mediated membrane localization, identify a novel mechanism for activation of an oncogenic FTK, and suggest ITK-SYK as a rational therapeutic target for t(5; 9)(q33; q22)-positive lymphomas.	[Bacon, Chris M.] Univ Newcastle, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Streubel, Berthold; Chott, Andreas] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Rigby, Sue; Huang, Yuanxue; Du, Ming-Qing; Turner, Suzanne D.] Univ Cambridge, Div Mol Histopathol, Dept Pathol, Cambridge CB2 2QQ, England	Newcastle University - UK; Medical University of Vienna; University of Cambridge	Bacon, CM (corresponding author), Univ Newcastle, Sch Med, No Inst Canc Res, Paul OGorman Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	chris.bacon@ncl.ac.uk	Turner, Suzanne Dawn/K-4405-2013	Turner, Suzanne Dawn/0000-0002-8439-4507; Bacon, Chris/0000-0002-8268-2812; Du, Ming-Qing/0000-0002-1017-5045	Medical Research Council; Leukaemia Research; Health Foundation; Royal College of Pathologists; Pathological Society of Great Britain and Ireland	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Research; Health Foundation; Royal College of Pathologists; Pathological Society of Great Britain and Ireland	This work was supported by funds from the Medical Research Council (to S. R.), Leukaemia Research (to Y. H., M.-Q. D., and S. D. T.), and the Health Foundation, the Royal College of Pathologists, and the Pathological Society of Great Britain and Ireland (to C. M. B.)	Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Brazin KN, 2000, J MOL BIOL, V302, P607, DOI 10.1006/jmbi.2000.4091; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Chalandon Y, 2005, HAEMATOLOGICA, V90, P949; CHAN AC, 1994, J IMMUNOL, V152, P4758; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Ching KA, 1999, J IMMUNOL, V163, P6006; Couture C, 1997, EUR J BIOCHEM, V246, P447, DOI 10.1111/j.1432-1033.1997.00447.x; De Keersmaecker K, 2008, MOL CELL, V31, P134, DOI 10.1016/j.molcel.2008.05.005; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Delaval B, 2005, CANCER RES, V65, P7231, DOI 10.1158/0008-5472.CAN-04-4167; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; Feldman AL, 2008, LEUKEMIA, V22, P1139, DOI 10.1038/leu.2008.77; Felices M, 2007, ADV IMMUNOL, V93, P145, DOI 10.1016/S0065-2776(06)93004-1; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Gomez-Rodriguez J, 2007, IMMUNOL REV, V218, P45, DOI 10.1111/j.1600-065X.2007.00534.x; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Huang YL, 2009, AM J SURG PATHOL, V33, P682, DOI 10.1097/PAS.0b013e3181971591; Jaffe ES, 2001, WHO CLASSIFICATION T; Keshvara LM, 1998, J IMMUNOL, V161, P5276; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kuno Y, 2001, BLOOD, V97, P1050, DOI 10.1182/blood.V97.4.1050; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Law CL, 1996, MOL CELL BIOL, V16, P1305; Maeda T, 2005, BLOOD, V105, P2115, DOI 10.1182/blood-2003-12-4290; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Qi Q, 2006, J BIOL CHEM, V281, P38529, DOI 10.1074/jbc.M609180200; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Rinaldi A, 2006, BRIT J HAEMATOL, V132, P303, DOI 10.1111/j.1365-2141.2005.05883.x; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; Saito K, 2001, J BIOL CHEM, V276, P16201, DOI 10.1074/jbc.M100873200; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Savage KJ, 2007, BLOOD REV, V21, P201, DOI 10.1016/j.blre.2007.03.001; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Stover EH, 2006, P NATL ACAD SCI USA, V103, P8078, DOI 10.1073/pnas.0601192103; Streubel B, 2006, LEUKEMIA, V20, P313, DOI 10.1038/sj.leu.2404045; Tao WJ, 2008, ONCOGENE, V27, P3194, DOI 10.1038/sj.onc.1210979; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Turner SD, 2006, LEUKEMIA, V20, P572, DOI 10.1038/sj.leu.2404125; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232; Wossning T, 2006, J EXP MED, V203, P2829, DOI 10.1084/jem.20060967; Yamamoto N, 2003, ANAL BIOCHEM, V315, P256, DOI 10.1016/S0003-2697(03)00026-5; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zlatkine P, 1997, J CELL SCI, V110, P673	58	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26871	26881		10.1074/jbc.M109.034272	http://dx.doi.org/10.1074/jbc.M109.034272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19535334	Green Published, hybrid			2022-12-27	WOS:000269969600068
J	Petrera, NS; Stafford, AR; Leslie, BA; Kretz, CA; Fredenburgh, JC; Weitz, JI				Petrera, Nicolas S.; Stafford, Alan R.; Leslie, Beverly A.; Kretz, Colin A.; Fredenburgh, James C.; Weitz, Jeffrey I.			Long Range Communication between Exosites 1 and 2 Modulates Thrombin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION-BINDING EXOSITE; HEPARIN-COFACTOR-II; FACTOR-V ACTIVATION; PROTHROMBIN FRAGMENT-2; CRYSTAL-STRUCTURE; ALLOSTERIC LINKAGE; BOVINE PROTHROMBIN; INHIBITS THROMBIN; ALPHA-THROMBIN; GAMMA'-PEPTIDE	Although exosites 1 and 2 regulate thrombin activity by binding substrates and cofactors and by allosterically modulating the active site, it is unclear whether there is direct allosteric linkage between the two exosites. To begin to address this, we first titrated a thrombin variant fluorescently labeled at exosite 1 with exosite 2 ligands, HD22 (a DNA aptamer), gamma'-peptide (an analog of the COOH terminus of the gamma'-chain of fibrinogen) or heparin. Concentration-dependent and saturable changes in fluorescence were elicited, supporting inter-exosite linkage. To explore the functional consequences of this phenomenon, we evaluated the capacity of exosite 2 ligands to inhibit thrombin binding to gamma(A)/gamma(A)-fibrin, an interaction mediated solely by exosite 1. When gamma(A)/gamma(A)-fibrinogen was clotted with thrombin in the presence of HD22, gamma'-peptide, or prothrombin fragment 2 there was a dose-dependent and saturable decrease in thrombin binding to the resultant fibrin clots. Furthermore, HD22 reduced the affinity of thrombin for gamma(A)/gamma(A)-fibrin 6-fold and accelerated the dissociation of thrombin from preformed gamma(A)/gamma(A)-fibrin clots. Similar responses were obtained when surface plasmon resonance was used to monitor the interaction of thrombin with gamma(A)/gamma(A)-fibrinogen or fibrin. There is bidirectional communication between the exosites, because exosite 1 ligands, HD1 (a DNA aptamer) or hirudin-(54- 65) (an analog of the COOH terminus of hirudin), inhibited the exosite 2-mediated interaction of thrombin with immobilized gamma'-peptide. These findings provide evidence for long range allosteric linkage between exosites 1 and 2 on thrombin, revealing further complexity to the mechanisms of thrombin regulation.	[Weitz, Jeffrey I.] Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Dept Med & Biochem, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Dept Biomed Sci, Hamilton, ON L8V 1C3, Canada	McMaster University; McMaster University	Weitz, JI (corresponding author), Henderson Res Ctr, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	jweitz@thrombosis.hhscr.org	Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550	Canadian Institutes of Health Research [MOP3992, CTP 79846]; Heart and Stroke Foundation of Ontario [T4729, T4730]; Ontario Research and Development Challenge Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Research and Development Challenge Fund(General Electric)	This work was supported, in part, by the Canadian Institutes of Health Research (Grants MOP3992 and CTP 79846), the Heart and Stroke Foundation of Ontario ( Grants T4729 and T4730), and the Ontario Research and Development Challenge Fund.	ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Baglia FA, 2002, J BIOL CHEM, V277, P1662, DOI 10.1074/jbc.M108319200; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Berny MA, 2008, ARTERIOSCL THROM VAS, V28, P329, DOI 10.1161/ATVBAHA.107.156273; BOCK PE, 1992, J BIOL CHEM, V267, P14974; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; CHURCH WR, 1991, J BIOL CHEM, V266, P8384; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Duffy EJ, 1997, BIOCHEM J, V321, P361, DOI 10.1042/bj3210361; ESMON CT, 1982, J BIOL CHEM, V257, P7944; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; HENRIKSEN RA, 1988, BIOCHEMISTRY-US, V27, P9160, DOI 10.1021/bi00426a013; HORTIN GL, 1991, J BIOL CHEM, V266, P6866; JAKUBOWSKI HV, 1986, J BIOL CHEM, V261, P3876; Kim Y, 2008, P NATL ACAD SCI USA, V105, P5664, DOI 10.1073/pnas.0711803105; Kretz CA, 2006, J BIOL CHEM, V281, P37477, DOI 10.1074/jbc.M607359200; Lancellotti S, 2008, J BIOL CHEM, V283, P30193, DOI 10.1074/jbc.M803659200; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Liaw PCY, 1998, J BIOL CHEM, V273, P8932, DOI 10.1074/jbc.273.15.8932; LIU LW, 1991, J BIOL CHEM, V266, P16977; LIU LW, 1991, J BIOL CHEM, V266, P23632; Long SB, 2008, RNA, V14, P2504, DOI 10.1261/rna.1239308; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Muller J, 2008, J THROMB HAEMOST, V6, P2105, DOI 10.1111/j.1538-7836.2008.03162.x; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; NASKI MC, 1990, J BIOL CHEM, V265, P13484; OLSON ST, 1982, J BIOL CHEM, V257, P4891; OWEN WG, 1974, J BIOL CHEM, V249, P594; Pineda AO, 2007, BIOPHYS CHEM, V125, P556, DOI 10.1016/j.bpc.2006.08.005; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Sabo TM, 2006, BIOCHEMISTRY-US, V45, P7434, DOI 10.1021/bi060360k; Sakharov DV, 1997, J BIOL CHEM, V272, P14477, DOI 10.1074/jbc.272.22.14477; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; WALKER FJ, 1979, J BIOL CHEM, V254, P5618; Wang W, 2000, J BIOL CHEM, V275, P22942, DOI 10.1074/jbc.M001760200; Weitz JI, 2002, CIRCULATION, V105, P1004, DOI 10.1161/hc0802.104331; YAMAGISHI R, 1987, FEBS LETT, V225, P109, DOI 10.1016/0014-5793(87)81140-7; YE J, 1991, J BIOL CHEM, V266, P23016; YE J, 1992, J BIOL CHEM, V267, P11023	48	54	57	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25620	25629		10.1074/jbc.M109.000042	http://dx.doi.org/10.1074/jbc.M109.000042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19589779	Green Published, hybrid			2022-12-27	WOS:000269738000020
J	Khatoon, M; Inagawa, K; Pospisil, P; Yamashita, A; Yoshioka, M; Lundin, B; Horie, J; Morita, N; Jajoo, A; Yamamoto, Y; Yamamoto, Y				Khatoon, Mahbuba; Inagawa, Kayo; Pospisil, Pavel; Yamashita, Amu; Yoshioka, Miho; Lundin, Bjoern; Horie, Junko; Morita, Noriko; Jajoo, Anjana; Yamamoto, Yoko; Yamamoto, Yasusi			Quality Control of Photosystem II THYLAKOID UNSTACKING IS NECESSARY TO AVOID FURTHER DAMAGE TO THE D1 PROTEIN AND TO FACILITATE D1 DEGRADATION UNDER LIGHT STRESS IN SPINACH THYLAKOIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYLAKOID MEMBRANES; SINGLET OXYGEN; 3-DIMENSIONAL STRUCTURE; GRANA STACKING; D1 PROTEIN; LIGHT; FTSH; ORGANIZATION; COMPLEX; PHOTOINHIBITION	Photosystem II is vulnerable to light damage. The reaction center-binding D1 protein is impaired during excessive illumination and is degraded and removed from photosystem II. Using isolated spinach thylakoids, we investigated the relationship between light-induced unstacking of thylakoids and damage to the D1 protein. Under light stress, thylakoids were expected to become unstacked so that the photodamaged photosystem II complexes in the grana and the proteases could move on the thylakoids for repair. Excessive light induced irreversible unstacking of thylakoids. By comparing the effects of light stress on stacked and unstacked thylakoids, photoinhibition of photosystem II was found to be more prominent in stacked thylakoids than in unstacked thylakoids. In accordance with this finding, EPR spin trapping measurements demonstrated higher production of hydroxyl radicals in stacked thylakoids than in unstacked thylakoids. We propose that unstacking of thylakoids has a crucial role in avoiding further damage to the D1 protein and facilitating degradation of the photodamaged D1 protein under light stress.	[Khatoon, Mahbuba; Inagawa, Kayo; Yamashita, Amu; Yoshioka, Miho; Lundin, Bjoern; Horie, Junko; Morita, Noriko; Yamamoto, Yasusi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Pospisil, Pavel] Palacky Univ, Biophys Lab, Dept Expt Phys, Fac Sci, Olomouc 77146, Czech Republic; [Jajoo, Anjana] Devi Ahilya Univ, Sch Life Sci, Indore 452017, Madhya Pradesh, India; [Yamamoto, Yoko] Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan	Okayama University; Palacky University Olomouc; Devi Ahilya University; Okayama University	Yamamoto, Y (corresponding author), 3-1-1 Tsushima Naka,Kita Ku, Okayama 7008530, Japan.	yasusiya@cc.okayama-u.ac.jp	POSPÍŠIL, Pavel/AAH-4451-2019; Yamamoto, Yasusi/B-2637-2011; Yoshioka-Nishimura, Miho/C-2745-2015	POSPÍŠIL, Pavel/0000-0001-9126-2011; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [20570039, 18208008]; Wesco Science Promotion Foundation; Ryobi Foundation; Ministry of Education, Youth and Sports of the Czech Republic [MSM 6198959215]; Japan Society for the Promotion of Science; Department of Biotechnology, India	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Wesco Science Promotion Foundation; Ryobi Foundation; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by Grant-in-Aid for Scientific Research 20570039 from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Wesco Science Promotion Foundation and the Ryobi Foundation (to Yasusi Yamamoto); Ministry of Education, Youth and Sports of the Czech Republic Grant MSM 6198959215 (to P. P.); a Japan Society for the Promotion of Science fellowship (to B. L.); a grant from Department of Biotechnology, India, (to A. J.); and Grant-in-Aid for Scientific Research 18208008 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Yoko Yamamoto).	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Albertsson PA, 2001, TRENDS PLANT SCI, V6, P349, DOI 10.1016/S1360-1385(01)02021-0; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; ANDERSON JM, 1988, TRENDS BIOCHEM SCI, V13, P351, DOI 10.1016/0968-0004(88)90106-5; Anderson JM, 1999, AUST J PLANT PHYSIOL, V26, P625, DOI 10.1071/PP99070; ANDERSON JM, 1988, AUST J PLANT PHYSIOL, V15, P11, DOI 10.1071/PP9880011; ANDERSON JM, 1994, PHOTOSYNTH RES, V41, P315, DOI 10.1007/BF00019409; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Barber J, 1998, BBA-BIOENERGETICS, V1365, P269, DOI 10.1016/S0005-2728(98)00079-6; Barber J, 2005, ADV PHOTO RESPIRAT, V22, P469; BENNETT J, 1980, P NATL ACAD SCI-BIOL, V77, P5253, DOI 10.1073/pnas.77.9.5253; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; CHOW WS, 1980, ARCH BIOCHEM BIOPHYS, V201, P347, DOI 10.1016/0003-9861(80)90520-2; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HIDEG E, 1994, PHOTOSYNTH RES, V39, P191, DOI 10.1007/BF00029386; Horton P, 1999, AUST J PLANT PHYSIOL, V26, P659, DOI 10.1071/PP99095; Jackowski G, 2001, BBA-BIOENERGETICS, V1504, P340, DOI 10.1016/S0005-2728(00)00262-0; Kirchhoff H, 2004, BBA-BIOENERGETICS, V1659, P63, DOI 10.1016/j.bbabio.2004.08.004; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Komayama K, 2007, BBA-BIOENERGETICS, V1767, P838, DOI 10.1016/j.bbabio.2007.05.001; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; MISHRA NP, 1994, BBA-BIOENERGETICS, V1186, P81, DOI 10.1016/0005-2728(94)90138-4; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; Mustardy L, 2003, TRENDS PLANT SCI, V8, P117, DOI 10.1016/S1360-1385(03)00015-3; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; Nilsson A, 1997, J BIOL CHEM, V272, P18350, DOI 10.1074/jbc.272.29.18350; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2007, BBA-BIOENERGETICS, V1767, P854, DOI 10.1016/j.bbabio.2007.02.011; POU S, 1994, ANAL BIOCHEM, V217, P76, DOI 10.1006/abio.1994.1085; Rhee KH, 1998, NATURE, V396, P283, DOI 10.1038/24421; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Shimoni E, 2005, PLANT CELL, V17, P2580, DOI 10.1105/tpc.105.035030; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Staehelin LA, 2003, PHOTOSYNTH RES, V76, P185, DOI 10.1023/A:1024994525586; Takechi K, 2000, PLANT CELL PHYSIOL, V41, P1334, DOI 10.1093/pcp/pcd067; TELFER A, 1994, J BIOL CHEM, V269, P13244; Tjus SE, 2001, PLANT PHYSIOL, V125, P2007, DOI 10.1104/pp.125.4.2007; TRISSL HW, 1993, TRENDS BIOCHEM SCI, V18, P415, DOI 10.1016/0968-0004(93)90136-B; Vass I, 2008, PRIMARY PROCESSES PH, P393; Witt HT, 2005, ADV PHOTO RESPIRAT, V22, P425; Yamamoto Y, 2004, METH MOL B, V274, P217; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; YAMAMOTO Y, 1981, PLANT PHYSIOL, V67, P1069, DOI 10.1104/pp.67.6.1069; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yamashita A, 2008, J BIOL CHEM, V283, P28380, DOI 10.1074/jbc.M710465200; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200	55	72	74	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25343	25352		10.1074/jbc.M109.007740	http://dx.doi.org/10.1074/jbc.M109.007740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617353	Green Published, hybrid			2022-12-27	WOS:000269734000067
J	Ragheb, D; Bompiani, K; Dalal, S; Klemba, M				Ragheb, Daniel; Bompiani, Kristin; Dalal, Seema; Klemba, Michael			Evidence for Catalytic Roles for Plasmodium falciparum Aminopeptidase P in the Food Vacuole and Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; LEUCYL AMINOPEPTIDASE; PROTEOLYTIC ACTIVITY; HEMOGLOBIN; SPECIFICITY; INHIBITION; EXPRESSION; PROTEASES; MALARIA	The metalloenzyme aminopeptidase P catalyzes the hydrolysis of amino acids from the amino termini of peptides with a prolyl residue in the second position. The human malaria parasite Plasmodium falciparum expresses a homolog of aminopeptidase P during its asexual intraerythrocytic cycle. P. falciparum aminopeptidase P (PfAPP) shares with mammalian cytosolic aminopeptidase P a three-domain, homodimeric organization and is most active with Mn(II) as the cofactor. A distinguishing feature of PfAPP is a 120-amino acid amino-terminal extension that appears to be removed from the mature protein. PfAPP is present in the food vacuole and cytosol of the parasite, a distribution that suggests roles in vacuolar hemoglobin catabolism and cytosolic peptide turnover. To evaluate the plausibility of these putative functions, the stability and kinetic properties of recombinant PfAPP were evaluated at the acidic pH of the food vacuole and at the near-neutral pH of the cytosol. PfAPP exhibited high stability at 37 degrees C in the pH range 5.0-7.5. In contrast, recombinant human cytosolic APP1 was unstable and formed a high molecular weight aggregate at acidic pH. At both acidic and slightly basic pH values, PfAPP efficiently hydrolyzed the amino-terminal X-Pro bond of the nonapeptide bradykinin and of two globin pentapeptides that are potential in vivo substrates. These results provide support for roles for PfAPP in peptide catabolism in both the food vacuole and the cytosol and suggest that PfAPP has evolved a dual distribution in response to the metabolic needs of the intraerythrocytic parasite.	[Ragheb, Daniel; Bompiani, Kristin; Dalal, Seema; Klemba, Michael] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Klemba, M (corresponding author), Virginia Tech, 306 Engel Hall, Blacksburg, VA 24061 USA.	klemba@vt.edu			National Institutes of Health [AI077638]; Thomas F. and Kate Miller Jeffress Memorial Trust; Institute for Biomedical and Public Health Studies at Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas F. and Kate Miller Jeffress Memorial Trust; Institute for Biomedical and Public Health Studies at Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077638. This work was also supported by a grant from the Thomas F. and Kate Miller Jeffress Memorial Trust and by the Institute for Biomedical and Public Health Studies at Virginia Tech.	Allary M, 2002, PARASITOLOGY, V125, P1, DOI 10.1017/S0031182002001828; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821; Beyer BB, 2005, BIOCHEMISTRY-US, V44, P1768, DOI 10.1021/bi047886u; Chavant P, 2005, INT J PARASITOL, V35, P1425, DOI 10.1016/j.ijpara.2005.05.009; CORNISHBOWDEN A, 2004, FUNDAMENTALS ENZYME, P140; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; D'souza VM, 2000, BIOCHEMISTRY-US, V39, P3817, DOI 10.1021/bi9925827; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; ERAHIN C, 1999, J CARDIOVASC PHARM, V34, P604; Ersahin C, 2005, ARCH BIOCHEM BIOPHYS, V435, P303, DOI 10.1016/j.abb.2004.12.023; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Graham SC, 2006, BIOCHEMISTRY-US, V45, P964, DOI 10.1021/bi0518904; Graham SC, 2005, BIOCHEMISTRY-US, V44, P13820, DOI 10.1021/bi0512849; Graham SC, 2008, ARCH BIOCHEM BIOPHYS, V469, P200, DOI 10.1016/j.abb.2007.10.009; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; HARBECK HT, 1991, EUR J BIOCHEM, V198, P451, DOI 10.1111/j.1432-1033.1991.tb16035.x; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Hatabu T, 2006, EXP PARASITOL, V112, P179, DOI 10.1016/j.exppara.2005.11.012; Hauser F, 2001, J BIOL CHEM, V276, P31732, DOI 10.1074/jbc.M103179200; Hayward R, 2006, J CELL SCI, V119, P1016, DOI 10.1242/jcs.02795; HELLERSTEIN S, 1970, J LAB CLIN MED, V76, P10; HOOPER NM, 1992, HYPERTENSION, V19, P281, DOI 10.1161/01.HYP.19.3.281; HOOPER NM, 1988, FEBS LETT, V229, P340, DOI 10.1016/0014-5793(88)81152-9; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; KITAMURA S, 1995, BRIT J PHARMACOL, V114, P6, DOI 10.1111/j.1476-5381.1995.tb14897.x; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Kulkarni G, 2002, J BIOCHEM, V131, P445, DOI 10.1093/oxfordjournals.jbchem.a003120; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Laurent V, 2001, EUR J BIOCHEM, V268, P5430, DOI 10.1046/j.0014-2956.2001.02483.x; Li X, 2008, J BIOL CHEM, V283, P22858, DOI 10.1074/jbc.M710274200; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Lloyd GS, 1996, BIOCHEM PHARMACOL, V52, P229, DOI 10.1016/0006-2952(96)00180-3; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; MARUYAMA S, 1994, BIOSCI BIOTECH BIOCH, V58, P2107, DOI 10.1271/bbb.58.2107; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; MILLER CG, 1983, J BACTERIOL, V153, P350, DOI 10.1128/JB.153.1.350-356.1983; ORAWSKI AT, 1995, BIOCHEMISTRY-US, V34, P11227, DOI 10.1021/bi00035a032; ORAWSKI AT, 1987, MOL CELL BIOCHEM, V75, P123; Prechel MM, 1995, J PHARMACOL EXP THER, V275, P1136; RUSU I, 1992, EUR J BIOCHEM, V210, P93, DOI 10.1111/j.1432-1033.1992.tb17395.x; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Siripurkpong P, 2002, J BIOL CHEM, V277, P41009, DOI 10.1074/jbc.M204852200; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Stockel-Maschek A, 2003, ANAL BIOCHEM, V322, P60, DOI 10.1016/S0003-2697(03)00464-0; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Subramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005156; Teuscher F, 2007, J BIOL CHEM, V282, P30817, DOI 10.1074/jbc.M704938200; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; VANHOOF G, 1992, BIOCHEM PHARMACOL, V44, P479, DOI 10.1016/0006-2952(92)90439-P; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Wolfrum S, 2001, BRIT J PHARMACOL, V134, P370, DOI 10.1038/sj.bjp.0704236; YOSHIMOTO T, 1994, ARCH BIOCHEM BIOPHYS, V311, P28, DOI 10.1006/abbi.1994.1204	66	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24806	24815		10.1074/jbc.M109.018424	http://dx.doi.org/10.1074/jbc.M109.018424			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19574214	Green Published, hybrid			2022-12-27	WOS:000269734000015
J	Schilling, SH; Hjelmeland, AB; Radiloff, DR; Liu, IM; Wakeman, TP; Fielhauer, JR; Foster, EH; Lathia, JD; Rich, JN; Wang, XF; Datto, MB				Schilling, Stephen H.; Hjelmeland, Anita B.; Radiloff, Daniel R.; Liu, Irwin M.; Wakeman, Timothy P.; Fielhauer, Jeffrey R.; Foster, Erika H.; Lathia, Justin D.; Rich, Jeremy N.; Wang, Xiao-Fan; Datto, Michael B.			NDRG4 Is Required for Cell Cycle Progression and Survival in Glioblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWNSTREAM-REGULATED GENE-2; METASTASIS SUPPRESSOR GENE; HUMAN COLON-CARCINOMA; GROWTH-FACTOR-BETA; N-MYC; DOWN-REGULATION; NEURITE OUTGROWTH; TUMOR-METASTASIS; PROSTATE-CANCER; BREAST-CANCER	NDRG4 is a largely unstudied member of the predominantly tumor suppressive N-Myc downstream-regulated gene (NDRG) family. Unlike its family members NDRG1-3, which are ubiquitously expressed, NDRG4 is expressed almost exclusively in the heart and brain. Given this tissue-specific expression pattern and the established tumor suppressive roles of the NDRG family in regulating cellular proliferation, we investigated the cellular and biochemical functions of NDRG4 in the context of astrocytes and glioblastoma multiforme (GBM) cells. We show that, in contrast to NDRG2, NDRG4 expression is elevated in GBM and NDRG4 is required for the viability of primary astrocytes, established GBM cell lines, and both CD133(+) (cancer stem cell (CSC)-enriched) and CD133(-) primary GBM xenograft cells. While NDRG4 overexpression has no effect on cell viability, NDRG4 knockdown causes G(1) cell cycle arrest followed by apoptosis. The initial G(1) arrest is associated with a decrease in cyclin D1 expression and an increase in p27(Kip1) expression, and the subsequent apoptosis is associated with a decrease in the expression of XIAP and survivin. As a result of these effects on cell cycle progression and survival, NDRG4 knockdown decreases the tumorigenic capacity of established GBM cell lines and GBM CSC-enriched cells that have been implanted intracranially into immunocompromised mice. Collectively, these data indicate that NDRG4 is required for cell cycle progression and survival, thereby diverging in function from its tumor suppressive family member NDRG2 in astrocytes and GBM cells.	[Rich, Jeremy N.; Wang, Xiao-Fan] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Hjelmeland, Anita B.; Lathia, Justin D.; Rich, Jeremy N.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Fielhauer, Jeffrey R.; Foster, Erika H.; Datto, Michael B.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Rich, Jeremy N.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Rich, Jeremy N.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Schilling, Stephen H.; Radiloff, Daniel R.; Wang, Xiao-Fan] Duke Univ, Med Ctr, Integrated Toxicol & Environm Hlth Program, Durham, NC 27710 USA; [Lathia, Justin D.; Rich, Jeremy N.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Wang, XF (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	wang0011@mc.duke.edu; michael.datto@duke.edu	Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022; Rich, Jeremy N./A-9501-2012		National Institutes of Health [1R01GM083000]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM083000.	Angst E, 2006, BRIT J CANCER, V95, P307, DOI 10.1038/sj.bjc.6603256; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Choi SC, 2007, EXP MOL MED, V39, P705, DOI 10.1038/emm.2007.77; Dang C, 2006, ONCOL REP, V16, P513; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Dubravka D, 2000, CELL RES, V10, P1, DOI 10.1038/sj.cr.7290031; Felsberg J, 2006, NEUROPATH APPL NEURO, V32, P517, DOI 10.1111/j.1365-2990.2006.00759.x; Fotovati A, 2006, CLIN CANCER RES, V12, P3010, DOI 10.1158/1078-0432.CCR-05-1962; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Hongo S, 2006, J CELL BIOCHEM, V98, P185, DOI 10.1002/jcb.20763; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kim KT, 2004, J BIOL CHEM, V279, P38597, DOI 10.1074/jbc.M400781200; Kim YJ, 2009, INT J CANCER, V124, P7, DOI 10.1002/ijc.23945; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; Kogiku M, 2008, J CLIN NEUROSCI, V15, P1198, DOI 10.1016/j.jocn.2007.11.012; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kurdistani SK, 1998, CANCER RES, V58, P4439; Kyuno J, 2003, BIOCHEM BIOPH RES CO, V309, P52, DOI 10.1016/S0006-291X(03)01522-5; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Ma JJ, 2008, BIOL PHARM BULL, V31, P1316, DOI 10.1248/bpb.31.1316; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Nakada N, 2002, DEV BRAIN RES, V135, P45, DOI 10.1016/S0165-3806(02)00303-6; Naumann U, 2007, GENE THER, V14, P147, DOI 10.1038/sj.gt.3302845; Nishimoto S, 2003, EUR J BIOCHEM, V270, P2521, DOI 10.1046/j.1432-1033.2003.03626.x; Ohki T, 2002, DEV BRAIN RES, V135, P55; Okuda T, 1999, BIOCHEM BIOPH RES CO, V266, P208, DOI 10.1006/bbrc.1999.1780; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Shah MA, 2005, CLIN CANCER RES, V11, P3296, DOI 10.1158/1078-0432.CCR-04-2417; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Takahashi K, 2005, NEUROSCI LETT, V388, P157, DOI 10.1016/j.neulet.2005.06.055; Tepel M, 2008, INT J CANCER, V123, P2080, DOI 10.1002/ijc.23705; Uematsu M, 2005, J NEURO-ONCOL, V72, P231, DOI 10.1007/s11060-004-2353-3; Waddell DS, 2004, J BIOL CHEM, V279, P29236, DOI 10.1074/jbc.M400880200; Wakeman TP, 2004, MUTAT RES-FUND MOL M, V554, P241, DOI 10.1016/j.mrfmmm.2004.05.006; Wang JF, 2009, J ENDOCRINOL, V201, P15, DOI 10.1677/JOE-08-0296; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961; Yamauchi Y, 1999, MOL BRAIN RES, V68, P149, DOI 10.1016/S0169-328X(99)00084-4; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Zhao HD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-303; Zhao W, 2001, BBA-GENE STRUCT EXPR, V1519, P134, DOI 10.1016/S0167-4781(01)00210-X; Zhen HN, 2007, INT J ONCOL, V31, P1111; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120	58	47	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25160	25169		10.1074/jbc.M109.012484	http://dx.doi.org/10.1074/jbc.M109.012484			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592488	Green Published, hybrid			2022-12-27	WOS:000269734000050
J	Claudinon, J; Gonnord, P; Beslard, E; Marchetti, M; Mitchell, K; Boularan, C; Johannes, L; Eid, P; Lamaze, C				Claudinon, Julie; Gonnord, Pauline; Beslard, Emilie; Marchetti, Marta; Mitchell, Keith; Boularan, Cedric; Johannes, Ludger; Eid, Pierre; Lamaze, Christophe			Palmitoylation of Interferon-alpha (IFN-alpha) Receptor Subunit IFNAR1 Is Required for the Activation of Stat1 and Stat2 by IFN-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; UBIQUITINATION; ENDOCYTOSIS; CELLS; CHAIN; LOCALIZATION; DEGRADATION; TRAFFICKING	Type I interferons (IFNs) bind IFNAR receptors and activate Jak kinases and Stat transcription factors to stimulate the transcription of genes downstream from IFN-stimulated response elements. In this study, we analyze the role of protein palmitoylation, a reversible post-translational lipid modification, in the functional properties of IFNAR. We report that pharmacological inhibition of protein palmitoylation results in severe defects of IFN receptor endocytosis and signaling. We generated mutants of the IFNAR1 subunit of the type I IFN receptor, in which each or both of the two cysteines present in the cytoplasmic domain are replaced by alanines. We show that cysteine 463 of IFNAR1, the more proximal of the two cytoplasmic cysteines, is palmitoylated. A thorough microscopic and biochemical analysis of the palmitoylation-deficient IFNAR1 mutant revealed that IFNAR1 palmitoylation is not required for receptor endocytosis, intracellular distribution, or stability at the cell surface. However, the lack of IFNAR1 palmitoylation affects selectively the activation of Stat2, which results in a lack of efficient Stat1 activation and nuclear translocation and IFN-alpha-activated gene transcription. Thus, receptor palmitoylation is a previously undescribed mechanism of regulating signaling activity by type I IFNs in the Jak/Stat pathway.	[Claudinon, Julie; Gonnord, Pauline; Beslard, Emilie; Marchetti, Marta; Mitchell, Keith; Johannes, Ludger; Lamaze, Christophe] Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, F-75248 Paris 05, France; [Claudinon, Julie; Gonnord, Pauline; Beslard, Emilie; Marchetti, Marta; Mitchell, Keith; Johannes, Ludger; Lamaze, Christophe] Univ Paris 11, CNRS, UMR144, F-94807 Villejuif, France; [Eid, Pierre] Univ Paris 11, INSERM, UMR542, F-94807 Villejuif, France; [Boularan, Cedric] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Eid, P (corresponding author), Hop Paul Brousse, 14 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	pierre.eid@inserm.fr; christophe.lamaze@curie.fr	Lamaze, Christophe/M-4912-2017; Johannes, Ludger/M-9778-2017; Johannes, Ludger/W-8593-2019	Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; LAMAZE, Christophe/0000-0001-5430-2707	Association pour la Recherche sur le Cancer [3143]; Agence Nationale de la Recherche [BLAN0211]; Ligue Contre le Cancer; Fondation de France	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France)	This work was supported in part by Association pour la Recherche sur le Cancer Grant 3143 and Agence Nationale de la Recherche Grant BLAN0211.; Both authors contributed equally to this work.; Supported by a predoctoral fellowship from Ligue Contre le Cancer.; Supported by a postdoctoral fellowship from Fondation de France.; Supported by an Association pour Ia Recherche sur le Cancer doctoral fellowship.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; ALVAREZ E, 1990, J BIOL CHEM, V265, P16644; Baychelier F, 2007, CELL SIGNAL, V19, P2080, DOI 10.1016/j.cellsig.2007.05.011; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Boute N, 2002, TRENDS PHARMACOL SCI, V23, P351, DOI 10.1016/S0165-6147(02)02062-X; Cajean-Feroldi C, 2004, BIOCHEMISTRY-US, V43, P12498, DOI 10.1021/bi049111r; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Cherukuri A, 2004, J BIOL CHEM, V279, P31973, DOI 10.1074/jbc.M404410200; Claudinon J, 2007, BIOCHIMIE, V89, P735, DOI 10.1016/j.biochi.2007.03.014; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Ducker CE, 2006, MOL CANCER THER, V5, P1647, DOI 10.1158/1535-7163.MCT-06-0114; Flaumenhaft R, 2005, HEMATOLOGY, V10, P511, DOI 10.1080/10245330500141507; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; Krishnan K, 1998, J BIOL CHEM, V273, P19495, DOI 10.1074/jbc.273.31.19495; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Kumaran J, 2007, FASEB J, V21, P3288, DOI 10.1096/fj.07-8585com; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076; MOUILLAC B, 1992, J BIOL CHEM, V267, P21733; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; Nadeau OW, 1999, J BIOL CHEM, V274, P4045, DOI 10.1074/jbc.274.7.4045; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Nguyen VP, 2002, J BIOL CHEM, V277, P9713, DOI 10.1074/jbc.m111161200; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Reid HM, 2007, CELL SIGNAL, V19, P1056, DOI 10.1016/j.cellsig.2006.12.001; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; UDDIN S, 1995, J BIOL CHEM, V270, P24627, DOI 10.1074/jbc.270.42.24627; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; van't Hof W, 1999, J CELL BIOL, V145, P377, DOI 10.1083/jcb.145.2.377; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	55	28	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24328	24340		10.1074/jbc.M109.021915	http://dx.doi.org/10.1074/jbc.M109.021915			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561067	Green Published, hybrid			2022-12-27	WOS:000269380200046
J	Jin, L; Wei, WT; Jiang, YB; Peng, H; Cai, JH; Mao, C; Dai, H; Choy, W; Bemis, JE; Jirousek, MR; Milne, JC; Westphal, CH; Perni, RB				Jin, Lei; Wei, Wentao; Jiang, Yaobin; Peng, Hao; Cai, Jianhua; Mao, Chen; Dai, Han; Choy, Wendy; Bemis, Jean E.; Jirousek, Michael R.; Milne, Jill C.; Westphal, Christoph H.; Perni, Robert B.			Crystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; DEPENDENT DEACETYLASE; CALORIE RESTRICTION; HISTONE/PROTEIN DEACETYLASES; PROTEIN DEACETYLASES; DIETARY RESTRICTION; LYSINE ACETYLATION; NICOTINAMIDE INHIBITION; TRANSCRIPTION FACTORS; THIOACETYL-LYSINE	SIRT3 is a major mitochondrial NAD(+)-dependent protein deacetylase playing important roles in regulating mitochondrial metabolism and energy production and has been linked to the beneficial effects of exercise and caloric restriction. SIRT3 is emerging as a potential therapeutic target to treat metabolic and neurological diseases. We report the first sets of crystal structures of human SIRT3, an apo-structure with no substrate, a structure with a peptide containing acetyl lysine of its natural substrate acetyl-CoA synthetase 2, a reaction intermediate structure trapped by a thioacetyl peptide, and a structure with the dethioacetylated peptide bound. These structures provide insights into the conformational changes induced by the two substrates required for the reaction, the acetylated substrate peptide andNAD(+). In addition, the binding study by isothermal titration calorimetry suggests that the acetylated peptide is the first substrate to bind to SIRT3, before NAD(+). These structures and biophysical studies provide key insight into the structural and functional relationship of the SIRT3 deacetylation activity.	[Jin, Lei; Dai, Han; Choy, Wendy; Bemis, Jean E.; Jirousek, Michael R.; Milne, Jill C.; Westphal, Christoph H.; Perni, Robert B.] GSK Co, Sirtris, Cambridge, MA 02139 USA; [Wei, Wentao; Jiang, Yaobin; Cai, Jianhua; Mao, Chen] Viva Biotech Ltd, Shanghai 201203, Peoples R China; [Wei, Wentao; Peng, Hao; Cai, Jianhua; Mao, Chen] Shanghai Medicilon Inc, Shanghai 201203, Peoples R China	GlaxoSmithKline	Jin, L (corresponding author), GSK Co, Sirtris, 200 Technol Sq, Cambridge, MA 02139 USA.	leijin05@yahoo.com						Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brosnan JT, 2000, J NUTR, V130, p988S, DOI 10.1093/jn/130.4.988S; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chang JH, 2002, J BIOL CHEM, V277, P34489, DOI 10.1074/jbc.M205460200; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Dutnall RN, 2001, CELL, V105, P161, DOI 10.1016/S0092-8674(01)00305-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fatkins DG, 2006, BIOORG MED CHEM LETT, V16, P3651, DOI 10.1016/j.bmcl.2006.04.075; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Garske AL, 2007, ACS CHEM BIOL, V2, P529, DOI 10.1021/cb700160d; Grimaldi B, 2009, INT J BIOCHEM CELL B, V41, P81, DOI 10.1016/j.biocel.2008.08.035; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jiang JC, 2000, FASEB J, V14, P2135; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Qin WP, 2006, J ALZHEIMERS DIS, V10, P417; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Sauve AA, 2004, CURR MED CHEM, V11, P807, DOI 10.2174/0929867043455675; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2007, BIOCHEMISTRY-US, V46, P14478, DOI 10.1021/bi7013294; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhang W, 2008, LIFE SCI, V83, P35, DOI 10.1016/j.lfs.2008.04.021; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao KH, 2004, J MOL BIOL, V337, P731, DOI 10.1016/j.jmb.2004.01.060; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101	89	158	167	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24394	24405		10.1074/jbc.M109.014928	http://dx.doi.org/10.1074/jbc.M109.014928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19535340	hybrid, Green Published			2022-12-27	WOS:000269380200052
J	Lee, HJ; Rakic, B; Gilbert, M; Wakarchuk, WW; Withers, SG; Strynadka, NCJ				Lee, Ho Jun; Rakic, Bojana; Gilbert, Michel; Wakarchuk, Warren W.; Withers, Stephen G.; Strynadka, Natalie C. J.			Structural and Kinetic Characterizations of the Polysialic Acid O-Acetyltransferase OatWY from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS TYPE 5; ESCHERICHIA-COLI; SEROGROUP-C; POLYSACCHARIDE ANTIGENS; FORM VARIATION; BETA-HELIX; ACETYLATION; CAPSULE; GENE; IDENTIFICATION	The neuroinvasive pathogen Neisseria meningitidis has 13 capsular serogroups, but the majority of disease is caused by only 5 of these. Groups B, C, Y, and W-135 all display a polymeric sialic acid-containing capsule that provides a means for the bacteria to evade the immune response during infection by mimicking host sialic acid-containing cell surface structures. These capsules in serogroups C, Y, and W-135 can be further acetylated by a sialic acid-specific O-acetyltransferase, a modification that correlates with decreased immunoreactivity and increased virulence. In N. meningitidis serogroup Y, the O-acetylation reaction is catalyzed by the enzyme OatWY, which we show has clear specificity toward the serogroup Y capsule ([Glc-(alpha 1 -> 4)-Sia](n)). To understand the underlying molecular basis of this process, we have performed crystallographic analysis of OatWY with bound substrate as well as determined kinetic parameters of the wild type enzyme and active site mutants. The structure of OatWY reveals an intimate homotrimer of left-handed beta-helix motifs that frame a deep active site cleft selective for the polysialic acid-bearing substrate. Within the active site, our structural, kinetic, and mutagenesis data support the role of two conserved residues in the catalytic mechanism (His-121 and Trp-145) and further highlight a significant movement of Tyr-171 that blocks the active site of the enzyme in its native form. Collectively, our results reveal the first structural features of a bacterial sialic acid O-acetyltransferase and provide significant new insight into its catalytic mechanism and specificity for the capsular polysaccharide of serogroup Y meningococci.	[Lee, Ho Jun; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Lee, Ho Jun; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Rakic, Bojana; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Gilbert, Michel; Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; National Research Council Canada	Strynadka, NCJ (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca	Wakarchuk, Warren/Q-9514-2017; Wakarchuk, Warren/AAO-2774-2020	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Rakic, Bojana/0000-0002-3460-6081; Gilbert, Michel/0000-0002-0204-4408	Canadian Institutes of Health Research; Howard Hughes Medical Institute International Scholar program; Michael Smith Foundation for Health Research for scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute International Scholar program(Howard Hughes Medical Institute); Michael Smith Foundation for Health Research for scholarship(Michael Smith Foundation for Health Research)	This work was supported in part by the Canadian Institutes of Health Research (to N. C. J. S., S. G. W., and W. W. W.), Howard Hughes Medical Institute International Scholar program (to N. C. J. S.) for operating funds, and the Michael Smith Foundation for Health Research for scholarship (to N. C. J. S.).	ALPERS DH, 1965, J BIOL CHEM, V240, P10; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beaman TW, 1998, BIOCHEMISTRY-US, V37, P6689, DOI 10.1021/bi980106v; Beaman TW, 1997, BIOCHEMISTRY-US, V36, P489, DOI 10.1021/bi962522q; Bergfeld AK, 2007, J BIOL CHEM, V282, P22217, DOI 10.1074/jbc.M703044200; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; Bhasin N, 1998, MOL MICROBIOL, V27, P9, DOI 10.1046/j.1365-2958.1998.00646.x; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Deszo EL, 2005, P NATL ACAD SCI USA, V102, P5564, DOI 10.1073/pnas.0407428102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fattom AI, 1998, INFECT IMMUN, V66, P4588, DOI 10.1128/IAI.66.10.4588-4592.1998; FRASA H, 1993, J CLIN MICROBIOL, V31, P3174, DOI 10.1128/JCM.31.12.3174-3178.1993; Fusco PC, 2007, CLIN VACCINE IMMUNOL, V14, P577, DOI 10.1128/CVI.00009-07; Houliston RS, 2006, J BIOL CHEM, V281, P11480, DOI 10.1074/jbc.M512183200; Iengar P, 2006, STRUCTURE, V14, P529, DOI 10.1016/j.str.2005.11.021; Kehoe LE, 2003, J BIOL CHEM, V278, P29963, DOI 10.1074/jbc.M303766200; Kim AR, 2006, BIOCHEMISTRY-US, V45, P14621, DOI 10.1021/bi061536l; Kim ML, 1999, FEMS IMMUNOL MED MIC, V26, P83, DOI 10.1111/j.1574-695X.1999.tb01375.x; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Klein A, 1998, BIOCHIMIE, V80, P49, DOI 10.1016/S0300-9084(98)80056-4; Lemercinier X, 1996, CARBOHYD RES, V296, P83, DOI 10.1016/S0008-6215(96)00253-4; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lo Leggio L, 2003, BIOCHEMISTRY-US, V42, P5225, DOI 10.1021/bi0271446; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; *N ATL TREAT ORG S, 1998, DIR METH SOLV MACR S, P131; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Rangarajan ES, 2008, BIOCHEMISTRY-US, V47, P1827, DOI 10.1021/bi702032r; RYAN KJ, 2004, SHERRIS MED MICROBIO, P327; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; SZU SC, 1991, INFECT IMMUN, V59, P4555, DOI 10.1128/IAI.59.12.4555-4561.1991; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROTT O, 2009, J COMPT CHE IN PRESS; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Wang XG, 2002, STRUCTURE, V10, P581, DOI 10.1016/S0969-2126(02)00741-4; Williams AH, 2006, P NATL ACAD SCI USA, V103, P10877, DOI 10.1073/pnas.0604465103	55	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24501	24511		10.1074/jbc.M109.006049	http://dx.doi.org/10.1074/jbc.M109.006049			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19525232	Green Published, hybrid			2022-12-27	WOS:000269380200062
J	Zhang, Y; Leung, DYM; Nordeen, SK; Goleva, E				Zhang, Yong; Leung, Donald Y. M.; Nordeen, Steven K.; Goleva, Elena			Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MAP KINASE; TRANSCRIPTIONAL ACTIVATION; GENE-TRANSCRIPTION; NEGATIVE REGULATOR; INDUCED APOPTOSIS; P38 MAPK; EXPRESSION; PHOSPHORYLATION; GROWTH	Although glucocorticoids suppress proliferation of many cell types and are used in the treatment of certain cancers, trials of glucocorticoid therapy in breast cancer have been a disappointment. Another suggestion that estrogens may affect glucocorticoid action is that the course of some inflammatory diseases tends to be more severe and less responsive to corticosteroid treatment in females. To date, the molecular mechanism of cross-talk between estrogens and glucocorticoids is poorly understood. Here we show that, in both MCF-7 and T47D breast cancer cells, estrogen inhibits glucocorticoid induction of the MKP-1 (mitogen-activated protein kinase phosphatase-1) and serum/glucocorticoid-regulated kinase genes. Estrogen did not affect glucocorticoid-induced glucocorticoid receptor (GR) nuclear translocation but reduced ligand-induced GR phosphorylation at Ser-211, which is associated with the active form of GR. We show that estrogen increases expression of protein phosphatase 5 (PP5), which mediates the dephosphorylation of GR at Ser-211. Gene knockdown of PP5 abolished the estrogen-mediated suppression of GR phosphorylation and induction of MKP-1 and serum/glucocorticoid-regulated kinase. More importantly, after PP5 knockdown estrogen-promoted cell proliferation was significantly suppressed by glucocorticoids. This study demonstrates cross-talk between estrogen-induced PP5 and GR action. It also reveals that PP5 inhibition may antagonize estrogen-promoted events in response to corticosteroid therapy.	[Zhang, Yong; Leung, Donald Y. M.; Goleva, Elena] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leung, Donald Y. M.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Nordeen, Steven K.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Goleva, E (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St,K1016A, Denver, CO 80206 USA.	golevae@njhealth.org			National Institutes of Health, NIAID [1R01AI070140]; University of Colorado Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070140] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Colorado Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI070140 from NIAID. This work was also supported by the University of Colorado Cancer Center.	Altucci L, 1996, ONCOGENE, V12, P2315; [Anonymous], US CANC STAT 2004 IN; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Chen B, 2005, INT J ONCOL, V27, P327; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chen YW, 2005, CARCINOGENESIS, V26, P1296, DOI 10.1093/carcin/bgi062; Fagan JK, 2001, ANN ALLERG ASTHMA IM, V86, P177, DOI 10.1016/S1081-1206(10)62688-9; Golden T, 2004, CANCER LETT, V215, P95, DOI 10.1016/j.canlet.2004.03.027; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Herold CI, 2008, CLIN BREAST CANCER, V8, P50, DOI 10.3816/CBC.2008.n.003; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Ikeda K, 2004, MOL ENDOCRINOL, V18, P1131, DOI 10.1210/me.2003-0308; Im JY, 2008, CHEM-BIOL INTERACT, V172, P235, DOI 10.1016/j.cbi.2008.01.007; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Jenkins BD, 2001, TRENDS ENDOCRIN MET, V12, P122, DOI 10.1016/S1043-2760(00)00357-X; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Keith BD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-84; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Kinyamu HK, 2003, MOL CELL BIOL, V23, P5867, DOI 10.1128/MCB.23.16.5867-5881.2003; Krishnan AV, 2001, J STEROID BIOCHEM, V77, P29, DOI 10.1016/S0960-0760(01)00030-9; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Kushner P J, 2000, Novartis Found Symp, V230, P20, DOI 10.1002/0470870818.ch3; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lee WL, 2008, TAIWAN J OBSTET GYNE, V47, P24, DOI 10.1016/S1028-4559(08)60051-0; Levin ER, 2001, J APPL PHYSIOL, V91, P1860, DOI 10.1152/jappl.2001.91.4.1860; Li LB, 2004, J ALLERGY CLIN IMMUN, V114, P1059, DOI 10.1016/j.jaci.2004.08.005; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Ludwig Breast Cancer Study Group, 1985, Cancer Res, V45, P4454; McGuire W L, 1980, Recent Prog Horm Res, V36, P135; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; Mouhieddine OB, 1996, ENDOCRINOLOGY, V137, P287, DOI 10.1210/en.137.1.287; Nabholtz Jean-Marc A, 2008, Ther Clin Risk Manag, V4, P189; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; NORDEEN SK, 1994, ENDOCRINOLOGY, V134, P1723, DOI 10.1210/en.134.4.1723; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Rohleder N, 2001, PSYCHOSOM MED, V63, P966, DOI 10.1097/00006842-200111000-00016; Sengupta S, 2008, ADV EXP MED BIOL, V630, P206; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; Tantisira KG, 2008, AM J RESP CRIT CARE, V178, P325, DOI 10.1164/rccm.200708-1174OC; Urban G, 2003, J BIOL CHEM, V278, P9747, DOI 10.1074/jbc.M210993200; Urban G, 2001, J BIOL CHEM, V276, P27638, DOI 10.1074/jbc.M103512200; Wang X, 2004, MOL PSYCHIATR, V9, P65, DOI 10.1038/sj.mp.4001339; Wang XH, 2005, NEUROPSYCHOPHARMACOL, V30, P242, DOI 10.1038/sj.npp.1300606; Wang Z, 2003, J BIOL CHEM, V278, P50897, DOI 10.1074/jbc.M310297200; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Weinshilboum R, 2008, ADV EXP MED BIOL, V630, P220; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Zhang Y, 2004, J BIOL CHEM, V279, P42545, DOI 10.1074/jbc.M314213200; Zuo Z, 1999, BIOCHEMISTRY-US, V38, P8849, DOI 10.1021/bi990842e	67	65	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24542	24552		10.1074/jbc.M109.021469	http://dx.doi.org/10.1074/jbc.M109.021469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586900	hybrid, Green Published			2022-12-27	WOS:000269380200065
J	Maji, SK; Loo, RRO; Inayathullah, M; Spring, SM; Vollers, SS; Condron, MM; Bitan, G; Loo, JA; Teplow, DB				Maji, Samir K.; Loo, Rachel R. Ogorzalek; Inayathullah, Mohammed; Spring, Sean M.; Vollers, Sabrina S.; Condron, Margaret M.; Bitan, Gal; Loo, Joseph A.; Teplow, David B.			Amino Acid Position-specific Contributions to Amyloid beta-Protein Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PHOTOINDUCED CROSS-LINKING; A-BETA; ALZHEIMERS-DISEASE; SECONDARY STRUCTURE; COGNITIVE FUNCTION; IN-VIVO; SYNAPTIC PLASTICITY; UNMODIFIED PROTEINS; SECRETED OLIGOMERS	Understanding the structural and assembly dynamics of the amyloid beta-protein (A beta) has direct relevance to the development of therapeutic agents for Alzheimer disease. To elucidate these dynamics, we combined scanning amino acid substitution with a method for quantitative determination of the A beta oligomer frequency distribution, photo-induced cross-linking of unmodified proteins (PICUP), to perform "scanning PICUP." Tyr, a reactive group in PICUP, was substituted at position 1, 10, 20, 30, or 40 ( for A beta 40) or 42 ( for A beta 42). The effects of these substitutions were probed using circular dichroism spectroscopy, thioflavin T binding, electron microscopy, PICUP, and mass spectrometry. All peptides displayed a random coil -> alpha/beta -> beta transition, but substitution-dependent alterations in assembly kinetics and conformer complexity were observed. Tyr(1)-substituted homologues of A beta 40 and A beta 42 assembled the slowest and yielded unusual patterns of oligomer bands in gel electrophoresis experiments, suggesting oligomer compaction had occurred. Consistent with this suggestion was the observation of relatively narrow [Tyr(1)] A beta 40 fibrils. Substitution of A beta 40 at the C terminus decreased the population conformational complexity and substantially extended the highest order of oligomers observed. This latter effect was observed in both A beta 40 and A beta 42 as the Tyr substitution position number increased. The ability of a single substitution (Tyr(1)) to alter A beta assembly kinetics and the oligomer frequency distribution suggests that the N terminus is not a benign peptide segment, but rather that A beta conformational dynamics and assembly are affected significantly by the competition between the N and C termini to form a stable complex with the central hydrophobic cluster.	[Maji, Samir K.; Inayathullah, Mohammed; Spring, Sean M.; Vollers, Sabrina S.; Condron, Margaret M.; Bitan, Gal; Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Loo, Rachel R. Ogorzalek; Loo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Loo, Rachel R. Ogorzalek; Bitan, Gal; Loo, Joseph A.; Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Bitan, Gal; Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Teplow, DB (corresponding author), 635 Charles E Young Dr S,Rm 445, Los Angeles, CA 90095 USA.	dteplow@ucla.edu	Maji, Samir K. K./B-9640-2019; Inayathullah, Mohammed/C-6953-2015; Bitan, Gal/U-2204-2019	Maji, Samir K. K./0000-0002-9110-1565; Inayathullah, Mohammed/0000-0001-7646-1709; Bitan, Gal/0000-0001-7046-3754; Vollers, Sabrina/0000-0002-6772-0155	National Institutes of Health [AG018921, AG027818, RR020004]; Zenith Award from the Alzheimer's Association; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027818, R01AG018921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zenith Award from the Alzheimer's Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG018921, AG027818, and RR020004. This work was also supported by a Zenith Award from the Alzheimer's Association.	Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bitan G, 2006, METHOD ENZYMOL, V413, P217, DOI 10.1016/S0076-6879(06)13012-8; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Castellanos-Serra L, 1999, ELECTROPHORESIS, V20, P732, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<732::AID-ELPS732>3.3.CO;2-H; Chellgren BW, 2006, J MOL BIOL, V361, P362, DOI 10.1016/j.jmb.2006.06.044; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Ezra D, 2004, MICROBIOL-SGM, V150, P785, DOI 10.1099/mic.0.26645-0; Fancy DA, 2000, CHEM BIOL, V7, P697, DOI 10.1016/S1074-5521(00)00020-X; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105; Fradinger Erica A., 2005, P83; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Haass C, 2001, NAT NEUROSCI, V4, P859, DOI 10.1038/nn0901-859; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Head E, 2008, J NEUROSCI, V28, P3555, DOI 10.1523/JNEUROSCI.0208-08.2008; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hetenyi C, 2002, BIOCHEM BIOPH RES CO, V292, P931, DOI 10.1006/bbrc.2002.6745; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jao SC, 1997, AMYLOID, V4, P240, DOI 10.3109/13506129709003835; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 2004, ANAL BIOCHEM, V335, P81, DOI 10.1016/j.ab.2004.08.014; Maji SK, 2005, BIOCHEMISTRY-US, V44, P13365, DOI 10.1021/bi0508284; Mason JM, 2003, CURR OPIN STRUC BIOL, V13, P526, DOI 10.1016/S0959-440X(03)00100-3; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Murakami K, 2005, J AM CHEM SOC, V127, P15168, DOI 10.1021/ja054041c; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Qahwash I, 2003, J BIOL CHEM, V278, P23187, DOI 10.1074/jbc.M213298200; Rowan MJ, 2003, PHILOS T R SOC B, V358, P821, DOI 10.1098/rstb.2002.1240; Small D H, 1998, Amyloid, V5, P301, DOI 10.3109/13506129809007304; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Szegedi V, 2005, NEUROBIOL DIS, V18, P499, DOI 10.1016/j.nbd.2004.12.008; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	78	68	68	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23580	23591		10.1074/jbc.M109.038133	http://dx.doi.org/10.1074/jbc.M109.038133			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19567875	hybrid, Green Published			2022-12-27	WOS:000269180000044
J	Lonhienne, TG; Forwood, JK; Marfori, M; Robin, G; Kobe, B; Carroll, BJ				Lonhienne, Thierry G.; Forwood, Jade K.; Marfori, Mary; Robin, Gautier; Kobe, Bostjan; Carroll, Bernard J.			Importin-beta Is a GDP-to-GTP Exchange Factor of Ran IMPLICATIONS FOR THE MECHANISM OF NUCLEAR IMPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; BINDING-PROTEIN; PORE COMPLEX; RCC1; ALPHA; P97; NTF2; NUCLEOPORINS; ASSOCIATION	Ran-GTP interacts strongly with importin-beta, and this interaction promotes the release of the importin-alpha-nuclear localization signal cargo from importin-beta. Ran-GDP also interacts with importin-beta, but this interaction is 4 orders of magnitude weaker than the Ran-GTP.importin-beta interaction. Here we use the yeast complement of nuclear import proteins to show that the interaction between Ran-GDP and importin-beta promotes the dissociation of GDP from Ran. The release of GDP from the Ran-GDP-importin-beta complex stabilizes the complex, which cannot be dissociated by importin-alpha. Although Ran has a higher affinity for GDP compared with GTP, Ran in complex with importin-beta has a higher affinity for GTP. This feature is responsible for the generation of Ran-GTP from Ran-GDP by importin-beta. Ran- binding protein-1 (RanBP1) activates this reaction by forming a trimeric complex with Ran-GDP and importin-beta. Importin-alpha inhibits theGDPexchange reaction by sequestering importin-beta, whereas RanBP1 restores the GDP nucleotide exchange by importin-beta by forming a tetrameric complex with importin-beta, Ran, and importin-alpha. The exchange is also inhibited by nuclear-transport factor-2 (NTF2). We suggest a mechanism for nuclear import, additional to the established RCC1 (Ran-guanine exchange factor)-dependent pathway that incorporates these results.	[Lonhienne, Thierry G.; Marfori, Mary; Kobe, Bostjan; Carroll, Bernard J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Lonhienne, Thierry G.; Carroll, Bernard J.] Univ Queensland, Australian Res Council Ctr Excellence Integrat Le, St Lucia, Qld 4072, Australia; [Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2650, Australia; [Marfori, Mary; Robin, Gautier; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Marfori, Mary; Robin, Gautier; Kobe, Bostjan] Univ Queensland, Special Res Ctr Funct & Appl Genom, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland; Charles Sturt University; University of Queensland; University of Queensland	Lonhienne, TG (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.	t.lonhienne@uq.edu.au	Kobe, Bostjan/D-1292-2009; Lonhienne, Thierry/A-5828-2011; Carroll, Bernard/C-7690-2009; Forwood, Jade K/K-4123-2014	Kobe, Bostjan/0000-0001-9413-9166; Forwood, Jade K/0000-0003-3267-9997; Carroll, Bernard/0000-0002-1976-8269; Christie, Mary/0000-0002-0955-665X	Australian Research Council (ARC); ARC Centre of Excellence for Integrative Legume Research	Australian Research Council (ARC)(Australian Research Council); ARC Centre of Excellence for Integrative Legume Research(Australian Research Council)	This research was funded by an Australian Research Council (ARC) Discovery Grant (to B.K., B.J.C., and T.G.L.) and by the ARC Centre of Excellence for Integrative Legume Research (to B.J.C.).	Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; CORBETT AH, 1995, J CELL BIOL, V130, P1017, DOI 10.1083/jcb.130.5.1017; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Dickmanns A, 1996, J CELL SCI, V109, P1449; Forwood JK, 2008, J MOL BIOL, V383, P772, DOI 10.1016/j.jmb.2008.07.090; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Joseph J, 2006, J CELL SCI, V119, P3481, DOI 10.1242/jcs.03071; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kunzler M, 2000, MOL CELL BIOL, V20, P4295, DOI 10.1128/MCB.20.12.4295-4308.2000; Kunzler M, 2001, GENETICS, V157, P1089; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Lounsbury KM, 1996, J BIOL CHEM, V271, P2357, DOI 10.1074/jbc.271.5.2357; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Meier I, 2009, CURR OPIN PLANT BIOL, V12, P87, DOI 10.1016/j.pbi.2008.09.001; MELCHIOR F, 1995, CURR OPIN CELL BIOL, V7, P310, DOI 10.1016/0955-0674(95)80084-0; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; MOORE MS, 1994, P NATL ACAD SCI USA, V91, P10212, DOI 10.1073/pnas.91.21.10212; Nehrbass U, 1996, SCIENCE, V272, P120, DOI 10.1126/science.272.5258.120; Ohba T, 1996, J BIOL CHEM, V271, P14665, DOI 10.1074/jbc.271.25.14665; Paschal BM, 1996, P NATL ACAD SCI USA, V93, P7679, DOI 10.1073/pnas.93.15.7679; Plafker K, 2000, MOL CELL BIOL, V20, P3510, DOI 10.1128/MCB.20.10.3510-3521.2000; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; SCHLENSTEDT G, 1995, EMBO J, V14, P5367, DOI 10.1002/j.1460-2075.1995.tb00221.x; Schwoebel ED, 1998, J BIOL CHEM, V273, P35170, DOI 10.1074/jbc.273.52.35170; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; TACHIBANA T, 1994, J BIOL CHEM, V269, P24542; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Yamada M, 1998, CURR BIOL, V8, P1339, DOI 10.1016/S0960-9822(07)00566-0; Yaseen NR, 1999, J BIOL CHEM, V274, P26493, DOI 10.1074/jbc.274.37.26493; Yaseen NR, 1999, P NATL ACAD SCI USA, V96, P5516, DOI 10.1073/pnas.96.10.5516	49	23	24	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22549	22558		10.1074/jbc.M109.019935	http://dx.doi.org/10.1074/jbc.M109.019935			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19549784	Green Published, hybrid			2022-12-27	WOS:000268963100008
J	Robertson, IM; Li, MX; Sykes, BD				Robertson, Ian M.; Li, Monica X.; Sykes, Brian D.			Solution Structure of Human Cardiac Troponin C in Complex with the Green Tea Polyphenol, (-)-Epigallocatechin 3-Gallate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; N-TERMINAL DOMAIN; SKELETAL-MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; REGULATORY DOMAIN; CA2+ SENSITIVITY; HEART-DISEASE; NMR; CONTRACTION; RESOLUTION	Heart muscle contraction is regulated by Ca2+ binding to the thin filament protein troponin C. In cardiovascular disease, the myofilament response to Ca2+ is often altered. Compounds that rectify this perturbation are of considerable interest as therapeutics. Plant flavonoids have been found to provide protection against a variety of human illnesses such as cancer, infection, and heart disease. (-)-Epigallocatechin gallate (EGCg), the prevalent flavonoid in green tea, modulates force generation in isolated guinea pig hearts (Hotta, Y., Huang, L., Muto, T., Yajima, M., Miyazeki, K., Ishikawa, N., Fukuzawa, Y., Wakida, Y., Tushima, H., Ando, H., and Nonogaki, T. (2006) Eur. J. Pharmacol. 552, 123 -130) and in skinned cardiac muscle fibers (Liou, Y. M., Kuo, S. C., and Hsieh, S. R. (2008) Pflugers Arch. 456, 787 -800; and Tadano, N., Yumoto, F., Tanokura, M., Ohtsuki, I., and Morimoto, S. (2005) Biophys. J. 88, 314a). In this study we describe the solution structure of the Ca2+-saturated C-terminal domain of troponin C in complex with EGCg. Moreover, we show that EGCg forms a ternary complex with the C-terminal domain of troponin C and the anchoring region of troponin I. The structural evidence indicates that the binding site of EGCg on the C-terminal domain of troponin C is in the hydrophobic pocket in the absence of troponin I, akin to EMD 57033. Based on chemical shift mapping, the binding of EGCg to the C-terminal domain of troponin C in the presence of troponin I may be to a new site formed by the troponin C.troponin I complex. This interaction of EGCg with the C-terminal domain of troponin C.troponin I complex has not been shown with other cardiotonic molecules and illustrates the potential mechanism by which EGCg modulates heart contraction.	[Robertson, Ian M.; Li, Monica X.; Sykes, Brian D.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Sykes, BD (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	brian.sykes@ualberta.ca	Robertson, Ian/D-8266-2013	Robertson, Ian/0000-0001-9561-1418	Canadian Institutes for Health Research [MOP 37760]; Heart and Stroke Foundation of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by a Queen Elizabeth II doctoral scholarship, Canadian Institutes for Health Research Grant MOP 37760, and the Heart and Stroke Foundation of Canada.	Adhikari BB, 2004, BIOPHYS J, V86, P359, DOI 10.1016/S0006-3495(04)74112-0; Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; Chandra M, 1997, BIOCHEMISTRY-US, V36, P13305, DOI 10.1021/bi9710129; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Endoh M, 2001, CARDIOVASC DRUG THER, V15, P397, DOI 10.1023/A:1013385305567; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Gasmi-Seabrook GMC, 1999, BIOCHEMISTRY-US, V38, P8313, DOI 10.1021/bi9902642; Gomes AV, 2002, IUBMB LIFE, V54, P323, DOI 10.1080/15216540216037; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; Hoffman RMB, 2005, BIOCHEMISTRY-US, V44, P15750, DOI 10.1021/bi051583y; Hotta Y, 2006, EUR J PHARMACOL, V552, P123, DOI 10.1016/j.ejphar.2006.09.017; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Ishizu T, 2006, MAGN RESON CHEM, V44, P776, DOI 10.1002/mrc.1848; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; Keli SO, 1996, ARCH INTERN MED, V156, P637, DOI 10.1001/archinte.156.6.637; Kitano K, 1997, BIOPHYS CHEM, V65, P157, DOI 10.1016/S0301-4622(96)02254-5; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kuhnle G, 2000, BIOCHEM BIOPH RES CO, V277, P507, DOI 10.1006/bbrc.2000.3701; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li MX, 2008, BIOCHEM BIOPH RES CO, V369, P88, DOI 10.1016/j.bbrc.2007.12.108; Li MX, 2006, BIOCHEMISTRY-US, V45, P9833, DOI 10.1021/bi060779a; Li MX, 2000, BIOCHEMISTRY-US, V39, P8782, DOI 10.1021/bi000473i; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; LI MX, 1995, BIOCHEMISTRY-US, V34, P8330, DOI 10.1021/bi00026a014; Lindhout DA, 2003, J BIOL CHEM, V278, P27024, DOI 10.1074/jbc.M302497200; Liou YM, 2008, PFLUG ARCH EUR J PHY, V456, P787, DOI 10.1007/s00424-008-0456-y; Lykkesfeldt J, 2000, ANAL BIOCHEM, V282, P89, DOI 10.1006/abio.2000.4592; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Mercier P, 2000, BIOCHEMISTRY-US, V39, P2902, DOI 10.1021/bi992579n; Pan BS, 1996, J BIOL CHEM, V271, P817, DOI 10.1074/jbc.271.2.817; Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SATYSHUR KA, 1988, J BIOL CHEM, V263, P1628; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sherrid MV, 2006, PROG CARDIOVASC DIS, V49, P123, DOI 10.1016/j.pcad.2006.08.001; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; SILVER PJ, 1986, BIOCHEM PHARMACOL, V35, P2545, DOI 10.1016/0006-2952(86)90052-3; Slupsky CM, 2003, J BIOMOL NMR, V27, P313, DOI 10.1023/A:1025870122182; SOLARO RJ, 1993, CIRC RES, V73, P981, DOI 10.1161/01.RES.73.6.981; Sorsa T, 2003, J MOL CELL CARDIOL, V35, P1055, DOI 10.1016/S0022-2828(03)00178-0; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Tadano N, 2005, BIOPHYS J, V88, p314A; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang X, 2001, J BIOL CHEM, V276, P25456, DOI 10.1074/jbc.M102418200; Wroblewski K, 2001, EUR J BIOCHEM, V268, P4384, DOI 10.1046/j.1432-1327.2001.02350.x	59	51	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23012	23023		10.1074/jbc.M109.021352	http://dx.doi.org/10.1074/jbc.M109.021352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542563	Green Published, hybrid			2022-12-27	WOS:000268963100054
J	Walsh, CP; Davies, A; Butcher, AJ; Dolphin, AC; Kitmitto, A				Walsh, Conor P.; Davies, Anthony; Butcher, Adrian J.; Dolphin, Annette C.; Kitmitto, Ashraf			Three-dimensional Structure of Ca(V)3.1 COMPARISON WITH THE CARDIAC L-TYPE VOLTAGE-GATED CALCIUM CHANNEL MONOMER ARCHITECTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN MODULATION; I-II-LOOP; CA2+ CHANNEL; ELECTRON CRYOMICROSCOPY; SKELETAL-MUSCLE; DEPENDENT INACTIVATION; AUXILIARY SUBUNITS; MOLECULAR DETERMINANTS; RECONSTRUCTION; EXPRESSION	Calcium entry through voltage-gated calcium channels has widespread cellular effects upon a host of physiological processes including neuronal excitability, muscle excitation-contraction coupling, and secretion. Using single particle analysis methods, we have determined the first three-dimensional structure, at 23 angstrom resolution, for a member of the low voltage-activated voltage-gated calcium channel family, Ca(V)3.1, a T-type channel. Ca(V)3.1 has dimensions of similar to 115 x 85 x 95 angstrom, composed of two distinct segments. The cytoplasmic densities form a vestibule below the transmembrane domain with the C terminus, unambiguously identified by the presence of a His tag being similar to 65 angstrom long and curling around the base of the structure. The cytoplasmic assembly has a large exposed surface area that may serve as a signaling hub with the C terminus acting as a "fishing rod" to bind regulatory proteins. We have also determined a three-dimensional structure, at a resolution of 25 angstrom, for the monomeric form of the cardiac L-type voltage-gated calcium (high voltage-activated) channel with accessory proteins beta and alpha(2)delta bound to the ion channel polypeptide Ca(V)1.2. Comparison with the skeletal muscle isoform finds a good match particularly with respect to the conformation, size, and shape of the domain identified as that formed by alpha(2). Furthermore, modeling of the Ca(V)3.1 structure (analogous to Ca(V)1.2 at these resolutions) into the heteromeric L-type voltage-gated calcium channel complex volume reveals multiple interaction sites for beta-Ca(V)1.2 binding and for the first time identifies the size and organization of the alpha(2)delta polypeptides.	[Walsh, Conor P.; Kitmitto, Ashraf] Univ Manchester, Fac Med & Human Sci, Sch Clin & Lab Sci, Manchester M13 9NT, Lancs, England; [Davies, Anthony; Butcher, Adrian J.; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of Manchester; University of London; University College London	Kitmitto, A (corresponding author), Cardiovasc Grp, Core Technol Facil, FI 3, Grafton St, Manchester M13 9NT, Lancs, England.	ashraf.kitmitto@manchester.ac.uk	Dolphin, Annette C/F-7416-2010; Tuluc, Petronel/C-2527-2011	Dolphin, Annette C/0000-0003-4626-4856; 	British Heart Foundation (BHF); MRC [G0700368] Funding Source: UKRI; Medical Research Council [G0700368] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a grant from the British Heart Foundation (BHF).	Adair B, 2008, BIOPHYS J, V94, P2106, DOI 10.1529/biophysj.107.118562; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; BERROW NS, 1995, J PHYSIOL-LONDON, V482, P481, DOI 10.1113/jphysiol.1995.sp020534; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Bouckaert J, 1999, CURR OPIN STRUC BIOL, V9, P572, DOI 10.1016/S0959-440X(99)00007-X; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Gennis R. B., 1989, BIOMEMBRANES MOL STR, P91; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Gradilone SA, 1998, ANAL BIOCHEM, V261, P224, DOI 10.1006/abio.1998.2747; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; JAY SD, 1991, J BIOL CHEM, V266, P3287; JONES LR, 1988, METHOD ENZYMOL, V157, P85; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marksteiner R, 2001, J PHYSIOL-LONDON, V537, P27, DOI 10.1111/j.1469-7793.2001.0027k.x; Murata K, 2001, BIOCHEM BIOPH RES CO, V282, P284, DOI 10.1006/bbrc.2001.4529; Okorokov AL, 2004, NAT STRUCT MOL BIOL, V11, P1021, DOI 10.1038/nsmb835; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Ruprecht J, 2001, PROG BIOPHYS MOL BIO, V75, P121, DOI 10.1016/S0079-6107(01)00004-9; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; Staes M, 2001, J PHYSIOL-LONDON, V530, P35, DOI 10.1111/j.1469-7793.2001.0035m.x; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Talavera K, 2003, J GEN PHYSIOL, V121, P529, DOI 10.1085/jgp.200308794; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; VASSORT G, 1994, J CARDIOVASC ELECTR, V5, P376, DOI 10.1111/j.1540-8167.1994.tb01175.x; Wang MC, 2004, J BIOL CHEM, V279, P7159, DOI 10.1074/jbc.M308057200; Wang MC, 2002, J MOL BIOL, V323, P85, DOI 10.1016/S0022-2836(02)00890-2; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Yunker AMR, 2003, J BIOENERG BIOMEMBR, V35, P533, DOI 10.1023/B:JOBB.0000008024.77488.48; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105	53	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22310	22321		10.1074/jbc.M109.017152	http://dx.doi.org/10.1074/jbc.M109.017152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520861	Green Published, hybrid			2022-12-27	WOS:000268783700054
J	Zaarour, N; Demaretz, S; Defontaine, N; Mordasini, D; Laghmani, K				Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Mordasini, David; Laghmani, Kamel			A Highly Conserved Motif at the COOH Terminus Dictates Endoplasmic Reticulum Exit and Cell Surface Expression of NKCC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; POLARIZED EPITHELIAL-CELLS; ANTENATAL BARTTER-SYNDROME; K-CL COTRANSPORTERS; CYSTIC-FIBROSIS; ER EXPORT; SELECTIVE EXPORT; CYTOPLASMIC TAIL; MOLECULAR-BASIS; QUALITY-CONTROL	Mutations in the apically located Na+ -K+ -2Cl(-) co-transporter, NKCC2, lead to type I Bartter syndrome, a life-threatening kidney disorder, yet the mechanisms underlying the regulation of mutated NKCC2 proteins in renal cells have not been investigated. Here, we identified a trihydrophobic motif in the distal COOH terminus of NKCC2 that was required for endoplasmic reticulum (ER) exit and surface expression of the cotransporter. Indeed, microscopic confocal imaging showed that a naturally occurring mutation depriving NKCC2 of its distal COOH-terminal region results in the absence of cell surface expression. Biotinylation assays revealed that lack of cell surface expression was associated with abolition of mature complex-glycosylated NKCC2. Pulse-chase analysis demonstrated that the absence of mature protein was not caused by reduced synthesis or increased rates of degradation of mutant co-transporters. Co-immunolocalization experiments revealed that these mutants co-localized with the ER marker protein-disulfide isomerase, demonstrating that they are retained in the ER. Cell treatment with proteasome or lysosome inhibitors failed to restore the loss of complex-glycosylated NKCC2, further eliminating the possibility that mutant co-transporters were processed by the Golgi apparatus. Serial truncation of the NKCC2 COOH terminus, followed by site-directed mutagenesis, identified hydrophobic residues (LLV1083)-L-1081 as an ER exit signal necessary for maturation of NKCC2. Mutation of (LLV1083)-L-1081 to AAA within the context of the full-length protein prevented NKCC2 ER exit independently of the expression system. This trihydrophobic motif is highly conserved in the COOH-terminal tails of all members of the cation-chloride co-transporter family, and thus may function as a common motif mediating their transport from the ER to the cell surface. Taken together, these data are consistent with a model whereby naturally occurring premature terminations that interfere with the LLV motif compromise co-transporter surface delivery through defective trafficking.	[Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Mordasini, David; Laghmani, Kamel] INSERM, UMRS 872, Equipe 3, ERL7226, F-75006 Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Mordasini, David; Laghmani, Kamel] Inst Biomed Cordeliers, IFR58, F-75006 Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Mordasini, David; Laghmani, Kamel] Univ Paris 05, F-75005 Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Mordasini, David; Laghmani, Kamel] Univ Paris 06, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Laghmani, K (corresponding author), Equipe 3 ERL7226, UMRS 872, 15 Rue Ecole Med, F-752270 Paris 06, France.	Kamel.Laghmani@crc.jussieu.fr	Laghmani, Kamel/AIE-9621-2022	Laghmani, Kamel/0000-0002-2167-5766	INSERM (Paris, France)	INSERM (Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from INSERM (Paris, France).	Adachi M, 2007, ENDOCR J, V54, P1003, DOI 10.1507/endocrj.K06-204; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; AMLAL H, 1994, J BIOL CHEM, V269, P21962; Bello V, 2001, MOL BIOL CELL, V12, P3004, DOI 10.1091/mbc.12.10.3004; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Caplan MJ, 1997, AM J PHYSIOL-RENAL, V272, pF425, DOI 10.1152/ajprenal.1997.272.4.F425; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Craig JC, 1996, LANCET, V347, P550, DOI 10.1016/S0140-6736(96)91183-6; CRYSTAL RG, 1989, TRENDS GENET, V5, P411, DOI 10.1016/0168-9525(89)90200-X; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Ficker E, 2000, AM J PHYSIOL-HEART C, V279, pH1748, DOI 10.1152/ajpheart.2000.279.4.H1748; Forbes A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702117200; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gamba G, 1999, KIDNEY INT, V56, P1606, DOI 10.1046/j.1523-1755.1999.00712.x; Garon L, 2000, J BIOL CHEM, V275, P32027, DOI 10.1074/jbc.M000108200; Gentzsch M, 2001, J BIOL CHEM, V276, P1291, DOI 10.1074/jbc.M003672200; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Jeck N, 2005, AM J PHYSIOL-REG I, V288, pR782, DOI 10.1152/ajpregu.00600.2004; Karim-Jimenez Z, 2000, P NATL ACAD SCI USA, V97, P2916, DOI 10.1073/pnas.97.6.2916; Kleta R, 2000, NEW ENGL J MED, V343, P661, DOI 10.1056/NEJM200008313430915; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Mount DB, 2006, AM J PHYSIOL-RENAL, V290, pF606, DOI 10.1152/ajprenal.00410.2005; Nezu A, 2009, J BIOL CHEM, V284, P6869, DOI 10.1074/jbc.M804302200; Nufer O, 2002, J CELL SCI, V115, P619; PATHAK RK, 1988, J CELL BIOL, V106, P1831, DOI 10.1083/jcb.106.6.1831; PAULAIS M, 1992, J CLIN INVEST, V89, P1142, DOI 10.1172/JCI115695; Pressler CA, 2006, J AM SOC NEPHROL, V17, P2136, DOI 10.1681/ASN.2005101071; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sato K, 2004, J BIOCHEM, V136, P755, DOI 10.1093/jb/mvh184; Simon DB, 1996, AM J PHYSIOL-RENAL, V271, pF961, DOI 10.1152/ajprenal.1996.271.5.F961; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P1419, DOI 10.1097/01.ASN.0000064948.39199.A0; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872; Vassilieva EV, 2009, BIOCHEM BIOPH RES CO, V379, P460, DOI 10.1016/j.bbrc.2008.12.118; Waheed A, 1997, P NATL ACAD SCI USA, V94, P12384, DOI 10.1073/pnas.94.23.12384; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	53	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21752	21764		10.1074/jbc.M109.000679	http://dx.doi.org/10.1074/jbc.M109.000679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535327	Green Published, hybrid			2022-12-27	WOS:000268564400067
J	Larson, ET; Parussini, F; Huynh, MH; Giebel, JD; Kelley, AM; Zhang, L; Bogyo, M; Merritt, EA; Carruthers, VB				Larson, Eric T.; Parussini, Fabiola; Huynh, My-Hang; Giebel, Jonathan D.; Kelley, Angela M.; Zhang, Li; Bogyo, Matthew; Merritt, Ethan A.; Carruthers, Vern B.			Toxoplasma gondii Cathepsin L Is the Primary Target of the Invasion-inhibitory Compound Morpholinurea-leucyl-homophenyl-vinyl Sulfone Phenyl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE INHIBITORS; STRUCTURE VALIDATION; RHOPTRY ORGANELLES; CRYSTAL-STRUCTURE; PARASITE; SECRETION; SURVIVAL; REVEALS; SYSTEM; POTENT	The protozoan parasite Toxoplasma gondii relies on posttranslational modification, including proteolysis, of proteins required for recognition and invasion of host cells. We have characterized the T. gondii cysteine protease cathepsin L (TgCPL), one of five cathepsins found in the T. gondii genome. We show that TgCPL is the primary target of the compound morpholinurea-leucyl-homophenyl-vinyl sulfone phenyl (LHVS), which was previously shown to inhibit parasite invasion by blocking the release of invasion proteins from microneme secretory organelles. As shown by fluorescently labeled LHVS and TgCPL-specific antibodies, TgCPL is associated with a discrete vesicular structure in the apical region of extracellular parasites but is found in multiple puncta throughout the cytoplasm of intracellular replicating parasites. LHVS fails to label cells lacking TgCPL due to targeted disruption of the TgCPL gene in two different parasite strains. We present a structural model for the inhibition of TgCPL by LHVS based on a 2.0 angstrom resolution crystal structure of TgCPL in complex with its propeptide. We discuss possible roles for TgCPL as a protease involved in the degradation or limited proteolysis of parasite proteins involved in invasion.	[Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Larson, Eric T.; Kelley, Angela M.; Zhang, Li; Merritt, Ethan A.] Univ Washington, Med Struct Genom Pathogen Protozoa Consortium, Seattle, WA 98195 USA; [Larson, Eric T.; Kelley, Angela M.; Zhang, Li; Merritt, Ethan A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Parussini, Fabiola] Univ Vermont, Burlington, VT 05405 USA; [Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vermont; Stanford University	Carruthers, VB (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu		Larson, Eric T./0000-0002-2862-4291; Carruthers, Vern/0000-0001-6859-8895; Bogyo, Matthew/0000-0003-3753-4412	National Institutes of Health [RR020843, GM64655, AI067921, AI063263]; Stanley Medical Research Institute [04R-796]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; NIGMS; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063263, P01AI067921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM064655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RR020843 (to M. B.), GM64655 (to E. A. M.), AI067921 (to E. A. M.), and AI063263 (to V. B. C.). This work was also supported by Stanley Medical Research Institute Grant 04R-796 (to V. B. C). The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and NIGMS.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Bromme D, 1996, BIOCHEM J, V315, P85; Brydges SD, 2008, BIOL CELL, V100, P253, DOI 10.1042/BC20070076; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Chowdhury SF, 2008, J MED CHEM, V51, P1361, DOI 10.1021/jm701190v; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Hoppe HC, 2000, NAT CELL BIOL, V2, P449, DOI 10.1038/35017090; Huang R, 2009, MOL BIOCHEM PARASIT, V164, P86, DOI 10.1016/j.molbiopara.2008.11.012; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ljunggren A, 2007, J MOL BIOL, V371, P137, DOI 10.1016/j.jmb.2007.05.005; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; McGrath ME, 1997, NAT STRUCT BIOL, V4, P105, DOI 10.1038/nsb0297-105; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; McMartin C, 1997, J COMPUT AID MOL DES, V11, P333, DOI 10.1023/A:1007907728892; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Ngo HM, 2003, J BIOL CHEM, V278, P5343, DOI 10.1074/jbc.M208291200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Que XC, 2007, J BIOL CHEM, V282, P4994, DOI 10.1074/jbc.M606764200; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Teo CF, 2007, ANTIMICROB AGENTS CH, V51, P679, DOI 10.1128/AAC.01059-06; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200	51	47	47	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26839	26850		10.1074/jbc.M109.003780	http://dx.doi.org/10.1074/jbc.M109.003780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19596863	Green Published, hybrid			2022-12-27	WOS:000269969600065
J	Frizzell, N; Rajesh, M; Jepson, MJ; Nagai, R; Carson, JA; Thorpe, SR; Baynes, JW				Frizzell, Norma; Rajesh, Mathur; Jepson, Matthew J.; Nagai, Ryoji; Carson, James A.; Thorpe, Suzanne R.; Baynes, John W.			Succination of Thiol Groups in Adipose Tissue Proteins in Diabetes SUCCINATION INHIBITS POLYMERIZATION AND SECRETION OF ADIPONECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-MODIFICATION; ADIPOCYTE DIFFERENTIATION; WEIGHT-LOSS; GLYCATION; S-(2-SUCCINYL)CYSTEINE; ACRP30/ADIPONECTIN; BIOMARKER; PRODUCTS; OBESITY; MUSCLE	S-(2-Succinyl) cysteine (2SC) is formed by reaction of the Krebs cycle intermediate fumarate with cysteine residues in protein, a process termed succination of protein. Both fumarate and succination of proteins are increased in adipocytes cultured in high glucose medium (Nagai, R., Brock, J. W., Blatnik, M., Baatz, J. E., Bethard, J., Walla, M. D., Thorpe, S. R., Baynes, J. W., and Frizzell, N. (2007) J. Biol. Chem. 282, 34219-34228). We show here that succination of protein is also increased in epididymal, mesenteric, and subcutaneous adipose tissue of diabetic (db/db) mice and that adiponectin is a major target for succination in both adipocytes and adipose tissue. Cys-39, which is involved in cross-linking of adiponectin monomers to form trimers, was identified as a key site of succination of adiponectin in adipocytes. 2SC was detected on two of seven monomeric forms of adiponectin immunoprecipitated from adipocytes and epididymal adipose tissue. Based on densitometry, 2SC-adiponectin accounted for similar to 7 and 8% of total intracellular adiponectin in cells and tissue, respectively. 2SC was found only in the intracellular, monomeric forms of adiponectin and was not detectable in polymeric forms of adiponectin in cell culture medium or plasma. We conclude that succination of adiponectin blocks its incorporation into trimeric and higher molecular weight, secreted forms of adiponectin. We propose that succination of proteins is a biomarker of mitochondrial stress and accumulation of Krebs cycle intermediates in adipose tissue in diabetes and that succination of adiponectin may contribute to the decrease in plasma adiponectin in diabetes.	[Baynes, John W.] Univ S Carolina, Arnold Sch Publ Hlth, Publ Hlth Res Ctr 301F, Dept Exercise Sci, Columbia, SC 29208 USA; [Nagai, Ryoji] Japan Womens Univ, Lab Nutr Sci & Biochem, Tokyo 1128681, Japan	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Japan Womens University	Baynes, JW (corresponding author), Univ S Carolina, Arnold Sch Publ Hlth, Publ Hlth Res Ctr 301F, Dept Exercise Sci, Columbia, SC 29208 USA.	john.baynes@sc.edu	Rajesh, Mathur/ABE-6500-2021; Carson, James/Q-5693-2019	Carson, James/0000-0003-3733-8796; Rajesh, Mathur/0000-0001-7641-7417	National Institutes of Health, NIDDK [DK-19971]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019971, R37DK019971] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant DK-19971.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; Alt N, 2004, ARCH BIOCHEM BIOPHYS, V425, P200, DOI 10.1016/j.abb.2004.03.012; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Blatnik M, 2008, DIABETES, V57, P41, DOI 10.2337/db07-0838; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; KINTER M, 2000, PROTEIN SEQUENCING I, P147, DOI DOI 10.1002/0471721980; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI RK, 1992, METABOLISM, V41, P545, DOI 10.1016/0026-0495(92)90216-W; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moien-Afshari F, 2008, DIABETOLOGIA, V51, P1327, DOI 10.1007/s00125-008-0996-x; Monnier VM, 2006, REJUV RES, V9, P264, DOI 10.1089/rej.2006.9.264; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Nagai R, 2007, J BIOL CHEM, V282, P34219, DOI 10.1074/jbc.M703551200; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Peake PW, 2007, J MOL ENDOCRINOL, V39, P45, DOI 10.1677/JME-07-0030; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Sato C, 2001, J BIOL CHEM, V276, P28849, DOI 10.1074/jbc.M104148200; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; TANAKA A, 1980, J CHROMATOGR, V194, P21, DOI 10.1016/S0021-9673(00)81046-8; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wang ZV, 2008, P NATL ACAD SCI USA, V105, P18077, DOI 10.1073/pnas.0810027105	32	71	72	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25772	25781		10.1074/jbc.M109.019257	http://dx.doi.org/10.1074/jbc.M109.019257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19592500	hybrid, Green Published			2022-12-27	WOS:000269738000035
J	Terauchi, AM; Lu, SF; Zaffagnini, M; Tappa, S; Hirasawa, M; Tripathy, JN; Knaff, DB; Farmer, PJ; Lemaire, SD; Hase, T; Merchant, SS				Terauchi, Aimee M.; Lu, Shu-Fen; Zaffagnini, Mirko; Tappa, Shane; Hirasawa, Masakazu; Tripathy, Jatindra N.; Knaff, David B.; Farmer, Patrick J.; Lemaire, Stephane D.; Hase, Toshiharu; Merchant, Sabeeha S.			Pattern of Expression and Substrate Specificity of Chloroplast Ferredoxins from Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; NITRITE REDUCTASE; GENE-EXPRESSION; GLUTAMATE SYNTHASE; GREEN-ALGA; OXIDATION-REDUCTION; NITRATE REDUCTASE; NITROGEN-FIXATION; ELECTRON-TRANSFER; MAIZE ROOTS	Ferredoxin (Fd) is the major iron-containing protein in photosynthetic organisms and is central to reductive metabolism in the chloroplast. The Chlamydomonas reinhardtii genome encodes six plant type [Fe2S2] ferredoxins, products of PETF, FDX2-FDX6. We performed the functional analysis of these ferredoxins by localizing Fd, Fdx2, Fdx3, and Fdx6 to the chloroplast by using isoform-specific antibodies and monitoring the pattern of gene expression by iron and copper nutrition, nitrogen source, and hydrogen peroxide stress. In addition, we also measured the midpoint redox potentials of Fd and Fdx2 and determined the kinetic parameters of their reactions with several ferredoxin-interacting proteins, namely nitrite reductase, Fd:NADP+ oxidoreductase, and Fd: thioredoxin reductase. We found that each of the FDX genes is differently regulated in response to changes in nutrient supply. Moreover, we show that Fdx2 (E-m = -321 mV), whose expression is regulated by nitrate, is a more efficient electron donor to nitrite reductase relative to Fd. Overall, the results suggest that each ferredoxin isoform has substrate specificity and that the presence of multiple ferredoxin isoforms allows for the allocation of reducing power to specific metabolic pathways in the chloroplast under various growth conditions.	[Terauchi, Aimee M.; Lu, Shu-Fen; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Zaffagnini, Mirko; Lemaire, Stephane D.] Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, F-91405 Orsay, France; [Tappa, Shane; Farmer, Patrick J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Hirasawa, Masakazu; Knaff, David B.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Tripathy, Jatindra N.; Knaff, David B.] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA; [Hase, Toshiharu] Osaka Univ, Inst Prot Res, Div Enzymol, Suita, Osaka 5650871, Japan	University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Irvine; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Osaka University	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	sabeeha@chem.ucla.edu	Farmer, Patrick J/J-3757-2019; Lemaire, Stéphane D/A-3530-2008; Hase, Toshiharu/H-9271-2013	Farmer, Patrick J/0000-0001-9911-999X; Lemaire, Stéphane D/0000-0001-6442-0547; Zaffagnini, Mirko/0000-0001-5115-0859	Department of Energy [DE-FD02-04ER15529, DE-FG03-99ER20346]; National Science Foundation (NSF) [CHE0517080-3]; Agence Nationale de la Recherche [ANRJC05-45741]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Department of Energy Grants DE-FD02-04ER15529 ( to S. S. M.) and DE-FG03-99ER20346 ( to D. B. K.), National Science Foundation (NSF) Grant CHE0517080-3 ( to P. J. F.), and Agence Nationale de la Recherche Grant ANRJC05-45741 ( to M. Z. and S. D. L.).	Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Avila L, 1999, J BIOL INORG CHEM, V4, P664, DOI 10.1007/s007750050390; Bertini I, 2002, PROTEINS, V46, P110, DOI 10.1002/prot.10009; BOWSHER CG, 1992, PLANT J, V2, P893, DOI 10.1111/j.1365-313X.1992.00893.x; Camargo A, 2007, PLANT CELL, V19, P3491, DOI 10.1105/tpc.106.045922; Dayer R, 2008, GENETICS, V179, P41, DOI 10.1534/genetics.107.086041; DECOTTIGNIES P, 1995, ARCH BIOCHEM BIOPHYS, V316, P249, DOI 10.1006/abbi.1995.1035; DROUX M, 1987, ARCH BIOCHEM BIOPHYS, V252, P426, DOI 10.1016/0003-9861(87)90049-X; ERIKSSON M, 1995, PLANT PHYSIOL, V107, P479, DOI 10.1104/pp.107.2.479; FERNANDEZ E, 1989, P NATL ACAD SCI USA, V86, P6449, DOI 10.1073/pnas.86.17.6449; Fukuyama K, 2004, PHOTOSYNTH RES, V81, P289, DOI 10.1023/B:PRES.0000036882.19322.0a; Garcia-Sanchez MI, 2000, J BIOL INORG CHEM, V5, P713, DOI 10.1007/s007750000160; GarciaSanchez MI, 1997, EUR J BIOCHEM, V250, P364, DOI 10.1111/j.1432-1033.1997.0364a.x; GORMAN DS, 1966, PLANT PHYSIOL, V41, P1643, DOI 10.1104/pp.41.10.1643; Goyer A, 2002, EUR J BIOCHEM, V269, P272, DOI 10.1046/j.0014-2956.2001.02648.x; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Hanke GT, 2008, PLANT CELL ENVIRON, V31, P1017, DOI 10.1111/j.1365-3040.2008.01814.x; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; HASE T, 1991, PLANT PHYSIOL, V97, P1395, DOI 10.1104/pp.97.4.1395; HASE T, 2006, PHOTOSYSTEM, V1; Hirasawa M, 1998, ARCH BIOCHEM BIOPHYS, V354, P95, DOI 10.1006/abbi.1998.0630; HIRASAWA M, 1994, BBA-BIOENERGETICS, V1185, P336, DOI 10.1016/0005-2728(94)90249-6; HOWE G, 1992, EMBO J, V11, P2789, DOI 10.1002/j.1460-2075.1992.tb05346.x; HUTBER GN, 1977, FEMS MICROBIOL LETT, V1, P193, DOI 10.1111/j.1574-6968.1977.tb00612.x; ISSAKIDIS E, 1992, J BIOL CHEM, V267, P21577; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Jacquot JP, 1997, FEBS LETT, V400, P293, DOI 10.1016/S0014-5793(96)01407-X; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; LAUDENBACH DE, 1988, J BACTERIOL, V170, P258, DOI 10.1128/jb.170.1.258-265.1988; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JC, 2008, GENETICS, V179, P137, DOI 10.1534/genetics.107.083824; Loppes R, 1999, PLANT MOL BIOL, V41, P701, DOI 10.1023/A:1006381527119; Matsumura T, 1997, PLANT PHYSIOL, V114, P653, DOI 10.1104/pp.114.2.653; McKay RML, 1997, PLANT PHYSIOL, V114, P615, DOI 10.1104/pp.114.2.615; Merchant S, 2005, PLANT CELL, V17, P648, DOI 10.1105/tpc.105.030676; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; MORTENSON LE, 1962, BIOCHEM BIOPH RES CO, V7, P448, DOI 10.1016/0006-291X(62)90333-9; Moseley JL, 2006, EUKARYOT CELL, V5, P26, DOI 10.1128/EC.5.1.26-44.2006; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Moseley JL, 2002, PLANT CELL, V14, P673, DOI 10.1105/tpc.010420; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Quinn JM, 2000, J BIOL CHEM, V275, P6080, DOI 10.1074/jbc.275.9.6080; Quinn JM, 2003, EUKARYOT CELL, V2, P995, DOI 10.1128/EC.2.5.995-1002.2003; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; Rochaix JD, 2002, FEBS LETT, V529, P34, DOI 10.1016/S0014-5793(02)03181-2; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Sambrook J., 2001, MOL CLONING LAB MANU; SANDMANN G, 1990, PHOTOSYNTH RES, V26, P119, DOI 10.1007/BF00047083; SCHMITTER JM, 1988, EUR J BIOCHEM, V172, P405, DOI 10.1111/j.1432-1033.1988.tb13901.x; SCHRAUTEMIER B, 1985, FEBS LETT, V184, P304, DOI 10.1016/0014-5793(85)80627-X; STEIN M, 1993, PLANT PHYSIOL, V102, P1349, DOI 10.1104/pp.102.4.1349; SUZUKI A, 1985, PLANT PHYSIOL, V78, P374, DOI 10.1104/pp.78.2.374; TAGAWA K, 1968, BIOCHIM BIOPHYS ACTA, V153, P602, DOI 10.1016/0005-2728(68)90188-6; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; Tripathy JN, 2007, PHOTOSYNTH RES, V94, P1, DOI 10.1007/s11120-007-9198-5; WADA K, 1989, J BIOCHEM, V105, P619, DOI 10.1093/oxfordjournals.jbchem.a122714; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	64	102	104	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25867	25878		10.1074/jbc.M109.023622	http://dx.doi.org/10.1074/jbc.M109.023622			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19586916	Green Published, hybrid			2022-12-27	WOS:000269738000044
J	Betzenhauser, MJ; Fike, JL; Wagner, LE; Yule, DI				Betzenhauser, Matthew J.; Fike, Jenna L.; Wagner, Larry E., II; Yule, David I.			Protein Kinase A Increases Type-2 Inositol 1,4,5-Trisphosphate Receptor Activity by Phosphorylation of Serine 937	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE; TRISPHOSPHATE RECEPTORS; ACINAR-CELLS; IP3 RECEPTOR; MEDIATED PHOSPHORYLATION; CYTOSOLIC CALCIUM; ELEMENTARY EVENTS; PHOSPHOLIPASE-C; PLASMA-MEMBRANE; AR4-2J CELLS	Protein kinase A (PKA) phosphorylation of inositol 1,4,5-trisphosphate receptors (InsP(3)Rs) represents a mechanism for shaping intracellular Ca2+ signals following a concomitant elevation in cAMP. Activation of PKA results in enhanced Ca2+ release in cells that express predominantly InsP(3)R2. PKA is known to phosphorylate InsP(3)R2, but the molecular determinants of this effect are not known. We have expressed mouse InsP(3)R2 in DT40-3KO cells that are devoid of endogenous InsP(3)R and examined the effects of PKA phosphorylation on this isoform in unambiguous isolation. Activation of PKA increased Ca2+ signals and augmented the single channel open probability of InsP(3)R2. A PKA phosphorylation site unique to the InsP(3)R2 was identified at Ser(937). The enhancing effects of PKA activation on this isoform required the phosphorylation of Ser(937), since replacing this residue with alanine eliminated the positive effects of PKA activation. These results provide a mechanism responsible for the enhanced Ca2+ signaling following PKA activation in cells that express predominantly InsP(3)R2.	[Betzenhauser, Matthew J.; Fike, Jenna L.; Wagner, Larry E., II; Yule, David I.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Yule, DI (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	David_Yule@urmc.rochester.edu			National Institutes of Health [RO1-DK054568, RO1-DE016999]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016999, T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK054568 and RO1-DE016999 (to D. I. Y.).	Arguin G, 2007, J ENDOCRINOL, V192, P659, DOI 10.1677/JOE-06-0179; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; BURGESS GM, 1991, J BIOL CHEM, V266, P4772; Dellis O, 2008, J BIOL CHEM, V283, P751, DOI 10.1074/jbc.M706960200; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; HAJNOCZKY G, 1993, BIOCHEM J, V293, P413, DOI 10.1042/bj2930413; Hernandez E, 2007, J BIOL CHEM, V282, P10057, DOI 10.1074/jbc.M700746200; Hirata K, 2002, GASTROENTEROLOGY, V122, P1088, DOI 10.1053/gast.2002.32363; Hirono C, 1998, J MEMBRANE BIOL, V164, P197, DOI 10.1007/s002329900405; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Maes K, 2000, CELL CALCIUM, V27, P257, DOI 10.1054/ceca.2000.0121; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Parker I, 1996, CELL CALCIUM, V20, P105, DOI 10.1016/S0143-4160(96)90100-1; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Pieper AA, 2001, NEUROSCIENCE, V102, P433, DOI 10.1016/S0306-4522(00)00470-X; Regimbald-Dumas Y, 2007, J CELL BIOCHEM, V101, P609, DOI 10.1002/jcb.21221; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Sheppard CA, 1997, J NEUROCHEM, V68, P2317; Soulsby MD, 2007, CELL CALCIUM, V42, P261, DOI 10.1016/j.ceca.2006.12.002; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Soulsby MD, 2004, FEBS LETT, V557, P181, DOI 10.1016/S0014-5793(03)01487-X; Straub SV, 2004, BIOL RES, V37, P593; Straub SV, 2002, J BIOL CHEM, V277, P31949, DOI 10.1074/jbc.M204318200; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Swatton JE, 2002, J BIOL CHEM, V277, P17571, DOI 10.1074/jbc.M200524200; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; VOLPE P, 1990, AM J PHYSIOL, V258, pC1086, DOI 10.1152/ajpcell.1990.258.6.C1086; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; WALAAS SI, 1986, J NEUROSCI, V6, P954; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zhang XJ, 1999, BIOCHEM J, V340, P519, DOI 10.1042/0264-6021:3400519	62	50	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25116	25125		10.1074/jbc.M109.010132	http://dx.doi.org/10.1074/jbc.M109.010132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19608738	Green Published, hybrid			2022-12-27	WOS:000269734000046
J	Caohuy, H; Jozwik, C; Pollard, HB				Caohuy, Hung; Jozwik, Catherine; Pollard, Harvey B.			Rescue of Delta F508-CFTR by the SGK1/Nedd4-2 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL NA+ CHANNEL; UBIQUITIN LIGASE NEDD4-2; INDUCIBLE KINASE SGK1; CYSTIC-FIBROSIS; SODIUM-CHANNEL; RNA INTERFERENCE; IMMATURE CFTR; CELL-LINE; SERUM	The most common mutation in cystic fibrosis (CF) is Delta F508, which is associated with failure of the mutant cystic fibrosis transmembrane conductance regulator (CFTR) to traffic to the plasma membrane. By a still unknown mechanism, the loss of correctly trafficked Delta F508-CFTR results in an excess of the epithelial sodium channel (ENaC) on the apical plasma membrane. ENaC trafficking is known to be regulated by a signaling pathway involving the glucocorticoid receptor, the serum-and glucocorticoid-regulated kinase SGK1, and the ubiquitin E3 ligase Nedd4-2. We show here that dexamethasone rescues functional expression of Delta F508-CFTR. The half-life of Delta F508-CFTR is also dramatically enhanced. Dexamethasone-activated Delta F508-CFTR rescue is blocked either by the glucocorticoid receptor antagonist RU38486 or by the phosphatidylinositol 3-kinase inhibitor LY294002. Co-immunoprecipitation studies indicate that Nedd4-2 binds to both wild-type-and Delta F508-CFTR. These complexes are inhibited by dexamethasone treatment, and CFTR ubiquitination is concomitantly decreased. We further show that knockdown of Nedd4-2 by small interfering RNA also corrects Delta F508-CFTR trafficking. Conversely, knockdown of SGK1 by small interfering RNA completely blocks dexamethasone-activated Delta F508-CFTR rescue. These data suggest that the SGK1/Nedd4-2 signaling pathway regulates both CFTR and ENaC trafficking in CF epithelial cells.	[Caohuy, Hung; Jozwik, Catherine; Pollard, Harvey B.] Uniformed Serv Univ Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Caohuy, H (corresponding author), 4301 Jones Bridge Rd,Bldg B, Bethesda, MD 20814 USA.	hcaohuy@usuhs.mil			National Institutes of Health [NO1-HV 28287, RO1-DK-35051]; Cystic Fibrosis Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grants NO1-HV 28287 and RO1-DK-35051 (to H.B.P.). This work was also supported by the Cystic Fibrosis Foundation (to H.B.P.).	Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Bradbury Neil A., 1999, Physiological Reviews, V79, pS175; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101; Henke G, 2004, J CELL PHYSIOL, V199, P194, DOI 10.1002/jcp.10430; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Jilling T, 1997, INT REV CYTOL, V172, P193, DOI 10.1016/S0074-7696(08)62361-X; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; KUNZELMANN K, 1995, PFLUG ARCH EUR J PHY, V431, P1, DOI 10.1007/BF00374371; Lang F, 2003, CELL PHYSIOL BIOCHEM, V13, P41, DOI 10.1159/000070248; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lukacs GL, 1997, BIOCHEM J, V328, P353; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Pondugula SR, 2004, AM J PHYSIOL-RENAL, V286, pF1127, DOI 10.1152/ajprenal.00387.2003; Quesnell RR, 2007, AM J PHYSIOL-CELL PH, V292, pC1739, DOI 10.1152/ajpcell.00369.2006; Rauz S, 2003, INVEST OPHTH VIS SCI, V44, P1643, DOI 10.1167/iovs.02-0514; Rennolds J, 2008, BIOCHEM BIOPH RES CO, V366, P1025, DOI 10.1016/j.bbrc.2007.12.065; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; SCHOUMACHER RA, 1990, P NATL ACAD SCI USA, V87, P4012, DOI 10.1073/pnas.87.10.4012; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Thomas CP, 2004, AM J PHYSIOL-LUNG C, V287, pL843, DOI 10.1152/ajplung.00340.2003; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wagner CA, 2001, CELL PHYSIOL BIOCHEM, V11, P209, DOI 10.1159/000051935; West MR, 1996, ANAL BIOCHEM, V241, P51, DOI 10.1006/abio.1996.0377; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	47	67	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25241	25253		10.1074/jbc.M109.035345	http://dx.doi.org/10.1074/jbc.M109.035345			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617352	Green Published, hybrid			2022-12-27	WOS:000269734000058
J	Akaike, T; Jin, MH; Yokoyama, U; Izumi-Nakaseko, H; Jiao, QB; Iwasaki, S; Iwamoto, M; Nishimaki, S; Sato, M; Yokota, S; Kamiya, Y; Adachi-Akahane, S; Ishikawa, Y; Minamisawa, S				Akaike, Toru; Jin, Mei-Hua; Yokoyama, Utako; Izumi-Nakaseko, Hiroko; Jiao, Qibin; Iwasaki, Shiho; Iwamoto, Mari; Nishimaki, Shigeru; Sato, Motohiko; Yokota, Shumpei; Kamiya, Yoshinori; Adachi-Akahane, Satomi; Ishikawa, Yoshihiro; Minamisawa, Susumu			T-type Ca2+ Channels Promote Oxygenation-induced Closure of the Rat Ductus Arteriosus Not Only by Vasoconstriction but Also by Neointima Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CALCIUM-CHANNEL; EXTRACELLULAR-MATRIX; CHRONIC-HYPOXIA; GROWTH-FACTOR; PROLIFERATION; EXPRESSION; MIGRATION; MYOCYTES; RABBIT	The ductus arteriosus (DA), an essential vascular shunt for fetal circulation, begins to close immediately after birth. Although Ca2+ influx through several membrane Ca2+ channels is known to regulate vasoconstriction of the DA, the role of the T-type voltage-dependent Ca2+ channel (VDCC) in DA closure remains unclear. Here we found that the expression of alpha 1G, a T-type isoform that is known to exhibit a tissue-restricted expression pattern in the rat neonatal DA, was significantly up-regulated in oxygenated rat DA tissues and smooth muscle cells (SMCs). Immunohistological analysis revealed that alpha 1G was localized predominantly in the central core of neonatal DA at birth. DA SMC migration was significantly increased by alpha 1G overexpression. Moreover, it was decreased by adding alpha 1G-specific small interfering RNAs or using R(-)-efonidipine, a highly selective T-type VDCC blocker. Furthermore, an oxygenation-mediated increase in an intracellular Ca2+ concentration of DA SMCs was significantly decreased by adding alpha 1G-specific siRNAs or using R(-)-efonidipine. Although a prostaglandin E receptor EP4 agonist potently promoted intimal thickening of the DA explants, R(-)-efonidipine (10(-6) M) significantly inhibited EP4-promoted intimal thickening by 40% using DA tissues at preterm in organ culture. Moreover, R(-)-efonidipine (10(-6) M) significantly attenuated oxygenation-induced vasoconstriction by similar to 27% using a vascular ring of fetal DA at term. Finally, R(-)-efonidipine significantly delayed the closure of in vivo DA in neonatal rats. These results indicate that T-type VDCC, especially alpha 1G, which is predominantly expressed in neonatal DA, plays a unique role in DA closure, implying that T-type VDCC is an alternative therapeutic target to regulate the patency of DA.	[Minamisawa, Susumu] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan; [Akaike, Toru; Jin, Mei-Hua; Yokoyama, Utako; Jiao, Qibin; Sato, Motohiko; Ishikawa, Yoshihiro; Minamisawa, Susumu] Yokohama City Univ, Cardiovasc Res Inst, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Izumi-Nakaseko, Hiroko; Adachi-Akahane, Satomi] Toho Univ, Sch Med, Grad Sch Med Sci, Dept Pharmacol,Fac Med, Toho 1438540, Japan; [Iwasaki, Shiho; Iwamoto, Mari; Nishimaki, Shigeru; Yokota, Shumpei] Yokohama City Univ, Sch Med, Dept Pediat, Yokohama, Kanagawa 2360004, Japan; [Kamiya, Yoshinori] Yokohama City Univ, Sch Med, Dept Anesthesiol, Yokohama, Kanagawa 2360004, Japan; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, Cardiovasc Res Inst, Dept Cell Biol, Newark, NJ 07101 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, Cardiovasc Res Inst, Dept Mol Med, Newark, NJ 07101 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, Cardiovasc Res Inst, Dept Med Cardiol, Newark, NJ 07101 USA; [Minamisawa, Susumu] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Inst Biomed Engn, Tokyo 1628480, Japan	Waseda University; Yokohama City University; Toho University; Yokohama City University; Yokohama City University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Waseda University	Minamisawa, S (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho,TWIns, Tokyo 1628480, Japan.	sminamis@waseda.jp	Yokoyama, Utako/AAD-1404-2022	Yokoyama, Utako/0000-0003-1803-0155; Kamiya, Yoshinori/0000-0001-9790-9867; Minamisawa, Susumu/0000-0003-4728-2116	National Institutes of Health [RO1GM067773]; Yokohama Foundation for Advanced Medical Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Special Coordination Funds for Promoting Science and Technology, MEXT; MEXT; Waseda University Grant; Mother and Child Health Foundation; Miyata Cardiology Research Promotion Founds; Takeda Science Foundation; Foundation for Growth Science; Japan Cardiovascular Research Foundation; Mitsubishi Pharma Research Foundation; Yokohama Academic Foundation; Inoue Foundation for Science; Naito Foundation; Uehara Memorial Foundation; Kitsuen Research Foundation; Japan Space Forum; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067773] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21590936] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yokohama Foundation for Advanced Medical Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Waseda University Grant; Mother and Child Health Foundation(Mother and Child Health Foundation); Miyata Cardiology Research Promotion Founds; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation for Growth Science; Japan Cardiovascular Research Foundation; Mitsubishi Pharma Research Foundation; Yokohama Academic Foundation; Inoue Foundation for Science(Inoue Foundation for Science); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Kitsuen Research Foundation; Japan Space Forum; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM067773 ( to Y. I.). This work was also supported by grants from the Yokohama Foundation for Advanced Medical Science ( to T. A., U. Y., Y. I., and S. M.), the Ministry of Education, Culture, Sports, Science and Technology of Japan ( to S. I., U. Y., Y. I., and S. M.), the Special Coordination Funds for Promoting Science and Technology, MEXT ( to S. M.), "High-Tech Research Center" Project for Private Universities: matching fund subsidy from MEXT ( to S. M.), Waseda University Grant for Special Research Projects ( to S. M.), the Mother and Child Health Foundation ( to S. M.), Miyata Cardiology Research Promotion Founds ( to U. Y. and S. M.), Takeda Science Foundation ( to S. M.), Foundation for Growth Science ( to S. M.), Japan Cardiovascular Research Foundation ( to S. M.), Mitsubishi Pharma Research Foundation ( to S. M.), Yokohama Academic Foundation ( to T. A. and S. I.), Inoue Foundation for Science ( to T. A.), the Naito Foundation ( to T. A.), the Uehara Memorial Foundation ( to U. Y.), the Kitsuen Research Foundation ( to Y. I.), and the Japan Space Forum ( to Y. I.).	Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Corsini A, 1996, J CARDIOVASC PHARM, V28, P687, DOI 10.1097/00005344-199611000-00012; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Del Toro R, 2003, J BIOL CHEM, V278, P22316, DOI 10.1074/jbc.M212576200; DEREEDER EG, 1989, ATHEROSCLEROSIS, V79, P29, DOI 10.1016/0021-9150(89)90030-0; Devlin MG, 2002, CLIN EXP PHARMACOL P, V29, P372, DOI 10.1046/j.1440-1681.2002.03670.x; Fearon IM, 2000, PFLUG ARCH EUR J PHY, V441, P181, DOI 10.1007/s004240000424; FleckensteinGrun G, 1996, PFLUG ARCH EUR J PHY, V432, pR53; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; Gollasch M, 2000, J HYPERTENS, V18, P989, DOI 10.1097/00004872-200018080-00001; Hollenbeck ST, 2004, J VASC SURG, V40, P351, DOI 10.1016/j.jvs.2004.03.047; Hong ZG, 2006, CIRCULATION, V114, P1372, DOI 10.1161/CIRCULATIONAHA.106.641126; Keck M, 2005, AM J PHYSIOL-LUNG C, V288, pL917, DOI 10.1152/ajplung.00403.2004; Kuga T, 1996, CIRC RES, V79, P14, DOI 10.1161/01.RES.79.1.14; Lijnen P, 1999, J CARDIOVASC PHARM, V33, P595, DOI 10.1097/00005344-199904000-00012; Louis H, 2006, CLIN EXP PHARMACOL P, V33, P131, DOI 10.1111/j.1440-1681.2006.04339.x; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NAKANISHI T, 1993, CIRC RES, V72, P1218, DOI 10.1161/01.RES.72.6.1218; Patel MK, 2005, BRIT J PHARMACOL, V145, P811, DOI 10.1038/sj.bjp.0706237; Rabinovitch M, 1996, SEMIN PERINATOL, V20, P531, DOI 10.1016/S0146-0005(96)80067-X; Rodman DM, 2005, CIRC RES, V96, P864, DOI 10.1161/01.RES.0000163066.07472.ff; Ruiz-Torres A, 2003, INT J CLIN PHARM TH, V41, P386; SCHMITT R, 1995, ARTERIOSCL THROM VAS, V15, P1161, DOI 10.1161/01.ATV.15.8.1161; SLOMP J, 1992, ATHEROSCLEROSIS, V93, P25, DOI 10.1016/0021-9150(92)90197-O; Smith GCS, 1998, PHARMACOL REV, V50, P35; SPERTI G, 1991, EUR J PHARM-MOLEC PH, V206, P279, DOI 10.1016/0922-4106(91)90110-4; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Tanaka H, 2004, J PHARMACOL SCI, V96, P499, DOI 10.1254/jphs.RCJ04001X; TristaniFirouzi M, 1996, J CLIN INVEST, V98, P1959, DOI 10.1172/JCI118999; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; YANG ZH, 1993, CIRCULATION, V88, P832, DOI 10.1161/01.CIR.88.3.832; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2008, J BIOL CHEM, V283, P28702, DOI 10.1074/jbc.M804223200; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639	35	28	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24025	24034		10.1074/jbc.M109.017061	http://dx.doi.org/10.1074/jbc.M109.017061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19567868	Green Published, hybrid			2022-12-27	WOS:000269380200017
J	Ransom, M; Williams, SK; Dechassa, ML; Das, C; Linger, J; Adkins, M; Liu, CW; Bartholomew, B; Tyler, JK				Ransom, Monica; Williams, Stephanie K.; Dechassa, Mekonnen L.; Das, Chandrima; Linger, Jeffrey; Adkins, Melissa; Liu, Chengwei; Bartholomew, Blaine; Tyler, Jessica K.			FACT and the Proteasome Promote Promoter Chromatin Disassembly and Transcriptional Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE H2B; PHO5 PROMOTER; REGULATORY PARTICLE; CRYSTAL-STRUCTURE; 26S PROTEASOME; IN-VIVO; NUCLEOSOME; BINDING; ACTIVATION	The packaging of the eukaryotic genome into chromatin represses gene expression by blocking access of the general transcription machinery to the underlying DNA sequences. Accordingly, eukaryotes have developed a variety of mechanisms to disrupt, alter, or disassemble nucleosomes from promoter regions and open reading frames to allow transcription to occur. Although we know that chromatin disassembly from the yeast PHO5 promoter is triggered by the Pho4 activator, the mechanism is far from clear. Here we show that the Pho4 activator can occupy its nucleosome-bound DNA binding site within the PHO5 promoter. In contrast to the role of Saccharomyces cerevisiae FACT (facilitates chromatin transcription) complex in assembling chromatin within open reading frames, we find that FACT is involved in the disassembly of histones H2A/H2B from the PHO5 promoter during transcriptional induction. We have also discovered that the proteasome is required for efficient chromatin disassembly and transcriptional induction from the PHO5 promoter. Mutants of the degradation function of the proteasome have a defect in recruitment of the Pho4 activator, whereas mutants of the ATPase cap of the proteasome do recruit Pho4 but are still delayed for chromatin assembly. Finally, we rule out the possibility that the proteasome or ATPase cap is driving chromatin disassembly via a potential ATP-dependent chromatin remodeling activity.	[Ransom, Monica; Williams, Stephanie K.; Das, Chandrima; Linger, Jeffrey; Adkins, Melissa; Liu, Chengwei; Tyler, Jessica K.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Dechassa, Mekonnen L.; Bartholomew, Blaine] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Southern Illinois University System; Southern Illinois University	Tyler, JK (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jessica.tyler@ucdenver.edu	Das, Chandrima/AAI-7398-2021	Das, Chandrima/0000-0002-8117-2810; Ransom, Monica/0000-0002-7527-7122; Linger, Jeffrey/0000-0003-3935-751X; Tyler, Jessica/0000-0001-9765-1659	National Institutes of Health [GM64475, CA082086]; NATIONAL CANCER INSTITUTE [T32CA082086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM64475 (to J.K.T.) and Training Grant T32 CA082086 (to M. R.).	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Burton BM, 2005, PROTEIN SCI, V14, P1945, DOI 10.1110/ps.051417505; COSTIGAN C, 1994, MOL CELL BIOL, V14, P2391, DOI 10.1128/MCB.14.4.2391; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Glowczewski L, 2000, MOL CELL BIOL, V20, P5700, DOI 10.1128/MCB.20.15.5700-5711.2000; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Imbalzano AN, 1998, METHODS, V15, P303, DOI 10.1006/meth.1998.0634; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Komeili A, 2000, CURR OPIN CELL BIOL, V12, P355, DOI 10.1016/S0955-0674(00)00100-9; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LI Q, 1995, MOL CELL BIOL, V15, P4375; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Morse RH, 2003, BIOCHEM CELL BIOL, V81, P101, DOI 10.1139/o03-039; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Paull TT, 1996, GENE DEV, V10, P2769, DOI 10.1101/gad.10.21.2769; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Russell SJ, 2001, J BIOL CHEM, V276, P9825, DOI 10.1074/jbc.M010889200; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Sun LP, 2002, BIOCHEM BIOPH RES CO, V296, P991, DOI 10.1016/S0006-291X(02)02026-0; WECHSLER DS, 1994, MOL CELL BIOL, V14, P4097, DOI 10.1128/MCB.14.6.4097; White CL, 2004, J MOL BIOL, V342, P1391, DOI 10.1016/j.jmb.2004.07.080; Williams LR, 2007, SIGHT SOUND, V17, P93; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; XU QL, 1995, MOL CELL BIOL, V15, P6025; Zhu ZW, 1996, CELL, V87, P459, DOI 10.1016/S0092-8674(00)81366-5	50	52	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23461	23471		10.1074/jbc.M109.019562	http://dx.doi.org/10.1074/jbc.M109.019562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574230	hybrid, Green Published			2022-12-27	WOS:000269180000031
J	Jin, K; Ewton, DZ; Park, S; Hu, J; Friedman, E				Jin, Kideok; Ewton, Daina Z.; Park, Sunju; Hu, Jing; Friedman, Eileen			Mirk Regulates the Exit of Colon Cancer Cells from Quiescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; CYCLIN-DEPENDENT KINASES; PROTEIN-KINASE; DNA-DAMAGE; STEM-CELLS; TRANSCRIPTIONAL ACTIVATOR; MIRK/DYRK1B KINASE; EPITHELIAL-CELLS; TUMOR-CELLS; KI-RAS	Mirk/Dyrk1B is a serine/threonine kinase widely expressed in colon cancers. Serum starvation induced HD6 colon carcinoma cells to enter a quiescent G0 state, characterized by a 2N DNA content and a lower RNA content than G1 cells. Compared with cycling cells, quiescent cells exhibited 16-fold higher levels of the retinoblastoma protein p130/Rb2, which sequesters E2F4 to block entry into G1, 10-fold elevated levels of the CDK inhibitor p27kip1, and 10-fold higher levels of Mirk. However, depletion of Mirk did not prevent entry into G0, but enabled quiescent HD6, SW480, and colo320 colon carcinoma cells to acquire some biochemical characteristics of G1 cells, including increased levels of cyclin D1 and cyclin D3 because of slower turnover, increased activity of their CDK4/cyclin D complexes, and increased phosphorylation and decreased E2F4 sequestering ability of the CDK4 target, p130/Rb2. As a result, depletion of Mirk allowed some cells to escape quiescence and enabled cells released from quiescence to traverse G1 more quickly. The kinase activity of Mirk was increased by the chemotherapeutic drug 5-fluorouracil (5-FU). Treatment of p53 mutant colon cancer cells with 5-FU led to an elongated G1 in a Mirk-dependent manner, as G1 was shortened by ectopic overexpression of cyclin D1 mutated at the Mirk phosphorylation site (T288A), but not by wild-type cyclin D1. Mirk, through regulating cyclin D turnover, and the CDK inhibitor p27, as shown by depletion studies, functioned independently and additively to regulate the exit of tumor cells from quiescence.	[Jin, Kideok; Ewton, Daina Z.; Park, Sunju; Hu, Jing; Friedman, Eileen] SUNY Syracuse, Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Friedman, E (corresponding author), SUNY Syracuse, Upstate Med Univ, Dept Pathol, 2305 Weiskotten Hall,750 E Adams St, Syracuse, NY 13210 USA.	friedmae@upstate.edu			NCI [R01 CA67405]; Jones/Rohner Foundation; NATIONAL CANCER INSTITUTE [R01CA067405] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jones/Rohner Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA67405 from the NCI (to E. F.). This work was also supported by the Jones/Rohner Foundation.	Barnes DJ, 2006, CELL CYCLE, V5, P2862, DOI 10.4161/cc.5.24.3573; Bielas JH, 2000, P NATL ACAD SCI USA, V97, P11391, DOI 10.1073/pnas.190330997; Bielas JH, 2004, DNA REPAIR, V3, P711, DOI 10.1016/j.dnarep.2004.02.010; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Connell-Crowley L, 1998, CURR BIOL, V8, P65, DOI 10.1016/S0960-9822(98)70021-1; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; Deng XB, 1999, CELL GROWTH DIFFER, V10, P11; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Deng XB, 2003, J BIOL CHEM, V278, P41347, DOI 10.1074/jbc.M306780200; Deng XB, 2009, CANCER RES, V69, P3317, DOI 10.1158/0008-5472.CAN-08-2903; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Ewton DZ, 2003, INT J CANCER, V103, P21, DOI 10.1002/ijc.10743; Germain D, 2000, J BIOL CHEM, V275, P12074, DOI 10.1074/jbc.275.16.12074; HUANG F, 1994, ONCOGENE, V9, P3701; Janumyan Y, 2008, J BIOL CHEM, V283, P34108, DOI 10.1074/jbc.M806294200; Jin K, 2005, J BIOL CHEM, V280, P42097, DOI 10.1074/jbc.M507301200; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lee K, 2000, CANCER RES, V60, P3631; Lim S, 2002, J BIOL CHEM, V277, P49438, DOI 10.1074/jbc.M206840200; Lim S, 2002, J BIOL CHEM, V277, P25040, DOI 10.1074/jbc.M203257200; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Robinson HMR, 2006, ONCOGENE, V25, P5359, DOI 10.1038/sj.onc.1209532; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Smith EJ, 1998, CELL GROWTH DIFFER, V9, P297; Takahashi-Yanaga F, 2006, J BIOL CHEM, V281, P38489, DOI 10.1074/jbc.M605205200; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang HLL, 2002, INT J CANCER, V101, P301, DOI 10.1002/ijc.10630; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Xiao Z, 2006, MOL CANCER THER, V5, P1935, DOI 10.1158/1535-7163.MCT-06-0077; Yan ZF, 1997, J BIOL CHEM, V272, P27902, DOI 10.1074/jbc.272.44.27902; Yan ZF, 1997, J BIOL CHEM, V272, P30928, DOI 10.1074/jbc.272.49.30928; Yoshikawa R, 2001, CANCER RES, V61, P1029; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	43	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22916	22925		10.1074/jbc.M109.035519	http://dx.doi.org/10.1074/jbc.M109.035519			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542220	hybrid, Green Published			2022-12-27	WOS:000268963100045
J	Dorn, M; Weiwad, M; Markwardt, F; Laug, L; Rudolph, R; Brandsch, M; Bosse-Doenecke, E				Dorn, Madlen; Weiwad, Matthias; Markwardt, Fritz; Laug, Linda; Rudolph, Rainer; Brandsch, Matthias; Bosse-Doenecke, Eva			Identification of a Disulfide Bridge Essential for Transport Function of the Human Proton-coupled Amino Acid Transporter hPAT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SEROTONIN TRANSPORTER; CYSTEINE RESIDUES; GLUCOSE-TRANSPORTER; SUBSTRATE TRANSPORT; PAT1; PROLINE; COTRANSPORTER; PROTEIN; CARRIER; CACO-2	The proton-coupled amino acid transporter 1 (PAT1, SLC36A1) mediates the uptake of small neutral amino acids at the apical membrane of intestinal epithelial cells after protein digestion. The transporter is currently under intense investigation, because it is a possible vehicle for oral drug delivery. Structural features of the protein such as the number of transmembrane domains, the substrate binding site, or essential amino acids are still unknown. In the present study we use mutagenesis experiments and biochemical approaches to determine the role of the three putative extracellular cysteine residues on transport function and their possible involvement in the formation of a disulfide bridge. As treatment with the reducing reagent dithiothreitol impaired transport function of hPAT1 wild type protein, substitution of putative extracellular cysteine residues Cys-180, Cys-329, and Cys-473 by alanine or serine was performed. Replacement of the two highly conserved cysteine residues Cys-180 and Cys-329 abolished the transport function of hPAT1 in Xenopus laevis oocytes. Studies of wild type and mutant transporters expressed in human retinal pigment epithelial (HRPE) cells suggested that the binding of the substrate was inhibited in these mutants. Substitution of the third putative extracellular nonconserved cysteine residue Cys-473 did not affect transport function. All mutants were expressed at the plasma membrane. Biotinylation of free sulfhydryl groups using maleimide-PEG(11)-biotin and SDS-PAGE analysis under reducing and nonreducing conditions provided direct evidence for the existence of an essential disulfide bond between Cys-180 and Cys-329. This disulfide bridge is very likely involved in forming or stabilizing the substrate binding site.	[Dorn, Madlen; Rudolph, Rainer; Bosse-Doenecke, Eva] Univ Halle Wittenberg, Fac Sci 1, Inst Biochem Biotechnol, D-06120 Halle, Germany; [Dorn, Madlen; Laug, Linda; Brandsch, Matthias] Univ Halle Wittenberg, Biozentrum, D-06120 Halle, Germany; [Weiwad, Matthias] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; [Markwardt, Fritz] Univ Halle Wittenberg, Fac Med, Julius Bernstein Inst Physiol, D-06097 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Max Planck Society; Martin Luther University Halle Wittenberg	Bosse-Doenecke, E (corresponding author), Univ Halle Wittenberg, Fac Sci 1, Inst Biochem Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	eva.bosse-doenecke@biochemtech.uni-halle.de	Markwardt, Fritz/F-7693-2013	Markwardt, Fritz/0000-0001-6761-2923	State Saxony-Anhalt Life Sciences Excellence Initiative [XB3599HP/0105T]	State Saxony-Anhalt Life Sciences Excellence Initiative	This work was supported by the State Saxony-Anhalt Life Sciences Excellence Initiative Grant XB3599HP/0105T ( to M. B. and E.B.-D.).	Anderson CMH, 2004, GASTROENTEROLOGY, V127, P1410, DOI 10.1053/j.gastro.2004.08.017; Asaka J, 2007, MOL PHARMACOL, V71, P1487, DOI 10.1124/mol.106.032938; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; Boll M, 2003, MOL MEMBR BIOL, V20, P261, DOI 10.1080/0968768031000100759; Boll M, 2003, GENOMICS, V82, P47, DOI 10.1016/S0888-7543(03)00099-5; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; Brandsch M, 2006, AMINO ACIDS, V31, P119, DOI 10.1007/s00726-006-0307-0; Bretschneider F, 1999, Methods Enzymol, V294, P180; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Chen Z, 2003, J PHYSIOL-LONDON, V546, P349, DOI 10.1113/jphysiol.2002.026500; Cook JVF, 1997, ENDOCRINOLOGY, V138, P2800, DOI 10.1210/en.138.7.2800; Dorn M, 2009, FEBS LETT, V583, P1631, DOI 10.1016/j.febslet.2009.04.037; Foltz M, 2005, BIOCHEM J, V386, P607, DOI 10.1042/BJ20041519; Frandberg PA, 2001, BIOCHEM BIOPH RES CO, V281, P851, DOI 10.1006/bbrc.2001.4429; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Gagnon DG, 2006, J GEN PHYSIOL, V127, P145, DOI 10.1085/jgp.200509439; HEBERT DN, 1991, BIOCHEMISTRY-US, V30, P4654, DOI 10.1021/bi00233a003; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Jess U, 1996, FEBS LETT, V394, P44, DOI 10.1016/0014-5793(96)00916-7; Kage K, 2005, CANCER SCI, V96, P866, DOI 10.1111/j.1349-7006.2005.00126.x; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Klapperstuck M, 2000, BBA-BIOMEMBRANES, V1467, P444, DOI 10.1016/S0005-2736(00)00245-5; Lambert G, 2000, J MEMBRANE BIOL, V176, P143, DOI 10.1007/s002320001083; Larsen M, 2008, EUR J PHARM SCI, V35, P86, DOI 10.1016/j.ejps.2008.06.007; Metzner L, 2005, FASEB J, V19, P1468, DOI 10.1096/fj.05-3683com; Metzner L, 2004, J PHARMACOL EXP THER, V309, P28, DOI 10.1124/jpet.103.059014; Metzner L, 2008, BBA-BIOMEMBRANES, V1778, P1042, DOI 10.1016/j.bbamem.2007.12.026; Pajor AM, 1999, BIOCHEM J, V344, P205, DOI 10.1042/0264-6021:3440205; Riedel T, 2007, BIOPHYS J, V92, P2377, DOI 10.1529/biophysj.106.091413; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Sturm A, 2007, AM J PHYSIOL-RENAL, V293, pF767, DOI 10.1152/ajprenal.00106.2007; Sur C, 1997, BIOCHEM BIOPH RES CO, V241, P68, DOI 10.1006/bbrc.1997.7771; Thwaites DT, 2007, BBA-BIOMEMBRANES, V1768, P179, DOI 10.1016/j.bbamem.2006.10.001; THWAITES DT, 1993, FEBS LETT, V333, P78, DOI 10.1016/0014-5793(93)80378-8; TURNER RJ, 1983, J BIOL CHEM, V258, P3565; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	39	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22123	22132		10.1074/jbc.M109.023713	http://dx.doi.org/10.1074/jbc.M109.023713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19549785	hybrid, Green Published			2022-12-27	WOS:000268783700036
J	Kawasaki, Y; Tsuji, S; Sagara, M; Echizen, K; Shibata, Y; Akiyama, T				Kawasaki, Yoshihiro; Tsuji, Shinnosuke; Sagara, Masaki; Echizen, Kanae; Shibata, Yoko; Akiyama, Tetsu			Adenomatous Polyposis Coli and Asef Function Downstream of Hepatocyte Growth Factor and Phosphatidylinositol 3-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TUMOR-SUPPRESSOR APC; COLORECTAL-CANCER; BETA-CATENIN; CRYSTAL-STRUCTURE; HUMAN BREAST; STEM-CELLS; PROTEIN; MEMBRANE; CDC42	Mutations of the tumor suppressor adenomatous polyposis coli (APC) are responsible for sporadic and familial colorectal tumors. APC negatively regulates Wnt signaling by inducing beta-catenin degradation. It has also been shown that APC plays a role in the organization of cytoskeletal networks. APC interacts with Asef and Asef2, Rac1- and Cdc42-specific guanine nucleotide exchange factors (GEFs), and stimulates their GEF activity; thereby regulating cell morphology, adhesion, and migration. Truncated mutant APCs present in colorectal tumor cells activate Asef and Asef2 constitutively and contribute to their aberrant migratory properties. We show here that hepatocyte growth factor (HGF), as well as basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF), induce the accumulation and colocalization of APC and Asef in membrane ruffles and lamellipodia of epithelial cells. Both APC and Asef were found to be required for HGF-induced cell migration. Furthermore, we show that the effects of HGF, bFGF, and EGF on APC and Asef are mediated by the activation of phosphatidylinositol 3-kinase (PI3-kinase) and require the PH domain of Asef. These results suggest that Asef and APC function downstream of HGF and PI3-kinase, and play critical roles in growth factor-mediated regulation of cell morphology and migration.	[Kawasaki, Yoshihiro; Tsuji, Shinnosuke; Sagara, Masaki; Echizen, Kanae; Shibata, Yoko; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo 113, Japan	University of Tokyo	Akiyama, T (corresponding author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 113, Japan.	akiyama@iam.u-tokyo.ac.jp		Tsuji, Shinnosuke/0000-0002-1929-4956	Kato Memorial Bioscience Foundation; MEXT, Japan	Kato Memorial Bioscience Foundation; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from Kato Memorial Bioscience Foundation, grants-in-aid for scientific research on priority areas and the Organization for Pharmaceutical Safety and Research, and in part by the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Arteaga CL, 2006, CANCER CELL, V9, P421, DOI 10.1016/j.ccr.2006.05.014; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Brocardo M, 2005, EMBO REP, V6, P184, DOI 10.1038/sj.embor.7400329; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Dvorak P, 2006, FEBS LETT, V580, P2869, DOI 10.1016/j.febslet.2006.01.095; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Gotthardt K, 2007, BIOL CHEM, V388, P67, DOI 10.1515/BC.2007.008; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Muroya K, 2007, BIOCHEM BIOPH RES CO, V355, P85, DOI 10.1016/j.bbrc.2007.01.131; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Vanni C, 2004, ONCOGENE, V23, P4098, DOI 10.1038/sj.onc.1207509; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	45	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22436	22443		10.1074/jbc.M109.020768	http://dx.doi.org/10.1074/jbc.M109.020768			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19525225	hybrid, Green Published			2022-12-27	WOS:000268783700065
J	Upadhyay, SK; Misra, A; Srivastava, R; Surolia, N; Surolia, A; Sundd, M				Upadhyay, Santosh Kumar; Misra, Ashish; Srivastava, Richa; Surolia, Namita; Surolia, Avadhesha; Sundd, Monica			Structural Insights into the Acyl Intermediates of the Plasmodium falciparum Fatty Acid Synthesis Pathway THE MECHANISM OF EXPANSION OF THE ACYL CARRIER PROTEIN CORE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN-BINDING-SITE; ESCHERICHIA-COLI; STREPTOMYCES-GLAUCESCENS; POLYKETIDE SYNTHASE; KEY RESIDUES; HOLO-FORMS; BIOSYNTHESIS; REDUCTASE; REVEAL; APO	Acyl carrier protein (ACP) plays a central role in fatty acid biosynthesis. However, the molecular machinery that mediates its function is not yet fully understood. Therefore, structural studies were carried out on the acyl-ACP intermediates of Plasmodium falciparum using NMR as a spectroscopic probe. Chemical shift perturbation studies put forth a new picture of the interaction of ACP molecule with the acyl chain, namely, the hydrophobic core can protect up to 12 carbon units, and additional carbons protrude out from the top of the hydrophobic cavity. The latter hypothesis stems from chemical shift changes observed in C-alpha and C-beta of Ser-37 in tetradecanoyl-ACP. C-13, N-15-Double-filtered nuclear Overhauser effect (NOE) spectroscopy experiments further substantiate the concept; in octanoyl (C-8)- and dodecanoyl (C-12)-ACP, a long range NOE is observed within the phosphopantetheine arm, suggesting an arch-like conformation. This NOE is nearly invisible in tetradecanoyl (C-14)-ACP, indicating a change in conformation of the prosthetic group. Furthermore, the present study provides insights into the molecular mechanism of ACP expansion, as revealed from a unique side chain-to-backbone hydrogen bond between two fairly conserved residues, Ile-55 HN and Glu-48 O. The backbone amide of Ile-55 HN reports a pK(a) value for the carboxylate, similar to 1.9 pH units higher than model compound value, suggesting strong electrostatic repulsion between helix II and helix III. Charge-charge repulsion between the helices in combination with thrust from inside due to acyl chain would energetically favor the separation of the two helices. Helix III has fewer structural restraints and, hence, undergoes major conformational change without altering the overall-fold of P. falciparum ACP.	[Upadhyay, Santosh Kumar; Surolia, Avadhesha; Sundd, Monica] Natl Inst Immunol, New Delhi 110067, India; [Misra, Ashish; Srivastava, Richa; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Surolia, Namita] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Surolia, A (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg,JNU Campus, New Delhi 110067, India.	surolia@nii.res.in	Upadhyay, Santosh Kumar/B-9967-2009; SUROLIA, AVADESHA/C-5442-2009	Upadhyay, Santosh Kumar/0000-0001-5999-4351; Misra, Ashish/0000-0002-3042-8302	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported through the NMR Facility at the National Institute of Immunology, New Delhi, supported by the Department of Biotechnology, Government of India.	Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; Clark AT, 2007, J MOL BIOL, V372, P992, DOI 10.1016/j.jmb.2007.06.089; Colizzi F, 2008, J CHEM INF MODEL, V48, P2289, DOI 10.1021/ci800297v; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Epple G, 1998, J BACTERIOL, V180, P4950, DOI 10.1128/JB.180.18.4950-4954.1998; Evans SE, 2008, CHEMBIOCHEM, V9, P2424, DOI 10.1002/cbic.200800180; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; Goddard T. D., SPARKY 3; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; JONES PJ, 1987, J BIOL CHEM, V262, P8963; Karmodiya K, 2008, FEBS J, V275, P4756, DOI 10.1111/j.1742-4658.2008.06608.x; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; KLEINKAUF H, 1990, EUR J BIOCHEM, V192, P1, DOI 10.1111/j.1432-1033.1990.tb19188.x; Lack G, 2006, J BIOL CHEM, V281, P9538, DOI 10.1074/jbc.M509119200; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Li Q, 2003, BIOCHEMISTRY-US, V42, P4648, DOI 10.1021/bi0274120; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Lu JZQ, 2005, COMB CHEM HIGH T SCR, V8, P15, DOI 10.2174/1386207053328192; Park SJ, 2004, J BIOCHEM, V135, P337, DOI 10.1093/jb/mvh041; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Sharma Shilpi, 2007, Antimicrob Agents Chemother, V51, P2552, DOI 10.1128/AAC.00124-07; Sharma SK, 2005, BIOCHEM BIOPH RES CO, V330, P1019, DOI 10.1016/j.bbrc.2005.03.094; SHEN B, 1992, J BACTERIOL, V174, P3818, DOI 10.1128/JB.174.11.3818-3821.1992; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; SUMMERS RG, 1995, BIOCHEMISTRY-US, V34, P9389, DOI 10.1021/bi00029a015; Sundd M, 2002, BIOCHEMISTRY-US, V41, P7586, DOI 10.1021/bi025571d; Sundd M, 2003, J MOL BIOL, V332, P927, DOI 10.1016/S0022-2836(03)00995-1; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Worsham LAS, 2003, BIOCHEMISTRY-US, V42, P167, DOI 10.1021/bi0261950; Wu BN, 2009, PROTEIN SCI, V18, P240, DOI 10.1002/pro.11; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	44	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22390	22400		10.1074/jbc.M109.014829	http://dx.doi.org/10.1074/jbc.M109.014829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520851	Green Published, hybrid			2022-12-27	WOS:000268783700061
J	Simmer, JP; Hu, YY; Lertlam, R; Yamakoshi, Y; Hu, JCC				Simmer, James P.; Hu, Yuanyuan; Lertlam, Rangsiyakorn; Yamakoshi, Yasuo; Hu, Jan C. -C.			Hypomaturation Enamel Defects in Klk4 Knockout/LacZ Knockin Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMELOGENESIS IMPERFECTA PHENOTYPE; KALLIKREIN-4 MESSENGER-RNA; PROSTATE-CANCER; RAT INCISOR; SERINE-PROTEASE; OVARIAN-CANCER; MATURATION AMELOBLASTS; ELECTRON-MICROSCOPY; BETA-GALACTOSIDASE; MOLECULAR-CLONING	Kallikrein 4 (Klk4) is believed to play an essential role in enamel biomineralization, because defects in KLK4 cause hypomaturation amelogenesis imperfecta. We used gene targeting to generate a knockin mouse that replaces the Klk4 gene sequence, starting at the translation initiation site, with a lacZ reporter gene. Correct targeting of the transgene was confirmed by Southern blot and PCR analyses. Histochemical X-gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) staining demonstrated expression of beta-galactosidase in maturation stage ameloblasts. No X-gal staining was observed in secretory stage ameloblasts or in odontoblasts. Retained enamel proteins were observed in the maturation stage enamel of the Klk4 null mouse, but not in the Klk4 heterozygous or wild-type mice. The enamel layer in the Klk4 null mouse was normal in thickness and contained decussating enamel rods but was rapidly abraded following weaning, despite the mice being maintained on soft chow. In function the enamel readily fractured within the initial rod and interrod enamel above the parallel enamel covering the dentino-enamel junction. Despite the lack of Klk4 and the retention of enamel proteins, significant levels of crystal maturation occurred (although delayed), and the enamel achieved a mineral density in some places greater than that detected in bone and dentin. An important finding was that individual enamel crystallites of erupted teeth failed to grow together, interlock, and function as a unit. Instead, individual crystallites seemed to spill out of the enamel when fractured. These results demonstrate that Klk4 is essential for the removal of enamel proteins and the proper maturation of enamel crystals.	[Simmer, James P.] Univ Michigan, Dent Res Lab, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48108 USA	University of Michigan System; University of Michigan	Simmer, JP (corresponding author), Univ Michigan, Dent Res Lab, Sch Dent, Dept Biol & Mat Sci, 1210 Eisenhower Pl, Ann Arbor, MI 48108 USA.	jsimmer@umich.edu	Hu, Jan C-C./F-5679-2015	Hu, Jan C-C./0000-0002-9294-0248; Simmer, James/0000-0002-7192-6105	National Institutes of Health; NIDCR [15846]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 15846 from NIDCR.	Bartlett JD, 1996, GENE, V183, P123, DOI 10.1016/S0378-1119(96)00525-2; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204; BARTLETT JD, 2004, HDB PROTEOLYTIC ENZY, P561; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; Borgono CA, 2007, BIOL CHEM, V388, P1215, DOI 10.1515/BC.2007.124; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Cerny R, 1996, J BONE MINER RES, V11, P883; Chai Y, 2000, DEVELOPMENT, V127, P1671; DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9; DACULSI G, 1984, CALCIFIED TISSUE INT, V36, P550, DOI 10.1007/BF02405364; Day CH, 2002, ONCOGENE, V21, P7114, DOI 10.1038/sj.onc.1205786; DEAKINS M., 1941, JOUR DENTAL RES, V20, P117, DOI 10.1177/00220345410200020201; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Dong Y, 2001, CLIN CANCER RES, V7, P2363; Fernando SC, 2006, REPRODUCTION, V132, P939, DOI 10.1530/rep.1.01013; Fukae M, 2007, J DENT RES, V86, P758, DOI 10.1177/154405910708600814; Fukae M, 2002, J DENT RES, V81, P668, DOI 10.1177/154405910208101003; FUKAE M, 1974, ARCH ORAL BIOL, V19, P381, DOI 10.1016/0003-9969(74)90179-4; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gao J, 2007, PROSTATE, V67, P348, DOI 10.1002/pros.20465; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Hu CC, 1998, CONNECT TISSUE RES, V39, P47, DOI 10.3109/03008209809023911; Hu CC, 1997, J DENT RES, V76, P1720, DOI 10.1177/00220345970760110201; Hu CC, 1997, J DENT RES, V76, P648, DOI 10.1177/00220345970760020501; Hu CC, 2000, J DENT RES, V79, P912, DOI 10.1177/00220345000790040501; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Hu JCC, 2000, J DENT RES, V79, P70, DOI 10.1177/00220345000790011301; KALLENBACH E, 1971, J ULTRA MOL STRUCT R, V35, P508, DOI 10.1016/S0022-5320(71)80008-4; KALLENBACH E, 1974, TISSUE CELL, V6, P173, DOI 10.1016/0040-8166(74)90030-5; KEREBEL B, 1979, J DENT RES, V58, P844, DOI 10.1177/00220345790580023701; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Klokk TI, 2007, CANCER RES, V67, P5221, DOI 10.1158/0008-5472.CAN-06-4728; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lyaruu DM, 2008, MATRIX BIOL, V27, P119, DOI 10.1016/j.matbio.2007.09.006; Mange A, 2008, BIOCHEM BIOPH RES CO, V375, P107, DOI 10.1016/j.bbrc.2008.07.138; Matsumura M, 2005, PROSTATE, V62, P1, DOI 10.1002/pros.20101; MIAKE Y, 1993, CALCIFIED TISSUE INT, V53, P249, DOI 10.1007/BF01320910; Mize GJ, 2008, MOL CANCER RES, V6, P1043, DOI 10.1158/1541-7786.MCR-08-0096; MJOR I, 1986, HUMAN ORAL EMBRYOLOG, P50; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; NYLEN MU, 1963, J CELL BIOL, V18, P109, DOI 10.1083/jcb.18.1.109; Obiezu CV, 2002, CLIN CHEM, V48, P1232; Obiezu CV, 2001, CLIN CANCER RES, V7, P2380; Ozdemir D, 2005, J DENT RES, V84, P1031, DOI 10.1177/154405910508401112; Papagerakis P, 2008, J DENT RES, V87, P56, DOI 10.1177/154405910808700109; Park CH, 2007, J PERIODONTOL, V78, P273, DOI 10.1902/jop.2007.060252; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; PROVENZA DV, 1988, FUNDAMENTALS ORAL HI, P151; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; REITH EJ, 1970, J ULTRA MOL STRUCT R, V30, P111, DOI 10.1016/S0022-5320(70)90068-7; ROBINSON C, 1990, CARIES RES, V24, P226, DOI 10.1159/000261272; Robinson C, 1989, Connect Tissue Res, V22, P139; ROSEN D, 1981, NEUROPATH APPL NEURO, V7, P331, DOI 10.1111/j.1365-2990.1981.tb00236.x; Ryu O, 2002, EUR J ORAL SCI, V110, P358, DOI 10.1034/j.1600-0722.2002.21349.x; Ryu OH, 1999, J DENT RES, V78, P743, DOI 10.1177/00220345990780030601; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; SASAKI T, 1984, HISTOCHEMISTRY, V80, P263, DOI 10.1007/BF00495775; Simmer J. P., 2004, HDB PROTEOLYTIC ENZY, P1612; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; SIMMER JP, 2004, BIOMINERALIZATION FO, P348; Sire JY, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-246; Smid JR, 2001, EUR J ORAL SCI, V109, P260, DOI 10.1034/j.1600-0722.2001.00025.x; Smith C E, 1987, Adv Dent Res, V1, P162; Smith C E, 1996, Adv Dent Res, V10, P159; SMITH CE, 1989, ANAT REC, V224, P292, DOI 10.1002/ar.1092240219; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3; SNEAD ML, 1983, P NATL ACAD SCI-BIOL, V80, P7254, DOI 10.1073/pnas.80.23.7254; SOGNNAES RF, 1949, J DENT RES, V28, P549, DOI 10.1177/00220345490280060401; Sun Z, 2008, J DENT RES, V87, P1133, DOI 10.1177/154405910808701212; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Toyosawa S, 1996, CELL TISSUE RES, V285, P217, DOI 10.1007/s004410050639; Turk BE, 2006, BIOCHEMISTRY-US, V45, P3863, DOI 10.1021/bi052252o; Wakida K, 1999, HISTOCHEM CELL BIOL, V111, P297, DOI 10.1007/s004180050360; WARSHAWSKY H, 1982, J DENT RES, V61, P1504; Weiss DJ, 1999, HISTOCHEM J, V31, P231, DOI 10.1023/A:1003642025421; Wright JT, 1996, J DENT RES, V75, P966, DOI 10.1177/00220345960750041101; Xi ZJ, 2004, GYNECOL ONCOL, V94, P80, DOI 10.1016/j.ygyno.2004.03.044; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; YOUNG DC, 1993, ANAL BIOCHEM, V215, P24, DOI 10.1006/abio.1993.1549; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	89	115	118	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19110	19121		10.1074/jbc.M109.013623	http://dx.doi.org/10.1074/jbc.M109.013623			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19578120	Green Published, hybrid			2022-12-27	WOS:000267711500059
J	Srivastava, V; Manchanda, M; Gupta, S; Singla, R; Behera, D; Das, G; Natarajan, K				Srivastava, Varsha; Manchanda, Mini; Gupta, Shashank; Singla, Rupak; Behera, Digamber; Das, Gobardhan; Natarajan, Krishnamurthy			Toll-like Receptor 2 and DC-SIGNR1 Differentially Regulate Suppressors of Cytokine Signaling 1 in Dendritic Cells during Mycobacterium tuberculosis Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; C-TYPE LECTIN; NF-KAPPA-B; DC-SIGN; IN-VIVO; PROTECTIVE IMMUNITY; MANNOSE RECEPTOR; ANTIGENS; ACTIVATION; IDENTIFICATION	A hallmark of protective immunity during Mycobacterium tuberculosis (M. tb) infection is the regulated secretion of pro-inflammatory and regulatory cytokines. Suppressors of Cytokine Signaling (SOCS) are key regulators of cytokine secretion and function. In this study we investigated regulation of Toll-like receptor 2 (TLR2) and dendritic cell-specific ICAM-3 grabbing non-integrin receptor 1 (DC-SIGNR1)-mediated SOCS1 expression in DCs during M. tb infection. We show that, compared with TLR2, stimulating DC-SIGNR1 on DCs induces higher SOCS1 expression and lower interleukin-12 production. Co-stimulating DC-SIGNR1 and TLR2 differentially regulates SOCS1 expression depending on the relative concentration of their ligands. Stimulating DC-SIGNR1 with M. tb infection increases SOCS1 expression, while stimulating TLR2 with M. tb infection reduces SOCS1 expression. Knockdown of SOCS1 in DCs by siRNA enhances interleukin-12 transcription and protein expression upon DC-SIGNR1 stimulation. Raf-1 and Syk differentially regulate TLR2- and DC-SIGNR1-mediated SOCS1 expression. In addition, DC-SIGNR1 shows greater association with SOCS1 when compared with TLR2. Interestingly, compared with healthy asymptomatic individuals, peripheral blood mononuclear cells of patients with active tuberculosis disease showed higher expression of SOCS1, which was reduced following chemotherapy. Similarly, stimulating DC-SIGNR1 on DCs from M. tb-infected TLR2(-/-) mice enhanced SOCS1 expression that was reduced following chemotherapy. Further, knockdown of SOCS1 in mouse DCs or human peripheral blood mononuclear cells resulted in increased killing of virulent M. tb. These results indicate that TLR2 and DC-SIGNR1 differentially regulate SOCS1 expression during M. tb infection. This in turn regulates M. tb survival by governing key cytokine expression.	[Srivastava, Varsha; Manchanda, Mini; Gupta, Shashank; Das, Gobardhan; Natarajan, Krishnamurthy] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Singla, Rupak; Behera, Digamber] Lala Ram Swarup Inst TB & Resp Dis, Dept TB & Resp Dis, New Delhi 110030, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Natarajan, K (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	natrajan@icgeb.res.in	Gupta, Shashank/E-7382-2016	Gupta, Shashank/0000-0003-0445-5195	Dept. of Biotechnology, Ministry of Science and Technology, Government of India	Dept. of Biotechnology, Ministry of Science and Technology, Government of India	This work was supported by grants from the Dept. of Biotechnology, Ministry of Science and Technology, Government of India (to K. N.).	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Caminschi I, 2006, INT IMMUNOL, V18, P741, DOI 10.1093/intimm/dxl011; de Jong MAWP, 2008, J CLIN INVEST, V118, P3440, DOI 10.1172/JCI34721; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Foote S, 1999, NAT GENET, V21, P345, DOI 10.1038/7663; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; Gramberg T, 2006, VIROLOGY, V345, P482, DOI 10.1016/j.virol.2005.10.008; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hess J, 2000, ADV IMMUNOL, V75, P1, DOI 10.1016/S0065-2776(00)75001-2; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Kaufmann SHE, 2003, J EXP MED, V197, P1, DOI 10.1084/jem.20021964; Koppel EA, 2004, IMMUNOBIOLOGY, V209, P117, DOI 10.1016/j.imbio.2004.03.003; Latchumanan VK, 2005, TUBERCULOSIS, V85, P377, DOI 10.1016/j.tube.2005.08.007; Latchumanan VK, 2002, J IMMUNOL, V169, P6856, DOI 10.4049/jimmunol.169.12.6856; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Nikonenko BV, 2004, ANTIMICROB AGENTS CH, V48, P4550, DOI 10.1128/AAC.48.12.4550-4555.2004; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Smith AL, 2007, J EXP MED, V204, P421, DOI 10.1084/jem.20061604; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; von Meyenn F, 2006, IMMUNOBIOLOGY, V211, P557, DOI 10.1016/j.imbio.2006.05.004; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018; World Health Organization (WHO), 2005, ELECTROMAGNETIC FIEL; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	45	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25532	25541		10.1074/jbc.M109.006221	http://dx.doi.org/10.1074/jbc.M109.006221			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617348	Green Published, hybrid			2022-12-27	WOS:000269738000010
J	Heikkinen, OK; Ruskamo, S; Konarev, PV; Svergun, DI; Iivanainen, T; Heikkinen, SM; Permi, P; Koskela, H; Kilpelainen, I; Ylanne, J				Heikkinen, Outi K.; Ruskamo, Salla; Konarev, Peter V.; Svergun, Dmitri I.; Iivanainen, Tatu; Heikkinen, Sami M.; Permi, Perttu; Koskela, Harri; Kilpelainen, Ilkka; Ylanne, Jari			Atomic Structures of Two Novel Immunoglobulin-like Domain Pairs in the Actin Cross-linking Protein Filamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; MOLECULAR-BASIS; BINDING; PROGRAM; COMPETITION; DISRUPTION; REVEALS; FILGAP	Filamins are actin filament cross-linking proteins composed of an N-terminal actin-binding domain and 24 immunoglobulin-like domains (IgFLNs). Filamins interact with numerous proteins, including the cytoplasmic domains of plasma membrane signaling and cell adhesion receptors. Thereby filamins mechanically and functionally link the cell membrane to the cytoskeleton. Most of the interactions have been mapped to the C-terminal IgFLNs 16-24. Similarly, as with the previously known compact domain pair of IgFLNa20-21, the two-domain fragments IgFLNa16-17 and IgFLNa18-19 were more compact in small angle x-ray scattering analysis than would be expected for two independent domains. Solution state NMR structures revealed that the domain packing in IgFLNa18-19 resembles the structure of IgFLNa20-21. In both domain pairs the integrin-binding site is masked, although the details of the domain-domain interaction are partly distinct. The structure of IgFLNa16-17 revealed a new domain packing mode where the adhesion receptor binding site of domain 17 is not masked. Sequence comparison suggests that similar packing of three tandem filamin domain pairs is present throughout the animal kingdom, and we propose that this packing is involved in the regulation of filamin interactions through a mechanosensor mechanism.	[Kilpelainen, Ilkka] Univ Helsinki, Dept Chem, FI-00014 Helsinki, Finland; [Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, FI-00014 Helsinki, Finland; [Koskela, Harri] Univ Helsinki, Finnish Inst Verificat Chem Weap Convent, FI-00014 Helsinki, Finland; [Ruskamo, Salla; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Ruskamo, Salla; Ylanne, Jari] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Konarev, Peter V.; Svergun, Dmitri I.] DESY, EMBL Hamburg, D-22603 Hamburg, Germany; [Svergun, Dmitri I.] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	University of Helsinki; University of Helsinki; University of Helsinki; University of Jyvaskyla; University of Jyvaskyla; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Kilpelainen, I (corresponding author), Univ Helsinki, Dept Chem, POB 55, FIN-00014 Helsinki, Finland.	ilkka.kilpelainen@helsinki.fi; jylanne@bytl.jyu.fi	Konarev, Petr V/W-1380-2017	Svergun, Dmitri/0000-0003-0830-5696; Koskela, Harri/0000-0002-7552-3813; Ylanne, Jari/0000-0003-4627-021X; Ruskamo, Salla/0000-0002-9740-9077; Konarev, Petr/0000-0002-5606-1596	Finnish National Graduate School in Informational and Structural Biology; Academy of Finland [114713]; European Union Design Study SAXIER [011934]; European Union Framework Program 6 [RII3/CT/2004/506008]	Finnish National Graduate School in Informational and Structural Biology; Academy of Finland(Academy of Finland); European Union Design Study SAXIER; European Union Framework Program 6(European Commission)	This work was supported by funds from the Finnish National Graduate School in Informational and Structural Biology (to S. R. and O. K. H.), Academy of Finland Grant 114713 (to J. Y.), European Union Design Study SAXIER Contract 011934 (to D. I. S. and P. V. K.), and European Union Framework Program 6 Contract RII3/CT/2004/506008.	Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; CASE DA, 2004, AMBER 8; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dalkilic I, 2006, MOL CELL BIOL, V26, P6522, DOI 10.1128/MCB.00243-06; Fabrice R, 2006, INT J BIOCHEM CELL B, V38, P404, DOI 10.1016/j.biocel.2005.09.020; Farrington-Rock C, 2008, HUM MOL GENET, V17, P631, DOI 10.1093/hmg/ddm188; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Heikkinen O, 2009, BIOMOL NMR ASSIGN, V3, P53, DOI 10.1007/s12104-008-9140-6; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	39	37	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25450	25458		10.1074/jbc.M109.019661	http://dx.doi.org/10.1074/jbc.M109.019661			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19622754	Green Published, hybrid			2022-12-27	WOS:000269734000077
J	Runyan, CE; Hayashida, T; Hubchak, S; Curley, JF; Schnaper, HW				Runyan, Constance E.; Hayashida, Tomoko; Hubchak, Susan; Curley, Jessica F.; Schnaper, H. William			Role of SARA (SMAD Anchor for Receptor Activation) in Maintenance of Epithelial Cell Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; MESENCHYMAL TRANSITION; GROWTH; PATHWAY; INTERNALIZATION; SPECIFICITY; TRANSCRIPTION; FIBROBLASTS; DEGRADATION; PROTEINS	By inducing epithelial-to-mesenchymal transition (EMT), transforming growth factor-beta (TGF-beta) promotes cancer progression and fibrosis. Here we show that expression of the TGF-beta receptor-associated protein, SARA (Smad anchor for receptor activation), decreases within 72 h of exposure to TGF-beta and that this decline is both required and sufficient for the induction of several markers of EMT. It has been suggested recently that expression of the TGF-beta signaling mediators, Smad2 and Smad3, may have different functional effects, with Smad2 loss being more permissive for EMT progression. We find that the loss of SARA expression leads to a concomitant decrease in Smad2 expression and a disruption of Smad2-specific transcriptional activity, with no effect on Smad3 signaling or expression. Further, the effects of inducing the loss of Smad2 mimic those of the loss of SARA, enhancing expression of the EMT marker, smooth muscle alpha-actin. Smad2 mRNA levels are not affected by the loss of SARA. However, the ubiquitination of Smad2 is increased in SARA-deficient cells. We therefore examined the E3 ubiquitin ligase Smurf2 and found that although Smurf2 expression was unaltered in SARA-deficient cells, the interaction of Smad2 and Smurf2 was enhanced. These results describe a significant role for SARA in regulating cell phenotype and suggest that its effects are mediated through modification of the balance between Smad2 and Smad3 signaling. In part, this is achieved by enhancing the association of Smad2 with Smurf2, leading to Smad2 degradation.	[Runyan, Constance E.; Hayashida, Tomoko; Hubchak, Susan; Curley, Jessica F.; Schnaper, H. William] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA	Northwestern University	Runyan, CE (corresponding author), 303 E Chicago Ave,Ward 12-110, Chicago, IL 60611 USA.	c-runyan@northwestern.edu		Hayashida, Tomoko/0000-0002-4160-7859	National Institutes of Health, NIDDK [R01-DK075663]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075663] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant R01-DK075663.	Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goto D, 2001, BIOCHEM BIOPH RES CO, V281, P1100, DOI 10.1006/bbrc.2001.4489; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu CH, 2003, J BIOL CHEM, V278, P11721, DOI 10.1074/jbc.M207728200; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; MIN BH, 1990, J BIOL CHEM, V265, P16667; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Pohlers D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2217; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Runyan CE, 2006, CELL SIGNAL, V18, P2077, DOI 10.1016/j.cellsig.2006.05.009; Semiali A, 2008, AM J RESP CELL MOL, V38, P202, DOI 10.1165/rcmb.2007-0031OC; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tan RY, 2008, AM J PHYSIOL-RENAL, V294, pF1076, DOI 10.1152/ajprenal.00323.2007; Tao Yan-Yan, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P909; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	32	34	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25181	25189		10.1074/jbc.M109.032847	http://dx.doi.org/10.1074/jbc.M109.032847			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19620243	Green Published, hybrid			2022-12-27	WOS:000269734000052
J	Zakrzewska, M; Wiedlocha, A; Szlachcic, A; Krowarsch, D; Otlewski, J; Olsnes, S				Zakrzewska, Malgorzata; Wiedlocha, Antoni; Szlachcic, Anna; Krowarsch, Daniel; Otlewski, Jacek; Olsnes, Sjur			Increased Protein Stability of FGF1 Can Compensate for Its Reduced Affinity for Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SITE-DIRECTED MUTAGENESIS; DIFFERENTIAL TYROSINE PHOSPHORYLATION; FACTOR-I; RECEPTOR-BINDING; DNA-SYNTHESIS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; TRANSLOCATION; SULFATE	Human FGF1 (fibroblast growth factor 1) is a powerful signaling molecule with a short half-life in vivo and a denaturation temperature close to physiological. Binding to heparin increases the stability of FGF1 and is believed to be important in the formation of FGF1.fibroblast growth factor receptor (FGFR) active complex. In order to reveal the function of heparin in FGF1.FGFR complex formation and signaling, we constructed several FGF1 variants with reduced affinity for heparin and with diverse stability. We determined their biophysical properties and biological activities as well as their ability to translocate across cellular membranes. Our study showed that increased thermodynamic stability of FGF1 nicely compensates for decreased binding of heparin in FGFR activation, induction of DNA synthesis, and cell proliferation. By stepwise introduction of stabilizing mutations into the K118E (K132E) FGF1 variant that shows reduced affinity for heparin and is inactive in stimulation of DNA synthesis, we were able to restore the full mitogenic activity of this mutant. Our results indicate that the main role of heparin in FGF-induced signaling is to protect this naturally unstable protein against heat and/or proteolytic degradation and that heparin is not essential for a direct FGF1-FGFR interaction and receptor activation.	[Olsnes, Sjur] Norwegian Radium Hosp, Dept Biochem, Inst Canc Res, N-0310 Oslo, Norway; [Olsnes, Sjur] Univ Oslo, Ctr Canc Biomed, N-0310 Oslo, Norway; [Zakrzewska, Malgorzata; Szlachcic, Anna; Otlewski, Jacek] Univ Wroclaw, Dept Prot Engn, PL-50137 Wroclaw, Poland; [Krowarsch, Daniel] Univ Wroclaw, Dept Prot Biotechnol, Fac Biotechnol, PL-50137 Wroclaw, Poland	University of Oslo; University of Oslo; University of Wroclaw; University of Wroclaw	Olsnes, S (corresponding author), Norwegian Radium Hosp, Dept Biochem, Inst Canc Res, N-0310 Oslo, Norway.	olsnes@radium.uio.no		Szlachcic, Anna/0000-0003-0574-1476; Krowarsch, Daniel/0000-0003-2856-218X; Zakrzewska, Malgorzata/0000-0001-8214-1533	Polish Ministry of Science and Higher Education [N N301 4192 33]; Norwegian Cancer Society	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by Polish Ministry of Science and Higher Education Grant N N301 4192 33, by the Norwegian Cancer Society, by Raquel and Chr. Bruuns legat, and by Torsteds legat.	Blaber SI, 1999, BIOPHYS J, V77, P470, DOI 10.1016/S0006-3495(99)76904-3; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; Citores L, 2001, J CELL SCI, V114, P1677; Culajay JF, 2000, BIOCHEMISTRY-US, V39, P7153, DOI 10.1021/bi9927742; DAMON DH, 1989, J CELL PHYSIOL, V138, P221, DOI 10.1002/jcp.1041380202; de Paz JL, 2001, CHEMBIOCHEM, V2, P673, DOI 10.1002/1439-7633(20010903)2:9<673::AID-CBIC673>3.0.CO;2-7; Delehedde M, 2000, J BIOL CHEM, V275, P33905, DOI 10.1074/jbc.M005949200; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fannon M, 1996, J BIOL CHEM, V271, P17949, DOI 10.1074/jbc.271.30.17949; GIMENEZGALLEGO G, 1986, BIOCHEM BIOPH RES CO, V138, P611, DOI 10.1016/S0006-291X(86)80540-X; GLEIZES PE, 1995, EUR J CELL BIOL, V66, P47; Gospodarowicz D., 1986, J CELL PHYSL, V128, P475, DOI DOI 10.1002/JCP.1041280317; HARPER JW, 1988, BIOCHEMISTRY-US, V27, P671, DOI 10.1021/bi00402a027; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; IMAMURA T, 1994, EXP CELL RES, V215, P363, DOI 10.1006/excr.1994.1353; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Klingenberg O, 1998, J BIOL CHEM, V273, P11164, DOI 10.1074/jbc.273.18.11164; Klingenberg O, 1999, J BIOL CHEM, V274, P18081, DOI 10.1074/jbc.274.25.18081; Lundin L, 2003, EXP CELL RES, V287, P190, DOI 10.1016/S0014-4827(03)00125-3; Malecki J, 2002, EMBO J, V21, P4480, DOI 10.1093/emboj/cdf472; Malecki J, 2004, MOL BIOL CELL, V15, P801, DOI 10.1091/mbc.E03-08-0589; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Motomura K, 2008, BBA-GEN SUBJECTS, V1780, P1432, DOI 10.1016/j.bbagen.2008.08.001; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; Olsnes S, 2003, PHYSIOL REV, V83, P163, DOI 10.1152/physrev.00021.2002; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; ORTEGA S, 1991, J BIOL CHEM, V266, P5842; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; PRESTA M, 1992, BIOCHEM BIOPH RES CO, V185, P1098, DOI 10.1016/0006-291X(92)91739-D; Regan JC, 2009, NEURON, V61, P27, DOI 10.1016/j.neuron.2008.11.030; ROGHANI M, 1992, J BIOL CHEM, V267, P22156; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sorensen V, 2008, MOL CELL BIOL, V28, P4129, DOI 10.1128/MCB.02117-07; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Szlachcic A, 2009, ACTA CRYSTALLOGR D, V65, P67, DOI 10.1107/S0907444908039486; VOLKIN DB, 1993, ARCH BIOCHEM BIOPHYS, V300, P30, DOI 10.1006/abbi.1993.1005; Waksman G, 1998, NAT STRUCT BIOL, V5, P527, DOI 10.1038/778; Wesche J, 2000, BIOCHEMISTRY-US, V39, P15091, DOI 10.1021/bi001831k; Wiedlocha A, 1995, J BIOL CHEM, V270, P30680, DOI 10.1074/jbc.270.51.30680; Wiedlocha A, 2005, MOL BIOL CELL, V16, P794; Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45; Wiedlocha A, 1996, MOL CELL BIOL, V16, P270; WONG P, 1995, J BIOL CHEM, V270, P25805, DOI 10.1074/jbc.270.43.25805; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Zakrzewska M, 2005, J MOL BIOL, V352, P860, DOI 10.1016/j.jmb.2005.07.066; Zakrzewska M, 2004, PROTEIN ENG DES SEL, V17, P603, DOI 10.1093/protein/gzh076; Zakrzewska M, 2006, BIOCHEMISTRY-US, V45, P15338, DOI 10.1021/bi0618114; ZHAN X, 1993, J BIOL CHEM, V268, P9611; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	60	47	68	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25388	25403		10.1074/jbc.M109.001289	http://dx.doi.org/10.1074/jbc.M109.001289			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19574212	Green Published, hybrid			2022-12-27	WOS:000269734000071
J	Bue, CA; Barlowe, C				Bue, Catherine A.; Barlowe, Charles			Molecular Dissection of Erv26p Identifies Separable Cargo Binding and Coat Protein Sorting Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; ALKALINE-PHOSPHATASE; TRANSPORT VESICLES; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEINS; SECRETORY PATHWAY; GOLGI TRANSPORT; LECTIN ERGIC-53; COPII; ER	Efficient export of secretory alkaline phosphatase (ALP) from the endoplasmic reticulum depends on the conserved transmembrane sorting adaptor Erv26p/Svp26p. In the present study we investigated the mechanism by which Erv26p couples pro-ALP to the coat protein complex II (COPII) export machinery. Site-specific mutations were introduced into Erv26p, and mutant proteins were assessed in cell-free assays that monitor interactions with pro-ALP cargo and packaging into COPII vesicles. Mutations in the second and third loop domains of Erv26p inhibited interaction with pro-ALP, whereas mutations in the C-terminal tail sequence influenced incorporation into COPII vesicles and subcellular distribution. Interestingly mutations in the second loop domain also influenced Erv26p homodimer associations. Finally we demonstrated that Ktr3p, a cis-Golgi-localized mannosyltransferase, also relies on Erv26p for efficient COPII-dependent export from the endoplasmic reticulum. These findings demonstrate that Erv26p acts as a protein sorting adaptor for a variety of Type II transmembrane cargo proteins and requires domain-specific interactions with both cargo and coat subunits to promote efficient secretory protein transport.	[Bue, Catherine A.; Barlowe, Charles] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	barlowe@dartmouth.edu			National Institutes of Health [T32GM008704, GM052549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052549, T32GM008704, R37GM052549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32GM008704 ( to C. A. B.) and GM052549.	Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; AUSUBEL RM, 1987, CURRENT PROTOCOLS MO; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 2001, J BIOL CHEM, V276, P43040, DOI 10.1074/jbc.M108113200; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Boulanger RR, 2003, J BIOL CHEM, V278, P23497, DOI 10.1074/jbc.M301105200; Bue CA, 2006, MOL BIOL CELL, V17, P4780, DOI 10.1091/mbc.E06-05-0455; CLARK DW, 1982, J BACTERIOL, V152, P865; Dancourt J, 2009, TRAFFIC, V10, P1006, DOI 10.1111/j.1600-0854.2009.00936.x; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hauri HP, 2000, J CELL SCI, V113, P587; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Itin C, 1996, MOL BIOL CELL, V7, P483, DOI 10.1091/mbc.7.3.483; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kawasaki N, 2008, BLOOD, V111, P1972, DOI 10.1182/blood-2007-06-097022; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Neve EPA, 2005, J MOL BIOL, V354, P556, DOI 10.1016/j.jmb.2005.09.077; NEWMAN AP, 1992, EMBO J, V11, P3609, DOI 10.1002/j.1460-2075.1992.tb05445.x; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nufer O, 2002, J CELL SCI, V115, P619; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Olson LJ, 2008, J BIOL CHEM, V283, P10124, DOI 10.1074/jbc.M708994200; ONISHI HR, 1979, J BIOL CHEM, V254, P1943; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; Sato K, 2003, MOL BIOL CELL, V14, P3055, DOI 10.1091/mbc.E03-02-0115; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Velloso LM, 2002, J BIOL CHEM, V277, P15979, DOI 10.1074/jbc.M112098200; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Yeung T, 1995, J BIOL CHEM, V270, P30567, DOI 10.1074/jbc.270.51.30567	49	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24049	24060		10.1074/jbc.M109.022590	http://dx.doi.org/10.1074/jbc.M109.022590			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574229	hybrid, Green Published			2022-12-27	WOS:000269380200019
J	Nakada, S; Sakakura, M; Takahashi, H; Okuda, S; Tokuda, H; Shimada, I				Nakada, Shingo; Sakakura, Masayoshi; Takahashi, Hideo; Okuda, Suguru; Tokuda, Hajime; Shimada, Ichio			Structural Investigation of the Interaction between LolA and LolB Using NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE LIPOPROTEIN; ESCHERICHIA-COLI LIPOPROTEINS; INNER MEMBRANE; HYDROPHOBIC CAVITY; FATTY-ACID; PROTEIN; LOCALIZATION; BINDING; RELEASE; TRANSPORTER	Lipoproteins that play critical roles in various cellular functions of Gram-negative bacteria are localized in the cells inner and outer membranes. Lol proteins (LolA, LolB, LolC, LolD, and LolE) are involved in the transportation of outer membrane-directed lipoproteins from the inner to the outer membrane. LolA is a periplasmic chaperone that transports lipoproteins, and LolB is an outer membrane receptor that accepts lipoproteins. To clarify the structural basis for the lipoprotein transfer from LolA to LolB, we examined the interaction between LolA and mLolB, a soluble mutant of LolB, using solution NMR spectroscopy. We determined the interaction mode between LolA and mLolB with conformational changes of LolA. Based upon the observations, we propose that the LolA center dot LolB complex forms a tunnel-like structure, where the hydrophobic insides of LolA and LolB are connected, which enables lipoproteins to transfer from LolA to LolB.	[Nakada, Shingo; Sakakura, Masayoshi; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Nakada, Shingo] Dainippon Sumitomo Pharma Ltd, Lab Genom Sci, Osaka 5640053, Japan; [Takahashi, Hideo; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Okuda, Suguru; Tokuda, Hajime] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Shimada, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Okuda, Suguru/K-6571-2017	Okuda, Suguru/0000-0002-9184-5601				BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Braun V., 1994, BACTERIAL CELL WALL, P319, DOI 10.1016/S0167-7306(08)60417-2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Hajduk PJ, 1997, J MED CHEM, V40, P3144, DOI 10.1021/jm9703404; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Nakada S, 2007, BIOMOL NMR ASSIGN, V1, P125, DOI 10.1007/s12104-007-9034-z; Nakada S, 2007, BIOMOL NMR ASSIGN, V1, P121, DOI 10.1007/s12104-007-9033-0; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Narita S, 2003, MOL MICROBIOL, V49, P167, DOI 10.1046/j.1365-2958.2003.03569.x; Narita S, 2002, J BACTERIOL, V184, P1417, DOI 10.1128/JB.184.5.1417-1422.2002; Oguchi Y, 2008, J BIOL CHEM, V283, P25414, DOI 10.1074/jbc.M804736200; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Tanaka K, 2001, J BACTERIOL, V183, P6538, DOI 10.1128/JB.183.22.6538-6542.2001; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; Tokuda H, 2007, PERIPLASM, P67; Wada R, 2004, BIOCHEM BIOPH RES CO, V323, P1069, DOI 10.1016/j.bbrc.2004.08.200; Watanabe S, 2008, J BIOL CHEM, V283, P25421, DOI 10.1074/jbc.M804737200; Yakushi T, 1998, J BIOL CHEM, V273, P32576, DOI 10.1074/jbc.273.49.32576; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Yakushi T, 1997, J BACTERIOL, V179, P2857, DOI 10.1128/jb.179.9.2857-2862.1997; Yokota N, 1999, J BIOL CHEM, V274, P30995, DOI 10.1074/jbc.274.43.30995	32	15	17	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24634	24643		10.1074/jbc.M109.001149	http://dx.doi.org/10.1074/jbc.M109.001149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19546215	Green Published, hybrid			2022-12-27	WOS:000269380200072
J	Vedula, LS; Brannigan, G; Economou, NJ; Xi, J; Hall, MA; Liu, R; Rossi, MJ; Dailey, WP; Grasty, KC; Klein, ML; Eckenhoff, RG; Loll, PJ				Vedula, L. Sangeetha; Brannigan, Grace; Economou, Nicoleta J.; Xi, Jin; Hall, Michael A.; Liu, Renyu; Rossi, Matthew J.; Dailey, William P.; Grasty, Kimberly C.; Klein, Michael L.; Eckenhoff, Roderic G.; Loll, Patrick J.			A Unitary Anesthetic Binding Site at High Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSE-SPLEEN APOFERRITIN; HUMAN SERUM-ALBUMIN; L-CHAIN APOFERRITIN; GENERAL-ANESTHETICS; GABA(A) RECEPTOR; PROPOFOL ANALOGS; STRUCTURAL BASIS; IDENTIFICATION; CAVITY; MODULATION	Propofol is the most widely used injectable general anesthetic. Its targets include ligand-gated ion channels such as the GABA(A) receptor, but such receptor-channel complexes remain challenging to study at atomic resolution. Until structural biology methods advance to the point of being able to deal with systems such as the GABA(A) receptor, it will be necessary to use more tractable surrogates to probe the molecular details of anesthetic recognition. We have previously shown that recognition of inhalational general anesthetics by the model protein apoferritin closely mirrors recognition by more complex and clinically relevant protein targets; here we show that apoferritin also binds propofol and related GABAergic anesthetics, and that the same binding site mediates recognition of both inhalational and injectable anesthetics. Apoferritin binding affinities for a series of propofol analogs were found to be strongly correlated with the ability to potentiate GABA responses at GABA(A) receptors, validating this model system for injectable anesthetics. High resolution x-ray crystal structures reveal that, despite the presence of hydrogen bond donors and acceptors, anesthetic recognition is mediated largely by van der Waals forces and the hydrophobic effect. Molecular dynamics simulations indicate that the ligands undergo considerable fluctuations about their equilibrium positions. Finally, apoferritin displays both structural and dynamic responses to anesthetic binding, which may mimic changes elicited by anesthetics in physiologic targets like ion channels.	[Economou, Nicoleta J.; Rossi, Matthew J.; Grasty, Kimberly C.; Loll, Patrick J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Economou, Nicoleta J.; Rossi, Matthew J.] Drexel Univ, Coll Med, Grad Program Biochem, Philadelphia, PA 19102 USA; [Vedula, L. Sangeetha; Xi, Jin; Liu, Renyu; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Brannigan, Grace; Hall, Michael A.; Dailey, William P.; Klein, Michael L.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Drexel University; Drexel University; University of Pennsylvania; University of Pennsylvania	Loll, PJ (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,MS 497, Philadelphia, PA 19102 USA.	patrick.loll@drexelmed.edu	Brannigan, Grace/ABA-2750-2021	Brannigan, Grace/0000-0001-8949-2694; Eckenhoff, Roderic/0000-0002-5581-746X; Rossi, Matthew/0000-0002-7796-919X	National Institutes of Health [GM51595, GM55876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876, R01GM051595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51595 and GM55876 (to R. G. E.).	AROSIO P, 2002, FERRITINS STRUCTURAL; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Breslow R, 2002, J AM CHEM SOC, V124, P3622, DOI 10.1021/ja012293h; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Chang CSS, 2003, J BIOL CHEM, V278, P42821, DOI 10.1074/jbc.M306978200; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Gallois B, 1997, J BIOL INORG CHEM, V2, P360, DOI 10.1007/s007750050143; Granier T, 1997, ACTA CRYSTALLOGR D, V53, P580, DOI 10.1107/S0907444997003314; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAMES R, 1980, J MED CHEM, V23, P1350, DOI 10.1021/jm00186a013; Jenkins A, 2002, NEUROPHARMACOLOGY, V43, P669, DOI 10.1016/S0028-3908(02)00175-2; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Ko SH, 1997, ANESTH ANALG, V85, P719, DOI 10.1097/00000539-199710000-00002; Kotani Y, 2008, CNS NEUROSCI THER, V14, P95, DOI 10.1111/j.1527-3458.2008.00043.x; Krasowski MD, 2002, J MED CHEM, V45, P3210, DOI 10.1021/jm010461a; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; Liu RY, 2004, BIOCHEM J, V380, P147, DOI 10.1042/BJ20031652; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mecozzi S, 1998, CHEM-EUR J, V4, P1016, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1016::AID-CHEM1016>3.0.CO;2-B; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; REYNOLDS JA, 1974, P NATL ACAD SCI USA, V71, P2925, DOI 10.1073/pnas.71.8.2925; Schofield CM, 2005, BRAIN RES, V1032, P30, DOI 10.1016/j.brainres.2004.11.002; Sewell JC, 2004, BRIT J ANAESTH, V92, P45, DOI 10.1093/bja/aeh016; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; THEIL EC, 2001, HDB METALLOPROTEINS; Thomas BR, 1998, J CRYST GROWTH, V187, P499, DOI 10.1016/S0022-0248(98)00033-5; Yoshizawa K, 2007, J BIOCHEM, V142, P707, DOI 10.1093/jb/mvm187	39	61	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24176	24184		10.1074/jbc.M109.017814	http://dx.doi.org/10.1074/jbc.M109.017814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19605349	Green Published, hybrid			2022-12-27	WOS:000269380200031
J	Kroeger, H; Miranda, E; MacLeod, I; Perez, J; Crowther, DC; Marciniak, SJ; Lomas, DA				Kroeger, Heike; Miranda, Elena; MacLeod, Ian; Perez, Juan; Crowther, Damian C.; Marciniak, Stefan J.; Lomas, David A.			Endoplasmic Reticulum-associated Degradation (ERAD) and Autophagy Cooperate to Degrade Polymerogenic Mutant Serpins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; CONFORMATIONAL DISEASE; ALPHA(1)-ANTITRYPSIN Z; PROTEASOME ACTIVITY; STRESS; ACCUMULATION; NEUROSERPIN; PATHWAY; SERPINOPATHIES	The serpinopathies are a family of diseases characterized by the accumulation of ordered polymers of mutant protein within the endoplasmic reticulum. They are a diverse group including alpha(1)-antitrypsin deficiency and the inherited dementia familial encephalopathy with neuroserpin inclusion bodies or FENIB. We have used transient transfection of COS7 cells and mouse embryonic fibroblasts, PC12 cell lines that conditionally express wild type and mutant neuroserpin and fly models of FENIB to assess the cellular handling of wild type and mutant serpins. By using a polymer-specific monoclonal antibody, we show that mutant neuroserpin forms polymers after a delay of at least 30 min and that polymers can be cleared in PC12 cell lines and from the brain in a fly model of FENIB. At steady state, the fractions of intracellular polymerogenic G392E mutant neuroserpin in the monomeric and polymeric states are comparable. Inhibition of the proteasome with MG132 reveals that both mutant neuroserpin and alpha(1)-antitrypsin are degraded predominantly by endoplasmic reticulum-associated degradation (ERAD). Pharmacological and genetic inhibitions demonstrate that autophagy is responsible for bulk turnover of wild type and mutant serpins, but can be stimulated by rapamycin to compensate for proteasome inhibition. The significance of these findings to the treatment of serpinopathies is discussed.	[Kroeger, Heike; Miranda, Elena; MacLeod, Ian; Perez, Juan; Marciniak, Stefan J.; Lomas, David A.] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Perez, Juan] Univ Malaga, Fac Ciencias, Dept Biol Celular Genet & Fisiol, E-29071 Malaga, Spain; [MacLeod, Ian; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; Universidad de Malaga; University of Cambridge	Marciniak, SJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med, Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England.	sjm20@cam.ac.uk	Miranda, Elena/J-4999-2012; Marciniak, Stefan J/F-1855-2010	Miranda, Elena/0000-0002-0586-8795; Marciniak, Stefan/0000-0001-8472-7183	Medical Research Council [G0700990]; Engineering and Physical Sciences Research Council; Alzheimer Research Trust; Papworth National Health Service Trust; German Academic Exchange Service (DAAD); Ministerio de Ciencia e Innovacion [PR2008-0615, BFU 2006-11754]; MRC [G0700990, G0500306, G0601840] Funding Source: UKRI; Medical Research Council [G0500306, G0601840] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alzheimer Research Trust; Papworth National Health Service Trust; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the Medical Research Council, Engineering and Physical Sciences Research Council, the Alzheimer Research Trust, and the Papworth National Health Service Trust.; 1 Funded by the German Academic Exchange Service (DAAD).; 2 Supported by the Ministerio de Ciencia e Innovacion, Grants PR2008-0615 and BFU 2006-11754 (Spain).; 3 Supported by the MRC (Grant G0700990).; 5 An MRC Clinician Scientist (Grant G0601840).	Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Davies MJ, 2009, J BIOL CHEM, V284, P18202, DOI 10.1074/jbc.M109.010744; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Gooptu B, 2008, J EXP MED, V205, P1529, DOI 10.1084/jem.20072080; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; Granell S, 2008, MOL BIOL CELL, V19, P572, DOI 10.1091/mbc.E07-06-0587; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Latouche M, 2007, J NEUROSCI, V27, P2483, DOI 10.1523/JNEUROSCI.5453-06.2007; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lomas DA, 2002, J CLIN INVEST, V110, P1585, DOI 10.1172/JCI200216782; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; MCCRACKEN AA, 1993, MOL BIOL CELL, V4, P729, DOI 10.1091/mbc.4.7.729; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Scott CM, 2007, MOL BIOL CELL, V18, P3776, DOI 10.1091/mbc.E07-01-0034; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Takao M, 2000, J NEUROPATH EXP NEUR, V59, P1070, DOI 10.1093/jnen/59.12.1070; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	39	103	104	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22793	22802		10.1074/jbc.M109.027102	http://dx.doi.org/10.1074/jbc.M109.027102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19549782	hybrid, Green Published			2022-12-27	WOS:000268963100033
J	Tsang, CK; Zheng, XFS				Tsang, Chi Kwan; Zheng, X. F. Steven			Opposing Role of Condensin and Radiation-sensitive Gene RAD52 in Ribosomal DNA Stability Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; RNA-POLYMERASE-I; TOR-SIGNALING PATHWAY; SACCHAROMYCES-CEREVISIAE; YEAST RDNA; RECOMBINATIONAL REPAIR; BLOCK PROTEIN; LIFE-SPAN; INTEGRITY; CHROMATIN	Blocking target of rapamycin signaling by starvation or rapamycin inhibits ribosomal DNA (rDNA) transcription and causes condensin-mediated rDNA condensation and nucleolar contraction. In the absence of condensin, however, repression of rDNA transcription leads to rDNA instability and elevated level of extrachromosomal rDNA circles and nucleolar fragmentation. Here, we show that mutations in the Rad52 homologous recombination machinery block rDNA instability. Rad52 is normally excluded from the nucleolus. In the absence of condensin, however, repression of rDNA transcription results in Rad52 localization to the nucleolus, association with rDNA and subsequent formation of extrachromosomal rDNA circles, and reduced cell survival. In contrast, deletion of RAD52 restores cell viability under the same conditions. These results reveal an opposing role of condensin and Rad52 in the control of rDNA stability under nutrient starvation conditions.	[Zheng, X. F. Steven] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Zheng, XFS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	zhengst@umdnj.edu	Tsang, Chi Kwan/AAD-6819-2020	Tsang, Chi Kwan/0000-0002-0133-1544	National Institutes of Health [RO1CA123391]; NATIONAL CANCER INSTITUTE [R01CA123391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA123391.	Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Brachmann CB, 1998, YEAST, V14, P115; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; BURKE D, 2000, METHODS YEAST GENETI, P135; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Johnson FB, 1998, CURR OPIN CELL BIOL, V10, P332, DOI 10.1016/S0955-0674(98)80008-2; Johzuka K, 2002, GENES CELLS, V7, P99, DOI 10.1046/j.1356-9597.2001.00508.x; KIM RA, 1989, CELL, V57, P975, DOI 10.1016/0092-8674(89)90336-X; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kobayashi T, 2008, BIOESSAYS, V30, P267, DOI 10.1002/bies.20723; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Park PU, 1999, MOL CELL BIOL, V19, P3848; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Shiloh Y, 2004, NAT CELL BIOL, V6, P923, DOI 10.1038/ncb1004-923; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith J, 1999, GENETICS, V151, P447; Smith JS, 1998, GENETICS, V149, P1205; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Tsang CK, 2007, CELL CYCLE, V6, P2213, DOI 10.4161/cc.6.18.4733; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Tsang CK, 2007, EMBO J, V26, P448, DOI 10.1038/sj.emboj.7601488; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463	37	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21908	21919		10.1074/jbc.M109.031302	http://dx.doi.org/10.1074/jbc.M109.031302			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520859	hybrid, Green Published			2022-12-27	WOS:000268783700015
J	Jagadeesan, S; Mann, P; Schink, CW; Higgs, PI				Jagadeesan, Sakthimala; Mann, Petra; Schink, Christian W.; Higgs, Penelope I.			A Novel "Four-component" Two-component Signal Transduction Mechanism Regulates Developmental Progression in Myxococcus xanthus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE PROTEIN-KINASE; CELL-CYCLE PROGRESSION; MULTISTEP PHOSPHORELAY; PHOSPHATASE-ACTIVITY; CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; DOMAINS; EXPRESSION; SYSTEM; PHOSPHORYLATION	Histidine-aspartate phosphorelays are employed by two-component signal transduction family proteins to mediate responses to specific signals or stimuli in microorganisms and plants. The Red-CDEF proteins constitute a novel signaling system in which four two-component proteins comprising a histidine kinase, a histidine-kinase like protein, and two response regulators function together to regulate progression through the elaborate developmental program of Myxococcus xanthus. A combination of in vivo phenotypic analyses of in-frame deletions and non-functional point mutations in each gene as well as in vitro autophosphorylation and phosphotransfer analyses of recombinant proteins indicate that the RedC histidine kinase protein autophosphorylates and donates a phosphoryl group to the single domain response regulator, RedF, to repress progression through the developmental program. To relieve this developmental repression, RedC instead phosphorylates RedD, a dual receiver response regulator protein. Surprisingly, RedD transfers the phosphoryl group to the histidine kinase-like protein RedE, which itself appears to be incapable of autophosphorylation. Phosphorylation of RedE may render RedE accessible to RedF, where it removes the phosphoryl group from RedF-P, which is otherwise an unusually stable phosphoprotein. These analyses reveal a novel "four-component" signaling mechanism that has probably arisen to temporally coordinate signals controlling the developmental program in M. xanthus. The RedCDEF signaling system provides an important example of how the inherent plasticity and modularity of the basic two-component signaling domains comprise a highly adaptable framework well suited to expansion into complex signaling mechanisms.	[Jagadeesan, Sakthimala; Mann, Petra; Schink, Christian W.; Higgs, Penelope I.] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany	Max Planck Society	Higgs, PI (corresponding author), Karl von Frisch Str 1, D-35043 Marburg, Germany.	higgs@mpi-marburg.mpg.de	Higgs, Penelope/Y-8862-2019	Higgs, Penelope/0000-0003-4726-3329	Max Planck Society; International Max Planck Research School	Max Planck Society(Max Planck SocietyFoundation CELLEX); International Max Planck Research School	This work was supported by the Max Planck Society and a fellowship from the International Max Planck Research School (to S. J.).	BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Biondi EG, 2006, MOL MICROBIOL, V59, P386, DOI 10.1111/j.1365-2958.2005.04970.x; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Cho KY, 1999, MOL MICROBIOL, V34, P714, DOI 10.1046/j.1365-2958.1999.01633.x; Ellehauge E, 1998, MOL MICROBIOL, V30, P807, DOI 10.1046/j.1365-2958.1998.01113.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; Higgs PI, 2008, J BACTERIOL, V190, P4416, DOI 10.1128/JB.00265-08; Higgs PI, 2005, J BACTERIOL, V187, P8191, DOI 10.1128/JB.187.23.8191-8195.2005; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Kaiser D, 2004, ANNU REV MICROBIOL, V58, P75, DOI 10.1146/annurev.micro.58.030603.123620; KAMBEROV ES, 1994, J BIOL CHEM, V269, P28294; Kato M, 1997, CELL, V88, P717, DOI 10.1016/S0092-8674(00)81914-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee B, 2005, J BACTERIOL, V187, P5029, DOI 10.1128/JB.187.14.5029-5031.2005; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Maniatis T., 1982, MOL CLONING; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Matsubara M, 2000, GENES CELLS, V5, P555, DOI 10.1046/j.1365-2443.2000.00347.x; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Perraud AL, 1999, TRENDS MICROBIOL, V7, P115, DOI 10.1016/S0966-842X(99)01458-4; PLAMANN L, 1995, J BACTERIOL, V177, P2014, DOI 10.1128/jb.177.8.2014-2020.1995; Pollack JS, 2001, J BACTERIOL, V183, P3589, DOI 10.1128/JB.183.12.3589-3596.2001; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rasmussen AA, 2006, MOL MICROBIOL, V60, P525, DOI 10.1111/j.1365-2958.2006.05118.x; Rasmussen AA, 2003, J BACTERIOL, V185, P5452, DOI 10.1128/JB.185.18.5452-5464.2003; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; Romagnoli S, 2006, J BACTERIOL, V188, P2780, DOI 10.1128/JB.188.8.2780-2791.2006; Romagnoli S, 2007, J BACTERIOL, V189, P325, DOI 10.1128/JB.01326-06; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Song HK, 1999, J MOL BIOL, V293, P753, DOI 10.1006/jmbi.1999.3215; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; Thomas SA, 2008, MOL MICROBIOL, V69, P453, DOI 10.1111/j.1365-2958.2008.06296.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Williams SB, 1997, MOL MICROBIOL, V26, P911, DOI 10.1046/j.1365-2958.1997.6262002.x; Xu QP, 1999, J MOL BIOL, V292, P1039, DOI 10.1006/jmbi.1999.3143; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808	53	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21435	21445		10.1074/jbc.M109.033415	http://dx.doi.org/10.1074/jbc.M109.033415			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535336	Green Published, hybrid			2022-12-27	WOS:000268564400038
J	Mochizuki, T; Sokabe, T; Araki, I; Fujishita, K; Shibasaki, K; Uchida, K; Naruse, K; Koizumi, S; Takeda, M; Tominaga, M				Mochizuki, Tsutomu; Sokabe, Takaaki; Araki, Isao; Fujishita, Kayoko; Shibasaki, Koji; Uchida, Kunitoshi; Naruse, Keiji; Koizumi, Schuichi; Takeda, Masayuki; Tominaga, Makoto			The TRPV4 Cation Channel Mediates Stretch-evoked Ca2+ Influx and ATP Release in Primary Urothelial Cell Cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL VANILLOID-4; RAT URINARY-BLADDER; SENSORY TRANSDUCTION; MICE LACKING; ION-CHANNEL; ACTIVATION; TEMPERATURE; EXPRESSION; INVOLVEMENT; HEAT	Transient receptor potential channels have recently been implicated in physiological functions in a urogenital system. In this study, we investigated the role of transient receptor potential vanilloid 4 (TRPV4) channels in a stretch sensing mechanism in mouse primary urothelial cell cultures. The selective TRPV4 agonist, 4 alpha-phorbol 12,13-didecanoate (4 alpha-PDD) evoked Ca2+ influx in wild-type (WT) urothelial cells, but not in TRPV4-deficient (TRPV4KO) cells. We established a cell-stretch system to investigate stretch-evoked changes in intracellular Ca2+ concentration and ATP release. Stretch stimulation evoked intracellular Ca2+ increases in a stretch speed- and distance-dependent manner in WT and TRPV4KO cells. In TRPV4KO urothelial cells, however, the intracellular Ca2+ increase in response to stretch stimulation was significantly attenuated compared with that in WT cells. Stretch-evoked Ca2+ increases in WT urothelium were partially reduced in the presence of ruthenium red, a broad TRP channel blocker, whereas that in TRPV4KO cells did not show such reduction. Potent ATP release occurred following stretch stimulation or 4 alpha-PDD administration in WT urothelial cells, which was dramatically suppressed in TRPV4KO cells. Stretch-dependent ATP release was almost completely eliminated in the presence of ruthenium red or in the absence of extracellular Ca2+. These results suggest that TRPV4 senses distension of the bladder urothelium, which is converted to an ATP signal in the micturition reflex pathway during urine storage.	[Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Yamanashi 4093898, Japan; [Mochizuki, Tsutomu; Sokabe, Takaaki; Shibasaki, Koji; Uchida, Kunitoshi; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Sokabe, Takaaki; Shibasaki, Koji; Uchida, Kunitoshi; Tominaga, Makoto] Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; [Naruse, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Physiol, Okayama 7008558, Japan; [Fujishita, Kayoko; Koizumi, Schuichi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pharmacol, Yamanashi 4093898, Japan	University of Yamanashi; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Okayama University; University of Yamanashi	Sokabe, T (corresponding author), Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	sokabe@nips.ac.jp; tominaga@nips.ac.jp	Shibasaki, Koji/U-8674-2018; NARUSE, Keiji/B-1620-2011; Sokabe, Masahiro/I-1565-2012; Koizumi, Schuichi/E-8568-2010	Shibasaki, Koji/0000-0003-2330-1749; Koizumi, Schuichi/0000-0001-6184-3106; Sokabe, Takaaki/0000-0003-1280-9424; naruse, keiji/0000-0003-4100-6444				Andrade EL, 2006, BIOCHEM PHARMACOL, V72, P104, DOI 10.1016/j.bcp.2006.04.003; Araki I, 2008, INT J UROL, V15, P681, DOI 10.1111/j.1442-2042.2008.02052.x; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Avelino A, 2006, N-S ARCH PHARMACOL, V373, P287, DOI 10.1007/s00210-006-0073-2; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Birder LA, 2005, AM J PHYSIOL-RENAL, V289, pF489, DOI 10.1152/ajprenal.00467.2004; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Birder LA, 2001, P NATL ACAD SCI USA, V98, P13396, DOI 10.1073/pnas.231243698; Birder L, 2007, J PHARMACOL EXP THER, V323, P227, DOI 10.1124/jpet.107.125435; Birder LA, 2007, NAT CLIN PRACT UROL, V4, P46, DOI 10.1038/ncpuro0672; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Denda M, 2007, J INVEST DERMATOL, V127, P654, DOI 10.1038/sj.jid.5700590; Du SQ, 2008, UROLOGY, V72, P450, DOI 10.1016/j.urology.2007.11.127; Du S, 2007, UROLOGY, V70, P826, DOI 10.1016/j.urology.2007.06.1110; Erman A, 2006, TISSUE CELL, V38, P293, DOI 10.1016/j.tice.2006.07.001; Everaerts W, 2008, NEUROUROL URODYNAM, V27, P264, DOI 10.1002/nau.20511; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Guler AD, 2002, J NEUROSCI, V22, P6408; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Kreft ME, 2005, FOLIA BIOL-PRAGUE, V51, P126; Kreft ME, 2002, CELL BIOL INT, V26, P63, DOI 10.1006/cbir.2001.0829; Kurzrock EA, 2005, J UROLOGY, V173, P281, DOI 10.1097/01.ju.0000141585.17953.fa; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Tabuchi K, 2005, NEUROSCI LETT, V382, P304, DOI 10.1016/j.neulet.2005.03.035; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Tsukimi Y, 2005, UROLOGY, V65, P406, DOI 10.1016/j.urology.2004.10.006; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Yoshimura N, 2008, N-S ARCH PHARMACOL, V377, P437, DOI 10.1007/s00210-007-0209-z; Zhang YY, 2001, IN VITRO CELL DEV-AN, V37, P419	49	206	210	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21257	21264		10.1074/jbc.M109.020206	http://dx.doi.org/10.1074/jbc.M109.020206			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531473	hybrid, Green Published			2022-12-27	WOS:000268564400019
J	Takeshita, M; Ishida, Y; Akamatsu, E; Ohmori, Y; Sudoh, M; Uto, H; Tsubouchi, H; Kataoka, H				Takeshita, Masahiko; Ishida, Yo-ichi; Akamatsu, Ena; Ohmori, Yusuke; Sudoh, Masayuki; Uto, Hirofumi; Tsubouchi, Hirohito; Kataoka, Hiroaki			Proanthocyanidin from Blueberry Leaves Suppresses Expression of Subgenomic Hepatitis C Virus RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-ENTRY SITE; TRANSLATION FACTOR EIF3; MASS-SPECTROMETRY; VIRAL-HEPATITIS; PROTEASE INHIBITOR; BINDING PROTEIN; SYNCYTIAL VIRUS; PLUS RIBAVIRIN; SP-303; PROCYANIDINS	Hepatitis C virus (HCV) infection is a major cause of chronic liver disease such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. While searching for new natural anti-HCV agents in agricultural products, we found a potent inhibitor of HCV RNA expression in extracts of blueberry leaves when examined in an HCV subgenomic replicon cell culture system. This activity was observed in a methanol extract fraction of blueberry leaves and was purified by repeated fractionations in reversed-phase high-performance liquid chromatography. The final purified fraction showed a 63-fold increase in specific activity compared with the initial methanol extracts and was composed only of carbon, hydrogen, and oxygen. Liquid chromatography/mass- ion trap-time of flight analysis and butanol-HCl hydrolysis analysis of the purified fraction revealed that the blueberry leaf-derived inhibitor was proanthocyanidin. Furthermore, structural analysis using acid thiolysis indicated that the mean degree of polymerization of the purified proanthocyanidin was 7.7, consisting predominantly of epicatechin. Proanthocyanidin with a polymerization degree of 8 to 9 showed the greatest potency at inhibiting the expression of subgenomic HCV RNA. Purified proanthocyanidin showed dose-dependent inhibition of expression of the neomycin-resistant gene and the NS-3 protein gene in the HCV subgenome in replicon cells. While characterizing the mechanism by which proanthocyanidin inhibited HCV subgenome expression, we found that heterogeneous nuclear ribonucleoprotein A2/B1 showed affinity to blueberry leaf-derived proanthocyanidin and was indispensable for HCV subgenome expression in replicon cells. These data suggest that proanthocyanidin isolated from blueberry leaves may have potential usefulness as an anti-HCV compound by inhibiting viral replication.	[Kataoka, Hiroaki] Miyazaki Univ, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, Miyazaki 8891692, Japan; [Ishida, Yo-ichi; Akamatsu, Ena] Miyazaki Prefectural Ind Support Fdn, Miyazaki 8800303, Japan; Minami Nippon Dairy Coop Co Ltd, Div Res, Miyazaki 8850073, Japan; [Ohmori, Yusuke; Sudoh, Masayuki] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Kanagawa 2478530, Japan; [Uto, Hirofumi; Tsubouchi, Hirohito] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Dis & Life Style Related Dis, Kagoshima 8908520, Japan	University of Miyazaki; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Kagoshima University	Kataoka, H (corresponding author), Miyazaki Univ, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, 5200 Kihara, Miyazaki 8891692, Japan.	mejina@fc.miyazaki-u.ac.jp			Collaboration of Regional virgatum Aiton); Japan Science and Technology Agency	Collaboration of Regional virgatum Aiton); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by a grant from the Collaboration of Regional virgatum Aiton), which is cultivated in southern areas of Japan. Entities for the Advancement of Technological Excellence (CREATE) from Japan Science and Technology Agency.	ARNOLD RA, 1978, AM J ENOL VITICULT, V29, P150; BARNARD DL, 1993, CHEMOTHERAPY, V39, P203, DOI 10.1159/000239127; BARNARD DL, 1993, CHEMOTHERAPY, V39, P212, DOI 10.1159/000239128; Brossaud F, 2001, AUST J GRAPE WINE R, V7, P33, DOI 10.1111/j.1755-0238.2001.tb00191.x; CHEN ZP, 1994, PLANTA MED, V60, P541, DOI 10.1055/s-2006-959567; Cheng Hua-Yew, 2002, Antivir Chem Chemother, V13, P223; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; De Franceschi L, 2000, HEPATOLOGY, V31, P997, DOI 10.1053/he.2000.5789; DIBISCEGLIE AM, 1991, AM J GASTROENTEROL, V86, P335; Dillon JF, 2004, J VIRAL HEPATITIS, V11, P23, DOI 10.1111/j.1365-2893.2004.00573.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; GILBERT BE, 1993, ANTIVIR RES, V21, P37, DOI 10.1016/0166-3542(93)90065-Q; Gu LW, 2002, J AGR FOOD CHEM, V50, P4852, DOI 10.1021/jf020214v; Guyot S, 2001, J AGR FOOD CHEM, V49, P14, DOI 10.1021/jf000814z; Hahn B, 1998, J VIROL, V72, P8782, DOI 10.1128/JVI.72.11.8782-8788.1998; Harris D, 2006, MOL CELL PROTEOMICS, V5, P1006, DOI 10.1074/mcp.M500429-MCP200; Hwang B, 2009, BIOCHEM BIOPH RES CO, V378, P584, DOI 10.1016/j.bbrc.2008.11.091; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kim JH, 2004, MOL CELL BIOL, V24, P7878, DOI 10.1128/MCB.24.18.7878-7890.2004; Kovtun YV, 2007, CANCER LETT, V255, P232, DOI 10.1016/j.canlet.2007.04.010; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Li DS, 2004, J VIROL, V78, P12075, DOI 10.1128/JVI.78.21.12075-12081.2004; Lu H, 2004, J PROTEOME RES, V3, P949, DOI 10.1021/pr0499592; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; Myles D C, 2001, Curr Opin Drug Discov Devel, V4, P411; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Ni ZJ, 2004, CURR OPIN DRUG DISC, V7, P446; OrozcoTopete R, 1997, ANTIVIR RES, V35, P91, DOI 10.1016/S0166-3542(97)00015-6; Pacheco A, 2008, PROTEOMICS, V8, P4782, DOI 10.1002/pmic.200800338; Pawlotsky JM, 2006, ANTIVIR THER, V11, P397; Porter L.J., 1988, FLAVONOIDS, P21, DOI DOI 10.1007/978-1-4899-2913-6_2; PORTER LJ, 1985, PHYTOCHEMISTRY, V25, P223, DOI 10.1016/S0031-9422(00)94533-3; Pudi R, 2005, J VIROL, V79, P9842, DOI 10.1128/JVI.79.15.9842-9853.2005; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Romero-Lopez C, 2007, CELL MOL LIFE SCI, V64, P2994, DOI 10.1007/s00018-007-7345-y; SAFRIN S, 1994, ANTIVIR RES, V25, P185, DOI 10.1016/0166-3542(94)90002-7; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; Seeff L.B., 1999, AM J MED, V107, P10, DOI [10.1016/S0002-9343(99)00374-5, DOI 10.1016/S0002-9343(99)00374-5]; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shoji T, 2006, J AGR FOOD CHEM, V54, P884, DOI 10.1021/jf052260b; SIDWELL RW, 1994, CHEMOTHERAPY, V40, P42, DOI 10.1159/000239169; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Stauber RE, 2006, J CLIN VIROL, V36, P87, DOI 10.1016/j.jcv.2006.02.003; Tonge R, 2001, PROTEOMICS, V1, P377; Williams J E, 2001, Altern Med Rev, V6, P567; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Xu L, 2008, EXP CLIN ENDOCR DIAB, V116, P215, DOI 10.1055/s-2007-993188; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	53	88	105	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21165	21176		10.1074/jbc.M109.004945	http://dx.doi.org/10.1074/jbc.M109.004945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531480	Green Published, hybrid			2022-12-27	WOS:000268564400009
J	Eggert, S; Midthune, B; Cottrell, B; Koo, EH				Eggert, Simone; Midthune, Brea; Cottrell, Barbara; Koo, Edward H.			Induced Dimerization of the Amyloid Precursor Protein Leads to Decreased Amyloid-beta Protein Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; INTRAMEMBRANE CLEAVAGE; A-BETA; TRANSMEMBRANE DOMAIN; TERMINAL FRAGMENT; GXXXG MOTIFS; CELL-SURFACE; HUMAN BRAIN; PRESENILIN	The amyloid precursor protein (APP) plays a central role in Alzheimer disease (AD) pathogenesis because sequential cleavages by beta- and gamma-secretase lead to the generation of the amyloid-beta (A beta) peptide, a key constituent in the amyloid plaques present in brains of AD individuals. In several studies APP has recently been shown to form homodimers, and this event appears to influence A beta generation. However, these studies have relied on APP mutations within the A beta sequence itself that may affect APP processing by interfering with secretase cleavages independent of dimerization. Therefore, the impact of APP dimerization on A beta production remains unclear. To address this question, we compared the approach of constitutive cysteine-induced APP dimerization with a regulatable dimerization system that does not require the introduction of mutations within the A beta sequence. To this end we generated an APP chimeric molecule by fusing a domain of the FK506-binding protein (FKBP) to the C terminus of APP. The addition of the synthetic membrane-permeant drug AP20187 induces rapid dimerization of the APP-FKBP chimera. Using this system we were able to induce up to 70% APP dimers. Our results showed that controlled homodimerization of APP-FKBP leads to a 50% reduction in total A beta levels in transfected N2a cells. Similar results were obtained with the direct precursor of beta-secretase cleavage, C99/SPA4CT-FKBP. Furthermore, there was no modulation of different A beta peptide species after APP dimerization in this system. Taken together, our results suggest that APP dimerization can directly affect gamma-secretase processing and that dimerization is not required for A beta production.	[Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, LBR, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Koo, EH (corresponding author), Univ Calif San Diego, Dept Neurosci, LBR, 9500 Gilman Dr, La Jolla, CA 92093 USA.	edkoo@ucsd.edu			National Institutes of Health [AG 12376]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE ON AGING [R01AG012376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG 12376 (to E. H. K.). This work was also supported in part by a Deutsche Forschungsgemeinschaft postdoctoral fellowship (to S. E.).	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Chan SL, 2008, J NEUROCHEM, V106, P793, DOI 10.1111/j.1471-4159.2008.05433.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Clackson T, 2006, CHEM BIOL DRUG DES, V67, P440, DOI 10.1111/j.1747-0285.2006.00403.x; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Florean C, 2008, BBA-MOL CELL RES, V1783, P1551, DOI 10.1016/j.bbamcr.2008.03.012; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goldsbury C, 2007, J NEUROSCI, V27, P3357, DOI 10.1523/JNEUROSCI.5024-06.2007; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Lu DC, 2003, ANN NEUROL, V54, P781, DOI 10.1002/ana.10761; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rebelo S, 2007, J MOL NEUROSCI, V32, P1, DOI 10.1007/s12031-007-0001-z; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; WANG R, 1991, J BIOL CHEM, V266, P16960; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200	54	74	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28943	28952		10.1074/jbc.M109.038646	http://dx.doi.org/10.1074/jbc.M109.038646			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19596858	Green Published, hybrid			2022-12-27	WOS:000270678900051
J	Chen, C; Fu, ZJ; Kim, JJP; Barbieri, JT; Baldwin, MR				Chen, Chen; Fu, Zhuji; Kim, Jung-Ja P.; Barbieri, Joseph T.; Baldwin, Michael R.			Gangliosides as High Affinity Receptors for Tetanus Neurotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-C FRAGMENT; CHOLERA-TOXIN; PROTEIN-RECEPTOR; BOTULINUM TOXINS; BINDING-SITES; CELLS; ENDOCYTOSIS; EXPRESSION; DOMAIN	Tetanus neurotoxin (TeNT) is an exotoxin produced by Clostridium tetani that causes paralytic death to hundreds of thousands of humans annually. TeNT cleaves vesicle-associated membrane protein-2, which inhibits neurotransmitter release in the central nervous system to elicit spastic paralysis, but the molecular basis for TeNT entry into neurons remains unclear. TeNT is a similar to 150-kDa protein that has AB structure-function properties; the A domain is a zinc metalloprotease, and the B domain encodes a translocation domain and C-terminal receptor-binding domain (HCR/T). Earlier studies showed that HCR/T bound gangliosides via two carbohydrate-binding sites, termed the lactose-binding site (the "W" pocket) and the sialic acid-binding site (the "R" pocket). Here we report that TeNT high affinity binding to neurons is mediated solely by gangliosides. Glycan array and solid phase binding analyses identified gangliosides that bound exclusively to either the W pocket or the R pocket of TeNT; GM1a bound to the W pocket, and GD3 bound to the R pocket. Using these gangliosides and mutated forms of HCR/T that lacked one or both carbohydrate-binding pocket, gangliosides binding to both of the W and R pockets were shown to be necessary for high affinity binding to neuronal and non-neuronal cells. The crystal structure of a ternary complex of HCR/T with sugar components of two gangliosides bound to the W and R supported the binding of gangliosides to both carbohydrate pockets. These data show that gangliosides are functional dual receptors for TeNT.	[Fu, Zhuji; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Chen, Chen; Barbieri, Joseph T.; Baldwin, Michael R.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Barbieri, JT (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jtb01@mcw.edu	Taylor, Graham/A-4027-2012		National Institutes of Health [1-U54-AI-057153, GM62116]; NIAID; National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases; NIGMS; NINDS, National Institutes of Health [1-K99-NS061763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Award 1-U54-AI-057153 (Region V Great Lakes Regional Center of Excellence), the NIAID, National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research Program, and NIGMS, National Institutes of Health Grant GM62116 to the Consortium for Functional Glycomics.; Supported by NINDS, National Institutes of Health Grant 1-K99-NS061763.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basu M, 1997, INDIAN J BIOCHEM BIO, V34, P142; Bilous J, 2006, LANCET, V367, P1464, DOI 10.1016/S0140-6736(06)68625-X; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; BURTON RM, 1962, BIOCHEM PHARMACOL, V11, P974, DOI 10.1016/0006-2952(62)90150-8; Chen C, 2008, BIOCHEMISTRY-US, V47, P7179, DOI 10.1021/bi800640y; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; CRITCHLEY DR, 1986, J NEUROCHEM, V47, P213; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Emsley P, 2000, J BIOL CHEM, V275, P8889, DOI 10.1074/jbc.275.12.8889; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Herreros J, 2001, MOL BIOL CELL, V12, P2947, DOI 10.1091/mbc.12.10.2947; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Karlsson KA, 1998, ACTA BIOCHIM POL, V45, P429, DOI 10.18388/abp.1998_4237; Kitamura M, 2005, BBA-MOL BASIS DIS, V1741, P1, DOI 10.1016/j.bbadis.2005.04.005; Kitamura M, 1999, BBA-MOL CELL BIOL L, V1441, P1, DOI 10.1016/S1388-1981(99)00140-7; MARGOLIS RU, 1984, FEBS LETT, V172, P339, DOI 10.1016/0014-5793(84)81153-9; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Mocchetti I, 2005, CELL MOL LIFE SCI, V62, P2283, DOI 10.1007/s00018-005-5188-y; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Nakayama J, 1996, J BIOL CHEM, V271, P3684; Pappas G, 2008, INT J INFECT DIS, V12, P347, DOI 10.1016/j.ijid.2007.11.003; ROUSSEL A, 1999, TURBO FRODO; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; SCHIAVO G, 1990, INFECT IMMUN, V58, P4136, DOI 10.1128/IAI.58.12.4136-4141.1990; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sinha K, 2000, MOL MICROBIOL, V37, P1041, DOI 10.1046/j.1365-2958.2000.02091.x; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; VANHEYNINGEN S, 1976, FEBS LETT, V68, P4; WALTON KM, 1988, J BIOL CHEM, V263, P2055; Williamson LC, 1999, J BIOL CHEM, V274, P25173, DOI 10.1074/jbc.274.35.25173; Wolf AA, 2008, INFECT IMMUN, V76, P1476, DOI 10.1128/IAI.01286-07; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200	40	88	93	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26569	26577		10.1074/jbc.M109.027391	http://dx.doi.org/10.1074/jbc.M109.027391			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19602728	Green Published, hybrid			2022-12-27	WOS:000269969600038
J	Zhang, YL; Yamaguchi, Y; Inouye, M				Zhang, Yonglong; Yamaguchi, Yoshihiro; Inouye, Masayori			Characterization of YafO, an Escherichia coli Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PROTEIN-SYNTHESIS; YOEB TOXIN; TRANSLATION; SITE; ANTITOXIN; TOLUENE; INHIBITION; INITIATION; RIBOSOMES	YafO is a toxin encoded by the yafN-yafO antitoxin-toxin operon in the Escherichia coli genome. Our results show that YafO inhibits protein synthesis but not DNA or RNA synthesis. The in vivo [S-35] methionine incorporation was inhibited within 5 min after YafO induction. In in vivo primer extension experiments with two different mRNAs, the specific cleavage bands appeared 11-13 bases downstream of the initiation codon, AUG, 2.5 min after the induction of YafO. An identical band was also detected in in vitro toeprinting experiments when YafO was added to the reaction mixture containing 70 S ribosomes and the same mRNAs even in the absence of tRNA(f)(Met). Notably, this band was not detected in the presence of YafO alone, indicating that YafO by itself does not have endoribonuclease activity under the conditions used. The full-length mRNAs almost completely disappeared 30 min after YafO induction in in vivo primer extension experiments, consistent with Northern blotting analysis. Over 84% of [S-35]methionine-tRNA(f)(Met) was released from the translation initiation complex at 5.43 mu M YafO in vitro. We demonstrated that the 70 S ribosome peak significantly increased upon YafO induction, and when the 70 S ribosomes dissociated into 50 and 30 S subunits, YafO was found to be associated with 50 S subunits. These results demonstrate that YafO is a ribosome-dependent mRNA interferase inhibiting protein synthesis.	[Zhang, Yonglong; Yamaguchi, Yoshihiro; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Ln, Piscataway, NJ 08854 USA.	inouye@umdnj.edu		Yamaguchi, Yoshihiro/0000-0003-4663-6963	National Institutes of Health [1RO1GM081567]; Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1GM081567 ( to M. I.). This work was also supported by a grant from Takara Bio Inc.	Aoki H, 2002, ANTIMICROB AGENTS CH, V46, P1080, DOI 10.1128/AAC.46.4.1080-1085.2002; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Brown JM, 2003, J BACTERIOL, V185, P6600, DOI 10.1128/JB.185.22.6600-6608.2003; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Courcelle J, 2001, GENETICS, V158, P41; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Du HS, 1998, J BIOL CHEM, V273, P20494, DOI 10.1074/jbc.273.32.20494; HALEGOUA S, 1976, EUR J BIOCHEM, V69, P163, DOI 10.1111/j.1432-1033.1976.tb10869.x; HALEGOUA S, 1976, J BACTERIOL, V126, P183, DOI 10.1128/JB.126.1.183-191.1976; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; McKenzie GJ, 2003, J BACTERIOL, V185, P3972, DOI 10.1128/JB.185.13.3972-3977.2003; Moll I, 2002, BIOCHEM BIOPH RES CO, V297, P1021, DOI 10.1016/S0006-291X(02)02333-1; MOSES RE, 1970, P NATL ACAD SCI USA, V67, P674, DOI 10.1073/pnas.67.2.674; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; PETERSON RL, 1971, J BACTERIOL, V107, P585, DOI 10.1128/JB.107.2.585-588.1971; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; Swaney SM, 1998, ANTIMICROB AGENTS CH, V42, P3251, DOI 10.1128/AAC.42.12.3251; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	25	43	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25522	25531		10.1074/jbc.M109.036624	http://dx.doi.org/10.1074/jbc.M109.036624			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617347	hybrid, Green Published			2022-12-27	WOS:000269738000009
J	Katsoulidis, E; Carayol, N; Woodard, J; Konieczna, I; Majchrzak-Kita, B; Jordan, A; Sassano, A; Eklund, EA; Fish, EN; Platanias, LC				Katsoulidis, Efstratios; Carayol, Nathalie; Woodard, Jennifer; Konieczna, Iwona; Majchrzak-Kita, Beata; Jordan, Alison; Sassano, Antonella; Eklund, Elizabeth A.; Fish, Eleanor N.; Platanias, Leonidas C.			Role of Schlafen 2 (SLFN2) in the Generation of Interferon alpha-induced Growth Inhibitory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA TRANSLATION; P38-ALPHA MAP KINASE; CELL-CYCLE ARREST; P70 S6 KINASE; I INTERFERONS; TRANSCRIPTIONAL ACTIVATION; RHEUMATOID-ARTHRITIS; MICROARRAY ANALYSIS; MAMMALIAN TARGET	The precise STAT-regulated gene targets that inhibit cell growth and generate the antitumor effects of Type I interferons (IFNs) remain unknown. We provide evidence that Type I IFNs regulate expression of Schlafens (SLFNs), a group of genes involved in the control of cell cycle progression and growth inhibitory responses. Using cells with targeted disruption of different STAT proteins and/or the p38 MAP kinase, we demonstrate that the IFN-dependent expression of distinct Schlafen genes is differentially regulated by STAT complexes and the p38 MAP kinase pathway. We also provide evidence for a key functional role of a member of the SLFN family, SLFN2, in the induction of the growth-suppressive effects of IFNs. This is shown in studies demonstrating that knockdown of SLFN2 enhances hematopoietic progenitor colony formation and reverses the growth-suppressive effects of IFN alpha on normal hematopoietic progenitors. Importantly, NIH3T3 or L929 cells with stable knockdown of SLFN2 form more colonies in soft agar, implicating this protein in the regulation of anchorage-independent growth. Altogether, our data implicate SLFN2 as a negative regulator of the metastatic and growth potential of malignant cells and strongly suggest a role for the SLFN family of proteins in the generation of the antiproliferative effects of Type I IFNs.	[Jordan, Alison; Sassano, Antonella; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Sch Med, Chicago, IL 60611 USA; [Jordan, Alison; Sassano, Antonella; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Div Hematol Oncol, Sch Med, Chicago, IL 60611 USA; [Jordan, Alison; Sassano, Antonella; Eklund, Elizabeth A.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Univ Hlth Network, Toronto Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M1, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Platanias, LC (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Sch Med, 710 N Fairbanks St,Olson 8250, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			National Institutes of Health [CA100579, CA77816, CA121192]; Department of Veterans Affairs; Canadian Institutes of Health Research [MOP 15094]; NATIONAL CANCER INSTITUTE [R01CA121192, R01CA077816, R01CA100579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100579, CA77816, and CA121192. This work was also supported by a Merit Review Grant from the Department of Veterans Affairs and by Canadian Institutes of Health Research Grant MOP 15094.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Bell TA, 2006, GENETICS, V172, P411, DOI 10.1534/genetics.105.047118; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Eskra L, 2003, INFECT IMMUN, V71, P1125, DOI 10.1128/IAI.71.3.1125-1133.2003; Fish EN, 1999, J BIOL CHEM, V274, P571, DOI 10.1074/jbc.274.2.571; Fujikado N, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1985; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1997, J IMMUNOL, V158, P2390; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Zhang YF, 2008, BIOCHEM J, V413, P239, DOI 10.1042/BJ20071510	45	55	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25051	25064		10.1074/jbc.M109.030445	http://dx.doi.org/10.1074/jbc.M109.030445			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592487	hybrid, Green Published			2022-12-27	WOS:000269734000040
J	Patwari, P; Chutkow, WA; Cummings, K; Verstraeten, VLRM; Lammerding, J; Schreiter, ER; Lee, RT				Patwari, Parth; Chutkow, William A.; Cummings, Kiersten; Verstraeten, Valerie L. R. M.; Lammerding, Jan; Schreiter, Eric R.; Lee, Richard T.			Thioredoxin-independent Regulation of Metabolism by the alpha-Arrestin Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING-PROTEIN; COUPLED RECEPTORS; OXIDATIVE STRESS; HELA-CELLS; BINDING; GENE; GLUCOSE; TXNIP; UBIQUITINATION; ENDOCYTOSIS	Thioredoxin-interacting protein (Txnip), originally characterized as an inhibitor of thioredoxin, is now known to be a critical regulator of glucose metabolism in vivo. Txnip is a member of the alpha-arrestin protein family; the alpha-arrestins are related to the classical beta-arrestins and visual arrestins. Txnip is the only alpha-arrestin known to bind thioredoxin, and it is not known whether the metabolic effects of Txnip are related to its ability to bind thioredoxin or related to conserved alpha-arrestin function. Here we show that wild type Txnip and Txnip C247S, a Txnip mutant that does not bind thioredoxin in vitro, both inhibit glucose uptake in mature adipocytes and in primary skin fibroblasts. Furthermore, we show that Txnip C247S does not bind thioredoxin in cells, using thiol alkylation to trap the Txnipthioredoxin complex. Because Txnip function was independent of thioredoxin binding, we tested whether inhibition of glucose uptake was conserved in the related alpha-arrestins Arrdc4 and Arrdc3. Both Txnip and Arrdc4 inhibited glucose uptake and lactate output, while Arrdc3 had no effect. Structure-function analysis indicated that Txnip and Arrdc4 inhibit glucose uptake independent of the C-terminal WW-domain binding motifs, recently identified as important in yeast alpha-arrestins. Instead, regulation of glucose uptake was intrinsic to the arrestin domains themselves. These data demonstrate that Txnip regulates cellular metabolism independent of its binding to thioredoxin and reveal the arrestin domains as crucial structural elements in metabolic functions of alpha-arrestin proteins.	[Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Cambridge, MA 02139 USA; [Lee, Richard T.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA; [Chutkow, William A.] Vet Adm Med Ctr, W Roxbury, MA 02132 USA; [Schreiter, Eric R.] Univ Puerto Rico, Dept Chem, San Juan, PR 00931 USA; [Schreiter, Eric R.] Univ Puerto Rico, Dept Biochem, San Juan, PR 00936 USA	Harvard University; Brigham & Women's Hospital; Harvard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico	Patwari, P (corresponding author), 65 Landsdowne St Rm 280, Cambridge, MA 02139 USA.	ppatwari@rics.bwh.harvard.edu	Lammerding, Jan/A-9498-2016; Schreiter, Eric/B-2641-2009	Lammerding, Jan/0000-0003-4335-8611; Lee, Richard/0000-0003-4687-1381; Schreiter, Eric/0000-0002-2864-7469	National Institutes of Health [K25 HL81523, K08 HL088977, P01 HL048743]; J. Ira and Nicki Harris Family award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. Ira and Nicki Harris Family award	This work was supported, in whole or in part, by National Institutes of Health Grants K25 HL81523, K08 HL088977, and P01 HL048743. This work was also supported by a J. Ira and Nicki Harris Family award.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Andoh T, 2002, FEBS LETT, V525, P131, DOI 10.1016/S0014-5793(02)03104-6; Boase NA, 2004, MOL MICROBIOL, V53, P929, DOI 10.1111/j.1365-2958.2004.04172.x; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; EAGLE H, 1958, J BIOL CHEM, V233, P551; Emilsson V. e. a., 2005, Patent No. [2005/111239, 2005111239]; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Hwang CY, 2004, ONCOGENE, V23, P8868, DOI 10.1038/sj.onc.1208116; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Mittal R, 2009, EMBO REP, V10, P41, DOI 10.1038/embor.2008.240; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Yamamoto Y, 2001, CLIN CANCER RES, V7, P297; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515	41	139	153	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24996	25003		10.1074/jbc.M109.018093	http://dx.doi.org/10.1074/jbc.M109.018093			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605364	Green Published, hybrid			2022-12-27	WOS:000269734000035
J	Stokasimov, E; Rubenstein, PA				Stokasimov, Ema; Rubenstein, Peter A.			Actin Isoform-specific Conformational Differences Observed with Hydrogen/Deuterium Exchange and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-EXCHANGE; YEAST ACTIN; STRUCTURAL DYNAMICS; PHALLOIDIN BINDING; ATOMIC MODEL; F-ACTIN; STATE; POLYMERIZATION; NUCLEOTIDE; MUSCLE	Actin can exist in multiple conformations necessary for normal function. Actin isoforms, although highly conserved in sequence, exhibit different biochemical properties and cellular roles. We used amide proton hydrogen/deuterium (HD) exchange detected by mass spectrometry to analyze conformational differences between Saccharomyces cerevisiae and muscle actins in the G and F forms to gain insight into these differences. We also utilized HD exchange to study interdomain and allosteric communication in yeast-muscle hybrid actins to better understand the conformational dynamics of actin. Areas showing differences in HD exchange between G-and F-actins are areas of intermonomer contacts, consistent with the current filament models. Our results showed greater exchange for yeast G-actin compared with muscle actin in the barbed end pivot region and areas in subdomains 1 and 2 and for F-actin in monomer-monomer contact areas. These results suggest greater flexibility of the yeast actin monomer and filament compared with muscle actin. For hybrid G-actins, the muscle-like and yeastlike parts of the molecule generally showed exchange characteristics resembling their parent actins. A few exceptions were a peptide on top of subdomain 2 and the pivot region between subdomains 1 and 3 with muscle actin-like exchange characteristics although the areas were yeastlike. These results demonstrate that there is cross-talk between subdomains 1 and 2 and the large and small domains. Hybrid F-actin data showing greater exchange compared with both yeast and muscle actins are consistent with mismatched yeast-muscle interfaces resulting in decreased stability of the hybrid filament contacts.	[Stokasimov, Ema; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM33689]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33689 (to P.A.R.).	Allen PG, 1996, BIOCHEMISTRY-US, V35, P14062, DOI 10.1021/bi961326g; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chik JK, 2003, J MOL BIOL, V334, P373, DOI 10.1016/j.jmb.2003.09.044; COOK RK, 1992, J BIOL CHEM, V267, P9430; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Ehring H, 1999, ANAL BIOCHEM, V267, P252, DOI 10.1006/abio.1998.3000; Engen Jr, 2000, METH MOL B, V146, P95, DOI 10.1385/1-59259-045-4:95; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; KARLSSON R, 1991, MOL CELL BIOL, V11, P213, DOI 10.1128/MCB.11.1.213; Khaitlina S, 2008, ARCH BIOCHEM BIOPHYS, V477, P279, DOI 10.1016/j.abb.2008.06.016; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9609, DOI 10.1021/bi00088a013; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Musib R, 2002, J BIOL CHEM, V277, P22699, DOI 10.1074/jbc.M203096200; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Orlova A, 1997, J MOL BIOL, V271, P235, DOI 10.1006/jmbi.1997.1163; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prochniewicz E, 1999, BIOCHEMISTRY-US, V38, P14860, DOI 10.1021/bi991343g; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Scoville D, 2006, BIOCHEMISTRY-US, V45, P13576, DOI 10.1021/bi061229f; Shvetsov A, 2002, BIOCHEMISTRY-US, V41, P10787, DOI 10.1021/bi020205f; Shvetsov A, 2008, J MOL BIOL, V375, P793, DOI 10.1016/j.jmb.2007.10.076; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TIRION MM, 1993, J MOL BIOL, V230, P186, DOI 10.1006/jmbi.1993.1135; Wales TE, 2006, J MOL BIOL, V357, P1592, DOI 10.1016/j.jmb.2006.01.075; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Wear MA, 2000, CURR BIOL, V10, pR891, DOI 10.1016/S0960-9822(00)00845-9; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443; Zencheck WD, 2009, J MOL BIOL, V390, P414, DOI 10.1016/j.jmb.2009.03.028; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	41	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25421	25430		10.1074/jbc.M109.013078	http://dx.doi.org/10.1074/jbc.M109.013078			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605362	hybrid, Green Published			2022-12-27	WOS:000269734000074
J	Zhang, Z; Albers, T; Fiumera, HL; Gameiro, A; Grewer, C				Zhang, Zhou; Albers, Thomas; Fiumera, Heather L.; Gameiro, Armanda; Grewer, Christof			A Conserved Na+ Binding Site of the Sodium-coupled Neutral Amino Acid Transporter 2 (SNAT2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE EXPRESSION PATTERN; SYSTEM N; BACTERIAL HOMOLOG; PROFILE ALIGNMENT; CRYSTAL-STRUCTURE; NEUROTRANSMITTER; MECHANISM; IDENTIFICATION; TRANSLOCATION; SUPERFAMILY	The SLC38 family of solute transporters mediates the coupled transport of amino acids and Na+ into or out of cells. The structural basis for this coupled transport process is not known. Here, a profile-based sequence analysis approach was used, predicting a distant relationship with the SLC5/6 transporter families. Homology models using the LeuT(Aa) and Mhp1 transporters of known structure as templates were established, predicting the location of a conserved Na+ binding site in the center of membrane helices 1 and 8. This homology model was tested experimentally in the SLC38 member SNAT2 by analyzing the effect of a mutation to Thr-384, which is predicted to be part of this Na+ binding site. The results show that the T384A mutation not only inhibits the anion leak current, which requires Na+ binding to SNAT2, but also dramatically lowers the Na+ affinity of the transporter. This result is consistent with a previous analysis of the N82A mutant transporter, which has a similar effect on anion leak current and Na+ binding and which is also expected to form part of the Na+ binding site. In contrast, random mutations to other sites in the transporter had little or no effect on Na+ affinity. Our results are consistent with a cation binding site formed by transmembrane helices 1 and 8 that is conserved among the SLC38 transporters as well as among many other bacterial and plant transporter families of unknown structure, which are homologous to SLC38.	[Albers, Thomas; Gameiro, Armanda; Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Fiumera, Heather L.] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Shanghai Normal University	Grewer, C (corresponding author), SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu	Albers, Thomas/A-9082-2012		National Institutes of Health [7R01NS049335-05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS049335, R01NS049335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 7R01NS049335-05 (to C.G.).	Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Clements JD, 2002, EUR J BIOCHEM, V269, P2101, DOI 10.1046/j.1432-1033.2002.02859.x; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FANG Y, 2009, NATURE IN PRESS; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; George RA, 2000, TRENDS BIOCHEM SCI, V25, P515, DOI 10.1016/S0968-0004(00)01643-1; Grewal S, 2009, J BIOL CHEM, V284, P11224, DOI 10.1074/jbc.M806470200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; Hu LA, 1998, BIOCHEM J, V336, P69, DOI 10.1042/bj3360069; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jung I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-298; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li M, 2002, FEBS LETT, V513, P247, DOI 10.1016/S0014-5793(02)02322-0; Lolkema JS, 1998, FEMS MICROBIOL REV, V22, P305, DOI 10.1016/S0168-6445(98)00018-7; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Schneider HP, 2007, J BIOL CHEM, V282, P3788, DOI 10.1074/jbc.M609452200; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Z, 2008, J BIOL CHEM, V283, P12284, DOI 10.1074/jbc.M706774200; Zhang Z, 2007, BIOPHYS J, V92, P2621, DOI 10.1529/biophysj.106.100776	50	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25314	25323		10.1074/jbc.M109.038422	http://dx.doi.org/10.1074/jbc.M109.038422			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19589777	hybrid, Green Published			2022-12-27	WOS:000269734000064
J	Lauer-Fields, JL; Chalmers, MJ; Busby, SA; Minond, D; Griffin, PR; Fields, GB				Lauer-Fields, Janelle L.; Chalmers, Michael J.; Busby, Scott A.; Minond, Dmitriy; Griffin, Patrick R.; Fields, Gregg B.			Identification of Specific Hemopexin-like Domain Residues That Facilitate Matrix Metalloproteinase Collagenolytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL COLLAGEN; C-TERMINAL DOMAIN; SUBSTRATE-SPECIFICITY; TISSUE INHIBITOR; INDUCED FIT; FIBROBLAST COLLAGENASE; FLUOROGENIC SUBSTRATE; MASS-SPECTROMETRY; CATALYTIC-DOMAIN; PEPTIDE MODELS	Collagen serves as a structural scaffold and a barrier between tissues, and thus collagen catabolism (collagenolysis) is required to be a tightly regulated process in normal physiology. In turn, the destruction or damage of collagen during pathological states plays a role in tumor growth and invasion, cartilage degradation, or atherosclerotic plaque formation and rupture. Several members of the matrix metalloproteinase (MMP) family catalyze the hydrolysis of collagen triple helical structure. This study has utilized triple helical peptide (THP) substrates and inhibitors to dissect MMP-1 collagenolytic behavior. Analysis of MMP-1/THP interactions by hydrogen/deuterium exchange mass spectrometry followed by evaluation of wild type and mutant MMP-1 kinetics led to the identification of three noncatalytic regions in MMP-1 (residues 285-295, 302-316, and 437-457) and two specific residues (Ile-290 and Arg-291) that participate in collagenolysis. Ile-290 and Arg-291 contribute to recognition of triple helical structure and facilitate both the binding and catalysis of the triple helix. Evidence from this study and prior studies indicates that the MMP-1 catalytic and hemopexin-like domains collaborate in collagen catabolism by properly aligning the triple helix and coupling conformational states to facilitate hydrolysis. This study is the first to document the roles of specific residues within the MMP-1 hemopexin-like domain in substrate binding and turnover. Noncatalytic sites, such as those identified here, can ultimately be utilized to create THP inhibitors that target MMPs implicated in disease progression while sparing proteases with host-beneficial functions.	[Lauer-Fields, Janelle L.; Fields, Gregg B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Chalmers, Michael J.; Minond, Dmitriy; Griffin, Patrick R.] Scripps Florida, Scripps Res Inst Mol Screening Ctr, Jupiter, FL 33458 USA; [Chalmers, Michael J.; Busby, Scott A.; Minond, Dmitriy; Griffin, Patrick R.; Fields, Gregg B.] Scripps Florida, Dept Mol Therapeut, Jupiter, FL 33458 USA	University of Texas System; University of Texas Health San Antonio; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Fields, GB (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr,542C 1 Med Sch Bldg, San Antonio, TX 78229 USA.	FieldsG@uthscsa.edu		Minond, Dmitriy/0000-0003-2473-5944; Chalmers, Michael/0000-0002-2139-6089	National Institutes of Health [CA98799]; Robert A. Welch Foundation; Texas Higher Education STAR Program; Glenn/American Federation for Aging research scholarship; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Texas Higher Education STAR Program; Glenn/American Federation for Aging research scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant CA98799. This work was also supported by the Robert A. Welch Foundation, the Texas Higher Education STAR Program ( to G. B. F.), and a Glenn/American Federation for Aging research scholarship ( to J.L.L.-F.).	ALLAN JA, 1991, J CELL SCI, V99, P789; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; Dai SY, 2008, P NATL ACAD SCI USA, V105, P7171, DOI 10.1073/pnas.0710802105; DeSouza SJ, 1996, FASEB J, V10, P927, DOI 10.1096/fasebj.10.8.8666171; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Garcia RA, 2005, MOL PHARMACOL, V67, P1128, DOI 10.1124/mol.104.006346; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; HIROSE T, 1993, P NATL ACAD SCI USA, V90, P2569, DOI 10.1073/pnas.90.7.2569; Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Knauper V, 2001, EUR J BIOCHEM, V268, P1888, DOI 10.1046/j.1432-1033.2001.02062.x; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Korzhnev DM, 2009, J MOL BIOL, V386, P391, DOI 10.1016/j.jmb.2008.11.055; Lauer-Fields J, 2007, J AM CHEM SOC, V129, P10408, DOI 10.1021/ja0715849; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields Janelle L, 2004, J Biomol Tech, V15, P305; Lauer-Fields JL, 2009, BIOORGAN MED CHEM, V17, P990, DOI 10.1016/j.bmc.2008.03.004; Lauer-Fields JL, 2000, J CHROMATOGR A, V890, P117, DOI 10.1016/S0021-9673(00)00396-4; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Liu YH, 2008, BIOCHEMISTRY-US, V47, P6342, DOI 10.1021/bi800463q; Malkar NB, 2003, BIOMACROMOLECULES, V4, P518, DOI 10.1021/bm0256597; Malkar NB, 2002, BIOCHEMISTRY-US, V41, P6054, DOI 10.1021/bi012071w; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; O'Farrell TJ, 2006, BIOCHEMISTRY-US, V45, P15411, DOI 10.1021/bi060849d; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Tsukada H, 2002, J BIOL CHEM, V277, P27378, DOI 10.1074/jbc.M201367200; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Woessner J.F., 2000, PROTEIN PROFILE SER; Wu B, 2000, J MOL BIOL, V295, P257, DOI 10.1006/jmbi.1999.3362; Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z; Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656	63	67	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24017	24024		10.1074/jbc.M109.016873	http://dx.doi.org/10.1074/jbc.M109.016873			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574232	hybrid, Green Published			2022-12-27	WOS:000269380200016
J	Schumann, F; Hoffmeister, H; Bader, R; Schmidt, M; Witzgall, R; Kalbitzer, HR				Schumann, Frank; Hoffmeister, Helen; Bader, Reto; Schmidt, Maren; Witzgall, Ralph; Kalbitzer, Hans Robert			Ca2(+)-dependent Conformational Changes in a C-terminal Cytosolic Domain of Polycystin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUTION NMR STRUCTURES; KIDNEY-DISEASE; CHEMICAL-SHIFT; CATION CHANNEL; PROTEIN; SPECTROSCOPY; DATABASE; SOLVENT; SERVER; ACID	The PKD1 and PKD2 genes are the genes that are mutated in patients suffering from autosomal dominant polycystic kidney disease. The human PKD2 gene codes for a968-amino acid long membrane protein called polycystin-2 that represents a cation channel whose activity can be regulated by Ca2+ ions. By CD, fluorescence, and NMR spectroscopy, we have studied a 117-amino acid-long fragment of the cytoplasmic domain of polycystin-2, polycystin-2-(680-796) that was proposed to contain a Ca2+-binding site. NMR structure determination reveals the existence of two Ca2+-binding sites in polycystin-2-(680-796) arranged in a typical and an a typical EF-hand motif. In the absence of Ca2+ the protein forms a dimer that is dissociated by Ca2+ binding. This dissociation may be related to the Ca2+ inactivation observed earlier. The calcium affinity of the protein was determined by fluorescence and NMR spectroscopy. At 293 K, the K-D values for the high and low affinity sites are 55 mu M and 179 mu M, respectively.	[Schumann, Frank; Bader, Reto; Schmidt, Maren; Kalbitzer, Hans Robert] Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany; [Hoffmeister, Helen; Witzgall, Ralph] Univ Regensburg, Inst Anat, D-93040 Regensburg, Germany	University of Regensburg; University of Regensburg	Kalbitzer, HR (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93040 Regensburg, Germany.	hans-robert.kalbitzer@biologie.uni-regensburg.de		Kalbitzer, Hans Robert/0000-0002-6514-2355; Witzgall, Ralph/0000-0002-5283-4846	Deutsche Forschungsgemeinschaft [SFB 699]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (Grant SFB 699) and the Fonds der Chemischen Industrie.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunner K, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-14; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Celic A, 2008, J BIOL CHEM, V283, P28305, DOI 10.1074/jbc.M802743200; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Gronwald W, 2004, PROG NUCL MAG RES SP, V44, P33, DOI 10.1016/j.pnmrs.2003.12.002; Gronwald W, 2001, STRUCTURE, V9, P1029, DOI 10.1016/S0969-2126(01)00671-2; Gronwald W, 2007, J BIOMOL NMR, V37, P15, DOI 10.1007/s10858-006-9096-8; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Maurer T, 2004, J BACTERIOL, V186, P5906, DOI 10.1128/JB.186.17.5906-5918.2004; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Munte CE, 2008, FEBS J, V275, P1163, DOI 10.1111/j.1742-4658.2008.06277.x; Nabuurs SB, 2004, PROTEINS, V55, P483, DOI 10.1002/prot.20118; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Schumann FH, 2009, BIOMOL NMR ASSIGN, V3, P141, DOI 10.1007/s12104-009-9160-x; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Weljie AM, 2004, J BIOL CHEM, V279, P35494, DOI 10.1074/jbc.M311520200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WIDER G, 1994, J MAGN RESON SER A, V108, P255, DOI 10.1006/jmra.1994.1120; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Witzgall R., 2007, V179, P363; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027	34	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24372	24383		10.1074/jbc.M109.025635	http://dx.doi.org/10.1074/jbc.M109.025635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19546223	Green Published, hybrid			2022-12-27	WOS:000269380200050
J	Warren, EM; Huang, H; Fanning, E; Chazin, WJ; Eichman, BF				Warren, Eric M. y; Huang, Hao; Fanning, Ellen; Chazin, Walter J.; Eichman, Brandt F.			Physical Interactions between Mcm10, DNA, and DNA Polymerase alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; CYCLIN-DEPENDENT KINASES; 70 KDA SUBUNIT; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; STRUCTURAL BASIS; BUDDING YEAST; CHROMATIN ASSOCIATION; CRYSTAL-STRUCTURE	Mcm10 is an essential eukaryotic protein required for the initiation and elongation phases of chromosomal replication. Specifically, Mcm10 is required for the association of several replication proteins, including DNA polymerase alpha (pol alpha), with chromatin. We showed previously that the internal (ID) and C-terminal (CTD) domains of Mcm10 physically interact with both single-stranded (ss) DNA and the catalytic p180 subunit of pol alpha. However, the mechanism by which Mcm10 interacts with pol alpha on and off DNA is unclear. As a first step toward understanding the structural details for these critical intermolecular interactions, x-ray crystallography and NMR spectroscopy were used to map the binary interfaces between Mcm10-ID, ssDNA, and p180. The crystal structure of an Mcm10-ID.ssDNA complex confirmed and extended our previous evidence that ssDNA binds within the oligonucleotide/oligosaccharide binding-fold cleft of Mcm10-ID. We show using NMR chemical shift perturbation and fluorescence spectroscopy that p180 also binds to the OB-fold and that ssDNA and p180 compete for binding to this motif. In addition, we map a minimal Mcm10 binding site on p180 to a small region within the p180 N-terminal domain (residues 286-310). These findings, together with data for DNA and p180 binding to an Mcm10 construct that contains both the ID and CTD, provide the first mechanistic insight into how Mcm10 might use a handoff mechanism to load and stabilize pol alpha within the replication fork.	[Warren, Eric M. y; Huang, Hao; Fanning, Ellen; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Chazin, Walter J.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Warren, Eric M. y; Chazin, Walter J.; Eichman, Brandt F.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Eichman, BF (corresponding author), VU Stn B, Box 351634, Nashville, TN 37235 USA.	brandt.eichman@vanderbilt.edu			National Institutes of Health [R01 GM080570, R01 GM65484, R01 GM52948, P30 ES000267, P30 CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080570, R01GM052948, R01GM065484, T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM080570 (to B. F. E.), R01 GM65484 (to W. J. C.), and R01 GM52948 (to E. F.). Additional support for crystallography and mass spectrometry facilities was provided by the Vanderbilt Center in Molecular Toxicology (National Institutes of Health Grant P30 ES000267) and the VanderbiltIngram Cancer Center (National Institutes of Health Grant P30 CA068485).	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Berthet-Colominas C, 1998, EMBO J, V17, P2947, DOI 10.1093/emboj/17.10.2947; Bhattacharya S, 2004, J BIOMOL NMR, V28, P195, DOI 10.1023/B:JNMR.0000013818.02364.3a; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; Daughdrill GW, 2003, NUCLEIC ACIDS RES, V31, P4176, DOI 10.1093/nar/gkg451; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; DURSO G, 1995, J CELL SCI, V108, P3109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fien K, 2006, J BIOL CHEM, V281, P22248, DOI 10.1074/jbc.M512997200; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Hall DR, 1999, EMBO J, V18, P1435, DOI 10.1093/emboj/18.6.1435; Hart EA, 2002, CURR GENET, V41, P342, DOI 10.1007/s00294-002-0316-9; Heikinheimo P, 1996, STRUCTURE, V4, P1491, DOI 10.1016/S0969-2126(96)00155-4; Homesley L, 2000, GENE DEV, V14, P913; HSI KL, 1990, NUCLEIC ACIDS RES, V18, P6231, DOI 10.1093/nar/18.21.6231; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Kawasaki Y, 2000, GENES CELLS, V5, P975, DOI 10.1046/j.1365-2443.2000.00387.x; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; LaRocque JR, 2007, GENETICS, V176, P1441, DOI 10.1534/genetics.107.073635; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JH, 2003, NUCLEIC ACIDS RES, V31, P4747, DOI 10.1093/nar/gkg683; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; MAINE GT, 1984, GENETICS, V106, P365; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Schub O, 2001, J BIOL CHEM, V276, P38076; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; SOLOMON NA, 1992, YEAST, V8, P273, DOI 10.1002/yea.320080405; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Taneja P, 2007, BIOCHEM J, V407, P313, DOI 10.1042/BJ20070794; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Williams DR, 2005, EUKARYOT CELL, V4, P166, DOI 10.1128/EC.4.1.166-177.2005; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	74	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24662	24672		10.1074/jbc.M109.020438	http://dx.doi.org/10.1074/jbc.M109.020438			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19608746	hybrid, Green Published			2022-12-27	WOS:000269380200075
J	Chen, MZ; Zhu, XH; Sun, HQ; Mao, YTS; Wei, YJ; Yamamoto, M; Yin, HL				Chen, Mark Z.; Zhu, Xiaohui; Sun, Hui-Qiao; Mao, Yuntao S.; Wei, Yongjie; Yamamoto, Masaya; Yin, Helen L.			Oxidative Stress Decreases Phosphatidylinositol 4,5-Bisphosphate Levels by Deactivating Phosphatidylinositol-4-phosphate 5-Kinase beta in a Syk-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; PLASMA-MEMBRANE; PROTEIN; ACTIN; GAMMA; INJURY; MOBILIZATION; CYTOSKELETON; MECHANISMS; EXPRESSION	Phosphatidylinositol 4,5-bisphosphate (PIP2) has many essential functions and its homeostasis is highly regulated. We previously found that hypertonic stress increases PIP2 by selectively activating the beta isoform of the type I phosphatidylinositol phosphate 5-kinase (PIP5K beta) through Ser/Thr dephosphorylation and promoting its translocation to the plasma membrane. Here we report that hydrogen peroxide (H2O2) also induces PIP5K beta Ser/Thr dephosphorylation, but it has the opposite effect on PIP2 homeostasis, PIP5K beta function, and the actin cytoskeleton. Brief H2O2 treatments decrease cellular PIP2 in a PIP5K beta-dependent manner. PIP5K beta is tyrosine phosphorylated, dissociates from the plasma membrane, and has decreased lipid kinase activity. In contrast, the other two PIP5K isoforms are not inhibited by H2O2. We identified spleen tyrosine kinase (Syk), which is activated by oxidants, as a candidate PIP5K beta kinase in this pathway, and mapped the oxidant-sensitive tyrosine phosphorylation site to residue 105. The PIP5K beta Y105E phosphomimetic is catalytically inactive and cytosolic, whereas the Y105F non-phosphorylatable mutant has higher intrinsic lipid kinase activity and is much more membrane associated than wild type PIP5K beta. These results suggest that during oxidative stress, as modeled by H2O2 treatment, Syk-dependent tyrosine phosphorylation of PIP5K beta is the dominant post-translational modification that is responsible for the decrease in cellular PIP2.	[Chen, Mark Z.; Zhu, Xiaohui; Sun, Hui-Qiao; Mao, Yuntao S.; Wei, Yongjie; Yamamoto, Masaya; Yin, Helen L.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Yin, HL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Helen.Yin@utsouthwestern.edu	Mao, Yuntao/E-9168-2012		National Institutes of Health [5P50-GM21681]; Robert A. Welch Foundation [I-1200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P50-GM21681 and Robert A. Welch Foundation I-1200 grant.	BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bonnerot C, 1998, EMBO J, V17, P4606, DOI 10.1093/emboj/17.16.4606; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chakraborty G, 2006, J BIOL CHEM, V281, P11322, DOI 10.1074/jbc.M512546200; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Fridlyand LE, 2006, CURR DIABETES REV, V2, P241, DOI 10.2174/157339906776818541; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Halstead JR, 2006, CURR BIOL, V16, P1850, DOI 10.1016/j.cub.2006.07.066; Horton JW, 2006, AM J PHYSIOL-HEART C, V290, pH1642, DOI 10.1152/ajpheart.00586.2005; Horton JW, 2003, TOXICOLOGY, V189, P75, DOI 10.1016/S0300-483X(03)00154-9; Kreimeier U, 2002, ACTA ANAESTH SCAND, V46, P625, DOI 10.1034/j.1399-6576.2002.460601.x; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Mesaeli N, 2000, ARCH BIOCHEM BIOPHYS, V382, P48, DOI 10.1006/abbi.2000.2012; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Qin SF, 1996, EUR J BIOCHEM, V236, P443, DOI 10.1111/j.1432-1033.1996.00443.x; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Renedo MA, 2001, EUR J IMMUNOL, V31, P1361, DOI 10.1002/1521-4141(200105)31:5<1361::AID-IMMU1361>3.0.CO;2-7; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Tohyama Y, 2006, IUBMB LIFE, V58, P304, DOI 10.1080/15216540600746377; Turnage RH, 2002, WORLD J SURG, V26, P848, DOI 10.1007/s00268-002-4063-3; Wang L, 2005, CANCER RES, V65, P10289, DOI 10.1158/0008-5472.CAN-05-2231; Wang YF, 2008, P NATL ACAD SCI USA, V105, P14064, DOI 10.1073/pnas.0804139105; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; WATTS RG, 1991, CELL MOTIL CYTOSKEL, V19, P159, DOI 10.1002/cm.970190304; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yamamoto M, 2006, J BIOL CHEM, V281, P32630, DOI 10.1074/jbc.M605928200; Yamamoto N, 2003, ANAL BIOCHEM, V315, P256, DOI 10.1016/S0003-2697(03)00026-5; Yanagi S, 2001, BIOCHEM BIOPH RES CO, V288, P495, DOI 10.1006/bbrc.2001.5788; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	44	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23743	23753		10.1074/jbc.M109.036509	http://dx.doi.org/10.1074/jbc.M109.036509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19553680	Green Published, hybrid			2022-12-27	WOS:000269180000059
J	Nold-Petry, CA; Nold, MF; Nielsen, JW; Bustamante, A; Zepp, JA; Storm, KA; Hong, JW; Kim, SH; Dinarello, CA				Nold-Petry, Claudia A.; Nold, Marcel F.; Nielsen, Jason W.; Bustamante, Alex; Zepp, Jarod A.; Storm, Kathleen A.; Hong, Jae-Woo; Kim, Soo-Hyun; Dinarello, Charles A.			Increased Cytokine Production in Interleukin-18 Receptor alpha-deficient Cells Is Associated with Dysregulation of Suppressors of Cytokine Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL INTERSTITIAL FIBROSIS; GAMMA-INDUCING FACTOR; NEGATIVE REGULATOR; IL-18; BLOOD; BINDING; PROTEIN; MICE; PATHOGENESIS; INHIBITION	Since interleukin (IL)-18 is a proinflammatory cytokine, mice lacking IL-18 or its ligand-binding receptor (IL-18R) should exhibit decreased cytokine and chemokine production. Indeed, production of IL-1 alpha, IL-6, and MIP-1 alpha was reduced in IL-18 knock-out (ko) mouse embryonic fibroblast (MEF)-like cells. Unexpectedly, we observed a paradoxical 10-fold increase in IL-1 beta-induced IL-6 production in MEF cells from mice deficient in the IL-18R alpha-chain (IL-18R alpha) compared with wild type MEF. Similar increases were observed for IL-1 alpha, MIP-1 alpha, and prostaglandin E-2. Likewise, coincubation with a specific IL-18R alpha-blocking antibody augmented IL-1 beta-induced cytokines in wild type and IL-18 ko MEF. Stable lines of IL-18R alpha-depleted human A549 cells were generated using shRNA, resulting in an increase of IL-1 beta-induced IL-1 alpha, IL-6, and IL-8 compared to scrambled small hairpin RNA. In addition, we silenced IL-18R alpha with small interfering RNA in primary human blood cells and observed up to 4-fold increases in the secretion of lipopolysaccharide- and IL-12/IL-18-induced IL-1 beta, IL-6, interferon-gamma, and CD40L. Mechanistically, despite increases in Stat1 and IL-6, induction of SOCS1 and -3 (suppressor of cytokine signaling 1 and 3) was markedly reduced in the absence of IL-18R alpha. Consistent with these observations, activation of the p38 alpha/beta and ERK1/2 MAPKs and of protein kinase B/Akt increased in IL-18R alpha ko MEF, whereas the negative feedback kinase MSK2 was more active in IL-18 ko cells. These data reveal a role for SOCS1 and -3 in the seemingly paradoxical hyperresponsive state in cells deficient in IL-18R alpha, supporting the concept that IL-18R alpha participates in both pro-and anti-inflammatory responses and that an endogenous ligand engages IL-18R alpha to deliver an inhibitory signal.	[Nold-Petry, Claudia A.; Nold, Marcel F.; Nielsen, Jason W.; Bustamante, Alex; Zepp, Jarod A.; Kim, Soo-Hyun; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Storm, Kathleen A.] Source Mol Diagnost Inc, Boulder, CO 80301 USA; [Hong, Jae-Woo; Kim, Soo-Hyun] Konkuk Univ, Dept Biomed Sci & Technol, Seoul 143701, South Korea	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Konkuk University	Dinarello, CA (corresponding author), Univ Colorado Denver, Dept Med, Box B168,12700 E 19th Ave, Aurora, CO 80045 USA.	cdinarello@mac.com	Dinarello, Charles/C-8524-2013	Nold, Marcel/0000-0001-9682-4618; Nold, Claudia/0000-0002-7439-3834; Hong, Jaewoo/0000-0003-3456-3672	National Institutes of Health [AI 15614, CA-04 6934]; Deutsche Forschungsgemeinschaft [747/1-1]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015614, R01AI015614, R56AI015614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 15614 and CA-04 6934 (Colorado Cancer Center) (to C. A. D.). This work was also supported by Deutsche Forschungsgemeinschaft Grant 747/1-1 (to M. F. N.).	Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Andoh T, 2008, J IMMUNOL, V180, P2322, DOI 10.4049/jimmunol.180.4.2322; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Bossu P, 2003, P NATL ACAD SCI USA, V100, P14181, DOI 10.1073/pnas.2336094100; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Debets R, 2000, J IMMUNOL, V165, P4950, DOI 10.4049/jimmunol.165.9.4950; DINARELLO CA, 1991, BRAIN RES, V562, P199, DOI 10.1016/0006-8993(91)90622-3; Fantuzzi G, 1998, BLOOD, V91, P2118, DOI 10.1182/blood.V91.6.2118.2118_2118_2125; Fantuzzi G, 2001, EUR J IMMUNOL, V31, P369, DOI 10.1002/1521-4141(200102)31:2<369::AID-IMMU369>3.0.CO;2-Y; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Hoshino K, 1999, J IMMUNOL, V162, P5041; Inaba M, 2005, BIOCHEM BIOPH RES CO, V328, P953, DOI 10.1016/j.bbrc.2005.01.046; Kang MJ, 2007, J IMMUNOL, V178, P1948, DOI 10.4049/jimmunol.178.3.1948; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kinoshita K, 2004, J IMMUNOL, V173, P5312, DOI 10.4049/jimmunol.173.8.5312; Konishi H, 2002, P NATL ACAD SCI USA, V99, P11340, DOI 10.1073/pnas.152337799; Lewis EC, 2006, P NATL ACAD SCI USA, V103, P16852, DOI 10.1073/pnas.0607917103; Lin L, 2005, ARTHRITIS RHEUM, V52, P984, DOI 10.1002/art.20961; LONNEMAN G, 1995, KIDNEY INT, V47, P837, DOI 10.1038/ki.1995.126; LONNEMANN G, 1995, KIDNEY INT, V47, P845, DOI 10.1038/ki.1995.127; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980; McLoughlin K, 2006, MOL MED, V12, P185, DOI 10.2119/2006-00018.McLoughlin; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Netea MG, 2002, J INFECT DIS, V185, P963, DOI 10.1086/339410; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; Petry C, 2004, BBA-MOL CELL BIOL L, V1636, P108, DOI 10.1016/j.bbalip.2003.11.007; Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398; Raeburn CD, 2002, AM J PHYSIOL-HEART C, V283, pH650, DOI 10.1152/ajpheart.00043.2002; Reddy P, 2003, J LAB CLIN MED, V141, P365, DOI 10.1016/S0022-2143(03)00028-3; Reznikov LL, 2002, J INTERF CYTOK RES, V22, P593, DOI 10.1089/10799900252982070; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Stuyt RJL, 2003, CYTOKINE, V21, P65, DOI 10.1016/S1043-4666(02)00501-X; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Vidal-Vanaclocha F, 2000, P NATL ACAD SCI USA, V97, P734, DOI 10.1073/pnas.97.2.734; Yoon DY, 2007, J BIOCHEM MOL BIOL, V40, P562; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zanin-Zhorov A, 2005, J IMMUNOL, V175, P276, DOI 10.4049/jimmunol.175.1.276; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	51	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25900	25911		10.1074/jbc.M109.004184	http://dx.doi.org/10.1074/jbc.M109.004184			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19592492	Green Published, hybrid			2022-12-27	WOS:000269738000047
J	Osawa, M; Yokogawa, M; Muramatsu, T; Kimura, T; Mase, Y; Shimada, I				Osawa, Masanori; Yokogawa, Mariko; Muramatsu, Takahiro; Kimura, Tomomi; Mase, Yoko; Shimada, Ichio			Evidence for the Direct Interaction of Spermine with the Inwardly Rectifying Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNELS; CYTOPLASMIC PORE; CRYSTAL-STRUCTURE; KIR2.1 CHANNELS; RECTIFICATION; POLYAMINES; MECHANISM; SITES; PERMEATION; CONSTANTS	The inwardly rectifying potassium channel (Kir) regulates resting membrane potential, K+ homeostasis, heart rate, and hormone secretion. The outward current is blocked in a voltage-dependent manner, upon the binding of intracellular polyamines or Mg2+ to the transmembrane pore domain. Meanwhile, electrophysiological studies have shown that mutations of several acidic residues in the intracellular regions affected the inward rectification. Although these acidic residues are assumed to bind polyamines, the functional role of the binding of polyamines and Mg2+ to the intracellular regions of Kirs remains unclear. Here, we report thermodynamic and structural studies of the interaction between polyamines and the cytoplasmic pore of mouse Kir3.1/GIRK1, which is gated by binding of G-protein beta gamma-subunit (G beta gamma). ITC analyses showed that two spermine molecules bind to a tetramer of Kir3.1/GIRK1 with a dissociation constant of 26 mu M, which is lower than other blockers. NMR analyses revealed that the spermine binding site is Asp-260 and its surrounding area. Small but significant chemical shift perturbations upon spermine binding were observed in the subunit-subunit interface of the tetramer, suggesting that spermine binding alters the relative orientations of the four subunits. Our ITC and NMR results postulated a spermine binding mode, where one spermine molecule bridges two Asp-260 side chains from adjacent subunits, with rearrangement of the subunit orientations. This suggests the functional roles of spermine binding to the cytoplasmic pore: stabilization of the resting state conformation of the channel, and instant translocation to the transmembrane pore upon activation through the G beta gamma-induced conformational rearrangement.	[Osawa, Masanori; Yokogawa, Mariko; Muramatsu, Takahiro; Kimura, Tomomi; Mase, Yoko; Shimada, Ichio] Univ Tokyo, Div Phys Chem, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo 1350064, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Osawa, Masanori/GRS-5726-2022	Osawa, Masanori/0000-0002-1285-4316	Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation	Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade, and Industry (METI) (to I. S.), a grant-in-aid for Scientific Research on Priority Areas from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to M. O. and I. S.), and a grant from Takeda Science Foundation (to M. O.).	Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Frassineti C, 2003, ANAL BIOANAL CHEM, V376, P1041, DOI 10.1007/s00216-003-2020-0; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xie LH, 2003, J PHYSIOL-LONDON, V550, P67, DOI 10.1113/jphysiol.2003.043117; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yokogawa M, 2009, BIOMOL NMR ASSIGN, V3, P125, DOI 10.1007/s12104-009-9156-6	26	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26117	26126		10.1074/jbc.M109.029355	http://dx.doi.org/10.1074/jbc.M109.029355			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19620244	hybrid, Green Published			2022-12-27	WOS:000269738000067
J	Doyon, G; St-Jean, S; Darsigny, M; Asselin, C; Boudreau, F				Doyon, Genevieve; St-Jean, Stephanie; Darsigny, Mathieu; Asselin, Claude; Boudreau, Francois			Nuclear Receptor Co-repressor Is Required to Maintain Proliferation of Normal Intestinal Epithelial Cells in Culture and Down-modulates the Expression of Pigment Epithelium-derived Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; RETINOIC ACID; STEM-CELLS; TRANSCRIPTIONAL ACTIVATION; GENE-TRANSCRIPTION; DIFFERENTIATION; COREPRESSOR; CANCER; GROWTH; GAMMA	Stem cells of the gut epithelium constantly produce precursors that progressively undergo a succession of molecular changes resulting in growth arrest and commitment to a specific differentiation program. Few transcriptional repressors have been identified that maintain the normal intestinal epithelial cell (IEC) proliferation state. Herein, we show that the nuclear receptor co-repressor (NCoR1) is differentially expressed during the proliferation-to-differentiation IEC transition. Silencing of NCoR1 expression in proliferating cells of crypt origin resulted in a rapid growth arrest without associated cell death. A genechip profiling analysis identified several candidate genes to be up-regulated in NCoR1-deficient IEC. Pigment epithelium-derived factor (PEDF, also known as serpinf1), a suspected tumor suppressor gene that plays a key role in the inhibition of epithelial tissue growth, was significantly up-regulated in these cells. Chromatin immunoprecipitation experiments showed that the PEDF gene promoter was occupied by NCoR1 in proliferating epithelial cells. Multiple retinoid X receptor (RXR) heterodimers interacting sites of the PEDF promoter were confirmed to interact with RXR and retinoid acid receptor (RAR). Cotransfection assays showed that RXR and RAR were able to transactivate the PEDF promoter and that NCoR1 was repressing this effect. Finally, forced expression of PEDF in IEC resulted in a slower rate of proliferation. These observations suggest that NCoR1 expression is required to maintain IEC in a proliferative state and identify PEDF as a novel transcriptional target for NCoR1 repressive action.	[Doyon, Genevieve; St-Jean, Stephanie; Darsigny, Mathieu; Asselin, Claude; Boudreau, Francois] Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Boudreau, F (corresponding author), Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	francois.boudreau@usherbrooke.ca			Natural Sciences and Engineering Research Council of Canada [262094-03]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada Grant Number 262094-03 (to F.B.).	Boudreau F, 2002, MOL CELL BIOL, V22, P5467, DOI 10.1128/MCB.22.15.5467-5478.2002; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Boudreau F, 2001, J BIOL CHEM, V276, P32122, DOI 10.1074/jbc.M102002200; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheung LWT, 2006, ENDOCRINOLOGY, V147, P4179, DOI 10.1210/en.2006-0168; Cohen Ronald N, 2006, Nucl Recept Signal, V4, pe003; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Ek ETH, 2007, CANCER GENE THER, V14, P616, DOI 10.1038/sj.cgt.7701044; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Feng X, 2001, J BIOL CHEM, V276, P15066, DOI 10.1074/jbc.M011027200; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Furuya F, 2007, MOL CELL BIOL, V27, P6116, DOI 10.1128/MCB.00900-07; Gheorghiu I, 2001, J BIOL CHEM, V276, P44331, DOI 10.1074/jbc.M107591200; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Gupta RA, 2003, J BIOL CHEM, V278, P22669, DOI 10.1074/jbc.M300637200; Hase R, 2005, CLIN CANCER RES, V11, P8737, DOI 10.1158/1078-0432.CCR-05-1323; HENNING SJ, 1985, ANNU REV PHYSIOL, V47, P231; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; HODIN RA, 1992, GASTROENTEROLOGY, V103, P1529, DOI 10.1016/0016-5085(92)91174-3; Hodin RA, 1996, SURGERY, V120, P138, DOI 10.1016/S0039-6060(96)80280-7; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Houde M, 2001, J BIOL CHEM, V276, P21885, DOI 10.1074/jbc.M100236200; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Kubota H, 2001, EXP CELL RES, V263, P163, DOI 10.1006/excr.2000.5113; Laniel MA, 2000, METH MOL B, V148, P13; Lazar Mitchell A, 2003, Nucl Recept Signal, V1, pe001; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; Malo MS, 2004, MOL ENDOCRINOL, V18, P1941, DOI 10.1210/me.2003-0351; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Pignolo RJ, 2003, J CELL PHYSIOL, V195, P12, DOI 10.1002/jcp.10212; Pumiglia K, 2006, NAT NEUROSCI, V9, P299, DOI 10.1038/nn0306-299; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Suh E, 1996, MOL CELL BIOL, V16, P619; Tombran-Tink J, 2004, EXP EYE RES, V78, P945, DOI 10.1016/j.exer.2003.12.013; Tou LQ, 2004, MOL CELL BIOL, V24, P3132, DOI 10.1128/MCB.24.8.3132-3139.2004; Uchida H, 2005, EXP EYE RES, V80, P23, DOI 10.1016/j.exer.2004.08.004; VACHON PH, 1992, GASTROENTEROLOGY, V103, P414, DOI 10.1016/0016-5085(92)90829-N; van den Brink GR, 2007, CANCER CELL, V11, P109, DOI 10.1016/j.ccr.2007.01.003; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Vidrich A, 2003, CURR OPIN GASTROEN, V19, P583, DOI 10.1097/00001574-200311000-00012; Weston AD, 2003, J CELL BIOL, V161, P223, DOI 10.1083/jcb.200211117; Wu GD, 2003, GASTROENTEROLOGY, V124, P1538, DOI 10.1016/S0016-5085(03)00345-7; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775	56	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25220	25229		10.1074/jbc.M109.022632	http://dx.doi.org/10.1074/jbc.M109.022632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19608741	hybrid, Green Published			2022-12-27	WOS:000269734000056
J	Thompson, NE; Glaser, BT; Foley, KM; Burton, ZF; Burgess, RR				Thompson, Nancy E.; Glaser, Bryan T.; Foley, Katherine M.; Burton, Zachary F.; Burgess, Richard R.			Minimal Promoter Systems Reveal the Importance of Conserved Residues in the B-finger of Human Transcription Factor IIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; START SITE SELECTION; TATA-BINDING PROTEIN; RESPONSIVE MONOCLONAL-ANTIBODY; IMMUNOAFFINITY CHROMATOGRAPHY; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; INITIATION COMPLEX; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	The "B-finger" of transcription factor IIB (TFIIB) is highly conserved and believed to play a role in the initiation process. We performed alanine substitutions across the B-finger of human TFIIB, made change-of-charge mutations in selected residues, and substituted the B-finger sequence from other organisms. Mutant proteins were examined in two minimal promoter systems (containing only RNA polymerase II, TATA-binding protein, and TFIIB) and in a complex system, using TFIIB-immunodepleted HeLa cell nuclear extract (NE). Mutations in conserved residues located on the sides of the B-finger had the greatest effect on activity in both minimal promoter systems, with mutations in residues Glu-51 and Arg-66 eliminating activity. The double change- of-charge mutant (E51R: R66E) did not show activity in either minimal promoter system. Mutations in the nonconserved residues at the tip of the B-finger did not significantly affect activity. However, all of the mutations in the B-finger showed at least 25% activity in the HeLa cell NE. Chimeric proteins, containing B-finger sequences from species with conserved residues on the side of the B-finger, showed wild-type activity in a minimal promoter system and in the HeLa cell NE. However, chimeric proteins whose sequence showed divergence on the sides of the B-finger had reduced activity. Transcription factor IIF(TFIIF) partially restored activity of the inactive mutants in the minimal promoter system, suggesting that TFIIF in HeLa cell NE helps to rescue the inactive mutations by interacting with either the B-finger or another component of the initiation complex that is influenced by the B-finger.	[Thompson, Nancy E.; Glaser, Bryan T.; Foley, Katherine M.; Burgess, Richard R.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Burton, Zachary F.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	University of Wisconsin System; University of Wisconsin Madison; Michigan State University	Thompson, NE (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	nethomps@wisc.edu		Burgess, Richard/0000-0001-9545-3165	National Institutes of Health [CA07175, CA23076, CA60896, GM28575, GM57461]; NATIONAL CANCER INSTITUTE [P01CA023076, R01CA060896, P30CA007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057461, R01GM028575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA07175, CA23076, CA60896, and GM28575 (to R.R.B. and the McArdle Laboratory) and GM57461 (to Z.F.B.). In compliance with the University of Wisconsin-Madison's Conflict of Interest Committee policy, the authors (R.R.B. and N.E.T.) acknowledge financial interest in NeoClone LLC (Madison, WI), which markets mAb IIB8.	Asturias FJ, 2004, CURR OPIN STRUC BIOL, V14, P121, DOI 10.1016/j.sbi.2004.03.007; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; BARBERIS A, 1993, P NATL ACAD SCI USA, V90, P5628, DOI 10.1073/pnas.90.12.5628; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Deng W, 2006, BIOCHEM SOC T, V34, P1051, DOI 10.1042/BST0341051; Duellman SJ, 2004, PROTEIN EXPRES PURIF, V35, P147, DOI 10.1016/j.pep.2003.12.011; Fairley JA, 2002, MOL CELL BIOL, V22, P6697, DOI 10.1128/MCB.22.19.6697-6705.2002; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Gilman B, 2009, J BIOL CHEM, V284, P9093, DOI 10.1074/jbc.M900019200; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hampsey M, 2006, NAT STRUCT MOL BIOL, V13, P564, DOI 10.1038/nsmb0706-564; Hawkes NA, 1999, J BIOL CHEM, V274, P14337, DOI 10.1074/jbc.274.20.14337; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; HODO HG, 1977, BIOCHEMISTRY-US, V16, P2334, DOI 10.1021/bi00630a005; Keene RG, 1999, J BIOL CHEM, V274, P11526, DOI 10.1074/jbc.274.17.11526; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; PAN GH, 1994, J BIOL CHEM, V269, P30101; Panaghie G, 2000, J MOL BIOL, V299, P1217, DOI 10.1006/jmbi.2000.3808; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PINTO I, 1994, J BIOL CHEM, V269, P30569; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Reese JC, 2003, CURR OPIN GENET DEV, V13, P114, DOI 10.1016/S0959-437X(03)00013-3; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; Shaw SP, 1996, MOL CELL BIOL, V16, P3651; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; Thompson NE, 2004, PROTEIN EXPRES PURIF, V36, P186, DOI 10.1016/j.pep.2004.02.020; THOMPSON NE, 1994, PROTEIN EXPRES PURIF, V5, P468, DOI 10.1006/prep.1994.1066; THOMPSON NE, 1995, J BIOL CHEM, V270, P4735, DOI 10.1074/jbc.270.9.4735; Thompson NE, 1999, PROTEIN EXPRES PURIF, V17, P260, DOI 10.1006/prep.1999.1128; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Tubon TC, 2004, MOL CELL BIOL, V24, P2863, DOI 10.1128/MCB.24.7.2863-2874.2004; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WANG BQ, 1994, PROTEIN EXPRES PURIF, V5, P476, DOI 10.1006/prep.1994.1067; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3	51	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24754	24766		10.1074/jbc.M109.030486	http://dx.doi.org/10.1074/jbc.M109.030486			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19590095	hybrid, Green Published			2022-12-27	WOS:000269734000010
J	Babelova, A; Moreth, K; Tsalastra-Greul, W; Zeng-Brouwers, J; Eickelberg, O; Young, MF; Bruckner, P; Pfeilschifter, J; Schaefer, RM; Grone, HJ; Schaefer, L				Babelova, Andrea; Moreth, Kristin; Tsalastra-Greul, Wasiliki; Zeng-Brouwers, Jinyang; Eickelberg, Oliver; Young, Marian F.; Bruckner, Peter; Pfeilschifter, Josef; Schaefer, Roland M.; Groene, Hermann-Josef; Schaefer, Liliana			Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH PROTEOGLYCANS; INNATE IMMUNE-RESPONSE; NALP3 INFLAMMASOME; CASPASE-1; IL-1-BETA; HYALURONAN; GENE; ATP; MACROPHAGES; SECRETION	The role of endogenous inducers of inflammation is poorly understood. To produce the proinflammatory master cytokine interleukin (IL)-1 beta, macrophages need double stimulation with ligands to both Toll-like receptors (TLRs) for IL-1 beta gene transcription and nucleotide-binding oligomerization domain-like receptors for activation of the inflammasome. It is particularly intriguing to define how this complex regulation is mediated in the absence of an infectious trigger. Biglycan, a ubiquitous leucine-rich repeat proteoglycan of the extracellular matrix, interacts with TLR2/4 on macrophages. The objective of this study was to define the role of biglycan in the synthesis and activation of IL-1 beta. Here we show that in macrophages, soluble biglycan induces the NLRP3/ASC inflammasome, activating caspase-1 and releasing mature IL-1 beta without the need for additional costimulatory factors. This is brought about by the interaction of biglycan with TLR2/4 and purinergic P2X(4)/P2X7 receptors, which induces receptor cooperativity. Furthermore, reactive oxygen species formation is involved in biglycan-mediated activation of the inflammasome. By signaling through TLR2/4, biglycan stimulates the expression of NLRP3 and proIL-1 beta mRNA. Both in a model of non-infectious inflammatory renal injury (unilateral ureteral obstruction) and in lipopolysaccharide-induced sepsis, biglycan-deficient mice displayed lower levels of active caspase-1 and mature IL-1 beta in the kidney, lung, and circulation. Our results provide evidence for direct activation of the NLRP3 inflammasome by biglycan and describe a fundamental paradigm of how tissue stress or injury is monitored by innate immune receptors detecting the release of the extracellular matrix components and turning such a signal into a robust inflammatory response.	[Babelova, Andrea; Moreth, Kristin; Tsalastra-Greul, Wasiliki; Zeng-Brouwers, Jinyang; Pfeilschifter, Josef; Schaefer, Liliana] Univ Frankfurt Klinikum, Inst Allgemeine Pharmakol & Toxikol, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany; [Moreth, Kristin; Zeng-Brouwers, Jinyang; Schaefer, Roland M.] Univ Munster, Dept Med D, D-48149 Munster, Germany; [Bruckner, Peter] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Moreth, Kristin; Zeng-Brouwers, Jinyang; Bruckner, Peter; Schaefer, Roland M.] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany; [Eickelberg, Oliver] Univ Munich, Comprehens Pneumol Ctr, D-85764 Neuherberg, Germany; [Young, Marian F.] NIH, Craniofacial & Skeletal Dis Branch, NIDCR, Bethesda, MD 20892 USA; [Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-69120 Heidelberg, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Munster; University of Munster; University of Munster; University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Helmholtz Association; German Cancer Research Center (DKFZ)	Schaefer, L (corresponding author), Univ Frankfurt Klinikum, Inst Allgemeine Pharmakol & Toxikol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Schaefer@med.uni-frankfurt.de	Babelova, Andrea/E-7768-2018; Eickelberg, Oliver/A-5461-2013; Bruckner, Peter/F-4817-2019	Babelova, Andrea/0000-0001-9548-6602; Eickelberg, Oliver/0000-0001-7170-0360; Bruckner, Peter/0000-0002-5566-5611; Young, Marian F/0000-0003-0929-8854; Schaefer, Liliana/0000-0002-3318-3005	Deutsche Forschungsgemeinschaft [SFB 815, SCHA 1082/2-1]; Excellence Cluster Cardiopulmonary System [SFB 405]; Interdisciplinary Center of Clinical Research, Muenster [Schae2/026/06, KliFo 118]; Else Kroner-Fresenius-Stiftung; National Institutes of Health; NIDCR; Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000379] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); Interdisciplinary Center of Clinical Research, Muenster; Else Kroner-Fresenius-Stiftung; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Deutsche Forschungsgemeinschaft SFB 815, Project A5 ( to L. S.) and SCHA 1082/2-1( to L. S. and H.-J.G.), the Excellence Cluster Cardiopulmonary System ( to L. S. and O.E.), SFB 405, Project B10 ( to H.-J.G.), Interdisciplinary Center of Clinical Research, Muenster, Grant Schae2/026/06 ( to L. S., R. M. S., and P. B.), KliFo 118 ( to O. E.), and Else Kroner-Fresenius-Stiftung( to L. S.). This work was also supported in part by the National Institutes of Health, NIDCR, Intramural Research Program ( to M. F. Y.).	Adams J, 2005, AM J PATHOL, V167, P285, DOI 10.1016/S0002-9440(10)62973-2; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gay Nicholas J., 2008, V183, P181; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Joshi VD, 2002, INFECT IMMUN, V70, P6896, DOI 10.1128/IAI.70.12.6896-6903.2002; Kahlenberg JM, 2004, J LEUKOCYTE BIOL, V76, P676, DOI 10.1189/jlb.0404221; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kresse H, 2001, J BIOL CHEM, V276, P13411, DOI 10.1074/jbc.M009321200; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2007, EUR J IMMUNOL, V37, P3003, DOI 10.1002/eji.200737871; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; MATHEW MK, 1983, MOL CELL BIOCHEM, V50, P47; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Netea MG, 2008, EXPERT OPIN BIOL TH, V8, P1867, DOI [10.1517/14712590802494212, 10.1517/14712590802494212 ]; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Ogier-Denis E, 2008, SEMIN IMMUNOPATHOL, V30, P291, DOI 10.1007/s00281-008-0120-9; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Pleskova M, 2005, FASEB J, V19, P139, DOI 10.1096/fj.05-3791fje; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raouf R, 2007, NEUROPHARMACOLOGY, V53, P496, DOI 10.1016/j.neuropharm.2007.06.010; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2003, J BIOL CHEM, V278, P26227, DOI 10.1074/jbc.M210574200; Schaefer L, 2001, FASEB J, V15, P559; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Walev I, 2000, J IMMUNOL, V164, P5120, DOI 10.4049/jimmunol.164.10.5120; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200	63	332	342	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24035	24048		10.1074/jbc.M109.014266	http://dx.doi.org/10.1074/jbc.M109.014266			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19605353	hybrid, Green Published			2022-12-27	WOS:000269380200018
J	Karena, E; Frillingos, S				Karena, Ekaterini; Frillingos, Stathis			Role of Intramembrane Polar Residues in the YgfO Xanthine Permease HIS-31 AND ASN-93 ARE CRUCIAL FOR AFFINITY AND SPECIFICITY, AND ASP-304 AND GLU-272 ARE IRREPLACEABLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING ANALYSIS; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; SUBSTRATE-SELECTIVITY; LACTOSE PERMEASE; SIGNATURE MOTIF; TRANSPORTER; FAMILY; BACTERIAL; HELIX	Using the YgfO xanthine permease of Escherichia coli as a bacterial model for the study of the evolutionarily ubiquitous nucleobase-ascorbate transporter (NAT/NCS2) family, we performed a systematic Cys-scanning and site-directed mutagenesis of 14 putatively charged (Asp, Glu, His, Lys, or Arg) and 7 highly polar (Gln or Asn) residues that are predicted to lie in transmembrane helices (TMs). Of 21 single-Cys mutants engineered in the background of a functional YgfO devoid of Cys residues (C-less), only four are inactive or have marginal activity (H31C, N93C, E272C, D304C). The 4 residues are conserved throughout the family in TM1 (His-31), TM3 (Asn-93/Ser/Thr), TM8 (Glu-272), and putative TM9a (Asp-304/Asn/Glu). Extensive site-directed mutagenesis in wild-type background showed that H31N and H31Q have high activity and affinity for xanthine but H31Q recognizes novel purine bases and analogues, whereas H31C and H31L have impaired affinity for xanthine and analogues, and H31K or H31R impairs expression in the membrane. N93S and N93A are highly active but more promiscuous for recognition of analogues at the imidazole moiety of substrate, N93D has low activity, N93T has low affinity for xanthine or analogues, and N93Q or N93C is inactive. All mutants replacing Glu-272 or Asp-304, including E272D, E272Q, D304E, and D304N, are inactive, although expressed to high levels in the membrane. Finally, one of the 17 assayable single-Cys mutants, Q258C, was sensitive to inactivation by N-ethylmaleimide. The findings suggest that polar residues important for the function of YgfO cluster in TMs 1, 3, 8 and 9a.	[Karena, Ekaterini; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, Ioannina 45110, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, Ioannina 45110, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021					Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FRILLINGOS S, 1995, BIOCHEMISTRY-US, V34, P9368, DOI 10.1021/bi00029a012; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P13363, DOI 10.1021/bi961453c; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Pantazopoulou A, 2006, MOL MEMBR BIOL, V23, P337, DOI 10.1080/09687860600738239; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Stroud Robert M., 2009, Journal of Structural and Functional Genomics, V10, P193, DOI 10.1007/s10969-008-9058-3; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Tavoulari S, 2008, J MOL BIOL, V376, P681, DOI 10.1016/j.jmb.2007.12.015; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Varma S, 2008, BIOCHEMISTRY-US, V47, P2952, DOI 10.1021/bi701666q; Vlanti A, 2006, J MOL BIOL, V357, P808, DOI 10.1016/j.jmb.2005.12.070; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]	25	19	20	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24257	24268		10.1074/jbc.M109.030734	http://dx.doi.org/10.1074/jbc.M109.030734			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19581302	Green Published, hybrid			2022-12-27	WOS:000269380200039
J	Mooren, OL; Kotova, TI; Moore, AJ; Schafer, DA				Mooren, Olivia L.; Kotova, Tatyana I.; Moore, Andrew J.; Schafer, Dorothy A.			Dynamin2 GTPase and Cortactin Remodel Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ARP2/3 COMPLEX; COATED PITS; F-ACTIN; DEPENDENT ENDOCYTOSIS; MEMBRANE FISSION; MOTILITY; CELLS; CYTOSKELETON; CONSTRICTION	The large GTPase dynamin, best known for its activities that remodel membranes during endocytosis, also regulates F-actin-rich structures, including podosomes, phagocytic cups, actin comet tails, subcortical ruffles, and stress fibers. The mechanisms by which dynamin regulates actin filaments are not known, but an emerging view is that dynamin influences F-actin via its interactions with proteins that interact directly or indirectly with actin filaments. We show here that dynamin2 GTPase activity remodels actin filaments in vitro via a mechanism that depends on the binding partner and F-actin-binding protein, cortactin. Tightly associated actin filaments crosslinked by dynamin2 and cortactin became loosely associated after GTP addition when viewed by transmission electron microscopy. Actin filaments were dynamically unraveled and fragmented after GTP addition when viewed in real time using total internal reflection fluorescence microscopy. Cortactin stimulated the intrinsic GTPase activity of dynamin2 and maintained a stable link between actin filaments and dynamin2, even in the presence of GTP. Filaments remodeled by dynamin2 GTPase in vitro exhibit enhanced sensitivity to severing by the actin depolymerizing factor, cofilin, suggesting that GTPase-dependent remodeling influences the interactions of actin regulatory proteins and F-actin. The global organization of the actomyosin cytoskeleton was perturbed in U2-OS cells depleted of dynamin2, implicating dynamin2 in remodeling actin filaments that comprise supramolecular F-actin arrays in vivo. We conclude that dynamin2 GTPase remodels actin filaments and plays a role in orchestrating the global actomyosin cytoskeleton.	[Mooren, Olivia L.; Kotova, Tatyana I.; Moore, Andrew J.; Schafer, Dorothy A.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA; [Mooren, Olivia L.] Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA	University of Virginia; University of Virginia; Washington University (WUSTL)	Schafer, DA (corresponding author), Univ Virginia, Dept Biol, McCormick Rd, Charlottesville, VA 22904 USA.	das9w@virginia.edu	Moore, Andrew/AAG-1905-2021	Moore, Andrew/0000-0002-3023-2502	National Institutes of Health [R01 GM067222, R01 GM038542]; NIGMS; Ruth L. Kirschstein National Research Service Award [F32 GM083538]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542, R01GM067222, F32GM083538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM067222 (to D. A. S.) from the NIGMS and Ruth L. Kirschstein National Research Service Award F32 GM083538 (to O. L. M.). This work was also supported by National Institutes of Health R01 GM038542 (awarded to J. A. Cooper, Washington University School of Medicine).	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Anderson TW, 2008, MOL BIOL CELL, V19, P5006, DOI 10.1091/mbc.E08-01-0034; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; BRYAN J, 1986, METHOD ENZYMOL, V134, P13; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Di AK, 2003, MOL BIOL CELL, V14, P2016, DOI 10.1091/mbc.e02-09-0626; Eccleston JF, 2002, EUR BIOPHYS J BIOPHY, V31, P275, DOI 10.1007/s00249-002-0226-2; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Gray NW, 2005, J CELL SCI, V118, P1279, DOI 10.1242/jcs.01711; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Huang S, 2005, PLANT CELL, V17, P486, DOI 10.1105/tpc.104.028555; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Lin HC, 1997, J BIOL CHEM, V272, P25999, DOI 10.1074/jbc.272.41.25999; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Salvarezza SB, 2009, MOL BIOL CELL, V20, P438, DOI 10.1091/mbc.E08-08-0891; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Unsworth KE, 2007, CELL MICROBIOL, V9, P438, DOI 10.1111/j.1462-5822.2006.00801.x; Upadhyaya A, 2003, CURR BIOL, V13, pR734, DOI 10.1016/j.cub.2003.08.051; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014	62	82	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23995	24005		10.1074/jbc.M109.024398	http://dx.doi.org/10.1074/jbc.M109.024398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19605363	Green Published, hybrid			2022-12-27	WOS:000269380200014
J	Fan, C; Ouyang, P; Timur, AA; He, P; You, SA; Hu, Y; Ke, T; Driscoll, DJ; Chen, QY; Wang, QK				Fan, Chun; Ouyang, Ping; Timur, Ayse A.; He, Ping; You, Sun-Ah; Hu, Ying; Ke, Tie; Driscoll, David J.; Chen, Qiuyun; Wang, Qing Kenneth			Novel Roles of GATA1 in Regulation of Angiogenic Factor AGGF1 and Endothelial Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLIPPEL-TRENAUNAY-SYNDROME; CORONARY-ARTERY-DISEASE; HOLT-ORAM-SYNDROME; MOLECULAR CHARACTERIZATION; MYOCARDIAL-INFARCTION; ESCHERICHIA-COLI; CHROMOSOME 9P21; GENE-EXPRESSION; 4 SNPS; IDENTIFICATION	AGGF1 is an angiogenic factor, and its deregulation is associated with a vascular malformation consistent with Klippel-Trenaunay syndrome (KTS). This study defines the molecular mechanism for transcriptional regulation of AGGF1 expression. Transcription of AGGF1 starts at two nearby sites, -367 and -364 bp upstream of the translation start site. Analyses of 5'- and 3'-serial promoter deletions defined the core promoter/regulatory elements, including two repressor sites (from -1971 to -3990 and from -7521 to -8391, respectively) and two activator sites (a GATA1 consensus binding site from -295 to -300 and a second activator site from -129 to -159). Both the GATA1 site and the second activator site are essential for AGGF1 expression. A similar expression profile was found for GATA1 and AGGF1 in cells (including various endothelial cells) and tissues. Electrophoretic mobility shift assay and chromatin immunoprecipitation assays demonstrated that GATA1 was able to bind to the AGGF1 DNA in vitro and in vivo. Overexpression of GATA1 increased expression of AGGF1. We identified one rare polymorphism -294C> T in a sporadic KTS patient, which is located in the GATA1 site, disrupts binding of GATA1 to DNA, and abolishes the GATA1 stimulatory effect on transcription of AGGF1. Knockdown of GATA1 expression by siRNA reduced expression of AGGF1, and resulted in endothelial cell apoptosis and inhibition of endothelial capillary vessel formation and cell migration, which was rescued by purified recombinant human AGGF1 protein. These results demonstrate that GATA1 regulates expression of AGGF1 and reveal a novel role for GATA1 in endothelial cell biology and angiogenesis.	[Wang, Qing Kenneth] Cleveland Clin, Ctr Cardiovasc Genet NE40, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Fan, Chun; Timur, Ayse A.; He, Ping; You, Sun-Ah; Hu, Ying; Ke, Tie; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Ctr Cardiovasc Genet, Cleveland, OH 44195 USA; [Fan, Chun; Timur, Ayse A.; He, Ping; You, Sun-Ah; Hu, Ying; Ke, Tie; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA; [Driscoll, David J.] Mayo Clin, Div Pediat Cardiol, Rochester, MN 55905 USA; [Ouyang, Ping; Ke, Tie; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Ouyang, Ping; Ke, Tie; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Mayo Clinic; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, QK (corresponding author), Cleveland Clin, Ctr Cardiovasc Genet NE40, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA.	wangq2@ccf.org	Ke, Tie/AIC-5771-2022	Ke, Tie/0000-0002-8888-8424	Cleveland Clinic Taussig Cancer Center; National Natural Science Foundation of China [30670857]	Cleveland Clinic Taussig Cancer Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a Scott Hamilton CARES research grant from the Cleveland Clinic Taussig Cancer Center and by the National Natural Science Foundation of China (Grant 30670857).	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Barker KT, 2006, J MED GENET, V43, P613, DOI 10.1136/jmg.2006.040790; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berry SA, 1998, AM J MED GENET, V79, P319, DOI 10.1002/(SICI)1096-8628(19981002)79:4<319::AID-AJMG15>3.3.CO;2-A; Bhagavatula MRK, 2004, HUM MOL GENET, V13, P3181, DOI 10.1093/hmg/ddh329; Callebaut I, 2005, BIOINFORMATICS, V21, P699, DOI 10.1093/bioinformatics/bti065; Cerbai E, 2008, CIRC RES, V102, P1304, DOI 10.1161/CIRCRESAHA.108.178079; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Fan C, 2003, J Med Genet, V40, pe29, DOI 10.1136/jmg.40.3.e29; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Gutierrez S, 2006, AM J MED GENET A, V140A, P2832, DOI 10.1002/ajmg.a.31532; HICKEY MJ, 1993, J BIOL CHEM, V268, P3438; HICKSTEIN DD, 1992, P NATL ACAD SCI USA, V89, P2105, DOI 10.1073/pnas.89.6.2105; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Hu Y, 2008, ANN HUM GENET, V72, P636, DOI 10.1111/j.1469-1809.2008.00458.x; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Kitamura Y, 2006, IMMUNOL ALLERGY CLIN, V26, P387, DOI 10.1016/j.iac.2006.05.004; Larouche K, 2000, J BIOL CHEM, V275, P39182, DOI 10.1074/jbc.M002945200; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Miquerol L, 2000, DEVELOPMENT, V127, P3941; PRANDINI MH, 1988, BIOCHEM BIOPH RES CO, V156, P595, DOI 10.1016/S0006-291X(88)80884-2; ROSMARIN AG, 1992, BLOOD, V79, P2598; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Shen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Shen GQ, 2007, AM J HUM GENET, V81, P780, DOI 10.1086/521581; Shen Gong-Qing, 2006, V128, P209; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Szalai G, 2006, CELL MOL LIFE SCI, V63, P2460, DOI 10.1007/s00018-006-6190-8; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7; Timur AA, 2004, ANN HUM GENET, V68, P353, DOI 10.1046/j.1529-8817.2004.00095.x; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; WANG Q, 1993, J MOL BIOL, V229, P306, DOI 10.1006/jmbi.1993.1036; WANG Q, 1993, MOL MICROBIOL, V7, P883, DOI 10.1111/j.1365-2958.1993.tb01179.x; WANG Q, 1993, EMBO J, V12, P2495, DOI 10.1002/j.1460-2075.1993.tb05904.x; Wang Q, 2001, CYTOGENET CELL GENET, V95, P183, DOI 10.1159/000059343; WANG Q, 1994, BIOTECHNIQUES, V17, P282; Wang Qing K., 2005, Lymphatic Research and Biology, V3, P226, DOI 10.1089/lrb.2005.3.226; WHELAN AJ, 1995, AM J MED GENET, V59, P492, DOI 10.1002/ajmg.1320590416; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; ZUTTER MM, 1994, J BIOL CHEM, V269, P463	44	45	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23331	23343		10.1074/jbc.M109.036079	http://dx.doi.org/10.1074/jbc.M109.036079			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19556247	Green Published, hybrid			2022-12-27	WOS:000269180000018
J	Mann, FM; Prisic, S; Hu, HY; Xu, MM; Coates, RM; Peters, RJ				Mann, Francis M.; Prisic, Sladjana; Hu, Huayou; Xu, Meimei; Coates, Robert M.; Peters, Reuben J.			Characterization and Inhibition of a Class II Diterpene Cyclase from Mycobacterium tuberculosis IMPLICATIONS FOR TUBERCULOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPALYL DIPHOSPHATE SYNTHASE; ABIETADIENE SYNTHASE; FUNCTIONAL-ANALYSIS; BIOSYNTHESIS; MECHANISM	Mycobacterium tuberculosis remains a widespread and devastating human pathogen, whose ability to infiltrate macrophage host cells from the human immune system is an active area of investigation. We have recently reported the discovery of a novel diterpene from M. tuberculosis, edaxadiene, whose ability to arrest phagosomal maturation in isolation presumably contributes to this critical process in M. tuberculosis infections. (Mann, F. M., Xu, M., Chen, X., Fulton, D.B., Russell, D.G., and Peters, R.J. (2009) J. Am. Chem. Soc., in press). Here, we present characterization of the class II diterpene cyclase that catalyzes the committed step in edaxadiene biosynthesis, i.e. the previously identified halimadienyl-diphosphate synthase (HPS; EC 5.5.1.16). Intriguingly, our kinetic analysis suggests a potential biochemical regulatory mechanism that triggers edaxadiene production upon phagosomal engulfment. Furthermore, we report characterization of potential HPS inhibitors: specifically, two related transition state analogs (15-aza-14,15-dihydrogeranylgeranyl diphosphate (7a) and 15-aza-14,15-dihydrogeranylgeranyl thiolodiphosphate (7b)) that exhibit very tight binding. Although arguably not suitable for clinical use, these nevertheless provide a basis for pharmaceutical design against this intriguing biosynthetic pathway. Finally, we provide evidence indicating that this pathway exists only in M. tuberculosis and is not functional in the closely related Mycobacterium bovis because of an inactivating frameshift in the HPS-encoding gene. Thus, we hypothesize that the inability to produce edaxadiene may be a contributing factor in the decreased infectivity and/or virulence of M. bovis relative to M. tuberculosis in humans.	[Mann, Francis M.; Prisic, Sladjana; Xu, Meimei; Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Hu, Huayou; Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign	Peters, RJ (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4216 Mol Biol Bldg, Ames, IA 50011 USA.	rjpeters@iastate.edu	Hu, Huayou/B-9521-2013; Peters, Reuben J./D-1196-2010	Hu, Huayou/0000-0003-4795-0866; Peters, Reuben J./0000-0003-4691-8477; Prisic, Sladjana/0000-0003-3137-4358	National Institutes of Health [GM076324, GM13956]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324, R01GM013956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM076324 (to R.J.P.) and GM13956 (to R. M. C.).	Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; GARCIADELPORTILLO F, 1992, MOL MICROBIOL, V6, P3289, DOI 10.1111/j.1365-2958.1992.tb02197.x; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; GRANGE JM, 1994, VET MICROBIOL, V40, P137, DOI 10.1016/0378-1135(94)90052-3; Hamano Y, 2002, J BIOL CHEM, V277, P37098, DOI 10.1074/jbc.M206382200; Hayashi Y, 2008, BIOSCI BIOTECH BIOCH, V72, P523, DOI 10.1271/bbb.70615; HURWITZ C, 1967, J BIOL CHEM, V242, P3719; Ikeda C, 2007, J BIOCHEM, V141, P37, DOI 10.1093/jb/mvm004; Kawaide H, 2000, J BIOL CHEM, V275, P2276, DOI 10.1074/jbc.275.4.2276; Kumar V., 2007, ROBBINS BASIC PATHOL, P516; MANN F, 2009, J AM CHEM S IN PRESS; Morrone D, 2009, FEBS LETT, V583, P475, DOI 10.1016/j.febslet.2008.12.052; Nakano C, 2005, CHEM COMMUN, P1016, DOI 10.1039/b415346d; Peters RJ, 2002, BIOCHEMISTRY-US, V41, P1836, DOI 10.1021/bi011879d; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Phan RM, 2001, J ORG CHEM, V66, P6705, DOI 10.1021/jo010505n; Prisic S, 2007, CHEMBIOCHEM, V8, P869, DOI 10.1002/cbic.200700045; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Ravn MM, 2000, EUR J ORG CHEM, V2000, P1401, DOI 10.1002/(SICI)1099-0690(200004)2000:8<1401::AID-EJOC1401>3.0.CO;2-P; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Schmitt SM, 1997, J WILDLIFE DIS, V33, P749, DOI 10.7589/0090-3558-33.4.749; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Xu MM, 2004, PLANT J, V39, P309, DOI 10.1111/j.1365-313X.2004.02137.x; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	28	31	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23574	23579		10.1074/jbc.M109.023788	http://dx.doi.org/10.1074/jbc.M109.023788			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574210	Green Published, hybrid			2022-12-27	WOS:000269180000043
J	Mirnikjoo, B; Balasubramanian, K; Schroit, AJ				Mirnikjoo, Banafsheh; Balasubramanian, Krishnakumar; Schroit, Alan J.			Suicidal Membrane Repair Regulates Phosphatidylserine Externalization during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; CELL-SURFACE; CHLOROQUINE; LYSOSOMES; FUSION; PHOSPHOLIPIDS; AUTOANTIGENS; RECOGNITION; ASYMMETRY; BODIES	One of the hallmarks of apoptosis is the redistribution of phosphatidylserine (PS) from the inner-to-outer plasma membrane (PM) leaflet, where it functions as a ligand for phagocyte recognition and the suppression of inflammatory responses. The mechanism by which apoptotic cells externalize PS has been assumed to involve "scramblases" that randomize phospholipids across the PM bilayer. These putative activities, however, have not been unequivocally proven to be responsible for the redistribution of lipids. Because elevated cytosolic Ca2+ is critical to this process and is also required for activation of lysosome-PM fusion during membrane repair, we hypothesized that apoptosis could activate a "pseudo"-membrane repair response that results in the fusion of lysosomes with the PM. Using a membrane-specific probe that labels endosomes and lysosomes and fluorescein-labeled annexin 5 that labels PS, we show that the appearance of PS at the cell surface during apoptosis is dependent on the fusion of lysosomes with the PM, a process that is inhibited with the lysosomotrophe, chloroquine. We demonstrate that apoptotic cells evoke a persistent pseudo-membrane repair response that likely redistributes lysosomal derived PS to the PM outer leaflet that leads to membrane expansion and the formation of apoptotic blebs. Our data suggest that inhibition of lysosome-PM fusion-dependent redistribution of PS that occurs as a result of chemotherapy- and radiotherapy-induced apoptosis will prevent PS-dependent anti-inflammatory responses that preclude the development of tumor- and patient-specific immune responses.	[Mirnikjoo, Banafsheh; Balasubramanian, Krishnakumar; Schroit, Alan J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Schroit, AJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aschroit@mdanderson.org			National Institutes of Health [CA98527]; Department of Defense [BCRPW81XWH-06-1-0347]; John Q. Gaines Foundation; NATIONAL CANCER INSTITUTE [R01CA098527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); John Q. Gaines Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA98527 (to A. J. S.). This work was also supported by Department of Defense Grant BCRPW81XWH-06-1-0347 (to B. M.) and a grant from the John Q. Gaines Foundation.	Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Briceno E, 2007, SURG NEUROL, V67, P388, DOI 10.1016/j.surneu.2006.08.080; Cocca BA, 2002, J IMMUNOL, V169, P159, DOI 10.4049/jimmunol.169.1.159; CONNOR J, 1987, BIOCHEMISTRY-US, V26, P5099, DOI 10.1021/bi00390a031; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Dasgupta SK, 2006, TRANSL RES, V148, P19, DOI 10.1016/j.lab.2006.03.006; Franz S, 2007, CELL DEATH DIFFER, V14, P733, DOI 10.1038/sj.cdd.4402066; HART PD, 1983, J EXP MED, V158, P477, DOI 10.1084/jem.158.2.477; Klotz KH, 1996, J BIOL CHEM, V271, P2383, DOI 10.1074/jbc.271.5.2383; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Savarino A, 2006, LANCET ONCOL, V7, P792, DOI 10.1016/S1470-2045(06)70875-0; Schiller M, 2008, CELL DEATH DIFFER, V15, P183, DOI 10.1038/sj.cdd.4402239; Shiratsuchi A, 2003, J BIOCHEM, V133, P211, DOI 10.1093/jb/mvg026; SHOEMAKER JP, 1978, CANCER RES, V38, P2700; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; Sorice M, 2000, CLIN EXP IMMUNOL, V122, P277, DOI 10.1046/j.1365-2249.2000.01353.x; STRUCK DK, 1980, J BIOL CHEM, V255, P5404; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhao H, 2005, RADIAT RES, V164, P250, DOI 10.1667/RR3436.1	29	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22512	22516		10.1074/jbc.C109.022913	http://dx.doi.org/10.1074/jbc.C109.022913			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561081	Green Published, hybrid			2022-12-27	WOS:000268963100003
J	Ishimoto, K; Nakamura, H; Tachibana, K; Yamasaki, D; Ota, A; Hirano, K; Tanaka, T; Hamakubo, T; Sakai, J; Kodama, T; Doi, T				Ishimoto, Kenji; Nakamura, Hiroki; Tachibana, Keisuke; Yamasaki, Daisuke; Ota, Akemi; Hirano, Ken-ichi; Tanaka, Toshiya; Hamakubo, Takao; Sakai, Juro; Kodama, Tatsuhiko; Doi, Takefumi			Sterol-mediated Regulation of Human Lipin 1 Gene Expression in Hepatoblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; PHOSPHATIDIC-ACID PHOSPHATASE; DENSITY-LIPOPROTEIN RECEPTOR; SUBCELLULAR-LOCALIZATION; TRANSCRIPTION FACTOR; SREBP PATHWAY; MICE; ADIPOGENESIS; CHOLESTEROL; TARGET	Lipin 1 plays a crucial role in lipid metabolism in adipose tissue, skeletal muscle, and liver. Its physiological role involves two cellular functions: regulation of phosphatidate phosphatase activity and regulation of fatty acid oxidation. In this study, we have demonstrated that lipin 1 gene (LPIN1) expression is regulated by cellular sterols, which are key regulators of lipid metabolism. We have also characterized the sterol-response element and nuclear factor Y-binding sites in the human LPIN1 promoter. Using a luciferase assay, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay, we demonstrated that these elements are responsible for the transcription of LPIN1 gene, mediated by SREBP-1 (sterol regulatory element-binding protein 1) and nuclear factor Y. Furthermore, we investigated whether lipin 1 is involved in lipogenesis by transfection of LPIN1 small interfering RNA. We infer that sterol-mediated regulation of lipin 1 gene transcription modulates triglyceride accumulation. This modulation involves changes in the activity of phosphatidate phosphatase.	[Ishimoto, Kenji; Nakamura, Hiroki; Tachibana, Keisuke; Yamasaki, Daisuke; Doi, Takefumi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Ishimoto, Kenji; Doi, Takefumi] Osaka Univ, Grad Sch Med, Dept Mol Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Ota, Akemi; Hirano, Ken-ichi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Tanaka, Toshiya; Hamakubo, Takao; Sakai, Juro; Kodama, Tatsuhiko] Univ Tokyo, Lab Syst Biol & Med, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan	Osaka University; Osaka University; Osaka University; University of Tokyo	Doi, T (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	doi@phs.osaka-u.ac.jp		Sakai, Juro/0000-0003-4043-1035	National Institute of Biomedical Innovation	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by the Program of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation.	Bhattacharya A, 2003, CANCER RES, V63, P8167; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Fukui K, 2005, DIABETES, V54, P1958, DOI 10.2337/diabetes.54.7.1958; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Grkovich A, 2006, J BIOL CHEM, V281, P32978, DOI 10.1074/jbc.M605935200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ikeda Y, 2001, J BIOL CHEM, V276, P34259, DOI 10.1074/jbc.M103848200; Ishimoto K, 2006, FEBS LETT, V580, P4929, DOI 10.1016/j.febslet.2006.08.010; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Lan H, 2003, DIABETES, V52, P688, DOI 10.2337/diabetes.52.3.688; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; MARTIN A, 1991, METHOD ENZYMOL, V197, P553; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Reue K, 2000, Curr Atheroscler Rep, V2, P390, DOI 10.1007/s11883-000-0077-1; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wassef H, 2004, J NUTR, V134, P2935, DOI 10.1093/jn/134.11.2935; Yao-Borengasser A, 2006, DIABETES, V55, P2811, DOI 10.2337/db05-1688; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	40	58	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22195	22205		10.1074/jbc.M109.028753	http://dx.doi.org/10.1074/jbc.M109.028753			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553673	Green Published, hybrid			2022-12-27	WOS:000268783700044
J	Zhang, H; Eoff, RL; Kozekov, ID; Rizzo, CJ; Egli, M; Guengerich, FP				Zhang, Huidong; Eoff, Robert L.; Kozekov, Ivan D.; Rizzo, Carmelo J.; Egli, Martin; Guengerich, F. Peter			Structure-Function Relationships in Miscoding by Sulfolobus solfataricus DNA Polymerase Dpo4 GUANINE N-2,N-2-DIMETHYL SUBSTITUTION PRODUCES INACTIVE AND MISCODING POLYMERASE COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASE; HIV-1 REVERSE-TRANSCRIPTASE; STEADY-STATE KINETICS; ERROR-FREE BYPASS; TRANSLESION SYNTHESIS; TRANSFER-RNA; SECONDARY STRUCTURE; KLENOW FRAGMENT; NITRIC-OXIDE; ACTIVE-SITE	Previous work has shown that Y-family DNA polymerases tolerate large DNA adducts, but a substantial decrease in catalytic efficiency and fidelity occurs during bypass of N-2,N-2-dimethyl (Me-2)-substituted guanine (N-2,N-2-Me(2)G), in contrast to a single methyl substitution. Therefore, it is unclear why the addition of two methyl groups is so disruptive. The presence of N-2,N-2-Me(2)G lowered the catalytic efficiency of the model enzyme Sulfolobus solfataricus Dpo4 16,000-fold. Dpo4 inserted dNTPs almost at random during bypass of N-2,N-2-Me(2)G, and much of the enzyme was kinetically trapped by an inactive ternary complex when N-2,N-2-Me(2)G was present, as judged by a reduced burst amplitude (5% of total enzyme) and kinetic modeling. One crystal structure of Dpo4 with a primer having a 3'-terminal dideoxycytosine (C-dd) opposite template N-2,N-2-Me(2)G in a post-insertion position showed C-dd folded back into the minor groove, as a catalytically incompetent complex. A second crystal had two unique orientations for the primer terminal C-dd as follows: (i) flipped into the minor groove and (ii) a long pairing with N-2,N-2-Me(2)G in which one hydrogen bond exists between the O-2 atom of C-dd and the N-1 atom of N-2,N-2-Me(2)G, with a second water-mediated hydrogen bond between the N-3 atom of Cdd and the O-6 atom of N-2,N-2-Me(2)G. A crystal structure of Dpo4 with dTTP opposite template N-2,N-2- Me(2)G revealed a wobble orientation. Collectively, these results explain, in a detailed manner, the basis for the reduced efficiency and fidelity of Dpo4-catalyzed bypass of N-2,N-2-Me(2)G compared with mono-substituted N-2-alkyl G adducts.	[Zhang, Huidong; Eoff, Robert L.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Zhang, Huidong; Eoff, Robert L.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Kozekov, Ivan D.; Rizzo, Carmelo J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Kozekov, Ivan D.; Rizzo, Carmelo J.] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Rizzo, Carmelo/0000-0001-9005-611X	National Institutes of Health [R01 ES010375, F32 CA119776, P01 ES05355, P30 ES000267]; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355, R01ES010375, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F. P. G.), F32 CA119776 (to R. L. E.), P01 ES05355 (to I. D. K., C.J.R., and M. E.), and P30 ES000267 (to F. P. G., C. J. R., and M. E.).	Armengaud J, 2004, J BIOL CHEM, V279, P37142, DOI 10.1074/jbc.M403845200; ARUOMA OI, 1989, J BIOL CHEM, V264, P13024; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBILLAU C, 1997, TURBO FRODO VERSION; CHENG KC, 1992, J BIOL CHEM, V267, P166; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Choi JY, 2004, J BIOL CHEM, V279, P19217, DOI 10.1074/jbc.M313759200; de los Santos C, 2001, J BIOL CHEM, V276, P9077, DOI 10.1074/jbc.M009028200; DeLano W.L, PYMOL MOL GRAPHICS S; Douki T, 2001, BIOCHEMISTRY-US, V40, P2495, DOI 10.1021/bi0022543; EDQVIST J, 1995, BIOCHIMIE, V77, P54, DOI 10.1016/0300-9084(96)88104-1; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fang JL, 1997, CARCINOGENESIS, V18, P627, DOI 10.1093/carcin/18.4.627; Forgacs E, 1997, J BIOL CHEM, V272, P8525, DOI 10.1074/jbc.272.13.8525; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Guengerich FP, 1999, IARC SCI PUBL, P137; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Irimia A, 2007, J BIOL CHEM, V282, P36421, DOI 10.1074/jbc.M707267200; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim TW, 2005, P NATL ACAD SCI USA, V102, P15803, DOI 10.1073/pnas.0505113102; KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lao YB, 2007, CHEM RES TOXICOL, V20, P246, DOI 10.1021/tx060208j; Lao YB, 2005, CHEM RES TOXICOL, V18, P711, DOI 10.1021/tx0497292; Lee HR, 2008, J BIOL CHEM, V283, P14402, DOI 10.1074/jbc.M705007200; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Liu X, 2006, BIOCHEMISTRY-US, V45, P12898, DOI 10.1021/bi060792v; Mao H, 1999, P NATL ACAD SCI USA, V96, P6615, DOI 10.1073/pnas.96.12.6615; MARQUET R, 1995, BIOCHIMIE, V77, P113, DOI 10.1016/0300-9084(96)88114-4; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Matsuda T, 1999, BIOCHEMISTRY-US, V38, P929, DOI 10.1021/bi982134j; MEEHAN T, 1979, NATURE, V277, P410, DOI 10.1038/277410a0; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Mizukami S, 2006, BIOCHEMISTRY-US, V45, P2772, DOI 10.1021/bi051961z; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Nair DT, 2008, STRUCTURE, V16, P239, DOI 10.1016/j.str.2007.12.009; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nakamura J, 1998, CANCER RES, V58, P222; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pattanayek R, 2004, J AM CHEM SOC, V126, P15006, DOI 10.1021/ja044637k; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; SCHAAPER RM, 1982, CANCER RES, V42, P3480; Searle C. F., 1984, CHEM CARCINOGENS; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; STEINBERG S, 1993, NUCLEIC ACIDS RES, V21, P3011, DOI 10.1093/nar/21.13.3011; Stone MP, 2008, ACCOUNTS CHEM RES, V41, P793, DOI 10.1021/ar700246x; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Suo ZC, 1998, J BIOL CHEM, V273, P27259, DOI 10.1074/jbc.273.42.27259; Terashima I, 2001, BIOCHEMISTRY-US, V40, P4106, DOI 10.1021/bi002719p; Trincao J, 2004, NAT STRUCT MOL BIOL, V11, P457, DOI 10.1038/nsmb755; TURESKY RJ, 1992, CHEM RES TOXICOL, V5, P479, DOI 10.1021/tx00028a005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Vellieux FMD, 1997, J APPL CRYSTALLOGR, V30, P396, DOI 10.1107/S0021889896012551; Wang MY, 2007, CHEM RES TOXICOL, V20, P625, DOI 10.1021/tx600332p; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Yasui M, 2001, NUCLEIC ACIDS RES, V29, P1994, DOI 10.1093/nar/29.9.1994; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang HD, 2009, J BIOL CHEM, V284, P3563, DOI 10.1074/jbc.M807778200; Zhang S, 2006, CHEM RES TOXICOL, V19, P1386, DOI 10.1021/tx060154d	81	33	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17687	17699		10.1074/jbc.M109014274	http://dx.doi.org/10.1074/jbc.M109014274			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19542237	Green Published, Bronze			2022-12-27	WOS:000267202500035
J	Kuszak, AJ; Pitchiaya, S; Anand, JP; Mosberg, HI; Walter, NG; Sunahara, RK				Kuszak, Adam J.; Pitchiaya, Sethuramasundaram; Anand, Jessica P.; Mosberg, Henry I.; Walter, Nils G.; Sunahara, Roger K.			Purification and Functional Reconstitution of Monomeric mu-Opioid Receptors ALLOSTERIC MODULATION OF AGONIST BINDING BY G(i2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DELTA; RHODOPSIN; HETERODIMERIZATION; OLIGOMERIZATION; DIMERIZATION; EXPRESSION; KAPPA; GENERATION; TRANSDUCIN	Despite extensive characterization of the mu-opioid receptor (MOR), the biochemical properties of the isolated receptor remain unclear. In light of recent reports, we proposed that the monomeric form of MOR can activate G proteins and be subject to allosteric regulation. A mu-opioid receptor fused to yellow fluorescent protein (YMOR) was constructed and expressed in insect cells. YMOR binds ligands with high affinity, displays agonist-stimulated [S-35]guanosine 5'-(gamma-thio)triphosphate binding to G alpha(i), and is allosterically regulated by coupled G(i) protein heterotrimer both in insect cell membranes and as purified protein reconstituted into a phospholipid bilayer in the form of high density lipoprotein particles. Single-particle imaging of fluorescently labeled receptor indicates that the reconstituted YMOR is monomeric. Moreover, single-molecule imaging of a Cy3-labeled agonist, [Lys(7), Cys(8)]dermorphin, illustrates a novel method for studying G protein-coupled receptor-ligand binding and suggests that one molecule of agonist binds per monomeric YMOR. Together these data support the notion that oligomerization of the mu-opioid receptor is not required for agonist and antagonist binding and that the monomeric receptor is the minimal functional unit in regard to G protein activation and strong allosteric regulation of agonist binding by G proteins.	[Kuszak, Adam J.; Sunahara, Roger K.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Pitchiaya, Sethuramasundaram; Walter, Nils G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Anand, Jessica P.; Mosberg, Henry I.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sunahara, RK (corresponding author), 1301 Med Sci Res Bldg 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sunahara@umich.edu	Pitchiaya, Sethuramasundaram/B-4238-2013; Sunahara, Roger/AAJ-8667-2020; Anand, Jessica/X-4064-2019; Walter, Nils/P-3163-2019; Walter, Nils G/G-7504-2016; Anand, Jessica/AAV-9499-2020	Pitchiaya, Sethuramasundaram/0000-0003-2529-5186; Walter, Nils/0000-0002-7301-1275; Walter, Nils G/0000-0002-7301-1275; Anand, Jessica/0000-0001-6560-2211; Kuszak, Adam/0000-0001-8719-145X	National Institutes of Health [GM068603, GM07767, GM081025, P60-DK020572]; Michigan Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068603, R01GM081025, T32GM007767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068603 (to R. K. S.), GM07767 (to A. J. K. and J. P. A.), GM081025 (to S. P. and N. G. W.), and P60-DK020572 (to R. K. S.). This work was also supported by a pilot and feasibility grant from the Michigan Diabetes Research and Training Center.	Alt A, 1998, J PHARMACOL EXP THER, V286, P282; ATTILA M, 1993, INT J PEPT PROT RES, V42, P550; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BLUME AJ, 1979, P NATL ACAD SCI USA, V76, P5626, DOI 10.1073/pnas.76.11.5626; CHO TM, 1985, LIFE SCI, V36, P1075, DOI 10.1016/0024-3205(85)90493-X; Clark MJ, 2006, J PHARMACOL EXP THER, V317, P858, DOI 10.1124/jpet.105.096818; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Emmerson PJ, 1996, J PHARMACOL EXP THER, V278, P1121; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; FRANCES B, 1985, EUR J PHARMACOL, V117, P223, DOI 10.1016/0014-2999(85)90607-7; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; GIOANNINI TL, 1985, J BIOL CHEM, V260, P5117; Gomes I, 2002, METHODS, V27, P358, DOI 10.1016/S1046-2023(02)00094-4; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; KOZASA T, 1999, CRC METH SIG TRANS, P23; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Levac BAR, 2002, CURR OPIN PHARMACOL, V2, P76, DOI 10.1016/S1471-4892(02)00124-8; LI LY, 1992, LIFE SCI, V51, P1177; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Martin NA, 2001, MOL PHARMACOL, V59, P774, DOI 10.1124/mol.59.4.774; Massotte D, 1997, J BIOL CHEM, V272, P19987, DOI 10.1074/jbc.272.32.19987; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2007, ERNST SCHERING FOUND, V2, P145, DOI 10.1007/2789_2006_007; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; Obermeier H, 1996, EUR J PHARMACOL, V318, P161, DOI 10.1016/S0014-2999(96)00743-1; OTT S, 1989, BIOCHEM PHARMACOL, V38, P1931, DOI 10.1016/0006-2952(89)90491-7; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Ramon E, 2003, VISION RES, V43, P3055, DOI 10.1016/j.visres.2003.08.009; RICHARDSON A, 1992, P NATL ACAD SCI USA, V89, P10198, DOI 10.1073/pnas.89.21.10198; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007; Sarramegna V, 2002, J BIOTECHNOL, V99, P23, DOI 10.1016/S0168-1656(02)00161-X; Sarramegna V, 2002, PROTEIN EXPRES PURIF, V24, P212, DOI 10.1006/prep.2001.1564; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Talmont F, 1996, FEBS LETT, V394, P268, DOI 10.1016/0014-5793(96)00971-4; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Wang DX, 2005, MOL PHARMACOL, V67, P2173, DOI 10.1124/mol.104.010272; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	47	147	149	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26732	26741		10.1074/jbc.M109.026922	http://dx.doi.org/10.1074/jbc.M109.026922			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19542234	hybrid, Green Published			2022-12-27	WOS:000269969600054
J	Chen, SY; Kesler, CT; Paschal, BM; Balk, SP				Chen, Shaoyong; Kesler, Cristina T.; Paschal, Bryce M.; Balk, Steven P.			Androgen Receptor Phosphorylation and Activity Are Regulated by an Association with Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; TERMINAL DOMAIN; TRANSCRIPTION; PROTEASOME; IDENTIFICATION; STABILIZATION; ACTIVATION; COMPLEX; BINDING; SITES	Androgen receptor (AR) is phosphorylated at multiple sites in response to ligand binding, but the functional consequences and mechanisms regulating AR phosphorylation remain to be established. We observed initially that okadaic acid, an inhibitor of the major PPP family serine/threonine phosphatases PP2A and protein phosphatase 1 (PP1), had cell type-dependent effects on ARexpression. More specific inhibitors of PP2A (fostriecin) and PP1 (tautomycin and siRNA against the PP1 alpha catalytic subunit) demonstrated that PP1 and protein phosphatase 2A had opposite effects on AR protein and transcriptional activity. PP1 inhibition enhanced proteasome-mediated AR degradation, while PP1 alpha overexpression increased AR expression and markedly enhanced AR transcriptional activity. Coprecipitation experiments demonstrated an AR-PP1 interaction, while immunofluorescence and nuclear-cytoplasmic fractionation showed androgen-stimulated nuclear translocation of both AR and PP1 in prostate cancer cells. Studies with phosphospecific AR antibodies showed that PP1 inhibition dramatically increased phosphorylation of Ser-650, a site in the AR hinge region shown to mediate nuclear export. Significantly, PP1 inhibition caused a marked decrease in nuclear localization of the wild-type AR, but did not alter total or nuclear levels of a S650A mutant AR. These findings reveal a critical role of PP1 in regulating AR protein stability and nuclear localization through dephosphorylation of Ser-650. Moreover, AR may function as a PP1 regulatory subunit and mediate PP1 recruitment to chromatin, where it can modulate transcription and splicing.	[Chen, Shaoyong; Balk, Steven P.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Hematol Oncol Div,Dept Med, Boston, MA 02215 USA; [Kesler, Cristina T.; Paschal, Bryce M.] Univ Virginia Hlth Syst, Ctr Cell Signaling, Dept Biochem & Mol Genet, Ctr Canc, Charlottesville, VA 22908 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Virginia	Chen, SY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Hematol Oncol Div,Dept Med, CLS 432,330 Brookline Ave, Boston, MA 02215 USA.	schen@bidmc.harvard.edu	CHEN, Shaoyong/ABF-3357-2021		Department of Defense (DOD) [PC060807]; National Institutes of Health [R01CA111803, P50 CA90381]; SPORE Career Development Award; DOD Postdoctoral Award [PC040499]; NIH [K99CA135592]; Hershey Family Prostate Cancer Research Fund; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA090381, R01CA111803, K99CA135592] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE Career Development Award; DOD Postdoctoral Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hershey Family Prostate Cancer Research Fund; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Defense (DOD) Grant PC060807 and National Institutes of Health Grants R01CA111803 and P50 CA90381 ( to S. P. B.). This work was also supported by a SPORE Career Development Award, DOD Postdoctoral Award PC040499, and NIH K99CA135592 ( to S. C.), by the Hershey Family Prostate Cancer Research Fund, and by a Challenge Award from the Prostate Cancer Foundation.	Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Cohen PTW, 2002, J CELL SCI, V115, P241; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Garcia A, 2004, CR BIOL, V327, P93, DOI 10.1016/j.crvi.2004.01.001; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; IKONEN T, 1994, ENDOCRINOLOGY, V135, P1359, DOI 10.1210/en.135.4.1359; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; KUIPER GGJM, 1995, BIOCHEMISTRY-US, V34, P1851, DOI 10.1021/bi00006a005; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Shank LC, 2008, J BIOL CHEM, V283, P10568, DOI 10.1074/jbc.M800810200; Sheflin L, 2000, BIOCHEM BIOPH RES CO, V276, P144, DOI 10.1006/bbrc.2000.3424; Tanner T, 2004, ANN NY ACAD SCI, V1030, P587, DOI 10.1196/annals.1329.068; Thompson J, 2006, EMBO J, V25, P2757, DOI 10.1038/sj.emboj.7601161; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Wong HY, 2004, BIOCHEM J, V383, P267, DOI 10.1042/BJ20040683; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Yang CS, 2007, MOL CELL BIOL, V27, P3390, DOI 10.1128/MCB.02411-06; Yang CS, 2005, MOL CELL BIOL, V25, P1298, DOI 10.1128/MCB.25.4.1298-1308.2005; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	31	58	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25576	25584		10.1074/jbc.M109.043133	http://dx.doi.org/10.1074/jbc.M109.043133			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19622840	Green Published, hybrid			2022-12-27	WOS:000269738000015
J	Casimir, M; Lasorsa, FM; Rubi, B; Caille, D; Palmieri, F; Meda, P; Maechler, P				Casimir, Marina; Lasorsa, Francesco M.; Rubi, Blanca; Caille, Dorothee; Palmieri, Ferdinando; Meda, Paolo; Maechler, Pierre			Mitochondrial Glutamate Carrier GC1 as a Newly Identified Player in the Control of Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; REGULATED ANAPLEROSIS; METABOLIC-FATE; AMINO-ACID; TRANSPORTER; ISLET; RECONSTITUTION; DEHYDROGENASE	The SLC25 carrier family mediates solute transport across the inner mitochondrial membrane, a process that is still poorly characterized regarding both the mechanisms and proteins implicated. This study investigated mitochondrial glutamate carrier GC1 in insulin-secreting beta-cells. GC1 was cloned from insulin-secreting cells, and sequence analysis revealed hydropathy profile of a six-transmembrane protein, characteristic of mitochondrial solute carriers. GC1 was found to be expressed at the mRNA and protein levels in INS-1E beta-cells and pancreatic rat islets. Immunohistochemistry showed that GC1 was present in mitochondria, and ultrastructural analysis by electron microscopy revealed inner mitochondrial membrane localization of the transporter. Silencing of GC1 in INS-1E beta-cells, mediated by adenoviral delivery of short hairpin RNA, reduced mitochondrial glutamate transport by 48% (p < 0.001). Insulin secretion at basal 2.5 mM glucose and stimulated either by intermediate 7.5 mM glucose or non-nutrient 30 mM KCl was not modified by GC1 silencing. Conversely, insulin secretion stimulated with optimal 15 mM glucose was reduced by 23% (p < 0.005) in GC1 knocked down cells compared with controls. Adjunct of cell-permeant glutamate (5 mM dimethyl glutamate) fully restored the secretory response at 15 mM glucose (p < 0.005). Kinetics of insulin secretion were investigated in peri-fused isolated rat islets. GC1 silencing in islets inhibited the secretory response induced by 16.7 mM glucose, both during first (-25%, p < 0.05) and second (-33%, p < 0.05) phases. This study demonstrates that insulin-secreting cells depend on GC1 for maximal glucose response, thereby assigning a physiological function to this newly identified mitochondrial glutamate carrier.	[Maechler, Pierre] Univ Geneva, Dept Cell Physiol & Metab, Fac Med, CH-1211 Geneva 4, Switzerland; [Lasorsa, Francesco M.; Palmieri, Ferdinando] Univ Bari, Dept Pharm Biol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; [Lasorsa, Francesco M.; Palmieri, Ferdinando] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy	University of Geneva; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Maechler, P (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Fac Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Pierre.Maechler@unige.ch	lasorsa, francesco massimo m/B-7931-2008	lasorsa, francesco massimo m/0000-0001-8418-5222; Maechler, Pierre/0000-0002-2005-1433	Swiss National Science Foundation; European Foundation for the Study of Diabetes/Novo Nordisk research; Novartis Foundation; Novo Nordisk; Ministero dell'Universita e della Ricerca; Apulia Region; Juvenile Diabetes Research Foundation; European Union	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Foundation for the Study of Diabetes/Novo Nordisk research; Novartis Foundation(Novartis); Novo Nordisk(Novo Nordisk); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Apulia Region; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission)	This work was supported by the Swiss National Science Foundation (to P. Maechler and P. Meda), the European Foundation for the Study of Diabetes/Novo Nordisk research grant (to P. Maechler), the Novartis Foundation (to P. Maechler), Novo Nordisk (P. Meda), the Ministero dell'Universita e della Ricerca (to F. P.) and Apulia Region (to F. P.), the Juvenile Diabetes Research Foundation (P. Meda), and the European Union (P. Meda). This study was part of the Geneva Programme for Metabolic Disorders.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Bai LQ, 2003, AM J PHYSIOL-GASTR L, V284, pG808, DOI 10.1152/ajpgi.00333.2002; Bosco D, 2005, DIABETOLOGIA, V48, P1523, DOI 10.1007/s00125-005-1816-1; Broca C, 2003, FEBS LETT, V545, P167, DOI 10.1016/S0014-5793(03)00526-X; Carobbio S, 2004, DIABETOLOGIA, V47, P266, DOI 10.1007/s00125-003-1306-2; Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200; del Arco A, 2005, CELL MOL LIFE SCI, V62, P2204, DOI 10.1007/s00018-005-5197-x; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Eto K, 2003, AM J PHYSIOL-ENDOC M, V285, pE262, DOI 10.1152/ajpendo.00542.2002; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Frigerio F, 2008, BBA-BIOENERGETICS, V1777, P965, DOI 10.1016/j.bbabio.2008.04.031; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; Jones PM, 1998, ENDOCR REV, V19, P429, DOI 10.1210/er.19.4.429; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kowluru A, 2001, DIABETES, V50, P1580, DOI 10.2337/diabetes.50.7.1580; Lehtihet M, 2005, BIOCHEM BIOPH RES CO, V328, P601, DOI 10.1016/j.bbrc.2005.01.024; Li CH, 2006, J BIOL CHEM, V281, P15064, DOI 10.1074/jbc.M600994200; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2002, DIABETES, V51, pS99, DOI 10.2337/diabetes.51.2007.S99; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Molinari F, 2005, AM J HUM GENET, V76, P334, DOI 10.1086/427564; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri L, 1999, MOL MICROBIOL, V31, P569, DOI 10.1046/j.1365-2958.1999.01197.x; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; PUIGSERVER P, 1992, BIOCHEM J, V284, P393, DOI 10.1042/bj2840393; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Rubi B, 2001, J BIOL CHEM, V276, P36391, DOI 10.1074/jbc.M104999200; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Scheiermann C, 2007, SCIENCE, V318, P1472, DOI 10.1126/science.1149276; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1981, DIABETOLOGIA, V21, P135; Shi YG, 2000, AM J PHYSIOL-ENDOC M, V279, pE684, DOI 10.1152/ajpendo.2000.279.3.E684; Storto M, 2006, MOL PHARMACOL, V69, P1234, DOI 10.1124/mol.105.018390; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Yang SN, 2005, AM J PHYSIOL-ENDOC M, V288, pE16, DOI 10.1152/ajpendo.00042.2004	53	52	54	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25004	25014		10.1074/jbc.M109.015495	http://dx.doi.org/10.1074/jbc.M109.015495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584051	Green Published, hybrid			2022-12-27	WOS:000269734000036
J	Garcia-Castillo, J; Pedersen, K; Angelini, PD; Bech-Serra, JJ; Colome, N; Cunningham, MP; Parra-Palau, JL; Canals, F; Baselga, J; Arribas, J				Garcia-Castillo, Jesus; Pedersen, Kim; Angelini, Pier-Davide; Josep Bech-Serra, Joan; Colome, Nuria; Paul Cunningham, Matthew; Lluis Parra-Palau, Josep; Canals, Francesc; Baselga, Jose; Arribas, Joaquin			HER2 Carboxyl-terminal Fragments Regulate Cell Migration and Cortactin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PHOSPHORYLATION; TUMOR-GROWTH; PROTEIN; INVASION; ADHESION; RECEPTOR; IDENTIFICATION; INVADOPODIA; EXPRESSION; PROTEOMICS	A group of breast cancer patients with a higher probability of developing metastasis expresses a series of carboxyl-terminal fragments (CTFs) of the tyrosine kinase receptor HER2. One of these fragments, 611-CTF, is a hyperactive form of HER2 that constitutively establishes homodimers maintained by disulfide bonds, making it an excellent model to study overactivation of HER2 during tumor progression and metastasis. Here we show that expression of 611-CTF increases cell motility in a variety of assays. Since cell motility is frequently regulated by phosphorylation/dephosphorylation, we looked for phosphoproteins mediating the effect of 611-CTF using two alternative proteomic approaches, stable isotope labeling with amino acids in cell culture and difference gel electrophoresis, and found that the latter is particularly well suited to detect changes in multiphosphorylated proteins. The difference gel electrophoresis screening identified cortactin, a cytoskeleton-binding protein involved in the regulation of cell migration, as a phosphoprotein probably regulated by 611-CTF. This result was validated by characterizing cortactin in cells expressing this HER2 fragment. Finally, we showed that the knockdown of cortactin impairs 611-CTF-induced cell migration. These results suggest that cortactin is a target of 611-CTF involved in the regulation of cell migration and, thus, in the metastatic behavior of breast tumors expressing this CTF.	[Paul Cunningham, Matthew; Lluis Parra-Palau, Josep; Canals, Francesc; Baselga, Jose; Arribas, Joaquin] Vall Hebron Univ Hosp, Med Oncol Res Program, Barcelona 08035, Spain; [Josep Bech-Serra, Joan; Colome, Nuria; Canals, Francesc] Vall Hebron Univ Hosp, Prote Lab, Res Inst Fdn, Barcelona 08035, Spain; [Josep Bech-Serra, Joan; Colome, Nuria; Canals, Francesc] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol, Barcelona 08035, Spain; [Angelini, Pier-Davide; Arribas, Joaquin] Autonomous Univ Barcelona, Dept Biochem & Mol Biol, Bellaterra 08193, Spain; [Arribas, Joaquin] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; ICREA	Parra-Palau, JL (corresponding author), Vall Hebron Univ Hosp, Med Oncol Res Program, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.	jarribas@ir.vhebron.net	Bech-Serra, Joan Josep/AAA-2330-2020; Garcia-Castillo, Jesus/GOE-4850-2022; Arribas, Joaquin/M-4482-2014	Bech-Serra, Joan Josep/0000-0003-3486-781X; Garcia-Castillo, Jesus/0000-0002-7520-6746; Arribas, Joaquin/0000-0002-0504-0664	Instituto de Salud Carlos III; Breast Cancer Research Foundation; La Marato de TV3; Juan de la Cierva Postdoctoral Program; Spanish Ministry of Education; ICREA Funding Source: Custom	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Breast Cancer Research Foundation; La Marato de TV3; Juan de la Cierva Postdoctoral Program; Spanish Ministry of Education(Spanish Government); ICREA(ICREA)	This work was supported by grants from the Instituto de Salud Carlos III (Intrasalud PI081154 and the network of cooperative cancer research), the Breast Cancer Research Foundation, and La Marato de TV3 (to J.A.).; Supported by a fellowship from the Juan de la Cierva Postdoctoral Program.; Supported by a predoctoral fellowship from the Spanish Ministry of Education.	Anido J, 2006, EMBO J, V25, P3234, DOI 10.1038/sj.emboj.7601191; Bech-Serra JJ, 2006, MOL CELL BIOL, V26, P5086, DOI 10.1128/MCB.02380-05; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Brandt BH, 1999, FASEB J, V13, P1939, DOI 10.1096/fasebj.13.14.1939; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Chaudhuri P, 2005, CIRC RES, V97, P674, DOI 10.1161/01.RES.0000184667.82354.b1; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Crostella L, 2001, ONCOGENE, V20, P3735, DOI 10.1038/sj.onc.1204474; Dittmar T, 2002, FASEB J, V16, P1823, DOI 10.1096/fj.02-0096fje; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Everley PA, 2005, ANN NY ACAD SCI, V1059, P1, DOI 10.1196/annals.1339.001; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Hill A, 2006, ONCOGENE, V25, P6079, DOI 10.1038/sj.onc.1209628; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Molina MA, 2002, CLIN CANCER RES, V8, P347; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Rusnak DW, 2001, CANCER RES, V61, P7196; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Shin KD, 2005, J BIOL CHEM, V280, P41439, DOI 10.1074/jbc.M507209200; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Takino T, 2003, J CELL SCI, V116, P3145, DOI 10.1242/jcs.00632; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Van den Bergh G, 2004, CURR OPIN BIOTECH, V15, P38, DOI 10.1016/j.copbio.2003.12.001; van Rossum AGSH, 2006, EXP CELL RES, V312, P1658, DOI 10.1016/j.yexcr.2006.01.033; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Webb BA, 2007, EUR J CELL BIOL, V86, P189, DOI 10.1016/j.ejcb.2007.01.003; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuan CX, 2003, PROTEIN EXPRES PURIF, V29, P217, DOI 10.1016/S1046-5928(03)00058-5	36	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25302	25313		10.1074/jbc.M109.001982	http://dx.doi.org/10.1074/jbc.M109.001982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19589785	hybrid, Green Published			2022-12-27	WOS:000269734000063
J	Fielhaber, JA; Han, YS; Tan, J; Xing, S; Biggs, CM; Joung, KB; Kristof, AS				Fielhaber, Jill A.; Han, Ying-Shan; Tan, Jason; Xing, Shuo; Biggs, Catherine M.; Joung, Kwang-Bo; Kristof, Arnold S.			Inactivation of Mammalian Target of Rapamycin Increases STAT1 Nuclear Content and Transcriptional Activity in alpha 4-and Protein Phosphatase 2A-dependent Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDE SYNTHASE PROMOTER; IFN-GAMMA; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; CATALYTIC SUBUNIT; SIGNALING PATHWAY; INDUCED APOPTOSIS; INTERFERON-GAMMA; GROWTH-CONTROL; IMMUNE-SYSTEM; CELL-DEATH	Target of rapamycin (TOR) is a highly conserved serine/threonine kinase that controls cell growth, primarily via regulation of protein synthesis. In Saccharomyces cerevisiae, TOR can also suppress the transcription of stress response genes by a mechanism involving Tap42, a serine/threonine phosphatase subunit, and the transcription factor Msn2. A physical association between mammalian TOR (mTOR) and the transcription factor signal transducer and activator of transcription-1 (STAT1) was recently identified in human cells, suggesting a similar role form TOR in the transcription of interferon-gamma-stimulated genes. In the current study, we identified a macromolecular protein complex composed of mTOR, STAT1, the Tap42 homologue alpha 4, and the protein phosphatase 2A catalytic subunit (PP2Ac). Inactivation of mTOR enhanced its association with STAT1 and increased STAT1 nuclear content in PP2Ac-dependent fashion. Depletion of alpha 4, PP2A, or mTOR enhanced the induction of early (i.e. IRF-1) and late (i.e. caspase-1, hiNOS, and Fas) STAT1-dependent genes. The regulation of IRF-1 or caspase-1 by mTOR was independent of other known mTOR effectors p70 S6 kinase and Akt. These results describe a new role for mTOR and alpha 4/PP2A in the control of STAT1 nuclear content, and the expression of interferon-gamma-sensitive genes involved in immunity and apoptosis.	McGill Univ, Fac Med, Crit Care Div, Montreal, PQ H3A 1A1, Canada; McGill Univ, Fac Med, Div Resp, Montreal, PQ H3A 1A1, Canada; McGill Univ, Fac Med, Meakins Christie Labs, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; McGill University	Kristof, AS (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, 687 Pine Ave W,L3-05, Montreal, PQ H3A 1A1, Canada.	arnold.kristof@mcgill.ca		Biggs, Catherine/0000-0002-4363-2660	National Institutes of Health [5R01CA125436]; McGill University Health Centre Confocal Core Facility; Canadian Institutes for Health Research; American Thoracic Society/Lymphangioleiomyomatosis Foundation Award; Tuberous Sclerosis Alliance; Tuberous Sclerosis Canada; NATIONAL CANCER INSTITUTE [R01CA125436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McGill University Health Centre Confocal Core Facility; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); American Thoracic Society/Lymphangioleiomyomatosis Foundation Award; Tuberous Sclerosis Alliance; Tuberous Sclerosis Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01CA125436. This work was also facilitated by the McGill University Health Centre Confocal Core Facility (S. Laporte) and funded by the Canadian Institutes for Health Research and by an American Thoracic Society/Lymphangioleiomyomatosis Foundation Award in partnership with the Tuberous Sclerosis Alliance and Tuberous Sclerosis Canada.	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; El-Hashemite N, 2005, AM J RESP CELL MOL, V33, P227, DOI 10.1165/rcmb.2005-0152RC; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Huang SL, 2001, CANCER RES, V61, P3373; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kirchhoff S, 2002, J IMMUNOL, V168, P1226, DOI 10.4049/jimmunol.168.3.1226; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kristof AS, 2006, J BIOL CHEM, V281, P23958, DOI 10.1074/jbc.M513918200; Kristof AS, 2003, J BIOL CHEM, V278, P33637, DOI 10.1074/jbc.M301053200; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; Kristof AS, 2003, INTERSTITIAL LUNG DI, P851; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Nien WL, 2007, MOL CELL ENDOCRINOL, V263, P10, DOI 10.1016/j.mce.2006.08.015; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Reich NC, 2007, CYTOKINE GROWTH F R, V18, P511, DOI 10.1016/j.cytogfr.2007.06.021; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; Wong LH, 2002, J BIOL CHEM, V277, P19408, DOI 10.1074/jbc.M111302200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	46	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24341	24353		10.1074/jbc.M109.033530	http://dx.doi.org/10.1074/jbc.M109.033530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19553685	Green Published, hybrid			2022-12-27	WOS:000269380200047
J	Ivashyna, O; Garcia-Saez, AJ; Ries, J; Christenson, ET; Schwille, P; Schlesinger, PH				Ivashyna, Olena; Garcia-Saez, Ana J.; Ries, Jonas; Christenson, Eric T.; Schwille, Petra; Schlesinger, Paul H.			Detergent-activated BAX Protein Is a Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; INTENSITY DISTRIBUTION ANALYSIS; CYTOCHROME-C; MITOCHONDRIAL-MEMBRANE; CONFORMATIONAL-CHANGE; APOPTOSIS; OLIGOMERIZATION; LIPOSOMES; BINDING; CELLS	BAX is a pro-apoptotic member of the BCL-2 protein family. At the onset of apoptosis, monomeric, cytoplasmic BAX is activated and translocates to the outer mitochondrial membrane, where it forms an oligomeric pore. The chemical mechanism of BAX activation is controversial, and several in vitro and in vivo methods of its activation are known. One of the most commonly used in vitro methods is activation with detergents, such as n-octyl glucoside. During BAX activation with n-octyl glucoside, it has been shown that BAX forms high molecular weight complexes that are larger than the combined molecular weight of BAX monomer and one detergent micelle. These large complexes have been ascribed to the oligomerization of BAX prior to its membrane insertion and pore formation. This is in contrast to the in vivo studies that suggest that active BAX inserts into the outer mitochondrial membrane as a monomer and then undergoes oligomerization. Here, to simultaneously determine the molecular weight and the number of BAX proteins per BAX-detergent micelle during detergent activation, we have used an approach that combines two single-molecule sensitivity technique, fluorescence correlation spectroscopy, and fluorescence-intensity distribution analysis. We have tested a range of detergents as follows: n-octyl glucoside, dodecyl maltoside, Triton X-100, Tween 20, 3-[(3- cholamidopropyl)dimethylammonio]-1-propanesulfonic acid, and cholic acid. With these detergents we observe that BAX is a monomer before, during, and after interaction with micelles. We conclude that detergent activation of BAX is not congruent with oligomerization and that in physiologic buffer conditions BAX can assume two stable monomeric conformations, one inactive and one active.	[Ivashyna, Olena; Christenson, Eric T.; Schlesinger, Paul H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Garcia-Saez, Ana J.; Ries, Jonas; Schwille, Petra] Tech Univ Dresden, Biophys Grp, BIOTEC, D-01307 Dresden, Germany	Washington University (WUSTL); Technische Universitat Dresden	Schlesinger, PH (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	paul@cellbiology.wustl.edu	Schlesinger, Paul H/C-6049-2012; Schwille, Petra/A-4983-2010; Ries, Jonas/Q-5157-2019; Saez, Ana J. Garcia/U-1611-2019; Ries, Jonas/P-3027-2014	Christenson, Eric/0000-0001-7463-7694; Ries, Jonas/0000-0002-6640-9250	National Institutes of Health Grant [GM 067056]; Europaischer Fonds fur regionale Entwicklung; International Society of Optical Engineering (SPIE) educational scholarship; Marie Curie Intra-European fellowship; 6th European Framework Program; Europaischen Fonds fur Regional Entwiklung Grant [4212/0608]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067056] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Europaischer Fonds fur regionale Entwicklung; International Society of Optical Engineering (SPIE) educational scholarship; Marie Curie Intra-European fellowship(European Commission); 6th European Framework Program(European Commission); Europaischen Fonds fur Regional Entwiklung Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 067056 ( to P. H. S.) and by Europaischer Fonds fur regionale Entwicklung ( to P. S. and J. R.). This work was also supported by the International Society of Optical Engineering (SPIE) educational scholarship ( to O.I.), by Marie Curie Intra-European fellowship ( to A. J. G. S.) within the 6th European Framework Program, and by Europaischen Fonds fur Regional Entwiklung Grant 4212/0608 ( to J. R. and P. S.).	Anderluh G, 2003, TOXICON, V42, P225, DOI 10.1016/S0041-0101(03)00197-1; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Bamber L, 2006, P NATL ACAD SCI USA, V103, P16224, DOI 10.1073/pnas.0607640103; Bavdek A, 2007, BIOCHEMISTRY-US, V46, P4425, DOI 10.1021/bi602497g; Christenson E, 2008, J MOL BIOL, V381, P1168, DOI 10.1016/j.jmb.2008.06.037; Dewson G, 2003, ONCOGENE, V22, P2643, DOI 10.1038/sj.onc.1206326; Enderlein J, 2004, CURR PHARM BIOTECHNO, V5, P155, DOI 10.2174/1389201043377020; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Haustein E, 2004, CURR OPIN STRUC BIOL, V14, P531, DOI 10.1016/j.sbi.2004.09.004; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; MacKenzie KR, 2008, CURR OPIN STRUC BIOL, V18, P412, DOI 10.1016/j.sbi.2008.04.007; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Ohrt T, 2006, NUCLEIC ACIDS RES, V34, P1369, DOI 10.1093/nar/gkl001; Rika J., 1989, PHYS REV A, V39, P2646; Rodnin MV, 2008, BIOPHYS J, V94, P4348, DOI 10.1529/biophysj.107.126235; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TARTOF KD, 1987, FOCUS, V9, P12; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	22	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23935	23946		10.1074/jbc.M109.023853	http://dx.doi.org/10.1074/jbc.M109.023853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19564333	hybrid, Green Published			2022-12-27	WOS:000269380200007
J	Johnson, JL; Erickson, JW; Cerione, RA				Johnson, Jared L.; Erickson, Jon W.; Cerione, Richard A.			New Insights into How the Rho Guanine Nucleotide Dissociation Inhibitor Regulates the Interaction of Cdc42 with Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-BINDING DOMAIN; CELL POLARITY; MOLECULAR-CLONING; PROTEIN CDC42HS; PLASMA-MEMBRANE; RAC; ACTIVATION; TRANSFORMATION; COMPLEX; GDP	The subcellular localization of the Rho family GTPases is of fundamental importance to their proper functioning in cells. The Rho guanine nucleotide dissociation inhibitor (RhoGDI) plays a key regulatory role by influencing the cellular localization of Rho GTPases and is essential for the transforming activity of oncogenic forms of Cdc42. However, the mechanism by which RhoGDI helps Cdc42 to undergo the transition between a membrane-associated protein and a soluble (cytosolic) species has been poorly understood. Here, we examine how RhoGDI influences the binding of Cdc42 to lipid bilayers. Despite having similar affinities for the signaling-inactive (GDP-bound) and signaling-active (GTP-bound) forms of Cdc42 in solution, we show that when RhoGDI interacts with Cdc42 along the membrane surface, it has a much higher affinity for GDP-bound Cdc42 compared with its GTP-bound counterpart. Interestingly, the rate for the dissociation of Cdc42.RhoGDI complexes from membranes is unaffected by the nucleotide-bound state of Cdc42. Moreover, the membrane release of Cdc42.RhoGDI complexes occurs at a similar rate as the release of Cdc42 alone, with the major effect of RhoGDI being to impede the re-association of Cdc42 with membranes. These findings lead us to propose a new model for how RhoGDI influences the ability of Cdc42 to move between membranes and the cytosol, which highlights the role of the membrane in helping RhoGDI to distinguish between the GDP-and GTP-bound forms of Cdc42 and holds important implications for how it functions as a key regulator of the cellular localization and signaling activities of this GTPase.	[Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Johnson, Jared L.; Erickson, Jon W.; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Johnson, Jared/0000-0003-1802-6527	National Institutes of Health [GM040654, GM047458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, R01GM047458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM040654 and GM047458.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Buboltz JT, 1999, BBA-BIOMEMBRANES, V1417, P232, DOI 10.1016/S0005-2736(99)00006-1; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Court H, 2007, MOL BIOL CELL, V18, P265, DOI 10.1091/mbc.E06-05-0411; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Lin Q, 2003, CURR BIOL, V13, P1469, DOI 10.1016/S0960-9822(03)00613-4; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nomanbhoy TK, 1999, BIOCHEMISTRY-US, V38, P1744, DOI 10.1021/bi982198u; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; THOM D, 1977, BIOCHEM J, V168, P187, DOI 10.1042/bj1680187; UEDA T, 1990, J BIOL CHEM, V265, P9373; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	60	59	60	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23860	23871		10.1074/jbc.M109.031815	http://dx.doi.org/10.1074/jbc.M109.031815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581296	Green Published, hybrid			2022-12-27	WOS:000269180000069
J	Obara, Y; Yamauchi, A; Takehara, S; Nemoto, W; Takahashi, M; Stork, PJS; Nakahata, N				Obara, Yutaro; Yamauchi, Arata; Takehara, Shin; Nemoto, Wataru; Takahashi, Maho; Stork, Philip J. S.; Nakahata, Norimichi			ERK5 Activity Is Required for Nerve Growth Factor-induced Neurite Outgrowth and Stabilization of Tyrosine Hydroxylase in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE-5; MAP KINASE; PHEOCHROMOCYTOMA CELLS; CORTICAL-NEURONS; RAP1 ACTIVATION; GENE-EXPRESSION; CYCLIC-AMP; T-CELLS; PATHWAY	Extracellular signal-regulated kinases (ERKs) play important physiological roles in proliferation, differentiation, and gene expression. ERK5 is approximately twice the size of ERK1/2, and its amino-terminal half contains the kinase domain that shares homology with ERK1/2 and TEY activation motif, whereas the carboxyl-terminal half is unique. In this study, we examined a physiological role of ERK5 in rat pheochromocytoma cells (PC12), comparing it with ERK1/2. Nerve growth factor (NGF) induced phosphorylation of both ERK5 and ERK1/2, whereas the cAMP analog dibutyryl cAMP (Bt(2)cAMP) caused only ERK1/2 phosphorylation. U0126, at 30 mu M, that blocks ERK1/2 signaling selectively attenuated neurite outgrowth induced by NGF and Bt(2)cAMP, but BIX02188 and BIX02189, at 30 mu M, that block ERK5 signaling and an ERK5 dominant-negative mutant suppressed only NGF-induced neurite outgrowth. Next, we examined the expression of tyrosine hydroxylase, a rate-limiting enzyme of catecholamine biosynthesis. Both NGF and Bt2cAMP increased tyrosine hydroxylase gene promoter activity in an ERK1/2-dependent manner but was ERK5-independent. However, when both ERK5 and ERK1/2 signalings were inhibited, tyrosine hydroxylase protein up-regulation by NGF and Bt2cAMP was abolished, because of the loss of stabilization of tyrosine hydroxylase protein by ERK5. Taking these results together, ERK5 is involved in neurite outgrowth and stabilization of tyrosine hydroxylase in PC12 cells, and ERK5, along with ERK1/2, plays essential roles in the neural differentiation process.	[Obara, Yutaro; Yamauchi, Arata; Takehara, Shin; Nemoto, Wataru; Nakahata, Norimichi] Tohoku Univ, Dept Cellular Signaling, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Obara, Yutaro; Nakahata, Norimichi] Tohoku Univ, 21st Century Ctr Excellence Program CRESCENDO, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Obara, Yutaro; Takahashi, Maho; Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Tohoku University; Tohoku University; Oregon Health & Science University	Obara, Y (corresponding author), Tohoku Univ, Dept Cellular Signaling, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	obaray@mail.pharm.tohoku.ac.jp	Nemoto, Wataru/AAK-6004-2021	Nemoto, Wataru/0000-0003-1253-5523	Japan Society for the Promotion of Science [20790053, 19659011]; Japan-United States Brain Research Cooperative Program; Exploratory Research Program for Young Scientists of Tohoku University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan-United States Brain Research Cooperative Program; Exploratory Research Program for Young Scientists of Tohoku University	This work was supported in part by Grants-in-aid from the Japan Society for the Promotion of Science 20790053 (to Y.O.) and 19659011 (to N.N.), Japan-United States Brain Research Cooperative Program (to Y.O.), and Exploratory Research Program for Young Scientists of Tohoku University (to Y.O.).	Carey KD, 2000, MOL CELL BIOL, V20, P8409, DOI 10.1128/MCB.20.22.8409-8419.2000; Cavanaugh JE, 2004, EUR J BIOCHEM, V271, P2056, DOI 10.1111/j.1432-1033.2004.04131.x; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Garaude J, 2006, J IMMUNOL, V177, P7607, DOI 10.4049/jimmunol.177.11.7607; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gueorguiev VD, 2006, J BIOL CHEM, V281, P10188, DOI 10.1074/jbc.M513806200; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Li GM, 2005, CELL IMMUNOL, V238, P10, DOI 10.1016/j.cellimm.2005.12.001; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Marchetti A, 2008, CELL SIGNAL, V20, P2113, DOI 10.1016/j.cellsig.2008.08.002; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Meng JW, 2002, J BIOL CHEM, V277, P43417, DOI 10.1074/jbc.M204074200; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Morimoto H, 2007, J BIOL CHEM, V282, P35449, DOI 10.1074/jbc.M704079200; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Nishimoto S, 2005, EMBO REP, V6, P1064, DOI 10.1038/sj.embor.7400515; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; Obara Y, 2002, J PHARMACOL EXP THER, V301, P803, DOI 10.1124/jpet.301.3.803; Obara Y, 2008, CELL SIGNAL, V20, P1275, DOI 10.1016/j.cellsig.2008.02.016; Obara Y, 2007, J NEUROCHEM, V101, P470, DOI 10.1111/j.1471-4159.2006.04390.x; Pearson GW, 2006, MOL CELL BIOL, V26, P3039, DOI 10.1128/MCB.26.8.3039-3047.2006; Pollack V, 2007, AM J PHYSIOL-RENAL, V293, pF1714, DOI 10.1152/ajprenal.00130.2007; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rosario M, 2007, J CELL BIOL, V178, P503, DOI 10.1083/jcb.200609146; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang YP, 2007, J NEUROCHEM, V102, P957, DOI 10.1111/j.1471-4159.2007.04606.x; Wang YP, 2006, J BIOL CHEM, V281, P35965, DOI 10.1074/jbc.M605503200; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	48	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23564	23573		10.1074/jbc.M109.027821	http://dx.doi.org/10.1074/jbc.M109.027821			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581298	Green Published, hybrid			2022-12-27	WOS:000269180000042
J	Raducanu, A; Hunziker, EB; Drosse, I; Aszodi, A				Raducanu, Aurelia; Hunziker, Ernst B.; Drosse, Inga; Aszodi, Attila			beta 1 Integrin Deficiency Results in Multiple Abnormalities of the Knee Joint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE HYPERTROPHIC DIFFERENTIATION; HUMAN ARTICULAR CHONDROCYTES; FIBRONECTIN FRAGMENTS; CARTILAGE; EXPRESSION; OSTEOARTHRITIS; KINASE; INTEGRINS; TRANSGLUTAMINASE-2; CHONDROLYSIS	The lack of beta 1 integrins on chondrocytes leads to severe chondrodysplasia associated with high mortality rate around birth. To assess the impact of beta 1 integrin-mediated cell-matrix interactions on the function of adult knee joints, we conditionally deleted the beta 1 integrin gene in early limb mesenchyme using the Prx1-cre transgene. Mutant mice developed short limbed dwarfism and had joint defects due to beta 1 integrin deficiency in articular regions. The articular cartilage (AC) was structurally disorganized, accompanied by accelerated terminal differentiation, altered shape, and disrupted actin cytoskeleton of the chondrocytes. Defects in chondrocyte proliferation, cytokinesis, and survival resulted in hypocellularity. However, no significant differences in cartilage erosion, in the expression of matrix-degrading proteases, or in the exposure of aggrecan and collagen II cleavage neoepitopes were observed between control and mutant AC. We found no evidence for disturbed activation of MAPKs (ERK1/2, p38, and JNK) in vivo. Furthermore, fibronectin fragment-stimulated ERK activation and MMP-13 expression were indistinguishable in control and mutant femoral head explants. The mutant synovium was hyperplastic and frequently underwent chondrogenic differentiation. beta 1-null synoviocytes showed increased proliferation and phospho-focal adhesion kinase expression. Taken together, deletion of beta 1 integrins in the limb bud results in multiple abnormalities of the knee joints; however, it does not accelerate AC destruction, perturb cartilage metabolism, or influence intracellular MAPK signaling pathways.	[Raducanu, Aurelia; Aszodi, Attila] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Hunziker, Ernst B.] Univ Bern, Dept Clin Res, Ctr Regenerat Med Skeletal Tissues, CH-3010 Bern, Switzerland; [Drosse, Inga] Univ Munich, Dept Surg, D-80336 Munich, Germany	Max Planck Society; University of Bern; University of Munich	Aszodi, A (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18, D-82152 Martinsried, Germany.	aszodi@biochem.mpg.de	Hunziker, Ernst B/GYA-1015-2022		Max Planck Society; Swiss National Science Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Max Planck Society (to A. R. and A. A.) and the Swiss National Science Foundation (to E. B. H.).	Aszodi A, 1998, J CELL BIOL, V143, P1399, DOI 10.1083/jcb.143.5.1399; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; Botter SM, 2008, OSTEOARTHR CARTILAGE, V16, P506, DOI 10.1016/j.joca.2007.08.005; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Caterson B, 2000, MATRIX BIOL, V19, P333, DOI 10.1016/S0945-053X(00)00078-0; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Ding L, 2008, OSTEOARTHR CARTILAGE, V16, P1253, DOI 10.1016/j.joca.2008.02.015; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.0.CO;2-G; Holloway I, 2004, OSTEOARTHR CARTILAGE, V12, P17, DOI 10.1016/j.joca.2003.09.001; HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597; HUNZIKER EB, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P183; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnson KA, 2008, J CELL SCI, V121, P2256, DOI 10.1242/jcs.011262; Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783; Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0; Lapadula G, 1998, CLIN RHEUMATOL, V17, P99, DOI 10.1007/BF01452253; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; LIPMAN JM, 1984, EXPERIENTIA, V40, P553, DOI 10.1007/BF01982326; Loeser RF, 2003, J BIOL CHEM, V278, P24577, DOI 10.1074/jbc.M304530200; LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Loeser RF, 2008, CURR OPIN RHEUMATOL, V20, P581, DOI 10.1097/BOR.0b013e3283090463; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; MODIS L, 1991, ORG EXTRACELLULAR MA, P269; Murphy G, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar572; Ostergaard K, 1998, ANN RHEUM DIS, V57, P303, DOI 10.1136/ard.57.5.303; Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004; Poole AR, 2003, BIOCHEM SOC SYMP, V70, P115, DOI 10.1042/bss0700115; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Pulai JI, 2002, ARTHRITIS RHEUM, V46, P1528, DOI 10.1002/art.10334; Sakai K, 2001, MATRIX BIOL, V19, P761, DOI 10.1016/S0945-053X(00)00122-0; Shahrara S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2318; Stanton H, 2002, BIOCHEM J, V364, P181, DOI 10.1042/bj3640181; Tanaka K, 2007, MATRIX BIOL, V26, P409, DOI 10.1016/j.matbio.2007.04.005; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; XIE DL, 1994, ARCH BIOCHEM BIOPHYS, V311, P205, DOI 10.1006/abbi.1994.1228; Zemmyo M, 2003, ARTHRITIS RHEUM-US, V48, P2873, DOI 10.1002/art.11246	45	35	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23780	23792		10.1074/jbc.M109.039347	http://dx.doi.org/10.1074/jbc.M109.039347			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19586917	Green Published, hybrid			2022-12-27	WOS:000269180000062
J	Kabotyanski, EB; Rijnkels, M; Freeman-Zadrowski, C; Buser, AC; Edwards, DP; Rosen, JM				Kabotyanski, Elena B.; Rijnkels, Monique; Freeman-Zadrowski, Courtneay; Buser, Adam C.; Edwards, Dean P.; Rosen, Jeffrey M.			Lactogenic Hormonal Induction of Long Distance Interactions between beta-Casein Gene Regulatory Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; GLUCOCORTICOID-RECEPTOR; GLOBIN LOCUS; TRANSCRIPTION FACTORS; EXTRACELLULAR-MATRIX; BREAST-CANCER; DNA-BINDING; IN-VIVO; STAT5; PROGESTERONE	Lactogenic hormone regulation of beta-casein gene expression in mammary epithelial cells provides an excellent model in which to study the mechanisms by which steroid and peptide hormone signaling control gene expression. Prolactin- and glucocorticoid-mediated induction of beta-casein gene expression involves two principal regulatory regions, a proximal promoter and a distal enhancer located in the mouse approximately -6kb upstream of the transcription start site. Using a chromosome conformation capture assay and quantitative real time PCR, we demonstrate that a chromatin loop is created in conjunction with the recruitment of specific transcription factors and p300 in HC11 mammary epithelial cells. Stimulation with both prolactin and hydrocortisone is required for the induction of these long range interactions between the promoter and enhancer, and no DNA looping was observed in nontreated cells or cells treated with each of the hormones separately. The lactogenic hormone-induced interaction between the proximal promoter and distal enhancer was confirmed in hormone-treated primary three-dimensional mammary acini cultures. In addition, the developmental regulation of DNA looping between the beta-casein regulatory regions was observed in lactating but not in virgin mouse mammary glands. Furthermore, beta-casein mRNA induction and long range interactions between these regulatory regions were inhibited in a progestin-dependent manner following stimulation with prolactin and hydrocortisone in HC11 cells expressing human PR-B. Collectively, these data suggest that the communication between these regulatory regions with intervening DNA looping is a crucial step required to both create and maintain active chromatin domains and regulate transcription.	[Kabotyanski, Elena B.; Buser, Adam C.; Edwards, Dean P.; Rosen, Jeffrey M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Edwards, Dean P.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Rijnkels, Monique; Freeman-Zadrowski, Courtneay] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA)	Rosen, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,Mail Box BCM 130, Houston, TX 77030 USA.	jrosen@bcm.edu			National Institutes of Health [CA16303, HD038129, CA46938]; CRIS/USDA [6250-51000-048-00]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA016303, R01CA046938, R37CA016303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRIS/USDA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA16303 (to J.M.R.), HD038129 (to D. P. E.), and CA46938 (to D. P. E.). This work was also supported by CRIS/USDA Grant 6250-51000-048-00 (to M. R.) from the United States Department of Agriculture/Agricultural Research Services.	AGGELER J, 1988, J DAIRY SCI, V71, P2830, DOI 10.3168/jds.S0022-0302(88)79879-3; Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Ausubel F.M., 2006, CURRENT PROTOCOLS MO; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barnett DH, 2008, CANCER RES, V68, P3505, DOI 10.1158/0008-5472.CAN-07-6151; Bauknecht T, 1996, J VIROL, V70, P7695, DOI 10.1128/JVI.70.11.7695-7705.1996; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Buser AC, 2007, MOL ENDOCRINOL, V21, P106, DOI 10.1210/me.2006-0297; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; Chang LK, 2000, NUCLEIC ACIDS RES, V28, P3918, DOI 10.1093/nar/28.20.3918; COPE NF, 2009, COLD SPRING HARBOR P; DEIS RP, 1983, J STEROID BIOCHEM, V18, P687, DOI 10.1016/0022-4731(83)90246-7; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Hennighausen L, 1991, Biotechnology, V16, P65; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Kabotyanski EB, 2006, MOL ENDOCRINOL, V20, P2355, DOI 10.1210/me.2006-0160; KUHN NJ, 1969, J ENDOCRINOL, V45, P615, DOI 10.1677/joe.0.0450615; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lechner J, 1997, IMMUNOBIOLOGY, V198, P112, DOI 10.1016/S0171-2985(97)80032-0; Lechner J, 1997, J BIOL CHEM, V272, P20954, DOI 10.1074/jbc.272.33.20954; MEIER VS, 1994, MOL CELL BIOL, V14, P128, DOI 10.1128/MCB.14.1.128; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MULLER HP, 1990, TRENDS GENET, V6, P300, DOI 10.1016/0168-9525(90)90236-Y; MULLER HP, 1989, CELL, V58, P767, DOI 10.1016/0092-8674(89)90110-4; Palmer MB, 2007, CANCER RES, V67, P6113, DOI 10.1158/0008-5472.CAN-06-4256; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; Rijnkels M, 2003, GENOMICS, V82, P417, DOI 10.1016/S0888-7543(03)00114-9; ROSEN JM, 1978, BIOCHEMISTRY-US, V17, P290, DOI 10.1021/bi00595a016; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wyszomierski SL, 1999, MOL ENDOCRINOL, V13, P330, DOI 10.1210/me.13.2.330; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	49	50	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22815	22824		10.1074/jbc.M109.032490	http://dx.doi.org/10.1074/jbc.M109.032490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542223	Green Published, hybrid			2022-12-27	WOS:000268963100035
J	Kohli, RM; Abrams, SR; Gajula, KS; Maul, RW; Gearhart, PJ; Stivers, JT				Kohli, Rahul M.; Abrams, Shaun R.; Gajula, Kiran S.; Maul, Robert W.; Gearhart, Patricia J.; Stivers, James T.			A Portable Hot Spot Recognition Loop Transfers Sequence Preferences from APOBEC Family Members to Activation-induced Cytidine Deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; IN-VIVO; CRYSTAL-STRUCTURE; MUTATION SPECTRA; ENZYME APOBEC3G; AID; SPECIFICITY; GENOME; DOMAIN	Enzymes of the AID/APOBEC family, characterized by the targeted deamination of cytosine to generate uracil within DNA, mediate numerous critical immune responses. One family member, activation-induced cytidine deaminase ( AID), selectively introduces uracil into antibody variable and switch regions, promoting antibody diversity through somatic hyper-mutation or class switching. Other family members, including APOBEC3F and APOBEC3G, play an important role in retroviral defense by acting on viral reverse transcripts. These enzymes are distinguished from one another by targeting cytosine within different DNA sequence contexts; however, the reason for these differences is not known. Here, we report the identification of a recognition loop of 9-11 amino acids that contributes significantly to the distinct sequence motifs of individual family members. When this recognition loop is grafted from the donor APOBEC3F or 3G proteins into the acceptor scaffold of AID, the mutational signature of AID changes toward that of the donor proteins. These loop-graft mutants of AID provide useful tools for dissecting the biological impact of DNA sequence preferences upon generation of antibody diversity, and the results have implications for the evolution and specialization of the AID/APOBEC family.	[Kohli, Rahul M.; Gajula, Kiran S.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Abrams, Shaun R.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Maul, Robert W.; Gearhart, Patricia J.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Stivers, JT (corresponding author), 733 N Broadway, Baltimore, MD 21205 USA.	jstivers@jhmi.edu	Gearhart, Patricia/Y-7227-2019; Maul, Robert W./Y-6818-2019; Gajula, Kiran/I-1115-2019; Gajula, Kiran/F-5813-2010	Gajula, Kiran/0000-0002-2047-2457; Kohli, Rahul/0000-0002-7689-5678; Maul, Robert/0000-0002-6958-8514	National Institutes of Health [GM056834-13]; NIA, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM056834-13 (to J.T.S.) and by the Intramural Research Program of the NIA, National Institutes of Health.	Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Fugmann SD, 2004, EUR J IMMUNOL, V34, P844, DOI 10.1002/eji.200324418; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Jonsson SR, 2006, NUCLEIC ACIDS RES, V34, P5683, DOI 10.1093/nar/gkl721; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Larijani M, 2005, IMMUNOGENETICS, V56, P840, DOI 10.1007/s00251-004-0748-0; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Tawfik DS, 2006, SCIENCE, V311, P475, DOI 10.1126/science.1123883; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183	43	105	108	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22898	22904		10.1074/jbc.M109.025536	http://dx.doi.org/10.1074/jbc.M109.025536			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561087	hybrid, Green Published			2022-12-27	WOS:000268963100043
J	Lintern, KB; Guidato, S; Rowe, A; Saldanha, JW; Itasaki, N				Lintern, Katherine B.; Guidato, Sonia; Rowe, Alison; Saldanha, Jose W.; Itasaki, Nobue			Characterization of Wise Protein and Its Molecular Mechanism to Interact with both Wnt and BMP Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; TISSUE GROWTH-FACTOR; SENSITIZATION-ASSOCIATED GENE-1; BONE MORPHOGENETIC PROTEINS; CELL-DIFFERENTIATION; RESPONSE ELEMENTS; MAMMALIAN TOOTH; DIMER FORMATION; ANTAGONIST; SCLEROSTIN	Cross-talk of BMP and Wnt signaling pathways has been implicated in many aspects of biological events during embryogenesis and in adulthood. A secreted protein Wise and its orthologs (Sostdc1, USAG-1, and Ectodin) have been shown to modulate Wnt signaling and also inhibit BMP signals. Modulation of Wnt signaling activity by Wise is brought about by an interaction with the Wnt co-receptor LRP6, whereas BMP inhibition is by binding to BMP ligands. Here we have investigated the mode of action of Wise on Wnt and BMP signals. It was found that Wise binds LRP6 through one of three loops formed by the cystine knot. The Wise deletion construct lacking the LRP6-interacting loop domain nevertheless binds BMP4 and inhibits BMP signals. Moreover, BMP4 does not interfere with Wise-LRP6 binding, suggesting separate domains for the physical interaction. Functional assays also show that the ability of Wise to block Wnt1 activity through LRP6 is not impeded by BMP4. In contrast, the ability of Wise to inhibit BMP4 is prevented by additional LRP6, implying a preference of Wise in binding LRP6 over BMP4. In addition to the interaction of Wise with BMP4 and LRP6, the molecular characteristics of Wise, such as glycosylation and association with heparan sulfate proteoglycans on the cell surface, are suggested. This study helps to understand the multiple functions of Wise at the molecular level and suggests a possible role for Wise in balancing Wnt and BMP signals.	[Lintern, Katherine B.; Guidato, Sonia; Rowe, Alison; Itasaki, Nobue] Natl Inst Med Res, Div Dev Neurobiol, MRC, London NW7 1AA, England; [Saldanha, Jose W.] Natl Inst Med Res, Div Math Biol, MRC, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Itasaki, N (corresponding author), Natl Inst Med Res, Div Dev Neurobiol, MRC, Ridgeway,Mill Hill, London NW7 1AA, England.	nitasak@nimr.mrc.ac.uk		Itasaki, Nobue/0000-0003-0587-9141	Medical Research Council (United Kingdom); MRC [MC_U117560543] Funding Source: UKRI; Medical Research Council [MC_U117560543] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (United Kingdom).	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Baeg GH, 2001, DEVELOPMENT, V128, P87; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Beaudoin GMJ, 2005, P NATL ACAD SCI USA, V102, P14653, DOI 10.1073/pnas.0507609102; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bell SL, 2003, BIOCHEM J, V373, P893, DOI 10.1042/BJ20030096; Bell SL, 2001, BIOCHEM J, V357, P203, DOI 10.1042/0264-6021:3570203; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Blish KR, 2008, MOL BIOL CELL, V19, P457, DOI 10.1091/mbc.E07-05-0433; Bonafede A, 2006, DEV BIOL, V299, P330, DOI 10.1016/j.ydbio.2006.02.054; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Bouma GJ, 2004, GENE EXPR PATTERNS, V5, P141, DOI 10.1016/j.modgep.2004.05.001; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Coveney D, 2007, GENE EXPR PATTERNS, V7, P82, DOI 10.1016/j.modgep.2006.05.012; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Fischer L, 2002, J CELL BIOCHEM, V84, P816, DOI 10.1002/jcb.10091; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Guidato S, 2007, DEV BIOL, V310, P250, DOI 10.1016/j.ydbio.2007.07.033; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; ITASAKI N, 2009, DEV DYN IN PRESS; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; KELLER KM, 1989, BIOCHEMISTRY-US, V28, P8100, DOI 10.1021/bi00446a021; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Knosp WM, 2007, J BIOL CHEM, V282, P6843, DOI 10.1074/jbc.M610775200; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; Menke Douglas B., 2002, Gene Expression Patterns, V2, P359, DOI 10.1016/S1567-133X(02)00022-4; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Munne PM, 2009, DEVELOPMENT, V136, P393, DOI 10.1242/dev.025064; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Murashima-Suginami A, 2008, BIOCHEM BIOPH RES CO, V369, P1012, DOI 10.1016/j.bbrc.2008.02.135; Murashima-Suginami A, 2007, BIOCHEM BIOPH RES CO, V359, P549, DOI 10.1016/j.bbrc.2007.05.148; O'Shaughnessy RFL, 2004, J INVEST DERMATOL, V123, P613, DOI 10.1111/j.0022-202X.2004.23410.x; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Rost B, 1996, METHOD ENZYMOL, V266, P525; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shigetani Y, 2007, DEV DYNAM, V236, P2277, DOI 10.1002/dvdy.21234; Simmons DG, 2002, BIOL REPROD, V67, P1638, DOI 10.1095/biolreprod.102.006858; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thompson CC, 2006, CELL CYCLE, V5, P1913, DOI 10.4161/cc.5.17.3189; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Winkler DG, 2004, J BIOL CHEM, V279, P36293, DOI 10.1074/jbc.M400521200; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Yanagita M, 2007, THER APHER DIAL, V11, pS38, DOI 10.1111/j.1744-9987.2007.00520.x; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	77	95	101	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23159	23168		10.1074/jbc.M109.025478	http://dx.doi.org/10.1074/jbc.M109.025478			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553665	hybrid, Green Published			2022-12-27	WOS:000268963100067
J	Chu, BB; Ge, L; Xie, C; Zhao, Y; Miao, HH; Wang, J; Li, BL; Song, BL				Chu, Bei-Bei; Ge, Liang; Xie, Chang; Zhao, Yang; Miao, Hong-Hua; Wang, Jing; Li, Bo-Liang; Song, Bao-Liang			Requirement of Myosin Vb.Rab11a.Rab11-FIP2 Complex in Cholesterol-regulated Translocation of NPC1L1 to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; EPITHELIAL-CELLS; RECYCLING ENDOSOMES; VB; ACTIN; CYTOSKELETON; TRAFFICKING; TRANSFERRIN; ABSORPTION; TRANSPORT	Niemann-Pick C1-like 1 (NPC1L1) plays a critical role in the enterohepatic absorption of free cholesterol. Cellular cholesterol depletion induces the transport of NPC1L1 from the endocytic recycling compartment to the plasma membrane (PM), and cholesterol replenishment causes the internalization of NPC1L1 together with cholesterol via clathrin-mediated endocytosis. Although NPC1L1 has been characterized, the other proteins involved in cholesterol absorption and the endocytic recycling of NPC1L1 are largely unknown. Most of the vesicular trafficking events are dependent on the cytoskeleton and motor proteins. Here, we investigated the roles of the microfilament and microfilament-associated triple complex composed of myosin Vb, Rab11a, and Rab11-FIP2 in the transport of NPC1L1 from the endocytic recycling compartment to the PM. Interfering with the dynamics of the microfilament by pharmacological treatment delayed the transport of NPC1L1 to the cell surface. Meanwhile, inactivation of any component of the myosin Vb.Rab11a.Rab11-FIP2 triple complex inhibited the export of NPC1L1. Expression of the dominant-negative mutants of myosin Vb, Rab11a, or Rab11-FIP2 decreased the cellular cholesterol uptake by blocking the transport of NPC1L1 to the PM. These results suggest that the efficient transport of NPC1L1 to the PM is dependent on the microfilament-associated myosin Vb.Rab11a.Rab11-FIP2 triple complex.	[Chu, Bei-Bei; Ge, Liang; Xie, Chang; Zhao, Yang; Miao, Hong-Hua; Wang, Jing; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	blsong@sibs.ac.cn	Xie, Chang/V-7099-2019; Xie, Chang/O-8270-2016	Xie, Chang/0000-0002-7643-5321; Song, Bao-Liang/0000-0002-6397-5935; Ge, Liang/0000-0002-7371-2039	Ministry of Science and Technology of China [2009CB919000, 2007AA09Z402]; National Natural Science Foundation of China [30670432, 90713025]; Shanghai Science and Technology Committee [08JC1421300, 08431900500]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by Grants 2009CB919000 and 2007AA09Z402 from the Ministry of Science and Technology of China, 30670432 and 90713025 from the National Natural Science Foundation of China, and 08JC1421300 and 08431900500 from the Shanghai Science and Technology Committee.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Caperta AD, 2006, PROTOPLASMA, V227, P147, DOI 10.1007/s00709-005-0137-z; Chang TY, 2008, CELL METAB, V7, P469, DOI 10.1016/j.cmet.2008.05.001; Dantzig JA, 2006, ANN NY ACAD SCI, V1080, P1, DOI 10.1196/annals.1380.002; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; Davis HR, 2007, J ATHEROSCLER THROMB, V14, P99, DOI 10.5551/jat.14.99; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dubinsky WP, 1999, P NATL ACAD SCI USA, V96, P9421, DOI 10.1073/pnas.96.16.9421; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Kessler A, 2000, DIABETOLOGIA, V43, P1518, DOI 10.1007/s001250051563; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; LEE JC, 1980, BIOCHEMISTRY-US, V19, P6209, DOI 10.1021/bi00567a041; Lindsay AJ, 2002, J BIOL CHEM, V277, P27193, DOI 10.1074/jbc.M200757200; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Millman EE, 2008, TRAFFIC, V9, P1958, DOI 10.1111/j.1600-0854.2008.00813.x; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Passeron T, 2004, FASEB J, V18, P989, DOI 10.1096/fj.03-1240fje; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; PRENTKI M, 1979, J CELL BIOL, V81, P592, DOI 10.1083/jcb.81.3.592; Provance DW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-44; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; SEGAWA A, 1989, CELL STRUCT FUNCT, V14, P531, DOI 10.1247/csf.14.531; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Tilelli CQ, 2003, NEUROSCIENCE, V121, P573, DOI 10.1016/S0306-4522(03)00546-3; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Vossenkamper A, 2007, AM J PHYSIOL-CELL PH, V293, pC1129, DOI 10.1152/ajpcell.00628.2006; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; Walikonis RS, 2000, J NEUROSCI, V20, P4069; WANG J, 2009, J LIPID RES IN PRESS; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Xie LL, 2008, CELL MOTIL CYTOSKEL, V65, P876, DOI 10.1002/cm.20309; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Yu LQ, 2008, CURR OPIN LIPIDOL, V19, P263, DOI 10.1097/MOL.0b013e3282f9b563; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	51	45	53	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22481	22490		10.1074/jbc.M109.034355	http://dx.doi.org/10.1074/jbc.M109.034355			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542231	hybrid, Green Published			2022-12-27	WOS:000268783700069
J	Liu, YY; Annis, DS; Mosher, DF				Liu, Yuanyuan; Annis, Douglas S.; Mosher, Deane F.			Interactions among the Epidermal Growth Factor-like Modules of Thrombospondin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HYDROXYASPARTIC ACID; SIGNATURE DOMAINS; PROTEIN-S; CALCIUM; BINDING; POLYMORPHISM; REPEATS	Epidermal growth factor (EGF)-like modules are defined in part by six cysteines joined by disulfides in a 1-3, 2-4, and 5-6 pattern. Thrombospondin-1 (TSP-1) is a multimodular glycoprotein with three EGF-like modules, E1, E2, and E3, arranged in tandem. These modules likely propagate conformational changes between surrounding C-terminal and N-terminal elements of TSP-1 and interact with other extracellular molecules. E1, E2, and their homologs in other TSPs are unique among EGF-like modules in having two residues rather than one between Cys-4 and Cys-5. In addition, E2 has a calcium-binding site and an unusually long loop between Cys-5 and Cys-6. The structure of E1, E2, or E3 expressed alone changed little upon heating as monitored by far-UV CD, whereas more marked changes occurred in E12, E23, and E123 tandem constructs. The individual modules denatured in differential scanning calorimetry experiments only at >85 degrees C. E12, E23, or E123 tandem constructs, however, had a transition in the range of 44-70 degrees C. The temperature of the transition was higher when calcium was present and higher with E123 than with E12 or E23. Isothermal titration calorimetry demonstrated K-D values of binding of calcium to E2, E12, E23, or E123 at 25 degrees C of 11.5, 2.9, 2.2, or 0.3 mu M, respectively. Monoclonal antibodies HB8432 and C6.7, which recognize epitopes in E2, bound to E12, E23, or E123 with greater affinity than to E2 alone. These results indicate that interactions among the modules of E123 influence the tertiary structure and calcium binding of E2.	[Mosher, Deane F.] Univ Wisconsin, Dept Med, Med Sci Ctr 4285, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Med, Med Sci Ctr 4285, 1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu	Liu, Yuanyuan/E-9439-2013		National Institutes of Health [ROIHL054462]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant ROIHL054462.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; BOSWELL EJ, 2004, HDB METALLOPROTEINS, V3, P553; Calzada MJ, 2008, MATRIX BIOL, V27, P339, DOI 10.1016/j.matbio.2007.12.002; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2008, J BIOL CHEM, V283, P20069, DOI 10.1074/jbc.M800223200; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Drakenberg T, 2005, BIOCHEMISTRY-US, V44, P8782, DOI 10.1021/bi050101f; FERNLUND P, 1983, J BIOL CHEM, V258, P2509; Hannah BLA, 2004, J BIOL CHEM, V279, P51915, DOI 10.1074/jbc.M409632200; HOLLADAY LA, 1976, BIOCHEMISTRY-US, V15, P2624, DOI 10.1021/bi00657a023; Kitamura M, 2004, GLYCOCONJUGATE J, V21, P197, DOI 10.1023/B:GLYC.0000045092.37417.0f; KOHDA D, 1992, BIOCHEMISTRY-US, V31, P11928, DOI 10.1021/bi00162a036; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; NARHI LO, 1992, INT J PEPT PROT RES, V39, P182; Persson KEM, 2006, BIOCHEMISTRY-US, V45, P10682, DOI 10.1021/bi0601151; PRESTRELSKI SJ, 1992, J BIOL CHEM, V267, P319; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; STENFLO J, 1988, J BIOL CHEM, V263, P21; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; Zanuttin F, 2004, EUR J BIOCHEM, V271, P4229, DOI 10.1111/j.1432-1033.2004.04363.x	28	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22206	22212		10.1074/jbc.M109.026120	http://dx.doi.org/10.1074/jbc.M109.026120			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531495	hybrid, Green Published			2022-12-27	WOS:000268783700045
J	Kumar, P; Vahedi-Faridi, A; Saenger, W; Merino, E; de Castro, JAL; Uchanska-Ziegler, B; Ziegler, A				Kumar, Pravin; Vahedi-Faridi, Ardeschir; Saenger, Wolfram; Merino, Elena; Lopez de Castro, Jose A.; Uchanska-Ziegler, Barbara; Ziegler, Andreas			Structural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 Antigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANKYLOSING-SPONDYLITIS; PEPTIDE-BINDING; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; LIMITED PEPTIDE; VIRAL PEPTIDE; SELF-PEPTIDE; COMPLEX; SUBTYPES	The existence of cytotoxic T cells (CTL) cross-reacting with the human major histocompatibility antigens HLA-B14 and HLA-B27 suggests that their alloreactivity could be due to presentation of shared peptides in similar binding modes by these molecules. We therefore determined the crystal structures of the subtypes HLAB*1402, HLA-B*2705, and HLA-B*2709 in complex with a proven self-ligand, pCatA (peptide with the sequence IRAAPPPLF derived from cathepsin A (residues 2-10)), and of HLA-B*1402 in complex with a viral peptide, pLMP2 (RRRWRRLTV, derived from latent membrane protein 2 (residues 236-244) of Epstein-Barr virus). Despite the exchange of 18 residues within the binding grooves of HLA-B*1402 and HLA-B*2705 or HLA-B*2709, the pCatA peptide is presented in nearly identical conformations. However, pLMP2 is displayed by HLA-B*1402 in a conformation distinct from those previously found in the two HLA-B27 subtypes. In addition, the complexes of HLA-B*1402 with the two peptides reveal a nonstandard, tetragonal mode of the peptide N terminus anchoring in the binding groove because of the exchange of the common Tyr-171 by His-171 of the HLA-B*1402 heavy chain. This exchange appears also responsible for reduced stability of HLA-B14-peptide complexes in vivo and slow assembly in vitro. The studies with the pCatA peptide uncover that CTL cross-reactive between HLA-B14 and HLA-B27 might primarily recognize the common structural features of the bound peptide, thus neglecting amino acid replacements within the rim of the binding grooves. In contrast, structural alterations between the three complexes with the pLMP2 peptide indicate how heavy chain polymorphisms can influence peptide display and prevent CTL cross-reactivity between HLA-B14 and HLA-B27 antigens.	[Uchanska-Ziegler, Barbara; Ziegler, Andreas] Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, D-14195 Berlin, Germany; [Vahedi-Faridi, Ardeschir; Saenger, Wolfram] Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany; [Merino, Elena; Lopez de Castro, Jose A.] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Merino, Elena; Lopez de Castro, Jose A.] CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Ziegler, A (corresponding author), Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, Campus Benjamin Franklin,Thielallee 73, D-14195 Berlin, Germany.	andreas.ziegler@charite.de			VolkswagenStiftung [I/79 983]; Deutsche Forschungsgemeinschaft [SFB 449, TP B6, Z3]; Senate of Berlin NaFoG Fellowship; Spanish Plan Nacional de I+D [SAF2008/00461]	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Senate of Berlin NaFoG Fellowship; Spanish Plan Nacional de I+D	This work was supported by VolkswagenStiftung Grant I/79 983 (to A. Z.) and a stipend (to P. K.), Deutsche Forschungsgemeinschaft Grants SFB 449, TP B6, and Z3 (to W. S., B. U.-Z., and A. Z.), the Senate of Berlin NaFoG Fellowship (to P. K.), and Spanish Plan Nacional de I+D Grant SAF2008/00461 (to J. A. L. d. C.).	Afzali B, 2007, TISSUE ANTIGENS, V69, P545, DOI 10.1111/j.1399-0039.2007.00834.x; Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beltrami A, 2008, J BIOL CHEM, V283, P27189, DOI 10.1074/jbc.M802818200; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; BREWERTON DA, 1973, LANCET, V1, P904; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; DeLano W.L, PYMOL MOL GRAPHICS S; DFAZPENA R, 2008, J RHEUMATOL, V35, P2236; DIBRINO M, 1994, J BIOL CHEM, V269, P32426; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALK K, 1995, IMMUNOGENETICS, V41, P162, DOI 10.1007/BF00182332; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garcia-Peydro M, 1999, J IMMUNOL, V163, P2299; Gould DS, 1999, IMMUNOL TODAY, V20, P77, DOI 10.1016/S0167-5699(98)01394-2; HEATH WR, 1991, P NATL ACAD SCI USA, V88, P5101, DOI 10.1073/pnas.88.12.5101; Hillig RC, 2004, J BIOL CHEM, V279, P652, DOI 10.1074/jbc.M307457200; Hourigan CS, 2006, EUR J IMMUNOL, V36, P3288, DOI 10.1002/eji.200636234; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Hulsmeyer M, 2005, J MOL BIOL, V346, P1367, DOI 10.1016/j.jmb.2004.12.047; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kamoun M, 2008, P NATL ACAD SCI USA, V105, P18883, DOI 10.1073/pnas.0810308105; Kazansky DB, 2008, J IMMUNOTOXICOL, V5, P369, DOI 10.1080/15476910802476708; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Khan MA, 2007, AUTOIMMUN REV, V6, P183, DOI 10.1016/j.autrev.2006.11.003; Kumar P, 2008, TRENDS BIOCHEM SCI, V33, P408, DOI 10.1016/j.tibs.2008.06.004; Kumar P, 2007, ACTA CRYSTALLOGR F, V63, P631, DOI 10.1107/S1744309107029077; Kumar P, 2009, PROTEIN SCI, V18, P37, DOI 10.1002/pro.4; Li X, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-22; LINDAHL KF, 1977, J EXP MED, V145, P508, DOI 10.1084/jem.145.3.508; Loll B, 2005, ACTA CRYSTALLOGR F, V61, P939, DOI 10.1107/S1744309105029234; de Castro JAL, 2009, ADV EXP MED BIOL, V649, P196; Lopez-Larrea C, 2002, ARTHRITIS RHEUM-US, V46, P2968, DOI 10.1002/art.10584; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Maenaka K, 2000, J IMMUNOL, V165, P3260, DOI 10.4049/jimmunol.165.6.3260; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; Menssen R, 1999, J MOL BIOL, V285, P645, DOI 10.1006/jmbi.1998.2363; Merino E, 2005, J BIOL CHEM, V280, P35868, DOI 10.1074/jbc.M505641200; Merino E, 2008, ARTHRITIS RHEUM-US, V58, P3693, DOI 10.1002/art.24045; Morris GP, 2009, J IMMUNOL, V182, P6639, DOI 10.4049/jimmunol.0900638; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paradela A, 1998, J IMMUNOL, V161, P5481; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Ramos M, 2002, TISSUE ANTIGENS, V60, P191, DOI 10.1034/j.1399-0039.2002.600301.x; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Sobao Y, 1999, ARTHRITIS RHEUM, V42, P175, DOI 10.1002/1529-0131(199901)42:1<175::AID-ANR21>3.0.CO;2-7; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; Urvater JA, 2001, J IMMUNOL, V166, P3334, DOI 10.4049/jimmunol.166.5.3334; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VILLADANGOS JA, 1995, EUR J IMMUNOL, V25, P2370, DOI 10.1002/eji.1830250837; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Wang W, 1998, J IMMUNOL, V160, P1091; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Yague J, 1999, TISSUE ANTIGENS, V53, P227, DOI 10.1034/j.1399-0039.1999.530302.x; YAMAGUCHI A, 1995, ARTHRITIS RHEUM-US, V38, P1672, DOI 10.1002/art.1780381120; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Ziegler A, 2009, ADV EXP MED BIOL, V649, P177	76	28	28	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29784	29797		10.1074/jbc.M109.038497	http://dx.doi.org/10.1074/jbc.M109.038497			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19617632	Green Published, hybrid			2022-12-27	WOS:000270896800059
J	Marq, JB; Hausmann, S; Luban, J; Kolakofsky, D; Garcin, D				Marq, Jean-Baptiste; Hausmann, Stephane; Luban, Jeremy; Kolakofsky, Daniel; Garcin, Dominique			The Double-stranded RNA Binding Domain of the Vaccinia Virus E3L Protein Inhibits Both RNA- and DNA-induced Activation of Interferon beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE PKR; RIG-I; RECOGNITION; RESPONSES; GENE; CELLS; EXPRESSION; RECEPTORS; INDUCTION; PROMOTER	Vaccinia virus, a large DNA virus that replicates in the cytoplasm, expresses its E3L protein to inhibit the cellular innate immune response and apoptosis. E3L is a bifunctional protein that contains an N-terminal DNA binding domain (BD) and a C-terminal double-stranded RNA (dsRNA)-BD (residues 100 190), both of which contribute to viral pathogenesis by blocking the activation of cellular genes that respond to the viral infection. We report that expression of the dsRNA-BD alone inhibits not only the dsRNA-induced activation of interferon beta(IFN beta) but also that of 5'-triphosphate single-stranded RNA and DNA-induced IFN beta activation even though E3L(100-190) does not bind the latter two pathogen-associated molecular patterns. This inhibition occurs in both human HeLa and A549 cells, where RIG-I appears to be required for dsDNA-induced IFN beta activation. Unexpectedly, the two residues most important for dsRNA binding are also critical for this domain's ability to inhibit all three nucleic acid-induced cellular responses.	[Marq, Jean-Baptiste; Hausmann, Stephane; Luban, Jeremy; Kolakofsky, Daniel; Garcin, Dominique] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland	University of Geneva	Kolakofsky, D (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, 9 Ave Champel, CH-1211 Geneva, Switzerland.	Daniel.kolakofsky@unige.ch		Luban, Jeremy/0000-0001-5650-4054				Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; COLBY C, 1969, P NATL ACAD SCI USA, V63, P160, DOI 10.1073/pnas.63.1.160; Ho CK, 1996, VIROLOGY, V217, P272, DOI 10.1006/viro.1996.0114; Ho CK, 1996, J VIROL, V70, P2611, DOI 10.1128/JVI.70.4.2611-2614.1996; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; KING P, 1994, J BIOL CHEM, V269, P30609; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; Rivas C, 1998, VIROLOGY, V243, P406, DOI 10.1006/viro.1998.9072; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Strahle L, 2003, J VIROL, V77, P7903, DOI 10.1128/JVI.77.14.7903-7913.2003; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; VORLICKOVA M, 1985, J BIOMOL STRUCT DYN, V3, P67, DOI 10.1080/07391102.1985.10508399; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	35	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25471	25478		10.1074/jbc.M109.018895	http://dx.doi.org/10.1074/jbc.M109.018895			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19584049	Green Published, hybrid			2022-12-27	WOS:000269738000004
J	Singh, P; Tripathi, P; Silva, GH; Pingoud, A; Muniyappa, K				Singh, Pawan; Tripathi, Pankaj; Silva, George H.; Pingoud, Alfred; Muniyappa, K.			Characterization of Mycobacterium leprae RecA Intein, a LAGLIDADG Homing Endonuclease, Reveals a Unique Mode of DNA Binding, Helical Distortion, and Cleavage Compared with a Canonical LAGLIDADG Homing Endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; HOMOLOGOUS RECOMBINATION; PYROCOCCUS-FURIOSUS; PI-PFUII; I-TEVI; PROTEIN; GENE; SITE; IDENTIFICATION; PURIFICATION	Mycobacterium leprae, which has undergone reductive evolution leaving behind a minimal set of essential genes, has retained intervening sequences in four of its genes implicating a vital role for them in the survival of the leprosy bacillus. A single in-frame intervening sequence has been found embedded within its recA gene. Comparison of the M. leprae recA intervening sequence with the known intervening sequences indicated that it has the consensus amino acid sequence necessary for being a LAGLIDADG-type homing endonuclease. In light of massive gene decay and function loss in the leprosy bacillus, we sought to investigate whether its recA intervening sequence encodes a catalytically active homing endonuclease. Here we show that the purified M. leprae RecA intein (PI-MleI) binds to cognate DNA and displays endonuclease activity in the presence of alternative divalent cations, Mg2+ or Mn2+. A combination of approaches, including four complementary footprinting assays such as DNase I, copper-phenanthroline, methylation protection, and KMnO4, enhancement of 2-aminopurine fluorescence, and mapping of the cleavage site revealed that PI-MleI binds to cognate DNA flanking its insertion site, induces helical distortion at the cleavage site, and generates two staggered double strand breaks. Taken together, these results implicate that PI-MleI possesses a modular structure with separate domains for DNA target recognition and cleavage, each with distinct sequence preferences. From a biological standpoint, it is tempting to speculate that our findings have implications for understanding the evolution of the LAGLIDADG family of homing endonucleases.	[Singh, Pawan; Tripathi, Pankaj; Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Silva, George H.; Pingoud, Alfred] Univ Giessen, Inst Biochem, D-35392 Giessen, Germany	Indian Institute of Science (IISC) - Bangalore; Justus Liebig University Giessen	Muniyappa, K (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	kmbc@biochem.iisc.ernet.in			Department of Biotechnology, New Delhi; J. C. Bose National Fellowship	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); J. C. Bose National Fellowship	This work was supported by a grant from the Department of Biotechnology, New Delhi, under the "Centre of Excellence" in research on mycobacteria and a J. C. Bose National Fellowship ( to K. M.). We have benefited by being partners in the European Commission-funded Asia-Link program on "Human Resources Development in the Study of Nucleic Acids."	AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bakhrat A, 2004, GENETICS, V166, P721, DOI 10.1534/genetics.166.2.721; Bakshi RP, 2001, J MOL ENDOCRINOL, V26, P193, DOI 10.1677/jme.0.0260193; Belfort M, 2005, NUCL ACID M, V16, P1; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; BELLPEDERSEN D, 1990, NUCLEIC ACIDS RES, V18, P3763, DOI 10.1093/nar/18.13.3763; Beylot B, 2001, J BIOL CHEM, V276, P25243, DOI 10.1074/jbc.M101200200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brosch R, 2000, RES MICROBIOL, V151, P135, DOI 10.1016/S0923-2508(00)00117-0; BRYK M, 1995, J MOL BIOL, V247, P197, DOI 10.1006/jmbi.1994.0133; CAREY J, 1991, METHOD ENZYMOL, V208, P103; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Cole ST, 2002, EUR RESPIR J, V20, p78S, DOI 10.1183/09031936.02.00400202; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; CUNNINGHAM RP, 1980, CELL, V20, P223, DOI 10.1016/0092-8674(80)90250-0; Dalgaard JZ, 1997, NUCLEIC ACIDS RES, V25, P4626, DOI 10.1093/nar/25.22.4626; DAVIS EO, 1994, EMBO J, V13, P699, DOI 10.1002/j.1460-2075.1994.tb06309.x; DAVIS EO, 1992, CELL, V71, P201, DOI 10.1016/0092-8674(92)90349-H; DAVIS EO, 1991, J BACTERIOL, V173, P5653, DOI 10.1128/jb.173.18.5653-5662.1991; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; Eastberg JH, 2007, NUCLEIC ACIDS RES, V35, P7209, DOI 10.1093/nar/gkm867; Edgell DR, 2004, NAT STRUCT MOL BIOL, V11, P936, DOI 10.1038/nsmb823; Frischkorn K, 2000, J BACTERIOL, V182, P3590, DOI 10.1128/JB.182.12.3590-3592.2000; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GIMBLE FS, 1992, NATURE, V357, P301, DOI 10.1038/357301a0; Guhan N, 2003, NUCLEIC ACIDS RES, V31, P4184, DOI 10.1093/nar/gkg475; Guhan N, 2003, CRIT REV BIOCHEM MOL, V38, P199, DOI 10.1080/713609235; Guhan N, 2002, J BIOL CHEM, V277, P40352, DOI 10.1074/jbc.M205697200; Guhan N, 2002, J BIOL CHEM, V277, P16257, DOI 10.1074/jbc.M112365200; Hampshire AJ, 2007, METHODS, V42, P128, DOI 10.1016/j.ymeth.2007.01.002; HARSHEY RM, 1977, J BACTERIOL, V129, P616, DOI 10.1128/JB.129.2.616-622.1977; Hayatsu H, 1996, J BIOCHEM-TOKYO, V119, P391; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; HIRATA R, 1990, J BIOL CHEM, V265, P6726; HIRIYANNA KT, 1986, ARCH MICROBIOL, V144, P105, DOI 10.1007/BF00414718; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; Jurica MS, 1999, CELL MOL LIFE SCI, V55, P1304, DOI 10.1007/s000180050372; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Komori K, 1999, NUCLEIC ACIDS RES, V27, P4175, DOI 10.1093/nar/27.21.4175; Komori K, 1999, NUCLEIC ACIDS RES, V27, P4167, DOI 10.1093/nar/27.21.4167; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lenz T, 2007, J AM CHEM SOC, V129, P6240, DOI 10.1021/ja069366n; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Malta E, 2008, DNA REPAIR, V7, P1647, DOI 10.1016/j.dnarep.2008.06.011; MAXAM AM, 1980, METHOD ENZYMOL, V65, P560; Millar DP, 1996, CURR OPIN STRUC BIOL, V6, P322, DOI 10.1016/S0959-440X(96)80050-9; Moure CM, 2003, J MOL BIOL, V334, P685, DOI 10.1016/j.jmb.2003.09.068; Moure CM, 2002, NAT STRUCT BIOL, V9, P764, DOI 10.1038/nsb840; Papavassiliou A G, 1994, Methods Mol Biol, V30, P43; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; PERRIN A, 1993, EMBO J, V12, P2939, DOI 10.1002/j.1460-2075.1993.tb05956.x; Pietrokovski S, 2001, TRENDS GENET, V17, P465, DOI 10.1016/S0168-9525(01)02365-4; Rhodes D., 1997, PROTEIN FUNCTION PRA, P215; RICHEY B, 1987, J BIOL CHEM, V262, P7157; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saves I, 2000, FEBS LETT, V480, P221, DOI 10.1016/S0014-5793(00)01944-X; Saves I, 2002, NUCLEIC ACIDS RES, V30, P4158, DOI 10.1093/nar/gkf556; Saves I, 2000, J BIOL CHEM, V275, P2335, DOI 10.1074/jbc.275.4.2335; Saves I, 2001, NUCLEIC ACIDS RES, V29, P4310, DOI 10.1093/nar/29.21.4310; Schlacher K, 2006, CHEM REV, V106, P406, DOI 10.1021/cr0404951; Shaw PE, 2000, METH MOL B, V148, P221; Silva GH, 1999, J MOL BIOL, V286, P1123, DOI 10.1006/jmbi.1998.2519; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; Southworth MW, 1999, BIOTECHNIQUES, V27, P110, DOI 10.2144/99271st04; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Tamulaitis G, 2007, NUCLEIC ACIDS RES, V35, P4792, DOI 10.1093/nar/gkm513; Tripathi P, 2006, J MOL BIOL, V364, P599, DOI 10.1016/j.jmb.2006.08.096; Wang JS, 1997, NUCLEIC ACIDS RES, V25, P3767, DOI 10.1093/nar/25.19.3767; Wende W, 1996, NUCLEIC ACIDS RES, V24, P4123, DOI 10.1093/nar/24.21.4123; Zhao L, 2007, EMBO J, V26, P2432, DOI 10.1038/sj.emboj.7601672	75	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25912	25928		10.1074/jbc.M109.042861	http://dx.doi.org/10.1074/jbc.M109.042861			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19605345	hybrid, Green Published			2022-12-27	WOS:000269738000048
J	Mahmoodzadeh, S; Fritschka, S; Dworatzek, E; Pham, TH; Becher, E; Kuehne, A; Davidson, MM; Regitz-Zagrosek, V				Mahmoodzadeh, Shokoufeh; Fritschka, Stephan; Dworatzek, Elke; Pham, Thi H.; Becher, Eva; Kuehne, Arne; Davidson, Mercy M.; Regitz-Zagrosek, Vera			Nuclear Factor-kappa B Regulates Estrogen Receptor-alpha-Transcription in the Human Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; HUMAN ER-ALPHA; UP-REGULATION; VENTRICULAR CARDIOMYOCYTES; DIFFERENTIAL REGULATION; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; OSTEOBLASTIC CELLS; PROMOTER USAGE; IN-VIVO	Estrogen receptor (ER)-mediated effects have been associated with the modulation of myocardial hypertrophy in animal models and in humans, but the regulation of ER expression in the human heart has not yet been analyzed. In various cell lines and tissues, multiple human estrogen receptor alpha (hER alpha) mRNA isoforms are transcribed from distinct promoters and differ in their 5'-untranslated regions. Using PCR-based strategies, we show that in the human heart the ER alpha mRNA is transcribed from multiple promoters, namely, A, B, C, and F, of which the F-promoter is most frequently used variant. Transient transfection reporter assays in a human cardiac myocyte cell line (AC16) with F-promoter deletion constructs demonstrated a negative regulatory region within this promoter. Site-directed mutagenesis and electrophoretic mobility shift assays indicated that NF-kappa B binds to this region. An inhibition of NF-kappa B activity by parthenolide significantly increased the transcriptional activity of the F-promoter. Increasing NF-kappa B expression by tumor necrosis factor-alpha reduced the expression of ER alpha, indicating that the NF-kappa B pathway inhibits expression of ER alpha in human cardiomyocytes. Finally, 17 beta-estradiol induced the transcriptional activity of hER alpha promoters A, B, C, and F. In conclusion, inflammatory stimuli suppress hER alpha expression via activation and subsequent binding of NF-kappa B to the ER alpha F-promoter, and 17 beta-estradiol/hER alpha may antagonize the inhibitory effect of NF-kappa B. This suggests interplay between estrogen/estrogen receptors and the pro-hypertrophic and inflammatory responses to NF-kappa B.	[Mahmoodzadeh, Shokoufeh] Charite, Inst Gender Med, Cardiovasc Res Ctr, D-10115 Berlin, Germany; [Regitz-Zagrosek, Vera] German Heart Inst, D-13353 Berlin, Germany; [Davidson, Mercy M.] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10032 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; Columbia University	Mahmoodzadeh, S (corresponding author), Charite, Inst Gender Med, Cardiovasc Res Ctr, Hess Str 3-4, D-10115 Berlin, Germany.	s.mahmoodzadeh@charite.de		Regitz-Zagrosek, Vera/0000-0002-3566-3467; Mahmoodzadeh, Shokoufeh/0000-0002-3094-7874; Becher, Eva/0000-0003-0861-6208	Nationales Genom Forschungsnetz; Deutsche Forschungsgemeinschaft [GRK 754, FG 1054, RE 662/6-1]	Nationales Genom Forschungsnetz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Nationales Genom Forschungsnetz and the Deutsche Forschungsgemeinschaft (GRK 754, FG 1054, RE 662/6-1).	Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Brand K, 1997, EXP PHYSIOL, V82, P297, DOI 10.1113/expphysiol.1997.sp004025; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; CHO HS, 1991, MOL ENDOCRINOL, V5, P1323, DOI 10.1210/mend-5-9-1323; Clayton SJ, 1997, MOL CELL ENDOCRINOL, V128, P57, DOI 10.1016/S0303-7207(96)04016-6; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Denger S, 2001, MOL CELL ENDOCRINOL, V178, P155, DOI 10.1016/S0303-7207(01)00417-8; Donaghue C, 1999, MOL ENDOCRINOL, V13, P1934, DOI 10.1210/me.13.11.1934; Eisner V, 2006, FEBS LETT, V580, P4495, DOI 10.1016/j.febslet.2006.07.029; Evans MJ, 2001, CIRC RES, V89, P823, DOI 10.1161/hh2101.098543; Flouriot G, 1998, MOL ENDOCRINOL, V12, P1939, DOI 10.1210/me.12.12.1939; FREYSCHUSS B, 1994, J ENDOCRINOL, V142, P285, DOI 10.1677/joe.0.1420285; Grandien K, 1996, MOL CELL ENDOCRINOL, V116, P207, DOI 10.1016/0303-7207(95)03716-0; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Hehner SP, 1998, J BIOL CHEM, V273, P1288, DOI 10.1074/jbc.273.3.1288; Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045; Hodis HN, 2003, NEW ENGL J MED, V349, P535, DOI 10.1056/NEJMoa030830; Holloway JN, 2004, MOL ENDOCRINOL, V18, P1396, DOI 10.1210/me.2004-0048; KARAS RH, 1994, CIRCULATION, V89, P1943, DOI 10.1161/01.CIR.89.5.1943; Kawano S, 2006, AM J PHYSIOL-HEART C, V291, pH1337, DOI 10.1152/ajpheart.01175.2005; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Lambertini E, 2003, BIOCHEM J, V372, P831, DOI 10.1042/BJ20021633; Lambertini E, 2007, EXP CELL RES, V313, P1548, DOI 10.1016/j.yexcr.2007.02.002; Lentsch AB, 2000, J PATHOL, V190, P343; Li YH, 2004, AM J PHYSIOL-HEART C, V287, pH1712, DOI 10.1152/ajpheart.00124.2004; Lindner V, 1998, PATHOBIOLOGY, V66, P311, DOI 10.1159/000028039; Mahmoodzadeh S, 2006, FASEB J, V20, P926, DOI 10.1096/fj.05-5148com; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Medina RA, 2003, BIOL RES, V36, P325, DOI 10.4067/S0716-97602003000300005; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Nakamura Y, 2004, MOL CELL ENDOCRINOL, V219, P17, DOI 10.1016/j.mce.2004.02.013; Nordmeyer J, 2004, CIRCULATION, V110, P3270, DOI 10.1161/01.CIR.0000147610.41984.E8; O'Donnell SM, 2005, J CLIN INVEST, V115, P2341, DOI 10.1172/JCI22428; Okuda Y, 2003, ENDOCR J, V50, P97, DOI 10.1507/endocrj.50.97; Onai Y, 2007, AM J PHYSIOL-HEART C, V292, pH530, DOI 10.1152/ajpheart.00549.2006; Pelligrino DA, 2001, JPN J PHARMACOL, V86, P137, DOI 10.1254/jjp.86.137; Pelzer T, 2001, BIOCHEM BIOPH RES CO, V286, P1153, DOI 10.1006/bbrc.2001.5519; Penolazzi L, 2004, J STEROID BIOCHEM, V91, P1, DOI 10.1016/j.jsbmb.2004.02.005; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Ropero AB, 2006, J MOL CELL CARDIOL, V41, P496, DOI 10.1016/j.yjmcc.2006.05.022; Sasaki H, 1999, ANTIOXID REDOX SIGN, V1, P317, DOI 10.1089/ars.1999.1.3-317; Schuur ER, 2001, J BIOL CHEM, V276, P15519, DOI 10.1074/jbc.M009001200; SHUPNIK MA, 1989, MOL ENDOCRINOL, V3, P660, DOI 10.1210/mend-3-4-660; Simoncini T, 2002, CIRCULATION, V105, P1368, DOI 10.1161/hc1102.105267; Tang ZQ, 1997, MOL CELL BIOL, V17, P1274, DOI 10.1128/MCB.17.3.1274; Tanimoto K, 1999, NUCLEIC ACIDS RES, V27, P903, DOI 10.1093/nar/27.3.903; Thompson DA, 1997, J STEROID BIOCHEM, V62, P143, DOI 10.1016/S0960-0760(97)00029-0; Treilleux I, 1997, MOL ENDOCRINOL, V11, P1319, DOI 10.1210/me.11.9.1319; Venkov CD, 1996, CIRCULATION, V94, P727, DOI 10.1161/01.CIR.94.4.727	53	22	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24705	24714		10.1074/jbc.M109.000463	http://dx.doi.org/10.1074/jbc.M109.000463			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584059	hybrid, Green Published			2022-12-27	WOS:000269734000005
J	Ng, SW; Nelson, C; Parekh, AB				Ng, Siaw-Wei; Nelson, Charmaine; Parekh, Anant B.			Coupling of Ca2+ Microdomains to Spatially and Temporally Distinct Cellular Responses by the Tyrosine Kinase Syk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CRAC CHANNELS; MAST-CELLS; GENE-EXPRESSION; C-FOS; CALCIUM; RELEASE; INFLUX; HOMEOSTASIS; SELECTIVITY; ACTIVATION	Communication between the cell surface and the nucleus is essential for regulated gene expression. In neurons, Ca2+-dependent gene transcription is sensitive to local Ca2+ entry. In immune cells, excitation-transcription coupling is thought to involve global Ca2+ signals. Here, we show that in mast cells, Ca2+ microdomains from store-operated Ca2+ release-activated Ca2+ channels activate expression of the transcription factor c-fos. Local Ca2+ entry is sensed by the tyrosine kinase Syk, which signals to the nucleus through the transcription factor STAT5. Ca2+ microdomains also promote secretion of proinflammatory messengers, which, like gene expression, requires Syk. Syk therefore couples Ca2+ microdomains to the activation of two spatially and temporally distinct cellular responses, revealing the versatility of local Ca2+ signals in driving cell activation.	[Ng, Siaw-Wei; Nelson, Charmaine; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council; MRC [G0601485] Funding Source: UKRI; Medical Research Council [G0601485] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council program grant (to A.B.P.).	Bakowski D, 2007, CELL CALCIUM, V42, P333, DOI 10.1016/j.ceca.2007.01.005; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Lee YN, 2004, J IMMUNOL, V173, P2571, DOI 10.4049/jimmunol.173.4.2571; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Parekh AB, 2007, CELL CALCIUM, V42, P111, DOI 10.1016/j.ceca.2007.02.012; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Straube S, 2002, PFLUG ARCH EUR J PHY, V444, P389, DOI 10.1007/s00424-002-0812-2; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108	29	112	114	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24767	24772		10.1074/jbc.M109.011692	http://dx.doi.org/10.1074/jbc.M109.011692			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584058	hybrid, Green Published			2022-12-27	WOS:000269734000011
J	Ronen, D; Ravid, S				Ronen, Daniel; Ravid, Shoshana			Myosin II Tailpiece Determines Its Paracrystal Structure, Filament Assembly Properties, and Cellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN ISOFORMS; CASEIN KINASE-II; SMOOTH-MUSCLE; COILED-COIL; NONMUSCLE; PHOSPHORYLATION; ROD; CYTOKINESIS; MECHANISMS; EXPRESSION	Non muscle myosin II (NMII) is a major motor protein present in all cell types. The three known vertebrate NMII isoforms share high sequence homology but play different cellular roles. The main difference in sequence resides in the C-terminal non-helical tailpiece (tailpiece). In this study we demonstrate that the tailpiece is crucial for proper filament size, overcoming the intrinsic properties of the coiled-coil rod. Furthermore, we show that the tailpiece by itself determines the NMII filament structure in an isoform-specific manner, thus providing a possible mechanism by which each NMII isoform carries out its unique cellular functions. We further show that the tailpiece determines the cellular localization of NMII-A and NMII-B and is important for NMII-C role in focal adhesion complexes. We mapped NMII-C sites phosphorylated by protein kinase C and casein kinase II and showed that these phosphorylations affect its solubility properties and cellular localization. Thus phosphorylation fine-tunes the tailpiece effects on the coiled-coil rod, enabling dynamic regulation of NMII-C assembly. We thus show that the small tailpiece of NMII is a distinct domain playing a role in isoform-specific filament assembly and cellular functions.	[Ronen, Daniel; Ravid, Shoshana] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res,Israel Canada, IL-91220 Jerusalem, Israel	Hebrew University of Jerusalem	Ravid, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res,Israel Canada, IL-91220 Jerusalem, Israel.	shoshr@ekmd.huji.ac.il						ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Ben-Ya'acov A, 2003, J BIOL CHEM, V278, P40032, DOI 10.1074/jbc.M306948200; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Clark K, 2008, FEBS LETT, V582, P2993, DOI 10.1016/j.febslet.2008.07.043; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; Hostetter D, 2004, PLOS BIOL, V2, P1880, DOI 10.1371/journal.pbio.0020356; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; KELLEY CA, 1990, J BIOL CHEM, V265, P17876; KENDRICKJONES J, 1971, J MOL BIOL, V59, P527, DOI 10.1016/0022-2836(71)90316-0; Kolega J, 1999, CELL MOTIL CYTOSKEL, V43, P255, DOI 10.1002/(SICI)1097-0169(1999)43:3<255::AID-CM8>3.0.CO;2-T; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kubo T, 2008, J NEUROCHEM, V105, P113, DOI 10.1111/j.1471-4159.2007.05125.x; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Martin AF, 2007, AM J PHYSIOL-CELL PH, V293, pC238, DOI 10.1152/ajpcell.00567.2006; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; Rovner AS, 2002, J CELL BIOL, V156, P113, DOI 10.1083/jcb.200107131; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Sandquist JC, 2008, MOL BIOL CELL, V19, P5156, DOI 10.1091/mbc.E08-05-0533; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Sellers J. R., 1999, MYOSINS; SHOHET RV, 1989, P NATL ACAD SCI USA, V86, P7726, DOI 10.1073/pnas.86.20.7726; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Straussman R, 2005, J MOL BIOL, V353, P613, DOI 10.1016/j.jmb.2005.08.010; Straussman R, 2001, J CELL SCI, V114, P3047; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wylie SR, 2003, MOL BIOL CELL, V14, P4654, DOI 10.1091/mbc.E03-03-0187; Wylie SR, 1998, P NATL ACAD SCI USA, V95, P12967, DOI 10.1073/pnas.95.22.12967; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744	47	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24948	24957		10.1074/jbc.M109.023754	http://dx.doi.org/10.1074/jbc.M109.023754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19553683	Green Published, hybrid			2022-12-27	WOS:000269734000029
J	Chaturvedi, D; Cohen, MS; Taunton, J; Patel, TB				Chaturvedi, Deepti; Cohen, Michael S.; Taunton, Jack; Patel, Tarun B.			The PKARI alpha Subunit of Protein Kinase A Modulates the Activation of p90(RSK1) and Its Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; CANCER-CELL-PROLIFERATION; AKAP SIGNALING COMPLEXES; CARNEY COMPLEX; REGULATORY SUBUNIT; ANCHORING PROTEIN; DOCKING SITE; ENDOCRINE OVERACTIVITY; SPOTTY PIGMENTATION; CATALYTIC SUBUNIT	Previously, we showed that interactions between p90(RSK1) (RSK1) and the subunits of type I protein kinase A (PKA) regulate the activity of PKA and cellular distribution of active RSK1 (Chaturvedi, D., Poppleton, H. M., Stringfield, T., Barbier, A., and Patel, T. B. (2006) Mol. Cell Biol. 26, 4586-4600). Here we examined the role of the PKARI alpha subunit of PKA in regulating RSK1 activation and cell survival. In mouse lung fibroblasts, silencing of the PKARI alpha increased the phosphorylation and activation of RSK1, but not of RSK2 and RSK3, in the absence of any stimulation. Silencing of PKARI alpha also decreased the nuclear accumulation of active RSK1 and increased its cytoplasmic content. The increased activation of RSK1 in the absence of any agonist and changes in its subcellular redistribution resulted in increased phosphorylation of its cytoplasmic substrate BAD and increased cell survival. The activity of PKA and phosphorylation of BAD (Ser-155) were also enhanced when PKARI alpha was silenced, and this, in part, contributed to increased cell survival in unstimulated cells. Furthermore, we show that RSK1, PKA subunits, D-AKAP1, and protein phosphatase 2A catalytic subunit (PP2Ac) exist in a complex, and dissociation of RSK1 from D-AKAP1 by either silencing of PKARI alpha, depletion of D-AKAP1, or by using a peptide that competes with PKARI alpha for binding to AKAPs, decreased the amount of PP2Ac in the RSK1 complex. We also demonstrate that PP2Ac is one of the phosphatases that dephosphorylates RSK, but not ERK1/2. Thus, in unstimulated cells, the increased phosphorylation and activation of RSK1 after silencing of PKARI alpha or depletion of D-AKAP1 are due to decreased association of PP2Ac in the RSK1 complex.	[Chaturvedi, Deepti; Patel, Tarun B.] Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA; [Cohen, Michael S.; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Loyola University Chicago; University of California System; University of California San Francisco	Patel, TB (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA.	tpatel7@lumc.edu			National Institutes of Health [GM 073181, GM 071434, AHA-ID-0830411Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071434, R01GM073181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 073181 (to T. B. P.), GM 071434 (to J. T.), and AHA-ID-0830411Z (to D. C.).	Alto N, 2002, DIABETES, V51, pS385, DOI 10.2337/diabetes.51.2007.S385; Alto NM, 2004, CELL BIOCHEM BIOPHYS, P201; Boikos SA, 2007, CURR OPIN ONCOL, V19, P24, DOI 10.1097/CCO.0b013e32801195eb; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bossis I, 2004, ENDOCRINOLOGY, V145, P5452, DOI 10.1210/en.2004-0900; BUECHLER YJ, 1991, J BIOL CHEM, V266, P3491; CARNEY JA, 1995, SEMIN DERMATOL, V14, P90, DOI 10.1016/S1085-5629(05)80003-3; CARNEY JA, 1986, MAYO CLIN PROC, V61, P165, DOI 10.1016/S0025-6196(12)61843-6; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Clark DE, 2005, CANCER RES, V65, P3108; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Deng WL, 2004, J BIOL CHEM, V279, P47871, DOI 10.1074/jbc.M405443200; Doehn U, 2004, BIOCHEM J, V382, P425, DOI 10.1042/BJ20040948; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Griffin KJ, 2004, CANCER RES, V64, P8811, DOI 10.1158/0008-5472.CAN-04-3620; Horvath A, 2008, CLIN CANCER RES, V14, P388, DOI 10.1158/1078-0432.CCR-07-1155; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Jin ZH, 2004, J BIOL CHEM, V279, P23837, DOI 10.1074/jbc.M402566200; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Robinson-White AJ, 2008, J CLIN ENDOCR METAB, V93, P1020, DOI 10.1210/jc.2007-2331; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Skalhegg Bjorn S., 1997, Frontiers in Bioscience (online), V2, pD331; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Veugelers M, 2004, P NATL ACAD SCI USA, V101, P14222, DOI 10.1073/pnas.0405535101; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; ZHAO Y, 1995, MOL CELL BIOL, V15, P4353; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200	47	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23670	23681		10.1074/jbc.M109.032813	http://dx.doi.org/10.1074/jbc.M109.032813			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570980	hybrid, Green Published			2022-12-27	WOS:000269180000053
J	Hung, HC; Maurer, C; Zorn, D; Chang, WL; Weber, F				Hung, Hsiu-Cheng; Maurer, Christian; Zorn, Daniela; Chang, Wai-Ling; Weber, Frank			Sequential and Compartment-specific Phosphorylation Controls the Life Cycle of the Circadian CLOCK Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PER-TIM COMPLEX; E-BOX BINDING; DROSOPHILA CLOCK; POSTTRANSLATIONAL REGULATION; LIMITING AMOUNTS; TRANSCRIPTION; NUCLEAR; BMAL1; EXPRESSION; TIMELESS	The circadian clock facilitates a temporal coordination of most homeostatic activities and their synchronization with the environmental cycles of day and night. The core oscillating activity of the circadian clock is formed by a heterodimer of the transcription factors CLOCK (CLK) and CYCLE (CYC). Posttranslational regulation of CLK/CYC has previously been shown to be crucial for clock function and accurate timing of circadian transcription. Here we report that a sequential and compartment-specific phosphorylation of the Drosophila CLK protein assigns specific localization and activity patterns. Total and nuclear amounts of CLK protein were found to oscillate over the course of a day in circadian neurons. Detailed analysis of the cellular distribution and phosphorylation of CLK revealed that newly synthesized CLK is hypophosphorylated in the cytoplasm prior to nuclear import. In the nucleus, CLK is converted into an intermediate phosphorylation state that correlates with transactivation of circadian transcription. Hyperphosphorylation and degradation are promoted by nuclear export of the CLK protein. Surprisingly, CLK localized to discrete nuclear foci in cell culture as well as in circadian neurons of the larval brain. These subnuclear sites likely contain a storage form of the transcription factor, while homogeneously distributed nuclear CLK appears to be the transcriptionally active form. These results show that sequential post-translational modifications and subcellular distribution regulate the activity of the CLK protein, indicating a core post-translational timing mechanism of the circadian clock.	[Hung, Hsiu-Cheng; Maurer, Christian; Zorn, Daniela; Chang, Wai-Ling; Weber, Frank] Univ Heidelberg, Biochem Ctr Heidelberg BZH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Weber, F (corresponding author), Univ Heidelberg, Biochem Ctr Heidelberg BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	Frank.Weber@bzh.uni-heidelberg.de			Emmy-Noether [WE2608/1-3]; Deutsche Forschungsgemeinschaft [WE2608/2-1]	Emmy-Noether(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Emmy-Noether Grant WE2608/1-3 and by Grant WE2608/2-1 of the Deutsche Forschungsgemeinschaft (to F. W.).	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Ashmore LJ, 2003, J NEUROSCI, V23, P7810; Bae K, 2000, J NEUROSCI, V20, P1746; Bae K, 2006, J BIOCHEM, V140, P609, DOI 10.1093/jb/mvj198; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Houl JH, 2006, J BIOL RHYTHM, V21, P93, DOI 10.1177/0748730405283697; Hung HC, 2007, J BIOL CHEM, V282, P31349, DOI 10.1074/jbc.M702319200; Hung HC, 2009, J BIOL RHYTHM, V24, P183, DOI 10.1177/0748730409333171; Kadener S, 2008, PLOS BIOL, V6, P965, DOI 10.1371/journal.pbio.0060119; Kim EY, 2006, P NATL ACAD SCI USA, V103, P6178, DOI 10.1073/pnas.0511215103; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Lim C, 2007, MOL CELL BIOL, V27, P4876, DOI 10.1128/MCB.02155-06; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Maurer C, 2009, FEBS LETT, V583, P1561, DOI 10.1016/j.febslet.2009.04.013; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Meyer P, 2006, SCIENCE, V311, P226, DOI 10.1126/science.1118126; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Taylor P, 2008, MOL CELL BIOL, V28, P4642, DOI 10.1128/MCB.01612-07; Weber F, 2003, FEBS LETT, V555, P341, DOI 10.1016/S0014-5793(03)01269-9; Weber F, 2006, J NEUROCHEM, V98, P248, DOI 10.1111/j.1471-4159.2006.03865.x; Weber F, 2009, NATURWISSENSCHAFTEN, V96, P321, DOI 10.1007/s00114-008-0474-9; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406	46	21	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23734	23742		10.1074/jbc.M109.025064	http://dx.doi.org/10.1074/jbc.M109.025064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19564332	hybrid, Green Published			2022-12-27	WOS:000269180000058
J	Jo, M; Lester, RD; Montel, V; Eastman, B; Takimoto, S; Gonias, SL				Jo, Minji; Lester, Robin D.; Montel, Valerie; Eastman, Boryana; Takimoto, Shinako; Gonias, Steven L.			Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; PLASMINOGEN-ACTIVATOR; TUMOR-METASTASIS; DOWN-REGULATION; GAMMA-CATENIN; HYPOXIA; CARCINOMA; PROTEIN; MIGRATION	Hypoxia induces expression of the urokinase receptor ( uPAR) and activates uPAR-dependent cell signaling in cancer cells. This process promotes epithelial-mesenchymal transition (EMT). uPAR overexpression in cancer cells also promotes EMT. In this study, we tested whether uPAR may be targeted to reverse cancer cell EMT. When MDA-MB 468 breast cancer cells were cultured in 1% O-2, uPAR expression increased, as anticipated. Cell-cell junctions were disrupted, vimentin expression increased, and E-cadherin was lost from cell surfaces, indicating EMT. Transferring these cells back to 21% O-2 decreased uPAR expression and reversed the signs of EMT. In uPAR-overexpressing MDA-MB 468 cells, EMT was reversed by silencing expression of endogenously produced urokinase-type plasminogen activator (uPA), which is necessary for uPAR-dependent cell signaling, or by targeting uPAR-activated cell signaling factors, including phosphatidylinositol 3-kinase, Src family kinases, and extracellular signal-regulated kinase. MDA-MB 231 breast cancer cells express high levels of uPA and uPAR and demonstrate mesenchymal cell morphology under normoxic culture conditions (21% O-2). Silencing uPA expression in MDA-MB-231 cells decreased expression of vimentin and Snail, and induced changes in morphology characteristic of epithelial cells. These results demonstrate that uPAR-initiated cell signaling may be targeted to reverse EMT in cancer.	[Jo, Minji; Lester, Robin D.; Montel, Valerie; Eastman, Boryana; Takimoto, Shinako; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92093 USA	University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sgonias@ucsd.edu			National Institutes of Health NCI [CA-94900]; NATIONAL CANCER INSTITUTE [R01CA094900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-94900 from the NCI.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bukholm IK, 1998, J PATHOL, V185, P262, DOI 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y; Bukholm IK, 2000, J PATHOL, V190, P15; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chandrasekar N, 2003, ONCOGENE, V22, P392, DOI 10.1038/sj.onc.1206164; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gond CS, 2007, INT J ONCOL, V31, P19; GRAFF JR, 1995, CANCER RES, V55, P5195; Hajra KM, 2002, CANCER RES, V62, P1613; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; Jo M, 2009, AM J PATHOL, V175, P190, DOI 10.2353/ajpath.2009.081053; Jo MJ, 2005, J BIOL CHEM, V280, P17449, DOI 10.1074/jbc.M413141200; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lester RD, 2005, J BIOL CHEM, V280, P39273, DOI 10.1074/jbc.M509446200; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Ma Z, 2001, J CELL SCI, V114, P3387; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PYKE C, 1991, AM J PATHOL, V138, P1059; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhong H, 1999, CANCER RES, V59, P5830; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	46	136	147	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22825	22833		10.1074/jbc.M109.023960	http://dx.doi.org/10.1074/jbc.M109.023960			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546228	Green Published, hybrid			2022-12-27	WOS:000268963100036
J	Lutz, AK; Exner, N; Fett, ME; Schlehe, JS; Kloos, K; Lammermann, K; Brunner, B; Kurz-Drexler, A; Vogel, F; Reichert, AS; Bouman, L; Vogt-Weisenhorn, D; Wurst, W; Tatzelt, J; Haass, C; Winklhofer, KF				Lutz, A. Kathrin; Exner, Nicole; Fett, Mareike E.; Schlehe, Julia S.; Kloos, Karina; Laemmermann, Kerstin; Brunner, Bettina; Kurz-Drexler, Annerose; Vogel, Frank; Reichert, Andreas S.; Bouman, Lena; Vogt-Weisenhorn, Daniela; Wurst, Wolfgang; Tatzelt, Joerg; Haass, Christian; Winklhofer, Konstanze F.			Loss of Parkin or PINK1 Function Increases Drp1-dependent Mitochondrial Fragmentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; CELL-DEATH; DYSFUNCTION; DROSOPHILA; FISSION; MORPHOLOGY; PROTEIN; PHOSPHORYLATION; PATHOLOGY	Loss-of-function mutations in the parkin gene (PARK2) and PINK1 gene (PARK6) are associated with autosomal recessive parkinsonism. PINK1 deficiency was recently linked to mitochondrial pathology in human cells and Drosophila melanogaster, which can be rescued by parkin, suggesting that both genes play a role in maintaining mitochondrial integrity. Here we demonstrate that an acute down-regulation of parkin in human SH-SY5Y cells severely affects mitochondrial morphology and function, a phenotype comparable with that induced by PINK1 deficiency. Alterations in both mitochondrial morphology and ATP production caused by either parkin or PINK1 loss of function could be rescued by the mitochondrial fusion proteins Mfn2 and OPA1 or by a dominant negative mutant of the fission protein Drp1. Both parkin and PINK1 were able to suppress mitochondrial fragmentation induced by Drp1. Moreover, in Drp1- deficient cells the parkin/PINK1 knockdown phenotype did not occur, indicating that mitochondrial alterations observed in parkin- or PINK1-deficient cells are associated with an increase in mitochondrial fission. Notably, mitochondrial fragmentation is an early phenomenon upon PINK1/parkin silencing that also occurs in primary mouse neurons and Drosophila S2 cells. We propose that the discrepant findings in adult flies can be explained by the time of phenotype analysis and suggest that in mammals different strategies may have evolved to cope with dysfunctional mitochondria.	[Lutz, A. Kathrin; Exner, Nicole; Fett, Mareike E.; Schlehe, Julia S.; Laemmermann, Kerstin; Brunner, Bettina; Bouman, Lena; Tatzelt, Joerg; Haass, Christian; Winklhofer, Konstanze F.] Univ Munich, Deutsch Zentrum Neurodegenarat Erkrankungen, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Kloos, Karina; Kurz-Drexler, Annerose; Vogt-Weisenhorn, Daniela; Wurst, Wolfgang] Tech Univ Munich, Inst Dev Genet, Helmholtz Ctr Munich, D-8000 Munich, Germany; [Vogel, Frank] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Reichert, Andreas S.] Univ Frankfurt, D-60590 Frankfurt, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Goethe University Frankfurt	Winklhofer, KF (corresponding author), Schillerstr 44, D-80336 Munich, Germany.	Konstanze.Winklhofer@med.uni-muenchen.de	Reichert, Andreas/A-4090-2012; Mueller-Rischart, Anne Kathrin/L-3219-2017	Tatzelt, Jorg/0000-0001-5017-5528; Wurst, Wolfgang/0000-0003-4422-7410; Reichert, Andreas/0000-0001-9340-3113; Winklhofer, Konstanze/0000-0002-7256-8231; Vogt Weisenhorn, Daniela/0000-0002-4566-6506	Deutsche Forschungsgemeinschaft (SFB 596 and CEF Macromolecular Complexes); German Ministry for Education and Research (Nationales Genomforschungsnetz plus "Functional Genomics of Parkinson's Disease"); Helmholtz Alliance Alliance "Mental Health in an Ageing Society,"; Virtual Institute of "Neurodegeneration and Ageing," the Center for Integrated Protein Science Munich; Hans and Ilse Breuer Foundation	Deutsche Forschungsgemeinschaft (SFB 596 and CEF Macromolecular Complexes)(German Research Foundation (DFG)); German Ministry for Education and Research (Nationales Genomforschungsnetz plus "Functional Genomics of Parkinson's Disease")(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance Alliance "Mental Health in an Ageing Society,"; Virtual Institute of "Neurodegeneration and Ageing," the Center for Integrated Protein Science Munich; Hans and Ilse Breuer Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 596 and CEF Macromolecular Complexes), German Ministry for Education and Research (Nationales Genomforschungsnetz plus "Functional Genomics of Parkinson's Disease"), the Helmholtz Alliance Alliance "Mental Health in an Ageing Society," the Virtual Institute of "Neurodegeneration and Ageing," the Center for Integrated Protein Science Munich, and the Hans and Ilse Breuer Foundation.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Bogaerts V, 2008, GENES BRAIN BEHAV, V7, P129, DOI 10.1111/j.1601-183X.2007.00342.x; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Consiglio A, 2001, NAT MED, V7, P310, DOI 10.1038/85454; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; GRUNEWALD A, 2009, EXP NEUROL IN PRESS; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Hwa JJ, 2002, MECH DEVELOP, V116, P213, DOI 10.1016/S0925-4773(02)00141-7; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jeyaraju DV, 2006, P NATL ACAD SCI USA, V103, P18562, DOI 10.1073/pnas.0604983103; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; Marongiu R, 2009, J NEUROCHEM, V108, P1561, DOI 10.1111/j.1471-4159.2009.05932.x; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schlehe JS, 2008, J BIOL CHEM, V283, P13771, DOI 10.1074/jbc.M707494200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Winklhofer KF, 2003, J BIOL CHEM, V278, P47199, DOI 10.1074/jbc.M306769200; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	50	308	313	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22938	22951		10.1074/jbc.M109.035774	http://dx.doi.org/10.1074/jbc.M109.035774			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546216	hybrid, Green Published			2022-12-27	WOS:000268963100047
J	Zhu, PM; Liu, XH; Treml, LS; Cancro, MP; Freedman, BD				Zhu, Peimin; Liu, Xiaohong; Treml, Laura S.; Cancro, Michael P.; Freedman, Bruce D.			Mechanism and Regulatory Function of CpG Signaling via Scavenger Receptor B1 in Primary B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NONSELECTIVE CATION CHANNELS; BACTERIAL-DNA; CA2+ ENTRY; ANTIBODY-PRODUCTION; INNATE IMMUNITY; TRP CHANNELS; ACTIVATION; CALCIUM; SYK	It is well established that CpG promotes pro-inflammatory cytokine and antibody production by B cells via the Toll-like receptor 9 (TLR9)-dependent pathway. However, scavenger receptors (SRs) are also capable of binding such pathogen-derived molecules, yet their contribution to CpG-induced signaling events has not yet been evaluated. Here we identified a novel TLR9-independent mechanism of CpG-induced signaling and immune function that is mediated by the scavenger B1 receptor (SR-B1). Specifically, we show that CpG/SR-B1 triggers calcium entry into primary B lymphocytes via phospholipase C gamma-1-mediated activation of TRPC3 channels and also B cell adhesion to vascular cell adhesion molecule-1. CpG-induced calcium signals and vascular cell adhesion molecule-1 adhesion are TLR9-independent and are mediated exclusively by SR-B1. Although proinflammatory cytokine and Ig production induced by CpG require TLR9 expression, we also found that SR-B1 negatively regulates TLR9-dependent production of interleukin-6, interleukin-10, and IgM. Thus, our results provide a novel perspective on the complexity of CpG signaling within B cells by demonstrating that SR-B1 is an alternative pathway for nucleic acid-induced signaling that provides feedback inhibition on specific TLR9-dependent responses of B cells. Consequently, these results have wide implications for understanding the mechanisms regulating immune tolerance to nucleic acids and pathogen-associated molecules.	[Zhu, Peimin; Liu, Xiaohong; Freedman, Bruce D.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Treml, Laura S.; Cancro, Michael P.] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Freedman, BD (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Rm 368E,Old Vet Bldg,3800 Spruce St, Philadelphia, PA 19104 USA.	bruce@vet.upenn.edu		Cancro, Michael/0000-0002-8659-3227	National Institutes of Health [AI 39678]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039678, R01AI060921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 39678 (to B. D. F.).	Abudula A, 2007, J BIOL CHEM, V282, P29059, DOI 10.1074/jbc.M704043200; Anolik JH, 2005, BEST PRACT RES CL RH, V19, P859, DOI 10.1016/j.berh.2005.05.006; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Busconi L, 2007, J IMMUNOL, V179, P7397, DOI 10.4049/jimmunol.179.11.7397; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Chung SC, 2007, J CELL BIOL, V177, P317, DOI 10.1083/jcb.200702050; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Hagar RE, 1998, NATURE, V396, P81, DOI 10.1038/23954; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hollifield M, 2007, INFECT IMMUN, V75, P3999, DOI 10.1128/IAI.00393-07; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305; Jozefowski S, 2006, J LEUKOCYTE BIOL, V80, P870, DOI 10.1189/jlb.0705357; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2003, NAT MED, V9, P831, DOI 10.1038/nm0703-831; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lenert P, 2005, J CLIN IMMUNOL, V25, P29, DOI 10.1007/s10875-005-0355-6; Liu QH, 2005, J IMMUNOL, V174, P68, DOI 10.4049/jimmunol.174.1.68; Liu XH, 2006, AM J PHYSIOL-CELL PH, V290, pC873, DOI 10.1152/ajpcell.00229.2005; Llorente L, 2003, J AUTOIMMUN, V20, P287, DOI 10.1016/S0896-8411(03)00043-X; Lof C, 2008, J CELL PHYSIOL, V216, P245, DOI 10.1002/jcp.21396; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Mukhopadhyay S, 2004, IMMUNOBIOLOGY, V209, P39, DOI 10.1016/j.imbio.2004.02.004; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Pearson AM, 1996, CURR OPIN IMMUNOL, V8, P20, DOI 10.1016/S0952-7915(96)80100-2; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Tyrrell-Price J, 2001, CLIN EXP IMMUNOL, V124, P118, DOI 10.1046/j.1365-2249.2001.01466.x; Uccellini MB, 2008, J IMMUNOL, V181, P5875, DOI 10.4049/jimmunol.181.9.5875; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Wang XY, 2007, CANCER RES, V67, P4996, DOI 10.1158/0008-5472.CAN-06-3138; Wang YQ, 2003, INT IMMUNOL, V15, P223, DOI 10.1093/intimm/dxg020; Wang YX, 2000, J PHYSIOL-LONDON, V523, P131, DOI 10.1111/j.1469-7793.2000.t01-3-00131.x; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600; Won WJ, 2008, J IMMUNOL, V180, P230, DOI 10.4049/jimmunol.180.1.230; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148; Zhu PM, 2005, J IMMUNOL, V175, P4981, DOI 10.4049/jimmunol.175.8.4981	54	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22878	22887		10.1074/jbc.M109.018580	http://dx.doi.org/10.1074/jbc.M109.018580			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542230	Green Published, hybrid			2022-12-27	WOS:000268963100041
J	Idkowiak-Baldys, J; Baldys, A; Raymond, JR; Hannun, YA				Idkowiak-Baldys, Jolanta; Baldys, Aleksander; Raymond, John R.; Hannun, Yusuf A.			Sustained Receptor Stimulation Leads to Sequestration of Recycling Endosomes in a Classical Protein Kinase C- and Phospholipase D-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; COUPLED RECEPTORS; PLASMA-MEMBRANE; 5-HYDROXYTRYPTAMINE(2A) RECEPTOR; DOPAMINE TRANSPORTER; ACTIVATED RECEPTOR-1; 5-HT2A RECEPTORS; BETA-II; DESENSITIZATION; ENDOCYTOSIS	Considerable insight has been garnered on initial mechanisms of endocytosis of plasma membrane proteins and their subsequent trafficking through the endosomal compartment. It is also well established that ligand stimulation of many plasma membrane receptors leads to their internalization. However, stimulus-induced regulation of endosomal trafficking has not received much attention. In previous studies, we showed that sustained stimulation of protein kinase C(PKC) with phorbol esters led to sequestration of recycling endosomes in a juxtanuclear region. In this study, we investigated whether G-protein-coupled receptors that activate PKC exerted effects on endosomal trafficking. Stimulation of cells with serotonin (5-hydroxytryptamine (5-HT)) led to sequestration of the 5-HT receptor(5-HT2AR) into a Rab11-positive juxtanuclear compartment. This sequestration coincided with translocation of PKC as shown by confocal microscopy. Mechanistically the observed sequestration of 5-HT2AR was shown to require continuous PKC activity because it was inhibited by pretreatment with classical PKC inhibitor Go6976 and could be reversed by posttreatment with this inhibitor. In addition, classical PKC autophosphorylation was necessary for receptor sequestration. Moreover inhibition of phospholipase D (PLD) activity and inhibition of PLD1 and PLD2 using dominant negative constructs also prevented this process. Functionally this sequestration did not affect receptor desensitization or resensitization as measured by intracellular calcium increase. However, the PKC- and PLD-dependent sequestration of receptors resulted in co-sequestration of other plasma membrane proteins and receptors as shown for epidermal growth factor receptor and protease activated receptor-1. This led to heterologous desensitization of those receptors and diverted their cellular fate by protecting them from agonist-induced degradation. Taken together, these results demonstrate a novel role for sustained receptor stimulation in regulation of intracellular trafficking, and this process requires sustained stimulation of PKC and PLD.	[Idkowiak-Baldys, Jolanta; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Baldys, Aleksander; Raymond, John R.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Baldys, Aleksander; Raymond, John R.] Ralph H Johnson Vet Affairs Med Ctr, Med & Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu			National Institutes of Health [HL43707, R01 GM-63909]; Veterans Affairs Merit and Research Enhancement Award Program Awards; American Heart Association [0725358U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit and Research Enhancement Award Program Awards; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL43707 (to Y. A. H.) and R01 GM-63909 (to J.R.R.). This work was also supported by Veterans Affairs Merit and Research Enhancement Award Program Awards (to J.R.R.), and American Heart Association Mid-Atlantic Affiliate Grant 0725358U (to A. B.).	Anji A, 2001, J NEUROCHEM, V77, P589, DOI 10.1046/j.1471-4159.2001.00261.x; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Becker KP, 2004, J BIOL CHEM, V279, P28251, DOI 10.1074/jbc.M400770200; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; BEGUINOT L, 1985, P NATL ACAD SCI USA, V82, P2774, DOI 10.1073/pnas.82.9.2774; Bhattacharyya S, 2002, P NATL ACAD SCI USA, V99, P14470, DOI 10.1073/pnas.212517999; Cameron AJ, 2007, BIOCHEM SOC T, V35, P1013, DOI 10.1042/BST0351013; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; CONN PJ, 1985, J PHARMACOL EXP THER, V234, P195; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gray JA, 2001, MOL PHARMACOL, V60, P1020, DOI 10.1124/mol.60.5.1020; Haberman Y, 2005, J CELL SCI, V118, P1641, DOI 10.1242/jcs.02276; Hanley NRS, 2002, J PHARMACOL EXP THER, V300, P468, DOI 10.1124/jpet.300.2.468; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hu TH, 2004, J BIOL CHEM, V279, P35702, DOI 10.1074/jbc.M402372200; Huang RQ, 2007, BIOCHEMISTRY-US, V46, P11484, DOI 10.1021/bi701093j; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Jayanthi LD, 2005, MOL PHARMACOL, V67, P2077, DOI 10.1124/mol.104.009555; KAGAYA A, 1990, J PHARMACOL EXP THER, V255, P305; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; KITATANI K, 2007, J BIOL CHEM; Koch T, 2006, J NEUROCHEM, V97, P365, DOI 10.1111/j.1471-4159.2006.03736.x; Koch T, 2004, J NEUROCHEM, V88, P680, DOI 10.1046/j.1471-4159.2003.02189.x; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lau T, 2009, NEUROCHEM INT, V54, P271, DOI 10.1016/j.neuint.2008.12.004; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Musashi M, 2000, INT J HEMATOL, V72, P12; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Roth BL, 1995, J PHARMACOL EXP THER, V275, P1638; Rotmann A, 2006, BIOCHEM J, V395, P117, DOI 10.1042/BJ20051558; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P4813, DOI 10.1074/jbc.270.9.4813; WANG CL, 1995, J BIOL CHEM, V270, P16677, DOI 10.1074/jbc.270.28.16677; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Yan WH, 1998, AM J PHYSIOL-CELL PH, V274, pC387, DOI 10.1152/ajpcell.1998.274.2.C387; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P808, DOI 10.1016/j.bbamem.2006.10.002; ZHANG Q, 2008, J BIOL CHEM	48	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22322	22331		10.1074/jbc.M109.026765	http://dx.doi.org/10.1074/jbc.M109.026765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19525236	Green Published, hybrid			2022-12-27	WOS:000268783700055
J	Guerin, ME; Schaeffer, F; Chaffotte, A; Gest, P; Giganti, D; Kordulakova, J; van der Woerd, M; Jackson, M; Alzari, PM				Guerin, Marcelo E.; Schaeffer, Francis; Chaffotte, Alain; Gest, Petra; Giganti, David; Kordulakova, Jana; van der Woerd, Mark; Jackson, Mary; Alzari, Pedro M.			Substrate-induced Conformational Changes in the Essential Peripheral Membrane-associated Mannosyltransferase PimA from Mycobacteria IMPLICATIONS FOR CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PHOSPHATIDYLINOSITOL MANNOSIDE; CRYSTALLOGRAPHIC ANALYSIS; BETA-GLUCOSYLTRANSFERASE; GLYCOGEN-SYNTHASE; BINDING; GLYCOSYLTRANSFERASES; TRANSFERASE; MECHANISM; PROTEINS	Phosphatidyl-myo-inositol mannosyltransferase A (PimA) is an essential glycosyltransferase (GT) involved in the biosynthesis of phosphatidyl-myo-inositol mannosides (PIMs), which are key components of the mycobacterial cell envelope. PimA is the paradigm of a large family of peripheral membrane-binding GTs for which the molecular mechanism of substrate/membrane recognition and catalysis is still unknown. Strong evidence is provided showing that PimA undergoes significant conformational changes upon substrate binding. Specifically, the binding of the donor GDP-Man triggered an important interdomain rearrangement that stabilized the enzyme and generated the binding site for the acceptor substrate, phosphatidyl-myo-inositol (PI). The interaction of PimA with the beta-phosphate of GDP-Man was essential for this conformational change to occur. In contrast, binding of PI had the opposite effect, inducing the formation of a more relaxed complex with PimA. Interestingly, GDP-Man stabilized and PI destabilized PimA by a similar enthalpic amount, suggesting that they formed or disrupted an equivalent number of interactions within the PimA complexes. Furthermore, molecular docking and site-directed mutagenesis experiments provided novel insights into the architecture of the myo-inositol 1-phosphate binding site and the involvement of an essential amphiphatic alpha-helix in membrane binding. Altogether, our experimental data support a model wherein the flexibility and conformational transitions confer the adaptability of PimA to the donor and acceptor substrates, which seems to be of importance during catalysis. The proposed mechanism has implications for the comprehension of the peripheral membrane-binding GTs at the molecular level.	[Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [van der Woerd, Mark] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Schaeffer, Francis; Giganti, David; Alzari, Pedro M.] Inst Pasteur, CNRS, URA 2185, Unite Biochim Struct, F-75724 Paris 15, France; [Chaffotte, Alain] Inst Pasteur, Unite RMN Biomol, F-75724 Paris 15, France; [Kordulakova, Jana] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia	Colorado State University; Colorado State University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Comenius University Bratislava		mrcguerin@gmail.com	Kordulakova, Jana/I-3887-2014; Jackson, Mary/D-5345-2017; Guerin, Marcelo M/N-7245-2016	Kordulakova, Jana/0000-0003-2834-0165; Jackson, Mary/0000-0002-9212-0258; Guerin, Marcelo M/0000-0001-9524-3184; Giganti, David/0000-0001-5735-5679; Alzari, Pedro/0000-0002-4233-1903	Infectious Disease SuperCluster at Colorado State University, Institut Pasteur Program GPH-5 [01-B-0095]; Ministere de la Recherche, France, and European Commission [LSHP-CT-2005-018923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	Infectious Disease SuperCluster at Colorado State University, Institut Pasteur Program GPH-5; Ministere de la Recherche, France, and European Commission(Ministry of Research, France); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064798 from NIAID. This work was also supported by the Infectious Disease SuperCluster at Colorado State University, Institut Pasteur Program GPH-5, Contract 01-B-0095 from the Ministere de la Recherche, France, and European Commission Contract LSHP-CT-2005-018923 (New Medicines for Tuberculosis).	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Barreras M, 2008, J BIOL CHEM, V283, P25027, DOI 10.1074/jbc.M801227200; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2000, METHOD ENZYMOL, V321, P38; FURUKAWA K, 1993, J BIOL CHEM, V268, P23837; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; GRIKO YV, 1995, J MOL BIOL, V252, P447, DOI 10.1006/jmbi.1995.0510; Grizot S, 2006, J MOL BIOL, V363, P383, DOI 10.1016/j.jmb.2006.07.057; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2005, ACTA CRYSTALLOGR F, V61, P518, DOI 10.1107/S1744309105012364; Hible G, 2005, J MOL BIOL, V352, P1044, DOI 10.1016/j.jmb.2005.07.042; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Leipold MD, 2007, J BIOL CHEM, V282, P1257, DOI 10.1074/jbc.M608164200; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; MAKHATADZE GI, 1990, J MOL BIOL, V213, P375, DOI 10.1016/S0022-2836(05)80197-4; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; Morera S, 2001, J MOL BIOL, V311, P569, DOI 10.1006/jmbi.2001.4905; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; OReilly M, 1997, NAT STRUCT BIOL, V4, P405, DOI 10.1038/nsb0597-405; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Plotnikov VV, 1997, ANAL BIOCHEM, V250, P237, DOI 10.1006/abio.1997.2236; Privalov PL, 2007, BIOPHYS CHEM, V126, P16, DOI 10.1016/j.bpc.2006.05.004; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Wang X, 2008, STRUCTURE, V16, P965, DOI 10.1016/j.str.2008.03.010; WIEPRECHT T, 2000, BIOCHEMISTRY-US, V39, P191; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151	50	33	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21613	21625		10.1074/jbc.M109.003947	http://dx.doi.org/10.1074/jbc.M109.003947			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520856	hybrid, Green Published			2022-12-27	WOS:000268564400055
J	Prochazkova, K; Shuvalova, LA; Minasov, G; Voburka, Z; Anderson, WF; Satchell, KJF				Prochazkova, Katerina; Shuvalova, Ludmilla A.; Minasov, George; Voburka, Zdenek; Anderson, Wayne F.; Satchell, Karla J. F.			Structural and Molecular Mechanism for Autoprocessing of MARTX Toxin of Vibrio cholerae at Multiple Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE DOMAIN; COVALENT CROSS-LINKING; THERMAL SHIFT ASSAYS; RTX TOXIN; HIGH-THROUGHPUT; DRUG DISCOVERY; CLEAVAGE SITE; GENE-CLUSTER; IDENTIFICATION; ACTIN	The multifunctional autoprocessing repeats-in-toxin (MARTX) toxin of Vibrio cholerae causes destruction of the actin cytoskeleton by covalent cross-linking of actin and inactivation of Rho GTPases. The effector domains responsible for these activities are here shown to be independent proteins released from the large toxin by autoproteolysis catalyzed by an embedded cysteine protease domain (CPD). The CPD is activated upon binding inositol hexakisphosphate (InsP(6)). In this study, we demonstrated that InsP(6) is not simply an allosteric cofactor, but rather binding of InsP(6) stabilized the CPD structure, facilitating formation of the enzyme-substrate complex. The 1.95-angstrom crystal structure of this InsP(6)-bound unprocessed form of CPD was determined and revealed the scissile bond Leu(3428)-Ala(3429) captured in the catalytic site. Upon processing at this site, CPD was converted to a form with 500-fold reduced affinity for InsP(6), but was reactivated for high affinity binding of InsP(6) by cooperative binding of both a new substrate and InsP(6). Reactivation of CPD allowed cleavage of the MARTX toxin at other sites, specifically at leucine residues between the effector domains. Processed CPD also cleaved other proteins in trans, including the leucine-rich protein YopM, demonstrating that it is a promiscuous leucine-specific protease.	[Satchell, Karla J. F.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Shuvalova, Ludmilla A.; Minasov, George; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Shuvalova, Ludmilla A.; Minasov, George; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Voburka, Zdenek] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague 16110 6, Czech Republic	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Satchell, KJF (corresponding author), 320 E Super Ave,Searle 3-525,MC S213, Chicago, IL 60611 USA.	k-satchell@northwestern.edu	Satchell, Karla/GSN-3100-2022	Minasov, George/0000-0001-5460-3462	National Institutes of Health, NIAID [RO1AI051490]; Dept. of Health and Human Services [HHSN272200700058C]; U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; The Searle Funds at the Chicago Community Trust; National Institute of Health [U54 AI057153]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dept. of Health and Human Services; U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; The Searle Funds at the Chicago Community Trust; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AI051490 (to K. J. F. S.) from NIAID. This work was also supported by the Dept. of Health and Human Services under Contract HHSN272200700058C (to W. F. A.). Use of the Advanced Photon Source was supported by the U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Use of the Life Science Collaborative Access Team Sector 21 was supported in part by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor Grant 085P1000817. FT-MS services were provided by the Chicago Biomedical Consortium-University of Illinois, Chicago Research Resources Center, which was established by funds from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium. Supported in part by a development project from National Institute of Health Grant U54 AI057153 to Great Lakes (Region V) Regional Center for Excellence in Biodefense and Emerging Infectious Diseases Research. Supported in part by a Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Disease Award.	Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; FRENCH PJ, 1991, P ROY SOC B-BIOL SCI, V245, P193, DOI 10.1098/rspb.1991.0109; Fullner KJ, 2000, EMBO J, V19, P5315, DOI 10.1093/emboj/19.20.5315; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Siebold C, 2005, P NATL ACAD SCI USA, V102, P16836, DOI 10.1073/pnas.0504997102; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Winn MD, 2002, ACTA CRYSTALLOGR D, V58, P1929, DOI 10.1107/S0907444902016116	38	64	74	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26557	26568		10.1074/jbc.M109.025510	http://dx.doi.org/10.1074/jbc.M109.025510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19620709	hybrid, Green Published			2022-12-27	WOS:000269969600037
J	Tchesnokov, EP; Obikhod, A; Schinazi, RF; Gotte, M				Tchesnokov, Egor P.; Obikhod, Aleksandr; Schinazi, Raymond F.; Gotte, Matthias			Engineering of a Chimeric RB69 DNA Polymerase Sensitive to Drugs Targeting the Cytomegalovirus Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; IMMUNODEFICIENCY-VIRUS TYPE-1; CATALYTIC SUBUNIT UL54; ANTIVIRAL DRUGS; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; RATCHET MODEL; UL97 PROTEIN; RESISTANCE; INHIBITION	Detailed structural and biochemical studies with the human cytomegalovirus(HCMVUL54) DNA polymerase are hampered by difficulties to obtain this enzyme in large quantities. The crystal structure of the related RB69 DNA polymerase (gp43) is often used as a model system to explain mechanisms of inhibition of DNA synthesis and drug resistance. However, here we demonstrate that gp43 is similar to 400-fold less sensitive to the pyrophosphate analog foscarnet, when compared with UL54. The RB69 enzyme is also able to discriminate against the nucleotide analog inhibitor acyclovir. In contrast, the HCMV polymerase is able to incorporate this compound with similar efficiency as observed with its natural counterpart. In an attempt to identify major determinants for drug activity, we replaced critical regions of the nucleotide-binding site of gp43 with equivalent regions of the HCMV enzyme. We show that chimeric gp43-UL54 enzymes that contain residues of helix N and helix P of UL54 are resensitized against foscarnet and acyclovir. Changing a region of three amino acids of helix N showed the strongest effects, and changes of two segments of three amino acids in helix P further contributed to the reversal of the phenotype. The engineered chimeric enzyme can be produced in large quantities and may therefore be a valuable surrogate system in drug development efforts. This system may likewise be used for detailed structural and biochemical studies on mechanisms associated with drug action and resistance.	[Tchesnokov, Egor P.; Gotte, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Obikhod, Aleksandr; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res, Atlanta, GA 30322 USA; [Obikhod, Aleksandr; Schinazi, Raymond F.] Vet Affairs Med Res, Atlanta, GA 30322 USA	McGill University; Emory University	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca			National Institutes of Health [5R37-AI-041980, 4R37-AI-025899]; Canadian Institutes for Health Research; United States Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI025899, R37AI041980, P30AI050409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R37-AI-041980 and 4R37-AI-025899 (to R. F. S.). This work was also supported by the Canadian Institutes for Health Research (to M. G.) and by the United States Department of Veterans Affairs (to R. F. S.).	Andrei G, 2008, CURR OPIN INVEST DR, V9, P132; Baldanti F, 1995, SCAND J INFECT DIS, P103; Baldanti F, 2004, HUM IMMUNOL, V65, P403, DOI 10.1016/j.humimm.2004.02.007; Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; BIRON KK, 1985, P NATL ACAD SCI USA, V82, P2473, DOI 10.1073/pnas.82.8.2473; BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Burgess K, 2000, CHEM REV, V100, P2047, DOI 10.1021/cr990045m; Chaudhuri M, 2003, J BIOL CHEM, V278, P8996, DOI 10.1074/jbc.M210023200; Cihlar T, 1998, VIROLOGY, V248, P382, DOI 10.1006/viro.1998.9299; Cihlar T, 1998, J VIROL, V72, P5927, DOI 10.1128/JVI.72.7.5927-5936.1998; Cihlar T, 1996, MOL PHARMACOL, V50, P1502; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; Copeiand R. A., 2005, EVALUATION ENZYME IN, P34; Copeland RA, 2000, ENZYMES PRACTICAL IN, P109; De Clercq E, 2005, NAT REV DRUG DISCOV, V4, P928, DOI 10.1038/nrd1877; De Clercq E, 2003, J ANTIMICROB CHEMOTH, V51, P1079, DOI 10.1093/jac/dkg205; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; DERSE D, 1981, J BIOL CHEM, V256, P1447; Deval J, 2005, J BIOL CHEM, V280, P3838, DOI 10.1074/jbc.M411559200; Deval J, 2009, DRUGS, V69, P151, DOI 10.2165/00003495-200969020-00002; Diallo K, 2003, ANTIMICROB AGENTS CH, V47, P3377, DOI 10.1128/AAC.47.11.3377-3383.2003; Ducancelle A, 2005, J VIROL METHODS, V125, P145, DOI 10.1016/j.jviromet.2005.01.005; ERIKSSON BFH, 1989, ANTIMICROB AGENTS CH, V33, P663, DOI 10.1128/AAC.33.5.663; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; FURMAN PA, 1984, J BIOL CHEM, V259, P9575; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Gilbert C, 2005, ANTIMICROB AGENTS CH, V49, P873, DOI 10.1128/AAC.49.3.873-883.2005; Gilbert C, 2002, DRUG RESIST UPDATE, V5, P88, DOI 10.1016/S1368-7646(02)00021-3; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Gotte M, 2000, DRUG RESIST UPDATE, V3, P30, DOI 10.1054/drup.2000.0126; Gotte Matthias, 2004, Expert Rev Anti Infect Ther, V2, P707, DOI 10.1586/14789072.2.5.707; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Griffiths PD, 2005, CURR OPIN INFECT DIS, V18, P241, DOI 10.1097/01.qco.0000168385.39390.1b; Hassan J, 2007, CLIN EXP IMMUNOL, V149, P205, DOI 10.1111/j.1365-2249.2007.03454.x; HO HT, 1992, MOL PHARMACOL, V41, P197; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Huang L, 1999, P NATL ACAD SCI USA, V96, P447, DOI 10.1073/pnas.96.2.447; KATI WM, 1992, J BIOL CHEM, V267, P25988; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; LITTLER E, 1992, NATURE, V358, P160, DOI 10.1038/358160a0; Liu SP, 2006, J BIOL CHEM, V281, P18193, DOI 10.1074/jbc.M602414200; Ljungman P, 2002, J INFECT DIS, V186, pS99, DOI 10.1086/342962; Loregian A, 2004, J VIROL, V78, P158, DOI 10.1128/JVI.78.1.158-167.2004; Loregian A, 2003, J VIROL, V77, P8336, DOI 10.1128/JVI.77.15.8336-8344.2003; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Mercorelli B, 2008, REV MED VIROL, V18, P177, DOI 10.1002/rmv.558; OBERG B, 1989, PHARMACOL THERAPEUT, V40, P213, DOI 10.1016/0163-7258(89)90097-1; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pescovitz MD, 2000, ANTIMICROB AGENTS CH, V44, P2811, DOI 10.1128/AAC.44.10.2811-2815.2000; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picard-Jean F, 2007, BIOCHEM J, V407, P331, DOI 10.1042/BJ20070853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; REID R, 1988, J BIOL CHEM, V263, P3898; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Shi R, 2006, PROTEINS, V64, P301, DOI 10.1002/prot.21005; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; SULLIVAN V, 1992, NATURE, V358, P162, DOI 10.1038/358162a0; Talarico CL, 1999, ANTIMICROB AGENTS CH, V43, P1941, DOI 10.1128/AAC.43.8.1941; Tchesnokov EP, 2006, J VIROL, V80, P1440, DOI 10.1128/JVI.80.3.1440-1450.2006; WAGSTAFF AJ, 1994, DRUGS, V48, P199, DOI 10.2165/00003495-199448020-00007; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Xiong XF, 1997, ANTIMICROB AGENTS CH, V41, P594, DOI 10.1128/AAC.41.3.594; Yang GW, 2002, BIOCHEMISTRY-US, V41, P2526, DOI 10.1021/bi0119924; Yang GW, 1999, BIOCHEMISTRY-US, V38, P8094, DOI 10.1021/bi990653w; Zimmermann A, 1997, ANTIVIR RES, V36, P35, DOI 10.1016/S0166-3542(97)00034-X	72	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26439	26446		10.1074/jbc.M109.012500	http://dx.doi.org/10.1074/jbc.M109.012500			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19622750	hybrid, Green Published			2022-12-27	WOS:000269969600025
J	Mizuguchi, M; Asao, H; Hara, T; Higuchi, M; Fujii, M; Nakamura, M				Mizuguchi, Mariko; Asao, Hironobu; Hara, Toshifumi; Higuchi, Masaya; Fujii, Masahiro; Nakamura, Masataka			Transcriptional Activation of the Interleukin-21 Gene and Its Receptor Gene by Human T-cell Leukemia Virus Type 1 Tax in Human T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LONG TERMINAL REPEAT; HTLV-I TAX; CONSTITUTIVE ACTIVATION; MONOCLONAL-ANTIBODIES; TRANSACTIVATOR GENE; GAMMA-CHAIN; EXPRESSION; PROTEIN; IL-21	At the incipient stages of the development of adult T-cell leukemia, T-cells infected with human T-cell leukemia virus type 1 (HTLV-1) suffer disregulation in cell growth caused by aberrant expression of host genes by the HTLV-1 transactivator protein Tax (Tax1). Tax1-mediated growth promotion is thought to result from, at least in part, up-regulation of genes for growth factors and their receptors that induce T-cell growth. In the present study, we demonstrate that Tax1 transactivates the interleukin-21 (IL-21) and its receptor (IL-21R) genes in human T-cells. Introduction of Tax1 via recombinant adenoviruses induced expression of endogenous IL-21 and IL-21R. Isolated promoters of the IL-21 and IL-21R genes were activated by Tax1 in reporter assays, which further revealed that there were at least two Tax1-responsive elements in either the IL-21 promoter or the IL-21R promoter. Chromatin immunoprecipitation assay and gel mobility shift assay exhibited that the IL-21 promoter elements bound transcription factors AP-1 and NF-kappa B, and the IL-21R promoter elements were associated with AP-1 and interferon regulatory factor. Collectively, Tax1-dependent activation of these transcriptional factors presumably contributes to expression of the IL-21 gene and its receptor gene. The related virus HTLV-2 with Tax2 similar to Tax1 is known not to be pathogenic. Tax2 exhibited little, if any, or no induction of the IL-21 transcription in CD4(+) T-cells, in contrast to Tax1. The study suggests insights into cytokine-dependent aberrant growth of HTLV-1-infected T-cells and the molecular basis of different pathogenicity between HTLV-1 and HTLV-2.	[Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, Tokyo 1138510, Japan; [Asao, Hironobu] Yamagata Univ, Fac Med, Dept Immunol, Yamagata 9909585, Japan; [Higuchi, Masaya; Fujii, Masahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, Niigata 9518510, Japan	Tokyo Medical & Dental University (TMDU); Yamagata University; Niigata University	Nakamura, M (corresponding author), Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	naka.gene@tmd.ac.jp	Higuchi, Masaya/L-2111-2019		Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akagi T, 1996, ONCOGENE, V12, P1645; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; Bowman, 1999, Cancer Control, V6, P615; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; GESSAIN A, 1985, LANCET, V2, P407; Good LF, 1996, EMBO J, V15, P3744, DOI 10.1002/j.1460-2075.1996.tb00744.x; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Hall WW, 2005, ONCOGENE, V24, P5965, DOI 10.1038/sj.onc.1208975; Haller K, 2002, MOL CELL BIOL, V22, P3327, DOI 10.1128/MCB.22.10.3327-3338.2002; Haller K, 2000, AIDS RES HUM RETROV, V16, P1683, DOI 10.1089/08892220050193146; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; HIRAI H, 1992, ONCOGENE, V7, P1737; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEE B, 1989, TOHOKU J EXP MED, V157, P1, DOI 10.1620/tjem.157.1; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Lewis MJ, 2000, VIROLOGY, V271, P142, DOI 10.1006/viro.2000.0284; Mariner JM, 2002, J IMMUNOL, V168, P5667, DOI 10.4049/jimmunol.168.11.5667; Mariner JM, 2001, J IMMUNOL, V166, P2602, DOI 10.4049/jimmunol.166.4.2602; Matsumoto K, 1997, J VIROL, V71, P4445, DOI 10.1128/JVI.71.6.4445-4451.1997; MCGUIRE KL, 1993, J VIROL, V67, P1590, DOI 10.1128/JVI.67.3.1590-1599.1993; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Mori N, 1999, BLOOD, V93, P2360; Mori N, 2000, BLOOD, V95, P3915; NAKAMURA M, 1989, J BIOL CHEM, V264, P20189; Niinuma A, 2005, J VIROL, V79, P11925, DOI 10.1128/JVI.79.18.11925-11934.2005; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; OHBO K, 1995, J BIOL CHEM, V270, P7479, DOI 10.1074/jbc.270.13.7479; Ohtani K, 2000, J BIOL CHEM, V275, P11154, DOI 10.1074/jbc.275.15.11154; OHTANI K, 1987, EMBO J, V6, P389, DOI 10.1002/j.1460-2075.1987.tb04767.x; OHTANI K, 1989, NUCLEIC ACIDS RES, V17, P1589, DOI 10.1093/nar/17.4.1589; Ohtani K, 2003, GANN MONOGR CANC RES, P43; Onoda T, 2007, INT IMMUNOL, V19, P1191, DOI 10.1093/intimm/dxm090; OSAME M, 1986, LANCET, V1, P1031; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rahman M, 2007, FEBS LETT, V581, P4001, DOI 10.1016/j.febslet.2007.07.034; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Ross TM, 1996, J VIROL, V70, P5194, DOI 10.1128/JVI.70.8.5194-5202.1996; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Sharma S, 2002, J IMMUNOL, V169, P3120, DOI 10.4049/jimmunol.169.6.3120; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Takahashi Y, 2000, GENE DEV, V14, P804; TANAKA Y, 1991, INT J CANCER, V48, P623, DOI 10.1002/ijc.2910480423; TANAKA Y, 1986, MICROBIOL IMMUNOL, V30, P373, DOI 10.1111/j.1348-0421.1986.tb00954.x; Ueda M, 2005, BRIT J HAEMATOL, V128, P169, DOI 10.1111/j.1365-2141.2004.05255.x; White LC, 1996, IMMUNITY, V5, P365, DOI 10.1016/S1074-7613(00)80262-9; Wu Z, 2005, MOL CELL BIOL, V25, P9741, DOI 10.1128/MCB.25.22.9741-9752.2005; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973	58	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25501	25511		10.1074/jbc.M109.010959	http://dx.doi.org/10.1074/jbc.M109.010959			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617351	hybrid, Green Published			2022-12-27	WOS:000269738000007
J	Engqvist, M; Drincovich, MF; Flugge, UI; Maurino, VG				Engqvist, Martin; Drincovich, Maria F.; Fluegge, Ulf-Ingo; Maurino, Veronica G.			Two D-2-Hydroxy-acid Dehydrogenases in Arabidopsis thaliana with Catalytic Capacities to Participate in the Last Reactions of the Methylglyoxal and beta-Oxidation Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-LACTATE DEHYDROGENASE; ELECTRON-TRANSFER FLAVOPROTEIN; ALPHA-HYDROXYGLUTARIC ACID; GLYOXALASE-II; MITOCHONDRIA; GENE; ENZYME; D-2-HYDROXYGLUTARATE; METABOLISM; SYSTEM	The Arabidopsis thaliana locus At5g06580 encodes an ortholog to Saccharomyces cerevisiae D-lactate dehydrogenase (AtD-LDH). The recombinant protein is a homodimer of 59-kDa subunits with one FAD per monomer. A substrate screen indicated that AtD-LDH catalyzes the oxidation of D-and L-lactate, D-2-hydroxybutyrate, glycerate, and glycolate using cytochrome c as an electron acceptor. AtD-LDH shows a clear preference for D-lactate, with a catalytic efficiency 200- and 2000-fold higher than that for L-lactate and glycolate, respectively, and a Km value for D-lactate of similar to 160 mu M. Knock-out mutants showed impaired growth in the presence of D-lactate or methylglyoxal. Collectively, the data indicated that the protein is a D-LDH that participates in planta in the methylglyoxal pathway. Web-based bioinformatic tools revealed the existence of a paralogous protein encoded by locus At4g36400. The recombinant protein is a homodimer of 61-kDa subunits with one FAD per monomer. A substrate screening revealed highly specific D-2-hydroxyglutarate (D-2HG) conversion in the presence of an organic cofactor with a K-m value of similar to 580 mu M. Thus, the enzyme was characterized as a D-2HG dehydrogenase (AtD-2HGDH). Analysis of knock-out mutants demonstrated that AtD-2HGDH is responsible for the total D-2HGDH activity present in A. thaliana. Gene coexpression analysis indicated that AtD-2HGDH is in the same network as several genes involved in beta-oxidation and degradation of branched-chain amino acids and chlorophyll. It is proposed that AtD-2HGDH participates in the catabolism of D-2HG most probably during the mobilization of alternative substrates from proteolysis and/or lipid degradation.	[Engqvist, Martin; Fluegge, Ulf-Ingo; Maurino, Veronica G.] Univ Cologne, Inst Bot, D-50931 Cologne, Germany; [Drincovich, Maria F.] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, RA-2000 Rosario, Argentina	University of Cologne; National University of Rosario	Maurino, VG (corresponding author), Univ Cologne, Inst Bot, Gyrhofstr 15, D-50931 Cologne, Germany.	v.maurino@uni-koeln.de	Drincovich, Maria F/F-3902-2017; Drincovich, Maria F/Q-4195-2019	Drincovich, Maria F/0000-0003-4897-3285; Drincovich, Maria F/0000-0003-4897-3285; Engqvist, Martin/0000-0003-2174-2225	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a Deutsche Forschungsgemeinschaft grant (to V. G. M.).	Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Arai Y, 2002, PLANT CELL PHYSIOL, V43, P555, DOI 10.1093/pcp/pcf068; Atlante A, 2005, BBA-BIOENERGETICS, V1708, P13, DOI 10.1016/j.bbabio.2005.03.003; Bari R, 2004, J EXP BOT, V55, P623, DOI 10.1093/jxb/erh079; BLEIWEIS AS, 1967, J BACTERIOL, V94, P1560, DOI 10.1128/JB.94.5.1560-1564.1967; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCKMAN HL, 1975, J BACTERIOL, V124, P1454, DOI 10.1128/JB.124.3.1454-1461.1975; CAMMACK R, 1969, BIOCHEM J, V115, P55, DOI 10.1042/bj1150055; Carlier JP, 1997, LETT APPL MICROBIOL, V25, P371, DOI 10.1046/j.1472-765X.1997.00245.x; Chelstowska A, 1999, YEAST, V15, P1377, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1377::AID-YEA473>3.0.CO;2-0; Cristescu ME, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-268; de Bari L, 2005, BIOCHEM BIOPH RES CO, V335, P1224, DOI 10.1016/j.bbrc.2005.08.022; Fahnenstich H, 2008, PLANT PHYSIOL, V148, P719, DOI 10.1104/pp.108.126789; Fernandez-Checa Jose C., 1993, P363; Frerman F. E., 2001, METABOLIC MOL BASES, P2357, DOI DOI 10.1036/OMMBID.131; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; GREGOLIN C, 1963, BIOCHIM BIOPHYS ACTA, V67, P201; Hammer VA, 1996, J NUTR, V126, P2218, DOI 10.1093/jn/126.9.2218; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Horikiri S, 2004, BIOSCI BIOTECH BIOCH, V68, P516, DOI 10.1271/bbb.68.516; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Ishizaki K, 2006, PLANT J, V47, P751, DOI 10.1111/j.1365-313X.2006.02826.x; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Keech O, 2005, PHYSIOL PLANTARUM, V124, P403, DOI 10.1111/j.1399-3054.2005.00521.x; LABEYRIE F, 1964, B SOC CHIM BIOL, V46, P1793; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CP, 2008, MOL CELL PROTEOMICS, V7, P1297, DOI 10.1074/mcp.M700535-MCP200; LINDAHL G, 1967, ARCH BIOCHEM BIOPHYS, V119, P347, DOI 10.1016/0003-9861(67)90463-8; LODI T, 1991, MOL CELL BIOL, V11, P3762, DOI 10.1128/MCB.11.7.3762; LODI T, 1993, MOL GEN GENET, V238, P315, DOI 10.1007/BF00291989; LODI T, 1994, MOL GEN GENET, V244, P622, DOI 10.1007/BF00282752; Lucas KA, 2007, J BIOL CHEM, V282, P24980, DOI 10.1074/jbc.M701028200; Maiti MK, 1997, PLANT MOL BIOL, V35, P471, DOI 10.1023/A:1005891123344; MIZUSHIMA S, 1964, J GEN APPL MICROBIOL, V10, P33, DOI 10.2323/jgam.10.33; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; OGATA M, 1981, J BIOCHEM-TOKYO, V89, P1423, DOI 10.1093/oxfordjournals.jbchem.a133334; Parker A, 2000, BIOCHEM J, V345, P429, DOI 10.1042/0264-6021:3450429; Passarella S, 2008, FEBS LETT, V582, P3569, DOI 10.1016/j.febslet.2008.09.042; Pracharoenwattana I, 2005, PLANT CELL, V17, P2037, DOI 10.1105/tpc.105.031856; RAYMOND P, 1992, PLANT PHYSIOL BIOCH, V30, P153; Reed DW, 1999, J BACTERIOL, V181, P7580, DOI 10.1128/JB.181.24.7580-7587.1999; REEVES HC, 1962, J BACTERIOL, V84, P186, DOI 10.1128/JB.84.1.186-187.1962; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Singla-Pareek SL, 2008, TRANSGENIC RES, V17, P171, DOI 10.1007/s11248-007-9082-2; Struys EA, 2006, J INHERIT METAB DIS, V29, P21, DOI 10.1007/s10545-006-0317-9; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Struys EA, 2004, FEBS LETT, V557, P115, DOI 10.1016/S0014-5793(03)01459-5; SUN ZY, 1995, BBA-PROTEIN STRUCT M, V1252, P269, DOI 10.1016/0167-4838(95)00120-J; TALESA V, 1990, BIOCHEM INT, V22, P1115; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; TUBBS PK, 1961, BIOCHEM J, V81, P104, DOI 10.1042/bj0810104; van den Brink DM, 2004, MOL GENET METAB, V82, P33, DOI 10.1016/j.ymgme.2004.01.019; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu Y, 2006, J BIOL CHEM, V281, P26702, DOI 10.1074/jbc.M604758200; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zolman BK, 2001, J BIOL CHEM, V276, P31037, DOI 10.1074/jbc.M104679200	59	97	101	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25026	25037		10.1074/jbc.M109.021253	http://dx.doi.org/10.1074/jbc.M109.021253			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19586914	hybrid, Green Published			2022-12-27	WOS:000269734000038
J	Epis, MR; Giles, KM; Barker, A; Kendrick, TS; Leedman, PJ				Epis, Michael R.; Giles, Keith M.; Barker, Andrew; Kendrick, Tulene S.; Leedman, Peter J.			miR-331-3p Regulates ERBB-2 Expression and Androgen Receptor Signaling in Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; MICRORNA EXPRESSION; MESSENGER-RNA; PHOSPHO-AKT; TRASTUZUMAB; PROGRESSION; MODULATION; INHIBITION; HER-2/NEU; MECHANISM	MicroRNAs (miRNAs) are short, non-coding RNAs that regulate gene expression and are aberrantly expressed in human cancer. The ERBB-2 tyrosine kinase receptor is frequently over-expressed in prostate cancer and is associated with disease progression and poor survival. We have identified two specific miR-331-3p target sites within the ERBB-2 mRNA 3'-untranslated region and show that miR-331-3p expression is decreased in prostate cancer tissue relative to normal adjacent prostate tissue. Transfection of multiple prostate cancer cell lines with miR-331-3p reduced ERBB-2 mRNA and protein expression and blocked downstream phosphatidylinositol 3-kinase/AKT signaling. Furthermore, miR-331-3p transfection blocked the androgen receptor signaling pathway in prostate cancer cells, reducing activity of an androgen-stimulated prostate-specific antigen promoter and blocking prostate-specific antigen expression. Our findings provide insight into the regulation of ERBB-2 expression in cancer and suggest that miR-331-3p has the capacity to regulate signaling pathways critical to the development and progression of prostate cancer cells.	Univ Western Australia, Lab Canc Med, Med Res Ctr, Western Australian Inst Med Res, Perth, WA 6000, Australia; Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6000, Australia	University of Western Australia; University of Western Australia	Leedman, PJ (corresponding author), Level 6,MRF Bldg,Rear 50 Murray St, Perth, WA 6000, Australia.	peterl@waimr.uwa.edu.au	Leedman, Peter J/O-4044-2014; Barker, Andrew/A-4289-2013		National Health and Medical Research Council of Australia; Cancer Council of Western Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia(Cancer Council Western Australia)	This work was supported by the National Health and Medical Research Council of Australia and the Cancer Council of Western Australia.	Albanell J, 2003, ADV EXP MED BIOL, V532, P253; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco AR, 2004, J CHEMOTHERAPY, V16, P52, DOI 10.1179/joc.2004.16.Supplement-1.52; Bradbury J, 2007, LANCET ONCOL, V8, P287, DOI 10.1016/S1470-2045(07)70090-6; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Festuccia C, 2008, INT J ONCOL, V33, P381, DOI 10.3892/ijo_00000019; Festuccia C, 2007, ENDOCR-RELAT CANCER, V14, P601, DOI 10.1677/ERC-07-0118; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Gravina GL, 2009, UROLOGY, V74, P452, DOI 10.1016/j.urology.2009.01.018; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Isharwal S, 2008, INT J CANCER, V123, P2636, DOI 10.1002/ijc.23838; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Liu YB, 2005, CANCER RES, V65, P3404, DOI 10.1158/0008-5472.CAN-04-4292; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Selcuklu SD, 2009, CANCER GENET CYTOGEN, V189, P15, DOI 10.1016/j.cancergencyto.2008.09.009; Shi XB, 2004, PROSTATE, V60, P257, DOI 10.1002/pros.20039; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Small EJ, 2001, SEMIN ONCOL, V28, P71, DOI 10.1053/sonc.2001.26908; Solit DB, 2007, J CLIN ONCOL, V25, P241, DOI 10.1200/JCO.2006.08.8187; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Vernimmen D, 2003, BRIT J CANCER, V89, P899, DOI 10.1038/sj.bjc.6601200; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	54	131	137	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24696	24704		10.1074/jbc.M109.030098	http://dx.doi.org/10.1074/jbc.M109.030098			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584056	Green Published, hybrid			2022-12-27	WOS:000269734000004
J	Pike, JE; Burgers, PMJ; Campbell, JL; Bambara, RA				Pike, Jason E.; Burgers, Peter M. J.; Campbell, Judith L.; Bambara, Robert A.			Pif1 Helicase Lengthens Some Okazaki Fragment Flaps Necessitating Dna2 Nuclease/Helicase Action in the Two-nuclease Processing Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; ENDONUCLEASE ACTIVITY; PRIMER REMOVAL; LIGATABLE NICK; YEAST; MATURATION	We have developed a system to reconstitute all of the proposed steps of Okazaki fragment processing using purified yeast proteins and model substrates. DNA polymerase delta was shown to extend an upstream fragment to displace a downstream fragment into a flap. In most cases, the flap was removed by flap endonuclease 1 (FEN1), in a reaction required to remove initiator RNA in vivo. The nick left after flap removal could be sealed by DNA ligase I to complete fragment joining. An alternative pathway involving FEN1 and the nuclease/helicase Dna2 has been proposed for flaps that become long enough to bind replication protein A (RPA). RPA binding can inhibit FEN1, but Dna2 can shorten RPA-bound flaps so that RPA dissociates. Recent reconstitution results indicated that Pif1 helicase, a known component of fragment processing, accelerated flap displacement, allowing the inhibitory action of RPA. In results presented here, Pif1 promoted DNA polymerase delta to displace strands that achieve a length to bind RPA, but also to be Dna2 substrates. Significantly, RPA binding to long flaps inhibited the formation of the final ligation products in the reconstituted system without Dna2. However, Dna2 reversed that inhibition to restore efficient ligation. These results suggest that the two-nuclease pathway is employed in cells to process long flap intermediates promoted by Pif1.	[Pike, Jason E.; Bambara, Robert A.] Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14642 USA; [Burgers, Peter M. J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; Washington University (WUSTL); California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_bambara@urmc.rochester.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM024441, GM087666, GM32431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM024441 (to R.A.B.), with additional support from Grants GM087666 ( to J.L.C.), and GM32431 (to P.M.B.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bessler JB, 2001, TRENDS CELL BIOL, V11, P60, DOI 10.1016/S0962-8924(00)01877-8; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Johansson E, 2004, J BIOL CHEM, V279, P22204, DOI 10.1074/jbc.M402652200; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kornberg A., 1992, DNA REPLICATION, VSecond, P113; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; Zhou JQ, 2002, MOL BIOL CELL, V13, P2180, DOI 10.1091/mbc.02-02-0021	38	81	84	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25170	25180		10.1074/jbc.M109.023325	http://dx.doi.org/10.1074/jbc.M109.023325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605347	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000269734000051
J	Shiozawa, K; Konarev, PV; Neufeld, C; Wilmanns, M; Svergun, DI				Shiozawa, Kumiko; Konarev, Petr V.; Neufeld, Christian; Wilmanns, Matthias; Svergun, Dmitri I.			Solution Structure of Human Pex5.Pex14.PTS1 Protein Complexes Obtained by Small Angle X-ray Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTOR PEX5P; PEROXISOMAL CYCLING RECEPTOR; TARGETING SIGNAL-1 RECEPTOR; BIOLOGICAL MACROMOLECULES; SYNCHROTRON-RADIATION; RECOGNITION; MEMBRANE; TRANSLOCATION; DOMAINS; PEX14	The Pex5p receptor recognizes newly synthesized peroxisomal matrix proteins which have a C-terminal peroxisomal targeting signal to the peroxisome. After docking to protein complexes on the membrane, these proteins are translocated across the membrane. The docking mechanism remains unclear, as no structural data on the multicomponent docking complex are available. As the interaction of the cargo-loaded Pex5p receptor and the peroxisomal membrane protein Pex14p is the essential primary docking step, we have investigated the solution structure of these complexes by small angle x-ray scattering and static light scattering. Titration studies yielded a 1:6 stoichiometry for the Pex5p.Pex14p complex, and low resolution structural models were reconstructed from the x-ray scattering data. The free full-length human Pex5p is monomeric in solution, with an elongated, partially unfolded N-terminal domain. The model of the complex reveals that the N terminus of Pex5p remains extended in the presence of cargo and Pex14p, the latter proteins being significantly intermingled with the Pex5p moiety. These results suggest that the extended structure of Pex5p may play a role in interactions with other substrates such as lipids and membrane proteins during the formation of functional multiprotein complexes.	[Shiozawa, Kumiko; Konarev, Petr V.; Neufeld, Christian; Wilmanns, Matthias; Svergun, Dmitri I.] DESY, European Mol Biol Lab Hamburg Outstn, D-22603 Hamburg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Svergun, DI (corresponding author), DESY, European Mol Biol Lab Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.	svergun@embl-hamburg.de	Konarev, Petr V/W-1380-2017	Svergun, Dmitri/0000-0003-0830-5696; Konarev, Petr/0000-0002-5606-1596; Wilmanns, Matthias/0000-0002-4643-5435	European Commission [LSHG-CT-2005512028]	European Commission(European CommissionEuropean Commission Joint Research Centre)	Supported by Integrated Project 3D Repertoire LSHG-CT-2005512028 from the European Commission (to M.W.).	Azevedo JE, 2006, BBA-MOL CELL RES, V1763, P1574, DOI 10.1016/j.bbamcr.2006.09.002; Brown LA, 2003, J CELL MOL MED, V7, P388, DOI 10.1111/j.1582-4934.2003.tb00241.x; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Colby R.H., 2003, POLYM PHYS; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kumar A, 2001, J MOL BIOL, V307, P271, DOI 10.1006/jmbi.2000.4465; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Moscicka KB, 2007, FEBS LETT, V581, P1758, DOI 10.1016/j.febslet.2007.03.061; Neufeld C, 2009, EMBO J, V28, P745, DOI 10.1038/emboj.2009.7; Nito K, 2002, PLANT CELL PHYSIOL, V43, P355, DOI 10.1093/pcp/pcf057; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Porod G, 1982, GEN THEORY SMALL ANG, P17; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Stanley WA, 2004, J SYNCHROTRON RADIAT, V11, P490, DOI 10.1107/S090904950402504X; Stanley WA, 2007, FEBS LETT, V581, P4795, DOI 10.1016/j.febslet.2007.09.001; Stanley WA, 2007, ARCH BIOCHEM BIOPHYS, V461, P50, DOI 10.1016/j.abb.2007.02.026; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345	42	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25334	25342		10.1074/jbc.M109.002311	http://dx.doi.org/10.1074/jbc.M109.002311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584060	Green Published, hybrid			2022-12-27	WOS:000269734000066
J	Thompson, D; Hakala, K; DeMartino, GN				Thompson, David; Hakala, Kevin; DeMartino, George N.			Subcomplexes of PA700, the 19 S Regulator of the 26 S Proteasome, Reveal Relative Roles of AAA Subunits in 26 S Proteasome Assembly and Activation and ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; 20S PROTEASOME; DEPENDENT ACTIVATOR; CORE PARTICLE; PURIFICATION; DEGRADATION; PATHWAY; COMPLEX; BINDING; RECOGNITION	We have identified, purified, and characterized three subcomplexes of PA700, the 19 S regulatory complex of the 26 S proteasome. These subcomplexes (denoted PS-1, PS-2, and PS-3) collectively account for all subunits present in purified PA700 but contain no overlapping components or significant levels of non-PA700 proteins. Each subcomplex contained two of the six AAA subunits (Rpt1-6) that form the binding interface of PA700 with the 20 S proteasome, the protease component of the 26 S proteasome. Unlike intact PA700, no individual PA700 subcomplex displayed ATPase activity or proteasome activating activity. However, both activities were manifested by ATP-dependent in vitro reconstitution of PA700 from the subcomplexes. We exploited functional reconstitution to define and distinguish roles of different PA700 subunits in PA700 function by selective alteration of subunits within individual subcomplexes prior to reconstitution. Carboxypeptidase treatment of either PS-2 or PS-3, subcomplexes containing specific Rpt subunits previously shown to have important roles in 26 S proteasome assembly and activation, inhibited these processes but did not affect PA700 reconstitution or ATPase activity. Thus, the intact C termini of both subunits are required for 26 S proteasome assembly and activation but not for PA700 reconstitution. Surprisingly, carboxypeptidase treatment of PS-1 also inhibited 26 S proteasome assembly and activation upon reconstitution with untreated PS-2 and PS-3. These results suggest a previously unidentified role for other PA700 subunits in 26 S proteasome assembly and activation. Our results reveal relative structural and functional relationships among the AAA subunits of PA700 and new insights about mechanisms of 26 S proteasome assembly and activation.	[Thompson, David; Hakala, Kevin; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	HHgeorge.demartino@utsouthwestern.edu			National Institutes of Health [R01 DK46181]; The Welch Foundation [I-500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK46181. This work was also supported by The Welch Foundation Grant I-500 (to G.N.D.).	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Chen CA, 2008, PROTEOMICS, V8, P508, DOI 10.1002/pmic.200700588; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Hastings R, 1999, MOL BIOL REP, V26, P35, DOI 10.1023/A:1006903903534; Hastings RA, 1999, J BIOL CHEM, V274, P25691, DOI 10.1074/jbc.274.36.25691; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; MA CP, 1994, J BIOL CHEM, V269, P3539; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramos PC, 2008, STRUCTURE, V16, P1296, DOI 10.1016/j.str.2008.07.001; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; RYAN CA, 1974, J BIOL CHEM, V249, P5495; Saeki Y, 2000, BIOCHEM BIOPH RES CO, V273, P509, DOI 10.1006/bbrc.2000.2980; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Seong KM, 2007, FEBS LETT, V581, P2567, DOI 10.1016/j.febslet.2007.04.064; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	74	45	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24891	24903		10.1074/jbc.M109.023218	http://dx.doi.org/10.1074/jbc.M109.023218			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19589775	Green Published, hybrid			2022-12-27	WOS:000269734000023
J	Young, DC; Kasmar, A; Moraski, G; Cheng, TY; Walz, AJ; Hu, JD; Xu, YP; Endres, GW; Uzieblo, A; Zajonc, D; Costello, CE; Miller, MJ; Moody, DB				Young, David C.; Kasmar, Anne; Moraski, Garrett; Cheng, Tan-Yun; Walz, Andrew J.; Hu, Jingdan; Xu, Yanping; Endres, Gregory W.; Uzieblo, Adam; Zajonc, Dirk; Costello, Catherine E.; Miller, Marvin J.; Moody, D. Branch			Synthesis of Dideoxymycobactin Antigens Presented by CD1a Reveals T Cell Fine Specificity for Natural Lipopeptide Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE PEPTIDE-SYNTHESIS; SOLID-PHASE; AMINO-ACIDS; MYCOBACTERIUM-TUBERCULOSIS; ANTIMYCOBACTERIAL AGENTS; DENDRITIC CELLS; RECOGNITION; IRON; SIDEROPHORE; ANALOGS	Mycobacterium tuberculosis survival in cells requires mycobactin siderophores. Recently, the search for lipid antigens presented by the CD1a antigen-presenting protein led to the discovery of a mycobactin-like compound, dideoxymycobactin (DDM). Here we synthesize DDMs using solution phase and solid phase peptide synthesis chemistry. Comparison of synthetic standards to natural mycobacterial mycobactins by nuclear magnetic resonance and mass spectrometry allowed identification of an unexpected alpha-methyl serine unit in natural DDM. This finding further distinguishes these pre-siderophores as foreign compounds distinct from conventional peptides, and we provide evidence that this chemical variation influences the T cell response. One synthetic DDM recapitulated natural structures and potently stimulated T cells, making it suitable for patient studies of CD1a in infectious disease. DDM analogs differing in the stereochemistry of their butyrate or oxazoline moieties were not recognized by human T cells. Therefore, we conclude that T cells show precise specificity for both arms of the peptide, which are predicted to lie at the CD1a-T cell receptor interface.	[Young, David C.; Kasmar, Anne; Cheng, Tan-Yun; Moody, D. Branch] Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Moraski, Garrett; Walz, Andrew J.; Hu, Jingdan; Xu, Yanping; Miller, Marvin J.] Univ Notre Dame, Dept Chem, Notre Dame, IN 46556 USA; [Moraski, Garrett; Walz, Andrew J.; Hu, Jingdan; Xu, Yanping; Miller, Marvin J.] Univ Notre Dame, Dept Biochem, Notre Dame, IN 46556 USA; [Endres, Gregory W.; Uzieblo, Adam] Cayman Chem Co, Ann Arbor, MI 48108 USA; [Zajonc, Dirk] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Costello, Catherine E.] Boston Univ, Sch Med, Boston, MA 02118 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Notre Dame; University of Notre Dame; La Jolla Institute for Immunology; Boston University	Moody, DB (corresponding author), Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Dept Med,Brigham & Womens Hosp, Smith Bldg,Rm 538,1 Jimmy Fund Way, Boston, MA 02115 USA.	bmoody@rics.bwh.harvard.edu	Moraski, Garrett/AAH-3616-2021	Costello, Catherine/0000-0003-1594-5122	National Institutes of Health [AI054193, AR 046832, AI 049313, AI 074952]; Cancer Research Institute; National Center for Research [P41-RR10888]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074952, R56AI074952, R01AI049313, R01AI054193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; National Center for Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI054193, AR 046832, AI 049313, and AI 074952. This work was also supported by a Cancer Research Institute Investigator Award (LIAI), National Center for Research Resources Grant P41-RR10888, and funds from the Howard Hughes Medical Institute Kwa-Zulu Natal Research Institute for Tuberculosis and HIV (K-RITH).	Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BIJVOET JM, 1951, NATURE, V168, P271, DOI 10.1038/168271a0; CHANG CD, 1978, INT J PEPT PROT RES, V11, P246; De Libero G, 2005, NAT REV IMMUNOL, V5, P485, DOI 10.1038/nri1631; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FLYNN EH, 1953, J AM CHEM SOC, V75, P5867, DOI 10.1021/ja01119a025; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; GREATBANKS D, 1969, BIOCHEM J, V115, P1047, DOI 10.1042/bj1151047; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Hu JD, 1997, J AM CHEM SOC, V119, P3462, DOI 10.1021/ja963968x; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; KAISER FE, 1974, J CHROMATOGR, V94, P113, DOI 10.1016/S0021-9673(01)92361-1; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; LEIMER KR, 1977, J CHROMATOGR, V141, P121, DOI 10.1016/S0021-9673(00)99131-3; MATSUTANI H, 1988, PHYTOCHEMISTRY, V27, P931, DOI 10.1016/0031-9422(88)84123-2; MAURER PJ, 1981, J ORG CHEM, V46, P2835, DOI 10.1021/jo00326a061; MAURER PJ, 1983, J AM CHEM SOC, V105, P240, DOI 10.1021/ja00340a017; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MERGLER M, 1988, TETRAHEDRON LETT, V29, P4009, DOI 10.1016/S0040-4039(00)80406-2; MERGLER M, 1988, TETRAHEDRON LETT, V29, P4005, DOI 10.1016/S0040-4039(00)80405-0; MERRIFIELD RB, 1964, BIOCHEMISTRY-US, V3, P1385, DOI 10.1021/bi00897a032; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Peerdeman A. F., 1951, P KONINKL NED AKAD B, VB54, P16; Phillips AJ, 2000, ORG LETT, V2, P1165, DOI 10.1021/ol005777b; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Poreddy AR, 2003, BIOORG MED CHEM LETT, V13, P2553, DOI 10.1016/S0960-894X(03)00473-6; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rosat JP, 1999, J IMMUNOL, V162, P366; Roura-Mir C, 2005, J IMMUNOL, V174, P3773, DOI 10.4049/jimmunol.174.6.3773; SERCKHANSSEN K, 1953, ARK KEMI, V5, P203; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Sieling PA, 2000, J IMMUNOL, V164, P4790, DOI 10.4049/jimmunol.164.9.4790; SNOW GA, 1969, BIOCHEM J, V115, P1031, DOI 10.1042/bj1151031; SNOW GA, 1970, BACTERIOL REV, V34, P99, DOI 10.1128/MMBR.34.2.99-125.1970; STILL WC, 1983, TETRAHEDRON LETT, V24, P4405, DOI 10.1016/S0040-4039(00)85909-2; TAKAMURA N, 1967, CHEM PHARM BULL, V15, P1776; Tsukamoto M, 1997, J ANTIBIOT, V50, P815, DOI 10.7164/antibiotics.50.815; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Van Rhijn I, 2009, J EXP MED, V206, P1409, DOI 10.1084/jem.20082480; WADSWORTH W, 1961, J AM CHEM SOC, V83, P1733, DOI 10.1021/ja01468a042; Walz AJ, 2007, ORG BIOMOL CHEM, V5, P1621, DOI 10.1039/b703116e; Xu YP, 1998, J ORG CHEM, V63, P4314, DOI 10.1021/jo980063o; Young DC, 2006, GLYCOBIOLOGY, V16, p103R, DOI 10.1093/glycob/cwj111; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009	52	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25087	25096		10.1074/jbc.M109.000802	http://dx.doi.org/10.1074/jbc.M109.000802			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605355	Green Published, hybrid			2022-12-27	WOS:000269734000043
J	Suree, N; Liew, CK; Villareal, VA; Thieu, W; Fadeev, EA; Clemens, JJ; Jung, ME; Clubb, RT				Suree, Nuttee; Liew, Chu Kong; Villareal, Valerie A.; Thieu, William; Fadeev, Evgeny A.; Clemens, Jeremy J.; Jung, Michael E.; Clubb, Robert T.			The Structure of the Staphylococcus aureus Sortase-Substrate Complex Reveals How the Universally Conserved LPXTG Sorting Signal Is Recognized	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; MAGNETIC-RESONANCE RELAXATION; NMR STRUCTURE DETERMINATION; IMIDAZOLIUM ION-PAIR; MODEL-FREE APPROACH; CELL-WALL ENVELOPE; SURFACE-PROTEINS; ACTIVE-SITE; TRANSPEPTIDASE-SRTA; KINETIC MECHANISM	In Gram-positive bacteria, sortase enzymes assemble surface proteins and pili in the cell wall envelope. Sortases catalyze a transpeptidation reaction that joins a highly conserved LPXTG sorting signal within their polypeptide substrate to the cell wall or to other pilin subunits. The molecular basis of transpeptidation and sorting signal recognition are not well understood, because the intermediates of catalysis are short lived. We have overcome this problem by synthesizing an analog of the LPXTG signal whose stable covalent complex with the enzyme mimics a key thioacyl catalytic intermediate. Here we report the solution structure and dynamics of its covalent complex with the Staphylococcus aureus SrtA sortase. In marked contrast to a previously reported crystal structure, we show that SrtA adaptively recognizes the LPXTG sorting signal by closing and immobilizing an active site loop. We have also used chemical shift mapping experiments to localize the binding site for the triglycine portion of lipid II, the second substrate to which surface proteins are attached. We propose a unified model of the transpeptidation reaction that explains the functions of key active site residues. Since the sortase-catalyzed anchoring reaction is required for the virulence of a number of bacterial pathogens, the results presented here may facilitate the development of new anti-infective agents.	[Suree, Nuttee; Liew, Chu Kong; Villareal, Valerie A.; Thieu, William; Fadeev, Evgeny A.; Clemens, Jeremy J.; Jung, Michael E.; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Suree, Nuttee; Villareal, Valerie A.; Thieu, William; Fadeev, Evgeny A.; Clubb, Robert T.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Proteom, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu	Liew, Chu Kong/H-1437-2011		National Institutes of Health [AI52217]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM075564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI52217 ( to R. T. C. and M. E. J.).	Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bruschweiler R, 2003, CURR OPIN STRUC BIOL, V13, P175, DOI 10.1016/S0959-440X(03)00036-8; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clow F, 2008, BIOTECHNOL LETT, V30, P1603, DOI 10.1007/s10529-008-9718-1; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Connolly KM, 2003, J BIOL CHEM, V278, P34061, DOI 10.1074/jbc.M305245200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W., 2006, PYMOL MOL GRAPHICS S; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Iwahara J, 2005, PROTEIN SCI, V14, P1140, DOI 10.1110/ps.041154405; Iwahara J, 2002, EMBO J, V21, P1197, DOI 10.1093/emboj/21.5.1197; Iwahara J, 2001, J BIOMOL NMR, V19, P231, DOI 10.1023/A:1011296112710; Jung ME, 2005, BIOORG MED CHEM LETT, V15, P5076, DOI 10.1016/j.bmcl.2005.07.073; Keller R., 2004, COMPUTER AIDED RESON, V1; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Mao HY, 2004, PROTEIN EXPRES PURIF, V37, P253, DOI 10.1016/j.pep.2004.06.013; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Maresso AW, 2007, J BIOL CHEM, V282, P23129, DOI 10.1074/jbc.M701857200; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	72	143	151	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24465	24477		10.1074/jbc.M109.022624	http://dx.doi.org/10.1074/jbc.M109.022624			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592495	hybrid, Green Published			2022-12-27	WOS:000269380200059
J	Yuan, FH; El Hokayem, J; Zhou, W; Zhang, YB				Yuan, Fenghua; El Hokayem, Jimmy; Zhou, Wen; Zhang, Yanbin			FANCI Protein Binds to DNA and Interacts with FANCD2 to Recognize Branched Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; ANEMIA CORE COMPLEX; DAMAGE RESPONSE; MONOUBIQUITINATED FANCD2; REPLICATION FORKS; S-PHASE; REPAIR; PATHWAY; BRCA1; IDENTIFICATION	In this study, we report that the purified wild-type FANCI (Fanconi anemia complementation group I) protein directly binds to a variety of DNA substrates. The DNA binding domain roughly encompasses residues 200-1000, as suggested by the truncation study. When co-expressed in insect cells, a small fraction of FANCI forms a stable complex with FANCD2 (Fanconi anemia complementation group D2). Intriguingly, the purified FANCI-FANCD2 complex preferentially binds to the branched DNA structures when compared with either FANCI or FANCD2 alone. Co-immunoprecipitation with purified proteins indicates that FANCI interacts with FANCD2 through its C-terminal amino acid 1001-1328 fragment. Although the C terminus of FANCI is dispensable for direct DNA binding, it seems to be involved in the regulation of DNA binding activity. This notion is further enhanced by two C-terminal point mutations, R1285Q and D1301A, which showed differentiated DNA binding activity. We also demonstrate that FANCI forms discrete nuclear foci in HeLa cells in the absence or presence of exogenous DNA damage. The FANCI foci are colocalized perfectly with FANCD2 and partially with proliferating cell nuclear antigen irrespective of mitomycin C treatment. An increased number of FANCI foci form and become resistant to Triton X extraction in response to mitomycin C treatment. Our data suggest that the FANCI-FANCD2 complex may participate in repair of damaged replication forks through its preferential recognition of branched structures.	[Yuan, Fenghua; El Hokayem, Jimmy; Zhou, Wen; Zhang, Yanbin] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Zhang, Yanbin] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami	Zhang, YB (corresponding author), Gautier Bldg,Rm 310,1011 NW 15th St, Miami, FL 33136 USA.	yzhang4@med.miami.edu	Yuan, Fenghua/F-8736-2011; Zhang, Yanbin/F-2998-2011; Zhou, Wen/A-5763-2010	Zhang, Yanbin/0000-0002-7263-5510; Zhou, Wen/0000-0002-5496-5815	University of Miami/Sylvester Pap Corps Cancer Research Development; Florida Bankhead-Coley Cancer Research Program	University of Miami/Sylvester Pap Corps Cancer Research Development; Florida Bankhead-Coley Cancer Research Program	This work was supported in part by a University of Miami/Sylvester Pap Corps Cancer Research Development Grant and the Florida Bankhead-Coley Cancer Research Program.	Alpi AF, 2009, DNA REPAIR, V8, P430, DOI 10.1016/j.dnarep.2009.01.019; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Alter BP, 2003, BLOOD, V101, P2072, DOI 10.1182/blood-2002-11-3597; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Demuth I, 2000, EUR J HUM GENET, V8, P861, DOI 10.1038/sj.ejhg.5200552; Dorsman JC, 2007, CELL ONCOL, V29, P211; Folias A, 2002, HUM MOL GENET, V11, P2591, DOI 10.1093/hmg/11.21.2591; Friedberg E. C., 2005, DNA REPAIR MUTAGENES, P9; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koester SK, 2001, METHOD CELL BIOL, V63, P253; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Levitus M, 2006, CELL ONCOL, V28, P3; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; Meetei AR, 2004, CELL CYCLE, V3, P179; Mi J, 2005, BLOOD, V105, P759, DOI 10.1182/blood-2004-01-0001; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Stone S, 2007, GENES CELLS, V12, P841, DOI 10.1111/j.1365-2443.2007.01096.x; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Thompson LH, 2005, ENVIRON MOL MUTAGEN, V45, P128, DOI 10.1002/em.20109; TOSCHI L, 1988, J CELL BIOL, V107, P1623, DOI 10.1083/jcb.107.5.1623; Tsuchiya N, 2004, BIOCHEM BIOPH RES CO, V317, P736, DOI 10.1016/j.bbrc.2004.03.103; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054	54	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24443	24452		10.1074/jbc.M109.016006	http://dx.doi.org/10.1074/jbc.M109.016006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561358	Green Published, hybrid			2022-12-27	WOS:000269380200057
J	Moldt, J; Pokorny, R; Orth, C; Linne, U; Geisselbrecht, Y; Marahiel, MA; Essen, LO; Batschauer, A				Moldt, Julia; Pokorny, Richard; Orth, Christian; Linne, Uwe; Geisselbrecht, Yann; Marahiel, Mohamed A.; Essen, Lars-Oliver; Batschauer, Alfred			Photoreduction of the Folate Cofactor in Members of the Photolyase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA PHOTOLYASE; ONE-CARBON METABOLISM; BLUE-LIGHT PHOTORECEPTORS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; REDUCTION POTENTIALS; ARABIDOPSIS-THALIANA; 2ND CHROMOPHORE; FLAVIN	Cryptochromes and DNA photolyases are related flavoproteins with flavin adenine dinucleotide as the common cofactor. Whereas photolyases repair DNA lesions caused by UV radiation, cryptochromes generally lack repair activity but act as UVA/blue light photoreceptors. Two distinct electron transfer (ET) pathways have been identified in DNA photolyases. One pathway uses within its catalytic cycle, light-driven electron transfer from FADH(-*) to the DNA lesion and electron back-transfer to semireduced FADHo after photoproduct cleavage. This cyclic ET pathway seems to be unique for the photolyase subfamily. The second ET pathway mediates photoreduction of semireduced or fully oxidized FAD via a triad of aromatic residues that is conserved in photolyases and cryptochromes. The 5,10-methenyltetrahydrofolate (5,10-methenylTHF) antenna cofactor in members of the photolyase family is bleached upon light excitation. This process has been described as photodecomposition of 5,10-methenylTHF. We show that photobleaching of 5,10-methenylTHF in Arabidopsis cry3, a member of the cryptochrome DASH family, with repair activity for cyclobutane pyrimidine dimer lesions in single-stranded DNA and in Escherichia coli photolyase results from reduction of 5,10-methenylTHF to 5,10-methylene THF that requires the intact tryptophan triad. Thus, a third ET pathway exists in members of the photolyase family that remained undiscovered so far.	[Batschauer, Alfred] Univ Marburg, Dept Plant Physiol & Photobiol, Fac Biol, D-35032 Marburg, Germany; [Linne, Uwe; Geisselbrecht, Yann; Marahiel, Mohamed A.; Essen, Lars-Oliver] Univ Marburg, Dept Biochem, Fac Chem, D-35032 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Batschauer, A (corresponding author), Univ Marburg, Dept Plant Physiol & Photobiol, Fac Biol, Karl von Frisch Str 8, D-35032 Marburg, Germany.	batschau@staff.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026	German Research Foundation (Deutsche Forschungsgemeinschaft Research Unit) [BA985/9-2]	German Research Foundation (Deutsche Forschungsgemeinschaft Research Unit)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft Research Unit 526 Grant BA985/9-2 (to A. B.)).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Byrdin M, 2003, P NATL ACAD SCI USA, V100, P8676, DOI 10.1073/pnas.1531645100; Cossins EA, 1997, PHYTOCHEMISTRY, V45, P437, DOI 10.1016/S0031-9422(96)00833-3; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; DARI L, 1991, J BIOL CHEM, V266, P23953; De Brouwer V, 2007, PHYTOCHEM ANALYSIS, V18, P496, DOI 10.1002/pca.1006; DEV IK, 1978, J BIOL CHEM, V253, P4245; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; EKER APM, 1990, J BIOL CHEM, V265, P8009; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; Fujihashi M, 2007, J MOL BIOL, V365, P903, DOI 10.1016/j.jmb.2006.10.012; HAMMALVAREZ S, 1989, J BIOL CHEM, V264, P9649; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Hanson AD, 2000, TRENDS PLANT SCI, V5, P206, DOI 10.1016/S1360-1385(00)01599-5; HEELIS PF, 1987, BIOCHEMISTRY-US, V26, P4634, DOI 10.1021/bi00389a007; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Horne DW, 2001, ANAL BIOCHEM, V297, P154, DOI 10.1006/abio.2001.5334; Huang YH, 2006, P NATL ACAD SCI USA, V103, P17701, DOI 10.1073/pnas.0608554103; Jabrin S, 2003, PLANT PHYSIOL, V131, P1431, DOI 10.1104/pp.016915; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; JORNS MS, 1987, BIOCHEMISTRY-US, V26, P6810, DOI 10.1021/bi00395a034; JORNS MS, 1990, BIOCHEMISTRY-US, V29, P552, DOI 10.1021/bi00454a032; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kavakli IH, 2004, BIOCHEMISTRY-US, V43, P15103, DOI 10.1021/bi0478796; KIM ST, 1992, BIOCHEMISTRY-US, V31, P11244, DOI 10.1021/bi00160a040; Klar T, 2007, J MOL BIOL, V366, P954, DOI 10.1016/j.jmb.2006.11.066; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; MALHOTRA K, 1992, J BIOL CHEM, V267, P2909; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; OSBORN MJ, 1960, J AM CHEM SOC, V82, P4921, DOI 10.1021/ja01503a043; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P7715, DOI 10.1021/bi00485a021; Pokorny R, 2005, ACTA CRYSTALLOGR F, V61, P935, DOI 10.1107/S1744309105028897; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Quinlivan EP, 2006, ANAL BIOCHEM, V348, P163, DOI 10.1016/j.ab.2005.09.017; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Rebeille F, 2006, PHYSIOL PLANTARUM, V126, P330, DOI 10.1111/j.1399-3054.2006.00587.x; Royant A, 2007, J APPL CRYSTALLOGR, V40, P1105, DOI 10.1107/S0021889807044196; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; Scannell MP, 1997, J AM CHEM SOC, V119, P1971, DOI 10.1021/ja963360o; Scannell MP, 1997, J PHYS CHEM A, V101, P4332, DOI 10.1021/jp970164a; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Song SH, 2006, J PHOTOCH PHOTOBIO B, V85, P1, DOI 10.1016/j.jphotobiol.2006.03.007; Thauer RK, 1996, CHEM REV, V96, P3031, DOI 10.1021/cr9500601; Tyagi A, 2009, CHEM PHYS, V358, P132, DOI 10.1016/j.chemphys.2009.01.005; Ueda T, 2005, J BIOL CHEM, V280, P36237, DOI 10.1074/jbc.M507972200; Van Wilder V, 2009, NEW PHYTOL, V182, P137, DOI 10.1111/j.1469-8137.2008.02707.x; WANG BY, 1989, BIOCHEMISTRY-US, V28, P1148, DOI 10.1021/bi00429a032; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200; Xu L, 2006, BBA-PROTEINS PROTEOM, V1764, P1454, DOI 10.1016/j.bbapap.2006.06.016; YEH SR, 1992, J AM CHEM SOC, V114, P7313, DOI 10.1021/ja00044a063	62	20	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21670	21683		10.1074/jbc.M109.018697	http://dx.doi.org/10.1074/jbc.M109.018697			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531478	Green Published, hybrid			2022-12-27	WOS:000268564400060
J	Pilankatta, R; Lewis, D; Adams, CM; Inesi, G				Pilankatta, Rajendra; Lewis, David; Adams, Christopher M.; Inesi, Giuseppe			High Yield Heterologous Expression of Wild-type and Mutant Cu+-ATPase (ATP7B, Wilson Disease Protein) for Functional Characterization of Catalytic Activity and Serine Residues Undergoing Copper-dependent Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; SARCOPLASMIC-RETICULUM; TRANSPORTING ATPASE; ENERGY INTERCONVERSION; MENKES DISEASE; CANDIDATE GENE; DIVERSITY; CELLS; LIVER	ATP7B is a P-type ATPase required for copper homeostasis and related to Wilson disease of humans. In addition to various domains corresponding to other P-type ATPases, ATP7B includes an N terminus extension (NMBD) with six copper binding sites. We obtained high yield expression of WT and mutant ATP7B in COS1 cells infected with adenovirus vector. ATP7B, isolated with the microsomal fraction of cell homogenates, accounts for 10-20% of the total protein. Copper-dependent, steady-state ATPase yields 30 nmol of Pi/mg of protein/min at 37 degrees C, pH 6.0. ATP7B phosphorylation with ATP occurs with diphasic kinetics and is totally copper-dependent. Alkali labile phosphoenzyme (catalytic intermediate of P-ATPases) accounts for a small fraction of the total phosphoprotein and is prevented by D1027N (P domain) or C983A/C985A (CXC copper binding motif in TM6) mutations. Decay of [P-32] phosphoenzyme following chase with non-radioactive ATP occurs with an initial burst involving alkali labile phosphoenzyme ( absent in D1027N and C983A/C985A mutants) and continues at a slow rate involving alkali-resistant phosphoenzyme. If a copper chelator is added with the ATP chase, the initial burst is smaller, and further cleavage is totally inhibited. Analysis by proteolysis and mass spectrometry demonstrates that the alkali stable phosphoenzyme involves Ser(478) and Ser(481) (NMBD), Ser(1121) ("N" domain) and Ser(1453) (C terminus), and occurs with the same pattern ex vivo (COS-1) and in vitro (microsomes). The overall copper dependence of phosphorylation and hydrolytic cleavage suggests long range conformational effects, including interactions of NMBD and headpiece domains, with strong influence on catalytic turnover.	[Pilankatta, Rajendra; Lewis, David; Inesi, Giuseppe] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA; [Adams, Christopher M.] Stanford Univ, Mass Spectrometry Lab, Stanford, CA 94305 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; Stanford University	Inesi, G (corresponding author), Calif Pacific Med Ctr, Res Inst, 475 Brannan St, San Francisco, CA 94107 USA.	ginesi@cpmcri.com	Pilankatta, Rajendra/ABC-8821-2021	Pilankatta, Rajendra/0000-0002-8587-8212	National Institutes of Health [RO301-69830]; NHBLI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHBLI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO301-69830 from the NHBLI.	Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Braiterman L, 2009, AM J PHYSIOL-GASTR L, V296, pG433, DOI 10.1152/ajpgi.90489.2008; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; FERNANDEZBELDA F, 1984, J BIOL CHEM, V259, P9687; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hung YH, 2007, BIOCHEM J, V401, P569, DOI 10.1042/BJ20060924; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mazanek M, 2007, NAT PROTOC, V2, P1059, DOI 10.1038/nprot.2006.280; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Smart SC, 1997, CARDIOVASC RES, V36, P174, DOI 10.1016/S0008-6363(97)00175-2; Takeda K, 1999, J MEMBRANE BIOL, V170, P13, DOI 10.1007/s002329900533; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Valverde RHF, 2008, FEBS LETT, V582, P891, DOI 10.1016/j.febslet.2008.02.022; Vanderwerf SM, 2002, BIOCHEM SOC T, V30, P739, DOI 10.1042/bst0300739; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Veldhuis N, 2009, BIOMETALS, V22, P177, DOI 10.1007/s10534-008-9183-2; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471	31	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21307	21316		10.1074/jbc.M109.023341	http://dx.doi.org/10.1074/jbc.M109.023341			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520855	Green Published, hybrid			2022-12-27	WOS:000268564400025
J	Rajagopalan, S; Andreeva, A; Teufel, DP; Freund, SM; Fersht, AR				Rajagopalan, Sridharan; Andreeva, Antonina; Teufel, Daniel P.; Freund, Stefan M.; Fersht, Alan R.			Interaction between the Transactivation Domain of p53 and PC4 Exemplifies Acidic Activation Domains as Single-stranded DNA Mimics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR PC4; TUMOR-SUPPRESSOR P53; REPLICATION PROTEIN-A; AMINO-ACIDS; STRUCTURAL BIOLOGY; TERMINAL DOMAIN; CHEMICAL-SHIFT; BINDING; NMR; VP16	The tumor suppressor p53 regulates cell cycle arrest and apoptosis by transactivating several genes that are critical for these processes. The transcriptional activity of p53 is often regulated by post-translational modifications and its interactions with various transcriptional coactivators. Here we report a physical interaction between the N-terminal transactivation domain (TAD) of p53 and the C-terminal DNA-binding domain of positive cofactor 4 (PC4(CTD)). Using NMR spectroscopy, we showed that residues 35-57 (TAD2) interact with PC4. N-15, H-1 HSQC and fluorescence competition experiments indicated that TAD binds to the DNA-binding site of PC4. Hepta-phosphorylation of the TAD peptide increased its binding affinity. Computer modeling of the p53N-PC4 complex revealed several important interactions that are reminiscent of those in the single-stranded DNA-PC4 complex. The ubiquitous nature of the acidic transactivation domain of p53 in mediating interactions with several transcription cofactors is also manifested as a DNA mimetic.	[Rajagopalan, Sridharan; Teufel, Daniel P.; Freund, Stefan M.; Fersht, Alan R.] MRC Ctr Prot Engn, Cambridge CB2 0QH, England; [Andreeva, Antonina] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; MRC Laboratory Molecular Biology	Fersht, AR (corresponding author), MRC Ctr Prot Engn, Hills Rd, Cambridge CB2 0QH, England.	arf25@cam.ac.uk	Fersht, Alan R/B-2189-2008	Andreeva, Antonina/0000-0002-0450-0091; Teufel, Daniel/0000-0002-6527-2117	Cambridge Commonwealth Trust; Medical Research Council; MRC [MC_U105474168, MC_U105192716] Funding Source: UKRI; Medical Research Council [MC_U105192716, MC_U105474168] Funding Source: researchfish	Cambridge Commonwealth Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a fellowship from the Cambridge Commonwealth Trust and Medical Research Council.	Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Banerjee S, 2004, MOL CELL BIOL, V24, P2052, DOI 10.1128/MCB.24.5.2052-2062.2004; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bonvin AMJJ, 2005, CURR OPIN CHEM BIOL, V9, P501, DOI 10.1016/j.cbpa.2005.08.011; Comuzzi Barbara, 2006, Cellscience, V3, P61; CRESS WD, 1991, SCIENCE, V251, P87, DOI 10.1126/science.1846049; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dryden DTF, 2006, BIOCHEM SOC T, V34, P317, DOI 10.1042/BST0340317; Ferreira ME, 2005, J BIOL CHEM, V280, P21779, DOI 10.1074/jbc.M502627200; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Haile DT, 1999, J BIOL CHEM, V274, P2113, DOI 10.1074/jbc.274.4.2113; Hermann S, 2001, J BIOL CHEM, V276, P40127, DOI 10.1074/jbc.M103793200; Huang SM, 2001, ONCOGENE, V20, P2134, DOI 10.1038/sj.onc.1204298; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Jonker HRA, 2006, BIOCHEMISTRY-US, V45, P5067, DOI 10.1021/bi052531b; Jonker HRA, 2005, BIOCHEMISTRY-US, V44, P827, DOI 10.1021/bi0482912; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Langlois C, 2008, J AM CHEM SOC, V130, P10596, DOI 10.1021/ja800975h; LEE CW, 2009, BIOCHEMISTR IN PRESS; Luo Y, 1998, MOL CELL BIOL, V18, P3803, DOI 10.1128/MCB.18.7.3803; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; Pan ZQ, 1996, J BIOL CHEM, V271, P22111, DOI 10.1074/jbc.271.36.22111; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; Sainz MB, 1997, MOL CELL BIOL, V17, P115, DOI 10.1128/MCB.17.1.115; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Werten S, 1999, J BIOL CHEM, V274, P3693, DOI 10.1074/jbc.274.6.3693; Werten S, 2006, NAT STRUCT MOL BIOL, V13, P181, DOI 10.1038/nsmb1044; Werten S, 1998, EMBO J, V17, P5103, DOI 10.1093/emboj/17.17.5103; Werten S, 1998, J MOL BIOL, V276, P367, DOI 10.1006/jmbi.1997.1534; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zhong L, 2003, GENE, V320, P155, DOI 10.1016/S0378-1119(03)00823-0; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	52	36	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21728	21737		10.1074/jbc.M109.006429	http://dx.doi.org/10.1074/jbc.M109.006429			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19525231	hybrid, Green Published			2022-12-27	WOS:000268564400065
J	Ou, CY; Kim, JH; Yang, CK; Stallcup, MR				Ou, Chen-Yin; Kim, Jeong Hoon; Yang, Catherine K.; Stallcup, Michael R.			Requirement of Cell Cycle and Apoptosis Regulator 1 for Target Gene Activation by Wnt and beta-Catenin and for Anchorage-independent Growth of Human Colon Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNERGISTIC COACTIVATOR FUNCTION; COLORECTAL-CANCER; IN-VIVO; C-MYC; TRANSCRIPTIONAL COACTIVATOR; PROTEIN METHYLTRANSFERASE; DEPENDENT TRANSCRIPTION; SIGNALING PATHWAYS; NEGATIVE REGULATOR; ANDROGEN RECEPTOR	Aberrant Wnt signaling promotes oncogenesis by increasing cellular levels of beta-catenin, which associates with DNA-bound transcription factors and activates Wnt target genes. However, the molecular mechanism by which beta-catenin mediates gene expression is still poorly understood. Here, we show that cell cycle and apoptosis regulator 1 (CCAR1), which was recently shown to function as a transcriptional coactivator for nuclear receptors, also interacts with beta-catenin and enhances the ability of beta-catenin to activate expression of transiently transfected reporter genes. Furthermore, association of CCAR1 with the promoter of an endogenous Wnt/beta-catenin target gene in a colon cancer cell line depends on the presence of beta-catenin. Depletion of CCAR1 inhibits expression of several Wnt/beta-catenin target genes and suppresses anchorage-independent growth of the colon cancer cell line. Thus, CCAR1 is a novel component of Wnt/beta-catenin signaling that plays an important role in transcriptional regulation by beta-catenin and that, therefore, may represent a novel target for therapeutic intervention in cancers involving aberrantly activated Wnt/beta-catenin signaling.	[Ou, Chen-Yin; Yang, Catherine K.; Stallcup, Michael R.] Univ So Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Kim, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Samsung Med Ctr, Seoul 135710, South Korea; [Kim, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Clin Res Ctr, Seoul 135710, South Korea	University of Southern California; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center	Stallcup, MR (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, 1441 Eastlake Ave,NOR 6316, Los Angeles, CA 90089 USA.	stallcup@usc.edu	Ou, Chenyin/AAM-7473-2020	Ou, Chenyin/0000-0002-8036-7317	National Institutes of Health [DK43093, T32 CA009320]; NATIONAL CANCER INSTITUTE [T32CA009320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK43093 ( to M. R. S.).; Supported in part by a postdoctoral fellowship from NIH Grant T32 CA009320.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen YH, 2007, NUCLEIC ACIDS RES, V35, P2084, DOI 10.1093/nar/gkm095; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Dahmen RP, 2001, CANCER RES, V61, P7039; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; DUBIK D, 1988, J BIOL CHEM, V263, P12705; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Feng Y, 2003, CANCER RES, V63, P8726; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koh SS, 2002, J BIOL CHEM, V277, P26031, DOI 10.1074/jbc.M110865200; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Lee YH, 2006, NUCLEIC ACIDS RES, V34, P5052, DOI 10.1093/nar/gkl652; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473; Miyagishi M, 2000, J BIOL CHEM, V275, P35170, DOI 10.1074/jbc.C000258200; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NEWELL KJ, 1994, MOL CARCINOGEN, V10, P199, DOI 10.1002/mc.2940100404; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Parker DS, 2002, DEVELOPMENT, V129, P2565; Polakis P, 2000, GENE DEV, V14, P1837; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Shah S, 2003, J BIOL CHEM, V278, P48137, DOI 10.1074/jbc.M307154200; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; SMITH DR, 1993, BRIT J CANCER, V68, P407, DOI 10.1038/bjc.1993.350; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Wang S, 2006, CURR BIOL, V16, P2239, DOI 10.1016/j.cub.2006.09.034; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu R, 2001, CANCER RES, V61, P8247; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yang CK, 2006, J BIOL CHEM, V281, P3389, DOI 10.1074/jbc.M510403200; Zhang T, 2001, CANCER RES, V61, P8664; Zhao J, 2002, BASIC RES CARDIOL, V97, P348, DOI 10.1007/s00395-002-0360-0; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	67	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20629	20637		10.1074/jbc.M109.014332	http://dx.doi.org/10.1074/jbc.M109.014332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19520846	Green Published, hybrid			2022-12-27	WOS:000268316100024
J	Chisada, S; Yoshimura, Y; Sakaguchi, K; Uemura, S; Go, S; Ikeda, K; Uchima, H; Matsunaga, N; Ogura, K; Tai, T; Okino, N; Taguchi, R; Inokuchi, J; Ito, M				Chisada, Shin-ichi; Yoshimura, Yukihiro; Sakaguchi, Keishi; Uemura, Satoshi; Go, Shinji; Ikeda, Kazutaka; Uchima, Hiroyuki; Matsunaga, Naoyuki; Ogura, Kiyoshi; Tai, Tadashi; Okino, Nozomu; Taguchi, Ryo; Inokuchi, Jinichi; Ito, Makoto			Zebrafish and Mouse alpha 2,3-Sialyltransferases Responsible for Synthesizing GM4 Ganglioside	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERAMIDE N-DEACYLASE; MOLECULAR-CLONING; EXPRESSION CLONING; BRAIN GANGLIOSIDES; GLYCOSPHINGOLIPIDS; ENDOGLYCOCERAMIDASE; SPHINGOLIPIDS; PURIFICATION; SENSITIVITY; SIALIDASE	We have previously reported that fish pathogens causing vibriosis specifically adhere to GM4 on the epithelial cells of fish intestinal tracts (Chisada, S., Horibata, Y., Hama, Y., Inagaki, M., Furuya, N., Okino, N., and Ito, M. ( 2005) Biochem. Biophys. Res. Commun. 333, 367-373). To identify the gene encoding the enzyme for GM4 synthesis in the fish intestinal tract, a phylogenetic tree of vertebrate ST3GalVs, including Danio rerio and Oryzias latipes, was generated in which two putative subfamilies of fish ST3GalVs were found. Two putative ST3GalVs of zebrafish (zST3GalV-1 and -2), each belonging to different subfamilies, were cloned from the zebrafish cDNA library. Interestingly, zST3GalV-1 synthesized GM3 (NeuAc alpha 2-3Gal beta 1-4Glc beta 1-1'Cer) but not GM4, whereas zSTGalV-2 synthesized both gangliosides in vitro when expressed in CHO-K1 and RPMI1846 cells. Flow cytometric analysis using anti-GM4 antibody revealed that the transformation of RPMI1846 cells with zST3GalV-2 but not zST3GalV-1 cDNA increased the cell-surface expression of GM4. Whole mount in situ hybridization showed that the zST3GalV-2 transcript was strongly expressed in the gastrointestinal tract, whereas zST3GalV-1 was expressed in the brain and esophagus but not gastrointestinal tract in 3-day post-fertilization embryos. It has long been a matter of controversy which enzyme is responsible for the synthesis of GM4 in mammals. We found that three isoforms of mouse ST3GalV(mST3GalV) having different N-terminal sequences can synthesize GM4 as well as GM3 when expressed in RPMI1846 and CHO-K1 cells. Furthermore, mST3GalV knock-out mice were found to lack GM4 synthase activity and GM4 in contrast to wild-type mice. These results clearly indicate that zST3GalV-2 and mST3GalV are the enzymes responsible for the synthesis of GM4 in zebrafish and mice, respectively.	[Chisada, Shin-ichi; Yoshimura, Yukihiro; Sakaguchi, Keishi; Uchima, Hiroyuki; Matsunaga, Naoyuki; Okino, Nozomu; Ito, Makoto] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Uemura, Satoshi; Go, Shinji; Inokuchi, Jinichi] Tohoku Pharmaceut Univ, Div Glycopathol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Ogura, Kiyoshi; Tai, Tadashi] Tokyo Metropolitan Inst Med Sci, Dept Tumor Immunol, Tokyo 1138613, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Ito, Makoto] Kyushu Univ, Bioarchitecture Ctr, Higashi Ku, Fukuoka 8128581, Japan; [Ikeda, Kazutaka; Okino, Nozomu; Taguchi, Ryo; Inokuchi, Jinichi; Ito, Makoto] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol Program, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Tohoku Medical & Pharmaceutical University; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Kyushu University; Japan Science & Technology Agency (JST)	Ito, M (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	makotoi@agr.kyushu-u.ac.jp	Yoshimura, Yukihiro/AAJ-5213-2020; Ito, Makoto/Q-6164-2019; Okino, Nozomu/AAY-2635-2021; Inokuchi, Jin-ichi/AAW-9964-2020	Inokuchi, Jin-ichi/0000-0002-0703-5746; ito, Makoto/0000-0003-3159-7818	CREST, Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [B19380061]	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by CREST, Japan Science and Technology Agency (to M.I., J.I., and R.T.), and Basic Research Grant B19380061 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M.I.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Berselli P, 2006, BBA-GENE STRUCT EXPR, V1759, P348, DOI 10.1016/j.bbaexp.2006.07.001; Chiba A, 1997, BRAIN RES, V745, P32, DOI 10.1016/S0006-8993(96)01123-7; Chisada S, 2005, BIOCHEM BIOPH RES CO, V333, P367, DOI 10.1016/j.bbrc.2005.05.110; Fukano Y, 1997, APPL ENVIRON MICROB, V63, P1861, DOI 10.1128/AEM.63.5.1861-1865.1997; Fukumoto S, 1999, J BIOL CHEM, V274, P9271, DOI 10.1074/jbc.274.14.9271; Furusato M, 2002, J BIOL CHEM, V277, P17300, DOI 10.1074/jbc.m110688200; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Ikeda K, 2008, J LIPID RES, V49, P2678, DOI 10.1194/jlr.D800038-JLR200; Inokuchi J, 2006, BIOL PHARM BULL, V29, P1532, DOI 10.1248/bpb.29.1532; Irie T, 2004, J VET MED SCI, V66, P205, DOI 10.1292/jvms.66.205; Ishibashi Y, 2007, J BIOL CHEM, V282, P11386, DOI 10.1074/jbc.M608445200; Ishii A, 1998, J BIOL CHEM, V273, P31652, DOI 10.1074/jbc.273.48.31652; ITO M, 1989, J BIOL CHEM, V264, P9510; ITO M, 1995, J BIOL CHEM, V270, P24370, DOI 10.1074/jbc.270.41.24370; Izu H, 1997, J BIOL CHEM, V272, P19846, DOI 10.1074/jbc.272.32.19846; Kapitonov D, 1999, GLYCOCONJUGATE J, V16, P337, DOI 10.1023/A:1007091926413; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; KASAHARA K, 1994, ANAL BIOCHEM, V218, P224, DOI 10.1006/abio.1994.1164; Kono M, 1998, BIOCHEM BIOPH RES CO, V253, P170, DOI 10.1006/bbrc.1998.9768; KUHN R, 1964, Z NATURFORSCH PT B, VB 19, P256; Mitsutake S, 1998, J BIOCHEM-TOKYO, V123, P859; MULLIN BR, 1984, BRAIN RES, V296, P174, DOI 10.1016/0006-8993(84)90527-4; NAKAMURA K, 1990, J BIOCHEM-TOKYO, V107, P3; NOHARAUCHIDA K, 1987, J BIOCHEM-TOKYO, V102, P923, DOI 10.1093/oxfordjournals.jbchem.a122133; NOJIRI H, 1986, P NATL ACAD SCI USA, V83, P782, DOI 10.1073/pnas.83.3.782; OHSAWA T, 1989, MECH AGEING DEV, V50, P169, DOI 10.1016/0047-6374(89)90012-2; OSTRANDER GK, 1988, J BIOL CHEM, V263, P3103; OZAWA H, 1993, J BIOCHEM-TOKYO, V114, P5, DOI 10.1093/oxfordjournals.jbchem.a124138; PREUSS U, 1993, J BIOL CHEM, V268, P26273; Shima T, 2006, J FISH DIS, V29, P249, DOI 10.1111/j.1365-2761.2006.00703.x; SHIRAISHI T, 1986, J BIOCHEM-TOKYO, V100, P553, DOI 10.1093/oxfordjournals.jbchem.a121746; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; TADANO K, 1980, BIOCHEM BIOPH RES CO, V97, P126, DOI 10.1016/S0006-291X(80)80144-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Uemura S, 2006, GLYCOBIOLOGY, V16, P258, DOI 10.1093/glycob/cwj060; Uemura S, 2009, MOL BIOL CELL, V20, P3088, DOI 10.1091/mbc.E08-12-1219; UENO K, 1978, J LIPID RES, V19, P863; WATARAI S, 1995, J BIOCHEM-TOKYO, V117, P1062, DOI 10.1093/oxfordjournals.jbchem.a124807; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yoshimura Y, 2004, J BIOL CHEM, V279, P44012, DOI 10.1074/jbc.M405598200; YU RK, 1976, J BIOL CHEM, V251, P198	47	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30534	30546		10.1074/jbc.M109.016188	http://dx.doi.org/10.1074/jbc.M109.016188			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19542236	hybrid, Green Published			2022-12-27	WOS:000271090000056
J	Bax, DV; Rodgers, UR; Bilek, MMM; Weiss, AS				Bax, Daniel V.; Rodgers, Ursula R.; Bilek, Marcela M. M.; Weiss, Anthony S.			Cell Adhesion to Tropoelastin Is Mediated via the C-terminal GRKRK Motif and Integrin alpha(V)beta(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELASTIN-DERIVED PEPTIDES; SMOOTH-MUSCLE; CUTIS LAXA; IN-VIVO; STRUCTURAL-CHANGES; ENDOTHELIAL-CELLS; DISEASE; DOMAIN; MUTATION; BINDS	Elastin fibers are predominantly composed of the secreted monomer tropoelastin. This protein assembly confers elasticity to all vertebrate elastic tissues including arteries, lung, skin, vocal folds, and elastic cartilage. In this study we examined the mechanism of cell interactions with recombinant human tropoelastin. Cell adhesion to human tropoelastin was divalent cation-dependent, and the inhibitory anti-integrin alpha(V)beta(3) antibody LM609 inhibited cell spreading on tropoelastin, identifying integrin alpha(V)beta(3) as the major fibroblast cell surface receptor for human tropoelastin. Cell adhesion was unaffected by lactose and heparin sulfate, indicating that the elastin-binding protein and cell surface glycosaminoglycans are not involved. The C-terminal GRKRK motif of tropoelastin can bind to cells in a divalent cation-dependent manner, identifying this as an integrin binding motif required for cell adhesion.	[Bax, Daniel V.; Rodgers, Ursula R.; Weiss, Anthony S.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Bax, Daniel V.; Bilek, Marcela M. M.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Bax, DV (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Bldg G08, Sydney, NSW 2006, Australia.	dbax@usyd.edu.au	Weiss, Anthony S/F-8103-2010; Weiss, Anthony S/GYV-0157-2022	Weiss, Anthony S/0000-0002-8106-4836; Bilek, Marcela/0000-0003-3363-2664	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council.	Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; AOTA S, 1994, J BIOL CHEM, V269, P24756; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Broekelmann TJ, 2008, MATRIX BIOL, V27, P631, DOI 10.1016/j.matbio.2008.06.001; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; DAVIS EC, 1993, CELL TISSUE RES, V272, P211, DOI 10.1007/BF00302726; Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007; Gibson MA, 1999, J BIOL CHEM, V274, P13060, DOI 10.1074/jbc.274.19.13060; GREEN LJ, 1999, ADV MOL CEL, V28, P3; Greiling D, 1997, J CELL SCI, V110, P861; Hahn CN, 1997, HUM MOL GENET, V6, P205, DOI 10.1093/hmg/6.2.205; HUMPHRIES MJ, 1998, CURR PROT CELL BIOL; Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407; Jung S, 1998, J NEUROPATH EXP NEUR, V57, P439, DOI 10.1097/00005072-199805000-00007; Karnik SK, 2003, MATRIX BIOL, V22, P409, DOI 10.1016/S0945-053X(03)00076-3; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kelleher CM, 2005, AM J RESP CELL MOL, V33, P355, DOI 10.1165/rcmb.2005-0206OC; Kielty CM, 2007, PHILOS T R SOC B, V362, P1293, DOI 10.1098/rstb.2007.2134; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Lemaire R, 2007, J BIOL CHEM, V282, P800, DOI 10.1074/jbc.M609692200; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mould AP, 1996, J CELL SCI, V109, P2613; Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Newham P, 1996, MOL MED TODAY, V2, P304, DOI 10.1016/1357-4310(96)10021-6; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Ramirez F, 2000, MATRIX BIOL, V19, P455, DOI 10.1016/S0945-053X(00)00098-6; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022; Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002; Rodriguez-Revenga L, 2004, ARCH DERMATOL, V140, P1135, DOI 10.1001/archderm.140.9.1135; SENIOR RM, 1982, J CLIN INVEST, V70, P614, DOI 10.1172/JCI110654; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Tassabehji M, 1998, HUM MOL GENET, V7, P1021, DOI 10.1093/hmg/7.6.1021; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	46	128	135	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28616	28623		10.1074/jbc.M109.017525	http://dx.doi.org/10.1074/jbc.M109.017525			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19617625	Green Published, hybrid			2022-12-27	WOS:000270678900016
J	Eggink, D; Langedijk, JPM; Bonvin, AMJJ; Deng, YQ; Lu, M; Berkhout, B; Sanders, RW				Eggink, Dirk; Langedijk, Johannes P. M.; Bonvin, Alexandre M. J. J.; Deng, Yiqun; Lu, Min; Berkhout, Ben; Sanders, Rogier W.			Detailed Mechanistic Insights into HIV-1 Sensitivity to Three Generations of Fusion Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; 6-HELIX BUNDLE STRUCTURE; VIRAL MEMBRANE-FUSION; 44 KDA ECTODOMAIN; ENVELOPE GLYCOPROTEIN; BASE-LINE; ANTIRETROVIRAL ACTIVITY; PHENOTYPIC RESISTANCE; REVERSE-TRANSCRIPTASE; ENFUVIRTIDE TREATMENT	Peptides based on the second heptad repeat (HR2) of viral class I fusion proteins are effective inhibitors of virus entry. One such fusion inhibitor has been approved for treatment of human immunodeficiency virus-1 (T20, enfuvirtide). Resistance to T20 usually maps to the peptide binding site in HR1. To better understand fusion inhibitor potency and resistance, we combined virological, computational, and biophysical experiments with comprehensive mutational analyses and tested resistance to T20 and second and third generation inhibitors (T1249 and T2635). We found that most amino acid substitutions caused resistance to the first generation peptide T20. Only charged amino acids caused resistance to T1249, and none caused resistance to T2635. Depending on the drug, we can distinguish four mechanisms of drug resistance: reduced contact, steric obstruction, electrostatic repulsion, and electrostatic attraction. Implications for the design of novel antiviral peptide inhibitors are discussed.	[Eggink, Dirk; Berkhout, Ben; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol,CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Langedijk, Johannes P. M.] Pepscan Therapeut BV, NL-8423 RC Lelystad, Netherlands; [Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Deng, Yiqun; Lu, Min] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Amsterdam; Academic Medical Center Amsterdam; Pepscan Therapeutics B.V.; Utrecht University; Cornell University; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol,CINIMA, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl	Bonvin, Alexandre M.J.J./A-5420-2009; Deng, Yiqun/K-7709-2013	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Deng, Yiqun/0000-0002-6838-3779; Eggink, Dirk/0000-0002-4248-6008	National Institutes of Health [AI42382]; AIDS Fund (Amsterdam) [2005021]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI042382, R21AI042382, R01AI042382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Fund (Amsterdam); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant AI42382 (to M. L.). This work was also supported in part by AIDS Fund (Amsterdam) Grant 2005021 (to B. B.).	Aquaro S, 2006, J ANTIMICROB CHEMOTH, V58, P714, DOI 10.1093/jac/dkl306; Bai XF, 2008, BIOCHEMISTRY-US, V47, P6662, DOI 10.1021/bi702509d; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; BOYER PL, 1995, ANTIMICROB AGENTS CH, V39, P1624, DOI 10.1128/AAC.39.7.1624; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 1997, J MOL BIOL, V271, P819, DOI 10.1006/jmbi.1997.1217; CANTOR C, 1980, BIOPHYSICAL CHEM 3, P1131; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chinnadurai R, 2005, AIDS, V19, P1401, DOI 10.1097/01.aids.0000180785.25800.de; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cladera J, 1999, J BIOL CHEM, V274, P29951, DOI 10.1074/jbc.274.42.29951; Das AT, 1999, J VIROL, V73, P81, DOI 10.1128/JVI.73.1.81-91.1999; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DECROLY E, 1994, J BIOL CHEM, V269, P12240; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Diallo K, 2003, ANTIMICROB AGENTS CH, V47, P3377, DOI 10.1128/AAC.47.11.3377-3383.2003; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P547, DOI 10.1021/bi00854a024; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jacobs A, 2008, VACCINE, V26, P3026, DOI 10.1016/j.vaccine.2007.12.026; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Keulen W, 1996, ANTIVIR RES, V31, P45, DOI 10.1016/0166-3542(96)00944-8; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Lu M, 1999, J VIROL, V73, P4433, DOI 10.1128/JVI.73.5.4433-4438.1999; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Mahalingam B, 1999, EUR J BIOCHEM, V263, P238, DOI 10.1046/j.1432-1327.1999.00514.x; Do Canto AMTM, 2008, J PEPT SCI, V14, P442, DOI 10.1002/psc.982; Melby T, 2007, AIDS RES HUM RETROV, V23, P1366, DOI 10.1089/aid.2006.0277; Melby T, 2006, AIDS RES HUM RETROV, V22, P375, DOI 10.1089/aid.2006.22.375; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Menzo S, 2004, MICROBIOLOGICA, V27, P51; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Ou W, 2005, J VIROL, V79, P4782, DOI 10.1128/JVI.79.8.4782-4792.2005; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Porotto M, 2007, J VIROL, V81, P10567, DOI 10.1128/JVI.01181-07; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Sanders RW, 2004, AIDS RES HUM RETROV, V20, P742, DOI 10.1089/0889222041524544; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; SANDERS RW, 2002, HIV SEQUENCE COMPEND, P43; Shu W, 1999, BIOCHEMISTRY-US, V38, P5378, DOI 10.1021/bi990199w; Sista PR, 2004, AIDS, V18, P1787, DOI 10.1097/00002030-200409030-00007; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Trivedi VD, 2003, PROTEIN ENG, V16, P311, DOI 10.1093/proeng/gzg036; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wang EX, 2003, BIOCHEM BIOPH RES CO, V302, P469, DOI 10.1016/S0006-291X(03)00197-9; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1995, AIDS RES HUM RETROV, V11, P323, DOI 10.1089/aid.1995.11.323; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005; Zhu JQ, 2005, J MOL BIOL, V354, P601, DOI 10.1016/j.jmb.2005.08.078	74	66	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26941	26950		10.1074/jbc.M109.004416	http://dx.doi.org/10.1074/jbc.M109.004416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19617355	Green Published, hybrid			2022-12-27	WOS:000269969600074
J	Stollar, EJ; Garcia, B; Chong, PA; Rath, A; Lin, H; Forman-Kay, JD; Davidson, AR				Stollar, Elliott J.; Garcia, Bianca; Chong, P. Andrew; Rath, Arianna; Lin, Hong; Forman-Kay, Julie D.; Davidson, Alan R.			Structural, Functional, and Bioinformatic Studies Demonstrate the Crucial Role of an Extended Peptide Binding Site for the SH3 Domain of Yeast Abp1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-INTERACTION NETWORKS; RECOGNITION MODULES; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; SEQUENCE HOMOLOGY; DIPOLAR COUPLINGS; HIV-1 NEF; SPECIFICITY; AFFINITY; NMR	SH3 domains, which are among the most frequently occurring protein interaction modules in nature, bind to peptide targets ranging in length from 7 to more than 25 residues. Although the bulk of studies on the peptide binding properties of SH3 domains have focused on interactions with relatively short peptides (less than 10 residues), a number of domains have been recently shown to require much longer sequences for optimal binding affinity. To gain greater insight into the binding mechanism and biological importance of interactions between an SH3 domain and extended peptide sequences, we have investigated interactions of the yeast Abp1p SH3 domain (AbpSH3) with several physiologically relevant 17-residue target peptide sequences. To obtain a molecular model for AbpSH3 interactions, we solved the structure of the AbpSH3 bound to a target peptide from the yeast actin patch kinase, Ark1p. Peptide target complexes from binding partners Scp1p and Sjl2p were also characterized, revealing that the AbpSH3 uses a common extended interface for interaction with these peptides, despite K-d values for these peptides ranging from 0.3 to 6 mu M. Mutagenesis studies demonstrated that residues across the whole 17-residue binding site are important both for maximal in vitro binding affinity and for in vivo function. Sequence conservation analysis revealed that both the AbpSH3 and its extended target sequences are highly conserved across diverse fungal species as well as higher eukaryotes. Our data imply that the AbpSH3 must bind extended target sites to function efficiently inside the cell.	[Stollar, Elliott J.; Chong, P. Andrew; Rath, Arianna; Lin, Hong; Forman-Kay, Julie D.; Davidson, Alan R.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Stollar, Elliott J.; Garcia, Bianca; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Forman-Kay, Julie D.; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Forman-Kay, JD (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	forman@sickkids.ca; alan.davidson@utoronto.ca		Forman-Kay, Julie/0000-0001-8265-972X	National Cancer Institute of Canada; Canadian Institutes of Health Research [MOP-13609]; Hospital for Sick Children	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children	This work was funded by operating grants from the National Cancer Institute of Canada (to J. F. K.), the Canadian Institutes of Health Research (CIHR ARD Grant MOP-13609), a Restracomp award from the Hospital for Sick Children (to E. J. S.), and a CIHR Training Program in Protein Folding award (to E. J. S.).	Agrawal V, 2002, PROTEIN PEPTIDE LETT, V9, P185, DOI 10.2174/0929866023408760; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arold S, 1998, BIOCHEMISTRY-US, V37, P14683, DOI 10.1021/bi980989q; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bauer F, 2005, PROTEIN SCI, V14, P2487, DOI 10.1110/ps.051563605; Beltrao P, 2005, PLOS COMPUT BIOL, V1, P202, DOI 10.1371/journal.pcbi.0010026; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P12; Haynes J, 2007, GENETICS, V176, P193, DOI 10.1534/genetics.106.070300; Hou P, 2003, HUM MOL GENET, V12, P1981, DOI 10.1093/hmg/ddg209; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Kim JM, 2008, J MOL BIOL, V377, P889, DOI 10.1016/j.jmb.2008.01.063; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Marles JA, 2004, MOL CELL, V14, P813, DOI 10.1016/j.molcel.2004.05.024; Mayer BJ, 2001, J CELL SCI, V114, P1253; Mittermaier A, 2001, J AM CHEM SOC, V123, P6892, DOI 10.1021/ja010595d; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Mott HR, 2005, BIOCHEMISTRY-US, V44, P10977, DOI 10.1021/bi050374a; Ogura K, 2006, J BIOL CHEM, V281, P3660, DOI 10.1074/jbc.M505193200; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Sekiya-Kawasaki M, 2003, J CELL BIOL, V162, P765, DOI 10.1083/jcb.200305077; Stefan CJ, 2005, MOL CELL BIOL, V25, P2910, DOI 10.1128/MCB.25.8.2910-2923.2005; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	45	23	25	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26918	26927		10.1074/jbc.M109.028431	http://dx.doi.org/10.1074/jbc.M109.028431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19590096	Green Published, hybrid			2022-12-27	WOS:000269969600072
J	Huang, GR; Zhang, Y; Kim, B; Ge, GX; Annis, DS; Mosher, DF; Greenspan, DS				Huang, Guorui; Zhang, Yue; Kim, Byoungjae; Ge, Gaoxiang; Annis, Douglas S.; Mosher, Deane F.; Greenspan, Daniel S.			Fibronectin Binds and Enhances the Activity of Bone Morphogenetic Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLLAGEN C-PROTEINASE; EXTRACELLULAR-MATRIX; PLASMA FIBRONECTIN; LYSYL OXIDASE; FIBROGENIC CELLS; METALLOPROTEINASES; COLLAGEN; FAMILY; FIBRILLOGENESIS; POLYMERIZATION	Bone morphogenetic protein-1-like proteinases play key roles in formation of the extracellular matrix (ECM) in vertebrates via biosynthetic processing of precursors into mature functional proteins involved in ECM assembly. Such processing includes proteolytic activation of the zymogen for lysyl oxidase. Fibronectin (FN) is an abundant protein component of the ECM that is capable of regulating manifold cellular functions through its interactions with various ECM and cell surface proteins. It was previously shown that proteolytic activation of lysyl oxidase is much reduced in cultures of FN-null mouse embryo fibroblasts (MEFs). Here we demonstrate that cellular fibronectin, the form produced by fibroblasts and various other tissue cell types, and plasma fibronectin bind BMP1 with dissociation constants (K-D) of similar to 100 nM, consistent with a physiological role. Also consistent with such a role, cellular fibronectin FN is shown to positively regulate BMP1 processing activity against Chordin, probiglycan, and type I procollagen in vitro. Endogenous FN and BMP1 are demonstrated to co-localize in cell layers and to form complexes in culture medium. In addition, processing of endogenous BMP1 substrates Chordin, probiglycan, and procollagen is demonstrated to be strikingly reduced in cultures of FN-/- MEFs compared with FN+/- MEF cultures despite similar levels of endogenous BMP1. These data support the conclusion that FN binds BMP1-like proteinases in vivo and that FN is an important determinant of the in vivo activity levels of BMP1-like proteinases.	[Huang, Guorui; Zhang, Yue; Kim, Byoungjae; Ge, Gaoxiang; Greenspan, Daniel S.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Zhang, Yue; Greenspan, Daniel S.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Greenspan, Daniel S.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Greenspan, DS (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, 1300 Univ Ave, Madison, WI 53706 USA.	dsgreens@wisc.edu	Huang, Guorui/M-9641-2013		National Institutes of Health [GM71679, AR53815]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM71679 and AR53815 (to D. S. G.).	AKIYAMA SK, 1985, J BIOL CHEM, V260, P4492; ALLIO AE, 1988, J CELL PHYSIOL, V135, P459, DOI 10.1002/jcp.1041350313; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; BIDANSET DJ, 1992, J CELL BIOL, V118, P1523, DOI 10.1083/jcb.118.6.1523; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Coito A J, 2000, Dev Immunol, V7, P239, DOI 10.1155/2000/98187; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; FFRENCHCONSTANT C, 1995, EXP CELL RES, V221, P261, DOI 10.1006/excr.1995.1374; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822; HAUTANEN A, 1989, J BIOL CHEM, V264, P1437; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Hynes RO, 1990, FIBRONECTINS; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; JOHANSSON S, 1980, BIOCHEM J, V187, P521, DOI 10.1042/bj1870521; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Mitrovic S, 1995, Srp Arh Celok Lek, V123, P198; Moretti FA, 2007, J BIOL CHEM, V282, P28057, DOI 10.1074/jbc.M611315200; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; PROCKOP DJ, 1994, EXTRACELLULAR MATRIX, P47; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; SEKIGUCHI K, 1986, BIOCHEMISTRY-US, V25, P4936, DOI 10.1021/bi00365a032; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113	49	65	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25879	25888		10.1074/jbc.M109.024125	http://dx.doi.org/10.1074/jbc.M109.024125			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617627	hybrid, Green Published			2022-12-27	WOS:000269738000045
J	Lubelski, J; Khusainov, R; Kuipers, OP				Lubelski, Jacek; Khusainov, Rustem; Kuipers, Oscar P.			Directionality and Coordination of Dehydration and Ring Formation during Biosynthesis of the Lantibiotic Nisin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOCOCCUS-LACTIS; POSTTRANSLATIONAL MODIFICATION; PEPTIDES; TRANSPORTER; PRENISIN; CYCLASE; LACTOBACILLUS; RESIDUES; IMMUNITY; COMPLEX	The lantibiotic nisin is a potent antimicrobial substance, which contains unusual lanthionine rings and dehydrated amino acid residues and is produced by Lactococcus lactis. Recently, the nisin biosynthetic machinery has been applied to introduce lanthionine rings in peptides other than nisin with potential therapeutic use. Due to difficulties in the isolation of the proposed synthetase complex (NisBTC), mechanistic information concerning the enzymatic biosynthesis of nisin is scarce. Here, we present the molecular characterization of a number of nisin mutants that affect ring formation. We have investigated in a systematic manner how these mutations influence dehydration events, which are performed enzymatically by the dehydratase NisB. Specific mutations that hampered ring formation allowed for the dehydration of serine residues that directly follow the rings and are normally unmodified. The combined information leads to the conclusion that 1) nisin biosynthesis is an organized directional process that starts at the N terminus of the molecule and continues toward the C terminus, and 2) NisB and NisC are alternating enzymes, whose activities follow one after another in a repetitive way. Thus, the dehydration and cyclization processes are not separated in time and space. On the basis of these results and previous knowledge, a working model for the sequence of events in the maturation of nisin is proposed.	[Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, NL-9751 NN Haren, Netherlands; Kluyver Ctr Genom Ind Fermentat, NL-9751 NN Haren, Netherlands	University of Groningen	Kuipers, OP (corresponding author), Univ Groningen, Dept Mol Genet, Kerklaan 30, NL-9751 NN Haren, Netherlands.	o.p.kuipers@rug.nl	Lubelski, Jacek/D-8639-2013; Khusainov, Rustem/E-1859-2012; Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735	Stichtling Technische Wetenschnappen [6927]; Aarden Levenswetenschappen-Nederlandse Organisatie voor Wetenschappelijk Onderzoek [816.02.005]	Stichtling Technische Wetenschnappen; Aarden Levenswetenschappen-Nederlandse Organisatie voor Wetenschappelijk Onderzoek	Supported by a grant from Stichtling Technische Wetenschnappen, Project 6927.; Supported by a grant from Aarden Levenswetenschappen-Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Project 816.02.005.	Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; ENGELKE G, 1992, APPL ENVIRON MICROB, V58, P3730, DOI 10.1128/AEM.58.11.3730-3743.1992; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Kleerebezem M, 1997, APPL ENVIRON MICROB, V63, P4581, DOI 10.1128/AEM.63.11.4581-4584.1997; Kluskens LD, 2005, BIOCHEMISTRY-US, V44, P12827, DOI 10.1021/bi050805p; Kluskens LD, 2009, J PHARMACOL EXP THER, V328, P849, DOI 10.1124/jpet.108.146431; Koponen O, 2002, MICROBIOL-SGM, V148, P3561, DOI 10.1099/00221287-148-11-3561; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; Kuipers A, 2006, APPL ENVIRON MICROB, V72, P7626, DOI 10.1128/AEM.01802-06; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li B, 2007, J BIOL CHEM, V282, P21169, DOI 10.1074/jbc.M701802200; Li B, 2009, METHOD ENZYMOL, V458, P533, DOI 10.1016/S0076-6879(09)04821-6; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2008, APPL ENVIRON MICROB, V74, P4680, DOI 10.1128/AEM.00112-08; Lubelski J, 2006, MOL MICROBIOL, V61, P771, DOI 10.1111/j.1365-2958.2006.05267.x; Ra R, 1999, MICROBIOL-SGM, V145, P1227, DOI 10.1099/13500872-145-5-1227; Rink R, 2005, BIOCHEMISTRY-US, V44, P8873, DOI 10.1021/bi050081h; Rink R, 2007, BIOCHEMISTRY-US, V46, P13179, DOI 10.1021/bi700106z; Rink R, 2007, APPL ENVIRON MICROB, V73, P5809, DOI 10.1128/AEM.01104-07; Rink R, 2007, APPL ENVIRON MICROB, V73, P1792, DOI 10.1128/AEM.02350-06; Rogers LA, 1928, J BACTERIOL, V16, P321, DOI 10.1128/JB.16.5.321-325.1928; Sambrook J., 2002, MOL CLONING LAB MANU; Siegers K, 1996, J BIOL CHEM, V271, P12294, DOI 10.1074/jbc.271.21.12294; van Saparoea HBV, 2008, APPL ENVIRON MICROB, V74, P5541, DOI 10.1128/AEM.00342-08	25	64	67	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25962	25972		10.1074/jbc.M109.026690	http://dx.doi.org/10.1074/jbc.M109.026690			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19620240	hybrid, Green Published			2022-12-27	WOS:000269738000053
J	Rytinki, MM; Palvimo, JJ				Rytinki, Miia M.; Palvimo, Jorma J.			SUMOylation Attenuates the Function of PGC-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES TRANSCRIPTIONAL REPRESSION; GAMMA COACTIVATOR 1-ALPHA; METABOLIC REGULATOR; ANDROGEN RECEPTOR; MODIFIER-1 SUMO-1; UBIQUITIN; PROTEIN; ACTIVATION; SIRT1; PGC-1	Peroxisome proliferator-activated receptor gamma-coactivator-1 alpha (PGC-1 alpha) is a key coordinator of gene programs in metabolism and energy homeostasis in mammals. It is highly responsive to changes in the cellular environment and physiological status of mammals and regulated by post-translational modifications: acetylation, phosphorylation, and methylation. Here, we show that PGC-1 alpha is covalently modified by small ubiquitin-like modifier (SUMO) 1 protein, an important regulator of signaling and transcription. Conserved lysine residue 183 located in the activation domain of PGC-1 alpha was identified as the major site of SUMO conjugation. Interestingly, the same Lys residue is also a target for acetylation. Therefore, the E185A mutation disrupting the SUMOylation consensus sequence was utilized to show that SUMOylation plays a role in the regulation of PGC-1 alpha function. Our results show that SUMOylation does not have an apparent effect on the subcellular localization or the stability of PGC-1 alpha, but it attenuates the transcriptional activity of the coactivator, probably by enhancing the interaction of PGC-1 alpha with corepressor RIP140. Mutation that abolished the SUMOylation augments the activity of PGC-1 alpha also in the context of PPAR gamma-dependent transcription. Thus, our findings showing that reversible SUMOylation can adjust the activity of PGC-1 alpha add a novel layer to the regulation of the coactivator.	[Rytinki, Miia M.; Palvimo, Jorma J.] Univ Kuopio, Inst Biomed Med Biochem, FI-70211 Kuopio, Finland	University of Eastern Finland	Palvimo, JJ (corresponding author), Univ Kuopio, Inst Biomed Med Biochem, POB 1627, FI-70211 Kuopio, Finland.	jorma.palvimo@uku.fi		Palvimo, Jorma/0000-0003-2373-0578	Academy of Finland; Finnish Cancer Foundation; Sigrid Juselius Foundation; Kuopio Graduate School of Molecular Medicine; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Kuopio Graduate School of Molecular Medicine; Emil Aaltonen Foundation	This work was supported by the Academy of Finland, the Finnish Cancer Foundation, the Sigrid Juselius Foundation, the Kuopio Graduate School of Molecular Medicine, and the Emil Aaltonen Foundation.	Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; HALLBERG M, 2008, MOL CELL BIOL; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; KAIKKONEN S, 2008, MOL ENDOCRINOL; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Kotaja N, 2000, MOL ENDOCRINOL, V14, P1986, DOI 10.1210/me.14.12.1986; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Molnar F, 2005, J BIOL CHEM, V280, P26543, DOI 10.1074/jbc.M502463200; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rytinki MM, 2008, J BIOL CHEM, V283, P11586, DOI 10.1074/jbc.M709359200; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Spengler ML, 2005, CELL SIGNAL, V17, P153, DOI 10.1016/j.cellsig.2004.06.007; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; Vertegaal ACO, 2007, BIOCHEM SOC T, V35, P1422, DOI 10.1042/BST0351422; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	50	79	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26184	26193		10.1074/jbc.M109.038943	http://dx.doi.org/10.1074/jbc.M109.038943			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19625249	Green Published, hybrid			2022-12-27	WOS:000269738000073
J	van den Beucken, T; Koritzinsky, M; Niessen, H; Dubois, L; Savelkouls, K; Mujcic, H; Jutten, B; Kopacek, J; Pastorekova, S; van der Kogel, AJ; Lambin, P; Voncken, W; Rouschop, KMA; Wouters, BG				van den Beucken, Twan; Koritzinsky, Marianne; Niessen, Hanneke; Dubois, Ludwig; Savelkouls, Kim; Mujcic, Hilda; Jutten, Barry; Kopacek, Juraj; Pastorekova, Sylvia; van der Kogel, Albert J.; Lambin, Philippe; Voncken, Willem; Rouschop, Kasper M. A.; Wouters, Bradly G.			Hypoxia-induced Expression of Carbonic Anhydrase 9 Is Dependent on the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL CONTROL; GENE-EXPRESSION; TUMOR HYPOXIA; TRANSCRIPTIONAL REGULATION; ENDOPLASMIC-RETICULUM; PIMONIDAZOLE BINDING; HISTONE DEMETHYLASES; INDUCIBLE EXPRESSION; STRESS-RESPONSE; MELANOMA-CELLS	Adaptation to tumor hypoxia is mediated in large part by changes in protein expression. These are driven by multiple pathways, including activation of the hypoxia inducible factor-1 (HIF-1) transcription factor and the PKR-like endoplasmic reticulum kinase PERK, a component of the unfolded protein response. Through gene expression profiling we discovered that induction of the HIF-1 target gene CA9 was defective in mouse embryo fibroblasts derived from mice harboring an eIF2 alpha S51A knock-in mutation. This finding was confirmed in two isogenic human cell lines with an engineered defect in eIF2 alpha phosphorylation. We show that impaired CA9 expression was not due to changes in HIF activity or CA9 mRNA stability. Using chromatin immunoprecipitation we show that the eIF2 alpha-dependent translationally regulated gene ATF4 binds directly to the CA9 promoter and is associated with loss of the transcriptional repressive histone 3 lysine 27 tri-methylation mark. Loss or overexpression of ATF4 confirmed its role in CA9 induction during hypoxia. Our data indicate that expression of CA9 is regulated through both the HIF-1 and unfolded protein response hypoxia response pathways in vitro and in vivo.	[van den Beucken, Twan; Koritzinsky, Marianne; Wouters, Bradly G.] Princess Margaret Hosp, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 2M9, Canada; [van den Beucken, Twan; Koritzinsky, Marianne; Dubois, Ludwig; Savelkouls, Kim; Mujcic, Hilda; Jutten, Barry; Lambin, Philippe; Rouschop, Kasper M. A.; Wouters, Bradly G.] Maastricht Univ, Dept Radiat Oncol, Maastro Lab, NL-6200 MD Maastricht, Netherlands; [Niessen, Hanneke; Voncken, Willem] Maastricht Univ, Dept Mol Genet, GROW Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Netherlands; [van der Kogel, Albert J.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6500 HB Nijmegen, Netherlands; [Kopacek, Juraj; Pastorekova, Sylvia] Slovak Acad Sci, Inst Virol, Ctr Mol Med, Bratislava 84505, Slovakia; [Koritzinsky, Marianne; Wouters, Bradly G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON M5S 1A8, Canada; [Wouters, Bradly G.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Wouters, Bradly G.] Ontario Inst Canc Res, Select Therapeut Program, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Maastricht University; Maastricht University; Radboud University Nijmegen; Slovak Academy of Sciences; University of Toronto; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Wouters, BG (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Div Signaling Biol, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	bwouters@uhnresearch.ca	Wouters, Bradly/T-1525-2017; Pastorekova, Silvia/C-6685-2018; Kopacek, Juraj/GRF-4984-2022; Niessen, Hanneke/B-7699-2009; van der Kogel, A.J./L-4441-2015	Wouters, Bradly/0000-0002-8187-592X; Niessen, Hanneke/0000-0002-2639-0938; van den Beucken, Twan/0000-0002-2233-7558; Kopacek, Juraj/0000-0003-3069-646X; Koritzinsky, Marianne/0000-0003-0547-2480; Lambin, Philippe/0000-0001-7961-0191; Rouschop, Kasper/0000-0002-4208-5415	Dutch Science Organization [912-03-047, 908-02-040, 016.046.362]; Dutch Cancer Society [2003-2821]; European Union 6th framework program; ZonMW VENI [016.056.015, 916.76.158]	Dutch Science Organization; Dutch Cancer Society(KWF Kankerbestrijding); European Union 6th framework program(European Commission); ZonMW VENI	This work was supported by the Dutch Science Organization (ZonMW-NWO Top Grant 912-03-047 to B. W. and Grants 908-02-040 and 016.046.362 to J. W. V.), the Dutch Cancer Society (KWF Grant UM 2003-2821 to B. W.), the European Union 6th framework program (Euroxy program to B. W.), and ZonMW VENI Grants 016.056.015 (to M. K.) and 916.76.158 (to K. R.).	Airley RE, 2003, INT J CANCER, V104, P85, DOI 10.1002/ijc.10904; Beasley NJP, 2001, CANCER RES, V61, P5262; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Dubois L, 2007, RADIOTHER ONCOL, V83, P367, DOI 10.1016/j.radonc.2007.04.018; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Jankovic B, 2006, CYTOM PART B-CLIN CY, V70B, P45, DOI 10.1002/cyto.b.20086; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Kaluz S, 1999, J BIOL CHEM, V274, P32588, DOI 10.1074/jbc.274.46.32588; Kaluz S, 2006, J CELL BIOCHEM, V97, P207, DOI 10.1002/jcb.20633; Kaluz S, 2002, CANCER RES, V62, P4469; Kopacek J, 2005, BBA-GENE STRUCT EXPR, V1729, P41, DOI 10.1016/j.bbaexp.2005.03.003; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koritzinsky M, 2007, RADIOTHER ONCOL, V83, P353, DOI 10.1016/j.radonc.2007.04.031; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Liang GS, 1997, J BIOL CHEM, V272, P24088, DOI 10.1074/jbc.272.38.24088; Lieskovska J, 1999, NEOPLASMA, V46, P17; Magagnin MG, 2006, DRUG RESIST UPDATE, V9, P185, DOI 10.1016/j.drup.2006.07.002; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Moellering RE, 2008, CLIN EXP METASTAS, V25, P411, DOI 10.1007/s10585-008-9145-7; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S, 2006, ADV CLIN CHEM, V42, P167, DOI 10.1016/S0065-2423(06)42005-9; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Rijken PEJW, 2002, RADIAT RES, V157, P626, DOI 10.1667/0033-7587(2002)157[0626:QAOVPO]2.0.CO;2; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sobhanifar S, 2005, CANCER RES, V65, P7259, DOI 10.1158/0008-5472.CAN-04-4480; Sok J, 1999, MOL CELL BIOL, V19, P495; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2008, BJU INT, V101, P22, DOI 10.1111/j.1464-410X.2008.07644.x; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Troost EGC, 2005, RADIOTHER ONCOL, V76, P194, DOI 10.1016/j.radonc.2005.06.031; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wykoff CC, 2000, CANCER RES, V60, P7075	54	45	45	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24204	24212		10.1074/jbc.M109.006510	http://dx.doi.org/10.1074/jbc.M109.006510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19564335	hybrid, Green Published			2022-12-27	WOS:000269380200034
J	Wu, RY; Richter, S; Zhang, RG; Anderson, VJ; Missiakas, D; Joachimiak, A				Wu, Ruiying; Richter, Stefan; Zhang, Rong-guang; Anderson, Valerie J.; Missiakas, Dominique; Joachimiak, Andrzej			Crystal Structure of Bacillus anthracis Transpeptidase Enzyme CapD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; LETHAL FACTOR; ESCHERICHIA-COLI; FUSION PROTEINS; CAPSULE; MODEL; EXPRESSION; MECHANISM; PROTEASE; PLASMID	Bacillus anthracis elaborates a poly-gamma-D-glutamic acid capsule that protects bacilli from phagocytic killing during infection. The enzyme CapD generates amide bonds with peptidoglycan cross-bridges to anchor capsular material within the cell wall envelope of B. anthracis. The capsular biosynthetic pathway is essential for virulence during anthrax infections and can be targeted for anti-infective inhibition with small molecules. Here, we present the crystal structures of the gamma-glutamyltranspeptidase CapD with and without alpha-L-Glu-L-Glu dipeptide, a non-hydrolyzable analog of poly-gamma-D-glutamic acid, in the active site. Purified CapD displays transpeptidation activity in vitro, and its structure reveals an active site broadly accessible for poly-gamma-glutamate binding and processing. Using structural and biochemical information, we derive a mechanistic model for CapD catalysis whereby Pro(427), Gly(428), and Gly(429) activate the catalytic residue of the enzyme, Thr(352), and stabilize an oxyanion hole via main chain amide hydrogen bonds.	[Richter, Stefan; Anderson, Valerie J.; Missiakas, Dominique] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Wu, Ruiying; Zhang, Rong-guang; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; [Wu, Ruiying; Zhang, Rong-guang; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Missiakas, D (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	dmissiak@bsd.uchicago.edu; andrzejj@anl.gov			National Institutes of Health [GM074942, AI057153]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM074942 and AI057153 (to A. J.). The work was also supported by the U.S. Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357 (to A. J.).	Ashiuchi M, 2001, EUR J BIOCHEM, V268, P5321, DOI 10.1046/j.0014-2956.2001.02475.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Boanca G, 2006, J BIOL CHEM, V281, P19029, DOI 10.1074/jbc.M603381200; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Ikeda Y, 2005, METHOD ENZYMOL, V401, P408, DOI 10.1016/S0076-6879(05)01025-6; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Keillor JW, 2005, METHOD ENZYMOL, V401, P449, DOI 10.1016/S0076-6879(05)01027-X; Kimura K, 2004, MICROBIOL-SGM, V150, P4115, DOI 10.1099/mic.0.27467-0; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Okada T, 2007, J BIOL CHEM, V282, P2433, DOI 10.1074/jbc.M607490200; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pasteur L., 1881, C R ACAD SCI AGR BUL, V92, P429; Richter S, 2009, MOL MICROBIOL, V71, P404, DOI 10.1111/j.1365-2958.2008.06533.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; STERNE M, 1988, J AM VET MED ASSOC, V192, P141; Sterne M, 1937, ONDERSTEPOORT J VET, V21, P41; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; TURNBULL PCB, 1992, J APPL BACTERIOL, V72, P21; UCHIDA I, 1993, MOL MICROBIOL, V9, P487, DOI 10.1111/j.1365-2958.1993.tb01710.x; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1168, DOI 10.1107/S0907444999003698	36	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24406	24414		10.1074/jbc.M109.019034	http://dx.doi.org/10.1074/jbc.M109.019034			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19535342	hybrid, Green Published			2022-12-27	WOS:000269380200053
J	Bianco, S; Lanvin, O; Tribollet, V; Macari, C; North, S; Vanacker, JM				Bianco, Stephanie; Lanvin, Olivia; Tribollet, Violaine; Macari, Claire; North, Sophie; Vanacker, Jean-Marc			Modulating Estrogen Receptor-related Receptor-alpha Activity Inhibits Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INDEPENDENT TRANSCRIPTIONAL ACTIVATION; ERR-ALPHA; THERAPEUTIC TARGET; GENE-TRANSCRIPTION; NUCLEAR RECEPTORS; PROSTATE-CANCER; ORPHAN RECEPTOR; SP1 SITES; EXPRESSION	High expression of the estrogen receptor-related receptor (ERR)-alpha in human tumors is correlated to a poor prognosis, suggesting an involvement of the receptor in cell proliferation. In this study, we show that a synthetic compound (XCT790) that modulates the activity of ERR alpha reduces the proliferation of various cell lines and blocks the G(1)/S transition of the cell cycle in an ERR alpha-dependent manner. XCT790 induces, in a p53-independent manner, the expression of the cell cycle inhibitor p21(waf/cip1) at the protein, mRNA, and promoter level, leading to an accumulation of hypophosphorylated Rb. Finally, XCT790 reduces cell tumorigenicity in Nude mice.	[Bianco, Stephanie; Lanvin, Olivia; Tribollet, Violaine; Macari, Claire; Vanacker, Jean-Marc] Univ Lyon 1, Inst Genom Fonct Lyon, INRA, Ecole Normale Super Lyon,CNRS, F-69364 Lyon 07, France; [North, Sophie] Univ Bordeaux 1, F-33400 Talence, France; [North, Sophie] INSERM, U920, F-33400 Talence, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vanacker, JM (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, INRA, Ecole Normale Super Lyon,CNRS, 46 Allee Italie, F-69364 Lyon 07, France.	Jean-Marc.Vanacker@ens-lyon.fr			Ligue Contre le Cancer (Comites Languedoc-Roussillon, Loire and Rhone); Association pour la Recherche sur le Cancer; Association pour la Recherche sur les Tumeurs de la Prostate; Institut National du Cancer	Ligue Contre le Cancer (Comites Languedoc-Roussillon, Loire and Rhone); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Association pour la Recherche sur les Tumeurs de la Prostate; Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by Ligue Contre le Cancer (Comites Languedoc-Roussillon, Loire and Rhone), Association pour la Recherche sur le Cancer, Association pour la Recherche sur les Tumeurs de la Prostate, and Institut National du Cancer.	Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Ariazi EA, 2002, CANCER RES, V62, P6510; Balaguer P, 2001, LUMINESCENCE, V16, P153, DOI 10.1002/bio.630; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bonnelye E, 1997, MECH DEVELOP, V65, P71, DOI 10.1016/S0925-4773(97)00059-2; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Carrier JC, 2004, J BIOL CHEM, V279, P52052, DOI 10.1074/jbc.M410337200; Carroll JS, 2003, CANCER RES, V63, P4322; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Laudet V, 2002, NUCL RECEPTOR FACTSB; Lin NU, 2008, J CLIN ONCOL, V26, P798, DOI 10.1200/JCO.2007.15.0946; Lu DS, 2001, CANCER RES, V61, P6755; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Nichol D, 2006, J BIOL CHEM, V281, P32140, DOI 10.1074/jbc.M604803200; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Suetsugi M, 2003, MOL CANCER RES, V1, P981; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Teyssier C, 2008, NUCLEIC ACIDS RES, V36, P5350, DOI 10.1093/nar/gkn520; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Varshochi R, 2005, J BIOL CHEM, V280, P3185, DOI 10.1074/jbc.M408063200; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; WU F, 2009, CHEM BIOL I IN PRESS; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855	43	74	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23286	23292		10.1074/jbc.M109.028191	http://dx.doi.org/10.1074/jbc.M109.028191			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19546226	Green Published, hybrid			2022-12-27	WOS:000269180000013
J	Eto, K; Eda, K; Hayano, M; Goto, S; Nagao, K; Kawasaki, T; Kashimura, H; Tarui, H; Nishimura, O; Agata, K; Abe, S				Eto, Ko; Eda, Kazufumi; Hayano, Motoshi; Goto, Syota; Nagao, Kenta; Kawasaki, Toshihiro; Kashimura, Hiroshi; Tarui, Hiroshi; Nishimura, Osamu; Agata, Kiyokazu; Abe, Shin-ichi			Reduced Expression of an RNA-binding Protein by Prolactin Leads to Translational Silencing of Programmed Cell Death Protein 4 and Apoptosis in Newt Spermatogonia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR PDCD4; MESSENGER-RNA; EUKARYOTIC TRANSLATION; MEIOSIS INITIATION; HNRNP A1; GENE; CYCLOOXYGENASE-2; RICH; TRANSFORMATION; TEMPERATURE	Recent studies indicate that the balance between cell survival and proapoptotic signals determines which cells commit to life or death. We have shown that the balance between follicle-stimulating hormone and prolactin determines differentiation or apoptosis in 7th generation spermatogonia during newt spermatogenesis; however, the molecular mechanisms specifying their fate are poorly understood. Here we show that the newt RNA-binding protein (nRBP) plays a critical role in determining their fate. nRBP was identified as a clone whose mRNA is decreased by prolactin, resulting in the reduction of the protein, which is otherwise expressed predominantly in the spermatogonia. nRBP protein associated with the mRNA for newt programmed cell death protein 4 (nPdcd4) at the 3'-untranslated region. nRBP reduction increased nPdcd4 mRNA but decreased its protein. In a cell-free system, cytoplasmic extracts containing reduced amounts of nRBP and nPdcd4 protein induced apoptosis, whereas adding nRBP protein to the extracts blocked apoptosis. Furthermore, overexpression of nRBP protected cells from apoptosis, stabilized the chimeric transcript containing the nPdcd4 3'-untranslated region, and accelerated its translation. These data suggest that, in the absence of nRBP, nPdcd4 mRNA is not stabilized and its translation is suppressed, leading to apoptosis in the spermatogonia.	[Eto, Ko; Eda, Kazufumi; Hayano, Motoshi; Goto, Syota; Nagao, Kenta; Kawasaki, Toshihiro; Kashimura, Hiroshi; Abe, Shin-ichi] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan; [Tarui, Hiroshi; Nishimura, Osamu; Agata, Kiyokazu] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan	Kumamoto University; RIKEN; Kyoto University	Eto, K (corresponding author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan.	etoko@gpo.kumamoto-u.ac.jp	Nishimura, Osamu/AAC-1236-2020	Nishimura, Osamu/0000-0003-1969-2580; Hayano, Motoshi/0000-0001-6453-2741; Agata, Kiyokazu/0000-0002-5195-2576				Abe S, 2004, ZOOL SCI, V21, P691, DOI 10.2108/zsj.21.691; Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Azzoni L, 1998, J IMMUNOL, V161, P3493; Bhatia R, 1999, CELL TISSUE RES, V297, P283, DOI 10.1007/s004410051356; Callard Gloria Vincz, 1991, P303; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Danno S, 2000, AM J PATHOL, V156, P1685, DOI 10.1016/S0002-9440(10)65039-0; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; DERRY JMJ, 1995, HUM MOL GENET, V4, P2307, DOI 10.1093/hmg/4.12.2307; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Eto K, 2006, BIOCHEM BIOPH RES CO, V350, P263, DOI 10.1016/j.bbrc.2006.09.028; Goke A, 2002, BIOCHEM BIOPH RES CO, V297, P78, DOI 10.1016/S0006-291X(02)02129-0; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Kita H, 2002, HUM MOL GENET, V11, P2279, DOI 10.1093/hmg/11.19.2279; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Macdonald P, 2001, CURR OPIN CELL BIOL, V13, P326, DOI 10.1016/S0955-0674(00)00215-5; MARTIN SJ, 1995, EMBO J, V14, P5191, DOI 10.1002/j.1460-2075.1995.tb00203.x; Matsumoto K, 2000, NUCLEIC ACIDS RES, V28, P4689, DOI 10.1093/nar/28.23.4689; MICHAEL WM, 1995, CELL, V83, P415; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Nishiyama H, 1997, GENE, V204, P115, DOI 10.1016/S0378-1119(97)00530-1; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Onishi Y, 1998, GENE, V215, P453, DOI 10.1016/S0378-1119(98)00313-8; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; Saribek B, 2006, BIOCHEM BIOPH RES CO, V349, P1190, DOI 10.1016/j.bbrc.2006.08.143; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Uochi T, 1998, GENE, V211, P245, DOI 10.1016/S0378-1119(98)00102-4; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yazawa T, 1999, GEN COMP ENDOCR, V113, P302, DOI 10.1006/gcen.1998.7207; Yazawa T, 2000, ENDOCRINOLOGY, V141, P2027, DOI 10.1210/en.141.6.2027; Yazawa T, 2002, BIOL REPROD, V66, P14, DOI 10.1095/biolreprod66.1.14	42	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23260	23271		10.1074/jbc.M109.018622	http://dx.doi.org/10.1074/jbc.M109.018622			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19556246	hybrid, Green Published			2022-12-27	WOS:000269180000011
J	Franzke, CW; Bruckner-Tuderman, L; Blobel, CP				Franzke, Claus-Werner; Bruckner-Tuderman, Leena; Blobel, Carl P.			Shedding of Collagen XVII/BP180 in Skin Depends on Both ADAM10 and ADAM9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA; TRANSMEMBRANE PROTEINS; OXIDATIVE STRESS; CELL-SURFACE; MICE LACKING; EXPRESSION; DISINTEGRIN; ECTODOMAIN; XVII; KERATINOCYTES	Collagen XVII is a transmembrane collagen and the major autoantigen of the autoimmune skin blistering disease bullous pemphigoid. Collagen XVII is proteolytically released from the membrane, and the pathogenic epitope harbors the cleavage site for its ectodomain shedding, suggesting that proteolysis has an important role in regulating the function of collagen XVII in skin homeostasis. Previous studies identified ADAMs 9, 10, and 17 as candidate collagen XVII sheddases and suggested that ADAM17 is a major sheddase. Here we show that ADAM17 only indirectly affects collagen XVII shedding and that ADAMs9 and 10 are the most prominent collagen XVII sheddases in primary keratinocytes because (a) collagen XVII shedding was not stimulated by phorbol esters, known activators of ADAM17, (b) constitutive and calcium influx-stimulated shedding was sensitive to the ADAM10-selective inhibitor GI254023X and was strongly reduced in Adam10(-/-) cells, (c) there was a 55% decrease in constitutive collagen XVII ectodomain shedding from Adam9(-/-) keratinocytes, and (d) H2O2 enhanced ADAM9 expression and stimulated collagen XVII shedding in skin and keratinocytes of wild type mice but not of Adam9(-/-) mice. We conclude that ADAM9 and ADAM10 can both contribute to collagen XVII shedding in skin with an enhanced relative contribution of ADAM9 in the presence of reactive oxygen species. These results provide critical new insights into the identity and regulation of the major sheddases for collagen XVII in keratinocytes and skin and have implications for the treatment of blistering diseases of the skin.	[Franzke, Claus-Werner; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Franzke, Claus-Werner; Bruckner-Tuderman, Leena] Univ Freiburg, Dept Dermatol, D-79104 Freiburg, Germany; [Bruckner-Tuderman, Leena] Sch Life Sci, Freiburg Inst Adv Studies, D-79085 Freiburg, Germany	University of Freiburg	Blobel, CP (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, Caspary Res Bldg,Rm 426,535 E 70th St, New York, NY 10021 USA.	blobelc@hss.edu			National Institutes of Health [GM64750]; German Research Foundation; Deutsche Forschungsgemeinschaft (DFG) [FR 2524/1, Br 1475/9-1]; German Network Epidermolysis bullosa; Emerald Foundation; Excellence Initiative of the German Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Network Epidermolysis bullosa; Emerald Foundation; Excellence Initiative of the German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM64750 (to C. P. B.). This work was also supported by scholarships from the German Research Foundation, Deutsche Forschungsgemeinschaft (DFG) (Grant FR 2524/1), the German Network Epidermolysis bullosa, and the Emerald Foundation (to C.-W.F.) and by the Excellence Initiative of the German Research Foundation (Freiburg Institute for Advanced Studies School of Life Sciences) and DFG Grant Br 1475/9-1 (to L.B.-T).	Areida SK, 2001, J BIOL CHEM, V276, P1594, DOI 10.1074/jbc.M008709200; Aumailley Monique, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000123; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borradori L, 1997, J CELL BIOL, V136, P1333, DOI 10.1083/jcb.136.6.1333; BRUCKNERTUDERMAN L, 1987, EUR J BIOCHEM, V165, P607, DOI 10.1111/j.1432-1033.1987.tb11483.x; Caldelari R, 2000, J INVEST DERMATOL, V114, P1064, DOI 10.1046/j.1523-1747.2000.00960-4.x; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Franzke CW, 2004, J BIOL CHEM, V279, P24521, DOI 10.1074/jbc.M308835200; Franzke CW, 2003, MATRIX BIOL, V22, P299, DOI 10.1016/S0945-053X(03)00051-9; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Horiuchi K, 2003, MOL CELL BIOL, V23, P5614, DOI 10.1128/MCB.23.16.5614-5624.2003; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Karan D, 2003, INT J ONCOL, V23, P1365; Kawaguchi N, 2007, J CELL SCI, V120, P943, DOI 10.1242/jcs.03403; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; Ko SY, 2007, CANCER LETT, V245, P33, DOI 10.1016/j.canlet.2005.10.019; Kondo S, 1994, Exp Dermatol, V3, P29, DOI 10.1111/j.1600-0625.1994.tb00263.x; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; LI KH, 1993, J BIOL CHEM, V268, P8825; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2008, J INVEST DERMATOL, V128, P1737, DOI 10.1038/sj.jid.5701242; McLaughlin SH, 1998, MATRIX BIOL, V16, P369, DOI 10.1016/S0945-053X(98)90010-5; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Myers SR, 2007, WOUND REPAIR REGEN, V15, P693, DOI 10.1111/j.1524-475X.2007.00297.x; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Raychaudhuri SP, 1999, ACTA DERM-VENEREOL, V79, P9; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937; Schlondorff J, 1999, J CELL SCI, V112, P3603; Scholz F, 2007, J INVEST DERMATOL, V127, P1444, DOI 10.1038/sj.jid.5700751; Schumann H, 2000, AM J PATHOL, V156, P685, DOI 10.1016/S0002-9440(10)64772-4; Shigemura K, 2007, PROSTATE, V67, P722, DOI 10.1002/pros.20565; Sung SY, 2006, CANCER RES, V66, P9519, DOI 10.1158/0008-5472.CAN-05-4375; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; Van den Bergh Francoise, 2003, Adv Dermatol, V19, P37; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Worley JR, 2003, J BIOL CHEM, V278, P51340, DOI 10.1074/jbc.M310865200; Yancey KB, 2005, J CLIN INVEST, V115, P825, DOI 10.1172/JCI200524855; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	51	70	74	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23386	23396		10.1074/jbc.M109.034090	http://dx.doi.org/10.1074/jbc.M109.034090			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574220	Green Published, hybrid			2022-12-27	WOS:000269180000023
J	Kaur, J; Bachhawat, AK				Kaur, Jaspreet; Bachhawat, Anand K.			Gln-222 in Transmembrane Domain 4 and Gln-526 in Transmembrane Domain 9 Are Critical for Substrate Recognition in the Yeast High Affinity Glutathione Transporter, Hgt1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE-GUANOSINE TRANSPORTER; MEMBRANE-PROTEIN STRUCTURE; AMINO-ACID-RESIDUES; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; OLIGOPEPTIDE TRANSPORTERS; CONFORMATIONAL-CHANGES; TOPOLOGY PREDICTION; LEISHMANIA-DONOVANI; CRYSTAL-STRUCTURE	Hgt1p, a member of the oligopeptide transporter family, is a high affinity glutathione transporter from the yeast Saccharomyces cerevisiae. We have explored the role of polar or charged residues in the putative transmembrane domains of Hgt1p to obtain insights into the structural features of Hgt1p that govern its substrate specificity. A total of 22 charged and polar residues in the predicted transmembrane domains and other conserved regions were subjected to alanine mutagenesis. Functional characterization of these 22 mutants identified 11 mutants which exhibited significant loss in functional activity. All 11 mutants except T114A had protein expression levels comparable with wild type, and all except E744A were proficient in trafficking to the cell surface. Kinetic analyses revealed differential contributions toward the functional activity of Hgt1p by these residues and identified Asn-124 in transmembrane domain 1 (TMD1), Gln-222 in TMD4, Gln-526 in TMD9, and Glu-544, Arg-554, and Lys-562 in the intracellular loop region 537-568 containing the highly conserved proline-rich motif to be essential for the transport activity of the protein. Furthermore, mutants Q222A and Q526A exhibited a nearly 4- and 8-fold increase in the K-m for glutathione. Interestingly, although Gln-222 is widely conserved among other functionally characterized oligopeptide transporter family members including those having a different substrate specificity, Gln-526 is present only in Hgt1p and Pgt1, the only two known high affinity glutathione transporters. These results provide the first insights into the substrate recognition residues of a high affinity glutathione transporter and on residues/helices involved in substrate translocation in the structurally uncharacterized oligopeptide transporter family.	[Kaur, Jaspreet; Bachhawat, Anand K.] Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Bachhawat, AK (corresponding author), Inst Microbial Technol, Sector 39-A, Chandigarh 160036, India.	anand@imtech.res.in			Department of Biotechnology and Departments of Science and Technology, Government of India	Department of Biotechnology and Departments of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaDepartment of Science & Technology (India))	This work was supported by grant-in-aid projects (to A. K. B.) from the Department of Biotechnology and Departments of Science and Technology, Government of India.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Falcon-Perez JM, 1999, J BIOL CHEM, V274, P23584, DOI 10.1074/jbc.274.33.23584; Falcon-Perez JM, 2001, J BACTERIOL, V183, P4761, DOI 10.1128/JB.183.16.4761-4770.2001; Fann MC, 1998, J MEMBRANE BIOL, V164, P187, DOI 10.1007/s002329900404; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Haimeur A, 2004, MOL PHARMACOL, V65, P1375, DOI 10.1124/mol.65.6.1375; Hauser M, 2000, J BIOL CHEM, V275, P3037, DOI 10.1074/jbc.275.5.3037; Hauser M, 2005, MOL MEMBR BIOL, V22, P215, DOI 10.1080/09687860500093248; Hiniker A, 2006, J BACTERIOL, V188, P7317, DOI 10.1128/JB.00383-06; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kasahara M, 1998, J BIOL CHEM, V273, P29106, DOI 10.1074/jbc.273.44.29106; Kasahara M, 1997, J BIOL CHEM, V272, P16721, DOI 10.1074/jbc.272.27.16721; KAUR J, 2009, FEMS YEAST IN PRESS; Kaur J, 2009, ANAL BIOCHEM, V384, P348, DOI 10.1016/j.ab.2008.10.005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; Lubkowitz MA, 1998, MOL MICROBIOL, V28, P729, DOI 10.1046/j.1365-2958.1998.00827.x; Lubkowitz MA, 1997, MICROBIOL-UK, V143, P387, DOI 10.1099/00221287-143-2-387; Lubkowitz Mark, 2006, Genet Eng (N Y), V27, P35, DOI 10.1007/0-387-25856-6_3; Miyake T, 2002, MOL GENET GENOMICS, V266, P1004, DOI 10.1007/s00438-001-0625-6; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Osawa H, 2006, BIOCHEM J, V393, P267, DOI 10.1042/BJ20050920; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Severance S, 2004, BIOCHEM J, V380, P487, DOI 10.1042/BJ20031921; Srikanth CV, 2005, CURR GENET, V47, P345, DOI 10.1007/s00294-005-0571-7; Stacey MG, 2008, PLANT PHYSIOL, V146, P589, DOI 10.1104/pp.107.108183; Thakur A, 2008, FEMS YEAST RES, V8, P916, DOI 10.1111/j.1567-1364.2008.00423.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Valdes R, 2006, J BIOL CHEM, V281, P22647, DOI 10.1074/jbc.M602366200; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586; Wiles AM, 2006, RES MICROBIOL, V157, P395, DOI 10.1016/j.resmic.2005.10.004; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yen MR, 2001, MICROBIOL-SGM, V147, P2881, DOI 10.1099/00221287-147-11-2881; Yu J, 2008, PROTEINS, V72, P1077, DOI 10.1002/prot.22096	46	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23872	23884		10.1074/jbc.M109.029728	http://dx.doi.org/10.1074/jbc.M109.029728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19589778	Green Published, hybrid			2022-12-27	WOS:000269180000070
J	Koharudin, LMI; Furey, W; Liu, H; Liu, YJ; Gronenborn, AM				Koharudin, Leonardus M. I.; Furey, William; Liu, Hao; Liu, Yong-Jian; Gronenborn, Angela M.			The Phox Domain of Sorting Nexin 5 Lacks Phosphatidylinositol 3-Phosphate (PtdIns(3)P) Specificity and Preferentially Binds to Phosphatidylinositol 4,5-Bisphosphate (PtdIns(4,5)P-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGY PX DOMAIN; CRYSTAL-STRUCTURE; ENDOSOMAL LOCALIZATION; PROTEIN; RETROMER; CLATHRIN; SNX5; VISUALIZATION; CURVATURE; RECEPTORS	Subcellular retrograde transport of cargo receptors from endosomes to the trans-Golgi network is critically involved in a broad range of physiological and pathological processes and highly regulated by a genetically conserved heteropentameric complex, termed retromer. Among the retromer components identified in mammals, sorting nexin 5 and 1 (SNX5; SNX1) have recently been found to interact, possibly controlling the membrane binding specificity of the complex. To elucidate how the unique sequence features of the SNX5 phox domain (SNX5-PX) influence retrograde transport, we have determined the SNX5-PX structure by NMR and x-ray crystallography at 1.5 angstrom resolution. Although the core fold of SNX5-PX resembles that of other known PX domains, we found novel structural features exclusive to SNX5-PX. It is most noteworthy that in SNX5-PX, a long helical hairpin is added to the core formed by a new alpha 2'-helix and a much longer alpha 3-helix. This results in a significantly altered overall shape of the protein. In addition, the unique double PXXP motif is tightly packed against the rest of the protein, rendering this part of the structure compact, occluding parts of the putative phosphatidylinositol (PtdIns) binding pocket. The PtdIns binding and specificity of SNX5-PX was evaluated by NMR titrations with eight different PtdIns and revealed that SNX5-PX preferentially and specifically binds to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2). The distinct structural and PtdIns binding characteristics of SNX5-PX impart specific properties on SNX5, influencing retromer-mediated regulation of retrograde trafficking of transmembrane cargo receptors.	[Koharudin, Leonardus M. I.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Furey, William; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Liu, Hao] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; [Liu, Yong-Jian] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15260 USA; [Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 5th Ave,BST3 Rm 1050, Pittsburgh, PA 15260 USA.	amg100@pitt.edu	Liu, Yongjian/J-7852-2018	Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [MH62092, NS058463]; University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH62092 and NS058463 (to Y. L.). This work was also supported by startup funds from the University of Pittsburgh School of Medicine (to A. M. G.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Choudhury R, 2005, MOL BIOL CELL, V16, P3467, DOI 10.1091/mbc.E05-02-0120; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Cozier GE, 2002, J BIOL CHEM, V277, P48730, DOI 10.1074/jbc.M206986200; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eaton S, 2008, DEV CELL, V14, P4, DOI 10.1016/j.devcel.2007.12.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hara S, 2008, MOL BIOL CELL, V19, P3823, DOI 10.1091/mbc.E08-03-0314; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim JP, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-58; Liu H, 2006, BIOCHEM BIOPH RES CO, V342, P537, DOI 10.1016/j.bbrc.2006.01.179; Mayeux R, 2008, LANCET NEUROL, V7, P2, DOI 10.1016/S1474-4422(07)70298-3; Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561; Nishida N, 2003, NAT STRUCT BIOL, V10, P53, DOI 10.1038/nsb876; Otsuki T, 1999, BIOCHEM BIOPH RES CO, V265, P630, DOI 10.1006/bbrc.1999.1731; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; SATTLER M, 1995, J BIOMOL NMR, V5, P97, DOI 10.1007/BF00227475; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Song JK, 2007, PROTEIN SCI, V16, P807, DOI 10.1110/ps.072752407; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Towler MC, 2004, MOL BIOL CELL, V15, P3181, DOI 10.1091/mbc.E04-03-0249; Verges M, 2008, INT REV CEL MOL BIO, V271, P153, DOI 10.1016/S1937-6448(08)01204-5; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Xu Y, 2001, BIOCHEM J, V360, P513, DOI 10.1042/0264-6021:3600513; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Yoo KW, 2006, FEBS LETT, V580, P4409, DOI 10.1016/j.febslet.2006.07.009; Zhong Q, 2005, MOL BIOL CELL, V16, P2049, DOI 10.1091/mbc.e04-06-0504; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200	59	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23697	23707		10.1074/jbc.M109.008995	http://dx.doi.org/10.1074/jbc.M109.008995			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19553671	hybrid, Green Published			2022-12-27	WOS:000269180000055
J	Wu, Y; Xiong, Y; Wang, S; Yi, H; Li, H; Pan, N; Horrigan, FT; Wu, YL; Ding, JP				Wu, Ying; Xiong, Yu; Wang, Sheng; Yi, Hong; Li, Hui; Pan, Na; Horrigan, Frank T.; Wu, Yingliang; Ding, Jiuping			Intersubunit Coupling in the Pore of BK Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; K+ CHANNEL; VOLTAGE SENSOR; BETA-1 SUBUNIT; CALCIUM; CONDUCTANCE; RESIDUE; FAMILY	The structural basis underlying the gating of large conductance Ca2+-activated K+ (BK) channels remains elusive. We found that substitution of Leu-312 in the S6 transmembrane segment of mSlo1 BK channels with hydrophilic amino acids of smaller side-chain volume favored the open state. The sensitivities of channels to calcium and voltage were modified by some mutations and completely abolished by others. Interpretation of the results in terms of an allosteric model suggests that the calcium-insensitive mutants greatly destabilize the closed relative to the open conformation and may also disrupt the allosteric coupling between Ca2+ or voltage sensors and the gate. Some Phe-315 mutations also favor the open state, suggesting that Leu-312 and Phe-315 may interact in the closed state, forming a major energy barrier that the channel has to overcome to open. Homology modeling and molecular dynamic simulations further support that the side chain of Leu-312 can couple strongly with the aromatic ring of Phe-315 in neighboring subunits (L-F coupling) to maintain the channel closed. Additionally, single-channel recordings indicate that the calcium-insensitive mutants, whose kinetics can be approximately characterized by a two-state closed-open (C-O) model, exhibit nearly 100% open probability under physiological conditions without alterations in single-channel conductance. These findings provide a basis for understanding the structure and gating of the BK channel pore.	[Yi, Hong; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Wu, Ying; Xiong, Yu; Wang, Sheng; Li, Hui; Pan, Na; Ding, Jiuping] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China; [Horrigan, Frank T.] Baylor Coll Med, Houston, TX 77030 USA	Wuhan University; Huazhong University of Science & Technology; Baylor College of Medicine	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	ylwu@whu.edu.cn; jpding@mail.hust.edu.cn		Horrigan, Frank/0000-0001-6703-9581	National Institutes of Health [NS042901]; National Science Foundation of China [30770522, 30530140, 30770519]; Program of Introducing Talents of Discipline to Universities [B08029]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS042901 (to F. T. H.). This work was also supported by National Science Foundation of China Grants 30770522, 30530140, and 30770519 and Program of Introducing Talents of Discipline to Universities Grant B08029.	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; CASE DA, 2004, AMBER, V8; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ELLINGTON A, 2001, CURR PROTOC MOL BIOL; Guo ZH, 2008, BIOPHYS J, V94, P3714, DOI 10.1529/biophysj.107.120022; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Li H, 2007, J BIOL CHEM, V282, P17720, DOI 10.1074/jbc.M607063200; Li WY, 2004, J GEN PHYSIOL, V124, P43, DOI 10.1085/jgp.200409067; Lippiat JD, 2000, J PHYSIOL-LONDON, V529, P131, DOI 10.1111/j.1469-7793.2000.00131.x; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Talukder G, 2000, BIOPHYS J, V78, P761, DOI 10.1016/S0006-3495(00)76634-3; Wang B, 2006, J GEN PHYSIOL, V128, P731, DOI 10.1085/jgp.200609596; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	27	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23353	23363		10.1074/jbc.M109.027789	http://dx.doi.org/10.1074/jbc.M109.027789			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561088	Green Published, hybrid			2022-12-27	WOS:000269180000020
J	Bonham, CA; Vacratsis, PO				Bonham, Christopher A.; Vacratsis, Panayiotis O.			Redox Regulation of the Human Dual Specificity Phosphatase YVH1 through Disulfide Bond Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; CATALYTIC MECHANISM; SULFENIC ACID; IN-VIVO; OXIDATION; CYSTEINE; GROWTH; IDENTIFICATION; INACTIVATION; DOMAIN	YVH1 was one of the first eukaryotic dual specificity phosphatases cloned, and orthologues posses a unique C-terminal zinc-coordinating domain in addition to a cysteine-based phosphatase domain. Our recent results revealed that human YVH1 (hYVH1) protects cells from oxidative stress. This function requires phosphatase activity and the zinc binding domain. This current study provides evidence that the thiol-rich zinc-coordinating domain may act as a redox sensor to impede the active site cysteine from inactivating oxidation. Furthermore, using differential thiol labeling and mass spectrometry, it was determined that hYVH1 forms intramolecular disulfide bonds at the catalytic cleft as well as within the zinc binding domain to avoid irreversible inactivation during severe oxidative stress. Importantly, zinc ejection is readily reversible and required for hYVH1 activity upon returning to favorable conditions. This inimitable mechanism provides a means for hYVH1 to remain functionally responsive for protecting cells during oxidative stimuli.	[Bonham, Christopher A.; Vacratsis, Panayiotis O.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	University of Windsor	Vacratsis, PO (corresponding author), Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	vacratsi@uwindsor.ca	Bonham, Christopher/K-3073-2012		Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery [298468]	Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant 298468 (to P.O.V.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Beeser AE, 2000, J BACTERIOL, V182, P3517, DOI 10.1128/JB.182.12.3517-3528.2000; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Das SK, 2006, DIABETES, V55, P2631, DOI 10.2337/db05-1369; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Fox GC, 2007, NATURE, V447, P487, DOI 10.1038/nature05804; Groen A, 2005, J BIOL CHEM, V280, P10298, DOI 10.1074/jbc.M412424200; Grzyska PK, 2004, BIOCHEMISTRY-US, V43, P8807, DOI 10.1021/bi049473z; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Kresse SH, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-39; Liu Y, 2009, GENETICS, V181, P907, DOI 10.1534/genetics.108.100099; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Muda M, 1999, J BIOL CHEM, V274, P23991, DOI 10.1074/jbc.274.34.23991; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; SHARDA PR, 2009, BIOCHEM J, V2, P391; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Weibrecht I, 2007, FREE RADICAL BIO MED, V43, P100, DOI 10.1016/j.freeradbiomed.2007.03.021; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624	24	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22853	22864		10.1074/jbc.M109.038612	http://dx.doi.org/10.1074/jbc.M109.038612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19567874	Green Published, hybrid			2022-12-27	WOS:000268963100039
J	Currie, MA; Merino, F; Skarina, T; Wong, AHY; Singer, A; Brown, G; Savchenko, A; Caniuguir, AS; Guixe, V; Yakunin, AF; Jia, ZC				Currie, Mark A.; Merino, Felipe; Skarina, Tatiana; Wong, Andrew H. Y.; Singer, Alexander; Brown, Greg; Savchenko, Alexei; Caniuguir, Andre S.; Guixe, Victoria; Yakunin, Alexander F.; Jia, Zongchao			ADP-dependent 6-Phosphofructokinase from Pyrococcus horikoshii OT3 STRUCTURE DETERMINATION AND BIOCHEMICAL CHARACTERIZATION OF PH1645	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PHOSPHOFRUCTOKINASE; HYPERTHERMOPHILIC ARCHAEON; BIOCHEMICAL-CHARACTERIZATION; CONFORMATIONAL-CHANGE; THERMOTOGA-MARITIMA; BIFUNCTIONAL ENZYME; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; FURIOSUS	Some hyperthermophilic archaea use a modified glycolytic pathway that employs an ADP-dependent glucokinase (ADPGK) and an ADP-dependent phosphofructokinase (ADP-PFK) or, in the case of Methanococcus jannaschii, a bifunctional ADP-dependent glucophosphofructokinase (ADP-GK/PFK). The crystal structures of three ADP-GKs have been determined. However, there is no structural information available for ADP-PFKs or the ADP-GK/PFK. Here, we present the first crystal structure of an ADP-PFK from Pyrococcus horikoshii OT3 (PhPFK) in both apo- and AMP-bound forms determined to 2.0-angstrom and 1.9-angstrom resolution, respectively, along with biochemical characterization of the enzyme. The overall structure of PhPFK maintains a similar large and small alpha/beta domain structure seen in the ADP-GK structures. A large conformational change accompanies binding of phosphoryl donor, acceptor, or both, in all members of the ribokinase superfamily characterized thus far, which is believed to be critical to enzyme function. Surprisingly, no such conformational change was observed in the AMP-bound PhPFK structure compared with the apo structure. Through comprehensive site-directed mutagenesis of the substrate binding pocket we identified residues that were critical for both substrate recognition and the phosphotransfer reaction. The catalytic residues and many of the substrate binding residues are conserved between PhPFK and ADP-GKs; however, four key residues differ in the sugar-binding pocket, which we have shown determine the sugar-binding specificity. Using these results we were able to engineer a mutant PhPFK that mimics the ADP-GK/PFK and is able to phosphorylate both fructose 6-phosphate and glucose.	[Currie, Mark A.; Wong, Andrew H. Y.; Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Merino, Felipe; Caniuguir, Andre S.; Guixe, Victoria] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Skarina, Tatiana; Singer, Alexander; Brown, Greg; Savchenko, Alexei; Yakunin, Alexander F.] Midwest Ctr Struct Genom, Toronto, ON M5G 1L6, Canada	Queens University - Canada; Universidad de Chile	Jia, ZC (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	jia@queensu.ca	Merino, Felipe/D-2740-2013; Yakunin, Alexander/J-1519-2014; Guixe, Victoria/I-1126-2013	Merino, Felipe/0000-0003-4166-8747; Guixe, Victoria/0000-0001-9643-1339; Yakunin, Alexander/0000-0003-0813-6490	National Institutes of Health [GM074942]; Genome Canada; Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) [1070111]; United States Department of Energy; Office of Biological Research [DE-AC02-06CH11357]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada(Genome Canada); Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); United States Department of Energy(United States Department of Energy (DOE)); Office of Biological Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942. This work was also supported by Genome Canada (through the Ontario Genomics Initiative), Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) Grant 1070111, the United States Department of Energy, Office of Biological Research, under contract DE-AC02-06CH11357, and the Canadian Institutes of Health Research.	ANDERSON CM, 1978, J MOL BIOL, V123, P15, DOI 10.1016/0022-2836(78)90374-1; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BERGER SA, 1990, NATURE, V343, P575, DOI 10.1038/343575a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabrera R, 2008, J MOL BIOL, V383, P588, DOI 10.1016/j.jmb.2008.08.029; CHARLES RS, 1994, DIABETES, V43, P784, DOI 10.2337/diab.43.6.784; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Guixe V, 1998, BIOCHEMISTRY-US, V37, P13269, DOI 10.1021/bi980576p; Hansen T, 2002, ARCH MICROBIOL, V177, P401, DOI 10.1007/s00203-002-0405-7; HELLINGA HW, 1987, NATURE, V327, P437, DOI 10.1038/327437a0; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Koga S, 2000, J BIOCHEM-TOKYO, V128, P1079, DOI 10.1093/oxfordjournals.jbchem.a022836; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merino F, 2008, FEBS J, V275, P4033, DOI 10.1111/j.1742-4658.2008.06544.x; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MUKUND S, 1995, J BIOL CHEM, V270, P8389, DOI 10.1074/jbc.270.15.8389; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sakuraba H, 2002, J BIOL CHEM, V277, P12495, DOI 10.1074/jbc.C200059200; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; Schut GJ, 2003, J BACTERIOL, V185, P3935, DOI 10.1128/JB.185.13.3935-3947.2003; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Torres JC, 1997, BIOCHEM J, V327, P675; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; van der Oost J, 1998, J BIOL CHEM, V273, P28149, DOI 10.1074/jbc.273.43.28149; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X; ZHENG RL, 1992, J BIOL CHEM, V267, P23640	39	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22664	22671		10.1074/jbc.M109.012401	http://dx.doi.org/10.1074/jbc.M109.012401			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553681	hybrid, Green Published			2022-12-27	WOS:000268963100020
J	Kim, K; Wang, L; Hwang, I				Kim, Kwangmi; Wang, Lin; Hwang, Inkyu			LFA-1-dependent Ca2+ Entry following Suboptimal T Cell Receptor Triggering Proceeds without Mobilization of Intracellular Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-PRESENTING CELLS; PHOSPHOLIPASE-C-GAMMA; ADHESION MOLECULE-1; DIRECT STIMULATION; MEMBRANE-VESICLES; DISTINCT ROLES; ACTIVATION; LYMPHOCYTES; LFA-1; KINASE	A surge in cytosolic calcium ion concentration by entry of extracellular Ca2+ is a hallmark of T cell activation. According to store-operated Ca2+ entry mechanism, the Ca2+ entry is preceded by activation of phospholipase C-gamma 1 (PLC-gamma 1) and the consequent mobilization of intracellular Ca2+. Using membrane vesicles expressing the mouse class I major histocompatibility complex, i.e. L-d plus costimulatory ligands, i.e. B7-1 and intercellular adhesion molecule-1 along with 2C T cell receptor transgenic T cells, we investigated the roles of CD28 and LFA-1 (lymphocyte function-associated antigen-1) in the activation of PLC-gamma 1 and Ca2+ signaling. Both CD28 and LFA-1 made significant and comparable contributions to the activation of PLC-gamma 1 as gauged by the level of its phosphorylation at tyrosine 783. In contrast, their roles in Ca2+ signaling were quite distinct so that LFA-1/intercellular adhesion molecule-1 interaction exerted a determining role, whereas CD28/B7-1 interaction played only a minimal role. In particular, when the T cells were activated by suboptimal T cell receptor stimulation, LFA-1 played an indispensable role in the Ca2+ signaling. Further experiments using Ca2+-free medium demonstrated that the entry of extracellular Ca2+ was not always accompanied by mobilization of intracellular Ca2+. Thus, intracellular Ca2+ mobilization was hardly detected under the condition that LFA-1 played the indispensable role in the entry of extracellular Ca2+, while a distinct level of intracellular Ca2+ mobilization was readily detected under the condition that LFA-1 played only the supporting role. These results ensure the unique role of LFA-1 in T cell Ca2+ signaling and reveal that LFA-1-dependent Ca2+ entry proceeds via a mechanism separate from store-operated Ca2+ entry.	[Kim, Kwangmi; Wang, Lin; Hwang, Inkyu] Scripps Res Inst, Dept Chem & Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Hwang, I (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	inkyu@scripps.edu		Hwang, Inkyu/0000-0001-8997-6090	National Institutes of Health Grant [AI066146]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI066146, R01AI066146] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI066146 (to I. H.). This is publication number 20067 from The Scripps Research Institute.	Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GOLDBERG DE, 1983, J BIOL CHEM, V258, P3159; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; KANNER SB, 1993, P NATL ACAD SCI USA, V90, P7099, DOI 10.1073/pnas.90.15.7099; Katagiri K, 2004, J BIOL CHEM, V279, P11875, DOI 10.1074/jbc.M310717200; Kim K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006044; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Kotturi MF, 2006, TRENDS PHARMACOL SCI, V27, P360, DOI 10.1016/j.tips.2006.05.007; Kovar M, 2006, P NATL ACAD SCI USA, V103, P11671, DOI 10.1073/pnas.0603466103; Law CL, 1996, MOL CELL BIOL, V16, P1305; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Okkenhaug K, 2004, BIOCHEM SOC T, V32, P332, DOI 10.1042/BST0320332; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Quintana A, 2005, PFLUG ARCH EUR J PHY, V450, P1, DOI 10.1007/s00424-004-1364-4; RABINOVITCH PS, 1986, J IMMUNOL, V137, P952; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Sirim P, 2001, J BIOL CHEM, V276, P42945, DOI 10.1074/jbc.M103224200; Soede RDM, 1998, J CELL BIOL, V142, P1371, DOI 10.1083/jcb.142.5.1371; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; VANSEVENTER GA, 1992, J IMMUNOL, V149, P3872; WANGE RL, 2000, SCI STKE, pRE1; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302	36	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22149	22154		10.1074/jbc.M109.000752	http://dx.doi.org/10.1074/jbc.M109.000752			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542227	Green Published, hybrid			2022-12-27	WOS:000268783700039
J	Mamat, U; Schmidt, H; Munoz, E; Lindner, B; Fukase, K; Hanuszkiewicz, A; Wu, J; Meredith, TC; Woodard, RW; Hilgenfeld, R; Mesters, JR; Holst, O				Mamat, Uwe; Schmidt, Helgo; Munoz, Eva; Lindner, Buko; Fukase, Koichi; Hanuszkiewicz, Anna; Wu, Jing; Meredith, Timothy C.; Woodard, Ronald W.; Hilgenfeld, Rolf; Mesters, Jeroen R.; Holst, Otto			WaaA of the Hyperthermophilic Bacterium Aquifex aeolicus Is a Monofunctional 3-Deoxy-D-manno-oct-2-ulosonic Acid Transferase Involved in Lipopolysaccharide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-DEPENDENT DEACETYLASE; GENUS-SPECIFIC EPITOPE; ESCHERICHIA-COLI K-12; LIPID-A; RHIZOBIUM-LEGUMINOSARUM; STRUCTURAL-ANALYSIS; KDO TRANSFERASE; SULFOLOBUS-SOLFATARICUS; BORDETELLA-PERTUSSIS; 8-PHOSPHATE SYNTHASE	The hyperthermophile Aquifex aeolicus belongs to the deepest branch in the bacterial genealogy. Although it has long been recognized that this unique Gram-negative bacterium carries genes for different steps of lipopolysaccharide (LPS) formation, data on the LPS itself or detailed knowledge of the LPS pathway beyond the first committed steps of lipid A and 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) synthesis are still lacking. We now report the functional characterization of the thermostable Kdo transferase WaaA from A. aeolicus and provide evidence that the enzyme is monofunctional. Compositional analysis and mass spectrometry of purified A. aeolicus LPS, showing the incorporation of a single Kdo residue as an integral component of the LPS, implicated a monofunctional Kdo transferase in LPS biosynthesis of A. aeolicus. Further, heterologous expression of the A. aeolicus waaA gene in a newly constructed Escherichia coli Delta waaA suppressor strain resulted in synthesis of lipid IVA precursors substituted with one Kdo sugar. When highly purified WaaA of A. aeolicus was subjected to in vitro assays using mass spectrometry for detection of the reaction products, the enzyme was found to catalyze the transfer of only a single Kdo residue from CMP-Kdo to differently modified lipid A acceptors. The Kdo transferase was capable of utilizing a broad spectrum of acceptor substrates, whereas surface plasmon resonance studies indicated a high selectivity for the donor substrate.	[Mamat, Uwe; Schmidt, Helgo; Hanuszkiewicz, Anna; Holst, Otto] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, D-23845 Borstel, Germany; [Lindner, Buko] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany; [Munoz, Eva] Med Univ Lubeck, Inst Chem, D-23538 Lubeck, Germany; [Schmidt, Helgo; Hilgenfeld, Rolf; Mesters, Jeroen R.] Med Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, D-23538 Lubeck, Germany; [Fukase, Koichi] Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan; [Meredith, Timothy C.; Woodard, Ronald W.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	Forschungszentrum Borstel; Forschungszentrum Borstel; University of Lubeck; University of Lubeck; Osaka University; University of Michigan System; University of Michigan	Mamat, U (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, Pk Allee 4A-4C, D-23845 Borstel, Germany.	umamat@fz-borstel.de	Lindner, Buko/G-9731-2014; Hilgenfeld, Rolf/C-9675-2011; Meredith, Timothy/X-2713-2019	Meredith, Timothy/0000-0002-1901-6841; Mesters, Jeroen/0000-0001-8532-6699; Woodard, Ronald/0000-0002-7472-3653	Deutsche Forschungsgemeinschaft [MA 1408/2-1, ME 2741/1-1, Li-448/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MA 1408/2-1 (to U. M.), Grant ME 2741/1-1 (to J.R.M. and R. H.), and Grant Li-448/4-1 (to B. L.). The BIAcore 3000 instrument was acquired with the support of Deutsche Forschungsgemeinschaft SFB470.	ADAMS MWW, 1993, ANNU REV MICROBIOL, V47, P627, DOI 10.1146/annurev.micro.47.1.627; BELUNIS CJ, 1995, J BIOL CHEM, V270, P27646, DOI 10.1074/jbc.270.46.27646; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BHAT UR, 1994, J BIOL CHEM, V269, P14402; Blume A, 2006, J BIOL CHEM, V281, P32728, DOI 10.1074/jbc.M600424200; Bode CE, 1998, EUR J BIOCHEM, V254, P404, DOI 10.1046/j.1432-1327.1998.2540404.x; Brabetz N, 2000, J BACTERIOL, V182, P4654, DOI 10.1128/JB.182.16.4654-4657.2000; Brabetz W, 2000, EUR J BIOCHEM, V267, P5458, DOI 10.1046/j.1432-1327.2000.01619.x; Brabetz W, 2000, J BIOL CHEM, V275, P34954, DOI 10.1074/jbc.M005204200; BRADE H, 1983, EUR J BIOCHEM, V131, P195, DOI 10.1111/j.1432-1033.1983.tb07249.x; BRADE H, 1984, CARBOHYD RES, V134, P157, DOI 10.1016/0008-6215(84)85030-2; BROZEK KA, 1990, J BIOL CHEM, V265, P15410; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Cacciapuoti G, 1999, PROTEIN EXPRES PURIF, V16, P125, DOI 10.1006/prep.1999.1076; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Duewel HS, 2001, J BIOL CHEM, V276, P8393, DOI 10.1074/jbc.M007884200; Duewel HS, 1999, BIOCHEM BIOPH RES CO, V263, P346, DOI 10.1006/bbrc.1999.1361; Fukase K, 1999, J ENDOTOXIN RES, V5, P46, DOI 10.1177/09680519990050012001; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gentile F, 2002, J BIOL CHEM, V277, P44050, DOI 10.1074/jbc.M206761200; Gronow S, 2000, EUR J BIOCHEM, V267, P6602, DOI 10.1046/j.1432-1327.2000.01754.x; Heine H, 2003, EUR J BIOCHEM, V270, P440, DOI 10.1046/j.1432-1033.2003.03392.x; HELANDER IM, 1988, EUR J BIOCHEM, V177, P483, DOI 10.1111/j.1432-1033.1988.tb14398.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; HOLST O, 1995, EUR J BIOCHEM, V229, P194, DOI 10.1111/j.1432-1033.1995.tb20455.x; HOLST O, 1993, EUR J BIOCHEM, V214, P703, DOI 10.1111/j.1432-1033.1993.tb17971.x; Holst O, 2007, FEMS MICROBIOL LETT, V271, P3, DOI 10.1111/j.1574-6968.2007.00708.x; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; IMOTO M, 1987, B CHEM SOC JPN, V60, P2197, DOI 10.1246/bcsj.60.2197; Isobe T, 1999, J BACTERIOL, V181, P2648, DOI 10.1128/JB.181.8.2648-2651.1999; Kamerling J. P., 2007, COMPREHENSIVE GLYCOS, V2; Karbarz MJ, 2009, J BIOL CHEM, V284, P414, DOI 10.1074/jbc.M808390200; Karlsson R, 2004, J MOL RECOGNIT, V17, P151, DOI 10.1002/jmr.660; Kataoka M, 2006, HETEROCYCLES, V69, P395; KOHLBRENNER WE, 1985, J BIOL CHEM, V260, P4695; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; KOPETZKI E, 1989, MOL GEN GENET, V216, P149, DOI 10.1007/BF00332244; Kusumoto S, 2006, CHEM REC, V6, P333, DOI 10.1002/tcr.20098; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDUR A, 1978, EUR J BIOCHEM, V84, P579, DOI 10.1111/j.1432-1033.1978.tb12201.x; Lin CH, 1997, BIOCHEMISTRY-US, V36, P780, DOI 10.1021/bi962055c; Liu WC, 1999, B CHEM SOC JPN, V72, P1377, DOI 10.1246/bcsj.72.1377; MAMAT U, 1993, MOL MICROBIOL, V10, P935, DOI 10.1111/j.1365-2958.1993.tb00965.x; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P1106, DOI 10.1021/bi048001h; Meredith TC, 2003, J BIOL CHEM, V278, P32771, DOI 10.1074/jbc.M303661200; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Noah C, 2001, J ENDOTOXIN RES, V7, P25, DOI 10.1179/096805101101532495; Plotz BM, 2000, J BIOL CHEM, V275, P11222, DOI 10.1074/jbc.275.15.11222; PRICE NPJ, 1995, P NATL ACAD SCI USA, V92, P7352, DOI 10.1073/pnas.92.16.7352; PRICE NPJ, 1994, J BACTERIOL, V176, P4646, DOI 10.1128/JB.176.15.4646-4655.1994; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAY PH, 1982, METHOD ENZYMOL, V83, P535; Rund S, 2000, EUR J BIOCHEM, V267, P5717, DOI 10.1046/j.1432-1327.2000.01635.x; Sambrook J., 2001, MOL CLONING LAB MANU; Seydel U, 2005, FEBS J, V272, P327, DOI 10.1111/j.1742-4658.2004.04471.x; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; Stead C, 2005, J BACTERIOL, V187, P3374, DOI 10.1128/JB.187.10.3374-3383.2005; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran AX, 2004, J BIOL CHEM, V279, P55780, DOI 10.1074/jbc.M406480200; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100; Wu J, 2003, J BIOL CHEM, V278, P18117, DOI 10.1074/jbc.M301983200; ZAHRINGER U, 1994, ADV CARBOHYD CHEM BI, V50, P211, DOI 10.1016/S0065-2318(08)60152-3; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	79	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22248	22262		10.1074/jbc.M109.033308	http://dx.doi.org/10.1074/jbc.M109.033308			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19546212	Green Published, hybrid			2022-12-27	WOS:000268783700049
J	Meima, ME; Webb, BA; Witkowska, HE; Barber, DL				Meima, Marcel E.; Webb, Bradley A.; Witkowska, H. Ewa; Barber, Diane L.			The Sodium-Hydrogen Exchanger NHE1 Is an Akt Substrate Necessary for Actin Filament Reorganization by Growth Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-H EXCHANGER; PROTEIN-KINASE-B; STRESS FIBER BREAKDOWN; CELL-CYCLE PROGRESSION; NA+/H+ EXCHANGER; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT PHOSPHORYLATION; MEDIATED PHOSPHORYLATION; TRANSCRIPTION FACTOR; PH DYNAMICS	The kinase Akt mediates signals from growth factor receptors for increased cell proliferation, survival, and migration, which contribute to the positive effects of Akt in cancer progression. Substrates are generally inhibited when phosphorylated by Akt; however, we show phosphorylation of the plasma membrane sodium-hydrogen exchanger NHE1 by Akt increases exchanger activity (H+ efflux). Our data fulfill criteria for NHE1 being a bona fide Akt substrate, including direct phosphorylation in vitro, using mass spectrometry and Akt phospho-substrate antibodies to identify Ser(648) as the Akt phosphorylation site and loss of increased exchanger phosphorylation and activity by insulin and platelet-derived growth factor in fibroblasts expressing a mutant NHE1-S648A. How Akt induces actin cytoskeleton remodeling to promote cell migration and tumor cell metastasis is unclear, but disassembly of actin stress fibers by platelet-derived growth factor and insulin and increased proliferation in growth medium are inhibited in fibroblasts expressing NHE1-S648A. We predict that other functions shared by Akt and NHE1, including cell growth and survival, might be regulated by increased H+ efflux.	[Meima, Marcel E.; Webb, Bradley A.; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Witkowska, H. Ewa] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barber, DL (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, Box 0512,513 Parnassus Ave, San Francisco, CA 94143 USA.	diane.barber@ucsf.edu	Webb, Bradley/F-6946-2013; Webb, Bradley/HDO-7820-2022	Webb, Bradley/0000-0002-5299-2852; 	National Institutes of Health [GM47413, T32-DE7306-11]; National Center for Research Resources [C06 RR16490]; Sandler Family Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Sandler Family Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM47413 (to D. L. B.). This work was also supported by Research Facilities Improvement Program Grant C06 RR16490 from the National Center for Research Resources, National Institutes of Health and by funds from the Sandler Family Foundation to the UCSF Sandler-Moore Core Mass Spectrometry Facility.; Supported by National Institutes of Health Training Grant T32-DE7306-11.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crouch MF, 1997, BIOCHEM BIOPH RES CO, V233, P193, DOI 10.1006/bbrc.1997.6419; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Di Sario A, 2001, J HEPATOL, V34, P378, DOI 10.1016/S0168-8278(00)00062-3; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; ERIKSSON A, 1992, EMBO J, V11, P543, DOI 10.1002/j.1460-2075.1992.tb05085.x; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gillis D, 2001, J MEMBRANE BIOL, V181, P205, DOI 10.1007/s00232-001-0023-3; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Harguindey S, 2005, BBA-REV CANCER, V1756, P1, DOI 10.1016/j.bbcan.2005.06.004; HERMAN B, 1985, J CELL BIOL, V100, P1031, DOI 10.1083/jcb.100.4.1031; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; JIMENEZ CR, 1998, PROTOCOLS PROTEIN SC; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; KNIGHT JB, 1995, J BIOL CHEM, V270, P10199, DOI 10.1074/jbc.270.17.10199; Konstantinidis D, 2006, CELL PHYSIOL BIOCHEM, V18, P211, DOI 10.1159/000097668; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; MA YH, 1994, J BIOL CHEM, V269, P30734; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin SS, 1996, ENDOCRINOLOGY, V137, P5045, DOI 10.1210/en.137.11.5045; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; McLachlin DT, 2001, CURR OPIN CHEM BIOL, V5, P591, DOI 10.1016/S1367-5931(00)00250-7; Nagano K, 2006, EMBO J, V25, P1871, DOI 10.1038/sj.emboj.7601059; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Patel H, 2005, J CELL BIOL, V169, P321, DOI 10.1083/jcb.200412145; Putney LK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-46; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Sauvage M, 2000, EUR J BIOCHEM, V267, P955, DOI 10.1046/j.1432-1327.2000.01084.x; Sbrissa D, 2004, ENDOCRINOLOGY, V145, P4853, DOI 10.1210/en.2004-0489; Sheng SJ, 2009, J CELL PHYSIOL, V218, P451, DOI 10.1002/jcp.21616; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang H, 1997, BIOCHEMISTRY-US, V36, P9151, DOI 10.1021/bi970802f; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200; Yang J, 2002, AM J PHYSIOL-ENDOC M, V283, pE1299, DOI 10.1152/ajpendo.00341.2002; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	69	81	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26666	26675		10.1074/jbc.M109.019448	http://dx.doi.org/10.1074/jbc.M109.019448			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19622752	Green Published, hybrid			2022-12-27	WOS:000269969600047
J	Adhikari, ND; Orler, R; Chory, J; Froehlich, JE; Larkin, RM				Adhikari, Neil D.; Orler, Robert; Chory, Joanne; Froehlich, John E.; Larkin, Robert M.			Porphyrins Promote the Association of GENOMES UNCOUPLED 4 and a Mg-chelatase Subunit with Chloroplast Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRINOGEN-IX-OXIDASE; INNER ENVELOPE MEMBRANE; MAGNESIUM-CHELATASE; TETRAPYRROLE BIOSYNTHESIS; UROPORPHYRINOGEN DECARBOXYLASE; SUBCELLULAR-LOCALIZATION; CHLOROPHYLL SYNTHESIS; GENE-EXPRESSION; ACTIVE PROTEIN; ANTISENSE RNA	In plants, chlorophylls and other tetrapyrroles are synthesized from a branched pathway that is located within chloroplasts. GUN4 (GENOMES UNCOUPLED 4) stimulates chlorophyll biosynthesis by activating Mg-chelatase, the enzyme that commits porphyrins to the chlorophyll branch. GUN4 stimulates Mg-chelatase by a mechanism that involves binding the ChlH subunit of Mg-chelatase, as well as a substrate (protoporphyrin IX) and product (Mg-protoporphyrin IX) of Mg-chelatase. We chose to test whether GUN4 might also affect interactions between Mg-chelatase and chloroplast membranes, the site of chlorophyll biosynthesis. To test this idea, we induced chlorophyll precursor levels in purified pea chloroplasts by feeding these chloroplasts with 5-aminolevulinic acid, determined the relative levels of GUN4 and Mg-chelatase subunits in soluble and membrane-containing fractions derived from these chloroplasts, and quantitated Mg-chelatase activity in membranes isolated from these chloroplasts. We also monitored GUN4 levels in the soluble and membrane-containing fractions derived from chloroplasts fed with various porphyrins. Our results indicate that 5-aminolevulinic acid feeding stimulates Mg-chelatase activity in chloroplast membranes and that the porphyrin-bound forms of GUN4 and possibly ChlH associate most stably with chloroplast membranes. These findings are consistent with GUN4 stimulating chlorophyll biosynthesis not only by activating Mg-chelatase but also by promoting interactions between ChlH and chloroplast membranes.	[Larkin, Robert M.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Adhikari, Neil D.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Larkin, Robert M.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Michigan State University; Michigan State University; Michigan State University; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Larkin, RM (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, Rm 106,Plant Biol Bldg, E Lansing, MI 48824 USA.	larkinr@msu.edu		Adhikari, Neil/0000-0002-2935-1870	Department of Energy [DE-FG02-91ER20021]; National Science Foundation [IOB 0517841, DE-FG02-04ER15540]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Department of Energy Grant DE-FG02-91ER20021 and National Science Foundation Grants IOB 0517841 (to R.M.L.) and DE-FG02-04ER15540 (to J.C.).	Block MA, 2002, EUR J BIOCHEM, V269, P240, DOI 10.1046/j.0014-2956.2001.02643.x; BROWN SB, 1969, BIOCHEM J, V115, P279, DOI 10.1042/bj1150279; Bruce BD, 1994, PLANT MOL BIOL MAN J, VJ1, P1; Che FS, 2000, PLANT PHYSIOL, V124, P59, DOI 10.1104/pp.124.1.59; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-5; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Eichwurzel I, 2000, J PHOTOCH PHOTOBIO B, V54, P194, DOI 10.1016/S1011-1344(00)00016-6; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; FUESLER TP, 1981, PLANT PHYSIOL, V67, P246, DOI 10.1104/pp.67.2.246; FUFSLER TP, 1984, PLANT PHYSIOL, V74, P928, DOI 10.1104/pp.74.4.928; Gibson LCD, 1996, PLANT PHYSIOL, V111, P61, DOI 10.1104/pp.111.1.61; GOUGH S, 1972, BIOCHIM BIOPHYS ACTA, V286, P36, DOI 10.1016/0304-4165(72)90086-4; GRANICK S, 1961, J BIOL CHEM, V236, P1168; Guo RB, 1998, PLANT PHYSIOL, V116, P605, DOI 10.1104/pp.116.2.605; HARLOW E, 1999, USING ANTIBODIES LAB, P70; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; Ishikawa A, 2001, PLANT J, V27, P89, DOI 10.1046/j.1365-313x.2001.01058.x; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jensen PE, 1999, FEBS LETT, V455, P349, DOI 10.1016/S0014-5793(99)00909-6; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Johnson ET, 2008, J BIOL CHEM, V283, P27776, DOI 10.1074/jbc.M804486200; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Kohler RH, 2000, J CELL SCI, V113, P3921; KONCZ C, 1990, EMBO J, V9, P1337, DOI 10.1002/j.1460-2075.1990.tb08248.x; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lermontova I, 1997, P NATL ACAD SCI USA, V94, P8895, DOI 10.1073/pnas.94.16.8895; Luo MZ, 1999, PLANT MOL BIOL, V41, P721, DOI 10.1023/A:1006335317876; Masuda T, 2008, PHOTOSYNTH RES, V96, P121, DOI 10.1007/s11120-008-9291-4; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Mock HP, 1999, J BIOL CHEM, V274, P4231, DOI 10.1074/jbc.274.7.4231; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; Mohapatra A, 2007, PHOTOSYNTH RES, V94, P401, DOI 10.1007/s11120-007-9209-6; Nakayama M, 1998, PLANT CELL PHYSIOL, V39, P275, DOI 10.1093/oxfordjournals.pcp.a029368; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Pruzinska A, 2005, PLANT PHYSIOL, V139, P52, DOI 10.1104/pp.105.065870; Rebeiz CA, 2002, HEME CHLOROPHYLL BIL, P111; RIMINGTON C, 1960, BIOCHEM J, V75, P620, DOI 10.1042/bj0750620; Sambrook J., 2001, MOL CLONING LAB MANU; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Sobotka R, 2008, J BIOL CHEM, V283, P25794, DOI 10.1074/jbc.M803787200; Stephenson PG, 2008, PHOTOCH PHOTOBIO SCI, V7, P1243, DOI 10.1039/b802596g; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Suzuki T, 2002, J BIOL CHEM, V277, P4731, DOI 10.1074/jbc.M105613200; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; THOMAS J, 1990, PLANT PHYSIOL, V94, P1414, DOI 10.1104/pp.94.3.1414; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; van Lis R, 2005, PLANT PHYSIOL, V139, P1946, DOI 10.1104/pp.105.069732; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Vinti G, 2000, PLANT J, V24, P883, DOI 10.1046/j.1365-313x.2000.00936.x; WALKER CJ, 1991, P NATL ACAD SCI USA, V88, P5789, DOI 10.1073/pnas.88.13.5789; WALKER CJ, 1991, PLANT PHYSIOL, V95, P1189, DOI 10.1104/pp.95.4.1189; Watanabe N, 2001, J BIOL CHEM, V276, P20474, DOI 10.1074/jbc.M101140200; Wilde A, 2004, FEBS LETT, V571, P119, DOI 10.1016/j.febslet.2004.06.063; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714	65	50	52	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24783	24796		10.1074/jbc.M109.025205	http://dx.doi.org/10.1074/jbc.M109.025205			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605356	Green Published, hybrid			2022-12-27	WOS:000269734000013
J	Bullen, HE; Tonkin, CJ; O'Donnell, RA; Tham, WH; Papenfuss, AT; Gould, S; Cowman, AF; Crabb, BS; Gilson, PR				Bullen, Hayley E.; Tonkin, Christopher J.; O'Donnell, Rebecca A.; Tham, Wai-Hong; Papenfuss, Anthony T.; Gould, Sven; Cowman, Alan F.; Crabb, Brendan S.; Gilson, Paul R.			A Novel Family of Apicomplexan Glideosome-associated Proteins with an Inner Membrane-anchoring Role	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE TOXOPLASMA-GONDII; HOST-CELL INVASION; PLASMODIUM-FALCIPARUM; MALARIA PARASITES; LIFE-CYCLE; XIV MYOSIN; EXPRESSION; MOTILITY; IDENTIFICATION; MEROZOITE	The phylum Apicomplexa are a group of obligate intracellular parasites responsible for a wide range of important diseases. Central to the lifecycle of these unicellular parasites is their ability to migrate through animal tissue and invade target host cells. Apicomplexan movement is generated by a unique system of gliding motility in which substrate adhesins and invasion-related proteins are pulled across the plasma membrane by an underlying actin-myosin motor. The myosins of this motor are inserted into a dual membrane layer called the inner membrane complex (IMC) that is sandwiched between the plasma membrane and an underlying cytoskeletal basket. Central to our understanding of gliding motility is the characterization of proteins residing within the IMC, but to date only a few proteins are known. We report here a novel family of six-pass transmembrane proteins, termed the GAPM family, which are highly conserved and specific to Apicomplexa. In Plasmodium falciparum and Toxoplasma gondii the GAPMs localize to the IMC where they form highly SDS-resistant oligomeric complexes. The GAPMs co-purify with the cytoskeletal alveolin proteins and also to some degree with the actin-myosin motor itself. Hence, these proteins are strong candidates for an IMC-anchoring role, either directly or indirectly tethering the motor to the cytoskeleton.	[Crabb, Brendan S.; Gilson, Paul R.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Bullen, Hayley E.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Bullen, Hayley E.; Tonkin, Christopher J.; O'Donnell, Rebecca A.; Tham, Wai-Hong; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic 3050, Australia; [Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Gould, Sven] Univ Melbourne, Sch Bot, Parkville, Vic 3050, Australia	Burnet Institute; University of Melbourne; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne	Gilson, PR (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	gilson@burnet.edu.au	Papenfuss, Anthony T/C-6297-2008; Tonkin, Christopher/K-6534-2019; Gould, Sven B/B-8192-2011; Crabb, Brendan/F-5287-2013; Tham, Wai-Hong/P-6474-2019; Cowman, Alan F/C-7642-2013; Tham, Wai-Hong/L-3173-2018	Papenfuss, Anthony T/0000-0002-1102-8506; Tonkin, Christopher/0000-0002-7036-6222; Tham, Wai-Hong/0000-0001-7950-8699; Cowman, Alan F/0000-0001-5145-9004; Tham, Wai-Hong/0000-0001-7950-8699; Gould, Sven/0000-0002-2038-8474; Bullen, Hayley/0000-0003-4923-3019	National Health and Medical Research Council of Australia; Wellcome Trust, UK	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, UK(Wellcome Trust)	This work was supported, in part, by the National Health and Medical Research Council of Australia and Wellcome Trust, UK.	Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crabb BS, 2004, METH MOL B, V270, P263; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Gould SB, 2008, MOL BIOL EVOL, V25, P1219, DOI 10.1093/molbev/msn070; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Morrissette NS, 1997, J CELL SCI, V110, P35; Pinder JC, 2000, PARASITOL TODAY, V16, P240, DOI 10.1016/S0169-4758(00)01664-1; Pinder JC, 1998, J CELL SCI, V111, P1831; Pomel S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000188; Raibaud A, 2001, J STRUCT BIOL, V135, P47, DOI 10.1006/jsbi.2001.4396; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013; Striepen B, 1998, MOL BIOCHEM PARASIT, V92, P325, DOI 10.1016/S0166-6851(98)00011-5; Tardieux I, 2008, TRAFFIC, V9, P627, DOI 10.1111/j.1600-0854.2008.00703.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; Wichroski MJ, 2002, INFECT IMMUN, V70, P4353, DOI 10.1128/IAI.70.8.4353-4361.2002	35	87	89	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25353	25363		10.1074/jbc.M109.036772	http://dx.doi.org/10.1074/jbc.M109.036772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19561073	Green Published, hybrid			2022-12-27	WOS:000269734000068
J	Cao, ZX; Wara, AK; Icli, B; Sun, XH; Packard, RRS; Esen, F; Stapleton, CJ; Subramaniam, M; Kretschmer, K; Apostolou, I; von Boehmer, H; Hansson, GK; Spelsberg, TC; Libby, P; Feinberg, MW				Cao, Zhuoxiao; Wara, Akm Khyrul; Icli, Basak; Sun, Xinghui; Packard, Rene R. S.; Esen, Fehim; Stapleton, Christopher J.; Subramaniam, Malayannan; Kretschmer, Karsten; Apostolou, Irina; von Boehmer, Harald; Hansson, Goran K.; Spelsberg, Thomas C.; Libby, Peter; Feinberg, Mark W.			Kruppel-like Factor KLF10 Targets Transforming Growth Factor-beta 1 to Regulate CD4(+)CD25(-) T Cells and T Regulatory Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR FOXP3; TGF-BETA; CUTTING EDGE; TRANSPLANT ARTERIOSCLEROSIS; ACCELERATES ATHEROSCLEROSIS; AGGRAVATES ATHEROSCLEROSIS; VASCULAR INFLAMMATION; PERIPHERAL TOLERANCE; FACTOR EKLF	CD4(+)CD25(+) regulatory T cells (T regs) play a major role in the maintenance of self-tolerance and immune suppression, although the mechanisms controlling T reg development and suppressor function remain incompletely understood. Herein, we provide evidence that Kruppel-like factor 10 (KLF10/TIEG1) constitutes an important regulator of T regulatory cell suppressor function and CD4(+)CD25(-) T cell activation through distinct mechanisms involving transforming growth factor (TGF)-beta 1 and Foxp3. KLF10 overexpressing CD4(+)CD25(-) T cells induced both TGF-beta 1 and Foxp3 expression, an effect associated with reduced T-Bet (Th1 marker) and Gata3 (Th2 marker) mRNA expression. Consistently, KLF10(-/-) CD4(+)CD25(-) T cells have enhanced differentiation along both Th1 and Th2 pathways and elaborate higher levels of Th1 and Th2 cytokines. Furthermore, KLF10(-/-) CD4(+)CD25(-) T cell effectors cannot be appropriately suppressed by wild-type T regs. Surprisingly, KLF10(-/-) T reg cells have reduced suppressor function, independent of Foxp3 expression, with decreased expression and elaboration of TGF-beta 1, an effect completely rescued by exogenous treatment with TGF-beta 1. Mechanistic studies demonstrate that in response to TGF-beta 1, KLF10 can transactivate both TGF-beta 1 and Foxp3 promoters, implicating KLF10 in a positive feedback loop that may promote cell-intrinsic control of T cell activation. Finally, KLF10(-/-) CD4(+)CD25(-) T cells promoted atherosclerosis by similar to 2-fold in ApoE(-/-)/scid/scid mice with increased leukocyte accumulation and peripheral pro-inflammatory cytokines. Thus, KLF10 is a critical regulator in the transcriptional network controlling TGF-beta 1 in both CD4(+)CD25(-) T cells and T regs and plays an important role in regulating atherosclerotic lesion formation in mice.	[Cao, Zhuoxiao; Wara, Akm Khyrul; Icli, Basak; Sun, Xinghui; Packard, Rene R. S.; Esen, Fehim; Stapleton, Christopher J.; Libby, Peter; Feinberg, Mark W.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Cardiovasc Div, Boston, MA 02115 USA; [Subramaniam, Malayannan; Spelsberg, Thomas C.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN 55905 USA; [Kretschmer, Karsten; Apostolou, Irina; von Boehmer, Harald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; [Hansson, Goran K.] Karolinska Inst, Ctr Mol Med, SE-17176 Stockholm, Sweden; [Hansson, Goran K.] Karolinska Inst, Dept Med, SE-17176 Stockholm, Sweden; [Stapleton, Christopher J.] Harvard Univ, Sch Med, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Mayo Clinic; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Karolinska Institutet; Karolinska Institutet; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute	Feinberg, MW (corresponding author), 77 Ave Louis Pasteur,NRB 742F, Boston, MA 02115 USA.	mfeinberg@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021; Stapleton, Christopher/AAZ-5389-2021; Kretschmer, Karsten/E-8174-2010; Hansson, Goran K/B-7423-2012; Esen, Fehim/AAA-1283-2022	Libby, Peter/0000-0002-1502-502X; Stapleton, Christopher/0000-0003-4805-0093; Kretschmer, Karsten/0000-0001-6770-4078; Esen, Fehim/0000-0002-9948-5575; Packard, Rene/0000-0002-8520-5843; Feinberg, Mark/0000-0001-9523-3859; Hansson, Goran/0000-0003-4148-5190	National Institutes of Health [HL080174, HL091076, F32HL086157, F32HL088819, DE14036]; American Cancer Society Research Scholar Grant [RSG0719501-LIB]; Leducq Transatlantic Network on Atherothrombosis; Swedish Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091076, F32HL088819, F32HL086157, R01HL080174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); Leducq Transatlantic Network on Atherothrombosis; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080174 and HL091076 (to M.W.F.), F32HL086157 (to Z.C.), F32HL088819 (to A.K.W.), and DE14036 (to T.C.S. and M.S.). This work was also supported by American Cancer Society Research Scholar Grant RSG0719501-LIB (to M. W. F.), the Leducq Transatlantic Network on Atherothrombosis (to R.R.S.P., G.K.H., and P.L.), and the Swedish Research Council (to G.K.H.).	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Bommireddy R, 2006, LAB INVEST, V86, P1008, DOI 10.1038/labinvest.3700460; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Feinberg MW, 2005, PANMINERVA MED, V47, P169; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Koglin J, 1998, CIRC RES, V83, P652, DOI 10.1161/01.RES.83.6.652; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Nikolcheva T, 2002, J CLIN INVEST, V110, P119, DOI 10.1172/JCI200215336; Noti JD, 2004, J BIOL CHEM, V279, P26948, DOI 10.1074/jbc.M310634200; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Ribeiro A, 1999, HEPATOLOGY, V30, P1490, DOI 10.1002/hep.510300620; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shi CW, 1999, J CLIN INVEST, V103, P469, DOI 10.1172/JCI4584; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Song A, 1999, IMMUNITY, V10, P93, DOI 10.1016/S1074-7613(00)80010-2; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Warke VG, 2003, J BIOL CHEM, V278, P14812, DOI 10.1074/jbc.M300787200; Yang XXO, 2003, BLOOD, V101, P4492, DOI 10.1182/blood-2002-08-2579; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou MX, 2007, J IMMUNOL, V178, P5496, DOI 10.4049/jimmunol.178.9.5496; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2006, ARTERIOSCL THROM VAS, V26, P864, DOI 10.1161/01.ATV.0000206122.61591.ff; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	62	74	75	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24914	24924		10.1074/jbc.M109.000059	http://dx.doi.org/10.1074/jbc.M109.000059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19602726	hybrid, Green Published			2022-12-27	WOS:000269734000025
J	Crow, A; Lewin, A; Hecht, O; Moller, MC; Moore, GR; Hederstedt, L; Le Brun, NE				Crow, Allister; Lewin, Allison; Hecht, Oliver; Moller, Mirja Carlsson; Moore, Geoffrey R.; Hederstedt, Lars; Le Brun, Nick E.			Crystal Structure and Biophysical Properties of Bacillus subtilis BdbD AN OXIDIZING THIOL: DISULFIDE OXIDOREDUCTASE CONTAINING A NOVEL METAL SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOND FORMATION INVIVO; EXTRACYTOPLASMIC THIOREDOXIN RESA; ELECTRON-DENSITY MAPS; FORMATION IN-VIVO; ESCHERICHIA-COLI; ACTIVE-SITE; REDOX PROPERTIES; FUNCTIONAL-CHARACTERIZATION; DESTABILIZING DISULFIDE; PSEUDOMONAS-AERUGINOSA	BdbD is a thiol: disulfide oxidoreductase (TDOR) from Bacillus subtilis that functions to introduce disulfide bonds in substrate proteins/peptides on the outside of the cytoplasmic membrane and, as such, plays a key role in disulfide bond management. Here we demonstrate that the protein is membrane-associated in B. subtilis and present the crystal structure of the soluble part of the protein lacking its membrane anchor. This reveals that BdbD is similar in structure to Escherichia coli DsbA, with a thioredoxin-like domain with an inserted helical domain. A major difference, however, is the presence in BdbD of a metal site, fully occupied by Ca2+, at an inter-domain position some 14 angstrom away from the CXXC active site. The midpoint reduction potential of soluble BdbD was determined as -75 mV versus normal hydrogen electrode, and the active site N-terminal cysteine thiol was shown to have a low pK(a), consistent with BdbD being an oxidizing TDOR. Equilibrium unfolding studies revealed that the oxidizing power of the protein is based on the instability introduced by the disulfide bond in the oxidized form. The crystal structure of Ca2+-depleted BdbD showed that the protein remained folded, with only minor conformational changes. However, the reduced form of Ca2+-depleted BdbD was significantly less stable than reduced Ca2+-containing protein, and the midpoint reduction potential was shifted by approximately -20 mV, suggesting that Ca2+ functions to boost the oxidizing power of the protein. Finally, we demonstrate that electron exchange does not occur between BdbD and B. subtilis ResA, a low potential extra-cytoplasmic TDOR.	[Moller, Mirja Carlsson; Hederstedt, Lars] Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden; [Crow, Allister; Lewin, Allison; Hecht, Oliver; Moore, Geoffrey R.; Le Brun, Nick E.] Univ E Anglia, Sch Chem Sci & Pharm, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	Lund University; University of East Anglia	Hederstedt, L (corresponding author), Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden.	Lars.Hederstedt@cob.lu.se; n.le-brun@uea.ac.uk	Crow, Allister/F-2147-2018	Crow, Allister/0000-0001-6856-5962; Le Brun, Nick/0000-0001-9780-4061; Carlsson Moller, Mirja/0000-0001-8695-6262; Hederstedt, Lars/0000-0002-6650-6296	Wellcome Trust [076017/Z/04/Z]; Swedish Research Council [621-2007-6094]; Biotechnology and Biological Sciences Research Council [BB/C503597/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant 076017/Z/04/Z from the Wellcome Trust and by Grant 621-2007-6094 from the Swedish Research Council.	Aslund F, 1999, J BACTERIOL, V181, P1375; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; CHAU MH, 1991, FEBS LETT, V291, P296, DOI 10.1016/0014-5793(91)81305-R; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; Crow A, 2009, J BIOL CHEM, V284, P10056, DOI 10.1074/jbc.M809566200; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlendsson LS, 2004, J BACTERIOL, V186, P6230, DOI 10.1128/JB.186.18.6230-6238.2004; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FULOP V, 1995, STRUCTURE, V3, P1225, DOI 10.1016/S0969-2126(01)00258-1; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Monika EM, 1997, J MOL BIOL, V271, P679, DOI 10.1006/jmbi.1997.1227; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Moutevelis E, 2004, PROTEIN SCI, V13, P2744, DOI 10.1110/ps.04804504; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pettigrew GW, 2006, J INORG BIOCHEM, V100, P551, DOI 10.1016/j.jinorgbio.2005.12.008; Piotukh K, 2007, FREE RADICAL BIO MED, V43, P1263, DOI 10.1016/j.freeradbiomed.2007.06.010; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rigden DJ, 2003, TRENDS MICROBIOL, V11, P295, DOI 10.1016/S0966-842X(03)00153-7; Rigden DJ, 2003, FEMS MICROBIOL LETT, V221, P103, DOI 10.1016/S0378-1097(03)00160-5; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SIEDLER F, 1993, BIOCHEMISTRY-US, V32, P7488, DOI 10.1021/bi00080a021; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; YAMANAKA H, 1994, J BACTERIOL, V176, P2906, DOI 10.1128/JB.176.10.2906-2913.1994; YU J, 1992, MOL MICROBIOL, V6, P1949, DOI 10.1111/j.1365-2958.1992.tb01368.x; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	75	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23719	23733		10.1074/jbc.M109.005785	http://dx.doi.org/10.1074/jbc.M109.005785			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19535335	Green Published, hybrid			2022-12-27	WOS:000269180000057
J	Kapiloff, MS; Piggott, LA; Sadana, R; Li, JL; Heredia, LA; Henson, E; Efendiev, R; Dessauer, CW				Kapiloff, Michael S.; Piggott, Leslie A.; Sadana, Rachna; Li, Jinliang; Heredia, Lorena A.; Henson, Edward; Efendiev, Riad; Dessauer, Carmen W.			An Adenylyl Cyclase-mAKAP beta Signaling Complex Regulates cAMP Levels in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; RYANODINE RECEPTOR; NUCLEAR-MEMBRANES; DISRUPTION; HYPERTROPHY; MOUSE; PHOSPHORYLATION; MECHANISM; ENVELOPE; STRESS	Protein kinase A-anchoring proteins (AKAPs) play important roles in the compartmentation of cAMP signaling, anchoring protein kinase A (PKA) to specific cellular organelles and serving as scaffolds that assemble localized signaling cascades. Although AKAPs have been recently shown to bind adenylyl cyclase (AC), the functional significance of this association has not been studied. In cardiac myocytes, the muscle protein kinase A-anchoring protein beta (mAKAP beta) coordinates cAMP-dependent, calcium, and MAP kinase pathways and is important for cellular hypertrophy. We now show that mAKAP beta selectively binds type 5 AC in the heart and that mAKAP beta-associated AC activity is absent in AC5 knock-out hearts. Consistent with its known inhibition by PKA phosphorylation, AC5 is inhibited by association with mAKAP beta-PKA complexes. AC5 binds to a unique N-terminal site on mAKAP-(245-340), and expression of this peptide disrupts endogenous mAKAP beta-AC association. Accordingly, disruption of mAKAP beta-AC5 complexes in neonatal cardiac myocytes results in increased cAMP and hypertrophy in the absence of agonist stimulation. Taken together, these results show that the association of AC5 with the mAKAP beta complex is required for the regulation of cAMP second messenger controlling cardiac myocyte hypertrophy.	[Kapiloff, Michael S.; Li, Jinliang; Heredia, Lorena A.; Henson, Edward] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Dept Med, Miami, FL 33101 USA; [Kapiloff, Michael S.; Li, Jinliang; Heredia, Lorena A.; Henson, Edward] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Dept Pediat, Miami, FL 33101 USA; [Piggott, Leslie A.; Sadana, Rachna; Efendiev, Riad; Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Miami; University of Miami; University of Texas System; University of Texas Health Science Center Houston	Kapiloff, MS (corresponding author), Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Dept Med, Miami, FL 33101 USA.	Mkapiloff@med.miami.edu; Carmen.W.Dessauer@uth.tmc.edu	; Dessauer, Carmen/N-6933-2018	Kapiloff, Michael/0000-0002-7005-6953; Dessauer, Carmen/0000-0003-1210-4280; Li, Jinliang/0000-0002-3018-0570	National Institutes of Health [GM60419, HL075398]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60419 ( to C. W. D.) and HL075398 ( to M. S. K.).	Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; BELCHEVA MM, 1995, J PHARMACOL EXP THER, V274, P1513; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; CARLISLE MJJ, 2004, BIOCHEM J, V381, P587; Chen YB, 1997, P NATL ACAD SCI USA, V94, P14100, DOI 10.1073/pnas.94.25.14100; Deng XF, 2000, CIRC RES, V87, P781, DOI 10.1161/01.RES.87.9.781; Dessauer CW, 2002, J BIOL CHEM, V277, P28823, DOI 10.1074/jbc.M203962200; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; IWAMI G, 1995, J BIOL CHEM, V270, P12481, DOI 10.1074/jbc.270.21.12481; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kapiloff MS, 2001, J CELL SCI, V114, P3167; KATSUSHIKA S, 1992, P NATL ACAD SCI USA, V89, P8774, DOI 10.1073/pnas.89.18.8774; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Tepe NM, 1999, FEBS LETT, V458, P236, DOI 10.1016/S0014-5793(99)01147-3; Yamamoto S, 1998, MICROSC RES TECHNIQ, V40, P479, DOI 10.1002/(SICI)1097-0029(19980301)40:6<479::AID-JEMT8>3.0.CO;2-K; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038	31	91	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23540	23546		10.1074/jbc.M109.030072	http://dx.doi.org/10.1074/jbc.M109.030072			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574217	hybrid, Green Published			2022-12-27	WOS:000269180000039
J	Lee, J; Tattoli, I; Wojtal, KA; Vavricka, SR; Philpott, DJ; Girardin, SE				Lee, Jooeun; Tattoli, Ivan; Wojtal, Kacper A.; Vavricka, Stephan R.; Philpott, Dana J.; Girardin, Stephen E.			pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; KAPPA-B; PHAGOSOME MATURATION; EXPRESSION CLONING; HOST RECOGNITION; DIPEPTIDE; INNATE; ACTIVATION; PEPTIDOGLYCAN; INDUCTION	Nod1 and Nod2 are members of the Nod-like receptor family that detect intracellular bacterial peptidoglycan-derived muramyl peptides. The biological effects of muramyl peptides have been described for over three decades, but the mechanism underlying their internalization to the cytosol remains unclear. Using the human epithelial cell line HEK293T as a model system, we demonstrate here that Nod1-activating ligands entered cells through endocytosis, most likely by the clathrin-coated pit pathway, as internalization was dynamin-dependent but not inhibited by methyl-beta-cyclodextrin. In the endocytic pathway, the cytosolic internalization of Nod1 ligands was pH-dependent, occurred prior to the acidification mediated by the vacuolar ATPase, and was optimal at pH ranging from 5.5 to 6. Similarly, the Nod2 ligand MDP was internalized into host cytosol through a similar pathway with optimal pH for internalization ranging from 5.5 to 6.5. Moreover, Nod1-activating muramyl peptides likely required processing by endosomal enzymes, prior to transport into the cytosol, suggesting the existence of a sterically gated endosomal transporter for Nod1 ligands. In support for this, we identified a role for SLC15A4, an oligopeptide transporter expressed in early endosomes, in Nod1-dependent NF-kappa B signaling. Interestingly, SLC15A4 expression was also up-regulated in colonic biopsies from patients with inflammatory bowel disease, a disorder associated with mutations in Nod1 and Nod2. Together, our results shed light on the mechanisms by which muramyl peptides get access to the host cytosol, where they are detected by Nod1 and Nod2, and might have implications for the understanding of human diseases, such as inflammatory bowel disease.	[Lee, Jooeun; Tattoli, Ivan; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Tattoli, Ivan; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Wojtal, Kacper A.; Vavricka, Stephan R.] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland	University of Toronto; University of Toronto; University of Zurich; University Zurich Hospital	Girardin, SE (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Med Sci Bldg,Rm 6336, Toronto, ON M5S 1A8, Canada.	Stephen.girardin@utoronto.ca	Tattoli, Ivan/H-2600-2017	Tattoli, Ivan/0000-0001-7925-4609	Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; Sandler Program for Asthma Research; National Science Foundation [320000-114009/1]; Swiss IBD Cohort [3347CO-108792]; Zurich Center of Integrative Human Physiology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada; Sandler Program for Asthma Research; National Science Foundation(National Science Foundation (NSF)); Swiss IBD Cohort; Zurich Center of Integrative Human Physiology	This work was supported by grants from Canadian Institutes of Health Research (to D. J. P.), Crohn's and Colitis Foundation of Canada (to S. E. G.), and the Sandler Program for Asthma Research (to D. J. P.). This work was also supported by the Swiss National Science Foundation (Grant 320000-114009/1 to S. R. V. and K. A. W.), Grant 3347CO-108792 (Swiss IBD Cohort), and a grant of the Zurich Center of Integrative Human Physiology.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; Biegel A, 2006, AMINO ACIDS, V31, P137, DOI 10.1007/s00726-006-0331-0; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boll M, 1996, P NATL ACAD SCI USA, V93, P284, DOI 10.1073/pnas.93.1.284; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Drubin David G, 2005, Novartis Found Symp, V269, P35; DRUBIN DG, 2005, NOVART FDN SYMP, V269, P223; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; FOGLER WE, 1987, INT J IMMUNOPHARMACO, V9, P141, DOI 10.1016/0192-0561(87)90088-9; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Le Bourhis L, 2007, BIOCHEM SOC T, V35, P1479, DOI 10.1042/BST0351479; LEDERER E, 1980, J MED CHEM, V23, P819, DOI 10.1021/jm00182a001; LEDERER E, 1986, DRUG EXP CLIN RES, V12, P429; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; MEHTA K, 1982, J RETICULOENDOTH SOC, V32, P155; Nayar R, 1986, Methods Enzymol, V132, P594; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; PHILLIPS NC, 1994, J IMMUNOTHER, V15, P185, DOI 10.1097/00002371-199404000-00004; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; SCHROIT AJ, 1982, CANCER RES, V42, P161; Steinberg BE, 2007, BIOCHEM SOC T, V35, P1083, DOI 10.1042/BST0351083; Swaan PW, 2008, AM J RESP CELL MOL, V39, P536, DOI 10.1165/rcmb.2008-0059OC; TAKADA H, 1979, INFECT IMMUN, V25, P48, DOI 10.1128/IAI.25.1.48-53.1979; Traub S, 2004, J BIOL CHEM, V279, P8694, DOI 10.1074/jbc.M310556200; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; WOJTAL KA, 2009, DRUG METAB DISPOS; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; ZUCCHELLI M, 2009, INFLAMM BOWEL DIS	45	155	166	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23818	23829		10.1074/jbc.M109.033670	http://dx.doi.org/10.1074/jbc.M109.033670			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570976	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000269180000065
J	Zhu, B; Lee, SJ; Richardson, CC				Zhu, Bin; Lee, Seung-Joo; Richardson, Charles C.			An in Trans Interaction at the Interface of the Helicase and Primase Domains of the Hexameric Gene 4 Protein of Bacteriophage T7 Modulates Their Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; STAPHYLOCOCCUS-AUREUS PRIMASE; ESCHERICHIA-COLI PRIMASE; TEMPLATE RECOGNITION; CRYSTAL-STRUCTURE; REPLICATION FORK; INITIATION SPECIFICITY; PRIMER SYNTHESIS; LINKER REGION; BINDING	DNA helicase and primase are essential for DNA replication. The helicase unwinds the DNA to provide single-stranded templates for DNA polymerase. The primase catalyzes the synthesis of oligoribonucleotides for the initiation of lagging strand synthesis. The two activities reside in a single polypeptide encoded by gene 4 of bacteriophage T7. Their coexistence within the same polypeptide facilitates their coordination during DNA replication. One surface of helix E within the helicase domain is positioned to interact with the primase domain and the linker connecting the two domains within the functional hexamer. The interaction occurs in trans such that helix E interacts with the primase domain and the linker of the adjacent subunit. Most alterations of residues on the surface of helix E (Arg(404), Lys(408), Tyr(411), and Gly(415)) eliminate the ability of the altered proteins to complement growth of T7 phage lacking gene 4. Both Tyr(411) and Gly(415) are important in oligomerization of the protein. Alterations G415V and K408A simultaneously influence helicase and primase activities in opposite manners that mimic events observed during coordinated DNA synthesis. The results suggest that Asp(263) located in the linker of one subunit can interact with Tyr(411), Lys(408), or Arg(404) in helix E of the adjacent subunit depending on the oligomerization state. Thus the switch in contacts between Asp(263) and its three interacting residues in helix E of the adjacent subunit results in conformational changes that modulate helicase and primase activity.	[Zhu, Bin; Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C.C.R.).	Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; Chintakayala K, 2008, MOL MICROBIOL, V68, P360, DOI 10.1111/j.1365-2958.2008.06155.x; Chintakayala K, 2007, MOL MICROBIOL, V63, P1629, DOI 10.1111/j.1365-2958.2007.05617.x; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; He ZG, 2004, J BIOL CHEM, V279, P22190, DOI 10.1074/jbc.M401100200; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; Jonson PH, 2001, PROTEIN ENG, V14, P397, DOI 10.1093/protein/14.6.397; Koepsell SA, 2008, MOL MICROBIOL, V68, P1570, DOI 10.1111/j.1365-2958.2008.06255.x; Koepsell SA, 2006, J BACTERIOL, V188, P4673, DOI 10.1128/JB.00316-06; Kornberg A., 1992, DNA REPLICATION; Kusakabe T, 1997, J BIOL CHEM, V272, P5943, DOI 10.1074/jbc.272.9.5943; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MENDELMAN LV, 1991, J BIOL CHEM, V266, P23240; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; ROTHSCHILD KJ, 1990, J BIOL CHEM, V265, P16985; Satapathy AK, 2009, J BIOL CHEM, V284, P14286, DOI 10.1074/jbc.M900557200; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2005, STRUCTURE, V13, P839, DOI 10.1016/j.str.2005.04.006; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Thirlway J, 2006, J BACTERIOL, V188, P1534, DOI 10.1128/JB.188.4.1534-1539.2006; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; TOUGU K, 1994, J BIOL CHEM, V269, P4675	51	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23842	23851		10.1074/jbc.M109.026104	http://dx.doi.org/10.1074/jbc.M109.026104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574219	Green Published, hybrid			2022-12-27	WOS:000269180000067
J	Zheng, B; Han, M; Bernier, M; Zhang, XH; Meng, F; Miao, SB; He, M; Zhao, XM; Wen, JK				Zheng, Bin; Han, Mei; Bernier, Michel; Zhang, Xin-hua; Meng, Fang; Miao, Sui-bing; He, Ming; Zhao, Xin-ming; Wen, Jin-kun			Kruppel-like Factor 4 Inhibits Proliferation by Platelet-derived Growth Factor Receptor beta-mediated, Not by Retinoic Acid Receptor alpha-mediated, Phosphatidylinositol 3-Kinase and ERK Signaling in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; EXPRESSION IN-VIVO; HEART LIM PROTEIN; GENE-EXPRESSION; ANGIOTENSIN-II; TISSUE TRANSGLUTAMINASE; TRANSCRIPTION FACTORS; NEOINTIMA FORMATION; INDUCED APOPTOSIS; EMERGING ROLE	Proliferation inhibition of vascular smooth muscle cells (VSMCs) is governed by the activity of a transcription factor network. Kruppel-like factor 4 (Klf4), retinoic acid receptor (RAR alpha), and platelet-derived growth factor receptor (PDGFR) are expressed in VSMCs and are components of such a network. However, the relationship among them in the regulation of VSMC proliferation remains unknown. Here, we investigated the mechanisms whereby Klf4 mediates the growth inhibitory effects in VSMCs through RAR alpha and PDGFR beta. We demonstrated that Klf4 directly binds to the 5' regulatory region of RAR alpha, down-regulates RAR alpha expression, and specifically inhibits RAR alpha-mediated phosphatidylinositol 3-kinase (PI3K) and ERK signaling in cultured VSMCs induced by the synthetic retinoid Am80. Of particular interest, Klf4 inhibits RAR alpha and PDGFR beta expression while blocking PI3K and ERK signaling induced by Am80 and PDGF-BB, respectively. The anti-proliferative effects of Klf4 on neointimal formation depend largely on PDGFR-mediated PI3K signaling without involvement of the RAR alpha-activated signaling pathways. These findings provide a novel mechanism for signal suppression and growth inhibitory effects of Klf4 in VSMCs. Moreover, the results of this study suggest that Klf4 is one of the key mediators of retinoid actions in VSMCs.	[Zheng, Bin; Han, Mei; Zhang, Xin-hua; Meng, Fang; Miao, Sui-bing; He, Ming; Zhao, Xin-ming; Wen, Jin-kun] Hebei Med Univ, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [Bernier, Michel] NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA	Hebei Medical University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wen, JK (corresponding author), Hebei Med Univ, Dept Biochem & Mol Biol, 361 Zhongshan E Rd, Shijiazhuang 050017, Peoples R China.	wjk@hebmu.edu.cn	Bernier, Michel/AAO-3983-2021; Cheng, Yunhui/A-5668-2010; Han, Mei/GXH-8347-2022; Bernier, Michel/Y-7139-2019	Bernier, Michel/0000-0002-5948-368X; Wen, Jinkun/0000-0002-8453-4549	NIA, National Institutes of Health; Major State Basic Research Development Program of China [2008CB517402]; National Natural Science Foundation of People's Republic of China [30770787, 30670845, 30871272]; Chinese Ministry of Education [206016]; Hebei Natural Science Foundation of People's Republic of China [C2007000831, C2009001541]	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of People's Republic of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Hebei Natural Science Foundation of People's Republic of China	This work was supported, in whole or in part, by the Intramural Research Program of the NIA, National Institutes of Health. This work was also supported by Program for Major State Basic Research Development Program of China Grant 2008CB517402, National Natural Science Foundation of People's Republic of China Grants 30770787, 30670845, and 30871272, Key Project of Chinese Ministry of Education Grant 206016, and Hebei Natural Science Foundation of People's Republic of China Grants C2007000831 and C2009001541.	Antonyak MA, 2002, J BIOL CHEM, V277, P14712, DOI 10.1074/jbc.M112259200; Autieri MV, 2008, CIRC RES, V102, P1455, DOI 10.1161/CIRCRESAHA.108.178954; Campbell M, 2004, CIRC RES, V95, P380, DOI 10.1161/01.RES.0000138019.82184.5d; Chen QY, 2002, IMMUNOLOGY, V107, P199, DOI 10.1046/j.1365-2567.2002.01485.x; Day RM, 2006, AM J RESP CELL MOL, V34, P695, DOI 10.1165/rcmb.2005-0306OC; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Gervais M, 2006, MOL BIOL CELL, V17, P3940, DOI 10.1091/mbc.E06-06-0501; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Haldar SM, 2007, J MOL CELL CARDIOL, V43, P1, DOI 10.1016/j.yjmcc.2007.04.005; Han M, 2006, AM J PHYSIOL-CELL PH, V291, pC50, DOI 10.1152/ajpcell.00524.2005; Haxsen V, 2001, CIRC RES, V88, P637, DOI 10.1161/01.RES.88.6.637; Kada N, 2007, ARTERIOSCL THROM VAS, V27, P1535, DOI 10.1161/ATVBAHA.106.134114; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Khan R, 2007, CARDIOVASC RES, V74, P223, DOI 10.1016/j.cardiores.2007.02.012; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Li AY, 2008, FEBS LETT, V582, P243, DOI 10.1016/j.febslet.2007.12.011; Liu B, 2008, J PHARMACOL EXP THER, V324, P292, DOI 10.1124/jpet.107.127407; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu Y, 2003, J BIOL CHEM, V278, P48004, DOI 10.1074/jbc.M301902200; Lu L, 2003, AM J PHYSIOL-HEART C, V285, pH1370, DOI 10.1152/ajpheart.00260.2003; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Mehrhof FB, 2005, CIRC RES, V96, P958, DOI 10.1161/01.RES.0000166924.31219.49; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Miano JM, 2001, ARTERIOSCL THROM VAS, V21, P724, DOI 10.1161/01.ATV.21.5.724; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Ou HS, 2000, CIRC RES, V87, P881, DOI 10.1161/01.RES.87.10.881; Papanicolaou KN, 2008, CIRC RES, V102, P16, DOI 10.1161/CIRCRESAHA.107.164186; Pettersson F, 2004, ONCOGENE, V23, P7053, DOI 10.1038/sj.onc.1207956; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Rosner D, 2006, AM J PATHOL, V168, P2054, DOI 10.2353/ajpath.2006.050473; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sano H, 2001, CIRCULATION, V103, P2955, DOI 10.1161/01.CIR.103.24.2955; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Uruno A, 2005, CIRCULATION, V112, P727, DOI 10.1161/CIRCULATIONAHA.104.500959; Venkatachalam K, 2008, AM J PHYSIOL-HEART C, V294, pH2078, DOI 10.1152/ajpheart.01363.2007; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Yamaguchi H, 2004, ARTERIOSCL THROM VAS, V24, P2095, DOI 10.1161/01.ATV.0000144009.35400.65; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Yen A, 1998, CANCER RES, V58, P3163; Zhang XH, 2009, FEBS LETT, V583, P1231, DOI 10.1016/j.febslet.2009.03.016; Zheng B, 2004, BBA-MOL BASIS DIS, V1690, P1, DOI 10.1016/j.bbadis.2004.04.009; Zheng B, 2008, BIOCHEMISTRY-MOSCOW+, V73, P353, DOI 10.1134/S0006297908030188; Zheng B, 2008, FEBS J, V275, P1568, DOI 10.1111/j.1742-4658.2008.06315.x; Zheng B, 2008, BIOCHEM J, V409, P683, DOI 10.1042/BJ20070977	50	45	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22773	22785		10.1074/jbc.M109.026989	http://dx.doi.org/10.1074/jbc.M109.026989			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531492	Green Published, hybrid			2022-12-27	WOS:000268963100031
J	Levitt, ES; Clark, MJ; Jenkins, PM; Martens, JR; Traynor, JR				Levitt, Erica S.; Clark, Mary J.; Jenkins, Paul M.; Martens, Jeffrey R.; Traynor, John R.			Differential Effect of Membrane Cholesterol Removal on mu- and delta-Opioid Receptors A PARALLEL COMPARISON OF ACUTE AND CHRONIC SIGNALING TO ADENYLYL CYCLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HETEROTRIMERIC G-PROTEINS; LIPID RAFT MICRODOMAINS; CAPACITATIVE CA2+ ENTRY; CHRONIC ACTIVATION; CARDIAC MYOCYTES; CELL-MEMBRANES; RETINOIC ACID; CAVEOLAE; LOCALIZATION	According to the lipid raft theory, the plasma membrane contains small domains enriched in cholesterol and sphingolipid, which may serve as platforms to organize membrane proteins. Using methyl-beta-cyclodextrin (M beta CD) to deplete membrane cholesterol, many G protein-coupled receptors have been shown to depend on putative lipid rafts for proper signaling. Here we examine the hypothesis that treatment of HEK293 cells stably expressing FLAG-tagged mu-opioid receptors (HEK FLAG-mu) or delta-opioid receptors (HEK FLAG-delta) with M beta CD will reduce opioid receptor signaling to adenylyl cyclase. The ability of the mu-opioid agonist [D-Ala(2),N-Me-Phe(4),Gly(5)-ol] enkephalin to acutely inhibit adenylyl cyclase or to cause sensitization of adenylyl cyclase following chronic treatment was attenuated with M beta CD. These effects were due to removal of cholesterol, because replenishment of cholesterol restored [D-Ala(2),N-Me-Phe(4),Gly(5)-ol] enkephalin responses back to control values, and were confirmed in SH-SY5Y cells endogenously expressing mu-opioid receptors. The effects of M beta CD may be due to uncoupling of the mu receptor from G proteins but were not because of decreases in receptor number and were not mimicked by cytoskeleton disruption. In contrast to the results in HEK FLAG-mu cells, M beta CD treatment of HEK FLAG-delta cells had no effect on acute inhibition or sensitization of adenylyl cyclase by delta-opioid agonists. The differential responses of mu- and delta-opioid agonists to cholesterol depletion suggest that mu-opioid receptors are more dependent on cholesterol for efficient signaling than delta receptors and can be partly explained by localization of mu- but not delta-opioid receptors in cholesterol- and caveolin-enriched membrane domains.	[Levitt, Erica S.; Clark, Mary J.; Jenkins, Paul M.; Martens, Jeffrey R.; Traynor, John R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Traynor, John R.] Univ Michigan, Subst Abuse Res Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Traynor, JR (corresponding author), 1150 W Med Ctr Dr,1301 MSRB 3, Ann Arbor, MI 48109 USA.	jtraynor@umich.edu	Jenkins, Paul/C-9098-2015; Levitt, Erica/AAJ-6755-2020	Jenkins, Paul/0000-0002-4207-5823; 	NHLBI NIH HHS [HL0270973] Funding Source: Medline; NIDA NIH HHS [R01 DA004087, F31 DA023339, R03 DA022377, T32 DA07267, R03 DA22377, R01 DA04087] Funding Source: Medline; NIDCD NIH HHS [T32 DC000011] Funding Source: Medline; NIGMS NIH HHS [GM07767] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA023339, R03DA022377, T32DA007267, R01DA004087] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Andre A, 2008, BBA-BIOMEMBRANES, V1778, P1483, DOI 10.1016/j.bbamem.2008.03.017; AvidorReiss T, 1997, J BIOL CHEM, V272, P5040, DOI 10.1074/jbc.272.8.5040; Bayewitch ML, 2000, MOL PHARMACOL, V57, P820, DOI 10.1124/mol.57.4.820; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady JD, 2004, MOL PHARMACOL, V65, P503, DOI 10.1124/mol.65.3.503; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chakrabarti S, 1997, MOL PHARMACOL, V52, P105, DOI 10.1124/mol.52.1.105; Cheema TA, 2008, J PHARMACOL EXP THER, V324, P648, DOI 10.1124/jpet.107.131110; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christian AE, 1997, J LIPID RES, V38, P2264; Clark MJ, 2003, J BIOL CHEM, V278, P9418, DOI 10.1074/jbc.M208885200; COSTA T, 1988, MOL PHARMACOL, V34, P744; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Divin MF, 2009, BRIT J PHARMACOL, V156, P1044, DOI 10.1111/j.1476-5381.2008.00035.x; Emmerson PJ, 1999, J NEUROCHEM, V73, P289, DOI 10.1046/j.1471-4159.1999.0730289.x; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FRA AM, 1994, J BIOL CHEM, V269, P30745; Gaibelet G, 2008, MOL MEMBR BIOL, V25, P423, DOI 10.1080/09687680802203380; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Huang P, 2007, BRAIN RES, V1184, P46, DOI 10.1016/j.brainres.2007.09.096; Huang P, 2007, BIOCHEM PHARMACOL, V73, P534, DOI 10.1016/j.bcp.2006.10.032; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nevo I, 1998, MOL PHARMACOL, V54, P419, DOI 10.1124/mol.54.2.419; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Patel HH, 2006, AM J PHYSIOL-HEART C, V291, pH344, DOI 10.1152/ajpheart.01100.2005; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pitt B, 2005, NEW ENGL J MED, V352, P1483, DOI 10.1056/NEJMe058052; POLASTRON J, 1992, EUR J PHARM-MOLEC PH, V226, P133, DOI 10.1016/0922-4106(92)90174-T; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; PREMONT RT, 1994, METHOD ENZYMOL, V238, P116; Quinton TM, 2005, J THROMB HAEMOST, V3, P1036, DOI 10.1111/j.1538-7836.2005.01325.x; Rhee MH, 2000, MOL PHARMACOL, V57, P746, DOI 10.1124/mol.57.4.746; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slotte JP, 1999, CHEM PHYS LIPIDS, V102, P13, DOI 10.1016/S0009-3084(99)00071-7; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Watts VJ, 2002, J PHARMACOL EXP THER, V302, P1, DOI 10.1124/jpet.302.1.1; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Zaki PA, 2001, J PHARMACOL EXP THER, V298, P1015; Zhang L, 2009, J BIOL CHEM, V284, P1990, DOI 10.1074/jbc.M807971200; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024	61	45	46	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22108	22122		10.1074/jbc.M109.030411	http://dx.doi.org/10.1074/jbc.M109.030411			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520863	hybrid, Green Published			2022-12-27	WOS:000268783700035
J	Miller, TW; Cherney, MM; Lee, AJ; Francoleon, NE; Farmer, PJ; King, SB; Hobbs, AJ; Miranda, KM; Burstyn, JN; Fukuto, JM				Miller, Thomas W.; Cherney, Melisa M.; Lee, Andrea J.; Francoleon, Nestor E.; Farmer, Patrick J.; King, S. Bruce; Hobbs, Adrian J.; Miranda, Katrina M.; Burstyn, Judith N.; Fukuto, Jon M.			The Effects of Nitroxyl (HNO) on Soluble Guanylate Cyclase Activity INTERACTIONS AT FERROUS HEME AND CYSTEINE THIOLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE NO; LIGAND-BINDING PROPERTIES; SMOOTH-MUSCLE RELAXATION; ANGELIS SALT; BOVINE LUNG; CENTER-DOT; DIOXYGEN COMPLEXES; BIOLOGICAL-SYSTEMS; PROTOPORPHYRIN-IX; AQUEOUS-SOLUTION	It has been previously proposed that nitric oxide (NO) is the only biologically relevant nitrogen oxide capable of activating the enzyme soluble guanylate cyclase (sGC). However, recent reports implicate HNO as another possible activator of sGC. Herein, we examine the affect of HNO donors on the activity of purified bovine lung sGC and find that, indeed, HNO is capable of activating this enzyme. Like NO, HNO activation appears to occur via interaction with the regulatory ferrous heme on sGC. Somewhat unexpectedly, HNO does not activate the ferric form of the enzyme. Finally, HNO-mediated cysteine thiol modification appears to also affect enzyme activity leading to inhibition. Thus, sGC activity can be regulated by HNO via interactions at both the regulatory heme and cysteine thiols.	[Miller, Thomas W.; Francoleon, Nestor E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cherney, Melisa M.; Lee, Andrea J.; Burstyn, Judith N.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Farmer, Patrick J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [King, S. Bruce] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Hobbs, Adrian J.] UCL, Dept Pharmacol, London WC1E 6BT, England; [Miranda, Katrina M.] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA; [Fukuto, Jon M.] Sonoma State Univ, Dept Chem, Rohnert Pk, CA 94928 USA	University of California System; University of California Los Angeles; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; Wake Forest University; University of London; University College London; University of Arizona; California State University System; Sonoma State University	Fukuto, JM (corresponding author), 1801 E Cotati Ave, Rohnert Pk, CA 94928 USA.	jon.fukuto@sonoma.edu	Farmer, Patrick J/J-3757-2019; Miranda, Katrina M/B-7823-2009; Miller, Thomas W/G-1215-2011	Farmer, Patrick J/0000-0001-9911-999X; Miller, Thomas W/0000-0001-8645-2785; Hobbs, Adrian/0000-0002-3589-7108; Burstyn, Judith/0000-0003-3245-5563	Wellcome Trust [067422] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDEREGG G, 1963, HELV CHIM ACTA, V46, P2397, DOI 10.1002/hlca.19630460657; Bari SE, 2003, J AM CHEM SOC, V125, P15272, DOI 10.1021/ja036370f; Bartberger MD, 2001, P NATL ACAD SCI USA, V98, P2194, DOI 10.1073/pnas.041481598; Bermejo E, 2005, THROMB HAEMOSTASIS, V94, P578, DOI 10.1160/TH05-01-0062; BONNER FT, 1975, INORG CHEM, V14, P558, DOI 10.1021/ic50145a022; BRANDWEIN HJ, 1981, J BIOL CHEM, V256, P2958; BURSTYN JN, 1995, BIOCHEMISTRY-US, V34, P5896, DOI 10.1021/bi00017a019; CRAVEN PA, 1983, BIOCHIM BIOPHYS ACTA, V745, P310, DOI 10.1016/0167-4838(83)90063-8; CRAVEN PA, 1978, BIOCHIM BIOPHYS ACTA, V524, P231, DOI 10.1016/0005-2744(78)90121-3; De Witt BJ, 2001, EUR J PHARMACOL, V430, P311, DOI 10.1016/S0014-2999(01)01289-4; DeMaster EG, 1998, BIOCHEM PHARMACOL, V55, P2007, DOI 10.1016/S0006-2952(98)00080-X; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Derbyshire ER, 2005, BIOCHEMISTRY-US, V44, P16257, DOI 10.1021/bi0515671; DERUBERTIS FR, 1977, J BIOL CHEM, V252, P5804; Dierks EA, 1996, BIOCHEM PHARMACOL, V51, P1593, DOI 10.1016/0006-2952(96)00078-0; DOYLE MP, 1988, J AM CHEM SOC, V110, P593, DOI 10.1021/ja00210a047; DRAGO RS, 1960, J AM CHEM SOC, V82, P96, DOI 10.1021/ja01486a021; Dutton AS, 2005, INORG CHEM, V44, P4024, DOI 10.1021/ic048734q; Dutton AS, 2004, J AM CHEM SOC, V126, P3795, DOI 10.1021/ja0391614; Ellis A, 2001, BRIT J PHARMACOL, V134, P521, DOI 10.1038/sj.bjp.0704287; Ellis A, 2000, BRIT J PHARMACOL, V129, P315, DOI 10.1038/sj.bjp.0703058; Farmer PJ, 2005, J INORG BIOCHEM, V99, P166, DOI 10.1016/j.jinorgbio.2004.11.005; Favaloro JL, 2007, CARDIOVASC RES, V73, P587, DOI 10.1016/j.cardiores.2006.11.018; Feelisch M, 2003, P NATL ACAD SCI USA, V100, P4978, DOI 10.1073/pnas.1031571100; FUKUTO JM, 1992, BIOCHEM PHARMACOL, V43, P607, DOI 10.1016/0006-2952(92)90584-6; FUKUTO JM, 1993, BIOCHEM BIOPH RES CO, V196, P707, DOI 10.1006/bbrc.1993.2307; HADDOX MK, 1978, J BIOL CHEM, V253, P3143; HALLIWELL B, 1989, FREE RADICAL BIO MED, P15; Hobbs AJ, 1996, METHOD ENZYMOL, V269, P134; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; IGNARRO LJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P49, DOI 10.1016/0304-4165(82)90008-3; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; Immoos CE, 2005, J AM CHEM SOC, V127, P814, DOI 10.1021/ja0433727; Irvine JC, 2003, HYPERTENSION, V41, P1301, DOI 10.1161/01.HYP.0000072010.54901.DE; Irvine JC, 2007, HYPERTENSION, V49, P885, DOI 10.1161/01.HYP.0000259328.04159.90; KAMISAKI Y, 1986, ARCH BIOCHEM BIOPHYS, V251, P709, DOI 10.1016/0003-9861(86)90380-2; KIM TD, 1994, J BIOL CHEM, V269, P15540; Lin R, 2000, J AM CHEM SOC, V122, P2393, DOI 10.1021/ja994079n; Lopez BE, 2007, FREE RADICAL BIO MED, V42, P482, DOI 10.1016/j.freeradbiomed.2006.11.015; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Miranda KM, 2005, J MED CHEM, V48, P8220, DOI 10.1021/jm050151i; Miranda KM, 2005, COORDIN CHEM REV, V249, P433, DOI 10.1016/j.ccr.2004.08.010; Miranda KM, 2003, P NATL ACAD SCI USA, V100, P9196, DOI 10.1073/pnas.1430507100; NIEDERHOFFER EC, 1984, CHEM REV, V84, P137, DOI 10.1021/cr00060a003; Paolocci N, 2003, P NATL ACAD SCI USA, V100, P5537, DOI 10.1073/pnas.0937302100; Paolocci N, 2007, PHARMACOL THERAPEUT, V113, P442, DOI 10.1016/j.pharmthera.2006.11.002; Pervitsky D, 2007, J AM CHEM SOC, V129, P9590, DOI 10.1021/ja073420y; PINO RZ, 1994, BIOCHEM BIOPH RES CO, V201, P54, DOI 10.1006/bbrc.1994.1668; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Rusche KM, 1998, BIOCHEMISTRY-US, V37, P15503, DOI 10.1021/bi9813936; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; SCHEIDT WR, 1973, J AM CHEM SOC, V95, P8281, DOI 10.1021/ja00806a013; Schmidt P, 2003, PROTEIN EXPRES PURIF, V31, P42, DOI 10.1016/S1046-5928(03)00142-6; Serfass L, 2001, ARCH BIOCHEM BIOPHYS, V387, P47, DOI 10.1006/abbi.2000.2090; Sha X, 2006, J AM CHEM SOC, V128, P9687, DOI 10.1021/ja062365a; Shafirovich V, 2002, P NATL ACAD SCI USA, V99, P7340, DOI 10.1073/pnas.112202099; Shahidullah M, 2002, EUR J PHARMACOL, V435, P93, DOI 10.1016/S0014-2999(01)01540-0; Shen B, 2005, BIOCHEMISTRY-US, V44, P14030, DOI 10.1021/bi0507478; SMITH PAS, 1960, J AM CHEM SOC, V82, P5731, DOI 10.1021/ja01506a043; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stone JR, 1996, BIOCHEMISTRY-US, V35, P3258, DOI 10.1021/bi952386+; STONE JR, 1995, BIOCHEM BIOPH RES CO, V207, P572, DOI 10.1006/bbrc.1995.1226; Sulc F, 2004, J AM CHEM SOC, V126, P1096, DOI 10.1021/ja0376184; Sulc F, 2003, J BIOL INORG CHEM, V8, P348, DOI 10.1007/s00775-002-0422-7; Thadani U, 2007, EXPERT OPIN DRUG SAF, V6, P385, DOI 10.1517/14740338.6.4.385; TURK T, 1992, BIOCHEM BIOPH RES CO, V183, P983, DOI 10.1016/S0006-291X(05)80287-6; Vaananen AJ, 2005, FREE RADICAL BIO MED, V38, P1102, DOI 10.1016/j.freeradbiomed.2005.01.007; Vaananen AJ, 2008, FREE RADICAL BIO MED, V45, P749, DOI 10.1016/j.freeradbiomed.2008.05.025; Wanstall JC, 2001, BRIT J PHARMACOL, V134, P463, DOI 10.1038/sj.bjp.0704269; WAYLAND BB, 1979, J AM CHEM SOC, V101, P6472, DOI 10.1021/ja00515a073; WAYLAND BB, 1974, J AM CHEM SOC, V96, P2795, DOI 10.1021/ja00816a022; WOLIN MS, 1982, J BIOL CHEM, V257, P13312; Wong PSY, 1998, BIOCHEMISTRY-US, V37, P5362, DOI 10.1021/bi973153g; YONETANI T, 1972, J BIOL CHEM, V247, P2447	76	83	84	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21788	21796		10.1074/jbc.M109.014282	http://dx.doi.org/10.1074/jbc.M109.014282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531488	hybrid, Green Published			2022-12-27	WOS:000268783700003
J	Van Rechem, C; Rood, BR; Touka, M; Pinte, S; Jenal, M; Guerardel, C; Ramsey, K; Monte, D; Begue, A; Tschan, MP; Stephan, DA; Leprince, D				Van Rechem, Capucine; Rood, Brian R.; Touka, Majid; Pinte, Sebastien; Jenal, Mathias; Guerardel, Cateline; Ramsey, Keri; Monte, Didier; Begue, Agnes; Tschan, Mario P.; Stephan, Dietrich A.; Leprince, Dominique			Scavenger Chemokine (CXC Motif) Receptor 7 (CXCR7) Is a Direct Target Gene of HIC1 (Hypermethylated in Cancer 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; TRANSCRIPTIONAL REPRESSION; PROSTATE-CANCER; DNA-DAMAGE; IN-VIVO; P53; GROWTH; HYPERMETHYLATION; SIRT1; IDENTIFICATION	The tumor suppressor gene HIC1 (Hypermethylated in Cancer 1) that is epigenetically silenced in many human tumors and is essential for mammalian development encodes a sequence-specific transcriptional repressor. The few genes that have been reported to be directly regulated by HIC1 include ATOH1, FGFBP1, SIRT1, and E2F1. HIC1 is thus involved in the complex regulatory loops modulating p53-dependent and E2F1-dependent cell survival and stress responses. We performed genome-wide expression profiling analyses to identify new HIC1 target genes, using HIC1-deficient U2OS human osteosarcoma cells infected with adenoviruses expressing either HIC1 or GFP as a negative control. These studies identified several putative direct target genes, including CXCR7, a G-protein-coupled receptor recently identified as a scavenger receptor for the chemokine SDF-1/CXCL12. CXCR7 is highly expressed in human breast, lung, and prostate cancers. Using quantitative reverse transcription-PCR analyses, we demonstrated that CXCR7 was repressed in U2OS cells overexpressing HIC1. Inversely, inactivation of endogenous HIC1 by RNA interference in normal human WI38 fibroblasts results in up-regulation of CXCR7 and SIRT1. In silico analyses followed by deletion studies and luciferase reporter assays identified a functional and phylogenetically conserved HIC1-responsive element in the human CXCR7 promoter. Moreover, chromatin immunoprecipitation (ChIP) and ChIP upon ChIP experiments demonstrated that endogenous HIC1 proteins are bound together with the C-terminal binding protein corepressor to the CXCR7 and SIRT1 promoters in WI38 cells. Taken together, our results implicate the tumor suppressor HIC1 in the transcriptional regulation of the chemokine receptor CXCR7, a key player in the promotion of tumorigenesis in a wide variety of cell types.	[Van Rechem, Capucine; Touka, Majid; Pinte, Sebastien; Guerardel, Cateline; Monte, Didier; Begue, Agnes; Leprince, Dominique] Univ Lille NORD France, CNRS, UMR 8161, Inst Pasteur Lille,Inst Biol Lille, F-59017 Lille, France; [Rood, Brian R.] George Washington Univ, Sch Med, Childrens Natl Med Ctr, Washington, DC 20010 USA; [Jenal, Mathias; Tschan, Mario P.] Univ Bern, Dept Clin Res Expt Oncol Hematol, CH-3010 Bern, Switzerland; [Ramsey, Keri; Stephan, Dietrich A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Children's National Health System; George Washington University; University of Bern; Translational Genomics Research Institute	Leprince, D (corresponding author), Univ Lille NORD France, CNRS, UMR 8161, Inst Pasteur Lille,Inst Biol Lille, 1 Rue Calmette,BP 447, F-59017 Lille, France.	dominique.leprince@ibl.fr		monte, didier/0000-0002-0613-6203; Van Rechem, Capucine/0000-0002-5408-6124; Leprince, Dominique/0000-0002-1999-0775; Tschan, Mario P./0000-0001-5897-3647	National Institutes of Health [5K12HD001399-05]; CNRS, Association for International Cancer Research (St. Andrews, United Kingdom); Pasteur Institute; Association pour la Recherche Contre le Cancer [3586, 3983]; Hope Street Kids [OCS-0182302-2006]; Werner and Hedy Berger-Janser Foundation of Cancer Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS, Association for International Cancer Research (St. Andrews, United Kingdom)(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute; Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Hope Street Kids; Werner and Hedy Berger-Janser Foundation of Cancer Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 5K12HD001399-05 from the NICHD (a Child Health Research career development award to B. R. R.). This work was also supported in part by funds from CNRS, Association for International Cancer Research (St. Andrews, United Kingdom), the Pasteur Institute and Association pour la Recherche Contre le Cancer 3586 and 3983 (to D. L.), Hope Street Kids Grants the Swiss Federation against Cancer/Oncosuisse Grant OCS-0182302-2006, and the Werner and Hedy Berger-Janser Foundation of Cancer Research (to M. P. T.).	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bernard D, 2004, CANCER RES, V64, P472, DOI 10.1158/0008-5472.CAN-03-0005; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Briones VR, 2006, BIOCHEM BIOPH RES CO, V345, P595, DOI 10.1016/j.bbrc.2006.04.052; Britschgi C, 2006, ONCOGENE, V25, P2030, DOI 10.1038/sj.onc.1209240; Britschgi C, 2008, BRIT J HAEMATOL, V141, P179, DOI 10.1111/j.1365-2141.2008.06992.x; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200; JENAL M, 2009, MOL CANC RE IN PRESS; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Li LC, 2004, BBA-REV CANCER, V1704, P87, DOI 10.1016/j.bbcan.2004.06.001; MAKOS M, 1993, CANCER RES, V53, P2719; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; Meijer J, 2008, BRIT J CANCER, V99, P1493, DOI 10.1038/sj.bjc.6604727; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Morton RA, 1996, J UROLOGY, V156, P512, DOI 10.1016/S0022-5347(01)65916-0; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Pinte S, 2004, ONCOGENE, V23, P4023, DOI 10.1038/sj.onc.1207504; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Rood BR, 2002, CANCER RES, V62, P3794; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Stocklein H, 2008, ONCOGENE, V27, P2613, DOI 10.1038/sj.onc.1210901; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Zhang B, 2009, ONCOGENE, V28, P651, DOI 10.1038/onc.2008.419; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	40	56	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20927	20935		10.1074/jbc.M109.022350	http://dx.doi.org/10.1074/jbc.M109.022350			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19525223	Green Published, hybrid			2022-12-27	WOS:000268316100056
J	Folco, EJ; Rocha, VZ; Lopez-Ilasaca, M; Libby, P				Folco, Eduardo J.; Rocha, Viviane Z.; Lopez-Ilasaca, Marco; Libby, Peter			Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; TNF-ALPHA PRODUCTION; COLLAGENOUS DOMAIN; INSULIN-RESISTANCE; DEFICIENT MICE; ATHEROSCLEROSIS; EXPRESSION; RESPONSES; PROTEIN	Macrophages participate pivotally in the pathogenesis of many chronic inflammatory diseases including atherosclerosis. Adiponectin, a vasculoprotective molecule with insulin-sensitizing and anti-atherogenic properties, suppresses pro-inflammatory gene expression in macrophages by mechanisms that remain incompletely understood. This study investigated the effects of adiponectin on major pro-inflammatory signaling pathways in human macrophages. We demonstrate that pretreatment of these cells with adiponectin inhibits phosphorylation of nuclear factor kappa B inhibitor (I kappa B), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (MAPK), induced by either lipopolysaccharide (LPS) or tumor necrosis factor (TNF) alpha, as well as STAT3 phosphorylation induced by interleukin-6 (IL6). Antagonism of IL10 by either neutralizing antibodies or siRNA-mediated silencing did not abrogate the anti-inflammatory actions of adiponectin, indicating that the ability of adiponectin to render human macrophages tolerant to various pro-inflammatory stimuli does not require this cytokine. A systematic search for adiponectin-inducible genes with established anti-inflammatory properties revealed that adiponectin augmented the expression of A20, suppressor of cytokine signaling (SOCS) 3, B-cell CLL/lymphoma (BCL) 3, TNF receptor-associated factor (TRAF) 1, and TNFAIP3-interacting protein (TNIP) 3. These results suggest that adiponectin triggers a multifaceted response in human macrophages by inducing the expression of various anti-inflammatory proteins that act at different levels in concert to suppress macrophage activation.	[Folco, Eduardo J.; Rocha, Viviane Z.; Lopez-Ilasaca, Marco; Libby, Peter] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Libby, P (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, 77 Ave Louis Pasteur,NRB 741, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X	National Institutes of Health NHLBI [R01-HL034636, R01-HL0831554]; Donald W. Reynolds Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034636] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health NHLBI Grants R01-HL034636 ( to P. L.) and R01-HL0831554 ( to M. L. I.). This work was also supported by grants from the Donald W. Reynolds Foundation.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Isoda K, 2008, ATHEROSCLEROSIS, V198, P307, DOI 10.1016/j.atherosclerosis.2007.10.035; Kobashi C, 2005, CIRC RES, V97, P1245, DOI 10.1161/01.RES.0000194328.57164.36; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wullaert A, 2007, J BIOL CHEM, V282, P81, DOI 10.1074/jbc.M607481200; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	42	98	107	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25569	25575		10.1074/jbc.M109.019786	http://dx.doi.org/10.1074/jbc.M109.019786			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617629	hybrid, Green Published			2022-12-27	WOS:000269738000014
J	Kaplan, JH; Lutsenko, S				Kaplan, Jack H.; Lutsenko, Svetlana			Copper Transport in Mammalian Cells: Special Care for a Metal with Special Needs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							WILSONS-DISEASE PROTEIN; P-TYPE ATPASES; BIOCHEMICAL-CHARACTERIZATION; THERMOTOGA-MARITIMA; EPITHELIAL-CELLS; PLASMA-MEMBRANE; HUMAN CTR1; HCTR1; MECHANISM; HOMEOSTASIS	Copper plays an essential role in human physiology. It is required for respiration, radical defense, neuronal myelination, angiogenesis, and many other processes. Copper has distinct physicochemical properties that pose uncommon challenges for its transport across biological membranes. Only small amounts of copper are present in biological fluids, and essentially none of it exists in a free ion form. These properties and the low redox potential of copper dictate special structural and mechanistic features in copper transporters. This minireview discusses molecular mechanisms through which copper enters and exits human cells.	[Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University	Kaplan, JH (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	kaplanj@uic.edu; lutsenko@jhmi.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [P01 067166, DK071865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 067166 ( to J.H.K.) and DK071865 ( to S. L.). This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; Arredondo M, 2003, AM J PHYSIOL-CELL PH, V284, pC1525, DOI 10.1152/ajpcell.00480.2002; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Bertinato J, 2008, BIOCHEM J, V409, P731, DOI 10.1042/BJ20071025; di Patti MC, 2009, J BIOL CHEM, V284, P4545, DOI 10.1074/jbc.M805688200; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Hardman B, 2007, CELL PHYSIOL BIOCHEM, V20, P1073, DOI 10.1159/000110718; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; Hatori Y, 2009, BIOCHEMISTRY-US, V48, P4871, DOI 10.1021/bi900338n; Hung YH, 2007, BIOCHEM J, V401, P569, DOI 10.1042/BJ20060924; Jiang JF, 2005, INORG CHEM, V44, P9787, DOI 10.1021/ic051180m; Kim H, 2009, AM J PHYSIOL-GASTR L, V296, pG356, DOI 10.1152/ajpgi.90632.2008; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Leonhardt K, 2009, J BIOL CHEM, V284, P7793, DOI 10.1074/jbc.M805145200; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Mercer JFB, 2003, BIOMETALS, V16, P175, DOI 10.1023/A:1020719016675; Michaiczyk A, 2008, J HISTOCHEM CYTOCHEM, V56, P389, DOI 10.1369/jhc.7A7300.2008; Moriya M, 2008, AM J PHYSIOL-CELL PH, V295, pC708, DOI 10.1152/ajpcell.00029.2008; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Ralle M, 2003, J BIOL CHEM, V278, P23163, DOI 10.1074/jbc.M303474200; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Safaei R, 2008, MOL PHARMACOL, V73, P461, DOI 10.1124/mol.107.040980; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Tsuda T, 2009, EMBO J, V28, P1782, DOI 10.1038/emboj.2009.143; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; Veldhuis N, 2009, BIOMETALS, V22, P177, DOI 10.1007/s10534-008-9183-2; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Weiss KH, 2008, J ANAT, V213, P232, DOI 10.1111/j.1469-7580.2008.00954.x; White C, 2009, J CELL SCI, V122, P1315, DOI 10.1242/jcs.043216; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200	48	119	121	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25461	25465		10.1074/jbc.R109.031286	http://dx.doi.org/10.1074/jbc.R109.031286			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19602511	hybrid, Green Published			2022-12-27	WOS:000269738000002
J	Zhang, HM; Kenaan, C; Hamdane, D; Hoa, GHB; Hollenberg, PF				Zhang, Haoming; Kenaan, Cesar; Hamdane, Djemel; Hoa, Gaston Hui Bon; Hollenberg, Paul F.			Effect of Conformational Dynamics on Substrate Recognition and Specificity as Probed by the Introduction of a de Novo Disulfide Bond into Cytochrome P450 2B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INACTIVATION; HEME SPIN-STATE; HIGH-PRESSURE; MOLECULAR-DYNAMICS; ACTIVE-SITE; STRUCTURAL BASIS; BINDING-SITE; AMINO-ACID; P450; IDENTIFICATION	The conformational dynamics of cytochrome P450 2B1 (CYP2B1) were investigated through the introduction of a disulfide bond to link the I- and K-helices by generation of a double Cys variant, Y309C/S360C. The consequences of the disulfide bonding were examined both experimentally and in silico by molecular dynamics simulations. Under high hydrostatic pressures, the partial inactivation volume for the Y309C/S360C variant was determined to be -21 cm(3)mol(-1), which is more than twice as much as those of the wild type (WT) and single Cys variants (Y309C, S360C). This result indicates that the engineered disulfide bond has substantially reduced the protein plasticity of the Y309C/S360C variant. Under steady-state turnover conditions, the S360C variant catalyzed the N-demethylation of benzphetamine and O-deethylation of 7-ethoxy-trifluoromethylcoumarin as the WT did, whereas the Y309C variant retained only 39% of the N-demethylation activity and 66% of the O-deethylation activity compared with the WT. Interestingly, the Y309C/S360C variant restored the N-demethylation activity to the same level as that of the WT but decreased the O-deethylation activity to only 19% of the WT. Furthermore, the Y309C/S360C variant showed increased substrate specificity for testosterone over androstenedione. Molecular dynamics simulations revealed that the engineered disulfide bond altered substrate access channels. Taken together, these results suggest that protein dynamics play an important role in regulating substrate entry and recognition.	[Zhang, Haoming; Kenaan, Cesar; Hollenberg, Paul F.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Hamdane, Djemel; Hoa, Gaston Hui Bon] INSERM, U779, F-94275 Le Kremlin Bicetre, France	University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hollenberg, PF (corresponding author), 1150 W Med Ctr Dr,MSRB 3, Ann Arbor, MI 48109 USA.	phollen@umich.edu	Hollenberg, Paul F/A-7538-2009; Zhang, Haoming/AAE-3749-2020	Zhang, Haoming/0000-0002-8765-4394	National Institutes of Health [CA16954]; NATIONAL CANCER INSTITUTE [R37CA016954, R01CA016954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA16954 ( to P. F. H.).	Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; Davydov DR, 2003, BIOCHEM BIOPH RES CO, V312, P121, DOI 10.1016/j.bbrc.2003.09.247; Domanski TL, 2001, ARCH BIOCHEM BIOPHYS, V394, P21, DOI 10.1006/abbi.2001.2504; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; GOTOH O, 1992, J BIOL CHEM, V267, P83; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Hamdane D, 2005, J BIOL CHEM, V280, P36809, DOI 10.1074/jbc.M506253200; Hanna IH, 1998, BIOCHEMISTRY-US, V37, P311, DOI 10.1021/bi971528s; Harris DL, 2004, PROTEINS, V55, P895, DOI 10.1002/prot.20062; HE YA, 1992, BIOCHEMISTRY-US, V31, P9220, DOI 10.1021/bi00153a015; HE YA, 1994, BIOCHEMISTRY-US, V33, P4419, DOI 10.1021/bi00180a040; HE YQ, 1995, CHEM RES TOXICOL, V8, P574, DOI 10.1021/tx00046a011; Hoa GHB, 2002, BBA-PROTEIN STRUCT M, V1595, P297, DOI 10.1016/S0167-4838(01)00352-1; HOA GHB, 1982, ANAL BIOCHEM, V120, P125, DOI 10.1016/0003-2697(82)90327-X; Hollenberg PF, 2008, CHEM RES TOXICOL, V21, P189, DOI 10.1021/tx7002504; Honma W, 2005, ARCH BIOCHEM BIOPHYS, V435, P157, DOI 10.1016/j.abb.2004.12.014; Kent UM, 2002, J PHARMACOL EXP THER, V300, P549, DOI 10.1124/jpet.300.2.549; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WH, 2005, DRUG METAB DISPOS, V33, P910, DOI 10.1124/dmd.105.004200; Lin HL, 2003, J PHARMACOL EXP THER, V306, P744, DOI 10.1124/jpet.103.050260; Lin HL, 2003, CHEM RES TOXICOL, V16, P129, DOI 10.1021/tx020040b; Luo Zongshu, 1994, Archives of Biochemistry and Biophysics, V309, P52; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; Nguyen TA, 2008, MOL PHARMACOL, V73, P1122, DOI 10.1124/mol.107.042861; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Reed JR, 2003, J INORG BIOCHEM, V93, P152, DOI 10.1016/S0162-0134(02)00597-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Seifert A, 2009, PROTEINS, V74, P1028, DOI 10.1002/prot.22242; Skopalik J, 2008, J PHYS CHEM B, V112, P8165, DOI 10.1021/jp800311c; Smith SV, 2000, BIOCHEMISTRY-US, V39, P5731, DOI 10.1021/bi000129l; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tschirret-Guth RA, 1998, J AM CHEM SOC, V120, P3590, DOI 10.1021/ja973909z; Von Weymarn LB, 2004, J PHARMACOL EXP THER, V311, P71, DOI 10.1124/jpet.104.069757; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Williams PA, 2000, J INORG BIOCHEM, V81, P183, DOI 10.1016/S0162-0134(00)00102-1; Yao H, 2007, PROTEINS, V69, P125, DOI 10.1002/prot.21508; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200	47	26	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25678	25686		10.1074/jbc.M109.032748	http://dx.doi.org/10.1074/jbc.M109.032748			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19605359	Green Published, hybrid			2022-12-27	WOS:000269738000025
J	Sasaki, M; Yoshitane, H; Du, NH; Okano, T; Fukada, Y				Sasaki, Momoko; Yoshitane, Hikari; Du, Ngoc-Hien; Okano, Toshiyuki; Fukada, Yoshitaka			Preferential Inhibition of BMAL2-CLOCK Activity by PER2 Reemphasizes Its Negative Role and a Positive Role of BMAL2 in the Circadian Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIOD HOMOLOGS; CKI-EPSILON; CLOCK; GENE; EXPRESSION; MPER2; PHOSPHORYLATION; IDENTIFICATION; OSCILLATIONS; ACTIVATION	In the molecular oscillatory mechanism governing circadian rhythms, positive regulators, including CLOCK and BMAL1, transactivate Per and Cry genes through E-box elements, and translated PER and CRY proteins negatively regulate their own transactivation. Like BMAL1, its paralog BMAL2 dimerizes with CLOCK to activate the E-box-dependent transcription, but the role of BMAL2 in the circadian clockwork is still elusive. Here we characterized BMAL2 function in NIH3T3 cells and found that the cellular rhythms monitored by Bmal1 promoter-driven bioluminescence signals were blunted by RNA interference-mediated suppression of Bmal2 as well as that of Bmal1. Transcription assays with a 2.1-kb mPer1 promoter revealed that CRY2 inhibited the transactivation mediated by BMAL1-CLOCK more strongly than that by BMAL2-CLOCK. In contrast, PER2 showed a stronger inhibitory effect on BMAL2-CLOCK than on BMAL1-CLOCK. The molecular link between BMAL2 and PER2 was further strengthened by the fact that PER2 exhibited a greater affinity for BMAL2 than for BMAL1 in co-immunoprecipitation experiments. These results indicate a functional partnership between BMAL2 and PER2 and reemphasize the negative role of PER2 in the circadian transcription. As a broad spectrum function, BMAL2-CLOCK activated transcription from a variety of SV40-driven reporters harboring various E/E'-box-containing sequences present in the upstream regions of clock and clock-controlled genes. Importantly, the efficiencies of BMAL2-CLOCK-mediated transactivation relative to that achieved by BMAL1-CLOCK were dependent heavily on the E-box-containing sequences, supporting distinguishable roles of the two BMALs. Collectively, it is strongly suggested that BMAL2 plays an active role in the circadian transcription.	[Sasaki, Momoko; Yoshitane, Hikari; Du, Ngoc-Hien; Okano, Toshiyuki; Fukada, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Okano, Toshiyuki] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo 1628480, Japan	University of Tokyo; Waseda University	Fukada, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	sfukada@mail.ecc.u-tokyo.ac.jp	Du, Ngoc-Hien/AAX-5215-2020; 吉孝, 深田/G-5090-2014	Okano, Toshiyuki/0000-0001-6740-6265; Yoshitane, Hikari/0000-0001-6319-3354	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research and by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Ikeda M, 2000, BIOCHEM BIOPH RES CO, V275, P493, DOI 10.1006/bbrc.2000.3248; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Loop S, 2005, EMBO REP, V6, P341, DOI 10.1038/sj.embor.7400372; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Okano T, 2001, GENES CELLS, V6, P825, DOI 10.1046/j.1365-2443.2001.00462.x; Okano T, 2001, NEUROSCI LETT, V300, P111, DOI 10.1016/S0304-3940(01)01581-6; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takano A, 2004, J BIOL CHEM, V279, P32578, DOI 10.1074/jbc.M403433200; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	43	38	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25149	25159		10.1074/jbc.M109.040758	http://dx.doi.org/10.1074/jbc.M109.040758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605937	Green Published, hybrid			2022-12-27	WOS:000269734000049
J	Spry, C; Saliba, KJ				Spry, Christina; Saliba, Kevin J.			The Human Malaria Parasite Plasmodium falciparum Is Not Dependent on Host Coenzyme A Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANTOTHENIC-ACID METABOLISM; FUNCTIONAL EXPRESSION; DUCK ERYTHROCYTES; AVIAN-MALARIA; KINASE; TRANSPORT; PATHWAYS; MEMBRANE; BLOOD; NA+	Pantothenate, a precursor of the fundamental enzyme cofactor coenzyme A (CoA), is essential for growth of the intraerythrocytic stage of human and avian malaria parasites. Avian malaria parasites have been reported to be incapable of de novo CoA synthesis and instead salvage CoA from the host erythrocyte; hence, pantothenate is required for CoA biosynthesis within the host cell and not the parasite itself. Whether the same is true of the intraerythrocytic stage of the human malaria parasite, Plasmodium falciparum, remained to be established. In this study we investigated the metabolic fate of [C-14]pantothenate within uninfected and P. falciparum-infected human erythrocytes. We provide evidence consistent with normal human erythrocytes, unlike rat erythrocytes (which have been reported to possess an incomplete CoA biosynthesis pathway), being capable of CoA biosynthesis from pantothenate. We also show that CoA biosynthesis is substantially higher in P. falciparum-infected erythrocytes and that P. falciparum, unlike its avian counterpart, generates most of the CoA synthesized in the infected erythrocyte, presumably necessitated by insufficient CoA biosynthesis in the host erythrocyte. Our data raise the possibility that malaria parasites rationalize their biosynthetic activity depending on the capacity of their host cell to synthesize the metabolites they require.	[Saliba, Kevin J.] Australian Natl Univ, Sch Med, Coll Med Biol & Environm, Canberra, ACT 0200, Australia; Australian Natl Univ, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT 0200, Australia	Australian National University; Australian National University	Saliba, KJ (corresponding author), Australian Natl Univ, Sch Med, Coll Med Biol & Environm, GPO Box 4, Canberra, ACT 0200, Australia.	kevin.saliba@anu.edu.au	Saliba, Kevin J/C-9166-2009	Saliba, Kevin J/0000-0003-3345-8440; Spry, Christina/0000-0002-8156-7070	Australian National Health and Medical Research Council [224245]; UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases; Gwendolyn Woodroofe Ph.D. scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases; Gwendolyn Woodroofe Ph.D. scholarship	This work was supported in part by the Australian National Health and Medical Research Council Grant 224245 and the UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases.; Supported by a Gwendolyn Woodroofe Ph.D. scholarship.	Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; ANNOUS KF, 1995, J NUTR, V125, P2586; BENNETT TP, 1967, J PROTOZOOL, V14, P214, DOI 10.1111/j.1550-7408.1967.tb01985.x; BROHN FH, 1975, P NATL ACAD SCI USA, V72, P2456, DOI 10.1073/pnas.72.6.2456; CABANTCHIK ZI, 1990, BLOOD CELLS, V16, P421; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; GINSBURG H, 1983, MOL BIOCHEM PARASIT, V8, P177, DOI 10.1016/0166-6851(83)90008-7; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; GINSBURG H, 1994, BIOCHEM PHARMACOL, V48, P1847, DOI 10.1016/0006-2952(94)90582-7; GUSE AH, 1993, J BIOL CHEM, V268, P7129; Handin RI, 2003, BLOOD PRINCIPLES PRA; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; KIRK K, 1994, J BIOL CHEM, V269, P3339; LADINSKY JL, 1967, CANCER RES, V27, P1689; Lehane AM, 2007, J BIOL CHEM, V282, P25395, DOI 10.1074/jbc.M704610200; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; MOFFATT JG, 1961, J AM CHEM SOC, V83, P663, DOI 10.1021/ja01464a036; Prasad PD, 1999, ARCH BIOCHEM BIOPHYS, V366, P95, DOI 10.1006/abbi.1999.1213; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; REIBEL DK, 1982, J NUTR, V112, P1144, DOI 10.1093/jn/112.6.1144; REIBEL DK, 1981, AM J PHYSIOL, V240, pE597, DOI 10.1152/ajpendo.1981.240.6.E597; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; ROBISHAW JD, 1984, AM J PHYSIOL, V246, pH532, DOI 10.1152/ajpheart.1984.246.4.H532; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Saliba KJ, 2005, ANTIMICROB AGENTS CH, V49, P632, DOI 10.1128/AAC.49.2.632-637.2005; Saliba KJ, 2001, J BIOL CHEM, V276, P18115, DOI 10.1074/jbc.M010942200; SOMOGYI M, 1945, J BIOL CHEM, V160, P69; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; Staines HM, 2001, AM J PHYSIOL-CELL PH, V280, pC1576, DOI 10.1152/ajpcell.2001.280.6.C1576; STOKES GB, 1974, ARCH BIOCHEM BIOPHYS, V162, P638, DOI 10.1016/0003-9861(74)90226-4; Strauss E, 2005, CHEMBIOCHEM, V6, P284, DOI 10.1002/cbic.200400340; Strauss E, 2002, J BIOL CHEM, V277, P48205, DOI 10.1074/jbc.M204560200; Strauss E, 2001, J BIOL CHEM, V276, P13513, DOI 10.1074/jbc.C100033200; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; TRAGER W, 1952, J EXP MED, V96, P465, DOI 10.1084/jem.96.5.465; TRAGER W, 1954, J PROTOZOOL, V1, P231, DOI 10.1111/j.1550-7408.1954.tb00822.x; Trager W, 1943, J EXP MED, V77, P411, DOI 10.1084/jem.77.5.411; UHLEMANN AC, 2000, MACS MORE, V4, P7; Wang HP, 1999, J BIOL CHEM, V274, P14875, DOI 10.1074/jbc.274.21.14875; WITTWER CT, 1989, AM J CLIN NUTR, V50, P1072, DOI 10.1093/ajcn/50.5.1072; Wunsch S, 1998, J CELL BIOL, V140, P335, DOI 10.1083/jcb.140.2.335	46	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24904	24913		10.1074/jbc.M109.025312	http://dx.doi.org/10.1074/jbc.M109.025312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584050	hybrid, Green Published			2022-12-27	WOS:000269734000024
J	Parrini, MC; Camonis, J; Matsuda, M; de Gunzburg, J				Parrini, Maria Carla; Camonis, Jacques; Matsuda, Michiyuki; de Gunzburg, Jean			Dissecting Activation of the PAK1 Kinase at Protrusions in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P21-ACTIVATED KINASE; GROWTH-FACTOR; MEMBRANE LOCALIZATION; FLUORESCENT PROTEIN; ADAPTER PROTEIN; CDC42; MECHANISM; PIX; RAC1; AUTOPHOSPHORYLATION	The p21-activated kinase (PAK) 1 kinase, an effector of the Cdc42 and Rac1 GTPases, regulates cell protrusions and motility by controlling actin and adhesion dynamics. Its deregulation has been linked to human cancer. We show here that activation of PAK1 is necessary for protrusive activity during cell spreading. To investigate PAK1 activation dynamics at live protrusions, we developed a conformational biosensor, based on fluorescence resonance energy transfer. This novel PAK1 biosensor allowed the spatiotemporal visualization of PAK1 activation during spreading of COS-7 cells and during motility of normal rat kidney cells. By using this imaging approach in COS-7 cells, the following new insights on PAK1 regulation were unveiled. First, PAK1 acquires an intermediate semi-open conformational state upon recruitment to the plasma membrane. This semi-open PAK1 species is selectively autophosphorylated on serines in the N-terminal regulatory region but not on the critical threonine 423 in the catalytic site. Second, this intermediate PAK1 state is hypersensitive to stimulation by Cdc42 and Rac1. Third, interaction with PIX proteins contributes to PAK1 stimulation at membrane protrusions, in a GTPase-independent way. Finally, trans-phosphorylation events occur between PAK1 molecules at the membrane possibly playing a relevant role for its activation. This study leads to a model for the complex and accurate regulation of PAK1 kinase in vivo at cell protrusions.	[Parrini, Maria Carla] INSERM, U830, Inst Curie, Sect Rech, F-75248 Paris, France; [Parrini, Maria Carla; Camonis, Jacques; de Gunzburg, Jean] Inst Curie, Ctr Rech, F-75248 Paris, France; [Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto 6068501, Japan	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Kyoto University	Parrini, MC (corresponding author), INSERM, U830, Inst Curie, Sect Rech, 26 Rue Ulm, F-75248 Paris, France.	parrini@curie.fr	Parrini, Maria Carla/J-5390-2016	Parrini, Maria Carla/0000-0002-7082-9792; Matsuda, Michiyuki/0000-0002-5876-9969	Association pour la Recherche sur la Cancer (ARC) [3131, 4845]; Agence Nationale de la Recherche; Association Christelle Bouillot	Association pour la Recherche sur la Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Christelle Bouillot	This work was supported in part by Grants 3131 and 4845 from the Association pour la Recherche sur la Cancer (ARC), Grants ANR05BLAN033802 and ANR08-BLAN-0290-01 from the Agence Nationale de la Recherche, and by the Association Christelle Bouillot (to J. C.).	Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Lu WG, 1999, ONCOGENE, V18, P797, DOI 10.1038/sj.onc.1202361; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Parrini MC, 2005, BIOCHEM SOC T, V33, P646, DOI 10.1042/BST0330646; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Puto LA, 2003, J BIOL CHEM, V278, P9388, DOI 10.1074/jbc.M208414200; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	36	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24133	24143		10.1074/jbc.M109.015271	http://dx.doi.org/10.1074/jbc.M109.015271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574218	Green Published, hybrid			2022-12-27	WOS:000269380200027
J	Paytubi, S; Wang, XM; Lam, YW; Izquierdo, L; Hunter, MJ; Jan, E; Hundal, HS; Proud, CG				Paytubi, Sonia; Wang, Xuemin; Lam, Yun W.; Izquierdo, Luis; Hunter, Mairi J.; Jan, Eric; Hundal, Harinder S.; Proud, Christopher G.			ABC50 Promotes Translation Initiation in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE PROTEIN; HEPATITIS-C VIRUS; ELONGATION FACTOR-III; ATP-DEPENDENT MANNER; RIBOSOME ENTRY SITE; KINASE GCN2; NUCLEAR-ENVELOPE; P-GLYCOPROTEIN; BIOGENESIS; COMPLEX	ABC50 is an ATP-binding cassette (ABC) protein, which, unlike most ABC proteins, does not possess membrane-spanning domains. ABC50 interacts with eukaryotic initiation factor 2 (eIF2), which plays a key role in translation initiation and its control. ABC50 binds to ribosomes, and this interaction requires both the N-terminal domain and at least one ABC domain. Knockdown of ABC50 by RNA interference impaired translation of both cap-dependent and -independent reporters, consistent with a positive role for ABC50 in the function of eIF2, which is required for both types of translation initiation. Mutation of the Walker box A or B motifs in both ABC regions of ABC50 yielded a mutant protein that exerted a dominant-interfering phenotype with respect to protein synthesis and translation initiation. Importantly, although dominant-interfering mutants of ABC50 impaired cap-dependent translation, translation driven by certain internal ribosome entry segments was not inhibited. ABC50 is located in the cytoplasm and nucleoplasm but not in the nucleolus. Thus, ABC50 is not likely to be directly involved in early ribosomal biogenesis, unlike some other ABC proteins. Taken together, the present data show that ABC50 plays a key role in translation initiation and has functions that are distinct from those of other non-membrane ABC proteins.	[Paytubi, Sonia; Wang, Xuemin; Hunter, Mairi J.; Hundal, Harinder S.; Proud, Christopher G.] Univ Dundee, Div Mol Physiol, Sch Life Sci, Dundee DD1 5EH, Scotland; [Lam, Yun W.] Univ Dundee, Div Gene Express, Sch Life Sci, Dundee DD1 5EH, Scotland; [Izquierdo, Luis] Univ Dundee, Div Biol Chem & Mol Microbiol, Sch Life Sci, Dundee DD1 5EH, Scotland; [Wang, Xuemin; Jan, Eric; Proud, Christopher G.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Wang, Xuemin; Proud, Christopher G.] Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	University of Dundee; University of Dundee; University of Dundee; University of British Columbia; University of Southampton	Proud, CG (corresponding author), Southampton Gen Hosp, MP 808,Duthie Bldg,Tremona Rd, Southampton SO16 6YD, Hants, England.	C.G.Proud@soton.ac.uk	Paytubi, Sonia/L-3372-2017; Izquierdo, Luis/L-9291-2015; Jan, Eric/O-1923-2019; Hundal, Hari/A-8990-2008	Paytubi, Sonia/0000-0002-5392-953X; Izquierdo, Luis/0000-0002-3704-9874; Hundal, Hari/0000-0002-7621-4932; Lam, Yun Wah/0000-0001-8929-5965; Proud, Christopher/0000-0003-0704-6442	UK Biotechnology and Biological Sciences Research Council; University of British Columbia; Biotechnology and Biological Sciences Research Council [C19142] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of British Columbia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a project grant from the UK Biotechnology and Biological Sciences Research Council ( to C. G. P.) and by funding from the University of British Columbia.	Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; BELFIELD GP, 1995, J MOL EVOL, V41, P376, DOI 10.1007/BF01215185; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HOFFMANN A, 1991, NUCLEIC ACIDS RES, V19, P6337, DOI 10.1093/nar/19.22.6337; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kerr ID, 2004, BIOCHEM BIOPH RES CO, V315, P166, DOI 10.1016/j.bbrc.2004.01.044; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kozak L, 2002, J BIOL CHEM, V277, P33580, DOI 10.1074/jbc.M205415200; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Leung AKL, 2004, J CELL BIOL, V166, P787, DOI 10.1083/jcb.200405013; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Paytubi S, 2008, BIOCHEM J, V409, P223, DOI 10.1042/BJ20070811; REIMER G, 1987, J CLIN INVEST, V79, P65, DOI 10.1172/JCI112809; Richard M, 1998, GENOMICS, V53, P137, DOI 10.1006/geno.1998.5480; Rivas-Estilla AM, 2002, J VIROL, V76, P10637, DOI 10.1128/JVI.76.21.10637-10653.2002; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANDBAKEN MG, 1990, J BIOL CHEM, V265, P15838; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Szakacs G, 2001, BIOCHEM J, V356, P71, DOI 10.1042/0264-6021:3560071; Tee AR, 2002, MOL CELL BIOL, V22, P1674, DOI 10.1128/MCB.22.6.1674-1683.2002; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; van der Does C, 2006, J BIOL CHEM, V281, P5694, DOI 10.1074/jbc.M511730200; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Yang HM, 1996, BBA-MOL CELL RES, V1310, P303, DOI 10.1016/0167-4889(95)00179-4; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zhao ZY, 2004, BIOCHEM BIOPH RES CO, V323, P104, DOI 10.1016/j.bbrc.2004.08.068	46	74	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24061	24073		10.1074/jbc.M109.031625	http://dx.doi.org/10.1074/jbc.M109.031625			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19570978	Green Published, hybrid			2022-12-27	WOS:000269380200020
J	Wohlgamuth-Benedum, JM; Rubio, MAT; Paris, Z; Long, SJ; Poliak, P; Lukes, J; Alfonzo, JD				Wohlgamuth-Benedum, Jessica M.; Rubio, Mary Anne T.; Paris, Zdenek; Long, Shaojun; Poliak, Pavel; Lukes, Julius; Alfonzo, Juan D.			Thiolation Controls Cytoplasmic tRNA Stability and Acts as a Negative Determinant for tRNA Editing in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST NFS1P; ISCS; BIOSYNTHESIS; PROTEINS; LOCALIZATION; DEGRADATION; BIOGENESIS; ANTICODON; GENOME; DNA	Kinetoplastids encode a single nuclear tryptophanyl tRNA that contains a CCA anticodon able to decode the UGG codons used in cytoplasmic protein synthesis but cannot decode the mitochondrial UGA codons. Following mitochondrial import, this problem is circumvented in Trypanosoma brucei by specifically editing the tRNA(Trp) anticodon to UCA, which can now decode the predominant mitochondrial UGA tryptophan codons. This tRNA also undergoes an unusual thiolation at position 33 of the anticodon loop, the only known modification at U33 in any tRNA. In other organisms, tRNA thiolation is mediated by the cysteine desulfurase, Nfs1 (IscS). However, T. brucei encodes two Nfs homologues, one cytoplasmic and the other mitochondrial. We show by a combination of RNA interference and Northern and Western analyses that the mitochondria-targeted TbNfs, and not TbNfs-like protein, is essential for thiolation of both cytosolic and mitochondrial tRNAs. Given the exclusive mitochondrial localization of TbNfs, how it mediates thiolation in the cytoplasm remains unclear. Furthermore, thiolation specifically affects thiolated tRNA stability in the cytoplasm but more surprisingly acts as a negative determinant for the essential C to U editing in T. brucei. This provides a first line of evidence for mitochondrial C to U editing regulation in this system.	[Wohlgamuth-Benedum, Jessica M.; Rubio, Mary Anne T.; Alfonzo, Juan D.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Wohlgamuth-Benedum, Jessica M.; Rubio, Mary Anne T.; Alfonzo, Juan D.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Wohlgamuth-Benedum, Jessica M.; Rubio, Mary Anne T.; Alfonzo, Juan D.] Ohio State Univ, Ohio State RNA Grp, Columbus, OH 43210 USA; [Paris, Zdenek; Long, Shaojun; Poliak, Pavel; Lukes, Julius] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Budweis, Czech Republic; [Paris, Zdenek; Long, Shaojun; Poliak, Pavel; Lukes, Julius] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Budweis, Czech Republic	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Alfonzo, JD (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave,376 Biosci Rm 440, Columbus, OH 43210 USA.	alfonzo.1@osu.edu	Lukes, Julius/H-6760-2012; Paris, Zdenek/G-7349-2014	Lukes, Julius/0000-0002-0578-6618; Paris, Zdenek/0000-0003-1019-7719	National Institutes of Health Grant from NIGMS [GM084065]; National Science Foundation [MCB-0620707]; Grant Agency of the Czech Republic [204/06/1558]; Czech Ministry of Education [LC07032, 2B06129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084065] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084065 from NIGMS ( to J. D. A.). This work was also supported by Grant MCB-0620707 from the National Science Foundation ( to J. D. A.), Grant 204/06/1558 from the Grant Agency of the Czech Republic, and Grants LC07032 and 2B06129 from the Czech Ministry of Education ( to J. L.).	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Copela LA, 2006, RNA, V12, P644, DOI 10.1261/rna.2307206; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; DELACRUZ VF, 1984, J BIOL CHEM, V259, P5136; Grosshans H, 2001, J BIOL CHEM, V276, P46333, DOI 10.1074/jbc.M107141200; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Johansson MJO, 2002, RNA, V8, P324, DOI 10.1017/S1355838202027851; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Kapushoc ST, 2000, J BIOL CHEM, V275, P37907, DOI 10.1074/jbc.M007838200; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Lauhon CT, 2002, J BACTERIOL, V184, P6820, DOI 10.1128/JB.184.24.6820-6829.2002; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Nilsson K, 2002, J BACTERIOL, V184, P6830, DOI 10.1128/JB.184.24.6830-6835.2002; Rubio MAT, 2005, TOP CURR GENET, V12, P71, DOI 10.1007/b106363; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; Smid O, 2006, J BIOL CHEM, V281, P28679, DOI 10.1074/jbc.M513781200; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200	32	35	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23947	23953		10.1074/jbc.M109.029421	http://dx.doi.org/10.1074/jbc.M109.029421			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574216	Green Published, hybrid			2022-12-27	WOS:000269380200008
J	Doz, E; Rose, S; Court, N; Front, S; Vasseur, V; Charron, S; Gilleron, M; Puzo, G; Fremaux, I; Delneste, Y; Erard, F; Ryffel, B; Martin, OR; Quesniaux, VFJ				Doz, Emilie; Rose, Stephanie; Court, Nathalie; Front, Sophie; Vasseur, Virginie; Charron, Sabine; Gilleron, Martine; Puzo, Germain; Fremaux, Isabelle; Delneste, Yves; Erard, Francois; Ryffel, Bernhard; Martin, Olivier R.; Quesniaux, Valerie F. J.			Mycobacterial Phosphatidylinositol Mannosides Negatively Regulate Host Toll-like Receptor 4, MyD88-dependent Proinflammatory Cytokines, and TRIF-dependent Co-stimulatory Molecule Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; MYO-INOSITOL MANNOSIDES; TRAP MASS-SPECTROMETRY; DC-SIGN; STRUCTURAL-CHARACTERIZATION; ACYLATION STATE; ELECTROSPRAY-IONIZATION; DENDRITIC CELLS; BOVIS BCG; TUBERCULOSIS	Mycobacterium tuberculosis modulates host immune responses through proteins and complex glycolipids. Here, we report that the glycosylphosphatidylinositol anchor phosphatidyl-myo-inositol hexamannosides PIM6 or PIM2 exert potent anti-inflammatory activities. PIM strongly inhibited the Toll-like receptor (TLR4) and myeloid differentiation protein 88 (MyD88)-mediated release of NO, cytokines, and chemokines, including tumor necrosis factor (TNF), interleukin 12 (IL-12) p40, IL-6, keratinocyte-derived chemokine, and also IL-10 by lipopolysaccharide (LPS)-activated macrophages. This effect was independent of the presence of TLR2. PIM also reduced the LPS-induced MyD88-independent, TIR domain-containing adaptor protein inducing interferon beta(TRIF)-mediated expression of co-stimulatory receptors. PIM inhibited LPS/TLR4-induced NF kappa B translocation. Synthetic PIM1 and a PIM2 mimetic recapitulated these in vitro activities and inhibited endotoxin-induced airway inflammation, TNF and keratinocyte-derived chemokine secretion, and neutrophil recruitment in vivo. Mannosyl, two acyl chains, and phosphatidyl residues are essential for PIM anti-inflammatory activity, whereas the inosityl moiety is dispensable. Therefore, PIM exert potent antiinflammatory effects both in vitro and in vivo that may contribute to the strategy developed by mycobacteria for repressing the host innate immunity, and synthetic PIM analogs represent powerful antiinflammatory leads.	[Doz, Emilie; Rose, Stephanie; Court, Nathalie; Front, Sophie; Vasseur, Virginie; Charron, Sabine; Erard, Francois; Ryffel, Bernhard; Quesniaux, Valerie F. J.] CNRS, MIE UMR6218, F-45071 Orleans 2, France; [Doz, Emilie; Rose, Stephanie; Court, Nathalie; Front, Sophie; Vasseur, Virginie; Charron, Sabine; Erard, Francois; Ryffel, Bernhard; Quesniaux, Valerie F. J.] Univ Orleans, F-45071 Orleans 2, France; [Martin, Olivier R.] Inst Chim Organ & Analyt, UMR6005, F-45071 Orleans, France; [Gilleron, Martine; Puzo, Germain] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Gilleron, Martine; Puzo, Germain] Univ Toulouse, F-31077 Toulouse, France; [Fremaux, Isabelle; Delneste, Yves] Ctr Rech Cancerol Nantes Angers, F-49933 Angers, France; [Fremaux, Isabelle; Delneste, Yves] Univ Angers, INSERM, U892, F-49933 Angers, France; [Delneste, Yves] Univ Hosp Angers, F-49933 Angers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Quesniaux, VFJ (corresponding author), CNRS, MIE UMR6218, 3B Rue Ferollerie, F-45071 Orleans 2, France.	quesniaux@cnrs-orleans.fr	DELNESTE, Yves/K-7367-2015; Delneste, Yves/O-3956-2016	DELNESTE, Yves/0000-0002-2142-596X; Doz-Deblauwe, Emilie/0000-0002-3126-4004; GILLERON, Martine/0000-0002-2581-3302	CNRS [ANR-05-MIIM-038-02, TB-SIGN]; European Union FEDER [1649-32264]	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union FEDER(European Commission)	This work was supported by CNRS, ANR-05-MIIM-038-02 Grant TB-SIGN, and European Union FEDER Grant 1649-32264.	Ainge GD, 2006, BIOORGAN MED CHEM, V14, P7615, DOI 10.1016/j.bmc.2006.07.003; Ainge GD, 2006, BIOORGAN MED CHEM, V14, P5632, DOI 10.1016/j.bmc.2006.04.037; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; Boonyarattanakalin S, 2008, J AM CHEM SOC, V130, P16791, DOI 10.1021/ja806283e; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; de Diego J, 1997, J IMMUNOL, V159, P4983; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Dyer BS, 2007, J ORG CHEM, V72, P3282, DOI 10.1021/jo0625599; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Heldwein KA, 2002, MICROBES INFECT, V4, P937, DOI 10.1016/S1286-4579(02)01611-8; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P466, DOI 10.1016/j.jasms.2006.10.012; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P479, DOI 10.1016/j.jasms.2006.10.020; ILANGUMARAN S, 1995, J IMMUNOL, V155, P1334; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Lefort J, 1998, J IMMUNOL, V161, P474; Liu XY, 2006, J AM CHEM SOC, V128, P3638, DOI 10.1021/ja0565368; Maeda N, 2003, J BIOL CHEM, V278, P5513, DOI 10.1074/jbc.C200586200; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pitarque S, 2005, BIOCHEM J, V392, P615, DOI 10.1042/BJ20050709; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Savoy F, 2006, IMMUNOBIOLOGY, V211, P767, DOI 10.1016/j.imbio.2006.06.001; Schnyder-Candrian S, 2005, J IMMUNOL, V175, P262, DOI 10.4049/jimmunol.175.1.262; SINGHGILL G, 2005, Patent No. 2005049631; Stadelmaier A, 2003, CARBOHYD RES, V338, P2557, DOI 10.1016/j.carres.2003.06.002; Stenger S, 2002, CURR OPIN IMMUNOL, V14, P452, DOI 10.1016/S0952-7915(02)00355-2; Stijlemans B, 2007, J IMMUNOL, V179, P4003, DOI 10.4049/jimmunol.179.6.4003; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Togbe D, 2007, EUR J IMMUNOL, V37, P768, DOI 10.1002/eji.200636371; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; VERCELLONE A, 1989, J BIOL CHEM, V264, P7447; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zajonc DM, 2006, J IMMUNOL, V177, P4577, DOI 10.4049/jimmunol.177.7.4577	58	53	54	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23187	23196		10.1074/jbc.M109.037846	http://dx.doi.org/10.1074/jbc.M109.037846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561082	hybrid, Green Published			2022-12-27	WOS:000269180000003
J	Longerich, S; Filippo, JS; Liu, DQ; Sung, P				Longerich, Simonne; Filippo, Joseph San; Liu, Dongqing; Sung, Patrick			FANCI Binds Branched DNA and Is Monoubiquitinated by UBE2T-FANCL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINK REPAIR; ANEMIA PATHWAY; UBIQUITIN LIGASE; FANCONIS ANEMIA; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; MITOSIS; SWITCH; BRCA1	FANCI is integral to the Fanconi anemia (FA) pathway of DNA damage repair. Upon the occurrence of DNA damage, FANCI becomes monoubiquitinated on Lys-523 and relocalizes to chromatin, where it functions with monoubiquitinated FANCD2 to facilitate DNA repair. We show that FANCI and its C-terminal fragment possess a DNA binding activity that prefers branched structures. We also demonstrate that FANCI can be ubiquitinated on Lys-523 by the UBE2T-FANCL pair in vitro. These findings should facilitate future efforts directed at elucidating molecular aspects of the FA pathway.	[Longerich, Simonne; Filippo, Joseph San; Liu, Dongqing; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Sung, P (corresponding author), 333 Cedar St, New Haven, CT 06520 USA.	patrick.sung@yale.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [PO1 CA92584, PO1 CA129186, RO1 ES015252]; NATIONAL CANCER INSTITUTE [P01CA129186, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 CA92584, PO1 CA129186, and RO1 ES015252.	Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; AUERBACH AD, 1988, BLOOD, V72, P366; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Dorsman JC, 2007, CELL ONCOL, V29, P211; GERMAN J, 1987, BLOOD, V69, P1637; Gurtan AM, 2006, DNA REPAIR, V5, P1119, DOI 10.1016/j.dnarep.2006.05.009; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Meetei AR, 2004, CELL CYCLE, V3, P179; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; POLL EHA, 1985, HUM GENET, V71, P206, DOI 10.1007/BF00284574; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Van Komen S, 2003, J BIOL CHEM, V278, P44331, DOI 10.1074/jbc.M307256200; Wang WD, 2008, NAT STRUCT MOL BIOL, V15, P1128, DOI 10.1038/nsmb1108-1128; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004	30	70	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23182	23186		10.1074/jbc.C109.038075	http://dx.doi.org/10.1074/jbc.C109.038075			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19589784	Green Published, hybrid			2022-12-27	WOS:000269180000002
J	Xiong, Y; Huo, YQ; Chen, C; Zeng, HY; Lu, XF; Wei, CL; Ruan, CG; Zhang, XY; Hu, ZQ; Shibuya, M; Luo, JC				Xiong, Yan; Huo, Yingqing; Chen, Chao; Zeng, Huiyan; Lu, Xiaofan; Wei, Chaoliang; Ruan, Changgeng; Zhang, Xiaoyu; Hu, Zhenqian; Shibuya, Masabumi; Luo, Jincai			Vascular Endothelial Growth Factor (VEGF) Receptor-2 Tyrosine 1175 Signaling Controls VEGF-induced von Willebrand Factor Release from Endothelial Cells via Phospholipase C-gamma 1-and Protein Kinase A-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEIBEL-PALADE BODIES; VONWILLEBRAND-FACTOR; ACTIVATION; ANGIOGENESIS; MIGRATION; PERMEABILITY; BARRIER; AUTOPHOSPHORYLATION; PROLIFERATION; INHIBITION	There is increasing evidence that vascular endothelial growth factor (VEGF) contributes to inflammation independent of its angiogenic functions. Targeting some of the components in endothelial Weibel-Palade bodies (WPBs) effectively inhibits VEGF-induced inflammation, but little is known about how VEGF regulates WPB exocytosis. In this study, we showed that VEGF receptor-2 (VEGFR2), but not VEGFR1, is responsible for VEGF-induced release of von Willebrand factor (vWF), a major marker of WPBs. This is in good contrast to VEGF-stimulated interleukin-6 release from endothelium, which is selectively mediated through VEGFR1. We further demonstrated that VEGFR2-initiated phospholipase C-gamma 1 (PLC gamma 1)/calcium signaling is important but insufficient for full vWF release, suggesting the possible participation of another effector pathway. We found that cAMP/protein kinase A (PKA) signaling is required for full vWF release. Importantly, a single mutation of Tyr(1175) in the C terminus of VEGFR2, a tyrosine residue crucial for embryonic vasculogenesis, abolished vWF release, concomitant with defective activations of both PLC gamma 1 and PKA. These data suggest that Tyr(1175) mediates both PLC gamma 1-dependent and PKA-dependent signaling pathways. Taken together, our results not only reveal a novel Tyr(1175)-mediated signaling pathway but also highlight a potentially new therapeutic target for the management of vascular inflammation.	[Xiong, Yan; Huo, Yingqing; Chen, Chao; Lu, Xiaofan; Zhang, Xiaoyu; Hu, Zhenqian; Luo, Jincai] Peking Univ, Inst Mol Med, Lab Vasc Biol, Beijing 10087, Peoples R China; [Wei, Chaoliang] Peking Univ, Inst Mol Med, Lab Calcium Signaling, Beijing 10087, Peoples R China; [Zeng, Huiyan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Ruan, Changgeng] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Jiangsu, Peoples R China; [Shibuya, Masabumi] Tokyo Med & Dent Univ, Dept Mol Oncol, Tokyo 2720827, Japan	Peking University; Peking University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Soochow University - China; Tokyo Medical & Dental University (TMDU)	Luo, JC (corresponding author), Peking Univ, Inst Mol Med, Lab Vasc Biol, New Life Sci Bldg,Rm 234, Beijing 100871, Peoples R China.	jincailuo@pku.edu.cn	Zhang, xiaoyu/GXA-3206-2022; Wei, Chaoliang/A-9008-2013; Jin Cai, Luo/A-7900-2011	, Yan/0000-0003-2339-130X	National Science Funds [30671030, 90607004]; Major State Basic Research Development Programs of China [2007CB512100]	National Science Funds; Major State Basic Research Development Programs of China(National Basic Research Program of China)	This work was supported in part by National Science Funds Grants 30671030 and 90607004 and the Major State Basic Research Development Programs of China Grant 2007CB512100.	Babich V, 2008, BLOOD, V111, P5282, DOI 10.1182/blood-2007-09-113746; Berger R, 2006, CANCER RES, V66, P5723, DOI 10.1158/0008-5472.CAN-05-3928; Bhushan M, 1999, BRIT J DERMATOL, V141, P1054, DOI 10.1046/j.1365-2133.1999.03205.x; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; Brockington A, 2004, NEUROPATH APPL NEURO, V30, P427, DOI 10.1111/j.1365-2990.2004.00600.x; BROWN LF, 1995, J INVEST DERMATOL, V104, P744, DOI 10.1111/1523-1747.ep12606974; CAREW MA, 1992, BIOCHEM J, V286, P631, DOI 10.1042/bj2860631; Desloges N, 2008, MED MICROBIOL IMMUN, V197, P353, DOI 10.1007/s00430-007-0068-8; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lorenzi O, 2008, J THROMB HAEMOST, V6, P1962, DOI 10.1111/j.1538-7836.2008.03138.x; Ma YF, 2005, J BIOL CHEM, V280, P26011, DOI 10.1074/jbc.M409081200; Mahadev K, 2008, CARDIOVASC RES, V78, P376, DOI 10.1093/cvr/cvn034; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Matsushita K, 2005, BLOOD, V105, P207, DOI 10.1182/blood-2004-04-1519; Meyer RD, 2002, J BIOL CHEM, V277, P27081, DOI 10.1074/jbc.M110544200; Mirzapoiazova T, 2006, AM J PHYSIOL-LUNG C, V291, pL718, DOI 10.1152/ajplung.00014.2006; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Pickkers P, 2005, SHOCK, V24, P508, DOI 10.1097/01.shk.0000190827.36406.6e; Rahimi N, 2006, EXP EYE RES, V83, P1005, DOI 10.1016/j.exer.2006.03.019; Reinders MEJ, 2003, J CLIN INVEST, V112, P1655, DOI 10.1172/JCI200317712; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; SADLER JE, 1991, ANN NY ACAD SCI, V614, P114; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; WAGNER DD, 1993, THROMB HAEMOSTASIS, V70, P105; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; Wong R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-15; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200; ZHOU QS, 1992, THROMB RES, V68, P109, DOI 10.1016/0049-3848(92)90026-7	44	43	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23217	23224		10.1074/jbc.M109.019679	http://dx.doi.org/10.1074/jbc.M109.019679			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570985	Green Published, hybrid			2022-12-27	WOS:000269180000006
J	Keshwani, MM; Gao, XX; Harris, TK				Keshwani, Malik M.; Gao, Xinxin; Harris, Thomas K.			Mechanism of PDK1-catalyzed Thr-229 Phosphorylation of the S6K1 Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BINDING POCKET; DOCKING SITE; B ALPHA; ACTIVATION; PDK1; EXPRESSION; 3-KINASE; DOMAIN; IDENTIFICATION	PDK1 (phosphoinositide-dependent protein kinase-1) catalyzes phosphorylation of Thr-229 in the T-loop of S6K1 alpha II (the 70-kDa 40 S ribosomal protein S6 kinase-1 alpha II isoform), and Thr-229 phosphorylation is synergistic with C-terminal Thr-389 phosphorylation to activate S6K1 alpha II regulatory functions in protein translation preinitiation complexes. Unlike its common AGC kinase subfamily member S6K1 alpha II, PDK1 does not contain the synergistic C-terminal phosphorylation site, and it has been proposed that phosphorylated Thr-389 in S6K1 alpha II may initially serve to trans-activate PDK1-catalyzed Thr-229 phosphorylation. Herein, we report direct binding and kinetic studies that showed PDK1 to exhibit nearly equal binding affinities and steady-state kinetic turnover numbers toward native (K-d(S6K1) = 1.2 mu M and k(cat) = 1.1 s(-1)) and the phosphomimicking T389E mutant S6K1 alpha II (K-d(S6K1) = 1.5 mu M and k(cat) = 1.2 s(-1)), although similar to 2-fold enhanced specificity was displayed for the T389E mutant (k(cat)/K-m(S6K1) = 0.08 mu M-1 s(-1) compared with 0.04 mu M-1 s(-1)). Considering that transient kinetic binding studies showed all nucleotide and S6K1 alpha II substrates and products to rapidly associate with PDK1 (k(on) = 1-6 mu M-1 s(-1)), it was concluded that positioning a negative charge at residue Thr389 reduced similar to 2-fold the occurrence of nonproductive binding events that precede formation of a reactive ternary complex for Thr-229 phosphorylation. In addition, steady-state kinetic data were most simply accommodated by an Ordered Bi Bi mechanism with competitive substrate inhibition, where (i) the initially formed PDK1-ATP complex phosphorylates the nucleotide-free form of the S6K1 alpha II kinase and (ii) initial binding of S6K1 alpha II precludes ATP binding to PDK1.	[Gao, Xinxin; Harris, Thomas K.] Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, Miami, FL 33136 USA; [Keshwani, Malik M.; Harris, Thomas K.] Univ Miami, Dept Chem, Coral Gables, FL 33124 USA	University of Miami; University of Miami	Harris, TK (corresponding author), Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, POB 016129, Miami, FL 33101 USA.	tkharris@miami.edu	Gao, Xinxin/D-3795-2009		National Institutes of Health; NIGMS [GM69868]; Maytag Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Maytag Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant GM69868 (to T. K. H.). This work was also supported by a Maytag Fellowship (to M. M. K.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Balendran A, 1999, J BIOL CHEM, V274, P37400, DOI 10.1074/jbc.274.52.37400; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; FERRARI S, 1992, P NATL ACAD SCI USA, V89, P7282, DOI 10.1073/pnas.89.15.7282; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Keshwani MM, 2008, J BIOL CHEM, V283, P11972, DOI 10.1074/jbc.M800114200; Keshwani MM, 2008, PROTEIN EXPRES PURIF, V58, P32, DOI 10.1016/j.pep.2007.11.003; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; SEGAL IH, 1975, ENZYME KINETICS; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Torbett NE, 2003, J BIOL CHEM, V278, P32344, DOI 10.1074/jbc.M303532200; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; WENG QP, 1995, MOL CELL BIOL, V15, P2333	39	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22611	22624		10.1074/jbc.M109.032177	http://dx.doi.org/10.1074/jbc.M109.032177			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19570988	Green Published, hybrid			2022-12-27	WOS:000268963100014
J	Liu, XS; Chopp, M; Zhang, RL; Hozeska-Solgot, A; Gregg, SC; Buller, B; Lu, M; Zhang, ZG				Liu, Xian Shuang; Chopp, Michael; Zhang, Rui Lan; Hozeska-Solgot, Ann; Gregg, Sara C.; Buller, Ben; Lu, Mei; Zhang, Zheng Gang			Angiopoietin 2 Mediates the Differentiation and Migration of Neural Progenitor Cells in the Subventricular Zone after Stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; ADULT MAMMALIAN FOREBRAIN; ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; IN-VIVO; NEUROBLAST MIGRATION; INDUCED NEUROGENESIS; SUBEPENDYMAL CELLS; RECEPTOR-BINDING	Ischemic stroke stimulates neurogenesis in the adult rodent brain. The molecules underlying stroke-induced neurogenesis have not been fully investigated. Using real-time reverse transcription-PCR, we found that stroke substantially up-regulated angiopoietin 2 (ANG2), a proangiogenic gene, expression in subventricular zone neural progenitor cells. Incubation of neural progenitor cells with recombinant human ANG2 significantly increased the number of beta-III tubulin-positive cells, a marker of immature neurons, but did not alter the number of glial fibrillary acidic protein (GFAP)-positive cells, a marker of astrocytes, suggesting that ANG2 promotes neuronal differentiation. Blockage of the ANG2 receptor, Tie2, with small interference RNA (siRNA)-Tie2 attenuated recombinant human ANG2 (rhANG2)-increased beta-III tubulin mRNA levels compared with levels in the progenitor cells transfected with control siRNA. Chromatin immunoprecipitation analysis revealed that CCAAT/enhancer-binding protein (C/EBP beta) up-regulated by rhANG2 bound to beta-III tubulin, which is consistent with published data that there are several C/EBP beta binding sites in the promoter of beta-III tubulin gene. In addition, rhANG2 enhanced migration of neural progenitor cells measured by single neurosphere assay. Blockage of Tie2 with siRNA-Tie2 and a Tie2-neutralizing antibody did not suppress ANG2-enhanced migration. However, inhibition of matrix metalloproteinases with GM6001 blocked ANG2-enhanced migration. Collectively, our data suggest that interaction of ANG2, a proangiogenic factor, with its receptor Tie2 promotes neural progenitor cell differentiation into neuronal lineage cells, whereas ANG2 regulates neural progenitor cell migration through matrix metalloproteinases, which do not require its receptor Tie2.	[Liu, Xian Shuang; Chopp, Michael; Zhang, Rui Lan; Hozeska-Solgot, Ann; Gregg, Sara C.; Buller, Ben; Zhang, Zheng Gang] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Chopp, Michael; Buller, Ben] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University	Zhang, ZG (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		National Institutes of Health [PO1 NS23393, PO1 NS42345, RO1 HL064766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042345, P01NS023393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 NS23393, PO1 NS42345, and RO1 HL064766.	Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Calella AM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-4; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Davis S, 2003, NAT STRUCT BIOL, V10, P38, DOI 10.1038/nsb880; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Katakowski M, 2005, NEUROSCI LETT, V385, P204, DOI 10.1016/j.neulet.2005.05.060; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Liu XS, 2007, J CEREBR BLOOD F MET, V27, P564, DOI 10.1038/sj.jcbfm.9600371; Liu XS, 2007, J NEUROSCI RES, V85, P2120, DOI 10.1002/jnr.21359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Luskin MB, 1998, J NEUROBIOL, V36, P221; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mao Y, 1999, MOL BRAIN RES, V63, P366, DOI 10.1016/S0169-328X(98)00271-X; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Reznikov K, 1997, DEV DYNAM, V210, P328, DOI 10.1002/(SICI)1097-0177(199711)210:3<328::AID-AJA12>3.0.CO;2-6; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Sterneck E, 1998, J NEUROCHEM, V70, P2424; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Uittenbogaard M, 2007, J NEUROSCI RES, V85, P1, DOI 10.1002/jnr.21093; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wang RG, 2002, ACTA PHARMACOL SIN, V23, P405; Weber CC, 2005, J BIOL CHEM, V280, P22445, DOI 10.1074/jbc.M410367200; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang RL, 2007, J CEREBR BLOOD F MET, V27, P1201, DOI 10.1038/sj.jcbfm.9600430; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhu YQ, 2005, STROKE, V36, P1533, DOI 10.1161/01.STR.0000170712.46106.2e	71	73	75	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22680	22689		10.1074/jbc.M109.006551	http://dx.doi.org/10.1074/jbc.M109.006551			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553662	Green Published, hybrid			2022-12-27	WOS:000268963100022
J	John, CM; Liu, MF; Jarvis, GA				John, Constance M.; Liu, Mingfeng; Jarvis, Gary A.			Natural Phosphoryl and Acyl Variants of Lipid A from Neisseria meningitidis Strain 89I Differentially Induce Tumor Necrosis Factor-alpha in Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIMULUS AMEBOCYTE LYSATE; MASS-SPECTROMETRY; BIOLOGICAL-ACTIVITIES; EPITHELIAL-CELLS; HUMAN MD-2; LIPOOLIGOSACCHARIDES; LIPOPOLYSACCHARIDES; GONORRHOEAE; DISEASE; BINDING	The native lipooligosaccharide (LOS) from Neisseria meningitidis strain 89I was analyzed by matrix-assisted laser desorption ionization (MALDI) time-of-flight (TOF) mass spectrometry and the spectrum compared with that of the LOS after O-deacylation and hydrogen fluoride treatment. The data are consistent with the presence of natural variations in the LOS, which include a triphosphorylated lipidA(LA) with and without a phosphoethanolamine group, and both hexa-and pentaacylated LA molecules. Thin-layer chromatography was performed on 89I LA produced by hydrolysis of the LOS, and the purified LA molecules were analyzed by MALDI-TOF and tested for their relative ability to induce the secretion of tumor necrosis factor-alpha by human monocytic THP-1 cells and primary human monocytes. The potency of tumor necrosis factor-alpha induction varied by similar to 2-10-fold, depending on the state of acylation and phosphorylation. The results highlight the significance of phosphorylation along with acylation of the LA component of LOS in stimulation of inflammatory signaling, and suggest that natural strain variation in these moieties may be a feature of meningococcal bacteria, which is of critical importance to the progression of the infection.	[John, Constance M.; Liu, Mingfeng; Jarvis, Gary A.] Vet Affairs Med Ctr, Ctr Immunochem, San Francisco, CA 94121 USA; [Liu, Mingfeng; Jarvis, Gary A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Jarvis, GA (corresponding author), Vet Affairs Med Ctr, Ctr Immunochem, Dept 111W1,4150 Clement St, San Francisco, CA 94121 USA.	Gary.Jarvis@ucsf.edu		Jarvis, Gary/0000-0002-7576-3702	National Institutes of Health NIAID [AI063927]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063927] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health NIAID Grant AI063927 from the United States Public Health Service. This work was also supported by the Department of Veterans Affairs, Veterans Health Administration Office of Biomedical Laboratory Research and Development. This is paper number 105 from the Center for Immunochemistry.	Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; APICELLA MA, 1994, METHOD ENZYMOL, V235, P242; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Chesson HW, 2000, J ACQ IMMUN DEF SYND, V24, P48; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Harvey HA, 2000, MOL MICROBIOL, V36, P1059, DOI 10.1046/j.1365-2958.2000.01938.x; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Jones JW, 2008, P NATL ACAD SCI USA, V105, P12742, DOI 10.1073/pnas.0800445105; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; Kundi M, 2007, EXPERT REV VACCINES, V6, P133, DOI 10.1586/14760584.6.2.133; LOPPNOW H, 1989, J IMMUNOL, V142, P3229; MANDRELL RE, 1991, J BACTERIOL, V173, P2823, DOI 10.1128/JB.173.9.2823-2832.1991; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Paavonen J, 1998, DERMATOL CLIN, V16, P747, DOI 10.1016/S0733-8635(05)70041-3; Post DMB, 2002, INFECT IMMUN, V70, P909, DOI 10.1128/IAI.70.2.909-920.2002; Pridmore AC, 2003, INFECT IMMUN, V71, P3901, DOI 10.1128/IAI.71.7.3901-3908.2003; Quan DN, 2008, MUCOSAL IMMUNOL, V1, P229, DOI 10.1038/mi.2008.1; Que NLS, 2000, J BIOL CHEM, V275, P28006; QURESHI N, 1982, J BIOL CHEM, V257, P1808; Rebeil R, 2006, J BACTERIOL, V188, P1381, DOI 10.1128/JB.188.4.1381-1388.2006; ROTH RI, 1992, INFECT IMMUN, V60, P762, DOI 10.1128/IAI.60.3.762-767.1992; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Schromm AB, 1998, J IMMUNOL, V161, P5464; Seydel U, 2000, CHEM IMMUNOL, V74, P5; Shin HJ, 2007, MOL CELLS, V24, P119; Silipo A, 2007, CHEM-EUR J, V13, P3501, DOI 10.1002/chem.200601406; Sturiale L, 2005, RAPID COMMUN MASS SP, V19, P1829, DOI 10.1002/rcm.1994; TAKAYAMA K, 1986, J BIOL CHEM, V261, P624; TAKAYAMA K, 1984, INFECT IMMUN, V45, P350, DOI 10.1128/IAI.45.2.350-355.1984; TANAMOTO K, 1984, INFECT IMMUN, V44, P421, DOI 10.1128/IAI.44.2.421-426.1984; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Zimmer SM, 2007, GLYCOBIOLOGY, V17, P847, DOI 10.1093/glycob/cwm057	39	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21515	21525		10.1074/jbc.M109.004887	http://dx.doi.org/10.1074/jbc.M109.004887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531474	Green Published, hybrid			2022-12-27	WOS:000268564400046
J	Ortega, X; Silipo, A; Saldfas, MS; Bates, CC; Molinaro, A; Valvano, MA				Ortega, Ximena; Silipo, Alba; Saldfas, M. Soledad; Bates, Christa C.; Molinaro, Antonio; Valvano, Miguel A.			Biosynthesis and Structure of the Burkholderia cenocepacia K56-2 Lipopolysaccharide Core Oligosaccharide TRUNCATION OF THE CORE OLIGOSACCHARIDE LEADS TO INCREASED BINDING AND SENSITIVITY TO POLYMYXIN B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMYXIN-B RESISTANCE; SURVIVAL IN-VIVO; ESCHERICHIA-COLI; INTRACELLULAR SURVIVAL; CEPACIA COMPLEX; PSEUDOMONAS-CEPACIA; EPITHELIAL-CELLS; CYSTIC-FIBROSIS; LIPID-A; SALMONELLA-TYPHIMURIUM	Burkholderia cenocepacia is an opportunistic pathogen that displays a remarkably high resistance to antimicrobial peptides. We hypothesize that high resistance to antimicrobial peptides in these bacteria is because of the barrier properties of the outer membrane. Here we report the identification of genes for the biosynthesis of the core oligosaccharide (OS) moiety of the B. cenocepacia lipopolysaccharide. We constructed a panel of isogenic mutants with truncated core OS that facilitated functional gene assignments and the elucidation of the core OS structure in the prototypic strain K56-2. The core OS structure consists of three heptoses in the inner core region, 3-deoxy-D-manno-octulosonic acid, D-glycero-D-talo-octulosonic acid, and 4-amino-4-deoxy-L-arabinose linked to D-glycero-D-talo-octulosonic acid. Also, glucose is linked to heptose I, whereas heptose II carries a second glucose and a terminal heptose, which is the site of attachment of the O antigen. We established that the level of core truncation in the mutants was proportional to their increased in vitro sensitivity to polymyxin B (PmB). Binding assays using fluorescent 5-dimethylaminonaphthalene-1-sulfonyl-labeled PmB demonstrated a correlation between sensitivity and increased binding of PmB to intact cells. Also, the mutant producing a heptoseless core OS did not survive in macrophages as compared with the parental K56-2 strain. Together, our results demonstrate that a complete core OS is required for full PmB resistance in B. cenocepacia and that resistance is due, at least in part, to the ability of B. cenocepacia to prevent binding of the peptide to the bacterial cell envelope.	[Ortega, Ximena; Saldfas, M. Soledad; Bates, Christa C.; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, Infect Dis Res Grp, London, ON N6A 5C1, Canada; [Valvano, Miguel A.] Univ Western Ontario, Dept Med, London, ON N6A 5C1, Canada; [Silipo, Alba; Molinaro, Antonio] Univ Naples Federico 2, Dipartimento Chim Organ & Biochim, I-80126 Naples, Italy	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Naples Federico II	Valvano, MA (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, Infect Dis Res Grp, Dent Sci Bldg 3014, London, ON N6A 5C1, Canada.	mvalvano@uwo.ca	Silipo, Alba/L-5929-2014; Molinaro, Antonio/J-1866-2012; Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641; Molinaro, Antonio/0000-0002-3456-7369; silipo, alba/0000-0002-5394-6532	Canadian Cystic Fibrosis Foundation; Italian Cystic Fibrosis Foundation Grant [FFC 8/2007]	Canadian Cystic Fibrosis Foundation; Italian Cystic Fibrosis Foundation Grant(Italian Cystic Fibrosis Research Foundation)	This work was supported in part by grants from the Canadian Cystic Fibrosis Foundation (to M. A. V.) and the Italian Cystic Fibrosis Foundation Grant FFC 8/2007, Furla Spa, GSV Spa, Delegazione FFC di Bologna (to A. M.).	Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Arjcharoen S, 2007, INFECT IMMUN, V75, P4298, DOI 10.1128/IAI.00285-07; BADER J, 1973, Z NATURFORSCH C, VC 28, P422; Baird RM, 1999, IMMUNOPHARMACOLOGY, V44, P267, DOI 10.1016/S0162-3109(99)00122-8; Balandreau J, 2001, APPL ENVIRON MICROB, V67, P982, DOI 10.1128/AEM.67.2.982-985.2001; BIRNBAUM GI, 1987, J CARBOHYD CHEM, V6, P17, DOI 10.1080/07328308708058858; BOCK K, 1994, EUR J BIOCHEM, V225, P1029, DOI 10.1111/j.1432-1033.1994.1029b.x; Burns JL, 1996, INFECT IMMUN, V64, P4054, DOI 10.1128/IAI.64.10.4054-4059.1996; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; COX AD, 1991, MOL MICROBIOL, V5, P641, DOI 10.1111/j.1365-2958.1991.tb00735.x; CRAIG FF, 1989, J GEN MICROBIOL, V135, P2885; Devine DA, 2003, MOL IMMUNOL, V40, P431, DOI 10.1016/S0161-5890(03)00162-7; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flannagan RS, 2008, MICROBIOL-SGM, V154, P643, DOI 10.1099/mic.0.2007/013714-0; Flannagan RS, 2007, INFECT IMMUN, V75, P1679, DOI 10.1128/IAI.01581-06; Gronow S, 2003, J BIOL CHEM, V278, P1647, DOI 10.1074/jbc.M206942200; Hoare A, 2006, INFECT IMMUN, V74, P1555, DOI 10.1128/IAI.74.3.1555-1564.2006; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; Holst O, 2007, FEMS MICROBIOL LETT, V271, P3, DOI 10.1111/j.1574-6968.2007.00708.x; Isshiki Y, 2003, CARBOHYD RES, V338, P2659, DOI 10.1016/j.carres.2003.07.005; Isshiki Y, 1998, CARBOHYD RES, V313, P21, DOI 10.1016/S0008-6215(98)00179-7; Keith KE, 2009, MICROBIOL-SGM, V155, P1004, DOI 10.1099/mic.0.026781-0; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Loutet SA, 2009, MICROBIOL-SGM, V155, P2029, DOI 10.1099/mic.0.027607-0; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; MAROLDA CL, 1990, J BACTERIOL, V172, P3590, DOI 10.1128/jb.172.7.3590-3599.1990; Marolda CL, 1999, MICROBIOL-SGM, V145, P1509, DOI 10.1099/13500872-145-7-1509; Masoud H, 2009, GLYCOBIOLOGY, V19, P462, DOI 10.1093/glycob/cwn155; Molinaro A, 2003, CHEM-EUR J, V9, P1542, DOI 10.1002/chem.200390177; Molinaro A, 2002, J BIOL CHEM, V277, P10058, DOI 10.1074/jbc.M110283200; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; MOORE RA, 1986, ANTIMICROB AGENTS CH, V30, P923, DOI 10.1128/AAC.30.6.923; Ortega X, 2005, J BACTERIOL, V187, P1324, DOI 10.1128/JB.187.4.1324-1333.2005; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Perez JM, 2008, MOL MICROBIOL, V70, P1424, DOI 10.1111/j.1365-2958.2008.06490.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Sahly H, 2003, ANTIMICROB AGENTS CH, V47, P1739, DOI 10.1128/AAC.47.5.1739-1741.2003; Saini LS, 1999, MICROBIOL-UK, V145, P3465, DOI 10.1099/00221287-145-12-3465; Saldias MS, 2008, INFECT IMMUN, V76, P1059, DOI 10.1128/IAI.01167-07; SCHINDLER PRG, 1975, ANTIMICROB AGENTS CH, V8, P95, DOI 10.1128/AAC.8.1.95; Silipo A, 2005, GLYCOBIOLOGY, V15, P561, DOI 10.1093/glycob/cwi029; Silipo A, 2007, CHEM-EUR J, V13, P3501, DOI 10.1002/chem.200601406; SPEERT DP, 1994, J INFECT DIS, V170, P1524, DOI 10.1093/infdis/170.6.1524; Via LE, 1998, J CELL SCI, V111, P897; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	56	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21738	21751		10.1074/jbc.M109.008532	http://dx.doi.org/10.1074/jbc.M109.008532			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19525227	Green Published, hybrid			2022-12-27	WOS:000268564400066
